PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brener, MI; Kaslow, SR				Brener, Michael I.; Kaslow, Sarah R.			Where Do the Children Play?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Brener, Michael I.] Columbia Univ, New York Presbyterian Hosp, Med Ctr, Div Cardiol,Dept Med, New York, NY 10032 USA; [Kaslow, Sarah R.] NYU, Dept Surg, Brooklyn, NY USA	Columbia University; NewYork-Presbyterian Hospital; New York University	Brener, MI (corresponding author), Columbia Univ, New York Presbyterian Hosp, Med Ctr, Div Cardiol,Dept Med, New York, NY 10032 USA.			Brener, Michael/0000-0002-2606-055X; Kaslow, Sarah/0000-0002-2179-6787				[Anonymous], 2019, RESULTS DATA 2019 MA; Farley L, 2012, PSYCHOANAL HIST, V14, P29, DOI 10.3366/pah.2012.0098	2	1	1	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2020	383	6							e35	10.1056/NEJMp2011100	http://dx.doi.org/10.1056/NEJMp2011100			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NB3TI	32459914	Bronze			2022-12-28	WOS:000560438400001
J	Larochelle, MR				Larochelle, Marc R.			"Is It Safe for Me to Go to Work?" Risk Stratification for Workers during the Covid-19 Pandemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A strategy to protect at-risk workers requires a framework for counseling patients about the risks posed by continuing to work, policy changes to ensure financial protections for people kept out of work, and a data-driven plan for safe reentry into the workforce.	[Larochelle, Marc R.] Boston Univ, Sch Med, Dept Med, Sect Gen Internal Med, Boston, MA 02118 USA; [Larochelle, Marc R.] Boston Med Ctr, Boston, MA 02118 USA	Boston University; Boston Medical Center	Larochelle, MR (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Gen Internal Med, Boston, MA 02118 USA.; Larochelle, MR (corresponding author), Boston Med Ctr, Boston, MA 02118 USA.							CDC COVID-19 Response Team, 2020, MMWR Morb Mortal Wkly Rep, V69, P477, DOI 10.15585/mmwr.mm6915e6; Folgueira MD, 2020, DELGADO R SARS COV 2; Himmelstein KEW, 2019, AM J PUBLIC HEALTH, V109, P198, DOI 10.2105/AJPH.2018.304801; The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WEEKLY FEB; United States Department of Health and Human Services, 2020, COR DIS 2019 COVID 1	5	45	47	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2020	383	5							e28	10.1056/NEJMp2013413	http://dx.doi.org/10.1056/NEJMp2013413			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MW2GI	32453518	Bronze			2022-12-28	WOS:000556861800003
J	Puras, D; de Mesquita, JB; Cabal, L; Maleche, A; Meier, BM				Puras, Dainius; de Mesquita, Judith Bueno; Cabal, Luisa; Maleche, Allan; Meier, Benjamin Mason			The right to health must guide responses to COVID-19	LANCET			English	Editorial Material									[Puras, Dainius] Vilnius Univ, Clin Psychiat, Fac Med, Vilnius, Lithuania; [de Mesquita, Judith Bueno] Univ Essex, Sch Law, Colchester CO4 3SQ, Essex, England; [de Mesquita, Judith Bueno] Univ Essex, Human Rights Ctr, Colchester CO4 3SQ, Essex, England; [Cabal, Luisa] UNAIDS, Geneva, Switzerland; [Maleche, Allan] Kenya Legal & Ethical Issues Network HIV & AIDS, Nairobi, Kenya; [Meier, Benjamin Mason] Univ N Carolina, Dept Publ Policy, Chapel Hill, NC 27515 USA	Vilnius University; University of Essex; University of Essex; UNAIDS; University of North Carolina; University of North Carolina Chapel Hill	de Mesquita, JB (corresponding author), Univ Essex, Sch Law, Colchester CO4 3SQ, Essex, England.; de Mesquita, JB (corresponding author), Univ Essex, Human Rights Ctr, Colchester CO4 3SQ, Essex, England.	jrbuen@essex.ac.uk						Council of Europe Commissioner for Human Rights, 2020, LEARN PAND BETT FULF; Global Health Law Committee of the International Law Association, 2020, STAT GLOB HLTH LAW C; Gostin LO, 2018, LANCET, V392, P2731, DOI 10.1016/S0140-6736(18)32997-0; Kenya Legal & Ethical Issues Network on HIV & AIDS Katiba Institute African Institute for Children Studies, 2020, ADV NOT ENS RIGHTS B; Leask M, 2022, ED ALL TIMES CRISIS; Meier Benjamin Mason, 2020, FDN GLOBAL HLTH HUMA, P155; Puras D, 2020, EXPERTS SAY     0326; Thomson M, 2017, PUBLIC HEALTH REV, V38, DOI 10.1186/s40985-017-0059-2; UN Committee on Economic Social and Cultural Rights, 2020, STAT COR DIS COVID 1; UN Secretary-General, 2020, OP REM COVID 19 PAND; UN Sustainable Development Group, 2020, UN FRAM IMM SOC RESP; UNAIDS, 2020, UN PEOPL VACC COVID; United Nations Commission on Human Rights American Association for the International Commission of Jurists (AAICJ), 1985, SIR PRINC LIM DER PR; United Nations Office for the Coordination of Humanitarian Affairs, 2020, GLOB HUM RESP PLAN C; World Health Organization, 2020, ADDR HUM RIGHTS KEY	15	24	24	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2020	395	10241					1888	1890		10.1016/S0140-6736(20)31255-1	http://dx.doi.org/10.1016/S0140-6736(20)31255-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2MV	32479828	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000552732200008
J	Haynes, RB; del Fiol, G; Michelson, M; Iorio, A				Haynes, R. Brian; del Fiol, Guilherme; Michelson, Matthew; Iorio, Alfonso			Context and Approach in Reporting Evaluations of Electronic Health Record-Based Implementation Projects	ANNALS OF INTERNAL MEDICINE			English	Article							INFORMATION-TECHNOLOGY; INTERVENTIONS	Electronic health records (EHRs) are ubiquitous yet still evolving, resulting in a moving target for determining the effects of context (features of the work environment, such as organization, payment systems, user training, and roles) on EHR implementation projects. Electronic health records have become instrumental in effecting quality improvement innovations and providing data to evaluate them. However, reports of studies typically fail to provide adequate descriptions of contextual details to permit readers to apply the findings. As for any evaluation, the quality of reporting is essential to learning from, and disseminating, the results. Extensive guidelines exist for reporting of virtually all types of applied health research, but they are not tailored to capture some contextual factors that may affect the outcomes of EHR implementations, such as attitudes toward implementation, format and amount of training, post go-live support, amount of local customization, and time diverted from direct interaction with patients to computers. Nevertheless, evaluators of EHR-based innovations can choose reporting guidelines that match the general purpose of their evaluation and the stage of their investigation (planning, protocol, execution, and analysis) and should report relevant contextual details (including, if pertinent, any pressures to help justify the huge investments and many years required for some implementations). Reporting guidelines are based on the scientific principles and practices that underlie sound research and should be consulted from the earliest stages of planning evaluations and onward, serving as guides for how evaluations should be conducted as well as reported.	[Haynes, R. Brian; Iorio, Alfonso] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hlth Informat Res Unit, 1280 Main St West,CRL 133, Hamilton, ON L8S 4K1, Canada; [del Fiol, Guilherme] Univ Utah, Dept Biomed Informat, 421 Wakara Way,Suite 140, Salt Lake City, UT 84108 USA; [Michelson, Matthew] Evid Sci, 2361 Rosecrans Ave,348, El Segundo, CA 90245 USA	McMaster University; Utah System of Higher Education; University of Utah	Haynes, RB (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hlth Informat Res Unit, 1280 Main St West,CRL 133, Hamilton, ON L8S 4K1, Canada.	bhaynes@mcmaster.ca						Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Colicchio TK, 2017, J BIOMED INFORM, V73, P62, DOI 10.1016/j.jbi.2017.07.014; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Flanders WD, 2017, AM J EPIDEMIOL, V185, P941, DOI 10.1093/aje/kwx013; Fleurence RL, 2014, J AM MED INFORM ASSN, V21, P578, DOI 10.1136/amiajnl-2014-002747; Glasgow RE, 2001, PATIENT EDUC COUNS, V44, P119, DOI 10.1016/S0738-3991(00)00186-5; Groenwold RHH, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0634-3; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Hripcsak G, 2018, J AM MED INFORM ASSN, V25, P289, DOI 10.1093/jamia/ocx110; Jones SS, 2014, ANN INTERN MED, V160, P48, DOI 10.7326/M13-1531; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Ogrinc Greg, 2016, BMJ Qual Saf, V25, P986, DOI 10.1136/bmjqs-2015-004411; Overhage JM, 2012, J AM MED INFORM ASSN, V19, P54, DOI 10.1136/amiajnl-2011-000376; Pinnock H, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6795; Pronovost P, 2018, PROCURING INTEROPERA, P1; Ratwani RM, 2018, JAMA-J AM MED ASSOC, V320, P2533, DOI 10.1001/jama.2018.14079; Reed JE, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3348-7; ROSHANOV PS, 2013, BMJ-BRIT MED J, V346, DOI [DOI 10.1136/BMJ.F657, 10.1136/bmj.f657]; Rudin RS, 2014, AM J MANAG CARE, V20, peSP1; Wright A, 2018, J AM MED INFORM ASSN, V25, P496, DOI 10.1093/jamia/ocx106	20	6	6	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2020	172			11			S73	S78		10.7326/M19-0874	http://dx.doi.org/10.7326/M19-0874			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MH8ZH	32479174				2022-12-28	WOS:000547009900002
J	Dyer, O				Dyer, Owen			Covid-19 hot spots appear across Latin America	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER O, 2020, BMJ-BRIT MED J, V369, P17354, DOI DOI 10.1136/BMJ.M1589	1	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2020	369								m2182	10.1136/bmj.m2182	http://dx.doi.org/10.1136/bmj.m2182			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0OM	32482681	Bronze			2022-12-28	WOS:000548486700006
J	Horton, R				Horton, Richard			Offline: After COVID-19-is an "alternate society" possible?	LANCET			English	Editorial Material												richard.horton@lancet.com							0	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2020	395	10238					1682	1682						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0PJ	32473667	Green Published, Bronze			2022-12-28	WOS:000561610000011
J	Urcelay, C; Austin, AT				Urcelay, Carlos; Austin, Amy T.			Exotic plants get a little help from their friends	SCIENCE			English	Editorial Material							DECOMPOSITION		[Urcelay, Carlos] Univ Nacl Cordoba, CONICET, Consejo Nacl Invest Cient & Tecn, Inst Multidisciplinario Biol Vegetal,UNC, Cordoba, Argentina; [Austin, Amy T.] Univ Buenos Aires, CONICET, Inst Invest Fisiol & Ecol Vinculadas Agr IFEVA, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Urcelay, C (corresponding author), Univ Nacl Cordoba, CONICET, Consejo Nacl Invest Cient & Tecn, Inst Multidisciplinario Biol Vegetal,UNC, Cordoba, Argentina.	curcelay@imbiv.unc.edu.ar	Austin, Amy/E-7988-2011	Austin, Amy/0000-0002-7468-5861	CONICET-UNC; Secretariat of Science and Technology; Ministerio de Ciencia de la Provincia de Cordoba; New Phytologist Trust	CONICET-UNC; Secretariat of Science and Technology; Ministerio de Ciencia de la Provincia de Cordoba; New Phytologist Trust	This work was supported by CONICET-UNC, the Secretariat of Science and Technology, and Ministerio de Ciencia de la Provincia de Cordoba (C.U.) and the New Phytologist Trust (A.T.A.)	Austin AT, 2014, NEW PHYTOL, V204, P257, DOI 10.1111/nph.13062; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Ehrenfeld JG, 2010, ANNU REV ECOL EVOL S, V41, P59, DOI 10.1146/annurev-ecolsys-102209-144650; Francioli D, 2021, PLANT SOIL, V461, P91, DOI 10.1007/s11104-020-04454-y; Jo I, 2015, BIOL INVASIONS, V17, P1545, DOI 10.1007/s10530-014-0814-y; Martin FM, 2017, SCIENCE, V356, DOI 10.1126/science.aad4501; Schadler M, 2003, OIKOS, V103, P121, DOI 10.1034/j.1600-0706.2003.12659.x; Tecco PA, 2010, J ECOL, V98, P17, DOI 10.1111/j.1365-2745.2009.01592.x; Thakur MP, 2019, NAT REV MICROBIOL, V17, P621, DOI 10.1038/s41579-019-0236-z; Vivanco L, 2008, J ECOL, V96, P727, DOI 10.1111/j.1365-2745.2008.01393.x; Waller LP, 2020, SCIENCE, V368, P967, DOI 10.1126/science.aba2225; Weisser WW, 2017, BASIC APPL ECOL, V23, P1, DOI 10.1016/j.baae.2017.06.002; Whitaker J, 2014, J ECOL, V102, P1058, DOI 10.1111/1365-2745.12247; Wilschut RA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09615-x	14	0	0	3	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					934	936		10.1126/science.abc3587	http://dx.doi.org/10.1126/science.abc3587			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LV3IK	32467374				2022-12-28	WOS:000538332600021
J	Rensing, SA				Rensing, Stefan A.			How Plants Conquered Land	CELL			English	Editorial Material							GENOMES	Approximately 500 Ma ago, freshwater algae adapted to live on Earth's surface, subsequently enabling animal life to pursue. Over the last decade, genomes of non-seed plants enabled us to infer trait evolution of early land plants. In this issue of Cell, Jiao et al. uncovered another genome, of the streptophyte algae Penium, enhancing our understanding of the water-to-land transition.	[Rensing, Stefan A.] Univ Marburg, Dept Biol, Marburg, Germany; [Rensing, Stefan A.] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, Freiburg, Germany; [Rensing, Stefan A.] Univ Marburg, SYNMIKRO Ctr Synthet Microbiol, Marburg, Germany	Philipps University Marburg; University of Freiburg; Philipps University Marburg	Rensing, SA (corresponding author), Univ Marburg, Dept Biol, Marburg, Germany.; Rensing, SA (corresponding author), Univ Freiburg, Ctr Biol Signaling Studies BIOSS, Freiburg, Germany.; Rensing, SA (corresponding author), Univ Marburg, SYNMIKRO Ctr Synthet Microbiol, Marburg, Germany.	stefan.rensing@biologie.uni-marburg.de						[Anonymous], 2019, NATURE, V574, P679, DOI [DOI 10.1038/s41586-019-1693-2, DOI 10.1038/S41586-019-1693-2]; [Anonymous], TITLE ERROR; Cheng SF, 2019, CELL, V179, P1057, DOI 10.1016/j.cell.2019.10.019; de Vries J, 2018, P NATL ACAD SCI USA, V115, pE3471, DOI 10.1073/pnas.1719230115; Hernandez-Garcia J, 2019, MOL BIOL EVOL, V36, P908, DOI 10.1093/molbev/msz009; Li FW, 2020, NAT PLANTS, V6, P259, DOI 10.1038/s41477-020-0618-2; Nishiyama T, 2018, CELL, V174, P448, DOI 10.1016/j.cell.2018.06.033; Puttick MN, 2018, CURR BIOL, V28, P733, DOI 10.1016/j.cub.2018.01.063; Wang SB, 2020, NAT PLANTS, V6, P95, DOI 10.1038/s41477-019-0560-3; Wilhelmsson PKI, 2017, GENOME BIOL EVOL, V9, P3384, DOI 10.1093/gbe/evx258	10	9	9	4	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2020	181	5					964	966		10.1016/j.cell.2020.05.011	http://dx.doi.org/10.1016/j.cell.2020.05.011			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LT9QF	32470404	Bronze			2022-12-28	WOS:000537399500003
J	Horton, R				Horton, Richard			Offline: Health in the unhappy time of COVID-19	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2020	395	10237					1600	1600		10.1016/S0140-6736(20)31206-X	http://dx.doi.org/10.1016/S0140-6736(20)31206-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LZ1JO	32446401	Green Published, Bronze			2022-12-28	WOS:000540986100013
J	Curtis, EA				Curtis, E. Anne			Synchronized to an optical atomic clock	SCIENCE			English	Editorial Material									[Curtis, E. Anne] Natl Phys Lab, Time & Frequency Dept, Opt Frequency Metrol Atom Clocks & Sensors, Quantum Metrol Inst, Teddington TW11 0LW, Middx, England	National Physical Laboratory - UK	Curtis, EA (corresponding author), Natl Phys Lab, Time & Frequency Dept, Opt Frequency Metrol Atom Clocks & Sensors, Quantum Metrol Inst, Teddington TW11 0LW, Middx, England.	anne.curtis@npl.co.uk		Curtis, Anne/0000-0003-3487-5588				Brewer SM, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.033201; Clivati C, 2017, SCI REP-UK, V7, DOI 10.1038/srep40992; Del'Haye P, 2016, NAT PHOTONICS, V10, P516, DOI [10.1038/NPHOTON.2016.105, 10.1038/nphoton.2016.105]; Delva P, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.221102; Diddams SA, 2001, SCIENCE, V293, P825, DOI 10.1126/science.1061171; Fortier T, 2019, COMMUN PHYS-UK, V2, DOI 10.1038/s42005-019-0249-y; Ghelfi P, 2014, NATURE, V507, P341, DOI 10.1038/nature13078; Gurvits LI, 2020, ADV SPACE RES, V65, P868, DOI 10.1016/j.asr.2019.05.042; Ludlow AD, 2015, REV MOD PHYS, V87, P637, DOI 10.1103/RevModPhys.87.637; Marra G, 2018, SCIENCE, V361, P486, DOI 10.1126/science.aat4458; Nakamura T, 2020, SCIENCE, V368, P889, DOI 10.1126/science.abb2473; Oelker E, 2019, NAT PHOTONICS, V13, P714, DOI 10.1038/s41566-019-0493-4; Sherman JA, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4950898	13	1	1	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					825	826		10.1126/science.abb8629	http://dx.doi.org/10.1126/science.abb8629			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU2DD	32439780				2022-12-28	WOS:000537569500026
J	Wise, J				Wise, Jacqui			Covid-19: Delaying school reopening by two weeks would halve risks to children, says iSAGE	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, BMJ, V369; Independent SAGE, 2020, SHOULD SCH REOP DRAF	2	5	5	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2020	369								m2079	10.1136/bmj.m2079	http://dx.doi.org/10.1136/bmj.m2079			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JU	32444387	Bronze			2022-12-28	WOS:000538336800019
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Cycle of 50 day lockdowns and 30 day relaxations could be effective, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Chowdhury R, 2020, EUR J EPIDEMIOL, V35, P389, DOI 10.1007/s10654-020-00649-w	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2020	369								m2037	10.1136/bmj.m2037	http://dx.doi.org/10.1136/bmj.m2037			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JK	32434797	Bronze			2022-12-28	WOS:000538335800011
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Practising in the dark	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2020	369								m2002	10.1136/bmj.m2002	http://dx.doi.org/10.1136/bmj.m2002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JI	32430308	Bronze			2022-12-28	WOS:000538335600005
J	Sharfstein, JM; Morphew, CC				Sharfstein, Joshua M.; Morphew, Christopher C.			The Urgency and Challenge of Opening K-12 Schools in the Fall of 2020	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint proposes a policy framework for reopening of US primary, middle, and high schools (kindergarten through 12th grade) in fall 2020, including ramping up community public health responses in the summer, symptom screening of students, and privileging return-to-school decisions for younger children and others at risk for education disparities.	[Sharfstein, Joshua M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Morphew, Christopher C.] Johns Hopkins Sch Educ, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Sharfstein, JM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St,Room W1033F, Baltimore, MD 21209 USA.	Joshua.Sharfstein@jhu.edu						Auxier B, SCH CLOSE DUE CORONA; Bauer L., COVID 19 CRISIS HAS; Bryant J, SAFELY BACK SCH CORO; Cicero A, FILLING BLANKS NATL; Education Week, MAP COR SCH CLOS; Esposito S, 2020, JAMA PEDIATR, V174, P921, DOI 10.1001/jamapediatrics.2020.1892; Faden R, THERES MORE REOPENIN; Kuhfeld M., COVID 19 SLIDE WHAT; US Department of Health and Human Services Administration for Children and Families Administration on children Youth and Families Children's Bureau, CHILD MALTR 2018; US Department of Health and Human Services Centers for Disease Control and Prevention, CDC ACT IN SUPP COVI	10	37	37	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2020	324	2					133	134		10.1001/jama.2020.10175	http://dx.doi.org/10.1001/jama.2020.10175			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ8RW	32478827	Bronze			2022-12-28	WOS:000553161000009
J	Brown, JM; Siddiqui, M; Calhoun, DA; Carey, RM; Hopkins, PN; Williams, GH; Vaidya, A				Brown, Jenifer M.; Siddiqui, Mohammed; Calhoun, David A.; Carey, Robert M.; Hopkins, Paul N.; Williams, Gordon H.; Vaidya, Anand			The Unrecognized Prevalence of Primary Aldosteronism A Cross-sectional Study	ANNALS OF INTERNAL MEDICINE			English	Article							PLASMA-RENIN ACTIVITY; BLOOD-PRESSURE; ESSENTIAL-HYPERTENSION; RESISTANT HYPERTENSION; POTASSIUM EXCRETION; URINARY SODIUM; SENSITIVITY; SECRETION; DIAGNOSIS; SPIRONOLACTONE	Background: Primary aldosteronism is a nonsuppressible reninin-dependent aldosterone production that causes hypertension and cardiovascular disease. Objective: To characterize the prevalence of nonsuppressible renin-independent aldosterone production, as well as biochemically overt primary aldosteronism, in relation to blood pressure. Design: Cross-sectional study. Setting: 4 U.S. academic medical centers. Participants: Participants with normotension (n = 289), stage 1 hypertension (n = 115), stage 2 hypertension (n = 203), and resistant hypertension (n = 408). Measurements: Participants completed an oral sodium suppression test, regardless of aldosterone or renin levels, as a confirmatory diagnostic for primary aldosteronism and to quantify the magnitude of renin-independent aldosterone production. Urinary aldosterone was measured in participants in high sodium balance with suppressed renin activity. Biochemically overt primary aldosteronism was diagnosed when urinary aldosterone levels were higher than 12 mu g/24 h. Results: Every blood pressure category had a continuum of renin-independent aldosterone production, where greater severity of production was associated with higher blood pressure, kaliuresis, and lower serum potassium levels. Mean adjusted lev-els of urinary aldosterone were 6.5 mu g/24 h (95% CI, 5.2 to 7.7 mu g/24 h) in normotension, 7.3 mu g/24 h (CI, 5.6 to 8.9 mu g/24 h) in stage 1 hypertension, 9.5 mu g/24 h (CI, 8.2 to 10.8 mu g/24 h) in stage 2 hypertension, and 14.6 mu g/24 h (CI, 12.9 to 16.2 mu g/24 h) in resistant hypertension; corresponding adjusted prevalence estimates for biochemically overt primary aldosteronism were 11.3% (CI, 5.9% to 16.8%), 15.7% (CI, 8.6% to 22.9%), 21.6% (CI, 16.1% to 27.0%), and 22.0% (CI, 17.2% to 26.8%). The aldosterone-renin ratio had poor sensitivity and negative predictive value for detecting biochemically overt primary aldosteronism. Limitation: Prevalence estimates rely on arbitrary and conventional thresholds, and the study population may not represent nationwide demographics. Conclusion: The prevalence of primary aldosteronism is high and largely unrecognized. Beyond this categorical definition of primary aldosteronism, there is a prevalent continuum of reninin-dependent aldosterone production that parallels the severity of hypertension. These findings redefine the primary aldosteronism syndrome and implicate it in the pathogenesis of "essential" hypertension.	[Brown, Jenifer M.; Williams, Gordon H.; Vaidya, Anand] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Siddiqui, Mohammed; Calhoun, David A.] Univ Alabama Birmingham, Birmingham, AL USA; [Carey, Robert M.] Univ Virginia Hlth Syst, Charlottesville, VA USA; [Hopkins, Paul N.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Brown, Jenifer M.] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Siddiqui, Mohammed] Univ Alabama Birmingham, 933 19th St South,Room 115, Birmingham, AL 35209 USA; [Calhoun, David A.] Univ Alabama Birmingham, Div Cardiol, BMR2 430, Birmingham, AL 35294 USA; [Carey, Robert M.] Univ Virginia Hlth Syst, POB 801414, Charlottesville, VA 22908 USA; [Hopkins, Paul N.] Univ Utah, Sch Med, Div Cardiovasc Genet, 50 North Med Dr,Room 1160, Salt Lake City, UT 84132 USA; [Williams, Gordon H.; Vaidya, Anand] Harvard Med Sch, Brigham & Womens Hosp, Ctr Adrenal Disorders, Div Endocrinol Diabet & Hypertens, 221 Longwood Ave, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; University of Virginia; Utah System of Higher Education; University of Utah; Harvard University; Brigham & Women's Hospital; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Virginia; Utah System of Higher Education; University of Utah; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Vaidya, A (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Ctr Adrenal Disorders, Div Endocrinol Diabet & Hypertens, 221 Longwood Ave, Boston, MA 02115 USA.	anandvaidya@bwh.harvard.edu			National Institutes of Health [T32 HL007604, 2T32HL007457-36A1, R01 HL113004, P01-HL-074940, R01-HL-128189, 5R01 HL136567, 1R01 HL144779, 1R01 HL114765, RM-07-2002, R01 HL085224, R01 HL086907, 5 P50 HL55000, R01 DK115392, R01 DK107407]; American Heart Association [AHA 5SFRN2390002]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	By grants T32 HL007604 (Dr. Brown); 2T32HL007457-36A1 (Dr. Siddiqui); R01 HL113004 (Dr. Calhoun); P01-HL-074940 and R01-HL-128189 (Dr. Carey); 5R01 HL136567, 1R01 HL144779, 1R01 HL114765, RM-07-2002, R01 HL085224, R01 HL086907, and 5 P50 HL55000 (Dr. Williams); and R01 DK115392 and R01 DK107407 (Dr. Vaidya) from the National Institutes of Health, and by grant AHA 5SFRN2390002 from the American Heart Association (Dr. Calhoun).	ADLIN EV, 1975, LANCET, V1, P699; ADLIN EV, 1972, ARCH INTERN MED, V130, P855, DOI 10.1001/archinte.130.6.855; Baudrand R, 2017, HYPERTENSION, V69, P950, DOI 10.1161/HYPERTENSIONAHA.116.08952; Baudrand R, 2016, J CLIN ENDOCR METAB, V101, P3989, DOI 10.1210/jc.2016-1963; Brown JM, 2017, ANN INTERN MED, V167, P630, DOI 10.7326/M17-0882; Burrello J, 2020, HYPERTENSION, V75, P1025, DOI 10.1161/HYPERTENSIONAHA.119.14063; Byrd JB, 2018, CIRCULATION, V138, P823, DOI 10.1161/CIRCULATIONAHA.118.033597; CAREY RM, 1972, ARCH INTERN MED, V130, P849; Carey RM, 2018, HYPERTENSION, V72, pE53, DOI 10.1161/HYP.0000000000000084; Carey RM, 2012, HYPERTENSION, V60, P1359, DOI 10.1161/HYPERTENSIONAHA.112.196071; Catena C, 2008, ARCH INTERN MED, V168, P80, DOI 10.1001/archinternmed.2007.33; CONN JW, 1965, J AMER MED ASSOC, V193, P200, DOI 10.1001/jama.1965.03090030022005; Dudenbostel T, 2016, HYPERTENSION, V68, P995, DOI 10.1161/HYPERTENSIONAHA.116.07806; El Ghorayeb N, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00072; Funder JW, 2016, J CLIN ENDOCR METAB, V101, P1889, DOI 10.1210/jc.2015-4061; Funder JW, 2015, PFLUG ARCH EUR J PHY, V467, P587, DOI 10.1007/s00424-014-1658-0; Funder JW, 2014, HYPERTENSION, V63, P1168, DOI 10.1161/HYPERTENSIONAHA.114.03127; GANGULY A, 1979, AM HEART J, V98, P642, DOI 10.1016/0002-8703(79)90292-8; Grim CE, 2004, CURR HYPERTENS REP, V6, P485, DOI 10.1007/s11906-004-0045-1; Hannemann A, 2012, EUR J ENDOCRINOL, V167, P7, DOI 10.1530/EJE-11-1013; Hannemann A, 2011, ATHEROSCLEROSIS, V219, P875, DOI 10.1016/j.atherosclerosis.2011.09.008; Huang LP, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m315; Hundemer GL, 2018, LANCET DIABETES ENDO, V6, P51, DOI 10.1016/S2213-8587(17)30367-4; Jaffe G, 2020, HYPERTENSION, V75, P650, DOI 10.1161/HYPERTENSIONAHA.119.14359; JOSE A, 1970, ANN INTERN MED, V72, P9, DOI 10.7326/0003-4819-72-1-9; KEM DC, 1978, J CLIN ENDOCR METAB, V46, P552, DOI 10.1210/jcem-46-4-552; Kline GA, 2019, J HYPERTENS, V37, P596, DOI 10.1097/HJH.0000000000001905; LARAGH JH, 1979, JAMA-J AM MED ASSOC, V241, P151, DOI 10.1001/jama.241.2.151; Maiolino G, 2017, J AM COLL CARDIOL, V69, P1821, DOI 10.1016/j.jacc.2017.02.041; Markou A, 2015, J CLIN ENDOCR METAB, V100, P2857, DOI 10.1210/jc.2015-1268; Markou A, 2013, J CLIN ENDOCR METAB, V98, P1409, DOI 10.1210/jc.2012-3353; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Monticone S, 2018, LANCET DIABETES ENDO, V6, P41, DOI 10.1016/S2213-8587(17)30319-4; Monticone S, 2017, J AM COLL CARDIOL, V69, P1811, DOI 10.1016/j.jacc.2017.01.052; Mosso L, 2003, HYPERTENSION, V42, P161, DOI 10.1161/01.HYP.0000079505.25750.11; Mulatero P, 2013, J CLIN ENDOCR METAB, V98, P4826, DOI 10.1210/jc.2013-2805; Newton-Cheh C, 2007, HYPERTENSION, V49, P846, DOI 10.1161/01.HYP.0000258554.87444.91; Nishimoto K, 2015, P NATL ACAD SCI USA, V112, pE4591, DOI 10.1073/pnas.1505529112; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; Omata K, 2017, J ENDOCR SOC, V1, P787, DOI 10.1210/js.2017-00134; Omura M, 2004, HYPERTENS RES, V27, P193, DOI 10.1291/hypres.27.193; Piazza M, 2019, HYPERTENSION, V74, P793, DOI 10.1161/HYPERTENSIONAHA.119.13388; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Rossi GP, 2019, J AM COLL CARDIOL, V74, P2799, DOI 10.1016/j.jacc.2019.09.057; Ruhle BC, 2019, SURGERY, V165, P221, DOI 10.1016/j.surg.2018.05.085; SIRAGY HM, 1995, J CLIN ENDOCR METAB, V80, P28, DOI 10.1210/jc.80.1.28; Stowasser M, 2003, J HYPERTENS, V21, P2149, DOI 10.1097/00004872-200311000-00025; Tanabe A, 2003, J CLIN ENDOCR METAB, V88, P2489, DOI 10.1210/jc.2002-021476; Tu WZ, 2014, HYPERTENSION, V63, P1212, DOI 10.1161/HYPERTENSIONAHA.113.02989; Vaidya A, 2018, ENDOCR REV, V39, P1057, DOI 10.1210/er.2018-00139; Vaidya A, 2017, ENDOCR PRACT, V23, P680, DOI 10.4158/EP161717.RA; Vasan RS, 2004, NEW ENGL J MED, V351, P33, DOI 10.1056/NEJMoa033263; VECCHIOLA A, 2019, AM J HYPERTENS, V32, P468, DOI DOI 10.1093/AJH/HPZ023; VIEWEG WVR, 1992, AM J PHYSIOL, V262, pF871, DOI 10.1152/ajprenal.1992.262.5.F871; Whelton Paul K, 2018, Hypertension, V71, pe13, DOI [10.1016/j.jash.2018.06.010, 10.1161/HYP.0000000000000065]; Williams B, 2018, LANCET DIABETES ENDO, V6, P464, DOI 10.1016/S2213-8587(18)30071-8; Williams B, 2015, LANCET, V386, P2059, DOI 10.1016/S0140-6736(15)00257-3; Williams TA, 2019, HYPERTENSION, V74, P784, DOI 10.1161/HYPERTENSIONAHA.119.13156	59	173	179	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2020	173	1					10	+		10.7326/M20-0065	http://dx.doi.org/10.7326/M20-0065			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MI6BV	32449886	Green Accepted			2022-12-28	WOS:000547491700004
J	Myles, PS; Maswime, S				Myles, Paul S.; Maswime, Salome			Mitigating the risks of surgery during the COVID-19 pandemic	LANCET			English	Editorial Material									[Myles, Paul S.] Alfred Hosp, Dept Anaesthesiol & Perioperat Med, Melbourne, Vic 3004, Australia; [Myles, Paul S.] Monash Univ, Melbourne, Vic 3004, Australia; [Maswime, Salome] Univ Cape Town, Dept Surg, Global Surg Div, Cape Town, South Africa	Florey Institute of Neuroscience & Mental Health; Monash University; University of Cape Town	Myles, PS (corresponding author), Alfred Hosp, Dept Anaesthesiol & Perioperat Med, Melbourne, Vic 3004, Australia.; Myles, PS (corresponding author), Monash Univ, Melbourne, Vic 3004, Australia.	p.myles@alfred.org.au	Maswime, Salome/AAL-9390-2021	Maswime, Salome/0000-0003-4013-5164				[Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9; Australian Health Protection Principal Committee, 2020, EX RES AG CAR 2018 2; Cheeyandira A, 2020, J SURG CASE REP, DOI 10.1093/jscr/rjaa109; COVIDsurg Collaborative, 2020, LANCET, V396, P27, DOI 10.1016/S0140-6736(20)31182-X; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jessop ZM, 2020, BRIT J SURG, V107, P1262, DOI 10.1002/bjs.11750; Kandel N, 2020, LANCET, V395, P1047, DOI 10.1016/S0140-6736(20)30553-5; Lapolla P, 2021, INFECT CONT HOSP EP, V42, P364, DOI 10.1017/ice.2020.241; Pearse RM, 2012, LANCET, V380, P1059, DOI 10.1016/S0140-6736(12)61148-9; Raurell-Torreda M, 2020, ENFERM INTENSIVA; Royal College of Surgeons of England, 2020, REC SURG SERV COVID; Shulman MA, 2015, ANESTHESIOLOGY, V122, P524, DOI 10.1097/ALN.0000000000000586; Stahel PF, 2020, PATIENT SAF SURG, V14, DOI 10.1186/s13037-020-00235-9	14	49	53	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2020	396	10243					2	3		10.1016/S0140-6736(20)31256-3	http://dx.doi.org/10.1016/S0140-6736(20)31256-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0VO	32479826	Green Published, hybrid			2022-12-28	WOS:000561626100003
J	Ortega, R; Gonzalez, M; Nozari, A; Canelli, R				Ortega, Rafael; Gonzalez, Mauricio; Nozari, Ala; Canelli, Robert			Personal Protective Equipment and Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ortega, Rafael; Gonzalez, Mauricio; Nozari, Ala; Canelli, Robert] Boston Med Ctr, Dept Anesthesiol, 750 Albany St, Boston, MA 02118 USA	Boston Medical Center	Ortega, R (corresponding author), Boston Med Ctr, Dept Anesthesiol, 750 Albany St, Boston, MA 02118 USA.	rafael.ortega@bmc.org	Nozari, Ala/AAH-6070-2021	Nozari, Ala/0000-0002-5755-6347				Mehra MR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMoa2007621; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]	2	50	52	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2020	382	26								10.1056/NEJMvcm2014809	http://dx.doi.org/10.1056/NEJMvcm2014809			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MF9CW	32427435	Bronze			2022-12-28	WOS:000545636400010
J	del Rio, C; Malani, P				del Rio, Carlos; Malani, Preeti			Translating Science on COVID-19 to Improve Clinical Care and Support the Public Health Response	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[del Rio, Carlos] Emory Univ, Sch Med, Div Infect Dis, Dept Internal Med, Atlanta, GA USA; [Malani, Preeti] Univ Michigan, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA	Emory University; University of Michigan System; University of Michigan	del Rio, C (corresponding author), Emory Univ, Sch Med, 49 Jesse Hill Jr Dr,FOB Room 201, Atlanta, GA 30303 USA.	cdelrio@emory.edu	del Rio, Carlos/B-3763-2012	del Rio, Carlos/0000-0002-0153-3517				[Anonymous], 2020, GILEAD ANNOUNCES RES; Bhimraj A, 2020, INFECT DISEASES SOC; COVID-19 Treatment Guidelines Panel, 2020, CORN DIS 2019 COVID; National Institute of Infectious Diseases, 2020, NIH CLIN TRIAL SHOWS; Omer SB, 2020, JAMA-J AM MED ASSOC, V323, P1767, DOI 10.1001/jama.2020.5788; Persad G, 2020, JAMA-J AM MED ASSOC, V323, P2241, DOI 10.1001/jama.2020.8102; Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630; Walensky RP, 2020, JAMA-J AM MED ASSOC, V323, P1889, DOI 10.1001/jama.2020.6572; WHO, 2020, IMM PASSP CONT COVID; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548	10	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2464	2465		10.1001/jama.2020.9252	http://dx.doi.org/10.1001/jama.2020.9252			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32442244	Bronze			2022-12-28	WOS:000590149400010
J	Griffin, S				Griffin, Shaun			Covid-19: UK deaths approach 50 000, but rate declines	BMJ-BRITISH MEDICAL JOURNAL			English	News Item													Griffin, Shaun/GLT-2847-2022					National Records of Scotland, 2020, DEATHS INV COR COV 1; Northern Ireland Statistics and Research Agency, 2020, WEEKL DEATHS NO IR D; Office for National Statistics, 2020, DEATHS REG WEEKL ENG	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2020	369								m2212	10.1136/bmj.m2212	http://dx.doi.org/10.1136/bmj.m2212			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1WU	32493706	Bronze			2022-12-28	WOS:000548578300003
J	Remme, M; Vassall, A; Fernando, G; Bloom, DE				Remme, Michelle; Vassall, Anna; Fernando, Gabriela; Bloom, David E.			Investing in the health of girls and women: a best buy for sustainable development	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLIMATE-CHANGE; POPULATION; EQUITY; INTERVENTIONS; COUNTRIES; COUNTDOWN; COVERAGE; PROGRAM; GENDER		[Remme, Michelle; Fernando, Gabriela] United Nations Univ, Int Inst Global Hlth, Kuala Lumpur, Malaysia; [Vassall, Anna] London Sch Hyg & Trop Med, London, England; [Bloom, David E.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA	University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health	Remme, M (corresponding author), United Nations Univ, Int Inst Global Hlth, Kuala Lumpur, Malaysia.	michelle.remme@unu.edu		Fernando, Gabriela/0000-0001-6107-2911	Norwegian Agency for Development Cooperation [QZA-0408QZA-12/0628]; National Institute on Ageing, National Institutes of Health [P30AG024409]	Norwegian Agency for Development Cooperation; National Institute on Ageing, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We have read and understood BMJ policy on declaration of interests and have no interests to declare. DEB's work on this paper was supported by the Norwegian Agency for Development Cooperation under grant number QZA-0408QZA-12/0628 and by the National Institute on Ageing, National Institutes of Health, under award number P30AG024409.	Alabas OA, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007123; Almond D, 2011, J ECON PERSPECT, V25, P153, DOI 10.1257/jep.25.3.153; [Anonymous], 2019, LANCET, V393, P1773, DOI 10.1016/S0140-6736(19)30990-0; [Anonymous], 2016, LANCET, V387, P506, DOI 10.1016/S0140-6736(16)00267-1; [Anonymous], 2010, NATURE, V465, P665, DOI 10.1038/465665b; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bhalotra S, 2011, J PUBLIC ECON, V95, P286, DOI 10.1016/j.jpubeco.2010.10.016; Bloom DE, 2018, SCIENCE, V361, DOI 10.1126/science.aat9644; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Bloom DE, EC J LOND; Bloom DE, 2017, FINANC DEV, V54, P50; Bryant L, 2009, B WORLD HEALTH ORGAN, V87, P852, DOI 10.2471/BLT.08.062562; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Corsi DJ, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S3; Crimmins EM, 2019, CLIN CHEM, V65, P135, DOI 10.1373/clinchem.2018.288332; Dabla-Norris E, 2019, FINANC DEV, V56, P1; Dasgupta PS, 2013, SCIENCE, V340, P324, DOI 10.1126/science.1224664; Diebolt C, 2013, AM ECON REV, V103, P545, DOI 10.1257/aer.103.3.545; Downe S, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0466-y; Duflo E, 2012, J ECON LIT, V50, P1051, DOI 10.1257/jel.50.4.1051; Gibbs A, 2019, PREVENTING VIOLENCE; Ginsburg O, 2017, LANCET, V389, P847, DOI [10.1016/S0140-6736(16)31392-7, 10.1]; Govender V, 2018, UNIVERSAL HLTH COVER; Gupta V, 2018, GLOB PUBLIC HEALTH, V13, P1796, DOI 10.1080/17441692.2018.1449232; Haghparast-Bidgoli H, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0216-5; Heymann J, 2019, LANCET, V393, P2522, DOI 10.1016/S0140-6736(19)30656-7; HODDINOTT J, 1995, OXFORD B ECON STAT, V57, P77, DOI 10.1111/j.1468-0084.1995.tb00028.x; International Labour Office, 2018, WORLD EMPL SOC OUTL; Jamison DT, 2015, SALUD PUBLICA MEXICO, V57, P444; Janssens W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166121; Kankeu HT, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-31; Kawachi I, 1999, SOC SCI MED, V48, P21, DOI 10.1016/S0277-9536(98)00286-X; Kes A, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S3; Kuruvilla S, 2018, B WORLD HEALTH ORGAN, V96, P42, DOI 10.2471/BLT.17.198358; Langer A, 2015, LANCET, V386, P1165, DOI 10.1016/S0140-6736(15)60497-4; LLOYD CB, 1988, STUD FAMILY PLANN, V19, P141, DOI 10.2307/1966750; Manandhar M, 2018, B WORLD HEALTH ORGAN, V96, P644, DOI 10.2471/BLT.18.211607; Michau L, 2015, LANCET, V385, P1672, DOI 10.1016/S0140-6736(14)61797-9; Mohan V, 2014, REPROD HEALTH MATTER, V22, P93, DOI 10.1016/S0968-8080(14)43766-2; Newman-Toker DE, 2014, DIAGNOSIS, V1, P155, DOI 10.1515/dx-2013-0038; Nilsson M, 2016, NATURE, V534, P320, DOI 10.1038/534320a; Onarheim KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150120; Pit SW, 2012, J WOMENS HEALTH, V21, P273, DOI 10.1089/jwh.2011.2872; Quick Jonathan, 2014, PLoS Med, V11, pe1001580, DOI 10.1371/journal.pmed.1001580; Ramirez FD, 2017, CIRCULATION, V135, P625, DOI 10.1161/CIRCULATIONAHA.116.026668; Starrs AM, 2018, LANCET, V391, P2642, DOI 10.1016/S0140-6736(18)30293-9; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Stephenson J, 2010, J PUBLIC HEALTH-UK, V32, P150, DOI 10.1093/pubmed/fdq038; Tangcharoensathien V, 2015, GLOB PUBLIC HEALTH, V10, P246, DOI 10.1080/17441692.2014.986166; Taukobong HFG, 2016, HEALTH POLICY PLANN, V31, P1492, DOI 10.1093/heapol/czw074; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Waage J, 2015, LANCET GLOB HEALTH, V3, pE251, DOI 10.1016/S2214-109X(15)70112-9; Waring M, 2003, CAR WORK CAR JOBS FU, V11, P35, DOI 10.1080/741954251; Waring M., 2003, GENDER DEV, V11, P35, DOI [10.1080/741954251, DOI 10.1080/741954251]; Watson S, 2019, ECLINICALMEDICINE, V17, DOI 10.1016/j.eclinm.2019.10.001; Weber AM, 2019, LANCET, V393, P2455, DOI 10.1016/S0140-6736(19)30765-2; WHO, 2010, WOR HEALT REP, P1; Witter S, 2017, HEALTH POLICY PLANN, V32, pV4, DOI 10.1093/heapol/czx063; World Health Organization, 2002, MAINSTR GEND EQ HLTH; World Health Organization, 2019, WHS 2019 GEND EQ GLO; Xu K, 2018, PUBLIC SPENDING HLTH	61	4	4	3	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2020	369								m1175	10.1136/bmj.m1175	http://dx.doi.org/10.1136/bmj.m1175			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MK0KV	32487585	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000548476700002
J	Mahase, E				Mahase, Elisabeth			Covid-19: WHO halts hydroxychloroquine trial to review links with increased mortality risk	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, RECR RECOVERY TRIAL; [Anonymous], 2020, BMJ BRIT MED J, DOI DOI 10.1136/BMJ.M1166; Baker P, 2020, NY TIMES; Mehra MR, 2020, LANCET	4	16	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2020	369								m2126	10.1136/bmj.m2126	http://dx.doi.org/10.1136/bmj.m2126			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JZ	32467095	Bronze			2022-12-28	WOS:000538337300011
J	Zhou, JM; Zhang, YL				Zhou, Jian-Min; Zhang, Yuelin			Plant Immunity: Danger Perception and Signaling	CELL			English	Review							NADPH OXIDASE RBOHD; SALICYLIC-ACID BIOSYNTHESIS; NAD(+) CLEAVAGE ACTIVITY; DISEASE RESISTANCE; TRIGGERED IMMUNITY; DOMAIN REVEALS; TIR DOMAINS; CELL-DEATH; RECEPTOR; ARABIDOPSIS	Plants employ numerous cell-surface and intracellular immune receptors to perceive a variety of immunogenic signals associated with pathogen infection and subsequently activate defenses. Immune signaling is potentiated by the major defense hormone salicylic acid (SA), which reprograms the transcriptome for defense. Here we highlight recent advances in understanding the mechanisms underlying activation of the main classes of immune receptors, summarize the current understanding of their signaling mechanisms, and discuss an updated model for SA perception and signaling. In addition, we discuss how different receptors are organized into networks and the implications of such networks in the integration of complex danger signals for appropriate defense outputs.	[Zhou, Jian-Min] Chinese Acad Sci, Innovat Acad Seed Design, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Zhou, Jian-Min] Univ Chinese Acad Sci, CAS Ctr Excellence Biot Interact, Beijing 100049, Peoples R China; [Zhang, Yuelin] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of British Columbia	Zhou, JM (corresponding author), Chinese Acad Sci, Innovat Acad Seed Design, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China.; Zhou, JM (corresponding author), Univ Chinese Acad Sci, CAS Ctr Excellence Biot Interact, Beijing 100049, Peoples R China.; Zhang, YL (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada.	jmzhou@genetics.ac.cn; yuelin.zhang@ubc.ca			National Natural Science Foundation of China [31830019, 31521001]; State Key Laboratory of Plant Genomics [SKLPG2016B-2]; Natural Sciences and Engineering Research Council of Canada	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Plant Genomics; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors are grateful to Cyril Zipfel, Xin Li, and Thomas DeFalco for critical reading of the manuscript and Yuan Qin for assistance in figure drawing. The work was supported by grants from National Natural Science Foundation of China (31830019, 31521001) and the State Key Laboratory of Plant Genomics (SKLPG2016B-2) to J.-M.Z., as well as by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada to Y.Z. We apologize to those whose work is not cited because of space limitation.	Adachi H, 2019, ELIFE, V8, DOI 10.7554/eLife.49956; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Bacete L, 2018, PLANT J, V93, P614, DOI 10.1111/tpj.13807; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Bhandari DD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08783-0; Bi GZ, 2018, PLANT CELL, V30, P1543, DOI 10.1105/tpc.17.00981; Bonardi V, 2011, P NATL ACAD SCI USA, V108, P16463, DOI 10.1073/pnas.1113726108; Bucherl CA, 2017, ELIFE, V6, DOI 10.7554/eLife.25114; Buscaill P, 2019, SCIENCE, V364, P145, DOI 10.1126/science.aav0748; Castel B, 2019, NEW PHYTOL, V222, P966, DOI 10.1111/nph.15659; Chen T, 2020, NATURE, V580, P653, DOI 10.1038/s41586-020-2185-0; Chen YC, 2018, P NATL ACAD SCI USA, V115, pE4920, DOI 10.1073/pnas.1805291115; Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635; Cui HT, 2015, ANNU REV PLANT BIOL, V66, P487, DOI 10.1146/annurev-arplant-050213-040012; Daskalov A, 2016, P NATL ACAD SCI USA, V113, P2720, DOI 10.1073/pnas.1522361113; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Dong OX, 2018, NAT PLANTS, V4, P699, DOI 10.1038/s41477-018-0216-8; Dong OX, 2016, NEW PHYTOL, V210, P960, DOI 10.1111/nph.13821; Dou DL, 2012, CELL HOST MICROBE, V12, P484, DOI 10.1016/j.chom.2012.09.003; Dunser K, 2019, EMBO J, V38, DOI 10.15252/embj.2018100353; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Feng F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12999-5; Gantner J, 2019, PLANT CELL, V31, P2456, DOI 10.1105/tpc.19.00099; Gong BQ, 2019, CELL HOST MICROBE, V26, P810, DOI 10.1016/j.chom.2019.10.010; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; Gust AA, 2017, TRENDS PLANT SCI, V22, P779, DOI 10.1016/j.tplants.2017.07.005; Halter T, 2014, CURR BIOL, V24, P134, DOI 10.1016/j.cub.2013.11.047; Hander T, 2019, SCIENCE, V363, P1301, DOI 10.1126/science.aar7486; Hartmann M, 2018, CELL, V173, P456, DOI 10.1016/j.cell.2018.02.049; Horsefield S, 2019, SCIENCE, V365, P793, DOI 10.1126/science.aax1911; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Huang WJ, 2020, MOL PLANT, V13, P31, DOI 10.1016/j.molp.2019.12.008; Imkampe J, 2017, PLANT CELL, V29, P2285, DOI 10.1105/tpc.17.00376; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Jubic LM, 2019, CURR OPIN PLANT BIOL, V50, P82, DOI 10.1016/j.pbi.2019.03.013; Kadota Y, 2019, NEW PHYTOL, V221, P2160, DOI 10.1111/nph.15523; Kadota Y, 2015, PLANT CELL PHYSIOL, V56, P1472, DOI 10.1093/pcp/pcv063; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kimura S, 2020, PLANT CELL, V32, P1063, DOI 10.1105/tpc.19.00525; Kourelis J, 2018, PLANT CELL, V30, P285, DOI 10.1105/tpc.17.00579; Lapin D, 2019, PLANT CELL, V31, P2430, DOI 10.1105/tpc.19.00118; Le Roux C, 2015, CELL, V161, P1074, DOI 10.1016/j.cell.2015.04.025; Lewis JD, 2013, P NATL ACAD SCI USA, V110, P18722, DOI 10.1073/pnas.1315520110; Li B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12847-6; Li L, 2014, CELL HOST MICROBE, V15, P329, DOI 10.1016/j.chom.2014.02.009; LI X, 2018, CELL, V17, DOI DOI 10.1186/S12943-018-0862-5; Li X, 2015, CURR OPIN IMMUNOL, V32, P114, DOI 10.1016/j.coi.2015.01.014; Liang XX, 2018, CELL RES, V28, P529, DOI 10.1038/s41422-018-0027-5; Liang XX, 2016, ELIFE, V5, DOI 10.7554/eLife.13568; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mang HG, 2017, PLANT CELL, V29, P3140, DOI 10.1105/tpc.17.00464; Mulvihill E, 2018, EMBO J, V37, DOI 10.15252/embj.201798321; Ngou B.P.M., 2020, BIORXIV, DOI [10.1101/2020.04.10.0341731-29, 10.1101/2020.04.10.034173, DOI 10.1101/2020.04.10.034173]; Nishimura MT, 2017, P NATL ACAD SCI USA, V114, pE2053, DOI 10.1073/pnas.1620973114; Peart JR, 2005, CURR BIOL, V15, P968, DOI 10.1016/j.cub.2005.04.053; Peng YJ, 2018, MOL PLANT MICROBE IN, V31, P403, DOI 10.1094/MPMI-06-17-0145-CR; Perraki A, 2018, NATURE, V561, P248, DOI 10.1038/s41586-018-0471-x; Qi T, 2018, P NATL ACAD SCI USA, V115, pE10979, DOI 10.1073/pnas.1814856115; Radojicic A, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01133; Rekhter D, 2019, SCIENCE, V365, P498, DOI 10.1126/science.aaw1720; Shen WZ, 2019, MOL PLANT, V12, P1524, DOI 10.1016/j.molp.2019.08.003; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Smakowska-Luzan E, 2018, NATURE, V553, P342, DOI 10.1038/nature25184; Stegmann M, 2017, SCIENCE, V355, P287, DOI 10.1126/science.aal2541; Su JB, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004122; Sun TJ, 2020, MOL PLANT, V13, P144, DOI 10.1016/j.molp.2019.10.016; Sun TJ, 2018, EMBO REP, V19, DOI 10.15252/embr.201745324; Sun TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10159; Tang DZ, 2017, PLANT CELL, V29, P618, DOI 10.1105/tpc.16.00891; Teixeira PJPL, 2019, CURR OPIN MICROBIOL, V49, P7, DOI 10.1016/j.mib.2019.08.003; Tian W, 2019, NATURE, V572, P131, DOI 10.1038/s41586-019-1413-y; Torrens-Spence MP, 2019, MOL PLANT, V12, P1577, DOI 10.1016/j.molp.2019.11.005; Tsuda K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004015; Van de Weyer AL, 2019, CELL, V178, P1260, DOI 10.1016/j.cell.2019.07.038; van Wersch S, 2019, TRENDS PLANT SCI, V24, P688, DOI 10.1016/j.tplants.2019.05.005; Wan L, 2019, SCIENCE, V365, P799, DOI 10.1126/science.aax1771; Wang GX, 2015, CELL HOST MICROBE, V18, P285, DOI 10.1016/j.chom.2015.08.004; Wang JC, 2019, CELL RES, V29, P820, DOI 10.1038/s41422-019-0219-7; Wang JZ, 2019, SCIENCE, V364, P43, DOI 10.1126/science.aav5868; Wang JZ, 2019, SCIENCE, V364, P44, DOI 10.1126/science.aav5870; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Williams SJ, 2014, SCIENCE, V344, P299, DOI 10.1126/science.1247357; Wu CH, 2017, P NATL ACAD SCI USA, V114, P8113, DOI 10.1073/pnas.1702041114; Wu ZS, 2019, NEW PHYTOL, V222, P938, DOI 10.1111/nph.15665; Xia BQ, 2016, CELL RES, V26, P517, DOI 10.1038/cr.2016.26; Xiao Y, 2019, NATURE, V572, P270, DOI 10.1038/s41586-019-1409-7; Yamada K, 2016, EMBO J, V35, P2468, DOI 10.15252/embj.201694248; Yamaguchi Y, 2010, PLANT CELL, V22, P508, DOI 10.1105/tpc.109.068874; Yan HJ, 2018, PLANT PHYSIOL, V176, P2991, DOI 10.1104/pp.17.01757; Yeh YH, 2016, PLANT CELL, V28, P1701, DOI 10.1105/tpc.16.00313; Yuan M., 2020, BIORXIV, DOI [10.1101/2020.04.10.031294, DOI 10.1101/2020.04.10.031294]; Zhang YX, 2010, P NATL ACAD SCI USA, V107, P18220, DOI 10.1073/pnas.1005225107; Zhang YL, 2019, CURR OPIN PLANT BIOL, V50, P29, DOI 10.1016/j.pbi.2019.02.004; Zhang ZB, 2017, EMBO REP, V18, P292, DOI 10.15252/embr.201642704; Zhou F, 2020, CELL, V180, P440, DOI 10.1016/j.cell.2020.01.013; Ziemann S, 2018, NAT PLANTS, V4, P172, DOI 10.1038/s41477-018-0116-y	97	230	241	67	244	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2020	181	5					978	989		10.1016/j.cell.2020.04.028	http://dx.doi.org/10.1016/j.cell.2020.04.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LT9QF	32442407	Bronze			2022-12-28	WOS:000537399500006
J	Iacobucci, G				Iacobucci, Gareth			Food and drink industry sought to influence scientists and academics, emails show	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Greenhalgh S, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5050; IACOBUCCI G, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1666; Ruskin G, PUSHING PARTNERSHIPS, DOI [10.1017/S1368980019005184, DOI 10.1017/S1368980019005184]	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2020	369								m2078	10.1136/bmj.m2078	http://dx.doi.org/10.1136/bmj.m2078			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JU	32444353				2022-12-28	WOS:000538336800018
J	Mahase, E				Mahase, Elisabeth			Covid-19: Roll out of 10m antibody tests to begin next week, government announces	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2066	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2020	369								m2072	10.1136/bmj.m2072	http://dx.doi.org/10.1136/bmj.m2072			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JU	32444365	Bronze			2022-12-28	WOS:000538336800015
J	Sun, W; Shen, J; Zhao, Z; Arellano, N; Rettner, C; Tang, JS; Cao, TY; Zhou, ZY; Ta, T; Streit, JK; Fagan, JA; Schaus, T; Zheng, M; Han, SJ; Shih, WM; Maune, HT; Yin, P				Sun, Wei; Shen, Jie; Zhao, Zhao; Arellano, Noel; Rettner, Charles; Tang, Jianshi; Cao, Tianyang; Zhou, Zhiyu; Ta, Toan; Streit, Jason K.; Fagan, Jeffrey A.; Schaus, Thomas; Zheng, Ming; Han, Shu-Jen; Shih, William M.; Maune, Hareem T.; Yin, Peng			Precise pitch-scaling of carbon nanotube arrays within three-dimensional DNA nanotrenches	SCIENCE			English	Article							SINGLE; GROWTH; DENSE	Precise fabrication of semiconducting carbon nanotubes (CNTs) into densely aligned evenly spaced arrays is required for ultrascaled technology nodes. We report the precise scaling of inter-CNT pitch using a supramolecular assembly method called spatially hindered integration of nanotube electronics. Specifically, by using DNA brick crystal-based nanotrenches to align DNA-wrapped CNTs through DNA hybridization, we constructed parallel CNT arrays with a uniform pitch as small as 10.4 nanometers, at an angular deviation <2 degrees and an assembly yield >95%.	[Sun, Wei; Shen, Jie; Zhao, Zhao; Cao, Tianyang; Zhou, Zhiyu; Schaus, Thomas; Shih, William M.; Yin, Peng] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Sun, Wei; Shen, Jie; Schaus, Thomas; Yin, Peng] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Zhao, Zhao; Shih, William M.] Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Zhao, Zhao; Shih, William M.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Arellano, Noel; Rettner, Charles; Ta, Toan; Maune, Hareem T.] IBM Almaden Res Ctr, San Jose, CA 95120 USA; [Tang, Jianshi; Han, Shu-Jen] IBM Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Streit, Jason K.; Fagan, Jeffrey A.; Zheng, Ming] NIST, Mat Sci & Engn Div, Gaithersburg, MD 20899 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; International Business Machines (IBM); International Business Machines (IBM); National Institute of Standards & Technology (NIST) - USA	Sun, W; Yin, P (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Sun, W; Yin, P (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.	sunwedaivd1@gmail.com; py@hms.harvard.edu	Tang, Jianshi/I-5543-2014	Tang, Jianshi/0000-0001-8369-0067; Shen, Jie/0000-0002-1671-007X; Streit, Jason/0000-0003-3209-2141; Cao, Tianyang/0000-0002-4262-8379; Zhou, Zhiyu/0000-0002-3581-5870	NSF [CMMI-1333215, CMMI-1344915, CBET-1729397]; ONR [N00014-14-1-0610, N00014-16-1-2410, N00014-18-1-2549]; AFOSR (MURI FATE) [FA9550-15-1-0514]; Molecular Robotics Initiative from Wyss Institute; NIST internal fund	NSF(National Science Foundation (NSF)); ONR(Office of Naval Research); AFOSR (MURI FATE); Molecular Robotics Initiative from Wyss Institute; NIST internal fund	This work is supported by NSF (CMMI-1333215, CMMI-1344915, CBET-1729397), ONR (N00014-14-1-0610, N00014-16-1-2410, N00014-18-1-2549), AFOSR (MURI FATE, FA9550-15-1-0514), and Molecular Robotics Initiative from Wyss Institute to P.Y. J.K.S., J.A.F., and M.Z. acknowledge the NIST internal fund for support.	[Anonymous], 2013, INT TECHNOLOGY ROADM; Brady GJ, 2017, J APPL PHYS, V122, DOI 10.1063/1.4996586; Brady GJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601240; Cao Q, 2017, SCIENCE, V356, P1369, DOI 10.1126/science.aan2476; Cao Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6071; Cao Q, 2013, NAT NANOTECHNOL, V8, P180, DOI [10.1038/nnano.2012.257, 10.1038/NNANO.2012.257]; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Gui H, 2015, NANO LETT, V15, P1642, DOI 10.1021/nl504189p; Han SP, 2012, NANO LETT, V12, P1129, DOI 10.1021/nl201818u; He XW, 2016, NAT NANOTECHNOL, V11, P633, DOI [10.1038/NNANO.2016.44, 10.1038/nnano.2016.44]; Hills G, 2018, IEEE T NANOTECHNOL, V17, P1259, DOI 10.1109/TNANO.2018.2871841; Hu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7099; Hu ZY, 2016, NAT NANOTECHNOL, V11, P559, DOI [10.1038/NNANO.2016.1, 10.1038/nnano.2016.1]; Jin Z, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2690; Ke YG, 2014, NAT CHEM, V6, P994, DOI [10.1038/NCHEM.2083, 10.1038/nchem.2083]; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Knudsen JB, 2015, NAT NANOTECHNOL, V10, P892, DOI [10.1038/NNANO.2015.190, 10.1038/nnano.2015.190]; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Liu XG, 2018, NATURE, V559, P593, DOI 10.1038/s41586-018-0332-7; Mangalum A, 2013, J AM CHEM SOC, V135, P2451, DOI 10.1021/ja312191a; Maune HT, 2010, NAT NANOTECHNOL, V5, P61, DOI [10.1038/nnano.2009.311, 10.1038/NNANO.2009.311]; Pei H, 2019, J AM CHEM SOC, V141, P11923, DOI 10.1021/jacs.9b03432; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shulaker M. M., 2014, 2014 IEEE INT EL DEV; Shulaker M. M., 2014, A014 IEEE INT EL DEV; Streit JK, 2017, ANAL CHEM, V89, P10496, DOI 10.1021/acs.analchem.7b02637; Sun W, 2014, SCIENCE, V346, P717, DOI 10.1126/science.1258361; Surwade SP, 2013, J AM CHEM SOC, V135, P6778, DOI 10.1021/ja401785h; Tulevski GS, 2014, ACS NANO, V8, P8730, DOI 10.1021/nn503627h; Wu J, 2013, SMALL, V9, P4142, DOI 10.1002/smll.201301547; Zhan PF, 2018, ANGEW CHEM INT EDIT, V57, P2846, DOI 10.1002/anie.201712749; Zhang J., P IEEE INT EL DEV M, p4.6.1; Zhao MY, 2020, SCIENCE, V368, P878, DOI 10.1126/science.aaz7435; Zhao Z, 2013, ORG BIOMOL CHEM, V11, P596, DOI 10.1039/c2ob26942b; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877	37	59	62	22	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					874	+		10.1126/science.aaz7440	http://dx.doi.org/10.1126/science.aaz7440			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU2DD	32439790				2022-12-28	WOS:000537569500043
J	Vize, R				Vize, Richard			How the erosion of our public health system hobbled England's covid-19 response	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Buck D., 2020, ENGLISH LOCAL GOVT P; Finch D, 2018, TAKING OUR HLTH GRAN; NHS England, 2019, NHS LONG TERM PLAN	3	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2020	369								m1934	10.1136/bmj.m1934	http://dx.doi.org/10.1136/bmj.m1934			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JS	32439750	Bronze			2022-12-28	WOS:000538336600002
J	Oliver, D				Oliver, David			David Oliver: Covid-19 has made news out of old news	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Bottery S., 2019, WHATS YOUR PROBLEM S; British Geriatrics Society, EFF HEALTHC OLD PEOP; British Geriatrics Society, 2012, SILV BOOK GUID EM CA; Doward, 2020, GUARDIAN; FRITZ Z, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.J813; Health Foundation, 2018, TAK OUR HLTH GRANT P; Healthcare Improvement Scotland, 2015, CAR OLD PEOPL HOSP S; Local Government Association, 2020, LGA RESP PUBL HLTH G; National Institute for Health and Care Excellence, AC CRIT CAR; Nuffield Trust, 2019, CLOSING GAP KEY AREA; OLIVER D, 2018, BMJ-BRIT MED J, V361, P64805, DOI DOI 10.1136/BMJ.K2123; OLIVER D, 2019, BMJ-BRIT MED J, V367, P66225, DOI DOI 10.1136/BMJ.L6149; Oliver D., 2020, BMJ OPINION; Prin M, 2012, CURR OPIN CRIT CARE, V18, P700, DOI 10.1097/MCC.0b013e32835914d5; Royal College of Physicians, 2018, TALKING DYING BEGIN; Royal College of Physicians, 2018, NEWS2 SUPP PHYS ROL	16	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2020	369								m1979	10.1136/bmj.m1979	http://dx.doi.org/10.1136/bmj.m1979			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JK	32434755	Bronze			2022-12-28	WOS:000538335800004
J	Raj, DK; Das Mohapatra, A; Jnawali, A; Zuromski, J; Jha, A; Cham-Kpu, G; Sherman, B; Rudlaff, RM; Nixon, CE; Hilton, N; Oleinikov, AV; Chesnokov, O; Merritt, J; Pond-Tor, S; Burns, L; Jolly, G; Ben Mamoun, C; Kabyemela, E; Muehlenbachs, A; Lambert, L; Orr-Gonzalez, S; Gnadig, NF; Fidock, DA; Park, S; Dvorin, JD; Pardi, N; Weissman, D; Mui, BL; Tam, YK; Friedman, JF; Fried, M; Duffy, PE; Kurtis, JD				Raj, Dipak K.; Das Mohapatra, Alok; Jnawali, Anup; Zuromski, Jenna; Jha, Ambrish; Cham-Kpu, Gerald; Sherman, Brett; Rudlaff, Rachel M.; Nixon, Christina E.; Hilton, Nicholas; Oleinikov, Andrew V.; Chesnokov, Olga; Merritt, Jordan; Pond-Tor, Sunthorn; Burns, Lauren; Jolly, Grant; Ben Mamoun, Choukri; Kabyemela, Edward; Muehlenbachs, Atis; Lambert, Lynn; Orr-Gonzalez, Sachy; Gnadig, Nina F.; Fidock, David A.; Park, Sangshin; Dvorin, Jeffrey D.; Pardi, Norbert; Weissman, Drew; Mui, Barbara L.; Tam, Ying K.; Friedman, Jennifer F.; Fried, Michal; Duffy, Patrick E.; Kurtis, Jonathan D.			Anti-PfGARP activates programmed cell death of parasites and reduces severe malaria	NATURE			English	Article							PLASMODIUM-FALCIPARUM; LIPID NANOPARTICLES; HUMAN RESISTANCE; MESSENGER-RNA; CRISIS FORMS; VACCINE; ANTIBODIES; INDUCTION; ANEMIA; GAMMA	Malaria caused by Plasmodium falciparum remains the leading single-agent cause of mortality in children(1), yet the promise of an effective vaccine has not been fulfilled. Here, using our previously described differential screening method to analyse the proteome of blood-stage P. falciparum parasites(2), we identify P. falciparum glutamic-acid-rich protein (PfGARP) as a parasite antigen that is recognized by antibodies in the plasma of children who are relatively resistant-but not those who are susceptible-to malaria caused by P. falciparum. PfGARP is a parasite antigen of 80 kDa that is expressed on the exofacial surface of erythrocytes infected by early-to-late-trophozoite-stage parasites. We demonstrate that antibodies against PfGARP kill trophozoite-infected erythrocytes in culture by inducing programmed cell death in the parasites, and that vaccinating non-human primates with PfGARP partially protects against a challenge with P. falciparum. Furthermore, our longitudinal cohort studies showed that, compared to individuals who had naturally occurring anti-PfGARP antibodies, Tanzanian children without anti-PfGARP antibodies had a 2.5-fold-higher risk of severe malaria and Kenyan adolescents and adults without these antibodies had a twofold-higher parasite density. By killing trophozoite-infected erythrocytes, PfGARP could synergize with other vaccines that target parasite invasion of hepatocytes or the invasion of and egress from erythrocytes. Antibodies against Plasmodium falciparum glutamic-acid-rich protein (PfGARP), an antigen expressed on the surface of infected red blood cells, kill P. falciparum parasites by inducing programmed cell death and reduce the risk of severe malaria.	[Raj, Dipak K.; Das Mohapatra, Alok; Jnawali, Anup; Zuromski, Jenna; Jha, Ambrish; Cham-Kpu, Gerald; Sherman, Brett; Nixon, Christina E.; Hilton, Nicholas; Pond-Tor, Sunthorn; Burns, Lauren; Park, Sangshin; Friedman, Jennifer F.; Kurtis, Jonathan D.] Brown Univ, Rhode Isl Hosp, Med Sch, Ctr Int Hlth Res, Providence, RI 02903 USA; [Raj, Dipak K.; Das Mohapatra, Alok; Jnawali, Anup; Zuromski, Jenna; Cham-Kpu, Gerald; Nixon, Christina E.; Pond-Tor, Sunthorn; Burns, Lauren; Jolly, Grant; Kurtis, Jonathan D.] Brown Univ, Dept Pathol & Lab Med, Med Sch, Providence, RI 02912 USA; [Rudlaff, Rachel M.; Dvorin, Jeffrey D.] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA; [Rudlaff, Rachel M.; Dvorin, Jeffrey D.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Oleinikov, Andrew V.; Chesnokov, Olga; Merritt, Jordan] Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA; [Ben Mamoun, Choukri] Yale Univ, Dept Internal Med, New Haven, CT USA; [Ben Mamoun, Choukri] Yale Univ, Dept Microbial Pathogenesis, New Haven, CT USA; [Kabyemela, Edward] Seattle Biomed Res Inst, Mother Offspring Malaria Studies MOMS Project, 4 Nickerson St, Seattle, WA 98109 USA; [Kabyemela, Edward] Muheza Designated Dist Hosp, Muheza, Tanzania; [Kabyemela, Edward] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Muehlenbachs, Atis] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Atlanta, GA USA; [Lambert, Lynn; Orr-Gonzalez, Sachy; Fried, Michal; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA; [Gnadig, Nina F.; Fidock, David A.] Columbia Univ, Irving Med Ctr, Dept Microbiol & Immunol, New York, NY USA; [Fidock, David A.] Columbia Univ, Div Infect Dis, Irving Med Ctr, Dept Med, New York, NY USA; [Park, Sangshin] Univ Seoul, Grad Sch Urban Publ Hlth, Seoul, South Korea; [Pardi, Norbert; Weissman, Drew] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Mui, Barbara L.; Tam, Ying K.] Acuitas Therapeut, Vancouver, BC, Canada; [Friedman, Jennifer F.] Brown Univ, Rhode Isl Hosp, Dept Pediat, Med Sch, Providence, RI 02903 USA; [Hilton, Nicholas] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; State University System of Florida; Florida Atlantic University; Yale University; Yale University; Center for Infectious Disease Research; Muhimbili University of Health & Allied Sciences; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; University of Seoul; University of Pennsylvania; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University of California System; University of California Davis	Kurtis, JD (corresponding author), Brown Univ, Rhode Isl Hosp, Med Sch, Ctr Int Hlth Res, Providence, RI 02903 USA.; Kurtis, JD (corresponding author), Brown Univ, Dept Pathol & Lab Med, Med Sch, Providence, RI 02912 USA.	Jonathan_Kurtis@Brown.edu		Dvorin, Jeffrey/0000-0002-5883-7271; Rudlaff, Rachel/0000-0003-1191-9293	US NIH [R01-AI076353, R01-AI127699, R01-AI110699, R01-AI52059]; internal Rhode Island Hospital Research Pilot Award; Bill & Melinda Gates Foundation [1364]; Intramural Research Program of the NIH National Institute of Allergy and Infectious Diseases (NIAID), NIH [R01-AI092120]; Florida Atlantic University start-up funds; NIH [R37-AI50234, R01-AI145941, R01-AI102907]; COBRE Center for Cancer Research Development [P20GM103421]; Office of the Director at the NIH [S10 OD023461]; Intramural Research Program of the NIAID	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); internal Rhode Island Hospital Research Pilot Award; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Intramural Research Program of the NIH National Institute of Allergy and Infectious Diseases (NIAID), NIH; Florida Atlantic University start-up funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COBRE Center for Cancer Research Development; Office of the Director at the NIH; Intramural Research Program of the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank MOMS project staff for their efforts in collecting clinical data, processing samples and interpreting malarial blood smears, and we thank the study participants and their families. This work was supported by grants from the US NIH (R01-AI076353, R01-AI127699 and R01-AI110699) and an internal Rhode Island Hospital Research Pilot Award grant to J.D.K.; grants from the US NIH (R01-AI52059) and the Bill & Melinda Gates Foundation (grant no. 1364) to P.E.D.; the Intramural Research Program of the NIH National Institute of Allergy and Infectious Diseases (NIAID), NIH grant R01-AI092120 and Florida Atlantic University start-up funds to A.V.O.; NIH grant R37-AI50234 to D.A.F.; and NIH grants R01-AI145941 and R01-AI102907 to J.D.D. We also acknowledge research core services provided by the Rhode Island Hospital imaging core (G. Hovanesian), the Leduc Bioimaging Facility (G. Williams) and core services supported by the COBRE Center for Cancer Research Development (P20GM103421). The Thermo Apreo Volume Scope scanning electron microscope that was used for the serial block-face imaging was purchased with a high-end instrumentation grant from the Office of the Director at the NIH (S10 OD023461). L.L., S. O.-G., M.F. and P.E.D. are supported by the Intramural Research Program of the NIAID.	Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; BEIER JC, 1994, AM J TROP MED HYG, V50, P529, DOI 10.4269/ajtmh.1994.50.529; Bejon P, 2011, J INFECT DIS, V204, P9, DOI 10.1093/infdis/jir222; Ch'ng JH, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.97; Cham GKK, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-108; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chou ES, 2018, FEBS J, V285, P848, DOI 10.1111/febs.14370; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Egan AF, 2002, BLOOD, V99, P3863, DOI 10.1182/blood.V99.10.3863; Ellman R, 1998, ANN TROP MED PARASIT, V92, P741, DOI 10.1080/00034989858989; Engelbrecht D, 2016, PARASITOL INT, V65, P715, DOI 10.1016/j.parint.2016.07.007; Friedman JF, 2003, J INFECT DIS, V188, P449, DOI 10.1086/376596; Ganesan SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10727; Gourley IS, 2002, J INFECT DIS, V186, P1007, DOI 10.1086/342947; GUNASEKARAN K, 1994, ACTA TROP, V58, P1, DOI 10.1016/0001-706X(94)90116-3; Jayaraman M, 2012, ANGEW CHEM INT EDIT, V51, P8529, DOI 10.1002/anie.201203263; JENSEN JB, 1982, SCIENCE, V216, P1230, DOI 10.1126/science.7043736; Kabyemela ER, 2008, J INFECT DIS, V198, P163, DOI 10.1086/589512; Kurtis JD, 2001, INFECT IMMUN, V69, P123, DOI 10.1128/IAI.69.1.123-128.2001; Kurtis JD, 1999, INFECT IMMUN, V67, P3424, DOI 10.1128/IAI.67.7.3424-3429.1999; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lopez-Barragan MJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-587; Maier MA, 2013, MOL THER, V21, P1570, DOI 10.1038/mt.2013.124; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Meslin B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023867; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Mutai BK, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-S3-S6; Nixon CP, 2005, J INFECT DIS, V192, P861, DOI 10.1086/432550; OCKENHOUSE CF, 1984, J IMMUNOL, V133, P1601; Oleinikov AV, 2007, J INFECT DIS, V196, P155, DOI 10.1086/518513; Oleinikov AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031011; Oleinikov AV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000386; Pardi N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05482-0; Pardi N, 2018, J EXP MED, V215, P1571, DOI 10.1084/jem.20171450; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Pardi Norbert, 2013, Methods Mol Biol, V969, P29, DOI 10.1007/978-1-62703-260-5_2; Pulcini S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14552; Raj DK, 2014, SCIENCE, V344, P871, DOI 10.1126/science.1254417; Rudlaff RM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10214-z; The RTS,S Clinical Trials Partnership, 2011, NEW ENGL J MED, V365, P1863; Thess A, 2015, MOL THER, V23, P1456, DOI 10.1038/mt.2015.103; Tiwari P, 2019, ELECTROPHORESIS, V40, P1273, DOI 10.1002/elps.201800219; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vandana, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00790; Weissman Drew, 2013, Methods Mol Biol, V969, P43, DOI 10.1007/978-1-62703-260-5_3; World Health Organization, 2019, WORLD HLTH STAT MON	47	32	33	4	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2020	582	7810					104	+		10.1038/s41586-020-2220-1	http://dx.doi.org/10.1038/s41586-020-2220-1		APR 2020	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LY1IO	32427965	Green Accepted			2022-12-28	WOS:000528161900006
J	Bunyavanich, S; Do, A; Vicencio, A				Bunyavanich, Supinda; Do, Anh; Vicencio, Alfin			Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study compares angiotensin-converting enzyme 2 (ACE2) gene expression, which has been associated with SARS-CoV-2 cell entry, in the nasal epithelium of children vs adults.	[Bunyavanich, Supinda; Vicencio, Alfin] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Do, Anh] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Bunyavanich, S (corresponding author), Icahn Sch Med Mt Sinai, 1425 Madison Ave 1498, New York, NY 10029 USA.	supinda@post.harvard.edu			National Institutes of Health [R01 AI118833]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by National Institutes of Health grant R01 AI118833.	Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4; Chun Y, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133707; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Schouten LR, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0529-4; Wu Z, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI [10.1001/jama.2020.2648, DOI 10.1001/JAMA.2020.2648]	6	452	462	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2020	323	23					2427	2429		10.1001/jama.2020.8707	http://dx.doi.org/10.1001/jama.2020.8707			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MC6EC	32432657	Green Published, Bronze			2022-12-28	WOS:000543376700029
J	Shepherd, A				Shepherd, Alison			Covid-19: Frontline doctors continue PPE fight	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1665	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2020	369								m2188	10.1136/bmj.m2188	http://dx.doi.org/10.1136/bmj.m2188			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0KV	32487701	Bronze			2022-12-28	WOS:000548476700010
J	Coyle, D				Coyle, Diane			Economists must collaborate courageously	NATURE			English	Editorial Material						Economics; Government; Society; Policy			[Coyle, Diane] Univ Cambridge, Publ Policy, Cambridge, England; [Coyle, Diane] United Kingdoms Econ & Social Res Council, Swindon, Wilts, England	University of Cambridge	Coyle, D (corresponding author), Univ Cambridge, Publ Policy, Cambridge, England.; Coyle, D (corresponding author), United Kingdoms Econ & Social Res Council, Swindon, Wilts, England.	dc700@cam.ac.uk							0	6	6	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2020	582	7810					9	9		10.1038/d41586-020-01505-3	http://dx.doi.org/10.1038/d41586-020-01505-3			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT0TZ	32472092	Green Submitted, Bronze			2022-12-28	WOS:000536790600001
J	Morley, J; Cowls, J; Taddeo, M; Floridi, L				Morley, Jessica; Cowls, Josh; Taddeo, Mariarosaria; Floridi, Luciano			Ethical guidelines for COVID-19 tracing apps	NATURE			English	Editorial Material						SARS-CoV-2; Technology; Policy; Public health			[Morley, Jessica; Cowls, Josh; Taddeo, Mariarosaria] Univ Oxford, Oxford Internet Inst, Oxford, England; [Taddeo, Mariarosaria] Alan Turing Inst, London, England; [Floridi, Luciano] Univ Oxford, Oxford Internet Inst, Philosophy & Eth Informat, Oxford, England; [Floridi, Luciano] Alan Turing Inst, Eth Grp, London, England	University of Oxford; University of Oxford	Floridi, L (corresponding author), Univ Oxford, Oxford Internet Inst, Philosophy & Eth Informat, Oxford, England.; Floridi, L (corresponding author), Alan Turing Inst, Eth Grp, London, England.	pa.floridi@oii.ox.ac.uk	Floridi, Luciano/G-7699-2014	Floridi, Luciano/0000-0002-5444-2280				European Centre for Disease Prevention and Control, 2020, NOV COR DIS 2019 COV; European Commission, 2020, RECOMMENDATION EU; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Floridi L, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2018.0081; Keeling M. J., 2020, PREPRINT MEDRXIV, DOI [10.1101/2020.02.14.20023036, DOI 10.1101/2020.02.14.20023036]; Wiewiorowski W., 2020, EU DIGITAL SOLIDARIT	6	108	110	3	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2020	582	7810					29	31		10.1038/d41586-020-01578-0	http://dx.doi.org/10.1038/d41586-020-01578-0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT0TZ	32467596	Green Submitted, Bronze			2022-12-28	WOS:000536790600003
J	Macquart, JP; Prochaska, JX; McQuinn, M; Bannister, KW; Bhandari, S; Day, CK; Deller, AT; Ekers, RD; James, CW; Marnoch, L; Oslowski, S; Phillips, C; Ryder, SD; Scott, DR; Shannon, RM; Tejos, N				Macquart, J. P.; Prochaska, J. X.; McQuinn, M.; Bannister, K. W.; Bhandari, S.; Day, C. K.; Deller, A. T.; Ekers, R. D.; James, C. W.; Marnoch, L.; Oslowski, S.; Phillips, C.; Ryder, S. D.; Scott, D. R.; Shannon, R. M.; Tejos, N.			A census of baryons in the Universe from localized fast radio bursts	NATURE			English	Article							REIONIZATION; HALOES; ENVIRONMENT; COSMOLOGY; GALAXIES; FEEDBACK; IMPACT; GAS; SKY	More than three-quarters of the baryonic content of the Universe resides in a highly diffuse state that is difficult to detect, with only a small fraction directly observed in galaxies and galaxy clusters(1,2). Censuses of the nearby Universe have used absorption line spectroscopy(3,4) to observe the 'invisible' baryons, but these measurements rely on large and uncertain corrections and are insensitive to most of the Universe's volume and probably most of its mass. In particular, quasar spectroscopy is sensitive either to the very small amounts of hydrogen that exist in the atomic state, or to highly ionized and enriched gas(4-6) in denser regions near galaxies(7). Other techniques to observe these invisible baryons also have limitations; Sunyaev-Zel'dovich analyses(8,9) can provide evidence from gas within filamentary structures, and studies of X-ray emission are most sensitive to gas near galaxy clusters(9,10). Here we report a measurement of the baryon content of the Universe using the dispersion of a sample of localized fast radio bursts; this technique determines the electron column density along each line of sight and accounts for every ionized baryon(11-13). We augment the sample of reported arcsecond-localized(14-18) fast radio bursts with four new localizations in host galaxies that have measured redshifts of 0.291, 0.118, 0.378 and 0.522. This completes a sample sufficiently large to account for dispersion variations along the lines of sight and in the host-galaxy environments(11), and we derive a cosmic baryon density of Omega(b) = 0.051(-0.025)(+0.021)h(70)(-1) (95 per cent confidence; h(70) = H-0/(70 km s(-1) Mpc(-1)) and H-0 is Hubble's constant). This independent measurement is consistent with values derived from the cosmic microwave background and from Big Bang nucleosynthesis(19,20).	[Macquart, J. P.; Ekers, R. D.; James, C. W.; Scott, D. R.] Curtin Univ, Int Ctr Radio Astron Res, Curtin Inst Radio Astron, Perth, WA, Australia; [Prochaska, J. X.] Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA; [Prochaska, J. X.] Kavli Inst Phys & Math Universe, Kashiwa, Chiba, Japan; [McQuinn, M.] Univ Washington, Astron Dept, Seattle, WA 98195 USA; [Bannister, K. W.; Bhandari, S.; Day, C. K.; Ekers, R. D.; Marnoch, L.; Phillips, C.] Commonwearth Sci & Ind Res Org, Australia Telescope Natl Facil, Epping, NSW, Australia; [Day, C. K.; Deller, A. T.; Oslowski, S.; Shannon, R. M.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic, Australia; [Marnoch, L.; Ryder, S. D.] Macquarie Univ, Dept Phys & Astron, N Ryde, NSW, Australia; [Tejos, N.] Pontificia Univ Catolica Valparaiso, Inst Fis, Valparaiso, Chile	Curtin University; University of California System; University of California Santa Cruz; University of Tokyo; University of Washington; University of Washington Seattle; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Swinburne University of Technology; Macquarie University; Pontificia Universidad Catolica de Valparaiso	Macquart, JP (corresponding author), Curtin Univ, Int Ctr Radio Astron Res, Curtin Inst Radio Astron, Perth, WA, Australia.; Prochaska, JX (corresponding author), Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA.; Prochaska, JX (corresponding author), Kavli Inst Phys & Math Universe, Kashiwa, Chiba, Japan.	J.Macquart@curtin.edu.au; xavier@ucolick.org	Phillips, Chris/T-3633-2019; Oslowski, Stefan/AAI-7959-2021; Ekers, Ron/AAY-6012-2020; Shannon, Ryan/AAW-8522-2020; Shannon, Ryan/ABD-6796-2021; James, Clancy/G-9178-2015	Phillips, Chris/0000-0002-5851-5264; Oslowski, Stefan/0000-0003-0289-0732; Ekers, Ron/0000-0002-3532-9928; Shannon, Ryan/0000-0002-7285-6348; Shannon, Ryan/0000-0002-7285-6348; Bannister, Keith/0000-0003-2149-0363; Ryder, Stuart/0000-0003-4501-8100; Macquart, Jean-Pierre/0000-0001-6763-8234; Bhandari, Shivani/0000-0003-3460-506X; Prochaska, J. Xavier/0000-0002-7738-6875; James, Clancy/0000-0002-6437-6176; Deller, Adam/0000-0001-9434-3837; Day, Cherie K./0000-0002-8101-3027; Marnoch, Lachlan/0000-0003-1483-0147; Tejos, Nicolas/0000-0002-1883-4252	Australian Research Council (ARC) [DP180100857]; ARC [CE170100004, FL150100148, FT150100415, FT190100155]; FONDECYT [11191217]; PUCV/VRIEA project [039.395/2019]; Australian Government; National Collaborative Research Infrastructure Strategy; Government of Western Australia; Science and Industry Endowment Fund; ESO programmes [0102.A-0450(A), 0103.A-0101(A), 0103.A-1010(B)]; Swinburne University of Technology; National Collaborative Research Infrastructure Strategy (NCRIS); Gemini Observatory [GS-2019B-Q-132]	Australian Research Council (ARC)(Australian Research Council); ARC(Australian Research Council); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); PUCV/VRIEA project; Australian Government(Australian GovernmentCGIAR); National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science); Government of Western Australia; Science and Industry Endowment Fund; ESO programmes; Swinburne University of Technology; National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science); Gemini Observatory	We thank H. Yang and L. Infante for providing IMACS imaging around FRB 190611 that informed the further follow-up observations on VLT and Gemini-S presented here. We are grateful to Australia Telescope National Facility (ATNF) operations staff and to Murchison Radio-astronomy Observatory staff for supporting our ASKAP operations, and the ATNF steering committee for allocating time for these observations. K.W.B., J.-P.M. and R.M.S. acknowledge support by Australian Research Council (ARC) grant DP180100857. A.T.D. and R.M.S. are the recipients of ARC Future Fellowships FT150100415 and FT190100155 respectively. S.O. and R.M.S. acknowledge support through ARC grant FL150100148. R.M.S. also acknowledges support through ARC grant CE170100004. N.T. acknowledges support from FONDECYT grant 11191217 and PUCV/VRIEA project 039.395/2019. The Australian Square Kilometre Array Pathfinder and Australia Telescope Compact Array are part of the Australia Telescope National Facility which is managed by CSIRO. Operation of ASKAP is funded by the Australian Government with support from the National Collaborative Research Infrastructure Strategy. ASKAP uses the resources of the Pawsey Supercomputing Centre. Establishment of ASKAP, the Murchison Radio-astronomy Observatory and the Pawsey Supercomputing Centre are initiatives of the Australian Government, with support from the Government of Western Australia and the Science and Industry Endowment Fund. Part of this work was performed on the OzSTAR national facility at Swinburne University of Technology. OzSTAR is funded by Swinburne University of Technology and the National Collaborative Research Infrastructure Strategy (NCRIS). We acknowledge the Wajarri Yamatji as the traditional owners of the Murchison Radio-astronomy Observatory site. This work includes observations collected at the European Southern Observatory under ESO programmes 0102.A-0450(A), 0103.A-0101(A) and 0103.A-1010(B). This work includes data obtained from programme GS-2019B-Q-132 at the Gemini Observatory, acquired through the Gemini Observatory Archive and processed using the Gemini PYRAF package. Gemini Observatory is operated by the Association of Universities for Research in Astronomy, Inc., under a cooperative agreement with the NSF on behalf of the Gemini partnership: the National Science Foundation (US), the National Research Council (Canada), CONICYT (Chile), Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina), Ministerio da Ciencia, Tecnologia e Inovacao (Brazil), and Korea Astronomy and Space Science Institute (Republic of Korea). PYRAF is a product of the Space Telescope Science Institute, which is operated by AURA for NASA.	Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; Abbott TMC, 2018, ASTROPHYS J SUPPL S, V239, DOI 10.3847/1538-4365/aae9f0; Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Akahori T, 2010, ASTROPHYS J, V723, P476, DOI 10.1088/0004-637X/723/1/476; Appenzeller I., 1998, ESO MESSENGER, V94, P1; Bannister KW, 2019, SCIENCE, V365, P565, DOI 10.1126/science.aaw5903; BECKER RH, 1995, ASTROPHYS J, V450, P559, DOI 10.1086/176166; Bernet ML, 2008, NATURE, V454, P302, DOI 10.1038/nature07105; Berriman GB, 2017, PUBL ASTRON SOC PAC, V129, DOI 10.1088/1538-3873/aa5456; Bhandari S., ASTROPHYS J; Bhat NDR, 2004, ASTROPHYS J, V605, P759, DOI 10.1086/382680; Cen RY, 2006, ASTROPHYS J, V650, P560, DOI 10.1086/506505; Chatterjee S, 2017, NATURE, V541, P58, DOI 10.1038/nature20797; Connor L, 2019, MON NOT R ASTRON SOC, V487, P5753, DOI 10.1093/mnras/stz1666; Cooke RJ, 2018, ASTROPHYS J, V855, DOI 10.3847/1538-4357/aaab53; Cordes J. M., 2002, PREPRINT; de Graaff A, 2019, ASTRON ASTROPHYS, V624, DOI 10.1051/0004-6361/201935159; Debackere SNB, 2020, MON NOT R ASTRON SOC, V492, P2285, DOI 10.1093/mnras/stz3446; Deller AT, 2011, PUBL ASTRON SOC PAC, V123, P275, DOI 10.1086/658907; Deng W, 2014, ASTROPHYS J LETT, V783, DOI 10.1088/2041-8205/783/2/L35; Eckert D, 2015, NATURE, V528, P105, DOI 10.1038/nature16058; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Faucher-Giguere CA, 2011, MON NOT R ASTRON SOC, V417, P2982, DOI 10.1111/j.1365-2966.2011.19457.x; Fielding D, 2017, MON NOT R ASTRON SOC, V466, P3810, DOI 10.1093/mnras/stw3326; Freudling W, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201322494; Fukugita M, 2004, ASTROPHYS J, V616, P643, DOI 10.1086/425155; Fukugita M, 1998, ASTROPHYS J, V503, P518, DOI 10.1086/306025; Gaensler BM, 2008, PUBL ASTRON SOC AUST, V25, P184, DOI 10.1071/AS08004; Gimeno G, 2016, PROC SPIE, V9908, DOI 10.1117/12.2233883; Greisen E.W., 2003, INFORM HANDLING ASTR, P109; Hafen Z, 2019, MON NOT R ASTRON SOC, V488, P1248, DOI 10.1093/mnras/stz1773; Inoue S, 2004, MON NOT R ASTRON SOC, V348, P999, DOI 10.1111/j.1365-2966.2004.07359.x; Jaroszynski M, 2019, MON NOT R ASTRON SOC, V484, P1637, DOI 10.1093/mnras/sty3529; Kettenis M., 2006, ASP C SER VOL 351, V351, P497; Krishnakumar MA, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/1/23; Lang D, 2010, ASTRON J, V139, P1782, DOI 10.1088/0004-6256/139/5/1782; Lindegren L, 2018, ASTRON ASTROPHYS, V616, DOI 10.1051/0004-6361/201832727; Macquart JP, 2018, MON NOT R ASTRON SOC, V480, P4211, DOI 10.1093/mnras/sty2083; Macquart J. P., 2015, ADV ASTROPHYSICS SQU, P55; Madau P, 2014, ANNU REV ASTRON ASTR, V52, P415, DOI 10.1146/annurev-astro-081811-125615; Mahony EK, 2018, ASTROPHYS J LETT, V867, DOI 10.3847/2041-8213/aae7cb; Marcote B, 2020, NATURE, V577, P190, DOI 10.1038/s41586-019-1866-z; McQuinn M, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/2/L33; Michilli D, 2018, NATURE, V553, P182, DOI 10.1038/nature25149; Miralda-Escude J, 2000, ASTROPHYS J, V530, P1, DOI 10.1086/308330; Nicastro F, 2018, NATURE, V558, P406, DOI 10.1038/s41586-018-0204-1; Noh Y, 2014, MON NOT R ASTRON SOC, V444, P503, DOI 10.1093/mnras/stu1412; Novikov A., 2019, J OPEN SOURCE SOFTWA, V4, P1230, DOI DOI 10.21105/JOSS.01230; Oppermann N, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201118526; Planck Collaboration, 2018, PREPRINT; Prochaska JX, 2017, ASTRON COMPUT, V19, P27, DOI 10.1016/j.ascom.2017.03.003; Prochaska JX, 2019, SCIENCE, V366, P231, DOI 10.1126/science.aay0073; Prochaska JX, 2019, MON NOT R ASTRON SOC, V485, P648, DOI 10.1093/mnras/stz261; Ravi V, 2019, NATURE, V572, P352, DOI 10.1038/s41586-019-1389-7; Ravi V, 2016, SCIENCE, V354, P1249, DOI 10.1126/science.aaf6807; Schnitzeler DHFM, 2012, MON NOT R ASTRON SOC, V427, P664, DOI 10.1111/j.1365-2966.2012.21869.x; Sharma P, 2012, MON NOT R ASTRON SOC, V427, P1219, DOI 10.1111/j.1365-2966.2012.22050.x; Shull JM, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/23; Tripp TM, 2002, ASTROPHYS J, V575, P697, DOI 10.1086/341338; Tumlinson J, 2011, SCIENCE, V334, P948, DOI 10.1126/science.1209840; Vernet J, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201117752; Voit GM, 2019, ASTROPHYS J, V880, DOI 10.3847/1538-4357/ab2bfd; Walters A, 2019, PHYS REV D, V100, DOI 10.1103/PhysRevD.100.103519; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Wright EL, 2006, PUBL ASTRON SOC PAC, V118, P1711, DOI 10.1086/510102; Yao JM, 2017, ASTROPHYS J, V835, DOI 10.3847/1538-4357/835/1/29	68	217	218	3	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 28	2020	581	7809					391	+		10.1038/s41586-020-2300-2	http://dx.doi.org/10.1038/s41586-020-2300-2			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX9ZJ	32461651	Green Submitted			2022-12-28	WOS:000576060000001
J	Zhang, LM; Ellis, RJ; Ma, MX; Cheung, EO; Hoyt, DB; Bilimoria, KY; Hu, YY				Zhang, Lindsey M.; Ellis, Ryan J.; Ma, Meixi; Cheung, Elaine O.; Hoyt, David B.; Bilimoria, Karl Y.; Hu, Yue-Yung			Prevalence, Types, and Sources of Bullying Reported by US General Surgery Residents in 2019	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							QUESTIONNAIRE		[Zhang, Lindsey M.; Ellis, Ryan J.; Ma, Meixi; Cheung, Elaine O.; Bilimoria, Karl Y.; Hu, Yue-Yung] Northwestern Univ, Surg Outcomes & Qual Improvement Ctr SOQIC, Chicago, IL 60611 USA; [Hoyt, David B.] Amer Coll Surg, Chicago, IL USA	Northwestern University; American College of Surgeons	Hu, YY (corresponding author), Northwestern Univ, Surg Outcomes & Qual Improvement Ctr SOQIC, Dept Surg, Feinberg Sch Med, 633 N St Clair St,20th Floor, Chicago, IL 60611 USA.	yue-yung.hu@northwestern.edu	Hu, Yue/HGE-1673-2022	Ellis, Ryan/0000-0003-2637-9445; Ma, Meixi/0000-0003-4887-4586	Accreditation Council for Graduate Medical Education; American College of Surgeons; John A. Hartford Foundation	Accreditation Council for Graduate Medical Education; American College of Surgeons; John A. Hartford Foundation	Funding for this work was provided by the Accreditation Council for Graduate Medical Education and the American College of Surgeons. Dr Zhang was supported with funding from the John A. Hartford Foundation.	Conway PM, 2018, ANN WORK EXPOS HEAL, V62, P281, DOI 10.1093/annweh/wxx105; Hu YY, 2019, NEW ENGL J MED, V381, P1741, DOI 10.1056/NEJMsa1903759; Ling M, 2016, WORLD J SURG, V40, P2560, DOI 10.1007/s00268-016-3642-7; Paice E, 2004, BRIT MED J, V329, P658, DOI 10.1136/bmj.38133.502569.AE; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	5	21	22	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					2093	2095		10.1001/jama.2020.2901	http://dx.doi.org/10.1001/jama.2020.2901			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU8UM	32453357	Green Published, Bronze			2022-12-28	WOS:000538023900045
J	Domcke, W; Sobolewski, AL				Domcke, Wolfgang; Sobolewski, Andrzej L.			Tracking both ultrafast electrons and nuclei	SCIENCE			English	Editorial Material							BENZENE		[Domcke, Wolfgang] Tech Univ Munich, Dept Chem, Munich, Germany; [Sobolewski, Andrzej L.] Polish Acad Sci Warsaw, Inst Phys, Warsaw, Poland	Technical University of Munich; University of Munich; Polish Academy of Sciences	Domcke, W (corresponding author), Tech Univ Munich, Dept Chem, Munich, Germany.	domcke@ch.tum.de						Boldissar S, 2018, PHYS CHEM CHEM PHYS, V20, P9701, DOI 10.1039/c8cp01236a; BRYCESMITH D, 1966, CHEM COMMUN, P559, DOI 10.1039/c19660000559; CALLOMON JH, 1972, CHEM PHYS LETT, V13, P125, DOI 10.1016/0009-2614(72)80059-9; KATO S, 1988, J CHEM PHYS, V88, P3045, DOI 10.1063/1.454731; Lobastov VA, 2001, J PHYS CHEM A, V105, P11159, DOI 10.1021/jp013705b; PALMER IJ, 1993, J AM CHEM SOC, V115, P673, DOI 10.1021/ja00055a042; RIEDLE E, 1989, J CHEM PHYS, V91, P4555, DOI 10.1063/1.456743; Shen X, 2019, STRUCT DYNAM-US, V6, DOI 10.1063/1.5120864; SOBOLEWSKI AL, 1993, J CHEM PHYS, V98, P5627, DOI 10.1063/1.464907; Yang J, 2020, SCIENCE, V368, P885, DOI 10.1126/science.abb2235; Yarkony D. R., 2004, CONICAL INTERSACTION	11	3	3	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					820	821		10.1126/science.abb9937	http://dx.doi.org/10.1126/science.abb9937			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU2DD	32439776				2022-12-28	WOS:000537569500022
J	Andrade, RD				Andrade, Rodrigo de Oliveira			Covid-19: Brazil now has third highest number of cases behind US and Russia	BMJ-BRITISH MEDICAL JOURNAL			English	News Item													de Oliveira Andrade, Rodrigo/AAC-3184-2020					Alvez G, 2020, BRAZIL SURPASSES MAR; [Anonymous], 2020, JUDICIARIO VAI MONIT; Paraguassu L, 2020, REUTERS; Sanchez A, 2020, CADERNOS SAUDE PUBLI	4	4	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2020	369								m2059	10.1136/bmj.m2059	http://dx.doi.org/10.1136/bmj.m2059			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JS	32439729	Bronze			2022-12-28	WOS:000538336600018
J	Sevestre, J; Kopec, L				Sevestre, Jacques; Kopec, Lora			Disseminated Fusariosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								An 8-year-old boy undergoing treatment for relapsing B-cell leukemia presented with subcutaneous nodules on the trunk, arms, and legs. A biopsy specimen showed septated hyphae and spores. The fungus Fusarium dimerum was identified in culture.	[Sevestre, Jacques; Kopec, Lora] IHU Mediterranee Infect, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite	Sevestre, J (corresponding author), IHU Mediterranee Infect, Marseille, France.	sevestre.j@chu-nice.fr	Sevestre, Jacques/AAU-8216-2020	Sevestre, Jacques/0000-0001-8020-0050					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2020	382	21							e64	10.1056/NEJMicm1911084	http://dx.doi.org/10.1056/NEJMicm1911084			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LT1TD	32433840				2022-12-28	WOS:000536856000004
J	Dyer, C				Dyer, Clare			Covid-19: Intensive care consultant has suspension cut short to help fight pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2020	369								m2040	10.1136/bmj.m2040	http://dx.doi.org/10.1136/bmj.m2040			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JK	32434904	Bronze			2022-12-28	WOS:000538335800014
J	Burberry, A; Wells, MF; Limone, F; Couto, A; Smith, KS; Keaney, J; Gillet, G; van Gastel, N; Wang, JY; Pietilainen, O; Qian, ML; Eggan, P; Cantrell, C; Mok, J; Kadiu, I; Scadden, DT; Eggan, K				Burberry, Aaron; Wells, Michael F.; Limone, Francesco; Couto, Alexander; Smith, Kevin S.; Keaney, James; Gillet, Gaelle; van Gastel, Nick; Wang Jin-Yuan; Pietilainen, Olli; Qian Menglu; Eggan, Pierce; Cantrell, Christopher; Mok, Joanie; Kadiu, Irena; Scadden, David T.; Eggan, Kevin			C9orf72 suppresses systemic and neural inflammation induced by gut bacteria	NATURE			English	Article							MICROGLIA; NEUROINFLAMMATION; REPEAT; ALS; MICROBIOME; EXPANSION; TOXICITY; MICE	A hexanucleotide-repeat expansion in C9ORF72 is the most common genetic variant that contributes to amyotrophic lateral sclerosis and frontotemporal dementia(1,2). The C9ORF72 mutation acts through gain- and loss-of-function mechanisms to induce pathways that are implicated in neural degeneration(3-9). The expansion is transcribed into a long repetitive RNA, which negatively sequesters RNA-binding proteins(5) before its non-canonical translation into neural-toxic dipeptide proteins(3,4). The failure of RNA polymerase to read through the mutation also reduces the abundance of the endogenous C9ORF72 gene product, which functions in endolysosomal pathways and suppresses systemic and neural inflammation(6-9). Notably, the effects of the repeat expansion act with incomplete penetrance in families with a high prevalence of amyotrophic lateral sclerosis or frontotemporal dementia, indicating that either genetic or environmental factors modify the risk of disease for each individual. Identifying disease modifiers is of considerable translational interest, as it could suggest strategies to diminish the risk of developing amyotrophic lateral sclerosis or frontotemporal dementia, or to slow progression. Here we report that an environment with reduced abundance of immune-stimulating bacteria(10,11) protects C9orf72-mutant mice from premature mortality and significantly ameliorates their underlying systemic inflammation and autoimmunity. Consistent with C9orf72 functioning to prevent microbiota from inducing a pathological inflammatory response, we found that reducing the microbial burden in mutant mice with broad spectrum antibiotics-as well as transplanting gut microflora from a protective environment-attenuated inflammatory phenotypes, even after their onset. Our studies provide further evidence that the microbial composition of our gut has an important role in brain health and can interact in surprising ways with well-known genetic risk factors for disorders of the nervous system. Reduced abundance of immune-stimulating gut bacteria ameliorated the inflammatory and autoimmune phenotypes of mice with mutations in C9orf72, which in the human orthologue are linked to amyotrophic lateral sclerosis and frontotemporal dementia.	[Burberry, Aaron; Wells, Michael F.; Limone, Francesco; Couto, Alexander; Smith, Kevin S.; van Gastel, Nick; Wang Jin-Yuan; Pietilainen, Olli; Qian Menglu; Eggan, Pierce; Cantrell, Christopher; Mok, Joanie; Scadden, David T.; Eggan, Kevin] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Burberry, Aaron; Wells, Michael F.; Limone, Francesco; Couto, Alexander; Smith, Kevin S.; Wang Jin-Yuan; Pietilainen, Olli; Qian Menglu; Eggan, Pierce; Cantrell, Christopher; Mok, Joanie; Eggan, Kevin] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Limone, Francesco] Royal Netherlands Acad Arts & Sci, Hubrecht Inst Dev Biol & Stem Cell Res, Utrecht, Netherlands; [Keaney, James; Gillet, Gaelle; Kadiu, Irena] UCB Biopharma SPRL, Neurosci Therapeut Area, New Med, Braine Lalleud, Belgium; [van Gastel, Nick; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Qian Menglu; Eggan, Kevin] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Harvard University; Massachusetts General Hospital; Harvard University	Eggan, K (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Eggan, K (corresponding author), Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.; Eggan, K (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	Eggan@mcb.harvard.edu	van Gastel, Nick/AFQ-4727-2022; van Gastel, Nick/P-7610-2018	van Gastel, Nick/0000-0002-0563-3590; Wells, Michael/0000-0002-1367-2565; Eggan, Pierce/0000-0001-6134-4569	Merkin Fund at the Broad Institute, Target ALS; NIH [5R01NS089742, 5K99AG057808-02, 1K99MH119327-01]; Harvard Stem Cell Institute; UCB	Merkin Fund at the Broad Institute, Target ALS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; UCB(UCB Pharma SA)	Support to K.E. was provided by The Merkin Fund at the Broad Institute, Target ALS, NIH 5R01NS089742, Harvard Stem Cell Institute and UCB. A.B. was supported by NIH 5K99AG057808-02, M.F.W. was supported by NIH 1K99MH119327-01. We thank J. Wang for providing faeces from mice housed Johns Hopkins University.	Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Atanasio A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23204; Blacher E, 2019, NATURE, V572, P474, DOI 10.1038/s41586-019-1443-5; Brenner D, 2018, NEUROBIOL AGING, V61, P132, DOI 10.1016/j.neurobiolaging.2017.09.023; Burberry A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6038; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Fang X, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01479; Flannigan KL, 2018, IMMUNOLOGY, V154, P537, DOI 10.1111/imm.12950; Fredi M, 2019, NEUROMOL MED, V21, P150, DOI 10.1007/s12017-019-08528-8; Harach T, 2017, SCI REP-UK, V7, DOI 10.1038/srep41802; He L, 2006, J IMMUNOL, V177, P3644, DOI 10.4049/jimmunol.177.6.3644; Henderson KS, 2013, J AM ASSOC LAB ANIM, V52, P763; Jiang J, 2016, NEURON, V90, P535, DOI 10.1016/j.neuron.2016.04.006; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Lall D, 2017, J CLIN INVEST, V127, P3250, DOI 10.1172/JCI90607; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; McCauley ME, 2019, ACTA NEUROPATHOL, V137, P715, DOI 10.1007/s00401-018-1933-9; Miller ZA, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000301; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Nassif M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00442; Nilsson HO, 2004, J CLIN MICROBIOL, V42, P3781, DOI 10.1128/JCM.42.8.3781-3788.2004; O'Rourke JG, 2016, SCIENCE, V351, P1324, DOI 10.1126/science.aaf1064; Olson CA, 2018, CELL, V173, P1728, DOI [10.1016/j.cell.2018.06.051, 10.1016/j.cell.2018.04.027]; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Shi YX, 2018, NAT MED, V24, P313, DOI 10.1038/nm.4490; Stine JG, 2013, CLIN LIVER DIS, V17, P609, DOI 10.1016/j.cld.2013.07.008; Tremlett H, 2017, ANN NEUROL, V81, P369, DOI 10.1002/ana.24901; Ugolino J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006443; Whary MT, 2004, COMPARATIVE MED, V54, P128; Zhai R, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00239; Zhang GX, 2002, EXP MOL PATHOL, V73, P35, DOI 10.1006/exmp.2002.2441; Zhang YY, 2018, GENE DEV, V32, P929, DOI 10.1101/gad.313932.118; Zhao WH, 2013, J NEUROIMMUNE PHARM, V8, P888, DOI 10.1007/s11481-013-9489-x; Zondler L, 2016, ACTA NEUROPATHOL, V132, P391, DOI 10.1007/s00401-016-1548-y	40	93	96	4	90	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 4	2020	582	7810					89	+		10.1038/s41586-020-2288-7	http://dx.doi.org/10.1038/s41586-020-2288-7		MAY 2020	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QP3TF	32483373	Green Accepted			2022-12-28	WOS:000532688300001
J	Li, L; Zhang, W; Hu, Y; Tong, XL; Zheng, SE; Yang, JT; Kong, YJ; Ren, LL; Wei, Q; Mei, H; Hu, CY; Tao, CH; Yang, R; Wang, J; Yu, YP; Guo, Y; Wu, XX; Xu, ZH; Zeng, L; Xiong, N; Chen, LF; Wang, J; Man, N; Liu, Y; Xu, HX; Deng, E; Zhang, XJ; Li, CY; Wang, CH; Su, SS; Zhang, LQ; Wang, JW; Wu, YY; Liu, Z				Li, Ling; Zhang, Wei; Hu, Yu; Tong, Xunliang; Zheng, Shangen; Yang, Juntao; Kong, Yujie; Ren, Lili; Wei, Qing; Mei, Heng; Hu, Caiying; Tao, Cuihua; Yang, Ru; Wang, Jue; Yu, Yongpei; Guo, Yong; Wu, Xiaoxiong; Xu, Zhihua; Zeng, Li; Xiong, Nian; Chen, Lifeng; Wang, Juan; Man, Ning; Liu, Yu; Xu, Haixia; Deng, E.; Zhang, Xuejun; Li, Chenyue; Wang, Conghui; Su, Shisheng; Zhang, Linqi; Wang, Jianwei; Wu, Yanyun; Liu, Zhong			Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Importance Convalescent plasma is a potential therapeutic option for patients with coronavirus disease 2019 (COVID-19), but further data from randomized clinical trials are needed. Objective To evaluate the efficacy and adverse effects of convalescent plasma therapy for patients with COVID-19. Design, Setting, and Participants Open-label, multicenter, randomized clinical trial performed in 7 medical centers in Wuhan, China, from February 14, 2020, to April 1, 2020, with final follow-up April 28, 2020. The trial included 103 participants with laboratory-confirmed COVID-19 that was severe (respiratory distress and/or hypoxemia) or life-threatening (shock, organ failure, or requiring mechanical ventilation). The trial was terminated early after 103 of a planned 200 patients were enrolled. Intervention Convalescent plasma in addition to standard treatment (n = 52) vs standard treatment alone (control) (n = 51), stratified by disease severity. Main Outcomes and Measures Primary outcome was time to clinical improvement within 28 days, defined as patient discharged alive or reduction of 2 points on a 6-point disease severity scale (ranging from 1 [discharge] to 6 [death]). Secondary outcomes included 28-day mortality, time to discharge, and the rate of viral polymerase chain reaction (PCR) results turned from positive at baseline to negative at up to 72 hours. Results Of 103 patients who were randomized (median age, 70 years; 60 [58.3%] male), 101 (98.1%) completed the trial. Clinical improvement occurred within 28 days in 51.9% (27/52) of the convalescent plasma group vs 43.1% (22/51) in the control group (difference, 8.8% [95% CI, -10.4% to 28.0%]; hazard ratio [HR], 1.40 [95% CI, 0.79-2.49]; P = .26). Among those with severe disease, the primary outcome occurred in 91.3% (21/23) of the convalescent plasma group vs 68.2% (15/22) of the control group (HR, 2.15 [95% CI, 1.07-4.32]; P = .03); among those with life-threatening disease the primary outcome occurred in 20.7% (6/29) of the convalescent plasma group vs 24.1% (7/29) of the control group (HR, 0.88 [95% CI, 0.30-2.63]; P = .83) (P for interaction = .17). There was no significant difference in 28-day mortality (15.7% vs 24.0%; OR, 0.59 [95% CI, 0.22-1.59]; P = .30) or time from randomization to discharge (51.0% vs 36.0% discharged by day 28; HR, 1.61 [95% CI, 0.88-2.95]; P = .12). Convalescent plasma treatment was associated with a negative conversion rate of viral PCR at 72 hours in 87.2% of the convalescent plasma group vs 37.5% of the control group (OR, 11.39 [95% CI, 3.91-33.18]; P < .001). Two patients in the convalescent plasma group experienced adverse events within hours after transfusion that improved with supportive care. Conclusion and Relevance Among patients with severe or life-threatening COVID-19, convalescent plasma therapy added to standard treatment, compared with standard treatment alone, did not result in a statistically significant improvement in time to clinical improvement within 28 days. Interpretation is limited by early termination of the trial, which may have been underpowered to detect a clinically important difference.	[Li, Ling; Kong, Yujie; Wang, Jue; Liu, Yu; Xu, Haixia; Deng, E.; Zhang, Xuejun; Li, Chenyue; Liu, Zhong] Chinese Acad Med Sci & Peking Union Med Coll, Inst Blood Transfus, 26 Huacai Rd, Chengdu 610052, Peoples R China; [Li, Ling; Kong, Yujie; Wang, Jue; Xu, Haixia; Li, Chenyue; Liu, Zhong] CAMS, Key Lab Transfus Adverse React, Chengdu, Peoples R China; [Zhang, Wei; Zeng, Li] Guanggu Dist Maternal & Child Hlth Hosp Hubei Pro, Wuhan, Peoples R China; [Zhang, Wei] Second Mil Med Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Shanghai, Peoples R China; [Hu, Yu; Mei, Heng] Huazhong Univ Sci & Technol, Inst Hematol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China; [Tong, Xunliang] Beijing Hosp, Dept Pulm & Crit Care Med, Natl Resp Qual Control Ctr, Natl Ctr Gerontol, Beijing, Peoples R China; [Zheng, Shangen] Gen Hosp Cent Theater Command PLA, Dept Transfus, Wuhan, Peoples R China; [Yang, Juntao] Chinese Acad Med Sci & Peking Union, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing, Beijing, Peoples R China; [Ren, Lili; Wang, Conghui; Wang, Jianwei] Chinese Acad Med Sci & Peking Union Med Coll, NHC Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing, Peoples R China; [Ren, Lili; Wang, Conghui; Wang, Jianwei] Chinese Acad Med Sci & Peking Union Med Coll, Christophe Merieux Lab, Inst Pathogen Biol, Beijing, Peoples R China; [Ren, Lili; Wang, Jianwei] Chinese Acad Med Sci & Peking Union Med Coll, Key Lab Resp Dis Pathogen, Beijing, Peoples R China; [Wei, Qing; Wang, Juan] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Blood Transfus, Tongji Med Coll, Wuhan, Peoples R China; [Hu, Caiying; Xu, Zhihua; Xiong, Nian] Wuhan Red Cross Hosp, Wuhan, Peoples R China; [Tao, Cuihua] Wuhan Asia Heart Hosp, Dept Blood Transfus, Wuhan, Peoples R China; [Tao, Cuihua] Wuhan Asia Gen Hosp, Dept Blood Transfus, Wuhan, Peoples R China; [Yang, Ru] Wuhan Blood Ctr, Wuhan, Peoples R China; [Yu, Yongpei] Peking Univ, Clin Res Inst, Hlth Sci Ctr, Beijing, Peoples R China; [Guo, Yong; Su, Shisheng] Tsinghua Univ, Sch Med, Dept Biomed Engn, Beijing, Peoples R China; [Wu, Xiaoxiong] Huazhong Univ Sci & Technol, Dept Emergency, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China; [Xu, Zhihua] Mianyang Cent Hosp, Mianyang, Sichuan, Peoples R China; [Zeng, Li] Second Mil Med Univ, Affiliated Hosp 1, Dept Organ Transplantat, Shanghai, Peoples R China; [Xiong, Nian] Huazhong Univ Sci & Technol, Dept Neurol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China; [Chen, Lifeng] Wuhan Pulm Hosp, Wuhan, Peoples R China; [Man, Ning] Wuhan Asia Gen Hosp, Dept Resp Med, Wuhan, Peoples R China; [Zhang, Linqi] Tsinghua Univ, Ctr Global Hlth & Infect Dis, Comprehens AIDS Res Ctr, Beijing, Peoples R China; [Zhang, Linqi] Tsinghua Univ, Sch Med, Beijing Adv Innovat Ctr Struct Biol, Beijing, Peoples R China; [Wu, Yanyun] Univ Miami, Dept Pathol, 1611 NW 12th Ave, Miami, FL 33136 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Naval Medical University; Huazhong University of Science & Technology; Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Huazhong University of Science & Technology; Peking University; Tsinghua University; Huazhong University of Science & Technology; Naval Medical University; Huazhong University of Science & Technology; Tsinghua University; Tsinghua University; University of Miami	Liu, Z (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Blood Transfus, 26 Huacai Rd, Chengdu 610052, Peoples R China.; Wu, YY (corresponding author), Univ Miami, Dept Pathol, 1611 NW 12th Ave, Miami, FL 33136 USA.	yxw1366@med.miami.edu; liuz@ibt.pumc.edu.cn	Liu, Zhong/ABH-8584-2020; Zhang, Wei/AAE-9322-2021; Wang, Jue/GWU-7207-2022; Wang, Jianwei/AAW-9499-2020; ZHANG, LIN/GYD-9123-2022; Wang, Jianwei/W-5916-2019	Zhang, Wei/0000-0001-5292-7308; Wang, Jue/0000-0002-2498-7335; Wang, Jianwei/0000-0002-1116-4559; 	Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (CIFMS) [2020-I2M-CoV19-006, 2016-I2M-3-024, 2017-I2M-1-009]; Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences [2018PT32016]	Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (CIFMS); Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences	This work was supported by the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (CIFMS) grants 2020-I2M-CoV19-006, 2016-I2M-3-024 (Dr Z. Liu), and 2017-I2M-1-009 (Dr L. Li) and the Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences grant 2018PT32016 (Dr Z. Liu).	[Anonymous], DAIL UPD COV 19; [Anonymous], 2019, ANN SHOT SERIOUS HAZ; Arabi YM, 2016, EMERG INFECT DIS, V22, P1554, DOI 10.3201/eid2209.151164; Beigel JH, 2019, LANCET RESP MED, V7, P941, DOI 10.1016/S2213-2600(19)30199-7; Cheng Y, 2005, EUR J CLIN MICROBIOL, V24, P44, DOI 10.1007/s10096-004-1271-9; Duan Kai, 2020, Proc Natl Acad Sci U S A, V117, P9490, DOI 10.1073/pnas.2004168117; Garraud O, 2016, TRANSFUS CLIN BIOL, V23, P39, DOI 10.1016/j.tracli.2015.12.003; Kleinbaum DG, 1996, SURVIVAL ANAL STAT H, P183; Kraft CS, 2015, CLIN INFECT DIS, V61, P496, DOI 10.1093/cid/civ334; National Health Commission of the People's Republic of China, COV 19 TREATM PLAN T; Network WBR, 2017, POS PAP US CONV PLAS; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Soo YOY, 2004, CLIN MICROBIOL INFEC, V10, P676, DOI 10.1111/j.1469-0691.2004.00956.x; U.S. Food & Drug Administration, 2020, REC INV COVID 19 CON; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; Wu Z, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI [10.1001/jama.2020.2648, DOI 10.1001/JAMA.2020.2648]; Yeh KM, 2005, J ANTIMICROB CHEMOTH, V56, P919, DOI 10.1093/jac/dki346	18	543	551	12	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					460	470		10.1001/jama.2020.10044	http://dx.doi.org/10.1001/jama.2020.10044			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32492084	Green Published, Bronze			2022-12-28	WOS:000561261900017
J	Kuderer, NM; Choueiri, TK; Shah, DP; Shyr, Y; Rubinstein, SM; Rivera, DR; Shete, S; Hsu, CY; Desai, A; Lopes, GD; Grivas, P; Painter, CA; Peters, S; Thompson, MA; Bakouny, Z; Batist, G; Bekaii-Saab, T; Bilen, MA; Bouganim, N; Larroya, MB; Castellano, D; Del Prete, SA; Doroshow, DB; Egan, PC; Elkrief, A; Farmakiotis, D; Flora, D; Galsky, MD; Glover, MJ; Griffiths, EA; Gulati, AP; Gupta, S; Hafez, N; Halfdanarson, TR; Hawley, JE; Hsu, E; Kasi, A; Khaki, AR; Lemmon, CA; Lewis, C; Logan, B; Masters, T; McKay, RR; Mesa, RA; Morgans, AK; Mulcahy, MF; Panagiotou, OA; Peddi, P; Pennell, NA; Reynolds, K; Rosen, LR; Rosovsky, R; Salazar, M; Schmidt, A; Shah, SA; Shaya, JA; Steinharter, J; Stockerl-Goldstein, KE; Subbiah, S; Vinh, DC; Wehbe, FH; Weissmann, LB; Wu, JTY; Wulff-Burchfield, E; Xie, ZE; Yeh, A; Yu, PP; Zhou, AY; Zubiri, L; Mishra, S; Lyman, GH; Rini, BI; Warner, JL				Kuderer, Nicole M.; Choueiri, Toni K.; Shah, Dimpy P.; Shyr, Yu; Rubinstein, Samuel M.; Rivera, Donna R.; Shete, Sanjay; Hsu, Chih-Yuan; Desai, Aakash; Lopes, Gilberto de Lima, Jr.; Grivas, Petros; Painter, Corrie A.; Peters, Solange; Thompson, Michael A.; Bakouny, Ziad; Batist, Gerald; Bekaii-Saab, Tanios; Bilen, Mehmet A.; Bouganim, Nathaniel; Larroya, Mateo Bover; Castellano, Daniel; Del Prete, Salvatore A.; Doroshow, Deborah B.; Egan, Pamela C.; Elkrief, Arielle; Farmakiotis, Dimitrios; Flora, Daniel; Galsky, Matthew D.; Glover, Michael J.; Griffiths, Elizabeth A.; Gulati, Anthony P.; Gupta, Shilpa; Hafez, Navid; Halfdanarson, Thorvardur R.; Hawley, Jessica E.; Hsu, Emily; Kasi, Anup; Khaki, Ali R.; Lemmon, Christopher A.; Lewis, Colleen; Logan, Barbara; Masters, Tyler; McKay, Rana R.; Mesa, Ruben A.; Morgans, Alicia K.; Mulcahy, Mary F.; Panagiotou, Orestis A.; Peddi, Prakash; Pennell, Nathan A.; Reynolds, Kerry; Rosen, Lane R.; Rosovsky, Rachel; Salazar, Mary; Schmidt, Andrew; Shah, Sumit A.; Shaya, Justin A.; Steinharter, John; Stockerl-Goldstein, Keith E.; Subbiah, Suki; Vinh, Donald C.; Wehbe, Firas H.; Weissmann, Lisa B.; Wu, Julie Tsu-Yu; Wulff-Burchfield, Elizabeth; Xie, Zhuoer; Yeh, Albert; Yu, Peter P.; Zhou, Alice Y.; Zubiri, Leyre; Mishra, Sanjay; Lyman, Gary H.; Rini, Brian, I; Warner, Jeremy L.		COVID-19 Canc Consortium	Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study	LANCET			English	Article							PROSTATE; OUTCOMES; TMPRSS2	Background Data on patients with COVID-19 who have cancer are lacking. Here we characterise the outcomes of a cohort of patients with cancer and COVID-19 and identify potential prognostic factors for mortality and severe illness. Methods In this cohort study, we collected de-identified data on patients with active or previous malignancy, aged 18 years and older, with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection from the USA, Canada, and Spain from the COVID-19 and Cancer Consortium (CCC19) database for whom baseline data were added between March 17 and April 16, 2020. We collected data on baseline clinical conditions, medications, cancer diagnosis and treatment, and COVID-19 disease course. The primary endpoint was all-cause mortality within 30 days of diagnosis of COVID-19. We assessed the association between the outcome and potential prognostic variables using logistic regression analyses, partially adjusted for age, sex, smoking status, and obesity. This study is registered with ClinicalTrials.gov, NCT04354701, and is ongoing. Findings Of 1035 records entered into the CCC19 database during the study period, 928 patients met inclusion criteria for our analysis. Median age was 66 years (IQR 57-76), 279 (30%) were aged 75 years or older, and 468 (50%) patients were male. The most prevalent malignancies were breast (191 [21%]) and prostate (152 [16%]). 366 (39%) patients were on active anticancer treatment, and 396 (43%) had active (measurable) cancer. At analysis (May 7, 2020), 121 (13%) patients had died. In logistic regression analysis, independent factors associated with increased 30-day mortality, after partial adjustment, were: increased age (per 10 years; partially adjusted odds ratio 1.84, 95% CI 1.53-2.21), male sex (1.63, 1.07-2.48), smoking status (former smoker vs never smoked: 1.60, 1.03-2.47), number of comorbidities (two vs none: 4.50, 1.33-15.28), Eastern Cooperative Oncology Group performance status of 2 or higher (status of 2 vs 0 or 1: 3.89, 2.11-7.18), active cancer (progressing vs remission: 5.20, 2.77-9.77), and receipt of azithromycin plus hydroxychloroquine (vs treatment with neither: 2.93, 1.79-4.79; confounding by indication cannot be excluded). Compared with residence in the US-Northeast, residence in Canada (0.24, 0.07-0.84) or the US-Midwest (0.50, 0.28-0.90) were associated with decreased 30-day all-cause mortality. Race and ethnicity, obesity status, cancer type, type of anticancer therapy, and recent surgery were not associated with mortality. Interpretation Among patients with cancer and COVID-19, 30-day all-cause mortality was high and associated with general risk factors and risk factors unique to patients with cancer. Longer follow-up is needed to better understand the effect of COVID-19 on outcomes in patients with cancer, including the ability to continue specific cancer treatments. Copyright (C) 2020 Elsevier Ltd. All rights reserved.	[Kuderer, Nicole M.] Adv Canc Res Grp, Kirkland, WA USA; [Choueiri, Toni K.; Bakouny, Ziad; Schmidt, Andrew; Steinharter, John] Dana Farber Canc Inst, Boston, MA 02115 USA; [Shah, Dimpy P.; Mesa, Ruben A.; Salazar, Mary] UT Hlth San Antonio MD Anderson Canc Ctr, Mays Canc Ctr, San Antonio, TX USA; [Shyr, Yu; Rubinstein, Samuel M.; Hsu, Chih-Yuan; Mishra, Sanjay; Rini, Brian, I; Warner, Jeremy L.] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Rivera, Donna R.] NCI, Div Canc Control & Populat Sci, Rockville, MD USA; [Shete, Sanjay] MD Anderson Canc Ctr, Houston, TX USA; [Desai, Aakash; Hsu, Emily] Univ Connecticut, Farmington, CT USA; [Lopes, Gilberto de Lima, Jr.] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Grivas, Petros; Khaki, Ali R.; Yeh, Albert; Lyman, Gary H.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Grivas, Petros; Khaki, Ali R.; Yeh, Albert; Lyman, Gary H.] Univ Washington, Seattle, WA 98195 USA; [Painter, Corrie A.] Count Me In, Cambridge, MA USA; [Peters, Solange] Lausanne Univ, Lausanne, Switzerland; [Thompson, Michael A.] Advocate Aurora Hlth, Milwaukee, WI USA; [Batist, Gerald; Elkrief, Arielle] McGill Univ, Segal Canc Ctr, Jewish Gen Hosp, Montreal, PQ, Canada; [Bekaii-Saab, Tanios] Mayo Clin, Ctr Canc, Phoenix, AZ USA; [Bilen, Mehmet A.; Lewis, Colleen] Emory Univ, Inst Canc, Atlanta, GA 30322 USA; [Bouganim, Nathaniel; Vinh, Donald C.] McGill Univ, Hlth Ctr, Montreal, PQ, Canada; [Larroya, Mateo Bover; Castellano, Daniel] Hosp Univ 12 Octubre, Madrid, Spain; [Del Prete, Salvatore A.; Gulati, Anthony P.] Stamford Hosp, Stamford, CT USA; [Doroshow, Deborah B.; Galsky, Matthew D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Egan, Pamela C.; Farmakiotis, Dimitrios] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Flora, Daniel; Logan, Barbara] St Elizabeth Healthcare, Edgewood, KY USA; [Glover, Michael J.; Shah, Sumit A.; Wu, Julie Tsu-Yu] Stanford Univ, Stanford, CA 94305 USA; [Griffiths, Elizabeth A.] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA; [Gupta, Shilpa; Lemmon, Christopher A.; Pennell, Nathan A.] Cleveland Clin, Cleveland, OH 44106 USA; [Hafez, Navid; Masters, Tyler] Smilow Canc Hosp Yale New Haven, New Haven, CT USA; [Halfdanarson, Thorvardur R.; Xie, Zhuoer] Mayo Clin, Ctr Canc, Rochester, MN USA; [Hawley, Jessica E.] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Hsu, Emily; Yu, Peter P.] Hartford Hlth Care, Hartford, CT USA; [Kasi, Anup; Wulff-Burchfield, Elizabeth] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [McKay, Rana R.; Shaya, Justin A.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Morgans, Alicia K.; Mulcahy, Mary F.; Wehbe, Firas H.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Panagiotou, Orestis A.] Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA; [Peddi, Prakash; Rosen, Lane R.] Willis Knighton Canc Ctr, Shreveport, LA USA; [Reynolds, Kerry; Rosovsky, Rachel; Zubiri, Leyre] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Stockerl-Goldstein, Keith E.; Zhou, Alice Y.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA; [Subbiah, Suki] LSU Hlth, Stanley S Scott Canc Ctr, New Orleans, LA USA; [Weissmann, Lisa B.] Mt Auburn Hosp, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; University of Connecticut; University of Miami; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Lausanne; McGill University; Mayo Clinic; Mayo Clinic Phoenix; Emory University; McGill University; Hospital Universitario 12 de Octubre; Stamford Hospital; Icahn School of Medicine at Mount Sinai; Brown University; Stanford University; Cleveland Clinic Foundation; Mayo Clinic; Columbia University; University of Kansas; University of Kansas Medical Center; University of California System; University of California San Diego; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Brown University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Harvard University; Harvard Medical School; Massachusetts General Hospital; Siteman Cancer Center; Washington University (WUSTL); Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Harvard University; Mount Auburn Hospital	Warner, JL (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA.	jeremy.warner@vumc.org	Panagiotou, Orestis/AAI-1268-2021; Lyman, Gary H/K-5227-2019; Lemmon, Christopher/AIA-1801-2022; Markham, Merry Jennifer/T-9446-2018; shah, chintan/W-4011-2019; Desai, Aakash/AAB-5803-2021; Doroshow, Deborah/GXF-4079-2022; Halfdanarson, Thorvardur/AAO-8706-2020; Choueiri, Toni/K-5238-2019; peters, solange/ABF-2187-2020; Mishra, Sanjay/ABF-9252-2021; Hsu, Chih-Yuan/GYA-1355-2022; Pennell, Nathan/AAH-9303-2021; Thompson, Michael Alan/B-8953-2013; Schmidt, Andrew/F-8446-2016; Rosovsky, Rachel/AAH-1166-2021; Kasi, Anup/ABF-5253-2020; Khaki, Ali Raza/AAO-2437-2020; Bakouny, Ziad/A-1149-2018; Barnholtz-Sloan, Jill/A-4817-2011; Desai, Aakash/ABD-6423-2020; Friese, Christopher/D-2097-2013	Lyman, Gary H/0000-0002-0823-8086; Lemmon, Christopher/0000-0003-4223-5847; Markham, Merry Jennifer/0000-0003-3567-3494; shah, chintan/0000-0002-2441-908X; Halfdanarson, Thorvardur/0000-0001-8460-1257; Choueiri, Toni/0000-0002-9201-3217; Mishra, Sanjay/0000-0002-7775-9600; Pennell, Nathan/0000-0002-1458-0064; Thompson, Michael Alan/0000-0001-7930-4610; Schmidt, Andrew/0000-0003-4930-4155; Khaki, Ali Raza/0000-0002-4655-4426; Bakouny, Ziad/0000-0003-1906-5704; Barnholtz-Sloan, Jill/0000-0001-6190-9304; Nelson, Heather/0000-0003-1901-9513; Stockerl-Goldstein, Keith/0000-0002-7234-1715; Stover, Daniel/0000-0001-9003-8165; McNair, Christopher/0000-0003-3204-8482; Friese, Christopher/0000-0002-2281-2056; Nguyen, Ruby/0000-0002-6598-8457; Gulati, Shuchi/0000-0001-6793-9694; Nuzzo, Pier Vitale/0000-0002-5618-8079; Wu, Julie/0000-0003-2388-1827; Rosenstein, Lori/0000-0002-8513-8994; Cabal, Angelo/0000-0002-0550-924X; Naidoo, Jarushka/0000-0002-3470-8686; Bekaii-Saab, Tanios/0000-0001-7721-1699; VIKAS, PRAVEEN/0000-0001-9193-9889; Nagaraj, Gayathri/0000-0002-7586-6920; Zimmer, Andrea/0000-0002-1460-0774; Shouse, Geoffrey/0000-0002-7917-5713; BASHIR, BABAR/0000-0002-6843-1179; Xie, Zhuoer/0000-0003-1266-9804; VINH, DONALD/0000-0003-1347-7767; Yeh, Albert/0000-0003-3455-7360; Pasquinelli, Mary/0000-0002-1015-1908	American Cancer Society; Hope Foundation for Cancer Research [MRSG-16-152-01-CCE]; Fonds de Recherche du Quebec-Sante clinician-scientist scholar program; Jim and Carol O'Hare Fund; National Cancer Institute [P30 CA013696, P30 CA016056, P30 CA016672, P30 CA023100, P30 CA054174, P30 CA060553, P30 CA068485, P30 CA196521, T32 CA009515, T32 CA203703, UG1 CA189974, U01 CA231840]; National Human Genome Research Institute [T32 HG008341]; Vanderbilt Institute for Clinical and Translational Research (NCATS/NIH) [UL1 TR000445]	American Cancer Society(American Cancer Society); Hope Foundation for Cancer Research; Fonds de Recherche du Quebec-Sante clinician-scientist scholar program; Jim and Carol O'Hare Fund; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Vanderbilt Institute for Clinical and Translational Research (NCATS/NIH)	This study was partly supported by grants from the American Cancer Society and Hope Foundation for Cancer Research (MRSG-16-152-01-CCE; to DPS); the Fonds de Recherche du Quebec-Sante clinician-scientist scholar program to DCV; the Jim and Carol O'Hare Fund (to SMR); the National Cancer Institute (P30 CA013696 to JEH; P30 CA016056 to EAG; P30 CA016672 to JAS; P30 CA023100 to RRM; P30 CA054174 to DPS, MS, and RAM; P30 CA060553 to FHW; P30 CA068485 to C-YH, BIR, JLW, SM, and YS; P30 CA196521 to DBD and MDG; T32 CA009515 to ARK; T32 CA203703 to JEH; UG1 CA189974 to GHL; and U01 CA231840 to JLW); and the National Human Genome Research Institute (T32 HG008341 to SMR). REDCap is developed and supported by Vanderbilt Institute for Clinical and Translational Research grant support (UL1 TR000445 from NCATS/NIH). We thank Pankil K Shah for statistical input, Margaret Madeleine for regulatory input, and Steven A Pergam for virological input.	Afar DEH, 2001, CANCER RES, V61, P1686; Alexander LEC, 2015, CHEST, V148, P1307, DOI 10.1378/chest.15-0409; Bleicher RJ, 2016, JAMA ONCOL, V2, P330, DOI 10.1001/jamaoncol.2015.4508; Blimark C, 2015, HAEMATOLOGICA, V100, P107, DOI 10.3324/haematol.2014.107714; Cai H, 2020, LANCET RESP MED, V8, pE20, DOI 10.1016/S2213-2600(20)30117-X; CDC COVID-19 Response Team, 2020, MMWR Morb Mortal Wkly Rep, V69, P477, DOI 10.15585/mmwr.mm6915e6; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Dai MY, 2020, CANCER DISCOV, V10, P783, DOI 10.1158/2159-8290.CD-20-0422; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Desai A, 2020, NAT CANCER, V1, P473, DOI 10.1038/s43018-020-0065-z; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6; Lin BY, 1999, CANCER RES, V59, P4180; Macarulla T, 2019, J CLIN ONCOL, V37, P230, DOI 10.1200/JCO.18.00089; Magagnoli J, 2020, MED-CAMBRIDGE, V1, P114, DOI [10.1016/j.medj.2020.06.001, 10.1101/2020.04.16.20065920]; Marron JM, 2020, J CLIN ONCOL, V38, P2201, DOI 10.1200/JCO.20.00960; Mehta V, 2020, CANCER DISCOV, V10, P935, DOI 10.1158/2159-8290.CD-20-0516; Miyashita H, 2020, ANN ONCOL, V31, P1088, DOI 10.1016/j.annonc.2020.04.006; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rosenbaum L, 2020, NEW ENGL J MED, V382, P1873, DOI 10.1056/NEJMp2005492; Samson P, 2015, ANN THORAC SURG, V99, P1906, DOI 10.1016/j.athoracsur.2015.02.022; Smith J.C., 2020, BIORXIV, DOI [10.1101/2020.03.28.013672, DOI 10.1101/2020.03.28.013672]; Stopsack KH, 2020, CANCER DISCOV, V10, P779, DOI 10.1158/2159-8290.CD-20-0451; Strzelak A, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15051033; United States Food and Drug Administration, 2020, FDA CAUT US HYDR CHL; Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760; Vardavas CI, 2020, TOB INDUC DIS, V18, DOI 10.18332/tid/119324; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; World Health Organization, WHO DIR GEN OP REM M; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zukin M, 2013, J CLIN ONCOL, V31, P2849, DOI 10.1200/JCO.2012.48.1911	36	954	971	12	89	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2020	395	10241					1907	1918		10.1016/S0140-6736(20)31187-9	http://dx.doi.org/10.1016/S0140-6736(20)31187-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ2MV	32473681	Bronze, Green Published			2022-12-28	WOS:000552732200031
J	Cohen, IG; Gostin, LO; Weitzner, DJ				Cohen, I. Glenn; Gostin, Lawrence O.; Weitzner, Daniel J.			Digital Smartphone Tracking for COVID-19 Public Health and Civil Liberties in Tension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint compares manual and digital strategies for coronavirus disease 2019 (COVID-19) contact tracing, describes how countries in Asia and Europe have used smartphone tracking, and discusses privacy and discrimination concerns and strategies for balancing public health and civil liberties in the US.	[Cohen, I. Glenn] Harvard Law Sch, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA USA; [Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Weitzner, Daniel J.] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Georgetown University; Massachusetts Institute of Technology (MIT)	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW,McDonough 568, Washington, DC 20001 USA.	gostin@law.georgetown.edu			Collaborative Research Program for Biomedical Innovation Law; Novo Nordisk Foundation [NNF17SA0027784]; MIT-IBMWatson AI Lab	Collaborative Research Program for Biomedical Innovation Law; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); MIT-IBMWatson AI Lab(International Business Machines (IBM))	Mr Cohen was supported by the Collaborative Research Program for Biomedical Innovation Law, a scientifically independent collaborative research program, which is supported by grant NNF17SA0027784 from the Novo Nordisk Foundation. MrWeitzner's research group, the MIT Internet Policy Research Initiative, was supported by a grant from the MIT-IBMWatson AI Lab for COVID-19 efforts.	Bond S, GETTING BACK NORMAL; Faulders K, STATES RACE START CO; Fernandez E, PRIVACY CONTACT TRAC; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Haaretz website, ISR TOP COURT NO SHI; Klimburg A, PANDEMIC MITIGATION; Park S, 2020, JAMA, DOI 10.1001/jama.2020.6602; Watson C, NATL PLAN ENABLE COM, P20201	8	50	51	2	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2020	323	23					2371	2372		10.1001/jama.2020.8570	http://dx.doi.org/10.1001/jama.2020.8570			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MC6EC	32459289	Bronze			2022-12-28	WOS:000543376700012
J	Robinson, JC				Robinson, James C.			Lower Prices and Greater Patient Access - Lessons from Germany's Drug-Purchasing Structure	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The German system for determining drug prices features collective negotiations on the part of competing health plans. It also creates incentives for agreement, limits price increases not justified by new evidence, and avoids heavy burdens on physicians and patients.	[Robinson, James C.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Robinson, JC (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.			Robinson, James/0000-0003-0056-3017				[Anonymous], 2019, BIOSIMILARS ZAHLEN; Berkemeier F, 2019, J MANAG CARE SPEC PH, V25, P1310, DOI 10.18553/jmcp.2019.25.12.1310; Cardiovascular Disease and Risk Management, 2019, DIABETES CARE, V2, pS103, DOI 10.2337/dc19-S010; Robinson JC, 2018, JAMA-J AM MED ASSOC, V319, P2169, DOI 10.1001/jama.2018.5367; Robinson JC., 2019, DRUG PRICES ARE NEGO	5	8	8	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2020	382	23					2177	2179		10.1056/NEJMp2000341	http://dx.doi.org/10.1056/NEJMp2000341			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LV0NI	32492300				2022-12-28	WOS:000538140600008
J	Oliver, D				Oliver, David			David Oliver: Covid-19 has highlighted the NHS's strengths and weaknesses	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Gov.uk, COR COVID 19; National Institute for Health and Care Excellence, COR COVID 19	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2020	369								m2124	10.1136/bmj.m2124	http://dx.doi.org/10.1136/bmj.m2124			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1WU	32493716	Bronze			2022-12-28	WOS:000548578300005
J	Atreya, CE; Turnbaugh, PJ				Atreya, Chloe E.; Turnbaugh, Peter J.			Probing the tumor micro(b)environment	SCIENCE			English	Editorial Material							MICROBIOME		[Atreya, Chloe E.] Univ Calif San Francisco, Dept Med, Div Hematol & Oncol, San Francisco, CA 94143 USA; [Atreya, Chloe E.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Turnbaugh, Peter J.] Univ Calif San Francisco, Dept Microbiol & Immunol, GW Hooper Res Fdn, San Francisco, CA 94143 USA; [Turnbaugh, Peter J.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Turnbaugh, PJ (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, GW Hooper Res Fdn, San Francisco, CA 94143 USA.; Turnbaugh, PJ (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	peter.turnbaugh@ucsf.edu		Turnbaugh, Peter/0000-0002-0888-2875	NIH [R21CA227232]; Damon Runyon Cancer Research Foundation [DRR-4216]; Bristol Meyers Squibb; Guardant Health; Merck; Novartis	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Bristol Meyers Squibb(Bristol-Myers Squibb); Guardant Health; Merck(Merck & Company); Novartis(Novartis)	Support is provided by NIH (R21CA227232) and the Damon Runyon Cancer Research Foundation (DRR-4216). C.E.A. is on the scientific advisory board for Pionyr Immunotherapeutics and has research funding from Bristol Meyers Squibb, Guardant Health, Merck,and Novartis. P.J.T. is on the scientific advisory boards for Kaleido, Pendulum, Seres, and SNIPR Biome.	Bess EN, 2020, NAT MICROBIOL, V5, P56, DOI 10.1038/s41564-019-0596-1; Bornigen D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17795-z; Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240; de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5; Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648; Geller LT, 2017, SCIENCE, V357, P1156, DOI 10.1126/science.aah5043; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Greathouse KL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1501-6; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Lam KN, 2019, CELL HOST MICROBE, V26, P22, DOI 10.1016/j.chom.2019.06.011; Moss SM, 2019, CELL HOST MICROBE, V25, P454, DOI 10.1016/j.chom.2019.01.006; Nejman D, 2020, SCIENCE, V368, P973, DOI 10.1126/science.aay9189; Riquelme E, 2019, CELL, V178, P795, DOI 10.1016/j.cell.2019.07.008; Sedighi M, 2019, CANCER MED-US, V8, P3167, DOI 10.1002/cam4.2148; Walter J, 2020, CELL, V180, P221, DOI 10.1016/j.cell.2019.12.025	15	14	15	10	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					938	939		10.1126/science.abc1464	http://dx.doi.org/10.1126/science.abc1464			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LV3IK	32467376				2022-12-28	WOS:000538332600023
J	Colantuono, D; Souied, E				Colantuono, Donato; Souied, Eric			Hyperoleon	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Colantuono, Donato; Souied, Eric] Ctr Hosp Intercommunal Creteil, Creteil, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil	Colantuono, D (corresponding author), Ctr Hosp Intercommunal Creteil, Creteil, France.	colantuono.donato88@gmail.com							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2020	382	22					2146	2146		10.1056/NEJMicm1914376	http://dx.doi.org/10.1056/NEJMicm1914376			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MA5NT	32459925				2022-12-28	WOS:000541960400020
J	Acquaviva, L; Boekhout, M; Karasu, ME; Brick, K; Pratto, F; Li, T; van Overbeek, M; Kauppi, L; Camerini-Otero, RD; Jasin, M; Keeney, S				Acquaviva, Laurent; Boekhout, Michiel; Karasu, Mehmet E.; Brick, Kevin; Pratto, Florencia; Li, Tao; van Overbeek, Megan; Kauppi, Liisa; Camerini-Otero, R. Daniel; Jasin, Maria; Keeney, Scott			Ensuring meiotic DNA break formation in the mouse pseudoautosomal region	NATURE			English	Article							CHROMOSOME AXIS; HIGH-FREQUENCY; RECOMBINATION; HETEROCHROMATIN; CONSERVATION; INITIATION	In mice, the pseudoautosomal region of the sex chromosomes undergoes a dynamic structural rearrangement to promote a high rate of DNA double-strand breaks and to ensure X-Y recombination. Sex chromosomes in males of most eutherian mammals share only a small homologous segment, the pseudoautosomal region (PAR), in which the formation of double-strand breaks (DSBs), pairing and crossing over must occur for correct meiotic segregation(1,2). How cells ensure that recombination occurs in the PAR is unknown. Here we present a dynamic ultrastructure of the PAR and identify controlling cis- and trans-acting factors that make the PAR the hottest segment for DSB formation in the male mouse genome. Before break formation, multiple DSB-promoting factors hyperaccumulate in the PAR, its chromosome axes elongate and the sister chromatids separate. These processes are linked to heterochromatic mo-2 minisatellite arrays, and require MEI4 and ANKRD31 proteins but not the axis components REC8 or HORMAD1. We propose that the repetitive DNA sequence of the PAR confers unique chromatin and higher-order structures that are crucial for recombination. Chromosome synapsis triggers collapse of the elongated PAR structure and, notably, oocytes can be reprogrammed to exhibit spermatocyte-like levels of DSBs in the PAR simply by delaying or preventing synapsis. Thus, the sexually dimorphic behaviour of the PAR is in part a result of kinetic differences between the sexes in a race between the maturation of the PAR structure, formation of DSBs and completion of pairing and synapsis. Our findings establish a mechanistic paradigm for the recombination of sex chromosomes during meiosis.	[Acquaviva, Laurent; Boekhout, Michiel; Karasu, Mehmet E.; Li, Tao; van Overbeek, Megan; Kauppi, Liisa; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10021 USA; [Karasu, Mehmet E.; Jasin, Maria; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10021 USA; [Brick, Kevin; Pratto, Florencia; Camerini-Otero, R. Daniel] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA; [Li, Tao; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA; [Boekhout, Michiel] Univ Utrecht, Oncode Inst, UMC Utrecht, Utrecht, Netherlands; [Karasu, Mehmet E.] Swiss Fed Inst Technol, Zurich, Switzerland; [van Overbeek, Megan] Inscripta Inc, Pleasanton, CA USA; [Kauppi, Liisa] Univ Helsinki, Fac Med, Helsinki, Finland	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Utrecht University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Helsinki	Acquaviva, L; Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10021 USA.; Jasin, M; Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10021 USA.; Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.; Jasin, M (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA.	acquavil@mskcc.org; m-jasin@ski.mskcc.org; s-keeney@ski.mskcc.org	Keeney, Scott/GVR-8515-2022	Acquaviva, Laurent/0000-0001-5080-3619; Kauppi, Liisa/0000-0002-6759-8997; Pratto, Florencia/0000-0002-9678-8044; Jasin, Maria/0000-0002-7976-2379; Li, Tao/0000-0002-5728-3721; Boekhout, Michiel/0000-0002-9626-438X	National Center For Research Resources [S10 RR031855]; Cancer Center Support Grant [P30 CA008748]; Lalor Foundation; Netherlands Organization for Scientific Research; NIH [F32 GM096692]; NIGMS [R35 GM118092, R35 GM118175]	National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Cancer Center Support Grant; Lalor Foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Toth and B. de Massy for antibodies, mice, discussions and sharing of unpublished information; A. North and the Bio-Imaging Resource Center at Rockefeller University for assistance with SIM (supported by award number S10 RR031855 from the National Center For Research Resources); and R. Hendrickson, R. Soni and Z. Li (MSKCC Proteomics Core) for assistance with mass spectrometry. This work used the computational resources of the NIH HPC Biowulf cluster (). MSKCC core facilities are supported by a Cancer Center Support Grant (P30 CA008748). L.A. was supported in part by a fellowship from the Lalor Foundation; M.B. was supported in part by a Rubicon fellowship from the Netherlands Organization for Scientific Research; and M.v.O. was supported in part by an NIH fellowship (F32 GM096692). This work was supported by NIGMS grants R35 GM118092 (S.K.) and R35 GM118175 (M.J.).	Arnold AP, 2009, J NEUROENDOCRINOL, V21, P377, DOI 10.1111/j.1365-2826.2009.01831.x; Bannister LA, 2004, GENESIS, V40, P184, DOI 10.1002/gene.20085; Bergs JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098203; Boekhout M, 2019, MOL CELL, V74, P1053, DOI 10.1016/j.molcel.2019.03.023; Brick K, 2018, NATURE, V561, P338, DOI 10.1038/s41586-018-0492-5; Brick K, 2018, METHOD ENZYMOL, V601, P391, DOI 10.1016/bs.mie.2017.11.037; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Costa Y, 2005, J CELL SCI, V118, P2755, DOI 10.1242/jcs.02402; Daniel K, 2011, NAT CELL BIOL, V13, P599, DOI 10.1038/ncb2213; de Massy B, 2013, ANNU REV GENET, V47, P563, DOI 10.1146/annurev-genet-110711-155423; Gaysinskaya V, 2015, CURR PROTOC CYTOM, V72, p7 441; HARBERS K, 1990, CYTOGENET CELL GENET, V53, P129, DOI 10.1159/000132912; HARBERS K, 1986, NATURE, V324, P682, DOI 10.1038/324682a0; Huang Tzu-Wen, 2014, BMC Res Notes, V7, P13, DOI 10.1186/1756-0500-7-13; Karasu ME, 2019, CHROMOSOMA, V128, P473, DOI 10.1007/s00412-019-00725-5; Karasu ME, 2019, J CELL BIOL, V218, P1265, DOI 10.1083/jcb.201808091; Kauppi L, 2013, GENE DEV, V27, P873, DOI 10.1101/gad.213652.113; Kauppi L, 2012, ANN NY ACAD SCI, V1267, P18, DOI 10.1111/j.1749-6632.2012.06593.x; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Khil PP, 2012, GENOME RES, V22, P957, DOI 10.1101/gr.130583.111; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Kipling D, 1996, NAT GENET, V13, P78, DOI 10.1038/ng0596-78; Kipling D, 1996, P NATL ACAD SCI USA, V93, P171, DOI 10.1073/pnas.93.1.171; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Kumar R, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800259; Kumar R, 2015, J CELL SCI, V128, P1800, DOI 10.1242/jcs.165464; Kumar R, 2010, GENE DEV, V24, P1266, DOI 10.1101/gad.571710; Lange J, 2016, CELL, V167, P695, DOI 10.1016/j.cell.2016.09.035; Murakami H, 2020, NATURE, V582, P124, DOI 10.1038/s41586-020-2248-2; Page J, 2012, CHROMOSOMA, V121, P307, DOI 10.1007/s00412-012-0364-y; Palmer S, 1997, P NATL ACAD SCI USA, V94, P12030, DOI 10.1073/pnas.94.22.12030; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Papanikos F, 2019, MOL CELL, V74, P1069, DOI 10.1016/j.molcel.2019.03.022; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Perry J, 2001, GENOME RES, V11, P1826, DOI 10.1101/gr.203001; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; R Core Team, 2018, R LANG ENV STAT COMP; Raudsepp T, 2012, SEX DEV, V6, P72, DOI 10.1159/000330627; Raudsepp T, 2015, CYTOGENET GENOME RES, V147, P81, DOI 10.1159/000443157; Reinholdt LG, 2005, CHROMOSOMA, V114, P127, DOI 10.1007/s00412-005-0346-4; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shin YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001190; SORIANO P, 1987, P NATL ACAD SCI USA, V84, P7218, DOI 10.1073/pnas.84.20.7218; Stanzione M, 2016, NAT CELL BIOL, V18, P1208, DOI 10.1038/ncb3417; TAKAHASHI Y, 1994, CHROMOSOMA, V103, P450, DOI 10.1007/BF00337383; Thacker D, 2014, NATURE, V510, P241, DOI 10.1038/nature13120; TRES LL, 1977, J CELL SCI, V25, P1; Turner JMA, 2001, J CELL SCI, V114, P3367; Venables WN., 2002, MODERN APPL STAT S; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	53	40	42	2	24	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 18	2020	582	7812					426	+		10.1038/s41586-020-2327-4	http://dx.doi.org/10.1038/s41586-020-2327-4		MAY 2020	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QP4IP	32461690	Green Accepted			2022-12-28	WOS:000535878900004
J	Shi, R; Shan, C; Duan, XM; Chen, ZH; Liu, PP; Song, JW; Song, T; Bi, XS; Han, C; Wu, LA; Gao, G; Hu, X; Zhang, YA; Tong, Z; Huang, WJ; Liu, WJ; Wu, GZ; Zhang, B; Wang, L; Qi, JX; Feng, H; Wang, FS; Wang, QH; Gao, GF; Yuan, ZM; Yan, JH				Shi, Rui; Shan, Chao; Duan, Xiaomin; Chen, Zhihai; Liu, Peipei; Song, Jinwen; Song, Tao; Bi, Xiaoshan; Han, Chao; Wu, Lianao; Gao, Ge; Hu, Xue; Zhang, Yanan; Tong, Zhou; Huang, Weijin; Liu, William Jun; Wu, Guizhen; Zhang, Bo; Wang, Lan; Qi, Jianxun; Feng, Hui; Wang, Fu-Sheng; Wang, Qihui; Gao, George Fu; Yuan, Zhiming; Yan, Jinghua			A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2	NATURE			English	Article							SARS-COV; SPIKE PROTEIN; CORONAVIRUS; FEATURES	An outbreak of coronavirus disease 2019 (COVID-19)(1-3), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)(4), has spread globally. Countermeasures are needed to treat and prevent further dissemination of the virus. Here we report the isolation of two specific human monoclonal antibodies (termed CA1 and CB6) from a patient convalescing from COVID-19. CA1 and CB6 demonstrated potent SARS-CoV-2-specific neutralization activity in vitro. In addition, CB6 inhibited infection with SARS-CoV-2 in rhesus monkeys in both prophylactic and treatment settings. We also performed structural studies, which revealed that CB6 recognizes an epitope that overlaps with angiotensin-converting enzyme 2 (ACE2)-binding sites in the SARS-CoV-2 receptor-binding domain, and thereby interferes with virus-receptor interactions by both steric hindrance and direct competition for interface residues. Our results suggest that CB6 deserves further study as a candidate for translation to the clinic. Two monoclonal antibodies isolated from a patient with COVID-19 are shown to interfere with SARS-CoV-2-receptor binding, and one displays potent action against this virus in vitro and in a rhesus macaque model.	[Shi, Rui; Duan, Xiaomin; Song, Tao; Bi, Xiaoshan; Han, Chao; Tong, Zhou; Wang, Qihui; Yan, Jinghua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Microbial Physiol & Metab Engn, Beijing, Peoples R China; [Shi, Rui; Duan, Xiaomin; Han, Chao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Shan, Chao; Gao, Ge; Hu, Xue; Zhang, Yanan; Zhang, Bo; Yuan, Zhiming] Chinese Acad Sci, Wuhan Inst Virol, Ctr Biosafety Mega Sci, Wuhan, Peoples R China; [Chen, Zhihai] Capital Med Univ, Beijing Ditan Hosp, Ctr Infect Dis, Beijing, Peoples R China; [Liu, Peipei; Liu, William Jun; Wu, Guizhen] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, NHC Key Lab Biosafety, Beijing, Peoples R China; [Song, Jinwen; Wang, Fu-Sheng] Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Infect Dis, Med Ctr 5, Treatment & Res Ctr Infect Dis, Beijing, Peoples R China; [Song, Tao] Shanxi Acad Adv Res & Innovat, Taiyuan, Peoples R China; [Song, Tao] Hebei Normal Univ Sci & Technol, Coll Anim Sci & Technol, Qinhuangdao, Hebei, Peoples R China; [Bi, Xiaoshan; Wu, Lianao] Anhui Univ, Inst Phys Sci & Informat, Hefei, Peoples R China; [Wu, Lianao; Tong, Zhou; Qi, Jianxun; Wang, Qihui; Gao, George Fu; Yan, Jinghua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Huang, Weijin; Wang, Lan] Natl Inst Food & Drug Control, Minist Hlth Res Qual & Standardizat Biotech Prod, Key Lab, Beijing, Peoples R China; [Qi, Jianxun; Wang, Qihui; Yan, Jinghua] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China; [Feng, Hui] Shanghai Junshi Biosci Co Ltd, Shanghai, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Capital Medical University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese People's Liberation Army General Hospital; Hebei Normal University of Science & Technology; Anhui University; Chinese Academy of Sciences; Institute of Microbiology, CAS; National Institute of Food & Drug Control - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, QH; Yan, JH (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Microbial Physiol & Metab Engn, Beijing, Peoples R China.; Yuan, ZM (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Ctr Biosafety Mega Sci, Wuhan, Peoples R China.; Wang, FS (corresponding author), Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Infect Dis, Med Ctr 5, Treatment & Res Ctr Infect Dis, Beijing, Peoples R China.; Wang, QH; Gao, GF; Yan, JH (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.; Wang, QH; Yan, JH (corresponding author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.	fswang302@163.com; wangqihui@im.ac.cn; gaof@im.ac.cn; yzm@wh.iov.cn; yanjh@im.ac.cn	Gao, George Fu/ABD-5229-2021; Song, Jin-Wen/GLN-3340-2022; Qi, Jianxun/ABF-1646-2021; huang, weijin/AAY-5028-2020; Qihui, Wang/GLR-4206-2022; Shan, Chao/AAN-8190-2021	Song, Jin-Wen/0000-0002-8582-8012; huang, weijin/0000-0002-4246-8889; Qihui, Wang/0000-0003-3768-0401; Shan, Chao/0000-0002-3953-3782; rui, shi/0000-0001-8469-8730; Wang, Fu-Sheng/0000-0002-8043-6685; Song, Tao/0000-0002-9730-7855	Strategic Priority Research Program of CAS [XDB29040201]; National Major Science and Technology Major Project [2018ZX09711003]; National Key Research and Development Program of China [2020YFC0841400]; National Natural Science Foundation of China [81922044, 81973228]; Youth Innovation Promotion Association CAS [2018119]; foundation of the NSFC Innovative Research Group [81621091]	Strategic Priority Research Program of CAS; National Major Science and Technology Major Project; National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association CAS; foundation of the NSFC Innovative Research Group	We thank S. Yao for his help in revising the manuscript; the staff of beamline BL17U1 at the Shanghai Synchrotron Radiation Facility for assistance during data collection; Z. Fan for her technical help in performing BLI and SPR; all colleagues of the National Biosafety Laboratory for their support during this study; Y. Yao and Y. Peng for supporting all the experiments in nonhuman primates; and F. Wang, Y. Hu, Y. Jia, S. Ren, L. Wu and S. Tan for their help in performing the experiments. This work was supported by the Strategic Priority Research Program of CAS (XDB29040201), the National Major Science and Technology Major Project (2018ZX09711003), the National Key Research and Development Program of China (2020YFC0841400) and the National Natural Science Foundation of China (81922044 and 81973228). Q.W. is supported by the Youth Innovation Promotion Association CAS (2018119). G.F.G and J.Y are supported by the foundation of the NSFC Innovative Research Group (81621091).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224; Du LY, 2011, JOVE-J VIS EXP, DOI 10.3791/2444; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao GF, 2018, CELL, V172, P1157, DOI 10.1016/j.cell.2018.02.025; Gaudinski MR, 2019, LANCET, V393, P889, DOI 10.1016/S0140-6736(19)30036-4; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Li Q, 2020, CHINA CDC WEEKLY, V2, P79; Li Y, 2015, CELL RES, V25, P1237, DOI 10.1038/cr.2015.113; Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158; Lu GW, 2015, TRENDS MICROBIOL, V23, P468, DOI 10.1016/j.tim.2015.06.003; Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; Tan WJ, 2020, CHINA CDC WEEKLY, V2, P61; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Wang QH, 2019, NAT MICROBIOL, V4, P1231, DOI 10.1038/s41564-019-0411-z; Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336; Wang QH, 2016, ANTIVIR RES, V133, P165, DOI 10.1016/j.antiviral.2016.07.015; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	31	719	756	24	139	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					120	+		10.1038/s41586-020-2381-y	http://dx.doi.org/10.1038/s41586-020-2381-y		MAY 2020	16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB1QU	32454512	Bronze			2022-12-28	WOS:000554511300001
J	Saini, A				Saini, Angela			The art of medicine	LANCET			English	Editorial Material																			0	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2020	395	10237					1604	1605		10.1016/S0140-6736(20)31139-9	http://dx.doi.org/10.1016/S0140-6736(20)31139-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LZ1JO	32446405	Green Published, Bronze			2022-12-28	WOS:000540986100017
J	Li, Z; Weng, XS				Li, Zeng; Weng, Xisheng			Hemophilic Pseudotumor	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 37-year-old man with hemophilia A presented with progressive difficulty in walking. Radiographs showed deformity and "soap bubble" appearance of the left femur consistent with a hemophilic pseudotumor.	[Li, Zeng; Weng, Xisheng] Peking Union Med Coll Hosp, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Weng, XS (corresponding author), Peking Union Med Coll Hosp, Beijing, Peoples R China.	doctorwxs@163.com		Weng, Xisheng/0000-0002-6021-1462; Xi-sheng, Weng/0000-0002-5752-015X					0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2020	382	21					2033	2033		10.1056/NEJMicm1914118	http://dx.doi.org/10.1056/NEJMicm1914118			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LT1TD	32433839				2022-12-28	WOS:000536856000018
J	Griffin, S				Griffin, Shaun			Covid-19: Experts urge strategies to prevent further outbreaks in care homes	BMJ-BRITISH MEDICAL JOURNAL			English	News Item													Griffin, Shaun/GLT-2847-2022					Griffin S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1931; Health and Social Care Committee, 2020, TUESD 19 MAY 2020 M; Office for National Statistics, 2020, DEATHS REG WEEKL ENG; Public Health England, 2020, COVID 19 NUMB OUTBR	4	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2020	369								m2039	10.1136/bmj.m2039	http://dx.doi.org/10.1136/bmj.m2039			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JK	32434756	Bronze			2022-12-28	WOS:000538335800013
J	Zhu, YM; Bateman, BT; Gray, KJ; Hernandez-Diaz, S; Mogun, H; Straub, L; Huybrechts, KF				Zhu, Yanmin; Bateman, Brian T.; Gray, Kathryn J.; Hernandez-Diaz, Sonia; Mogun, Helen; Straub, Loreen; Huybrechts, Krista F.			Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREGNANCY OUTCOMES; 1ST-TRIMESTER EXPOSURE; ANTIDEPRESSANT USE; CANDIDIASIS; ANOMALIES; THERAPY	OBJECTIVE To examine the risk of congenital malformations associated with exposure to oral fluconazole at commonly used doses in the first trimester of pregnancy for the treatment of vulvovaginal candidiasis. DESIGN Population based cohort study. SETTING A cohort of pregnancies publicly insured in the United States, with data from the nationwide Medicaid Analytic eXtract 2000-14. PARTICIPANTS Pregnancies of women enrolled in Medicaid from three or more months before the last menstrual period to one month after delivery, and infants enrolled for three or more months after birth. INTERVENTIONS Use of fluconazole and topical azoles was established by requiring one or more prescriptions during the first trimester of pregnancy. MAIN OUTCOME MEASURES Risk of musculoskeletal malformations, conotruncal malformations, and oral clefts (primary outcomes), associated with exposure to oral fluconazole, diagnosed during the first 90 days after delivery, were examined. RESULTS The study cohort of 1 969 954 pregnancies included 37 650 (1.9%) pregnancies exposed to oral fluconazole and 82 090 (4.2%) pregnancies exposed to topical azoles during the first trimester. The risk of musculoskeletal malformations was 52.1 (95% confidence interval 44.8 to 59.3) per 10 000 pregnancies exposed to fluconazole versus 37.3 (33.1 to 41.4) per 10 000 pregnancies exposed to topical azoles. The risks of conotruncal malformations were 9.6 (6.4 to 12.7) versus 8.3 (6.3 to 10.3) per 10 000 pregnancies exposed to fluconazole and topical azoles, respectively; risks of oral clefts were 9.3 (6.2 to 12.4) versus 10.6 (8.4 to 12.8) per 10 000 pregnancies, respectively. The adjusted relative risk after fine stratification of the propensity score was 1.30 (1.09 to 1.56) for musculoskeletal malformations, 1.04 (0.70 to 1.55) for conotruncal malformations, and 0.91 (0.61 to 1.35) for oral clefts overall. Based on cumulative doses of fluconazole, the adjusted relative risks for musculoskeletal malformations, conotruncal malformations, and oral clefts overall were 1.29 (1.05 to 1.58), 1.12 (0.71 to 1.77), and 0.88 (0.55 to 1.40) for 150 mg of fluconazole; 1.24 (0.93 to 1.66), 0.61 (0.26 to 1.39), and 1.08 (0.58 to 2.04) for more than 150 mg up to 450 mg of fluconazole; and 1.98 (1.23 to 3.17), 2.30 (0.93 to 5.65), and 0.94 (0.23 to 3.82) for more than 450 mg of fluconazole, respectively. CONCLUSIONS Oral fluconazole use in the first trimester was not associated with oral clefts or conotruncal malformations, but an association with musculoskeletal malformations was found, corresponding to a small adjusted risk difference of about 12 incidents per 10 000 exposed pregnancies overall.	[Zhu, Yanmin; Bateman, Brian T.; Mogun, Helen; Straub, Loreen; Huybrechts, Krista F.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA; [Zhu, Yanmin; Bateman, Brian T.; Mogun, Helen; Straub, Loreen; Huybrechts, Krista F.] Harvard Med Sch, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA; [Bateman, Brian T.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA; [Gray, Kathryn J.] Brigham & Womens Hosp, Dept Obstet & Gynecol, Div Mat Fetal Med, 75 Francis St, Boston, MA 02115 USA; [Hernandez-Diaz, Sonia] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Zhu, YM (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.; Zhu, YM (corresponding author), Harvard Med Sch, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	yzhu15@bwh.harvard.edu		Zhu, Yanmin/0000-0001-6697-6450	Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital; K12 BIRCWH career development award from the Office of Research on Women's Health	Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital; K12 BIRCWH career development award from the Office of Research on Women's Health	This study was funded by the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital. KJG was supported by the K12 BIRCWH career development award from the Office of Research on Women's Health to Harvard Medical School. The funders had no role in considering the study design or in the collection, analysis, interpretation of the data, writing of the report, or decision to submit the article for publication.	Aguin TJ, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-015-0462-0; Aleck KA, 1997, AM J MED GENET, V72, P253, DOI 10.1002/(SICI)1096-8628(19971031)72:3&lt;253::AID-AJMG1&gt;3.0.CO;2-S; [Anonymous], 2013, OBSTET GYNECOL, V122, P957, DOI 10.1097/AOG.0b013e3182a603bb; Bateman BT, 2018, ANN INTERN MED, V169, P665, DOI 10.7326/M18-0338; Bateman BT, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1035; Berard A, 2019, CAN MED ASSOC J, V191, pE179, DOI 10.1503/cmaj.180963; Cooper WO, 2008, PHARMACOEPIDEM DR S, V17, P455, DOI 10.1002/pds.1534; Cottreau JM, 2016, PHARMACOTHERAPY, V36, P668, DOI 10.1002/phar.1764; Czeizel AE, 1999, EPIDEMIOLOGY, V10, P437, DOI 10.1097/00001648-199907000-00016; Czeizel Andrew Endre, 2004, Congenital Anomalies, V44, P41, DOI 10.1111/j.1741-4520.2004.00007.x; Desai RJ, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5657; Desai RJ, 2017, EPIDEMIOLOGY, V28, P249, DOI 10.1097/EDE.0000000000000595; Giavini E, 2010, TOXICOL LETT, V198, P106, DOI 10.1016/j.toxlet.2010.07.005; Howley MM, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.022; Huybrechts KF, 2018, JAMA-J AM MED ASSOC, V320, P2429, DOI 10.1001/jama.2018.18307; Huybrechts KF, 2015, JAMA-J AM MED ASSOC, V313, P2142, DOI 10.1001/jama.2015.5605; Huybrechts KF, 2014, NEW ENGL J MED, V370, P2397, DOI 10.1056/NEJMoa1312828; Jick SS, 1999, PHARMACOTHERAPY, V19, P221, DOI 10.1592/phco.19.3.221.30919; King CT, 1998, CLIN INFECT DIS, V27, P1151, DOI 10.1086/514977; Knox CA, 2019, PHARMACOEPIDEM DR S, V28, P1222, DOI 10.1002/pds.4843; LEE BE, 1992, PEDIATR INFECT DIS J, V11, P1062, DOI 10.1097/00006454-199211120-00017; Liu D, 2020, INT J GYNECOL OBSTET, V148, P6, DOI 10.1002/ijgo.12993; Lopez-Rangel E, 2005, BIRTH DEFECTS RES A, V73, P919, DOI 10.1002/bdra.20189; Mastroiacovo P, 1996, AM J OBSTET GYNECOL, V175, P1645, DOI 10.1016/S0002-9378(96)70119-9; Menegola E, 2003, BIRTH DEFECTS RES A, V67, P116, DOI 10.1002/bdra.10022; Menegola E, 2001, REPROD TOXICOL, V15, P421, DOI 10.1016/S0890-6238(01)00143-5; Molgaard-Nielsen D, 2013, NEW ENGL J MED, V369, P830, DOI 10.1056/NEJMoa1301066; Norgaard M, 2008, J ANTIMICROB CHEMOTH, V62, P172, DOI 10.1093/jac/dkn157; Palmsten K, 2015, OBSTET GYNECOL, V126, P465, DOI 10.1097/AOG.0000000000000982; Palmsten K, 2014, PHARMACOEPIDEM DR S, V23, P646, DOI 10.1002/pds.3627; Palmsten K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067405; Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933; Patorno E, 2017, NEW ENGL J MED, V376, P2245, DOI 10.1056/NEJMoa1612222; Peahl AF, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7863; Pilmis B, 2015, J ANTIMICROB CHEMOTH, V70, P14, DOI 10.1093/jac/dku355; Pursley TJ, 1996, CLIN INFECT DIS, V22, P336, DOI 10.1093/clinids/22.2.336; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Rotem R, 2018, BJOG-INT J OBSTET GY, V125, P1550, DOI 10.1111/1471-0528.15293; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Sobel JD, 2014, PATIENT PREFER ADHER, V8, P31, DOI 10.2147/PPA.S38984; Soong D, 2009, CAN FAM PHYSICIAN, V55, P255; Sorensen HT, 1999, BRIT J CLIN PHARMACO, V48, P234, DOI 10.1046/j.1365-2125.1999.00989.x; Tiboni GM, 2005, PEDIATR RES, V58, P94, DOI 10.1203/01.PDR.0000166754.24957.73; TIBONI GM, 1993, RES COMMUN CHEM PATH, V79, P381	44	10	13	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2020	369								m1494	10.1136/bmj.m1494	http://dx.doi.org/10.1136/bmj.m1494			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JK	32434758	Green Published, hybrid			2022-12-28	WOS:000538335800001
J	[Anonymous]				[Anonymous]			Summary for Patients: Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2020	173	3								10.7326/P20-0008	http://dx.doi.org/10.7326/P20-0008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MW7BG	32479170				2022-12-28	WOS:000557186700001
J	Michealraj, KA; Kumar, SA; Kim, LJY; Cavalli, FMG; Przelicki, D; Wojcik, JB; Delaidelli, A; Bajic, A; Saulnier, O; MacLeod, G; Vellanki, RN; Vladoiu, MC; Guilhamon, P; Ong, WN; Lee, JJY; Jiang, YQ; Holgado, BL; Rasnitsyn, A; Malik, AA; Tsai, R; Richman, CM; Juraschka, K; Haapasalo, J; Wang, EY; De Antonellis, P; Suzuki, H; Farooq, H; Balin, P; Kharas, K; Van Ommeren, R; Sirbu, O; Rastan, A; Krumholtz, SL; Ly, M; Ahmadi, M; Deblois, G; Srikanthan, D; Luu, B; Loukides, J; Wu, XC; Garzia, L; Ramaswamy, V; Kanshin, E; Sanchez-Osuna, M; El-Hamamy, I; Coutinho, FJ; Prinos, P; Singh, S; Donovan, LK; Daniels, C; Schramek, D; Tyers, M; Weiss, S; Stein, LD; Lupien, M; Wouters, BG; Garcia, BA; Arrowsmith, CH; Sorensen, PH; Angers, S; Jabado, N; Dirks, PB; Mack, SC; Agnihotri, S; Rich, JN; Taylor, MD				Michealraj, Kulandaimanuvel Antony; Kumar, Sachin A.; Kim, Leo J. Y.; Cavalli, Florence M. G.; Przelicki, David; Wojcik, John B.; Delaidelli, Alberto; Bajic, Andrea; Saulnier, Olivier; MacLeod, Graham; Vellanki, Ravi N.; Vladoiu, Maria C.; Guilhamon, Paul; Ong, Winnie; Lee, John J. Y.; Jiang, Yanqing; Holgado, Borja L.; Rasnitsyn, Alex; Malik, Ahmad A.; Tsai, Ricky; Richman, Cory M.; Juraschka, Kyle; Haapasalo, Joonas; Wang, Evan Y.; De Antonellis, Pasqualino; Suzuki, Hiromichi; Farooq, Hamza; Balin, Polina; Kharas, Kaitlin; Van Ommeren, Randy; Sirbu, Olga; Rastan, Avesta; Krumholtz, Stacey L.; Ly, Michelle; Ahmadi, Moloud; Deblois, Genevieve; Srikanthan, Dilakshan; Luu, Betty; Loukides, James; Wu, Xiaochong; Garzia, Livia; Ramaswamy, Vijay; Kanshin, Evgeny; Sanchez-Osuna, Maria; El-Hamamy, Ibrahim; Coutinho, Fiona J.; Prinos, Panagiotis; Singh, Sheila; Donovan, Laura K.; Daniels, Craig; Schramek, Daniel; Tyers, Mike; Weiss, Samuel; Stein, Lincoln D.; Lupien, Mathieu; Wouters, Bradly G.; Garcia, Benjamin A.; Arrowsmith, Cheryl H.; Sorensen, Poul H.; Angers, Stephane; Jabado, Nada; Dirks, Peter B.; Mack, Stephen C.; Agnihotri, Sameer; Rich, Jeremy N.; Taylor, Michael D.			Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma	CELL			English	Article							POSTERIOR-FOSSA EPENDYMOMA; READ ALIGNMENT; COPY NUMBER; CELL; HYPOXIA; CANCER; GENES; MUTATIONS; IDENTIFICATION; LIPOGENESIS	Posterior fossa A (PFA) ependymomas are lethal malignancies of the hindbrain in infants and toddlers. Lacking highly recurrent somatic mutations, PFA ependymomas are proposed to be epigenetically driven tumors for which model systems are lacking. Here we demonstrate that PFA ependymomas are maintained under hypoxia, associated with restricted availability of specific metabolites to diminish histone methylation, and increase histone demethylation and acetylation at histone 3 lysine 27 (H3K27). PFA ependymomas initiate from a cell lineage in the first trimester of human development that resides in restricted oxygen. Unlike other ependymomas, transient exposure of PFA cells to ambient oxygen induces irreversible cellular toxicity. PFA tumors exhibit a low basal level of H3K27me3, and, paradoxically, inhibition of H3K27 methylation specifically disrupts PFA tumor growth. Targeting metabolism and/or the epigenome presents a unique opportunity for rational therapy for infants with PFA ependymoma.	[Michealraj, Kulandaimanuvel Antony; Cavalli, Florence M. G.; Przelicki, David; Saulnier, Olivier; Vladoiu, Maria C.; Guilhamon, Paul; Lee, John J. Y.; Holgado, Borja L.; Rasnitsyn, Alex; Richman, Cory M.; Juraschka, Kyle; Haapasalo, Joonas; Wang, Evan Y.; De Antonellis, Pasqualino; Suzuki, Hiromichi; Farooq, Hamza; Balin, Polina; Kharas, Kaitlin; Sirbu, Olga; Rastan, Avesta; Ly, Michelle; Srikanthan, Dilakshan; Luu, Betty; Loukides, James; Coutinho, Fiona J.; Donovan, Laura K.; Daniels, Craig; Dirks, Peter B.; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON M5G 0A4, Canada; [Michealraj, Kulandaimanuvel Antony; Kumar, Sachin A.; Cavalli, Florence M. G.; Przelicki, David; Saulnier, Olivier; Vladoiu, Maria C.; Guilhamon, Paul; Ong, Winnie; Lee, John J. Y.; Jiang, Yanqing; Holgado, Borja L.; Rasnitsyn, Alex; Richman, Cory M.; Juraschka, Kyle; Haapasalo, Joonas; Wang, Evan Y.; De Antonellis, Pasqualino; Suzuki, Hiromichi; Farooq, Hamza; Balin, Polina; Kharas, Kaitlin; Van Ommeren, Randy; Sirbu, Olga; Rastan, Avesta; Krumholtz, Stacey L.; Ly, Michelle; Srikanthan, Dilakshan; Luu, Betty; Loukides, James; Wu, Xiaochong; Coutinho, Fiona J.; Donovan, Laura K.; Daniels, Craig; Dirks, Peter B.; Taylor, Michael D.] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 0A4, Canada; [Kumar, Sachin A.; Przelicki, David; Vladoiu, Maria C.; Ong, Winnie; Lee, John J. Y.; Juraschka, Kyle; Balin, Polina; Kharas, Kaitlin; Van Ommeren, Randy; Ly, Michelle; Srikanthan, Dilakshan; Taylor, Michael D.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L7, Canada; [Kim, Leo J. Y.; Rich, Jeremy N.] Univ Calif San Diego, Dept Med, Div Regenerat Med, La Jolla, CA 92037 USA; [Wojcik, John B.; Garcia, Benjamin A.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Wojcik, John B.; Garcia, Benjamin A.] Univ Penn, Perelman Sch Med, Penn Epigenet Inst, Philadelphia, PA 19104 USA; [Delaidelli, Alberto; Sorensen, Poul H.] British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V6T 1Z2, Canada; [Delaidelli, Alberto; Sorensen, Poul H.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z2, Canada; [Bajic, Andrea; Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [MacLeod, Graham; Ahmadi, Moloud; Angers, Stephane] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 3M2, Canada; [Rasnitsyn, Alex; Richman, Cory M.; Wang, Evan Y.; Sirbu, Olga; Arrowsmith, Cheryl H.; Taylor, Michael D.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Malik, Ahmad A.; Tsai, Ricky; Schramek, Daniel] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Ctr Mol & Syst Biol, Toronto, ON, Canada; [Vellanki, Ravi N.; Deblois, Genevieve; Lupien, Mathieu; Wouters, Bradly G.; Arrowsmith, Cheryl H.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Garzia, Livia] McGill Univ, Hlth Ctr, Res Inst, Canc Res Program, Montreal, PQ H4A 3J1, Canada; [Ramaswamy, Vijay] Hosp Sick Children, Dept Pediat, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada; [Kanshin, Evgeny; Sanchez-Osuna, Maria; Tyers, Mike] Univ Montreal, Dept Med, Inst Res Immunol & Canc IRIC, Montreal, PQ H3C 3J7, Canada; [El-Hamamy, Ibrahim; Stein, Lincoln D.] Ontario Inst Canc Res, Computat Biol Program, Adapt Oncol Theme, Toronto, ON M5G 0A3, Canada; [Malik, Ahmad A.; El-Hamamy, Ibrahim; Schramek, Daniel; Stein, Lincoln D.; Dirks, Peter B.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [Prinos, Panagiotis; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, MaRS Ctr, 101 Coll St,South Tower, Toronto, ON M5G 1L7, Canada; [Singh, Sheila] McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON L8S 4K1, Canada; [Singh, Sheila] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Singh, Sheila] McMaster Univ, Dept Surg, Hamilton, ON L8S 4K1, Canada; [Weiss, Samuel] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Angers, Stephane] Univ Toronto, Dept Biochem, Fac Med, Toronto, ON, Canada; [Jabado, Nada] McGill Univ, Hlth Ctr, Res Inst, Dept Pediat, Montreal, PQ H4A 3J1, Canada; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1L7, Canada; [Mack, Stephen C.] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Dan L Duncan Canc Ctr,Canc Ctr, Houston, TX 77030 USA; [Agnihotri, Sameer] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15213 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of California System; University of California San Diego; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; British Columbia Cancer Agency; University of British Columbia; McGill University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Universite de Montreal; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; Structural Genomics Consortium; McMaster University; McMaster University; McMaster University; University of Calgary; University of Toronto; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Taylor, MD (corresponding author), Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON M5G 0A4, Canada.; Taylor, MD (corresponding author), Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 0A4, Canada.; Taylor, MD (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L7, Canada.; Rich, JN (corresponding author), Univ Calif San Diego, Dept Med, Div Regenerat Med, La Jolla, CA 92037 USA.; Taylor, MD (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada.; Taylor, MD (corresponding author), Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1L7, Canada.; Mack, SC (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Dan L Duncan Canc Ctr,Canc Ctr, Houston, TX 77030 USA.; Agnihotri, S (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15213 USA.	stephen.mack@bcm.edu; sameer.agnihotri@gmail.com; drjeremyrich@gmail.com; mdt.cns@gmail.com	Tyers, Michael/ABE-3194-2021; Suzuki, Hiromichi/AAO-4664-2021; de Antonellis, Pasqualino/AAT-1233-2020; Schramek, Daniel/AAL-1470-2020; Michealraj, Antony/AAJ-7925-2020; Singh, Sheila K/W-2799-2018; Kanshin, Evgeny/GXM-7047-2022; Angers, Stephane/E-1432-2014; Rich, Jeremy/AAM-1445-2021	Suzuki, Hiromichi/0000-0002-8858-0294; de Antonellis, Pasqualino/0000-0001-8551-9431; Schramek, Daniel/0000-0001-9977-2104; Michealraj, Antony/0000-0002-3967-0816; Singh, Sheila K/0000-0003-1272-5300; Angers, Stephane/0000-0001-7241-9044; Deblois, Genevieve/0000-0002-3067-2807; Donovan, Laura/0000-0001-5557-5539; Jiang, Yanqing/0000-0003-1240-0784; Srikanthan, Dilakshan/0000-0002-7564-5458; Prinos, Panagiotis/0000-0001-8785-7856; Juraschka, Kyle/0000-0002-9549-9224; Rastan, Azuravesta/0000-0002-8632-430X; AGNIHOTRI, SAMEER/0000-0001-6584-3795; Kumar, Sachin/0000-0002-4853-3864; Vellanki, Ravi/0000-0002-5081-3187; Saulnier, Olivier/0000-0003-4111-1017; Cavalli, Florence M. G./0000-0002-4409-9642	National Institutes of Health [CA203101, CA197718, CA154130, CA169117, CA171652, CA238662, NS087913, NS103434, NS089272, CA148699, CA159859]; Stand Up To Cancer (SU2C) St. Baldrick's Pediatric Dream Team translational research grant by the Government of Canada through Genome Canada [SU2C-AACR-DT1113]; SU2C Canada Cancer Stem Cell Dream Team by the Government of Canada through Genome Canada [SU2C-AACR-DT-19-15]; Canadian Institutes of Health Research; Government of Ontario; Pediatric Brain Tumor Foundation; Terry Fox Research Institute; Cure Search Foundation; b.r.a.i.n.child; Meagan's Walk; SWIFTY Foundation; Brain Tumour Charity; Genome Canada; Genome BC; Genome Quebec; Ontario Research Fund; Worldwide Cancer Research; V-Foundation for Cancer Research; Ontario Institute for Cancer Research by the Government of Ontario; Canadian Cancer Society Research Institute Impact grant; Cancer Research UK Brain Tumour Award; Garron Family Chair in Childhood Cancer Research at the Hospital for Sick Children; University of Toronto; MITACSELEVATE postdoctoral fellowship; ResTraComp doctoral scholarship; Hospital for Sick Children; McLaughlin Centre; Ruggles Family Foundation, University of Toronto; Cancer Prevention Research Institute of Texas (CPRIT) scholar award [RR170023]; Alex's Lemonade Stand Foundation(ALSF) Aaward and Young Investigator award; Pediatric Brain Tumor Foundation award; Chad Tough Young Investigator award; Cookies for Cancer research grant; RALLY research grant; BEAR Necessities Pediatric Cancer Foundation grant; Children's Cancer Research Fund award; Children's Brain TumorFoundation award; Baylor College of Medicine Junior Faculty award; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Eshelman Institute for Innovation; Genome Canada through the Ontario Genomics Institute [OGI-055]; Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD grant) [115766]; Janssen; Merck KGaA (Darmstadt, Germany); MSD; Novartis Pharma AG; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up To Cancer (SU2C) St. Baldrick's Pediatric Dream Team translational research grant by the Government of Canada through Genome Canada; SU2C Canada Cancer Stem Cell Dream Team by the Government of Canada through Genome Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Government of Ontario; Pediatric Brain Tumor Foundation; Terry Fox Research Institute; Cure Search Foundation; b.r.a.i.n.child; Meagan's Walk; SWIFTY Foundation; Brain Tumour Charity; Genome Canada(Genome Canada); Genome BC; Genome Quebec; Ontario Research Fund; Worldwide Cancer Research; V-Foundation for Cancer Research; Ontario Institute for Cancer Research by the Government of Ontario; Canadian Cancer Society Research Institute Impact grant; Cancer Research UK Brain Tumour Award; Garron Family Chair in Childhood Cancer Research at the Hospital for Sick Children; University of Toronto(University of Toronto); MITACSELEVATE postdoctoral fellowship; ResTraComp doctoral scholarship; Hospital for Sick Children; McLaughlin Centre; Ruggles Family Foundation, University of Toronto; Cancer Prevention Research Institute of Texas (CPRIT) scholar award; Alex's Lemonade Stand Foundation(ALSF) Aaward and Young Investigator award; Pediatric Brain Tumor Foundation award; Chad Tough Young Investigator award; Cookies for Cancer research grant; RALLY research grant; BEAR Necessities Pediatric Cancer Foundation grant; Children's Cancer Research Fund award; Children's Brain TumorFoundation award; Baylor College of Medicine Junior Faculty award; AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Eshelman Institute for Innovation; Genome Canada through the Ontario Genomics Institute(Genome Canada); Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD grant); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck KGaA (Darmstadt, Germany); MSD; Novartis Pharma AG; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome	This work was supported by National Institutes of Health grants CA203101 (to L.J.Y.K.); CA197718, CA154130, CA169117, CA171652, CA238662, NS087913, NS103434, and NS089272 (to J.N.R.); and CA148699 and CA159859 (to M.D.T.). M.D.T. is also supported by a Stand Up To Cancer (SU2C) St. Baldrick's Pediatric Dream Team translational research grant (SU2C-AACR-DT1113) and SU2C Canada Cancer Stem Cell Dream Team research funding (SU2C-AACR-DT-19-15) provided by the Government of Canada through Genome Canada and the Canadian Institutes of Health Research, with supplementary support from the Ontario Institute for Cancer Research through funding provided by the Government of Ontario. SU2C is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. M.D.T. is also supported by the Pediatric Brain Tumor Foundation, the Terry Fox Research Institute, the Canadian Institutes of Health Research, the Cure Search Foundation, b.r.a.i.n.child, Meagan's Walk, the SWIFTY Foundation, the Brain Tumour Charity, Genome Canada, Genome BC, Genome Quebec, the Ontario Research Fund, Worldwide Cancer Research, the V-Foundation for Cancer Research, and the Ontario Institute for Cancer Research through funding provided by the Government of Ontario. Additionally, M.D.T. is supported by a Canadian Cancer Society Research Institute Impact grant, a Cancer Research UK Brain Tumour Award, the Garron Family Chair in Childhood Cancer Research at the Hospital for Sick Children, and the University of Toronto. The authors would also like to thank Meera Kamal (administrative assistant) and James Loukides (Tumour Bank manager) and recognize the Labatt Brain Tumour Research Centre and the Michael and Amira Dan Brain Tumour Bank Network. We would also like to acknowledge the Isla Kerr Fund for continued support of ependymoma research at SickKids. K.A.M. is supported by aMITACSELEVATEpostdoctoral fellowship. S.A.K. is supportedby aResTraComp doctoral scholarship, the Hospital for Sick Children, the McLaughlin Centre, the University of Toronto, and the Ruggles Family Foundation, University of Toronto. S.C.M. is supported by a Cancer Prevention Research Institute of Texas (CPRIT) scholar award (RR170023), an Alex's Lemonade Stand Foundation(ALSF) AawardandYoung Investigatoraward, aPediatric Brain TumorFoundation award, a Chad Tough Young Investigator award, a Cookies for Cancer research grant, a RALLY research grant, a BEAR Necessities Pediatric Cancer Foundation grant, a Children's Cancer Research Fund award, a Children's Brain TumorFoundation award, andaBaylorCollege ofMedicineJuniorFacultyaward. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, the Eshelman Institute for Innovation, Genome Canada through the Ontario Genomics Institute (OGI-055), the Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD grant 115766), Janssen, Merck KGaA (Darmstadt, Germany), MSD, Novartis Pharma AG, Pfizer, the Sa~ o Paulo Research Foundation-FAPESP, Takeda, and Wellcome.	Aldape K, 2019, NAT REV CLIN ONCOL, V16, P509, DOI 10.1038/s41571-019-0177-5; Amemiya HM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45839-z; Andrews S., 2010, FASTQC QUALITY CONTR; Badur MG, 2018, CELL REP, V25, P1018, DOI 10.1016/j.celrep.2018.09.074; Beringer M, 2016, MOL CELL, V64, P645, DOI 10.1016/j.molcel.2016.10.018; Buffa FM, 2010, BRIT J CANCER, V102, P428, DOI 10.1038/sj.bjc.6605450; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Connor AA, 2019, CANCER CELL, V35, P267, DOI 10.1016/j.ccell.2018.12.010; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fan Y, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1029-6; Fardin P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-474; Favaro E, 2011, GENOME MED, V3, DOI 10.1186/gm271; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; Gao X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11960; Hakimi AA, 2016, CANCER CELL, V29, P104, DOI 10.1016/j.ccell.2015.12.004; Harris BHL, 2015, CLIN ONCOL-UK, V27, P547, DOI 10.1016/j.clon.2015.07.004; Hart T, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1015-8; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hubner JM, 2019, NEURO-ONCOLOGY, V21, P878, DOI 10.1093/neuonc/noz058; Jain SU, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09981-6; Josephidou M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv135; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kondo S, 2006, ONCOGENE, V25, P1099, DOI 10.1038/sj.onc.1209129; Koong AC, 2000, CANCER RES, V60, P883; Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Mack SC, 2016, NAT NEUROSCI, V19, P10, DOI 10.1038/nn.4190; MacLeod G, 2019, CELL REP, V27, P971, DOI 10.1016/j.celrep.2019.03.047; Maina EN, 2005, ONCOGENE, V24, P4549, DOI 10.1038/sj.onc.1208649; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Pajtler KW, 2018, ACTA NEUROPATHOL, V136, P211, DOI 10.1007/s00401-018-1877-0; Pajtler KW, 2015, CANCER CELL, V27, P728, DOI 10.1016/j.ccell.2015.04.002; Panwalkar P, 2017, ACTA NEUROPATHOL, V134, P705, DOI 10.1007/s00401-017-1752-4; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2014, R VERS 360 R PROJ ST; Ramaswamy V, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0155-6; Ramaswamy V, 2016, J CLIN ONCOL, V34, P2468, DOI 10.1200/JCO.2015.65.7825; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ryall S, 2017, CHILD NERV SYST, V33, P1047, DOI 10.1007/s00381-017-3481-3; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sidoli S, 2016, JOVE-J VIS EXP, DOI 10.3791/54112; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Sorensen BS, 2010, ACTA ONCOL, V49, P895, DOI 10.3109/02841861003614343; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson YY, 2015, CHILD NERV SYST, V31, P1699, DOI 10.1007/s00381-015-2823-2; Tian Y, 2017, BIOINFORMATICS, V33, P3982, DOI 10.1093/bioinformatics/btx513; Toustrup K, 2011, CANCER RES, V71, P5923, DOI 10.1158/0008-5472.CAN-11-1182; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Ulanovskaya OA, 2013, NAT CHEM BIOL, V9, P300, DOI [10.1038/NCHEMBIO.1204, 10.1038/nchembio.1204]; Vladoiu MC, 2019, NATURE, V572, P67, DOI 10.1038/s41586-019-1158-7; Walmsley SR, 2011, J CLIN INVEST, V121, P1053, DOI 10.1172/JCI43273; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wei T., 2017, CORRPLOT VISUALIZATI; Winter SC, 2007, CANCER RES, V67, P3441, DOI 10.1158/0008-5472.CAN-06-3322; Witt H, 2011, CANCER CELL, V20, P143, DOI 10.1016/j.ccr.2011.07.007; Yuan ZF, 2018, J PROTEOME RES, V17, P2533, DOI 10.1021/acs.jproteome.8b00133; Zhang H, 2016, CELL REP, V16, P1536, DOI 10.1016/j.celrep.2016.06.102	75	54	56	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2020	181	6					1329	+		10.1016/j.cell.2020.04.047	http://dx.doi.org/10.1016/j.cell.2020.04.047			41	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LY9TE	32445698	Bronze			2022-12-28	WOS:000540869600014
J	Parola, P; Izri, A				Parola, Philippe; Izri, Arezki			Bedbugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BUGS CIMEX-LECTULARIUS; BED BUGS; INFESTATION; DERMATITIS	Cimex lectularius (the "bedbug") is an insect that feeds nocturnally, taking a requisite blood meal from a sleeping human or other parasitized host. Immunological reactions to bedbug saliva vary, but typically, bites yield erythematous and pruritic papules. The face and distal extremities, areas uncovered by sleeping clothes or blankets, are preferentially involved. Until the late 1990s, bedbug infestations in the United States were declining. Resurgence is attributed to increased travel and resistance to insecticides. Although hepatitis or human immunodeficiency virus is not effectively transmitted by the bedbug, pruritus and the fear and perceived violation of an infestation can be debilitating. Bedbugs are small but robust, and their ability to remain ensconced in crevices within the bedroom makes eradication difficult. As more patients present with bedbug bites, physicians must possess the knowledge to diagnose, treat, and educate with regard to bedbug bites and bedbug infestations.	[Parola, Philippe] Inst Hosp Univ Mediterranee Infect, VITROME Vecteurs Infect Trop & Mediterraneennes R, Marseille, France; [Izri, Arezki] Avicenne Hosp, Parasitol Mycol Dept, Bobigny, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP	Parola, P (corresponding author), Inst Hosp Univ Mediterranee Infect, 19-21 Blvd Jean Moulin, F-13005 Marseille, France.	philippe.parola@univ-amu.fr	Parola, Philippe/AAY-4346-2021	Parola, Philippe/0000-0002-1061-1927				Akhoundi M, 2019, J INSECT SCI, V19, DOI 10.1093/jisesa/iez095; Anders D, 2010, EUR J DERMATOL, V20, P239, DOI 10.1684/ejd.2010.0872; [Anonymous], BED BUGS AD REP BED; [Anonymous], 2019, DETECTION DESINSECTI; [Anonymous], 2015, J CROHNS COLITIS S1, V9, pS15; Armed Forces Pest Management Board, 2019, BED BUGS IMP BIOL CO; Berenger JM, 2015, J MED ENTOMOL, V52, P513, DOI 10.1093/jme/tjv019; Bernardes F, 2015, AN BRAS DERMATOL, V90, P240, DOI 10.1590/abd1806-4841.20153214; Bernardeschi C, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f138; Burrows S, 2013, AM J CASE REP, V14, P176, DOI 10.12659/AJCR.883926; Candy K, 2018, J MED ENTOMOL, V55, P1648, DOI 10.1093/jme/tjy126; Cooper R, 2014, J ECON ENTOMOL, V107, P2171, DOI 10.1603/EC14195; Criado PR, 2011, BRAZ J INFECT DIS, V15, P74, DOI [10.1590/S1413-86702011000100014, 10.1016/S1413-8670(11)70144-1]; Dang K, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2232-3; Delaunay P, 2012, J TRAVEL MED, V19, P373, DOI 10.1111/j.1708-8305.2012.00653.x; Delaunay P, 2011, CLIN INFECT DIS, V52, P200, DOI 10.1093/cid/ciq102; Delaunay P, 2009, EMERG INFECT DIS, V15, P989, DOI 10.3201/eid1506.081480; Doggett SL, 2018, ADV BIOL MANAGEMENT, P43; Doggett SL, 2012, CLIN MICROBIOL REV, V25, P164, DOI 10.1128/CMR.05015-11; Durand R, 2012, PARASITE, V19, P381, DOI 10.1051/parasite/2012194381; El Hamzaoui B, 2019, AM J TROP MED HYG, V100, P1407, DOI 10.4269/ajtmh.18-0804; Francischetti IMB, 2010, J PROTEOME RES, V9, P3820, DOI 10.1021/pr1000169; Goddard J, 2012, AM J MED, V125, P101, DOI 10.1016/j.amjmed.2011.08.010; Goddard J, 2009, JAMA-J AM MED ASSOC, V301, P1358, DOI 10.1001/jama.2009.405; Kells Stephen A, 2011, Insects, V2, P412, DOI 10.3390/insects2030412; Mouchtouri VA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-100; Peres G, 2018, AN BRAS DERMATOL, V93, P759, DOI 10.1590/abd1806-4841.20187384; Reinhardt K, 2009, MED VET ENTOMOL, V23, P163, DOI 10.1111/j.1365-2915.2008.00793.x; Reinhardt K, 2008, J MED ENTOMOL, V45, P956, DOI 10.1603/0022-2585(2008)45[956:WKTBBK]2.0.CO;2; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Romero A, 2017, J INTEGR PEST MANAG, V8, DOI 10.1093/jipm/pmx009; Salazar R, 2015, AM J TROP MED HYG, V92, P331, DOI 10.4269/ajtmh.14-0483; Scarpino SV, 2019, P NATL ACAD SCI USA, V116, P7160, DOI 10.1073/pnas.1902404116; Seidel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051083; Sheele JM, 2017, INFECT CONT HOSP EP, V38, P623, DOI 10.1017/ice.2017.13; Wang CL, 2018, PEST MANAG SCI, V74, P1302, DOI 10.1002/ps.4830; Wang CL, 2016, J MED ENTOMOL, V53, P639, DOI 10.1093/jme/tjw018; Wang Changlu, 2012, Insects, V3, P402, DOI 10.3390/insects3020402; Wang DS, 2018, PEST MANAG SCI, V74, P2030, DOI 10.1002/ps.4933; Zorrilla-Vaca A, 2014, CLIN INFECT DIS, V59, P1351, DOI 10.1093/cid/ciu575	40	17	18	2	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2020	382	23					2230	2237		10.1056/NEJMcp1905840	http://dx.doi.org/10.1056/NEJMcp1905840			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV0NI	32492304				2022-12-28	WOS:000538140600016
J	Inomata, T; Triadan, D; Lopez, VAV; Fernandez-Diaz, JC; Omori, T; Bauer, MBM; Hernandez, MG; Beach, T; Cagnato, C; Aoyama, K; Nasu, H				Inomata, Takeshi; Triadan, Daniela; Vazquez Lopez, Veronica A.; Fernandez-Diaz, Juan Carlos; Omori, Takayuki; Mendez Bauer, Maria Belen; Garcia Hernandez, Melina; Beach, Timothy; Cagnato, Clarissa; Aoyama, Kazuo; Nasu, Hiroo			Monumental architecture at Aguada Fenix and the rise of Maya civilization	NATURE			English	Article							AIRBORNE LIDAR; ARCHAEOLOGICAL FEATURES; VISUALIZATION; ORIGINS; MODELS; SITE; CALIBRATION; REVOLUTION; BUILDINGS; GUATEMALA	Archaeologists have traditionally thought that the development of Maya civilization was gradual, assuming that small villages began to emerge during the Middle Preclassic period (1000-350 bc; dates are calibrated throughout) along with the use of ceramics and the adoption of sedentism(1). Recent finds of early ceremonial complexes are beginning to challenge this model. Here we describe an airborne lidar survey and excavations of the previously unknown site of Aguada Fenix (Tabasco, Mexico) with an artificial plateau, which measures 1,400 m in length and 10 to 15 m in height and has 9 causeways radiating out from it. We dated this construction to between 1000 and 800 bc using a Bayesian analysis of radiocarbon dates. To our knowledge, this is the oldest monumental construction ever found in the Maya area and the largest in the entire pre-Hispanic history of the region. Although the site exhibits some similarities to the earlier Olmec centre of San Lorenzo, the community of Aguada Fenix probably did not have marked social inequality comparable to that of San Lorenzo. Aguada Fenix and other ceremonial complexes of the same period suggest the importance of communal work in the initial development of Maya civilization. Lidar survey of the Maya lowlands uncovers the monumental site of Aguada Fenix, which dates to around 1000-800 bc and points to the role of communal construction in the development of Maya civilization.	[Inomata, Takeshi; Triadan, Daniela] Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA; [Vazquez Lopez, Veronica A.] Univ Calgary, Dept Anthropol & Archaeol, Calgary, AB, Canada; [Fernandez-Diaz, Juan Carlos] Univ Houston, Natl Ctr Airborne Laser Mapping NCALM, Houston, TX USA; [Omori, Takayuki] Univ Tokyo, Univ Museum, Tokyo, Japan; [Mendez Bauer, Maria Belen] Univ Nacl Autonoma Mexico, Estudios Mesoamer, Mexico City, DF, Mexico; [Garcia Hernandez, Melina] Middle Usumacinta Archaeol Project, Balancan, Mexico; [Beach, Timothy] Univ Texas Austin, Dept Geog & Environm, Austin, TX 78712 USA; [Cagnato, Clarissa] Archeol Amer, UMR 8096, Nanterre, France; [Aoyama, Kazuo] Ibaraki Univ, Fac Humanities, Mito, Ibaraki, Japan; [Nasu, Hiroo] Okayama Univ Sci, Fac Biosphere Geosphere Sci, Okayama, Japan	University of Arizona; University of Calgary; University of Houston System; University of Houston; University of Tokyo; Universidad Nacional Autonoma de Mexico; University of Texas System; University of Texas Austin; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Ibaraki University; Okayama University of Science	Inomata, T (corresponding author), Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA.	inomata@arizona.edu	Fernandez-Diaz, Juan Carlos/ABA-4796-2021	Fernandez-Diaz, Juan Carlos/0000-0003-3703-7555; Vazquez Lopez, Veronica Amellali/0000-0003-2832-3795; Cagnato, Clarissa/0000-0002-2010-1437	Alphawood Foundation; National Science Foundation [BCS-1826909]; Agnese Nelms Haury Program of the University of Arizona; JSPS KAKENHI [26101003]	Alphawood Foundation; National Science Foundation(National Science Foundation (NSF)); Agnese Nelms Haury Program of the University of Arizona; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The permit for our research was granted by the Instituto Nacional de Antropologia e Historia. Funding was provided by the Alphawood Foundation, the National Science Foundation (BCS-1826909), the Agnese Nelms Haury Program of the University of Arizona and JSPS KAKENHI (26101003). We thank R. Liendo, K. Teranishi, F. Kupprat, V. Poston, A. Flores, F. Pinzon, M. Mollinedo, C. Alvarado, H. Zanotto, D. Ramirez, S. Mendoza and O. Garcia for their dedicated work.	Abrams Elliot M., 1994, MAYA BUILT THEIR WOR, DOI DOI 10.7560/704619; Andrews EW, 2018, MAYA STUD, P49; Bachand B. R., 2012, ARQUEOLOGIA RECIENTE, P45; Bayliss A, 2015, WORLD ARCHAEOL, V47, P677, DOI 10.1080/00438243.2015.1067640; Bayliss A, 2009, RADIOCARBON, V51, P123, DOI 10.1017/S0033822200033750; Beach T, 2019, P NATL ACAD SCI USA, V116, P21469, DOI 10.1073/pnas.1910553116; Beach T, 2018, GEOMORPHOLOGY, V305, P185, DOI 10.1016/j.geomorph.2017.07.027; Bennett R, 2012, ARCHAEOL PROSPECT, V19, P41, DOI 10.1002/arp.1414; BLAKE M, 1992, CURR ANTHROPOL, V33, P83, DOI 10.1086/204038; Bronk Ramsey C., 2019, OXCAL 4 3; Buck C.E., 1996, BAYESIAN APPROACH IN; BUCK CE, 1991, ANTIQUITY, V65, P808, DOI 10.1017/S0003598X00080534; Burger Richard L., 2012, EARLY NEW WORLD MONU; Burger Richard L., 2012, EARLY NEW WORLD MONU, P198, DOI DOI 10.5744/FLORIDA/9780813038087.001.0001; Canuto MA, 2018, SCIENCE, V361, P1355, DOI 10.1126/science.aau0137; Challis K, 2011, ARCHAEOL PROSPECT, V18, P279, DOI 10.1002/arp.421; Chase AF, 2014, REMOTE SENS-BASEL, V6, P8671, DOI 10.3390/rs6098671; Chase AF, 2012, P NATL ACAD SCI USA, V109, P12916, DOI 10.1073/pnas.1205198109; Chase AF, 2011, J ARCHAEOL SCI, V38, P387, DOI 10.1016/j.jas.2010.09.018; Chiba T., 2008, INT ARCH PHOTOGRAMME, V37, P1071; Chiba T., 2008, ADV SURV TECHNOL, V96, P32; Clark JE, 2016, PENN MUSEUM INT RES, V7, P123; Clark John E., 2001, ROYAL COURTS ANCIENT, V2, P1, DOI DOI 10.4324/9780429497537-1; Clark John E., 2007, ARCHAEOLOGY ART ETHN, V68, P23; Coe Michael D., 1980, LAND OLMEC; Coe William R., 1990, 14 U PENNS U MUS; Cyphers A, 2016, PENN MUSEUM INT RES, V7, P83; Cyphers Ann, 2014, MESOAMERICAN PLAZAS, P71; Devereux BJ, 2008, ANTIQUITY, V82, P470, DOI 10.1017/S0003598X00096952; Drucker P, 1959, EXCAVATIONS VENTA TA, V170; ERASMUS CJ, 1965, SOUTHWEST J ANTHROP, V21, P277, DOI 10.1086/soutjanth.21.4.3629433; Estrada -Belli Francisco, 2011, 1 MAYA CIVILIZATION; Evans D, 2016, J ARCHAEOL SCI, V74, P164, DOI 10.1016/j.jas.2016.05.009; Evans DH, 2013, P NATL ACAD SCI USA, V110, P12595, DOI 10.1073/pnas.1306539110; Fernandez-Diaz JC, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8110936; Fernandez-Diaz JC, 2014, REMOTE SENS-BASEL, V6, P9951, DOI 10.3390/rs6109951; Freidel David A, 2017, MAYA E GROUPS CALEND; Negron TG, 2018, MAYA STUD, P276; Gonzalez Lauck Rebecca, 2010, PLACE STONE MONUMENT, P177; Harmon JM, 2006, AM ANTIQUITY, V71, P649, DOI 10.2307/40035883; Hernandez Alcides, 1983, NEOLIBERALISMO HONDU; Hirth K, 2013, J ARCHAEOL SCI, V40, P2784, DOI 10.1016/j.jas.2013.01.033; Hodgson JohnG., 2010, MEXICON, V32, P139; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Hutson SR, 2016, ADV ARCHAEOL PRACT, V4, P268, DOI 10.7183/2326-3768.4.3.268; Hutson SR, 2015, J ARCHAEOL SCI-REP, V4, P252, DOI 10.1016/j.jasrep.2015.09.012; Inomata T., 2016, MAYA ARCHAEOLOGY, V3, P56; Inomata T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221943; Inomata T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191619; Inomata T, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9060563; Inomata T, 2017, ANCIENT MESOAM, V28, P329, DOI 10.1017/S0956536117000049; Inomata T, 2017, ANCIENT MESOAM, V28, P187, DOI 10.1017/S0956536117000037; Inomata T, 2017, P NATL ACAD SCI USA, V114, P1293, DOI 10.1073/pnas.1618022114; Inomata T, 2015, P NATL ACAD SCI USA, V112, P4268, DOI 10.1073/pnas.1501212112; Inomata T, 2014, LAT AM ANTIQ, V25, P377, DOI 10.7183/1045-6635.25.4.377; Inomata T, 2013, SCIENCE, V340, P467, DOI 10.1126/science.1234493; Kennett DJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01597; Lohse JC, 2010, LAT AM ANTIQ, V21, P312, DOI 10.7183/1045-6635.21.3.312; Loughlin ML, 2016, ADV ARCHAEOL PRACT, V4, P301, DOI 10.7183/2326-3768.4.3.301; Love M, 2011, EARLY MESOAMERICAN SOCIAL TRANSFORMATIONS: ARCHAIC AND FORMATIVE LIFEWAYS IN THE SOCONUSCO REGION, P170; Lowe GW, 1977, ORIGINS MAYA CIVILIZ, P197; Lowe GW, 1981, OLMEC THEIR NEIGHBOR, P231; Magnoni A, 2016, ADV ARCHAEOL PRACT, V4, P232, DOI 10.7183/2326-3768.4.3.232; Marquina I, 1970, PROYECTO CHOLULA; Millard K, 2009, GEOARCHAEOLOGY, V24, P576, DOI 10.1002/gea.20281; MILLON R, 1960, AM ANTIQUITY, V26, P1, DOI 10.2307/277155; Ortmann AL, 2013, GEOARCHAEOLOGY, V28, P66, DOI 10.1002/gea.21430; Piperno DR, 2009, P NATL ACAD SCI USA, V106, P5019, DOI 10.1073/pnas.0812525106; Prufer KM, 2015, J ARCHAEOL SCI, V57, P1, DOI 10.1016/j.jas.2015.02.013; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rands Robert L., 1977, ORIGINS MAYA CIVILIZ, P159; Reese-Taylor K, 2017, GROUPS CALENDARS AST, P480; Reese-Taylor K, 2016, ADV ARCHAEOL PRACT, V4, P314, DOI 10.7183/2326-3768.4.3.314; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rosenswig RM, 2018, ANTIQUITY, V92, P1292, DOI 10.15184/aqy.2018.166; Rosenswig RM, 2013, J ARCHAEOL SCI, V40, P1493, DOI 10.1016/j.jas.2012.10.034; Rosenswig RM, 2011, EARLY MESOAMERICAN SOCIAL TRANSFORMATIONS: ARCHAIC AND FORMATIVE LIFEWAYS IN THE SOCONUSCO REGION, P242; Sabloff Jeremy A., 1975, EXCAVATIONS SEIBAL D; Sanders William T., 1977, ORIGINS MAYA CIVILIZ, P287; Saunders JW, 2005, AM ANTIQUITY, V70, P631, DOI 10.2307/40035868; Schmidt K, 2010, DOC PRAEHIST, V37, P239, DOI 10.4312/dp.37.21; Solis RS, 2001, SCIENCE, V292, P723, DOI 10.1126/science.1059519; Stanish C, 2017, EVOLUTION OF HUMAN CO-OPERATION: RITUAL AND SOCIAL COMPLEXITY IN STATELESS SOCIETIES, P1, DOI 10.1017/9781316848128; Stular B, 2012, J ARCHAEOL SCI, V39, P3354, DOI 10.1016/j.jas.2012.05.029; Venter ML, 2018, ANCIENT MESOAM, V29, P81, DOI 10.1017/S0956536117000128; Webster D, 1995, J ANTHROPOL RES, V51, P363, DOI 10.1086/jar.51.4.3630143	88	71	72	3	35	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2020	582	7813					530	+		10.1038/s41586-020-2343-4	http://dx.doi.org/10.1038/s41586-020-2343-4		JUN 2020	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OL0DJ	32494009				2022-12-28	WOS:000537932200003
J	Slabicki, M; Kozicka, Z; Petzold, G; Li, YD; Manojkumar, M; Bunker, RD; Donovan, KA; Sievers, QL; Koeppel, J; Suchyta, D; Sperling, AS; Fink, EC; Gasser, JA; Wang, LR; Corsello, SM; Sellar, RS; Jan, M; Gillingham, D; Scholl, C; Frohling, S; Golub, TR; Fischer, ES; Thoma, NH; Ebert, BL				Slabicki, Mikolaj; Kozicka, Zuzanna; Petzold, Georg; Li, Yen-Der; Manojkumar, Manisha; Bunker, Richard D.; Donovan, Katherine A.; Sievers, Quinlan L.; Koeppel, Jonas; Suchyta, Dakota; Sperling, Adam S.; Fink, Emma C.; Gasser, Jessica A.; Wang, Li R.; Corsello, Steven M.; Sellar, Rob S.; Jan, Max; Gillingham, Dennis; Scholl, Claudia; Frohling, Stefan; Golub, Todd R.; Fischer, Eric S.; Thoma, Nicolas H.; Ebert, Benjamin L.			The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K	NATURE			English	Article							UBIQUITIN LIGASE; SELECTIVE DEGRADATION; DEPENDENT KINASES; ROSCOVITINE; IDENTIFICATION; ARCHITECTURE; EXPRESSION; VECTORS; TARGET; POTENT	The cyclin-dependent kinase inhibitor CR8 acts as a molecular glue compound by inducing the formation of a complex between CDK12-cyclin K and DDB1, which results in the ubiquitination and degradation of cyclin K. Molecular glue compounds induce protein-protein interactions that, in the context of a ubiquitin ligase, lead to protein degradation(1). Unlike traditional enzyme inhibitors, these molecular glue degraders act substoichiometrically to catalyse the rapid depletion of previously inaccessible targets(2). They are clinically effective and highly sought-after, but have thus far only been discovered serendipitously. Here, through systematically mining databases for correlations between the cytotoxicity of 4,518 clinical and preclinical small molecules and the expression levels of E3 ligase components across hundreds of human cancer cell lines(3-5), we identify CR8-a cyclin-dependent kinase (CDK) inhibitor(6)-as a compound that acts as a molecular glue degrader. The CDK-bound form of CR8 has a solvent-exposed pyridyl moiety that induces the formation of a complex between CDK12-cyclin K and the CUL4 adaptor protein DDB1, bypassing the requirement for a substrate receptor and presenting cyclin K for ubiquitination and degradation. Our studies demonstrate that chemical alteration of surface-exposed moieties can confer gain-of-function glue properties to an inhibitor, and we propose this as a broader strategy through which target-binding molecules could be converted into molecular glues.	[Slabicki, Mikolaj; Li, Yen-Der; Manojkumar, Manisha; Sievers, Quinlan L.; Koeppel, Jonas; Sperling, Adam S.; Fink, Emma C.; Gasser, Jessica A.; Wang, Li R.; Corsello, Steven M.; Sellar, Rob S.; Jan, Max; Golub, Todd R.; Ebert, Benjamin L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Slabicki, Mikolaj; Li, Yen-Der; Manojkumar, Manisha; Sievers, Quinlan L.; Koeppel, Jonas; Sperling, Adam S.; Fink, Emma C.; Gasser, Jessica A.; Corsello, Steven M.; Sellar, Rob S.; Jan, Max; Ebert, Benjamin L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Slabicki, Mikolaj; Manojkumar, Manisha; Koeppel, Jonas; Frohling, Stefan] German Canc Res Ctr, Div Translat Med Oncol, Heidelberg, Germany; [Slabicki, Mikolaj; Manojkumar, Manisha; Koeppel, Jonas; Scholl, Claudia; Frohling, Stefan] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Kozicka, Zuzanna; Petzold, Georg; Bunker, Richard D.; Suchyta, Dakota; Thoma, Nicolas H.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Kozicka, Zuzanna; Suchyta, Dakota; Gillingham, Dennis] Univ Basel, Fac Sci, Basel, Switzerland; [Li, Yen-Der; Fischer, Eric S.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Donovan, Katherine A.; Fischer, Eric S.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Donovan, Katherine A.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Sellar, Rob S.] UCL, UCL Canc Inst, Dept Haematol, London, England; [Scholl, Claudia] German Canc Res Ctr, Div Appl Funct Genom, Heidelberg, Germany; [Frohling, Stefan] German Canc Consortium, Heidelberg, Germany; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.; Ebert, Benjamin L.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Bunker, Richard D.] Monte Rosa Therapeut, Basel, Switzerland	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Friedrich Miescher Institute for Biomedical Research; University of Basel; Harvard University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of London; University College London; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Ebert, BL (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Ebert, BL (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Thoma, NH (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.; Ebert, BL (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	nicolas.thoma@fmi.ch; benjamin_ebert@dfci.harvard.edu	Donovan, Katherine Aleisha/R-7539-2018; Sperling, Adam/AAJ-3613-2021; Wang, Liran/GSN-0160-2022	Donovan, Katherine Aleisha/0000-0002-8539-5106; Sperling, Adam/0000-0002-9369-4413; Slabicki, Mikolaj/0000-0001-6317-9296; Koeppel, Jonas/0000-0003-1306-3994; Corsello, Steven/0000-0002-9929-3709; Thoma, Nicolas/0000-0003-2685-906X; Bunker, Richard/0000-0001-8866-5290; Kozicka, Zuzanna/0000-0003-0085-6565	NIH [R01HL082945, P01CA108631, P50CA206963, NCI R01CA214608, R01CA218278]; Howard Hughes Medical Institute; Edward P. Evans Foundation; Leukaemia and Lymphoma Society; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [666068]; Gebert Ruf Stiftung [GRS-057/14]; Novartis Research Foundation; Mark Foundation Emerging Leader Award; European Union's Horizon 2020 Research and Innovation Program under the Marie Skodowska-Curie grant [702642, 765445]; Human Frontier Science Program (HFSP Long-Term Fellowship) [LT000210/2014]; European Molecular Biology Organization (EMBO Advanced Fellowship) [aALTF 761-2016]; DF/HCC K12 grant; Conquer Cancer Foundation Young Investigator Award; Wong Family Foundation; Intermediate Fellowship from the Kay Kendall Leukaemia Fund; Advanced Clinician Scientist Fellowship from Cancer Research UK;  [KL2 TR002542];  [K08 CA230220]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Edward P. Evans Foundation; Leukaemia and Lymphoma Society; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); Gebert Ruf Stiftung; Novartis Research Foundation; Mark Foundation Emerging Leader Award; European Union's Horizon 2020 Research and Innovation Program under the Marie Skodowska-Curie grant; Human Frontier Science Program (HFSP Long-Term Fellowship); European Molecular Biology Organization (EMBO Advanced Fellowship); DF/HCC K12 grant; Conquer Cancer Foundation Young Investigator Award; Wong Family Foundation; Intermediate Fellowship from the Kay Kendall Leukaemia Fund; Advanced Clinician Scientist Fellowship from Cancer Research UK; ; 	We thank S. Cavadini and A. Schenk for support during electron microscopy data collection and processing; M. Kolesnikov for help with ITC experiments; the Broad Institute PRISM (particularly M. Kocak); the Compound Management, Cancer Data Science, Walk-up Sequencing, Genetic Perturbation Platform and Flow Facility teams (particularly P. Rogers), K. DeRuff for the introduction to the Agilent BRAVO Automated Liquid Handling Platform, and J. Kennedy for providing sgRNA.SFFV.tBFP and sgRNA.EFS.RFP657 backbones. We acknowledge the Paul Scherrer Institute for provision of synchrotron radiation beam time at beamline PXI of the SLS and thank T. Tomizaki for assistance. We are grateful to all members of the Ebert group, particularly R. Belizaire, S. Koochaki, P. Miller and C. Zou; as well as R. Nowak and P. Tsvetkov, for discussions. This work was supported by the NIH (grants R01HL082945, P01CA108631 and P50CA206963), the Howard Hughes Medical Institute, the Edward P. Evans Foundation and the Leukaemia and Lymphoma Society (to B.L.E.); funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program grant agreement no. 666068, the Gebert Ruf Stiftung (GRS-057/14) and the Novartis Research Foundation (to N.H.T.); and NIH grants NCI R01CA214608 and R01CA218278 and a Mark Foundation Emerging Leader Award (to E.S.F.). M.S. received funding from the European Union's Horizon 2020 Research and Innovation Program under the Marie Skodowska-Curie grant agreement no. 702642; Z.K. was supported by the European Union's Horizon 2020 Research and Innovation Program under the Marie Skodowska-Curie grant agreement no. 765445; G.P. was supported by the Human Frontier Science Program (HFSP Long-Term Fellowship LT000210/2014) and the European Molecular Biology Organization (EMBO Advanced Fellowship aALTF 761-2016); A.S.S. was supported by a DF/HCC K12 grant, a Conquer Cancer Foundation Young Investigator Award and an award from the Wong Family Foundation; R.S.S. was supported by an Intermediate Fellowship from the Kay Kendall Leukaemia Fund and an Advanced Clinician Scientist Fellowship from Cancer Research UK; and S.M.C. received funding from grants KL2 TR002542 and K08 CA230220.	Abdulrahman W, 2009, ANAL BIOCHEM, V385, P383, DOI 10.1016/j.ab.2008.10.044; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bettayeb K, 2008, ONCOGENE, V27, P5797, DOI 10.1038/onc.2008.191; Bosken CA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4505; Bondeson DP, 2015, NAT CHEM BIOL, V11, P611, DOI [10.1038/NCHEMBIO.1858, 10.1038/nchembio.1858]; Bricogne G., 2017, BUSTER; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng SWG, 2012, MOL CELL BIOL, V32, P4691, DOI 10.1128/MCB.06267-11; Chopra Rajesh, 2019, Drug Discov Today Technol, V31, P5, DOI 10.1016/j.ddtec.2019.02.002; Corsello SM, 2020, NAT CANCER, V1, P235, DOI 10.1038/s43018-019-0018-6; Dixon-Clarke SE, 2015, SCI REP-UK, V5, DOI 10.1038/srep17122; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Donovan KA, 2018, ELIFE, V7, DOI 10.7554/eLife.38430; DYKES GW, 1979, J MOL BIOL, V130, P451, DOI 10.1016/0022-2836(79)90434-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faust TB, 2020, NAT CHEM BIOL, V16, P7, DOI 10.1038/s41589-019-0378-3; Fink EC, 2015, BLOOD, V126, P2366, DOI 10.1182/blood-2015-07-567958; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Garcia-Seisdedos H, 2017, NATURE, V548, P244, DOI 10.1038/nature23320; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Han T, 2017, SCIENCE, V356, DOI 10.1126/science.aal3755; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Johnson SF, 2016, CELL REP, V17, P2367, DOI 10.1016/j.celrep.2016.10.077; Jones LH, 2018, CELL CHEM BIOL, V25, P30, DOI 10.1016/j.chembiol.2017.10.011; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Li T, 2005, METHOD ENZYMOL, V398, P125, DOI 10.1016/S0076-6879(05)98012-9; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Matyskiela ME, 2016, NATURE, V535, P252, DOI 10.1038/nature18611; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Oumata N, 2008, J MED CHEM, V51, P5229, DOI 10.1021/jm800109e; Petzold G, 2016, NATURE, V532, P127, DOI 10.1038/nature16979; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schreiber SL, 2019, ISR J CHEM, V59, P52, DOI 10.1002/ijch.201800113; Sedlacek HH, 1996, INT J ONCOL, V9, P1143, DOI 10.3892/ijo.9.6.1143; Sievers QL, 2018, SCIENCE, V362, P558, DOI 10.1126/science.aat0572; Sievers QL, 2018, BLOOD, V132, P1293, DOI 10.1182/blood-2018-01-821769; Sperling AS, 2019, BLOOD, V134, P160, DOI 10.1182/blood.2019000789; Stanton BZ, 2018, SCIENCE, V359, DOI 10.1126/science.aao5902; Tickle I.J., 2018, STARANISO; Uehara T, 2017, NAT CHEM BIOL, V13, P675, DOI 10.1038/nchembio.2363; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu CN, 2016, NAT BIOTECHNOL, V34, P419, DOI 10.1038/nbt.3460; Zhang TH, 2016, NAT CHEM BIOL, V12, P876, DOI 10.1038/nchembio.2166	51	115	118	17	128	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 10	2020	585	7824					293	+		10.1038/s41586-020-2374-x	http://dx.doi.org/10.1038/s41586-020-2374-x		JUN 2020	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QP5ZL	32494016	Green Submitted, Green Accepted			2022-12-28	WOS:000537663800004
J	Rimmer, A				Rimmer, Abi			Covid-19: Leading statistician welcomes UK government's move to improve testing data	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, COVID 19 UK TESTING; Department of Health and Social Care, 2020, TWITTER; Department of Health and Social Care, 2020, COMMUNICATION; Devlin H., 2020, GUARDIAN; Merrick R., 2020, INDEPENDENT; Morgan Piers, 2020, TWITTER; Rimmer A., 2020, BMJ-BRIT MED J, V369	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2020	369								m2175	10.1136/bmj.m2175	http://dx.doi.org/10.1136/bmj.m2175			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0OM	32482685	Bronze			2022-12-28	WOS:000548486700010
J	Argenziano, MG; Bruce, SL; Slater, CL; Tiao, JR; Baldwin, MR; Barr, RG; Chang, BP; Chau, KH; Choi, JJ; Gavin, N; Goyal, P; Mills, AM; Patel, AA; Romney, MLS; Safford, MM; Schluger, NW; Sengupta, S; Sobieszczyk, ME; Zucker, JE; Asadourian, PA; Bell, FM; Boyd, R; Cohen, MF; Colquhoun, MI; Colville, LA; de Jonge, JH; Dershowitz, LB; Dey, SA; Eiseman, KA; Girvin, ZP; Goni, DT; Harb, AA; Herzik, N; Householder, S; Karaaslan, LE; Lee, H; Lieberman, E; Ling, A; Lu, R; Shou, AY; Sisti, AC; Snow, ZE; Sperring, CP; Xiong, YQ; Zhou, HW; Natarajan, K; Hripcsak, G; Chen, RJ				Argenziano, Michael G.; Bruce, Samuel L.; Slater, Cody L.; Tiao, Jonathan R.; Baldwin, Matthew R.; Barr, R. Graham; Chang, Bernard P.; Chau, Katherine H.; Choi, Justin J.; Gavin, Nicholas; Goyal, Parag; Mills, Angela M.; Patel, Ashmi A.; Romney, Marie-Laure S.; Safford, Monika M.; Schluger, Neil W.; Sengupta, Soumitra; Sobieszczyk, Magdalena E.; Zucker, Jason E.; Asadourian, Paul A.; Bell, Fletcher M.; Boyd, Rebekah; Cohen, Matthew F.; Colquhoun, MacAlistair I.; Colville, Lucy A.; de Jonge, Joseph H.; Dershowitz, Lyle B.; Dey, Shirin A.; Eiseman, Katherine A.; Girvin, Zachary P.; Goni, Daniella T.; Harb, Amro A.; Herzik, Nicholas; Householder, Sarah; Karaaslan, Lara E.; Lee, Heather; Lieberman, Evan; Ling, Andrew; Lu, Ree; Shou, Arthur Y.; Sisti, Alexander C.; Snow, Zachary E.; Sperring, Colin P.; Xiong, Yuqing; Zhou, Henry W.; Natarajan, Karthik; Hripcsak, George; Chen, Ruijun			Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVE To characterize patients with coronavirus disease 2019 (covid-19) in a large New York City medical center and describe their clinical course across the emergency department, hospital wards, and intensive care units. DESIGN Retrospective manual medical record review. SETTING NewYork-Presbyterian/Columbia University Irving Medical Center, a quaternary care academic medical center in New York City. PARTICIPANTS The first 1000 consecutive patients with a positive result on the reverse transcriptase polymerase chain reaction assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who presented to the emergency department or were admitted to hospital between 1 March and 5 April 2020. Patient data were manually abstracted from electronic medical records. MAIN OUTCOME MEASURES Characterization of patients, including demographics, presenting symptoms, comorbidities on presentation, hospital course, time to intubation, complications, mortality, and disposition. RESULTS Of the first 1000 patients, 150 presented to the emergency department, 614 were admitted to hospital (not intensive care units), and 236 were admitted or transferred to intensive care units. The most common presenting symptoms were cough (732/1000), fever (728/1000), and dyspnea (631/1000). Patients in hospital, particularly those treated in intensive care units, often had baseline comorbidities including hypertension, diabetes, and obesity. Patients admitted to intensive care units were older, predominantly male (158/236, 66.9%), and had long lengths of stay (median 23 days, interquartile range 12-32 days); 78.0% (184/236) developed acute kidney injury and 35.2% (83/236) needed dialysis. Only 4.4% (6/136) of patients who required mechanical ventilation were first intubated more than 14 days after symptom onset. lime to intubation from symptom onset had a bimodal distribution, with modes at three to four days, and at nine days. As of 30 April, 90 patients remained in hospital and 211 had died in hospital. CONCLUSIONS Patients admitted to hospital with covid-19 at this medical center faced major morbidity and mortality, with high rates of acute kidney injury and inpatient dialysis, prolonged intubations, and a bimodal distribution of time to intubation from symptom onset.	[Argenziano, Michael G.; Bruce, Samuel L.; Slater, Cody L.; Tiao, Jonathan R.; Asadourian, Paul A.; Bell, Fletcher M.; Boyd, Rebekah; Cohen, Matthew F.; Colquhoun, MacAlistair I.; Colville, Lucy A.; de Jonge, Joseph H.; Dershowitz, Lyle B.; Dey, Shirin A.; Eiseman, Katherine A.; Girvin, Zachary P.; Goni, Daniella T.; Harb, Amro A.; Herzik, Nicholas; Householder, Sarah; Karaaslan, Lara E.; Lee, Heather; Lieberman, Evan; Ling, Andrew; Lu, Ree; Shou, Arthur Y.; Sisti, Alexander C.; Snow, Zachary E.; Sperring, Colin P.; Xiong, Yuqing; Zhou, Henry W.] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY USA; [Argenziano, Michael G.; Bruce, Samuel L.; Slater, Cody L.; Tiao, Jonathan R.; Sengupta, Soumitra; Natarajan, Karthik; Hripcsak, George; Chen, Ruijun] Columbia Univ, Irving Med Ctr, Dept Biomed Informat, 622 West 168th St,PH-20, New York, NY 10032 USA; [Baldwin, Matthew R.; Schluger, Neil W.] Columbia Univ, Irving Med Ctr, Div Pulm Allergy & Crit Care Med, Dept Med,New York Presbyterian, New York, NY USA; [Barr, R. Graham; Patel, Ashmi A.] Columbia Univ, Irving Med Ctr, New York Presbyterian, Div Gen Med,Dept Med, New York, NY USA; [Chang, Bernard P.; Gavin, Nicholas; Mills, Angela M.; Romney, Marie-Laure S.] Columbia Univ, Irving Med Ctr, New York Presbyterian, Dept Emergency Med, New York, NY USA; [Chau, Katherine H.] Columbia Univ, Irving Med Ctr, New York Presbyterian, Div Cardiol,Dept Med, New York, NY USA; [Choi, Justin J.; Goyal, Parag; Safford, Monika M.; Chen, Ruijun] Weill Cornell Med, Dept Med, New York, NY 10065 USA; [Sobieszczyk, Magdalena E.; Zucker, Jason E.] Columbia Univ, Irving Med Ctr, New York Presbyterian, Div Infect Dis,Dept Med, New York, NY USA	Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Cornell University; Columbia University; NewYork-Presbyterian Hospital	Chen, RJ (corresponding author), Columbia Univ, Irving Med Ctr, Dept Biomed Informat, 622 West 168th St,PH-20, New York, NY 10032 USA.; Chen, RJ (corresponding author), Weill Cornell Med, Dept Med, New York, NY 10065 USA.	ruijun.chen@columbia.edu	Zucker, Jason/H-7241-2019; Schluger, Neil/ABA-1793-2021; Slater, Cody/AAR-1194-2020; Baldwin, Matthew/GQY-7234-2022	Zucker, Jason/0000-0001-6987-6412; Argenziano, Michael/0000-0003-3374-9037; Cohen, Matthew/0000-0001-9087-2678; Harb, Amro/0000-0002-1400-0648; Chen, RuiJun/0000-0001-5281-4143; Ling, Andrew/0000-0001-7351-8650; Zhou, Henry/0000-0003-4060-8187; Gavin, Nicholas/0000-0001-6900-3953	US National Institute of Health [R01HL077612, R01HL093081]; National Heart Lung and Blood Institute [R01 HL141811, R01 HL146911]; US National Institutes of Health/National Heart, Lung, and Blood Institute [T32HL007854]; US National Institute of Health/National Center for Advancing Translational Science; US National Institute of Health/National Library of Medicine [R01 LM006910, T15 LM007079];  [UL1 TR001873]	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institute of Health/National Center for Advancing Translational Science; US National Institute of Health/National Library of Medicine; 	This study received no specific funding or grant from any agency in the public, commercial, or not-for-profit sectors. MRB is supported by UL1 TR001873. RGB is supported by grant R01HL077612 and R01HL093081 from the US National Institute of Health. BPC is supported by grants R01 HL141811 and R01 HL146911 from the National Heart Lung and Blood Institute. KHC is supported by grant T32HL007854 from US National Institutes of Health/National Heart, Lung, and Blood Institute. JJC is supported by grants from the US National Institute of Health/National Center for Advancing Translational Science. GH is supported by grant R01 LM006910 from the US National Institute of Health/National Library of Medicine. RC is supported by grant T15 LM007079 from the US National Institute of Health/National Library of Medicine. No funding organization or sponsor was involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Beumer MC, 2019, J CRIT CARE, V50, P59, DOI 10.1016/j.jcrc.2018.11.013; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Cascella M, 2020, STATPEARLS; Cummings Matthew J, 2020, Lancet, V395, P1763, DOI [10.1101/2020.04.15.20067157, 10.1016/S0140-6736(20)31189-2]; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Fletcher SN, 2003, CRIT CARE MED, V31, P1012, DOI 10.1097/01.CCM.0000053651.38421.D9; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; HARTIGAN PM, 1985, J R STAT SOC C-APPL, V34, P320; Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597; Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kim MJ, 2015, ANN REHABIL MED-ARM, V39, P763, DOI 10.5535/arm.2015.39.5.763; NYC Department of Health, 2020, COVID 19 DAT BAS; NYS Department of Health, 2020, NYS HLTH PROF; Petrilli CM, 2020, FACTORS ASS HOSPITAL, V2020, P4, DOI [DOI 10.1101/2020.04.08.20057794, 10.1101/2020.04.08.20057794, DOI 10.1136/BMJ.M1966]; Prin M, 2012, CURR OPIN CRIT CARE, V18, P700, DOI 10.1097/MCC.0b013e32835914d5; R Development Core Team, 2009, R LANG ENV STAT COMP; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8044; Richardson S, 2020, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775]; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	26	333	338	2	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2020	369								m1996	10.1136/bmj.m1996	http://dx.doi.org/10.1136/bmj.m1996			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3KB	32471884	Green Published, hybrid			2022-12-28	WOS:000538337500001
J	Lakdawala, SS; Menachery, VD				Lakdawala, Seema S.; Menachery, Vineet D.			The search for a COVID-19 animal model	SCIENCE			English	Editorial Material							SARS; MERS		[Lakdawala, Seema S.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Ctr Vaccine Res, Pittsburgh, PA 15260 USA; [Menachery, Vineet D.] Univ Texas Med Branch, World Reference Ctr Emerging Viruses & Arboviruse, Inst Human Infect & Immun, Dept Microbiol & Immunol, Galveston, TX 77555 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Medical Branch Galveston	Lakdawala, SS (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.	lakdawala@pitt.edu; vimenach@utmb.edu			NIH CEIRS [HHSN272201400007C, R00 AG049092]	NIH CEIRS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors are funded by NIH CEIRS HHSN272201400007C (S.S.L.) and R00 AG049092 (V.D.M.).	Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Chen YB, 2020, J CONTEMP CHINA, V29, P1, DOI [10.1080/10670564.2019.1621526, 10.1080/01932691.2020.1791172]; Daly N., 2020, NATL GEOGR; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Gretebeck LM, 2015, CURR OPIN VIROL, V13, P123, DOI 10.1016/j.coviro.2015.06.009; Kim Y. I., 2020, CELL HOST MICROBE, V20, P30187; Lakdawala SS, 2015, NATURE, V526, P122, DOI 10.1038/nature15379; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; Menachery VD, 2020, J VIROL, V94, DOI 10.1128/JVI.01774-19; Menachery VD, 2016, P NATL ACAD SCI USA, V113, P3048, DOI 10.1073/pnas.1517719113; Rockx Barry, 2020, Science, V368, P1012, DOI 10.1126/science.abb7314; Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015; Sia S. F., 2020, RES SQUARE, DOI [10.21203/rs.3.rs-20774/v1, DOI 10.21203/RS.3.RS-20774/V1]; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	15	56	56	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					942	943		10.1126/science.abc6141	http://dx.doi.org/10.1126/science.abc6141			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LV3IK	32467379				2022-12-28	WOS:000538332600026
J	[Anonymous]				[Anonymous]			Seven days in medicine: 20-26 May 2020	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2020	369								m2074	10.1136/bmj.m2074	http://dx.doi.org/10.1136/bmj.m2074			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JZ	32467097				2022-12-28	WOS:000538337300006
J	Kullberg, BJ; Vrijmoeth, HD; van de Schoor, F; Hovius, JW				Kullberg, Bart Jan; Vrijmoeth, Hedwig D.; van de Schoor, Freek; Hovius, Joppe W.			Lyme borreliosis: diagnosis and management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BURGDORFERI-SENSU-LATO; ACRODERMATITIS CHRONICA ATROPHICANS; POLYMERASE-CHAIN-REACTION; CLINICAL-PRACTICE GUIDELINES; MULTIVALENT OSPA VACCINE; ERYTHEMA MIGRANS; DOUBLE-BLIND; ANTIBIOTIC-TREATMENT; CEREBROSPINAL-FLUID; TICK BITE	Lyme borreliosis is the most common vectorborne disease in the northern hemisphere. It usually begins with erythema migrans; early disseminated infection particularly causes multiple erythema migrans or neurologic disease, and late manifestations predominantly include arthritis in North America, and acrodermatitis chronica atrophicans (ACA) in Europe. Diagnosis of Lyme borreliosis is based on characteristic clinical signs and symptoms, complemented by serological confirmation of infection once an antibody response has been mounted. Manifestations usually respond to appropriate antibiotic regimens, but the disease can be followed by sequelae, such as immune arthritis or residual damage to affected tissues. A subset of individuals reports persistent symptoms, including fatigue, pain, arthralgia, and neurocognitive symptoms, which in some people are severe enough to fulfil the criteria for post-treatment Lyme disease syndrome. The reported prevalence of such persistent symptoms following antimicrobial treatment varies considerably, and its pathophysiology is unclear. Persistent active infection in humans has not been identified as a cause of this syndrome, and randomized treatment trials have invariably failed to show any benefit of prolonged antibiotic treatment. For prevention of Lyme borreliosis, post-exposure prophylaxis may be indicated in specific cases, and novel vaccine strategies are under development.	[Kullberg, Bart Jan; Vrijmoeth, Hedwig D.; van de Schoor, Freek] Radboud Univ Nijmegen, Med Ctr, Dept Med, Nijmegen, Netherlands; [Kullberg, Bart Jan; Vrijmoeth, Hedwig D.; van de Schoor, Freek] Radboud Univ Nijmegen, Med Ctr, Radboudumc Ctr Infect Dis, Nijmegen, Netherlands; [Hovius, Joppe W.] Univ Amsterdam, Med Ctr, Dept Med, Div Infect Dis, Amsterdam, Netherlands; [Hovius, Joppe W.] Amsterdam Multidisciplinary Lyme Borreliosis Ctr, Amsterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam	Kullberg, BJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, Nijmegen, Netherlands.; Kullberg, BJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboudumc Ctr Infect Dis, Nijmegen, Netherlands.	BJ.Kullberg@radboudumc.nl	Vrijmoeth, Hedwig/A-1660-2016; Hovius, Joppe/GZL-6894-2022	Vrijmoeth, Hedwig/0000-0001-9459-4089; Hovius, Joppe/0000-0003-0066-2437				Aase A, 2016, INFECT DIS-NOR, V48, P411, DOI 10.3109/23744235.2016.1144931; Aberer E, 1996, INFECTION, V24, P85, DOI 10.1007/BF01780666; Adeolu M, 2014, ANTON LEEUW INT J G, V105, P1049, DOI 10.1007/s10482-014-0164-x; Agterof MJ, 2008, NETH J MED, V66, P176; Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; Ang CW, 2011, EUR J CLIN MICROBIOL, V30, P1027, DOI 10.1007/s10096-011-1157-6; Arnez M, 2015, PEDIATR INFECT DIS J, V34, P1319, DOI 10.1097/INF.0000000000000884; Arnez M, 2015, PEDIATR INFECT DIS J, V34, P1045, DOI 10.1097/INF.0000000000000804; Aronowitz RA, 2012, MILBANK Q, V90, P250, DOI 10.1111/j.1468-0009.2012.00663.x; Arvikar SL, 2015, INFECT DIS CLIN N AM, V29, P269, DOI 10.1016/j.idc.2015.02.004; ASBRINK E, 1988, ANN NY ACAD SCI, V539, P4, DOI 10.1111/j.1749-6632.1988.tb31833.x; ASBRINK E, 1986, ZBL BAKT-INT J MED M, V263, P253; Aucott JN, 2016, CLIN VACCINE IMMUNOL, V23, P757, DOI 10.1128/CVI.00071-16; Aucott JN, 2013, INT J INFECT DIS, V17, pE443, DOI 10.1016/j.ijid.2013.01.008; Avery RA, 2005, PEDIATR INFECT DIS J, V24, P705, DOI 10.1097/01.inf.0000172903.14077.4c; Babady NE, 2008, DIAGN MICR INFEC DIS, V62, P464, DOI 10.1016/j.diagmicrobio.2008.08.016; Barbour A, 2012, J CLIN INVEST, V122, P2344, DOI 10.1172/JCI63975; Barsic B, 2000, INFECTION, V28, P153, DOI 10.1007/s150100050069; Batheja S, 2013, J NEUROPSYCH CLIN N, V25, P176, DOI 10.1176/appi.neuropsych.12090223; Bennet L, 2006, EUR J CLIN MICROBIOL, V25, P426, DOI 10.1007/s10096-006-0167-2; Bennet L, 2006, WIEN KLIN WOCHENSCHR, V118, P531, DOI 10.1007/s00508-006-0659-1; Berende A, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4452-y; Berende A, 2019, NEUROLOGY, V92, pE1447, DOI 10.1212/WNL.0000000000007186; Berende A, 2016, NEW ENGL J MED, V374, P1209, DOI 10.1056/NEJMoa1505425; Berende A, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0543-y; Berglund J, 2002, SCAND J INFECT DIS, V34, P421, DOI 10.1080/00365540110080421; BERGLUND J, 1995, NEW ENGL J MED, V333, P1319, DOI 10.1056/NEJM199511163332004; Blanc F, 2007, NEUROLOGY, V69, P953, DOI 10.1212/01.wnl.0000269672.17807.e0; Borsic K, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120506; Bremell D, 2014, EUR J NEUROL, V21, P1162, DOI 10.1111/ene.12420; Cairns V, 2005, INT J EPIDEMIOL, V34, P1340, DOI 10.1093/ije/dyi129; Callister SM, 2016, CLIN INFECT DIS, V62, P1235, DOI 10.1093/cid/ciw112; Cameron D, 2008, Minerva Med, V99, P489; Cameron DJ, 2014, EXPERT REV ANTI-INFE, V12, P1103, DOI 10.1586/14787210.2014.940900; CAPERTON EM, 1990, ARCH INTERN MED, V150, P1677, DOI 10.1001/archinte.150.8.1677; Centers for Disease Control and Prevention, 2017, LYM DIS BORR BURGD 2; Centers for Disease Control and Prevention, 2019, LYM DIS DAT SURV; Cerar D, 2010, AM J MED, V123, P79, DOI 10.1016/j.amjmed.2009.05.011; Cerar T, 2013, CLIN VACCINE IMMUNOL, V20, P1578, DOI 10.1128/CVI.00353-13; Cerar T, 2008, J CLIN MICROBIOL, V46, P3375, DOI 10.1128/JCM.00410-08; Cerar T, 2010, CLIN VACCINE IMMUNOL, V17, P645, DOI 10.1128/CVI.00341-09; Cetin E, 2006, WIEN KLIN WOCHENSCHR, V118, P677, DOI 10.1007/s00508-006-0694-y; Chandra A, 2010, BRAIN BEHAV IMMUN, V24, P1018, DOI 10.1016/j.bbi.2010.03.002; Charrel RN, 2004, CLIN MICROBIOL INFEC, V10, P1040, DOI 10.1111/j.1469-0691.2004.01022.x; Chiang SS, 2014, LANCET INFECT DIS, V14, P947, DOI 10.1016/S1473-3099(14)70852-7; Colli C, 2004, J CUTAN PATHOL, V31, P232, DOI 10.1111/j.0303-6987.2003.00167.x; Comstedt P, 2015, VACCINE, V33, P5982, DOI 10.1016/j.vaccine.2015.07.095; Coulter P, 2005, J CLIN MICROBIOL, V43, P5080, DOI 10.1128/JCM.43.10.5080-5084.2005; Crowley JT, 2016, J AUTOIMMUN, V69, P24, DOI 10.1016/j.jaut.2016.02.005; Cruickshank M, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1261; DeLong AK, 2012, CONTEMP CLIN TRIALS, V33, P1132, DOI 10.1016/j.cct.2012.08.009; Dersch R, 2015, EUR J NEUROL, V22, P1249, DOI 10.1111/ene.12744; Dessau RB, 2018, CLIN MICROBIOL INFEC, V24, P118, DOI 10.1016/j.cmi.2017.08.025; Dessau RB, 2014, CLIN MICROBIOL INFEC, V20, pO785, DOI 10.1111/1469-0691.12583; Donta Sam T, 2003, Med Sci Monit, V9, pPI136; Donta ST, 1997, CLIN INFECT DIS, V25, pS52, DOI 10.1086/516171; Dumler JS, 2005, ANN NY ACAD SCI, V1063, P361, DOI 10.1196/annals.1355.069; Eikeland R, 2013, ACTA NEUROL SCAND, V127, P154, DOI 10.1111/j.1600-0404.2012.01690.x; Eikeland R, 2011, ACTA NEUROL SCAND, V124, P349, DOI 10.1111/j.1600-0404.2010.01482.x; Eisen RJ, 2018, TRENDS PARASITOL, V34, P295, DOI 10.1016/j.pt.2017.12.006; Embers ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029914; Estrada-Pena A, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0163-7; European Parliament, PARL CALLS AL SPREAD; Fallon BA, 2008, NEUROLOGY, V70, P992, DOI 10.1212/01.WNL.0000284604.61160.2d; Fallon Brian A, 2012, Open Neurol J, V6, P79, DOI 10.2174/1874205X01206010079; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Garkowski A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00146; Gomes-Solecki M, 2020, CLIN INFECT DIS, V70, P1768, DOI 10.1093/cid/ciz872; Grillon A, 2019, SEMIN ARTHRITIS RHEU, V48, P1105, DOI 10.1016/j.semarthrit.2018.09.007; Gupta RS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221397; Halperin JJ, 2007, NEUROLOGY, V69, P91, DOI 10.1212/01.wnl.0000265517.66976.28; Halperin JJ, 2003, MUSCLE NERVE, V28, P133, DOI 10.1002/mus.10337; HALPERIN JJ, 1991, NEUROLOGY, V41, P1571, DOI 10.1212/WNL.41.10.1571; Halperin JJ, 2013, CURR TREAT OPTION NE, V15, P454, DOI 10.1007/s11940-013-0240-y; HAMMERSBERGGREN S, 1994, J CLIN MICROBIOL, V32, P1519, DOI 10.1128/JCM.32.6.1519-1525.1994; HANSEN K, 1991, ANN NEUROL, V30, P197, DOI 10.1002/ana.410300212; HANSEN K, 1992, BRAIN, V115, P399, DOI 10.1093/brain/115.2.399; Hassett AL, 2009, AM J MED, V122, P843, DOI 10.1016/j.amjmed.2009.02.022; Hilton E, 1999, AM J MED, V106, P404, DOI 10.1016/S0002-9343(99)00046-7; Hitt E, 2002, NAT MED, V8, P311, DOI 10.1038/nm0402-311b; Hofhuis A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181807; Hofmann Heidelore, 2017, Ger Med Sci, V15, pDoc14, DOI 10.3205/000255; Holl-Wieden A, 2007, RHEUMATOL INT, V27, P1091, DOI 10.1007/s00296-007-0333-6; Huegli D, 2011, TICKS TICK-BORNE DIS, V2, P129, DOI 10.1016/j.ttbdis.2011.05.002; Hunfeld KP, 2005, ANTIMICROB AGENTS CH, V49, P1294, DOI 10.1128/AAC.49.4.1294-1301.2005; Hytonen J, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-103; Jahfari S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005042; Jaulhac B, 2019, MED MALADIES INFECT, V49, P335, DOI 10.1016/j.medmal.2019.05.001; Jaulhac B, 1996, ARTHRITIS RHEUM, V39, P736, DOI 10.1002/art.1780390505; Jutras BL, 2019, P NATL ACAD SCI USA, V116, P13498, DOI 10.1073/pnas.1904170116; Kalish RA, 2001, CLIN INFECT DIS, V33, P780, DOI 10.1086/322669; Kaplan RF, 2003, NEUROLOGY, V60, P1916, DOI 10.1212/01.WNL.0000068030.26992.25; Kindstrand E, 2002, ACTA NEUROL SCAND, V106, P253, DOI 10.1034/j.1600-0404.2002.01336.x; Klempner MS, 2013, AM J MED, V126, P665, DOI 10.1016/j.amjmed.2013.02.014; Klempner MS, 2005, J INFECT DIS, V192, P1010, DOI 10.1086/432733; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Knudtzen FC, 2017, CLIN INFECT DIS, V65, P1489, DOI 10.1093/cid/cix568; Kobayashi T, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz299; Kowalski TJ, 2010, CLIN INFECT DIS, V50, P512, DOI 10.1086/649920; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Krause PJ, 1996, JAMA-J AM MED ASSOC, V275, P1657, DOI 10.1001/jama.275.21.1657; Krupp LB, 2003, NEUROLOGY, V60, P1923, DOI 10.1212/01.WNL.0000071227.23769.9E; Kubanek M, 2012, EUR J HEART FAIL, V14, P588, DOI 10.1093/eurjhf/hfs027; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V310, P1110, DOI 10.1001/jama.2013.278331; Kung F, 2016, J INFECT DIS, V213, P1786, DOI 10.1093/infdis/jiw013; Lakos A, 2010, INT J INFECT DIS, V14, pE494, DOI 10.1016/j.ijid.2009.07.019; Lantos PM, 2014, AM J MED, V127, P1105, DOI 10.1016/j.amjmed.2014.05.036; Lantos PM, 2014, CLIN INFECT DIS, V58, P663, DOI 10.1093/cid/cit810; Lebech AM, 2000, MOL DIAGN, V5, P139, DOI 10.1016/S1084-8592(00)80031-4; Leeflang MMG, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1468-4; Lelovas P, 2008, INT J CARDIOL, V129, P15, DOI 10.1016/j.ijcard.2008.01.044; Lenormand C, 2016, J AM ACAD DERMATOL, V74, P685, DOI 10.1016/j.jaad.2015.10.046; Lewinsohn DM, 2017, CLIN INFECT DIS, V64, pE1, DOI 10.1093/cid/ciw694; Li X, 2011, ARTHRITIS RHEUM-US, V63, P2238, DOI 10.1002/art.30384; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; Lindgren E, 2006, LYME BORRELIOSIS EUR; Livey I, 2011, CLIN INFECT DIS, V52, pS266, DOI 10.1093/cid/ciq118; Ljostad U, 2007, EUR J NEUROL, V14, P873, DOI 10.1111/j.1468-1331.2007.01799.x; Ljostad U, 2010, EUR J NEUROL, V17, P118, DOI 10.1111/j.1468-1331.2009.02756.x; Ljostad U, 2008, LANCET NEUROL, V7, P690, DOI 10.1016/S1474-4422(08)70119-4; Lochhead RB, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.12954; Lochhead RB, 2017, ARTHRITIS RHEUMATOL, V69, P1100, DOI 10.1002/art.40039; LOGIGIAN EL, 1990, NEW ENGL J MED, V323, P1438, DOI 10.1056/NEJM199011223232102; Lohr B, 2018, CRIT REV CL LAB SCI, V55, P219, DOI 10.1080/10408363.2018.1450353; Luft BJ, 1996, ANN INTERN MED, V124, P785, DOI 10.7326/0003-4819-124-9-199605010-00002; Mac S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210280; Magni R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0701-z; Maraspin V, 2002, WIEN KLIN WOCHENSCHR, V114, P515; Maraspin V, 2016, CLIN INFECT DIS, V63, P914, DOI 10.1093/cid/ciw417; Margos G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208432; MARKOWITZ LE, 1986, JAMA-J AM MED ASSOC, V255, P3394, DOI 10.1001/jama.255.24.3394; Marques A, 2009, CLIN VACCINE IMMUNOL, V16, P1249, DOI 10.1128/CVI.00167-09; Meltzer MI, 1999, EMERG INFECT DIS, V5, P321, DOI 10.3201/eid0503.990302; Mullegger RR, 2008, AM J CLIN DERMATOL, V9, P355, DOI 10.2165/0128071-200809060-00002; Mygland A, 2010, EUR J NEUROL, V17, P8, DOI 10.1111/j.1468-1331.2009.02862.x; NADELMAN RB, 1993, AM J MED, V94, P583, DOI 10.1016/0002-9343(93)90208-7; Nadelman RB, 1996, AM J MED, V100, P502, DOI 10.1016/S0002-9343(95)99915-9; Nadelman RB, 2001, NEW ENGL J MED, V345, P79, DOI 10.1056/NEJM200107123450201; Nadelman RB, 2012, NEW ENGL J MED, V367, P1883, DOI 10.1056/NEJMoa1114362; Narasimhan S, 2014, CELL HOST MICROBE, V15, P58, DOI 10.1016/j.chom.2013.12.001; Nassal M, 2008, INT J MED MICROBIOL, V298, P135, DOI 10.1016/j.ijmm.2007.08.002; Nigrovic LE, 2007, EPIDEMIOL INFECT, V135, P1, DOI 10.1017/S0950268806007096; NIH, 2019, STRAT PLAN TICKB DIS; Ogrinc K, 2017, TICKS TICK-BORNE DIS, V8, P266, DOI 10.1016/j.ttbdis.2016.11.011; Ogrinc K, 2016, CLIN INFECT DIS, V63, P346, DOI 10.1093/cid/ciw299; Oksi J, 2007, EUR J CLIN MICROBIOL, V26, P571, DOI 10.1007/s10096-007-0340-2; Pancewicz Slawomir A, 2015, Przegl Epidemiol, V69, P309; Paules CI, 2018, NEW ENGL J MED, V379, P701, DOI 10.1056/NEJMp1807870; Plotkin SA, 2016, NEW ENGL J MED, V375, P911, DOI 10.1056/NEJMp1607146; Pritt BS, 2016, LANCET INFECT DIS, V16, P556, DOI 10.1016/S1473-3099(15)00464-8; Pritt BS, 2011, NEW ENGL J MED, V365, P422, DOI 10.1056/NEJMoa1010493; Rauter C, 2005, CLIN DIAGN LAB IMMUN, V12, P910, DOI 10.1128/CDLI.12.8.910-917.2005; Rizzoli A, 2011, EUROSURVEILLANCE, V16, P2; Rojko T, 2019, TICKS TICK-BORNE DIS, V10, P398, DOI 10.1016/j.ttbdis.2018.11.019; Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1; Rupprecht TA, 2018, CLIN MICROBIOL INFEC, V24, P1234, DOI 10.1016/j.cmi.2018.04.007; Ruzic-Sabljic E, 2017, EXPERT REV MOL DIAGN, V17, P19, DOI 10.1080/14737159.2016.1246959; Scheffold N, 2015, DTSCH ARZTEBL INT, V112, P202, DOI 10.3238/arztebl.2015.0202; SCHLESINGER PA, 1985, ANN INTERN MED, V103, P67, DOI 10.7326/0003-4819-103-1-67; Schwameis M, 2017, LANCET INFECT DIS, V17, P322, DOI [10.1016/s1473-3099(16)30529-1, 10.1016/S1473-3099(16)30529-1]; SHADICK NA, 1994, ANN INTERN MED, V121, P560, DOI 10.7326/0003-4819-121-8-199410150-00002; Shadick NA, 2001, ARCH INTERN MED, V161, P554, DOI 10.1001/archinte.161.4.554; SHIRTS SR, 1983, OBSTET GYNECOL, V62, P256; Sigal LH, 1998, NEW ENGL J MED, V339, P216, DOI 10.1056/NEJM199807233390402; Sjowall J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018220; Sodermark L, 2017, PEDIATR INFECT DIS J, V36, P1052, DOI 10.1097/INF.0000000000001653; Sprong H, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2744-5; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P69, DOI 10.1111/j.1469-0691.2010.03175.x; STANEK G, 1990, NEW ENGL J MED, V322, P249, DOI 10.1056/NEJM199001253220407; Stanek G, 2018, FEMS MICROBIOL REV, V42, P233, DOI 10.1093/femsre/fux047; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; STEERE AC, 1990, NEW ENGL J MED, V323, P219, DOI 10.1056/NEJM199007263230402; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; STEERE AC, 1994, ARTHRITIS RHEUM-US, V37, P878, DOI 10.1002/art.1780370616; Steere AC, 2003, CLIN INFECT DIS, V36, P1078, DOI 10.1086/368187; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; Steere AC, 2006, ARTHRITIS RHEUM-US, V54, P3079, DOI 10.1002/art.22131; Steere AC, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.90; Stein E, 2017, MMWR-MORBID MORTAL W, V66, P687, DOI 10.15585/mmwr.mm6626a2; Strle F, 1996, CLIN INFECT DIS, V23, P61, DOI 10.1093/clinids/23.1.61; Strle F, 1996, INFECTION, V24, P64, DOI 10.1007/BF01780661; STRLE F, 1993, INFECTION, V21, P83, DOI 10.1007/BF01710737; Strle F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103188; Strle F, 2011, VECTOR-BORNE ZOONOT, V11, P1253, DOI 10.1089/vbz.2010.0230; Strle K, 2017, CLIN INFECT DIS, V64, P930, DOI 10.1093/cid/cix002; Strle K, 2014, CLIN INFECT DIS, V58, P372, DOI 10.1093/cid/cit735; Strle K, 2012, ARTHRITIS RHEUM-US, V64, P1497, DOI 10.1002/art.34383; Strnad M, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.00609-17, 10.1128/aem.00609-17]; Stupica D, 2018, J ANTIMICROB CHEMOTH, V73, P1352, DOI 10.1093/jac/dkx534; Stupica D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136600; Stupica D, 2012, CLIN INFECT DIS, V55, P343, DOI 10.1093/cid/cis402; Sykes RA, 2017, J PUBLIC HEALTH-UK, V39, P74, DOI 10.1093/pubmed/fdw017; TABER LH, 1979, PEDIATR CLIN N AM, V26, P377; Telford SR, 1997, EMERG INFECT DIS, V3, P165, DOI 10.3201/eid0302.970209; Thomas V, 2001, INFECT IMMUN, V69, P3359, DOI 10.1128/IAI.69.5.3359-3371.2001; Torbahn G, 2018, JAMA DERMATOL, V154, P1292, DOI 10.1001/jamadermatol.2018.3186; TUMANI H, 1995, NEUROLOGY, V45, P1663, DOI 10.1212/WNL.45.9.1663; van Burgel ND, 2011, J CLIN MICROBIOL, V49, P2027, DOI 10.1128/JCM.00084-11; van de Schoor FR, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4323-6; van den Wijngaard CC, 2017, EUROSURVEILLANCE, V22, P15, DOI 10.2807/1560-7917.ES.2017.22.27.30569; Van Middendorp H, 2020, EXPECTANCIES P UNPUB; VANDAM AP, 1993, CLIN INFECT DIS, V17, P708, DOI 10.1093/clinids/17.4.708; Vannier E, 2012, NEW ENGL J MED, V366, P2397, DOI 10.1056/NEJMra1202018; Vogt NA, 2019, J VET INTERN MED, V33, P23, DOI 10.1111/jvim.15344; Vrijmoeth HD, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3949-8; Waddell LA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207067; Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168613; Wagemakers A, 2015, TRENDS PARASITOL, V31, P260, DOI 10.1016/j.pt.2015.03.008; Wang ZD, 2019, NEW ENGL J MED, V380, P2116, DOI 10.1056/NEJMoa1805068; Warshafsky S, 2010, J ANTIMICROB CHEMOTH, V65, P1137, DOI 10.1093/jac/dkq097; Wass L, 2019, EMERG MICROBES INFEC, V8, P413, DOI 10.1080/22221751.2019.1584017; WEBER K, 1988, PEDIATR INFECT DIS J, V7, P286, DOI 10.1097/00006454-198804000-00010; Weitzner E, 2015, CLIN INFECT DIS, V61, P1800, DOI 10.1093/cid/civ735; Wenneras C, 2015, CLIN MICROBIOL INFEC, V21, P621, DOI 10.1016/j.cmi.2015.02.030; Wilhelmsson P, 2016, TICKS TICK-BORNE DIS, V7, P71, DOI 10.1016/j.ttbdis.2015.08.009; Wills AB, 2016, CLIN INFECT DIS, V62, P1546, DOI 10.1093/cid/ciw189; Wormser GP, 2008, CLIN VACCINE IMMUNOL, V15, P1519, DOI 10.1128/CVI.00109-08; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2018, DIAGN MICR INFEC DIS, V92, P183, DOI 10.1016/j.diagmicrobio.2018.06.007; Wormser GP, 2017, DIAGN MICR INFEC DIS, V87, P163, DOI 10.1016/j.diagmicrobio.2016.11.003; Wormser GP, 2012, CLIN RHEUMATOL, V31, P989, DOI 10.1007/s10067-012-1964-x; Wormser GP, 2009, J WOMENS HEALTH, V18, P831, DOI 10.1089/jwh.2008.1193; Wormser GP, 2003, ANN INTERN MED, V138, P697, DOI 10.7326/0003-4819-138-9-200305060-00005; Wormser GP, 2001, J INFECT DIS, V184, P1070, DOI 10.1086/323424; Wressnigg N, 2014, CLIN VACCINE IMMUNOL, V21, P1490, DOI 10.1128/CVI.00406-14; Wressnigg N, 2013, LANCET INFECT DIS, V13, P680, DOI 10.1016/S1473-3099(13)70110-5; Xu G, 2019, VECTOR-BORNE ZOONOT, V19, P106, DOI 10.1089/vbz.2018.2323	227	39	39	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2020	369								m1041	10.1136/bmj.m1041	http://dx.doi.org/10.1136/bmj.m1041			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JW	32457042				2022-12-28	WOS:000538337000001
J	Yang, J; Zhu, XL; Nunes, JPF; Yu, JK; Parrish, RM; Wolf, TJA; Centurion, M; Guhr, M; Li, RK; Liu, YS; Moore, B; Niebuhr, M; Park, S; Shen, XZ; Weathersby, S; Weinacht, T; Martinez, TJ; Wang, XJ				Yang, Jie; Zhu, Xiaolei; Nunes, J. Pedro F.; Yu, Jimmy K.; Parrish, Robert M.; Wolf, Thomas J. A.; Centurion, Martin; Guehr, Markus; Li, Renkai; Liu, Yusong; Moore, Bryan; Niebuhr, Mario; Park, Suji; Shen, Xiaozhe; Weathersby, Stephen; Weinacht, Thomas; Martinez, Todd J.; Wang, Xijie			Simultaneous observation of nuclear and electronic dynamics by ultrafast electron diffraction	SCIENCE			English	Article							SCATTERING CROSS-SECTIONS; EXCITATION-ENERGY DEPENDENCE; FEMTOSECOND DYNAMICS; MOLECULAR-STRUCTURES; TIME RESOLUTION; PYRIDINE; PHOTOPHYSICS; ABSORPTION; PHASE; STATE	Simultaneous observation of nuclear and electronic motion is crucial for a complete understanding of molecular dynamics in excited electronic states. It is challenging for a single experiment to independently follow both electronic and nuclear dynamics at the same time. Here we show that ultrafast electron diffraction can be used to simultaneously record both electronic and nuclear dynamics in isolated pyridine molecules, naturally disentangling the two components. Electronic state changes (S-1 -> S-0 internal conversion) were reflected by a strong transient signal in small-angle inelastic scattering, and nuclear structural changes (ring puckering) were monitored by large-angle elastic diffraction. Supported by ab initio nonadiabatic molecular dynamics and diffraction simulations, our experiment provides a clear view of the interplay between electronic and nuclear dynamics of the photoexcited pyridine molecule.	[Yang, Jie; Zhu, Xiaolei; Parrish, Robert M.; Wolf, Thomas J. A.; Li, Renkai; Park, Suji; Shen, Xiaozhe; Weathersby, Stephen; Martinez, Todd J.; Wang, Xijie] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Yang, Jie; Zhu, Xiaolei; Yu, Jimmy K.; Parrish, Robert M.; Wolf, Thomas J. A.; Martinez, Todd J.] SLAC Natl Accelerator Lab, Stanford PULSE Inst, Menlo Pk, CA 94025 USA; [Zhu, Xiaolei; Yu, Jimmy K.; Parrish, Robert M.; Martinez, Todd J.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Nunes, J. Pedro F.; Centurion, Martin; Moore, Bryan] Univ Nebraska, Dept Phys & Astron, Lincoln, NE 68588 USA; [Yu, Jimmy K.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Guehr, Markus; Niebuhr, Mario] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany; [Liu, Yusong; Weinacht, Thomas] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; University of Nebraska System; University of Nebraska Lincoln; Stanford University; University of Potsdam; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Yang, J; Martinez, TJ; Wang, XJ (corresponding author), SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA.; Yang, J; Martinez, TJ (corresponding author), SLAC Natl Accelerator Lab, Stanford PULSE Inst, Menlo Pk, CA 94025 USA.; Martinez, TJ (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	jieyang@slac.stanford.edu; todd.martinez@stanford.edu; wangxj@slac.stanford.edu	Wolf, Thomas/AAQ-5838-2020; Martinez, Todd/HDN-6985-2022; Martinez, Todd/F-4306-2010; Yang, Jie/I-1661-2018	Wolf, Thomas/0000-0002-0641-1279; Martinez, Todd/0000-0002-4798-8947; Liu, Yusong/0000-0002-5156-6720; Yu, Jimmy/0000-0001-8536-4038; Yang, Jie/0000-0002-5115-2413; Centurion, Martin/0000-0002-5662-2293; Figueira Nunes, Joao Pedro/0000-0003-0670-6023	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences (DOE BES) SUF Division Accelerator & Detector RD program; LCLS facility; SLAC [DE-AC02-05-CH11231, DE-AC02-76SF00515]; AMOS program within the Chemical Sciences, Geosciences, and Biosciences Division of the DOE BES; Lichtenberg Professorship of the Volkswagen Foundation; DOE BES [DE-SC0014170]; DOE [DE-FG02-08ER15984]	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences (DOE BES) SUF Division Accelerator & Detector RD program(United States Department of Energy (DOE)); LCLS facility; SLAC; AMOS program within the Chemical Sciences, Geosciences, and Biosciences Division of the DOE BES(United States Department of Energy (DOE)); Lichtenberg Professorship of the Volkswagen Foundation; DOE BES(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE))	The experimental part of this research was performed at SLAC MeV-UED, which is supported in part by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences (DOE BES) SUF Division Accelerator & Detector R&D program, the LCLS facility, and SLAC under contract nos. DE-AC02-05-CH11231 and DE-AC02-76SF00515. T.J.M., T.J.A.W., X.Z., J.K.Y., and R.M.P. were supported by the AMOS program within the Chemical Sciences, Geosciences, and Biosciences Division of the DOE BES. M.G. and M.N. are funded via a Lichtenberg Professorship of the Volkswagen Foundation. J.P.F.N., B.M., and M.C. were supported by the DOE BES under award no. DE-SC0014170. Y.L. and T.W. were supported by the DOE under award no. DE-FG02-08ER15984.	BARTELL LS, 1964, J AM CHEM SOC, V86, P3493, DOI 10.1021/ja01071a019; BOLOVINOS A, 1984, J MOL SPECTROSC, V103, P240, DOI 10.1016/0022-2852(84)90051-1; BREITENSTEIN M, 1984, CHEM PHYS LETT, V108, P430, DOI 10.1016/0009-2614(84)85173-8; BREITENSTEIN M, 1984, PHYS REV LETT, V53, P2398, DOI 10.1103/PhysRevLett.53.2398; BREITENSTEIN M, 1983, CHEM PHYS LETT, V97, P403, DOI 10.1016/0009-2614(83)80517-X; Carrascosa AM, 2019, J CHEM THEORY COMPUT, V15, P2836, DOI 10.1021/acs.jctc.9b00056; Chachisvilis M, 1999, J PHYS CHEM A, V103, P7408, DOI 10.1021/jp991821x; Curchod BFE, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4943571; DANTUS M, 1994, J PHYS CHEM-US, V98, P2782, DOI 10.1021/j100062a011; Domcke W., 2004, CONICAL INTERSECTION, VVol. 15; Dudek RC, 2001, J PHYS CHEM A, V105, P4167, DOI 10.1021/jp010122t; Errami M, 2016, CHEM PHYS LETT, V662, P141, DOI 10.1016/j.cplett.2016.09.030; FOGARASI G, 1992, J AM CHEM SOC, V114, P8191, DOI 10.1021/ja00047a032; Habershon S, 2006, CHEMPHYSCHEM, V7, P353, DOI 10.1002/cphc.200500532; Hensley CJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.133202; Ihee H, 2002, J PHYS CHEM A, V106, P4087, DOI 10.1021/jp014144r; IIJIMA T, 1963, J PHYS CHEM-US, V67, P1472, DOI 10.1021/j100801a017; Improta R, 2016, CHEM REV, V116, P3540, DOI 10.1021/acs.chemrev.5b00444; Kowalewski M, 2017, STRUCT DYNAM-US, V4, DOI 10.1063/1.4984241; Lias S. G., 2018, 69 NIST; LIM EC, 1986, J PHYS CHEM-US, V90, P6770, DOI 10.1021/j100284a012; Lim EC, 1997, ADV PHOTOCH, V23, P165; Lobastov VA, 2001, J PHYS CHEM A, V105, P11159, DOI 10.1021/jp013705b; LORENTZON J, 1995, THEOR CHIM ACTA, V92, P67, DOI 10.1007/BF01134214; MCCLELLAND JJ, 1985, PHYS REV LETT, V54, P2218, DOI 10.1103/PhysRevLett.54.2218; Minitti MP, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.255501; Newton MA, 2002, CHEM SOC REV, V31, P83, DOI 10.1039/b100115a; OTIS CE, 1983, J PHYS CHEM-US, V87, P2232, DOI 10.1021/j100235a037; PYCKHOUT W, 1987, J MOL STRUCT, V156, P315, DOI 10.1016/0022-2860(87)87034-5; Salvat F, 2005, COMPUT PHYS COMMUN, V165, P157, DOI 10.1016/j.cpc.2004.09.006; SASAKI Y, 1992, INT J QUANTUM CHEM, V43, P701, DOI 10.1002/qua.560430508; SELCO JI, 1983, J CHEM PHYS, V79, P3269, DOI 10.1063/1.446220; Shen X, 2019, STRUCT DYNAM-US, V6, DOI 10.1063/1.5120864; SHIBATA S, 1980, INT J QUANTUM CHEM, V18, P281, DOI 10.1002/qua.560180139; Simmermacher M, 2019, J CHEM PHYS, V151, DOI 10.1063/1.5110040; SOBOLEWSKI AL, 1991, CHEM PHYS LETT, V180, P381, DOI 10.1016/0009-2614(91)90337-9; Srinivasan R, 2005, SCIENCE, V307, P558, DOI 10.1126/science.1107291; Srinivasan R, 2003, HELV CHIM ACTA, V86, P1763; Stankus B, 2019, NAT CHEM, V11, P716, DOI 10.1038/s41557-019-0291-0; Stolow A, 2004, CHEM REV, V104, P1719, DOI 10.1021/cr020683w; The Math Works Inc, 2019, MATLAB; Tsubouchi M, 2003, J PHYS CHEM A, V107, P10897, DOI 10.1021/jp036333a; Ufimtsev IS, 2009, J CHEM THEORY COMPUT, V5, P2619, DOI 10.1021/ct9003004; VILLA E, 1988, J PHYS CHEM-US, V92, P5393, DOI 10.1021/j100330a015; Wang BX, 2010, INT J MASS SPECTROM, V289, P92, DOI 10.1016/j.ijms.2009.09.014; WANG JH, 1994, J CHEM PHYS, V101, P4842, DOI 10.1063/1.467407; Williamson JC, 1997, NATURE, V386, P159, DOI 10.1038/386159a0; Wolf TJA, 2019, NAT CHEM, V11, P504, DOI 10.1038/s41557-019-0252-7; YAMAZAKI I, 1979, J CHEM PHYS, V71, P381, DOI 10.1063/1.438081; YANG C, 2020, CH CRC BIG DATA SER, P1; Yang J, 2018, SCIENCE, V361, P64, DOI 10.1126/science.aat0049; Yang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11232; Zhong DP, 1998, CHEM PHYS LETT, V298, P129, DOI 10.1016/S0009-2614(98)01160-9	53	54	55	13	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					885	+		10.1126/science.abb2235	http://dx.doi.org/10.1126/science.abb2235			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU2DD	32439793				2022-12-28	WOS:000537569500046
J	Gonzalez-Reiche, AS; Hernandez, MM; Sullivan, MJ; Ciferri, B; Alshammary, H; Obla, A; Fabre, S; Kleiner, G; Polanco, J; Khan, Z; Alburquerque, B; van de Guchte, A; Dutta, J; Francoeur, N; Melo, BS; Oussenko, I; Deikus, G; Soto, J; Sridhar, SH; Wang, YC; Twyman, K; Kasarskis, A; Altman, DR; Smith, M; Sebra, R; Aberg, J; Krammer, F; Garcia-Sastre, A; Luksza, M; Patel, G; Paniz-Mondolfi, A; Gitman, M; Sordillo, EM; Simon, V; van Bakel, H				Gonzalez-Reiche, Ana S.; Hernandez, Matthew M.; Sullivan, Mitchell J.; Ciferri, Brianne; Alshammary, Hala; Obla, Ajay; Fabre, Shelcie; Kleiner, Giulio; Polanco, Jose; Khan, Zenab; Alburquerque, Bremy; van de Guchte, Adriana; Dutta, Jayeeta; Francoeur, Nancy; Melo, Betsaida Salom; Oussenko, Irina; Deikus, Gintaras; Soto, Juan; Sridhar, Shwetha Hara; Wang, Ying-Chih; Twyman, Kathryn; Kasarskis, Andrew; Altman, Deena R.; Smith, Melissa; Sebra, Robert; Aberg, Judith; Krammer, Florian; Garcia-Sastre, Adolfo; Luksza, Marta; Patel, Gopi; Paniz-Mondolfi, Alberto; Gitman, Melissa; Sordillo, Emilia Mia; Simon, Viviana; van Bakel, Harm			Introductions and early spread of SARS-CoV-2 in the New York City area	SCIENCE			English	Article								New York City (NYC) has emerged as one of the epicenters of the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. To identify the early transmission events underlying the rapid spread of the virus in the NYC metropolitan area, we sequenced the virus that causes coronavirus disease 2019 (COVID-19) in patients seeking care at the Mount Sinai Health System. Phylogenetic analysis of 84 distinct SARS-CoV-2 genomes indicates multiple, independent, but isolated introductions mainly from Europe and other parts of the United States. Moreover, we found evidence for community transmission of SARS-CoV-2 as suggested by clusters of related viruses found in patients living in different neighborhoods of the city.	[Gonzalez-Reiche, Ana S.; Sullivan, Mitchell J.; Ciferri, Brianne; Obla, Ajay; Polanco, Jose; Khan, Zenab; Alburquerque, Bremy; van de Guchte, Adriana; Dutta, Jayeeta; Francoeur, Nancy; Melo, Betsaida Salom; Oussenko, Irina; Deikus, Gintaras; Soto, Juan; Sridhar, Shwetha Hara; Wang, Ying-Chih; Kasarskis, Andrew; Altman, Deena R.; Smith, Melissa; Sebra, Robert; Luksza, Marta; van Bakel, Harm] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Hernandez, Matthew M.; Alshammary, Hala; Kleiner, Giulio; Polanco, Jose; Krammer, Florian; Garcia-Sastre, Adolfo; Simon, Viviana] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Hernandez, Matthew M.; Alburquerque, Bremy; Paniz-Mondolfi, Alberto; Gitman, Melissa; Sordillo, Emilia Mia] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Fabre, Shelcie] Icahn Sch Med Mt Sinai, Dept Pathol Mol & Cell Based Med, Clin Microbiol Lab, New York, NY 10029 USA; [Melo, Betsaida Salom; Oussenko, Irina; Deikus, Gintaras; Soto, Juan; Sridhar, Shwetha Hara; Wang, Ying-Chih; Kasarskis, Andrew; Smith, Melissa; Sebra, Robert; Patel, Gopi; Simon, Viviana] Icahn Sch Med Mt Sinai, Icahn Inst Data Sci & Genom Technol, New York, NY 10029 USA; [Twyman, Kathryn; Kasarskis, Andrew; Simon, Viviana] Mt Sinai Hlth Syst, Mt Sinai Data Off, New York, NY 10029 USA; [Altman, Deena R.; Aberg, Judith; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Sebra, Robert; van Bakel, Harm] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Sebra, Robert] Sema4, Stamford, CT 06902 USA; [Krammer, Florian; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Luksza, Marta] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	van Bakel, H (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Simon, V (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Sordillo, EM (corresponding author), Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA.; Simon, V (corresponding author), Icahn Sch Med Mt Sinai, Icahn Inst Data Sci & Genom Technol, New York, NY 10029 USA.; Simon, V (corresponding author), Mt Sinai Hlth Syst, Mt Sinai Data Off, New York, NY 10029 USA.; van Bakel, H (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA.	emilia.sordillo@mssm.edu; viviana.simon@mssm.edu; harm.vanbakel@mssm.edu	Hernandez, Matthew M/AAJ-3909-2021; Obla, Ajay/GON-8118-2022; Sordillo, Emilia Mia/AAF-3012-2021; Krammer, Florian/H-3237-2019; simon, viviana/A-9131-2008; Gonzalez-Reiche, Ana/ABH-2585-2020	Hernandez, Matthew M/0000-0001-6217-7264; Sordillo, Emilia Mia/0000-0001-7787-3051; Krammer, Florian/0000-0003-4121-776X; simon, viviana/0000-0002-6416-5096; Gonzalez-Reiche, Ana/0000-0003-3583-4497; Soto, Juan/0000-0003-1127-590X	Office of Research Infrastructure of the National Institutes of Health (NIH) [S10OD018522, S10OD026880]; CRIP (Center for Research on Influenza Pathogenesis), an NIH [HHSN272201400008C]	Office of Research Infrastructure of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CRIP (Center for Research on Influenza Pathogenesis), an NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Research reported in this paper was supported by the Office of Research Infrastructure of the National Institutes of Health (NIH) under awards S10OD018522 and S10OD026880 as well as institutional and philanthropic funds. Protocols established for this study were in part based on influenza virus sequencing protocols established with the support of CRIP (Center for Research on Influenza Pathogenesis), an NIH-funded Center of Excellence for Influenza Research and Surveillance (CEIRS, contract HHSN272201400008C). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Bedford T., 2020, NEXTSTRAIN BUILD NOV; Bedford T., 2020, CRYPTIC TRANSMISSION; Bedford Trevor, 2020, medRxiv, DOI [10.1126/science.abc0523, 10.1101/2020.04.02.20051417]; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fauver J. R., 2020, CELL; Fauver JR, 2020, CELL, V181, P990, DOI 10.1016/j.cell.2020.04.021; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kingman JFC., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Maurano Matthew T, 2020, Genome Res, V30, P1781, DOI [10.1101/2020.04.15.20064931, 10.1101/gr.266676.120]; Maurano MT, 2020, SEQUENCING IDENTIFIE; Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066; Rambaut A, 2014, FIGTREE 1 4 2 SOFTWA; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963	23	167	167	4	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2020	369	6501					297	+		10.1126/science.abc1917	http://dx.doi.org/10.1126/science.abc1917			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MO0EN	32471856	Green Submitted, Green Published			2022-12-28	WOS:000551210700047
J	Nardell, EA; Nathavitharana, RR				Nardell, Edward A.; Nathavitharana, Ruvandhi R.			Airborne Spread of SARS-CoV-2 and a Potential Role for Air Disinfection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE RESPIRATORY SYNDROME; TRANSMISSION	In the context of potential aerosol spread of SARS-CoV-2 infection, this Viewpoint argues for use of upper-room germicidal UV (GUV) fixtures as a means to disinfect circulating air and prevent spread of COVID-19 and other infections in health care settings.	[Nardell, Edward A.] Harvard Med Sch, Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [Nathavitharana, Ruvandhi R.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Nardell, EA (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.	enardell@bwh.harvard.edu			NIAID NIH HHS [K23 AI132648] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersson L, 2020, WEATHER CLIM EXTREME, V28, DOI 10.1016/j.wace.2019.100241; Bourouiba L, 2020, JAMA-J AM MED ASSOC, V323, P1837, DOI 10.1001/jama.2020.4756; Centers for Disease Control and Prevention, 2003, GUIDELINES ENV INFEC; Cowling BJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2922; Darnell MER, 2004, J VIROL METHODS, V121, P85, DOI 10.1016/j.jviromet.2004.06.006; Fineberg H.V., 2020, RAPID EXPERT CONSULT; McDevitt JJ, 2012, APPL ENVIRON MICROB, V78, P1666, DOI 10.1128/AEM.06960-11; Mphaphlele M, 2015, AM J RESP CRIT CARE, V192, P477, DOI 10.1164/rccm.201501-0060OC; Waldrop T, 2020, 2 DEAD CORONAVIRUS 4; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867	10	56	57	5	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2020	324	2					141	142		10.1001/jama.2020.7603	http://dx.doi.org/10.1001/jama.2020.7603			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ8RW	32478797	Bronze			2022-12-28	WOS:000553161000013
J	Shi, L; Bucknall, MP; Young, TL; Zhang, M; Hu, L; Bing, JM; Lee, DS; Kim, J; Wu, T; Takamure, N; McKenzie, DR; Huang, SJ; Green, MA; Ho-Baillie, AWY				Shi, Lei; Bucknall, Martin P.; Young, Trevor L.; Zhang, Meng; Hu, Long; Bing, Jueming; Lee, Da Seul; Kim, Jincheol; Wu, Tom; Takamure, Noboru; McKenzie, David R.; Huang, Shujuan; Green, Martin A.; Ho-Baillie, Anita W. Y.			Gas chromatography-mass spectrometry analyses of encapsulated stable perovskite solar cells	SCIENCE			English	Article							LEAD HALIDE PEROVSKITES; CH3NH3PBI3 PEROVSKITE; THERMAL-DECOMPOSITION; IODIDE PEROVSKITE; DEGRADATION; EFFICIENT; STABILITY; FORMAMIDINIUM; DESIGN; LAYER	Although perovskite solar cells have produced remarkable energy conversion efficiencies, they cannot become commercially viable without improvements in durability. We used gas chromatography-mass spectrometry (GC-MS) to reveal signature volatile products of the decomposition of organic hybrid perovskites under thermal stress. In addition, we were able to use GC-MS to confirm that a low-cost polymer/glass stack encapsulation is effective in suppressing such outgassing. Using such an encapsulation scheme, we produced multi-cation, multi-halide perovskite solar cells containing methylammonium that exceed the requirements of the International Electrotechnical Commission 61215:2016 standard by surviving more than 1800 hours of the Damp Heat test and 75 cycles of the Humidity Freeze test.	[Shi, Lei; Young, Trevor L.; Zhang, Meng; Bing, Jueming; Lee, Da Seul; Kim, Jincheol; Huang, Shujuan; Green, Martin A.; Ho-Baillie, Anita W. Y.] Univ New South Wales, Sch Photovolta & Renewable Energy Engn, Australian Ctr Adv Photovolta, Sydney, NSW 2052, Australia; [Bucknall, Martin P.] Univ New South Wales, Mark Wainwright Analyt Ctr, Bioanalyt Mass Spectrometry Facil, Sydney, NSW 2052, Australia; [Bucknall, Martin P.] Univ New South Wales, Sch Optometry & Vis Sci, Sydney, NSW 2052, Australia; [Zhang, Meng] Southwest Petr Univ, Inst Photovolta, Chengdu 610500, Peoples R China; [Hu, Long; Wu, Tom] Univ New South Wales, Sch Mat Sci & Engn, Sydney, NSW 2052, Australia; [Bing, Jueming; Takamure, Noboru; McKenzie, David R.; Ho-Baillie, Anita W. Y.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Bing, Jueming; Ho-Baillie, Anita W. Y.] Univ Sydney, Nano Inst, Sydney, NSW 2006, Australia; [Kim, Jincheol] Korea Elect Technol Inst, New & Renewable Energy Res Ctr, Seong Nam, South Korea; [Huang, Shujuan] Macquarie Univ, Sch Engn, Sydney, NSW 2109, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Southwest Petroleum University; University of New South Wales Sydney; University of Sydney; University of Sydney; Macquarie University	Shi, L; Ho-Baillie, AWY (corresponding author), Univ New South Wales, Sch Photovolta & Renewable Energy Engn, Australian Ctr Adv Photovolta, Sydney, NSW 2052, Australia.; Ho-Baillie, AWY (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.; Ho-Baillie, AWY (corresponding author), Univ Sydney, Nano Inst, Sydney, NSW 2006, Australia.	lei.shi@unsw.edu.au; anita.ho-baillie@sydney.edu.au	Wu, Tom/A-1158-2012; Green, Martin A/H-7567-2012; Ho-Baillie, Anita/R-4801-2018; Bucknall, Martin/N-8880-2018; Kim, Jincheol/O-5037-2015	Wu, Tom/0000-0003-0845-4827; Green, Martin A/0000-0002-8860-396X; Ho-Baillie, Anita/0000-0001-9849-4755; Bing, Jueming/0000-0002-3886-0757; Zhang, Meng/0000-0002-1004-5662; Shi, Lei/0000-0001-7033-2746; Bucknall, Martin/0000-0002-9418-5936; Young, Trevor/0000-0002-9792-6402; Kim, Jincheol/0000-0001-7374-2740; Takamure, Noboru/0000-0002-7137-0055; Hu, Long/0000-0001-7408-5631; Huang, Shujuan/0000-0003-3468-4773	Australian Government through the Australian Renewable Energy Agency (ARENA); ARENA	Australian Government through the Australian Renewable Energy Agency (ARENA)(Australian Renewable Energy Agency (ARENA)); ARENA(Australian Renewable Energy Agency (ARENA))	The Australian Centre for Advanced Photovoltaics (ACAP) encompasses the Australian-based activities of the Australia-U.S. Institute for Advanced Photovoltaics (AUSIAPV) and is supported by the Australian Government through the Australian Renewable Energy Agency (ARENA). L.S. also thanks ARENA for scholarship funding support.	Ahmad J, 2013, RENEW SUST ENERG REV, V27, P104, DOI 10.1016/j.rser.2013.06.027; Akbulatov AF, 2020, J PHYS CHEM LETT, V11, P333, DOI 10.1021/acs.jpclett.9b03308; [Anonymous], 1999, J CHROMATOGR SCI, V37, P313, DOI [10.1093/chromsci/37.8.313, DOI 10.1093/CHROMSCI/37.8.313]; Arora N, 2017, SCIENCE, V358, P768, DOI 10.1126/science.aam5655; Asghar MI, 2017, RENEW SUST ENERG REV, V77, P131, DOI 10.1016/j.rser.2017.04.003; Bi EB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15330; Bipp H., 2011, ULLMANNS ENCY IND CH, V16; Boyd CC, 2019, CHEM REV, V119, P3418, DOI 10.1021/acs.chemrev.8b00336; Boyd CC, 2018, ACS ENERGY LETT, V3, P1772, DOI 10.1021/acsenergylett.8b00926; Brinkmann KO, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13938; Bush KA, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.9; Bush KA, 2016, ADV MATER, V28, P3937, DOI 10.1002/adma.201505279; Chang NL, 2017, PROG PHOTOVOLTAICS, V25, P390, DOI 10.1002/pip.2871; Cheacharoen R, 2018, SUSTAIN ENERG FUELS, V2, P2398, DOI 10.1039/c8se00250a; Cheacharoen R, 2018, ENERG ENVIRON SCI, V11, P144, DOI 10.1039/c7ee02564e; Chen Y, 2018, ADV MATER, V30, DOI 10.1002/adma.201805660; Christians JA, 2015, J AM CHEM SOC, V137, P1530, DOI 10.1021/ja511132a; Conings B, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201500477; Dong Q, 2016, CHEMSUSCHEM, V9, P2597, DOI 10.1002/cssc.201600868; Dualeh A, 2014, CHEM MATER, V26, P6160, DOI 10.1021/cm502468k; Dualeh A, 2014, ADV FUNCT MATER, V24, P3250, DOI 10.1002/adfm.201304022; Dunbar RB, 2017, J MATER CHEM A, V5, P22542, DOI 10.1039/c7ta05609e; Eperon GE, 2014, ENERG ENVIRON SCI, V7, P982, DOI 10.1039/c3ee43822h; Fan Z, 2017, JOULE, V1, P548, DOI 10.1016/j.joule.2017.08.005; Grancini G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15684; Green MA, 2020, PROG PHOTOVOLTAICS, V28, P3, DOI 10.1002/pip.3228; Green MA, 2017, ACS ENERGY LETT, V2, P822, DOI 10.1021/acsenergylett.7b00137; Green MA, 2014, NAT PHOTONICS, V8, P506, DOI [10.1038/nphoton.2014.134, 10.1038/NPHOTON.2014.134]; Habisreutinger SN, 2014, NANO LETT, V14, P5561, DOI 10.1021/nl501982b; Han Y, 2015, J MATER CHEM A, V3, P8139, DOI 10.1039/c5ta00358j; Huang JB, 2017, ENERG ENVIRON SCI, V10, P2284, DOI 10.1039/c7ee01674c; International Electrotechnical Commission, TERR PHOT PV MOD D 1; Islam MB, 2017, ACS OMEGA, V2, P2291, DOI 10.1021/acsomega.7b00538; Ito S, 2014, J PHYS CHEM C, V118, P16995, DOI 10.1021/jp500449z; Ivanov IL, 2018, J CHEM THERMODYN, V116, P253, DOI 10.1016/j.jct.2017.09.026; Jiang Q, 2019, NAT PHOTONICS, V13, P460, DOI 10.1038/s41566-019-0398-2; Juarez-Perez EJ, 2019, J MATER CHEM A, V7, P16912, DOI 10.1039/c9ta06058h; Juarez-Perez EJ, 2019, ACS APPL MATER INTER, V11, P12586, DOI 10.1021/acsami.9b02374; Juarez-Perez EJ, 2018, J MATER CHEM A, V6, P9604, DOI 10.1039/c8ta03501f; Juarez-Perez EJ, 2016, ENERG ENVIRON SCI, V9, P3406, DOI 10.1039/c6ee02016j; Kempe MD, 2014, PROG PHOTOVOLTAICS, V22, P1159, DOI 10.1002/pip.2374; Kim J, 2017, SOL ENERG MAT SOL C, V162, P41, DOI 10.1016/j.solmat.2016.12.043; Kim NK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04690-w; Kim YC, 2017, ENERG ENVIRON SCI, V10, P2109, DOI 10.1039/c7ee01931a; Latini A, 2017, SUSTAIN ENERG FUELS, V1, P1351, DOI 10.1039/c7se00114b; Lee YI, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201701928; Leijtens T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3885; LI N, 2017, ADV ENERGY MATER, V7, DOI DOI 10.1002/AENM.201601307; Li Z, 2016, CHEM MATER, V28, P284, DOI 10.1021/acs.chemmater.5b04107; Liu SS, 2017, J MATER CHEM A, V5, P22952, DOI 10.1039/c7ta07660f; Ma L, 2019, CHEM MATER, V31, P8515, DOI 10.1021/acs.chemmater.9b03190; Matteocci F, 2016, NANO ENERGY, V30, P162, DOI 10.1016/j.nanoen.2016.09.041; National Renewable Energy Laboratory, 2019, EFF CHART; Nenon DP, 2016, ENERG ENVIRON SCI, V9, P2072, DOI 10.1039/c6ee01047d; Niu GD, 2014, J MATER CHEM A, V2, P705, DOI 10.1039/c3ta13606j; Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Pern F. J., 2012, SPIE OPT PHOT SAN DI; Philippe B, 2015, CHEM MATER, V27, P1720, DOI 10.1021/acs.chemmater.5b00348; Saliba M, 2016, SCIENCE, V354, P206, DOI 10.1126/science.aah5557; Saliba M, 2016, ENERG ENVIRON SCI, V9, P1989, DOI 10.1039/c5ee03874j; Seo S, 2018, ADV MATER, V30, DOI 10.1002/adma.201801010; Shi L, 2017, ACS APPL MATER INTER, V9, P25073, DOI 10.1021/acsami.7b07625; Speight J.G., 2004, LANGES HDB CHEM; Tan HR, 2017, SCIENCE, V355, P722, DOI 10.1126/science.aai9081; Tang WL, 2018, ACS APPL MATER INTER, V10, P5485, DOI 10.1021/acsami.7b15263; Tsai HH, 2016, NATURE, V536, P312, DOI 10.1038/nature18306; Turowec BA, 2017, POLYM INT, V66, P42, DOI 10.1002/pi.5250; Uddin A, 2019, COATINGS, V9, DOI 10.3390/coatings9020065; Wang P, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201807661; Wang ZP, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.135; Weerasinghe HC, 2016, SOL ENERG MAT SOL C, V155, P108, DOI 10.1016/j.solmat.2016.04.051; Williams AE, 2014, J MATER CHEM A, V2, P19338, DOI 10.1039/c4ta04725g; Wu YH, 2018, CHEMSUSCHEM, V11, P837, DOI 10.1002/cssc.201702221; Yi CY, 2016, ENERG ENVIRON SCI, V9, P656, DOI 10.1039/c5ee03255e; Yu D, 2016, OPT COMMUN, V362, P43, DOI 10.1016/j.optcom.2015.08.021; Yusoff AB, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201702073; Zhang M, 2018, JOULE, V2, P2694, DOI 10.1016/j.joule.2018.08.012	77	207	209	69	446	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2020	368	6497					1328	+	eaba2412	10.1126/science.aba2412	http://dx.doi.org/10.1126/science.aba2412			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MD5NG	32439657				2022-12-28	WOS:000544017600037
J	Antiel, RM				Antiel, Ryan M.			Oedipus and the Coronavirus Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Antiel, Ryan M.] Washington Univ, Sch Med, Dept Surg, Div Pediat Surg, One Childrens Pl, St Louis, MO 63110 USA	Washington University (WUSTL)	Antiel, RM (corresponding author), Washington Univ, Sch Med, Dept Surg, Div Pediat Surg, One Childrens Pl, St Louis, MO 63110 USA.	ryan.antiel@wustl.edu						BERRY W, 1995, ANOTHER TURN CRANK E; Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562; Sophocles, 1991, SOPHOCLES, P145; Sophocles, 1991, SOPHOCLES, P73	4	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2020	323	22					2231	2232		10.1001/jama.2020.8594	http://dx.doi.org/10.1001/jama.2020.8594			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MA5KO	32437526	Bronze			2022-12-28	WOS:000541952100001
J	Chai, YC; Han, X; Li, WY; Liu, SS; Yao, SK; Wang, C; Shi, W; Da-Silva, I; Manuel, P; Cheng, YQ; Daemen, LD; Ramirez-Cuesta, AJ; Tang, CC; Jiang, L; Yang, SH; Guan, NJ; Li, LD				Chai, Yuchao; Han, Xue; Li, Weiyao; Liu, Shanshan; Yao, Sikai; Wang, Chong; Shi, Wei; da-Silva, Ivan; Manuel, Pascal; Cheng, Yongqiang; Daemen, Luke D.; Ramirez-Cuesta, Anibal J.; Tang, Chiu C.; Jiang, Ling; Yang, Sihai; Guan, Naijia; Li, Landong			Control of zeolite pore interior for chemoselective alkyne/olefin separations	SCIENCE			English	Article							METAL-ORGANIC FRAMEWORK; EFFICIENT REMOVAL; ACETYLENE; NICKEL; ADSORPTION; ETHYLENE; THERMODYNAMICS; DEHYDRATION; PALLADIUM; CATALYSTS	The efficient removal of alkyne impurities for the production of polymer-grade lower olefins remains an important and challenging goal for many industries. We report a strategy to control the pore interior of faujasite (FAU) zeolites by the confinement of isolated open nickel(II) sites in their six-membered rings. Under ambient conditions, Ni@FAU showed remarkable adsorption of alkynes and efficient separations of acetylene/ethylene, propyne/propylene. and butyne/1,3-butadiene mixtures, with unprecedented dynamic separation selectivities of 100, 92, and 83, respectively. In situ neutron diffraction and inelastic neutron scattering revealed that confined nickel(II) sites enabled chemoselective and reversible binding to acetylene through the formation of metastable [Ni(II)(C2H2)(3)] complexes. Control of the chemistry of pore interiors of easily scalable zeolites has unlocked their potential in challenging industrial separations.	[Chai, Yuchao; Liu, Shanshan; Yao, Sikai; Guan, Naijia; Li, Landong] Nankai Univ, Sch Mat Sci & Engn, Tianjin 300350, Peoples R China; [Chai, Yuchao; Liu, Shanshan; Yao, Sikai; Guan, Naijia; Li, Landong] Nankai Univ, Natl Inst Adv Mat, Tianjin 300350, Peoples R China; [Han, Xue; Li, Weiyao; Yang, Sihai] Univ Manchester, Dept Chem, Manchester M13 9PL, Lancs, England; [Wang, Chong; Jiang, Ling] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Dalian 116023, Peoples R China; [Shi, Wei; Guan, Naijia; Li, Landong] Nankai Univ, Key Lab Adv Energy Mat Chem, Minist Educ, Tianjin 300071, Peoples R China; [da-Silva, Ivan; Manuel, Pascal] Rutherford Appleton Lab, ISIS Facil, Sci & Technol Facil Council STFC, Chilton OX11 0QX, Oxon, England; [Cheng, Yongqiang; Daemen, Luke D.; Ramirez-Cuesta, Anibal J.] Oak Ridge Natl Lab ORNL, Neutron Scattering Div, Neutron Sci Directorate, Oak Ridge, TN 37831 USA; [Tang, Chiu C.] Diamond Light Source, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England	Nankai University; Nankai University; University of Manchester; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Nankai University; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Diamond Light Source	Li, LD (corresponding author), Nankai Univ, Sch Mat Sci & Engn, Tianjin 300350, Peoples R China.; Li, LD (corresponding author), Nankai Univ, Natl Inst Adv Mat, Tianjin 300350, Peoples R China.; Yang, SH (corresponding author), Univ Manchester, Dept Chem, Manchester M13 9PL, Lancs, England.; Li, LD (corresponding author), Nankai Univ, Key Lab Adv Energy Mat Chem, Minist Educ, Tianjin 300071, Peoples R China.	sihai.yang@manchester.ac.uk; lild@nankai.edu.cn	Shi, Wei/N-4167-2014; Ramirez, Timmy/AAT-4480-2020; Li, Landong/ABB-4866-2020; Li, Landong/B-7329-2017; da Silva, Ivan/C-5545-2014	Shi, Wei/0000-0001-6130-1227; Ramirez, Timmy/0000-0003-1231-0068; Li, Landong/0000-0003-0998-4061; Li, Landong/0000-0003-0998-4061; Cheng, Yongqiang/0000-0002-3263-4812; Manuel, Pascal/0000-0002-8845-6576; han, xue/0000-0002-0390-422X; Chai, Yuchao/0000-0002-3959-3857; Yang, Sihai/0000-0002-1111-9272; da Silva, Ivan/0000-0002-4472-9675	National Natural Science Fund of China [21722303, 21421001, 21688102]; Municipal Natural Science Fund of Tianjin [18JCJQJC47400, 18JCZDJC37400]; 111 Project [B12015, B18030]; U.K. Engineering and Physical Sciences Research Council [EP/P011632/1]; University of Manchester; Royal Society; Scientific User Facilities Division, Office of Basic Energy Sciences (BES), U.S. Department of Energy (DOE) [DE-AC0500OR22725]; UT Battelle, LLC; Laboratory Directed Research and Development program at ORNL; EPSRC [EP/P011632/1] Funding Source: UKRI	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Municipal Natural Science Fund of Tianjin; 111 Project(Ministry of Education, China - 111 Project); U.K. Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Manchester; Royal Society(Royal Society of London); Scientific User Facilities Division, Office of Basic Energy Sciences (BES), U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); UT Battelle, LLC; Laboratory Directed Research and Development program at ORNL; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by the National Natural Science Fund of China (21722303, 21421001, and 21688102), the Municipal Natural Science Fund of Tianjin (18JCJQJC47400 and 18JCZDJC37400), the 111 Project (B12015 and B18030), the U.K. Engineering and Physical Sciences Research Council (EP/P011632/1), and the University of Manchester and Newton Advanced Fellowship by the Royal Society (to W.S. and S.Yan.). Beamlines WISH and I11 were accessed through the STFC ISIS Facility and Diamond Light Source, respectively. INS experiments were conducted at the VISION beamline at ORNL's Spallation Neutron Source, which is supported by the Scientific User Facilities Division, Office of Basic Energy Sciences (BES), U.S. Department of Energy (DOE), under contract no. DE-AC0500OR22725 with UT Battelle, LLC. The computing resources were made available through the VirtuES and the ICEMAN projects, funded by the Laboratory Directed Research and Development program at ORNL.	Bao ZB, 2018, J AM CHEM SOC, V140, P4596, DOI 10.1021/jacs.7b13706; Bereciartua PJ, 2017, SCIENCE, V358, P1068, DOI 10.1126/science.aao0092; Bloch ED, 2012, SCIENCE, V335, P1606, DOI 10.1126/science.1217544; Borodzinki A, 2006, CATAL REV, V48, P91, DOI 10.1080/01614940500364909; Cadiau A, 2016, SCIENCE, V353, P137, DOI 10.1126/science.aaf6323; Chapon Laurent C., 2011, NEUTRON NEWS, V22, P22; Cheng YQ, 2019, J CHEM THEORY COMPUT, V15, P1974, DOI 10.1021/acs.jctc.8b01250; Choi M, 2010, J AM CHEM SOC, V132, P9129, DOI 10.1021/ja102778e; Choi SW, 2017, J CATAL, V345, P113, DOI 10.1016/j.jcat.2016.11.017; Cui XL, 2016, SCIENCE, V353, P141, DOI 10.1126/science.aaf2458; DOORYHEE E, 1991, J PHYS CHEM-US, V95, P4514, DOI 10.1021/j100164a062; ERKELENS J, 1978, J CATAL, V54, P143, DOI 10.1016/0021-9517(78)90037-4; GALLEZOT P, 1973, J PHYS CHEM-US, V77, P652, DOI 10.1021/j100624a019; Goedecker S, 1996, PHYS REV B, V54, P1703, DOI 10.1103/PhysRevB.54.1703; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Guesmi H, 2011, J PHYS CHEM C, V115, P5607, DOI 10.1021/jp108172t; Herm ZR, 2013, SCIENCE, V340, P960, DOI 10.1126/science.1234071; Hu TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8328; Hutter J, 2014, WIRES COMPUT MOL SCI, V4, P15, DOI 10.1002/wcms.1159; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kuznicki SM, 2001, NATURE, V412, P720, DOI 10.1038/35089052; LAPINSKI MP, 1990, J PHYS CHEM-US, V94, P4599, DOI 10.1021/j100374a044; Lee J, 2018, ANGEW CHEM INT EDIT, V57, P7869, DOI 10.1002/anie.201804442; Lee K, 2015, CHEM MATER, V27, P668, DOI 10.1021/cm502760q; Lei X, 2018, PHYS CHEM CHEM PHYS, V20, DOI 10.1039/c8cp03672a; Li B, 2017, ADV MATER, V29, DOI 10.1002/adma.201704210; Li J, 2019, J AM CHEM SOC, V141, P3807, DOI 10.1021/jacs.8b13463; Li LB, 2018, ANGEW CHEM INT EDIT, V57, P15183, DOI 10.1002/anie.201809869; Li LB, 2017, J AM CHEM SOC, V139, P7733, DOI 10.1021/jacs.7b04268; Liao PQ, 2017, SCIENCE, V356, P1193, DOI 10.1126/science.aam7232; Lin RB, 2017, J AM CHEM SOC, V139, P8022, DOI 10.1021/jacs.7b03850; Lippert G, 1997, MOL PHYS, V92, P477, DOI 10.1080/00268979709482119; Louisfrema W, 2016, J PHYS CHEM C, V120, P18115, DOI 10.1021/acs.jpcc.6b05657; Mitchell PCH, 2005, VIBRATIONAL SPECTROS; MYERS AL, 1965, AICHE J, V11, P121, DOI 10.1002/aic.690110125; NELSON JH, 1971, COORDIN CHEM REV, V6, P27, DOI 10.1016/S0010-8545(00)80033-8; Nugent P, 2013, NATURE, V495, P80, DOI 10.1038/nature11893; Patai S., 1978, CHEM CARBON CARBON T; Peng YL, 2018, ANGEW CHEM INT EDIT, V57, P10971, DOI 10.1002/anie.201806732; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Sholl DS, 2016, NATURE, V532, P435, DOI 10.1038/532435a; THOMAS JM, 1988, J CHEM SOC FARAD T 1, V84, P2915, DOI 10.1039/f19888402915; Thompson SP, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3167217; VandeVondele J, 2005, COMPUT PHYS COMMUN, V167, P103, DOI 10.1016/j.cpc.2004.12.014; VandeVondele J, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2770708; Walton KS, 2015, AICHE J, V61, P2757, DOI 10.1002/aic.14878; Wang PK, 2017, ANGEW CHEM INT EDIT, V56, P8716, DOI 10.1002/anie.201703695; Wellendorff J, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.235149; Xiang SC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1206; Yang LF, 2018, ADV MATER, V30, DOI 10.1002/adma.201705374; Yang R.T., 1997, GAS SEPARATION ADSOR; Yang SH, 2015, NAT CHEM, V7, P121, DOI 10.1038/nchem.2114; Yu HS, 2015, NUCL SCI TECH, V26, DOI 10.13538/j.1001-8042/nst.26.050102; Zimmermann H., 2000, ULLMANNS ENCY IND CH, DOI Weinheim, Germany	55	90	91	64	460	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					1002	+		10.1126/science.aay8447	http://dx.doi.org/10.1126/science.aay8447			77	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LV3IK	32467390	Green Submitted			2022-12-28	WOS:000538332600046
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Battening down the hatches for a second wave	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Boycott-Owen M, 2020, TELEGRAPH; General Medical Council, CONS PAT DOCT MAK DE; Griffith Richard, 2020, Br J Nurs, V29, P326, DOI 10.12968/bjon.2020.29.5.326; Scally G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1932	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2020	369								m2076	10.1136/bmj.m2076	http://dx.doi.org/10.1136/bmj.m2076			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JX	32461233	Bronze			2022-12-28	WOS:000538337100008
J	Tullus, K; Shaikh, N				Tullus, Kjell; Shaikh, Nader			tract infections in children	LANCET			English	Review							AMBULATORY BLOOD-PRESSURE; SWEDISH REFLUX TRIAL; URINARY-TRACT; VESICOURETERAL REFLUX; ESCHERICHIA-COLI; ASYMPTOMATIC BACTERIURIA; ANTIBIOTIC-PROPHYLAXIS; INTERNATIONAL REFLUX; SURGICAL-TREATMENT; FEBRILE INFANTS		[Tullus, Kjell] Great Ormond St Hosp Sick Children, Renal Unit, London WC1N 3JH, England; [Shaikh, Nader] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tullus, K (corresponding author), Great Ormond St Hosp Sick Children, Renal Unit, London WC1N 3JH, England.	kjell.tullus@gosh.nhs.uk	Tullus, Kjell/C-6589-2008					Allen HA, 2007, UROLOGY, V69, P962, DOI 10.1016/j.urology.2007.01.049; [Anonymous], CONTRIB NEPHROL; [Anonymous], YB PEDIAT 2017; [Anonymous], IMMUNODEFIENCY FORFA; Bitsori M, 2014, PEDIATR NEPHROL, V29, P1053, DOI 10.1007/s00467-013-2719-x; Brandstrom P, 2010, J UROLOGY, V184, P274, DOI 10.1016/j.juro.2010.01.055; Brandstrom P, 2010, J UROLOGY, V184, P286, DOI 10.1016/j.juro.2010.01.061; Brandstrom P, 2010, J UROLOGY, V184, P292, DOI 10.1016/j.juro.2010.01.060; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Clothier JC, 2018, PEDIATR NEPHROL, V33, P381, DOI 10.1007/s00467-017-3679-3; Cochrane D, 2015, INT J INTEGR CARE, V15; Coulthard MG, 2009, PEDIATR NEPHROL, V24, P227, DOI 10.1007/s00467-008-0911-1; Craig JC, 2009, NEW ENGL J MED, V361, P1748, DOI 10.1056/NEJMoa0902295; DUCKETT JW, 1992, J UROLOGY, V148, P1674, DOI 10.1016/S0022-5347(17)36999-9; EDEN CS, 1976, LANCET, V2, P490; Elder JS, 2006, J UROLOGY, V175, P716, DOI 10.1016/S0022-5347(05)00210-7; Elder JS, 1997, J UROLOGY, V157, P1846, DOI 10.1016/S0022-5347(01)64882-1; Etoubleau C, 2009, J PEDIATR-US, V154, P803, DOI 10.1016/j.jpeds.2009.01.008; Farhat W, 2000, J UROLOGY, V164, P1011, DOI 10.1016/S0022-5347(05)67239-4; Fitzgerald A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006857.pub2; Geback C, 2015, PEDIATR NEPHROL, V30, P1493, DOI 10.1007/s00467-015-3084-8; Geback C, 2014, J HYPERTENS, V32, P1658, DOI 10.1097/HJH.0000000000000234; Hannula A, 2010, PEDIATR NEPHROL, V25, P1463, DOI 10.1007/s00467-010-1542-x; HANSSON S, 1989, PEDIATRICS, V84, P964; HANSSON S, 1989, BMJ-BRIT MED J, V298, P856, DOI 10.1136/bmj.298.6677.856; HANSSON S, 1990, J UROLOGY, V143, P333, DOI 10.1016/S0022-5347(17)39951-2; Hari P, 2015, PEDIATR NEPHROL, V30, P479, DOI 10.1007/s00467-014-2943-z; Hay AD, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20510; HELLSTROM A, 1991, ARCH DIS CHILD, V66, P232, DOI 10.1136/adc.66.2.232; Hoberman A, 2003, NEW ENGL J MED, V348, P195, DOI 10.1056/NEJMoa021698; Hoberman A, 1999, PEDIATRICS, V104, P79, DOI 10.1542/peds.104.1.79; Hoberman A, 2014, NEW ENGL J MED, V370, P2367, DOI 10.1056/NEJMoa1401811; Jepson RG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001321.pub5; Jodal U, 1987, Infect Dis Clin North Am, V1, P713; KALLENIUS G, 1981, LANCET, V2, P604; KALLENIUS G, 1981, LANCET, V2, P1369; KASS EH, 1962, ANN INTERN MED, V56, P46, DOI 10.7326/0003-4819-56-1-46; KOLLERMA.MW, 1967, Z KINDERHEILKD, V100, P185, DOI 10.1007/BF00504296; La Scola C, 2013, PEDIATRICS, V131, pE665, DOI 10.1542/peds.2012-0164; Martinell J, 1996, PEDIATR NEPHROL, V10, P139; MARTINELL J, 1990, BRIT MED J, V300, P840, DOI 10.1136/bmj.300.6728.840; Montini G, 2011, NEW ENGL J MED, V365, P239, DOI 10.1056/NEJMra1007755; Mori R, 2007, BRIT MED J, V335, P395, DOI 10.1136/bmj.39286.700891.AD; Nelson CP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2490; Olbing H, 2003, PEDIATR NEPHROL, V18, P1128, DOI 10.1007/s00467-003-1256-4; Pohl HG, 2009, ADV UROL, V2009, DOI 10.1155/2009/783409; Ragnarsdottir B, 2011, NAT REV UROL, V8, P449, DOI 10.1038/nrurol.2011.100; Roberts KB, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3239; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Saedi NA, 2003, PEDIATR NEPHROL, V18, P894, DOI 10.1007/s00467-003-1210-5; SAVAGE DCL, 1975, LANCET, V1, P358; Schwaderer AL, 2016, J AM SOC NEPHROL, V27, P3175, DOI 10.1681/ASN.2015060700; Shaikh N, 2003, PEDIATRICS, V112, P1134, DOI 10.1542/peds.112.5.1134; Shaikh N, 2020, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00530; Shaikh N, 2020, J PEDIATR-US, V217, P110, DOI 10.1016/j.jpeds.2019.10.019; Shaikh N, 2018, JAMA PEDIATR, V172, P550, DOI 10.1001/jamapediatrics.2018.0217; Shaikh N, 2016, JAMA PEDIATR, V170, P848, DOI 10.1001/jamapediatrics.2016.1181; Shaikh N, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0087; Shaikh N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2982; Shaikh N, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009185.pub2; Shaikh N, 2014, JAMA PEDIATR, V168, P893, DOI 10.1001/jamapediatrics.2014.637; Shaikh N, 2012, J UROLOGY, V188, P1895, DOI 10.1016/j.juro.2012.07.013; Shaikh N, 2010, PEDIATRICS, V126, P1084, DOI 10.1542/peds.2010-0685; Singh-Grewal D, 2005, ARCH DIS CHILD, V90, P853, DOI 10.1136/adc.2004.049353; Smellie JM, 2001, LANCET, V357, P1329, DOI 10.1016/S0140-6736(00)04520-7; SMELLIE JM, 1992, PEDIATR NEPHROL, V6, P223, DOI 10.1007/BF00878353; Strohmeier Y, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003772.pub4; Swerkersson S, 2016, PEDIATR NEPHROL, V31, P239, DOI 10.1007/s00467-015-3199-y; Thom M, 2012, J PEDIATR UROL, V8, P20, DOI 10.1016/j.jpurol.2011.01.004; Toffolo A, 2012, ACTA PAEDIATR, V101, P1018, DOI 10.1111/j.1651-2227.2012.02785.x; TULLUS K, 1991, J UROLOGY, V146, P1153, DOI 10.1016/S0022-5347(17)38029-1; Tullus K, 2017, PEDIATR NEPHROL, V32, P107, DOI 10.1007/s00467-016-3463-9; Tullus K, 2016, PEDIATR NEPHROL, V31, P171, DOI 10.1007/s00467-015-3227-y; Tullus K, 2015, LANCET, V385, P371, DOI 10.1016/S0140-6736(14)60383-4; Tullus K, 2011, PEDIATR NEPHROL, V26, P1923, DOI 10.1007/s00467-011-1966-y; TURNER GM, 1995, BRIT MED J, V311, P924; Venhola M, 2010, ACTA PAEDIATR, V99, P1875, DOI 10.1111/j.1651-2227.2010.01909.x; Wennerstrom M, 2000, ARCH PEDIAT ADOL MED, V154, P339, DOI 10.1001/archpedi.154.4.339; Wennerstrom M, 2000, J HYPERTENS, V18, P485, DOI 10.1097/00004872-200018040-00019; WETTERGREN B, 1985, ACTA PAEDIATR SCAND, V74, P925, DOI 10.1111/j.1651-2227.1985.tb10059.x; WETTERGREN B, 1990, ACTA PAEDIATR SCAND, V79, P300, DOI 10.1111/j.1651-2227.1990.tb11460.x; Wiener JS, 2000, J UROLOGY, V164, P786, DOI 10.1016/S0022-5347(05)67313-2; Williams G, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001532.pub5; Williams GJ, 2010, LANCET INFECT DIS, V10, P240, DOI 10.1016/S1473-3099(10)70031-1; WINBERG J, 1974, ACTA PAEDIATR SCAND, P2; WISWELL TE, 1985, PEDIATRICS, V75, P901	86	35	39	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2020	395	10237					1659	1668		10.1016/S0140-6736(20)30676-0	http://dx.doi.org/10.1016/S0140-6736(20)30676-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LZ1JO	32446408				2022-12-28	WOS:000540986100028
J	Muench, DE; Olsson, A; Ferchen, K; Pham, G; Serafin, RA; Chutipongtanate, S; Dwivedi, P; Song, BB; Hay, S; Chetal, K; Trump-Durbin, LR; Mookerjee-Basu, J; Zhang, KJ; Yu, JNC; Lutzko, C; Myers, KC; Nazor, KL; Greis, KD; Kappes, DJ; Way, SS; Salomonis, N; Grimes, HL				Muench, David E.; Olsson, Andre; Ferchen, Kyle; Pham, Giang; Serafin, Rachel A.; Chutipongtanate, Somchai; Dwivedi, Pankaj; Song, Baobao; Hay, Stuart; Chetal, Kashish; Trump-Durbin, Lisa R.; Mookerjee-Basu, Jayati; Zhang, Kejian; Yu, Jennifer C.; Lutzko, Carolyn; Myers, Kasiani C.; Nazor, Kristopher L.; Greis, Kenneth D.; Kappes, Dietmar J.; Way, Sing Sing; Salomonis, Nathan; Grimes, H. Leighton			Mouse models of neutropenia reveal progenitor-stage-specific defects	NATURE			English	Article							GFI-1; IDENTIFICATION; NEUTROPHILS; MUTATIONS; ELANE; MICE	Advances in genetics and sequencing have identified a plethora of disease-associated and disease-causing genetic alterations. To determine causality between genetics and disease, accurate models for molecular dissection are required; however, the rapid expansion of transcriptional populations identified through single-cell analyses presents a major challenge for accurate comparisons between mutant and wild-type cells. Here we generate mouse models of human severe congenital neutropenia (SCN) using patient-derived mutations in the GFI1 transcription factor. To determine the effects of SCN mutations, we generated single-cell references for granulopoietic genomic states with linked epitopes(1), aligned mutant cells to their wild-type equivalents and identified differentially expressed genes and epigenetic loci. We find that GFI1-target genes are altered sequentially, as cells go through successive states of differentiation. These insights facilitated the genetic rescue of granulocytic specification but not post-commitment defects in innate immune effector function, and underscore the importance of evaluating the effects of mutations and therapy within each relevant cell state. Mouse models of severe congenital neutropenia using patient-derived mutations in the GFI1 locus are used to determine the mechanisms by which the disease progresses.	[Muench, David E.; Olsson, Andre; Ferchen, Kyle; Serafin, Rachel A.; Song, Baobao; Grimes, H. Leighton] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Muench, David E.; Olsson, Andre; Ferchen, Kyle; Serafin, Rachel A.; Song, Baobao; Grimes, H. Leighton] Cincinnati Childrens Hosp Med Ctr, Ctr Syst Immunol, Cincinnati, OH 45229 USA; [Muench, David E.] Cincinnati Childrens Hosp Med Ctr, Mol & Dev Biol Grad Program, Cincinnati, OH 45229 USA; [Ferchen, Kyle; Chutipongtanate, Somchai; Dwivedi, Pankaj; Greis, Kenneth D.] Univ Cincinnati, Dept Canc Biol, Cincinnati, OH USA; [Pham, Giang; Way, Sing Sing] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Chutipongtanate, Somchai] Mahidol Univ, Pediat Translat Res Unit, Dept Pediat, Fac Med,Ramathibodi Hosp, Bangkok, Thailand; [Song, Baobao] Cincinnati Childrens Hosp Med Ctr, Immunol Grad Program, Cincinnati, OH 45229 USA; [Hay, Stuart; Chetal, Kashish; Salomonis, Nathan] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Trump-Durbin, Lisa R.; Lutzko, Carolyn; Grimes, H. Leighton] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Mookerjee-Basu, Jayati; Kappes, Dietmar J.] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Zhang, Kejian] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Zhang, Kejian; Lutzko, Carolyn; Myers, Kasiani C.; Way, Sing Sing; Salomonis, Nathan; Grimes, H. Leighton] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Yu, Jennifer C.] Rady Childrens Hosp San Diego, Div Pediat Hematol Oncol, San Diego, CA USA; [Yu, Jennifer C.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Myers, Kasiani C.] Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA; [Nazor, Kristopher L.] BioLegend Inc, San Diego, CA USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Mahidol University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Fox Chase Cancer Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Cincinnati Children's Hospital Medical Center	Grimes, HL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA.; Grimes, HL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Syst Immunol, Cincinnati, OH 45229 USA.; Salomonis, N (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA.; Grimes, HL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.; Salomonis, N; Grimes, HL (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati, OH USA.	nathan.salomonis@cchmc.org; lee.grimes@cchmc.org	Chutipongtanate, Somchai/H-6936-2019; Chetal, Kashish/S-2498-2019; Dwivedi, Pankaj/M-8669-2014	Chutipongtanate, Somchai/0000-0001-6398-5626; Chetal, Kashish/0000-0001-9314-5759; Muench, David E./0000-0002-8723-3389; Grimes, H. Leighton/0000-0001-8162-6758; Dwivedi, Pankaj/0000-0002-7666-9216; Song, Baobao/0000-0002-0062-2710	National Institutes of Health (NIH) [AR-47363, NIH DK78392, NIH DK90971]; NIH [DP1AI131080, T32 ES007250, S10RR027015, R01HL122661]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Singh for GFI1 antisera, H. C. Morse for supplying Irf8-GFP mice, members of the Cincinnati Children's Hospital Medical Center (CCHMC) DNA sequencing and Genotyping Core and the Research Flow Cytometry Core (supported in part by National Institutes of Health (NIH) grants AR-47363, NIH DK78392 and NIH DK90971), and A. Sproles for assistance with cytokine analyses; S. Smith, H. Chi Liang and K. Rangel in the CCHMC Gene Expression Core for generating scRNA-seq libraries; T. Newkold for technical assistance; and H. Singh, J. Cancelas, S. Kogan, R. Kopan, J. Wells and T. Gruber for questions and discussions. This work was partly funded by support from NIH DP1AI131080 (S.S.W.) T32 ES007250 (to D.E.M.), S10RR027015 (to K.D.G.), and R01HL122661 (H.L.G.).	Abe T, 2013, DEVELOPMENT, V140, P237, DOI 10.1242/dev.084111; Belyaev NN, 2010, NAT IMMUNOL, V11, P477, DOI 10.1038/ni.1869; Bonthuis PJ, 2015, CELL REP, V12, P979, DOI 10.1016/j.celrep.2015.07.017; DePasquale EAK, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz789; Deshmukh HS, 2014, NAT MED, V20, P528, DOI 10.1038/nm.3542; Drissen R, 2016, NAT IMMUNOL, V17, P666, DOI 10.1038/ni.3412; ELSNER J, 1993, EXP HEMATOL, V21, P38; Evrard M, 2018, IMMUNITY, V48, P364, DOI 10.1016/j.immuni.2018.02.002; Fang R, 2019, PREPRINT, DOI [10.1101/615179v2, DOI 10.1101/615179V2]; Farrell JA, 2018, SCIENCE, V360, P979, DOI 10.1126/science.aar3131; Gilbert S.F., 2000, DEV BIOL; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Kim MH, 2017, SCI REP-UK, V7, DOI 10.1038/srep39804; Ng LG, 2019, NAT REV IMMUNOL, V19, P255, DOI 10.1038/s41577-019-0141-8; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; MacNamara KC, 2011, J IMMUNOL, V186, P1032, DOI 10.4049/jimmunol.1001893; MEMPEL K, 1991, BLOOD, V77, P1919; Meyer SE, 2016, CANCER DISCOV, V6, P501, DOI 10.1158/2159-8290.CD-16-0008; Nayak RC, 2015, J CLIN INVEST, V125, P3103, DOI 10.1172/JCI80924; Olsson A, 2016, NATURE, V537, P698, DOI 10.1038/nature19348; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Venkatasubramanian M., 2020, BIOINFORMATICS; Wang HS, 2014, J IMMUNOL, V193, P1766, DOI 10.4049/jimmunol.1301939; Xia J, 2009, BRIT J HAEMATOL, V147, P535, DOI 10.1111/j.1365-2141.2009.07888.x; Yanez A, 2017, IMMUNITY, V47, P890, DOI 10.1016/j.immuni.2017.10.021; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhu YFPP, 2018, CELL REP, V24, P2329, DOI 10.1016/j.celrep.2018.07.097; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	34	45	45	0	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN	2020	582	7810					109	+		10.1038/s41586-020-2227-7	http://dx.doi.org/10.1038/s41586-020-2227-7		APR 2020	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LY1IO	32494068	Green Accepted			2022-12-28	WOS:000528161900003
J	Skov, L; Macia, MC; Sveinbjornsson, G; Mafessoni, F; Lucotte, EA; Einarsdottir, MS; Jonsson, H; Halldorsson, B; Gudbjartsson, DF; Helgason, A; Schierup, MH; Stefansson, K				Skov, Laurits; Coll Macia, Moises; Sveinbjoernsson, Gardar; Mafessoni, Fabrizio; Lucotte, Elise A.; Einarsdottir, Margret S.; Jonsson, Hakon; Halldorsson, Bjarni; Gudbjartsson, Daniel F.; Helgason, Agnar; Schierup, Mikkel Heide; Stefansson, Kari			The nature of Neanderthal introgression revealed by 27,566 Icelandic genomes	NATURE			English	Article							MODERN HUMANS; SEQUENCE; ADMIXTURE; ANCESTRY; LANDSCAPE; HISTORY	Analysis of Icelandic genomes reveals chromosome fragments of Neanderthal and Denisovan origin, the latter of which occurred through Denisovan gene flow either into ancestors of the Neanderthals or directly into humans. Human evolutionary history is rich with the interbreeding of divergent populations. Most humans outside of Africa trace about 2% of their genomes to admixture from Neanderthals, which occurred 50-60 thousand years ago(1). Here we examine the effect of this event using 14.4 million putative archaic chromosome fragments that were detected in fully phased whole-genome sequences from 27,566 Icelanders, corresponding to a range of 56,388-112,709 unique archaic fragments that cover 38.0-48.2% of the callable genome. On the basis of the similarity with known archaic genomes, we assign 84.5% of fragments to an Altai or Vindija Neanderthal origin and 3.3% to Denisovan origin; 12.2% of fragments are of unknown origin. We find that Icelanders have more Denisovan-like fragments than expected through incomplete lineage sorting. This is best explained by Denisovan gene flow, either into ancestors of the introgressing Neanderthals or directly into humans. A within-individual, paired comparison of archaic fragments with syntenic non-archaic fragments revealed that, although the overall rate of mutation was similar in humans and Neanderthals during the 500 thousand years that their lineages were separate, there were differences in the relative frequencies of mutation types-perhaps due to different generation intervals for males and females. Finally, we assessed 271 phenotypes, report 5 associations driven by variants in archaic fragments and show that the majority of previously reported associations are better explained by non-archaic variants.	[Skov, Laurits; Coll Macia, Moises; Lucotte, Elise A.; Schierup, Mikkel Heide] Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark; [Skov, Laurits; Mafessoni, Fabrizio] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Sveinbjoernsson, Gardar; Einarsdottir, Margret S.; Jonsson, Hakon; Halldorsson, Bjarni; Gudbjartsson, Daniel F.; Helgason, Agnar; Stefansson, Kari] Amgen Inc, deCODE Genet, Reykjavik, Iceland; [Halldorsson, Bjarni] Reykjavik Univ, Sch Sci & Engn, Reykjavik, Iceland; [Helgason, Agnar] Univ Iceland, Dept Anthropol, Reykjavik, Iceland; [Stefansson, Kari] Univ Iceland, Fac Med, Sch Hlth Sci, Reykjavik, Iceland	Aarhus University; Max Planck Society; Reykjavik University; University of Iceland; University of Iceland	Skov, L; Schierup, MH (corresponding author), Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark.; Skov, L (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.; Stefansson, K (corresponding author), Amgen Inc, deCODE Genet, Reykjavik, Iceland.; Stefansson, K (corresponding author), Univ Iceland, Fac Med, Sch Hlth Sci, Reykjavik, Iceland.	laurits_skov@eva.mpg.de; mheide@birc.au.dk; kari.stefansson@decode.is	Helgason, Agnar/K-1522-2015; mafessoni, fabrizio/AAD-9425-2022	Lucotte, Elise/0000-0001-8442-2654; Halldorsson, Bjarni/0000-0003-0756-0767; Sveinbjornsson, Gardar/0000-0003-2429-9468; Gudbjartsson, Daniel/0000-0002-5222-9857; Jonsson, Hakon/0000-0001-6197-494X; Helgason, Agnar/0000-0002-8545-3767	Novo Nordisk Foundation [NNF18OC0031004]; Research Council of Independent Research [6108-00385]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Research Council of Independent Research	We thank K. Pruefer, B. Vernot, B. Peter, J. Kelso and S. Paabo for comments on an earlier version of the manuscript. The study was supported by grant NNF18OC0031004 from the Novo Nordisk Foundation and grant 6108-00385 from the Research Council of Independent Research.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Besenbacher S, 2019, NAT ECOL EVOL, V3, P286, DOI 10.1038/s41559-018-0778-x; Browning SR, 2018, CELL, V173, P53, DOI 10.1016/j.cell.2018.02.031; Castellano S, 2014, P NATL ACAD SCI USA, V111, P6666, DOI 10.1073/pnas.1405138111; Dannemann M, 2017, AM J HUM GENET, V101, P578, DOI 10.1016/j.ajhg.2017.09.010; Dannemann M, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1181-7; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Gittelman RM, 2016, CURR BIOL, V26, P3375, DOI 10.1016/j.cub.2016.10.041; Gregory MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06587-0; Hajdinjak M, 2018, NATURE, V555, P652, DOI 10.1038/nature26151; Harris K, 2016, GENETICS, V203, P881, DOI 10.1534/genetics.116.186890; Harris K, 2017, ELIFE, V6, DOI 10.7554/eLife.24284; Jonsson H, 2017, NATURE, V549, P519, DOI 10.1038/nature24018; Juric I, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006340; Kim BY, 2015, AM J HUM GENET, V96, P454, DOI 10.1016/j.ajhg.2014.12.029; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kote-Jarai Z, 2011, HUM GENET, V129, P687, DOI 10.1007/s00439-011-0981-1; McCoy RC, 2017, CELL, V168, P916, DOI 10.1016/j.cell.2017.01.038; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Moorjani P, 2016, P NATL ACAD SCI USA, V113, P10607, DOI 10.1073/pnas.1600374113; Prufer K, 2017, SCIENCE, V358, P655, DOI 10.1126/science.aao1887; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Sankararaman S, 2016, CURR BIOL, V26, P1241, DOI 10.1016/j.cub.2016.03.037; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Schumer M, 2018, SCIENCE, V360, P656, DOI 10.1126/science.aar3684; Simonti CN, 2016, SCIENCE, V351, P737, DOI 10.1126/science.aad2149; Skov L, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007641; Slon V, 2018, NATURE, V561, P113, DOI 10.1038/s41586-018-0455-x; Steinrucken M, 2018, MOL ECOL, V27, P3873, DOI 10.1111/mec.14565; Sveinbjornsson G, 2016, NAT GENET, V48, P314, DOI 10.1038/ng.3507; Vernot B, 2016, SCIENCE, V352, P235, DOI 10.1126/science.aad9416; Vernot B, 2015, AM J HUM GENET, V96, P448, DOI 10.1016/j.ajhg.2015.01.006; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Villanea FA, 2019, NAT ECOL EVOL, V3, P39, DOI 10.1038/s41559-018-0735-8; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213	36	35	35	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2020	582	7810					78	+		10.1038/s41586-020-2225-9	http://dx.doi.org/10.1038/s41586-020-2225-9		APR 2020	14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LY1IO	32494067				2022-12-28	WOS:000528161900002
J	Schweighauser, M; Shi, Y; Tarutani, A; Kametani, F; Murzin, AG; Ghetti, B; Matsubara, T; Tomita, T; Ando, T; Hasegawa, K; Murayama, S; Yoshida, M; Hasegawa, M; Scheres, SHW; Goedert, M				Schweighauser, Manuel; Shi, Yang; Tarutani, Airi; Kametani, Fuyuki; Murzin, Alexey G.; Ghetti, Bernardino; Matsubara, Tomoyasu; Tomita, Taisuke; Ando, Takashi; Hasegawa, Kazuko; Murayama, Shigeo; Yoshida, Mari; Hasegawa, Masato; Scheres, Sjors H. W.; Goedert, Michel			Structures of alpha-synuclein filaments from multiple system atrophy	NATURE			English	Article							GLIAL CYTOPLASMIC INCLUSIONS; PARKINSONS-DISEASE; LEWY BODIES; OLIVOPONTOCEREBELLAR ATROPHY; PATHOGENIC FIBRIL; TAU; AGGREGATION; DEMENTIA; MUTATION; DEGENERATION	Synucleinopathies, which include multiple system atrophy (MSA), Parkinson's disease, Parkinson's disease with dementia and dementia with Lewy bodies (DLB), are human neurodegenerative diseases(1). Existing treatments are at best symptomatic. These diseases are characterized by the presence of, and believed to be caused by the formation of, filamentous inclusions of alpha-synuclein in brain cells(,)(2)(3). However, the structures of alpha-synuclein filaments from the human brain are unknown. Here, using cryo-electron microscopy, we show that alpha-synuclein inclusions from the brains of individuals with MSA are made of two types of filament, each of which consists of two different protofilaments. In each type of filament, non-proteinaceous molecules are present at the interface of the two protofilaments. Using two-dimensional class averaging, we show that alpha-synuclein filaments from the brains of individuals with MSA differ from those of individuals with DLB, which suggests that distinct conformers or strains characterize specific synucleinopathies. As is the case with tau assemblies(4-9), the structures of alpha-synuclein filaments extracted from the brains of individuals with MSA differ from those formed in vitro using recombinant proteins, which has implications for understanding the mechanisms of aggregate propagation and neurodegeneration in the human brain. These findings have diagnostic and potential therapeutic relevance, especially because of the unmet clinical need to be able to image filamentous alpha-synuclein inclusions in the human brain.	[Schweighauser, Manuel; Shi, Yang; Murzin, Alexey G.; Scheres, Sjors H. W.; Goedert, Michel] MRC Lab Mol Biol, Cambridge, England; [Tarutani, Airi; Kametani, Fuyuki; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Brain & Neurosci, Tokyo, Japan; [Tarutani, Airi; Tomita, Taisuke] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Ghetti, Bernardino] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Matsubara, Tomoyasu; Murayama, Shigeo] Tokyo Metropolitan Inst Gerontol, Dept Neuropathol, Tokyo, Japan; [Ando, Takashi] Nagoya Univ, Dept Neurol, Grad Sch Med, Nagoya, Aichi, Japan; [Hasegawa, Kazuko] Sagamihara Natl Hosp, Div Neurol, Sagamihara, Kanagawa, Japan; [Yoshida, Mari] Aichi Med Univ, Inst Med Sci Aging, Nagakute, Aichi, Japan	MRC Laboratory Molecular Biology; Tokyo Metropolitan Institute of Medical Science; University of Tokyo; Indiana University System; Indiana University Bloomington; Tokyo Metropolitan Institute of Gerontology; Nagoya University; Aichi Medical University	Scheres, SHW; Goedert, M (corresponding author), MRC Lab Mol Biol, Cambridge, England.	scheres@mrc-lmb.cam.ac.uk; mg@mrc-lmb.cam.ac.uk	Matsubara, Tomoyasu/AAB-4925-2021; Kametani, Fuyuki/G-4752-2011; Tarutani, Airi/AAU-7462-2021; Scheres, Sjors H.W./AAY-2265-2021; Tomita, Taisuke/L-5427-2015	Matsubara, Tomoyasu/0000-0002-7559-8284; Kametani, Fuyuki/0000-0001-9125-7001; Scheres, Sjors H.W./0000-0002-0462-6540; Ando, Takashi/0000-0001-7045-7098; Tarutani, Airi/0000-0003-3835-9070; Tomita, Taisuke/0000-0002-0075-5943; Shi, Yang/0000-0003-1579-7561; Schweighauser, Manuel/0000-0002-1848-1610	MRC [MC_U105184291, MC_UP_A025_1013, MC_EX_MR/N027892/1] Funding Source: UKRI; Medical Research Council [MC_EX_MR/N027892/1, MC_UP_A025_1013, MC_U105184291] Funding Source: Medline; NIA NIH HHS [P30 AG010133] Funding Source: Medline; NINDS NIH HHS [U01 NS110437] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust)		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Boyer DR, 2020, P NATL ACAD SCI USA, V117, P3592, DOI 10.1073/pnas.1917914117; Boyer DR, 2019, NAT STRUCT MOL BIOL, V26, P1044, DOI 10.1038/s41594-019-0322-y; Campbell BCV, 2001, J NEUROCHEM, V76, P87, DOI 10.1046/j.1471-4159.2001.00021.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dejerine J, 1900, NOUV ICONOG SALPETRI, V13, P330; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Falcon B, 2018, ACTA NEUROPATHOL, V136, P699, DOI 10.1007/s00401-018-1914-z; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Goedert M, 2018, COLD SH Q B, V83, P163, DOI 10.1101/sqb.2018.83.037580; Goedert M, 2017, J PARKINSON DIS, V7, pS53, DOI 10.3233/JPD-179005; GRAHAM JG, 1969, J NEUROL NEUROSUR PS, V32, P28, DOI 10.1136/jnnp.32.1.28; Guerrero-Ferreira R, 2019, ELIFE, V8, DOI 10.7554/eLife.48907; Guerrero-Ferreira R, 2018, ELIFE, V7, DOI 10.7554/eLife.36402; He SD, 2017, J STRUCT BIOL, V198, P163, DOI 10.1016/j.jsb.2017.02.003; Kametani F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23281; KATO S, 1990, ACTA NEUROPATHOL, V79, P584, DOI 10.1007/BF00294235; Kiely AP, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0038-3; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Klingstedt T, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0840-1; Lavenir I, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0804-5; Li B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03169-0; Li HT, 2002, BIOPOLYMERS, V64, P221, DOI 10.1002/bip.10179; Li YW, 2018, CELL RES, V28, P897, DOI 10.1038/s41422-018-0075-x; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Osterberg VR, 2015, CELL REP, V10, P1252, DOI 10.1016/j.celrep.2015.01.060; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Peng C, 2018, NATURE, V557, P558, DOI 10.1038/s41586-018-0104-4; Petrovic IN, 2012, MOVEMENT DISORD, V27, P1184, DOI 10.1002/mds.25115; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; QUINN N, 1989, J NEUROL NEUROSUR PS, P78; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sangwan S, 2020, ELIFE, V9, DOI 10.7554/eLife.46775; Scheres SHW, 2020, ACTA CRYSTALLOGR D, V76, P94, DOI 10.1107/S2059798319016577; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shahnawaz M, 2020, NATURE, V578, P273, DOI 10.1038/s41586-020-1984-7; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Spina S, 2008, BRAIN, V131, P72, DOI 10.1093/brain/awm280; Strohaker T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13564-w; Tarutani A, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0532-2; Tarutani A, 2016, J BIOL CHEM, V291, P18675, DOI 10.1074/jbc.M116.734707; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Yamasaki TR, 2019, J BIOL CHEM, V294, P1045, DOI 10.1074/jbc.RA118.004471; Zhang WJ, 2019, ELIFE, V8, DOI 10.7554/eLife.43584; Zhang WJ, 2020, NATURE, V580, P283, DOI 10.1038/s41586-020-2043-0; Zhao K., PREPRINT, DOI [10.1101/870758V2, DOI 10.1101/870758V2]; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	69	239	239	33	112	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 17	2020	585	7825					464	+		10.1038/s41586-020-2317-6	http://dx.doi.org/10.1038/s41586-020-2317-6			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NZ5TH	32461689	Green Submitted, Green Accepted			2022-12-28	WOS:000577167600001
J	Mello, MM; Persad, G; White, DB				Mello, Michelle M.; Persad, Govind; White, Douglas B.			Respecting Disability Rights - Toward Improved Crisis Standards of Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Disability rights advocates have filed complaints regarding crisis standards of care put forth by several U.S. states. Policymakers and hospitals can take key steps to honor commitments to antidiscrimination principles while appropriately stewarding scarce resources.	[Mello, Michelle M.] Stanford Univ, Sch Med, Stanford Law Sch, Stanford, CA 94305 USA; [Mello, Michelle M.] Stanford Univ, Sch Med, Ctr Hlth Policy, Stanford, CA 94305 USA; [Mello, Michelle M.] Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Dept Med, Stanford, CA 94305 USA; [Persad, Govind] Univ Denver, Sturm Coll Law, Denver, CO USA; [White, Douglas B.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Program Eth & Decis Making Crit Illness, Pittsburgh, PA USA	Stanford University; Stanford University; Stanford University; University of Denver; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mello, MM (corresponding author), Stanford Univ, Sch Med, Stanford Law Sch, Stanford, CA 94305 USA.; Mello, MM (corresponding author), Stanford Univ, Sch Med, Ctr Hlth Policy, Stanford, CA 94305 USA.; Mello, MM (corresponding author), Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Dept Med, Stanford, CA 94305 USA.			Mello, Michelle/0000-0003-2877-4270; Persad, Govind/0000-0002-9436-9209	NHLBI NIH HHS [K24 HL148314] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2011, THER ADV MED ONCOL, V3, pS7; [Anonymous], 2020, COMMUNICATION   0410; [Anonymous], 2020, HIPPA COVID B; Persad G, 2020, YALE LAW J FORUM	4	37	37	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2020	383	5								10.1056/NEJMp2011997	http://dx.doi.org/10.1056/NEJMp2011997			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MW2GI	32427433	Bronze			2022-12-28	WOS:000556861800001
J	Sen, S; Karaca-Mandic, P; Georgiou, A				Sen, Soumya; Karaca-Mandic, Pinar; Georgiou, Archelle			Association of Stay-at-Home Orders With COVID-19 Hospitalizations in 4 States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Sen, Soumya] Univ Minnesota, Carlson Sch Management, Dept Informat & Decis Sci, Minneapolis, MN 55455 USA; [Karaca-Mandic, Pinar] Univ Minnesota, Carlson Sch Management, Dept Finance, Minneapolis, MN 55455 USA; [Georgiou, Archelle] Starkey Hearing Technol, Eden Prairie, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Karaca-Mandic, P (corresponding author), Univ Minnesota, Carlson Sch Management, 321 19th Ave S, Minneapolis, MN 55455 USA.	pkmandic@umn.edu		Georgiou, Archelle/0000-0001-5832-8998	University of Minnesota Office of Academic Clinical Affairs; United Health Foundation	University of Minnesota Office of Academic Clinical Affairs; United Health Foundation	This research uses publicly available data from the University of Minnesota COVID-19 Hospitalization Project, which is partially funded by the University of Minnesota Office of Academic Clinical Affairs and United Health Foundation.	Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Karaca-Mandic P, 2020, HLTH AFFAIRS BLOG, DOI 10.1377/hblog20200406.532030/full/?cookieSet=1; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585	4	45	46	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2522	2524		10.1001/jama.2020.9176	http://dx.doi.org/10.1001/jama.2020.9176			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32459287	Bronze, Green Published			2022-12-28	WOS:000590149400027
J	Wong, PP; Munoz-Felix, JM; Hijazi, M; Kim, H; Robinson, SD; De Luxan-Delgado, B; Rodriguez-Hernandez, I; Maiques, O; Meng, YM; Meng, Q; Bodrug, N; Dukinfield, MS; Reynolds, LE; Elia, G; Clear, A; Harwood, C; Wang, Y; Campbell, JJ; Singh, R; Zhang, PL; Schall, TJ; Matchett, KP; Henderson, NC; Szlosarek, PW; Dreger, SA; Smith, S; Jones, JL; Gribben, JG; Cutillas, PR; Meier, P; Sanz-Moreno, V; Hodivala-Dilke, KM				Wong, Ping-Pui; Munoz-Felix, Jose M.; Hijazi, Maruan; Kim, Hyojin; Robinson, Stephen D.; De Luxan-Delgado, Beatriz; Rodriguez-Hernandez, Irene; Maiques, Oscar; Meng, Ya-Ming; Meng, Qiong; Bodrug, Natalia; Dukinfield, Matthew Scott; Reynolds, Louise E.; Elia, George; Clear, Andrew; Harwood, Catherine; Wang, Yu; Campbell, James J.; Singh, Rajinder; Zhang, Penglie; Schall, Thomas J.; Matchett, Kylie P.; Henderson, Neil C.; Szlosarek, Peter W.; Dreger, Sally A.; Smith, Sally; Jones, J. Louise; Gribben, John G.; Cutillas, Pedro R.; Meier, Pascal; Sanz-Moreno, Victoria; Hodivala-Dilke, Kairbaan M.			Cancer Burden Is Controlled by Mural Cell-beta 3-Integrin Regulated Crosstalk with Tumor Cells	CELL			English	Article							NF-KAPPA-B; INTEGRIN ALPHA(V)BETA(3); ENDOTHELIAL-CELLS; GROWTH; ANGIOGENESIS; PERICYTES; MOTILITY; CILENGITIDE; METASTASIS; INHIBITION	Enhanced blood vessel (BV) formation is thought to drive tumor growth through elevated nutrient delivery. However, this observation has overlooked potential roles for mural cells in directly affecting tumor growth independent of BV function. Here we provide clinical data correlating high percentages of mural-beta 3-integrin-negative tumor BVs with increased tumor sizes but no effect on BV numbers. Mural-beta 3-integrin loss also enhances tumor growth in implanted and autochthonous mouse tumor models with no detectable effects on BV numbers or function. At a molecular level, mural-cell beta 3-integrin loss enhances signaling via FAK-p-HGFR-p-Akt-p-p65, driving CXCL1, CCL2, and TIMP-1 production. In particular, mural-cell-derived CCL2 stimulates tumor cell MEK1-ERK1/2-ROCK2-dependent signaling and enhances tumor cell survival and tumor growth. Overall, our data indicate that mural cells can control tumor growth via paracrine signals regulated by beta 3-integrin, providing a previously unrecognized mechanism of cancer growth control.	[Wong, Ping-Pui; Meng, Ya-Ming; Meng, Qiong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China; [Wong, Ping-Pui; Meng, Ya-Ming; Meng, Qiong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangzhou 510120, Guangdong, Peoples R China; [Wong, Ping-Pui; Munoz-Felix, Jose M.; De Luxan-Delgado, Beatriz; Bodrug, Natalia; Dukinfield, Matthew Scott; Reynolds, Louise E.; Elia, George; Dreger, Sally A.; Smith, Sally; Jones, J. Louise; Hodivala-Dilke, Kairbaan M.] Queen Mary Univ London, John Vane Sci Ctr, Barts Canc Inst, Ctr Tumor Biol, Charterhouse Sq, London EC1M 6BQ, England; [Hijazi, Maruan; Clear, Andrew; Gribben, John G.; Cutillas, Pedro R.] Queen Mary Univ London, John Vane Sci Ctr, Barts Canc Inst, Ctr Haematooncol, Charterhouse Sq, London EC1M 6BQ, England; [Rodriguez-Hernandez, Irene; Maiques, Oscar; Sanz-Moreno, Victoria] Queen Mary Univ London, John Vane Sci Ctr, Barts Canc Inst, Ctr Tumour Microenvironm, Charterhouse Sq, London EC1M 6BQ, England; [Szlosarek, Peter W.] Queen Mary Univ London, John Vane Sci Ctr, Barts Canc Inst, Ctr Mol Oncol, Charterhouse Sq, London EC1M 6BQ, England; [Kim, Hyojin; Meier, Pascal] Chester Beatty Labs, Breast Canc Now Toby Robins Res Ctr, Inst Canc Res, Mary Jean Mitchell Green Bldg,237 Fulham Rd, London SW3 6JB, England; [Robinson, Stephen D.] Quadram Inst Biosci, Gut Microbes & Hlth, Norwich Res Pk, Norwich NR4 7UQ, Norfolk, England; [Robinson, Stephen D.] Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Harwood, Catherine] Queen Mary Univ London, Ctr Cell Biol & Cutaneous Res, Blizard Inst, Barts & London Sch Med & Dent, London E1 2AT, England; [Wang, Yu; Campbell, James J.; Singh, Rajinder; Zhang, Penglie; Schall, Thomas J.] ChemoCentryx Inc, 850 Maude Ave, Mountain View, CA 94043 USA; [Matchett, Kylie P.; Henderson, Neil C.] Univ Edinburgh, Edinburgh BioQuarter, Queens Med Res Inst, Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland	Sun Yat Sen University; Sun Yat Sen University; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of London; Queen Mary University London; University of Edinburgh	Wong, PP (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China.; Wong, PP (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangzhou 510120, Guangdong, Peoples R China.; Wong, PP; Munoz-Felix, JM; Hodivala-Dilke, KM (corresponding author), Queen Mary Univ London, John Vane Sci Ctr, Barts Canc Inst, Ctr Tumor Biol, Charterhouse Sq, London EC1M 6BQ, England.	huangbp3@mail.sysu.edu.cn; j.munoz-felix@qmul.ac.uk; k.hodivala-dilke@qmul.ac.uk	Hijazi Vega, Maruan/AAH-7934-2019; Maiques, Oscar/J-4156-2017	Hijazi Vega, Maruan/0000-0003-0861-7577; Wong, Ping Pui/0000-0003-1592-4823; Maiques, Oscar/0000-0002-2172-4388; Harwood, Catherine/0000-0002-1375-0965; Rodriguez-Hernandez, Irene/0000-0002-6487-452X; Robinson, Stephen/0000-0002-6606-7588; Sanz-Moreno, Victoria/0000-0002-5096-9456; Jones, J Louise/0000-0003-3880-3274	Natural Science Foundation of China [81920108028, 81872142]; Guangzhou Science and Technology Program [201904020008]; Key Training Program for Young Scholars of Sun Yat-Sen University [18ykzd07]; Guangdong Science and Technology Department [2017B030314026]; CRUK [C33043/A24478, C8218/A18673]; Worldwide Cancer Research [16-0390, 19-0108]; British Heart Foundation [FS/14/66/31293]; Wellcome Trust Senior Research Fellowship in Clinical Science [103749]; Breast Cancer; NIHR; Barts Charity; BBSRC [BB/L021684/1] Funding Source: UKRI; MRC [G1000089, MR/M019217/1] Funding Source: UKRI	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science and Technology Program; Key Training Program for Young Scholars of Sun Yat-Sen University; Guangdong Science and Technology Department; CRUK(Cancer Research UK); Worldwide Cancer Research; British Heart Foundation(British Heart Foundation); Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust); Breast Cancer; NIHR(National Institute for Health Research (NIHR)); Barts Charity; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank Barts Cancer Institute members Julie Holdsworth and Bruce Williams for technical assistance, Jane Sosabowski for technical advice regarding microCT imaging, Prof. Ralf Adams (Max Planck Institute for Molecular Biomedicine, Munster, Germany) for providing the pdgfrbcre+ mice, Prof. Katherine Weilbaecher for generating and providing the b3fl/fl mice, Dr. Ste ' phanie Kermorgant for technical advice regarding HGFR inhibitor experiments, and Dr. Ilaria Malanchi and Anna Pedrix for providing shRNA reagents. This work was supported by grants from the Natural Science Foundation of China (81920108028 and 81872142), the Guangzhou Science and Technology Program (201904020008); the Key Training Program for Young Scholars of Sun Yat-Sen University (18ykzd07), the Guangdong Science and Technology Department (2017B030314026), CRUK C8218/A18673, Worldwide Cancer Research (16-0390 and 19-0108), and the British Heart Foundation (FS/14/66/31293). N.C.H. is supported by Wellcome Trust Senior Research Fellowship in Clinical Science 103749. H.K. and P.M. are funded by program grants from Breast Cancer Now as part of program funding to the Breast Cancer Now Toby Robins Research Centre. P.M. acknowledges NIHRfunding to the Royal Marsden Hospital Biomedical Research Centre (BRC). V.S.-M., I.R.-H., and O.M. are supported by CRUK C33043/A24478 and Barts Charity. The authors wish to acknowledge the role of the Breast Cancer Now Tissue Bank in collecting and making available the samples used in the generation of this publication.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Arozarena I, 2011, CANCER CELL, V19, P45, DOI 10.1016/j.ccr.2010.10.029; Batista S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6054; Brantley-Sieders DM, 2011, CANCER RES, V71, P976, DOI 10.1158/0008-5472.CAN-10-3396; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Cao ZW, 2017, CANCER CELL, V31, P110, DOI 10.1016/j.ccell.2016.11.010; Cao ZW, 2014, CANCER CELL, V25, P350, DOI 10.1016/j.ccr.2014.02.005; Caspani EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101402; Cheng J, 2011, J BIOL CHEM, V286, P36076, DOI 10.1074/jbc.M111.259549; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Cooke VG, 2012, CANCER CELL, V21, P66, DOI 10.1016/j.ccr.2011.11.024; Cutillas PR, 2017, METHOD ENZYMOL, V585, P245, DOI 10.1016/bs.mie.2016.09.021; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fang WB, 2012, J BIOL CHEM, V287, P36593, DOI 10.1074/jbc.M112.365999; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Furuhashi M, 2004, CANCER RES, V64, P2725, DOI 10.1158/0008-5472.CAN-03-1489; Garmy-Susini B, 2005, J CLIN INVEST, V115, P1542, DOI 10.1172/JCI23445; Georgouli M, 2019, CELL, V176, P757, DOI 10.1016/j.cell.2018.12.038; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Ghiabi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112424; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Guan JL, 2010, IUBMB LIFE, V62, P268, DOI 10.1002/iub.303; Guerrouahen BS, 2014, MOL CANCER THER, V13, P3123, DOI 10.1158/1535-7163.MCT-13-1053; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Keskin D, 2015, CELL REP, V10, P1066, DOI 10.1016/j.celrep.2015.01.035; LaBarbera KE, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12309; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; Mas-Moruno C, 2010, ANTI-CANCER AGENT ME, V10, P753, DOI 10.2174/187152010794728639; Mason WP, 2015, NEURO-ONCOLOGY, V17, P634, DOI 10.1093/neuonc/nov018; McComb S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad2986; Montoya A, 2011, METHODS, V54, P370, DOI 10.1016/j.ymeth.2011.02.004; Morgan EA, 2010, FASEB J, V24, P1117, DOI 10.1096/fj.09-138420; O'Keeffe MB, 2008, ONCOL RES, V17, P93, DOI 10.3727/096504008785055530; Orgaz JL, 2020, CANCER CELL, V37, P85, DOI 10.1016/j.ccell.2019.12.003; Pedrosa AR, 2015, ONCOTARGET, V6, P24404, DOI 10.18632/oncotarget.4380; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Pietras K, 2002, CANCER RES, V62, P5476; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Poulos MG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13829; Raza A, 2010, AM J HEMATOL, V85, P593, DOI 10.1002/ajh.21745; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Reynolds AR, 2004, CANCER RES, V64, P8643, DOI 10.1158/0008-5472.CAN-04-2760; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Reynolds LE, 2017, J CELL SCI, V130, P1583, DOI 10.1242/jcs.197848; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sennino B, 2007, CANCER RES, V67, P7358, DOI 10.1158/0008-5472.CAN-07-0293; Sinha D, 2016, CLIN CANCER RES, V22, P1813, DOI 10.1158/1078-0432.CCR-15-1931; Steri V, 2014, CIRC RES, V114, P79, DOI 10.1161/CIRCRESAHA.114.301591; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Stupp R, 2007, J CLIN ONCOL, V25, P1637, DOI 10.1200/JCO.2006.09.8376; Tang CH, 2012, BIOCHEM PHARMACOL, V83, P335, DOI 10.1016/j.bcp.2011.11.013; Tavora B, 2014, NATURE, V514, P112, DOI 10.1038/nature13541; Tucci M, 2014, LANCET ONCOL, V15, pE584, DOI 10.1016/S1470-2045(14)70462-0; Usatyuk PV, 2014, J BIOL CHEM, V289, P13476, DOI 10.1074/jbc.M113.527556; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang Z, 2010, BBA-REV CANCER, V1806, P122, DOI 10.1016/j.bbcan.2010.04.003; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Wieland E, 2017, CANCER CELL, V31, P355, DOI 10.1016/j.ccell.2017.01.007; Wilkes EH, 2017, MOL CELL PROTEOMICS, V16, P1694, DOI 10.1074/mcp.O116.064360; Wong PP, 2015, CANCER CELL, V27, P123, DOI 10.1016/j.ccell.2014.10.015; Xian XJ, 2006, J CLIN INVEST, V116, P642, DOI 10.1172/JCI25705; Xing YZ, 2015, FEBS J, V282, P3892, DOI 10.1111/febs.13402; Yonenaga Y, 2005, ONCOLOGY-BASEL, V69, P159, DOI 10.1159/000087840; You WK, 2014, ANGIOGENESIS, V17, P61, DOI 10.1007/s10456-013-9378-1	76	22	23	4	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2020	181	6					1346	+		10.1016/j.cell.2020.02.003	http://dx.doi.org/10.1016/j.cell.2020.02.003			39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LY9TE	32473126	Green Accepted, Bronze			2022-12-28	WOS:000540869600015
J	Naci, H; Kesselheim, AS				Naci, Huseyin; Kesselheim, Aaron S.			Specialty Drugs - A Distinctly American Phenomenon	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Various stakeholders in the pharmaceutical supply chain assign the specialty label to drugs on the basis of a combination of several unrelated factors, including whether a drug treats a rare condition. But the single most common feature of specialty drugs is high cost.	[Naci, Huseyin] London Sch Econ & Polit Sci, Dept Hlth Policy, London, England; [Naci, Huseyin; Kesselheim, Aaron S.] Harvard Med Sch, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA	University of London; London School Economics & Political Science; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Naci, H (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, London, England.; Naci, H (corresponding author), Harvard Med Sch, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA.							Congressional Budget Office, 2019, PRIC SPEND SPEC DR D; Cubanski Juliette., 2019, OUT OF POCKET COST D; Dusetzina SB, 2016, HEALTH AFFAIR, V35, P1241, DOI 10.1377/hlthaff.2015.1657; Hartung DM, 2019, HEALTH AFFAIR, V38, P303, DOI 10.1377/hlthaff.2018.05357	4	6	6	2	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2020	382	23					2179	2181		10.1056/NEJMp1909513	http://dx.doi.org/10.1056/NEJMp1909513			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LV0NI	32492301	Green Published			2022-12-28	WOS:000538140600009
J	Saito, Y; Koya, J; Araki, M; Kogure, Y; Shingaki, S; Tabata, M; McClure, MB; Yoshifuji, K; Matsumoto, S; Isaka, Y; Tanaka, H; Kanai, T; Miyano, S; Shiraishi, Y; Okuno, Y; Kataoka, K				Saito, Yuki; Koya, Junji; Araki, Mitsugu; Kogure, Yasunori; Shingaki, Sumito; Tabata, Mariko; McClure, Marni B.; Yoshifuji, Kota; Matsumoto, Shigeyuki; Isaka, Yuta; Tanaka, Hiroko; Kanai, Takanori; Miyano, Satoru; Shiraishi, Yuichi; Okuno, Yasushi; Kataoka, Keisuke			Landscape and function of multiple mutations within individual oncogenes	NATURE			English	Article							CANCER GENOME; PRECISION MEDICINE; SOMATIC MUTATIONS; CELL; RESISTANCE; DISCOVERY; PROGNOSIS; JAK2	Sporadic reports have described cancer cases in which multiple driver mutations (MMs) occur in the same oncogene(1,2). However, the overall landscape and relevance of MMs remain elusive. Here we carried out a pan-cancer analysis of 60,954 cancer samples, and identified 14 pan-cancer and 6 cancer-type-specific oncogenes in which MMs occur more frequently than expected: 9% of samples with at least one mutation in these genes harboured MMs. In various oncogenes, MMs are preferentially present in cis and show markedly different mutational patterns compared with single mutations in terms of type (missense mutations versus in-frame indels), position and amino-acid substitution, suggesting a cis-acting effect on mutational selection. MMs show an overrepresentation of functionally weak, infrequent mutations, which confer enhanced oncogenicity in combination. Cells with MMs in the PIK3CA and NOTCH1 genes exhibit stronger dependencies on the mutated genes themselves, enhanced downstream signalling activation and/or greater sensitivity to inhibitory drugs than those with single mutations. Together oncogenic MMs are a relatively common driver event, providing the underlying mechanism for clonal selection of suboptimal mutations that are individually rare but collectively account for a substantial proportion of oncogenic mutations.	[Saito, Yuki; Koya, Junji; Kogure, Yasunori; Shingaki, Sumito; Tabata, Mariko; McClure, Marni B.; Yoshifuji, Kota; Kataoka, Keisuke] Natl Canc Ctr, Div Mol Oncol, Tokyo, Japan; [Saito, Yuki; Kanai, Takanori] Keio Univ, Dept Gastroenterol, Sch Med, Tokyo, Japan; [Araki, Mitsugu; Okuno, Yasushi] Kyoto Univ, Grad Sch Med, Dept Clin Syst Oncoinformat, Kyoto, Japan; [Tabata, Mariko] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan; [Yoshifuji, Kota] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Tokyo, Japan; [Matsumoto, Shigeyuki] RIKEN, Med Sci Innovat Hub Program, Cluster Sci Technol & Innovat Hub, Yokohama, Kanagawa, Japan; [Isaka, Yuta] Fdn Biomed Res & Innovat, Ctr Cluster Dev & Coordinat, Res & Dev Grp Silico Drug Discovery, Kobe, Hyogo, Japan; [Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Human Genome Ctr, Inst Med Sci, Lab Sequence Anal, Tokyo, Japan; [Shiraishi, Yuichi] Natl Canc Ctr, Ctr Canc Genom & Adv Therapeut, Tokyo, Japan	National Cancer Center - Japan; Keio University; Kyoto University; University of Tokyo; Tokyo Medical & Dental University (TMDU); RIKEN; Institute for Biomedical Research & Innovation (IBRI); University of Tokyo; National Cancer Center - Japan	Kataoka, K (corresponding author), Natl Canc Ctr, Div Mol Oncol, Tokyo, Japan.	kkataoka-tky@umin.ac.jp	Kataoka, Keisuke/AAS-2546-2020; Kogure, Yasunori/AFP-1112-2022; Kogure, Yasunori/AAM-8386-2020	Kataoka, Keisuke/0000-0002-8263-9902; Kogure, Yasunori/0000-0003-1158-5131; Koya, Junji/0000-0002-0605-1226; Araki, Mitsugu/0000-0002-7810-4905; Saito, Yuki/0000-0003-2686-9604; McClure, Marni/0000-0002-0807-4368	Japan Society for the Promotion of Science (JSPS) KAKENHI [17K19592,18K06594, 15H05912]; National Cancer Center Research and Development Funds [30-A-1]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Cancer Center Research and Development Funds	We acknowledge support from the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant numbers 17K19592,18K06594 and 15H05912) and National Cancer Center Research and Development Funds (30-A-1), together with many other funding bodies, organizations and individuals (see Supplementary Note).	Andre F, 2017, CANCER DISCOV, V7, P818, DOI 10.1158/2159-8290.CD-17-0151; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Bielski CM, 2018, CANCER CELL, V34, P852, DOI 10.1016/j.ccell.2018.10.003; Buisson R, 2019, SCIENCE, V364, P1251, DOI 10.1126/science.aaw2872; Campbell BB, 2017, CELL, V171, P1042, DOI 10.1016/j.cell.2017.09.048; Chakravarty Debyani, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00011; Chang MT, 2018, CANCER DISCOV, V8, P174, DOI 10.1158/2159-8290.CD-17-0321; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Chapuy B, 2018, NAT MED, V24, P679, DOI 10.1038/s41591-018-0016-8; Ding L, 2018, CELL, V173, P305, DOI 10.1016/j.cell.2018.03.033; Dogruluk T, 2015, CANCER RES, V75, P5341, DOI 10.1158/0008-5472.CAN-15-1654; Forero-Castro M, 2017, BRIT J CANCER, V117, P256, DOI 10.1038/bjc.2017.152; Gao JJ, 2017, GENOME MED, V9, DOI 10.1186/s13073-016-0393-x; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Gkeka P, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003895; Griffith M, 2017, NAT GENET, V49, P170, DOI 10.1038/ng.3774; Gu ZH, 2019, NAT GENET, V51, P296, DOI 10.1038/s41588-018-0315-5; Hartmaier RJ, 2017, CANCER RES, V77, P2464, DOI 10.1158/0008-5472.CAN-16-2479; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Huang LD, 2017, J AM MED INFORM ASSN, V24, P513, DOI 10.1093/jamia/ocw148; Kataoka K, 2015, NAT GENET, V47, P1304, DOI 10.1038/ng.3415; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kohsaka S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan6566; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li JF, 2018, P NATL ACAD SCI USA, V115, pE11711, DOI 10.1073/pnas.1814397115; Ma XT, 2018, NATURE, V555, P371, DOI 10.1038/nature25795; Madsen RR, 2019, P NATL ACAD SCI USA, V116, P8380, DOI 10.1073/pnas.1821093116; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Ng PKS, 2018, CANCER CELL, V33, P450, DOI 10.1016/j.ccell.2018.01.021; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Puente XS, 2015, NATURE, V526, P519, DOI 10.1038/nature14666; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Soh J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007464; Steeghs EMP, 2017, ONCOTARGET, V8, P89923, DOI 10.18632/oncotarget.21027; Tamborero D, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0531-8; Tokheim C, 2019, CELL SYST, V9, P9, DOI 10.1016/j.cels.2019.05.005; Tokheim C, 2016, CANCER RES, V76, P3719, DOI 10.1158/0008-5472.CAN-15-3190; Tyner JW, 2018, NATURE, V562, P526, DOI 10.1038/s41586-018-0623-z; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Zhang MZ, 2019, CHEM SCI, V10, P3671, DOI 10.1039/c8sc04498h	45	46	47	4	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2020	582	7810					95	+		10.1038/s41586-020-2175-2	http://dx.doi.org/10.1038/s41586-020-2175-2			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE2YU	32494066				2022-12-28	WOS:000562464400001
J	Lee, JY; Rabbani, CC; Gao, HY; Steinhart, MR; Woodruff, BM; Pflum, ZE; Kim, A; Heller, S; Liu, YL; Shipchandler, TZ; Koehler, KR				Lee, Jiyoon; Rabbani, Cyrus C.; Gao, Hongyu; Steinhart, Matthew R.; Woodruff, Benjamin M.; Pflum, Zachary E.; Kim, Alexander; Heller, Stefan; Liu, Yunlong; Shipchandler, Taha Z.; Koehler, Karl R.			Hair-bearing human skin generated entirely from pluripotent stem cells	NATURE			English	Article							MERKEL CELLS; ARCHITECTURE; INDUCTION; DIVERSITY; ORGANOIDS; NICHE; FATE	Skin organoids generated in vitro from human pluripotent stem cells form complex, multilayered skin tissue with hair follicles, sebaceous glands and neural circuitry, and integrate with endogenous skin when grafted onto immunocompromised mice. The skin is a multilayered organ, equipped with appendages (that is, follicles and glands), that is critical for regulating body temperature and the retention of bodily fluids, guarding against external stresses and mediating the sensation of touch and pain(1,2). Reconstructing appendage-bearing skin in cultures and in bioengineered grafts is a biomedical challenge that has yet to be met(3-9). Here we report an organoid culture system that generates complex skin from human pluripotent stem cells. We use stepwise modulation of the transforming growth factor beta (TGF beta) and fibroblast growth factor (FGF) signalling pathways to co-induce cranial epithelial cells and neural crest cells within a spherical cell aggregate. During an incubation period of 4-5 months, we observe the emergence of a cyst-like skin organoid composed of stratified epidermis, fat-rich dermis and pigmented hair follicles that are equipped with sebaceous glands. A network of sensory neurons and Schwann cells form nerve-like bundles that target Merkel cells in organoid hair follicles, mimicking the neural circuitry associated with human touch. Single-cell RNA sequencing and direct comparison to fetal specimens suggest that the skin organoids are equivalent to the facial skin of human fetuses in the second trimester of development. Moreover, we show that skin organoids form planar hair-bearing skin when grafted onto nude mice. Together, our results demonstrate that nearly complete skin can self-assemble in vitro and be used to reconstitute skin in vivo. We anticipate that our skin organoids will provide a foundation for future studies of human skin development, disease modelling and reconstructive surgery.	[Lee, Jiyoon; Koehler, Karl R.] Boston Childrens Hosp, Dept Otolaryngol, Boston, MA 02115 USA; [Lee, Jiyoon; Steinhart, Matthew R.; Koehler, Karl R.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Lee, Jiyoon; Koehler, Karl R.] Harvard Med Sch, Dept Otolaryngol Head & Neck Surg, Boston, MA 02115 USA; [Rabbani, Cyrus C.; Steinhart, Matthew R.; Pflum, Zachary E.; Kim, Alexander; Shipchandler, Taha Z.; Koehler, Karl R.] Indiana Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46202 USA; [Rabbani, Cyrus C.] Johns Hopkins Univ, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA; [Gao, Hongyu; Liu, Yunlong] Indiana Univ Sch Med, Ctr Med Genom, Indianapolis, IN 46202 USA; [Steinhart, Matthew R.] Indiana Univ Sch Med, Med Neurosci Grad Program, Indianapolis, IN 46202 USA; [Woodruff, Benjamin M.; Heller, Stefan] Stanford Univ, Dept Otolaryngol, Palo Alto, CA 94304 USA; [Koehler, Karl R.] Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA 02115 USA; [Koehler, Karl R.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Koehler, Karl R.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Indiana University System; Indiana University Bloomington; Johns Hopkins University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Stanford University; Harvard University; Boston Children's Hospital; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Koehler, KR (corresponding author), Boston Childrens Hosp, Dept Otolaryngol, Boston, MA 02115 USA.; Koehler, KR (corresponding author), Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.; Koehler, KR (corresponding author), Harvard Med Sch, Dept Otolaryngol Head & Neck Surg, Boston, MA 02115 USA.; Koehler, KR (corresponding author), Indiana Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46202 USA.; Koehler, KR (corresponding author), Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA 02115 USA.; Koehler, KR (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.; Koehler, KR (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA.	karl.koehler@childrens.harvard.edu		Woodruff, Benjamin/0000-0003-3045-4196; Koehler, Karl/0000-0002-0685-538X; Steinhart, Matthew/0000-0002-9619-6057; Lee, Jiyoon/0000-0002-5561-5331	Ralph W. and Grace M. Showalter Trust; Indiana Clinical and Translational Sciences Institute [UL1 TR001108]; Indiana Center for Biomedical Innovation (Technology Enhancement Grant); NIH [R01AR075018, R01DC017461, R03DC015624, C06 RR020128-01]; NIH from the Eunice Kennedy Shriver National Institute of Child Health and Human Development [5R24HD000836]	Ralph W. and Grace M. Showalter Trust; Indiana Clinical and Translational Sciences Institute; Indiana Center for Biomedical Innovation (Technology Enhancement Grant); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from the Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Ralph W. and Grace M. Showalter Trust (K.R.K.), the Indiana Clinical and Translational Sciences Institute (core pilot grant UL1 TR001108 to K.R.K. and A. Shekhar), the Indiana Center for Biomedical Innovation (Technology Enhancement Grant to K.R.K.) and the NIH (grants R01AR075018, R01DC017461 and R03DC015624 to K.R.K.). Cell lines associated with this study were stored in a facility constructed with support from the NIH (grant C06 RR020128-01). The University of Washington Birth Defects Research Laboratory was supported by NIH award number 5R24HD000836 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. We thank B. Koh, W. van der Valk, D. O'Day, I. Glass, A. Tward, S. Frumm, D. Spandau, J. Foley, U. Arimpur, E. Longworth-Mills, P.-C. Tang, A. Elghouche, M. Kamocka and C. Miller for their technical assistance, and M. Rendl and N. Saxena for critical comments on the manuscript.	Abaci HE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07579-y; Betters E, 2010, DEV BIOL, V344, P578, DOI 10.1016/j.ydbio.2010.05.012; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chuong CM, 2013, WIRES DEV BIOL, V2, P97, DOI 10.1002/wdev.74; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Gatto G, 2019, CURR OPIN NEUROBIOL, V56, P167, DOI 10.1016/j.conb.2019.03.002; Gledhill K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136713; Hama H, 2015, NAT NEUROSCI, V18, P1518, DOI 10.1038/nn.4107; Heitman N, 2018, CURR OPIN CELL BIOL, V55, P87, DOI 10.1016/j.ceb.2018.06.012; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Itoh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077673; Jenkins BA, 2017, DEVELOPMENT, V144, P4078, DOI 10.1242/dev.120402; Joost S, 2016, CELL SYST, V3, P221, DOI 10.1016/j.cels.2016.08.010; Koehler KR, 2017, NAT BIOTECHNOL, V35, P583, DOI 10.1038/nbt.3840; Koehler KR, 2013, NATURE, V500, P217, DOI 10.1038/nature12298; Lanctot C, 1999, DEVELOPMENT, V126, P1805; Langbein L, 2010, J INVEST DERMATOL, V130, P55, DOI 10.1038/jid.2009.192; Lee J., 2020, RES SQUARE, DOI [10.21203/rs.3.pex-889/v1, DOI 10.21203/RS.3.PEX-889/V1]; Lee J, 2018, CELL REP, V22, P242, DOI 10.1016/j.celrep.2017.12.007; Lee RTH, 2013, DEVELOPMENT, V140, P4890, DOI 10.1242/dev.094680; Lei MX, 2017, P NATL ACAD SCI USA, V114, pE7101, DOI 10.1073/pnas.1700475114; Lim XH, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008029; Minoux M, 2013, DEVELOPMENT, V140, P4386, DOI 10.1242/dev.098046; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; NARISAWA Y, 1993, ARCH DERMATOL RES, V285, P261, DOI 10.1007/BF00371594; Perdigoto CN, 2014, DEVELOPMENT, V141, P4690, DOI 10.1242/dev.112169; Pijuan-Sala B, 2019, NATURE, V566, P490, DOI 10.1038/s41586-019-0933-9; Richardson GD, 2009, DEVELOPMENT, V136, P2153, DOI 10.1242/dev.031427; Roberts B, 2017, MOL BIOL CELL, V28, P2854, DOI 10.1091/mbc.E17-03-0209; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Sennett R, 2015, DEV CELL, V34, P577, DOI 10.1016/j.devcel.2015.06.023; Soldatov R, 2019, SCIENCE, V364, P971, DOI 10.1126/science.aas9536; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sun BK, 2014, SCIENCE, V346, P941, DOI 10.1126/science.1253836; Tchieu J, 2017, CELL STEM CELL, V21, P399, DOI 10.1016/j.stem.2017.08.015; Toyoshima K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1784; Velasco S, 2019, NATURE, V570, P523, DOI 10.1038/s41586-019-1289-x; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Yang Ruifeng, 2014, Nat Commun, V5, P3071, DOI 10.1038/ncomms4071; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zhu XJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004687	42	123	131	25	158	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 18	2020	582	7812					399	+		10.1038/s41586-020-2352-3	http://dx.doi.org/10.1038/s41586-020-2352-3		JUN 2020	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QP4IP	32494013	Green Accepted, Green Submitted			2022-12-28	WOS:000537932200001
J	Bruckner, JM				Bruckner, Julia Michie			Securing the Sails	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this narrative medicine essay, a pediatrician confronts an impending neurofibromatosis type 1 diagnosis in her infant son and finds heroic parents of her patients who have profound medical challenges.	[Bruckner, Julia Michie] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Bruckner, JM (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Colorado Childrens Hosp,Sect Emergency Med, 13001 E 17th Pl, Aurora, CO 80045 USA.	julia.bruckner@cuanschutz.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2020	323	21					2143	2144		10.1001/jama.2020.7164	http://dx.doi.org/10.1001/jama.2020.7164			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LY8YS	32484537				2022-12-28	WOS:000540816000016
J	Voelker, R				Voelker, Rebecca			Hemodialysis Device for Very Small Pediatric Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2020	323	21					2122	2122		10.1001/jama.2020.8778	http://dx.doi.org/10.1001/jama.2020.8778			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LY8YS	32484524				2022-12-28	WOS:000540816000006
J	[Anonymous]				[Anonymous]			Fact and Opinion on the Present Epidemic of Respiratory Disease (Reprinted from JAMA, vol 71, pg 2074-2075, 1918)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		[Anonymous], 1918, JAMA-J AM MED ASSOC, P1408; 1918, JAMA, V71, P2074	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2020	323	21					2207	2207		10.1001/jama.2020.6391	http://dx.doi.org/10.1001/jama.2020.6391			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LY8YS	32484526				2022-12-28	WOS:000540816000030
J	Viglione, G				Viglione, Giuliana			HOW CONFERENCES WILL SURVIVE THE CORONAVIRUS SHOCK	NATURE			English	News Item																			0	22	24	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN	2020	582	7811					166	167		10.1038/d41586-020-01521-3	http://dx.doi.org/10.1038/d41586-020-01521-3			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LW3IT	32488188	Bronze			2022-12-28	WOS:000539039000004
J	Proulx, C				Proulx, Caroline			Catching up to nature's ribosomes	SCIENCE			English	Editorial Material									[Proulx, Caroline] North Carolina State Univ, Dept Chem, Box 8204, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Proulx, C (corresponding author), North Carolina State Univ, Dept Chem, Box 8204, Raleigh, NC 27695 USA.	cproulx@ncsu.edu			North Carolina State University	North Carolina State University	The author gratefully acknowledges North Carolina State University for startup support.	Agouridas V, 2019, CHEM REV, V119, P7328, DOI 10.1021/acs.chemrev.8b00712; Behrendt R, 2016, J PEPT SCI, V22, P4, DOI 10.1002/psc.2836; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Hartrampf N, 2020, SCIENCE, V368, P980, DOI 10.1126/science.abb2491; Kent SBH, 2009, CHEM SOC REV, V38, P338, DOI 10.1039/b700141j; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Mijalis AJ, 2017, NAT CHEM BIOL, V13, P464, DOI [10.1038/NCHEMBIO.2318, 10.1038/nchembio.2318]; Wang L, 2005, ANGEW CHEM INT EDIT, V44, P34, DOI 10.1002/anie.200460627	8	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					941	941		10.1126/science.abb9711	http://dx.doi.org/10.1126/science.abb9711			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LV3IK	32467378				2022-12-28	WOS:000538332600025
J	Dyer, C				Dyer, Clare			Maternity unit under investigation for baby deaths was often operating without senior doctor	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1445	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2020	369								m2156	10.1136/bmj.m2156	http://dx.doi.org/10.1136/bmj.m2156			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JZ	32467134				2022-12-28	WOS:000538337300014
J	Hadian, K; Stockwell, BR				Hadian, Kamyar; Stockwell, Brent R.			SnapShot: Ferroptosis	CELL			English	Editorial Material									[Hadian, Kamyar] Helmholtz Zentrum Munchen, Assay Dev & Screening Platform, Neuherberg, Germany; [Stockwell, Brent R.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, New York, NY 10027 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Columbia University; Columbia University	Hadian, K (corresponding author), Helmholtz Zentrum Munchen, Assay Dev & Screening Platform, Neuherberg, Germany.		Hadian, Kamyar/B-6314-2013; Stockwell, Brent R/AAE-7200-2019	Hadian, Kamyar/0000-0001-8727-2575; Stockwell, Brent R/0000-0002-3532-3868	NCI [P01CA87497, R35CA209896]; NINDS [R61NS109407]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	B.R.S. is supported by NCI grants P01CA87497 and R35CA209896 and NINDS grant R61NS109407.	Bersuker K, 2019, NATURE, V575, P688, DOI 10.1038/s41586-019-1705-2; Brown CW, 2019, DEV CELL, V51, P575, DOI 10.1016/j.devcel.2019.10.007; Doll S, 2019, NATURE, V575, P693, DOI 10.1038/s41586-019-1707-0; Kraft VAN, 2020, ACS CENTRAL SCI, V6, P41, DOI 10.1021/acscentsci.9b01063; Lee H, 2020, NAT CELL BIOL, V22, DOI 10.1038/s41556-020-0461-8; Lei G, 2020, CELL RES, V30, P146, DOI 10.1038/s41422-019-0263-3; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Venkatesh D, 2020, GENE DEV, V34, P526, DOI 10.1101/gad.334219.119; Ye LF, 2020, ACS CHEM BIOL, V15, P469, DOI 10.1021/acschembio.9b00939; Zou YL, 2020, NAT CHEM BIOL, V16, P302, DOI 10.1038/s41589-020-0472-6	10	82	86	14	99	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2020	181	5					1188	U472		10.1016/j.cell.2020.04.039	http://dx.doi.org/10.1016/j.cell.2020.04.039			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LT9QF	32470402	Green Accepted, Bronze			2022-12-28	WOS:000537399500021
J	Sheppard, JP; Burt, J; Lown, M; Temple, E; Lowe, R; Fraser, R; Allen, J; Ford, GA; Heneghan, C; Hobbs, FDR; Jowett, S; Kodabuckus, S; Little, P; Mant, J; Mollison, J; Payne, RA; Williams, M; Yu, LM; McManus, RJ				Sheppard, James P.; Burt, Jenni; Lown, Mark; Temple, Eleanor; Lowe, Rebecca; Fraser, Rosalyn; Allen, Julie; Ford, Gary A.; Heneghan, Carl; Hobbs, F. D. Richard; Jowett, Sue; Kodabuckus, Shahela; Little, Paul; Mant, Jonathan; Mollison, Jill; Payne, Rupert A.; Williams, Marney; Yu, Ly-Mee; McManus, Richard J.		OPTIMISE Investigators	Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older The OPTIMISE Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMERICAN-COLLEGE; MANAGEMENT; ADULTS; DISCONTINUATION; WITHDRAWAL; GUIDELINE	IMPORTANCE Deprescribing of antihypertensive medications is recommended for some older patients with polypharmacy and multimorbidity when the benefits of continued treatment may not outweigh the harms. OBJECTIVE This study aimed to establish whether antihypertensive medication reduction is possible without significant changes in systolic blood pressure control or adverse events during 12-week follow-up. DESIGN, SETTING, AND PARTICIPANTS The Optimising Treatment for Mild Systolic Hypertension in the Elderly (OPTIMISE) study was a randomized, unblinded, noninferiority trial conducted in 69 primary care sites in England. Participants, whose primary care physician considered them appropriate for medication reduction, were aged 80 years and older, had systolic blood pressure lower than 150 mm Hg, and were receiving at least 2 antihypertensive medications were included. Participants enrolled between April 2017 and September 2018 and underwent follow-up until January 2019. INTERVENTIONS Participants were randomized (1:1 ratio) to a strategy of antihypertensive medication reduction (removal of 1 drug [intervention], n = 282) or usual care (control, n = 287), in which no medication changes were mandated. MAIN OUTCOMES AND MEASURES The primary outcome was systolic blood pressure lower than 150 mm Hg at 12-week follow-up. The prespecified noninferiority margin was a relative risk (RR) of 0.90. Secondary outcomes included the proportion of participants maintaining medication reduction and differences in blood pressure, frailty, quality of life, adverse effects, and serious adverse events. RESULTS Among 569 patients randomized (mean age, 84.8 years; 276 [48.5%] women; median of 2 antihypertensive medications prescribed at baseline), 534 (93.8%) completed the trial. Overall, 229 (86.4%) patients in the intervention group and 236 (87.7%) patients in the control group had a systolic blood pressure lower than 150 mm Hg at 12 weeks (adjusted RR, 0.98 [97.5% 1-sided CI, 0.92 to infinity]). Of 7 prespecified secondary end points, 5 showed no significant difference. Medication reduction was sustained in 187 (66.3%) participants at 12 weeks. Mean change in systolic blood pressure was 3.4 mm Hg (95% CI, 1.1 to 5.8 mm Hg) higher in the intervention group compared with the control group. Twelve (4.3%) participants in the intervention group and 7 (2.4%) in the control group reported at least 1 serious adverse event (adjusted RR, 1.72 [95% CI, 0.7 to 4.3]). CONCLUSIONS AND RELEVANCE Among older patients treated with multiple antihypertensive medications, a strategy of medication reduction, compared with usual care, was noninferior with regard to systolic blood pressure control at 12 weeks. The findings suggest antihypertensive medication reduction in some older patients with hypertension is not associated with substantial change in blood pressure control, although further research is needed to understand long-term clinical outcomes.	[Sheppard, James P.; Temple, Eleanor; Lowe, Rebecca; Fraser, Rosalyn; Allen, Julie; Heneghan, Carl; Hobbs, F. D. Richard; Mollison, Jill; Yu, Ly-Mee; McManus, Richard J.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Burt, Jenni] Univ Cambridge, Healthcare Improvement Studies Inst, Cambridge, England; [Lown, Mark] Univ Southampton, Primary Care Res Grp, Southampton, Hants, England; [Ford, Gary A.] Oxford Univ Hosp NHS Fdn Trust, Radcliffe Dept Med, Oxford, England; [Jowett, Sue; Kodabuckus, Shahela] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Little, Paul] Univ Southampton, Primary Care Populat Sci & Med Educ Unit, Southampton, Hants, England; [Mant, Jonathan] Univ Cambridge, Primary Care Unit, Dept Publ Hlth & Primary Care, Cambridge, England; [Payne, Rupert A.] Univ Bristol, Ctr Acad Primary Care Populat Hlth Sci, Bristol, Avon, England	University of Oxford; University of Cambridge; University of Southampton; Oxford University Hospitals NHS Foundation Trust; University of Birmingham; University of Southampton; University of Cambridge; University of Bristol	Sheppard, JP (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, Radcliffe Primary Care Bldg, Oxford OX2 6GG, England.	james.sheppard@phc.ox.ac.uk	Ford, Gary/AAY-6405-2020; Jowett, Sue/AAO-4198-2021; Sheppard, James/AAR-6793-2021; Burt, Jenni/L-2951-2013	Ford, Gary/0000-0001-8719-4968; Jowett, Sue/0000-0001-8936-3745; Sheppard, James/0000-0002-4461-8756; Mant, Jonathan/0000-0002-9531-0268; Yu, Ly-Mee/0000-0003-0331-7364; Little, Paul/0000-0003-3664-1873; Burt, Jenni/0000-0002-0037-274X; Mollison, Jill/0000-0002-5539-5615; Lown, Mark/0000-0001-8309-568X	NIHR CLAHRC at Oxford Health NHS Foundation Trust [P2-501]; NIHR School for Primary Care Research [335]; NIHR professorship [NIHR-RP-R2-12-015]; Wellcome Trust/Royal Society via a Sir Henry Dale Fellowship [211182/Z/18/Z]; NIHR Oxford Biomedical Research Centre; NIHR; NIHR School for Primary Care Research; NIHR CLAHRC Oxford	NIHR CLAHRC at Oxford Health NHS Foundation Trust; NIHR School for Primary Care Research; NIHR professorship; Wellcome Trust/Royal Society via a Sir Henry Dale Fellowship; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); NIHR School for Primary Care Research; NIHR CLAHRC Oxford	This work received joint funding from NIHR CLAHRC at Oxford Health NHS Foundation Trust (P2-501) and the NIHR School for Primary Care Research (335). Drs Sheppard and McManus were funded by an NIHR professorship (NIHR-RP-R2-12-015). Dr Sheppard reports receipt of funding from the Wellcome Trust/Royal Society via a Sir Henry Dale Fellowship (211182/Z/18/Z) and an NIHR Oxford Biomedical Research Centre senior fellowship. Drs McManus, Heneghan, and Ford are supported by NIHR senior investigator awards. Dr Heneghan reports receipt of support from the NIHR School for Primary Care Research and NIHR Oxford Biomedical Research Centre. Dr Hobbs reports receipt of partial support from NIHR School for Primary Care Research, NIHR CLAHRC Oxford, and the NIHR Oxford Biomedical Research Centre. Dr Payne reports receipt of funding from NIHR for polypharmacy and medicines optimization research.	[Anonymous], 1986, Br Med J (Clin Res Ed), V293, P988; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Benetos A, 2016, HYPERTENSION, V67, P820, DOI 10.1161/HYPERTENSIONAHA.115.07020; Benetos A, 2015, JAMA INTERN MED, V175, P989, DOI 10.1001/jamainternmed.2014.8012; Bress AP, 2016, J AM COLL CARDIOL, V67, P463, DOI 10.1016/j.jacc.2015.10.037; Clegg A, 2016, AGE AGEING, V45, P353, DOI 10.1093/ageing/afw039; Dennis M, 2012, STROKE, V43, P851, DOI 10.1161/STROKEAHA.111.639708; FREIS ED, 1989, AM J CARDIOL, V63, P702, DOI 10.1016/0002-9149(89)90255-5; Gulla C, 2018, J GERIATR CARDIOL, V15, P275, DOI 10.11909/j.issn.1671-5411.2018.04.011; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Joint Comission, SPEC MAN JOINT COMM; Kostis JB, 1998, AM J CARDIOL, V82, P1501, DOI 10.1016/S0002-9149(98)00694-8; Krishnaswami A, 2019, J AM COLL CARDIOL, V73, P2584, DOI 10.1016/j.jacc.2019.03.467; Lahrmann H, 2006, EUR J NEUROL, V13, P930, DOI 10.1111/j.1468-1331.2006.01512.x; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luymes CH, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0988-0; Mansfield KE, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012690; Mattu GS, 2004, BLOOD PRESS MONIT, V9, P47, DOI 10.1097/00126097-200402000-00009; Moonen JEF, 2015, JAMA INTERN MED, V175, P1622, DOI 10.1001/jamainternmed.2015.4103; Morley JE, 2012, J NUTR HEALTH AGING, V16, P601, DOI 10.1007/s12603-012-0084-2; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; National Institute for Health and Care Excellence, 2019, HYPERTENSION ADULTS; National Institute for Health and Care Excellence, 2016, MULT ASS PRIOR MAN C, V56; Office for National Statistics, MEAS EQ GUID COLL CL; Palagyi A, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0181-x; Qaseem A, 2017, ANN INTERN MED, V166, P430, DOI 10.7326/M16-1785; Schuling J, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-56; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Sheppard JP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4535; Sheppard JP, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022930; Sieg-Dobrescu D, 2001, J HYPERTENS, V19, P1387, DOI 10.1097/00004872-200108000-00006; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Tinetti ME, 2014, JAMA INTERN MED, V174, P588, DOI 10.1001/jamainternmed.2013.14764; van der Wardt V, 2017, J HYPERTENS, V35, P1742, DOI 10.1097/HJH.0000000000001405; van Deudekom FJ, 2017, PLOS ONE, V12, DOI [10.1371/.journal.pone.0174053, 10.1371/journal.pone.0174053]; van Hout B, 2012, VALUE HEALTH, V15, P708, DOI 10.1016/j.jval.2012.02.008; Violan C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-530; Whelton PK, 2018, J AM COLL CARDIOL, V71, pE127, DOI 10.1016/j.jacc.2017.11.006; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050	41	50	51	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					2039	2051		10.1001/jama.2020.4871	http://dx.doi.org/10.1001/jama.2020.4871			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LU8UM	32453368	Green Published, Bronze			2022-12-28	WOS:000538023900035
J	Slomski, A				Slomski, Anita			Psoriasis Drug Guselkumab Improved Psoriatic Arthritis Symptoms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					1999	1999		10.1001/jama.2020.7970	http://dx.doi.org/10.1001/jama.2020.7970			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OC4XG	32453367				2022-12-28	WOS:000579160500005
J	Burki, T				Burki, Talha			England and Wales see 20 000 excess deaths in care homes	LANCET			English	Editorial Material																			0	50	51	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2020	395	10237					1602	1602						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LZ1JO	32446403	Bronze, Green Published			2022-12-28	WOS:000540986100015
J	Li, F; Eriksen, J; Finer-Moore, J; Chang, R; Nguyen, P; Bowen, A; Myasnikov, A; Yu, ZL; Bulkley, D; Cheng, YF; Edwards, RH; Stroud, RM				Li, Fei; Eriksen, Jacob; Finer-Moore, Janet; Chang, Roger; Phuong Nguyen; Bowen, Alisa; Myasnikov, Alexander; Yu, Zanlin; Bulkley, David; Cheng, Yifan; Edwards, Robert H.; Stroud, Robert M.			Ion transport and regulation in a synaptic vesicle glutamate transporter	SCIENCE			English	Article							BEAM-INDUCED MOTION; CRYO-EM; BAYESIAN-APPROACH; EXPRESSION; CHLORIDE; VGLUT1; ANION; MECHANISM; LEAKAGE	Synaptic vesicles accumulate neurotransmitters, enabling the quantal release by exocytosis that underlies synaptic transmission. Specific neurotransmitter transporters are responsible for this activity and therefore are essential for brain function. The vesicular glutamate transporters (VGLUTs) concentrate the principal excitatory neurotransmitter glutamate into synaptic vesicles, driven by membrane potential. However, the mechanism by which they do so remains poorly understood owing to a lack of structural information. We report the cryo-electron microscopy structure of rat VGLUT2 at 3.8-angstrom resolution and propose structure-based mechanisms for substrate recognition and allosteric activation by low pH and chloride. A potential permeation pathway for chloride intersects with the glutamate binding site. These results demonstrate how the activity of VGLUTs can be coordinated with large shifts in proton and chloride concentrations during the synaptic vesicle cycle to ensure normal synaptic transmission.	[Li, Fei; Finer-Moore, Janet; Phuong Nguyen; Bowen, Alisa; Myasnikov, Alexander; Yu, Zanlin; Bulkley, David; Cheng, Yifan; Stroud, Robert M.] Univ Calif San Francisco, Sch Med, Dept Biochem & Biophys, San Francisco, CA 94117 USA; [Li, Fei; Eriksen, Jacob; Chang, Roger; Edwards, Robert H.] UCSF Sch Med, Dept Neurol, San Francisco, CA 94117 USA; [Li, Fei; Eriksen, Jacob; Chang, Roger; Edwards, Robert H.] UCSF Sch Med, Dept Physiol, San Francisco, CA 94117 USA; [Chang, Roger] UCSF, Grad Program Biomed Sci, San Francisco, CA USA; [Cheng, Yifan] UCSF, Howard Hughes Med Inst, San Francisco, CA USA; [Chang, Roger] Univ Washington, Sch Med, Dept Neurol, Seattle, WA USA; [Myasnikov, Alexander] St Jude Childrens Res Hosp, Cryoelect Microscopy & Tomog Ctr, 332 N Lauderdale St, Memphis, TN 38105 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; St Jude Children's Research Hospital	Stroud, RM (corresponding author), Univ Calif San Francisco, Sch Med, Dept Biochem & Biophys, San Francisco, CA 94117 USA.; Edwards, RH (corresponding author), UCSF Sch Med, Dept Neurol, San Francisco, CA 94117 USA.; Edwards, RH (corresponding author), UCSF Sch Med, Dept Physiol, San Francisco, CA 94117 USA.	robert.edwards@ucsf.edu; stroud@msg.ucsf.edu		Bowen, Alisa/0000-0002-8518-6697; Li, Fei/0000-0003-0720-3129; Myasnikov, Alexander/0000-0003-2607-7121; Yu, Zanlin/0000-0001-8381-8788; Bulkley, David/0000-0002-2535-904X; Eriksen, Jacob/0000-0003-0726-9769; Cheng, Yifan/0000-0001-9535-0369	American Heart Association [17POST33660928]; National Institute of Mental Health [K99MH119591]; NIH [S10OD020054, S10OD021741];  [R01NS089713];  [R37MH50712]	American Heart Association(American Heart Association); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; 	This work is supported by R01NS089713 to R.M.S. and R.H.E. and R37MH50712 to R.H.E. F.L. is supported by postdoctoral fellowships from the American Heart Association (17POST33660928) and the National Institute of Mental Health (K99MH119591). The UCSF Electron Microscopy (EM) facility is supported by NIH grants S10OD020054 and S10OD021741. Y.C. is a Howard Hughes Medical Institute Investigator.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Carugo O, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/s12900-014-0019-8; Chang R, 2018, ELIFE, V7, DOI 10.7554/eLife.34896; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eriksen J, 2016, NEURON, V90, P768, DOI 10.1016/j.neuron.2016.03.026; Fremeau Jr R. T., 2001, NEURON, V31, P247; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Goh GY, 2011, NAT NEUROSCI, V14, P1285, DOI 10.1038/nn.2898; HARTINGER J, 1993, J BIOL CHEM, V268, P23122; Hiasa M, 2014, CURR PHARM DESIGN, V20, P2745, DOI 10.2174/13816128113199990574; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; Kashani A, 2007, NEUROBIOL AGING, V28, P568, DOI 10.1016/j.neurobiolaging.2006.02.010; KATZ B, 1971, SCIENCE, V173, P123, DOI 10.1126/science.173.3992.123; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Leano JB, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000260; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; LLC. Schrodinger, PYMOL MOL GRAPH SYST; Mackenzie B, 2008, NEUROCHEM RES, V33, P238, DOI 10.1007/s11064-007-9546-z; Martineau M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01752-5; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; Morin P, 2004, EMBO J, V23, P4560, DOI 10.1038/sj.emboj.7600464; NAITO S, 1985, J NEUROCHEM, V44, P99, DOI 10.1111/j.1471-4159.1985.tb07118.x; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Oni-Orisan A, 2008, BIOL PSYCHIAT, V63, P766, DOI 10.1016/j.biopsych.2007.10.020; Paulino C, 2017, NATURE, V552, P421, DOI 10.1038/nature24652; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pravda L, 2018, NUCLEIC ACIDS RES, V46, pW368, DOI 10.1093/nar/gky309; Preobraschenski J, 2014, NEURON, V84, P1287, DOI 10.1016/j.neuron.2014.11.008; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Reimer RJ, 2013, MOL ASPECTS MED, V34, P350, DOI 10.1016/j.mam.2012.05.004; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Schenck S, 2009, NAT NEUROSCI, V12, P156, DOI 10.1038/nn.2248; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schorb M, 2019, NAT METHODS, V16, P471, DOI 10.1038/s41592-019-0396-9; TABB JS, 1992, J BIOL CHEM, V267, P15412; Takami C, 2017, J PHYSIOL-LONDON, V595, P1263, DOI 10.1113/JP273467; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Wolosker H, 1996, J BIOL CHEM, V271, P11726, DOI 10.1074/jbc.271.20.11726; Wreden CC, 2005, J BIOL CHEM, V280, P1408, DOI 10.1074/jbc.M411295200; Yan N, 2015, ANNU REV BIOPHYS, V44, P257, DOI 10.1146/annurev-biophys-060414-033901; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X	48	28	29	7	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					893	+		10.1126/science.aba9202	http://dx.doi.org/10.1126/science.aba9202			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU2DD	32439795	Green Accepted			2022-12-28	WOS:000537569500048
J	Wulff, BBH; Jones, JDG				Wulff, Brande B. H.; Jones, Jonathan D. G.			Breeding a fungal gene into wheat	SCIENCE			English	Editorial Material									[Wulff, Brande B. H.] John Innes Ctr, Norwich Res Pk, Norwich, Norfolk, England; [Jones, Jonathan D. G.] Univ East Anglia, Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	Wulff, BBH (corresponding author), John Innes Ctr, Norwich Res Pk, Norwich, Norfolk, England.	brande.wulff@jic.ac.uk; jonathan.jones@tsl.ac.uk	Wulff, Brande BH/C-7465-2013; Jones, Jonathan DG/J-5129-2012	Wulff, Brande BH/0000-0003-4044-4346; Jones, Jonathan DG/0000-0002-4953-261X	Biotechnology and Biological Sciences Research Council; 2Blades Foundation; Gatsby Foundation; BBSRC [BBS/E/J/000PR9798] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); 2Blades Foundation; Gatsby Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are supported by the Biotechnology and Biological Sciences Research Council (B.B.H.W. and J.D.G.J.), the 2Blades Foundation (B.B.H.W. and J.D.G.J.), and the Gatsby Foundation (J.D.G.J).We thank G. Brar for helpful discussions.	Arora S, 2019, NAT BIOTECHNOL, V37, P139, DOI 10.1038/s41587-018-0007-9; Bai GH, 2002, MYCOPATHOLOGIA, V153, P91, DOI 10.1023/A:1014419323550; Buerstmayr M, 2020, PLANT BREEDING, V139, P429, DOI 10.1111/pbr.12797; Chevalier P, 2020, SCIENCE, V368, DOI 10.1126/science.abc5418; GALLAGHER RT, 1981, NEW ZEAL VET J, V29, P189, DOI 10.1080/00480169.1981.34843; Kyndt T, 2015, P NATL ACAD SCI USA, V112, P5844, DOI 10.1073/pnas.1419685112; Lagudah ES, 2019, NAT GENET, V51, P1070, DOI 10.1038/s41588-019-0454-3; Savary S, 2019, NAT ECOL EVOL, V3, P430, DOI 10.1038/s41559-018-0793-y; Wulff BBH, 2018, SCIENCE, V361, P451, DOI 10.1126/science.aat5119; Yoshida S, 2010, SCIENCE, V328, P1128, DOI 10.1126/science.1187145	10	4	4	4	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					822	823		10.1126/science.abb9991	http://dx.doi.org/10.1126/science.abb9991			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU2DD	32439778	Green Accepted			2022-12-28	WOS:000537569500024
J	Sui, XW; Wang, K; Gluchowski, NL; Elliott, SD; Liao, MF; Walther, TC; Farese, RV				Sui Xuewu; Wang Kun; Gluchowski, Nina L.; Elliott, Shane D.; Liao Maofu; Walther, Tobias C.; Farese, Robert V., Jr.			Structure and catalytic mechanism of a human triacylglycerol-synthesis enzyme	NATURE			English	Article							COA-DIACYLGLYCEROL ACYLTRANSFERASE; DGAT1; PURIFICATION; SEQUENCE; CLONING; FAMILY; ER	Triacylglycerols store metabolic energy in organisms and have industrial uses as foods and fuels. Excessive accumulation of triacylglycerols in humans causes obesity and is associated with metabolic diseases(1). Triacylglycerol synthesis is catalysed by acyl-CoA diacylglycerol acyltransferase (DGAT) enzymes(2-4), the structures and catalytic mechanisms of which remain unknown. Here we determined the structure of dimeric human DGAT1, a member of the membrane-bound O-acyltransferase (MBOAT) family, by cryo-electron microscopy at approximately 3.0 angstrom resolution. DGAT1 forms a homodimer through N-terminal segments and a hydrophobic interface, with putative active sites within the membrane region. A structure obtained with oleoyl-CoA substrate resolved at approximately 3.2 angstrom shows that the CoA moiety binds DGAT1 on the cytosolic side and the acyl group lies deep within a hydrophobic channel, positioning the acyl-CoA thioester bond near an invariant catalytic histidine residue. The reaction centre is located inside a large cavity, which opens laterally to the membrane bilayer, providing lipid access to the active site. A lipid-like density-possibly representing an acyl-acceptor molecule-is located within the reaction centre, orthogonal to acyl-CoA. Insights provided by the DGAT1 structures, together with mutagenesis and functional studies, provide the basis for a model of the catalysis of triacylglycerol synthesis by DGAT. Cryo-electron microscopy structures and functional and mutagenesis studies provide insights into the catalysis of triacylglycerol synthesis by human acyl-CoA diacylglycerol acyltransferase at its intramembrane active site.	[Sui Xuewu; Wang Kun; Gluchowski, Nina L.; Elliott, Shane D.; Walther, Tobias C.; Farese, Robert V., Jr.] Harvard TH Chan Sch Publ Hlth, Dept Mol Metab, Boston, MA 02115 USA; [Sui Xuewu; Wang Kun; Gluchowski, Nina L.; Elliott, Shane D.; Liao Maofu; Walther, Tobias C.; Farese, Robert V., Jr.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Gluchowski, Nina L.] Boston Childrens Hosp, Dept Gastroenterol Hepatol & Nutr, Boston, MA USA; [Walther, Tobias C.; Farese, Robert V., Jr.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Walther, Tobias C.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute	Walther, TC; Farese, RV (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Mol Metab, Boston, MA 02115 USA.; Liao, MF; Walther, TC; Farese, RV (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.; Walther, TC; Farese, RV (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Walther, TC (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	maofu_liao@hms.harvard.edu; twalther@hsph.harvard.edu; robert@hsph.harvard.edu	Liao, Maofu/AAD-7333-2021	Liao, Maofu/0000-0002-3481-450X	National Institutes of Health [R01GM124348, R01GM097194]; American Heart Association [18POST34030308]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	We thank Z. Li, S. Sterling, R. Walsh and S. Rawson at the Harvard cryo-EM centre and C. Xu, K. Song and K. Lee at the University of Massachusetts cryo-EM facility for electron microscopy data collection; members of the Liao and Farese and Walther laboratories for helpful discussions; B. Schulman and T. Rapoport for comments on the manuscript; and G. Howard for editorial assistance. This work was supported by National Institutes of Health grants R01GM124348 (to R.V.F.), and R01GM097194 (to T.C.W.). X.S. was supported by the American Heart Association postdoctoral fellowship 18POST34030308. T.C.W. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Booth DS, 2011, JOVE-J VIS EXP, DOI 10.3791/3227; Caldo KMP, 2017, PLANT PHYSIOL, V175, P667, DOI 10.1104/pp.17.00934; Caldo KMP, 2015, FEBS LETT, V589, P773, DOI 10.1016/j.febslet.2015.02.008; Campana MB, 2019, J BIOL CHEM, V294, P14166, DOI 10.1074/jbc.AC119.009749; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng D, 2001, BIOCHEM J, V359, P707, DOI 10.1042/0264-6021:3590707; Chitraju C, 2019, J LIPID RES, V60, P1112, DOI 10.1194/jlr.M093112; Chitraju C, 2017, CELL METAB, V26, P407, DOI 10.1016/j.cmet.2017.07.012; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gluchowski NL, 2017, J LIPID RES, V58, P1230, DOI 10.1194/jlr.P075119; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; Haas JT, 2012, J CLIN INVEST, V122, P4680, DOI 10.1172/JCI64873; He SW, 2014, ACS MED CHEM LETT, V5, P1082, DOI 10.1021/ml5003426; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Liao MF, 2014, CURR OPIN STRUC BIOL, V27, P1, DOI 10.1016/j.sbi.2014.02.005; Ma D, 2018, NATURE, V562, P286, DOI 10.1038/s41586-018-0568-2; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Panigrahi R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34339-1; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rottig A, 2013, MICROBIOL MOL BIOL R, V77, P277, DOI 10.1128/MMBR.00010-13; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Ru H, 2015, CELL, V163, P1138, DOI 10.1016/j.cell.2015.10.055; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walther TC, 2017, ANNU REV CELL DEV BI, V33, P491, DOI 10.1146/annurev-cellbio-100616-060608; WEISS SB, 1960, J BIOL CHEM, V235, P40; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	45	29	29	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY	2020	581	7808					323	+		10.1038/s41586-020-2289-6	http://dx.doi.org/10.1038/s41586-020-2289-6		MAY 2020	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ2CZ	32433611	Green Accepted			2022-12-28	WOS:000532688300002
J	Zhang, RP; Zhao, ST; Ding, J; Chong, Y; Jia, T; Ophus, C; Asta, M; Ritchie, RO; Minor, AM				Zhang, Ruopeng; Zhao, Shiteng; Ding, Jun; Chong, Yan; Jia, Tao; Ophus, Colin; Asta, Mark; Ritchie, Robert O.; Minor, Andrew M.			Short-range order and its impact on the CrCoNi medium-entropy alloy	NATURE			English	Article							STACKING-FAULT ENERGIES; MECHANICAL-PROPERTIES; PLANAR SLIP; ORIGIN; DISLOCATIONS; EXPLORATION; CONTRAST; BEHAVIOR	Traditional metallic alloys are mixtures of elements in which the atoms of minority species tend to be distributed randomly if they are below their solubility limit, or to form secondary phases if they are above it. The concept of multiple-principal-element alloys has recently expanded this view, as these materials are single-phase solid solutions of generally equiatomic mixtures of metallic elements. This group of materials has received much interest owing to their enhanced mechanical properties(1-5). They are usually called medium-entropy alloys in ternary systems and high-entropy alloys in quaternary or quinary systems, alluding to their high degree of configurational entropy. However, the question has remained as to how random these solid solutions actually are, with the influence of short-range order being suggested in computational simulations but not seen experimentally(6,7). Here we report the observation, using energy-filtered transmission electron microscopy, of structural features attributable to short-range order in the CrCoNi medium-entropy alloy. Increasing amounts of such order give rise to both higher stacking-fault energy and hardness. These findings suggest that the degree of local ordering at the nanometre scale can be tailored through thermomechanical processing, providing a new avenue for tuning the mechanical properties of medium- and high-entropy alloys. Metal alloys consisting of three or more major elemental components show enhanced mechanical properties, which are now shown to be correlated with short-range order observed with electron microscopy.	[Zhang, Ruopeng; Zhao, Shiteng; Chong, Yan; Asta, Mark; Ritchie, Robert O.; Minor, Andrew M.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Zhang, Ruopeng; Zhao, Shiteng; Chong, Yan; Ophus, Colin; Minor, Andrew M.] Lawrence Berkeley Natl Lab, Natl Ctr Electron Microscopy, Mol Foundry, Berkeley, CA 94720 USA; [Ding, Jun; Asta, Mark; Ritchie, Robert O.] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA USA; [Jia, Tao] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Stanford University	Minor, AM (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.; Minor, AM (corresponding author), Lawrence Berkeley Natl Lab, Natl Ctr Electron Microscopy, Mol Foundry, Berkeley, CA 94720 USA.	aminor@lbl.gov	Zhao, Shiteng/AAP-2946-2021; Ding, Jun/K-1989-2012; Zhao, Shiteng/AAQ-5126-2020	Zhao, Shiteng/0000-0003-4828-9651; Ding, Jun/0000-0002-4091-8663; Zhang, Ruopeng/0000-0001-7677-4051; Minor, Andrew/0000-0003-3606-8309; Asta, Mark/0000-0002-8968-321X; Ophus, Colin/0000-0003-2348-8558				Anderson P. M., 2017, THEORY DISLOCATIONS, V3rd; Britton TB, 2015, P ROY SOC A-MATH PHY, V471, DOI 10.1098/rspa.2014.0881; Cantor B, 2004, MAT SCI ENG A-STRUCT, V375, P213, DOI 10.1016/j.msea.2003.10.257; COCKAYNE DJ, 1969, PHILOS MAG, V20, P1265, DOI 10.1080/14786436908228210; Cockayne DJH, 1974, J PHYS C, V35, pC7; Ding J, 2018, P NATL ACAD SCI USA, V115, P8919, DOI 10.1073/pnas.1808660115; FISHER JC, 1954, ACTA METALL MATER, V2, P9, DOI 10.1016/0001-6160(54)90087-5; Fultz B., 2008, TRANSMISSION ELECT M, Vthird; Gao M.C., 2016, HIGH ENTROPY ALLOYS; George EP, 2019, NAT REV MATER, V4, P515, DOI 10.1038/s41578-019-0121-4; GEROLD V, 1989, ACTA METALL MATER, V37, P2177, DOI 10.1016/0001-6160(89)90143-0; Gludovatz B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10602; Gludovatz B, 2014, SCIENCE, V345, P1153, DOI 10.1126/science.1254581; Gouldstone A, 2007, ACTA MATER, V55, P4015, DOI 10.1016/j.actamat.2006.08.044; Hamdi F, 2010, SCRIPTA MATER, V62, P693, DOI 10.1016/j.scriptamat.2010.01.031; Laplanche G, 2018, J ALLOY COMPD, V746, P244, DOI 10.1016/j.jallcom.2018.02.251; Laplanche G, 2017, ACTA MATER, V128, P292, DOI 10.1016/j.actamat.2017.02.036; Li QJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11464-7; Li ZZ, 2019, PROG MATER SCI, V102, P296, DOI 10.1016/j.pmatsci.2018.12.003; Li ZM, 2016, NATURE, V534, P227, DOI 10.1038/nature17981; Linden Y, 2017, SCRIPTA MATER, V139, P49, DOI 10.1016/j.scriptamat.2017.06.015; Lucas MS, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4730327; Ma Y, 2018, SCRIPTA MATER, V144, P64, DOI 10.1016/j.scriptamat.2017.09.049; Miracle DB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09700-1; Miracle DB, 2014, ENTROPY-SWITZ, V16, P494, DOI 10.3390/e16010494; Neeraj T, 2001, MAT SCI ENG A-STRUCT, V319, P415, DOI 10.1016/S0921-5093(01)01045-0; Niu C, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4918996; Niu CN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03846-0; Okamoto NL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35863; Ophus C, 2016, ULTRAMICROSCOPY, V162, P1, DOI 10.1016/j.ultramic.2015.12.002; Pekin TC, 2018, SCRIPTA MATER, V146, P87, DOI 10.1016/j.scriptamat.2017.11.005; Phillips PJ, 2012, ULTRAMICROSCOPY, V116, P47, DOI 10.1016/j.ultramic.2012.03.013; Phillips PJ, 2011, ULTRAMICROSCOPY, V111, P1483, DOI 10.1016/j.ultramic.2011.07.001; Pierce DT, 2014, ACTA MATER, V68, P238, DOI 10.1016/j.actamat.2014.01.001; Senkov ON, 2018, J MATER RES, V33, P3092, DOI 10.1557/jmr.2018.153; Singh P, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.224204; Smith TM, 2016, ACTA MATER, V110, P352, DOI 10.1016/j.actamat.2016.03.045; Tamm A, 2015, ACTA MATER, V99, P307, DOI 10.1016/j.actamat.2015.08.015; Van de Walle A, 2002, METALL MATER TRANS A, V33, P735; Van Tendeloo G, 1998, PHASE TRANSIT, V67, P101, DOI 10.1080/01411599808219190; Williams JC, 2003, ACTA MATER, V51, P5775, DOI 10.1016/j.actamat.2003.08.023; Yang T, 2018, SCIENCE, V362, P933, DOI 10.1126/science.aas8815; Yeh JW, 2004, ADV ENG MATER, V6, P299, DOI 10.1002/adem.200300567; Zaddach AJ, 2013, JOM-US, V65, P1780, DOI 10.1007/s11837-013-0771-4; Zhang FX, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.205501; Zhang RP, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax2799; Zhang YH, 2017, SCRIPTA MATER, V130, P96, DOI 10.1016/j.scriptamat.2016.11.014; Zhang Y, 2014, PROG MATER SCI, V61, P1, DOI 10.1016/j.pmatsci.2013.10.001; Zhang ZJ, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms14390, 10.1038/ncomms14560]; Zhao SJ, 2017, ACTA MATER, V134, P334, DOI 10.1016/j.actamat.2017.05.001	50	317	323	116	689	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY	2020	581	7808					283	+		10.1038/s41586-020-2275-z	http://dx.doi.org/10.1038/s41586-020-2275-z			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ2CZ	32433617	Green Submitted			2022-12-28	WOS:000534818200011
J	Arzi, A; Rozenkrantz, L; Gorodisky, L; Rozenkrantz, D; Holtzman, Y; Ravia, A; Bekinschtein, TA; Galperin, T; Krimchansky, B; Cohen, G; Oksamitni, A; Aidinoff, E; Sacher, Y; Sobel, N				Arzi, Anat; Rozenkrantz, Liron; Gorodisky, Lior; Rozenkrantz, Danit; Holtzman, Yael; Ravia, Aharon; Bekinschtein, Tristan A.; Galperin, Tatyana; Krimchansky, Ben-Zion; Cohen, Gal; Oksamitni, Anna; Aidinoff, Elena; Sacher, Yaron; Sobel, Noam			Olfactory sniffing signals consciousness in unresponsive patients with brain injuries	NATURE			English	Article							DISORDERS; COMMUNICATION; STIMULATION; DIAGNOSIS; PATTERNS; STATES	After severe brain injury, it can be difficult to determine the state of consciousness of a patient, to determine whether the patient is unresponsive or perhaps minimally conscious(1), and to predict whether they will recover. These diagnoses and prognoses are crucial, as they determine therapeutic strategies such as pain management, and can underlie end-of-life decisions(2,3). Nevertheless, there is an error rate of up to 40% in determining the state of consciousness in patients with brain injuries(4,5). Olfaction relies on brain structures that are involved in the basic mechanisms of arousal(6), and we therefore hypothesized that it may serve as a biomarker for consciousness(7). Here we use a non-verbal non-task-dependent measure known as the sniff response(8-11) to determine consciousness in patients with brain injuries. By measuring odorant-dependent sniffing, we gain a sensitive measure of olfactory function(10-15). We measured the sniff response repeatedly over time in patients with severe brain injuries and found that sniff responses significantly discriminated between unresponsive and minimally conscious states at the group level. Notably, at the single-patient level, if an unresponsive patient had a sniff response, this assured future regaining of consciousness. In addition, olfactory sniff responses were associated with long-term survival rates. These results highlight the importance of olfaction in human brain function, and provide an accessible tool that signals consciousness and recovery in patients with brain injuries. Odorant-dependent sniff responses predicted the long-term survival rates of patients with severe brain injury, and discriminated between individuals who were unresponsive and in minimally conscious states.	[Arzi, Anat; Bekinschtein, Tristan A.] Univ Cambridge, Dept Psychol, Cambridge, England; [Arzi, Anat; Rozenkrantz, Liron; Gorodisky, Lior; Holtzman, Yael; Ravia, Aharon; Sobel, Noam] Weizmann Inst Sci, Azrieli Ctr Human Brain Imaging & Res, Rehovot, Israel; [Arzi, Anat; Rozenkrantz, Liron; Gorodisky, Lior; Holtzman, Yael; Ravia, Aharon; Sobel, Noam] Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel; [Rozenkrantz, Danit; Galperin, Tatyana; Krimchansky, Ben-Zion; Cohen, Gal; Oksamitni, Anna; Aidinoff, Elena; Sacher, Yaron] Loewenstein Hosp Rehabil Ctr, Raanana, Israel; [Sacher, Yaron] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	University of Cambridge; Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine	Arzi, A (corresponding author), Univ Cambridge, Dept Psychol, Cambridge, England.; Arzi, A; Sobel, N (corresponding author), Weizmann Inst Sci, Azrieli Ctr Human Brain Imaging & Res, Rehovot, Israel.; Arzi, A; Sobel, N (corresponding author), Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel.	anat.arzi@gmail.com; noam.sobel@weizmann.ac.il		Rozenkrantz, Liron/0000-0002-6496-4592; Arzi, Anat/0000-0003-1005-1752; Ravia, Aharon/0000-0003-2183-9254	Rob and Cheryl McEwen Fund for Brain Research; Blavatnik Family Foundation; Royal Society - Kohn International fellowship [NF150851]; European Molecular Biology Organization (EMBO) fellowship [ALTF 33-2016]	Rob and Cheryl McEwen Fund for Brain Research; Blavatnik Family Foundation; Royal Society - Kohn International fellowship(Royal Society of London); European Molecular Biology Organization (EMBO) fellowship(European Molecular Biology Organization (EMBO))	We thank the patients, their families and their caregivers for their cooperation; and O. Perl, L. Rosler and A. Elite for discussions. Work in the Sobel laboratory is supported by the Rob and Cheryl McEwen Fund for Brain Research. A.A. is supported by the Blavatnik Family Foundation, a Royal Society - Kohn International fellowship (NF150851) and an European Molecular Biology Organization (EMBO) fellowship (ALTF 33-2016).	Aidinoff E, 2018, BRAIN INJURY, V32, P297, DOI 10.1080/02699052.2017.1418535; Arzi A, 2014, J NEUROSCI, V34, P15382, DOI 10.1523/JNEUROSCI.2291-14.2014; Arzi A, 2014, CURR BIOL, V24, pR263, DOI 10.1016/j.cub.2014.02.004; Arzi A, 2012, NAT NEUROSCI, V15, P1460, DOI 10.1038/nn.3193; Arzi A, 2010, CHEM SENSES, V35, P31, DOI 10.1093/chemse/bjp079; Bareham CA, 2019, BRAIN COMMUN, V1, DOI 10.1093/braincomms/fcz017; Bareham CA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00676; Bekinschtein TA, 2009, NAT NEUROSCI, V12, P1343, DOI 10.1038/nn.2391; Borer-Alafi N, 2002, BRAIN INJURY, V16, P593, DOI 10.1080/02699050110119484; Charland-Verville V, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01020; CLIFF N, 1993, PSYCHOL BULL, V114, P494, DOI 10.1037/0033-2909.114.3.494; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Engemann DA, 2018, BRAIN, V141, P3179, DOI 10.1093/brain/awy251; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Forgacs PB, 2014, ANN NEUROL, V76, P869, DOI 10.1002/ana.24283; Frank RA, 2003, PHYSIOL BEHAV, V78, P195, DOI 10.1016/S0031-9384(02)00965-4; Giacino J. T., 2004, COMA RECOVERY SCALER; Giacino JT, 2018, NEUROLOGY, V91, P461, DOI 10.1212/WNL.0000000000005928; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Haviv L, 2017, IEEE T NEUR SYS REH, V25, P1461, DOI 10.1109/TNSRE.2016.2632754; Johnson BN, 2003, J NEUROPHYSIOL, V90, P1084, DOI 10.1152/jn.00115.2003; Johnson BN, 2006, CHEM SENSES, V31, P795, DOI 10.1093/chemse/bjl021; Keller A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00380; Kim Hae-Young, 2017, Restor Dent Endod, V42, P152, DOI 10.5395/rde.2017.42.2.152; Kondziella D, 2016, J NEUROL NEUROSUR PS, V87, P485, DOI 10.1136/jnnp-2015-310958; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Merrick C, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01011; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Napolitani M, 2014, BRAIN INJURY, V28, P1180, DOI 10.3109/02699052.2014.920524; Nigri A, 2016, EUR J NEUROL, V23, P605, DOI 10.1111/ene.12907; Noirhomme Q, 2017, NEUROIMAGE, V145, P288, DOI 10.1016/j.neuroimage.2015.12.006; Owen A., 2017, GRAY ZONE NEUROSCIEN; Plotkin A, 2010, P NATL ACAD SCI USA, V107, P14413, DOI 10.1073/pnas.1006746107; Price J.L., 1990, HUMAN NERVOUS SYSTEM; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; Reden J, 2016, EUR ARCH OTO-RHINO-L, V273, P927, DOI 10.1007/s00405-015-3682-x; Rojas-Libano D, 2012, J NEUROSCI, V32, P15577, DOI 10.1523/JNEUROSCI.1464-12.2012; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; Rozenkrantz L, 2015, CURR BIOL, V25, P1904, DOI 10.1016/j.cub.2015.05.048; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Sela L, 2010, EXP BRAIN RES, V205, P13, DOI 10.1007/s00221-010-2348-6; Sobel N, 2001, P NATL ACAD SCI USA, V98, P4154, DOI 10.1073/pnas.071061598; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Stevenson RJ, 2009, CONSCIOUS COGN, V18, P1004, DOI 10.1016/j.concog.2009.09.005; Thibaut A, 2019, LANCET NEUROL, V18, P600, DOI 10.1016/S1474-4422(19)30031-6; Wachowiak M, 2011, NEURON, V71, P962, DOI 10.1016/j.neuron.2011.08.030; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962	52	16	17	1	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 28	2020	581	7809					428	+		10.1038/s41586-020-2245-5	http://dx.doi.org/10.1038/s41586-020-2245-5		APR 2020	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX9ZL	32461641	Green Published			2022-12-28	WOS:000529600400004
J	Hernandez, AV; Roman, YM; Pasupuleti, V; Barboza, JJ; White, CM				Hernandez, Adrian V.; Roman, Yuani M.; Pasupuleti, Vinay; Barboza, Joshuan J.; White, C. Michael			Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19 A Living Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review								Background: Hydroxychloroquine and chloroquine have antiviral effects in vitro against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Purpose: To summarize evidence about the benefits and harms of hydroxychloroquine or chloroquine for the treatment or prophylaxis of coronavirus disease 2019 (COVID-19). Data Sources: PubMed (via MEDLINE), EMBASE (via Ovid), Scopus, Web of Science, Cochrane Library, bioRxiv, Preprints, ClinicalTrials.gov, World Health Organization International Clinical Trials Registry Platform, and the Chinese Clinical Trials Registry from 1 December 2019 until 8 May 2020. Study Selection: Studies in any language reporting efficacy or safety outcomes from hydroxychloroquine or chloroquine use in any setting in adults or children with suspected COVID-19 or at risk for SARS-CoV-2 infection. Data Extraction: Independent, dually performed data extraction and quality assessments. Data Synthesis: Four randomized controlled trials, 10 cohort studies, and 9 case series assessed treatment effects of the medications, but no studies evaluated prophylaxis. Evidence was conflicting and insufficient regarding the effect of hydroxychloroquine on such outcomes as all-cause mortality, progression to severe disease, clinical symptoms, and upper respiratory viro- logic clearance with antigen testing. Several studies found that patients receiving hydroxychloroquine developed a QTc interval of 500 ms or greater, but the proportion of patients with this finding varied among the studies. Two studies assessed the efficacy of chloroquine; 1 trial, which compared higher-dose (600 mg twice daily for 10 days) with lower-dose (450 mg twice daily on day 1 and once daily for 4 days) therapy, was stopped owing to concern that the higher dose therapy increased lethality and QTc interval prolongation. An observational study that compared adults with COVID-19 receiving chloroquine phosphate, 500 mg once or twice daily, with patients not receiving chloroquine found minor fever resolution and virologic clearance benefits with chloroquine. Limitation: There were few controlled studies, and control for confounding was inadequate in observational studies. Conclusion: Evidence on the benefits and harms of using hydroxychloroquine or chloroquine to treat COVID-19 is very weak and conflicting.	[Hernandez, Adrian V.; Roman, Yuani M.; White, C. Michael] Univ Connecticut, Hlth Outcomes Policy & Evidence Synth Grp, Hartford, CT 06112 USA; [Hernandez, Adrian V.; Roman, Yuani M.; White, C. Michael] Hartford Hosp, Dept Res Adm, Hartford, CT 06115 USA; [Hernandez, Adrian V.; White, C. Michael] Sch Pharm, Storrs, CT USA; [Hernandez, Adrian V.; Barboza, Joshuan J.] Univ San Ignacio de Loyola, Vicerrectorado Invest, Lima, Peru; [Pasupuleti, Vinay] MedErgy HealthGrp, Yardley, PA USA; [Hernandez, Adrian V.; Roman, Yuani M.; White, C. Michael] Hlth Outcomes Policy & Evidence Synth Grp, 69 North Eagleville Rd,U3092, Storrs, CT 06269 USA; [Pasupuleti, Vinay] MedErgy HealthGrp Inc, 790 Township Line Rd, Yardley, PA 19067 USA; [Barboza, Joshuan J.] Univ San Ignacio de Loyola USIL, Vicerrectorado Invest, Ave Fontana 750, Lima 15024, Peru	Hartford Hospital; University of Connecticut; Hartford Hospital; Universidad San Ignacio de Loyola; Hartford Hospital; Universidad San Ignacio de Loyola	White, CM (corresponding author), Univ Connecticut, Sch Pharm, 69 North Eagleville Rd,U-3092, Storrs, CT 06269 USA.	charles.white@uconn.edu	Meca, Joshuan Jordano Barboza/J-2378-2019; Barboza Meca, Joshuan/N-8950-2017; Hernandez, Adrian V./ABD-4616-2021	Meca, Joshuan Jordano Barboza/0000-0002-2896-1407; Barboza Meca, Joshuan/0000-0002-2896-1407; Hernandez, Adrian V./0000-0002-9999-4003; White, C. Michael/0000-0002-9367-4893	AHRQ [HHSA290-2015-00012I]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By AHRQ (contract HHSA290-2015-00012I).	Agency for Healthcare Research and Quality, 2014, AHRQ PUBL, V10; Barbosa J, 2020, BIBLIOVID       0412; Berkman ND, 2013, AHRQ PUBL, V13; Bessiere F, 2020, JAMA CARDIOL, V5, P1067, DOI 10.1001/jamacardio.2020.1787; Biot C, 2006, J MED CHEM, V49, P2845, DOI 10.1021/jm0601856; Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857; Borba MGS, 2020, CHLOROQUINE DIPHOSPH, DOI [10.1101/2020.04.07.20056424, 10.1101/ 2020.04.07.20056424., DOI 10.1101/2020.04.07.20056424]; Chatre C, 2018, DRUG SAFETY, V41, P919, DOI 10.1007/s40264-018-0689-4; Chen Jun, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P215, DOI 10.3785/j.issn.1008-9292.2020.03.03; Chen Z, ME DRXIV, DOI [10.1101/2020.03.22.20040758, DOI 10.1101/2020.03.22]; Chorin E, 2020, MEDRXIV, DOI [10.1101/2020.04.27.20074583, DOI 10.1101/2020.04.27.20074583]; Colson Philippe, 2020, Int J Antimicrob Agents, V55, P105932, DOI 10.1016/j.ijantimicag.2020.105932; Concordia Pharmaceuticals, 2017, PLAQ HYDR PRESCR INF; Cortegiani A, 2020, J CRIT CARE, V57, P279, DOI 10.1016/j.jcrc.2020.03.005; Dai M, 2020, MEDRXIV, DOI [10.1101/2020.04.02.20047050, DOI 10.1101/2020.04.02.20047050]; Elliott JH, 2017, J CLIN EPIDEMIOL, V91, P23, DOI 10.1016/j.jclinepi.2017.08.010; Epistemonikos Foundation, 2020, ANT TREATM COVID 19; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Gautret P, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101663; Gbinigie Kome, 2020, BJGP Open, V4, DOI 10.3399/bjgpopen20X101069; Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410; Huang M, 2020, NATL SCI REV, DOI [10.1101/2020.04.26.20081059, DOI 10.1093/NSR/NWAA113]; Huang MX, 2020, J MOL CELL BIOL, V12, P322, DOI 10.1093/jmcb/mjaa014; Infectious Diseases Society of America, 2020, INF DIS SOC AM GUID; Institut national d'excellence en sante et en services sociaux (INESSS), 2020, REP RAP; Khalafallah A, 2010, MEDITERR J HEMATOL I, V2, DOI [10.4084/MJHID.2010.005, 10.1136/bmj.l4898]; Laine C, 2020, ANN INTERN MED, V173, P153, DOI 10.7326/M20-2627; Lowe D., 2020, SCIENCE TRANSLATIONA; Magagnoli J, 2020, MED-CAMBRIDGE, V1, P114, DOI [10.1016/j.medj.2020.06.001, 10.1101/2020.04.16.20065920]; Mahevas M., 2020, NO EVIDENCE CLIN EFF, DOI [10.1101/2020.04.10.20060699, DOI 10.1101/2020.04.10.20060699]; Mallat J., 2020, HYDROXYCHLOROQUINE I, P1, DOI [10.1101/2020.04.27.20082180, DOI 10.1101/2020.04.27.20082180]; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Membrillo de Novales FJ, PREPRINTS, DOI [10.20944/preprints202005.0057.v1, DOI 10.20944/PREPRINTS202005.0057]; Mercuro Nicholas J, 2020, JAMA Cardiol, V5, P1036, DOI 10.1001/jamacardio.2020.1834; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006; National Institutes of Health, 2020, COR DIS 2019 COVID 1; Ponticelli C, 2017, EXPERT OPIN DRUG SAF, V16, P411, DOI 10.1080/14740338.2017.1269168; Qaseem A, 2020, ANN INTERN MED, V173, P137, DOI 10.7326/M20-1998; RAMIREDDY A, 2020, EXPERIENCE HYDROXYCH; Roden DM, 2020, CIRCULATION, V141, pE906, DOI 10.1161/CIRCULATIONAHA.120.047521; Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630; Saleh M, 2020, CIRC-ARRHYTHMIA ELEC, V13, DOI 10.1161/CIRCEP.120.008662; Sanofi-Aventis, 2013, AR CHLOR PRESCR INF; Shah SK, 2020, INT J RHEUM DIS, V23, P613, DOI 10.1111/1756-185X.13842; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Tang W., 2020, HYDROXYCHLOROQUINE P, DOI [10.1101/2020.04.10.20060558, DOI 10.1101/2020.04.10.20060558]; Tang W, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1849; U.S. Food and Drug Administration, 2020, FDA CAUT US HYDR CHR; van den Broek MPH, 2020, NETH HEART J, V28, P406, DOI 10.1007/s12471-020-01429-7; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237; Yu B., 2020, MEDRXIV, DOI [10.1101/2020.04.27.20073379, DOI 10.1101/2020.04.27.20073379]	53	136	145	4	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2020	173	4					287	+		10.7326/M20-2496	http://dx.doi.org/10.7326/M20-2496			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK9TG	32459529				2022-12-28	WOS:000567070300018
J	Pilonis, ND; Bugajski, M; Wieszczy, P; Franczyk, R; Didkowska, J; Wojciechowska, U; Pisera, M; Rupinski, M; Regula, J; Kaminski, MF				Pilonis, Nastazja Dagny; Bugajski, Marek; Wieszczy, Paulina; Franczyk, Robert; Didkowska, Joanna; Wojciechowska, Urszula; Pisera, Malgorzata; Rupinski, Maciej; Regula, Jaroslaw; Kaminski, Michal Filip			Long-Term Colorectal Cancer Incidence and Mortality After a Single Negative Screening Colonoscopy	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY INDICATORS; FOLLOW-UP; RISK; SIGMOIDOSCOPY; ASSOCIATION; GUIDELINES; ASSURANCE; POLYPS	Background: Current guidelines recommend a 10-year interval between screening colonoscopies, but evidence is limited. Objective: To assess the long-term risk for colorectal cancer (CRC) and death from CRC after a high- and low-quality single negative screening colonoscopy. Design: Observational study. Setting: Polish Colonoscopy Screening Program. Participants: Average-risk individuals aged 50 to 66 years who had a single negative colonoscopy (no neoplastic findings). Measurements: Standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs) of CRC after high- and low-quality single negative screening colonoscopy. High-quality colonoscopy included a complete examination, with adequate bowel preparation, performed by endoscopists with an adenoma detection rate of 20% or greater. Results: Among 165 887 individuals followed for up to 17.4 years, CRC incidence (0.28 [95% CI, 0.25 to 0.30]) and mortality (0.19 [CI, 0.16 to 0.21]) were 72% and 81% lower, respectively, than in the general population. High-quality examination resulted in 2-fold lower CRC incidence (SIR, 0.16 [CI, 0.13 to 0.20]) and mortality (SMR, 0.10 [CI, 0.06 to 0.14]) than low-quality examination (SIR, 0.32 [CI, 0.29 to 0.35]; SMR, 0.22 [CI, 0.18 to 0.25]). In multivariable analysis, the hazard ratios for CRC incidence after high-quality versus low-quality colonoscopy were 0.55 (CI, 0.35 to 0.86) for 0 to 5 years, 0.54 (CI, 0.38 to 0.77) for 5.1 to 10 years, and 0.46 (CI, 0.25 to 0.86) for 10 to 17.4 years. Only after high-quality colonoscopy did the SIR and SMR for 10.1 to 17.4 years of follow-up not differ compared with earlier observation periods. Limitation: The general population was used as the comparison group. Conclusion: A single negative screening colonoscopy was associated with reduced CRC incidence and mortality for up to 17.4 years. Only high-quality colonoscopy yielded profound and stable reductions in CRC incidence and mortality throughout the entire follow-up.	[Pilonis, Nastazja Dagny; Bugajski, Marek; Franczyk, Robert; Rupinski, Maciej; Regula, Jaroslaw] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Gastroenterol, Roentgen St 5, PL-02781 Warsaw, Poland; [Wieszczy, Paulina] Maria Sklodowska Curie Natl Res Inst Oncol, Warsaw, Poland; [Pilonis, Nastazja Dagny; Bugajski, Marek; Wieszczy, Paulina; Rupinski, Maciej; Regula, Jaroslaw; Kaminski, Michal Filip] Med Ctr Postgrad Educ, Warsaw, Poland; [Wieszczy, Paulina; Pisera, Malgorzata; Kaminski, Michal Filip] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Gastroenterol Hepatol & Oncol, Med Ctr Postgrad Educ, Roentgen St 5, PL-02781 Warsaw, Poland; [Didkowska, Joanna; Wojciechowska, Urszula] Maria Sklodowska Curie Natl Res Inst Oncol, Natl Canc Registry Poland, Wawelska St 15B, PL-02034 Warsaw, Poland; [Kaminski, Michal Filip] Univ Oslo, Inst Hlth & Soc, Oslo, Norway	Centre of Postgraduate Medical Education - Poland; Centre of Postgraduate Medical Education - Poland; University of Oslo	Pilonis, ND (corresponding author), Maria Sklodowska Curie Natl Res Inst Oncol, Dept Gastroenterol, Roentgen St 5, PL-02781 Warsaw, Poland.	nastazja@gmail.com	Didkowska, Joanna Aleksandra/ABG-8672-2020; Kaminski, Michal F./AFN-3411-2022	Didkowska, Joanna Aleksandra/0000-0001-9160-9118; Kaminski, Michal/0000-0002-9714-6457; Wojciechowska, Urszula/0000-0002-4767-1384; Pisera, Malgorzata/0000-0002-8259-4716; Bugajski, Marek/0000-0002-3284-8482; Wieszczy-Szczepanik, Paulina/0000-0001-7930-1305; Rupinski, Maciej/0000-0002-1041-1159; Regula, Jaroslaw/0000-0001-7071-3151	Polish Ministry of Health	Polish Ministry of Health	Polish Ministry of Health.	Aronchick CA, 1999, AM J GASTROENTEROL, V94, P2667; Atkin W, 2017, LANCET, V389, P1299, DOI 10.1016/S0140-6736(17)30396-3; Baxter NN, 2012, J CLIN ONCOL, V30, P2664, DOI 10.1200/JCO.2011.40.4772; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Brenner H, 2006, GUT, V55, P1145, DOI [10.1136/gut.2005.087130, 10.1136/gut.2005087130]; Brenner H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2467; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Breslow NE, 1987, DESIGN ANAL COHORT S, VII, P82; Corley DA, 2014, NEW ENGL J MED, V370, P1298, DOI 10.1056/NEJMoa1309086; Didkowska JWU, 2015, CANC POLAND 2013; EDERER F, 1974, AM J EPIDEMIOL, V100, P165, DOI 10.1093/oxfordjournals.aje.a112024; HELSINGEN LM, 2019, BMJ-BRIT MED J, V367, DOI DOI 10.1136/BMJ.L5515; Holme O, 2018, ANN INTERN MED, V168, P775, DOI 10.7326/M17-1441; Holme O, 2014, JAMA-J AM MED ASSOC, V312, P606, DOI 10.1001/jama.2014.8266; IJspeert JEG, 2016, GUT, V65, P963, DOI 10.1136/gutjnl-2014-308411; Kahi CJ, 2012, GASTROINTEST ENDOSC, V75, P515, DOI 10.1016/j.gie.2011.08.021; Kaminski MF, 2017, GASTROENTEROLOGY, V153, P98, DOI 10.1053/j.gastro.2017.04.006; Kaminski MF, 2017, ENDOSCOPY, V49, P378, DOI 10.1055/s-0043-103411; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Knudsen AB, 2016, JAMA-J AM MED ASSOC, V315, P2595, DOI 10.1001/jama.2016.6828; Lakoff J, 2008, CLIN GASTROENTEROL H, V6, P1117, DOI 10.1016/j.cgh.2008.05.016; Lee JK, 2019, JAMA INTERN MED, V179, P153, DOI 10.1001/jamainternmed.2018.5565; Lieberman D, 2007, GASTROINTEST ENDOSC, V65, P757, DOI 10.1016/j.gie.2006.12.055; Lieberman DA, 2014, GASTROENTEROLOGY, V147, P343, DOI 10.1053/j.gastro.2014.04.020; Murthy SK, 2017, ENDOSCOPY, V49, P1229, DOI 10.1055/s-0043-117402; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Ponugoti PL, 2017, GASTROINTEST ENDOSC, V85, P221, DOI 10.1016/j.gie.2016.05.024; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rex DK, 2006, GASTROINTEST ENDOSC, V63, pS16, DOI 10.1016/j.gie.2006.02.021; Rex DK, 2017, GASTROINTEST ENDOSC, V86, P18, DOI 10.1016/j.gie.2017.04.003; Rex DK, 2015, GASTROINTEST ENDOSC, V81, P31, DOI 10.1016/j.gie.2014.07.058; Robertson DJ, 2014, GUT, V63, P949, DOI 10.1136/gutjnl-2012-303796; Rondagh EJA, 2012, GASTROINTEST ENDOSC, V75, P1218, DOI 10.1016/j.gie.2012.02.010; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; von Karsa L, 2013, ENDOSCOPY, V45, P51, DOI 10.1055/s-0032-1325997; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; Wolf AMD, 2018, CA-CANCER J CLIN, V68, P250, DOI 10.3322/caac.21457; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	39	41	43	1	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2020	173	2					81	+		10.7326/M19-2477	http://dx.doi.org/10.7326/M19-2477			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ0RK	32449884				2022-12-28	WOS:000552604300014
J	Funder, JW				Funder, John W.			Primary Aldosteronism: At the Tipping Point	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SECRETION		[Funder, John W.] Hudson Inst Med Res, 64 Parker Rd, Wandin East, Vic 3139, Australia	Hudson Institute of Medical Research	Funder, JW (corresponding author), Hudson Inst Med Res, 64 Parker Rd, Wandin East, Vic 3139, Australia.	john.funder@hudson.org.au						Baudrand R, 2017, HYPERTENSION, V69, P950, DOI 10.1161/HYPERTENSIONAHA.116.08952; Brown JM, 2020, ANN INTERN MED, V173, P10, DOI 10.7326/M20-0065; Funder JW, 2016, J CLIN ENDOCR METAB, V101, P1889, DOI 10.1210/jc.2015-4061; Gouli A, 2011, EUR J CLIN INVEST, V41, P1227, DOI 10.1111/j.1365-2362.2011.02531.x; HELBER A, 1980, KLIN WOCHENSCHR, V58, P439, DOI 10.1007/BF01476798; Hundemer GL, 2018, LANCET DIABETES ENDO, V6, P51, DOI 10.1016/S2213-8587(17)30367-4; Markou A, 2015, J CLIN ENDOCR METAB, V100, P2857, DOI 10.1210/jc.2015-1268; Williams B, 2018, LANCET DIABETES ENDO, V6, P600, DOI 10.1016/S2213-8587(18)30174-8	8	17	18	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2020	173	1					65	66		10.7326/M20-1758	http://dx.doi.org/10.7326/M20-1758			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MI6BV	32449882				2022-12-28	WOS:000547491700013
J	Campbell, KH; Tornatore, JM; Lawrence, KE; Illuzzi, JL; Sussman, LS; Lipkind, HS; Pettker, CM				Campbell, Katherine H.; Tornatore, Jean M.; Lawrence, Kirsten E.; Illuzzi, Jessica L.; Sussman, L. Scott; Lipkind, Heather S.; Pettker, Christian M.			Prevalence of SARS-CoV-2 Among Patients Admitted for Childbirth in Southern Connecticut	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Campbell, Katherine H.; Lawrence, Kirsten E.; Illuzzi, Jessica L.; Lipkind, Heather S.; Pettker, Christian M.] Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, 330 Cedar St,FMB 302, New Haven, CT 06520 USA; [Tornatore, Jean M.] Bridgeport Hosp, Dept Obstet & Gynecol, Bridgeport, CT USA; [Sussman, L. Scott] Yale New Haven Hlth, Clin Redesign, New Haven, CT USA	Yale University; Yale University	Campbell, KH (corresponding author), Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, 330 Cedar St,FMB 302, New Haven, CT 06520 USA.	katherine.campbell@yale.edu			NCATS NIH HHS [UL1 TR001863] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		[Anonymous], 2020, NY TIMES; Sutton D, 2020, NEW ENGL J MED, V382, P2163, DOI 10.1056/NEJMc2009316	2	69	71	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2520	2522		10.1001/jama.2020.8904	http://dx.doi.org/10.1001/jama.2020.8904			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32453390	Bronze, Green Published			2022-12-28	WOS:000590149400026
J	Miller, AM; DeAngelis, LM				Miller, Alexandra M.; DeAngelis, Lisa M.			Reevaluation of the Frequent Use of PD-1 Checkpoint Inhibitors for Treatment of Glioblastoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADJUVANT TEMOZOLOMIDE; RADIOTHERAPY; CONCOMITANT		[Miller, Alexandra M.; DeAngelis, Lisa M.] Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	DeAngelis, LM (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	deangell@mskcc.org			NIH/NCI Cancer Center support grant [P30 CA008748]	NIH/NCI Cancer Center support grant	Supported through the NIH/NCI Cancer Center support grant P30 CA008748.	Arbour KC, 2018, J CLIN ONCOL, V36, P2872, DOI 10.1200/JCO.2018.79.0006; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Cloughesy TF, 2019, NAT MED, V25, P477, DOI 10.1038/s41591-018-0337-7; Jacobs JFM, 2009, NEURO-ONCOLOGY, V11, P394, DOI 10.1215/15228517-2008-104; Keskin DB, 2019, NATURE, V565, P234, DOI 10.1038/s41586-018-0792-9; Kurz SC, 2018, NEUROLOGY, V91, pE1355, DOI 10.1212/WNL.0000000000006283; Makker V, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.19.02627; Mandal R, 2019, SCIENCE, V364, P485, DOI 10.1126/science.aau0447; Mandel JJ, 2018, EXPERT REV ANTICANC, V18, P1031, DOI 10.1080/14737140.2018.1496824; Omuro A, 2018, NEURO-ONCOLOGY, V20, P674, DOI 10.1093/neuonc/nox208; Ostrom QT, 2018, NEURO-ONCOLOGY, V20, P1, DOI 10.1093/neuonc/noy131; Ott PA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00202; Reardon DA, 2020, JAMA ONCOL, V6, P1003, DOI 10.1001/jamaoncol.2020.1024; Reardon DA, 2016, CANCER IMMUNOL RES, V4, P124, DOI 10.1158/2326-6066.CIR-15-0151; Schalper KA, 2019, NAT MED, V25, P470, DOI 10.1038/s41591-018-0339-5; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Zhao J, 2019, NAT MED, V25, P462, DOI 10.1038/s41591-019-0349-y	18	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2482	2484		10.1001/jama.2020.5934	http://dx.doi.org/10.1001/jama.2020.5934			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32453825				2022-12-28	WOS:000590149400019
J	Desdin-Mico, G; Soto-Heredero, G; Aranda, JF; Oller, J; Carrasco, E; Gabande-Rodriguez, E; Blanco, EM; Alfranca, A; Cusso, L; Desco, M; Ibanez, B; Gortazar, AR; Fernandez-Marcos, P; Navarro, MN; Hernaez, B; Alcami, A; Baixauli, F; Mittelbrunn, M				Desdin-Mico, Gabriela; Soto-Heredero, Gonzalo; Francisco Aranda, Juan; Oller, Jorge; Carrasco, Elisa; Gabande-Rodriguez, Enrique; Maria Blanco, Eva; Alfranca, Arantzazu; Cusso, Lorena; Desco, Manuel; Ibanez, Borja; Gortazar, Arancha R.; Fernandez-Marcos, Pablo; Navarro, Maria N.; Hernaez, Bruno; Alcami, Antonio; Baixauli, Francesc; Mittelbrunn, Maria			T cells with dysfunctional mitochondria induce multimorbidity and premature senescence	SCIENCE			English	Article							NAD(+); IMMUNOMETABOLISM; METABOLISM; ACTIVATION; GENE	The effect of immunometabolism on age-associated diseases remains uncertain. In this work, we show that T cells with dysfunctional mitochondria owing to mitochondrial transcription factor A (TFAM) deficiency act as accelerators of senescence. In mice, these cells instigate multiple aging-related features, including metabolic, cognitive, physical, and cardiovascular alterations, which together result in premature death. T cell metabolic failure induces the accumulation of circulating cytokines, which resembles the chronic inflammation that is characteristic of aging ("inflammaging"). This cytokine storm itself acts as a systemic inducer of senescence. Blocking tumor necrosis factor-a signaling or preventing senescence with nicotinamide adenine dinucleotide precursors partially rescues premature aging in mice with Tfam-deficient T cells. Thus, T cells can regulate organismal fitness and life span, which highlights the importance of tight immunometabolic control in both aging and the onset of age-associated diseases.	[Desdin-Mico, Gabriela; Soto-Heredero, Gonzalo; Francisco Aranda, Juan; Oller, Jorge; Carrasco, Elisa; Gabande-Rodriguez, Enrique; Maria Blanco, Eva; Mittelbrunn, Maria] Hosp 12 Octubre imas12, Inst Invest Sanitaria, Madrid, Spain; [Desdin-Mico, Gabriela; Soto-Heredero, Gonzalo; Francisco Aranda, Juan; Oller, Jorge; Carrasco, Elisa; Gabande-Rodriguez, Enrique; Maria Blanco, Eva; Navarro, Maria N.; Hernaez, Bruno; Alcami, Antonio; Mittelbrunn, Maria] Univ Autonoma Madrid UAM, CSIC, Ctr Biol Mol Severo Ochoa CBMSO, Dept Biol Mol, Madrid, Spain; [Alfranca, Arantzazu; Navarro, Maria N.] Hosp Univ Princesa, Madrid, Spain; [Cusso, Lorena; Desco, Manuel] Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroesp, Madrid, Spain; [Cusso, Lorena; Desco, Manuel; Ibanez, Borja] Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain; [Cusso, Lorena; Desco, Manuel] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Cusso, Lorena; Desco, Manuel] Ctr Invest Biomed Red Salud Mental CIBERSA, Madrid, Spain; [Ibanez, Borja] IIS Fdn Jimenez Diaz, Madrid, Spain; [Ibanez, Borja] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain; [Gortazar, Arancha R.] Univ San Pablo CEU, Appl Mol Med Inst IMMA, Bone Physiopathol Lab, Madrid, Spain; [Fernandez-Marcos, Pablo] CEI UAM, Madrid Inst Adv Studies IMDEA Food, Metab Syndrome Grp BIOPROMET, CSIC, Madrid, Spain; [Baixauli, Francesc] Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, Freiburg, Germany	Hospital Universitario 12 de Octubre; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital de La Princesa; Universidad Carlos III de Madrid; Centro Nacional de Investigaciones Cardiovasculares (CNIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; San Pablo CEU University; Consejo Superior de Investigaciones Cientificas (CSIC); Max Planck Society	Mittelbrunn, M (corresponding author), Hosp 12 Octubre imas12, Inst Invest Sanitaria, Madrid, Spain.; Mittelbrunn, M (corresponding author), Univ Autonoma Madrid UAM, CSIC, Ctr Biol Mol Severo Ochoa CBMSO, Dept Biol Mol, Madrid, Spain.	mmittelbrunn@cbm.csic.es	Ibáñez, Borja/J-6993-2014; Hernaez, Bruno/N-4547-2014; Aranda, Juan Francisco/S-6388-2018; Gortazar, Arancha/G-5385-2017; Mittelbrunn, Maria/J-9146-2019; Desdín-Micó, Gabriela/ABE-5242-2021; Soto-Heredero, Gonzalo/S-6347-2018; Carrasco, Elisa/G-7746-2015; Alcami, Antonio/F-8512-2015; Baixauli, Francesc/L-4957-2016; Desco, Manuel/D-2822-2009	Ibáñez, Borja/0000-0002-5036-254X; Hernaez, Bruno/0000-0002-4351-0102; Aranda, Juan Francisco/0000-0002-5598-2465; Gortazar, Arancha/0000-0001-5072-3141; Mittelbrunn, Maria/0000-0003-3487-8762; Desdín-Micó, Gabriela/0000-0001-8136-4145; Soto-Heredero, Gonzalo/0000-0001-8043-7314; Carrasco, Elisa/0000-0002-0817-1627; Gabande-Rodriguez, Enrique/0000-0002-9715-8714; Oller Pedrosa, Jorge/0000-0002-2224-2954; Alcami, Antonio/0000-0002-3333-6016; Baixauli, Francesc/0000-0002-9676-2901; Blanco-Ruiz, Eva/0000-0001-5940-1827; Alfranca, Arantzazu/0000-0002-3732-5816; Desco, Manuel/0000-0003-0989-3231; CUSSO, LORENA/0000-0001-9298-0015	Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III [PI16/02188, PI19/00855, PI16/02110]; European Regional Development Fund (ERDF); European Commission through H2020-EU.1.1; European Research Council [ERC-2016-StG 715322-EndoMitTalk]; Comunidad de Madrid [S2017/BMD-3867 RENIM-CM, 2017-T2/BMD-5766]; FPI-UAM; Juan de la Cierva [FJCI-2017-33855, IJC2018-036850]; UAM [2017-T2/BMD-5766]; ERC [ERC-2018-CoG 819775-MATRIX]; Miguel Servet Program [CPII 19/00014]	Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III(Instituto de Salud Carlos III); European Regional Development Fund (ERDF)(European Commission); European Commission through H2020-EU.1.1; European Research Council(European Research Council (ERC)European Commission); Comunidad de Madrid(Comunidad de Madrid); FPI-UAM; Juan de la Cierva(Instituto de Salud Carlos III); UAM; ERC(European Research Council (ERC)European Commission); Miguel Servet Program	This study was supported by the Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III (PI16/02188 and PI19/00855; and PI16/02110 to B.I.), the European Regional Development Fund (ERDF), and the European Commission through H2020-EU.1.1 and European Research Council grant ERC-2016-StG 715322-EndoMitTalk. This work was partially supported by Comunidad de Madrid (S2017/BMD-3867 RENIM-CM). M.M. is supported by the Miguel Servet Program (CPII 19/00014). G.S.-H. is supported by FPI-UAM, J.O. (FJCI-2017-33855) and E.G.-R. (IJC2018-036850) by Juan de la Cierva, and E.C. by Atraccion de Talento Investigador 2017-T2/BMD-5766 (Comunidad de Madrid and UAM). B.I. was supported by ERC research grant ERC-2018-CoG 819775-MATRIX.	Baixauli F, 2015, CELL METAB, V22, P485, DOI 10.1016/j.cmet.2015.07.020; Bellantuono I, 2018, NATURE, V554, P293, DOI 10.1038/d41586-018-01668-0; Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Chang CH, 2016, NAT IMMUNOL, V17, P364, DOI 10.1038/ni.3415; Chapman NM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04392-5; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Elhassan YS, 2019, CELL REP, V28, P1717, DOI 10.1016/j.celrep.2019.07.043; Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2; Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4; Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; He S, 2019, NATURE, V566, P115, DOI 10.1038/s41586-018-0849-9; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Hotamisligil GS, 2017, IMMUNITY, V47, P406, DOI 10.1016/j.immuni.2017.08.009; Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li L., 2019, CELL METAB, V29, P103; Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704; Mitchell SJ, 2018, CELL METAB, V27, P667, DOI 10.1016/j.cmet.2018.02.001; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Rankin LC, 2018, CELL, V173, P554, DOI 10.1016/j.cell.2018.03.013; Rhoads JP, 2017, NAT REV RHEUMATOL, V13, P313, DOI 10.1038/nrrheum.2017.54; Ron-Harel N, 2018, P NATL ACAD SCI USA, V115, P13347, DOI 10.1073/pnas.1804149115; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Tarasenko TN, 2017, CELL METAB, V25, P1254, DOI 10.1016/j.cmet.2017.05.007; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; Wang A, 2019, SCIENCE, V363, P140, DOI 10.1126/science.aar3932; Weinberg SE, 2019, NATURE, V565, P495, DOI 10.1038/s41586-018-0846-z; Xia LY, 2019, CELL METAB, V29, P103, DOI 10.1016/j.cmet.2018.09.020; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693	31	130	130	21	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2020	368	6497					1371	+		10.1126/science.aax0860	http://dx.doi.org/10.1126/science.aax0860			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MD5NG	32439659				2022-12-28	WOS:000544017600048
J	Hirsch, IB; Gaudiani, LM				Hirsch, Irl B.; Gaudiani, Linda M.			Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMPLICATIONS	This JAMA Insights Clinical Update reviews indications and timing of insulin therapy for management of type 2 diabetes, emphasizing the likely benefit of its use as first-line therapy in patients with HbA(1c)levels less than 9.0%.	[Hirsch, Irl B.] Univ Washington, Sch Med, 750 Republican St,Bldg F,Third Floor, Seattle, WA 98109 USA; [Gaudiani, Linda M.] Braden Diabet Ctr, Greenbrae, CA USA	University of Washington; University of Washington Seattle	Hirsch, IB (corresponding author), Univ Washington, Sch Med, 750 Republican St,Bldg F,Third Floor, Seattle, WA 98109 USA.	ihirsch@uw.edu						Blonde L, 2018, DIABETES THER, V9, P1169, DOI 10.1007/s13300-018-0429-x; Esposito K, 2012, DIABETES OBES METAB, V14, P228, DOI 10.1111/j.1463-1326.2011.01512.x; multicenter collaboration group of Department of S Technology of Guangdong P Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus p, 2020, ZHONGHUA JIE HE HE H, V43, pE019, DOI DOI 10.2337/dc20-Sint; National Interagency Coordination Center (NICC), 2020, NAT DIAB STAT REP WE; Pilla SJ, 2018, J GEN INTERN MED, V33, P839, DOI 10.1007/s11606-017-4282-9; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X	8	7	7	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2020	323	23					2419	2420		10.1001/jama.2020.1303	http://dx.doi.org/10.1001/jama.2020.1303			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MC6EC	32442246				2022-12-28	WOS:000543376700025
J	Sheather, J; Chisholm, J				Sheather, Julian; Chisholm, John			Duty to treat: where do the limits lie?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sheather, Julian; Chisholm, John] British Med Assoc, London, England		Sheather, J (corresponding author), British Med Assoc, London, England.	jsheather@bma.org							0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2020	369								m2150	10.1136/bmj.m2150	http://dx.doi.org/10.1136/bmj.m2150			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0OM	32482667	Bronze			2022-12-28	WOS:000548486700001
J	Mahase, E				Mahase, Elisabeth			Covid-19: How does the NHS test and trace service work?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Armstrong S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2085; Department of Health and Social Care, 2020, NHS TEST TRAC IT WOR; Hern Alex, 2020, GUARDIAN; Mahase E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2169; Perraudin F, 2020, GUARDIAN; Smyth C, 2020, TIMES	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2020	369								m2174	10.1136/bmj.m2174	http://dx.doi.org/10.1136/bmj.m2174			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3KB	32471822	Bronze			2022-12-28	WOS:000538337500023
J	Waller, LP; Allen, WJ; Barratt, BIP; Condron, LM; Franca, FM; Hunt, JE; Koele, N; Orwin, KH; Steel, GS; Tylianakis, JM; Wakelin, SA; Dickie, IA				Waller, L. P.; Allen, W. J.; Barratt, B. I. P.; Condron, L. M.; Franca, F. M.; Hunt, J. E.; Koele, N.; Orwin, K. H.; Steel, G. S.; Tylianakis, J. M.; Wakelin, S. A.; Dickie, I. A.			Biotic interactions drive ecosystem responses to exotic plant invaders	SCIENCE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; FATTY-ACID ANALYSIS; INVASIVE PLANTS; ORGANIC-MATTER; USE EFFICIENCY; SOIL; CARBON; COMMUNITIES; BACTERIAL; LITTER	Ecosystem process rates typically increase after plant invasion, but the extent to which this is driven by (i) changes in productivity, (ii) exotic species' traits, or (iii) novel (non-coevolved) biotic interactions has never been quantified. We created communities varying in exotic plant dominance, plant traits, soil biota, and invertebrate herbivores and measured indicators of carbon cycling. Interactions with soil biota and herbivores were the strongest drivers of exotic plant effects, particularly on measures of soil carbon turnover. Moreover, plant traits related to growth and nutrient acquisition explained differences in the ways that exotic plants interacted with novel biota compared with natives. We conclude that novel biological interactions with exotic species are a more important driver of ecosystem transformation than was previously recognized.	[Waller, L. P.; Condron, L. M.] Lincoln Univ, Bioprotect Res Ctr, Lincoln 7647, New Zealand; [Allen, W. J.; Steel, G. S.; Tylianakis, J. M.; Dickie, I. A.] Univ Canterbury, Sch Biol Sci, Bioprotect Res Ctr, Christchurch 8041, New Zealand; [Barratt, B. I. P.] AgResearch, Invermay Res Ctr, Mosgiel 9092, New Zealand; [Barratt, B. I. P.] Univ Otago, Dept Bot, Dunedin 9016, New Zealand; [Franca, F. M.] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [Franca, F. M.] Embrapa Amazonia Oriental, BR-66095100 Belem, Para, Brazil; [Hunt, J. E.; Koele, N.; Orwin, K. H.] Manaaki Whenua Landcare Res, Lincoln 7640, New Zealand; [Wakelin, S. A.] Scion, Christchurch 8011, New Zealand	Lincoln University - New Zealand; University of Canterbury; AgResearch - New Zealand; University of Otago; Lancaster University; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Landcare Research - New Zealand; Scion	Waller, LP (corresponding author), Lincoln Univ, Bioprotect Res Ctr, Lincoln 7647, New Zealand.; Dickie, IA (corresponding author), Univ Canterbury, Sch Biol Sci, Bioprotect Res Ctr, Christchurch 8041, New Zealand.	laurenpwaller@gmail.com; Ian.Dickie@canterbury.ac.nz	Franca, Filipe Machado/G-1545-2016; Tylianakis, Jason/B-6634-2011	Franca, Filipe Machado/0000-0003-3827-1917; Waller, Lauren/0000-0002-7110-6027; Hunt, John/0000-0002-8966-8773; Tylianakis, Jason/0000-0001-7402-5620; Barratt, Barbara I.P./0000-0002-8424-8729; Koele, Nina/0000-0003-2181-8584; Steel, Georgia/0000-0002-0923-5864				Agrawal AA, 2005, ECOLOGY, V86, P2979, DOI 10.1890/05-0219; Agrawal AA, 2003, ECOL LETT, V6, P712, DOI 10.1046/j.1461-0248.2003.00498.x; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Bardgett RD, 2014, TRENDS ECOL EVOL, V29, P692, DOI 10.1016/j.tree.2014.10.006; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Becklin KM, 2012, J ECOL, V100, P343, DOI 10.1111/j.1365-2745.2011.01903.x; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bird JA, 2011, SOIL BIOL BIOCHEM, V43, P718, DOI 10.1016/j.soilbio.2010.08.010; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; BRIGHT DE, 1994, ANN ENTOMOL SOC AM, V87, P277, DOI 10.1093/aesa/87.3.277; Brzostek ER, 2015, NEW PHYTOL, V206, P1274, DOI 10.1111/nph.13303; Bunn RA, 2015, J ECOL, V103, P1547, DOI 10.1111/1365-2745.12456; Buyer JS, 2012, APPL SOIL ECOL, V61, P127, DOI 10.1016/j.apsoil.2012.06.005; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Craine JM, 2006, ECOL STU AN, V186, P167; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Dodet M, 2012, BIOL INVASIONS, V14, P1765, DOI 10.1007/s10530-012-0202-4; DORMAAR JF, 1990, BIOL FERT SOILS, V10, P121; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Ehrenfeld JG, 2010, ANNU REV ECOL EVOL S, V41, P59, DOI 10.1146/annurev-ecolsys-102209-144650; Fanin N, 2019, SOIL BIOL BIOCHEM, V128, P111, DOI 10.1016/j.soilbio.2018.10.010; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Holland JN, 1996, OECOLOGIA, V107, P87, DOI 10.1007/BF00582238; Hopkins D. W., 2005, Biological diversity and function in soils, P57, DOI 10.1017/CBO9780511541926.005; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Johnston CA, 2004, FRONT ECOL ENVIRON, V2, P522, DOI 10.1890/1540-9295(2004)002[0522:CCIS]2.0.CO;2; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; KAIN WM, 1972, NEW ZEAL J SCI, V15, P85; KELSEY J. M., 1965, NEW ZEAL J SCI, V8, P173; KNIGHT W J, 1976, New Zealand Journal of Zoology, V3, P71; Koziol L, 2015, ECOLOGY, V96, P1768, DOI 10.1890/14-2208.1; Kramer C, 2008, SOIL BIOL BIOCHEM, V40, P425, DOI 10.1016/j.soilbio.2007.09.016; Laliberte E, 2012, ECOLOGY, V93, P145, DOI 10.1890/11-0338.1; Lefcheck L., 2015, METHODS ECOL EVOL, V573, P573, DOI DOI 10.1111/2041-210X.12512|; Leifheit EF, 2015, SOIL BIOL BIOCHEM, V81, P323, DOI 10.1016/j.soilbio.2014.12.003; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Olsson PA, 2005, ECOL LETT, V8, P1264, DOI 10.1111/j.1461-0248.2005.00831.x; Peltzer DA, 2010, GLOBAL CHANGE BIOL, V16, P732, DOI 10.1111/j.1365-2486.2009.02038.x; Phillips RP, 2006, ECOLOGY, V87, P1302, DOI 10.1890/0012-9658(2006)87[1302:TSAMAI]2.0.CO;2; Poorter H, 1998, OECOLOGIA, V116, P26, DOI 10.1007/s004420050560; Rasband W.S., 1997, IMAGEJ; Rout ME, 2009, SCIENCE, V324, P734, DOI 10.1126/science.1173651; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Staddon PL, 2003, SCIENCE, V300, P1138, DOI 10.1126/science.1084269; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Svenningsen NB, 2018, ISME J, V12, P1296, DOI 10.1038/s41396-018-0059-3; Tamura M, 2014, NEW PHYTOL, V203, P110, DOI 10.1111/nph.12795; van der Putten WH, 2007, ISME J, V1, P28, DOI 10.1038/ismej.2007.9; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Verbruggen E, 2016, J ECOL, V104, P261, DOI 10.1111/1365-2745.12496; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Waller L. P., 2020, DATA BIOTIC INTERACT, DOI [10.5061/dryad.wwpzgmsgb., DOI 10.5061/DRYAD.WWPZGMSGB]; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; WARDLE DA, 1993, FUNCT ECOL, V7, P346, DOI 10.2307/2390215; Wilson GWT, 1998, AM J BOT, V85, P1732, DOI 10.2307/2446507; Wolfe BE, 2005, BIOSCIENCE, V55, P477, DOI 10.1641/0006-3568(2005)055[0477:BNGSCA]2.0.CO;2; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533; Zhang BW, 2016, SCI REP-UK, V6, DOI 10.1038/srep19990; Zhu YG, 2003, TRENDS PLANT SCI, V8, P407, DOI 10.1016/S1360-1385(03)00184-5	66	34	34	27	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					967	+		10.1126/science.aba2225	http://dx.doi.org/10.1126/science.aba2225			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LV3IK	32467385				2022-12-28	WOS:000538332600041
J	Cohen, BR; Mahoney, KM; Baro, E; Squire, C; Beck, M; Travis, S; Pike-McCrudden, A; Izem, R; Woodcock, J				Cohen, Barbara R.; Mahoney, Karen M.; Baro, Elande; Squire, Claudia; Beck, Melissa; Travis, Sara; Pike-McCrudden, Amanda; Izem, Rima; Woodcock, Janet			FDA Initiative for Drug Facts Label for Over-the-Counter Naloxone	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								This article recounts the FDA testing performed to create a drug facts label for the use of naloxone obtained through over-the-counter sales. The study involved structured interviews with 710 adults and adolescents, including many who use opioids and their family and friends. Background The opioid crisis highlights the need to increase access to naloxone, possibly through regulatory approval for over-the-counter sales. To address industry-perceived barriers to such access, the Food and Drug Administration (FDA) developed a model drug facts label for such sales to assess whether consumers understood the key statements for safe and effective use. Methods In this label-comprehension study, we conducted individual structured interviews with 710 adults and adolescents, including 430 adults who use opioids and their family and friends. Eight primary end points were developed to assess user comprehension of each of the key steps in the label. Each of these end points included a prespecified target threshold ranging from 80 to 90% that was evaluated through a comparison of the lower boundary of the 95% exact confidence interval. Results The results for performance on six primary end points met or exceeded thresholds, including the steps "Check for a suspected overdose" (threshold, 85%; point estimate [PE], 95.8%; 95% confidence interval [CI], 94.0 to 97.1) and "Give the first dose" (threshold, 85%; PE, 98.2%; 95% CI, 96.9 to 99.0). The lower boundaries for four other primary end points ranged from 88.8 to 94.0%. One exception was comprehension of "Call 911 immediately," but this instruction closely approximated the target of 90% (PE, 90.3%; 95% CI, 87.9 to 92.4). Another exception was comprehension of the composite step of "Check, give, and call 911 immediately" (threshold, 85%; PE, 81.1%; 95% CI, 78.0 to 83.9). Conclusions Consumers met thresholds for sufficient understanding of six of eight components of the instructions in the drug facts label for naloxone use and came close on two others. Overall, the FDA found that the model label was adequate for use in the development of a naloxone product intended for over-the-counter sales.	[Cohen, Barbara R.; Mahoney, Karen M.; Baro, Elande; Squire, Claudia; Beck, Melissa; Travis, Sara; Pike-McCrudden, Amanda; Izem, Rima; Woodcock, Janet] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Cohen, BR (corresponding author), Ctr Drug Evaluat & Res, Food & Adm, 10903 New Hampshire Ave,Rm 5418,Bldg 22, White Oak, MD 20993 USA.	barbara.r.cohen@fda.hhs.gov		, Barbara R. Cohen/0000-0002-6509-3637; Squire, Claudia M./0000-0002-8363-0651				[Anonymous], 2010, GUID IND LAB COMPR S; [Anonymous], 2017, TRANSFUSION, V57, p3A; Davis T C, 1993, Fam Med, V25, P391; Davis TC, 2006, PEDIATRICS, V118, pE1707, DOI 10.1542/peds.2006-1139; Harm Reduction International, 2018, POL HARM RED; Mullen RJ, 2018, PATIENT EDUC COUNS, V101, P1351, DOI 10.1016/j.pec.2018.03.012; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; Stegemann S, 2016, AAPS J, V18, P1047, DOI 10.1208/s12248-016-9938-6; WHO, 2014, COMM MAN OP OV	9	14	14	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2020	382	22					2129	2136		10.1056/NEJMsa1912403	http://dx.doi.org/10.1056/NEJMsa1912403			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MA5NT	32459923	Bronze			2022-12-28	WOS:000541960400018
J	Cummings, BB; Karczewski, KJ; Kosmicki, JA; Seaby, EG; Watts, NA; Singer-Berk, M; Mudge, JM; Karjalainen, J; Satterstrom, FK; O'Donnell-Luria, AH; Poterba, T; Seed, C; Solomonson, M; Alfoldi, J; Daly, MJ; MacArthur, DG				Cummings, Beryl B.; Karczewski, Konrad J.; Kosmicki, Jack A.; Seaby, Eleanor G.; Watts, Nicholas A.; Singer-Berk, Moriel; Mudge, Jonathan M.; Karjalainen, Juha; Satterstrom, F. Kyle; O'Donnell-Luria, Anne H.; Poterba, Timothy; Seed, Cotton; Solomonson, Matthew; Alfoldi, Jessica; Daly, Mark J.; MacArthur, Daniel G.		Genome Aggregation Database Prod T; Genome Aggregation Database Consor	Transcript expression-aware annotation improves rare variant interpretation	NATURE			English	Article							GENES; ARRHYTHMIA; MUTATIONS	The acceleration of DNA sequencing in samples from patients and population studies has resulted in extensive catalogues of human genetic variation, but the interpretation of rare genetic variants remains problematic. A notable example of this challenge is the existence of disruptive variants in dosage-sensitive disease genes, even in apparently healthy individuals. Here, by manual curation of putative loss-of-function (pLoF) variants in haploinsufficient disease genes in the Genome Aggregation Database (gnomAD)(1), we show that one explanation for this paradox involves alternative splicing of mRNA, which allows exons of a gene to be expressed at varying levels across different cell types. Currently, no existing annotation tool systematically incorporates information about exon expression into the interpretation of variants. We develop a transcript-level annotation metric known as the 'proportion expressed across transcripts', which quantifies isoform expression for variants. We calculate this metric using 11,706 tissue samples from the Genotype Tissue Expression (GTEx) project(2) and show that it can differentiate between weakly and highly evolutionarily conserved exons, a proxy for functional importance. We demonstrate that expression-based annotation selectively filters 22.8% of falsely annotated pLoF variants found in haploinsufficient disease genes in gnomAD, while removing less than 4% of high-confidence pathogenic variants in the same genes. Finally, we apply our expression filter to the analysis of de novo variants in patients with autism spectrum disorder and intellectual disability or developmental disorders to show that pLoF variants in weakly expressed regions have similar effect sizes to those of synonymous variants, whereas pLoF variants in highly expressed exons are most strongly enriched among cases. Our annotation is fast, flexible and generalizable, making it possible for any variant file to be annotated with any isoform expression dataset, and will be valuable for the genetic diagnosis of rare diseases, the analysis of rare variant burden in complex disorders, and the curation and prioritization of variants in recall-by-genotype studies.	[Cummings, Beryl B.; Karczewski, Konrad J.; Kosmicki, Jack A.; Seaby, Eleanor G.; Watts, Nicholas A.; Singer-Berk, Moriel; Karjalainen, Juha; Satterstrom, F. Kyle; O'Donnell-Luria, Anne H.; Poterba, Timothy; Solomonson, Matthew; Alfoldi, Jessica; Daly, Mark J.; MacArthur, Daniel G.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Cummings, Beryl B.; Karczewski, Konrad J.; Kosmicki, Jack A.; Seaby, Eleanor G.; Watts, Nicholas A.; Karjalainen, Juha; Satterstrom, F. Kyle; Poterba, Timothy; Seed, Cotton; Solomonson, Matthew; Alfoldi, Jessica; Daly, Mark J.; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Cummings, Beryl B.] Harvard Med Sch, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Kosmicki, Jack A.] Harvard Med Sch, Program Bioinformat & Integrat Genom, Boston, MA 02115 USA; [Seaby, Eleanor G.] Univ Hosp Southampton, Genom Informat Grp, Southampton, Hants, England; [Mudge, Jonathan M.] European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Cambridge, England; [Karjalainen, Juha; Satterstrom, F. Kyle; Poterba, Timothy; Seed, Cotton] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [O'Donnell-Luria, Anne H.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA USA; [O'Donnell-Luria, Anne H.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [MacArthur, Daniel G.] Garvan Inst Med Res, Ctr Populat Genom, Syndney, Australia; [MacArthur, Daniel G.] UNSW Sydney, Sydney, NSW, Australia; [MacArthur, Daniel G.] Murdoch Childrens Res Inst, Ctr Populat Genom, Melbourne, Vic, Australia	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; European Molecular Biology Laboratory (EMBL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of New South Wales Sydney; Murdoch Children's Research Institute	MacArthur, DG (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.; MacArthur, DG (corresponding author), Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA.; MacArthur, DG (corresponding author), Garvan Inst Med Res, Ctr Populat Genom, Syndney, Australia.; MacArthur, DG (corresponding author), UNSW Sydney, Sydney, NSW, Australia.; MacArthur, DG (corresponding author), Murdoch Childrens Res Inst, Ctr Populat Genom, Melbourne, Vic, Australia.	d.macarthur@garvan.org.au	Rioux, John D/A-9599-2015; Ware, James S/G-5139-2012; Cohen, Bruce M./AAZ-4986-2020; Ma, Ronald/C-2788-2009; Kaprio, Jaakko/A-1820-2008; Färkkilä, Martti/AAG-6970-2021; Erdmann, Jeanette/P-7513-2014; Glaser, Benjamin/F-8411-2017; sokol, harry/E-2290-2019; Bown, Matthew/P-1957-2016; Loos, Ruth/Q-2862-2016	Rioux, John D/0000-0001-7560-8326; Ware, James S/0000-0002-6110-5880; Ma, Ronald/0000-0002-1227-803X; Kaprio, Jaakko/0000-0002-3716-2455; Färkkilä, Martti/0000-0002-0250-8559; ELOSUA, ROBERTO/0000-0001-8235-0095; Melander, Olle/0000-0002-2581-484X; Palotie, Aarno/0000-0002-2527-5874; Satterstrom, Frederick/0000-0001-6187-7680; Solomonson, Matthew/0000-0002-5344-9026; Armean, Irina/0000-0002-1043-4756; Erdmann, Jeanette/0000-0002-4486-6231; Cibulskis, Kristian/0000-0003-1343-1582; Mudge, Jonathan/0000-0003-4789-7495; O'Donnell-Luria, Anne/0000-0001-6418-9592; Tai, E Shyong/0000-0003-2929-8966; Glaser, Benjamin/0000-0003-4711-5000; Seaby, Eleanor/0000-0002-6814-8648; solinas, emilia/0000-0003-3532-1317; MacArthur, Daniel/0000-0002-5771-2290; sokol, harry/0000-0002-2914-1822; Tuomi, Tiinamaija/0000-0002-8306-6202; Bown, Matthew/0000-0002-6180-3611; Loos, Ruth/0000-0002-8532-5087	NIDDK [U54 DK105566]; NIGMS [F32 GM115208, R01 GM104371]; Broad Institute; NICHD [K12 HD052896]; National Human Genome Research Institute of the National Institutes of Health [U41HG007234]; MRC [MC_UP_1102/20] Funding Source: UKRI	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Broad Institute; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all of the research participants for contributing their data. This work was supported by NIDDK U54 DK105566, NIGMS R01 GM104371, and the Broad Institute. KJK was supported by NIGMS F32 GM115208. A.O.L was supported by NICHD K12 HD052896. The GENCODE project is supported by the National Human Genome Research Institute of the National Institutes of Health under Award Number U41HG007234. The results published here are in part based on data: (1) generated by The Cancer Genome Atlas (TCGA) managed by the NCI and NHGRI (accession: phs000178.v10.p8); information about TCGA can be found at http://cancergenome.nih.gov; (2) generated by the Genotype-Tissue Expression Project (GTEx) managed by the NIH Common Fund and NHGRI (accession: phs000424.v7.p2); (3) generated by the Exome Sequencing Project, managed by NHLBI; and (4) generated by the Alzheimer's Disease Sequencing Project (ADSP), managed by the NIA and NHGRI (accession: phs000572. v7.p4). We thank E. Pierce-Hoffman for previous analysis and thoughts on characterizing loss-of-function variants in haploinsufficient genes. We thank the iPSYCH/SSI/Broad Institute psychiatric genetics study for the use of exome count data. We have complied with all relevant ethical regulations. This study was overseen by the Broad Institute's Office of Research Subject Protection and the Partners Human Research Committee, and was given a determination of Not Human Subjects Research. Informed consent was obtained from all participants. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berg JS, 2013, GENET MED, V15, P36, DOI 10.1038/gim.2012.112; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Blencowe BJ, 2017, TRENDS BIOCHEM SCI, V42, P407, DOI 10.1016/j.tibs.2017.04.001; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; da Costa PJ, 2017, INT J BIOCHEM CELL B, V91, P168, DOI 10.1016/j.biocel.2017.07.013; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Dick IE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10370; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Goldstein DB, 2013, NAT REV GENET, V14, P460, DOI 10.1038/nrg3455; Guven A, 2013, J MED GENET, V50, P199, DOI 10.1136/jmedgenet-2012-101313; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Jin SC, 2017, NAT GENET, V49, P1593, DOI 10.1038/ng.3970; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liao P, 2010, PFLUG ARCH EUR J PHY, V460, P353, DOI 10.1007/s00424-009-0753-0; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Lindsay SJ, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00086; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Minikel EV, 2020, NATURE, V581, P459, DOI 10.1038/s41586-020-2267-z; Nousbeck J, 2011, AM J HUM GENET, V89, P302, DOI 10.1016/j.ajhg.2011.07.004; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; Riggs ER, 2018, HUM MUTAT, V39, P1650, DOI 10.1002/humu.23610; Roberts AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010134; Satterstrom F. K, 2018, ASD ADHD HAVE SIMILA, DOI 10.1101/277707v1; Satterstrom FK, 2020, CELL, V180, P568, DOI 10.1016/j.cell.2019.12.036; Sifrim A, 2016, NAT GENET, V48, P1060, DOI 10.1038/ng.3627; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Sweatt JD, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.32; Teng MX, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0940-1; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tress ML, 2017, TRENDS BIOCHEM SCI, V42, P98, DOI 10.1016/j.tibs.2016.08.008; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Zheng W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-290	51	59	61	3	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 28	2020	581	7809					452	+		10.1038/s41586-020-2329-2	http://dx.doi.org/10.1038/s41586-020-2329-2			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX9ZL	32461655	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000576060200005
J	Hempel, EV				Hempel, Eliana V.			Blood Ties	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hempel, Eliana V.] Penn State Hlth, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Hempel, EV (corresponding author), Penn State Hlth, Hershey, PA 17033 USA.			Hempel, Eliana/0000-0002-0558-7432					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2020	382	22					2077	2079		10.1056/NEJMp2000134	http://dx.doi.org/10.1056/NEJMp2000134			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MA5NT	32459921				2022-12-28	WOS:000541960400013
J	Rimmer, A				Rimmer, Abi			Scrap NHS fees for overseas healthcare staff, says Labour	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2020	369								m2054	10.1136/bmj.m2054	http://dx.doi.org/10.1136/bmj.m2054			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JS	32439685	Bronze			2022-12-28	WOS:000538336600015
J	[Anonymous]				[Anonymous]			Seven days in medicine: 13-19 May 2020	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, COCHRANE DATABASE SY; NHS England and NHS Improvement, A E ATT EM ADM	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2020	369								m2006	10.1136/bmj.m2006	http://dx.doi.org/10.1136/bmj.m2006			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JS	32439697	Bronze			2022-12-28	WOS:000538336600004
J	Kuehn, BM				Kuehn, Bridget M.			Studies Explore HIV Treatment and Prevention in Pregnant Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2020	323	19					1886	1886		10.1001/jama.2020.7627	http://dx.doi.org/10.1001/jama.2020.7627			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LT2XF	32427311				2022-12-28	WOS:000536934300027
J	Hoffman, GS				Hoffman, Gary S.			Vasculitis: Again, Changing the Standard of Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							GRANULOMATOSIS; RITUXIMAB		[Hoffman, Gary S.] Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Hoffman, GS (corresponding author), 30060 Bolingbrook Rd, Pepper Pike, OH 44124 USA.	hoffmag@ccf.org						Charles P, 2020, ANN INTERN MED, V173, P179, DOI 10.7326/M19-3827; Charles P, 2018, ANN RHEUM DIS, V77, P1144, DOI 10.1136/annrheumdis-2017-212878; FAUCI AS, 1973, MEDICINE, V52, P535, DOI 10.1097/00005792-197311000-00002; Guillevin L, 2014, NEW ENGL J MED, V371, P1771, DOI 10.1056/NEJMoa1404231; Hoffman GS, 2014, NAT REV RHEUMATOL, V10, P454, DOI 10.1038/nrrheum.2014.89; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; Hogan SL, 1996, J AM SOC NEPHROL, V7, P23; Lyons PA, 2012, NEW ENGL J MED, V367, P214, DOI 10.1056/NEJMoa1108735; Pryshchep O, 2008, CIRCULATION, V118, P1276, DOI 10.1161/CIRCULATIONAHA.108.789172; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905	10	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2020	173	3					236	U134		10.7326/M20-2853	http://dx.doi.org/10.7326/M20-2853			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MW7BG	32479173				2022-12-28	WOS:000557186700014
J	Vaduganathan, M; Claggett, BL; Jhund, PS; Cunningham, JW; Ferreira, JP; Zannad, F; Packer, M; Fonarow, GC; McMurray, JJV; Solomon, SD				Vaduganathan, Muthiah; Claggett, Brian L.; Jhund, Pardeep S.; Cunningham, Jonathan W.; Ferreira, Joao Pedro; Zannad, Faiez; Packer, Milton; Fonarow, Gregg C.; McMurray, John J. V.; Solomon, Scott D.			Estimating lifetime benefits of comprehensive disease -modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials	LANCET			English	Article							ACTIVE-CONTROL TRIALS; CLINICAL-OUTCOMES; PUTATIVE PLACEBO; HF; ENALAPRIL; LCZ696	Background Three drug classes (mineralocorticoid receptor antagonists [MRAs], angiotensin receptor-neprilysin inhibitors [ARNIs], and sodium/glucose cotransporter 2 [SGLT2] inhibitors) reduce mortality in patients with heart failure with reduced ejection fraction (HFrEF) beyond conventional therapy consisting of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) and beta blockers. Each class was previously studied with different background therapies and the expected treatment benefits with their combined use are not known. Here, we used data from three previously reported randomised controlled trials to estimate lifetime gains in event-free survival and overall survival with comprehensive therapy versus conventional therapy in patients with chronic HFrEF. Methods In this cross-trial analysis, we estimated treatment effects of comprehensive disease-modifying pharmacological therapy (ARNI, beta blocker, MRA, and SGLT2 inhibitor) versus conventional therapy (ACE inhibitor or ARB and beta blocker) in patients with chronic HFrEF by making indirect comparisons of three pivotal trials, EMPHASIS-HF (n=2737), PARADIGM-HF (n=8399), and DAPA-HF (n=4744). Our primary endpoint was a composite of cardiovascular death or first hospital admission for heart failure; we also assessed these endpoints individually and assessed all-cause mortality. Assuming these relative treatment effects are consistent over time, we then projected incremental long-term gains in event-free survival and overall survival with comprehensive disease-modifying therapy in the control group of the EMPHASIS-HF trial (ACE inhibitor or ARB and beta blocker). Findings The hazard ratio (HR) for the imputed aggregate treatment effects of comprehensive disease-modifying therapy versus conventional therapy on the primary endpoint of cardiovascular death or hospital admission for heart failure was 0.38 (95% CI 0.30-0.47). HRs were also favourable for cardiovascular death alone (HR 0.50 [95% CI 0.37-0.67]), hospital admission for heart failure alone (0.32 [0.24-0.43]), and all-cause mortality (0.53 [0.40-0.70]). Treatment with comprehensive disease-modifying pharmacological therapy was estimated to afford 2.7 additional years ( for an 80-year-old) to 8.3 additional years ( for a 55-year-old) free from cardiovascular death or first hospital admission for heart failure and 1.4 additional years (for an 80-year-old) to 6.3 additional years (for a 55-year-old) of survival compared with conventional therapy. Interpretation Among patients with HFrEF, the anticipated aggregate treatment effects of early comprehensive disease-modifying pharmacological therapy are substantial and support the combination use of an ARNI, beta blocker, MRA, and SGLT2 inhibitor as a new therapeutic standard.	[Vaduganathan, Muthiah; Claggett, Brian L.; Cunningham, Jonathan W.; Solomon, Scott D.] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Boston, MA 02115 USA; [Jhund, Pardeep S.; McMurray, John J. V.] Univ Glasgow, British Heart Fdn, Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Ferreira, Joao Pedro; Zannad, Faiez] Univ Lorraine, CHRU Nancy, Ctr Invest Clin Plurithemat 1433, F CRIN INI CRCT,INSERM,U1116, Nancy, France; [Ferreira, Joao Pedro] Univ Porto, Dept Physiol & Cardiothorac Surg, Porto, Portugal; [Packer, Milton] Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst, Dallas, TX USA; [Packer, Milton] Imperial Coll, London, England; [Fonarow, Gregg C.] Univ Calif Los Angeles, David Geffen Sch Med, Med Ctr, Div Cardiol, Los Angeles, CA 90095 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Glasgow; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Universidade do Porto; Baylor University; Baylor University Medical Center; Imperial College London; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Solomon, SD (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Boston, MA 02115 USA.	ssolomon@bwh.harvard.edu	Jhund, Pardeep/GLS-9508-2022; Ferreira, João Pedro/AAB-2489-2022	Jhund, Pardeep/0000-0003-4306-5317; Ferreira, João Pedro/0000-0002-2304-6138; mcmurray, john/0000-0002-6317-3975; Cunningham, Jonathan/0000-0003-4481-7867	KL2/Catalyst medical research investigator training award from Harvard Catalyst (National Institutes of Health (NIH)/National Center for Advancing Translational Sciences) [UL 1TR002541]; French National Research Agency Fighting Heart Failure [ANR-15-RHU-0004]; French Program Improvement Award project Lorraine Universite d'Excellence Functional Genomic, Epigenomic and ENvironment interplay to IMPACT the Understanding, diagnosis and management of healthy and pathological AGEing [ANR-15-IDEX-04-LUE]	KL2/Catalyst medical research investigator training award from Harvard Catalyst (National Institutes of Health (NIH)/National Center for Advancing Translational Sciences); French National Research Agency Fighting Heart Failure(French National Research Agency (ANR)); French Program Improvement Award project Lorraine Universite d'Excellence Functional Genomic, Epigenomic and ENvironment interplay to IMPACT the Understanding, diagnosis and management of healthy and pathological AGEing	MV is supported by the KL2/Catalyst medical research investigator training award from Harvard Catalyst (National Institutes of Health (NIH)/National Center for Advancing Translational Sciences award UL 1TR002541) and serves on advisory boards for Amgen, AstraZeneca, Baxter Healthcare, Bayer, Boehringer Ingelheim, Cytokinetics, and Relypsa. BLC has received consultancy fees from Boehringer Ingelheim, Gilead, AOBiome, and Corvia. PSJ is a consultant for and has received advisory board and speaker fees from Novartis, Vifor Pharma, Cytokinetics, and Boehringer Ingelheim; and has received research support from Boehringer Ingelheim. PSJ's employer, University of Glasgow, has been paid for time spent working on PARADIGM-HF by Novartis and DAPA-HF by AstraZeneca. JWC reports no competing interests. JPF and FZ are supported by the French National Research Agency Fighting Heart Failure, grant ANR-15-RHU-0004, by the French Program Improvement Award project Lorraine Universite d'Excellence Functional Genomic, Epigenomic and ENvironment interplay to IMPACT the Understanding, diagnosis and management of healthy and pathological AGEing, grant ANR-15-IDEX-04-LUE, the Contrat de Plan Etat Region Lorraine, and the FEDER IT2MP. FZ has received fees for serving on the board of Boston Scientific; consulting fees from Novartis, Takeda, AstraZeneca, Boehringer Ingelheim, GE Healthcare, Relypsa, Servier, Boston Scientific, Bayer, Johnson & Johnson, and Resmed; and speaker fees from Pfizer and AstraZeneca. MP has received personal fees from Akcea, AstraZeneca, Amgen, Actavis, AbbVie, Bayer, Boehringer Ingelheim, Cardiorentis, Daiichi Sankyo, Johnson & Johnson, Novo Nordisk, Pfizer, Sanofi, Synthetic Biologics, and Theravance. GCF reports research funding from NIH and has served as a consultant for Abbott, Amgen, AstraZeneca, Bayer, CHF Solutions, Janssen, Medtronic, Merck, and Novartis. JJVM has served as a coprincipal investigator of the PARADIGM-HF and DAPA-HF trials; and his employer, University of Glasgow, has been paid by Novartis and AstraZeneca, respectively, for his time spent in these roles. SDS has received research grants from Alnylam, Amgen, AstraZeneca, Bellerophon, Celladon, Gilead, GlaxoSmithKline, Ionis Pharmaceutics, Lone Star Heart, Mesoblast, MyoKardia, NIH/National Heart, Lung, and Blood Institute, Novartis, Sanofi Pasteur, and Theracos; and has consulted for Alnylam, Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Corvia, Gilead, GlaxoSmithKline, Ironwood, Merck, Novartis, Pfizer, Takeda, and Theracos.	Alter DA, 2012, J GEN INTERN MED, V27, P1171, DOI 10.1007/s11606-012-2072-y; Bhagat AA, 2019, JACC-HEART FAIL, V7, P1, DOI 10.1016/j.jchf.2018.06.011; Brunner-La Rocca HP, 2019, JACC-HEART FAIL, V7, P13, DOI 10.1016/j.jchf.2018.10.010; Burnett H, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003529; Claggett B, 2015, NEW ENGL J MED, V373, P2289, DOI 10.1056/NEJMc1509753; Desai AS, 2017, JAMA CARDIOL, V2, P79, DOI 10.1001/jamacardio.2016.4733; Durrleman S, 2003, STAT MED, V22, P941, DOI 10.1002/sim.1454; Ferreira JP, 2019, JACC-HEART FAIL, V7, P1012, DOI 10.1016/j.jchf.2019.08.017; Fisher LD, 2001, AM HEART J, V141, P26, DOI 10.1067/mhj.2001.111262; Greene SJ, 2019, J AM COLL CARDIOL, V73, P2365, DOI 10.1016/j.jacc.2019.02.015; Hasselblad V, 2001, DRUG INF J, V35, P435, DOI 10.1177/009286150103500212; Jhund PS, 2015, EUR HEART J, V36, P2576, DOI 10.1093/eurheartj/ehv330; Komajda M, 2019, EUR J HEART FAIL, V21, P921, DOI 10.1002/ejhf.1459; Martinez FA, 2020, CIRCULATION, V141, P100, DOI 10.1161/CIRCULATIONAHA.119.044133; McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303; McMurray J, 2015, EUR HEART J, V36, P434, DOI 10.1093/eurheartj/ehu455; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Mentz RJ, 2018, J AM COLL CARDIOL, V72, P41, DOI 10.1016/j.jacc.2018.04.038; Paladino J, 2019, JAMA-J AM MED ASSOC, V322, P1345, DOI 10.1001/jama.2019.11533; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Shah KS, 2017, J AM COLL CARDIOL, V70, P2476, DOI 10.1016/j.jacc.2017.08.074; Stienen S, 2019, J AM COLL CARDIOL, V73, P2357, DOI 10.1016/j.jacc.2019.02.043; Tsao CW, 2018, JACC-HEART FAIL, V6, P678, DOI 10.1016/j.jchf.2018.03.006; Vaduganathan M, 2020, EUR HEART J, V41, P2356, DOI 10.1093/eurheartj/ehaa184; Vaduganathan M, 2020, JACC-HEART FAIL, V8, P469, DOI 10.1016/j.jchf.2019.12.015; Vaduganathan M, 2013, J CARD FAIL, V19, P540, DOI 10.1016/j.cardfail.2013.05.017; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	27	197	202	4	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2020	396	10244					121	128		10.1016/S0140-6736(20)30748-0	http://dx.doi.org/10.1016/S0140-6736(20)30748-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ2JY	32446323	Green Submitted, Green Accepted			2022-12-28	WOS:000552724600016
J	McGinty, EE; Presskreischer, R; Han, H; Barry, CL				McGinty, Emma E.; Presskreischer, Rachel; Han, Hahrie; Barry, Colleen L.			Psychological Distress and Loneliness Reported by US Adults in 2018 and April 2020	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[McGinty, Emma E.; Presskreischer, Rachel; Barry, Colleen L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 N Broadway,Room 359, Baltimore, MD 21205 USA; [Han, Hahrie] Johns Hopkins Univ, Dept Polit Sci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	McGinty, EE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 N Broadway,Room 359, Baltimore, MD 21205 USA.	bmcginty@jhu.edu		Han, Hahrie/0000-0002-5259-8943	Johns Hopkins University; RobertWood Johnson Foundation; Johns Hopkins Bloomberg School of Public Health	Johns Hopkins University(Johns Hopkins University); RobertWood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Johns Hopkins Bloomberg School of Public Health(Johns Hopkins University)	Dr McGinty reported receiving a Faculty Innovation Award from Johns Hopkins University. Dr Han reported receiving a grant from the RobertWood Johnson Foundation. Dr Barry reported receiving endowment funds from the Johns Hopkins Bloomberg School of Public Health.	American Association for Public Opinion Research, 2010, REP ONL PAN; Centers for Disease Control and Prevention, NAT CTR HLTH STAT DA NAT CTR HLTH STAT DA; Kaiser Family Foundation, 2018, SURV LON SOC IS US U; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; NORC at the University of Chicago, 2019, TECHN OV AMERISPEAK	6	441	446	2	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2020	324	1					93	94		10.1001/jama.2020.9740	http://dx.doi.org/10.1001/jama.2020.9740			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM5FX	32492088	Green Published, Bronze			2022-12-28	WOS:000568123600026
J	Shitara, K; Bang, YJ; Iwasa, S; Sugimoto, N; Ryu, MH; Sakai, D; Chung, HC; Kawakami, H; Yabusaki, H; Lee, J; Saito, K; Kawaguchi, Y; Kamio, T; Kojima, A; Sugihara, M; Yamaguchi, K				Shitara, Kohei; Bang, Yung-Jue; Iwasa, Satoru; Sugimoto, Naotoshi; Ryu, Min-Hee; Sakai, Daisuke; Chung, Hyun-Cheol; Kawakami, Hisato; Yabusaki, Hiroshi; Lee, Jeeyun; Saito, Kaku; Kawaguchi, Yoshinori; Kamio, Takahiro; Kojima, Akihito; Sugihara, Masahiro; Yamaguchi, Kensei		DESTINY Gastric01 Investigators	Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND; PLUS PACLITAXEL; CATHEPSIN-B; HER2; EMTANSINE; THERAPY; CHEMOTHERAPY; PERTUZUMAB; DOCETAXEL; LAPATINIB	Background Trastuzumab deruxtecan (DS-8201) is an antibody-drug conjugate consisting of an anti-HER2 (human epidermal growth factor receptor 2) antibody, a cleavable tetrapeptide-based linker, and a cytotoxic topoisomerase I inhibitor. The drug may have efficacy in patients with HER2-positive advanced gastric cancer. Methods In an open-label, randomized, phase 2 trial, we evaluated trastuzumab deruxtecan as compared with chemotherapy in patients with HER2-positive advanced gastric cancer. Patients with centrally confirmed HER2-positive gastric or gastroesophageal junction adenocarcinoma that had progressed while they were receiving at least two previous therapies, including trastuzumab, were randomly assigned in a 2:1 ratio to receive trastuzumab deruxtecan (6.4 mg per kilogram of body weight every 3 weeks) or physician's choice of chemotherapy. The primary end point was the objective response, according to independent central review. Secondary end points included overall survival, response duration, progression-free survival, confirmed response (response persisting >= 4 weeks), and safety. Results Of 187 treated patients, 125 received trastuzumab deruxtecan and 62 chemotherapy (55 received irinotecan and 7 paclitaxel). An objective response was reported in 51% of the patients in the trastuzumab deruxtecan group, as compared with 14% of those in the physician's choice group (P<0.001). Overall survival was longer with trastuzumab deruxtecan than with chemotherapy (median, 12.5 vs. 8.4 months; hazard ratio for death, 0.59; 95% confidence interval, 0.39 to 0.88; P=0.01, which crossed the prespecified O'Brien-Fleming boundary [0.0202 on the basis of number of deaths]). The most common adverse events of grade 3 or higher were a decreased neutrophil count (in 51% of the trastuzumab deruxtecan group and 24% of the physician's choice group), anemia (38% and 23%, respectively), and decreased white-cell count (21% and 11%). A total of 12 patients had trastuzumab deruxtecan-related interstitial lung disease or pneumonitis (grade 1 or 2 in 9 patients and grade 3 or 4 in 3), as adjudicated by an independent committee. One drug-related death (due to pneumonia) was noted in the trastuzumab deruxtecan group; no drug-related deaths occurred in the physician's choice group. Conclusions Therapy with trastuzumab deruxtecan led to significant improvements in response and overall survival, as compared with standard therapies, among patients with HER2-positive gastric cancer. Myelosuppression and interstitial lung disease were the notable toxic effects. (Funded by Daiichi Sankyo; DESTINY-Gastric01 ClinicalTrials.gov number,.) Approximately 15 to 20% of gastric adenocarcinomas express HER2. Trastuzumab deruxtecan is an antibody-drug conjugate composed of trastuzumab and the topoisomerase I inhibitor deruxtecan. In a randomized trial, the antibody-drug conjugate led to higher response and longer overall survival than physician's choice of therapy among patients with relapsed disease.	[Shitara, Kohei] Natl Canc Ctr Hosp East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan; [Iwasa, Satoru] Natl Canc Ctr, Tokyo, Japan; [Kamio, Takahiro; Kojima, Akihito; Sugihara, Masahiro] Daiichi Sankyo, Tokyo, Japan; [Yamaguchi, Kensei] Canc Inst Hosp JFCR, Tokyo, Japan; [Sugimoto, Naotoshi] Osaka Int Canc Inst, Osaka, Japan; [Sakai, Daisuke] Osaka Univ Hosp, Osaka, Japan; [Kawakami, Hisato] Kindai Univ Hosp, Osaka, Japan; [Yabusaki, Hiroshi] Niigata Canc Ctr Hosp, Niigata, Japan; [Bang, Yung-Jue] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Ryu, Min-Hee] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea; [Chung, Hyun-Cheol] Yonsei Univ, Yonsei Canc Ctr, Coll Med, Seoul, South Korea; [Lee, Jeeyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Saito, Kaku; Kawaguchi, Yoshinori] Daiichi Sankyo, Basking Ridge, NJ USA	National Cancer Center - Japan; National Cancer Center - Japan; Daiichi Sankyo Company Limited; Japanese Foundation for Cancer Research; Osaka University; Seoul National University (SNU); University of Ulsan; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center; Daiichi Sankyo Company Limited	Shitara, K (corresponding author), Natl Canc Ctr Hosp East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	kshitara@east.ncc.go.jp	Shitara, Kohei/AAA-3877-2021; Kawakami, Hisato/L-6845-2019; Bang, Yung Jue/J-2759-2012	Kawakami, Hisato/0000-0002-3280-4850; Bang, Yung Jue/0000-0001-6000-4597; Chung, Hyun/0000-0002-0920-9471	Daiichi Sankyo	Daiichi Sankyo(Daiichi Sankyo Company Limited)	Funded by Daiichi Sankyo; DESTINY-Gastric01 ClinicalTrials.gov number, NCT03329690.	Aggarwal N, 2014, PROTEOM CLIN APPL, V8, P427, DOI 10.1002/prca.201300105; [Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01; Bang YJ, 2018, ANN ONCOL, V29, P2052, DOI 10.1093/annonc/mdy264; Bang YJ, 2010, LANCET, V376, P1302; Bartley AN, 2017, J CLIN ONCOL, V35, P446, DOI 10.1200/JCO.2016.69.4836; BROOKMEYER R, 1982, BIOMETRICS, V38, P29, DOI 10.2307/2530286; Dimopoulou I, 2006, ANN ONCOL, V17, P372, DOI 10.1093/annonc/mdj057; Grabsch H, 2010, CELL ONCOL, V32, P57, DOI 10.3233/CLO-2009-0497; Grillo F, 2016, WORLD J GASTROENTERO, V22, P5879, DOI 10.3748/wjg.v22.i26.5879; Hecht JR, 2016, J CLIN ONCOL, V34, P443, DOI 10.1200/JCO.2015.62.6598; Janjigian YY, 2018, CANCER DISCOV, V8, P49, DOI 10.1158/2159-8290.CD-17-0787; Kang YK, 2017, LANCET, V390, P2461, DOI 10.1016/S0140-6736(17)31827-5; Krop IE, 2015, J CLIN ONCOL, V33, P1136, DOI 10.1200/JCO.2014.58.7782; Makiyama A, 2020, J CLIN ONCOL; Marcoux J, 2015, PROTEIN SCI, V24, P1210, DOI 10.1002/pro.2666; Modi S, 2020, J CLIN ONCOL; Modi S, 2020, NEW ENGL J MED, V382, P610, DOI 10.1056/NEJMoa1914510; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Muro K, 2019, ANN ONCOL, V30, P19, DOI 10.1093/annonc/mdy502; Nagai Y, 2019, XENOBIOTICA, V49, P1086, DOI 10.1080/00498254.2018.1531158; National Comprehensive Cancer Network, 2019, GASTR CANC, V4; Niedergethmann M, 2004, PANCREAS, V29, P204, DOI 10.1097/00006676-200410000-00005; Ogitani Y, 2016, BIOORG MED CHEM LETT, V26, P5069, DOI 10.1016/j.bmcl.2016.08.082; Ogitani Y, 2016, CLIN CANCER RES, V22, P5097, DOI 10.1158/1078-0432.CCR-15-2822; Ogitani Y, 2016, CANCER SCI, V107, P1039, DOI 10.1111/cas.12966; Pietrantonio F, 2016, INT J CANCER, V139, P2859, DOI 10.1002/ijc.30408; Satoh T, 2014, J CLIN ONCOL, V32, P2039, DOI 10.1200/JCO.2013.53.6136; Shiose Y, 2007, BIOL PHARM BULL, V30, P2365, DOI 10.1248/bpb.30.2365; Shitara K, 2019, LANCET ONCOL, V20, P827, DOI 10.1016/S1470-2045(19)30088-9; Shitara K, 2018, LANCET ONCOL, V19, P1437, DOI 10.1016/S1470-2045(18)30739-3; Swain SM, 2020, LANCET ONCOL, V21, P519, DOI 10.1016/S1470-2045(19)30863-0; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513; Tabernero J, 2018, LANCET ONCOL, V19, P1372, DOI 10.1016/S1470-2045(18)30481-9; Takegawa N, 2019, INT J CANCER, V145, P3414, DOI 10.1002/ijc.32408; Thuss-Patience PC, 2017, LANCET ONCOL, V18, P640, DOI 10.1016/S1470-2045(17)30111-0; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Van Cutsem E, 2015, GASTRIC CANCER, V18, P476, DOI 10.1007/s10120-014-0402-y; Wang DS, 2019, GUT, V68, P1152, DOI 10.1136/gutjnl-2018-316522; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6	39	314	328	14	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2020	382	25					2419	2430		10.1056/NEJMoa2004413	http://dx.doi.org/10.1056/NEJMoa2004413			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MF9FX	32469182	Bronze			2022-12-28	WOS:000545644400007
J	Grasselli, G; Zanella, A				Grasselli, Giacomo; Zanella, Alberto			Critically ill patients with COVID-19 in New York City	LANCET			English	Editorial Material									[Grasselli, Giacomo; Zanella, Alberto] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dipartimento Anestesia Rianimaz & Emergenza Urgen, I-20122 Milan, Italy; [Grasselli, Giacomo; Zanella, Alberto] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Grasselli, G (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dipartimento Anestesia Rianimaz & Emergenza Urgen, I-20122 Milan, Italy.; Grasselli, G (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.	giacomo.grasselli@unimi.it						Azoulay E, 2001, CRIT CARE MED, V29, P2132, DOI 10.1097/00003246-200111000-00014; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Myers LC, 2020, JAMA-J AM MED ASSOC, V323, P2195, DOI 10.1001/jama.2020.7202; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Wang T, 2020, LANCET HAEMATOL, V7, pE362, DOI 10.1016/S2352-3026(20)30109-5; Wang Y, 2020, AM J RESP CRIT CARE, V201, P1430, DOI 10.1164/rccm.202003-0736LE; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	10	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2020	395	10239					1740	1741		10.1016/S0140-6736(20)31190-9	http://dx.doi.org/10.1016/S0140-6736(20)31190-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LZ1MK	32442530	Green Published, Bronze			2022-12-28	WOS:000540993600003
J	Dance, A				Dance, Amber			SURVIVAL OF THE LITTLEST	NATURE			English	News Item							ASSOCIATION; BIRTH											Bolton CE, 2012, J PEDIATR-US, V161, P595, DOI 10.1016/j.jpeds.2012.03.052; British Association of Perinatal Medicine, 2019, PER MAN EXTR PRET BI; Crump C, 2019, JAMA-J AM MED ASSOC, V322, P1580, DOI 10.1001/jama.2019.15040; Doyle LW, 2017, THORAX, V72, P712, DOI 10.1136/thoraxjnl-2016-208524; Flahault A, 2020, HYPERTENSION, V75, P796, DOI 10.1161/HYPERTENSIONAHA.119.14335; Garfield CF, 2017, JAMA PEDIATR, V171, P764, DOI 10.1001/jamapediatrics.2017.1020; Gire C, 2019, ARCH DIS CHILD, V104, P333, DOI 10.1136/archdischild-2018-315046; Halkerwal A, 2019, HYPERTENSION, V75, P211; Harkin P, 2016, J PEDIATR-US, V177, P72, DOI 10.1016/j.jpeds.2016.04.066; Ley D, 2019, J PEDIATR-US, V206, P56, DOI 10.1016/j.jpeds.2018.10.033; Liu YY, 2018, J PEDIATR-US, V200, P91, DOI 10.1016/j.jpeds.2018.04.038; O'Reilly H, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-2087; Saigal S, 2006, PEDIATRICS, V118, P1140, DOI 10.1542/peds.2006-0119; Soll R., 1997, COCHRANE DB SYST REV, V1997, pCD000511, DOI [10.1002/14651858.CD000511, DOI 10.1002/14651858.CD000511]; Soll R., 1998, COCHRANE DB SYST REV, V1998, DOI [10.1002/14651858.CD001149, DOI 10.1002/14651858.CD001149]; Stahl A, 2019, LANCET, V394, P1551, DOI 10.1016/S0140-6736(19)31344-3; Vohr B, 2017, J PEDIATR-US, V185, P42, DOI 10.1016/j.jpeds.2017.01.056	17	7	7	1	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 4	2020	582	7810					20	23		10.1038/d41586-020-01517-z	http://dx.doi.org/10.1038/d41586-020-01517-z			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE2XI	32488165				2022-12-28	WOS:000562460500003
J	Mahase, E				Mahase, Elisabeth			Covid-19: 146 researchers raise concerns over chloroquine study that halted WHO trial	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, SURGISPHERE, DOI [10.1016/S0140-6736(20)31180-6, DOI 10.1016/S0140-6736(20)31180-6]; [Anonymous], 2020, LANCET; MAHASE E, 2020, BMJ-BRIT MED J, V369, P32034, DOI DOI 10.1136/BMJ.M2126; Mehra MR, 2020, LANCET; Watson J, 2020, LANCET; Wellcome, 2020, SHARING RES DATA FIN	6	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2020	369								m2197	10.1136/bmj.m2197	http://dx.doi.org/10.1136/bmj.m2197			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0KV	32487664	Bronze			2022-12-28	WOS:000548476700009
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Testing times for GPs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Brooks M., 2020, NEW SCI; NHS, 2020, WHAT YOUR COR TEST R	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2020	369								m2180	10.1136/bmj.m2180	http://dx.doi.org/10.1136/bmj.m2180			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0KV	32487711	Bronze			2022-12-28	WOS:000548476700004
J	Brier, MI; Dordick, JS				Brier, Matthew I.; Dordick, Jonathan S.			Remote activation of cellular signaling	SCIENCE			English	Editorial Material									[Brier, Matthew I.; Dordick, Jonathan S.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Brier, Matthew I.; Dordick, Jonathan S.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Dordick, Jonathan S.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Dordick, Jonathan S.] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Dordick, JS (corresponding author), Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA.; Dordick, JS (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.; Dordick, JS (corresponding author), Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.; Dordick, JS (corresponding author), Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA.	dordick@rpi.edu			NIH [R01 NS097184]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by NIH grant R01 NS097184.	Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chen S, 2018, SCIENCE, V359, P679, DOI 10.1126/science.aaq1144; Duret G, 2018, BIOPHYS J, V114, p669A; Hernandez-Morales M, 2020, CELL REP, V30, P3250, DOI 10.1016/j.celrep.2020.02.070; Huang H, 2010, NAT NANOTECHNOL, V5, P602, DOI [10.1038/NNANO.2010.125, 10.1038/nnano.2010.125]; Krawczyk K, 2020, SCIENCE, V368, P993, DOI 10.1126/science.aau7187; Kubanek J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24170; Meister M, 2016, ELIFE, V5, DOI 10.7554/eLife.17210; Mosabbir AA, 2018, ACS SYNTH BIOL, V7, P718, DOI 10.1021/acssynbio.7b00415; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Pan YJ, 2018, P NATL ACAD SCI USA, V115, P992, DOI 10.1073/pnas.1714900115; Stanley SA, 2016, NATURE, V531, P647, DOI 10.1038/nature17183; Stanley SA, 2015, NAT MED, V21, P92, DOI 10.1038/nm.3730; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	15	1	1	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					936	937		10.1126/science.abb9122	http://dx.doi.org/10.1126/science.abb9122			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LV3IK	32467375				2022-12-28	WOS:000538332600022
J	Arroyo, V; Moreau, R; Jalan, R				Arroyo, Vicente; Moreau, Richard; Jalan, Rajiv			Acute-on-Chronic Liver Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ASIAN-PACIFIC ASSOCIATION; CONSENSUS RECOMMENDATIONS; ACUTE DECOMPENSATION; CLINICAL-COURSE; RENAL-FAILURE; CIRRHOSIS; MANAGEMENT; SURVIVAL	Acute decompensation in patients with chronic liver disease is called acute-on-chronic liver failure. Usually, systemic inflammation from infection or an acute hepatic injury precipitates liver dysfunction and extrahepatic organ failures, with increased mortality.	[Arroyo, Vicente; Moreau, Richard; Jalan, Rajiv] European Fdn Study Chron Liver Failure EF Clif, Baracaldo, Spain; [Arroyo, Vicente; Moreau, Richard; Jalan, Rajiv] Liver Chron Liver Failure EASL CLIF Consortium, European Assoc Study Liver, Baracaldo, Spain; [Moreau, Richard] Univ Paris, Ctr Rech Inflammat, INSERM, Clichy, France; [Moreau, Richard] Hop Beaujon, AP HP, Serv Hepatol, Clichy, France; [Jalan, Rajiv] UCL, Royal Free Hosp, Inst Liver Dis Hlth, Liver Failure Grp, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Arroyo, V (corresponding author), EF Clif, Travessera Gracia 11,7th Fl, Barcelona 08021, Spain.	vicente.arroyo@efclif.com	Moreau, Richard/S-1300-2019; Moreau, Richard/N-2197-2017; Arroyo, Vicente/F-9189-2015	Moreau, Richard/0000-0003-0862-403X; Moreau, Richard/0000-0003-0862-403X; Arroyo, Vicente/0000-0002-2728-1848				Amarapurkar D, 2015, INDIAN J GASTROENTER, V34, P216, DOI 10.1007/s12664-015-0574-3; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Artru F, 2017, J HEPATOL, V67, P708, DOI 10.1016/j.jhep.2017.06.009; Bajaj JS, 2014, HEPATOLOGY, V60, P250, DOI 10.1002/hep.27077; Banares R, 2013, HEPATOLOGY, V57, P1153, DOI 10.1002/hep.26185; Bernsmeier C, 2015, GASTROENTEROLOGY, V148, P603, DOI 10.1053/j.gastro.2014.11.045; Cardenas A, 2001, HEPATOLOGY, V34, P671, DOI 10.1053/jhep.2001.27830; Chen T, 2019, HEPATOL INT, V13, P695, DOI 10.1007/s12072-019-09992-x; Claria J, 2016, HEPATOLOGY, V64, P1249, DOI 10.1002/hep.28740; Fernandez J, 2019, GASTROENTEROLOGY, V157, P149, DOI 10.1053/j.gastro.2019.03.021; Fernandez J, 2018, GUT, V67, P1870, DOI 10.1136/gutjnl-2017-314240; Garcia-Tsao G, 2010, NEW ENGL J MED, V362, P823, DOI 10.1056/NEJMra0901512; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; Gustot T, 2015, HEPATOLOGY, V62, P243, DOI 10.1002/hep.27849; Hernaez R, 2019, J HEPATOL, V70, P639, DOI 10.1016/j.jhep.2018.12.018; Jalan R, 2002, BLOOD PURIFICAT, V20, P252, DOI 10.1159/000047017; Jalan R, 2014, J HEPATOL, V61, P1038, DOI 10.1016/j.jhep.2014.06.012; Kribben A, 2012, GASTROENTEROLOGY, V142, P782, DOI 10.1053/j.gastro.2011.12.056; Li H, 2016, SCI REP-UK, V6, DOI 10.1038/srep25487; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Mahmud N, 2019, HEPATOLOGY, V69, P2150, DOI 10.1002/hep.30494; Moreau R, 2020, J HEPATOL, V72, P688, DOI 10.1016/j.jhep.2019.11.009; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Nadim MK, 2016, J HEPATOL, V64, P717, DOI 10.1016/j.jhep.2015.10.019; O'Leary JG, 2018, HEPATOLOGY, V67, P2367, DOI 10.1002/hep.29773; Piano S, 2018, CLIN GASTROENTEROL H, V16, P1792, DOI 10.1016/j.cgh.2018.01.035; Romero-Gomez M, 2015, J HEPATOL, V62, P437, DOI 10.1016/j.jhep.2014.09.005; Sarin SK, 2019, HEPATOL INT, V13, P353, DOI 10.1007/s12072-019-09946-3; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Serste T, 2018, J HEPATOL, V69, P318, DOI 10.1016/j.jhep.2018.02.022; SK AZ, 2016, DIABETOL STOFFWECHS, V11, pS01; Sundaram V, 2019, GASTROENTEROLOGY, V156, P1381; Thompson J, 2018, LIVER TRANSPLANT, V24, P380, DOI 10.1002/lt.24986; Thuluvath PJ, 2018, J HEPATOL, V69, P1047, DOI 10.1016/j.jhep.2018.07.007; Wu TZ, 2018, GUT, V67, P2181, DOI 10.1136/gutjnl-2017-314641	35	174	175	26	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2020	382	22					2137	2145		10.1056/NEJMra1914900	http://dx.doi.org/10.1056/NEJMra1914900			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MA5NT	32459924				2022-12-28	WOS:000541960400019
J	Minikel, EV; Karczewski, KJ; Martin, HC; Cummings, BB; Whiffin, N; Rhodes, D; Alfoldi, J; Trembath, RC; van Heel, DA; Daly, MJ; Schreiber, SL; MacArthur, DG				Minikel, Eric Vallabh; Karczewski, Konrad J.; Martin, Hilary C.; Cummings, Beryl B.; Whiffin, Nicola; Rhodes, Daniel; Alfoldi, Jessica; Trembath, Richard C.; van Heel, David A.; Daly, Mark J.; Schreiber, Stuart L.; MacArthur, Daniel G.		Genome Aggregation Database Prod T; Genome Aggregation Database Consor	Evaluating drug targets through human loss-of-function genetic variation	NATURE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; HUNTINGTONS-DISEASE GENE; FAMILIAL PRION DISEASE; PARKINSONS-DISEASE; MUTATIONS; PROTEIN; PREVALENCE; PENETRANCE; VARIANTS; EPIDEMIOLOGY	Naturally occurring human genetic variants that are predicted to inactivate protein-coding genes provide an in vivo model of human gene inactivation that complements knockout studies in cells and model organisms. Here we report three key findings regarding the assessment of candidate drug targets using human loss-of-function variants. First, even essential genes, in which loss-of-function variants are not tolerated, can be highly successful as targets of inhibitory drugs. Second, in most genes, loss-of-function variants are sufficiently rare that genotype-based ascertainment of homozygous or compound heterozygous 'knockout' humans will await sample sizes that are approximately 1,000 times those presently available, unless recruitment focuses on consanguineous individuals. Third, automated variant annotation and filtering are powerful, but manual curation remains crucial for removing artefacts, and is a prerequisite for recall-by-genotype efforts. Our results provide a roadmap for human knockout studies and should guide the interpretation of loss-of-function variants in drug development.	[Minikel, Eric Vallabh; Karczewski, Konrad J.; Cummings, Beryl B.; Whiffin, Nicola; Alfoldi, Jessica; Daly, Mark J.; MacArthur, Daniel G.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Minikel, Eric Vallabh] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Minikel, Eric Vallabh; Schreiber, Stuart L.] Broad Inst MIT & Harvard, Chem Biol & Therapeut Sci Program, Cambridge, MA 02142 USA; [Minikel, Eric Vallabh; Karczewski, Konrad J.; Cummings, Beryl B.; Alfoldi, Jessica; Daly, Mark J.; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Minikel, Eric Vallabh; Cummings, Beryl B.] Harvard Med Sch, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Minikel, Eric Vallabh] Massachusetts Gen Hosp, Henry & Allison McCance Ctr Brain Hlth, Boston, MA 02114 USA; [Minikel, Eric Vallabh] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Minikel, Eric Vallabh] Prion Alliance, Cambridge, MA 02139 USA; [Martin, Hilary C.] Wellcome Sanger Inst, Hinxton, Cambs, England; [Whiffin, Nicola] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Whiffin, Nicola] Imperial Coll London, MRC London Inst Med Sci, London, England; [Rhodes, Daniel] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Translat Bioinformat, London, England; [Rhodes, Daniel] Barts Hearth NHS Trust, London, England; [Trembath, Richard C.] Kings Coll London, Fac Life Sci & Med, Sch Basic & Med Biosci, London, England; [van Heel, David A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Schreiber, Stuart L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [MacArthur, Daniel G.] Garvan Inst Med Res, Ctr Populat Genom, Sydney, NSW, Australia; [MacArthur, Daniel G.] UNSW Sydney, Sydney, NSW, Australia; [MacArthur, Daniel G.] Murdoch Childrens Res Inst, Ctr Populat Genom, Melbourne, Vic, Australia	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Wellcome Trust Sanger Institute; Imperial College London; Imperial College London; University of London; Queen Mary University London; University of London; King's College London; University of London; Queen Mary University London; Harvard University; Garvan Institute of Medical Research; University of New South Wales Sydney; Murdoch Children's Research Institute	Minikel, EV; MacArthur, DG (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Minikel, EV (corresponding author), Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.; Minikel, EV (corresponding author), Broad Inst MIT & Harvard, Chem Biol & Therapeut Sci Program, Cambridge, MA 02142 USA.; Minikel, EV; MacArthur, DG (corresponding author), Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA.; Minikel, EV (corresponding author), Harvard Med Sch, Program Biol & Biomed Sci, Boston, MA 02115 USA.; Minikel, EV (corresponding author), Massachusetts Gen Hosp, Henry & Allison McCance Ctr Brain Hlth, Boston, MA 02114 USA.; Minikel, EV (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.; Minikel, EV (corresponding author), Prion Alliance, Cambridge, MA 02139 USA.; MacArthur, DG (corresponding author), Garvan Inst Med Res, Ctr Populat Genom, Sydney, NSW, Australia.; MacArthur, DG (corresponding author), UNSW Sydney, Sydney, NSW, Australia.; MacArthur, DG (corresponding author), Murdoch Childrens Res Inst, Ctr Populat Genom, Melbourne, Vic, Australia.	eminikel@broadinstitute.org; d.macarthur@garvan.org.au	Cohen, Bruce M./AAZ-4986-2020; Ware, James S/G-5139-2012; Kaprio, Jaakko/A-1820-2008; Ma, Ronald/C-2788-2009; Färkkilä, Martti/AAG-6970-2021; Rioux, John D/A-9599-2015; sokol, harry/E-2290-2019; Glaser, Benjamin/F-8411-2017; Daly, Mark/B-2453-2017; Erdmann, Jeanette/P-7513-2014; Bown, Matthew/P-1957-2016; Loos, Ruth/Q-2862-2016	Ware, James S/0000-0002-6110-5880; Kaprio, Jaakko/0000-0002-3716-2455; Ma, Ronald/0000-0002-1227-803X; Färkkilä, Martti/0000-0002-0250-8559; Rioux, John D/0000-0001-7560-8326; Tai, E Shyong/0000-0003-2929-8966; Cibulskis, Kristian/0000-0003-1343-1582; sokol, harry/0000-0002-2914-1822; Glaser, Benjamin/0000-0003-4711-5000; Daly, Mark/0000-0002-0949-8752; Melander, Olle/0000-0002-2581-484X; Palotie, Aarno/0000-0002-2527-5874; Rhodes, Daniel/0000-0002-2021-4773; Armean, Irina/0000-0002-1043-4756; van Heel, David/0000-0002-0637-2265; solinas, emilia/0000-0003-3532-1317; Tuomi, Tiinamaija/0000-0002-8306-6202; Erdmann, Jeanette/0000-0002-4486-6231; ELOSUA, ROBERTO/0000-0001-8235-0095; MacArthur, Daniel/0000-0002-5771-2290; Solomonson, Matthew/0000-0002-5344-9026; Bown, Matthew/0000-0002-6180-3611; Loos, Ruth/0000-0002-8532-5087	National Institutes of Health (NIH) [F31 AI122592]; NIDDK [U54 DK105566]; NIGMS [R01 GM104371]; Wellcome Trust [102627, 210561]; Medical Research Council [M009017]; Higher Education Funding Council for England Catalyst; Barts Charity [845/1796]; Health Data Research UK; Rosetrees and Stoneygate Imperial College Research Fellowship; Academy of Finland [312073]; Broad Institute; MRC [MC_UP_1102/20, MR/M009017/1] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Higher Education Funding Council for England Catalyst(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Barts Charity; Health Data Research UK; Rosetrees and Stoneygate Imperial College Research Fellowship; Academy of Finland(Academy of Finland); Broad Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was performed under ethical approval from the Partners Healthcare Institutional Research Board (2013P001339/MGH) and the Broad Institute Office of Research Subjects Protection (ORSP-3862) in compliance with all relevant ethical regulations; written informed consent was obtained from all research participants. We thank all of the research participants for contributing their data. E.V.M. acknowledges support from the National Institutes of Health (NIH) (F31 AI122592) and an anonymous organization. gnomAD data aggregation was supported primarily by the Broad Institute, gnomAD analysis was supported in part by NIDDK U54 DK105566, and development of LOFTEE by NIGMS R01 GM104371. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. E.L.G.H. is funded by the Wellcome Trust (102627, 210561), the Medical Research Council (M009017), Higher Education Funding Council for England Catalyst, Barts Charity (845/1796), Health Data Research UK (for London substantive site), and research delivery support from the NHS National Institute for Health Research Clinical Research Network (North Thames). N.W. is supported by a Rosetrees and Stoneygate Imperial College Research Fellowship. The results published here are in part based upon data: (1) generated by The Cancer Genome Atlas managed by the NCI and NHGRI (accession: phs000178.v10.p8). Information about TCGA can be found at http://cancergenome.nih.gov; (2) generated by the Genotype-Tissue Expression Project (GTEx) managed by the NIH Common Fund and NHGRI (accession: phs000424.v7.p2); (3) generated by the Exome Sequencing Project, managed by NHLBI; (4) generated by the Alzheimer's Disease Sequencing Project (ADSP), managed by the NIA and NHGRI (accession: phs000572.v7.p4). We thank J. Kaprio and M. Kurki (Finnish Twins AD cohort) and Academy of Finland grant 312073, and Ruth McPherson (Ottawa Genomics Heart Study) for providing information on individuals with PRNP-truncating variants. We thank J. B. Carroll, K. Heilbron, J. Fah Sathirapongsasuti, and L. C. Francioli for comments and suggestions. A subset of the analyses reported here originally appeared as a blog post on CureFFI.org (http://www.cureffi.org/2018/09/12/lof-and-drug-safety/).	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; AMBROSE CM, 1994, SOMAT CELL MOLEC GEN, V20, P27, DOI 10.1007/BF02257483; Andreadis A, 2012, J CELL PHYSIOL, V227, P1220, DOI 10.1002/jcp.22842; Bang J, 2015, LANCET, V386, P1672, DOI 10.1016/S0140-6736(15)00461-4; Bittles AH, 2010, P NATL ACAD SCI USA, V107, P1779, DOI 10.1073/pnas.0906079106; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Bommarito G, 2018, EUR J NEUROL, V25, pE91, DOI 10.1111/ene.13665; Byrne S, 2011, J NEUROL NEUROSUR PS, V82, P623, DOI 10.1136/jnnp.2010.224501; Capellari S, 2018, ANN CLIN TRANSL NEUR, V5, P777, DOI 10.1002/acn3.568; Chen JH, 2018, EUR NEUROL, V79, P256, DOI 10.1159/000488938; Chio A, 2008, NEUROLOGY, V70, P533, DOI 10.1212/01.wnl.0000299187.90432.3f; Cole TA, 2019, BIORXIV, DOI 10.1101/830554; Collins RL, 2020, NATURE, V581, P444, DOI 10.1038/s41586-020-2287-8; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; Cummings BB, 2020, NATURE, V581, P452, DOI 10.1038/s41586-020-2329-2; DeBoever C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03910-9; DeVos SL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0481; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Finckh U, 2000, AM J HUM GENET, V66, P110, DOI 10.1086/302702; Findlay GM, 2018, NATURE, V562, P217, DOI 10.1038/s41586-018-0461-z; Finer S, 2019, INT J EPIDEMIOL, V49, P20; Fisher ER, 2014, MOVEMENT DISORD, V29, P105, DOI 10.1002/mds.25717; Fong JC, 2017, J ALZHEIMERS DIS, V55, P249, DOI 10.3233/JAD-160300; Fuller ZL, 2019, NAT GENET, V51, P772, DOI 10.1038/s41588-019-0383-1; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Goldwurm S, 2007, NEUROLOGY, V68, P1141, DOI 10.1212/01.wnl.0000254483.19854.ef; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Harding SD, 2018, NUCLEIC ACIDS RES, V46, pD1091, DOI 10.1093/nar/gkx1121; Hart T, 2017, G3-GENES GENOM GENET, V7, P2719, DOI 10.1534/g3.117.041277; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hernandez DG, 2016, J NEUROCHEM, V139, P59, DOI 10.1111/jnc.13593; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jansen C, 2010, ACTA NEUROPATHOL, V119, P189, DOI 10.1007/s00401-009-0609-x; Jayadev S, 2011, ANN NEUROL, V69, P712, DOI 10.1002/ana.22264; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kay C, 2016, NEUROLOGY, V87, P282, DOI 10.1212/WNL.0000000000002858; Keum JW, 2016, AM J HUM GENET, V98, P287, DOI 10.1016/j.ajhg.2015.12.018; King EA, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008489; Kinoshita T, 2016, J LIPID RES, V57, P6, DOI 10.1194/jlr.R063313; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V192, P525, DOI 10.1006/bbrc.1993.1447; Kosmicki JA, 2017, NAT GENET, V49, P504, DOI 10.1038/ng.3789; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525; Lv WH, 2016, ONCOTARGET, V7, P4961, DOI 10.18632/oncotarget.6755; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Maddox RA, 2020, NEUROLOGY, V94, pE153, DOI 10.1212/WNL.0000000000008680; Mainland JD, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.2; Matsuzono K, 2013, EUR J NEUROL, V20, pe67, DOI 10.1111/ene.12089; McCampbell A, 2018, J CLIN INVEST, V128, P3558, DOI 10.1172/JCI99081; Mead S, 2013, NEW ENGL J MED, V369, P1904, DOI 10.1056/NEJMoa1214747; Minikel EV, 2019, NEUROLOGY, V93, pE125, DOI 10.1212/WNL.0000000000007745; Minikel EV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5169; Minikel EV, 2020, NEUROSCIENCE, DOI [10.1101/2020.03.27.011940, DOI 10.1101/2020.03.27.011940]; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Motenko H, 2015, MAMM GENOME, V26, P325, DOI 10.1007/s00335-015-9573-z; Musunuru K, 2019, CELL, V177, P132, DOI 10.1016/j.cell.2019.02.015; Nagashima S, 2012, ARTERIOSCL THROM VAS, V32, P1824, DOI 10.1161/ATVBAHA.111.240754; Narasimhan VM, 2016, SCIENCE, V352, P474, DOI 10.1126/science.aac8624; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Ohashi K, 2003, J BIOL CHEM, V278, P42936, DOI 10.1074/jbc.M307228200; Onyike CU, 2013, INT REV PSYCHIATR, V25, P130, DOI 10.3109/09540261.2013.776523; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Pringsheim T, 2012, MOVEMENT DISORD, V27, P1083, DOI 10.1002/mds.25075; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Rodan LH, 2016, EUR J HUM GENET, V24, P1826, DOI 10.1038/ejhg.2016.74; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Saleheen D, 2017, NATURE, V544, P235, DOI 10.1038/nature22034; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243; Tabrizi SJ, 2019, NEW ENGL J MED, V380, P2307, DOI 10.1056/NEJMoa1900907; Trinh J, 2014, JAMA NEUROL, V71, P1535, DOI 10.1001/jamaneurol.2014.1909; Uhl K, 2002, DRUG SAFETY, V25, P885, DOI 10.2165/00002018-200225120-00006; Whiffin N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-10717-9; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; Yates B, 2017, NUCLEIC ACIDS RES, V45, pD619, DOI 10.1093/nar/gkw1033; Zambrowicz BP, 2003, NAT REV DRUG DISCOV, V2, P38, DOI 10.1038/nrd987; Zhang W, 1996, J EXP MED, V183, P413, DOI 10.1084/jem.183.2.413; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	89	54	54	2	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 28	2020	581	7809					459	+		10.1038/s41586-020-2267-z	http://dx.doi.org/10.1038/s41586-020-2267-z			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX9ZL	32461653	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000576060200006
J	Orlando, L				Orlando, Ludovic			Filling Important Gaps in the Genomic History of Southwest Asia	CELL			English	Editorial Material								Many crucial developments in human prehistory occurred in Southwest Asia, including the transition to agriculture as well as the emergence of writing and of the earliest civilization. Two new studies in this issue of Cell map the genetic composition of human groups inhabiting the region during the sixth and first millennia Before Common Era (BCE) and uncover periods of significant population turnover.	[Orlando, Ludovic] Univ Paul Sabatier, Univ Toulouse, Lab Anthropobiol Mol & Imagerie Synth, CNRS,UMR 5288, F-31000 Toulouse, France; [Orlando, Ludovic] Univ Copenhagen, Globe Inst, Lundbeck Fdn GeoGenet Ctr, DK-1350K Copenhagen, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Copenhagen	Orlando, L (corresponding author), Univ Paul Sabatier, Univ Toulouse, Lab Anthropobiol Mol & Imagerie Synth, CNRS,UMR 5288, F-31000 Toulouse, France.; Orlando, L (corresponding author), Univ Copenhagen, Globe Inst, Lundbeck Fdn GeoGenet Ctr, DK-1350K Copenhagen, Denmark.	ludovic.orlando@univ-tlse3.fr	Orlando, Ludovic/A-8932-2013	Orlando, Ludovic/0000-0003-3936-1850				[Anonymous], TITLE ERROR; Daly KG, 2018, SCIENCE, V361, P85, DOI 10.1126/science.aas9411; Feldman MI, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0061; Feldman M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09209-7; Hanghoj K., 2018, PALEOGENOMICS, P75; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Mills B., 2017, OXFORD HDB SW ARCHAE, P928; Orlando L, 2015, NAT REV GENET, V16, P395, DOI 10.1038/nrg3935; WEISS H, 1993, SCIENCE, V261, P995, DOI 10.1126/science.261.5124.995	9	0	0	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2020	181	5					966	+		10.1016/j.cell.2020.05.010	http://dx.doi.org/10.1016/j.cell.2020.05.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LT9QF	32470405	Green Submitted, Bronze			2022-12-28	WOS:000537399500004
J	Ruiz, RFG; Berger, R; Billowes, J; Binnersley, CL; Bissell, ML; Breier, AA; Brinson, AJ; Chrysalidis, K; Cocolios, TE; Cooper, BS; Flanagan, KT; Giesen, TF; de Groote, RP; Franchoo, S; Gustafsson, FP; Isaev, TA; Koszorus, A; Neyens, G; Perrett, HA; Ricketts, CM; Rothe, S; Schweikhard, L; Vernon, AR; Wendt, KDA; Wienholtz, F; Wilkins, SG; Yang, XF				Ruiz, R. F. Garcia; Berger, R.; Billowes, J.; Binnersley, C. L.; Bissell, M. L.; Breier, A. A.; Brinson, A. J.; Chrysalidis, K.; Cocolios, T. E.; Cooper, B. S.; Flanagan, K. T.; Giesen, T. F.; de Groote, R. P.; Franchoo, S.; Gustafsson, F. P.; Isaev, T. A.; Koszorus, A.; Neyens, G.; Perrett, H. A.; Ricketts, C. M.; Rothe, S.; Schweikhard, L.; Vernon, A. R.; Wendt, K. D. A.; Wienholtz, F.; Wilkins, S. G.; Yang, X. F.			Spectroscopy of short-lived radioactive molecules	NATURE			English	Article							NUCLEI	Molecular spectroscopy offers opportunities for the exploration of the fundamental laws of nature and the search for new particle physics beyond the standard model(1-4). Radioactive molecules-in which one or more of the atoms possesses a radioactive nucleus-can contain heavy and deformed nuclei, offering high sensitivity for investigating parity- and time-reversal-violation effects(5,6). Radium monofluoride, RaF, is of particular interest because it is predicted to have an electronic structure appropriate for laser cooling(6), thus paving the way for its use in high-precision spectroscopic studies. Furthermore, the effects of symmetry-violating nuclear moments are strongly enhanced(5,7-9) in molecules containing octupole-deformed radium isotopes(10,11). However, the study of RaF has been impeded by the lack of stable isotopes of radium. Here we present an experimental approach to studying short-lived radioactive molecules, which allows us to measure molecules with lifetimes of just tens of milliseconds. Energetically low-lying electronic states were measured for different isotopically pure RaF molecules using collinear resonance ionisation at the ISOLDE ion-beam facility at CERN. Our results provide evidence of the existence of a suitable laser-cooling scheme for these molecules and represent a key step towards high-precision studies in these systems. Our findings will enable further studies of short-lived radioactive molecules for fundamental physics research.	[Ruiz, R. F. Garcia; Chrysalidis, K.; Neyens, G.; Rothe, S.; Wienholtz, F.; Wilkins, S. G.] CERN, Geneva, Switzerland; [Ruiz, R. F. Garcia; Brinson, A. J.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Berger, R.] Philipps Univ Marburg, Fachbereich Chem, Marburg, Germany; [Billowes, J.; Binnersley, C. L.; Bissell, M. L.; Cooper, B. S.; Flanagan, K. T.; Perrett, H. A.; Ricketts, C. M.; Vernon, A. R.] Univ Manchester, Dept Phys & Astron, Manchester, Lancs, England; [Breier, A. A.; Giesen, T. F.] Univ Kassel, Inst Phys, Astrophys Lab, Kassel, Germany; [Cocolios, T. E.; Gustafsson, F. P.; Koszorus, A.; Neyens, G.] Katholieke Univ Leuven, Inst Kern & Stralingsfys, Leuven, Belgium; [Flanagan, K. T.] Univ Manchester, Photon Sci Inst, Manchester, Lancs, England; [de Groote, R. P.] Univ Jyvaskyla, Dept Phys, Jyvaskyla, Finland; [Franchoo, S.] Inst Phys Nucl Orsay, Orsay, France; [Isaev, T. A.] NRC Kurchatov Inst PNPI, Gatchina, Russia; [Schweikhard, L.; Wienholtz, F.] Ernst Moritz Arndt Univ Greifswald, Inst Phys, Greifswald, Germany; [Wendt, K. D. A.] Johannes Gutenberg Univ Mainz, Inst Phys, Mainz, Germany; [Yang, X. F.] Peking Univ, Sch Phys, Beijing, Peoples R China; [Yang, X. F.] Peking Univ, State Key Lab Nucl Phys & Technol, Beijing, Peoples R China	European Organization for Nuclear Research (CERN); Massachusetts Institute of Technology (MIT); Philipps University Marburg; University of Manchester; Universitat Kassel; KU Leuven; University of Manchester; University of Jyvaskyla; UDICE-French Research Universities; Universite Paris Saclay; Ernst Moritz Arndt Universitat Greifswald; Johannes Gutenberg University of Mainz; Peking University; Peking University	Ruiz, RFG (corresponding author), CERN, Geneva, Switzerland.; Ruiz, RFG (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Berger, R (corresponding author), Philipps Univ Marburg, Fachbereich Chem, Marburg, Germany.	rgarciar@mit.edu; robert.berger@uni-marburg.de	de Groote, Ruben Pieter/AAX-8908-2020; Yang, Xiaofei/AAC-4290-2022; Schweikhard, Lutz/AAX-3044-2021; Isaev, Timur/HGB-7169-2022; Flanagan, Kieran/B-7575-2015	de Groote, Ruben Pieter/0000-0003-4942-1220; Yang, Xiaofei/0000-0002-1633-4000; Chrysalidis, Katerina/0000-0003-2908-8424; Vernon, Adam/0000-0001-8130-0109; Ricketts, Christopher/0000-0003-1084-3573; Koszorus, Agota/0000-0001-7959-8786; Flanagan, Kieran/0000-0003-0847-2662; Brinson, Alex/0000-0002-9551-5298; Cocolios, Thomas Elias/0000-0002-0456-7878; Parnefjord Gustafsson, Fredrik Olof Andre/0000-0003-2063-4310	ERC Consolidator grant [648381]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [328961117 - SFB 1319 ELCH]; STFC [ST/L005794/1, ST/L005786/1, ST/P004423/1]; Ernest Rutherford grant [ST/L002868/1]; FWO-Vlaanderen; GOA from KU Leuven [15/010]; BriX IAP research programme [P7/12]; European Union [654002]; Russian Science Foundation [18-12-00227]; BMBF [05P15HGCIA, 05P18HGCIA]; Henry W. Kendall (1955) Fellowship; STFC [ST/G006415/1, ST/L002868/1, ST/J000159/1, 2023247, EP/D075769/1, ST/J004189/1] Funding Source: UKRI	ERC Consolidator grant(European Research Council (ERC)); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Ernest Rutherford grant; FWO-Vlaanderen(FWO); GOA from KU Leuven; BriX IAP research programme; European Union(European Commission); Russian Science Foundation(Russian Science Foundation (RSF)); BMBF(Federal Ministry of Education & Research (BMBF)); Henry W. Kendall (1955) Fellowship; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by the ERC Consolidator grant no. 648381 (FNPMLS); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) project no. 328961117 - SFB 1319 ELCH; STFC grants ST/L005794/1, ST/L005786/1 and ST/P004423/1, and Ernest Rutherford grant no. ST/L002868/1; projects from FWO-Vlaanderen, GOA 15/010 from KU Leuven and BriX IAP research programme no. P7/12; European Union grant agreement no. 654002 (ENSAR2); the Russian Science Foundation under grant no. 18-12-00227; and BMBF grants 05P15HGCIA and 05P18HGCIA. We thank J. P. Ramos, J. Ballof and T. Stora for their support in the production of RaF molecules. A.J.B. was suppported by the Henry W. Kendall (1955) Fellowship. We would also like to thank the ISOLDE technical group for their support and assistance. We thank D. Budker for comments and suggestions as well as A. Petrov for discussions on. states. R.B. acknowledges I. Tietje for early discussions on various experiments at CERN and thanks A. Welker for sharing knowledge on isotope production and separation as well as for initial discussions on the RaF studies. R.B. acknowledges discussions with K. Gaul on molecular properties and with D. Andrae on finite nuclear size effects. R.B. and T.A.I. acknowledge S. Hoekstra and L. Willmann for early discussions on the production of RaF. T.A.I. thanks A. Zaitsevskii for discussions on the coupled-cluster method.	Altuntas E, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.142501; Anderegg L, 2018, NAT PHYS, V14, P890, DOI 10.1038/s41567-018-0191-z; Andreev V, 2018, NATURE, V562, P355, DOI 10.1038/s41586-018-0599-8; [Anonymous], 2018, HSC CHEM 9 V 9 8 1 2; Antypas D, 2019, NAT PHYS, V15, P120, DOI 10.1038/s41567-018-0312-8; Auerbach N, 1996, PHYS REV LETT, V76, P4316, DOI 10.1103/PhysRevLett.76.4316; Barry JF, 2014, NATURE, V512, P286, DOI 10.1038/nature13634; Berger R, 2019, WIRES COMPUT MOL SCI, V9, DOI 10.1002/wcms.1396; BERNARD A, 1989, MOL PHYS, V67, P1, DOI 10.1080/00268978900100891; Bohlen TT, 2014, NUCL DATA SHEETS, V120, P211, DOI 10.1016/j.nds.2014.07.049; Breier AA, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4971854; Butler PA, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.042503; Cairncross WB, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.153001; de Groote RP, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.132501; Di Rosa MD, 2004, EUR PHYS J D, V31, P395, DOI 10.1140/epjd/e2004-00167-2; Fazil NM, 2019, PHYS REV A, V99, DOI 10.1103/PhysRevA.99.052502; Flambaum VV, 2020, PHYS REV A, V101, DOI 10.1103/PhysRevA.101.042504; Flambaum VV, 2019, PHYS REV C, V99, DOI 10.1103/PhysRevC.99.035501; Flambaum VV, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.103003; Flambaum VV, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.024501; Flanagan KT, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.212501; Formanuik A, 2017, NAT CHEM, V9, P578, DOI [10.1038/NCHEM.2692, 10.1038/nchem.2692]; Gaffney LP, 2013, NATURE, V497, P199, DOI 10.1038/nature12073; Gaul K, 2019, PHYS REV A, V99, DOI 10.1103/PhysRevA.99.032509; Guglielmetti A, 2001, EUR PHYS J A, V12, P383, DOI 10.1007/s10050-001-8661-5; Isaev TA, 2017, J PHYS B-AT MOL OPT, V50, DOI 10.1088/1361-6455/aa8f34; Isaev TA, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.052521; Isaev T. A., 2013, PREPRINT; Isaev TA, 2018, CHIMIA, V72, P375, DOI 10.2533/chimia.2018.375; Isaev TA, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.063006; Kaminski T, 2018, NAT ASTRON, V2, P778, DOI 10.1038/s41550-018-0541-x; Kreim S, 2013, NUCL INSTRUM METH B, V317, P492, DOI 10.1016/j.nimb.2013.07.072; Kudashov AD, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.052513; Lim J, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.123201; Parker RH, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.233002; Ruiz RFG, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.041005; Safronova MS, 2018, REV MOD PHYS, V90, DOI 10.1103/RevModPhys.90.025008; SANDARS PGH, 1967, PHYS REV LETT, V19, P1396, DOI 10.1103/PhysRevLett.19.1396; Sasmal S, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.062506; Shuman ES, 2010, NATURE, V467, P820, DOI 10.1038/nature09443; Truppe S, 2017, NAT PHYS, V13, P1173, DOI 10.1038/NPHYS4241; Wolf RN, 2013, INT J MASS SPECTROM, V349, P123, DOI 10.1016/j.ijms.2013.03.020; Wood CS, 1997, SCIENCE, V275, P1759, DOI 10.1126/science.275.5307.1759	44	36	36	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2020	581	7809					396	+		10.1038/s41586-020-2299-4	http://dx.doi.org/10.1038/s41586-020-2299-4			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MR8GF	32461650	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000553828700001
J	Berber, O; Ahmad, I; Gidwani, S				Berber, Onur; Ahmad, Imtiaz; Gidwani, Sam			Fractures of the scaphoid	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COST; IMMOBILIZATION		[Berber, Onur] Whittington Hosp, London, England; [Ahmad, Imtiaz] South Lambeth Rd Practice, London, England; Queens Pk Rangers Football Club, London, England; [Gidwani, Sam] Guys & St Thomas NHS Fdn Trust, London, England; [Gidwani, Sam] London Bridge Hosp, London, England	University of London; University College London; Guy's & St Thomas' NHS Foundation Trust	Gidwani, S (corresponding author), Guys & St Thomas NHS Fdn Trust, London, England.; Gidwani, S (corresponding author), London Bridge Hosp, London, England.			Ahmad, Imran/0000-0003-3675-7040				Backer HC, 2020, J WRIST SURG, V9, P81, DOI 10.1055/s-0039-1693147; Berber O, 2020, J HAND SURG-EUR VOL, V45, P643, DOI 10.1177/1753193420909491; Buijze GA, 2014, J HAND SURG-AM, V39, P621, DOI 10.1016/j.jhsa.2013.12.039; Clementson M, 2020, EFORT OPEN REV, V5, P96, DOI 10.1302/2058-5241.5.190025; COONEY WP, 1980, CLIN ORTHOP RELAT R, P90; Dias J, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1107-7; Duckworth AD, 2012, J TRAUMA ACUTE CARE, V72, pE41, DOI 10.1097/TA.0b013e31822458e8; Eastley N, 2013, J HAND SURG-EUR VOL, V38, P888, DOI 10.1177/1753193412451424; Garala K, 2016, BONE JOINT J, V98B, P654, DOI 10.1302/0301-620X.98B5.36938; GELBERMAN RH, 1980, J HAND SURG-AM, V5, P508, DOI 10.1016/S0363-5023(80)80087-6; Goffin JS, 2019, WORLD J ORTHOP, V10, P101, DOI 10.5312/wjo.v10.i2.101; Grewal Ruby, 2016, Open Orthop J, V10, P431; Harrison W, 2015, EUR J EMERG MED, V22, P142, DOI 10.1097/MEJ.0000000000000152; Jenkins PJ, 2008, INJURY, V39, P768, DOI 10.1016/j.injury.2008.01.003; Johnson MR, 2013, SPORTS HEALTH, V5, P183, DOI 10.1177/1941738112464762; LANGHOFF O, 1988, J HAND SURG-BRIT EUR, V13B, P77, DOI 10.1016/0266-7681(88)90058-7; Mallee WH, 2014, J HAND SURG-AM, V39, P1683, DOI 10.1016/j.jhsa.2014.06.004; National Institute for Health and Care Excellence, 2016, FRACT NONC ASS MAN; Offiah AC, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170883; Parvizi J, 1998, J HAND SURG-BRIT EUR, V23B, P324, DOI 10.1016/S0266-7681(98)80050-8; Ring J, 2015, INJURY, V46, P682, DOI 10.1016/j.injury.2015.01.017; Rua T, 2019, BONE JOINT J, V101B, P984, DOI 10.1302/0301-620X.101B8.BJJ-2018-1590.R1; VENDER MI, 1987, J HAND SURG-AM, V12A, P514, DOI 10.1016/S0363-5023(87)80198-3; WAECKERLE JF, 1987, ANN EMERG MED, V16, P733, DOI 10.1016/S0196-0644(87)80563-2	24	1	2	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2020	369								m1908	10.1136/bmj.m1908	http://dx.doi.org/10.1136/bmj.m1908			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JX	32461327				2022-12-28	WOS:000538337100004
J	Oliver, D				Oliver, David			David Oliver: Doughnut deliveries, hospital staff, and the pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2020, TWITTER; [Anonymous], 2020, DIABETES TIMES; Ford S., 2018, NURSING TIMES; Malhotra A., 2020, TWITTER; National Health Executive, 2017, NHS ENGL CRACKS DOWN; NHS England, 2015, 5MILLION PLAN IMPR H; O'Rahilly S, 2016, CLIN MED, V16, P551, DOI 10.7861/clinmedicine.16-6-551; Townshend T, 2017, PERSPECT PUBLIC HEAL, V137, P38, DOI 10.1177/1757913916679860	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2020	369								m2042	10.1136/bmj.m2042	http://dx.doi.org/10.1136/bmj.m2042			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JX	32461248	Bronze			2022-12-28	WOS:000538337100005
J	Dyer, C				Dyer, Clare			Children in care can be vaccinated against parents' wishes without court action	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2020	369								m2083	10.1136/bmj.m2083	http://dx.doi.org/10.1136/bmj.m2083			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JW	32457033				2022-12-28	WOS:000538337000009
J	Riddles, T; Saad, N; Benham, H				Riddles, Timothy; Saad, Nivene; Benham, Helen			Alternative causes of ankle pain in a patient with enthesopathy and X-linked hypophosphataemia	LANCET			English	Editorial Material									[Riddles, Timothy; Benham, Helen] Princess Alexandra Hosp, Dept Rheumatol, Brisbane, Qld, Australia; [Saad, Nivene] Princess Alexandra Hosp, Dept Radiol, Brisbane, Qld, Australia; [Riddles, Timothy; Saad, Nivene; Benham, Helen] Univ Queensland, Fac Med, Brisbane, Qld, Australia	University of Queensland	Riddles, T (corresponding author), Princess Alexandra Hosp, Brisbane, Qld, Australia.	timothy.riddles@health.qld.gov.au							0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2020	395	10237					E97	E97		10.1016/S0140-6736(20)30935-1	http://dx.doi.org/10.1016/S0140-6736(20)30935-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LZ1JO	32446409				2022-12-28	WOS:000540986100005
J	Rauh, AL; Linder, JA				Rauh, Alicia L.; Linder, Jeffrey A.			Covid-19 care before, during, and beyond the hospital	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rauh, Alicia L.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Hosp Med, Chicago, IL 60611 USA; [Linder, Jeffrey A.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Gen Internal Med & Geriatr, 750 North Lake Shore Dr,10th Floor, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Linder, JA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Gen Internal Med & Geriatr, 750 North Lake Shore Dr,10th Floor, Chicago, IL 60611 USA.	jlinder@northwestern.edu	Linder, Jeffrey/AAF-3424-2021	Linder, Jeffrey/0000-0003-2217-184X				Arons MM, 2020, N ENGL J MED; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Johns Hopkins University, 2022, COVID 19 DASHB CTR S; Lewnard JA, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1923; National Institute for Health and Care Excellence, 2020, COVID 19 POSITIVE OU; Onder G, 2020, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2020.4683, DOI 10.1001/JAMA.2020.468]; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Richardson S., 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.7681]; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Wang ZL, 2020, CLIN INFECT DIS, V71, P769, DOI 10.1093/cid/ciaa272; Williamson E, 2020, OPENSAFELY FACTORS A, DOI [10.1101/2020.05.06.20092999v1, DOI 10.1101/2020.05.06.20092999V1]; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	15	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2020	369								m2035	10.1136/bmj.m2035	http://dx.doi.org/10.1136/bmj.m2035			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JU	32444351	Bronze			2022-12-28	WOS:000538336800005
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Doctors sound alarm over hospital transmissions	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Bhanot SM, 2020, BMJ; Harding, 2020, GUARDIAN; Rivett L, 2020, ELIFE, V9, DOI 10.7554/eLife.58728	3	24	25	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2020	369								m2013	10.1136/bmj.m2013	http://dx.doi.org/10.1136/bmj.m2013			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JI	32430304	Bronze			2022-12-28	WOS:000538335600006
J	Gu, LL; Poddar, S; Lin, YJ; Long, ZH; Zhang, DQ; Zhang, QP; Shu, L; Qiu, X; Kam, M; Javey, A; Fan, ZY				Gu, Leilei; Poddar, Swapnadeep; Lin, Yuanjing; Long, Zhenghao; Zhang, Daquan; Zhang, Qianpeng; Shu, Lei; Qiu, Xiao; Kam, Matthew; Javey, Ali; Fan, Zhiyong			A biomimetic eye with a hemispherical perovskite nanowire array retina	NATURE			English	Article							LITHOGRAPHY	A biomimetic electrochemical eye is presented that has a hemispherical retina made from a high-density array of perovskite nanowires that are sensitive to light, mimicking the photoreceptors of a biological retina. Human eyes possess exceptional image-sensing characteristics such as an extremely wide field of view, high resolution and sensitivity with low aberration(1). Biomimetic eyes with such characteristics are highly desirable, especially in robotics and visual prostheses. However, the spherical shape and the retina of the biological eye pose an enormous fabrication challenge for biomimetic devices(2,3). Here we present an electrochemical eye with a hemispherical retina made of a high-density array of nanowires mimicking the photoreceptors on a human retina. The device design has a high degree of structural similarity to a human eye with the potential to achieve high imaging resolution when individual nanowires are electrically addressed. Additionally, we demonstrate the image-sensing function of our biomimetic device by reconstructing the optical patterns projected onto the device. This work may lead to biomimetic photosensing devices that could find use in a wide spectrum of technological applications.	[Gu, Leilei; Poddar, Swapnadeep; Lin, Yuanjing; Long, Zhenghao; Zhang, Daquan; Zhang, Qianpeng; Shu, Lei; Qiu, Xiao; Kam, Matthew; Fan, Zhiyong] Hong Kong Univ Sci & Technol, Dept Elect & Comp Engn, Kowloon, Hong Kong, Peoples R China; [Lin, Yuanjing; Javey, Ali] Univ Calif Berkeley, Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Javey, Ali] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA USA	Hong Kong University of Science & Technology; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Fan, ZY (corresponding author), Hong Kong Univ Sci & Technol, Dept Elect & Comp Engn, Kowloon, Hong Kong, Peoples R China.	eezfan@ust.hk	Lin, Yuanjing/AAF-1542-2019; Qiu, Xiao/ABF-3549-2020; Zhang, Qianpeng/I-8678-2014; gu, leilei/AAS-4042-2020; Poddar, Swapnadeep/HHA-3672-2022; Fan, Zhiyong/C-4970-2012; Gu, Lei/GWQ-6785-2022; Javey, Ali/B-4818-2013; Zhang, Qianpeng/P-3357-2014	Lin, Yuanjing/0000-0002-8568-1786; Zhang, Qianpeng/0000-0002-2317-4383; Fan, Zhiyong/0000-0002-5397-0129; Javey, Ali/0000-0001-7214-7931; Zhang, Qianpeng/0000-0002-2317-4383; Qiu, Xiao/0000-0003-1624-5187				Atchison D., 2000, OPTICS HUMAN EYE, V35; Ayton LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115239; Boschloo G, 2009, ACCOUNTS CHEM RES, V42, P1819, DOI 10.1021/ar900138m; Dickey MD, 2008, ADV FUNCT MATER, V18, P1097, DOI 10.1002/adfm.200701216; Fan ZY, 2010, NANO LETT, V10, P3823, DOI 10.1021/nl1010788; Fan ZY, 2009, NAT MATER, V8, P648, DOI [10.1038/NMAT2493, 10.1038/nmat2493]; Fujikado T, 2007, GRAEF ARCH CLIN EXP, V245, P1411, DOI 10.1007/s00417-007-0563-z; Gu LL, 2018, NANOSCALE, V10, P15164, DOI 10.1039/c8nr03058h; Gu LL, 2016, ADV MATER, V28, P9713, DOI 10.1002/adma.201601603; Han QF, 2016, ADV MATER, V28, P2253, DOI 10.1002/adma.201505002; JONAS JB, 1992, GRAEF ARCH CLIN EXP, V230, P505, DOI 10.1007/BF00181769; Jung IW, 2011, P NATL ACAD SCI USA, V108, P1788, DOI 10.1073/pnas.1015440108; Kawano R, 2003, CHEM COMMUN, P330, DOI 10.1039/b208388b; Ko HC, 2008, NATURE, V454, P748, DOI 10.1038/nature07113; Mustafi D, 2009, PROG RETIN EYE RES, V28, P289, DOI 10.1016/j.preteyeres.2009.05.003; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Navarro R, 2009, J OPTOM, V2, P3, DOI DOI 10.3921/JOPTOM.2009.3; POCOCK DCD, 1981, T I BRIT GEOGR, V6, P385, DOI 10.2307/621875; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Ramdani MR, 2010, NANO LETT, V10, P1836, DOI 10.1021/nl100557d; Rayner K, 2009, PSYCHOL SCI, V20, P6, DOI 10.1111/j.1467-9280.2008.02243.x; SCHEIN SJ, 1988, J COMP NEUROL, V269, P479, DOI 10.1002/cne.902690403; Shivdasani MN, 2014, INVEST OPHTH VIS SCI, V55, P6467, DOI 10.1167/iovs.14-14396; Song YM, 2013, NATURE, V497, P95, DOI 10.1038/nature12083; Waleed A, 2017, NANO LETT, V17, P523, DOI 10.1021/acs.nanolett.6b04587; Wandell B. A., 1995, FDN VISION, V8; Wen CY, 2009, SCIENCE, V326, P1247, DOI 10.1126/science.1178606; Zhang J, 2014, ACS NANO, V8, P3483, DOI 10.1021/nn4064659; Zhang K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01926-1	29	197	200	112	553	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY	2020	581	7808					278	+		10.1038/s41586-020-2285-x	http://dx.doi.org/10.1038/s41586-020-2285-x			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ2CZ	32433619	Green Submitted			2022-12-28	WOS:000534818200010
J	Wigginton, NS; Cunningham, RM; Katz, RH; Lidstrom, ME; Moler, KA; Wirtz, D; Zuber, MT				Wigginton, N. S.; Cunningham, R. M.; Katz, R. H.; Lidstrom, M. E.; Moler, K. A.; Wirtz, D.; Zuber, M. T.			Moving academic research forward during COVID-19	SCIENCE			English	Editorial Material									[Wigginton, N. S.; Cunningham, R. M.] Univ Michigan, Ann Arbor, MI 48109 USA; [Wigginton, N. S.; Moler, K. A.] Stanford Univ, Stanford, CA 94305 USA; [Katz, R. H.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Lidstrom, M. E.] Univ Washington, Seattle, WA 98195 USA; [Wirtz, D.] Johns Hopkins Univ, Baltimore, MD USA; [Zuber, M. T.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA	University of Michigan System; University of Michigan; Stanford University; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; Johns Hopkins University; Massachusetts Institute of Technology (MIT)	Wigginton, NS (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.; Wigginton, NS (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	nwigg@umich.edu	; Wigginton, Nicholas/F-1747-2011	Moler, Kathryn/0000-0002-0233-8123; Wigginton, Nicholas/0000-0001-9161-6131				Altmann DM, 2020, LANCET, V395, P1527, DOI 10.1016/S0140-6736(20)30985-5; American College Health Association, 2020, CONS REOP I HIGH ED; Chen QY, 2020, NATURE, V579, P193, DOI 10.1038/d41586-020-00694-1; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Larkins F., 2020, IMPACT PANDEMIC AUST, P14; National Academies of Sciences Engineering and Medicine., 2017, STRENGTH DIS RES AC; NationalCenter forScience and Engineering Statistics, 2019, 20307 NSF; NationalCenter forScience and Engineering Statistics (NCSES), 2018, HIGH ED RES DEV SURV; Rivers C, 2020, PUBLIC HLTH PRINCIPL; The Institute for Research on Innovation & Science, 2020, IRIS, DOI [10.21987/a07t-1c72, DOI 10.21987/A07T-1C72]; Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105; U.S.Centers forDisease Control and Prevention (CDC), 2020, INT GUID ADM US I HI; Wellcome, 2020, SHAR RES DAT FIND RE	13	40	41	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2020	368	6496					1190	1192		10.1126/science.abc5599	http://dx.doi.org/10.1126/science.abc5599			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MD5SF	32467332				2022-12-28	WOS:000544031400019
J	Katija, K; Troni, G; Daniels, J; Lance, K; Sherlock, RE; Sherman, AD; Robison, BH				Katija, Kakani; Troni, Giancarlo; Daniels, Joost; Lance, Kelly; Sherlock, Rob E.; Sherman, Alana D.; Robison, Bruce H.			Revealing enigmatic mucus structures in the deep sea using DeepPIV	NATURE			English	Article							GIANT LARVACEAN HOUSES; OIKOPLEURA-DIOICA; APPENDICULARIANS; FISH; MECHANISMS; BEHAVIOR	Advanced deep-sea imaging tools yield insights into the structure and function of mucus filtration houses built by midwater giant larvaceans. Many animals build complex structures to aid in their survival, but very few are built exclusively from materials that animals create (1,2). In the midwaters of the ocean, mucoid structures are readily secreted by numerous animals, and serve many vital functions(3,4). However, little is known about these mucoid structures owing to the challenges of observing them in the deep sea. Among these mucoid forms, the 'houses' of larvaceans are marvels of nature(5), and in the ocean twilight zone giant larvaceans secrete and build mucus filtering structures that can reach diameters of more than 1 m(6). Here we describe in situ laser-imaging technology(7) that reconstructs three-dimensional models of mucus forms. The models provide high-resolution views of giant larvacean houses and elucidate the role that house structure has in food capture and predator avoidance. Now that tools exist to study mucus structures found throughout the ocean, we can shed light on some of nature's most complex forms.	[Katija, Kakani; Daniels, Joost; Lance, Kelly; Sherlock, Rob E.; Sherman, Alana D.; Robison, Bruce H.] Monterey Bay Aquarium Res Inst, Res & Dev, Moss Landing, CA 95039 USA; [Troni, Giancarlo] Pontificia Univ Catolica Chile, Santiago, Chile	Monterey Bay Aquarium Research Institute; Pontificia Universidad Catolica de Chile	Katija, K (corresponding author), Monterey Bay Aquarium Res Inst, Res & Dev, Moss Landing, CA 95039 USA.	kakani@mbari.org			David and Lucile Packard Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	We thank D. Graves, C. Kecy, D. Klimov, J. Erickson and MBARI technical staff for their engineering contributions to the development of DeepPIV, the crews of RVs Rachel Carson and Western Flyer, and the pilots of ROVs Doc Ricketts, Ventana and MiniROV for their contributions to this project. This work is a contribution of the Deep Ocean Inspiration Group and was supported by the David and Lucile Packard Foundation.	Acuna JL, 1996, LIMNOL OCEANOGR, V41, P1800; ALLDREDGE A, 1976, SCI AM, V235, P94, DOI 10.1038/scientificamerican0776-94; ALLDREDGE AL, 1976, MAR BIOL, V38, P29, DOI 10.1007/BF00391483; ALLDREDGE AL, 1977, J ZOOL, V181, P175; BARHAM EG, 1979, SCIENCE, V205, P1129, DOI 10.1126/science.205.4411.1129; Batchelor G.K., 2000, INTRO FLUID DYNAMICS; Conley KR, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0056; Conley KR, 2018, LIMNOL OCEANOGR, V63, P927, DOI 10.1002/lno.10680; Conley KR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183105; DEIBEL D, 1986, MAR BIOL, V93, P429, DOI 10.1007/BF00401110; Ellis AE, 2001, DEV COMP IMMUNOL, V25, P827, DOI 10.1016/S0145-305X(01)00038-6; FENAUX R, 1985, B MAR SCI, V37, P498; Fernandez D, 2004, MAR ECOL PROG SER, V266, P89, DOI 10.3354/meps266089; Flood, 2005, RESPONSE MARINE ECOS, P59; Flood Per R., 1998, P105; FLOOD PR, 1990, BIOL BULL, V178, P118, DOI 10.2307/1541970; Flood PR, 2003, MAR BIOL, V143, P467, DOI 10.1007/s00227-003-1075-y; FLOOD PR, 1991, MAR BIOL, V111, P95, DOI 10.1007/BF01986351; Fol H., 1872, MEM SOC PHYS DHISTOI, V21, P445; GILMER RW, 1972, SCIENCE, V176, P1239, DOI 10.1126/science.176.4040.1239; Gorsky G., 1998, P161; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Grutter AS, 2011, BIOL LETTERS, V7, P292, DOI 10.1098/rsbl.2010.0916; HAMNER WM, 1992, DEEP-SEA RES, V39, P1299, DOI 10.1016/0198-0149(92)90070-A; Hansell M., 2007, BUILT ANIMALS NATURA; Hopcroft RR, 1999, J PLANKTON RES, V21, P1923, DOI 10.1093/plankt/21.10.1923; Hopcroft RR, 1998, J PLANKTON RES, V20, P557, DOI 10.1093/plankt/20.3.557; Hosp J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040172; Janssen J., 2006, COMMUNICATION FISHES, V1, P207; Jaspers C, 2009, J PLANKTON RES, V31, P525, DOI 10.1093/plankt/fbp002; Katija K, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700715; Katija K, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602374; Kishi K, 2017, DEV BIOL, V428, P245, DOI 10.1016/j.ydbio.2017.06.008; Korner W. F., 1954, Zeitschrift fuer Morphologie und Oekologie der Tiere, V41, P1, DOI 10.1007/BF00407623; LANDRY MR, 1994, MAR ECOL PROG SER, V115, P55, DOI 10.3354/meps115055; Marti-Solans J, 2015, GENESIS, V53, P183, DOI 10.1002/dvg.22800; Montgomery J.C., 1989, P561; Purcell J., 2005, RESPONSE MARINE ECOS, P359; Robison BH, 2005, SCIENCE, V308, P1609, DOI 10.1126/science.1109104; Sagane Y, 2011, CELL MOL LIFE SCI, V68, P1611, DOI 10.1007/s00018-010-0547-8; Sherlock R. E., 2016, Marine Biodiversity Records, V9, P79, DOI 10.1186/s41200-016-0075-9; Sherlock RE, 2017, MAR BIOL, V164, DOI 10.1007/s00227-016-3046-0; Silver MW, 1998, LIMNOL OCEANOGR, V43, P498, DOI 10.4319/lo.1998.43.3.0498; Vaugeois M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078255	45	17	17	1	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					78	+		10.1038/s41586-020-2345-2	http://dx.doi.org/10.1038/s41586-020-2345-2		JUN 2020	13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME6OV	32494011				2022-12-28	WOS:000537932200005
J	Kar, P				Kar, Partha			Partha Kar: Covid-19-time for parity in commissioning diabetes services	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kar, Partha] Portsmouth Hosp NHS Trust, Portsmouth, Hants, England	Portsmouth Hospitals NHS Trust	Kar, P (corresponding author), Portsmouth Hosp NHS Trust, Portsmouth, Hants, England.	drparthakar@gmail.com	Kar, Partha/AAT-4839-2020					NHS Digital, 2019, NAT DIAB AUD 2017 78; *NHS ENGL, 2020, TYP 1 TYP 2 DIAB COV, P32034; Williamson E, 2020, MEDRXIV, V7, P1, DOI [10.1101/2020.05.06.20092999v1, 10.1101/2020.05.06.20092999]	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2020	369								m2154	10.1136/bmj.m2154	http://dx.doi.org/10.1136/bmj.m2154			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0KV	32487540	Bronze			2022-12-28	WOS:000548476700011
J	Takata, T; Jiang, JZ; Sakata, Y; Nakabayashi, M; Shibata, N; Nandal, V; Seki, K; Hisatomi, T; Domen, K				Takata, Tsuyoshi; Jiang, Junzhe; Sakata, Yoshihisa; Nakabayashi, Mamiko; Shibata, Naoya; Nandal, Vikas; Seki, Kazuhiko; Hisatomi, Takashi; Domen, Kazunari			Photocatalytic water splitting with a quantum efficiency of almost unity	NATURE			English	Article							DOPED SRTIO3; OPTICAL-PROPERTIES; SINGLE-CRYSTALS; ION	Overall water splitting, evolving hydrogen and oxygen in a 2:1 stoichiometric ratio, using particulate photocatalysts is a potential means of achieving scalable and economically viable solar hydrogen production. To obtain high solar energy conversion efficiency, the quantum efficiency of the photocatalytic reaction must be increased over a wide range of wavelengths and semiconductors with narrow bandgaps need to be designed. However, the quantum efficiency associated with overall water splitting using existing photocatalysts is typically lower than ten per cent(1,2). Thus, whether a particulate photocatalyst can enable a quantum efficiency of 100 per cent for the greatly endergonic water-splitting reaction remains an open question. Here we demonstrate overall water splitting at an external quantum efficiency of up to 96 per cent at wavelengths between 350 and 360 nanometres, which is equivalent to an internal quantum efficiency of almost unity, using a modified aluminium-doped strontium titanate (SrTiO3:Al) photocatalyst(3,4). By selectively photodepositing the cocatalysts Rh/Cr2O3 (ref.(5)) and CoOOH (refs.(3,6)) for the hydrogen and oxygen evolution reactions, respectively, on different crystal facets of the semiconductor particles using anisotropic charge transport, the hydrogen and oxygen evolution reactions could be promoted separately. This enabled multiple consecutive forward charge transfers without backward charge transfer, reaching the upper limit of quantum efficiency for overall water splitting. Our work demonstrates the feasibility of overall water splitting free from charge recombination losses and introduces an ideal cocatalyst/photocatalyst structure for efficient water splitting.	[Takata, Tsuyoshi; Hisatomi, Takashi; Domen, Kazunari] Shinshu Univ, Res Initiat Supra Mat, Nagano, Japan; [Jiang, Junzhe; Sakata, Yoshihisa] Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Ube, Yamaguchi, Japan; [Nakabayashi, Mamiko; Shibata, Naoya] Univ Tokyo, Inst Engn Innovat, Sch Engn, Tokyo, Japan; [Nandal, Vikas; Seki, Kazuhiko] Natl Inst Adv Ind Sci & Technol, Nanomat Res Inst, Tsukuba, Ibaraki, Japan; [Domen, Kazunari] Univ Tokyo, Off Univ Prof, Tokyo, Japan	Shinshu University; Yamaguchi University; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Domen, K (corresponding author), Shinshu Univ, Res Initiat Supra Mat, Nagano, Japan.; Domen, K (corresponding author), Univ Tokyo, Off Univ Prof, Tokyo, Japan.	domen@shinshu-u.ac.jp	Hisatomi, Takashi/AFK-8145-2022; Nandal, Vikas/AAR-7456-2020; Shibata, Naoya/E-5327-2013; Seki, Kazuhiko/L-1986-2018	Hisatomi, Takashi/0000-0002-5009-2383; Nandal, Vikas/0000-0002-7356-3926; Seki, Kazuhiko/0000-0001-9858-2552; Domen, Kazunari/0000-0001-7995-4832	Artificial Photosynthesis Project of the New Energy and Industrial Technology Development Organization (NEDO); JSPS KAKENHI [JP19K05669, JP16K06862]; "Nanotechnology Platform" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [JPMXP09A-19-UT-0023]	Artificial Photosynthesis Project of the New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); "Nanotechnology Platform" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was primarily supported by the Artificial Photosynthesis Project of the New Energy and Industrial Technology Development Organization (NEDO) and partly supported by JSPS KAKENHI grant number JP19K05669, JP16K06862. A part of this work was conducted at the Advanced Characterization Nanotechnology Platform of the University of Tokyo, supported by "Nanotechnology Platform" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (grant number JPMXP09A-19-UT-0023). We are grateful to M. Yamaguchi and Y. Kuromiya at the University of Tokyo for the preparation and evaluation of photocatalysts.	Chen SS, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2017.50; Chiang TH, 2018, ACS CATAL, V8, P2782, DOI 10.1021/acscatal.7b04264; COHEN MI, 1968, PHYS REV, V168, P929, DOI 10.1103/PhysRev.168.929; DOMEN K, 1980, J CHEM SOC CHEM COMM, P543, DOI 10.1039/c39800000543; FREDERIKSE HPR, 1964, PHYS REV, V134, pA442, DOI 10.1103/PhysRev.134.A442; Goto Y, 2018, JOULE, V2, P509, DOI 10.1016/j.joule.2017.12.009; Ham Y, 2016, J MATER CHEM A, V4, P3027, DOI 10.1039/c5ta04843e; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; Kato H, 2003, J AM CHEM SOC, V125, P3082, DOI 10.1021/ja027751g; Konta R, 2004, J PHYS CHEM B, V108, P8992, DOI 10.1021/jp049556p; Kudo A, 2009, CHEM SOC REV, V38, P253, DOI 10.1039/b800489g; LEHN JM, 1982, ISRAEL J CHEM, V22, P168; Li RG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2401; Li YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12385-1; Liu G, 2011, CHEM COMMUN, V47, P6763, DOI 10.1039/c1cc10665a; Luo Y, 2019, ACS APPL MATER INTER, V11, P22264, DOI 10.1021/acsami.9b03747; Lyu H, 2019, CHEM SCI, V10, P3196, DOI 10.1039/c8sc05757e; Maeda K, 2010, J PHYS CHEM LETT, V1, P2655, DOI 10.1021/jz1007966; Mu LC, 2016, ENERG ENVIRON SCI, V9, P2463, DOI 10.1039/c6ee00526h; Ohno T, 2002, NEW J CHEM, V26, P1167, DOI 10.1039/b202140d; Sakata Y, 2015, CHEM COMMUN, V51, P12935, DOI 10.1039/c5cc03483c; Sze S., 1981, PHYS SEMICONDUCTOR D, V2nd ed., P85; Takata T, 2009, J PHYS CHEM C, V113, P19386, DOI 10.1021/jp908621e; WAGNER FT, 1980, J AM CHEM SOC, V102, P5494, DOI 10.1021/ja00537a013; Wang Q, 2019, NAT MATER, V18, P827, DOI 10.1038/s41563-019-0399-z; Wang Z, 2018, NAT CATAL, V1, P756, DOI 10.1038/s41929-018-0134-1; WEAVER HE, 1959, J PHYS CHEM SOLIDS, V11, P274, DOI 10.1016/0022-3697(59)90226-4; Xie YP, 2012, J MATER CHEM, V22, P6746, DOI 10.1039/c2jm16178h; Zhao ZQ, 2019, ENERG ENVIRON SCI, V12, P1385, DOI 10.1039/c9ee00310j; Zhen C, 2014, CHEM COMMUN, V50, P10416, DOI 10.1039/c4cc04999c; Zollner S, 2000, J VAC SCI TECHNOL B, V18, P2242, DOI 10.1116/1.1303741	31	627	628	225	1398	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 28	2020	581	7809					411	+		10.1038/s41586-020-2278-9	http://dx.doi.org/10.1038/s41586-020-2278-9			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX6EI	32461647				2022-12-28	WOS:000575801600001
J	Moynihan, R; Albarqouni, L; Nangla, C; Dunn, AG; Lexchin, J; Bero, L				Moynihan, Ray; Albarqouni, Loai; Nangla, Conrad; Dunn, Adam G.; Lexchin, Joel; Bero, Lisa			Financial ties between leaders of influential US professional medical associations and industry: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVE To investigate the nature and extent of financial relationships between leaders of influential professional medical associations in the United States and pharmaceutical and device companies. DESIGN Cross sectional study. SETTING Professional associations for the 10 costliest disease areas in the US according to the US Agency for Healthcare Research and Quality. Financial data for association leadership, 2017-19, were obtained from the Open Payments database. POPULATION 328 leaders, such as board members, of 10 professional medical associations: American College of Cardiology, Orthopaedic Trauma Association, American Psychiatric Association, Endocrine Society, American College of Rheumatology, American Society of Clinical Oncology, American Thoracic Society, North American Spine Society, Infectious Diseases Society of America, and American College of Physicians. MAIN OUTCOME MEASURES Proportion of leaders with financial ties to industry in the year of leadership, the four years before and the year after board membership, and the nature and extent of these financial relationships. RESULTS 235 of 328 leaders (72%) had financial ties to industry. Among 293 leaders who were medical doctors or doctors of osteopathy, 235 (80%) had ties. Total payments for 2017-19 leadership were almost $130m (103m; pound (sic)119m), with a median amount for each leader of $31 805 (interquartile range $1157 to $254 272). General payments, including those for consultancy and hospitality, were $24.8m and research payments were $104.6m-predominantly payments to academic institutions with association leaders named as principle investigators. Variation was great among the associations: median amounts varied from $212 for the American Psychiatric Association leaders to $518 000 for the American Society of Clinical Oncology. CONCLUSIONS Financial relationships between the leaders of influential US professional medical associations and industry are extensive, although with variation among the associations. The quantum of payments raises questions about independence and integrity, adding weight to calls for policy reform.	[Moynihan, Ray; Albarqouni, Loai; Nangla, Conrad] Bond Univ, Inst Evidence Based Healthcare, Gold Coast, Qld 4229, Australia; [Dunn, Adam G.] Univ Sydney, Discipline Biomed Informat & Digital Hlth, Sydney, NSW, Australia; [Lexchin, Joel] York Univ, Sch Hlth Policy & Management, Toronto, ON, Canada; [Bero, Lisa] Univ Sydney, Fac Med & Hlth, Charles Perkins Ctr, Sydney, NSW, Australia; [Bero, Lisa] Univ Sydney, Fac Med & Hlth, Sch Pharm, Sydney, NSW, Australia	Bond University; University of Sydney; York University - Canada; University of Sydney; University of Sydney	Moynihan, R (corresponding author), Bond Univ, Inst Evidence Based Healthcare, Gold Coast, Qld 4229, Australia.	raymoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020	Albarqouni, Loai/0000-0002-4114-9106	National Health and Medical Research Council (NHMRC) [1124207, 1104136]; NHMRC [1139997]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	RM is supported by a research fellowship funded by the National Health and Medical Research Council (NHMRC, grant No 1124207) and a chief investigator on a Centre for Research Excellence (grant No 1104136). LB funded in part by NHMRC (grant No 1139997). All authors had full access to all data and can take responsibility for the integrity of the data and the accuracy of the data analysis.	Agency for Healthcare Research and Quality, MEPS SUMM TABL MED C; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Centres for Medicare & Medicaid Services, OP PAYM DAT; DeJong C, 2016, JAMA INTERN MED, V176, P1114, DOI 10.1001/jamainternmed.2016.2765; Dunn Adam G, 2016, Res Integr Peer Rev, V1; Jatoi I, 2019, CAN MED ASSOC J, V191, pE297, DOI 10.1503/cmaj.181496; Liu JJ, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4619; Lo B, 2009, CONFLICT INTEREST ME; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Morgan DJ, 2019, JAMA INT MED; Moynihan R, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6576; Moynihan R, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1706; Moynihan R, 2019, BMJ EVID-BASED MED, V24, P170, DOI 10.1136/bmjebm-2018-111148; Moynihan RN, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001500; Nusrat S, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.6343; OECD, 2017, TACKL WAST SPEND HLT; Pathirana T, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3879; Rothman DJ, 2016, PAIN MED, V17, P218, DOI 10.1093/pm/pnv041_2; Rothman DJ, 2009, JAMA-J AM MED ASSOC, V301, P1367, DOI 10.1001/jama.2009.407; Saito H, 2019, JAMA INTERN MED, V179, P578, DOI 10.1001/jamainternmed.2018.7283; Shnier A, 2017, INT J RISK SAF MED, V29, P1, DOI 10.3233/JRS-170731; Smith CD, 2009, JAMA-J AM MED ASSOC, V302, P738, DOI 10.1001/jama.2009.1195; Wang AT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1344; World Health Organization, 2010, WHO CONFL INT GUID D	24	21	21	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2020	369								m1505	10.1136/bmj.m1505	http://dx.doi.org/10.1136/bmj.m1505			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JX	32461201	Green Published, hybrid			2022-12-28	WOS:000538337100001
J	Looi, MK				Looi, Mun-Keat			Covid-19: Japan ends state of emergency but warns of "new normal"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, JAPAN TIMES; [Anonymous], 2020, NHK WORLD NEWS  0526; Looi MK, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1447	3	15	15	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2020	369								m2100	10.1136/bmj.m2100	http://dx.doi.org/10.1136/bmj.m2100			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JW	32457055	Bronze			2022-12-28	WOS:000538337000013
J	Slomski, A				Slomski, Anita			Daily Aspirin Not Neuroprotective in ASPREE Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					1999	1999		10.1001/jama.2020.7967	http://dx.doi.org/10.1001/jama.2020.7967			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU8UM	32453364				2022-12-28	WOS:000538023900016
J	Slomski, A				Slomski, Anita			No Benefit for Lopinavir-Ritonavir in Severe COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					1999	1999		10.1001/jama.2020.6793	http://dx.doi.org/10.1001/jama.2020.6793			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU8UM	32453363	Bronze			2022-12-28	WOS:000538023900015
J	Mahase, E				Mahase, Elisabeth			Sixty seconds on... the druggle	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2020	369								m2075	10.1136/bmj.m2075	http://dx.doi.org/10.1136/bmj.m2075			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JU	32444355				2022-12-28	WOS:000538336800017
J	Thomas, JD				deLima Thomas, Jane			Pandemic as Teacher - Forcing Clinicians to Inhabit the Experience of Serious Illness	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								As a palliative care leader plans for a Covid surge, she sees that planning for the worst isn't as simple as she imagined when she asked patients to do it. In many ways, the pandemic is forcing clinicians to gain insight into the experience of seriously ill patients.	[deLima Thomas, Jane] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Thomas, JD (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.			Thomas, Jane/0000-0002-6197-2861					0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2020	383	4					306	307		10.1056/NEJMp2015024	http://dx.doi.org/10.1056/NEJMp2015024			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MU1XJ	32433860	Bronze			2022-12-28	WOS:000555465900015
J	Malatre-Lansac, A; Engel, CC; Xenakis, L; Carlasare, L; Blake, K; Vargo, C; Botts, C; Chen, PG; Friedberg, MW				Malatre-Lansac, Angele; Engel, Charles C.; Xenakis, Lea; Carlasare, Lindsey; Blake, Kathleen; Vargo, Carol; Botts, Christopher; Chen, Peggy G.; Friedberg, Mark W.			Factors Influencing Physician Practices' Adoption of Behavioral Health Integration in the United States A Qualitative Study	ANNALS OF INTERNAL MEDICINE			English	Article							MENTAL-HEALTH; PRIMARY-CARE; COLLABORATIVE CARE; TELEMEDICINE; PAYMENT; PARITY	Background: Behavioral health integration is uncommon among U.S. physician practices despite recent policy changes that may encourage its adoption. Objective: To describe factors influencing physician practices' implementation of behavioral health integration. Design: Semistructured interviews with leaders and clinicians from physician practices that adopted behavioral health integration, supplemented by contextual interviews with experts and vendors in behavioral health integration. Setting: 30 physician practices, sampled for diversity on specialty, size, affiliation with parent organizations, geographic location, and behavioral health integration model (collaborative or co-located). Participants: 47 physician practice leaders and clinicians, 20 experts, and 5 vendors. Measurements: Qualitative analysis (cyclical coding) of interview transcripts. Results: Four overarching factors affecting physician practices' implementation of behavioral health integration were identified. First, practices' motivations for integrating behavioral health care included expanding access to behavioral health services, improving other clinicians' abilities to respond to patients' behavioral health needs, and enhancing practice reputation. Second, practices tailored their implementation of behavioral health integration to local resources, financial incentives, and patient populations. Third, barriers to behavioral health integration included cultural differences and incomplete information flow between behavioral and nonbehavioral health clinicians and billing difficulties. Fourth, practices described the advantages and disadvantages of both fee-for-service and alternative payment models, and few reported positive financial returns. Limitation: The practice sample was not nationally representative and excluded practices that did not implement or sustain behavioral health integration, potentially limiting generalizability. Conclusion: Practices currently using behavioral health integration face cultural, informational, and financial barriers to implementing and sustaining behavioral health integration. Tailored, context-specific technical support to guide practices' implementation and payment models that improve the business case for practices may enhance the dissemination and long-term sustainability of behavioral health integration.	[Malatre-Lansac, Angele; Engel, Charles C.; Friedberg, Mark W.] RAND Corp, San Francisco, CA USA; [Xenakis, Lea] RAND Corp, 315 Montgomery St,Suite 920, Santa Monica, CA 94104 USA; [Chen, Peggy G.] RAND Corp, 1776 Main St, Santa Monica, CA 90407 USA; [Carlasare, Lindsey; Blake, Kathleen; Vargo, Carol; Botts, Christopher] Amer Med Assoc, 330 North Wabash Ave,Suite 39300, Chicago, IL 60611 USA; [Friedberg, Mark W.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Friedberg, Mark W.] Harvard Med Sch, Boston, MA 02115 USA; [Malatre-Lansac, Angele] Inst Montaigne, 59 Rue Boetie, F-75008 Paris, France; [Engel, Charles C.] RAND Corp, 20 Pk Plaza,Room 9312, Boston, MA 02116 USA; [Blake, Kathleen; Vargo, Carol; Botts, Christopher] Amer Med Assoc, 25 Massachusetts Ave NW 600, Washington, DC 20001 USA; [Friedberg, Mark W.] 101 Huntington Ave,Suite 1300, Boston, MA 02199 USA	RAND Corporation; RAND Corporation; RAND Corporation; American Medical Association; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; RAND Corporation; American Medical Association	Chen, PG (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90407 USA.	pchen@rand.org		Engel, Charles/0000-0002-9232-3389; Friedberg, Mark/0000-0002-7907-8358	American Medical Association; Commonwealth Fund	American Medical Association; Commonwealth Fund	American Medical Association and The Commonwealth Fund.	Bao YH, 2017, AM J MANAG CARE, V23, P48; Beronio K, 2014, J BEHAV HEALTH SER R, V41, P410, DOI 10.1007/s11414-014-9412-0; Carlo AD, 2019, J GEN INTERN MED, V34, P2150, DOI 10.1007/s11606-019-05195-0; Centers for Medicare & Medicaid Services, 2020, MED TEL HLTH CAR PRO; Chapman E, 2017, PSYCHIAT SERV, V68, P756, DOI 10.1176/appi.ps.201700085; Chen PG, 2019, JT COMM J QUAL PATIE, V45, P487, DOI 10.1016/j.jcjq.2019.02.009; Chung H, 2019, EVALUATION CONTINUUM; Crowley RA, 2015, ANN INTERN MED, V163, P298, DOI 10.7326/M15-0510; Cummings NA, 2003, 3 REN C INT BEH HLTH; Druss BG, 2018, AM J PSYCHIAT, V175, P1199, DOI 10.1176/appi.ajp.2018.18020169; Engel CC, 2016, JAMA INTERN MED, V176, P948, DOI 10.1001/jamainternmed.2016.2402; Fortney JC, 2007, J GEN INTERN MED, V22, P1086, DOI 10.1007/s11606-007-0201-9; Frank R. G., 2006, BETTER NOT WELL MENT; Frank RG, 2017, JAMA PSYCHIAT, V74, P117, DOI 10.1001/jamapsychiatry.2016.3002; Friedberg Mark W, 2015, Rand Health Q, V5, P8; Gerrity M., 2016, EVOLVING MODELS BEHA; Melek SP, 2014, EC IMPACT INTEGRATED; Miller BF, 2014, J AM BOARD FAM MED, V27, P367, DOI 10.3122/jabfm.2014.03.130260; Payne G., 2004, KEY CONCEPTS SOCIAL, DOI [10.4135/9781849209397, DOI 10.4135/9781849209397]; Press MJ, 2017, NEW ENGL J MED, V376, P405, DOI 10.1056/NEJMp1614134; Reed SJ, 2016, JAMA INTERN MED, V176, P691, DOI 10.1001/jamainternmed.2016.0804; Richman EL., 2018, IS BEHAV HLTH INTEGR; Rockwell KL, 2020, AM J MANAG CARE, V26, P147, DOI 10.37765/ajmc.2020.42784; Saldana J, 2012, CODING MANUAL QUALIT, VKindle Edition; SAMHSA-HRSA Center for Integrated Health Solutions, 2019, BILL TOOLS PAYING PR; Sofaer S, 1999, HEALTH SERV RES, V34, P1101; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Unutzer J, 2008, AM J MANAG CARE, V14, P95; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Wilson RL, 2018, MENTAL HLTH, P175	30	10	10	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2020	173	2					92	+		10.7326/M20-0132	http://dx.doi.org/10.7326/M20-0132			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ0RK	32479169				2022-12-28	WOS:000552604300015
J	Hammoud, MM; Standiford, T; Carmody, JB				Hammoud, Maya M.; Standiford, Taylor; Carmody, J. Bryan			Potential Implications of COVID-19 for the 2020-2021 Residency Application Cycle	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hammoud, Maya M.; Standiford, Taylor] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [Carmody, J. Bryan] Eastern Virginia Med Sch, Norfolk, VA 23501 USA	University of Michigan System; University of Michigan; Eastern Virginia Medical School	Hammoud, MM (corresponding author), Univ Michigan, Sch Med, Dept Obstet & Gynecol, L4000 Von Voigtlander Womens Hosp, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	immaya@umich.edu						Association of American Medical Colleges, ERAS STAT; Association of American Medical Colleges, PROGR DIR SURV; Bird SB, 2019, ACAD MED, V94, P1489, DOI 10.1097/ACM.0000000000002705; Cawley J., GUIDE ADVICE EC US J; Crane MA, 2020, JAMA-J AM MED ASSOC, V323, P2013, DOI 10.1001/jama.2020.2950; Hammoud MM, 2020, JAMA-J AM MED ASSOC, V323, P503, DOI 10.1001/jama.2019.21212; Johnson AP, 2015, JAMA OTOLARYNGOL, V141, P424, DOI 10.1001/jamaoto.2015.0219; Lee AH, 2019, LARYNGOSCOPE, V129, P627, DOI 10.1002/lary.27521; National Resident Matching Program, 2018, CHART OUTC MATCH US; Whipple Mark E, 2019, J Grad Med Educ, V11, P30, DOI 10.4300/JGME-D-18-00397.1	10	72	71	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2020	324	1					29	30		10.1001/jama.2020.8911	http://dx.doi.org/10.1001/jama.2020.8911			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM5FX	32492097	Bronze			2022-12-28	WOS:000568123600012
J	Uscher-Pines, L; Huskamp, HA; Mehrotra, A				Uscher-Pines, Lori; Huskamp, Haiden A.; Mehrotra, Ateev			Treating Patients With Opioid Use Disorder in Their Homes: An Emerging Treatment Model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; TRENDS		[Uscher-Pines, Lori] RAND Corp, 1200 S Hayes St, Arlington, VA 22202 USA; [Huskamp, Haiden A.; Mehrotra, Ateev] Harvard Med Sch, Boston, MA 02115 USA	RAND Corporation; Harvard University; Harvard Medical School	Uscher-Pines, L (corresponding author), RAND Corp, 1200 S Hayes St, Arlington, VA 22202 USA.	luscherp@rand.org	Mehrotra, Ateev/AAO-8454-2021	Mehrotra, Ateev/0000-0003-2223-1582	National Institute on Drug Abuse [R01DA048533-01]	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors are funded by grant R01DA048533-01 from the National Institute on Drug Abuse.	Andrilla CHA, 2019, J RURAL HEALTH, V35, P108, DOI 10.1111/jrh.12307; California Healthcare Foundation, 2019, TEL MAT; Han B, 2020, JAMA-J AM MED ASSOC, V323, P568, DOI 10.1001/jama.2019.20844; Lister JJ, 2020, AM J DRUG ALCOHOL AB, V46, P273, DOI 10.1080/00952990.2019.1694536; National Institutes of Health, 2020, RUR EXP MED TREATM O; Olfson M, 2020, JAMA-J AM MED ASSOC, V323, P276, DOI 10.1001/jama.2019.18913; Olfson M, 2019, JAMA-J AM MED ASSOC, V322, P2340, DOI 10.1001/jama.2019.16566; Saloner B, 2015, JAMA-J AM MED ASSOC, V314, P1515, DOI 10.1001/jama.2015.10345; Sigmon SC, 2014, JAMA PSYCHIAT, V71, P359, DOI 10.1001/jamapsychiatry.2013.4450	9	15	15	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2020	324	1					39	40		10.1001/jama.2020.3940	http://dx.doi.org/10.1001/jama.2020.3940			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM5FX	32459292	Green Accepted			2022-12-28	WOS:000568123600017
J	Zhu, FC; Li, YH; Guan, XH; Hou, LH; Wang, WJ; Li, JX; Wu, SP; Wang, BS; Wang, Z; Wang, L; Jia, SY; Jiang, HDC; Wang, L; Jiang, T; Hu, Y; Gou, JB; Xu, SB; Xu, JJ; Wang, XW; Wang, W; Chen, W				Zhu, Feng-Cai; Li, Yu-Hua; Guan, Xu-Hua; Hou, Li-Hua; Wang, Wen-Juan; Li, Jing-Xin; Wu, Shi-Po; Wang, Bu-Sen; Wang, Zhao; Wang, Lei; Jia, Si-Yue; Jiang, Hu-Dachuan; Wang, Ling; Jiang, Tao; Hu, Yi; Gou, Jin-Bo; Xu, Sha-Bei; Xu, Jun-Jie; Wang, Xue-Wen; Wang, Wei; Chen, Wei			Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial	LANCET			English	Article							HEALTHY-ADULTS; EBOLA VACCINE; CORONAVIRUS; PROTECTION; RESPONSES; DISEASE; REGIMEN	Background A vaccine to protect against COVID-19 is urgently needed. We aimed to assess the safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 (Ad5) vectored COVID-19 vaccine expressing the spike glycoprotein of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain. Methods We did a dose-escalation, single-centre, open-label, non-randomised, phase 1 trial of an Ad5 vectored COVID-19 vaccine in Wuhan, China. Healthy adults aged between 18 and 60 years were sequentially enrolled and allocated to one of three dose groups (5 x 10(10), 1 x 10(11), and 1.5 x 10(11) viral particles) to receive an intramuscular injection of vaccine. The primary outcome was adverse events in the 7 days post-vaccination. Safety was assessed over 28 days post-vaccination. Specific antibodies were measured with ELISA, and the neutralising antibody responses induced by vaccination were detected with SARS-CoV-2 virus neutralisation and pseudovirus neutralisation tests. T-cell responses were assessed by enzyme-linked immunospot and flow-cytometry assays. This study is registered with ClinicalTrials.gov, NCT04313127. Findings Between March 16 and March 27, 2020, we screened 195 individuals for eligibility. Of them, 108 participants (51% male, 49% female; mean age 36.3 years) were recruited and received the low dose (n=36), middle dose (n=36), or high dose (n=36) of the vaccine. All enrolled participants were included in the analysis. At least one adverse reaction within the first 7 days after the vaccination was reported in 30 (83%) par-ticipants in the low dose group, 30 (83%) participants in the middle dose group, and 27 (75%) participants in the high dose group. The most common injection site adverse reaction was pain, which was reported in 58 (54%) vaccine recipients, and the most commonly reported systematic adverse reactions were fever (50 [46%]), fatigue (47 [44%]), headache (42 [39%]), and muscle pain (18 [17%]. Most adverse reactions that were reported in all dose groups were mild or moderate in severity. No serious adverse event was noted within 28 days post-vaccination. ELISA antibodies and neutralising antibodies increased significantly at day 14, and peaked 28 days post-vaccination. Specific T-cell response peaked at day 14 post-vaccination. Interpretation The Ad5 vectored COVID-19 vaccine is tolerable and immunogenic at 28 days post-vaccination. Humoral responses against SARS-CoV-2 peaked at day 28 post-vaccination in healthy adults, and rapid specific T-cell responses were noted from day 14 post-vaccination. Our findings suggest that the Ad5 vectored COVID-19 vaccine warrants further investigation. Copyright (C) 2020 Elsevier Ltd. All rights reserved.	[Hou, Li-Hua; Wu, Shi-Po; Wang, Bu-Sen; Xu, Jun-Jie; Chen, Wei] Beijing Inst Biotechnol, Beijing 100071, Peoples R China; [Zhu, Feng-Cai; Wang, Wen-Juan; Li, Jing-Xin; Jia, Si-Yue; Jiang, Hu-Dachuan] Jiangsu Prov Ctr Dis Control & Prevent, NHC Key Lab Enter Pathogen Microbiol, Nanjing 210009, Peoples R China; [Li, Yu-Hua; Wang, Ling] China Natl Inst Food & Drug Control, Beijing, Peoples R China; [Guan, Xu-Hua; Wang, Zhao; Wang, Lei] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Jiang, Tao; Hu, Yi] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Gou, Jin-Bo] CanSino Biol, Tianjin, Peoples R China; [Xu, Sha-Bei; Wang, Wei] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Res Ctr, Wuhan 430032, Peoples R China; [Wang, Xue-Wen] Shanghai Canming Med Technol, Shanghai, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; National Institute of Food & Drug Control - China; Beijing Institute of Microbiology & Epidemiology; Huazhong University of Science & Technology	Chen, W (corresponding author), Beijing Inst Biotechnol, Beijing 100071, Peoples R China.; Zhu, FC (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, NHC Key Lab Enter Pathogen Microbiol, Nanjing 210009, Peoples R China.; Wang, W (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Res Ctr, Wuhan 430032, Peoples R China.	jszfc@vip.sina.com; wwang@vip.126.com; cw0226@foxmail.com	Li, yu/HHZ-5236-2022; wang, busen/GSN-0655-2022; Li, Jing/GYU-5036-2022	Wang, Busen/0000-0001-9041-1919	National Key R&D Program of China; National Science and Technology Major Project; CanSino Biologics	National Key R&D Program of China; National Science and Technology Major Project; CanSino Biologics	National Key R&D Program of China, National Science and Technology Major Project, and CanSino Biologics.	Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007; [Anonymous], JAMA J AM MED ASSOC, DOI DOI 10.1001/JAMA.2020.0757; Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3; Channappanavar R, 2014, J VIROL, V88, P11034, DOI 10.1128/JVI.01505-14; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Cowling BJ, 2020, LANCET PUBLIC HEALTH, V5, pE279, DOI 10.1016/S2468-2667(20)30090-6; De Santis O, 2016, LANCET INFECT DIS, V16, P311, DOI 10.1016/S1473-3099(15)00486-7; Dolzhikova IV, 2017, HUM VACC IMMUNOTHER, V13, P613, DOI 10.1080/21645515.2016.1238535; Duan JZ, 2005, BIOCHEM BIOPH RES CO, V333, P186, DOI 10.1016/j.bbrc.2005.05.089; Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627; Gray GE, 2014, LANCET INFECT DIS, V14, P388, DOI 10.1016/S1473-3099(14)70020-9; Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Lurie N, 2020, NEW ENGL J MED, V382, P1969, DOI 10.1056/NEJMp2005630; Nie JH, 2020, EMERG MICROBES INFEC, V9, P680, DOI 10.1080/22221751.2020.1743767; Shukarev G, 2017, HUM VACC IMMUNOTHER, V13, P266, DOI 10.1080/21645515.2017.1264755; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Venkatraman N, 2019, J INFECT DIS, V219, P1187, DOI 10.1093/infdis/jiy639; Wang QD, 2016, ACS INFECT DIS, V2, P361, DOI 10.1021/acsinfecdis.6b00006; Wang X, NEUTRALIZING ANTIBOD, DOI 2020.04.15.20065623; Weiss P, 2020, LANCET, V395, P1014, DOI 10.1016/S0140-6736(20)30633-4; WHO, 2020, DRAFT LANDSC COVID 1; World Health Organization, 2020, 64 WHO; Wu F, 2020, NEUTRALIZING ANTIBOD; Ye GM, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.001; Yong CY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01781; Zhao JC, 2010, J VIROL, V84, P9318, DOI 10.1128/JVI.01049-10; Zhu F-C, 2020, PROTOCOL SINGLE CTR; Zhu FC, 2015, LANCET, V385, P2272, DOI 10.1016/S0140-6736(15)60553-0; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	31	758	837	34	261	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2020	395	10240					1845	1854		10.1016/S0140-6736(20)31208-3	http://dx.doi.org/10.1016/S0140-6736(20)31208-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NH4GA	32450106	Green Published, Bronze			2022-12-28	WOS:000564628700027
J	Sulkowski, PL; Oeck, S; Dow, J; Economos, NG; Mirfakhraie, L; Liu, YF; Noronha, K; Bao, X; Li, J; Shuch, BM; King, MC; Bindra, RS; Glazer, PM				Sulkowski, Parker L.; Oeck, Sebastian; Dow, Jonathan; Economos, Nicholas G.; Mirfakhraie, Lily; Liu, Yanfeng; Noronha, Katelyn; Bao, Xun; Li, Jing; Shuch, Brian M.; King, Megan C.; Bindra, Ranjit S.; Glazer, Peter M.			Oncometabolites suppress DNA repair by disrupting local chromatin signalling	NATURE			English	Article							HISTONE H3; DAMAGE; METHYLATION; IDH; DEMETHYLASES; MUTATIONS; FUMARATE; PROTEIN; CANCER; BREAKS	Metabolites that are elevated in tumours inhibit the lysine demethylase KDM4B, resulting in aberrant hypermethylation of histone 3 lysine 9 and decreased homology-dependent DNA repair. Deregulation of metabolism and disruption of genome integrity are hallmarks of cancer(1). Increased levels of the metabolites 2-hydroxyglutarate, succinate and fumarate occur in human malignancies owing to somatic mutations in the isocitrate dehydrogenase-1 or -2 (IDH1 or IDH2) genes, or germline mutations in the fumarate hydratase (FH) and succinate dehydrogenase genes (SDHA, SDHB, SDHC and SDHD), respectively(2-4). Recent work has made an unexpected connection between these metabolites and DNA repair by showing that they suppress the pathway of homology-dependent repair (HDR)(5,6) and confer an exquisite sensitivity to inhibitors of poly (ADP-ribose) polymerase (PARP) that are being tested in clinical trials. However, the mechanism by which these oncometabolites inhibit HDR remains poorly understood. Here we determine the pathway by which these metabolites disrupt DNA repair. We show that oncometabolite-induced inhibition of the lysine demethylase KDM4B results in aberrant hypermethylation of histone 3 lysine 9 (H3K9) at loci surrounding DNA breaks, masking a local H3K9 trimethylation signal that is essential for the proper execution of HDR. Consequently, recruitment of TIP60 and ATM, two key proximal HDR factors, is substantially impaired at DNA breaks, with reduced end resection and diminished recruitment of downstream repair factors. These findings provide a mechanistic basis for oncometabolite-induced HDR suppression and may guide effective strategies to exploit these defects for therapeutic gain.	[Sulkowski, Parker L.; Oeck, Sebastian; Dow, Jonathan; Economos, Nicholas G.; Liu, Yanfeng; Noronha, Katelyn; Bindra, Ranjit S.; Glazer, Peter M.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT USA; [Sulkowski, Parker L.; Dow, Jonathan; Economos, Nicholas G.; Glazer, Peter M.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Oeck, Sebastian] Univ Duisburg Essen, Dept Med Oncol, Essen, Germany; [Mirfakhraie, Lily; King, Megan C.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Noronha, Katelyn] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Bao, Xun; Li, Jing] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Shuch, Brian M.] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA USA; [Bindra, Ranjit S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Yale University; Yale University; University of Duisburg Essen; Yale University; Yale University; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of California System; University of California Los Angeles; Yale University	Bindra, RS; Glazer, PM (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT USA.; Glazer, PM (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.; Bindra, RS (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	ranjit.bindra@yale.edu; peter.glazer@yale.edu	Oeck, Sebastian/AAS-2707-2020	Oeck, Sebastian/0000-0001-9695-8771; Dow, Jonathan/0000-0003-1354-1124; Economos, Nicholas/0000-0003-4691-808X	NIH [R01ES005775, R35CA197574, R01CA215453]; American Cancer Society; NIH National Institute of General Medical Sciences [T32GM007223]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Hegan and A. Dhawan for their assistance. This work was supported by the NIH (grants R01ES005775 and R35CA197574 to P.M.G., and R01CA215453 to R.S.B.) and by the American Cancer Society (Research Scholar Grant to R.S.B.). P.L.S. was supported by the NIH National Institute of General Medical Sciences training grant T32GM007223.	Ayrapetov MK, 2014, P NATL ACAD SCI USA, V111, P9169, DOI 10.1073/pnas.1403565111; Bindra RS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt255; Black JC, 2013, CELL, V154, P541, DOI 10.1016/j.cell.2013.06.051; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Pedersen MT, 2016, EMBO J, V35, P1550, DOI 10.15252/embj.201593317; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Shan CM, 2016, ELIFE, V5, DOI 10.7554/eLife.17903; Sulkowski PL, 2018, NAT GENET, V50, P1086, DOI 10.1038/s41588-018-0170-4; Sulkowski PL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2463; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Toro JR, 2003, AM J HUM GENET, V73, P95, DOI 10.1086/376435; Turcan S, 2018, NAT GENET, V50, P62, DOI 10.1038/s41588-017-0001-z; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Wang P, 2015, CELL REP, V13, P2353, DOI 10.1016/j.celrep.2015.11.029; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Williamson EA, 2012, PROG MOL BIOL TRANSL, V110, P207, DOI 10.1016/B978-0-12-387665-2.00008-0; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Young LC, 2013, J BIOL CHEM, V288, P21376, DOI 10.1074/jbc.M113.491514; Zhou Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1309	28	103	103	3	43	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2020	582	7813					586	+		10.1038/s41586-020-2363-0	http://dx.doi.org/10.1038/s41586-020-2363-0		JUN 2020	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OL0DJ	32494005	Green Accepted			2022-12-28	WOS:000537932200002
J	Voelker, R				Voelker, Rebecca			e-Cigarette Hoodies and Backpacks Prompt FDA Warnings	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2020	323	21					2122	2122		10.1001/jama.2020.8313	http://dx.doi.org/10.1001/jama.2020.8313			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LY8YS	32484523				2022-12-28	WOS:000540816000005
J	Tsanni, A				Tsanni, Abdullahi			African scientists leverage open hardware	NATURE			English	Editorial Material						Biotechnology; Developing world; Drug discovery												Chagas AM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002702	1	4	4	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN	2020	582	7810					138	138		10.1038/d41586-020-01606-z	http://dx.doi.org/10.1038/d41586-020-01606-z			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LW8VX	32483348	Bronze			2022-12-28	WOS:000539422600005
J	Wang, L; Qian, HW; Nian, Y; Han, YM; Ren, ZN; Zhang, HZ; Hu, LY; Prasad, BVV; Laganowsky, A; Yan, N; Zhou, M				Wang Lie; Qian Hongwu; Nian Yin; Han Yimo; Ren Zhenning; Zhang Hanzhi; Hu Liya; Prasad, B. V. Venkataram; Laganowsky, Arthur; Yan Nieng; Zhou Ming			Structure and mechanism of human diacylglycerol O-acyltransferase 1	NATURE			English	Article							IDENTIFICATION; ENZYME; VALIDATION; RESIDUES; DIAGRAMS; FEATURES; OBESITY; DGAT1	The structure of human diacylglycerol O-acyltransferase 1, a membrane protein that synthesizes triacylglycerides, is solved with cryo-electron microscopy, providing insight into its function and mechanism of enzymatic activity. Diacylglycerol O-acyltransferase 1 (DGAT1) synthesizes triacylglycerides and is required for dietary fat absorption and fat storage in humans(1). DGAT1 belongs to the membrane-bound O-acyltransferase (MBOAT) superfamily, members of which are found in all kingdoms of life and are involved in the acylation of lipids and proteins(2,3). How human DGAT1 and other mammalian members of the MBOAT family recognize their substrates and catalyse their reactions is unknown. The absence of three-dimensional structures also hampers rational targeting of DGAT1 for therapeutic purposes. Here we present the cryo-electron microscopy structure of human DGAT1 in complex with an oleoyl-CoA substrate. Each DGAT1 protomer has nine transmembrane helices, eight of which form a conserved structural fold that we name the MBOAT fold. The MBOAT fold in DGAT1 forms a hollow chamber in the membrane that encloses highly conserved catalytic residues. The chamber has separate entrances for each of the two substrates, fatty acyl-CoA and diacylglycerol. DGAT1 can exist as either a homodimer or a homotetramer and the two forms have similar enzymatic activity. The N terminus of DGAT1 interacts with the neighbouring protomer and these interactions are required for enzymatic activity.	[Wang Lie; Nian Yin; Ren Zhenning; Zhang Hanzhi; Hu Liya; Prasad, B. V. Venkataram; Zhou Ming] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Qian Hongwu; Han Yimo; Yan Nieng] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Laganowsky, Arthur] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Nian Yin] Chinese Acad Sci, Kunming Inst Zool, Ion Channel Res & Drug Dev Ctr, Kunming, Yunnan, Peoples R China; [Han Yimo] Rice Univ, Dept Mat Sci & Nanoengn, Houston, TX USA	Baylor College of Medicine; Princeton University; Texas A&M University System; Texas A&M University College Station; Chinese Academy of Sciences; Kunming Institute of Zoology; Rice University	Zhou, M (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.; Yan, N (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	nyan@princeton.edu; mzhou@bcm.edu	Wang, Lie/AAJ-3592-2020; Qian, Hongwu/GPT-1612-2022; Qian, Hongwu/AAL-7468-2021	Yan, Nieng/0000-0003-4829-7416; Prasad, B.V.Venkataram/0000-0002-1172-2071; Wang, Lie/0000-0002-9406-5168	NIH [DK122784, HL086392, GM098878]; Cancer Prevention and Research Institute of Texas [R1223]; Robert Welch Foundation [Q1279]; Ara Parseghian Medical Research Foundation; New Jersey Council for Cancer Research; Princeton University; Princeton Center for Complex Materials; National Science Foundation (NSF)-MRSEC program [DMR-1420541]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Robert Welch Foundation(The Welch Foundation); Ara Parseghian Medical Research Foundation; New Jersey Council for Cancer Research; Princeton University(Princeton University); Princeton Center for Complex Materials; National Science Foundation (NSF)-MRSEC program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by grants from the NIH (DK122784, HL086392 and GM098878 to M.Z.), the Cancer Prevention and Research Institute of Texas (R1223 to M.Z.), the Robert Welch Foundation (Q1279 to B.V.V.P.), the Ara Parseghian Medical Research Foundation (to N.Y. and Y.H.) and the New Jersey Council for Cancer Research (to H.Q.). N.Y. is supported by the Shirley M. Tilghman endowed professorship from Princeton University. We thank P. Shao for technical support during the acquisition of electron microscope images, and A. Banerjee for advice on the enzymatic assay and purification of alpha KDH. We acknowledge the use of the Imaging and Analysis Center at Princeton University, which is partially supported by the Princeton Center for Complex Materials, and the National Science Foundation (NSF)-MRSEC program (DMR-1420541).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai YH, 2015, NATURE, V524, P252, DOI 10.1038/nature14549; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bhatt-Wessel B, 2018, ARCH BIOCHEM BIOPHYS, V655, P1, DOI 10.1016/j.abb.2018.08.001; Caldo KMP, 2017, PLANT PHYSIOL, V175, P667, DOI 10.1104/pp.17.00934; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Cheng D, 2001, BIOCHEM J, V359, P707, DOI 10.1042/0264-6021:3590707; Das A, 2008, J LIPID RES, V49, P1770, DOI 10.1194/jlr.M800131-JLR200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Guo ZM, 2001, J LIPID RES, V42, P1282; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kuhn C, 2004, GENETICS, V167, P1873, DOI 10.1534/genetics.103.022749; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Ma D, 2018, NATURE, V562, P286, DOI 10.1038/s41586-018-0568-2; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Panigrahi R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34339-1; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rana MS, 2018, SCIENCE, V359, P176, DOI 10.1126/science.aao6326; Ren ZN, 2018, P NATL ACAD SCI USA, V115, P5962, DOI 10.1073/pnas.1800647115; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; STANLEY CJ, 1980, BIOCHEM J, V191, P147, DOI 10.1042/bj1910147; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weselake Randall J., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-24; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yen CLE, 2015, J LIPID RES, V56, P489, DOI 10.1194/jlr.R052902; Zhang J, 2014, J BIOL CHEM, V289, P10909, DOI 10.1074/jbc.M113.530022; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhao G, 2008, J MED CHEM, V51, P380, DOI 10.1021/jm7013887; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	45	31	32	4	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY	2020	581	7808					329	+		10.1038/s41586-020-2280-2	http://dx.doi.org/10.1038/s41586-020-2280-2		MAY 2020	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ2CZ	32433610	Green Accepted, Green Submitted			2022-12-28	WOS:000532688300005
J	Butcher, TW; Yang, JL; Amberg, WM; Watkins, NB; Wilkinson, ND; Hartwig, JF				Butcher, Trevor W.; Yang, Jonathan L.; Amberg, Willi M.; Watkins, Nicholas B.; Wilkinson, Natalie D.; Hartwig, John F.			Desymmetrization of difluoromethylene groups by C-F bond activation	NATURE			English	Article								Tertiary stereogenic centres containing one fluorine atom are valuable for medicinal chemistry because they mimic common tertiary stereogenic centres containing one hydrogen atom, but they possess distinct charge distribution, lipophilicity, conformation and metabolic stability(1-3). Although tertiary stereogenic centres containing one hydrogen atom are often set by enantioselective desymmetrization reactions at one of the two carbon-hydrogen (C-H) bonds of a methylene group, tertiary stereocentres containing fluorine have not yet been constructed by the analogous desymmetrization reaction at one of the two carbon-fluorine (C-F) bonds of a difluoromethylene group(3). Fluorine atoms are similar in size to hydrogen atoms but have distinct electronic properties, causing C-F bonds to be exceptionally strong and geminal C-F bonds to strengthen one another(4). Thus, exhaustive defluorination typically dominates over the selective replacement of a single C-F bond, hindering the development of the enantioselective substitution of one fluorine atom to form a stereogenic centre(5,6). Here we report the catalytic, enantioselective activation of a single C-F bond in an allylic difluoromethylene group to provide a broad range of products containing a monofluorinated tertiary stereogenic centre. By combining a tailored chiral iridium phosphoramidite catalyst, which controls regioselectivity, chemoselectivity and enantioselectivity, with a fluorophilic activator, which assists the oxidative addition of the C-F bond, these reactions occur in high yield and selectivity. The design principles proposed in this work extend to palladium-catalysed benzylic substitution, demonstrating the generality of the approach.	[Butcher, Trevor W.; Yang, Jonathan L.; Amberg, Willi M.; Watkins, Nicholas B.; Wilkinson, Natalie D.; Hartwig, John F.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Hartwig, JF (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	jhartwig@berkeley.edu	Watkins, Nicholas/GZK-6755-2022	Watkins, Nicholas/0000-0001-7251-9387; Amberg, Willi M./0000-0002-7053-5815	NIH HHS [S10 OD024998] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Amii H, 2009, CHEM REV, V109, P2119, DOI 10.1021/cr800388c; An L, 2018, ANGEW CHEM INT EDIT, V57, P6921, DOI 10.1002/anie.201802713; An L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01540-1; Arp FO, 2005, J AM CHEM SOC, V127, P10482, DOI 10.1021/ja053751f; Beak P, 1996, ACCOUNTS CHEM RES, V29, P552, DOI 10.1021/ar950142b; Benedetto E, 2012, ORGANOMETALLICS, V31, P1408, DOI 10.1021/om201029m; Blessley G, 2012, ORG LETT, V14, P2754, DOI 10.1021/ol300977f; Butcher TW, 2018, ANGEW CHEM INT EDIT, V57, P13125, DOI 10.1002/anie.201807474; Feng Z, 2018, ACCOUNTS CHEM RES, V51, P2264, DOI 10.1021/acs.accounts.8b00230; Franzen J, 2005, J AM CHEM SOC, V127, P18296, DOI 10.1021/ja056120u; Fuchibe K, 2018, CHEM-EUR J, V24, P17932, DOI 10.1002/chem.201805054; Gillis EP, 2015, J MED CHEM, V58, P8315, DOI 10.1021/acs.jmedchem.5b00258; GROVES JT, 1989, J AM CHEM SOC, V111, P8537, DOI 10.1021/ja00204a047; Hartwig JF, 2010, ACCOUNTS CHEM RES, V43, P1461, DOI 10.1021/ar100047x; Haufe G, 2012, ANGEW CHEM INT EDIT, V51, P12275, DOI 10.1002/anie.201207304; Hazari A, 2009, ANGEW CHEM INT EDIT, V48, P1296, DOI 10.1002/anie.200804310; Jiang XY, 2017, ANGEW CHEM INT EDIT, V56, P8887, DOI 10.1002/anie.201704354; Liao KB, 2016, NATURE, V533, P230, DOI 10.1038/nature17651; Madrahimov ST, 2012, J AM CHEM SOC, V134, P8136, DOI 10.1021/ja212217j; Min QQ, 2014, J AM CHEM SOC, V136, P1230, DOI 10.1021/ja4114825; Nishimine T, 2014, ANGEW CHEM INT EDIT, V53, P517, DOI 10.1002/anie.201308071; Nishioka Y, 2013, ANGEW CHEM INT EDIT, V52, P1739, DOI 10.1002/anie.201208906; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Pigeon X, 2010, ANGEW CHEM INT EDIT, V49, P1123, DOI 10.1002/anie.200904747; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Rossler SL, 2019, ACCOUNTS CHEM RES, V52, P2657, DOI 10.1021/acs.accounts.9b00209; Saint-Denis TG, 2018, SCIENCE, V359, P759, DOI 10.1126/science.aao4798; Shen Q, 2015, J FLUORINE CHEM, V179, P14, DOI 10.1016/j.jfluchem.2015.07.007; Shockley SE, 2017, ANGEW CHEM INT EDIT, V56, P11545, DOI 10.1002/anie.201707015; Smith AMR, 2011, CHEM REV, V111, P1637, DOI 10.1021/cr100197z; Stahl T, 2013, ACS CATAL, V3, P1578, DOI 10.1021/cs4003244; Tabuchi S, 2016, ANGEW CHEM INT EDIT, V55, P6973, DOI 10.1002/anie.201602075; Tanaka J, 2016, ANGEW CHEM INT EDIT, V55, P9432, DOI 10.1002/anie.201603210; Trost BM, 2012, J AM CHEM SOC, V134, P5778, DOI 10.1021/ja301461p; Trost BM, 2010, J AM CHEM SOC, V132, P15534, DOI 10.1021/ja1079755; Trost BM, 2001, J AM CHEM SOC, V123, P3687, DOI 10.1021/ja003775g; Vogt DB, 2019, J AM CHEM SOC, V141, P13203, DOI 10.1021/jacs.9b06004; Wisniewska HM, 2013, J AM CHEM SOC, V135, P9083, DOI 10.1021/ja4034999; Xiao YL, 2014, ANGEW CHEM INT EDIT, V53, P9909, DOI 10.1002/anie.201405653; Yoshida S, 2016, ANGEW CHEM INT EDIT, V55, P10406, DOI 10.1002/anie.201604776; Zhang W, 2016, SCIENCE, V353, P1014, DOI 10.1126/science.aaf7783; Zhou Q, 2013, J AM CHEM SOC, V135, P3307, DOI 10.1021/ja312087x; Zhu Y, 2018, CHEM REV, V118, P3887, DOI 10.1021/acs.chemrev.7b00778	43	47	47	11	104	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 23	2020	583	7817					548	+		10.1038/s41586-020-2399-1	http://dx.doi.org/10.1038/s41586-020-2399-1			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QP4ZH	32480398				2022-12-28	WOS:000623845100001
J	Bugiardini, R; Cenko, E				Bugiardini, Raffaele; Cenko, Edina			Sex differences in myocardial infarction deaths	LANCET			English	Editorial Material							HEART-FAILURE; OUTCOMES		[Bugiardini, Raffaele; Cenko, Edina] Univ Bologna, Dept Expt Diagnost & Specialty Med, I-40138 Bologna, Italy	University of Bologna	Bugiardini, R (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med, I-40138 Bologna, Italy.	raffaele.bugiardini@unibo.it	Cenko, Edina/L-6438-2015	Cenko, Edina/0000-0001-8102-3324				[Anonymous], 2020, Circulation, V141, pe33, DOI 10.1161/CIR.0000000000000746; Cenko E, 2019, J AM COLL CARDIOL, V74, P2379, DOI 10.1016/j.jacc.2019.08.1047; Cenko E, 2018, JAMA INTERN MED, V178, P632, DOI 10.1001/jamainternmed.2018.0514; Fang J, 2010, AM J MED, V123, P259, DOI 10.1016/j.amjmed.2009.08.018; Kaul P, 2013, AM HEART J, V165, P379, DOI 10.1016/j.ahj.2012.12.005; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P2174, DOI 10.1001/jama.290.16.2174; Sarma AA, 2019, J AM COLL CARDIOL, V74, P3013, DOI 10.1016/j.jacc.2019.09.065; Sidney S, 2016, JAMA CARDIOL, V1, P594, DOI 10.1001/jamacardio.2016.1326; Walli-Attaei M, 2020, LANCET, V396, P97, DOI 10.1016/S0140-6736(20)30543-2; Wilkinson C, 2019, HEART, V105, P516, DOI 10.1136/heartjnl-2018-313959; Wu AH, 2002, J AM COLL CARDIOL, V40, P1389, DOI 10.1016/S0735-1097(02)02173-3	12	6	6	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2020	396	10244					72	73		10.1016/S0140-6736(20)31049-7	http://dx.doi.org/10.1016/S0140-6736(20)31049-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2JY	32445694				2022-12-28	WOS:000552724600003
J	Schaller, T; Hirschbuhl, K; Burkhardt, K; Braun, G; Trepel, M; Markl, B; Claus, R				Schaller, Tina; Hirschbuehl, Klaus; Burkhardt, Katrin; Braun, Georg; Trepel, Martin; Maerkl, Bruno; Claus, Rainer			Postmortem Examination of Patients With COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							PATHOGENESIS		[Schaller, Tina; Maerkl, Bruno] Univ Med Ctr Augsburg, Inst Pathol & Mol Diagnost, Augsburg, Germany; [Hirschbuehl, Klaus; Trepel, Martin; Claus, Rainer] Univ Med Ctr Augsburg, Dept Hematol & Clin Oncol, Stenglinstr 2, D-86156 Augsburg, Germany; [Burkhardt, Katrin] Univ Med Ctr Augsburg, Inst Lab Med & Microbiol, Augsburg, Germany; [Braun, Georg] Univ Med Ctr Augsburg, Dept Gastroenterol, Augsburg, Germany		Claus, R (corresponding author), Univ Med Ctr Augsburg, Dept Hematol & Clin Oncol, Stenglinstr 2, D-86156 Augsburg, Germany.	rainer.claus@uk-augsburg.de	Claus, Rainer/AAZ-5606-2020	Claus, Rainer/0000-0003-2617-8766				Gu J, 2007, AM J PATHOL, V170, P1136, DOI 10.2353/ajpath.2007.061088; Hanley B, 2020, J CLIN PATHOL, V73, P239, DOI 10.1136/jclinpath-2020-206522; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; van den Brand JMA, 2015, J PATHOL, V235, P175, DOI 10.1002/path.4458; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585	5	334	342	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2518	2520		10.1001/jama.2020.8907	http://dx.doi.org/10.1001/jama.2020.8907			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32437497	Bronze, Green Published			2022-12-28	WOS:000590149400025
J	Dobbs, LK; Morikawa, H				Dobbs, Lauren K.; Morikawa, Hitoshi			Biasing Neurotensin Receptor Signaling to Arrest Psychostimulant Abuse	CELL			English	Editorial Material								Biasing G protein-coupled receptor signaling with ligands that promote select pathways is emerging as a powerful approach for therapeutic drug discovery. In this issue of Cell, Slosky et al. report a beta-arrestin-biased neurotensin receptor ligand that may curtail drug abuse without the side effects induced by G protein signaling.	[Dobbs, Lauren K.; Morikawa, Hitoshi] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA; [Dobbs, Lauren K.; Morikawa, Hitoshi] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Morikawa, H (corresponding author), Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA.; Morikawa, H (corresponding author), Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA.	morikawa@utexas.edu						Binder EB, 2001, PHARMACOL REV, V53, P453; Dobbs LK, 2017, GENES BRAIN BEHAV, V16, P56, DOI 10.1111/gbb.12361; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Pinkerton AB, 2019, J MED CHEM, V62, P8357, DOI 10.1021/acs.jmedchem.9b00340; Slosky LM, 2020, CELL, V181, P1364, DOI 10.1016/j.cell.2020.04.053; Smith JS, 2018, NAT REV DRUG DISCOV, V17, P243, DOI 10.1038/nrd.2017.229; Urs NM, 2017, BIOL PSYCHIAT, V81, P78, DOI 10.1016/j.biopsych.2016.10.011; van Gastel J, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01369; Verrico CD, 2013, EXPERT OPIN INV DRUG, V22, P1549, DOI 10.1517/13543784.2013.836488	10	1	1	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2020	181	6					1205	1206		10.1016/j.cell.2020.05.009	http://dx.doi.org/10.1016/j.cell.2020.05.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LY9TE	32470394	Bronze			2022-12-28	WOS:000540869600005
J	Murakami, H; Lam, I; Huang, PC; Song, J; van Overbeek, M; Keeney, S				Murakami, Hajime; Lam, Isabel; Huang, Pei-Ching; Song, Jacquelyn; van Overbeek, Megan; Keeney, Scott			Multilayered mechanisms ensure that short chromosomes recombine in meiosis	NATURE			English	Article							DOUBLE-STRAND BREAKS; MEIOTIC DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; GENE DISRUPTION; GLOBAL ANALYSIS; INITIATION; MEI4; REC114; SPO11; SITES	In most species, homologous chromosomes must recombine in order to segregate accurately during meiosis(1). Because small chromosomes would be at risk of missegregation if recombination were randomly distributed, the double-strand breaks (DSBs) that initiate recombination are not located arbitrarily(2). How the nonrandomness of DSB distributions is controlled is not understood, although several pathways are known to regulate the timing, location and number of DSBs. Meiotic DSBs are generated by Spo11 and accessory DSB proteins, including Rec114 and Mer(2), which assemble on chromosomes(3-7) and are nearly universal in eukaryotes(8-11). Here we demonstrate how Saccharomyces cerevisiae integrates multiple temporally distinct pathways to regulate the binding of Rec114 and Mer2 to chromosomes, thereby controlling the duration of a DSB-competent state. The engagement of homologous chromosomes with each other regulates the dissociation of Rec114 and Mer2 later in prophase I, whereas the timing of replication and the proximity to centromeres or telomeres influence the accumulation of Rec114 and Mer2 early in prophase I. Another early mechanism enhances the binding of Rec114 and Mer2 specifically on the shortest chromosomes, and is subject to selection pressure to maintain the hyperrecombinogenic properties of these chromosomes. Thus, the karyotype of an organism and its risk of meiotic missegregation influence the shape and evolution of its recombination landscape. Our results provide a cohesive view of a multifaceted and evolutionarily constrained system that allocates DSBs to all pairs of homologous chromosomes.	[Murakami, Hajime; Lam, Isabel; Huang, Pei-Ching; Song, Jacquelyn; van Overbeek, Megan; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10021 USA; [Lam, Isabel; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10021 USA; [Huang, Pei-Ching; Keeney, Scott] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA; [Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 1275 York Ave, New York, NY 10021 USA; [Lam, Isabel] Brigham & Womens Hosp, Dept Neurol, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA; [Lam, Isabel] Harvard Med Sch, Boston, MA 02115 USA; [van Overbeek, Megan] Caribou Biosci Inc, Berkeley, CA USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Murakami, H; Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10021 USA.; Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10021 USA.; Keeney, S (corresponding author), Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA.; Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 1275 York Ave, New York, NY 10021 USA.	murakamh@mskcc.org; s-keeney@ski.mskcc.org	Keeney, Scott/GVR-8515-2022; Murakami, Hajime/AAX-9411-2021	Keeney, Scott/0000-0002-1283-6417; Murakami, Hajime/0000-0002-7022-6887	National Institutes of Health (NIH) [F31 GM097861, F32 GM096692]; NIH [R01 GM058673, R35 GM118092]; NCI Cancer Center Support Grant [P30 CA008748]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Viale and N. Mohibullah of the Memorial Sloan Kettering Cancer Center (MSKCC) Integrated Genomics Operation for DNA sequencing; N. Socci at the MSKCC Bioinformatics Core Facility for mapping ChIP-seq and Spo11-oligo reads; and members of the Keeney laboratory, especially S. Yamada for advice on data analysis and L. Acquaviva for sharing unpublished information. We thank V. Subramanian, A. Hochwagen and F. Klein for discussions and for sharing unpublished information; and M. Lichten, E. Louis, K. Ohta, A. Amon, W. Zachariae, J. Matos and R. Rothstein for strains or plasmids. I.L. and M.v.O. were supported in part by National Institutes of Health (NIH) fellowships F31 GM097861 and F32 GM096692, respectively. This work was supported by NIH grants R01 GM058673 and R35 GM118092 to S.K. MSKCC core facilities are supported by NCI Cancer Center Support Grant P30 CA008748.	Acquaviva L., NATURE; Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; Bao ZH, 2015, ACS SYNTH BIOL, V4, P585, DOI 10.1021/sb500255k; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Blitzblau HG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002643; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Carballo JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003545; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Cooper TJ, 2014, EXP CELL RES, V329, P124, DOI 10.1016/j.yexcr.2014.07.016; Fischer G, 2000, NATURE, V405, P451, DOI 10.1038/35013058; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gray S, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130019; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; Kauppi L, 2013, GENE DEV, V27, P873, DOI 10.1101/gad.213652.113; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Keeney S, 2014, ANNU REV GENET, V48, P187, DOI 10.1146/annurev-genet-120213-092304; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kleckner N, 2003, TRENDS GENET, V19, P623, DOI 10.1016/j.tig.2003.09.004; Kugou K, 2009, MOL BIOL CELL, V20, P3064, DOI 10.1091/mbc.E08-12-1223; Kumar R, 2010, GENE DEV, V24, P1266, DOI 10.1101/gad.571710; Lam I, 2015, SCIENCE, V350, P932, DOI 10.1126/science.aad0814; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; Li J, 2006, GENETICS, V173, P1969, DOI 10.1534/genetics.106.058768; Maleki S, 2007, CHROMOSOMA, V116, P471, DOI 10.1007/s00412-007-0111-y; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Mimitou EP, 2017, SCIENCE, V355, P40, DOI 10.1126/science.aak9704; Mohibullah N, 2017, GENOME RES, V27, P278, DOI 10.1101/gr.213587.116; Murakami H, 2014, CELL, V158, P861, DOI 10.1016/j.cell.2014.06.028; Murakami H, 2009, METHODS MOL BIOL, V557, P117, DOI 10.1007/978-1-59745-527-5_9; Neale MJ, 2009, METHODS MOL BIOL, V557, P183, DOI 10.1007/978-1-59745-527-5_12; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Picard D, 1999, NUCL RECEPTORS PRACT, P261; Reid RJD, 2002, YEAST, V19, P319, DOI 10.1002/yea.817; Robert T, 2016, SCIENCE, V351, P943, DOI 10.1126/science.aad5309; Scannell DR, 2011, G3-GENES GENOM GENET, V1, P11, DOI 10.1534/g3.111.000273; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Stanzione M, 2016, NAT CELL BIOL, V18, P1208, DOI 10.1038/ncb3417; Subramanian VV, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08875-x; Sun XJ, 2015, ELIFE, V4, DOI 10.7554/eLife.07424; Tesse S, 2017, GENE DEV, V31, P1880, DOI 10.1101/gad.304543.117; Thacker D, 2014, NATURE, V510, P241, DOI 10.1038/nature13120; Thacker D, 2011, GENETICS, V189, P423, DOI 10.1534/genetics.111.131326; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702; Yue JX, 2017, NAT GENET, V49, P913, DOI 10.1038/ng.3847; Zhang LR, 2014, NATURE, V511, P551, DOI 10.1038/nature13442; Zhang LR, 2011, P NATL ACAD SCI USA, V108, P20036, DOI 10.1073/pnas.1117937108; Zhu X, 2015, GENETICS, V201, P525, DOI 10.1534/genetics.115.178293	56	25	25	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2020	582	7810					124	+		10.1038/s41586-020-2248-2	http://dx.doi.org/10.1038/s41586-020-2248-2			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE2ZE	32494071	Green Accepted, Green Submitted			2022-12-28	WOS:000562465400001
J	Salik, JR; Thomas, SS				Salik, Jonathan R.; Thomas, Sunu S.			Atrioventricular Dissociation during Ventricular Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Salik, Jonathan R.; Thomas, Sunu S.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Thomas, SS (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	sunu.thomas@mgh.harvard.edu		Salik, Jonathan/0000-0002-3796-866X					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2020	382	23							e84	10.1056/NEJMicm1916823	http://dx.doi.org/10.1056/NEJMicm1916823			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LV0NI	32492307				2022-12-28	WOS:000538140600003
J	Kawamoto, K; McDonald, CJ				Kawamoto, Kensaku; McDonald, Clement J.			Designing, Conducting, and Reporting Clinical Decision Support Studies: Recommendations and Call to Action	ANNALS OF INTERNAL MEDICINE			English	Article							PATIENT OUTCOMES; PRACTITIONER PERFORMANCE; OVERRIDE RATES; SYSTEMS; COMPUTER; INPATIENT; REMINDERS; ALERTS; CARE; INTERVENTIONS	By enabling more efficient and effective medical decision making, computer-based clinical decision support (CDS) could unlock widespread benefits from the significant investment in electronic health record (EHR) systems in the United States. Evidence from high-quality CDS studies is needed to enable and support this vision of CDS-facilitated care optimization, but limited guidance is available in the literature for designing and reporting CDS studies. To address this research gap, this article provides recommendations for designing, conducting, and reporting CDS studies to: 1) ensure that EHR data to inform the CDS are available; 2) choose decision rules that are consistent with local care processes; 3) target the right users and workflows; 4) make the CDS easy to access and use; 5) minimize the burden placed on users; 6) incorporate CDS success factors identified in the literature, in particular the automatic provision of CDS as a part of clinician workflow; 7) ensure that the CDS rules are adequately tested; 8) select meaningful evaluation measures; 9) use as rigorous a study design as is feasible; 10) think about how to deploy the CDS beyond the original host organization; 11) report the study in context; 12) help the audience understand why the intervention succeeded or failed; and 13) consider the financial implications. If adopted, these recommendations should help advance the vision of more efficient, effective care facilitated by useful and widely available CDS.	[Kawamoto, Kensaku] Univ Utah, 421 Wakara Way,Suite 108, Salt Lake City, UT 84108 USA; [McDonald, Clement J.] Natl Lib Med, Lister Hill Natl Ctr Biomed Commun, Bethesda, MD USA; [McDonald, Clement J.] NIH, Natl Lib Med, 8600 Rockville Pike,Bldg 38,2S22, Bethesda, MD 20894 USA	Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Kawamoto, K (corresponding author), Univ Utah, 421 Wakara Way,Suite 108, Salt Lake City, UT 84108 USA.	kensaku.kawamoto@utah.edu						Adler-Milstein J, 2017, HEALTH AFFAIR, V36, P1416, DOI 10.1377/hlthaff.2016.1651; Arndt BG, 2017, ANN FAM MED, V15, P419, DOI 10.1370/afm.2121; Barker W., 2018, HEAT WAVE US IS POIS; Bates DW, 2020, ANN INTERN MED, V172, pS137, DOI 10.7326/M19-0872; Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Berlan ED, 2014, PEDIATRICS, V133, pE1305, DOI 10.1542/peds.2013-3232; Borab ZM, 2017, JAMA SURG, V152, P638, DOI 10.1001/jamasurg.2017.0131; Bright TJ, 2012, ANN INTERN MED, V157, P29, DOI 10.7326/0003-4819-157-1-201207030-00450; Bryant AD, 2014, APPL CLIN INFORM, V5, P802, DOI 10.4338/ACI-2013-12-RA-0103; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Carroll AE, 2011, J AM MED INFORM ASSN, V18, P485, DOI 10.1136/amiajnl-2011-000088; Chen M, 2019, HEALTH AFFAIR, V38, P197, DOI 10.1377/hlthaff.2018.05447; Cho Insook, 2018, Yearb Med Inform, V27, P114, DOI 10.1055/s-0038-1641221; Curtis CE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183062; Demner-Fushman D, 2009, J BIOMED INFORM, V42, P760, DOI 10.1016/j.jbi.2009.08.007; Dexter PR, 2004, JAMA-J AM MED ASSOC, V292, P2366, DOI 10.1001/jama.292.19.2366; Donner A, 2004, AM J PUBLIC HEALTH, V94, P416, DOI 10.2105/AJPH.94.3.416; Downing NL, 2018, ANN INTERN MED, V169, P50, DOI 10.7326/M18-0139; Fillmore CL, 2015, J BIOMED INFORM, V56, P65, DOI 10.1016/j.jbi.2015.05.007; Fillmore CL, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-135; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Goldzweig CL, 2015, ANN INTERN MED, V162, P557, DOI 10.7326/M14-2600; Gomes M, 2012, MED DECIS MAKING, V32, P350, DOI 10.1177/0272989X11418372; Guyatt G, 2014, USERS GUIDES MED LIT; Health Level Seven International, 2019, OP SOURC FHIR IMPL; Health Level Seven International, 2019, HL7 FAST HEALTHC INT; Health Level Seven International, 2019, HL7 CROSS PAR SPEC C; Hemens BJ, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-89; Horsky J, 2013, INT J MED INFORM, V82, P492, DOI 10.1016/j.ijmedinf.2013.02.003; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; Imler TD, 2014, CLIN GASTROENTEROL H, V12, P1130, DOI 10.1016/j.cgh.2013.11.025; Jaspers MWM, 2011, J AM MED INFORM ASSN, V18, P327, DOI 10.1136/amiajnl-2011-000094; Kass-Hout TA, 2019, AWS GOVT ED NONPROFI; Kawamanto Kensaku, 2018, AMIA Annu Symp Proc, V2018, P624; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Kawamoto Kensaku, 2003, AMIA Annu Symp Proc, P361; Kho A, 2007, J AM BOARD FAM MED, V20, P196, DOI 10.3122/jabfm.2007.02.060114; Kho Abel, 2005, AMIA Annu Symp Proc, P390; Kilsdonk E, 2017, INT J MED INFORM, V98, P56, DOI 10.1016/j.ijmedinf.2016.12.001; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LITZELMAN DK, 1993, J GEN INTERN MED, V8, P311, DOI 10.1007/BF02600144; Lo HG, 2009, J AM MED INFORM ASSN, V16, P66, DOI 10.1197/jamia.M2687; Lobach David, 2012, Evid Rep Technol Assess (Full Rep), P1; Mandel JC, 2016, J AM MED INFORM ASSN, V23, P899, DOI 10.1093/jamia/ocv189; May TA, 2006, AM J CLIN PATHOL, V126, P200, DOI 10.1309/WP59YM73L6CEGX2F; Mccoy AB, 2014, OCHSNER J, V14, P195; MCDONALD CJ, 1976, NEW ENGL J MED, V295, P1351, DOI 10.1056/NEJM197612092952405; McDonald CJ, 1999, INT J MED INFORM, V54, P225, DOI 10.1016/S1386-5056(99)00009-X; MCDONALD CJ, 1976, ANN INTERN MED, V84, P162, DOI 10.7326/0003-4819-84-2-162; MCDONALD CJ, 1994, ANN INTERN MED, V121, P469, DOI 10.7326/0003-4819-121-6-199409150-00017; MCDONALD CJ, 1984, ANN INTERN MED, V100, P130, DOI 10.7326/0003-4819-100-1-130; MCDONALD CJ, 1994, JAMA-J AM MED ASSOC, V271, P872, DOI 10.1001/jama.271.11.872; McDonald CJ, 1992, P GUID COMP BAS MED; Miller K, 2018, INT J MED INFORM, V117, P19, DOI 10.1016/j.ijmedinf.2018.05.008; Miller K, 2018, J AM MED INFORM ASSN, V25, P585, DOI 10.1093/jamia/ocx118; MILLER ME, 1993, MED CARE, V31, pYS16, DOI 10.1097/00005650-199305001-00004; Moxey A, 2010, J AM MED INFORM ASSN, V17, P25, DOI 10.1197/jamia.M3170; Nieuwlaat R, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-90; Office of the National Coordinator for Health Information Technology, 2017, NONF AC CAR HOSP EL; Office of the National Coordinator for Health Information Technology, 2019, INT STAND ADV SECT 1; Office of the National Coordinator for Health Information Technology, 2019, TRUST EXCH FRAM COMM; Office of the National Coordinator for Health Information Technology, 2019, OFF BAS PHYS EL HLTH; Ogrinc Greg, 2016, BMJ Qual Saf, V25, P986, DOI 10.1136/bmjqs-2015-004411; Osheroff JA, 2011, IMPROVING OUTCOMES C; Osheroff JA, 2007, J AM MED INFORM ASSN, V14, P141, DOI 10.1197/jamia.M2334; Page N, 2017, INT J MED INFORM, V105, P22, DOI 10.1016/j.ijmedinf.2017.05.011; Patel TA, 2017, CANCER-AM CANCER SOC, V123, P114, DOI 10.1002/cncr.30245; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; Pevnick JM, 2016, J AM MED INFORM ASSN, V23, P942, DOI 10.1093/jamia/ocv171; Phansalkar S, 2013, J AM MED INFORM ASSN, V20, P489, DOI 10.1136/amiajnl-2012-001089; Roshanov PS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f657; Roshanov PS, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-88; Roshanov PS, 2011, IMPLEMENT SCI, V6, DOI [10.1186/1748-5908-6-92, 10.1186/1748-5908-6-88]; Sahota N, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-91; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Shapiro S, 1997, J Natl Cancer Inst Monogr, P27; Slight SP, 2017, BMJ QUAL SAF, V26, P217, DOI 10.1136/bmjqs-2015-004851; Souza NM, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-87; Van de Velde S, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0790-1; Van de Velde S, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0772-3; Varghese J, 2018, J AM MED INFORM ASSN, V25, P593, DOI 10.1093/jamia/ocx100; Wong A, 2019, DRUG SAFETY, V42, P573, DOI 10.1007/s40264-018-0756-x; Wyatt J, 1997, INT J MED INFORM, V47, P165, DOI 10.1016/S1386-5056(97)00100-7; Yusof MM, 2005, ST HEAL T, V116, P855	84	21	22	2	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2020	172			11			S101	S109		10.7326/M19-0875	http://dx.doi.org/10.7326/M19-0875			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MH8ZH	32479177				2022-12-28	WOS:000547009900006
J	Lyles, CR; Nelson, EC; Frampton, S; Dykes, PC; Cemballi, AG; Sarkar, U				Lyles, Courtney R.; Nelson, Eugene C.; Frampton, Susan; Dykes, Patricia C.; Cemballi, Anupama G.; Sarkar, Urmimala			Using Electronic Health Record Portals to Improve Patient Engagement: Research Priorities and Best Practices	ANNALS OF INTERNAL MEDICINE			English	Article							MEANINGFUL USE; OLDER-ADULTS; DIGITAL DIVIDE; SAFETY-NET; CARE; OUTCOMES; TECHNOLOGY; IMPACT; IMPLEMENTATION; COMMUNICATION	Ninety percent of health care systems now offer patient portals to access electronic health records (EHRs) in the United States, but only 15% to 30% of patients use these platforms. Using PubMed, the authors identified 53 studies published from September 2013 to June 2019 that informed best practices and priorities for future research on patient engagement with EHR data through patient portals, These studies mostly involved outpatient settings and fell into 3 major categories: interventions to increase use of patient portals, usability testing of portal interfaces, and documentation of patient and clinician barriers to portal use. Interventions that used one-on-one patient training were associated with the highest portal use. Patients with limited health or digital literacy faced challenges to portal use. Clinicians reported a lack of workflows to support patient use of portals in routine practice. These studies suggest that achieving higher rates of patient engagement through EHR portals will require paying more attention to the needs of diverse patients and systematically measuring usability as well as scope of content. Future work should incorporate implementation science approaches and directly address the key role of clinicians and staff in promoting portal use.	[Lyles, Courtney R.; Cemballi, Anupama G.; Sarkar, Urmimala] San Francisco Gen Hosp, Dept Med, Ctr Vulnerable Populat Zuckerberg, San Francisco, CA 94110 USA; [Nelson, Eugene C.] Dartmouth Coll, Geisel Sch Med, 1 Med Ctr Dr,WTRB 5, Lebanon, NH 03766 USA; [Frampton, Susan] Planetree Int, 130 Div St, Derby, CT 06418 USA; [Dykes, Patricia C.] Brigham & Womens Hosp, Ctr Patient Safety Res & Practice, 1 Brigham Circle, Boston, MA 02120 USA; [Lyles, Courtney R.; Cemballi, Anupama G.; Sarkar, Urmimala] Univ Calif San Francisco, 1001 Potrero Ave,Bldg 10,W13 UCSF Box,1363, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; Dartmouth College; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco	Lyles, CR (corresponding author), Univ Calif San Francisco, 1001 Potrero Ave,Bldg 10,W13 UCSF Box,1363, San Francisco, CA 94143 USA.	courtney.lyles@ucsf.edu		Cemballi, Anupama Gunshekar/0000-0003-1453-8963	National Library of Medicine [R01LM013045]; National Cancer Institute [K24CA212294]; Agency for Healthcare Research and Quality [P30HS023558]	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By grant R01LM013045, Creating Community Driven, Personalized Health Maps for Patients with Diabetes, Mapping to Amplify the Vitality of Engaged Neighborhoods (MAVEN), from the National Library of Medicine to Dr. Lyles and grant K24CA212294, Improving Survivorship Care for Diverse Cancer Patients Cared for in Safety-net Settings, from the National Cancer Institute and grant P30HS023558, Building an Ambulatory Patient Safety Learning Laboratory for Diverse Populations: The San Francisco Ambulatory Safety CEnter for iNnovaTion (ASCENT), from the Agency for Healthcare Research and Quality to Dr. Sarkar.	Ackerman SL, 2017, J AM MED INFORM ASSN, V24, P903, DOI 10.1093/jamia/ocx015; Alpert JM, 2019, HEALTH COMMUN, V34, P1395, DOI 10.1080/10410236.2018.1493418; Alpert JM, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5451; Ancker Jessica S, 2016, AMIA Annu Symp Proc, V2016, P277; Anderson M, 2019, 10 AM DONT USE INTER; Arcia Adriana, 2017, EGEMS (Wash DC), V5, P5, DOI 10.13063/2327-9214.1281; Bell K, 2018, AM J MED QUAL, V33, P649, DOI 10.1177/1062860618765083; Black H, 2015, AM J MANAG CARE, V21, pE329; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Bose-Brill S, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9203; Bush RA, 2018, UROL PRACT, V5, P279, DOI 10.1016/j.urpr.2017.05.002; Colorafi Karen, 2018, Mhealth, V4, P8, DOI 10.21037/mhealth.2018.03.04; Coughlin Steven S, 2017, Mhealth, V3, P50, DOI 10.21037/mhealth.2017.10.02; Czaja SJ, 2015, HUM FACTORS, V57, P491, DOI 10.1177/0018720814549238; Dalal AK, 2016, J AM MED INFORM ASSN, V23, P80, DOI 10.1093/jamia/ocv093; Delbanco T, 2010, ANN INTERN MED, V153, P121, DOI 10.7326/0003-4819-153-2-201007200-00008; Dhanireddy S, 2014, HEALTH EXPECT, V17, P724, DOI 10.1111/j.1369-7625.2012.00799.x; Dykes PC, 2017, CRIT CARE MED, V45, pE806, DOI 10.1097/CCM.0000000000002449; Dykes Patricia C, 2014, AMIA Annu Symp Proc, V2014, P486; Fiks AG, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5610; Gerard M, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7212; Giardina Traber Davis, 2015, Patient Exp J, V2, P148; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Goldzweig CL, 2013, ANN INTERN MED, V159, P677, DOI 10.7326/0003-4819-159-10-201311190-00006; Graetz I, 2016, MED CARE, V54, P772, DOI 10.1097/MLR.0000000000000560; Greenberg AJ, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7417; Greysen SR, 2018, J AM MED INFORM ASSN, V25, P1626, DOI 10.1093/jamia/ocy125; Grossman LV, 2018, J AM MED INFORM ASSN, V25, P370, DOI 10.1093/jamia/ocx074; Haun JN, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.8614; Hefner JL, 2019, BMC FAM PRACT, V20, DOI 10.1186/s12875-019-0948-1; Holden RJ, 2017, INT J MED INFORM, V108, P158, DOI 10.1016/j.ijmedinf.2017.10.006; Irizarry T, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7099; Kamo N, 2017, HEALTHCARE-J DEL SCI, V5, P221, DOI 10.1016/j.hjdsi.2016.09.003; Kelly MM, 2017, J AM MED INFORM ASSN, V24, P153, DOI 10.1093/jamia/ocw070; Kidwell KM, 2019, J PEDIAT HEMATOL ONC, V41, P561, DOI 10.1097/MPH.0000000000001341; Kim S, 2018, INT J MED INFORM, V120, P126, DOI 10.1016/j.ijmedinf.2018.10.004; Krist AH, 2017, ANN FAM MED, V15, P217, DOI 10.1370/afm.2063; Krist AH, 2014, ANN FAM MED, V12, P418, DOI 10.1370/afm.1691; Kruse CS, 2015, J MED INTERNET RES, V17, P70, DOI [10.2196/jmir.3171, 10.2196/jmir.3703]; Lindblad S, 2017, QJM-INT J MED, V110, P125, DOI 10.1093/qjmed/hcw188; Lyles CR, 2012, MED CARE, V50, P434, DOI 10.1097/MLR.0b013e318249d81b; Mackert M, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.6349; Mandel JC, 2016, J AM MED INFORM ASSN, V23, P899, DOI 10.1093/jamia/ocv189; Martinez William, 2018, JMIR Hum Factors, V5, pe26, DOI 10.2196/humanfactors.9569; McCleary NJ, 2018, J ONCOL PRACT, V14, P490, DOI 10.1200/JOP.17.00008; Mishuris RG, 2015, HEALTH EXPECT, V18, P2296, DOI 10.1111/hex.12199; Mook PJ, 2018, CIN-COMPUT INFORM NU, V36, P18, DOI 10.1097/CIN.0000000000000392; Morrow D, 2017, J BIOMED INFORM, V69, P63, DOI 10.1016/j.jbi.2017.03.015; National Health Service, 2018, TRASNSF DIG HLTH; Nazi KM, 2018, J MED INTERNET RES, V20, DOI 10.2196/10413; Nelson EC, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3319; Nystrom Daniel T, 2018, EGEMS (Wash DC), V6, P15, DOI 10.5334/egems.255; O'Leary KJ, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0363-7; O'Leary KJ, 2016, J AM MED INFORM ASSN, V23, P159, DOI 10.1093/jamia/ocv058; Ochoa A, 2017, J AM MED INFORM ASSN, V24, P1160, DOI 10.1093/jamia/ocx040; Pecina J, 2017, J AFFECT DISORDERS, V208, P1, DOI 10.1016/j.jad.2016.08.034; Perez S., 2016, TECHCRUNCH      0531; Pillemer F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154743; Portz JD, 2019, J MED INTERNET RES, V21, DOI 10.2196/11604; Price-Haywood EG, 2017, POPUL HEALTH MANAG, V20, P486, DOI 10.1089/pop.2016.0164; Quinn CC, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.9265; Raghu TS, 2015, INT J MED INFORM, V84, P754, DOI 10.1016/j.ijmedinf.2015.06.003; Ralston JD, 2009, DIABETES CARE, V32, P234, DOI 10.2337/dc08-1220; Ramsey A, 2018, J ADOLESCENT HEALTH, V62, P29, DOI 10.1016/j.jadohealth.2017.08.029; Ratliff-Schaub Karen, 2017, Pediatr Qual Saf, V2, pe049, DOI 10.1097/pq9.0000000000000049; Sadasivaiah S, 2019, J MED INTERNET RES, V21, DOI 10.2196/11421; Shaw CL, 2017, CIN-COMPUT INFORM NU, V35, P512, DOI 10.1097/CIN.0000000000000361; Sieck CJ, 2017, JMIR MED INF, V5, P13, DOI [10.2196/medinform.7516, 10.2196/medinform.7707]; Sorondo Barbara, 2016, EGEMS (Wash DC), V4, P1262, DOI 10.13063/2327-9214.1262; Stein JN, 2018, APPL CLIN INFORM, V9, P875, DOI 10.1055/s-0038-1676333; Taha J, 2014, J APPL GERONTOL, V33, P416, DOI 10.1177/0733464812447283; Tang PC, 2006, J AM MED INFORM ASSN, V13, P121, DOI 10.1197/jamia.M2025; Thompson LA, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.8340; Tieu L, 2017, J AM MED INFORM ASSN, V24, pE47, DOI 10.1093/jamia/ocw098; Tieu L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4847; Toscos T, 2016, J AM MED INFORM ASSN, V23, P119, DOI 10.1093/jamia/ocv164; U.S. Government Accountability Office, 2017, HLTH INF TECHN HHS S; Woods SS, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7895; Woolf SH, 2018, AM J PREV MED, V54, P237, DOI 10.1016/j.amepre.2017.10.027; Yamin CK, 2011, ARCH INTERN MED, V171, P568, DOI 10.1001/archinternmed.2011.34; Yardley L, 2016, AM J PREV MED, V51, P833, DOI 10.1016/j.amepre.2016.06.015; Yen PY, 2018, INT J MED INFORM, V110, P10, DOI 10.1016/j.ijmedinf.2017.11.007; Zweig M, 2019, ROCK HLTH	83	34	34	4	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2020	172			11			S123	U93		10.7326/M19-0876	http://dx.doi.org/10.7326/M19-0876			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MH8ZH	32479176	Green Accepted			2022-12-28	WOS:000547009900009
J	Gotham, D; Barber, MJ; Hill, AM				Gotham, Dzintars; Barber, Melissa J.; Hill, Andrew M.			How a US-UK trade agreement could affect NHS drug prices	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Barber, Melissa J.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Hill, Andrew M.] Univ Liverpool, Dept Translat Med, Liverpool, Merseyside, England	Harvard University; Harvard T.H. Chan School of Public Health; University of Liverpool	Hill, AM (corresponding author), Univ Liverpool, Dept Translat Med, Liverpool, Merseyside, England.	microhaart@aol.com		Barber, Melissa/0000-0003-3646-9428				[Anonymous], 2019, CONSERVATIVE UNIONIS; [Anonymous], 2018, PRESIDENT DONALD J T; Department for International Trade, UK US FREE TRAD AGRE; Department of Foreign Affairs and Trade Review of Export Policies and Programs, REV EXP POL PROGR; Faunce T., 2010, J GENERIC MED, V7, P18, DOI DOI 10.1057/JGM.2009.40; Gleeson D, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0518-2; Inman P., 2016, GUARDIAN; Jarman H, 2018, LANCET, V392, P447, DOI 10.1016/S0140-6736(18)31492-2; Kapczynski A, 2017, 572 YAL LAW EC; Lexchin J, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-30; Lopert R, 2013, J LAW MED ETHICS, V41, P199, DOI 10.1111/jlme.12014; NHS Confederation, 2019, NHS FUT FUT FREE TRA; NHS Digital, 2017, PRESCR COSTS HOSP CO; OECD, PHARM SPEND; Office of the United States Trade Representative, 2019, 6 7 US UK TRAD INV W; Office of the United States Trade Representative, 2019, PUBL HEAR NEG OBJ US; Rimmer M, 2017, VICTORIA U LAW JUSTI, V7, P76; Shaffer ER, 2009, HEALTH AFFAIR, V28, pW957, DOI 10.1377/hlthaff.28.5.w957	18	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2020	369								m1332	10.1136/bmj.m1332	http://dx.doi.org/10.1136/bmj.m1332			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0OM	32482625				2022-12-28	WOS:000548486700013
J	Ruger, JP; Horton, R				Ruger, Jennifer Prah; Horton, Richard			Justice and health: The Lancet-Health Equity and Policy Lab Commission	LANCET			English	Editorial Material									[Ruger, Jennifer Prah] Univ Penn, Hlth Equ & Policy Lab, Philadelphia, PA 19104 USA; [Ruger, Jennifer Prah] Univ Penn, Sch Social Policy & Practice, Philadelphia, PA 19104 USA; [Ruger, Jennifer Prah] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Horton, Richard] Lancet, London, England	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Ruger, JP (corresponding author), Univ Penn, Hlth Equ & Policy Lab, Philadelphia, PA 19104 USA.; Ruger, JP (corresponding author), Univ Penn, Sch Social Policy & Practice, Philadelphia, PA 19104 USA.; Ruger, JP (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	jenpr@upenn.edu						Horton R, 2018, LANCET, V391, P2307, DOI 10.1016/S0140-6736(18)31304-7; Ruger JP, 2018, GLOBAL HLTH JUSTICE; Ruger JP, 2010, HLTH SOCIAL JUSTICE	3	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2020	395	10238					1680	1681						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0PJ	32473666				2022-12-28	WOS:000561610000010
J	Li, JG; Pu, SX; Cao, WB; Li, L; Guo, RY				Li, Jiangong; Pu, Sanxu; Cao, Wenbin; Li, Lu; Guo, Ruiyun			Comment on "High-surface-area corundum by mechanochemically induced phase transformation of boehmite" COMMENT	SCIENCE			English	Editorial Material							SELECTIVE CORROSION; NANOPARTICLES	Amrute et al. (Reports, 25 October 2019, p. 485) claimed that no methods were able to produce high-purity alpha-Al2O3 with surface areas greater than 100 m(2) g(-1), even though much higher surface areas up to 253 m(2) g(-1) have been reported. Moreover, the materials they obtained could be porous aggregates and may not be 13-nm nanoparticles, as claimed.	[Li, Jiangong; Pu, Sanxu; Cao, Wenbin; Li, Lu; Guo, Ruiyun] Lanzhou Univ, Inst Mat Sci & Engn, Lanzhou 730000, Peoples R China	Lanzhou University	Li, JG (corresponding author), Lanzhou Univ, Inst Mat Sci & Engn, Lanzhou 730000, Peoples R China.	lijg@lzu.edu.cn	Li, Jiangong/GQG-9511-2022	Li, Jiangong/0000-0001-6837-1084; sanxu, pu/0000-0003-3132-8992; Guo, Ruiyun/0000-0003-3821-3952	National Natural Science Foundation of China [51272098, 51551201, 51772137]; Fundamental Research Funds for the Central Universities [lzujbky-2019-sp03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Supported by the National Natural Science Foundation of China (51272098, 51551201, and 51772137) and the Fundamental Research Funds for the Central Universities(lzujbky-2019-sp03).	Amrute AP, 2019, SCIENCE, V366, P485, DOI 10.1126/science.aaw9377; Balakrishnan A, 2010, ACTA MATER, V58, P802, DOI 10.1016/j.actamat.2009.09.058; Guo RY, 2016, J AM CERAM SOC, V99, P3556, DOI 10.1111/jace.14403; Li L, 2018, ADV POWDER TECHNOL, V29, P2194, DOI 10.1016/j.apt.2018.06.003; Pu SX, 2015, SCI REP-UK, V5, DOI 10.1038/srep11575; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603	6	4	4	5	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494							abb0142	10.1126/science.abb0142	http://dx.doi.org/10.1126/science.abb0142			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LV3IK	32467360				2022-12-28	WOS:000538332600001
J	Nejman, D; Livyatan, I; Fuks, G; Gavert, N; Zwang, Y; Geller, LT; Rotter-Maskowitz, A; Weiser, R; Mallel, G; Gigi, E; Meltser, A; Douglas, GM; Kamer, I; Gopalakrishnan, V; Dadosh, T; Levin-Zaidman, S; Avnet, S; Atlan, T; Cooper, ZA; Arora, R; Cogdill, AP; Khan, MAW; Ologun, G; Bussi, Y; Weinberger, A; Lotan-Pompan, M; Golani, O; Perry, G; Rokah, M; Bahar-Shany, K; Rozeman, EA; Blank, CU; Ronai, A; Shaoul, R; Amit, A; Dorfman, T; Kremer, R; Cohen, ZR; Harnof, S; Siegal, T; Yehuda-Shnaidman, E; Gal-Yam, EN; Shapira, H; Baldini, N; Langille, MGI; Ben-Nun, A; Kaufman, B; Nissan, A; Golan, T; Dadiani, M; Levanon, K; Bar, J; Yust-Katz, S; Barshack, I; Peeper, DS; Raz, DJ; Segal, E; Wargo, JA; Sandbank, J; Shental, N; Straussman, R				Nejman, Deborah; Livyatan, Ilana; Fuks, Garold; Gavert, Nancy; Zwang, Yaara; Geller, Leore T.; Rotter-Maskowitz, Aviva; Weiser, Roi; Mallel, Giuseppe; Gigi, Elinor; Meltser, Arnon; Douglas, Gavin M.; Kamer, Iris; Gopalakrishnan, Vancheswaran; Dadosh, Tali; Levin-Zaidman, Smadar; Avnet, Sofia; Atlan, Tehila; Cooper, Zachary A.; Arora, Reetakshi; Cogdill, Alexandria P.; Khan, Md Abdul Wadud; Ologun, Gabriel; Bussi, Yuval; Weinberger, Adina; Lotan-Pompan, Maya; Golani, Ofra; Perry, Gili; Rokah, Merav; Bahar-Shany, Keren; Rozeman, Elisa A.; Blank, Christian U.; Ronai, Anat; Shaoul, Ron; Amit, Amnon; Dorfman, Tatiana; Kremer, Ran; Cohen, Zvi R.; Harnof, Sagi; Siegal, Tali; Yehuda-Shnaidman, Einav; Gal-Yam, Einav Nili; Shapira, Hagit; Baldini, Nicola; Langille, Morgan G. I.; Ben-Nun, Alon; Kaufman, Bella; Nissan, Aviram; Golan, Talia; Dadiani, Maya; Levanon, Keren; Bar, Jair; Yust-Katz, Shlomit; Barshack, Iris; Peeper, Daniel S.; Raz, Dan J.; Segal, Eran; Wargo, Jennifer A.; Sandbank, Judith; Shental, Noam; Straussman, Ravid			The human tumor microbiome is composed of tumor type-specific intracellular bacteria	SCIENCE			English	Article							INTESTINAL MICROBIOTA; CANCER; CONTAMINATION; DIVERSITY; LIPOPOLYSACCHARIDE; PROGRESSION; EXTRACTION; MULTIPLE; TISSUE	Bacteria were first detected in human tumors more than 100 years ago, but the characterization of the tumor microbiome has remained challenging because of its low biomass. We undertook a comprehensive analysis of the tumor microbiome, studying 1526 tumors and their adjacent normal tissues across seven cancer types, including breast, lung, ovary, pancreas, melanoma, bone, and brain tumors. We found that each tumor type has a distinct microbiome composition and that breast cancer has a particularly rich and diverse microbiome. The intratumor bacteria are mostly intracellular and are present in both cancer and immune cells. We also noted correlations between intratumor bacteria or their predicted functions with tumor types and subtypes, patients' smoking status, and the response to immunotherapy.	[Nejman, Deborah; Livyatan, Ilana; Gavert, Nancy; Zwang, Yaara; Geller, Leore T.; Rotter-Maskowitz, Aviva; Mallel, Giuseppe; Gigi, Elinor; Meltser, Arnon; Bussi, Yuval; Weinberger, Adina; Lotan-Pompan, Maya; Segal, Eran; Straussman, Ravid] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Livyatan, Ilana; Bussi, Yuval; Weinberger, Adina; Lotan-Pompan, Maya; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, Rehovot, Israel; [Fuks, Garold] Weizmann Inst Sci, Dept Phys Complex Syst, Rehovot, Israel; [Weiser, Roi] Tel Aviv Sourasky Med Ctr, Div Surg, Tel Aviv, Israel; [Weiser, Roi; Cohen, Zvi R.; Harnof, Sagi; Ben-Nun, Alon; Kaufman, Bella; Golan, Talia; Levanon, Keren; Bar, Jair; Yust-Katz, Shlomit; Barshack, Iris] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Douglas, Gavin M.; Langille, Morgan G. I.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Kamer, Iris; Kaufman, Bella; Golan, Talia; Bar, Jair] Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel; [Gopalakrishnan, Vancheswaran; Arora, Reetakshi; Khan, Md Abdul Wadud; Ologun, Gabriel; Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Dadosh, Tali; Levin-Zaidman, Smadar] Weizmann Inst Sci, Dept Chem Res Support, Rehovot, Israel; [Avnet, Sofia; Baldini, Nicola] Ist Ortoped Rizzoli, IRCCS, Orthopaed Pathophysiol & Regenerat Unit, Bologna, Italy; [Atlan, Tehila] Jerusalem Coll Technol, Dept Bioinformat, Jerusalem, Israel; [Cooper, Zachary A.] AstraZeneca, Oncol R&D, Translat Med, Gaithersburg, MD USA; [Cogdill, Alexandria P.; Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Bussi, Yuval] Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel; [Golani, Ofra] Weizmann Inst Sci, Dept Life Sci Core Facil, Rehovot, Israel; [Perry, Gili; Bahar-Shany, Keren; Dadiani, Maya; Levanon, Keren] Sheba Med Ctr, Canc Res Ctr, Ramat Gan, Israel; [Rokah, Merav; Ben-Nun, Alon] Sheba Med Ctr, Dept Thorac Surg, Ramat Gan, Israel; [Rozeman, Elisa A.; Blank, Christian U.] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands; [Rozeman, Elisa A.; Blank, Christian U.] Netherlands Canc Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [Ronai, Anat; Shaoul, Ron] Rambam Med Ctr, Pediat Gastroenterol Inst, Haifa, Israel; [Amit, Amnon] Technion Israel Inst Technol, Fac Med, Haifa, Israel; [Amit, Amnon] Rambam Hlth Care Campus, Dept Obstet & Gynecol, Haifa, Israel; [Dorfman, Tatiana] Rambam Hlth Care Campus, Div Gen Surg, Haifa, Israel; [Dorfman, Tatiana] Rambam Hlth Care Campus, Ambulatory & Breast Surg Serv, Haifa, Israel; [Kremer, Ran] Rambam Hlth Care Campus, Dept Thorac Surg, Haifa, Israel; [Cohen, Zvi R.] Sheba Med Ctr, Dept Neurosurg, Ramat Gan, Israel; [Harnof, Sagi] Beilinson Med Ctr, Rabin Med Ctr, Dept Neurosurg, Petah Tiqwa, Israel; [Siegal, Tali; Yust-Katz, Shlomit] Beilinson Med Ctr, Rabin Med Ctr, Neurooncol Unit, Petah Tiqwa, Israel; [Yehuda-Shnaidman, Einav; Shapira, Hagit; Sandbank, Judith] Maccabi Healthcare Serv, Megalab, Inst Pathol, Rehovot, Israel; [Gal-Yam, Einav Nili] Sheba Med Ctr, Breast Oncol Inst, Ramat Gan, Israel; [Baldini, Nicola] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Langille, Morgan G. I.] Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada; [Nissan, Aviram] Sheba Med Ctr, Dept Surg Oncol Surg C, Ramat Gan, Israel; [Barshack, Iris] Sheba Med Ctr, Dept Pathol, Ramat Gan, Israel; [Peeper, Daniel S.] Netherlands Canc Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [Raz, Dan J.] City Hope Med Ctr, Div Thorac Surg, Duarte, CA USA; [Shental, Noam] Open Univ Israel, Dept Math & Comp Sci, Raanana, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Dalhousie University; Chaim Sheba Medical Center; University of Texas System; UTMD Anderson Cancer Center; Weizmann Institute of Science; IRCCS Istituto Ortopedico Rizzoli; AstraZeneca; University of Texas System; UTMD Anderson Cancer Center; Weizmann Institute of Science; Weizmann Institute of Science; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Netherlands Cancer Institute; Netherlands Cancer Institute; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Rambam Health Care Campus; Rambam Health Care Campus; Rambam Health Care Campus; Chaim Sheba Medical Center; Rabin Medical Center; Rabin Medical Center; Chaim Sheba Medical Center; University of Bologna; Dalhousie University; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Netherlands Cancer Institute; City of Hope; Open University Israel	Straussman, R (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.	ravidst@weizmann.ac.il	Bar, Jair/AAS-5743-2021; Baldini, Nicola/J-4806-2016; Avnet, Sofia/B-3220-2018	Bar, Jair/0000-0002-1224-3646; Baldini, Nicola/0000-0003-2228-3833; Rotter Maskowitz, Aviva/0000-0001-6091-5470; Weiser, Roi/0000-0002-4522-6404; Dadiani, Maya/0000-0002-1561-0755; Cogdill, Alexandria/0000-0001-8917-9462; Langille, Morgan/0000-0002-6604-3009; Atlan, Tehila/0000-0001-6836-7659; Avnet, Sofia/0000-0002-7843-0591; Fuks, Garold/0000-0002-5851-5483; Gavert, Nancy/0000-0003-1639-4684; Bussi, Yuval/0000-0003-0365-431X; Mallel, Giuseppe/0000-0002-8673-7526	Israel Science Foundation [2044/17]; Binational Science Foundation [2013332]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [818086]; Fabrikant-Morse Families Research Fund for Humanity; Chantal d'Adesky Scheinberg Research Fund; Moross Integrated Cancer Center; Rising Tide Foundation; Jacki and Bruce Barron Cancer Research Scholars' Program; Israel Cancer Research Fund; City of Hope (COH) - Harvey L. Miller Family Foundation; Ministry of Science, Technology and Space, Israel [3-11174]; National Cancer Institute of the National Institutes of Health [P30CA033572]; Cancer Prevention and Research Institute of Texas Research Training Program [RP170067]	Israel Science Foundation(Israel Science Foundation); Binational Science Foundation(US-Israel Binational Science Foundation); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); Fabrikant-Morse Families Research Fund for Humanity; Chantal d'Adesky Scheinberg Research Fund; Moross Integrated Cancer Center; Rising Tide Foundation; Jacki and Bruce Barron Cancer Research Scholars' Program; Israel Cancer Research Fund; City of Hope (COH) - Harvey L. Miller Family Foundation; Ministry of Science, Technology and Space, Israel(Ministry of Science, Technology and Space (MOST), Israel); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention and Research Institute of Texas Research Training Program	R.St. is funded by the Israel Science Foundation (grant no. 2044/17), the Binational Science Foundation (grant no. 2013332), the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement no. 818086), the Fabrikant-Morse Families Research Fund for Humanity, the Chantal d'Adesky Scheinberg Research Fund, the Moross Integrated Cancer Center, the Rising Tide Foundation, the International Collaboration Grant from the Jacki and Bruce Barron Cancer Research Scholars' Program, and a partnership of the Israel Cancer Research Fund and City of Hope (COH), as supported by The Harvey L. Miller Family Foundation. R.St. is the incumbent of the Roel C. Buck Career Development Chair. N.S. is funded by the Ministry of Science, Technology and Space, Israel (grant no. 3-11174). Research reported in this publication included work performed in the COH Pathology Research Services Core supported by the National Cancer Institute of the National Institutes of Health under award no. P30CA033572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. A.P.C. is supported by the Cancer Prevention and Research Institute of Texas Research Training Program (RP170067).	Abada A, 2017, P NATL ACAD SCI USA, V114, P12749, DOI 10.1073/pnas.1705572114; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; [Anonymous], 1994, NEW COMPREHENSIVE BI; Apostolou P, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-137; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Baban Chwanrow K, 2010, Bioeng Bugs, V1, P385, DOI 10.4161/bbug.1.6.13146; Banerjee S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00951; Banerjee S, 2017, ONCOTARGET, V8, P36225, DOI 10.18632/oncotarget.16717; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Barton HA, 2006, J MICROBIOL METH, V66, P21, DOI 10.1016/j.mimet.2005.10.005; Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Costantini L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35329-z; Cummins J, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-11; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Douglas GM, 2019, PICRUST2 IMPROVED EX, DOI [10.1101/672295v1, DOI 10.1101/672295V1]; Du J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035957; Eisenhofer R, 2019, TRENDS MICROBIOL, V27, P105, DOI 10.1016/j.tim.2018.11.003; Eng A, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0425-4; Errington J, 2017, BIOCHEM SOC T, V45, P287, DOI 10.1042/BST20160435; Errington J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120143; Forestier C, 1999, J IMMUNOL, V162, P6784; Fuks G, 2018, MICROBIOME, V6, DOI 10.1186/s40168-017-0396-x; Gao ZG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00020; Geller LT, 2017, SCIENCE, V357, P1156, DOI 10.1126/science.aah5043; Glassing A, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0103-7; Goodman B, 2018, J PATHOL, V244, P667, DOI 10.1002/path.5047; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Greathouse KL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1501-6; Helmink BA, 2019, NAT MED, V25, P377, DOI 10.1038/s41591-019-0377-7; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Karihtala P, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-262; Khanjani N, 2017, REV ENVIRON HEALTH, V32, P267, DOI 10.1515/reveh-2016-0068; KLIENEBERGERNOBEL E, 1949, J GEN MICROBIOL, V3, P434, DOI 10.1099/00221287-3-3-434; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kuperman A, 2020, BJOG-INT J OBSTET GY, V127, P159, DOI 10.1111/1471-0528.15896; Lau JT, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0327-7; Lauder AP, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0172-3; Livyatan I., 2020, ZENODO, DOI [10.5281/zenodo.3740536, DOI 10.5281/ZENODO.3740536]; Louca S, 2018, BIOINFORMATICS, V34, P1053, DOI 10.1093/bioinformatics/btx701; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; NAKAGAWA MASASHI, 1967, NAGOYA J MED SCI, V29, P345; Nistal E, 2012, INFLAMM BOWEL DIS, V18, P649, DOI 10.1002/ibd.21830; Ou GW, 2009, AM J GASTROENTEROL, V104, P3058, DOI 10.1038/ajg.2009.524; Peters BA, 2019, CANCER EPIDEM BIOMAR, V28, P731, DOI 10.1158/1055-9965.EPI-18-0966; Poore GD, 2020, NATURE, V579, P567, DOI 10.1038/s41586-020-2095-1; Pope JL, 2017, TRANSL RES, V179, P139, DOI 10.1016/j.trsl.2016.07.021; Pushalkar S, 2018, CANCER DISCOV, V8, P403, DOI 10.1158/2159-8290.CD-17-1134; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reyes AM, 2018, ANTIOXID REDOX SIGN, V28, P487, DOI 10.1089/ars.2017.7074; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Rutkowski MR, 2015, CANCER CELL, V27, P27, DOI 10.1016/j.ccell.2014.11.009; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sfanos KS, 2008, PROSTATE, V68, P306, DOI 10.1002/pros.20680; Siegrist MS, 2013, ACS CHEM BIOL, V8, P500, DOI 10.1021/cb3004995; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Thompson KJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188873; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; Urbaniak C, 2016, APPL ENVIRON MICROB, V82, P5039, DOI 10.1128/AEM.01235-16; Urbaniak C, 2014, APPL ENVIRON MICROB, V80, P3007, DOI 10.1128/AEM.00242-14; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Weyrich LS, 2019, MOL ECOL RESOUR, V19, P982, DOI 10.1111/1755-0998.13011; Wong SH, 2017, GASTROENTEROLOGY, V153, P1621, DOI 10.1053/j.gastro.2017.08.022; Xuan CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083744; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465; Yu GQ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1021-1	75	496	512	127	621	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					973	+		10.1126/science.aay9189	http://dx.doi.org/10.1126/science.aay9189			66	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LV3IK	32467386	Green Accepted			2022-12-28	WOS:000538332600042
J	Katayama, H; Hama, H; Nagasawa, K; Kurokawa, H; Sugiyama, M; Ando, R; Funata, M; Yoshida, N; Homma, M; Nishimura, T; Takahashi, M; Ishida, Y; Hioki, H; Tsujihata, Y; Miyawaki, A				Katayama, Hiroyuki; Hama, Hiroshi; Nagasawa, Koji; Kurokawa, Hiroshi; Sugiyama, Mayu; Ando, Ryoko; Funata, Masaaki; Yoshida, Nobuyo; Homma, Misaki; Nishimura, Takanori; Takahashi, Megumu; Ishida, Yoko; Hioki, Hiroyuki; Tsujihata, Yoshiyuki; Miyawaki, Atsushi			Visualizing and Modulating Mitophagy for Therapeutic Studies of Neurodegeneration	CELL			English	Article							FLUORESCENT PROTEINS; MITOCHONDRIAL; AUTOPHAGY; DEGRADATION; GFP; EXPRESSION; REGULATOR; NEURONS; SCREEN; RED	Dysfunctional mitochondria accumulate in many human diseases. Accordingly, mitophagy, which removes these mitochondria through lysosomal degradation, is attracting broad attention. Due to uncertainties in the operational principles of conventional mitophagy probes, however, the specificity and quantitativeness of their readouts are disputable. Thorough investigation of the behaviors and fates of fluorescent proteins inside and outside lysosomes enabled us to develop an indicator for mitophagy, mito-SRAI. Through strict control of its mitochondrial targeting, we were able to monitor mitophagy in fixed biological samples more reproducibly than before. Large-scale image-based high-throughput screening led to the discovery of a hit compound that induces selective mitophagy of damaged mitochondria. In a mouse model of Parkinsons disease, we found that dopaminergic neurons selectively failed to execute mitophagy that promoted their survival within lesions. These results show that mito-SRAI is an essential tool for quantitative studies of mito-chondrial quality control.	[Katayama, Hiroyuki; Hama, Hiroshi; Kurokawa, Hiroshi; Sugiyama, Mayu; Ando, Ryoko; Miyawaki, Atsushi] RIKEN, Lab Cell Funct Dynam, Ctr Brain Sci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Nagasawa, Koji; Funata, Masaaki; Nishimura, Takanori; Tsujihata, Yoshiyuki] Takeda Pharmaceut Co Ltd, Innovat Biol Labs, Neurosci Drug Discovery Unit, Res, Fujisawa, Kanagawa 2518555, Japan; [Yoshida, Nobuyo] Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Cardiovasc & Metab Drug Discovery Unit, Fujisawa, Kanagawa 2518555, Japan; [Homma, Misaki] Takeda Pharmaceut Co Ltd, Neurosci Drug Discovery Unit, Res, Drug Discovery Chem Labs, Fujisawa, Kanagawa 2518555, Japan; [Takahashi, Megumu; Ishida, Yoko; Hioki, Hiroyuki] Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Tokyo 1138421, Japan; [Miyawaki, Atsushi] RIKEN, Ctr Adv Photon, Biotechnol Opt Res Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Yoshida, Nobuyo] Reborna Biosci, Fujisawa, Kanagawa 2510012, Japan	RIKEN; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Juntendo University; RIKEN	Miyawaki, A (corresponding author), RIKEN, Lab Cell Funct Dynam, Ctr Brain Sci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.; Tsujihata, Y (corresponding author), Takeda Pharmaceut Co Ltd, Innovat Biol Labs, Neurosci Drug Discovery Unit, Res, Fujisawa, Kanagawa 2518555, Japan.; Miyawaki, A (corresponding author), RIKEN, Ctr Adv Photon, Biotechnol Opt Res Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yoshiyuki.tsujihata@takeda.com; atsushi.miyawaki@riken.jp	Miyawaki, Atsushi/K-3569-2014; Hioki, Hiroyuki/J-9412-2017	Miyawaki, Atsushi/0000-0002-2329-3235; Hioki, Hiroyuki/0000-0002-0152-7854; Ishida, Yoko/0000-0003-4436-6787; Takahashi, Megumu/0000-0001-5993-8245	Japan Ministry of Education, Culture, Sports, Science and Technology [JP15H05948, JP16H01426]; JSPS KAKENHI [JP25830043, JP16K07046]; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS); (AMED-CREST) from Japan Agency for Medical Research and Development; AMED; RIKEN-BSI Takeda Collaboration Center; Uehara Memorial Foundation	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS); (AMED-CREST) from Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); AMED; RIKEN-BSI Takeda Collaboration Center; Uehara Memorial Foundation(Uehara Memorial Foundation)	The authors thank K. Ohtawa, K. Higuchi, R. Takahashi, N. Komatsu, and RIKEN CBS Olympus Collaboration Center (BOCC) for technical assistance; N. Mizushima (The Univ. of Tokyo) for MEFs; S. Okabe (The Univ. of Tokyo), Y. Miyashita (RIKEN, CBS), C. Davies, K. Yamamoto, K. Hirai, and T. Hioki (Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited); S. Karasawa and T. Nakajo (Medical & Biological Laboratories Company Limited) for scientific support and advice; and M. Kobayashi (Axce-lead Drug Discovery Partners) for assistance in high-throughput screening. This work was supported in part by grants from the Japan Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research on Innovative Areas: Resonance Bio (JP15H05948 to A.M.; JP16H01426 to H. Hioki), JSPS KAKENHI (JP25830043, JP16K07046 to H. Katayama), the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS), (AMED-CREST) from Japan Agency for Medical Research and Development, AMED, RIKEN-BSI Takeda Collaboration Center, and the Uehara Memorial Foundation.	Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Beeson CC, 2010, ANAL BIOCHEM, V404, P75, DOI 10.1016/j.ab.2010.04.040; CADWELL RC, 1994, PCR METH APPL, V3, pS136; East DA, 2014, CHEM BIOL, V21, P1585, DOI 10.1016/j.chembiol.2014.09.019; GHODA L, 1992, MOL CELL BIOL, V12, P2178, DOI 10.1128/MCB.12.5.2178; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748; Hioki H, 2009, NEUROSCI RES, V63, P149, DOI 10.1016/j.neures.2008.10.010; Hoshino A, 2019, NATURE, V575, P375, DOI 10.1038/s41586-019-1667-4; Ivatt RM, 2014, P NATL ACAD SCI USA, V111, P8494, DOI 10.1073/pnas.1321207111; JEON BS, 1995, NEURODEGENERATION, V4, P131, DOI 10.1006/neur.1995.0016; Kaizuka T, 2016, MOL CELL, V64, P835, DOI 10.1016/j.molcel.2016.09.037; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Katayama H, 2008, CELL STRUCT FUNCT, V33, P1, DOI 10.1247/csf.07011; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kondapuram S.K., 2019, J CANC METASTASIS TR, V5, P32, DOI DOI 10.20517/2394-4722.2018.105; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuma A, 2017, AUTOPHAGY, V13, P1619, DOI 10.1080/15548627.2017.1343770; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Martensson CU, 2019, NATURE, V569, P679, DOI 10.1038/s41586-019-1227-y; McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008; McWilliams TG, 2016, J CELL BIOL, V214, P333, DOI 10.1083/jcb.201603039; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034; Potting C, 2018, P NATL ACAD SCI USA, V115, pE180, DOI 10.1073/pnas.1711023115; Rudolf R, 2004, J CELL BIOL, V166, P527, DOI 10.1083/jcb.200403102; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shimozono S, 2008, METHOD CELL BIOL, V85, P381, DOI 10.1016/S0091-679X(08)85016-9; Shinoda H, 2018, CELL CHEM BIOL, V25, P330, DOI 10.1016/j.chembiol.2017.12.005; Sohn J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169611; Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009; Thiele SL, 2012, JOVE-J VIS EXP, DOI 10.3791/3234; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wang CR, 2015, ONCOL REP, V34, P1708, DOI 10.3892/or.2015.4146; Whitworth AJ, 2017, CURR OPIN GENET DEV, V44, P47, DOI 10.1016/j.gde.2017.01.016; Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5	45	45	45	6	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2020	181	5					1176	+		10.1016/j.cell.2020.04.025	http://dx.doi.org/10.1016/j.cell.2020.04.025			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LT9QF	32437660	Bronze			2022-12-28	WOS:000537399500020
J	Mukherjee, S; Rechtsman, MC				Mukherjee, Sebabrata; Rechtsman, Mikael C.			Observation of Floquet solitons in a topological bandgap	SCIENCE			English	Article							SPATIAL SOLITONS; WAVE-GUIDES; EDGE STATES; BACKSCATTERING; ARRAYS	Topological protection is a universal phenomenon that applies to electronic, photonic, ultracold atomic, mechanical, and other systems. The vast majority of research in these systems has explored the linear domain, where interparticle interactions are negligible. We experimentally observed solitons-waves that propagate without changing shape as a result of nonlinearity-in a photonic Floquet topological insulator. These solitons exhibited distinct behavior in that they executed cyclotron-like orbits associated with the underlying topology. Specifically, we used a waveguide array with periodic variations along the waveguide axis, giving rise to nonzero winding number, and the nonlinearity arose from the optical Kerr effect. This result applies to a range of bosonic systems because it is described by the focusing nonlinear Schrodinger equation (equivalently, the attractive Gross-Pitaevskii equation).	[Mukherjee, Sebabrata; Rechtsman, Mikael C.] Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Mukherjee, S; Rechtsman, MC (corresponding author), Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA.	mukherjeesebabrata@gmail.com; mcrworld@psu.edu	Rechtsman, Mikael C/HCH-3650-2022; Rechtsman, Mikael C./L-8926-2013	Rechtsman, Mikael C./0000-0002-6909-8355; Mukherjee, Sebabrata/0000-0003-1942-2521	Office of Naval Research [N00014-18-1-2595]; Packard Foundation [2017-66821]; Kaufman Foundation [KA2017-91788]	Office of Naval Research(Office of Naval Research); Packard Foundation(The David & Lucile Packard Foundation); Kaufman Foundation	Supported by Office of Naval Research award N00014-18-1-2595 (S.M. and M.C.R.) and by Packard Foundation fellowship 2017-66821 and Kaufman Foundation award KA2017-91788 (M.C.R.).	Ablowitz MJ, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.023813; Aidelsburger M, 2015, NAT PHYS, V11, P162, DOI 10.1038/NPHYS3171; Ams M, 2005, OPT EXPRESS, V13, P5676, DOI 10.1364/OPEX.13.005676; Atala M, 2013, NAT PHYS, V9, P795, DOI [10.1038/nphys2790, 10.1038/NPHYS2790]; BARTHELEMY A, 1985, OPT COMMUN, V55, P201, DOI 10.1016/0030-4018(85)90047-1; BUTTIKER M, 1988, PHYS REV B, V38, P9375, DOI 10.1103/PhysRevB.38.9375; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; CHRISTODOULIDES DN, 1988, OPT LETT, V13, P794, DOI 10.1364/OL.13.000794; Clark L. W., 2019, 190705872CONDMATQUAN; Davis KM, 1996, OPT LETT, V21, P1729, DOI 10.1364/OL.21.001729; Eisenberg HS, 1998, PHYS REV LETT, V81, P3383, DOI 10.1103/PhysRevLett.81.3383; Fleischer JW, 2003, NATURE, V422, P147, DOI 10.1038/nature01452; Hadad Y, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.155112; Hafezi M, 2013, NAT PHOTONICS, V7, P1001, DOI [10.1038/NPHOTON.2013.274, 10.1038/nphoton.2013.274]; He L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12231-4; JENSEN SM, 1982, IEEE J QUANTUM ELECT, V18, P1580, DOI 10.1109/TMTT.1982.1131291; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Karzig T, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031001; Kitagawa T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.235114; Kruk S, 2019, NAT NANOTECHNOL, V14, P126, DOI 10.1038/s41565-018-0324-7; Leykam D, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.023901; Leykam D, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.143901; Lu L, 2014, NAT PHOTONICS, V8, P821, DOI [10.1038/nphoton.2014.248, 10.1038/NPHOTON.2014.248]; Lumer Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.243905; Maczewsky LJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13756; Marzuola J. L., 2019, 190410312CONDMATMESH; Mukherjee S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06723-y; Mukherjee S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13918; Nalitov AV, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.116401; Nash LM, 2015, P NATL ACAD SCI USA, V112, P14495, DOI 10.1073/pnas.1507413112; Ningyuan J, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021031; Ozawa T, 2019, REV MOD PHYS, V91, DOI 10.1103/RevModPhys.91.015006; Raghu S, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.033834; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Rudner MS, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.031005; SEGEV M, 1992, PHYS REV LETT, V68, P923, DOI 10.1103/PhysRevLett.68.923; SHEIKBAHAE M, 1990, IEEE J QUANTUM ELECT, V26, P760, DOI 10.1109/3.53394; Smirnova D, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.103901; Stegeman GI, 1999, SCIENCE, V286, P1518, DOI 10.1126/science.286.5444.1518; Susstrunk R, 2015, SCIENCE, V349, P47, DOI 10.1126/science.aab0239; Szameit A, 2006, OPT EXPRESS, V14, P6055, DOI 10.1364/OE.14.006055; Szameit A, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/16/163001; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Wang Z, 2009, NATURE, V461, P772, DOI 10.1038/nature08293	45	122	123	16	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					856	+		10.1126/science.aba8725	http://dx.doi.org/10.1126/science.aba8725			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU2DD	32439788	Green Submitted			2022-12-28	WOS:000537569500040
J	Zheng, Y				Zheng, Yan			Global solutions to a silent poison	SCIENCE			English	Editorial Material							HEALTH; WATER		[Zheng, Yan] Southern Univ Sci & Technol, Sch Environm Sci & Engn, Shenzhen 518055, Guangdong, Peoples R China	Southern University of Science & Technology	Zheng, Y (corresponding author), Southern Univ Sci & Technol, Sch Environm Sci & Engn, Shenzhen 518055, Guangdong, Peoples R China.	yan.zheng@sustech.edu.cn			Strategic Priority Research Program of the Chinese Academy of Sciences [XDA20060402]; National Natural Science Foundation [41831279]; U.S. National Institute of Environmental Health Sciences, Superfund Research Program [P42 ES010349]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); U.S. National Institute of Environmental Health Sciences, Superfund Research Program	J. D. Ayotte,A. Navas-Acien, and D.K. Nordstrom provided comments. Figure courtesy of A. Bozack,Z.Tan, and B. Xu. Y.Z. is supported by Strategic Priority Research Program of the Chinese Academy of Sciences (XDA20060402), the National Natural Science Foundation (41831279), and the U.S. National Institute of Environmental Health Sciences, Superfund Research Program (P42 ES010349).	Ahmad A, 2020, ENVIRON INT, V134, DOI 10.1016/j.envint.2019.105253; Ayotte JD, 2017, ENVIRON SCI TECHNOL, V51, P12443, DOI 10.1021/acs.est.7b02881; Ayotte JD, 2016, ENVIRON SCI TECHNOL, V50, P7555, DOI 10.1021/acs.est.6b01914; Demanelis K, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP3849; Flanagan SV, 2012, B WORLD HEALTH ORGAN, V90, P839, DOI 10.2471/BLT.11.101253; Moon KA, 2013, ANN INTERN MED, V159, P649, DOI 10.7326/0003-4819-159-10-201311190-00719; National Research Council, 2013, CRIT ASP EPAS IRIS A; Navas-Acien A, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1272-9; Nordstrom DK, 2002, SCIENCE, V296, P2143, DOI 10.1126/science.1072375; Podgorski J, 2020, SCIENCE, V368, P845, DOI 10.1126/science.aba1510; Winkel L, 2008, NAT GEOSCI, V1, P536, DOI 10.1038/ngeo254; Zheng Y, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP629	12	38	40	25	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					818	819		10.1126/science.abb9746	http://dx.doi.org/10.1126/science.abb9746			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU2DD	32439775				2022-12-28	WOS:000537569500021
J	Klein, RS				Klein, Robyn S.			On Complement, Memory, and Microglia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A study of memory and forgetting in the mouse suggests that microglia and complement proteins compromise the neuronal synapses that store memory. The act of forgetting may be an active process in which synapses are tagged for removal.	[Klein, Robyn S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA.							Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Wang C, 2020, SCIENCE, V367, P688, DOI 10.1126/science.aaz2288; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577	5	2	2	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2020	382	21					2056	2058		10.1056/NEJMcibr2002480	http://dx.doi.org/10.1056/NEJMcibr2002480			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LT1TD	32433843	Green Published			2022-12-28	WOS:000536856000023
J	Rintoul, A; Colbert, A; Garner, S; Kotwani, A; Vogler, S; Bouvy, J; Hill, A				Rintoul, Andrew; Colbert, Allison; Garner, Sarah; Kotwani, Anita; Vogler, Sabine; Bouvy, Jacoline; Hill, Andrew			Medicines with one seller and many buyers: strategies to increase the power of the payer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rintoul, Andrew; Colbert, Allison; Garner, Sarah] World Hlth Org, Geneva, Switzerland; [Kotwani, Anita] Univ Delhi, VP Chest Inst, Delhi, India; [Vogler, Sabine] Gesundheit Osterreich, Vienna, Austria; [Bouvy, Jacoline] Natl Inst Hlth & Care Excellence, London, England; [Hill, Andrew] Univ Liverpool, Liverpool, Merseyside, England	World Health Organization; University of Delhi; National Institute for Health & Care Excellence; University of Liverpool	Colbert, A (corresponding author), World Hlth Org, Geneva, Switzerland.	colberta@who.int	Kotwani, Anita/ABF-6201-2021	Kotwani, Anita/0000-0003-3182-5155				Bouvy JC, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00280; Danzon PM, 2015, HEALTH ECON, V24, P238, DOI 10.1002/hec.3013; Department of Health and Human Services, 2019, FED REGISTER, V84, P2340; European Union, 2018, INN PAYM MOD HIGH CO; Flume Mathias, 2016, J Mark Access Health Policy, V4, DOI 10.3402/jmahp.v4.30970; Garner S, 2018, PHARMACOECONOMICS, V36, P5, DOI 10.1007/s40273-017-0567-4; Kotwani A., 2013, EC POLIT WKLY, P104; Kotwani A, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-285; Mackintosh M, 2018, SOC SCI MED, V200, P182, DOI 10.1016/j.socscimed.2018.01.008; Morgan SG, 2017, HEALTH POLICY, V121, P354, DOI 10.1016/j.healthpol.2017.02.002; OECD, 2018, PHARM INN ACC MED; OECD, 2017, NEW HLTH TECHN MAN A, DOI [10.1787/9789264266438, DOI 10.1787/9789264266438]; Organisation of Eastern Caribbean States, 2016, PHARM PROC SERV REP; Pan American Health Organization, WHAT IS PAHO REV FUN; Pacheco-Unguetti AP, 2014, SPAN J PSYCHOL, V17, DOI 10.1017/sjp.2014.32; Schneider P, 2019, MED PRICE SURVEYS AN; Thomson S, 2019, CAN PEOPLE AFFORD PA; Towse A, 2013, INT J TECHNOL ASSESS, V29, P360, DOI 10.1017/S0266462313000524; Vogler S, 2015, STUDY ENHANCED CROSS; Vogler S, 2018, POLICY BRIEF; Williams OD, 2015, AM J PUBLIC HEALTH, V105, P1290, DOI 10.2105/AJPH.2015.302554; Wirtz VJ, 2017, LANCET, V389, P403, DOI 10.1016/S0140-6736(16)31599-9; World Bank, 2017, WORK TOG BETT PROC O; World Health Organization, 2016, CHALL OPP IMPR ACC M; World Health Organization, 2007, WHOTCMMPM20071; World Health Organization, 2015, WHO GUID COUNTR PHAR	26	7	7	3	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2020	369								m1705	10.1136/bmj.m1705	http://dx.doi.org/10.1136/bmj.m1705			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LV3JK	32434753	hybrid, Green Published			2022-12-28	WOS:000538335800003
J	Zhang, XN; Tan, Y; Ling, Y; Lu, G; Liu, F; Yi, ZG; Jia, XF; Wu, M; Shi, BS; Xu, SB; Chen, J; Wang, W; Chen, B; Jiang, L; Yu, ST; Lu, J; Wang, JZ; Xu, MZ; Yuan, ZH; Zhang, Q; Zhang, XX; Zhao, GP; Wang, SY; Chen, SJ; Lu, HZ				Zhang, Xiaonan; Tan, Yun; Ling, Yun; Lu, Gang; Liu, Feng; Yi, Zhigang; Jia, Xiaofang; Wu, Min; Shi, Bisheng; Xu, Shuibao; Chen, Jun; Wang, Wei; Chen, Bing; Jiang, Lu; Yu, Shuting; Lu, Jing; Wang, Jinzeng; Xu, Mingzhu; Yuan, Zhenghong; Zhang, Qin; Zhang, Xinxin; Zhao, Guoping; Wang, Shengyue; Chen, Saijuan; Lu, Hongzhou			Viral and host factors related to the clinical outcome of COVID-19	NATURE			English	Article							CORONAVIRUS; ALIGNMENT	In December 2019, coronavirus disease 2019 (COVID-19), which is caused by the new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in Wuhan (Hubei province, China)(1); it soon spread across the world. In this ongoing pandemic, public health concerns and the urgent need for effective therapeutic measures require a deep understanding of the epidemiology, transmissibility and pathogenesis of COVID-19. Here we analysed clinical, molecular and immunological data from 326 patients with confirmed SARS-CoV-2 infection in Shanghai. The genomic sequences of SARS-CoV-2, assembled from 112 high-quality samples together with sequences in the Global Initiative on Sharing All Influenza Data (GISAID) dataset, showed a stable evolution and suggested that there were two major lineages with differential exposure history during the early phase of the outbreak in Wuhan. Nevertheless, they exhibited similar virulence and clinical outcomes. Lymphocytopenia, especially reduced CD4(+)and CD8(+)T cell counts upon hospital admission, was predictive of disease progression. High levels of interleukin (IL)-6 and IL-8 during treatment were observed in patients with severe or critical disease and correlated with decreased lymphocyte count. The determinants of disease severity seemed to stem mostly from host factors such as age and lymphocytopenia (and its associated cytokine storm), whereas viral genetic variation did not significantly affect outcomes. Genome sequences from 112 patients with confirmed SARS-CoV-2 infection showed two clades of SARS-CoV-2 virus with similar virulence and clinical outcome, and clinical data from 326 cases suggest that T cell depletion and cytokine bursts are associated with a worse prognosis.	[Zhang, Xiaonan; Ling, Yun; Yi, Zhigang; Jia, Xiaofang; Wu, Min; Shi, Bisheng; Xu, Shuibao; Chen, Jun; Wang, Wei; Xu, Mingzhu; Lu, Hongzhou] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China; [Tan, Yun; Lu, Gang; Liu, Feng; Chen, Bing; Jiang, Lu; Yu, Shuting; Lu, Jing; Wang, Jinzeng; Wang, Shengyue; Chen, Saijuan] Shanghai Jiao Tong Univ SJTU, Nat Res Ctr Translat Med, State Key Lab Med Genom, Shanghai Inst Hematol,Ruijin Hosp,Sch Med, Shanghai, Peoples R China; [Yi, Zhigang; Yuan, Zhenghong] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai, Peoples R China; [Zhang, Qin] Shanghai Jiao Tong Univ, Sch Med, Tong Ren Hosp, Shanghai, Peoples R China; [Zhang, Xinxin] Shanghai Jiao Tong Univ SJTU, Sch Med, Res Lab Clin Virol, Ruijin Hosp, Shanghai, Peoples R China; [Zhao, Guoping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Lu, HZ (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.; Wang, SY; Chen, SJ (corresponding author), Shanghai Jiao Tong Univ SJTU, Nat Res Ctr Translat Med, State Key Lab Med Genom, Shanghai Inst Hematol,Ruijin Hosp,Sch Med, Shanghai, Peoples R China.	wsy12115@rjh.com.cn; sjchen@stn.sh.cn; luhongzhou@shphc.org.cn	Chen, Jun/GXH-9420-2022	Chen, Jun/0000-0002-3850-4875; Zhang, Xiaofeng/0000-0003-0972-8842; Lu, hongzhou/0000-0003-3590-4790; Tan, Yun/0000-0001-8450-0392; Zhang, Xiaonan/0000-0002-1286-7280; Zhao, Guo-Ping/0000-0002-7621-6620; Yun, Ling/0000-0002-4289-3594; Jiang, Lu/0000-0003-1816-0523	National Megaprojects of China for Infectious Diseases [2017ZX10103009-001, 2018ZX10305409-001-005]; Double First-Class Project of Fudan University [IDF162005]; Scientific Research for Special Subjects on 2019 Novel Coronavirus of Shanghai Public Health Clinical Center [2020YJKY01]; Double First-Class Project from the Ministry of Education, State Key Laboratory of Medical Genomics [WF510162602]; Overseas Expertise Introduction Project for Discipline Innovation (111 Project) [B17029]; National Key R&D Program of China [2019YFA0905902]; Shanghai Guangci Translational Medical Research Development Foundation	National Megaprojects of China for Infectious Diseases; Double First-Class Project of Fudan University; Scientific Research for Special Subjects on 2019 Novel Coronavirus of Shanghai Public Health Clinical Center; Double First-Class Project from the Ministry of Education, State Key Laboratory of Medical Genomics; Overseas Expertise Introduction Project for Discipline Innovation (111 Project); National Key R&D Program of China; Shanghai Guangci Translational Medical Research Development Foundation	This work was supported by National Megaprojects of China for Infectious Diseases (2017ZX10103009-001, 2018ZX10305409-001-005); Double First-Class Project of Fudan University (no. IDF162005); Scientific Research for Special Subjects on 2019 Novel Coronavirus of Shanghai Public Health Clinical Center (no. 2020YJKY01); Double First-Class Project (WF510162602) from the Ministry of Education, State Key Laboratory of Medical Genomics; Overseas Expertise Introduction Project for Discipline Innovation (111 Project, B17029); National Key R&D Program of China (2019YFA0905902); and the Shanghai Guangci Translational Medical Research Development Foundation. We acknowledge all healthcare personnel involved in the diagnosis and treatment of patients in Shanghai Public Health Clinical Center and we thank Z. Chen for guidance regarding study design, interpretation of results and critical revision of the manuscript. We also thank all researchers who shared SARS-CoV-2 genome sequences in GISAID. We thank the late Y. Hu of Shanghai Public Health Clinical Center for her lifelong commitment to infectious disease research.	Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; [Anonymous], 2020, DIAGN TREATM PROT CO; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Fedonin GG, 2019, BRIEF BIOINFORM, V20, P15, DOI 10.1093/bib/bbx079; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Lam TTY, 2020, NATURE, V583, P282, DOI 10.1038/s41586-020-2169-0; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; MacLean O. A., 2020, RESPONSE ORIGIN CONT; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066; Ren LL, 2020, CHINESE MED J-PEKING, V133, P1015, DOI 10.1097/CM9.0000000000000722; Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042; Shan C, 2020, PREPRINT, DOI [10.21203/rs.2.25200/v1, DOI 10.21203/RS.2.25200/V1]; Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036; Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010; Wang C., 2020, RES SQUARE, DOI 10.21203/rs.3.rs-19346/v1; Wong RSM, 2003, BRIT MED J, V326, P1358, DOI 10.1136/bmj.326.7403.1358; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	25	473	482	13	81	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 16	2020	583	7816					437	+		10.1038/s41586-020-2355-0	http://dx.doi.org/10.1038/s41586-020-2355-0		MAY 2020	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MK4AA	32434211	Green Submitted, Bronze			2022-12-28	WOS:000547610600001
J	Armstrong, AW; Read, C				Armstrong, April W.; Read, Charlotte			Pathophysiology, Clinical Presentation, and Treatment of Psoriasis A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SEVERE PLAQUE PSORIASIS; DOUBLE-BLIND; PHASE-III; CONTROLLED-TRIAL; MONOCLONAL-ANTIBODY; VS. METHOTREXATE; EFFICACY; SAFETY; MODERATE; RISK	This narrative review summarizes current evidence regarding the pathogenesis, clinical presentation, diagnosis, and treatments of plaque psoriasis. Importance Approximately 125 million people worldwide have psoriasis. Patients with psoriasis experience substantial morbidity and increased rates of inflammatory arthritis, cardiometabolic diseases, and mental health disorders. Observations Plaque psoriasis is the most common variant of psoriasis. The most rapid advancements addressing plaque psoriasis have been in its pathogenesis, genetics, comorbidities, and biologic treatments. Plaque psoriasis is associated with a number of comorbidities including psoriatic arthritis, cardiometabolic diseases, and depression. For patients with mild psoriasis, topical agents remain the mainstay of treatment, and they include topical corticosteroids, vitamin D analogues, calcineurin inhibitors, and keratolytics. The American Academy of Dermatology-National Psoriasis Foundation guidelines recommend biologics as an option for first-line treatment of moderate to severe plaque psoriasis because of their efficacy in treating it and acceptable safety profiles. Specifically, inhibitors to tumor necrosis factor alpha (TNF-alpha) include etanercept, adalimumab, certolizumab, and infliximab. Other biologics inhibit cytokines such as the p40 subunit of the cytokines IL-12 and IL-13 (ustekinumab), IL-17 (secukinumab, ixekizumab, bimekizumab, and brodalumab), and the p19 subunit of IL-23 (guselkumab, tildrakizumab, risankizumab, and mirikizumab). Biologics that inhibit TNF-alpha, p40IL-12/23, and IL-17 are also approved for the treatment of psoriatic arthritis. Oral treatments include traditional agents such as methotrexate, acitretin, cyclosporine, and the advanced small molecule apremilast, which is a phosphodiesterase 4 inhibitor. The most commonly prescribed light therapy used to treat plaque psoriasis is narrowband UV-B phototherapy. Conclusions and Relevance Psoriasis is an inflammatory skin disease that is associated with multiple comorbidities and substantially diminishes patients' quality of life. Topical therapies remain the cornerstone for treating mild psoriasis. Therapeutic advancements for moderate to severe plaque psoriasis include biologics that inhibit TNF-alpha, p40IL-12/23, IL-17, and p19IL-23, as well as an oral phosphodiesterase 4 inhibitor.	[Armstrong, April W.; Read, Charlotte] Univ Southern Calif Los Angeles, Dept Dermatol, Keck Sch Med, Los Angeles, CA USA; [Read, Charlotte] Imperial Coll London, Dept Med, London, England	Imperial College London	Armstrong, AW (corresponding author), Univ Southern Calif, 1975 Zonal Ave,KAM 510,MC 9034, Los Angeles, CA 90089 USA.	aprilarmstrong@post.harvard.edu						Abuabara K, 2010, BRIT J DERMATOL, V163, P586, DOI 10.1111/j.1365-2133.2010.09941.x; Ahlehoff O, 2011, J INTERN MED, V270, P147, DOI 10.1111/j.1365-2796.2010.02310.x; Ahlehoff O, 2012, EUR HEART J, V33, P2054, DOI 10.1093/eurheartj/ehr285; Alwan W, 2015, CLIN EXP RHEUMATOL, V33, pS2; ANDRESSEN C, 1982, HAUTARZT, V33, P214; Armstrong AW, 2020, JAMA DERMATOL, V156, P258, DOI 10.1001/jamadermatol.2019.4029; Armstrong AW, 2015, J AM ACAD DERMATOL, V72, P968, DOI 10.1016/j.jaad.2015.02.1095; Armstrong AW, 2014, JAMA DERMATOL, V150, P963, DOI 10.1001/jamadermatol.2014.1019; Armstrong AW, 2013, J AM ACAD DERMATOL, V68, P654, DOI 10.1016/j.jaad.2012.08.015; Armstrong AW, 2013, JAMA DERMATOL, V149, P84, DOI 10.1001/2013.jamadermatol.406; Armstrong AW, 2012, AM J CARDIOL, V109, P976, DOI 10.1016/j.amjcard.2011.11.025; Armstrong EJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000062; Bagel J, 2017, J AM ACAD DERMATOL, V77, P667, DOI 10.1016/j.jaad.2017.05.033; Barker J, 2011, BRIT J DERMATOL, V165, P1109, DOI 10.1111/j.1365-2133.2011.10615.x; Blauvelt A, 2017, J AM ACAD DERMATOL, V76, P405, DOI 10.1016/j.jaad.2016.11.041; Blauvelt A, 2017, J AM ACAD DERMATOL, V76, P60, DOI 10.1016/j.jaad.2016.08.008; Bruner Christine R, 2003, Dermatol Online J, V9, P2; Coates LC, 2013, BRIT J DERMATOL, V168, P802, DOI 10.1111/bjd.12190; Dalgard FJ, 2015, J INVEST DERMATOL, V135, P984, DOI 10.1038/jid.2014.530; Darley CR, 1996, BRIT J DERMATOL, V135, P390, DOI 10.1046/j.1365-2133.1996.d01-1010.x; Dey AK, 2017, JAMA CARDIOL, V2, P1013, DOI 10.1001/jamacardio.2017.1213; Dogra S, 2013, J EUR ACAD DERMATOL, V27, pe305, DOI 10.1111/j.1468-3083.2012.04644.x; Dowlatshahi EA, 2014, J INVEST DERMATOL, V134, P1542, DOI 10.1038/jid.2013.508; ELLIS CN, 1991, NEW ENGL J MED, V324, P277, DOI 10.1056/NEJM199101313240501; Elmets CA, 2019, J AM ACAD DERMATOL, V81, P775, DOI 10.1016/j.jaad.2019.04.042; Elmets CA, 2019, J AM ACAD DERMATOL, V80, P1073, DOI 10.1016/j.jaad.2018.11.058; Eppinga H, 2017, INFLAMM BOWEL DIS, V23, P1783, DOI 10.1097/MIB.0000000000001169; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gelfand JM, 2009, J INVEST DERMATOL, V129, P2411, DOI 10.1038/jid.2009.112; Gold LS, 2018, J AM ACAD DERMATOL, V79, P287, DOI 10.1016/j.jaad.2018.03.040; Gordon KB, 2018, LANCET, V392, P650, DOI 10.1016/S0140-6736(18)31713-6; Gottlieb A, 2017, J AM ACAD DERMATOL, V76, P70, DOI 10.1016/j.jaad.2016.07.058; Gottlieb AB, 2018, J AM ACAD DERMATOL, V79, P302, DOI 10.1016/j.jaad.2018.04.012; Gribetz C, 2004, J AM ACAD DERMATOL, V51, P731, DOI 10.1016/j.jaad.2004.06.010; Griffiths CEM, 2015, LANCET, V386, P541, DOI 10.1016/S0140-6736(15)60125-8; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Husni ME, 2007, J AM ACAD DERMATOL, V57, P581, DOI 10.1016/j.jaad.2007.04.001; Ito K, 2016, J DERMATOL, V43, P402, DOI 10.1111/1346-8138.13158; Kalb RE, 2015, JAMA DERMATOL, V151, P961, DOI 10.1001/jamadermatol.2015.0718; Karason A, 2003, AM J HUM GENET, V72, P125, DOI 10.1086/345646; Kimball AB, 2015, J AM ACAD DERMATOL, V72, P115, DOI 10.1016/j.jaad.2014.08.050; Koo JYM, 2000, J AM ACAD DERMATOL, V43, P821, DOI 10.1067/mjd.2000.107940; Landells I, 2015, J AM ACAD DERMATOL, V73, P594, DOI 10.1016/j.jaad.2015.07.002; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Lebwohl M, 2015, NEW ENGL J MED, V373, P1318, DOI 10.1056/NEJMoa1503824; Lebwohl Mark, 2007, J Drugs Dermatol, V6, P428; Lebwohl MG, 2019, J AM ACAD DERMATOL, V80, P282, DOI 10.1016/j.jaad.2018.09.002; Leonardi C, 2015, J DRUGS DERMATOL, V14, P1468; Lerman JB, 2017, CIRCULATION, V136, P263, DOI 10.1161/CIRCULATIONAHA.116.026859; Liao YH, 2007, BRIT J DERMATOL, V157, P1005, DOI 10.1111/j.1365-2133.2007.08201.x; Lin HW, 2011, J AM ACAD DERMATOL, V64, P495, DOI 10.1016/j.jaad.2010.01.050; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Mansouri B, 2016, JAMA DERMATOL, V152, P1244, DOI 10.1001/jamadermatol.2016.2907; Mariette X, 2011, ANN RHEUM DIS, V70, P1895, DOI 10.1136/ard.2010.149419; Mease P, 2005, J AM ACAD DERMATOL, V52, P1, DOI 10.1016/j.jaad.2004.06.013; Mease PJ, 2020, ANN RHEUM DIS, V79, P123, DOI 10.1136/annrheumdis-2019-215386; Mehta NN, 2010, EUR HEART J, V31, P1000, DOI 10.1093/eurheartj/ehp567; Menter A, 2008, J AM ACAD DERMATOL, V58, P106, DOI 10.1016/j.jaad.2007.09.010; Menter A, 2019, J AM ACAD DERMATOL, V80, P1029, DOI 10.1016/j.jaad.2018.11.057; Menter A, 2017, DERMATOLOGY THER, V7, P365, DOI 10.1007/s13555-017-0198-x; Menter A, 2009, J AM ACAD DERMATOL, V61, P451, DOI 10.1016/j.jaad.2009.03.027; Menter A, 2009, J AM ACAD DERMATOL, V60, P643, DOI 10.1016/j.jaad.2008.12.032; Michalek IM, 2017, J EUR ACAD DERMATOL, V31, P205, DOI 10.1111/jdv.13854; Mody E, 2007, BRIT J DERMATOL, V157, P1050, DOI 10.1111/j.1365-2133.2007.08139.x; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Oranje AP, 1997, J AM ACAD DERMATOL, V36, P203, DOI 10.1016/S0190-9622(97)70281-0; Paller AS, 2008, NEW ENGL J MED, V358, P241, DOI 10.1056/NEJMoa066886; Paller AS, 2018, J DRUGS DERMATOL, V17, P187; Papp KA, 2005, BRIT J DERMATOL, V152, P1304, DOI 10.1111/j.1365-2133.2005.06688.x; Papp K, 2015, J AM ACAD DERMATOL, V73, P37, DOI 10.1016/j.jaad.2015.03.049; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Paul C, 2019, J AM ACAD DERMATOL, V80, P70, DOI 10.1016/j.jaad.2018.06.039; Rachakonda TD, 2014, J AM ACAD DERMATOL, V70, P512, DOI 10.1016/j.jaad.2013.11.013; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Reich K, 2019, BRIT J DERMATOL, V181, P954, DOI 10.1111/bjd.17351; Reich K, 2019, LANCET, V394, P831, DOI 10.1016/S0140-6736(19)31773-8; Reich K, 2019, LANCET, V394, P576, DOI 10.1016/S0140-6736(19)30952-3; Reich K, 2017, LANCET, V390, P276, DOI 10.1016/S0140-6736(17)31279-5; Saurat JH, 2008, BRIT J DERMATOL, V158, P558, DOI 10.1111/j.1365-2133.2007.08315.x; Singh JA, 2019, ARTHRITIS RHEUMATOL, V71, P5, DOI 10.1002/art.40726; Singh S, 2017, J AM ACAD DERMATOL, V77, P425, DOI 10.1016/j.jaad.2017.05.019; Soleymani T, 2015, INT J DERMATOL, V54, P383, DOI 10.1111/ijd.12790; Stern RS, 2012, J AM ACAD DERMATOL, V66, P553, DOI 10.1016/j.jaad.2011.04.004; Stern RS, 2011, J INVEST DERMATOL, V131, P1159, DOI 10.1038/jid.2010.399; Tillett W, 2012, J RHEUMATOL, V39, P154, DOI 10.3899/jrheum.110845; Tom BDM, 2015, J RHEUMATOL, V42, P841, DOI 10.3899/jrheum.140857; Tsai TF, 2011, J DERMATOL SCI, V63, P40, DOI 10.1016/j.jdermsci.2011.03.002; Tsoi LC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15382; Warren RB, 2017, LANCET, V389, P528, DOI 10.1016/S0140-6736(16)32127-4; Weinstein GD, 1997, J AM ACAD DERMATOL, V37, P85, DOI 10.1016/S0190-9622(97)70216-0; World Health Organization, GLOB REP PSOR; Yeung H, 2013, JAMA DERMATOL, V149, P1173, DOI 10.1001/jamadermatol.2013.5015	94	391	413	48	185	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2020	323	19					1945	1960		10.1001/jama.2020.4006	http://dx.doi.org/10.1001/jama.2020.4006			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LT2XF	32427307				2022-12-28	WOS:000536934300021
J	Solomon, MZ; Wynia, MK; Gostin, LO				Solomon, Mildred Z.; Wynia, Matthew K.; Gostin, Lawrence O.			Covid-19 Crisis Triage - Optimizing Health Outcomes and Disability Rights	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Crisis triage protocols should seek to optimize health outcomes, but doing so requires explicit protection of core values, such as the equal moral worth of all people, including those with disabilities. Some thoughtful policies are capable of meeting both goals.	[Solomon, Mildred Z.] Hastings Ctr, Garrison, NY 10524 USA; [Solomon, Mildred Z.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Wynia, Matthew K.] Univ Colorado, Ctr Bioeth & Humanities, Dept Med, Sch Med, Aurora, CO USA; [Wynia, Matthew K.] Colorado Sch Publ Hlth, Dept Hlth Syst Management & Policy, Anschutz Med Campus, Aurora, CO USA; [Gostin, Lawrence O.] Georgetown Univ, Georgetown Law Sch, ONeill Inst Natl & Global Hlth Law, Washington, DC USA	Harvard University; Harvard Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Georgetown University	Solomon, MZ (corresponding author), Hastings Ctr, Garrison, NY 10524 USA.; Solomon, MZ (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA.							Fodor P, 2020, MICROCIRCULATION, V27, DOI 10.1111/micc.12585; HHS Office for Civil Rights in Action, 2020, HHS OFF CIV RIGHTS C; Lagu T, 2013, ANN INTERN MED, V158, P441, DOI 10.7326/0003-4819-158-6-201303190-00003; Ne'eman A., 2020, NEW YORK TIMES	4	49	49	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2020	383	5							e27	10.1056/NEJMp2008300	http://dx.doi.org/10.1056/NEJMp2008300			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MW2GI	32427434	Bronze			2022-12-28	WOS:000556861800002
J	Arora, KS; Mauch, JT; Gibson, KS				Arora, Kavita Shah; Mauch, Jaclyn T.; Gibson, Kelly Smith			Labor and Delivery Visitor Policies During the COVID-19 Pandemic: Balancing Risks and Benefits	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BIRTH		[Arora, Kavita Shah; Gibson, Kelly Smith] Case Western Reserve Univ, Metrohlth Med Ctr, Dept Obstet & Gynecol, Cleveland, OH 44106 USA; [Arora, Kavita Shah] Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH USA; [Mauch, Jaclyn T.] Univ Penn, Perelman Sch Med, Dept Bioeth, Philadelphia, PA 19104 USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University; University of Pennsylvania; Pennsylvania Medicine	Arora, KS (corresponding author), 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	kavita.shah.arora@gmail.com		Arora, Kavita/0000-0002-9912-9466; MAUCH, JACLYN T./0000-0002-1590-733X	Clinical and Translational Science Collaborative of Cleveland from the National Center for Advancing Translational Sciences component of the National Institutes of Health [KL2TR0002547]; National Institutes of Health roadmap for Medical Research	Clinical and Translational Science Collaborative of Cleveland from the National Center for Advancing Translational Sciences component of the National Institutes of Health; National Institutes of Health roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr Arora reported that she serves as vice chair of the American College of Obstetricians and Gynecologists' Ethics Committee and is funded by the Clinical and Translational Science Collaborative of Cleveland, grant KL2TR0002547 from the National Center for Advancing Translational Sciences component of the National Institutes of Health and National Institutes of Health roadmap for Medical Research. No other disclosures were reported.	American College of Obstetricians and Gynecologists, 2020, COVID 19 RES; Bohren MA, 2017, COCHRANE DB SYST REV, V7; Caron C, 2020, NY TIMES; Centers for Disease Control and Prevention, 2020, CONS INP OBST HEALTH; Centers for Disease Control and Prevention, 2019, RAC ETHN DISP CONT P; Kozhimannil KB, 2013, AM J PUBLIC HEALTH, V103, pE113, DOI 10.2105/AJPH.2012.301201; New York Department of Health, 2020, PREG COVID 19 RES HL; New York Governor Andrew Cuomo, 2020, NO 202 12 CONT TEMP; Snowden JM, 2015, NEW ENGL J MED, V373, P2642, DOI 10.1056/NEJMsa1501738; World Health Organization, 2016, COMP CHOIC DUR LAB C	10	34	34	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2468	2469		10.1001/jama.2020.7563	http://dx.doi.org/10.1001/jama.2020.7563			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OS4QL	32442264	Bronze, Green Accepted			2022-12-28	WOS:000590149400012
J	Volpp, KG; Diamond, SM; Shrank, WH				Volpp, Kevin G.; Diamond, Susan M.; Shrank, William H.			Innovation in Home Care Time for a New Payment Model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Volpp, Kevin G.] Philadelphia VA Med Ctr, Philadelphia, PA USA; [Volpp, Kevin G.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,1120 Blockley Hall, Philadelphia, PA 19104 USA; [Volpp, Kevin G.] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA; [Diamond, Susan M.; Shrank, William H.] Humana Inc, Louisville, KY USA	University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Humana Inc.	Volpp, KG (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,1120 Blockley Hall, Philadelphia, PA 19104 USA.	volpp70@wharton.upenn.edu			Humana to the University of Pennsylvania	Humana to the University of Pennsylvania	Supported by a grant from Humana to the University of Pennsylvania.	Asch D, 2017, HARVARD BUSINESS REV; Emanuel EJ, 2016, ANN INTERN MED, V164, P114, DOI 10.7326/M15-1330; Navathe AS, 2019, JAMA-J AM MED ASSOC, V322, P57, DOI 10.1001/jama.2019.8113; Pryor K, 2018, NEW ENGL J MED, V378, P1761, DOI 10.1056/NEJMp1716272; Shinkman R., 2018, NEJM CATALYST, V4, P1; Volpp KG, 2018, JAMA CARDIOL, V3, P363, DOI 10.1001/jamacardio.2017.5353	6	16	16	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2474	2475		10.1001/jama.2020.1036	http://dx.doi.org/10.1001/jama.2020.1036			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32437503				2022-12-28	WOS:000590149400015
J	Honigsbaum, M				Honigsbaum, Mark			Revisiting the 1957 and 1968 influenza pandemics	LANCET			English	Editorial Material														honigsbaum, mark/0000-0002-1891-8763					0	32	34	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2020	395	10240					1824	1826		10.1016/S0140-6736(20)31201-0	http://dx.doi.org/10.1016/S0140-6736(20)31201-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NH4GA	32464113	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000564628700012
J	Anava, S; Neuhof, M; Gingold, H; Sagy, O; Munters, A; Svensson, EM; Afshinnekoo, E; Danko, D; Foox, J; Shor, P; Riestra, B; Huchon, D; Mason, CE; Mizrahi, N; Jakobsson, M; Rechavi, O				Anava, Sarit; Neuhof, Moran; Gingold, Hila; Sagy, Or; Munters, Arielle; Svensson, Emma M.; Afshinnekoo, Ebrahim; Danko, David; Foox, Jonathan; Shor, Pnina; Riestra, Beatriz; Huchon, Dorothee; Mason, Christopher E.; Mizrahi, Noam; Jakobsson, Mattias; Rechavi, Oded			Illuminating Genetic Mysteries of the Dead Sea Scrolls	CELL			English	Article							THE-SABBATH-SACRIFICE; ANCIENT DNA; MITOCHONDRIAL GENOME; READ ALIGNMENT; SEQUENCE; SHEEP; REVEAL; CONTAMINATION; POPULATIONS; QUMRAN	The discovery of the 2,000-year-old Dead Sea Scrolls had an incomparable impact on the historical understanding of Judaism and Christianity. "Piecing together'' scroll fragments is like solving jigsaw puzzles with an unknown number of missing parts. We used the fact that most scrolls are made from animal skins to "fingerprint'' pieces based on DNA sequences. Genetic sorting of the scrolls illuminates their textual relationship and historical significance. Disambiguating the contested relationship between Jeremiah fragments supplies evidence that some scrolls were brought to the Qumran caves from elsewhere; significantly, they demonstrate that divergent versions of Jeremiah circulated in parallel throughout Israel (ancient Judea). Similarly, patterns discovered in non-biblical scrolls, particularly the Songs of the Sabbath Sacrifice, suggest that the Qumran scrolls represent the broader cultural milieu of the period. Finally, genetic analysis divorces debated fragments from the Qumran scrolls. Our study demonstrates that interdisciplinary approaches enrich the scholar's toolkit.	[Anava, Sarit; Neuhof, Moran; Gingold, Hila; Sagy, Or; Rechavi, Oded] Tel Aviv Univ, George Wise Fac Life Sci, Dept Neurobiol, IL-6997801 Tel Aviv, Israel; [Munters, Arielle; Svensson, Emma M.; Jakobsson, Mattias] Uppsala Univ, Dept Organismal Biol, Human Evolut, S-75105 Uppsala, Sweden; [Munters, Arielle; Svensson, Emma M.; Jakobsson, Mattias] Uppsala Univ, SciLife Lab, S-75105 Uppsala, Sweden; [Afshinnekoo, Ebrahim; Danko, David; Foox, Jonathan; Mason, Christopher E.] Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10065 USA; [Afshinnekoo, Ebrahim; Danko, David; Foox, Jonathan; Mason, Christopher E.] Weill Cornell Med, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10065 USA; [Afshinnekoo, Ebrahim; Danko, David; Foox, Jonathan; Mason, Christopher E.] WorldQuant Initiat Quantitate Predict, New York, NY 10065 USA; [Shor, Pnina; Riestra, Beatriz] Israel Antiqu Author, Dead Sea Scroll Projects, IL-91710 Jerusalem, Israel; [Huchon, Dorothee] Tel Aviv Univ, Steinhardt Museum Nat Hist, IL-6997801 Tel Aviv, Israel; [Huchon, Dorothee] Tel Aviv Univ, Israel Natl Ctr Biodivers Studies, IL-6997801 Tel Aviv, Israel; [Huchon, Dorothee] Tel Aviv Univ, Dept Zool, George S Wise Fac Life Sci, IL-6997801 Tel Aviv, Israel; [Mizrahi, Noam] Tel Aviv Univ, Lester & Sally Entin Fac Humanities, Dept Bibl Studies, IL-6997801 Tel Aviv, Israel	Tel Aviv University; Uppsala University; SciLifeLab; Uppsala University; Cornell University; Cornell University; Tel Aviv University; Tel Aviv University; Tel Aviv University; Tel Aviv University	Rechavi, O (corresponding author), Tel Aviv Univ, George Wise Fac Life Sci, Dept Neurobiol, IL-6997801 Tel Aviv, Israel.; Jakobsson, M (corresponding author), Uppsala Univ, Dept Organismal Biol, Human Evolut, S-75105 Uppsala, Sweden.; Jakobsson, M (corresponding author), Uppsala Univ, SciLife Lab, S-75105 Uppsala, Sweden.; Mizrahi, N (corresponding author), Tel Aviv Univ, Lester & Sally Entin Fac Humanities, Dept Bibl Studies, IL-6997801 Tel Aviv, Israel.	noam.m.mizrahi@gmail.com; mattias.jakobsson@ebc.uu.se; odedrechavi@gmail.com	Jakobsson, Mattias/A-6116-2011; Huchon, Dorothée/ABA-3160-2020; Mason, Christopher/HCH-3977-2022	Jakobsson, Mattias/0000-0001-7840-7853; Huchon, Dorothée/0000-0002-5047-244X; Mizrahi, Noam/0000-0002-4957-4211	NASA [NNX14AH50G, 1515Omni2-0063]; Alfred P. Sloan Foundation [G-2015-13964]; Formas [2011-1138]; Israel Science Foundation [723/13]; Adelis Foundation [01430001000]; Schmidt Futures program [590772]	NASA(National Aeronautics & Space Administration (NASA)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Formas(Swedish Research Council Formas); Israel Science Foundation(Israel Science Foundation); Adelis Foundation; Schmidt Futures program	We would like to thank the IAA for generously providing access to the DSS and for many helpful discussions and consultations. In particular, special thanks are due to Helena Libman, Tanya Treiger, and Tanya Bitler, DSS Senior Conservators, for sampling the scrolls and to Dr. Illit Cohen-Ofri, Head of the DSS Conservation Laboratory, for providing valuable input. We gratefully acknowledge the contributions of Dr. Orit Shamir and Dr. Na'ama Sukenik for allowing us to sample related artefacts. We would like to thank David Mevorach, Senior Curator of the Hellenistic, Roman, and Byzantine Periods at the Israel Museum, for generously providing access to ancient specimens. We would like to thank Hannah Edlund for her technical assistance and Noah Alexander and Jorge Gandara for protocol testing and optimization. We would like to thank Dror Cohen for his assistance in the graphical design of many of the figures shown in the paper, Noa Alon for the design of the graphical abstract, and Viktor Koen for designing the cover suggestion. We would like to thank Prof. Elisha Gootwine and Prof. Eyal Seroussi for sharing their knowledge regarding ancient sheep populations in the area. We would like to thank the Epigenomics Core Facility at Weill Cornell Medicine as well as the Bert L. and N. Kuggie Vallee Foundation, the WorldQuant Foundation, NASA (NNX14AH50G, 1515Omni2-0063), the Alfred P. Sloan Foundation (G-2015-13964), the Knut and Alice Wallenberg Foundation, and the Goran Gustavsson Foundation. Sequencing was performed at SciLifeLab's National Genomics Infrastructure (NGI), Uppsala, Sweden. Computations were performed at the Swedish National Infrastructure for Computing (SNIC-UPPMAX) and with help and support from the HPC team at the TAU Computational Center. E.M.S. is supported by Formas (2011-1138). Research regarding the Songs is supported by the Israel Science Foundation (723/13). O.R. is supported by the Adelis Foundation (01430001000). This work was funded by the generosity of Eric and Wendy Schmidt by recommendation of the Schmidt Futures program (590772).	Abusch R, 2003, STUD TEXT DES JUDAH, V46, P220; Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; Ahmed S, 2017, MITOCHONDRIAL DNA A, V28, P711, DOI 10.3109/24701394.2016.1174225; Alexander AL, 2010, PARALLEL WORLDS: THE REMARKABLE GIBBS-HUNTS AND THE ENDURING (IN)SIGNIFICANCE OF MELANIN, P215; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andrews S., 2010, FASTQC QUALITY CONTR; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Bouchnik R., 2016, BONES IDENTITY ZOOAR, P303; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brinda K., 2016, ARXIV160509070; Brooke George, 2018, DEAD SEA SCROLLS GER; Campana MG, 2010, J ARCHAEOL SCI, V37, P1317, DOI 10.1016/j.jas.2009.12.036; Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Chang ES, 2015, P NATL ACAD SCI USA, V112, P14912, DOI 10.1073/pnas.1511468112; Chevreux B, 1999, COMP SCI BIOL P GER, V99, P45, DOI DOI 10.1.1.23/7465; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Colli L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2342-2; Collins JJ, 2013, LIVES GREAT RELIG, P1; Collins John J., 2010, QUMRAN COMMUNITY SEC; Dabney J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012567; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Davies Philip R., 2002, COMPLETE WORLD DEAD; Davis K, 2018, MANUSCRIPTA BIBLICA, V3, P39, DOI 10.1515/9783110603477-003; Dimant D., 2014, HIST IDEOLOGY BIBLE; Doudna Gregory, 1998, DEAD SEA SCROLLS 50, V1, P430; Duhm B., 1901, DAS BUCH JEREMIA; Duncan J., 1997, REV QUMRAN, V18, P43; Duncan J., 1991, MADRID QUMRAN C, P199; Duncan J.A., 1995, 4QDEUT QUMRAN CAVE 4, P75; E GX, 2018, MITOCHONDRIAL DNA A, V29, P91, DOI 10.1080/24701394.2016.1242582; Gilbert MTP, 2004, CURR BIOL, V14, pR463, DOI 10.1016/j.cub.2004.06.008; Gootwine E., 2015, QADMONIOT, V150, P125; Gorkhali NA, 2016, MITOCHONDRIAL DNA A, V27, P2645, DOI 10.3109/19401736.2015.1041134; Gunther T, 2015, P NATL ACAD SCI USA, V112, P11917, DOI 10.1073/pnas.1509851112; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Haldane JBS, 1919, J GENET, V8, P299; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; HARAN M, 1985, HEBREW UNION COLL AN, V56, P21; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Hassanin A, 2010, MITOCHONDR DNA, V21, P68, DOI 10.3109/19401736.2010.490583; Hassanin A, 2009, J MOL EVOL, V68, P293, DOI 10.1007/s00239-009-9208-7; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; JULL AJT, 1995, RADIOCARBON, V37, P11, DOI 10.1017/S0033822200014740; Kahila BarGal G., 2000, THESIS; Kang DWD, 2019, PEERJ, V7, DOI 10.7717/peerj.7359; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kircher M, 2012, METHODS MOL BIOL, V840, P197, DOI 10.1007/978-1-61779-516-9_23; Kuhn JMM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195491; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li H., 2016, SEQTK; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lv FH, 2015, MOL BIOL EVOL, V32, P2515, DOI 10.1093/molbev/msv139; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Mizrahi N, 2013, STUD TEXT DES JUDAH, V108, P147; Najman H., 2010, DEAD SEA SCROLLS TRA, V92, P173, DOI [DOI 10.1163/EJ.9789004185845.I-274.60, 10.1163/ej.9789004185845.i-274.60]; Newsom C.A., 1997, SHIROT OLAT HASHAB 1, P173; Newsom C. A., 1990, HEBREW BIBLE ITS INT, P167; Olivieri A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141170; Olm MR, 2017, ISME J, V11, P2864, DOI 10.1038/ismej.2017.126; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Pietro P, 2003, DNA SEQUENCE, V14, P199, DOI 10.1080/1042517031000089487; POOLE JB, 1962, TECHNOL CULT, V3, P1, DOI 10.2307/3100798; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Ratzon E, 2017, J BIBLICAL LIT, V136, P905, DOI 10.15699/jbl.1364.2017.290288; Reed R., 1964, P LEEDS PHILOS LIT S, V9, P1; Renaud G, 2017, BIOINFORMATICS, V33, P577, DOI 10.1093/bioinformatics/btw670; RYDER ML, 1958, NATURE, V182, P781, DOI 10.1038/182781a0; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Schafer P., 2006, MYSTICAL APPROACHES, P37; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Skehan P.W., 1997, DISCOVERIES JUDAEAN, P7; Skoglund P, 2014, SCIENCE, V344, P747, DOI 10.1126/science.1253448; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Supreme J., 2013, DETERMINATION GENETI; Teasdale MD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0379; Tov E., 1989, REVQ, V14, P189; Tov E., 2012, TEXTUAL CRITICISM HE; Tov E., 1997, QUMRAN CAVE 4 X PROP, P145; Tov E., 2019, WINGS PRAYER SOURCES, P135; Tov Emanuel, 2004, SCRIBAL PRACTICES AP, V54; UllmannMargalit E., 2006, OUT CAVE PHILOS INQU; VanderKam J., 2005, MEANING DEAD SEA SCR; Wingett S., 2015, FASTQ SCREEN; Wood NJ, 1996, ANIM GENET, V27, P25, DOI 10.1111/j.1365-2052.1996.tb01173.x; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2; Yardeni A., 1990, TEXTUS, V15, P233; Yardeni A., 1997, ARAMAIC HEBREW GREEK, P283; Yuditsky A., 2017, LESHONENU, V79, P478	100	8	9	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2020	181	6					1218	+		10.1016/j.cell.2020.04.046	http://dx.doi.org/10.1016/j.cell.2020.04.046			40	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	LY9TE	32492404	Bronze			2022-12-28	WOS:000540869600007
J	Dyer, O				Dyer, Owen			Covid-19: Pandemic is having "severe" impact on non-communicable disease care, WHO survey finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		World Health Organization, 2020, PREL RES RAP ASS SER	1	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2020	369								m2210	10.1136/bmj.m2210	http://dx.doi.org/10.1136/bmj.m2210			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1WU	32493728	Bronze			2022-12-28	WOS:000548578300009
J	Melnick, ER; Ioannidis, JPA				Melnick, Edward R.; Ioannidis, John P. A.			Should governments continue lockdown to slow the spread of covid-19?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFLUENZA		[Melnick, Edward R.] Yale Sch Med, Dept Emergency Med, New Haven, CT 06510 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Epidemiol & Populat Hlth, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA	Yale University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Melnick, ER (corresponding author), Yale Sch Med, Dept Emergency Med, New Haven, CT 06510 USA.	edward.melnick@yale.edu; jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011	Ioannidis, John P./0000-0003-3118-6859				Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Basu A., 2020, HLTH AFF MILLWOOD; Bendavid E, 2020, COVID 19 ANTIBODY SE, DOI [10.1101/2020.04.14.20062463, DOI 10.1101/2020.04.14.20062463]; Boccia S, 2020, JAMA INTERN MED, V180, P927, DOI 10.1001/jamainternmed.2020.1447; Booth R., 2020, GUARDIAN; Brown E, 2020, WASHINGTON POST; De Filippo O, 2020, NEW ENGL J MED, V383, P88, DOI 10.1056/NEJMc2009166; Docherty K, 2020, DEATHS COVID 19 WHO, DOI [10.1101/2020.04.21.20073114v2.abstract, DOI 10.1101/2020.04.21.20073114V2.ABSTRACT]; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Ioannidis JPA, 2020, EUR J CLIN INVEST, V50, DOI [10.1111/eci.13222, 10.1111/eci.13223]; Ioannidis JPA, 2020, POPULATION EVEL COVI, DOI [10.1101/2020.04.05.20054361, DOI 10.1101/2020.04.05.20054361]; Kaplan EH, 2020, JAMA HLTH FORUM, V1; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Metzler B, 2020, EUR HEART J, V41, P1852, DOI 10.1093/eurheartj/ehaa314; Moser D. A., 2020, YEARS LIFE LOST DUE, P1, DOI 10.1101/2020.04.17.20069716; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Niforatos JD, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1113; Picheta R, 2020, CNN; Sud A, 2020, COLLATERAL DAMAGE IM, DOI [10.1101/2020.04.21.20073833v2.full, DOI 10.1101/2020.04.21.20073833V2.FULL]; Wang X, 2020, LANCET GLOB HEALTH, V8, pE497, DOI 10.1016/S2214-109X(19)30545-5	21	54	56	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2020	369								m1924	10.1136/bmj.m1924	http://dx.doi.org/10.1136/bmj.m1924			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1WU	32493767	Bronze			2022-12-28	WOS:000548578300001
J	Bates, DW; Auerbach, A; Schulam, P; Wright, A; Saria, S				Bates, David W.; Auerbach, Andrew; Schulam, Peter; Wright, Adam; Saria, Suchi			Reporting and Implementing Interventions Involving Machine Learning and Artificial Intelligence	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL DECISION-SUPPORT; ROTHMAN INDEX; CARE; ANALYTICS; MEDICINE; SEPSIS; MODELS	Increasingly, interventions aimed at improving care are likely to use such technologies as machine learning and artificial intelligence. However, health care has been relatively late to adopt them. This article provides clinical examples in which machine learning and artificial intelligence are already in use in health care and appear to deliver benefit. Three key bottlenecks toward increasing the pace of diffusion and adoption are methodological issues in evaluation of artificial intelligence-based interventions, reporting standards to enable assessment of model performance, and issues that need to be addressed for an institution to adopt these interventions. Methodological best practices will include external validation, ideally at a different site; use of pro-active learning algorithms to correct for site-specific biases and increase robustness as algorithms are deployed across multiple sites; addressing subgroup performance; and communicating to providers the uncertainty of predictions. Regarding reporting, especially important issues are the extent to which implementing standardized approaches for introducing clinical decision support has been followed, describing the data sources, reporting on data assumptions, and addressing biases. Although most health care organizations in the United States have adopted electronic health records, they may be ill prepared to adopt machine learning and artificial intelligence. Several steps can enable this: preparing data, developing tools to get suggestions to clinicians in useful ways, and getting clinicians engaged in the process. Open challenges and the role of regulation in this area are briefly discussed. Although these techniques have enormous potential to improve care and personalize recommendations for individuals, the hype regarding them is tremendous. Organizations will need to approach this domain carefully with knowledgeable partners to obtain the hoped-for benefits and avoid failures.	[Bates, David W.] Brigham & Womens Hosp, Div Gen Internal Med, 1620 Tremont St, Boston, MA 02115 USA; [Auerbach, Andrew] Univ Calif San Francisco, 533 Parnassus Ave, San Francisco, CA 94117 USA; [Schulam, Peter] Johns Hopkins Univ, 3400 North Charles St, Baltimore, MD 21218 USA; [Wright, Adam] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, 2525 West End Ave,Suite 1475, Nashville, TN 37203 USA; [Saria, Suchi] Hall 333,3400 North Charles St, Baltimore, MD 21218 USA	Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco; Johns Hopkins University; Vanderbilt University	Bates, DW (corresponding author), Brigham & Womens Hosp, Div Gen Internal Med, 1620 Tremont St, Boston, MA 02115 USA.				Gordon and Betty Moore Foundation, Palo Alto, California	Gordon and Betty Moore Foundation, Palo Alto, California(Gordon and Betty Moore Foundation)	By the Gordon and Betty Moore Foundation, Palo Alto, California.	Abramoff MD, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0040-6; [Anonymous], 2016, Nature, V537, P138, DOI 10.1038/537138a; Baowaly MK, 2019, J AM MED INFORM ASSN, V26, P228, DOI 10.1093/jamia/ocy142; Bates DW, 2014, HEALTH AFFAIR, V33, P1123, DOI 10.1377/hlthaff.2014.0041; Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Baylor D, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1387, DOI 10.1145/3097983.3098021; Calvert JS, 2016, COMPUT BIOL MED, V74, P69, DOI 10.1016/j.compbiomed.2016.05.003; Che Zhengping, 2016, AMIA Annu Symp Proc, V2016, P371; Choi E, 2017, P MACH LEARN HEALTHC; Churpek MM, 2016, CRIT CARE MED, V44, P368, DOI 10.1097/CCM.0000000000001571; Clifton L., 2011, 2011 Federated Conference on Computer Science and Information Systems (FedCSIS), P125; Collins GS, 2019, LANCET, V393, P1577, DOI 10.1016/S0140-6736(19)30037-6; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; Desautels T, 2016, JMIR MED INF, V4, P67, DOI 10.2196/medinform.5909; Donze J, 2013, JAMA INTERN MED, V173, P632, DOI 10.1001/jamainternmed.2013.3023; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Emanuel EJ, 2019, JAMA-J AM MED ASSOC, V321, P2281, DOI 10.1001/jama.2019.4914; Finlay GD, 2014, J HOSP MED, V9, P116, DOI 10.1002/jhm.2132; Garza M, 2016, J BIOMED INFORM, V64, P333, DOI 10.1016/j.jbi.2016.10.016; Gultepe E, 2014, J AM MED INFORM ASSN, V21, P315, DOI 10.1136/amiajnl-2013-001815; Guo CA, 2017, PR MACH LEARN RES, V70; Henry KE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3719; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Johnson AEW, 2016, P IEEE, V104, P444, DOI 10.1109/JPROC.2015.2501978; Kim KG, 2016, HEALTHC INFORM RES, V22, P351, DOI 10.4258/hir.2016.22.4.351; Kwon BC, 2019, IEEE T VIS COMPUT GR, V25, P299, DOI 10.1109/TVCG.2018.2865027; Lakshminarayanan B., 2017, ADV NEURAL INFORM PR, V30, P6402, DOI DOI 10.5555/3295222.3295387; Ma FL, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1903, DOI 10.1145/3097983.3098088; Marschollek M, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-19; Ni B, 2012, 37 INT C AC SPEECH S; Ojetola O., 2011, 2011 7th International Conference on Intelligent Environments, P318, DOI 10.1109/IE.2011.38; Pannurat N, 2014, SENSORS-BASEL, V14, P12900, DOI 10.3390/s140712900; Parikh RB, 2016, JAMA-J AM MED ASSOC, V315, P651, DOI 10.1001/jama.2015.19417; Piper GL, 2014, J TRAUMA ACUTE CARE, V77, P78, DOI 10.1097/TA.0000000000000265; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Saria S, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002721; Schulam P, 2017, P 31 C NEUR INF PROC, P2017; Schulam P, 2019, P 22 INT C ART INT S; Sculley D, 2017, P 28 C NEUR INF PROC; Soleimani H, 2018, IEEE T PATTERN ANAL, V40, P1948, DOI 10.1109/TPAMI.2017.2742504; Strickland E., 2018, IEEE SPECTRUM; Subbaswamy A, 2017, UNCERTAINTY ARTIFICI; Subbaswamy A, 2019, 2019 ACM C FAIRN ACC; Subbaswamy A, 2019, PR MACH LEARN RES, V89; Tcheng JE, 2017, OPTIMIZING STRATEGIE; Topol EJ, 2019, NAT MED, V25, P44, DOI 10.1038/s41591-018-0300-7; U.S. Food and Drug Administration, 2018, FDA PERM MARK ART IN; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117	49	28	29	3	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2020	172			11			S137	S144		10.7326/M19-0872	http://dx.doi.org/10.7326/M19-0872			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MH8ZH	32479180				2022-12-28	WOS:000547009900011
J	Devi, S				Devi, Sharmila			Fears of "highly catastrophic" COVID-19 spread in Yemen	LANCET			English	Editorial Material																			0	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2020	395	10238					1683	1683						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0PJ	32473668	Green Published, Bronze			2022-12-28	WOS:000561610000012
J	Fraser, B				Fraser, Barbara			COVID-19 strains remote regions of Peru	LANCET			English	Editorial Material																			0	14	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2020	395	10238					1684	1684						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0PJ	32473669	Bronze, Green Published			2022-12-28	WOS:000561610000013
J	Kaiser, J				Kaiser, Jocelyn			FORCED INTO BATTLE	SCIENCE			English	Editorial Material																			0	3	3	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					930	933		10.1126/science.368.6494.930	http://dx.doi.org/10.1126/science.368.6494.930			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LV3IK	32467373				2022-12-28	WOS:000538332600020
J	Zhang, Y; Zhang, ZG; Chen, DK; Qiu, B; Wang, W				Zhang, Yu; Zhang, Zhengguang; Chen, Dake; Qiu, Bo; Wang, Wei			Strengthening of the Kuroshio current by intensifying tropical cyclones	SCIENCE			English	Article							GEOSTROPHIC ADJUSTMENT; HURRICANES KATRINA; OCEAN CIRCULATION; NORTH PACIFIC; EDDY; TOPEX/POSEIDON; EDDIES; VARIABILITY; MODULATION; TRANSPORT	A positive feedback mechanism between tropical cyclones (TCs) and climate warming can be seen by examining TC-induced energy and potential vorticity (PV) changes of oceanic geostrophic eddies. We found that substantial dissipation of eddies, with a strong bias toward dissipation of anticyclonic eddies, is directly linked to TC activity. East of Taiwan, where TCs show a remarkable intensifying trend in recent decades, the ocean exhibits a corresponding upward trend of positive PV anomalies. Carried westward by eddies, increasing numbers of positive PV anomalies impinge on the Kuroshio current, causing the mean current to accelerate downstream. This acts in opposition to decreasing basin-scale wind stress and has a potentially important warming impact on the extratropical ocean and climate.	[Zhang, Yu; Zhang, Zhengguang; Wang, Wei] Ocean Univ China, Phys Oceanog Lab CIMST, Qingdao, Peoples R China; [Zhang, Yu; Zhang, Zhengguang; Wang, Wei] Qingdao Natl Lab Marine Sci & Technol, Qingdao, Peoples R China; [Chen, Dake] Minist Nat Resources, State Key Lab Satellite Ocean Environm Dynam, Inst Oceanog 2, Hangzhou, Peoples R China; [Chen, Dake] Southern Marine Sci & Engn Guangdong Lab Zhuhai, Zhuhai, Peoples R China; [Qiu, Bo] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology; Ministry of Natural Resources of the People's Republic of China; Southern Marine Science & Engineering Guangdong Laboratory; University of Hawaii System; University of Hawaii Manoa	Zhang, Y (corresponding author), Ocean Univ China, Phys Oceanog Lab CIMST, Qingdao, Peoples R China.; Zhang, Y (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Qingdao, Peoples R China.	yuz@ouc.edu.cn	Qiu, Bo/D-9569-2017	Chen, Dake/0000-0002-8193-7158; Wang, Wei/0000-0002-7880-5920; Zhang, Yu/0000-0001-6373-7024	National Natural Science Foundation [41722602, 41730535, 41876007]; National Basic Research Priorities Program of China [2015CB954300]; National Program on Global Change and Air-Sea Interaction grant [GASI-IPOVAI-04]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Priorities Program of China(National Basic Research Program of China); National Program on Global Change and Air-Sea Interaction grant	Supported by National Natural Science Foundation grants 41722602, 41730535, and 41876007; National Basic Research Priorities Program of China grant 2015CB954300; and National Program on Global Change and Air-Sea Interaction grant GASI-IPOVAI-04.	Bryden H.L., 2001, INT GEOPHYS SERIES, VVol. 77, P455, DOI DOI 10.1016/S0074-6142(01)80134-0; CAHN A, 1945, J METEOROL, V2, P113, DOI 10.1175/1520-0469(1945)002<0113:AIOTFO>2.0.CO;2; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; Coutino A, 2017, NONLINEAR PROC GEOPH, V24, P61, DOI 10.5194/npg-24-61-2017; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Emanuel K, 2003, ANNU REV EARTH PL SC, V31, P75, DOI 10.1146/annurev.earth.31.100901.141259; Emanuel K, 2001, J GEOPHYS RES-ATMOS, V106, P14771, DOI 10.1029/2000JD900641; EMANUEL KA, 1987, NATURE, V326, P483, DOI 10.1038/326483a0; Emanuel K, 2017, P NATL ACAD SCI USA, V114, P12681, DOI 10.1073/pnas.1716222114; Emanuel KA, 2013, P NATL ACAD SCI USA, V110, P12219, DOI 10.1073/pnas.1301293110; Ferrari R, 2010, TELLUS A, V62, P92, DOI 10.1111/j.1600-0870.2009.00432.x; Ferrari R, 2009, ANNU REV FLUID MECH, V41, P253, DOI 10.1146/annurev.fluid.40.111406.102139; FU LL, 1983, J GEOPHYS RES-OCEANS, V88, P4331, DOI 10.1029/JC088iC07p04331; GILL AE, 1976, J FLUID MECH, V77, P603, DOI 10.1017/S0022112076002280; GONELLA J, 1972, DEEP-SEA RES, V19, P833, DOI 10.1016/0011-7471(72)90002-2; Gould J., 2011, EOS T AGU, V85, P185, DOI [10.1029/2004EO190002, DOI 10.1029/2004EO190002]; Holland GJ, 1997, J ATMOS SCI, V54, P2519, DOI 10.1175/1520-0469(1997)054<2519:TMPIOT>2.0.CO;2; Hsin YC, 2015, J GEOPHYS RES-OCEANS, V120, P1792, DOI 10.1002/2014JC010582; Hwang CW, 2002, GEOPHYS J INT, V151, P835, DOI 10.1046/j.1365-246X.2002.01811.x; Jaimes B, 2010, J PHYS OCEANOGR, V40, P1320, DOI 10.1175/2010JPO4309.1; Jaimes B, 2009, MON WEATHER REV, V137, P4188, DOI 10.1175/2009MWR2849.1; Jansen M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036796; Kuo AC, 1999, J FLUID MECH, V394, P1, DOI 10.1017/S0022112099005534; Kwon YO, 2010, J CLIMATE, V23, P3249, DOI 10.1175/2010JCLI3343.1; Lim YK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34343-5; Lu ZM, 2016, J PHYS OCEANOGR, V46, P2403, DOI 10.1175/JPO-D-16-0040.1; Oouchi K, 2006, J METEOROL SOC JPN, V84, P259, DOI 10.2151/jmsj.84.259; OU HW, 1984, J PHYS OCEANOGR, V14, P994, DOI 10.1175/1520-0485(1984)014<0994:GAAMFF>2.0.CO;2; Pedlosky J., 1987, GEOPHYS FLUID DYN, VVolume 710; PRICE JF, 1981, J PHYS OCEANOGR, V11, P153, DOI 10.1175/1520-0485(1981)011<0153:UORTAH>2.0.CO;2; Qiu B, 1999, J PHYS OCEANOGR, V29, P2471, DOI 10.1175/1520-0485(1999)029<2471:SEFMOT>2.0.CO;2; Qiu B., 2001, ENCY OCEAN SCI, P1413, DOI DOI 10.1006/RWOS.2001.0350; Qiu B, 2017, J CLIMATE, V30, P9591, DOI 10.1175/JCLI-D-17-0397.1; RHINES PB, 1979, DYNAM ATMOS OCEANS, V3, P289, DOI 10.1016/0377-0265(79)90015-0; Rossby CG, 1938, J MAR RES, V1, P239, DOI 10.1357/002224038806440520; Shang XD, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/340432; Shay LK, 2000, MON WEATHER REV, V128, P1366, DOI 10.1175/1520-0493(2000)128<1366:EOAWOF>2.0.CO;2; Sun L, 2014, J GEOPHYS RES-OCEANS, V119, P5585, DOI 10.1002/2013JC009575; Vallis GK, 2006, ATMOSPHERE OCEAN FLU; Walker ND, 2014, GEOPHYS RES LETT, V41, P7595, DOI 10.1002/2014GL061584; Wang W, 2004, J PHYS OCEANOGR, V34, P1267, DOI 10.1175/1520-0485(2004)034<1267:WEITTE>2.0.CO;2; Wang YL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32843-y; Wu CR, 2013, PROG OCEANOGR, V110, P49, DOI 10.1016/j.pocean.2012.12.001; Wu CC, 2007, J ATMOS SCI, V64, P3562, DOI 10.1175/JAS4051.1; Zhang DX, 2001, J PHYS OCEANOGR, V31, P1054, DOI 10.1175/1520-0485(2001)031<1054:TKEOTM>2.0.CO;2; Zhang ZG, 2014, SCIENCE, V345, P322, DOI 10.1126/science.1252418; Zhang ZG, 2013, GEOPHYS RES LETT, V40, P3677, DOI 10.1002/grl.50736	47	28	30	12	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					988	+		10.1126/science.aax5758	http://dx.doi.org/10.1126/science.aax5758			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LV3IK	32467388				2022-12-28	WOS:000538332600044
J	Contrepois, K; Wu, S; Moneghetti, KJ; Hornburg, D; Ahadi, S; Tsai, MS; Metwally, AA; Wei, E; Lee-McMullen, B; Quijada, JV; Chen, SJ; Christle, JW; Ellenberger, M; Balliu, B; Taylor, S; Durrant, MG; Knowles, DA; Choudhry, H; Ashland, M; Bahmani, A; Enslen, B; Amsallem, M; Kobayashi, Y; Avina, M; Perelman, D; Rose, SMSF; Zhou, WY; Ashley, EA; Montgomery, SB; Chaib, H; Haddad, F; Snyder, MP				Contrepois, Kevin; Wu, Si; Moneghetti, Kegan J.; Hornburg, Daniel; Ahadi, Sara; Tsai, Ming-Shian; Metwally, Ahmed A.; Wei, Eric; Lee-McMullen, Brittany; Quijada, Jeniffer, V; Chen, Songjie; Christle, Jeffrey W.; Ellenberger, Mathew; Balliu, Brunilda; Taylor, Shalina; Durrant, Matthew G.; Knowles, David A.; Choudhry, Hani; Ashland, Melanie; Bahmani, Amir; Enslen, Brooke; Amsallem, Myriam; Kobayashi, Yukari; Avina, Monika; Perelman, Dalia; Rose, Sophia Miryam Schussler-Fiorenza; Zhou, Wenyu; Ashley, Euan A.; Montgomery, Stephen B.; Chaib, Hassan; Haddad, Francois; Snyder, Michael P.			Molecular Choreography of Acute Exercise	CELL			English	Article							BLOOD MONONUCLEAR-CELLS; CORONARY-HEART-DISEASE; LEAN BODY-MASS; SKELETAL-MUSCLE; GENE-EXPRESSION; ADHESION MOLECULES; AEROBIC CAPACITY; MAXIMAL EXERCISE; FITNESS REGISTRY; ARTERY CALCIUM	Acute physical activity leads to several changes in metabolic, cardiovascular, and immune pathways. Although studies have examined selected changes in these pathways, the system-wide molecular response to an acute bout of exercise has not been fully characterized. We performed longitudinal multi- omic profiling of plasma and peripheral blood mononuclear cells including metabolome, lipidome, immunome, proteome, and transcriptome from 36 well-characterized volunteers, before and after a controlled bout of symptomlimited exercise. Time-series analysis revealed thousands of molecular changes and an orchestrated choreography of biological processes involving energy metabolism, oxidative stress, inflammation, tissue repair, and growth factor response, as well as regulatory pathways. Most of these processes were dampened and some were reversed in insulin-resistant participants. Finally, we discovered biological pathways involved in cardiopulmonary exercise response and developed prediction models revealing potential resting bloodbased biomarkers of peak oxygen consumption.	[Contrepois, Kevin; Wu, Si; Hornburg, Daniel; Ahadi, Sara; Tsai, Ming-Shian; Metwally, Ahmed A.; Wei, Eric; Lee-McMullen, Brittany; Quijada, Jeniffer, V; Chen, Songjie; Ellenberger, Mathew; Durrant, Matthew G.; Knowles, David A.; Ashland, Melanie; Bahmani, Amir; Enslen, Brooke; Avina, Monika; Perelman, Dalia; Rose, Sophia Miryam Schussler-Fiorenza; Zhou, Wenyu; Ashley, Euan A.; Montgomery, Stephen B.; Chaib, Hassan; Snyder, Michael P.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Contrepois, Kevin; Moneghetti, Kegan J.; Christle, Jeffrey W.; Amsallem, Myriam; Kobayashi, Yukari; Haddad, Francois; Snyder, Michael P.] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Moneghetti, Kegan J.; Christle, Jeffrey W.; Amsallem, Myriam; Kobayashi, Yukari; Ashley, Euan A.; Haddad, Francois] Stanford Univ, Div Cardiovasc Med, Sch Med, Stanford, CA 94305 USA; [Moneghetti, Kegan J.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Moneghetti, Kegan J.; Christle, Jeffrey W.] Stanford Univ, Dept Med, Stanford Sports Cardiol, Stanford, CA 94305 USA; [Balliu, Brunilda; Montgomery, Stephen B.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Taylor, Shalina] Stanford Univ, Pediat Dept, Sch Med, Stanford, CA 94305 USA; [Knowles, David A.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Choudhry, Hani] King Abdulaziz Univ, Canc & Mutagenesis Unit, King Fahd Ctr Med Res, Fac Sci,Dept Biochem, Jeddah, Saudi Arabia; [Ashley, Euan A.] Stanford Univ, Ctr Undiagnosed Dis, Stanford, CA 94305 USA; [Haddad, Francois; Snyder, Michael P.] Stanford Univ, Stanford Diabet Res Ctr, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; St Vincent's Hospital Melbourne; University of Melbourne; Stanford University; Stanford University; Stanford University; Stanford University; King Abdulaziz University; Stanford University; Stanford University	Snyder, MP (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Haddad, F; Snyder, MP (corresponding author), Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.; Haddad, F (corresponding author), Stanford Univ, Div Cardiovasc Med, Sch Med, Stanford, CA 94305 USA.; Haddad, F; Snyder, MP (corresponding author), Stanford Univ, Stanford Diabet Res Ctr, Stanford, CA 94305 USA.	fhaddad@stanford.edu; mpsnyder@stanford.edu	Schussler-Fiorenza Rose, Sophia Miryam/E-6411-2013	Schussler-Fiorenza Rose, Sophia Miryam/0000-0002-6311-6671; Zhou, Wenyu/0000-0002-8447-8815; Abdelhadi Metwally, Ahmed/0000-0002-0155-7412; Choudhry, Hani/0000-0003-0401-6619; Ashland, Melanie/0000-0002-3340-3573; Moneghetti, Kegan/0000-0001-9503-6660; Snyder, Michael/0000-0003-0784-7987	NIH Human Microbiome Project (HMP) [1U54DE02378901, S10OD020141]; Stanford Diabetes Research Center (SDRC) [P30DK116074]; Australian Government Research Training Program (RTP) Scholarship; Deanship of Scientific Research (DSR), King Abdulaziz University (KAU); Jeddah the Ministry of Education for Saudi Arabia	NIH Human Microbiome Project (HMP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Diabetes Research Center (SDRC); Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Deanship of Scientific Research (DSR), King Abdulaziz University (KAU); Jeddah the Ministry of Education for Saudi Arabia	We thank Yael Rosenberg-Hasson and the Human Immune Monitoring Center (HIMC) at Stanford for generating targeted proteomic data. We also would like to thank the iPOP participants who generously gave their time and biological samples. This work was supported by grants from the NIH Human Microbiome Project (HMP) (1U54DE02378901 and S10OD020141) and Stanford Diabetes Research Center (SDRC) (P30DK116074). K.J.M. received support from an Australian Government Research Training Program (RTP) Scholarship. We would like to acknowledge the support from the Deanship of Scientific Research (DSR), King Abdulaziz University (KAU), and Jeddah the Ministry of Education for Saudi Arabia.	Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Albouaini K, 2007, HEART, V93, P1285, DOI 10.1136/hrt.2007.121558; Arena R, 2003, CHEST, V124, P720, DOI 10.1378/chest.124.2.720; Arena R, 2004, AM HEART J, V147, P354, DOI 10.1016/j.ahj.2003.07.014; Arena R, 2011, CIRCULATION, V123, P668, DOI 10.1161/CIRCULATIONAHA.109.914788; Barupal DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15231-w; Beisser D, 2010, BIOINFORMATICS, V26, P1129, DOI 10.1093/bioinformatics/btq089; Belcastro AN, 1996, J APPL PHYSIOL, V80, P1331, DOI 10.1152/jappl.1996.80.4.1331; Bird Stephen R, 2016, BMJ Open Sport Exerc Med, V2, pe000143, DOI 10.1136/bmjsem-2016-000143; Bowen TS, 2015, J CACHEXIA SARCOPENI, V6, P197, DOI 10.1002/jcsm.12043; Brevetti G, 2001, CLIN HEMORHEOL MICRO, V24, P193; Calabia J, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-13; Carlson LA, 2011, EUR J APPL PHYSIOL, V111, P2919, DOI 10.1007/s00421-011-1923-2; Chen XP, 2009, CELL BIOCHEM FUNCT, V27, P407, DOI 10.1002/cbf.1596; Claudel T, 2005, ARTERIOSCL THROM VAS, V25, P2020, DOI 10.1161/01.ATV.0000178994.21828.a7; Connolly PH, 2004, J APPL PHYSIOL, V97, P1461, DOI 10.1152/japplphysiol.00316.2004; Contrepois K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35807-4; Contrepois K, 2015, MOL CELL PROTEOMICS, V14, P1684, DOI 10.1074/mcp.M114.046508; Cunha TF, 1985, J APPL PHYSIOL, V112, P1839; Droste SK, 2003, ENDOCRINOLOGY, V144, P3012, DOI 10.1210/en.2003-0097; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Gjevestad GO, 2015, CURR CARDIOVASC RISK, V9, DOI 10.1007/s12170-015-0463-4; Golbidi S, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/726861; Goodwin Matthew L, 2007, J Diabetes Sci Technol, V1, P558; Graham ZA, 2015, J MUSCLE RES CELL M, V36, P305, DOI 10.1007/s10974-015-9415-3; Guasch-Ferre M, 2016, DIABETES CARE, V39, P833, DOI 10.2337/dc15-2251; Gutierrez-Arcelus M, 2019, BIORXIV, DOI [10.1101/599449, DOI 10.1101/599449]; Hakonarson H, 1999, J CLIN INVEST, V104, P657, DOI 10.1172/JCI7137; HENRIKSSON J, 1991, J EXP BIOL, V160, P149; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang YH, 2007, SCIENCE, V316, P886, DOI 10.1126/science.1138684; Ingenbleek Y, 2015, ADV NUTR, V6, P572, DOI 10.3945/an.115.008508; Jilma B, 1997, IMMUNOBIOLOGY, V197, P505, DOI 10.1016/S0171-2985(97)80082-4; Kaminsky LA, 2015, MAYO CLIN PROC, V90, P1515, DOI 10.1016/j.mayocp.2015.07.026; KING NA, 1994, EUR J CLIN NUTR, V48, P715; Kinugawa T, 2003, INT J CARDIOL, V87, P83, DOI 10.1016/S0167-5273(02)00200-0; Kjaer M, 1998, ADV EXP MED BIOL, V441, P117; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; Knowles DA, 2017, NAT METHODS, V14, P699, DOI 10.1038/nmeth.4298; Koch LG, 2011, CIRC RES, V109, P1162, DOI 10.1161/CIRCRESAHA.111.253807; Kojok K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174185; Kusudo T, 2011, GENES CELLS, V16, P681, DOI 10.1111/j.1365-2443.2011.01517.x; Ladenvall P, 2016, EUR J PREV CARDIOL, V23, P1557, DOI 10.1177/2047487316655466; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lee DH, 2017, BRIT J NUTR, V118, P858, DOI [10.1017/S0007114517002665, 10.1017/s0007114517002665]; Lee KK, 2010, CIRCULATION, V122, P1478, DOI 10.1161/CIRCULATIONAHA.110.947960; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Lehmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011519; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Marasciulo FL, 2006, CURR MED CHEM, V13, P1655, DOI 10.2174/092986706777441968; McClelland RL, 2015, J AM COLL CARDIOL, V66, P1643, DOI 10.1016/j.jacc.2015.08.035; Melanson SEF, 2006, AM J CLIN PATHOL, V126, P888, DOI 10.1309/1D62H6KRFTVQRJ0A; Millard AL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00125; Morozov VI, 2006, EUR J APPL PHYSIOL, V97, P716, DOI 10.1007/s00421-006-0193-x; Myers J, 2017, PROG CARDIOVASC DIS, V60, P21, DOI 10.1016/j.pcad.2017.03.002; Myers Jonathan, 1993, Cardiology Clinics, V11, P199; Negro M, 2008, J SPORT MED PHYS FIT, V48, P347; Nielsen R, 2019, CIRCULATION, V139, P2129, DOI 10.1161/CIRCULATIONAHA.118.036459; Nieman DC, 2013, J PROTEOME RES, V12, P4577, DOI 10.1021/pr400717j; Odobasic D, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/2349817; Otto GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124429; Overmyer KA, 2015, CELL METAB, V21, P468, DOI 10.1016/j.cmet.2015.02.007; Palange P, 2007, EUR RESPIR J, V29, P185, DOI 10.1183/09031936.00046906; Pallister T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13722-4; Philippou A, 2012, ADV CLIN CHEM, V58, P49, DOI 10.1016/B978-0-12-394383-5.00010-2; Piening BD, 2018, CELL SYST, V6, P157, DOI 10.1016/j.cels.2017.12.013; Qi L, 2013, JAMA-J AM MED ASSOC, V310, P821, DOI 10.1001/jama.2013.276305; Radom-Aizik S, 2009, PEDIATR RES, V65, P447, DOI 10.1203/PDR.0b013e3181993473; Ranallo RF, 1998, SPORTS MED, V26, P29, DOI 10.2165/00007256-199826010-00003; Reihmane D, 2012, SCAND J IMMUNOL, V76, P188, DOI 10.1111/j.1365-3083.2012.02720.x; Ren YY, 2016, PHYSIOL GENOMICS, V48, P816, DOI 10.1152/physiolgenomics.00118.2015; Ribisl PM, 2007, DIABETES CARE, V30, P2679, DOI 10.2337/dc06-2487; Rose SMSF, 2019, NAT MED, V25, P792, DOI 10.1038/s41591-019-0414-6; Rost HL, 2016, NAT METHODS, V13, P777, DOI [10.1038/NMETH.3954, 10.1038/nmeth.3954]; Sarullo FM, 2010, OPEN CARDIOVASC MED, V4, P127, DOI 10.2174/1874192401004010127; Scheiman J, 2019, NAT MED, V25, P1104, DOI 10.1038/s41591-019-0485-4; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Sethi JK, 1999, SEMIN CELL DEV BIOL, V10, P19, DOI 10.1006/scdb.1998.0273; Shah SH, 2017, JACC-HEART FAIL, V5, P833, DOI 10.1016/j.jchf.2017.08.025; SHINKAI S, 1992, INT J SPORTS MED, V13, P452, DOI 10.1055/s-2007-1021297; Smith DA, 2016, ANN INTERN MED, V164, pJC35, DOI 10.7326/ACPJC-2016-164-6-035; Stakiw J, 2008, J THROMB HAEMOST, V6, P90; SUTTON JR, 1980, METABOLISM, V29, P254, DOI 10.1016/0026-0495(80)90067-0; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; TAHILIANI AG, 1991, VITAM HORM, V46, P165; TANAKA T, 1991, CLIN BIOCHEM, V24, P195, DOI 10.1016/0009-9120(91)90571-U; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Ulven SM, 2015, ARCH PHYSIOL BIOCHEM, V121, P41, DOI 10.3109/13813455.2014.1003566; Vijayaraghava A, 2015, J CLIN DIAGN RES, V9, pCC8, DOI 10.7860/JCDR/2015/12851.6021; Wallentin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078797; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wegiel B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00047; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; YANAGISAWA M, 1994, CIRCULATION, V89, P1320, DOI 10.1161/01.CIR.89.3.1320; Zhang J, 2017, EXP PHYSIOL, V102, P48, DOI 10.1113/EP086019; Zhou WY, 2019, NATURE, V569, P663, DOI 10.1038/s41586-019-1236-x	102	122	126	13	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2020	181	5					1112	+		10.1016/j.cell.2020.04.043	http://dx.doi.org/10.1016/j.cell.2020.04.043			35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LT9QF	32470399	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000537399500016
J	Kmietowicz, Z				Kmietowicz, Zosia			Covid-19: Selected NHS patients will be treated with remdesivir	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; MAHASE E, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1798; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9	3	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2020	369								m2097	10.1136/bmj.m2097	http://dx.doi.org/10.1136/bmj.m2097			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JW	32457029	Bronze			2022-12-28	WOS:000538337000012
J	Kuehn, BM				Kuehn, Bridget M.			Nonfatal, Fatal Overdoses Rising	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					2000	2000		10.1001/jama.2020.7795	http://dx.doi.org/10.1001/jama.2020.7795			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU8UM	32453376				2022-12-28	WOS:000538023900018
J	Lachin, JM				Lachin, John M.			Nonparametric Statistical Analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lachin, John M.] George Washington Univ, Biostat Ctr, Dept Biostat & Bioinformat, Milken Inst Sch Publ Hlth, Rockville, MD USA	George Washington University	Lachin, JM (corresponding author), GeorgeWashington Univ, Biostat Ctr, 6110 Execut Blvd, Rockville, MD 20852 USA.	jml@bsc.gwu.edu						Baxter BT, 2020, JAMA-J AM MED ASSOC, V323, P2029, DOI 10.1001/jama.2020.5230; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; CONOVER WJ, 1982, BIOMETRICS, V38, P715, DOI 10.2307/2530051; Lachin JM, 1999, CONTROL CLIN TRIALS, V20, P408, DOI 10.1016/S0197-2456(99)00022-7; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Newgard CD, 2015, JAMA-J AM MED ASSOC, V314, P940, DOI 10.1001/jama.2015.10516; Randles R, 1979, INTRO THEORY NONPARA; Tolles J, 2016, JAMA-J AM MED ASSOC, V315, P1046, DOI 10.1001/jama.2016.1825; van der Waerden B., 1952, INDAGATIONES MATHEMA, V14, P453, DOI [10.1016/S1385-7258(53)50012-5, DOI 10.1016/S1385-7258(52)50063-5]; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269	10	9	9	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					2080	2081		10.1001/jama.2020.5874	http://dx.doi.org/10.1001/jama.2020.5874			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU8UM	32453350				2022-12-28	WOS:000538023900039
J	Armstrong, KA; Cohen, JV; Shepard, JAO; Folch, EE; Mansour, MK; Stefely, JA				Armstrong, Katrina A.; Cohen, Justine V.; Shepard, Jo-Anne O.; Folch, Erik E.; Mansour, Michael K.; Stefely, Jonathan A.			Case 16-2020: A 47-Year-Old Woman with Recurrent Melanoma and Pulmonary Nodules	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSBRONCHIAL NEEDLE ASPIRATION; DIAGNOSIS; UTILITY	An asymptomatic 47-year-old woman with a history of recurrent melanoma presented to the hospital after routine quarterly surveillance imaging, performed after resection of right axillary melanoma, radiation therapy, and pembrolizumab therapy, had revealed new hilar and mediastinal lymphadenopathy and new pulmonary nodules. Diagnostic tests were performed.	[Armstrong, Katrina A.; Cohen, Justine V.; Folch, Erik E.; Mansour, Michael K.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Shepard, Jo-Anne O.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Stefely, Jonathan A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Armstrong, Katrina A.; Cohen, Justine V.; Folch, Erik E.; Mansour, Michael K.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Shepard, Jo-Anne O.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Stefely, Jonathan A.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Armstrong, KA (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Armstrong, KA (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.							[Anonymous], 2014, DIABETES CARE, V1, pS14; Azar MM, 2017, J CLIN MICROBIOL, V55, P1612, DOI 10.1128/JCM.02430-16; Blair JE, 2014, EMERG INFECT DIS, V20, P983, DOI 10.3201/eid2006.131842; Cheshire SC, 2018, RADIOLOGY, V289, P564, DOI 10.1148/radiol.2018180572; Darling ST., 1906, JAMA-J AM MED ASSOC, V46, P1283, DOI [10.1001/jama.1906.62510440037003, DOI 10.1001/JAMA.1906.62510440037003]; DISMUKES WE, 1992, AM J MED, V93, P489, DOI 10.1016/0002-9343(92)90575-V; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; GOODWIN RA, 1981, MEDICINE, V60, P231, DOI 10.1097/00005792-198107000-00001; Hage CA, 2019, AM J RESP CRIT CARE, V200, P535, DOI 10.1164/rccm.201906-1185ST; Hage CA, 2011, CLIN VACCINE IMMUNOL, V18, P661, DOI 10.1128/CVI.00389-10; Harris RM, 2016, DIAGN MICR INFEC DIS, V84, P170, DOI 10.1016/j.diagmicrobio.2015.10.013; Lee PP, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00735; Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI [10.1056/NEJMra1703481, 10.1056/NEJMc1801663]; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Tetzlaff MT, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0323-0; Theel ES, 2014, J CLIN MICROBIOL, V52, P3444, DOI 10.1128/JCM.01598-14; Tyan CC, 2017, RESPIRATION, V94, P457, DOI 10.1159/000479745; Ungprasert P, 2016, LUNG, V194, P91, DOI 10.1007/s00408-015-9826-3	18	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2020	382	21					2034	2043		10.1056/NEJMcpc1916258	http://dx.doi.org/10.1056/NEJMcpc1916258			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LT1TD	32433841				2022-12-28	WOS:000536856000019
J	McCormack, T; Harrisingh, MC; Horner, D; Bewley, S				McCormack, Terry; Harrisingh, Marie C.; Horner, Daniel; Bewley, Susan		Guideline Comm	Venous thromboembolism in adults: summary of updated NICE guidance on diagnosis, management, and thrombophilia testing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PULMONARY-EMBOLISM; D-DIMER; RULE; THROMBOSIS; ASPIRIN		[McCormack, Terry] Hull York Med Sch, Inst Clin & Appl Hlth Res, Kingston Upon Hull, N Humberside, England; [Harrisingh, Marie C.] Natl Inst Hlth & Care Excellence, London, England; [Horner, Daniel] Salford Royal NHS Fdn Trust, Stott Lane, Salford, Lancs, England; [Horner, Daniel] Univ Manchester, Div Infect Immun & Resp Med, Manchester, Lancs, England; [Bewley, Susan] Kings Coll London, Sch Life Course Sci, Div Women & Childrens Hlth, London, England	University of Hull; University of York - UK; National Institute for Health & Care Excellence; Salford Royal NHS Foundation Trust; University of Manchester; University of London; King's College London	Harrisingh, MC (corresponding author), Natl Inst Hlth & Care Excellence, London, England.	marie.harrisingh@nice.org.uk		Horner, Daniel Edward/0000-0002-0400-2017				Agnelli G, 2018, THROMB HAEMOSTASIS, V118, P1668, DOI 10.1055/s-0038-1668523; Aujesky D, 2011, J GEN INTERNAL MED, V26, P1220; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Bledsoe JR, 2018, CHEST, V154, P249, DOI 10.1016/j.chest.2018.01.035; Freund Y, 2018, JAMA-J AM MED ASSOC, V319, P559, DOI 10.1001/jama.2017.21904; Howard LSGE, 2018, THORAX, V73, P1, DOI 10.1136/thoraxjnl-2018-211539; Investigation, 2012, INV MAN ANT SYNDR; Kline JA, 2008, J THROMB HAEMOST, V6, P772, DOI 10.1111/j.1538-7836.2008.02944.x; Konstantinides SV, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.01647-2019; McBane R, 2017, THROMB HAEMOSTASIS, V117, P1952, DOI 10.1160/TH17-03-0193; Medicines and Healthcare products Regulatory Agency, 2019, DIR ACT OR ANT DOACS; National Institute for Health and Care Excellence (NICE), 2020, VEN THROMB DIS DIAGN; Peacock WF, 2018, ACAD EMERG MED, V25, P995, DOI 10.1111/acem.13451; Pengo V, 2018, BLOOD, V132, P1365, DOI 10.1182/blood-2018-04-848333; Raskob GE, 2014, J THROMB HAEMOST, V12, P1580, DOI 10.1111/jth.12698; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Simes J, 2014, CIRCULATION, V130, P1062, DOI 10.1161/CIRCULATIONAHA.114.008828; Tagalakis V, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.02.024; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153	20	16	17	3	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2020	369								m1565	10.1136/bmj.m1565	http://dx.doi.org/10.1136/bmj.m1565			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JI	32430311				2022-12-28	WOS:000538335600001
J	Trogen, B; Oshinsky, D; Caplan, A				Trogen, Brit; Oshinsky, David; Caplan, Arthur			Adverse Consequences of Rushing a SARS-CoV-2 Vaccine Implications for Public Trust	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Trogen, Brit; Oshinsky, David; Caplan, Arthur] NYU Langone Hlth, New York, NY USA	NYU Langone Medical Center	Trogen, B (corresponding author), 15J-1510 Lexington Ave, New York, NY 10029 USA.	brit.trogen@nyulangone.org		Caplan, Art/0000-0002-4061-8011; Trogen, Brit/0000-0003-2830-4703				[Anonymous], 2005, CUTTER INCIDENT AM 1; Dube E, 2015, EXPERT REV VACCINES, V14, P99, DOI 10.1586/14760584.2015.964212; Hotez P, 2019, PEDIATR RES, V85, P912, DOI 10.1038/s41390-019-0354-3; Oshinsky DM., 2005, POLIO AM STORY; Plotkin SA, 2020, VACCINE, V38, P3987, DOI 10.1016/j.vaccine.2020.04.039; Sanger DE, 2020, NEW YORK TIMES; Sencer DJ, 2006, EMERG INFECT DIS, V12, P29; World Health Organization, 2019, 10 THREATS GLOB HLTH	8	45	46	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2460	2461		10.1001/jama.2020.8917	http://dx.doi.org/10.1001/jama.2020.8917			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32453392	Bronze			2022-12-28	WOS:000590149400008
J	Bai, L; You, QL; Feng, X; Kovach, A; Li, HL				Bai, Lin; You, Qinglong; Feng, Xiang; Kovach, Amanda; Li, Huilin			Structure of the ER membrane complex, a transmembrane-domain insertase	NATURE			English	Article							PROTEIN COMPLEX; YIDC	The cryo-electron microscopy structure of the ER membrane complex provides insight into its overall architecture, evolution and function in co-translational protein insertion. The endoplasmic reticulum (ER) membrane complex (EMC) cooperates with the Sec61 translocon to co-translationally insert a transmembrane helix (TMH) of many multi-pass integral membrane proteins into the ER membrane, and it is also responsible for inserting the TMH of some tail-anchored proteins(1-3). How EMC accomplishes this feat has been unclear. Here we report the first, to our knowledge, cryo-electron microscopy structure of the eukaryotic EMC. We found that the Saccharomyces cerevisiae EMC contains eight subunits (Emc1-6, Emc7 and Emc10), has a large lumenal region and a smaller cytosolic region, and has a transmembrane region formed by Emc4, Emc5 and Emc6 plus the transmembrane domains of Emc1 and Emc3. We identified a five-TMH fold centred around Emc3 that resembles the prokaryotic YidC insertase and that delineates a largely hydrophilic client protein pocket. The transmembrane domain of Emc4 tilts away from the main transmembrane region of EMC and is partially mobile. Mutational studies demonstrated that the flexibility of Emc4 and the hydrophilicity of the client pocket are required for EMC function. The EMC structure reveals notable evolutionary conservation with the prokaryotic insertases(4,5), suggests that eukaryotic TMH insertion involves a similar mechanism, and provides a framework for detailed understanding of membrane insertion for numerous eukaryotic integral membrane proteins and tail-anchored proteins.	[Bai, Lin; You, Qinglong; Feng, Xiang; Kovach, Amanda; Li, Huilin] Van Andel Inst, Struct Biol Program, Grand Rapids, MI 49503 USA	Van Andel Institute	Bai, L; Li, HL (corresponding author), Van Andel Inst, Struct Biol Program, Grand Rapids, MI 49503 USA.	lin.bai@vai.org; huilin.li@vai.org	Feng, Xiang/AGG-8475-2022	Feng, Xiang/0000-0002-4441-3152; Li, Huilin/0000-0001-8085-8928	US National Institutes of Health (NIH) [R01 CA231466]; Van Andel Institute	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Van Andel Institute	Cryo-EM images were collected in the David Van Andel Advanced Cryo-Electron Microscopy Suite at Van Andel Research Institute. We thank G. Zhao and X. Meng for assistance with data collection and D. Nadziejka for critical reading of the manuscript. This work was supported by the US National Institutes of Health (NIH) (R01 CA231466 to H.L.) and Van Andel Institute (to H.L.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Anghel SA, 2017, CELL REP, V21, P3708, DOI 10.1016/j.celrep.2017.12.006; Bagchi P, 2016, ELIFE, V5, DOI 10.7554/eLife.21470; Bassler J, 2015, J CELL BIOL, V210, P169, DOI 10.1083/jcb.20140811106112015c; Bircham PW, 2011, MOL BIOSYST, V7, P2589, DOI 10.1039/c1mb05175j; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YY, 2018, TRENDS BIOCHEM SCI, V43, P151, DOI 10.1016/j.tibs.2017.12.005; Chitwood PJ, 2018, CELL, V175, P1507, DOI 10.1016/j.cell.2018.10.009; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Coelho JPL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08632-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fry MY, 2018, SCIENCE, V359, P390, DOI 10.1126/science.aar5992; Funakoshi M, 2009, YEAST, V26, P185, DOI 10.1002/yea.1658; Guna A, 2018, SCIENCE, V359, P470, DOI 10.1126/science.aao3099; Hiramatsu N, 2019, MOL BIOL CELL, V30, P2890, DOI 10.1091/mbc.E19-08-0434; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kammers Kai, 2015, EuPA Open Proteom, V7, P11; Kedrov A, 2016, CELL REP, V17, P2943, DOI 10.1016/j.celrep.2016.11.059; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Kudze T, 2018, CELL STRESS CHAPERON, V23, P1101, DOI 10.1007/s12192-018-0908-z; Kumazaki K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07299; Kumazaki K, 2014, NATURE, V509, P516, DOI 10.1038/nature13167; Lahiri S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001969; Lin DL, 2019, CELL REP, V27, P1666, DOI 10.1016/j.celrep.2019.04.051; Luo WJ, 2002, TRAFFIC, V3, P730, DOI 10.1034/j.1600-0854.2002.31005.x; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Pausch P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8494; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110; Sachelaru I, 2013, J BIOL CHEM, V288, P16295, DOI 10.1074/jbc.M112.446583; Shurtleffn MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37018; Tang XJ, 2012, P NATL ACAD SCI USA, V109, P3287, DOI 10.1073/pnas.1116455109; Tian SH, 2019, CELL REP, V28, P2517, DOI 10.1016/j.celrep.2019.08.006; Wickles S, 2014, ELIFE, V3, DOI 10.7554/eLife.03035; Wideman Jeremy G, 2015, F1000Res, V4, P624, DOI 10.12688/f1000research.6944.1; Xie K, 2006, BIOCHEMISTRY-US, V45, P13401, DOI 10.1021/bi060826z; Xin YL, 2018, FASEB J, V32, P2411, DOI 10.1096/fj.201700893RR; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	40	46	46	1	38	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 20	2020	584	7821					475	+		10.1038/s41586-020-2389-3	http://dx.doi.org/10.1038/s41586-020-2389-3		JUN 2020	16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NG4DR	32494008	Green Accepted			2022-12-28	WOS:000537663800001
J	Muth, CC				Muth, Christopher C.			Long-term Outcomes After Thrombolytic Therapy for Acute Ischemic Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GUIDELINES		[Muth, Christopher C.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA	Rush University	Muth, CC (corresponding author), 330 N Wabash Ave, Chicago, IL 60611 USA.	christopher.muth@jamanetwork.org						Kwatkowski TG, 1999, NEW ENGL J MED, V340, P1781; Man SM, 2020, JAMA-J AM MED ASSOC, V323, P2170, DOI 10.1001/jama.2020.5697; Muruet W, 2018, STROKE, V49, P607, DOI 10.1161/STROKEAHA.117.019889; Ormseth CH, 2017, STROKE VASC NEUROL, V2, P94, DOI 10.1136/svn-2017-000092; Powers WJ, 2019, STROKE, V50, pE344, DOI 10.1161/STR.0000000000000211; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959	6	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2020	323	21					2184	2185		10.1001/jama.2020.5269	http://dx.doi.org/10.1001/jama.2020.5269			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LY8YS	32484521	Bronze			2022-12-28	WOS:000540816000022
J	Pletcher, MJ; Flaherman, V; Najafi, N; Patel, S; Rushakoff, RJ; Hoffman, A; Robinson, A; Cucina, RJ; McCulloch, CE; Gonzales, R; Auerbach, A				Pletcher, Mark J.; Flaherman, Valerie; Najafi, Nader; Patel, Sajan; Rushakoff, Robert J.; Hoffman, Ari; Robinson, Andrew; Cucina, Russell J.; McCulloch, Charles E.; Gonzales, Ralph; Auerbach, Andrew			Randomized Controlled Trials of Electronic Health Record Interventions: Design, Conduct, and Reporting Considerations	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY IMPROVEMENT; INFORMED-CONSENT; DECISION-SUPPORT; CARE; STATEMENT; IMPACT	Electronic health record (EHR) systems can be configured to deliver novel EHR interventions that influence clinical decision making and to support efficient randomized controlled trials (RCTs) designed to evaluate the effectiveness, safety, and costs of those interventions. In designing RCTs of EHR interventions, one should carefully consider the unit of randomization (for example, patient, encounter, clinician, or clinical unit), balancing concerns about contamination of an intervention across randomization units within clusters (for example, patients within clinical units) against the superior control of measured and unmeasured confounders that comes with randomizing a larger number of units. One should also consider whether the key computational assessment components of the EHR intervention, such as a predictive algorithm used to target a subgroup for decision support, should occur before randomization (so that only 1 subgroup is randomized) or after randomization (including all subgroups). When these components are applied after randomization, one must consider expected heterogeneity in the effect of the differential decision support across subgroups, which has implications for overall impact potential, analytic approach, and sample size planning. Trials of EHR interventions should be reviewed by an institutional review board, but may not require patient-level informed consent when the interventions being tested can be considered minimal risk or quality improvement, and when clinical decision making is supported, rather than controlled, by an EHR intervention. Data and safety monitoring for RCTs of EHR interventions should be conducted to guide institutional pragmatic decision making about implementation and ensure that continuing randomization remains justified. Reporting should follow the CONSORT (Consolidated Standards of Reporting Trials) Statement, with extensions for pragmatic trials and cluster RCTs when applicable, and should include detailed materials to enhance reproducibility.	[Pletcher, Mark J.] Univ Calif San Francisco, Box 0560,550 16th St,Mission Hall,2nd Floor, San Francisco, CA 94143 USA; [Flaherman, Valerie] Univ Calif San Francisco, Box 0503,3333 Calif St,245, San Francisco, CA 94143 USA; [Najafi, Nader; Patel, Sajan; Hoffman, Ari] Univ Calif San Francisco, Box 0131,533 Parnassus Ave,127B, San Francisco, CA 94143 USA; [Rushakoff, Robert J.] Univ Calif San Francisco, Box 1616,2200 Post St,C4-30, San Francisco, CA 94143 USA; [Robinson, Andrew; Gonzales, Ralph] Univ Calif San Francisco, Box 0558,550 16th St, San Francisco, CA 94143 USA; [Cucina, Russell J.] Univ Calif San Francisco, Box 0914,350 Parnassus Ave,210F, San Francisco, CA 94143 USA; [McCulloch, Charles E.] Univ Calif San Francisco, Box 0560,550 16th St,2430, San Francisco, CA 94143 USA; [Auerbach, Andrew] Univ Calif San Francisco, Box 0131,533 Parnassus Ave,131, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pletcher, MJ (corresponding author), Univ Calif San Francisco, Box 0560,550 16th St,Mission Hall,2nd Floor, San Francisco, CA 94143 USA.	mark.pletcher@ucsf.edu			National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI [UL1 TR000004, UL1 TR001872]; UCSF Health System	National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI; UCSF Health System	This publication was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant Numbers UL1 TR000004 and UL1 TR001872, and by the UCSF Health System.	Ancker JS, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0430-8; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; Auerbach AD, 2007, NEW ENGL J MED, V357, P608, DOI 10.1056/NEJMsb070738; Bernstein SL, 2017, TRANSL BEHAV MED, V7, DOI 10.1007/s13142-017-0470-8; Brender J, 2013, APPL CLIN INFORM, V4, P331, DOI 10.4338/ACI-2013-04-RA-0024; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Department of Homeland Security, 2017, Fed Regist, V82, P7149; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Faden RR, 2013, HASTINGS CENT REP, V43, pS16, DOI 10.1002/hast.134; Federman AD, 2017, MED CARE, V55, P590, DOI 10.1097/MLR.0000000000000715; Fiks AG, 2009, PEDIATRICS, V124, P159, DOI 10.1542/peds.2008-2823; Finkelstein JA, 2015, CLIN TRIALS, V12, P457, DOI 10.1177/1740774515597682; Friedman CP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001456; Gawande A, 2018, NEW YORKER 1112, P12; Hemming K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h391; Institute of Medicine, 2007, LEARNING HEALTHCARE; Institute of Medicine, 2013, LARG SIMPL TRIALS KN; Kane-Gill SL, 2017, CRIT CARE MED, V45, P1481, DOI 10.1097/CCM.0000000000002580; Mandel JC, 2016, J AM MED INFORM ASSN, V23, P899, DOI 10.1093/jamia/ocv189; McCall J, 2019, CLIN TRIALS; McKinney RE, 2015, CLIN TRIALS, V12, P494, DOI 10.1177/1740774515597688; Najafi N, 2019, JAMA INTERN MED, V179, P11, DOI 10.1001/jamainternmed.2018.5859; Niazkhani Z, 2009, J AM MED INFORM ASSN, V16, P539, DOI 10.1197/jamia.M2419; O'Connor PJ, 2011, ANN FAM MED, V9, P12, DOI 10.1370/afm.1196; Patel MS, 2018, NEW ENGL J MED, V378, P214, DOI 10.1056/NEJMp1712984; Pedroza C, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1480-4; Pletcher MJ, 2014, JAMA INTERN MED, V174, P668, DOI 10.1001/jamainternmed.2013.13297; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Sedrak MS, 2017, JAMA INTERN MED, V177, P939, DOI 10.1001/jamainternmed.2017.1144; Spiegelhalter DJ, 2004, STAT SCI, V19, P156, DOI 10.1214/088342304000000080; Terrell KM, 2009, J AM GERIATR SOC, V57, P1388, DOI 10.1111/j.1532-5415.2009.02352.x; Turner EL, 2017, AM J PUBLIC HEALTH, V107, P907, DOI 10.2105/AJPH.2017.303706; Washington V, 2017, NEW ENGL J MED, V377, P904, DOI 10.1056/NEJMp1703370; Westbrook JI, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011811; Yu JH, 2016, STAT METHODS MED RES, V25, P64, DOI 10.1177/0962280212440535; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	36	5	5	3	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2020	172			11			S85	S91		10.7326/M19-0877	http://dx.doi.org/10.7326/M19-0877			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MH8ZH	32479183				2022-12-28	WOS:000547009900004
J	Voelker, R				Voelker, Rebecca			Triple-Negative Breast Cancer Drug Receives Approval	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2020	323	21					2122	2122		10.1001/jama.2020.8312	http://dx.doi.org/10.1001/jama.2020.8312			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LY8YS	32484522				2022-12-28	WOS:000540816000004
J	Wright, A; McCoy, AB; Choudhry, NK				Wright, Adam; McCoy, Allison B.; Choudhry, Niteesh K.			Recommendations for the Conduct and Reporting of Research Involving Flexible Electronic Health Record-Based Interventions	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DECISION-SUPPORT; INFORMATION-TECHNOLOGY; STARE-HI; STATEMENT; TRIALS; CAPABILITIES; DELIVERY; ADOPTION	In the past 2 decades, the United States has seen widespread adoption of electronic health records (EHRs) and a transition from mostly locally developed EHRs to commercial systems. However, most research on quality improvement and safety interventions in EHRs is still conducted at a single site, in a single EHR. Although single-site studies are important early in the innovation lifecycle, multisite studies of EHR interventions are critical for generalizability. Because EHR software, configuration, and local context differ considerably across health care organizations, it can be difficult to implement a single, standardized intervention across multiple sites in a study. This article outlines key strengths, weaknesses, challenges, and opportunities for standardization of EHR interventions in multisite studies and describes flexible trial designs suitable for studying complex interventions, including EHR interventions. It also outlines key considerations for reporting on flexible trials of EHR interventions, including sharing details of the process for designing interventions and their content, details of outcomes being studied and approaches for pooling, and the importance of sharing code and configuration whenever possible.	[Wright, Adam; McCoy, Allison B.] Vanderbilt Univ, Med Ctr, 2525 West End Ave 1475, Nashville, TN 37203 USA; [Choudhry, Niteesh K.] Brigham & Womens Hosp, 1620 Tremont St 3030, Boston, MA 02120 USA	Vanderbilt University; Harvard University; Brigham & Women's Hospital	Wright, A (corresponding author), Vanderbilt Univ, Med Ctr, 2525 West End Ave 1475, Nashville, TN 37203 USA.	adam.wright@vumc.org	McCoy, Allison/I-1951-2013	McCoy, Allison/0000-0003-2292-9147	National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL122225]; National Library of Medicine [R21LM012448]	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	By the National Heart, Lung, and Blood Institute of the National Institutes of Health (R01HL122225) and the National Library of Medicine (R21LM012448).	Adler-Milstein J, 2017, J AM MED INFORM ASSN, V24, P1142, DOI 10.1093/jamia/ocx080; [Anonymous], 2016, OFF BAS PHYS EL HLTH; Baker TB, 2010, PATIENT EDUC COUNS, V81, pS77, DOI 10.1016/j.pec.2010.07.040; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; Blencowe NS, 2016, BRIT J SURG, V103, P1377, DOI 10.1002/bjs.10254; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Blumenthal D, 2009, NEW ENGL J MED, V360, P1477, DOI 10.1056/NEJMp0901592; Brender J, 2013, APPL CLIN INFORM, V4, P331, DOI 10.4338/ACI-2013-04-RA-0024; Bright TJ, 2012, ANN INTERN MED, V157, P29, DOI 10.7326/0003-4819-157-1-201207030-00450; Callen JL, 2009, METHOD INFORM MED, V48, P196, DOI 10.3414/ME9212; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Eccles MP, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-28; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1923; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Hawe P, 2004, BMJ-BRIT MED J, V328, P1561, DOI 10.1136/bmj.328.7455.1561; Koppel R, 2009, JAMA-J AM MED ASSOC, V301, P1276, DOI 10.1001/jama.2009.398; Laxmisan A, 2012, APPL CLIN INFORM, V3, P80, DOI 10.4338/ACI-2011-11-RA-0066; Mandel JC, 2016, J AM MED INFORM ASSN, V23, P899, DOI 10.1093/jamia/ocv189; Mandl KD, 2009, NEW ENGL J MED, V360, P1278, DOI 10.1056/NEJMp0900411; McCoy AB, 2015, J AM MED INFORM ASSN, V22, P1081, DOI 10.1093/jamia/ocv073; McCoy AB, 2013, BMJ QUAL SAF, V22, P219, DOI 10.1136/bmjqs-2012-001419; McEvoy DS, 2017, J AM MED INFORM ASSN, V24, P331, DOI 10.1093/jamia/ocw114; Metzger J, 2010, HEALTH AFFAIR, V29, P655, DOI 10.1377/hlthaff.2010.0160; Miller RA, 2005, J BIOMED INFORM, V38, P469, DOI 10.1016/j.jbi.2005.08.009; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; National Institutes of Health, 2019, SINGL IRB POL MULT R; Nykanen P, 2011, INT J MED INFORM, V80, P815, DOI 10.1016/j.ijmedinf.2011.08.004; Off. Natl. Coord. Health Inf. Technol, 2019, HLTH ITQUICK STAT 55; Office of the National Coordinator for Health Information Technology, 2017, NONF AC CAR HOSP EL; Ratwani RM, 2018, JAMA-J AM MED ASSOC, V320, P2533, DOI 10.1001/jama.2018.14079; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Singh H, 2020, ANN INTERN MED, V172, pS92, DOI 10.7326/M19-0879; Sittig DF, 2014, J COMP EFFECT RES, V3, P447, DOI [10.2217/CER.14.46, 10.2217/cer.14.46]; Sittig DF, 2012, MED CARE, V50, pS49, DOI 10.1097/MLR.0b013e318259c02b; Sittig DF, 2010, QUAL SAF HEALTH CARE, V19, pI68, DOI 10.1136/qshc.2010.042085; Talmon J, 2009, INT J MED INFORM, V78, P1, DOI 10.1016/j.ijmedinf.2008.09.002; Wright A., 2016, IMPROVING QUALITY MA; Wright A, 2015, INT J MED INFORM, V84, P784, DOI 10.1016/j.ijmedinf.2015.06.011; Wright A, 2013, NEW ENGL J MED, V368, P779, DOI 10.1056/NEJMc1213481	40	4	4	2	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2020	172			11			S110	S115		10.7326/M19-0880	http://dx.doi.org/10.7326/M19-0880			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MH8ZH	32479179				2022-12-28	WOS:000547009900007
J	Bargas, O				Bargas, Omar			Submucosal Cleft Palate	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bargas, Omar] Univ Anbar, Coll Med, Ramadi, Iraq	University of Anbar	Bargas, O (corresponding author), Univ Anbar, Coll Med, Ramadi, Iraq.	omar.alrawi@uoanbar.edu.iq	Bargas, omar/AAE-8781-2021	Bargas, omar/0000-0001-7962-7030					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2020	382	22					E77	E77		10.1056/NEJMicm1913924	http://dx.doi.org/10.1056/NEJMicm1913924			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MA5NT	32459926				2022-12-28	WOS:000541960400008
J	Sullenger, BA				Sullenger, Bruce A.			RGEN Editing of RNA and DNA: The Long and Winding Road from Catalytic RNAs to CRISPR to the Clinic	CELL			English	Editorial Material							RIBOZYME-MEDIATED REPAIR; GROUP-II INTRONS; SITES	The first clinical studies utilizing RNA-guided endonucleases (RGENs) to therapeutically edit RNA and DNA in cancer patients were recently published. These groundbreaking technological advances promise to revolutionize genetic therapy and, as I discuss, represent the culmination of decades of innovative work to engineer RGENs for such editing applications.	[Sullenger, Bruce A.] Duke Univ, Dept Surg, 2 Genome Ct, Durham, NC 27710 USA; [Sullenger, Bruce A.] Duke Univ, Dept Pharmacol & Canc Biol, 2 Genome Ct, Durham, NC 27710 USA; [Sullenger, Bruce A.] Duke Univ, Dept Biomed Engn, 2 Genome Ct, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Sullenger, BA (corresponding author), Duke Univ, Dept Surg, 2 Genome Ct, Durham, NC 27710 USA.; Sullenger, BA (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, 2 Genome Ct, Durham, NC 27710 USA.; Sullenger, BA (corresponding author), Duke Univ, Dept Biomed Engn, 2 Genome Ct, Durham, NC 27710 USA.	bruce.sullenger@duke.edu			NIH; Department of Defense	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense)	The author gratefully acknowledges many colleagues in the RGEN-mediated editing field for insightful discussions over the years as well as Robert Lefkowitz, Dani Bolognesi, Victor Dzau, Bethany Gray, and Rachel Rempel for helpful discussions on the preparation of this manuscript. The author is supported by the NIH and the Department of Defense.	Doudna JA, 2020, NATURE, V578, P229, DOI 10.1038/s41586-020-1978-5; Guo HT, 2000, SCIENCE, V289, P452, DOI 10.1126/science.289.5478.452; HERSCHLAG D, 1990, NATURE, V344, P405, DOI 10.1038/344405a0; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones JP, 2005, MOL THER, V11, P687, DOI 10.1016/j.ymthe.2005.01.014; Jones JT, 1996, NAT MED, V2, P643, DOI 10.1038/nm0696-643; Lan N, 1998, SCIENCE, V280, P1593, DOI 10.1126/science.280.5369.1593; Lee CH, 2018, PROG MOL BIOL TRANSL, V159, P79, DOI 10.1016/bs.pmbts.2018.07.001; Lee SJ, 2019, CANCER GENE THER, V26, P174, DOI 10.1038/s41417-018-0055-9; Phylactou LA, 1998, NAT GENET, V18, P378, DOI 10.1038/ng0498-378; Stadtmauer EA, 2020, SCIENCE, V367, P1001, DOI 10.1126/science.aba7365; SULLENGER BA, 1994, NATURE, V371, P619, DOI 10.1038/371619a0; Truong DM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005422; Xu L, 2019, NEW ENGL J MED, V381, P1240, DOI 10.1056/NEJMoa1817426; ZAUG AJ, 1986, NATURE, V324, P429, DOI 10.1038/324429a0	15	1	1	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2020	181	5					955	960		10.1016/j.cell.2020.04.050	http://dx.doi.org/10.1016/j.cell.2020.04.050			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LT9QF	32470403	Bronze			2022-12-28	WOS:000537399500001
J	Clark, MD; Contreras, GF; Shen, R; Perozo, E				Clark, Michael David; Contreras, Gustavo F.; Shen, Rong; Perozo, Eduardo			Electromechanical coupling in the hyperpolarization-activated K+ channel KAT1	NATURE			English	Article							CRYO-EM STRUCTURE; VOLTAGE SENSOR; MOLECULAR-DYNAMICS; ION CHANNELS; STRUCTURAL BASIS; GATING CHARGE; PORE DOMAIN; MODEL; TOOLS; VISUALIZATION	Voltage-gated potassium (K-v) channels coordinate electrical signalling and control cell volume by gating in response to membrane depolarization or hyperpolarization. However, although voltage-sensing domains transduce transmembrane electric field changes by a common mechanism involving the outward or inward translocation of gating charges(1-3), the general determinants of channel gating polarity remain poorly understood(4). Here we suggest a molecular mechanism for electromechanical coupling and gating polarity in non-domain-swapped K-v channels on the basis of the cryo-electron microscopy structure of KAT1, the hyperpolarization-activated K-v channel from Arabidopsis thaliana. KAT1 displays a depolarized voltage sensor, which interacts with a closed pore domain directly via two interfaces and indirectly via an intercalated phospholipid. Functional evaluation of KAT1 structure-guided mutants at the sensor-pore interfaces suggests a mechanism in which direct interaction between the sensor and the C-linker hairpin in the adjacent pore subunit is the primary determinant of gating polarity. We suggest that an inward motion of the S4 sensor helix of approximately 5-7 angstrom can underlie a direct-coupling mechanism, driving a conformational reorientation of the C-linker and ultimately opening the activation gate formed by the S6 intracellular bundle. This direct-coupling mechanism contrasts with allosteric mechanisms proposed for hyperpolarization-activated cyclic nucleotide-gated channels(5), and may represent an unexpected link between depolarization- and hyperpolarization-activated channels. The cryo-electron microscopy structure of the hyperpolarization-activated K+ channel KAT1 points to a direct-coupling mechanism between S4 movement and the reorientation of the C-linker.	[Clark, Michael David; Contreras, Gustavo F.; Shen, Rong; Perozo, Eduardo] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA	University of Chicago	Perozo, E (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	eperozo@uchicago.edu		Clark, Michael/0000-0001-9782-6682	Pittsburgh Supercomputing Center (PSC) through National Institutes of Health [R01GM116961]; National Cancer Institute's National Cryo-EM Facility at the Frederick National Laboratory for Cancer Research; Consortium for Membrane Protein Dynamics;  [R01GM088406];  [F30MH116647];  [T32GM007281]	Pittsburgh Supercomputing Center (PSC) through National Institutes of Health; National Cancer Institute's National Cryo-EM Facility at the Frederick National Laboratory for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Consortium for Membrane Protein Dynamics; ; ; 	We thank U. Baxa and T. J. Edwards at NCEF for cryo-EM data collection; P. Rodriguez, J. Austin II and T. Lavoie at the University of Chicago Advanced Electron Microscopy Facility for microscope maintenance and training; and P. Bezanilla, M. Zhao, T. Li and B. Reddy for advice and discussions at all stages of the project. Anton 2 computer time was provided by the Pittsburgh Supercomputing Center (PSC) through Grant R01GM116961 from the National Institutes of Health. The Anton 2 machine at PSC was generously made available by D. E. Shaw Research. This research was partly supported by the National Cancer Institute's National Cryo-EM Facility at the Frederick National Laboratory for Cancer Research. This work was supported by the Consortium for Membrane Protein Dynamics and by grant R01GM088406 to EP. MDC was supported by F30MH116647 and T32GM007281.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P814, DOI 10.1107/S2059798318009324; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; Alvarez-Baron CP, 2018, J GEN PHYSIOL, V150, P1203, DOI 10.1085/jgp.201812031; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Blunck R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00166; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Carvalho-de-Souza JL, 2018, J GEN PHYSIOL, V150, P307, DOI 10.1085/jgp.201711882; Chen S, 2007, J GEN PHYSIOL, V129, P175, DOI 10.1085/jgp.200609585; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chowdhury S, 2012, J GEN PHYSIOL, V140, P613, DOI 10.1085/jgp.201210840; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; Guo JT, 2016, NATURE, V531, P196, DOI 10.1038/nature16446; Hedrich R, 2012, PHYSIOL REV, V92, P1777, DOI 10.1152/physrev.00038.2011; Hertel B, 2005, J EXP BOT, V56, P3103, DOI 10.1093/jxb/eri307; HOSHI T, 1995, J GEN PHYSIOL, V105, P309, DOI 10.1085/jgp.105.3.309; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; James ZM, 2018, J GEN PHYSIOL, V150, P225, DOI 10.1085/jgp.201711898; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kasimova MA, 2019, ELIFE, V8, DOI 10.7554/eLife.53400; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022; Lai HC, 2005, NEURON, V47, P395, DOI 10.1016/j.neuron.2005.06.019; Latorre R, 2003, J GEN PHYSIOL, V122, P459, DOI 10.1085/jgp.200308818; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Lee CH, 2019, CELL, V179, P1582, DOI 10.1016/j.cell.2019.11.006; Lee CH, 2017, CELL, V168, P111, DOI 10.1016/j.cell.2016.12.023; Li QF, 2014, NAT STRUCT MOL BIOL, V21, P244, DOI 10.1038/nsmb.2768; Liu K, 2005, PLANT J, V42, P433, DOI 10.1111/j.1365-313X.2005.02384.x; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; MARTYNA GJ, 1992, J CHEM PHYS, V97, P2635, DOI 10.1063/1.463940; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Moroni A, 2000, BIOPHYS J, V78, P1862, DOI 10.1016/S0006-3495(00)76735-X; Papanatsiou M, 2019, SCIENCE, V363, P1456, DOI 10.1126/science.aaw0046; Perissinotti LL, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00207; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pintilie G, 2016, BIOPHYS J, V110, P827, DOI 10.1016/j.bpj.2015.11.3522; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Pravda L, 2018, NUCLEIC ACIDS RES, V46, pW368, DOI 10.1093/nar/gky309; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Roux B, 2008, BIOPHYS J, V95, P4205, DOI 10.1529/biophysj.108.136499; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sesti F, 2003, NAT NEUROSCI, V6, P353, DOI 10.1038/nn1028; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Shaya D, 2011, P NATL ACAD SCI USA, V108, P12313, DOI 10.1073/pnas.1106811108; Shih TM, 1998, METHOD ENZYMOL, V293, P529; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Vardanyan V, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00145; Vargas E, 2012, J GEN PHYSIOL, V140, P587, DOI 10.1085/jgp.201210873; Wang WW, 2017, CELL, V169, P422, DOI 10.1016/j.cell.2017.03.048; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070; Xu H, 2019, CELL, V176, P702, DOI 10.1016/j.cell.2018.12.018; Yan Z, 2017, CELL, V170, P470, DOI 10.1016/j.cell.2017.06.039; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	77	22	23	5	35	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					145	+		10.1038/s41586-020-2335-4	http://dx.doi.org/10.1038/s41586-020-2335-4		MAY 2020	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME6OV	32461693	Green Accepted			2022-12-28	WOS:000535878900001
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Public health must be "at the core" of global recovery plans, say doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2020	369								m2077	10.1136/bmj.m2077	http://dx.doi.org/10.1136/bmj.m2077			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JW	32451324	Bronze			2022-12-28	WOS:000538337000008
J	Ablowitz, MJ; Cole, JT				Ablowitz, Mark J.; Cole, Justin T.			Solitons and topological waves	SCIENCE			English	Editorial Material									[Ablowitz, Mark J.; Cole, Justin T.] Univ Colorado, Dept Appl Math, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Ablowitz, MJ (corresponding author), Univ Colorado, Dept Appl Math, Boulder, CO 80309 USA.	mark.ablowitz@colorado.edu; justin.t.cole@colorado.edu		Cole, Justin/0000-0002-2206-6487	Air Force Office of Scientific Research [FA9550-19-1-0084]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	Supported by Air Force Office of Scientific Research grant FA9550-19-1-0084.	Ablowitz M., 2011, NONLINEAR DISPERSIVE; Ablowitz MJ, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.023813; CHRISTODOULIDES DN, 1988, OPT LETT, V13, P794, DOI 10.1364/OL.13.000794; Eisenberg HS, 1998, PHYS REV LETT, V81, P3383, DOI 10.1103/PhysRevLett.81.3383; Fleischer JW, 2003, NATURE, V422, P147, DOI 10.1038/nature01452; Haldane FDM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013904; Lumer Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.243905; Mukherjee S, 2020, SCIENCE, V368, P856, DOI 10.1126/science.aba8725; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; Wang Z, 2009, NATURE, V461, P772, DOI 10.1038/nature08293; ZABUSKY NJ, 1965, PHYS REV LETT, V15, P240, DOI 10.1103/PhysRevLett.15.240	12	4	4	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					821	822		10.1126/science.abb5162	http://dx.doi.org/10.1126/science.abb5162			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU2DD	32439777				2022-12-28	WOS:000537569500023
J	Podgorski, J; Berg, M				Podgorski, Joel; Berg, Michael			Global threat of arsenic in groundwater	SCIENCE			English	Article							MIDDLE GANGA PLAIN; DRINKING-WATER RESOURCES; WEST-BENGAL; CONTAMINATED GROUNDWATER; TRACE-ELEMENTS; UTTAR-PRADESH; QUATERNARY STRATIGRAPHY; HUMAN HEALTH; DELTA PLAIN; EAST INDIA	Naturally occurring arsenic in groundwater affects millions of people worldwide. We created a global prediction map of groundwater arsenic exceeding 10 micrograms per liter using a random forest machine-learning model based on 11 geospatial environmental parameters and more than 50,000 aggregated data points of measured groundwater arsenic concentration. Our global prediction map includes known arsenic-affected areas and previously undocumented areas of concern. By combining the global arsenic prediction model with household groundwater-usage statistics, we estimate that 94 million to 220 million people are potentially exposed to high arsenic concentrations in groundwater, the vast majority (94%) being in Asia. Because groundwater is increasingly used to support growing populations and buffer against water scarcity due to changing climate, this work is important to raise awareness, identify areas for safe wells, and help prioritize testing.	[Podgorski, Joel; Berg, Michael] Swiss Fed Inst Aquat Sci & Technol, Eawag, Dept Water Resources & Drinking Water, CH-8600 Dubendorf, Switzerland; [Podgorski, Joel] Univ Manchester, Dept Earth & Environm Sci, Manchester M13 9PL, Lancs, England; [Berg, Michael] Univ Southern Queensland, UNESCO Chair Groundwater Arsen 2030 Agenda Sustai, Toowoomba, Qld 4350, Australia	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Manchester; University of Southern Queensland	Podgorski, J; Berg, M (corresponding author), Swiss Fed Inst Aquat Sci & Technol, Eawag, Dept Water Resources & Drinking Water, CH-8600 Dubendorf, Switzerland.; Podgorski, J (corresponding author), Univ Manchester, Dept Earth & Environm Sci, Manchester M13 9PL, Lancs, England.; Berg, M (corresponding author), Univ Southern Queensland, UNESCO Chair Groundwater Arsen 2030 Agenda Sustai, Toowoomba, Qld 4350, Australia.	joel.podgorski@eawag.ch; michael.berg@eawag.ch	Berg, Michael/C-3738-2012	Berg, Michael/0000-0002-7342-4061; Podgorski, Joel/0000-0003-2522-1021	Swiss Agency for Development and Cooperation [7F-09010.01.01, 7F-09963.01.01]; University of Manchester EPSRC IAA Impact Support Fund Award	Swiss Agency for Development and Cooperation; University of Manchester EPSRC IAA Impact Support Fund Award(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the Swiss Agency for Development and Cooperation (project nos. 7F-09010.01.01 and 7F-09963.01.01) for long-term support and cofunding of this study, as well as a University of Manchester EPSRC IAA Impact Support Fund Award to D. A. Polya.	Amini M, 2008, ENVIRON SCI TECHNOL, V42, P3669, DOI 10.1021/es702859e; Auge M., 2013, 8 CONGRESO ARGENTINO, P58, DOI [DOI 10.13140/RG.2.1.3333.4245, 10.13140/RG.2.1.3333.4245]; Ayotte J. D., 1999, WATER RESOUR INVEST, V99, P4162; Ayotte JD, 2017, ENVIRON SCI TECHNOL, V51, P12443, DOI 10.1021/acs.est.7b02881; Berg M, 2001, ENVIRON SCI TECHNOL, V35, P2621, DOI 10.1021/es010027y; Berg M, 2008, CHEM GEOL, V249, P91, DOI 10.1016/j.chemgeo.2007.12.007; Berg M, 2007, SCI TOTAL ENVIRON, V372, P413, DOI 10.1016/j.scitotenv.2006.09.010; Bindal S, 2019, WATER RES, V159, P65, DOI 10.1016/j.watres.2019.04.054; Blarasin M., 2004, 33 IAH 7 ALHSUD C ZA; Boyle D. R., 1996, 3306 GEOL SURV CAN; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bretzler A, 2017, SCI TOTAL ENVIRON, V584, P958, DOI 10.1016/j.scitotenv.2017.01.147; Bretzler A, 2011, J HYDROL, V402, P274, DOI 10.1016/j.jhydrol.2011.03.022; Broshears R. E., 2005, 20055090 USGS; Buschmann J, 2008, ENVIRON INT, V34, P756, DOI 10.1016/j.envint.2007.12.025; Buschmann J, 2007, ENVIRON SCI TECHNOL, V41, P2146, DOI 10.1021/es062056k; Chandra S, 2011, PHYS CHEM EARTH, V36, P1353, DOI 10.1016/j.pce.2011.05.009; Chatterjee D, 2005, ENVIRON GEOL, V49, P188, DOI 10.1007/s00254-005-0011-5; Chauhan VS, 2009, CHEMOSPHERE, V75, P83, DOI 10.1016/j.chemosphere.2008.11.065; Chidambaram S, 2017, ENVIRON DEV SUSTAIN, V19, P1015, DOI 10.1007/s10668-016-9786-7; Clohessy S.G., 2012, HYDROGEOLOGICAL RECO; de Caritat P, 1998, J HYDROL, V208, P92, DOI 10.1016/S0022-1694(98)00147-4; de Meyer CMC, 2017, SCI TOTAL ENVIRON, V607, P1437, DOI 10.1016/j.scitotenv.2017.07.059; Deflorin O., 2004, THESIS; Del Razo L. M., 2020, ARSENICO FLUORURO AG; EEA, 2019, AIR QUALITY CELL MON; Fan Y, 2013, SCIENCE, V339, P940, DOI 10.1126/science.1229881; FAO, 2016, AQUASTAT MAIN DAT; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fendorf S, 2010, SCIENCE, V328, P1123, DOI 10.1126/science.1172974; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fitzgerald J., 1999, GROUNDWATER QUALITY, P1; Frengstad B, 2000, SCI TOTAL ENVIRON, V246, P21, DOI 10.1016/S0048-9697(99)00413-1; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Geological Survey of Brazil (CPRM), 2017, GEOL SURV BRAZ CPRM; Geological Survey of Sweden, 2007, DAT ENV MON GROUNDW; Ghosh S, 2013, WATER RES, V47, P6992, DOI 10.1016/j.watres.2013.08.044; Ghosh T, 2014, ENVIRON EARTH SCI, V72, P2475, DOI 10.1007/s12665-014-3155-3; GORCHEV HG, 1984, WHO CHRON, V38, P104; Haldimann Max, 2005, Mitteilungen aus Lebensmitteluntersuchung und Hygiene, V96, P89; Hartmann J, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004370; Hastie T., 2009, SPRINGER SERIES STAT, DOI 10.1007/978-0-387-84858-7; Hengl T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169748; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hughes MF, 2002, TOXICOL LETT, V133, P1, DOI 10.1016/S0378-4274(02)00084-X; Ivkovic K., 1998, GROUNDWATER QUALITY; Kar S, 2010, APPL GEOCHEM, V25, P1805, DOI 10.1016/j.apgeochem.2010.09.007; Katsoyiannis IA, 2007, SCI TOTAL ENVIRON, V383, P128, DOI 10.1016/j.scitotenv.2007.04.035; Kinniburgh D., 2001, ARSENIC CONTAMINATIO; Kortatsi B.K., 2008, W AFR J APP ECOL, V13, P16, DOI 10.4314/wajae; Kumar M, 2016, SCI TOTAL ENVIRON, V573, P1103, DOI 10.1016/j.scitotenv.2016.08.109; Larsen R. M., 1998, GROUNDWATER QUALITY; Litter MI, 2019, SCI TOTAL ENVIRON, V676, P756, DOI 10.1016/j.scitotenv.2019.04.262; Maity JP, 2011, J ENVIRON SCI HEAL A, V46, P1163, DOI 10.1080/10934529.2012.598711; Marohn C, 2012, NAT HAZARD EARTH SYS, V12, P2879, DOI 10.5194/nhess-12-2879-2012; McArthur JM, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006552; McArthur JM, 2001, WATER RESOUR RES, V37, P109, DOI 10.1029/2000WR900270; McCaffrey L. P., 2001, 526101 WRC; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Ministry of Rural Development of Cambodia, 2015, CAMB WELLMAP; Mondal D, 2010, ENVIRON GEOCHEM HLTH, V32, P463, DOI 10.1007/s10653-010-9319-5; Morgada M. E., 2008, REV ELECT CIENCIAS T, V5, P1; Mukherjee A, 2007, J HYDROL, V334, P151, DOI 10.1016/j.jhydrol.2006.10.004; Mukherjee A, 2018, SCI TOTAL ENVIRON, V645, P1371, DOI 10.1016/j.scitotenv.2018.06.376; Murcott S., 2012, Arsenic contamination in the world: an international sourcebook; Nath B, 2008, APPL GEOCHEM, V23, P977, DOI 10.1016/j.apgeochem.2007.11.016; Nath B, 2008, WATER AIR SOIL POLL, V190, P95, DOI 10.1007/s11270-007-9583-x; Nickson R, 2007, J ENVIRON SCI HEAL A, V42, P1707, DOI 10.1080/10934520701564194; Nickson R, 1998, NATURE, V395, P338, DOI 10.1038/26387; Nickson RT, 2005, APPL GEOCHEM, V20, P55, DOI 10.1016/j.apgeochem.2004.06.004; NICOLLI HB, 1989, ENVIRON GEOL WATER S, V14, P3, DOI 10.1007/BF01740581; Olea RA, 2018, STOCH ENV RES RISK A, V32, P241, DOI 10.1007/s00477-017-1390-3; Paul D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118735; Planer-Friedrich B., 2000, THESIS; Planer-Friedrich B., 2000, HYDROGEOLOGICAL HYDR; Podgorski J., 2020, PODGORSKI BERG 2020, DOI [10.25678/0001ZT, DOI 10.25678/0001ZT]; Podgorski JE, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700935; Pritchard M, 2008, PHYS CHEM EARTH, V33, P812, DOI 10.1016/j.pce.2008.06.036; Prosun Bhattacharya, 1997, International Journal of Water Resources Development, V13, P79, DOI 10.1080/07900629749944; R Development Core Team, 2009, R LANG ENV STAT COMP; Rango T, 2010, J AFR EARTH SCI, V57, P479, DOI 10.1016/j.jafrearsci.2009.12.005; Ravenscroft P., 2009, ARSENIC POLLUTION GL, V28; Ravenscroft P., 2007, PREDICTING GLO UNPUB; Read EK, 2017, WATER RESOUR RES, V53, P1735, DOI 10.1002/2016WR019993; Reimann C., 2002, 20020333 GEOL SURV N, P131; Rodriguez-Lado L, 2013, SCIENCE, V341, P866, DOI 10.1126/science.1237484; Ross CW, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.91; Rowland HAL, 2011, APPL GEOCHEM, V26, P1, DOI 10.1016/j.apgeochem.2010.10.006; Saha D, 2016, ENVIRON GEOCHEM HLTH, V38, P315, DOI 10.1007/s10653-015-9730-z; Sailo L, 2014, ENVIRON MONIT ASSESS, V186, P6805, DOI 10.1007/s10661-014-3890-7; Shah BA, 2008, ENVIRON GEOL, V53, P1553, DOI 10.1007/s00254-007-0766-y; Shah BA, 2015, ENVIRON EARTH SCI, V73, P1505, DOI 10.1007/s12665-014-3501-5; Shah BA, 2012, ENVIRON EARTH SCI, V66, P2491, DOI 10.1007/s12665-011-1472-3; Shah BA, 2010, CURR SCI INDIA, V98, P1359; Sharma S, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5507-9; Shrestha B. R., 2004, STATE ARSENIC NEPAL; Shukla DP, 2010, J HYDROL, V395, P49, DOI 10.1016/j.jhydrol.2010.10.011; Sikharani Hazarika, 2013, Archives of Applied Science Research, V5, P57; Smedley P., 2002, FLUORIDE GROUNDWATER, DOI [10.1111/j.1745-6584.2002.tb02490.x, DOI 10.1111/J.1745-6584.2002.TB02490.X]; Smedley PL, 2003, APPL GEOCHEM, V18, P1453, DOI 10.1016/S0883-2927(03)00062-3; Smedley PL, 2002, GROUND WATER, V40, P44, DOI 10.1111/j.1745-6584.2002.tb02490.x; Smedley PL, 1996, J AFR EARTH SCI, V22, P459, DOI 10.1016/0899-5362(96)00023-1; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; Smith AH, 2000, B WORLD HEALTH ORGAN, V78, P1093; Alarcon-Herrera MT, 2013, J HAZARD MATER, V262, P960, DOI 10.1016/j.jhazmat.2012.08.005; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Trabucco A., 2009, GLOBAL ARIDITY INDEX; U.S. Geological Survey-Energy Resources Program Central Energy Resources Science Center, 2015, WORLD GEOL MAPS; UN Environment Programme (UNEP), 2005, WAT QUAL 2005 STAT U; United Nations High Commissioner for Refugees (UNHCR), 2019, BOR GIS PORT; van Geen A, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001617; van Geen A, 2014, SCI TOTAL ENVIRON, V478, P21, DOI 10.1016/j.scitotenv.2014.01.073; Water Resources Consultants, 2004, 103520002001 TB DEP; WHO/UNICEF Joint Monitoring Program (JMP), 2019, GLOB DAT WAT SUPPL S; Winkel L, 2008, NAT GEOSCI, V1, P536, DOI 10.1038/ngeo254; Winkel LHE, 2011, P NATL ACAD SCI USA, V108, P1246, DOI 10.1073/pnas.1011915108; Yang NF, 2014, ENVIRON SCI TECHNOL, V48, P5660, DOI 10.1021/es405670g; Yang Q, 2012, ENVIRON SCI TECHNOL, V46, P2080, DOI 10.1021/es203793x; Zabala ME, 2016, J HYDROL, V541, P1067, DOI [10.1016/j.jhydrol.2016.08,023, 10.1016/j.jhydrol.2016.08.023]; Zhang Q, 2013, J HAZARD MATER, V262, P1147, DOI 10.1016/j.jhazmat.2013.02.017; Zheng Yan, 2017, Curr Environ Health Rep, V4, P373, DOI 10.1007/s40572-017-0157-9; Zheng Y, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP629; Zhou YZ, 2017, APPL GEOCHEM, V77, P116, DOI 10.1016/j.apgeochem.2016.09.005; Zomer, 2010, GLOBAL SOIL WATER BA	124	323	331	211	839	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					845	+		10.1126/science.aba1510	http://dx.doi.org/10.1126/science.aba1510			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU2DD	32439786	Green Accepted			2022-12-28	WOS:000537569500038
J	Hughes, D; Judge, C; Murphy, R; Loughlin, E; Costello, M; Whiteley, W; Bosch, J; O'Donnell, MJ; Canavan, M				Hughes, Diarmaid; Judge, Conor; Murphy, Robert; Loughlin, Elaine; Costello, Maria; Whiteley, William; Bosch, Jackie; O'Donnell, Martin J.; Canavan, Michelle			Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RISK-FACTORS; DOUBLE-BLIND; HYPERTENSION; PREVENTION; TRIAL; DECLINE; DISEASE; STROKE	Question Is there an association between blood pressure lowering with antihypertensive therapy and the incidence of dementia or cognitive impairment? Findings In this meta-analysis that included 12 trials with 92 135 participants for the primary outcome measure, blood pressure lowering with antihypertensive agents, compared with control, was associated with the development of a composite dementia or cognitive impairment outcome in 7.0% vs 7.5% of patients over a mean trial follow-up of 4.1 years, a difference that was statistically significant. Meaning Lowering blood pressure may be associated with a lower risk of dementia or cognitive impairment. Importance The benefit of blood pressure lowering for the prevention of dementia or cognitive impairment is unclear. Objective To determine the association of blood pressure lowering with dementia or cognitive impairment. Data Sources and Study Selection Search of PubMed, EMBASE, and CENTRAL for randomized clinical trials published from database inception through December 31, 2019, that evaluated the association of blood pressure lowering on cognitive outcomes. The control groups consisted of either placebo, alternative antihypertensive agents, or higher blood pressure targets. Data Extraction and Synthesis Data were screened and extracted independently by 2 authors. Random-effects meta-analysis models were used to report pooled treatment effects and CIs. Main Outcomes and Measures The primary outcome was dementia or cognitive impairment. The secondary outcomes were cognitive decline and changes in cognitive test scores. Results Fourteen randomized clinical trials were eligible for inclusion (96 158 participants), of which 12 reported the incidence of dementia (or composite of dementia and cognitive impairment [3 trials]) on follow-up and were included in the primary meta-analysis, 8 reported cognitive decline, and 8 reported changes in cognitive test scores. The mean (SD) age of trial participants was 69 (5.4) years and 40 617 (42.2%) were women. The mean systolic baseline blood pressure was 154 (14.9) mm Hg and the mean diastolic blood pressure was 83.3 (9.9) mm Hg. The mean duration of follow-up was 49.2 months. Blood pressure lowering with antihypertensive agents compared with control was significantly associated with a reduced risk of dementia or cognitive impairment (12 trials; 92 & x202f;135 participants) (7.0% vs 7.5% of patients over a mean trial follow-up of 4.1 years; odds ratio [OR], 0.93 [95% CI, 0.88-0.98]; absolute risk reduction, 0.39% [95% CI, 0.09%-0.68%]; I-2 = 0.0%) and cognitive decline (8 trials) (20.2% vs 21.1% of participants over a mean trial follow-up of 4.1 years; OR, 0.93 [95% CI, 0.88-0.99]; absolute risk reduction, 0.71% [95% CI, 0.19%-1.2%]; I-2 = 36.1%). Blood pressure lowering was not significantly associated with a change in cognitive test scores. Conclusions and Relevance In this meta-analysis of randomized clinical trials, blood pressure lowering with antihypertensive agents compared with control was significantly associated with a lower risk of incident dementia or cognitive impairment. This systematic review and meta-analysis examines whether blood pressure lowering is associated with a reduced risk of dementia or cognitive impairment.	[Hughes, Diarmaid; Judge, Conor; Murphy, Robert; Loughlin, Elaine; Costello, Maria; O'Donnell, Martin J.; Canavan, Michelle] NUI Galway, HRB Clin Res Facil, NUI Galway, Galway, Ireland; [Hughes, Diarmaid; Judge, Conor; Murphy, Robert; Loughlin, Elaine; Costello, Maria; O'Donnell, Martin J.; Canavan, Michelle] Saolta Univ Hosp Grp, Galway, Ireland; [Judge, Conor] NUI Galway, Translat Med Device Lab, Galway, Ireland; [Judge, Conor] Irish Clin Acad Training, Wellcome Trust HRB, Dublin, Ireland; [Whiteley, William] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Bosch, Jackie; O'Donnell, Martin J.] Populat Hlth Res Inst, Hamilton, ON, Canada	Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; University of Edinburgh; Population Health Research Institute	Canavan, M (corresponding author), Galway Univ Hosp, HRB Clin Res Facil, Newcastle Rd, Galway H91YR7, Ireland.	michelle.canavan@hse.ie	Bosch, Jacqueline/AAP-6910-2021; O'Donnell, Martin/ABE-7459-2020; Judge, Conor/L-7422-2018	Bosch, Jacqueline/0000-0001-6292-4207; O'Donnell, Martin/0000-0002-7347-7761; Whiteley, William/0000-0002-4816-8991; Murphy, Robert P/0000-0001-5446-4175; Judge, Conor/0000-0001-9473-2920	Irish Clinical Academic Training Programme; Wellcome Trust; Health Research Board [203930/B/16/Z]; Health Service Executive; National Doctors Training and Planning; Health and Social Care Research and Development Division Northern Ireland; European Research Council (COSIP) [640580]	Irish Clinical Academic Training Programme; Wellcome Trust(Wellcome Trust); Health Research Board; Health Service Executive; National Doctors Training and Planning; Health and Social Care Research and Development Division Northern Ireland; European Research Council (COSIP)	Dr Judge was supported by the Irish Clinical Academic Training Programme, the Wellcome Trust, the Health Research Board (grant number 203930/B/16/Z), the Health Service Executive, National Doctors Training and Planning, and the Health and Social Care Research and Development Division Northern Ireland. Dr O'Donnell was supported by the European Research Council (COSIP grant 640580).	Abell JG, 2018, EUR HEART J, V39, P3119, DOI 10.1093/eurheartj/ehy288; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Anderson C, 2011, LANCET NEUROL, V10, P43, DOI 10.1016/S1474-4422(10)70250-7; [Anonymous], WHO GLOB PLAN DEM; APPLEGATE WB, 1994, ARCH INTERN MED, V154, P2154, DOI 10.1001/archinte.154.19.2154; Atal I, 2019, J CLIN EPIDEMIOL, V111, P32, DOI 10.1016/j.jclinepi.2019.03.012; Bosch J, 2019, NEUROLOGY, V92, pE1435, DOI 10.1212/WNL.0000000000007174; de Galan BE, 2009, DIABETOLOGIA, V52, P2328, DOI 10.1007/s00125-009-1484-7; Dienert HC, 2008, LANCET NEUROL, V7, P875, DOI 10.1016/S1474-4422(08)70198-4; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Launer LJ, 2000, NEUROBIOL AGING, V21, P49, DOI 10.1016/S0197-4580(00)00096-8; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Marpillat NL, 2013, J HYPERTENS, V31, P1073, DOI 10.1097/HJH.0b013e3283603f53; McGuinness B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004034.pub3; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mukadam N, 2019, LANCET GLOB HEALTH, V7, pE596, DOI 10.1016/S2214-109X(19)30074-9; Nasrallah IM, 2019, JAMA-J AM MED ASSOC, V322, P524, DOI 10.1001/jama.2019.10551; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Park TH, 2015, J STROKE, V17, P302, DOI 10.5853/jos.2015.17.3.302; Pearce LA, 2014, LANCET NEUROL, V13, P1177, DOI 10.1016/S1474-4422(14)70224-8; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Peters R, 2019, NEUROLOGY, V92, P1017, DOI 10.1212/WNL.0000000000007543; Posner HB, 2002, NEUROLOGY, V58, P1175, DOI 10.1212/WNL.58.8.1175; Prince MJ, 1996, BMJ-BRIT MED J, V312, P801; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Tendal B, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4829; Tzourio C, 2003, ARCH INTERN MED, V163, P1069; van Middelaar T, 2018, J HYPERTENS, V36, P1780, DOI 10.1097/HJH.0000000000001829; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Whiteley WN, 2020, AGE AGEING, V49, P154, DOI 10.1093/ageing/afz152; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Williamson JD, 2019, JAMA-J AM MED ASSOC, V321, P553, DOI 10.1001/jama.2018.21442; Williamson JD, 2014, JAMA INTERN MED, V174, P324, DOI 10.1001/jamainternmed.2013.13656; Zonneveld TP, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007858.pub2	38	123	126	6	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2020	323	19					1934	1944		10.1001/jama.2020.4249	http://dx.doi.org/10.1001/jama.2020.4249			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LT2XF	32427305	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000536934300020
J	Kofler, N; Baylis, F				Kofler, Natalie; Baylis, Francoise			Ten reasons why immunity passports are a bad idea	NATURE			English	Editorial Material						SARS-CoV-2; Technology; Immunology; Public health; Policy		Restricting movement on the basis of biology threatens freedom, fairness and public health. Restricting movement on the basis of biology threatens freedom, fairness and public health.	[Kofler, Natalie] Harvard Med Sch, Global Initiat Editing Nat, Boston, MA 02115 USA; [Kofler, Natalie] Harvard Med Sch, Sci Citizenship Initiat, Boston, MA 02115 USA; [Baylis, Francoise] Dalhousie Univ, Philosophy Specializat Bioeth, Halifax, NS, Canada	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Dalhousie University	Kofler, N (corresponding author), Harvard Med Sch, Global Initiat Editing Nat, Boston, MA 02115 USA.; Kofler, N (corresponding author), Harvard Med Sch, Sci Citizenship Initiat, Boston, MA 02115 USA.	natalie.kofler@hms.harvard.edu	Baylis, Francoise/AAP-4565-2021					Baylis F, 2008, PUBLIC HEALTH ETH-UK, V1, P196, DOI 10.1093/phe/phn025; Bocquier A, 2017, EXPERT REV VACCINES, V16, P1107, DOI 10.1080/14760584.2017.1381020; Clayton EW, 2019, J LAW BIOSCI, V6, P1, DOI 10.1093/jlb/lsz007; Fraser B, 2020, LANCET, V395, P1473, DOI 10.1016/S0140-6736(20)31096-5; Ienca M, 2020, NAT MED, V26, P463, DOI 10.1038/s41591-020-0832-5; Olivarius K, 2019, AM HIST REV, V124, P425, DOI 10.1093/ahr/rhz176; Phelan AL, 2020, LANCET, V395, P1595, DOI 10.1016/S0140-6736(20)31034-5; Southall Ashley, 2020, NEW YORK TIMES	8	72	73	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY	2020	581	7809					379	381		10.1038/d41586-020-01451-0	http://dx.doi.org/10.1038/d41586-020-01451-0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ1VO	32439992				2022-12-28	WOS:000534798900002
J	Pleiner, T; Tomaleri, GP; Januszyk, K; Inglis, AJ; Hazu, M; Voorhees, RM				Pleiner, Tino; Tomaleri, Giovani Pinton; Januszyk, Kurt; Inglis, Alison J.; Hazu, Masami; Voorhees, Rebecca M.			Structural basis for membrane insertion by the human ER membrane protein complex	SCIENCE			English	Article							CRYO-EM; RECOGNITION; IDENTIFICATION; TRANSLOCATION; MODULATION; PREDICTION; SYSTEM	A defining step in the biogenesis of a membrane protein is the insertion of its hydrophobic transmembrane helices into the lipid bilayer. The nine-subunit endoplasmic reticulum (ER) membrane protein complex (EMC) is a conserved co- and posttranslational insertase at the ER. We determined the structure of the human EMC in a lipid nanodisc to an overall resolution of 3.4 angstroms by cryo-electron microscopy, permitting building of a nearly complete atomic model. We used structure-guided mutagenesis to demonstrate that substrate insertion requires a methionine-rich cytosolic loop and occurs via an enclosed hydrophilic vestibule within the membrane formed by the subunits EMC3 and EMC6. We propose that the EMC uses local membrane thinning and a positively charged patch to decrease the energetic barrier for insertion into the bilayer.	[Pleiner, Tino; Tomaleri, Giovani Pinton; Januszyk, Kurt; Inglis, Alison J.; Hazu, Masami; Voorhees, Rebecca M.] CALTECH, Div Biol & Biol Engn, 1200 E Calif Ave, Pasadena, CA 91125 USA	California Institute of Technology	Voorhees, RM (corresponding author), CALTECH, Div Biol & Biol Engn, 1200 E Calif Ave, Pasadena, CA 91125 USA.	voorhees@caltech.edu		Pleiner, Tino/0000-0002-5104-0315; Inglis, Alison/0000-0002-9008-8565; VOORHEES, REBECCA/0000-0003-1640-2293	Heritage Medical Research Institute; Kinship Foundation; Pew-Stewart Foundation; NIH's National Institute of General Medical Sciences [DP2GM137412]; Deutsche Forschungsgemeinschaft	Heritage Medical Research Institute; Kinship Foundation; Pew-Stewart Foundation; NIH's National Institute of General Medical Sciences; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Heritage Medical Research Institute, the Kinship Foundation, the Pew-Stewart Foundation, and the NIH's National Institute of General Medical Sciences (DP2GM137412). T.P. is funded by a postdoctoral fellowship from the Deutsche Forschungsgemeinschaft.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Anghel SA, 2017, CELL REP, V21, P3708, DOI 10.1016/j.celrep.2017.12.006; Aviram N, 2016, NATURE, V540, P134, DOI 10.1038/nature20169; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Borowska MT, 2015, STRUCTURE, V23, P1715, DOI 10.1016/j.str.2015.06.025; Carvalho HJF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48363-2; Casanal A, 2020, PROTEIN SCI, V29, P1069, DOI 10.1002/pro.3791; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YY, 2017, STRUCTURE, V25, P1403, DOI 10.1016/j.str.2017.07.008; Chitwood PJ, 2019, TRENDS CELL BIOL, V29, P371, DOI 10.1016/j.tcb.2019.01.007; Chitwood PJ, 2018, CELL, V175, P1507, DOI 10.1016/j.cell.2018.10.009; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fairhead Michael, 2015, Methods Mol Biol, V1266, P171, DOI 10.1007/978-1-4939-2272-7_12; Frey S, 2014, J CHROMATOGR A, V1337, P95, DOI 10.1016/j.chroma.2014.02.029; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Guna A, 2018, CURR BIOL, V28, pR498, DOI 10.1016/j.cub.2018.02.004; Guna A, 2018, SCIENCE, V359, P470, DOI 10.1126/science.aao3099; Harel T, 2016, AM J HUM GENET, V98, P562, DOI 10.1016/j.ajhg.2016.01.011; Hennon SW, 2015, J BIOL CHEM, V290, P14866, DOI 10.1074/jbc.R115.638171; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Ho CM, 2020, NAT METHODS, V17, P79, DOI 10.1038/s41592-019-0637-y; Inglis AJ, 2020, CELL REP, V30, P3691, DOI 10.1016/j.celrep.2020.02.084; Itakura E, 2016, MOL CELL, V63, P21, DOI 10.1016/j.molcel.2016.05.020; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumazaki K, 2014, NATURE, V509, P516, DOI 10.1038/nature13167; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liu L, 2008, PROTEIN EXPRES PURIF, V62, P21, DOI 10.1016/j.pep.2008.07.010; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Noinaj N, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2016.191; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pleiner T, 2018, J CELL BIOL, V217, P1143, DOI 10.1083/jcb.201709115; Pleiner T, 2015, ELIFE, V4, DOI [10.7554/eLife.11349, 10.7554/eLife.15597]; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rodriguez AV, 2019, J CELL BIOL, V218, P2006, DOI 10.1083/jcb.201812091; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shao SC, 2017, SCIENCE, V355, P298, DOI 10.1126/science.aah6130; Sharma A, 2010, METHODS MOL BIOL, V619, P339, DOI 10.1007/978-1-60327-412-8_20; Shurtleffn MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37018; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Tian SH, 2019, CELL REP, V28, P2517, DOI 10.1016/j.celrep.2019.08.006; Volkmar N, 2019, J CELL SCI, V132, DOI 10.1242/jcs.223453; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Wideman Jeremy G, 2015, F1000Res, V4, P624, DOI 10.12688/f1000research.6944.1; Wu XD, 2020, SCIENCE, V368, P385, DOI 10.1126/science.aaz2449; Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]; Yang JY, 2020, P NATL ACAD SCI USA, V117, P1496, DOI 10.1073/pnas.1914677117; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	63	52	52	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2020	369	6502					433	+		10.1126/science.abb5008	http://dx.doi.org/10.1126/science.abb5008			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV3MR	32439656	Green Accepted, Bronze			2022-12-28	WOS:000556265800043
J	Friebel, E; Kapolou, K; Unger, S; Nunez, NG; Utz, S; Rushing, EJ; Regli, L; Weller, M; Greter, M; Tugues, S; Neidert, MC; Becher, B				Friebel, Ekaterina; Kapolou, Konstantina; Unger, Susanne; Nunez, Nicolas Gonzalo; Utz, Sebastian; Rushing, Elisabeth Jane; Regli, Luca; Weller, Michael; Greter, Melanie; Tugues, Sonia; Neidert, Marian Christoph; Becher, Burkhard			Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; INFILTRATING LYMPHOCYTES; MACROPHAGE ONTOGENY; MASS CYTOMETRY; IMMUNE; MICROGLIA; GLIOBLASTOMA; VISUALIZATION; POLARIZATION; EXPRESSION	Brain malignancies can either originate from within the CNS (gliomas) or invade from other locations in the body (metastases). A highly immunosuppressive tumor microenvironment (TME) influences brain tumor outgrowth. Whether the TME is predominantly shaped by the CNS micromilieu or by the malignancy itself is unknown, as is the diversity, origin, and function of CNS tumor-associated macrophages (TAMs). Here, we have mapped the leukocyte landscape of brain tumors using high-dimensional single-cell profiling (Cy-TOF). The heterogeneous composition of tissue-resident and invading immune cells within the TME alone permitted a clear distinction between gliomas and brain metastases (BrM). The glioma TME presented predominantly with tissue-resident, reactive microglia, whereas tissue-invading leukocytes accumulated in BrM. Tissue-invading TAMs showed a distinctive signature trajectory, revealing tumor-driven instruction along with contrasting lymphocyte activation and exhaustion. Defining the specific immunological signature of brain tumors can facilitate the rational design of targeted immunotherapy strategies.	[Friebel, Ekaterina; Unger, Susanne; Nunez, Nicolas Gonzalo; Utz, Sebastian; Greter, Melanie; Tugues, Sonia; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland; [Kapolou, Konstantina; Weller, Michael; Neidert, Marian Christoph] Univ Hosp Zurich, Clin Neurosci Ctr, Dept Neurol, Lab Mol Neurooncol, CH-8091 Zurich, Switzerland; [Kapolou, Konstantina; Rushing, Elisabeth Jane; Regli, Luca; Weller, Michael; Neidert, Marian Christoph] Univ Zurich, CH-8091 Zurich, Switzerland; [Regli, Luca; Neidert, Marian Christoph] Univ Hosp Zurich, Clin Neurosci Ctr, Dept Neurosurg, CH-8091 Zurich, Switzerland; [Rushing, Elisabeth Jane] Univ Hosp Zurich, Dept Neuropathol, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland.	becher@immunology.uzh.ch	Becher, Burkhard/ABE-4225-2020; Friebel, Ekaterina/ABF-1308-2021	Becher, Burkhard/0000-0002-1541-7867; Friebel, Ekaterina/0000-0003-1419-2376; Greter, Melanie/0000-0002-7220-5369; Unger, Susanne/0000-0001-6916-7544	Swiss Cancer League [KFS-4431-02-2018]; Swiss National Science Foundation [733310030_170320, 310030_188450, CRSII5_183478]; European Union [826121]; Clinical Research Priority Program ImmunoCure; University Research Priority Program Translational Cancer Research of the University of Zurich	Swiss Cancer League; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); Clinical Research Priority Program ImmunoCure; University Research Priority Program Translational Cancer Research of the University of Zurich	Sall1CreER mice were kindly provided by R. Nishinakamura (Kumamoto University). We thank the Mass-and Flow Cytometry Facility (University of Zurich) for technical assistance, the Department of Neuropathology (University Hospital Zurich and University of Zurich) for performing immunohistochemistry staining, and Helen Pickersgill of Life Science Editors for critical review and editing of the manuscript. This work was supported by grants from the Swiss Cancer League (KFS-4431-02-2018), the Swiss National Science Foundation (733310030_170320, 310030_188450, and CRSII5_183478) to B.B., the European Union H2020 Project iPC (826121 to B.B.), the Clinical Research Priority Program ImmunoCure (to B.B., M.W., and M.C.N.), and the University Research Priority Program Translational Cancer Research of the University of Zurich (to B.B. and M.W.).	Aldape K, 2019, NAT REV CLIN ONCOL, V16, P509, DOI 10.1038/s41571-019-0177-5; Amankulor NM, 2017, GENE DEV, V31, P774, DOI 10.1101/gad.294991.116; Amit M, 2013, CANCER MED-US, V2, P155, DOI 10.1002/cam4.45; An J, 2017, MICRO NANO TECHNOL, P1, DOI 10.1016/B978-0-323-41481-4.00001-0; [Anonymous], 2019, GPLOTS STAT PACKAGE; [Anonymous], 2020, UMAP UNIFORM MANIFOL; Bastian M., 2009, ICWSM, V3, P361, DOI 10.13140/2.1.1341.1520; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Berghoff AS, 2017, NEURO-ONCOLOGY, V19, P1460, DOI 10.1093/neuonc/nox054; Berghoff AS, 2015, NEURO-ONCOLOGY, V17, P1064, DOI 10.1093/neuonc/nou307; Bienkowski M, 2015, CURR OPIN NEUROL, V28, P647, DOI 10.1097/WCO.0000000000000251; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Bouffet E, 2016, J CLIN ONCOL, V34, P2206, DOI 10.1200/JCO.2016.66.6552; Bowman RL, 2016, CELL REP, V17, P2445, DOI 10.1016/j.celrep.2016.10.052; Buja A, 2008, J COMPUT GRAPH STAT, V17, P444, DOI 10.1198/106186008X318440; Bunse L, 2018, NAT MED, V24, P1192, DOI 10.1038/s41591-018-0095-6; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Chen ZH, 2017, CANCER RES, V77, P2266, DOI 10.1158/0008-5472.CAN-16-2310; Cheng Y, 2016, J IMMUNOL, V196, P924, DOI 10.4049/jimmunol.1501928; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Daniel P, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00041; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Eisenring M, 2010, NAT IMMUNOL, V11, P1030, DOI 10.1038/ni.1947; Ellis B., 2019, FLOWCORE BASIC STRUC; Field A., 2013, FLOWWORKSPACEDATA DA; Field A., 2013, DISCOVERING STAT USI; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Forrester JV, 2018, NAT REV NEUROSCI, V19, P655, DOI 10.1038/s41583-018-0070-8; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldberg SB, 2016, LANCET ONCOL, V17, P976, DOI 10.1016/S1470-2045(16)30053-5; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Good Z, 2019, NAT BIOTECHNOL, V37, P259, DOI 10.1038/s41587-019-0033-2; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Hahne F., 2020, FLOWSTATS STAT METHO; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Harrell F.E., 2020, CONTRIBUTIONS CHARLE; Harter PN, 2015, ONCOTARGET, V6, P40836, DOI 10.18632/oncotarget.5696; Hartmann FJ, 2016, J EXP MED, V213, P2621, DOI 10.1084/jem.20160897; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hopperton K, 2018, MOL PSYCHIATR, V23, P177, DOI 10.1038/mp.2017.246; Inoue S, 2010, GENESIS, V48, P207, DOI 10.1002/dvg.20603; Jacob F, 2020, CELL, V180, P188, DOI 10.1016/j.cell.2019.11.036; Jacobs JFM, 2010, J NEUROIMMUNOL, V225, P195, DOI 10.1016/j.jneuroim.2010.05.020; Johanns TM, 2016, CANCER DISCOV, V6, P1230, DOI 10.1158/2159-8290.CD-16-0575; Keenan TE, 2019, NAT MED, V25, P389, DOI 10.1038/s41591-019-0382-x; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kiss M, 2018, CELL IMMUNOL, V330, P188, DOI 10.1016/j.cellimm.2018.02.008; Kluger HM, 2019, J CLIN ONCOL, V37, P52, DOI 10.1200/JCO.18.00204; Kohanbash G, 2017, J CLIN INVEST, V127, P1425, DOI 10.1172/JCI90644; Kolde R, 2019, PACKAGE PHEATMAPR PA; KUPPNER MC, 1988, INT J CANCER, V42, P562, DOI 10.1002/ijc.2910420416; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Mei HE, 2016, CYTOM PART A, V89A, P292, DOI 10.1002/cyto.a.22778; Miyai M, 2017, J NEURO-ONCOL, V135, P423, DOI 10.1007/s11060-017-2626-2; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Mrdjen D, 2017, METHODS MOL BIOL, V1559, P321, DOI 10.1007/978-1-4939-6786-5_22; Muller S, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1362-4; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Nowicka Malgorzata, 2017, F1000Res, V6, P748, DOI 10.12688/f1000research.11622.3; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Quail DF, 2016, SCIENCE, V352, DOI 10.1126/science.aad3018; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; RStudio, 2021, RSTUDIO INT DEV ENV; Samusik N, 2016, NAT METHODS, V13, P493, DOI [10.1038/NMETH.3863, 10.1038/nmeth.3863]; Sankowski R, 2019, NAT NEUROSCI, V22, P2098, DOI 10.1038/s41593-019-0532-y; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schulz D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38127-9; Shi Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15080; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Smolders J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07053-9; Spitzer MH, 2015, SCIENCE, V349, DOI 10.1126/science.1259425; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Takasato M, 2004, MECH DEVELOP, V121, P547, DOI 10.1016/j.mod.2004.04.007; Takenaka MC, 2019, NAT NEUROSCI, V22, P729, DOI 10.1038/s41593-019-0370-y; Tawbi HA, 2018, NEW ENGL J MED, V379, P722, DOI 10.1056/NEJMoa1805453; Team RC., 2022, LANG ENV STAT COMP; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; Tugues S, 2019, SEMIN IMMUNOL, V41, DOI 10.1016/j.smim.2019.03.002; Uhl M, 2004, CANCER RES, V64, P7954, DOI 10.1158/0008-5472.CAN-04-1013; Unruh D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45346-1; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Van Hove H, 2019, NAT NEUROSCI, V22, P1021, DOI 10.1038/s41593-019-0393-4; Venteicher AS, 2017, SCIENCE, V355, DOI 10.1126/science.aai8478; Walker DG, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0139-9; Wickham H., 2019, GGPLOT2 CREATE ELEGA; Wickham H., 2020, DPLYR GRAMMAR DATA M; Woroniecka Karolina, 2018, Oncotarget, V9, P35287, DOI 10.18632/oncotarget.26228; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Zhou WC, 2015, NAT CELL BIOL, V17, P170, DOI 10.1038/ncb3090; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	102	211	212	18	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2020	181	7					1626	+		10.1016/j.cell.2020.04.055	http://dx.doi.org/10.1016/j.cell.2020.04.055			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MD2SA	32470397	Bronze			2022-12-28	WOS:000543822100018
J	Campbell, TL				Campbell, Thomas L.			Screening for Adverse Childhood Experiences (ACEs) in Primary Care A Cautionary Note	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH	This Viewpoint discusses the effects that adverse childhood experiences (ACEs) can have on long-term mental and physical health and reviews the potential benefits and harms of screening for ACEs in primary care settings.	[Campbell, Thomas L.] Univ Rochester, Sch Med & Dent, Dept Family Med, 777 S Clinton Ave, Rochester, NY 14618 USA	University of Rochester	Campbell, TL (corresponding author), Univ Rochester, Sch Med & Dent, Dept Family Med, 777 S Clinton Ave, Rochester, NY 14618 USA.	tom_campbell@urmc.rochester.edu						Bellis MA, 2019, LANCET PUBLIC HEALTH, V4, pE517, DOI 10.1016/S2468-2667(19)30145-8; Deighton S, 2018, PSYCHIAT RES, V269, P719, DOI 10.1016/j.psychres.2018.08.097; Dobrow MJ, 2018, CAN MED ASSOC J, V190, pE422, DOI 10.1503/cmaj.171154; Ford K, 2019, CHILD ABUSE NEGLECT, V91, P131, DOI 10.1016/j.chiabu.2019.03.007; Garner AS, 2012, PEDIATRICS, V129, pE224, DOI 10.1542/peds.2011-2662; Hughes K, 2017, LANCET PUBLIC HEALTH, V2, pE356, DOI 10.1016/S2468-2667(17)30118-4; Oral R, 2016, PEDIATR RES, V79, P227, DOI 10.1038/pr.2015.197; Vig KD, 2020, ADVERSE CHILDHOOD EXPERIENCES: USING EVIDENCE TO ADVANCE RESEARCH, PRACTICE, POLICY, AND PREVENTION, P71, DOI 10.1016/B978-0-12-816065-7.00005-7	8	34	34	3	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2020	323	23					2379	2380		10.1001/jama.2020.4365	http://dx.doi.org/10.1001/jama.2020.4365			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MC6EC	32463425				2022-12-28	WOS:000543376700016
J	Gorelick, AN; Sanchez-Rivera, FJ; Cai, YY; Bielski, CM; Biederstedt, E; Jonsson, P; Richards, AL; Vasan, N; Penson, AV; Friedman, ND; Ho, YJ; Baslan, T; Bandlamudi, C; Scaltriti, M; Schultz, N; Lowe, SW; Reznik, E; Taylor, BS				Gorelick, Alexander N.; Sanchez-Rivera, Francisco J.; Cai, Yanyan; Bielski, Craig M.; Biederstedt, Evan; Jonsson, Philip; Richards, Allison L.; Vasan, Neil; Penson, Alexander, V; Friedman, Noah D.; Ho, Yu-Jui; Baslan, Timour; Bandlamudi, Chaitanya; Scaltriti, Maurizio; Schultz, Nikolaus; Lowe, Scott W.; Reznik, Ed; Taylor, Barry S.			Phase and context shape the function of composite oncogenic mutations	NATURE			English	Article							LUNG-CANCER; TERT PROMOTER; SIGNATURES; SEQUENCE; BINDING; SEARCH; REPAIR	Cancers develop as a result of driver mutations(1,2) that lead to clonal outgrowth and the evolution of disease(3,4). The discovery and functional characterization of individual driver mutations are central aims of cancer research, and have elucidated myriad phenotypes(5) and therapeutic vulnerabilities(6). However, the serial genetic evolution of mutant cancer genes(7,8) and the allelic context in which they arise is poorly understood in both common and rare cancer genes and tumour types. Here we find that nearly one in four human tumours contains a composite mutation of a cancer-associated gene, defined as two or more nonsynonymous somatic mutations in the same gene and tumour. Composite mutations are enriched in specific genes, have an elevated rate of use of less-common hotspot mutations acquired in a chronology driven in part by oncogenic fitness, and arise in an allelic configuration that reflects context-specific selective pressures. cis-acting composite mutations are hypermorphic in some genes in which dosage effects predominate (such as TERT), whereas they lead to selection of function in other genes (such as TP53). Collectively, composite mutations are driver alterations that arise from context- and allele-specific selective pressures that are dependent in part on gene and mutation function, and which lead to complex-often neomorphic-functions of biological and therapeutic importance.	[Gorelick, Alexander N.; Bielski, Craig M.; Vasan, Neil; Penson, Alexander, V; Friedman, Noah D.; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Gorelick, Alexander N.; Bielski, Craig M.; Biederstedt, Evan; Penson, Alexander, V; Friedman, Noah D.; Schultz, Nikolaus; Reznik, Ed; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Sanchez-Rivera, Francisco J.; Ho, Yu-Jui; Baslan, Timour; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Cai, Yanyan; Scaltriti, Maurizio] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Jonsson, Philip; Richards, Allison L.; Bandlamudi, Chaitanya; Schultz, Nikolaus; Reznik, Ed; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA; [Vasan, Neil] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Schultz, Nikolaus; Taylor, Barry S.] Weill Cornell Med Coll, New York, NY 10065 USA; [Lowe, Scott W.] Howard Hughes Med Inst, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Howard Hughes Medical Institute	Taylor, BS (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Reznik, E; Taylor, BS (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA.; Reznik, E; Taylor, BS (corresponding author), Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA.; Taylor, BS (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.	reznike@mskcc.org; taylorb@mskcc.org	Schultz, Nikolaus/ABE-6347-2020; Sánchez-Rivera, Francisco J./AAV-6985-2020; Vasan, Neil/AAD-6718-2021	Sánchez-Rivera, Francisco J./0000-0002-8466-8563; Cai, Yanyan/0000-0002-2779-6163; Ho, Yu-jui/0000-0002-7540-024X; Gorelick, Alexander/0000-0001-6736-8246	National Institutes of Health [P30 CA008748, P01 CA087497, U54 OD020355, R01 CA207244, R01 CA204749, R01 CA245069]; Brown Performance Group ICI Fund; Society of MSK; American Cancer Society; Josie Robertson Foundation; MSKCC Translational Research Oncology Training Fellowship [T32-CA160001]; Anna Fuller Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown Performance Group ICI Fund; Society of MSK; American Cancer Society(American Cancer Society); Josie Robertson Foundation; MSKCC Translational Research Oncology Training Fellowship; Anna Fuller Fund	We thank the members of the E.R. and B.S.T. laboratories for discussion and support. This work was supported by National Institutes of Health awards P30 CA008748, P01 CA087497 (S.W.L.), U54 OD020355 (S.W.L. and B.S.T.), R01 CA207244 (B.S.T.), R01 CA204749 (B.S.T.), R01 CA245069 (B.S.T.); Brown Performance Group ICI Fund (N.V. and E.R.), Society of MSK (N.V. and E.R.), American Cancer Society, Anna Fuller Fund and the Josie Robertson Foundation (B.S.T.). F.J.S.-R. is an HHMI Hanna Gray Fellow supported in part by an MSKCC Translational Research Oncology Training Fellowship (T32-CA160001). S.W.L. is an investigator of the Howard Hughes Medical Institute.	Alexandrov LB, 2020, NATURE, V578, P94, DOI 10.1038/s41586-020-1943-3; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Bell RJA, 2015, SCIENCE, V348, P1036, DOI 10.1126/science.aab0015; Berenjeno IM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02002-4; Bielski CM, 2018, CANCER CELL, V34, P852, DOI 10.1016/j.ccell.2018.10.003; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buisson R, 2019, SCIENCE, V364, P1251, DOI 10.1126/science.aaw2872; Bult CJ, 2019, NUCLEIC ACIDS RES, V47, pD801, DOI 10.1093/nar/gky1056; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Campbell BB, 2017, CELL, V171, P1042, DOI 10.1016/j.cell.2017.09.048; Chakravarty Debyani, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00011; Chang MT, 2018, CANCER DISCOV, V8, P174, DOI 10.1158/2159-8290.CD-17-0321; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Chen Z, 2008, ONCOGENE, V27, P4336, DOI 10.1038/onc.2008.71; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Dimitrova N, 2016, CANCER DISCOV, V6, P188, DOI 10.1158/2159-8290.CD-15-0854; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gainor JF, 2016, CANCER DISCOV, V6, P1118, DOI 10.1158/2159-8290.CD-16-0596; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hess JM, 2019, CANCER CELL, V36, P288, DOI 10.1016/j.ccell.2019.08.002; Hidaka N, 2017, LUNG CANCER, V108, P75, DOI 10.1016/j.lungcan.2017.02.019; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Hyman DM, 2017, CELL, V168, P584, DOI 10.1016/j.cell.2016.12.015; Hyman DM, 2015, DRUG DISCOV TODAY, V20, P1422, DOI 10.1016/j.drudis.2015.08.005; Intlekofer AM, 2018, NATURE, V559, P125, DOI 10.1038/s41586-018-0251-7; Jin GL, 2013, CANCER RES, V73, P496, DOI 10.1158/0008-5472.CAN-12-2852; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kinross KM, 2012, J CLIN INVEST, V122, P553, DOI 10.1172/JCI59309; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madsen RR, 2019, P NATL ACAD SCI USA, V116, P8380, DOI 10.1073/pnas.1821093116; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; Middha S, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00084; Mueller S, 2018, NATURE, V554, P62, DOI 10.1038/nature25459; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Niu BF, 2014, BIOINFORMATICS, V30, P1015, DOI 10.1093/bioinformatics/btt755; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pich O, 2018, CELL, V175, P1074, DOI 10.1016/j.cell.2018.10.004; Sabarinathan R, 2016, NATURE, V532, P264, DOI 10.1038/nature17661; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Supek F, 2017, CELL, V170, P534, DOI 10.1016/j.cell.2017.07.003; Tan G, 2016, BIOINFORMATICS, V32, P1555, DOI 10.1093/bioinformatics/btw024; Touzet H, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-15; Vasan N, 2019, SCIENCE, V366, P714, DOI 10.1126/science.aaw9032; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333	54	15	15	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2020	582	7810					100	+		10.1038/s41586-020-2315-8	http://dx.doi.org/10.1038/s41586-020-2315-8			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE2YU	32461694	Green Accepted			2022-12-28	WOS:000562464400002
J	Yozamp, N; Hornick, JL; Chiodo, CP; Miller, AL; Loscalzo, J				Yozamp, Nicholas; Hornick, Jason L.; Chiodo, Christopher P.; Miller, Amy L.; Loscalzo, Joseph			The Game Is Afoot	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TUMOR-INDUCED OSTEOMALACIA; LOCALIZATION; SERIES; PET/CT		[Yozamp, Nicholas; Miller, Amy L.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Hornick, Jason L.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Chiodo, Christopher P.] Brigham & Womens Hosp, Dept Orthoped Surg, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Miller, AL (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	almiller@partners.org	Loscalzo, Joseph/ABD-8980-2021					Agrawal K, 2015, CLIN NUCL MED, V40, pE6, DOI 10.1097/RLU.0000000000000460; Andreopoulou P, 2011, J BONE MINER RES, V26, P1295, DOI 10.1002/jbmr.316; Chong WH, 2013, J BONE MINER RES, V28, P1386, DOI 10.1002/jbmr.1881; Chong WH, 2011, ENDOCR-RELAT CANCER, V18, pR53, DOI 10.1530/ERC-11-0006; Day AL, 2020, JOINT BONE SPINE, V87, P81, DOI 10.1016/j.jbspin.2019.07.012; El-Maouche D, 2016, J CLIN ENDOCR METAB, V101, P3575, DOI 10.1210/jc.2016-2052; Hesse E, 2007, NEW ENGL J MED, V357, P422, DOI 10.1056/NEJMc070347; Houang M, 2013, HUM PATHOL, V44, P2711, DOI 10.1016/j.humpath.2013.07.016; Jadhav S, 2014, CLIN ENDOCRINOL, V81, P31, DOI 10.1111/cen.12426; Lee JC, 2016, MODERN PATHOL, V29, P1335, DOI 10.1038/modpathol.2016.137; Li X, 2020, J BONE MINER RES, V35, P469, DOI 10.1002/jbmr.3903; Smith ER, 2012, J CLIN ENDOCR METAB, V97, P3357, DOI 10.1210/jc.2012-1811; Tarasova VD, 2013, J CLIN ENDOCR METAB, V98, P4267, DOI 10.1210/jc.2013-2528; Tella SH, 2017, J BONE MINER RES, V32, P2248, DOI 10.1002/jbmr.3219; WALTON RJ, 1975, LANCET, V2, P309, DOI 10.1016/S0140-6736(75)92736-1	15	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2020	382	23					2249	2255		10.1056/NEJMcps1913599	http://dx.doi.org/10.1056/NEJMcps1913599			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LV0NI	32492308				2022-12-28	WOS:000538140600019
J	Singh, H; Sittig, DF				Singh, Hardeep; Sittig, Dean F.			A Sociotechnical Framework for Safety-Related Electronic Health Record Research Reporting: The SAFER Reporting Framework	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIAN ORDER ENTRY; CLINICAL DECISION-SUPPORT; PATIENT SAFETY; FOLLOW-UP; MISSED OPPORTUNITIES; INFORMATICS; IMPLEMENTATION; EDUCATION; IMPACT; TECHNOLOGY	Electronic health record (EHR)-based interventions to improve patient safety are complex and sensitive to who, what, where, why, when, and how they are delivered. Success or failure depends not only on the characteristics and behaviors of individuals who are targeted by an intervention, but also on the technical characteristics of the intervention and the culture and environment of the health system that implements it. Current reporting guidelines do not capture the complexity of sociotechnical factors (technical and nontechnical factors, such as workflow and organizational issues) that confound or influence these interventions. This article proposes a methodological reporting framework for EHR interventions targeting patient safety and builds on an 8-dimension sociotechnical model previously developed by the authors for design, development, implementation, use, and evaluation of health information technology. The Safety-related EHR Research (SAFER) Reporting Framework enables reporting of patient safety-focused EHR-based interventions while accounting for the multifaceted, dynamic sociotechnical context affecting intervention implementation, effectiveness, and generalizability. As an example, an EHR-based intervention to improve communication and timely follow-up of subcritical abnormal test results to operationalize the framework is presented. For each dimension, reporting should include what sociotechnical changes were made to implement an EHR-related intervention to improve patient safety, why the intervention did or did not lead to safety improvements, and how this intervention can be applied or exported to other health care organizations. A foundational list of research and reporting recommendations to address implementation, effectiveness, and generalizability of EHR-based interventions needed to effectively reduce preventable patient harm is provided. The SAFER Reporting Framework is not meant to replace previous research reporting guidelines, but rather provides a sociotechnical adjunct that complements their use.	[Singh, Hardeep] Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety, Houston, TX 77030 USA; [Singh, Hardeep] Baylor Coll Med, Houston, TX 77030 USA; [Sittig, Dean F.] Univ Texas Hlth Sci Ctr Houston, Univ Texas Mem Hermann Ctr Healthcare Qual & Safe, Sch Biomed Informat, Houston, TX 77030 USA; [Sittig, Dean F.] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, 7000 Fannin St,Suite 600, Houston, TX 77030 USA; [Singh, Hardeep] Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety 152, 2002 Holcombe Blvd 152, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Singh, H (corresponding author), Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety 152, 2002 Holcombe Blvd 152, Houston, TX 77030 USA.	hardeeps@bcm.edu	Sittig, Dean F./D-2471-2009	Sittig, Dean F./0000-0001-5811-8915	Veterans Affairs (VA) Health Services Research and Development Service (HSRD) [CRE-12-033]; Veterans Affairs (VA) Health Services Research and Development Service (HSRAMP;D) (Presidential Early Career Award for Scientists and Engineers USA ) [14-274]; Agency for Healthcare Research and Quality [R01HS022087, P30HS024459, R18HS017820]; VA National Center for Patient Safety; Houston VA HSRAMP;D Center for Innovations in Quality, Effectiveness, and Safety [CIN 13-413]; Gordon and Betty Moore Foundation	Veterans Affairs (VA) Health Services Research and Development Service (HSRD); Veterans Affairs (VA) Health Services Research and Development Service (HSRAMP;D) (Presidential Early Career Award for Scientists and Engineers USA ); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); VA National Center for Patient Safety; Houston VA HSRAMP;D Center for Innovations in Quality, Effectiveness, and Safety; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	Dr. Singh's research that informs this work was funded by the Veterans Affairs (VA) Health Services Research and Development Service (HSR&D) (CRE-12-033 and the Presidential Early Career Award for Scientists and Engineers USA 14-274), the Agency for Healthcare Research and Quality (R01HS022087, P30HS024459, and R18HS017820), the VA National Center for Patient Safety, the Houston VA HSR&D Center for Innovations in Quality, Effectiveness, and Safety (CIN 13-413), and the Gordon and Betty Moore Foundation. Dr. Sittig was supported in part by the Agency for Healthcare Research and Quality (P30HS024459).	Ash Joan S, 2007, AMIA Annu Symp Proc, P26; Baker DP, 2005, JT COMM J QUAL PATIE, V31, P185, DOI 10.1016/S1553-7250(05)31025-7; Barnett ML, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3835; Barnett ML, 2016, J GEN INTERN MED, V31, P343, DOI 10.1007/s11606-015-3516-y; Bates DW, 1999, J AM MED INFORM ASSN, V6, P313, DOI 10.1136/jamia.1999.00660313; Bobb AM, 2007, J AM MED INFORM ASSN, V14, P41, DOI 10.1197/jamia.M2184; Campbell EM, 2006, J AM MED INFORM ASSN, V13, P547, DOI 10.1197/jamia.M2042; Chassin MR, 2013, MILBANK Q, V91, P459, DOI 10.1111/1468-0009.12023; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Cresswell K, 2017, INT J PHARM PRACT, V25, P5, DOI 10.1111/ijpp.12274; Davidoff F, 2005, QUAL SAF HEALTH CARE, V14, P319, DOI 10.1136/qshc.2005.014787; Detmer DE, 2014, JAMA-J AM MED ASSOC, V311, P2067, DOI 10.1001/jama.2014.3514; Feldstein AC, 2006, ARCH INTERN MED, V166, P1009, DOI 10.1001/archinte.166.9.1009; Fiks AG, 2009, PEDIATRICS, V124, P159, DOI 10.1542/peds.2008-2823; Giardina TD, 2018, J AM MED INFORM ASSN, V25, P440, DOI 10.1093/jamia/ocx140; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Griebel L, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0145-7; Holden RJ, 2011, J PATIENT SAF, V7, P193, DOI 10.1097/PTS.0b013e3182388cfa; Hysong SJ, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-84; Kannry J, 2016, APPL CLIN INFORM, V7, P143, DOI 10.4338/ACI-2015-12-R-0174; Koppel R, 2015, J AM MED INFORM ASSN, V22, P465, DOI 10.1136/amiajnl-2014-003023; Kulikowski CA, 2012, J AM MED INFORM ASSN, V19, P931, DOI 10.1136/amiajnl-2012-001053; Laxmisan A, 2012, MED CARE, V50, P898, DOI 10.1097/MLR.0b013e31825f6619; Lee KH, 2012, HEALTHC INFORM RES, V18, P266, DOI 10.4258/hir.2012.18.4.266; McEvoy DS, 2017, J AM MED INFORM ASSN, V24, P331, DOI 10.1093/jamia/ocw114; Meeks Derek W, 2014, J Am Med Inform Assoc, V21, pe28, DOI 10.1136/amiajnl-2013-001762; Meeks DW, 2014, J AM MED INFORM ASSN, V21, P1053, DOI 10.1136/amiajnl-2013-002578; Menon S, 2017, J AM MED INFORM ASSN, V24, P261, DOI 10.1093/jamia/ocw153; Menon S, 2016, APPL CLIN INFORM, V7, P543, DOI 10.4338/ACI-2015-10-RA-0135; Menon S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005985; Metzger J, 2010, HEALTH AFFAIR, V29, P655, DOI 10.1377/hlthaff.2010.0160; Millett LI, 2007, SOFTWARE DEPENDABLE; Nykanen P, 2011, INT J MED INFORM, V80, P815, DOI 10.1016/j.ijmedinf.2011.08.004; Petersen L A, 1998, Jt Comm J Qual Improv, V24, P77; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Poon EG, 2003, J BIOMED INFORM, V36, P80, DOI 10.1016/S1532-0464(03)00061-3; Ratwani RM, 2019, JAMA-J AM MED ASSOC, V321, P743, DOI 10.1001/jama.2019.0161; Rouse WB, 2008, BRIDGE, V38, P17; Russ AL, 2017, J BIOMED INFORM, V66, P11, DOI 10.1016/j.jbi.2016.11.011; Schiff GD, 2013, JAMA INTERN MED, V173, P2063, DOI 10.1001/jamainternmed.2013.11070; Singh H, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.033712; Singh H, 2010, J CLIN ONCOL, V28, P3307, DOI 10.1200/JCO.2009.25.6636; Singh H, 2009, AM J GASTROENTEROL, V104, P2543, DOI 10.1038/ajg.2009.324; Sirajuddin Anwar M, 2009, J Healthc Inf Manag, V23, P38; Sittig DF, 2006, PEDIATRICS, V118, P797, DOI 10.1542/peds.2005-3132; Sittig DF, 2012, J GEN INTERN MED, V27, P1235, DOI 10.1007/s11606-012-2161-y; Sittig DF, 2010, QUAL SAF HEALTH CARE, V19, pI68, DOI 10.1136/qshc.2010.042085; Sittig DF, 1999, INT J MED INFORM, V55, P149, DOI 10.1016/S1386-5056(99)00027-1; Strom BL, 2010, ARCH INTERN MED, V170, P1578, DOI 10.1001/archinternmed.2010.324; Talmon J, 2009, INT J MED INFORM, V78, P1, DOI 10.1016/j.ijmedinf.2008.09.002; Tenner CT, 2010, ARCH INTERN MED, V170, P392, DOI 10.1001/archinternmed.2010.9; Vaughn VM, 2019, BMJ QUAL SAF, V28, P74, DOI 10.1136/bmjqs-2017-007573; Walter Z, 2008, DECIS SUPPORT SYST, V46, P206, DOI 10.1016/j.dss.2008.06.004; Wang Y, 2016, J BIOMED INFORM, V59, P308, DOI 10.1016/j.jbi.2015.12.016; Wright A, 2011, J AM MED INFORM ASSN, V18, P232, DOI 10.1136/amiajnl-2011-000113; Wright A, 2011, J AM MED INFORM ASSN, V18, P187, DOI 10.1136/jamia.2009.002030; Yackel TR, 2010, J AM MED INFORM ASSN, V17, P104, DOI 10.1197/jamia.M3294	59	18	18	4	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2020	172			11			S92	S100		10.7326/M19-0879	http://dx.doi.org/10.7326/M19-0879			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MH8ZH	32479184				2022-12-28	WOS:000547009900005
J	Wilkinson, E				Wilkinson, Emma			How mental health services are adapting to provide care in the pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												emmalwilkinson@gmail.com						CWTCH Cymru, 2020, READY SET GO STEP BY	1	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2020	369								m2106	10.1136/bmj.m2106	http://dx.doi.org/10.1136/bmj.m2106			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MK0KV	32487536	Bronze			2022-12-28	WOS:000548476700008
J	Zheng, K; Ratwani, RM; Adler-Milstein, J				Zheng, Kai; Ratwani, Raj M.; Adler-Milstein, Julia			Studying Workflow and Workarounds in Electronic Health Record-Supported Work to Improve Health System Performance	ANNALS OF INTERNAL MEDICINE			English	Article							TIME-AND-MOTION; CARE; USABILITY; MEDICINE	Clinical workflow is the enactment of a series of steps to perform a clinical activity. The transition from paper to electronic health records (EHRs) over the past decade has been characterized by profound challenges supporting clinical workflow, impeding frontline clinicians' ability to deliver safe, efficient, and effective care. In response, there has been substantial effort to study clinical workflow as well as workarounds-exceptions to routine workflow-in order to identify opportunities for improvement. This article describes predominant methods of studying workflow and workarounds and provides examples of the applications of these methods along with the resulting insights. Challenges to studying workflow and workarounds are described, and recommendations for how to approach such studies are given. Although there is not yet a set of standard approaches, this article helps advance workflow research that ultimately serves to inform how to coevolve the design of EHR systems and organizational decisions about processes, roles, and responsibilities in order to support clinical workflow that more consistently delivers on the potential benefits of a digitized health care system.	[Zheng, Kai] Univ Calif Irvine, Sch Informat & Comp Sci, 6095 Donald Bren Hall, Irvine, CA 92697 USA; [Zheng, Kai] Univ Calif Irvine, Sch Med, 6095 Donald Bren Hall, Irvine, CA 92697 USA; [Ratwani, Raj M.] MedStar Hlth Natl Ctr Human Factors Healthcare, 3007 Tilden St NW,Suite 6N, Washington, DC 20008 USA; [Adler-Milstein, Julia] Univ Calif San Francisco, Sch Med, 3333 Calif St,Suite 265, San Francisco, CA 94118 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California San Francisco	Adler-Milstein, J (corresponding author), Univ Calif San Francisco, Sch Med, 3333 Calif St,Suite 265, San Francisco, CA 94118 USA.	Julia.adler-milstein@ucsf.edu						Adler-Milstein J, 2017, J AM MED INFORM ASSN, V24, P1142, DOI 10.1093/jamia/ocx080; Ash JS, 2003, J AM MED INFORM ASSN, V10, P188, DOI 10.1197/jamia.M770; Bloomrosen M, 2011, J AM MED INFORM ASSN, V18, P82, DOI 10.1136/jamia.2010.007567; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Burke TA, 2000, J NURS ADMIN, V30, P118, DOI 10.1097/00005110-200003000-00003; Cain C, 2008, PATIENT SAFETY QUALI; Calvitti A, 2017, J BIOMED INFORM, V69, P135, DOI 10.1016/j.jbi.2017.03.011; Carayon P, 2010, AHRQ PUBLICATION, V10-0074-EF; Deng XD, 2015, PROCEEDINGS OF THE 2ND INTERNATIONAL CONFERENCE ON INTELLIGENT COMPUTING AND COGNITIVE INFORMATICS, P111; Everson J, 2017, J AM MED INFORM ASSN, V24, pE103, DOI 10.1093/jamia/ocw116; FINKLER SA, 1993, HEALTH SERV RES, V28, P577; Furniss Stephanie K, 2016, AMIA Annu Symp Proc, V2016, P580; Halbesleben JRB, 2008, HEALTH CARE MANAGE R, V33, P2, DOI 10.1097/01.HMR.0000304495.95522.ca; Hirsch AG, 2017, J AM MED INFORM ASSN, V24, pE28, DOI 10.1093/jamia/ocw088; Howe JL, 2018, JAMA-J AM MED ASSOC, V319, P1276, DOI 10.1001/jama.2018.1171; Jamoom EW, 2016, NCHS DATA BRIEF, P1; Kannampallil T, 2011, J BIOMED INFORM, V44, P441, DOI 10.1016/j.jbi.2011.02.007; Kim MO, 2017, J AM MED INFORM ASSN, V24, P246, DOI 10.1093/jamia/ocw154; Kobayashi M, 2005, CHI LATE BREAKING RE, P1561, DOI DOI 10.1145/1056808.1056966; Koppel R, 2008, J AM MED INFORM ASSN, V15, P408, DOI 10.1197/jamia.M2616; Lopetegui M, 2014, J BIOMED INFORM, V49, P292, DOI 10.1016/j.jbi.2014.02.017; Lopetegui Marcelo, 2012, AMIA Annu Symp Proc, V2012, P596; National Research Council, 2009, COMPUTATIONAL TECHNO; Niazkhani Z, 2011, INT J MED INFORM, V80, P490, DOI 10.1016/j.ijmedinf.2011.03.009; Niazkhani Z, 2009, J AM MED INFORM ASSN, V16, P539, DOI 10.1197/jamia.M2419; Overhage JM, 2001, J AM MED INFORM ASSN, V8, P361, DOI 10.1136/jamia.2001.0080361; Pizziferri L, 2005, J BIOMED INFORM, V38, P176, DOI 10.1016/j.jbi.2004.11.009; Powers EM, 2018, J AM MED INFORM ASSN, V25, P1556, DOI 10.1093/jamia/ocy112; Ratwani RM, 2018, HEALTH AFFAIR, V37, P1752, DOI 10.1377/hlthaff.2018.0699; Ratwani RM, 2018, J AM MED INFORM ASSN, V25, P1197, DOI 10.1093/jamia/ocy088; Rosenbaum L, 2015, NEW ENGL J MED, V373, P1585, DOI 10.1056/NEJMp1509961; Schwarz N, 2001, AM J EVAL, V22, P127, DOI 10.1177/109821400102200202; Tai-Seale M, 2017, HEALTH AFFAIR, V36, P655, DOI 10.1377/hlthaff.2016.0811; Unertl KM, 2010, J AM MED INFORM ASSN, V17, P265, DOI 10.1136/jamia.2010.004333; Walter SR, 2019, COGNITIVE INFORM HLT; Westbrook Johanna I, 2009, Int J Med Inform, V78 Suppl 1, pS25, DOI 10.1016/j.ijmedinf.2008.09.003; Zheng K, 2016, Yearb Med Inform, P13; Zheng K, 2015, EXAMINING RELATIONSH; Zheng K, 2011, J AM MED INFORM ASSN, V18, P883, DOI 10.1136/amiajnl-2011-000118; Zheng K, 2011, J AM MED INFORM ASSN, V18, P704, DOI 10.1136/amiajnl-2011-000083; Zheng K, 2010, J AM MED INFORM ASSN, V17, P454, DOI 10.1136/jamia.2010.004440; Zheng K, 2009, J AM MED INFORM ASSN, V16, P228, DOI 10.1197/jamia.M2852	42	19	19	2	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2020	172			11			S116	S122		10.7326/M19-0871	http://dx.doi.org/10.7326/M19-0871			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MH8ZH	32479181	Green Accepted			2022-12-28	WOS:000547009900008
J	Krzeszinski, JY; Wei, W; Huynh, H; Jin, ZX; Wang, XD; Chang, TC; Xie, XJ; He, L; Mangala, LS; Lopez-Berestein, G; Sood, AK; Mendell, JT; Wan, YH				Krzeszinski, Jing Y.; Wei, Wei; Huynh, HoangDinh; Jin, Zixue; Wang, Xunde; Chang, Tsung-Cheng; Xie, Xian-Jin; He, Lin; Mangala, Lingegowda S.; Lopez-Berestein, Gabriel; Sood, Anil K.; Mendell, Joshua T.; Wan, Yihong			RETRACTION: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 (vol 512,pg 431, 2014) (Retraction of Vol 512, Pg 431, 2014)	NATURE			English	Retraction								A Retraction to this paper has been published and can be accessed via a link at the top of the paper.				yihong.wan@utsouthwestern.edu	Sood, Anoop Kumar/A-7344-2013	Sood, Anoop Kumar/0000-0001-5702-4108				Krzeszinski JY, 2014, NATURE, V512, P431, DOI 10.1038/nature13375	1	4	4	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2020	582	7810					134	134		10.1038/s41586-020-2273-1	http://dx.doi.org/10.1038/s41586-020-2273-1		JUN 2020	1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LY1IO	32483375	Green Accepted, Bronze			2022-12-28	WOS:000539700500001
J	Mahase, E				Mahase, Elisabeth			US to withdraw from WHO as China has "total control" over it, Trump claims	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER O, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M941; MAHASE E, 2020, BMJ-BRIT MED J, V369, P95763, DOI DOI 10.1136/BMJ.M1502	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2020	369								m2178	10.1136/bmj.m2178	http://dx.doi.org/10.1136/bmj.m2178			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0OM	32482732	Bronze			2022-12-28	WOS:000548486700012
J	Abel, HJ; Larson, DE; Regier, AA; Chiang, C; Das, I; Kanchi, KL; Layer, RM; Neale, BM; Salerno, WJ; Reeves, C; Buyske, S; Matise, TC; Muzny, DM; Zody, MC; Lander, ES; Dutcher, SK; Stitziel, NO; Hall, IM				Abel, Haley J.; Larson, David E.; Regier, Allison A.; Chiang, Colby; Das, Indraniel; Kanchi, Krishna L.; Layer, Ryan M.; Neale, Benjamin M.; Salerno, William J.; Reeves, Catherine; Buyske, Steven; Matise, Tara C.; Muzny, Donna M.; Zody, Michael C.; Lander, Eric S.; Dutcher, Susan K.; Stitziel, Nathan O.; Hall, Ira M.		NHGRI Ctr Common	Mapping and characterization of structural variation in 17,795 human genomes	NATURE			English	Article							COPY NUMBER VARIATION; COMMUNITY-DRIVEN RESOURCE; WIDE ASSOCIATION; VARIANTS; IMPACT; ELEMENTS; DATABASE; NUCLEOTIDE; PREDICTION; FRAMEWORK	Structural variants in more than 17,000 human genomes are mapped and characterized using whole-genome sequencing, showing how this type of variation contributes to rare deleterious coding and noncoding alleles. A key goal of whole-genome sequencing for studies of human genetics is to interrogate all forms of variation, including single-nucleotide variants, small insertion or deletion (indel) variants and structural variants. However, tools and resources for the study of structural variants have lagged behind those for smaller variants. Here we used a scalable pipeline(1)to map and characterize structural variants in 17,795 deeply sequenced human genomes. We publicly release site-frequency data to create the largest, to our knowledge, whole-genome-sequencing-based structural variant resource so far. On average, individuals carry 2.9 rare structural variants that alter coding regions; these variants affect the dosage or structure of 4.2 genes and account for 4.0-11.2% of rare high-impact coding alleles. Using a computational model, we estimate that structural variants account for 17.2% of rare alleles genome-wide, with predicted deleterious effects that are equivalent to loss-of-function coding alleles; approximately 90% of such structural variants are noncoding deletions (mean 19.1 per genome). We report 158,991 ultra-rare structural variants and show that 2% of individuals carry ultra-rare megabase-scale structural variants, nearly half of which are balanced or complex rearrangements. Finally, we infer the dosage sensitivity of genes and noncoding elements, and reveal trends that relate to element class and conservation. This work will help to guide the analysis and interpretation of structural variants in the era of whole-genome sequencing.	[Abel, Haley J.; Larson, David E.; Regier, Allison A.; Chiang, Colby; Das, Indraniel; Kanchi, Krishna L.; Dutcher, Susan K.; Stitziel, Nathan O.; Hall, Ira M.] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO 63110 USA; [Abel, Haley J.; Larson, David E.; Dutcher, Susan K.; Stitziel, Nathan O.; Hall, Ira M.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Regier, Allison A.; Stitziel, Nathan O.; Hall, Ira M.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Layer, Ryan M.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Layer, Ryan M.] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Neale, Benjamin M.; Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Neale, Benjamin M.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Neale, Benjamin M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Salerno, William J.; Muzny, Donna M.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Reeves, Catherine; Zody, Michael C.] New York Genome Ctr, New York, NY USA; [Buyske, Steven] Rutgers State Univ, Dept Stat, Piscataway, NJ USA; [Matise, Tara C.] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA USA; [Lander, Eric S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Baylor College of Medicine; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Hall, IM (corresponding author), Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO 63110 USA.; Hall, IM (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.; Hall, IM (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	ihall@genome.wustl.edu	Momin, Zeineen/AAK-4751-2021; Stitziel, Nathan/AAL-8413-2021; Darnell, Robert/B-9022-2008; Loos, Ruth/Q-2862-2016	Momin, Zeineen/0000-0001-7646-2234; Stitziel, Nathan/0000-0002-4963-8211; Darnell, Robert/0000-0002-5134-8088; Menon, Vipin/0000-0001-7404-678X; Marcus, Gregory/0000-0001-5197-7696; Larson, David/0000-0001-7934-5906; Palotie, Aarno/0000-0002-2527-5874; Stevens, Christine/0000-0002-2621-2234; Chiang, Colby/0000-0002-4113-6065; Rich, Stephen/0000-0003-3872-7793; Loos, Ruth/0000-0002-8532-5087; Young, Erica/0000-0002-3671-211X; Reeves, Catherine/0000-0002-9942-8909; Taskinen, Marja-Riitta/0000-0002-6229-3588; Buyske, Steven/0000-0001-8539-5416; doddapaneni, harshavardhan/0000-0002-2433-633X; Bustamante, Carlos D./0000-0002-4187-7920	NHGRI CCDG [UM1 HG008853, UM1 HG008895, UM1 HG008898, UM1 HG008901]; NHGRI GSP Coordinating Center [U24 HG008956]; Burroughs Wellcome Fund Career Award; NHGRI [5U54HG003079]; Academy of Finland [321428]; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; Kuopio University Hospital; Centre of Excellence of Cardiovascular and Metabolic Diseases; Academy of Finland; George S. and Dolores Dore Eccles Foundation; NIH [GM118335, GM059290]; DDRCC [NIDDK P30 DK052574]; Helmsley Charitable Trust; NIH/NIDDK [P01 DK046763, U01 DK062413]; Dell Loy Hansen Heart Foundation; NHLBI [HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700004I, HHSN268201700005I]; NHGRI; NIMHD [U01HG007416, U01HG007417, U01HG007397, U01HG007376, U01HG007419, P60MD006902, R01MD010443, RL5GM118984]; NIMHD; NIDCD; NIDCR; NIDDK; NINDS; NIH ODS; NCI [R37CA54281, R01 CA63, P01CA33619, U01CA136792, U01CA98758]; Burroughs Welcome Fund; Charles Rosenkranz Prize for Health Care Research in Developing Countries; Sandler Family Foundation; American Asthma Foundation; RWJF Amos Medical Faculty Development Program; NIEHS [R01ES015794, R21ES24844]; Tobacco-Related Disease Research Program [24RT0025];  [4R01HL113315-05];  [U24AG021886];  [U24AG056270];  [U24AG026395];  [R01AG041797];  [N01-HC65233];  [N01-HC65234];  [N01-HC65235];  [N01-HC65236];  [N01-HC65237];  [HHSN268201100046C];  [HHSN268201100001C];  [HHSN268201100002C];  [HHSN268201100003C];  [HHSN268201100004C];  [HHSN271201100004C];  [R01HL117004];  [R01HL128439];  [R01HL135156];  [X01HL134589]	NHGRI CCDG; NHGRI GSP Coordinating Center; Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Kuopio University Hospital; Centre of Excellence of Cardiovascular and Metabolic Diseases; Academy of Finland(Academy of Finland); George S. and Dolores Dore Eccles Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DDRCC; Helmsley Charitable Trust; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Dell Loy Hansen Heart Foundation; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMHD; NIMHD; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH ODS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Burroughs Welcome Fund(Burroughs Wellcome Fund); Charles Rosenkranz Prize for Health Care Research in Developing Countries; Sandler Family Foundation; American Asthma Foundation; RWJF Amos Medical Faculty Development Program; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Tobacco-Related Disease Research Program(University of California System); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; 	We thank staff at the NHGRI for supporting this effort. This study was funded by NHGRI CCDG awards to Washington University in St Louis (UM1 HG008853), the Broad Institute of MIT and Harvard (UM1 HG008895), Baylor College of Medicine (UM1 HG008898) and New York Genome Center (UM1 HG008901); an NHGRI GSP Coordinating Center grant to Rutgers (U24 HG008956); and a Burroughs Wellcome Fund Career Award to I.M.H. Additional data production at Washington University in St Louis was funded by a separate NHGRI award (5U54HG003079). We thank S. Sunyaev for comments on the manuscript; T. Teshiba for coordinating samples for FINRISK and EUFAM sequencing; and the staff and participants of the ARIC study for their contributions; and we acknowledge all individuals who were involved in the collection of samples that were analysed for this study. Data production for EUFAM was funded by 4R01HL113315-05; the Metabolic Syndrome in Men (METSIM) study was supported by grants to M. Laakso from the Academy of Finland (no. 321428), the Sigrid Juselius Foundation, the Finnish Foundation for Cardiovascular Research, Kuopio University Hospital and the Centre of Excellence of Cardiovascular and Metabolic Diseases supported by the Academy of Finland; data collection for the CEPH pedigrees was funded by the George S. and Dolores Dore Eccles Foundation and NIH grants GM118335 and GM059290; study recruitment at Washington University in St Louis was funded by the DDRCC (NIDDK P30 DK052574) and the Helmsley Charitable Trust; study recruitment at Cedars-Sinai was supported by the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, NIH/NIDDK grants P01 DK046763 and U01 DK062413 and the Helmsley Charitable Trust; study recruitment at Intermountain Medical Center was funded by the Dell Loy Hansen Heart Foundation; the Late Onset Alzheimer's Disease Study (LOAD) study was funded by grants to T. Foroud (U24AG021886, U24AG056270, U24AG026395 and R01AG041797); the Atherosclerosis Risk in Communities (ARIC) study was funded by the NHLBI (HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700004I and HHSN268201700005I); and the PAGE programme is funded by the NHGRI with co-funding from the NIMHD (U01HG007416, U01HG007417, U01HG007397, U01HG007376 and U01HG007419). Samples from the BioMe Biobank were provided by The Charles Bronfman Institute for Personalized Medicine at the Icahn School of Medicine at Mount Sinai. The Hispanic Community Health Study/Study of Latinos was carried out as a collaborative study supported by the NHLBI (N01-HC65233, N01-HC65234, N01-HC65235, N01-HC65236 and N01-HC65237), with contributions from the NIMHD, NIDCD, NIDCR, NIDDK, NINDS and NIH ODS. The Multiethnic Cohort (MEC) study is funded through the NCI (R37CA54281, R01 CA63, P01CA33619, U01CA136792 and U01CA98758). For the Stanford Global Reference Panel, individuals from Puno, Peru were recruited by J. Baker and C. Bustamante, with funding from the Burroughs Welcome Fund, and individuals from Rapa Nui (Easter Island) were recruited by K. Sandoval Mendoza and A. Moreno Estrada, with funding from the Charles Rosenkranz Prize for Health Care Research in Developing Countries. The Women's Health Initiative (WHI) programme is funded by the NHLBI (HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C and HHSN271201100004C). The GALA II study and E. G. Burchard are supported by the Sandler Family Foundation, the American Asthma Foundation, the RWJF Amos Medical Faculty Development Program, the Harry Wm. and Diana V.; Hind Distinguished Professor in Pharmaceutical Sciences II, the NHLBI (R01HL117004, R01HL128439, R01HL135156 and X01HL134589), the NIEHS (R01ES015794, R21ES24844), the NIMHD (P60MD006902, R01MD010443, RL5GM118984) and the Tobacco-Related Disease Research Program (24RT0025). We acknowledge the following GALA II co-investigators for recruitment of individuals, sample processing and quality control: C. Eng, S. Salazar, S. Huntsman, D. Hu, A. C.Y. Mak, L. Caine, S. Thyne, H. J. Farber, P. C. Avila, D. Serebrisky, W. Rodriguez-Cintron, Jose R. Rodriguez-Santana, R. Kumar, L. N. Borrell, E. Brigino-Buenaventura, A. Davis, M. A. LeNoir, K. Meade, S. Sen and F. Lurmann, and we thank the staff and participants who contributed to the GALA II study.	Abyzov A, 2013, GENOME RES, V23, P2042, DOI 10.1101/gr.154625.113; Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ashoor H, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav085; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bragin E, 2014, NUCLEIC ACIDS RES, V42, pD993, DOI 10.1093/nar/gkt937; Brandler WM, 2018, SCIENCE, V360, P327, DOI 10.1126/science.aan2261; Chaisson MJP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08148-z; Chiang C, 2017, NAT GENET, V49, P692, DOI 10.1038/ng.3834; Chiang C, 2015, NAT METHODS, V12, P966, DOI [10.1038/nmeth.3505, 10.1038/NMETH.3505]; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ewing AD, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r22; Faust GG, 2012, BIOINFORMATICS, V28, P2417, DOI 10.1093/bioinformatics/bts456; Fishilevich S., 2017, DATABASE, V2017, P2017, DOI DOI 10.1093/DATABASE/BAX028; Forabosco A, 2009, EUR J HUM GENET, V17, P897, DOI 10.1038/ejhg.2008.265; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fu Y, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0480-5; Ganel L, 2017, BIOINFORMATICS, V33, P1083, DOI 10.1093/bioinformatics/btw789; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Hehir-Kwa JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12989; Hook EB, 1977, POPULATION CYTOGENET, P63; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Huang YF, 2017, NAT GENET, V49, P618, DOI 10.1038/ng.3810; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lappalainen I, 2013, NUCLEIC ACIDS RES, V41, pD936, DOI 10.1093/nar/gks1213; Larson DE, 2019, BIOINFORMATICS, V35, P4782, DOI 10.1093/bioinformatics/btz492; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lesurf R, 2016, NUCLEIC ACIDS RES, V44, pD126, DOI 10.1093/nar/gkv1203; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Malhotra A, 2013, GENOME RES, V23, P762, DOI 10.1101/gr.143677.112; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Rodriguez JM, 2013, NUCLEIC ACIDS RES, V41, pD110, DOI 10.1093/nar/gks1058; Maretty L, 2017, NATURE, V548, P87, DOI 10.1038/nature23264; Marshall CR, 2017, NAT GENET, V49, P27, DOI 10.1038/ng.3725; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Poplin R., 2017, SCALING ACCURATE GEN, DOI [10.1101/201178V3, DOI 10.1101/201178V3]; Quinlan AR, 2012, TRENDS GENET, V28, P43, DOI 10.1016/j.tig.2011.10.002; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Regier AA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06159-4; Ruderfer DM, 2016, NAT GENET, V48, P1107, DOI 10.1038/ng.3638; Schrider DR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003242; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Sudmant PH, 2015, SCIENCE, V349, DOI 10.1126/science.aab3761; Tan A, 2015, BIOINFORMATICS, V31, P2202, DOI 10.1093/bioinformatics/btv112; Turner TN, 2017, CELL, V171, P710, DOI 10.1016/j.cell.2017.08.047; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Werling DM, 2018, NAT GENET, V50, P727, DOI 10.1038/s41588-018-0107-y; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730	73	82	82	4	34	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					83	+		10.1038/s41586-020-2371-0	http://dx.doi.org/10.1038/s41586-020-2371-0		MAY 2020	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME6OV	32460305	Green Submitted, Green Accepted			2022-12-28	WOS:000543232200001
J	Baronti, L; Guzzetti, I; Ebrahimi, P; Sandoz, SF; Steiner, E; Schlagnitweit, J; Fromm, B; Silva, L; Fontana, C; Chen, AA; Petzold, K				Baronti, Lorenzo; Guzzetti, Ileana; Ebrahimi, Parisa; Friebe Sandoz, Sarah; Steiner, Emilie; Schlagnitweit, Judith; Fromm, Bastian; Silva, Luis; Fontana, Carolina; Chen, Alan A.; Petzold, Katja			Base-pair conformational switch modulates miR-34a targeting of Sirt1 mRNA	NATURE			English	Article							EXCITED-STATES; ARGONAUTE; GUIDE; MICRORNAS; DYNAMICS; DETERMINANTS; SIMULATIONS; PARAMETERS; CLEAVAGE	MicroRNAs (miRNAs) regulate the levels of translation of messenger RNAs (mRNAs). At present, the major parameter that can explain the selection of the target mRNA and the efficiency of translation repression is the base pairing between the 'seed' region of the miRNA and its counterpart mRNA(1). Here we use R-1 rho relaxation-dispersion nuclear magnetic resonance(2) and molecular simulations(3) to reveal a dynamic switch-based on the rearrangement of a single base pair in the miRNA-mRNA duplex-that elongates a weak five-base-pair seed to a complete seven-base-pair seed. This switch also causes coaxial stacking of the seed and supplementary helix fitting into human Argonaute 2 protein (Ago2), reminiscent of an active state in prokaryotic Ago(4,5). Stabilizing this transient state leads to enhanced repression of the target mRNA in cells, revealing the importance of this miRNA-mRNA structure. Our observations tie together previous findings regarding the stepwise miRNA targeting process from an initial 'screening' state to an 'active' state, and unveil the role of the RNA duplex beyond the seed in Ago2. Repression of a messenger RNA by a cognate microRNA depends not only on complementary base pairing, but also on the rearrangement of a single base pair, producing a conformation that fits better within the human Ago2 protein.	[Baronti, Lorenzo; Guzzetti, Ileana; Friebe Sandoz, Sarah; Steiner, Emilie; Schlagnitweit, Judith; Silva, Luis; Fontana, Carolina; Petzold, Katja] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Ebrahimi, Parisa; Chen, Alan A.] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Ebrahimi, Parisa; Chen, Alan A.] SUNY Albany, RNA Inst, Albany, NY 12222 USA; [Fromm, Bastian] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Sci Life Lab, Stockholm, Sweden; [Steiner, Emilie] Univ Paris Saclay, Univ Evry Val dEssonne, UMR INSERM 1204, Lab SABNP, Evry, France; [Fontana, Carolina] Univ Republ, Fac Quim, Dept Quim Litoral, Paysandu, Uruguay; [Fontana, Carolina] Univ Republ, CENUR Litoral Norte, Paysandu, Uruguay	Karolinska Institutet; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Stockholm University; UDICE-French Research Universities; Universite Paris Saclay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Petzold, K (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	katja.petzold@ki.se	Chen, Alan/HGD-3414-2022; Petzold, Katja/E-9816-2011; Fontana, Carolina/AAA-3564-2022; Fromm, Bastian/B-4480-2017; Ebrahimi, Parisa/GLT-7081-2022; Chen, Alan/D-6940-2014	Petzold, Katja/0000-0001-9470-0347; Fontana, Carolina/0000-0002-7362-2180; Fromm, Bastian/0000-0003-0352-3037; Silva, Luis/0000-0003-1684-9271; , Parisa/0000-0002-1809-2316; Chen, Alan/0000-0001-8246-2935; Baronti, Lorenzo/0000-0001-5393-3822	Swedish Research Council [2014-04303]; Swedish Foundation for Strategic Research [ICA14-0023]; Carl Tryggers stiftelse [CTS14-383, 15-383]; Harald och Greta Jeansson Stiftelse [JS20140009]; Eva och Oscar Ahrens Stiftelse; Angstromke Wiberg Stiftelse [467080968, M14-0109]; Cancerfonden [CAN 2015/388]; Karolinska Institute Department of Medical Biochemistry and Biophysics [KID 2-3707/2013]; Ragnar Soderberg Stiftelse [M91/14]; National Science Foundation [MCB1651877, ACI-1548562]; Strategic Research Area (SFO) program of the Swedish Research Council (VR) through Stockholm University; Extreme Science and Engineering Discovery Environment (XSEDE) [TG-MCB140273]; Marie Sklodowska-Curie Individual Fellowship (EU H2020/project) [747446]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Carl Tryggers stiftelse; Harald och Greta Jeansson Stiftelse; Eva och Oscar Ahrens Stiftelse; Angstromke Wiberg Stiftelse; Cancerfonden(Swedish Cancer Society); Karolinska Institute Department of Medical Biochemistry and Biophysics; Ragnar Soderberg Stiftelse; National Science Foundation(National Science Foundation (NSF)); Strategic Research Area (SFO) program of the Swedish Research Council (VR) through Stockholm University; Extreme Science and Engineering Discovery Environment (XSEDE); Marie Sklodowska-Curie Individual Fellowship (EU H2020/project)	We thank the members of the Petzold and the E. R. Andersson laboratories for insightful discussions; N. H. Hopkins for providing the curated chemical shifts and for contributing to the MC-Fold secondary-structure-prediction script; I. MacRae for the gift of plasmid expressing human Ago2; and the Lund University Protein Production Platform (LP3) (Lund, Sweden) and the Protein Science Facility at the Karolinska Institute Department of Medical Biochemistry and Biophysics (Stockholm, Sweden) for help with human Ago2. K.P. acknowledges funding from the Swedish Research Council (grant number 2014-04303), the Swedish Foundation for Strategic Research (project number ICA14-0023), Harald och Greta Jeansson Stiftelse (JS20140009), Carl Tryggers stiftelse (CTS14-383 and 15-383), Eva och Oscar Ahrens Stiftelse, angstrom ke Wiberg Stiftelse (467080968 and M14-0109), Cancerfonden (CAN 2015/388), the Karolinska Institute Department of Medical Biochemistry and Biophysics (grant number KID 2-3707/2013 and support for the purchase of a 600-MHz Bruker NMR spectrometer) and Ragnar Soderberg Stiftelse (M91/14). A.A.C. acknowledges support from National Science Foundation (grant MCB1651877). B.F. acknowledges funding from the Strategic Research Area (SFO) program of the Swedish Research Council (VR) through Stockholm University. This work used the computational resources of the Extreme Science and Engineering Discovery Environment (XSEDE) (allocation TG-MCB140273 to A.A.C.), which is supported by National Science Foundation grant number ACI-1548562. J.S. acknowledges funding through a Marie Sklodowska-Curie Individual Fellowship (EU H2020/project number 747446).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Baronti L, 2018, ANAL BIOANAL CHEM, V410, P3239, DOI 10.1007/s00216-018-0943-8; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Beckert B, 2011, METHODS MOL BIOL, V703, P29, DOI 10.1007/978-1-59745-248-9_3; Brancati G, 2018, NUCLEIC ACIDS RES, V46, P3259, DOI 10.1093/nar/gky201; Broughton JP, 2016, MOL CELL, V64, P320, DOI 10.1016/j.molcel.2016.09.004; Chen AA, 2013, P NATL ACAD SCI USA, V110, P16820, DOI 10.1073/pnas.1309392110; Clay MC, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx525; De N, 2013, MOL CELL, V50, P344, DOI 10.1016/j.molcel.2013.04.001; De N, 2011, METHODS MOL BIOL, V725, P107, DOI 10.1007/978-1-61779-046-1_8; Dethoff EA, 2012, NATURE, V491, P724, DOI 10.1038/nature11498; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Furtig B, 2003, CHEMBIOCHEM, V4, P936, DOI 10.1002/cbic.200300700; Gebert LFR, 2019, NAT REV MOL CELL BIO, V20, P21, DOI 10.1038/s41580-018-0045-7; Grentzmann G, 1998, RNA, V4, P479; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hansen AL, 2009, J AM CHEM SOC, V131, P3818, DOI 10.1021/ja8091399; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Helmling C, 2015, J BIOMOL NMR, V63, P67, DOI 10.1007/s10858-015-9967-y; Horn HW, 2004, J CHEM PHYS, V120, P9665, DOI 10.1063/1.1683075; Hu H, 2002, MOL SIMULAT, V28, P67, DOI 10.1080/08927020211971; Huang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094382; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kao C, 1999, RNA, V5, P1268, DOI 10.1017/S1355838299991033; Klum SM, 2018, EMBO J, V37, P75, DOI 10.15252/embj.201796474; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Marusic M, 2019, CHEMBIOCHEM, V20, P2685, DOI 10.1002/cbic.201900072; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Nikolova EN, 2012, J AM CHEM SOC, V134, P3667, DOI 10.1021/ja2117816; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Palmer AG, 2006, CHEM REV, V106, P1700, DOI 10.1021/cr0404287; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Park JH, 2017, NUCLEIC ACIDS RES, V45, P1569, DOI 10.1093/nar/gkx029; Popenda M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-231; Rio D. C., 2014, COLD SPRING HARBOR P, V2014, ppdbprot080838; Salzman DW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10954; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Schlagnitweit J, 2018, CHEM-EUR J, V24, P6067, DOI 10.1002/chem.201800992; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Sheu-Gruttadauria J, 2019, EMBO J, V38, DOI 10.15252/embj.2018101153; Steinbrecher T, 2012, J CHEM THEORY COMPUT, V8, P4405, DOI 10.1021/ct300613v; Steiner E, 2016, ANGEW CHEM INT EDIT, V55, P15869, DOI 10.1002/anie.201609102; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Vecenie CJ, 2004, BIOCHEMISTRY-US, V43, P11813, DOI 10.1021/bi049954i; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YH, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000866; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Xue Y, 2015, METHOD ENZYMOL, V558, P39, DOI 10.1016/bs.mie.2015.02.002; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105	58	22	22	3	36	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					139	+		10.1038/s41586-020-2336-3	http://dx.doi.org/10.1038/s41586-020-2336-3		MAY 2020	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME6OV	32461691				2022-12-28	WOS:000535878900002
J	Mannu, GS; Wang, Z; Broggio, J; Charman, J; Cheung, S; Kearins, O; Dodwell, D; Darby, SC				Mannu, Gurdeep S.; Wang, Zhe; Broggio, John; Charman, Jackie; Cheung, Shan; Kearins, Olive; Dodwell, David; Darby, Sarah C.			Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK; OUTCOMES; DCIS; RADIOTHERAPY; PREDICTORS; RECURRENCE; DIAGNOSIS; TRIAL	OBJECTIVE To evaluate the long term risks of invasive breast cancer and death from breast cancer after ductal carcinoma in situ (DCIS) diagnosed through breast screening. DESIGN Population based observational cohort study. SETTING Data from the NHS Breast Screening Programme and the National Cancer Registration and Analysis Service. PARTICIPANTS All 35 024 women in England diagnosed as having DCIS by the NHS Breast Screening Programme from its start in 1988 until March 2014. MAIN OUTCOME MEASURES Incident invasive breast cancer and death from breast cancer. RESULTS By December 2014, 13 606 women had been followed for up to five years, 10 998 for five to nine years, 6861 for 10-14 years, 2620 for 15-19 years, and 939 for at least 20 years. Among these women, 2076 developed invasive breast cancer, corresponding to an incidence rate of 8.82 (95% confidence interval 8.45 to 9.21) per 1000 women per year and more than double that expected from national cancer incidence rates (ratio of observed rate to expected rate 2.52, 95% confidence interval 2.41 to 2.63). The increase started in the second year after diagnosis of DCIS and continued until the end of follow-up. In the same group of women, 310 died from breast cancer, corresponding to a death rate of 1.26 (1.13 to 1.41) per 1000 women per year and 70% higher than that expected from national breast cancer mortality rates (observed:expected ratio 1.70, 1.52 to 1.90). During the first five years after diagnosis of DCIS, the breast cancer death rate was similar to that expected from national mortality rates (observed:expected ratio 0.87, 0.69 to 1.10), but it then increased, with values of 1.98 (1.65 to 2.37), 2.99 (2.41 to 3.70), and 2.77 (2.01 to 3.80) in years five to nine, 10-14, and 15 or more after DCIS diagnosis. Among 29 044 women with unilateral DCIS undergoing surgery, those who had more intensive treatment (mastectomy, radiotherapy for women who had breast conserving surgery, and endocrine treatment in oestrogen receptor positive disease) and those with larger final surgical margins had lower rates of invasive breast cancer. CONCLUSIONS To date, women with DCIS detected by screening have, on average, experienced higher long term risks of invasive breast cancer and death from breast cancer than women in the general population during a period of at least two decades after their diagnosis. More intensive treatment and larger final surgical margins were associated with lower risks of invasive breast cancer.	[Mannu, Gurdeep S.; Wang, Zhe; Dodwell, David; Darby, Sarah C.] Univ Oxford, Nuffield Dept Populat Hlth, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England; [Broggio, John; Charman, Jackie; Cheung, Shan; Kearins, Olive] Publ Hlth England, Natl Canc Registrat & Anal Serv, Birmingham, W Midlands, England	University of Oxford; Public Health England	Mannu, GS (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	gurdeep.mannu@ndph.ox.ac.uk	Mannu, Gurdeep S/B-5825-2015; Broggio, John/F-2295-2018	Kearins, Olive/0000-0002-4135-3035; Mannu, Gurdeep/0000-0003-0219-9474; Broggio, John/0000-0001-9429-2275	Cancer Research UK [C8225/A21133]; National Institute for Health Research Oxford Biomedical Research Centre; UK Medical Research Council [MC_U137686858]	Cancer Research UK(Cancer Research UK); National Institute for Health Research Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding was provided by Cancer Research UK (grant C8225/A21133), the National Institute for Health Research Oxford Biomedical Research Centre, and the UK Medical Research Council (grant MC_U137686858). These funding bodies had no role in the data collection, analysis, interpretation, or reporting.	[Anonymous], BREAST SCREEN PROGR; Benson JR, 2013, LANCET ONCOL, V14, pE348, DOI 10.1016/S1470-2045(13)70135-9; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Breslow NE, 1980, STAT METHODS CANC RE; Cheung S, 2014, BREAST, V23, P807, DOI 10.1016/j.breast.2014.08.013; Correa C, 2010, J NATL CANC I MONOGR, V2010, P162, DOI [DOI 10.1093/JNCIMONOGRAPHS/LGQ039, DOI 10.1093/JNCIM0N0GRAPHS/LGQ039]; Cuzick J, 2011, LANCET ONCOL, V12, P21, DOI 10.1016/S1470-2045(10)70266-7; Duffy SW, 2016, LANCET ONCOL, V17, P109, DOI 10.1016/S1470-2045(15)00446-5; Elshof LE, 2016, BREAST CANCER RES TR, V159, P553, DOI 10.1007/s10549-016-3973-y; Elshof LE, 2015, EUR J CANCER, V51, P1497, DOI 10.1016/j.ejca.2015.05.008; Francis A, 2015, CLIN ONCOL-UK, V27, P6, DOI 10.1016/j.clon.2014.09.015; Kanbayashi C, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.TPS603; Kerlikowske Karla, 2010, Journal of the National Cancer Institute Monographs, P139, DOI 10.1093/jncimonographs/lgq027; Marinovich ML, 2016, ANN SURG ONCOL, V23, P3811, DOI 10.1245/s10434-016-5446-2; Narod SA, 2015, JAMA ONCOL, V1, P888, DOI 10.1001/jamaoncol.2015.2510; National Cancer Intelligence Network, 2010, NAT CANC REG AN SERV; National Institute of Clinical Excellence, 2018, EARL LOC ADV BREAST; Ponti A, 2019, BREAST CANCER RES TR, V177, P761, DOI 10.1007/s10549-019-05333-6; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rakovitch E, 2013, BREAST CANCER RES TR, V138, P581, DOI 10.1007/s10549-013-2455-8; Roman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083121; Tadros AB, 2019, ANN SURG, V269, P150, DOI 10.1097/SLA.0000000000002439; The Trustees of the Association of Breast Surgery, 2015, CONSENSUS STATEMENT; Thompson AM, 2018, EUR J CANCER, V101, P210, DOI 10.1016/j.ejca.2018.06.027; Thompson M, 2013, WISE MANAGEMENT IN ORGANISATIONAL COMPLEXITY, P1; Virnig BA, 2010, J NATL CANCER I, V102, P170, DOI 10.1093/jnci/djp482; Visser LL, 2019, CANCER EPIDEM BIOMAR, V28, P835, DOI 10.1158/1055-9965.EPI-18-0976; Wapnir IL, 2011, J NATL CANCER I, V103, P478, DOI 10.1093/jnci/djr027; Youngwirth Linda M, 2017, Bull Am Coll Surg, V102, P62	29	27	27	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2020	369								m1570	10.1136/bmj.m1570	http://dx.doi.org/10.1136/bmj.m1570			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JX	32461218	hybrid, Green Published			2022-12-28	WOS:000538337100002
J	Ju, B; Zhang, Q; Ge, JW; Wang, RK; Sun, J; Ge, XY; Yu, JZ; Shan, SS; Zhou, B; Song, S; Tang, X; Yu, JF; Lan, J; Yuan, J; Wang, HY; Zhao, JN; Zhang, SY; Wang, YC; Shi, XL; Liu, L; Zhao, JC; Wang, XQ; Zhang, Z; Zhang, LQ				Ju, Bin; Zhang, Qi; Ge, Jiwan; Wang, Ruoke; Sun, Jing; Ge, Xiangyang; Yu, Jiazhen; Shan, Sisi; Zhou, Bing; Song, Shuo; Tang, Xian; Yu, Jinfang; Lan, Jun; Yuan, Jing; Wang, Haiyan; Zhao, Juanjuan; Zhang, Shuye; Wang, Youchun; Shi, Xuanling; Liu, Lei; Zhao, Jincun; Wang, Xinquan; Zhang, Zheng; Zhang, Linqi			Human neutralizing antibodies elicited by SARS-CoV-2 infection	NATURE			English	Article							SARS CORONAVIRUS; SPIKE PROTEIN; COV; VACCINE; BINDING	The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents a global health emergency that is in urgent need of intervention(1-3). The entry of SARS-CoV-2 into its target cells depends on binding between the receptor-binding domain (RBD) of the viral spike protein and its cellular receptor, angiotensin-converting enzyme 2 (ACE2)(2,4-6). Here we report the isolation and characterization of 206 RBD-specific monoclonal antibodies derived from single B cells from 8 individuals infected with SARS-CoV-2. We identified antibodies that potently neutralize SARS-CoV-2; this activity correlates with competition with ACE2 for binding to RBD. Unexpectedly, the anti-SARS-CoV-2 antibodies and the infected plasma did not cross-react with the RBDs of SARS-CoV or Middle East respiratory syndrome-related coronavirus (MERS-CoV), although there was substantial plasma cross-reactivity to their trimeric spike proteins. Analysis of the crystal structure of RBD-bound antibody revealed that steric hindrance inhibits viral engagement with ACE2, thereby blocking viral entry. These findings suggest that anti-RBD antibodies are largely viral-species-specific inhibitors. The antibodies identified here may be candidates for development of clinical interventions against SARS-CoV-2. In a study of antibodies isolated from patients infected with SARS-CoV-2, antibodies that potently neutralized the virus competed with angiotensin-converting enzyme 2 for binding to the receptor-binding domain of the viral spike protein, suggesting that antibodies that disrupt this interaction could be developed to treat SARS-CoV-2 infection.	[Ju, Bin; Ge, Xiangyang; Yu, Jiazhen; Zhou, Bing; Song, Shuo; Tang, Xian; Wang, Haiyan; Zhao, Juanjuan; Liu, Lei; Zhang, Zheng] Shenzhen Third Peoples Hosp, Inst Hepatol, Natl Clin Res Ctr Infect Dis, Shenzhen, Peoples R China; [Ju, Bin; Zhao, Juanjuan; Liu, Lei; Zhang, Zheng] Southern Univ Sci & Technol, Sch Med, Affiliated Hosp 2, Shenzhen, Peoples R China; [Zhang, Qi; Wang, Ruoke; Shan, Sisi; Shi, Xuanling; Zhang, Linqi] Tsinghua Univ, Comprehens AIDS Res Ctr, Ctr Global Hlth & Infect Dis, Beijing, Peoples R China; [Zhang, Qi; Wang, Ruoke; Shan, Sisi; Shi, Xuanling; Zhang, Linqi] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Med, Beijing, Peoples R China; [Zhang, Qi; Wang, Ruoke; Shan, Sisi; Shi, Xuanling; Zhang, Linqi] Tsinghua Univ, Vanke Sch Publ Hlth, Beijing, Peoples R China; [Ge, Jiwan; Yu, Jinfang; Lan, Jun; Wang, Xinquan] Tsinghua Univ, Collaborat Innovat Ctr Biotherapy,Sch Life Sci, Beijing Frontier Res Ctr Biol Struct,Minist Educ, Beijing Adv Innovat Ctr Struct Biol,Key Lab Prot, Beijing, Peoples R China; [Sun, Jing; Zhao, Jincun] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis,State Key Lab Resp Dis, Guangzhou, Peoples R China; [Yuan, Jing] Shenzhen Third Peoples Hosp, Dept Infect Dis, Shenzhen, Peoples R China; [Zhang, Shuye] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China; [Zhang, Shuye] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China; [Wang, Youchun] Natl Inst Food & Drug Control, Div HIV AIDS & Sex Transmitted Virus Vaccines, Beijing, Peoples R China	Southern University of Science & Technology; Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Fudan University; Fudan University; National Institute of Food & Drug Control - China	Zhang, Z (corresponding author), Shenzhen Third Peoples Hosp, Inst Hepatol, Natl Clin Res Ctr Infect Dis, Shenzhen, Peoples R China.; Zhang, Z (corresponding author), Southern Univ Sci & Technol, Sch Med, Affiliated Hosp 2, Shenzhen, Peoples R China.; Zhang, LQ (corresponding author), Tsinghua Univ, Comprehens AIDS Res Ctr, Ctr Global Hlth & Infect Dis, Beijing, Peoples R China.; Zhang, LQ (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Med, Beijing, Peoples R China.; Zhang, LQ (corresponding author), Tsinghua Univ, Vanke Sch Publ Hlth, Beijing, Peoples R China.; Wang, XQ (corresponding author), Tsinghua Univ, Collaborat Innovat Ctr Biotherapy,Sch Life Sci, Beijing Frontier Res Ctr Biol Struct,Minist Educ, Beijing Adv Innovat Ctr Struct Biol,Key Lab Prot, Beijing, Peoples R China.	xinquanwang@mail.tsinghua.edu.cn; zhangzheng1975@aliyun.com; zhanglinqi@tsinghua.edu.cn	Zhao, Jincun/ABD-8679-2021; ZHANG, LIN/GYD-9123-2022; Zhang, Shuye/ABG-7815-2021; sun, jing/GWQ-6926-2022	Zhao, Jincun/0000-0003-2515-5589; Zhang, Shuye/0000-0002-4749-6790; shan, sisi/0000-0002-7184-6818	Bill & Melinda Gates Foundation; Science and Technology Innovation Committee of Shenzhen Municipality [202002073000002]; Tsinghua University Initiative Scientific Research Program [20201080053]; National Beijing Municipal Science and Technology Commission [171100000517-001, 171100000517-003]; Beijing Advanced Innovation Center for Structural Biology at Tsinghua University; National Key Plan for Scientific Research and Development of China [2016YFD0500307]; Tencent Foundation; Shuidi Foundation; TH Capital	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Science and Technology Innovation Committee of Shenzhen Municipality; Tsinghua University Initiative Scientific Research Program; National Beijing Municipal Science and Technology Commission; Beijing Advanced Innovation Center for Structural Biology at Tsinghua University; National Key Plan for Scientific Research and Development of China; Tencent Foundation; Shuidi Foundation; TH Capital	We acknowledge the work and contribution of all the health providers from Shenzhen Third People's Hospital. We also thank patients for their active participation. This study was supported by Bill & Melinda Gates Foundation, the Science and Technology Innovation Committee of Shenzhen Municipality (202002073000002), and by Tsinghua University Initiative Scientific Research Program (20201080053). This work is also partially supported by the National Beijing Municipal Science and Technology Commission (171100000517-001 and 171100000517-003), Beijing Advanced Innovation Center for Structural Biology at Tsinghua University, the National Key Plan for Scientific Research and Development of China (grant number 2016YFD0500307), Tencent Foundation, Shuidi Foundation and TH Capital. The funders had no role in study design, data collection, data analysis, data interpretation or writing of the report.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gui M, 2017, CELL RES, V27, P119, DOI 10.1038/cr.2016.152; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Janson G, 2017, BIOINFORMATICS, V33, P444, DOI 10.1093/bioinformatics/btw638; Jia WX, 2019, EMERG MICROBES INFEC, V8, P760, DOI 10.1080/22221751.2019.1620083; Jiang LW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008140; Kirchdoerfer RN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34171-7; Kong L, 2016, IMMUNITY, V44, P939, DOI 10.1016/j.immuni.2016.03.006; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Niu PH, 2018, J INFECT DIS, V218, P1249, DOI 10.1093/infdis/jiy311; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Song WF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007236; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Tian XL, 2020, EMERG MICROBES INFEC, V9, P382, DOI 10.1080/22221751.2020.1729069; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang NS, 2013, CELL RES, V23, P986, DOI 10.1038/cr.2013.92; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xu JY, 2019, EMERG MICROBES INFEC, V8, P841, DOI 10.1080/22221751.2019.1624482; Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Zhang LQ, 2006, J MED VIROL, V78, P1, DOI 10.1002/jmv.20499; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhu ZY, 2007, P NATL ACAD SCI USA, V104, P12123, DOI 10.1073/pnas.0701000104	35	867	901	37	186	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					115	+		10.1038/s41586-020-2380-z	http://dx.doi.org/10.1038/s41586-020-2380-z		MAY 2020	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB1QU	32454513	Bronze, Green Submitted			2022-12-28	WOS:000554511300002
J	Baker, M				Baker, Matt			John Horton Conway (1937-2020)	SCIENCE			English	Biographical-Item									[Baker, Matt] Georgia Inst Technol, Sch Math, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Baker, M (corresponding author), Georgia Inst Technol, Sch Math, Atlanta, GA 30332 USA.	mbaker@math.gatech.edu						CONWAY JS, PUBLICATION LIST	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					831	831		10.1126/science.abc5331	http://dx.doi.org/10.1126/science.abc5331			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU2DD	32439782				2022-12-28	WOS:000537569500029
J	Hublin, JJ; Sirakov, N; Aldeias, V; Bailey, S; Bard, E; Delvigne, V; Endarova, E; Fagault, Y; Fewlass, H; Hajdinjak, M; Kromer, B; Krumov, I; Marreiros, J; Martisius, NL; Paskulin, L; Sinet-Mathiot, V; Meyer, M; Paabo, S; Popov, V; Rezek, Z; Sirakova, S; Skinner, MM; Smith, GM; Spasov, R; Talamo, S; Tuna, T; Wacker, L; Welker, F; Wilcke, A; Zahariev, N; McPherron, SP; Tsanova, T				Hublin, Jean-Jacques; Sirakov, Nikolay; Aldeias, Vera; Bailey, Shara; Bard, Edouard; Delvigne, Vincent; Endarova, Elena; Fagault, Yoann; Fewlass, Helen; Hajdinjak, Mateja; Kromer, Bernd; Krumov, Ivaylo; Marreiros, Joao; Martisius, Naomi L.; Paskulin, Lindsey; Sinet-Mathiot, Virginie; Meyer, Matthias; Paabo, Svante; Popov, Vasil; Rezek, Zeljko; Sirakova, Svoboda; Skinner, Matthew M.; Smith, Geoff M.; Spasov, Rosen; Talamo, Sahra; Tuna, Thibaut; Wacker, Lukas; Welker, Frido; Wilcke, Arndt; Zahariev, Nikolay; McPherron, Shannon P.; Tsanova, Tsenka			Initial Upper Palaeolithic Homo sapiens from Bacho Kiro Cave Bulgaria	NATURE			English	Article							MITOCHONDRIAL GENOME SEQUENCE; MODERN HUMANS; GLUTAMINE DEAMIDATION; COLLAGEN EXTRACTION; DNA-SEQUENCES; ANCIENT BONES; NEANDERTHAL; HOMININ; CONTAMINATION; AGE	The Middle to Upper Palaeolithic transition in Europe witnessed the replacement and partial absorption of local Neanderthal populations by Homo sapiens populations of African origin(1). However, this process probably varied across regions and its details remain largely unknown. In particular, the duration of chronological overlap between the two groups is much debated, as are the implications of this overlap for the nature of the biological and cultural interactions between Neanderthals and H. sapiens. Here we report the discovery and direct dating of human remains found in association with Initial Upper Palaeolithic artefacts(2), from excavations at Bacho Kiro Cave (Bulgaria). Morphological analysis of a tooth and mitochondrial DNA from several hominin bone fragments, identified through proteomic screening, assign these finds to H. sapiens and link the expansion of Initial Upper Palaeolithic technologies with the spread of H. sapiens into the mid-latitudes of Eurasia before 45 thousand years ago(3). The excavations yielded a wealth of bone artefacts, including pendants manufactured from cave bear teeth that are reminiscent of those later produced by the last Neanderthals of western Europe(4-6). These finds are consistent with models based on the arrival of multiple waves of H. sapiens into Europe coming into contact with declining Neanderthal populations(7,8).	[Hublin, Jean-Jacques; Fewlass, Helen; Kromer, Bernd; Sinet-Mathiot, Virginie; Rezek, Zeljko; Skinner, Matthew M.; Smith, Geoff M.; Talamo, Sahra; Welker, Frido; McPherron, Shannon P.; Tsanova, Tsenka] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Hublin, Jean-Jacques] Coll France, Chaire Int Paleoanthropol, Paris, France; [Sirakov, Nikolay; Sirakova, Svoboda] Bulgarian Acad Sci, Natl Inst Archaeol Museum, Sofia, Bulgaria; [Aldeias, Vera; Marreiros, Joao] Univ Algarve, Interdisciplinary Ctr Archaeol & Evolut Human Beh, Faro, Portugal; [Bailey, Shara] NYU, Dept Anthropol, New York, NY 10003 USA; [Bard, Edouard; Fagault, Yoann; Tuna, Thibaut] Aix Marseille Univ, CEREGE, CNRS, IRD,INRAE, Aix En Provence, France; [Delvigne, Vincent] Univ Liege, Serv Prehistoire, Liege, Belgium; [Delvigne, Vincent] Univ Bordeaux, CNRS, UMR 5199 PACEA, Pessac, France; [Endarova, Elena] Natl Hist Museum, Sofia, Bulgaria; [Hajdinjak, Mateja; Meyer, Matthias; Paabo, Svante; Skinner, Matthew M.; Smith, Geoff M.] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Krumov, Ivaylo] Hist Museum, Belogradchik, Bulgaria; [Marreiros, Joao] RGZM, Monrepos Archaeol Res Ctr, TraCEr, Mainz, Germany; [Martisius, Naomi L.] RGZM, Museum Human Behav Evolut, Mainz, Germany; [Paskulin, Lindsey] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Popov, Vasil] Univ Aberdeen, Dept Archaeol, Aberdeen, Scotland; [Rezek, Zeljko] Bulgarian Acad Sci, Inst Biodivers & Ecosyst Res, Sofia, Bulgaria; [Skinner, Matthew M.] Univ Penn, Museum Archaeol & Anthropol, Philadelphia, PA 19104 USA; [Spasov, Rosen] Univ Kent, Sch Anthropol & Conservat, Canterbury, Kent, England; [Talamo, Sahra] New Bulgarian Univ, Dept Archaeol, Sofia, Bulgaria; [Wacker, Lukas] Univ Bologna, Dept Chem G Ciamician, Bologna, Italy; [Welker, Frido] Swiss Fed Inst Technol, Dept Earth Sci, Zurich, Switzerland; [Wilcke, Arndt] Univ Copenhagen, Globe Inst, Evolutionary Genom Sect, Copenhagen, Denmark; [Zahariev, Nikolay] Fraunhofer Inst Cell Therapy & Immunol, Dept Cell Therapy, Leipzig, Germany; New Bulgarian Univ, Dept Archaeol, Sofia, Bulgaria	Max Planck Society; UDICE-French Research Universities; PSL Research University Paris; College de France; Bulgarian Academy of Sciences; Universidade do Algarve; New York University; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; University of Liege; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Bulgarian Academy of Sciences; Max Planck Society; Leibniz-Forschungsinstitut fur Archaologie (RGZM); Leibniz-Forschungsinstitut fur Archaologie (RGZM); University of California System; University of California Davis; University of Aberdeen; Bulgarian Academy of Sciences; University of Pennsylvania; University of Kent; New Bulgarian University; University of Bologna; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Copenhagen; Fraunhofer Gesellschaft; New Bulgarian University	Hublin, JJ (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.; Hublin, JJ (corresponding author), Coll France, Chaire Int Paleoanthropol, Paris, France.	hublin@eva.mpg.de	Virginie, Sinet-Mathiot/AAW-6253-2020; Fewlass, Helen/AAW-7239-2020; Talamo, Sahra/AAD-1774-2022; Smith, Geoff/GSD-3294-2022	Virginie, Sinet-Mathiot/0000-0003-3228-5824; Fewlass, Helen/0000-0002-9093-3490; Talamo, Sahra/0000-0002-2406-3132; Smith, Geoff/0000-0001-7155-5140; Bailey, Shara/0000-0002-4626-9262; Hajdinjak, Mateja/0000-0002-4064-0331; Martisius, Naomi/0000-0002-4671-9366; Popov, Vasil/0000-0002-0446-1168	Max Planck Society; College de France; EQUIPEX ASTER-CEREGE; European Research Council under the European Union [803147-951]; European Research Council [694707]	Max Planck Society(Max Planck SocietyFoundation CELLEX); College de France; EQUIPEX ASTER-CEREGE; European Research Council under the European Union(European Research Council (ERC)); European Research Council(European Research Council (ERC)European Commission)	We thank the tourism association of Bacho Kiro Cave in the town of Dryanovo, the History museum - Dryanovo, the Regional History museum in the city of Gabrovo, Dryanovo town hall and V. Lafchiiski for their assistance with the fieldwork and in the laboratory; N. Spassov from the National Museum of Natural History in Sofia for cooperating and hosting researchers of our project; H. Temming and J. Honeyford for their technical assistance and S. Nagel, B. Nickel, B. Schellbach and A. Weihmann for their help with the ancient DNA laboratory procedures and sequencing. Field operations were funded by the Max Planck Society. AixMICADAS and its operation are funded by College de France and the EQUIPEX ASTER-CEREGE (principal investigator, E.B.). S.T. is funded by the European Research Council under the European Union's Horizon 2020 Research and Innovation Programme (grant agreement no. 803147-951 RESOLUTION). The ancient DNA part of this study was funded by the Max Planck Society and the European Research Council (grant agreement no. 694707 to S.P.).	Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bailey SE, 2011, AM J PHYS ANTHROPOL, V145, P505, DOI 10.1002/ajpa.21468; Bailey Shara E., 2002, Anatomical Record, V269, P148, DOI 10.1002/ar.10116; Benazzi S, 2015, SCIENCE, V348, P793, DOI 10.1126/science.aaa2773; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Brock F, 2007, RADIOCARBON, V49, P187, DOI 10.1017/S0033822200042107; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; Buckley M, 2009, RAPID COMMUN MASS SP, V23, P3843, DOI 10.1002/rcm.4316; Chase, 2009, CAVE FONTECHEVADE RE, P28; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dibble H., 1995, MIDDLE PALEOLITHIC S; Ermini L, 2008, CURR BIOL, V18, P1687, DOI 10.1016/j.cub.2008.09.028; Fewlass H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41557-8; Fewlass H, 2020, NAT ECOL EVOL, V4, P794, DOI 10.1038/s41559-020-1136-3; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gansauge MT, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx033; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Glocke I, 2017, GENOME RES, V27, P1230, DOI 10.1101/gr.219675.116; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; GUERIN C, 1982, Geobios (Villeurbanne), V15, P593, DOI 10.1016/S0016-6995(82)80076-4; Hedges R.E., 1994, ARCHAEOMETRY, V36, P337, DOI DOI 10.1111/J.1475-4754.1994.TB00975.X; Hershkovitz I, 2015, NATURE, V520, P216, DOI 10.1038/nature14134; Higham T, 2011, NATURE, V479, P521, DOI 10.1038/nature10484; HORAI S, 1992, J MOL EVOL, V35, P32, DOI 10.1007/BF00160258; Hublin JJ, 2015, QUATERNARY SCI REV, V118, P194, DOI 10.1016/j.quascirev.2014.08.011; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P18743, DOI 10.1073/pnas.1212924109; Hublin JJ, 1996, NATURE, V381, P224, DOI 10.1038/381224a0; Jaubert, 2008, SOC PALEOLITHIQUE GR, P83; Kallay J., 1963, P75; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keith A, 1913, Proc R Soc Med, V6, P103; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Kivisild T, 2015, INVESTIG GENET, V6, DOI 10.1186/s13323-015-0022-2; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Korlevic P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22472-w; Korlevic P, 2015, BIOTECHNIQUES, V59, P87, DOI 10.2144/000114320; Kozlowski, 1982, EXCAVATION BACHO KIR, P172; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Kuhn SL, 2004, J ANTHROPOL ARCHAEOL, V23, P431, DOI 10.1016/j.jaa.2004.09.001; Kuhn SL, 2014, QUATERN INT, V347, P29, DOI 10.1016/j.quaint.2014.05.040; Kuhn SL, 2009, J HUM EVOL, V56, P87, DOI 10.1016/j.jhevol.2008.07.014; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lippold Sebastian, 2014, Investig Genet, V5, P13, DOI 10.1186/2041-2223-5-13; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Lopez Varela, 2018, ENCY ARCHAEOLOGICAL, P1; Macphail, 1989, SOILS MICROMORPHOLOG, P344; Meyer M, 2016, NATURE, V531, P504, DOI 10.1038/nature17405; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Muller UC, 2011, QUATERNARY SCI REV, V30, P273, DOI 10.1016/j.quascirev.2010.11.016; Posth C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16046; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Ramsey CB, 2004, RADIOCARBON, V46, P155, DOI 10.1017/S0033822200039473; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Renaud G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0776-0; Renaud G, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku699; Richter D, 2017, NATURE, V546, P293, DOI 10.1038/nature22335; Rougier H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29005; Ruebens K, 2015, J HUM EVOL, V86, P55, DOI 10.1016/j.jhevol.2015.06.011; Sandgathe DM, 2018, CAVE KARST SYSTEMS, P1, DOI 10.1007/978-3-319-57524-7_1; Sawyer S, 2015, P NATL ACAD SCI USA, V112, P15696, DOI 10.1073/pnas.1519905112; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Shaw, 1938, TEETH BONY PALATE MA; Sinet-Mathiot V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48706-z; Skinner MM, 2009, AM J PHYS ANTHROPOL, V140, P234, DOI 10.1002/ajpa.21057; Skinner MM, 2008, J HUM EVOL, V55, P979, DOI 10.1016/j.jhevol.2008.08.013; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Slon V, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700186; Slon V, 2017, SCIENCE, V356, P605, DOI 10.1126/science.aam9695; Soressi M, 2013, P NATL ACAD SCI USA, V110, P14186, DOI 10.1073/pnas.1302730110; Stoops G., 2003, GUIDELINES ANAL DESC, P184; Tsanova T., 2003, P ESF WORKSH TSON TS, P41; Wacker L, 2010, RADIOCARBON, V52, P252, DOI 10.1017/S0033822200045288; Wacker L, 2010, NUCL INSTRUM METH B, V268, P931, DOI 10.1016/j.nimb.2009.10.067; Wacker L, 2010, NUCL INSTRUM METH B, V268, P976, DOI 10.1016/j.nimb.2009.10.078; Welker F, 2017, SCI TECHNOL ARCHAEOL, V3, P15, DOI 10.1080/20548923.2016.1258825; Welker F, 2016, P NATL ACAD SCI USA, V113, P11162, DOI 10.1073/pnas.1605834113; White M, 2012, EUR J ARCHAEOL, V15, P392, DOI 10.1179/1461957112Y.0000000019; White R., 2001, ATHENA REV, V2, P41, DOI DOI 10.1016/J.JHEVOL.2008.08.017; Wilson J, 2012, ANAL CHEM, V84, P9041, DOI 10.1021/ac301333t; Zilhao J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131181	93	105	106	6	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 21	2020	581	7808					299	+		10.1038/s41586-020-2259-z	http://dx.doi.org/10.1038/s41586-020-2259-z			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QP3KS	32433609	Green Accepted, Green Submitted			2022-12-28	WOS:000623736500001
J	Razai, MS; Oakeshott, P; Kankam, H; Galea, S; Stokes-Lampard, H				Razai, Mohammad S.; Oakeshott, Pippa; Kankam, Hadyn; Galea, Sandro; Stokes-Lampard, Helen			Mitigating the psychological effects of social isolation during the covid-19 pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							E-MENTAL HEALTH; LONELINESS; QUARANTINE; SCALE; MORTALITY; IMPACT		[Razai, Mohammad S.; Oakeshott, Pippa] St George Univ London, Populat Hlth Res Inst, London, England; [Kankam, Hadyn] St Georges Univ Hosp NHS Fdn Trust, London, England; [Galea, Sandro] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Stokes-Lampard, Helen] Univ Birmingham, Inst Clin Sci, Birmingham, W Midlands, England	St Georges University London; Boston University; University of Birmingham	Razai, MS (corresponding author), St George Univ London, Populat Hlth Res Inst, London, England.	mrazai@sgul.ac.uk	Galea, Sandro/GLR-6066-2022; Razai, Mohammad S/AAW-4269-2020	Razai, Mohammad S/0000-0002-6671-5557; Oakeshott, Pippa/0000-0003-2568-8211; Kankam, Hadyn K.N./0000-0002-2102-1797				Advice Services Alliance, 2015, ROL ADV SERV HLTH OU; Alderwick HAJ, 2018, AM J PREV MED, V54, P715, DOI 10.1016/j.amepre.2018.01.039; Andrews G, 2018, J ANXIETY DISORD, V55, P70, DOI 10.1016/j.janxdis.2018.01.001; Beaney T, 2020, BMJ OPINION; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8, 10.1016/S0140-6736(20)30460-8.]; Chavooshi B, 2016, PSYCHOSOMATICS, V57, P292, DOI 10.1016/j.psym.2016.01.001; Choi NG, 2014, AM J GERIAT PSYCHIAT, V22, P263, DOI 10.1016/j.jagp.2013.01.037; Courtin E, 2017, HEALTH SOC CARE COMM, V25, P799, DOI 10.1111/hsc.12311; Donaghy E, 2019, BRIT J GEN PRACT, V69, pE586, DOI 10.3399/bjgp19X704141; Drinkwater C, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l1285; Druss BG, 2020, JAMA PSYCHIAT, V77, P891, DOI 10.1001/jamapsychiatry.2020.0894; Durak M, 2010, EDUC GERONTOL, V36, P988, DOI 10.1080/03601271003756628; FERENCHICK EK, 2019, BMJ-BRIT MED J, V365, DOI DOI 10.1136/BMJ.L794; Gray E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017593; Greenhalgh T, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1182; Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703; Heath I, 1995, MYST GEN PRACT; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; Jensen A, 2017, PERSPECT PUBLIC HEAL, V137, P268, DOI 10.1177/1757913916676853; Jeong H, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016048; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Kurtz SM, 1996, MED EDUC, V30, P83, DOI 10.1111/j.1365-2923.1996.tb00724.x; Lal S, 2014, PSYCHIAT SERV, V65, P24, DOI 10.1176/appi.ps.201300009; Mahase E, 2018, PULSE; McKinstry B, 2009, BRIT J GEN PRACT, V59, P433, DOI 10.3399/bjgp09X420941; NHS England, 2020, SOC PRESCR COMM BAS; Office for National Statistics, 2019, INT US; Park IH, 2019, EDUC GERONTOL, V45, P581, DOI 10.1080/03601277.2019.1670908; Peplau L.A., 1982, LONELINESS SOURCEBOO, P1, DOI DOI 10.2307/2068915; Public Health England, 2020, GUID PUBL MENT HLTH; Reynolds DL, 2008, EPIDEMIOL INFECT, V136, P997, DOI 10.1017/S0950268807009156; Ridd M, 2009, BRIT J GEN PRACT, V59, P268, DOI 10.3399/bjgp09X420248; Shaw S, 2018, HLTH SERVICES DELIVE; Sprang G, 2013, DISASTER MED PUBLIC, V7, P105, DOI 10.1017/dmp.2013.22; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Taylor MR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-347; Teuton J., 2018, SOCIAL ISOLATION LON; Tsai HH, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-1426-2; van der Krieke L, 2014, PSYCHIAT SERV, V65, P33, DOI 10.1176/appi.ps.201300050; World Health Organisation,, 2020, MENT HLTH PSYCH CONS	42	92	94	3	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2020	369								m1904	10.1136/bmj.m1904	http://dx.doi.org/10.1136/bmj.m1904			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LV3JS	32439691	Green Accepted, Bronze			2022-12-28	WOS:000538336600001
J	Pillai, AS; Chandler, SA; Liu, Y; Signor, AV; Cortez-Romero, CR; Benesch, JLP; Laganowsky, A; Storz, JF; Hochberg, GKA; Thornton, JW				Pillai, Arvind S.; Chandler, Shane A.; Liu, Yang; Signor, Anthony, V; Cortez-Romero, Carlos R.; Benesch, Justin L. P.; Laganowsky, Arthur; Storz, Jay F.; Hochberg, Georg K. A.; Thornton, Joseph W.			Origin of complexity in haemoglobin evolution	NATURE			English	Article							3-DIMENSIONAL FOURIER SYNTHESIS; LIGAND-BINDING; GLOBIN GENE; PROTEIN; ALPHA; DIVERSIFICATION; RESOLUTION; OXYGEN; CYTOGLOBIN; MYOGLOBIN	Most proteins associate into multimeric complexes with specific architectures(1,2), which often have functional properties such as cooperative ligand binding or allosteric regulation(3). No detailed knowledge is available about how any multimer and its functions arose during evolution. Here we use ancestral protein reconstruction and biophysical assays to elucidate the origins of vertebrate haemoglobin, a heterotetramer of paralogous alpha- and beta-subunits that mediates respiratory oxygen transport and exchange by cooperatively binding oxygen with moderate affinity. We show that modern haemoglobin evolved from an ancient monomer and characterize the historical 'missing link' through which the modern tetramer evolved-a noncooperative homodimer with high oxygen affinity that existed before the gene duplication that generated distinct alpha- and beta-subunits. Reintroducing just two post-duplication historical substitutions into the ancestral protein is sufficient to cause strong tetramerization by creating favourable contacts with more ancient residues on the opposing subunit. These surface substitutions markedly reduce oxygen affinity and even confer cooperativity, because an ancient linkage between the oxygen binding site and the multimerization interface was already an intrinsic feature of the protein's structure. Our findings establish that evolution can produce new complex molecular structures and functions via simple genetic mechanisms that recruit existing biophysical features into higher-level architectures. Experimental analysis of reconstructed ancestral globins reveals that haemoglobin's complex tetrameric structure and oxygen-binding functions evolved by simple genetic and biophysical mechanisms.	[Pillai, Arvind S.; Hochberg, Georg K. A.; Thornton, Joseph W.] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA; [Chandler, Shane A.; Benesch, Justin L. P.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford, England; [Liu, Yang; Laganowsky, Arthur] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Signor, Anthony, V; Storz, Jay F.] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Cortez-Romero, Carlos R.] Univ Chicago, Program Cell & Mol Biol, Chicago, IL 60637 USA; [Thornton, Joseph W.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Hochberg, Georg K. A.] Max Planck Inst Terr Microbiol, Marburg, Germany	University of Chicago; University of Oxford; Texas A&M University System; Texas A&M University College Station; University of Nebraska System; University of Nebraska Lincoln; University of Chicago; University of Chicago; Max Planck Society	Thornton, JW (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.; Thornton, JW (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	joet1@uchicago.edu	Thornton, Joseph/GSN-4190-2022; Hochberg, Georg/AAC-4185-2021	Thornton, Joseph/0000-0001-9589-6994; Laganowsky, Arthur/0000-0001-5012-5547; Pillai, Arvind/0000-0002-5012-1199; Benesch, Justin/0000-0002-1507-3742; Signore, Anthony/0000-0002-0664-0864	NIH [R01-GM131128, R01-GM121931, R01-HL087216, T32-GM007197]; NSF [OIA-1736249]; Chicago Fellowship; BBSRC [BB/L017067/1]; Waters Corp.	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Chicago Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Waters Corp.	We thank C. Natarajan for technical advice and the Hb co-expression plasmid and members of the Thornton laboratory for technical advice and comments on the manuscript. Supported by NIH R01-GM131128 and R01-GM121931 (J.W.T.), NIH R01-HL087216 and NSF OIA-1736249 (J.F.S.), NIH T32-GM007197 (C.R.C.-R.), a Chicago Fellowship (G.K.A.H.), BBSRC BB/L017067/1 and Waters Corp. (J.L.P.B.).	ACKERS GK, 1980, BIOPHYS J, V32, P331, DOI 10.1016/S0006-3495(80)84960-5; Ahnert SE, 2015, SCIENCE, V350, DOI 10.1126/science.aaa2245; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; ARNONE A, 1972, NATURE, V237, P146, DOI 10.1038/237146a0; Arnone APM, 1974, NATURE, V249, P195; Barends TRM, 2015, SCIENCE, V350, P445, DOI 10.1126/science.aac5492; BENESCH R, 1968, P NATL ACAD SCI USA, V61, P1102, DOI 10.1073/pnas.61.3.1102; Blank M, 2011, J BIOL CHEM, V286, P26507, DOI 10.1074/jbc.M111.224634; BONAVENTURA C, 1980, AM ZOOL, V20, P131; COATES ML, 1975, J MOL EVOL, V6, P285, DOI 10.1007/BF01794636; Cong X, 2016, J AM CHEM SOC, V138, P4346, DOI 10.1021/jacs.6b01771; Coyle SM, 2013, CELL, V154, P875, DOI 10.1016/j.cell.2013.07.019; Darwin C, 1859, ORIGIN SPECIES MEANS; Dawkins R., 1997, CLIMBING MOUNT IMPRO; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; Fago A, 2018, BBA-PROTEINS PROTEOM, V1866, P283, DOI 10.1016/j.bbapap.2017.11.009; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Finnigan GC, 2012, NATURE, V481, P360, DOI 10.1038/nature10724; Garcia-Seisdedos H, 2017, NATURE, V548, P244, DOI 10.1038/nature23320; GELIN BR, 1983, J MOL BIOL, V171, P489, DOI 10.1016/0022-2836(83)90042-6; GOODMAN M, 1973, SYST ZOOL, V22, P508, DOI 10.2307/2412957; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; Grispo MT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375600; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Heaslet HA, 1999, STRUCT FOLD DES, V7, P517, DOI 10.1016/S0969-2126(99)80068-9; HOFFMAN SJ, 1990, P NATL ACAD SCI USA, V87, P8521, DOI 10.1073/pnas.87.21.8521; Hoffmann FG, 2007, MOL BIOL EVOL, V24, P1982, DOI 10.1093/molbev/msm127; Hoffmann FG, 2012, MOL BIOL EVOL, V29, P1735, DOI 10.1093/molbev/mss018; Imai K., 1982, ALLOSTERIC EFFECTS H; IMAIZUMI K, 1979, J BIOCHEM, V86, P1829, DOI 10.1093/oxfordjournals.jbchem.a132705; ISAACKS RE, 1980, AM ZOOL, V20, P115; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; Kidd RD, 2001, PROTEIN SCI, V10, P1739, DOI 10.1110/ps.11701; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar KK, 2014, ACTA CRYSTALLOGR F, V70, P1032, DOI 10.1107/S2053230X14012175; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lechauve C, 2010, FEBS J, V277, P2696, DOI [10.1111/j.1742-4658.2010.07686.x, 10.1111/j.1742-464X.2010.07686.x]; Lynch M, 2013, P NATL ACAD SCI USA, V110, pE2821, DOI 10.1073/pnas.1310980110; Makino M, 2006, ACTA CRYSTALLOGR D, V62, P671, DOI 10.1107/S0907444906013813; Manning LR, 1999, METHOD ENZYMOL, V306, P113; Marsh JA, 2015, ANNU REV BIOCHEM, V84, P551, DOI 10.1146/annurev-biochem-060614-034142; Marty MT, 2015, ANAL CHEM, V87, P4370, DOI 10.1021/acs.analchem.5b00140; Mihailescu MR, 2001, P NATL ACAD SCI USA, V98, P3773, DOI 10.1073/pnas.071493598; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Natarajan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020176; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; RICHARD V, 1993, J MOL BIOL, V233, P270, DOI 10.1006/jmbi.1993.1505; Rivalta I, 2012, P NATL ACAD SCI USA, V109, pE1428, DOI 10.1073/pnas.1120536109; Sato A, 2007, P NATL ACAD SCI USA, V104, P9627, DOI 10.1073/pnas.0611560104; Schwarze K, 2015, GENOME BIOL EVOL, V7, P1896, DOI 10.1093/gbe/evv114; Siddiq MA, 2017, CURR OPIN STRUC BIOL, V47, P113, DOI 10.1016/j.sbi.2017.07.003; Storz J., 2018, HEMOGLOBIN INSIGHTS; TYUMA I, 1966, BIOCHEMISTRY-US, V5, P2957, DOI 10.1021/bi00873a027; WEBER RE, 1988, ANNU REV PHYSIOL, V50, P161, DOI 10.1146/annurev.ph.50.030188.001113; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; ZUCKERKANDL E, 1965, SCI AM, V212, P110, DOI 10.1038/scientificamerican0565-110	62	41	41	7	57	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 28	2020	581	7809					480	+		10.1038/s41586-020-2292-y	http://dx.doi.org/10.1038/s41586-020-2292-y		MAY 2020	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX9ZL	32461643	Green Accepted, Green Submitted			2022-12-28	WOS:000534879300001
J	Dyer, C				Dyer, Clare			Agency is criticised over its investigation into baby's death from hypoxia	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2020	369								m2032	10.1136/bmj.m2032	http://dx.doi.org/10.1136/bmj.m2032			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JI	32430435				2022-12-28	WOS:000538335600011
J	Heinz, LX; Lee, J; Kapoor, U; Kartnig, F; Sedlyarov, V; Papakostas, K; Cesar-Razquin, A; Essletzbichler, P; Goldmann, U; Stefanovic, A; Bigenzahn, JW; Scorzoni, S; Pizzagalli, MD; Bensimon, A; Muller, AC; King, FJ; Li, J; Girardi, E; Mbow, ML; Whitehurst, CE; Rebsamen, M; Superti-Furga, G				Heinz, Leonhard X.; Lee, JangEun; Kapoor, Utkarsh; Kartnig, Felix; Sedlyarov, Vitaly; Papakostas, Konstantinos; Cesar-Razquin, Adrian; Essletzbichler, Patrick; Goldmann, Ulrich; Stefanovic, Adrijana; Bigenzahn, Johannes W.; Scorzoni, Stefania; Pizzagalli, Mattia D.; Bensimon, Ariel; Mueller, Andre C.; King, F. James; Li Jun; Girardi, Enrico; Mbow, M. Lamine; Whitehurst, Charles E.; Rebsamen, Manuele; Superti-Furga, Giulio			TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9	NATURE			English	Article							INTERFERON REGULATORY FACTOR; MASS-SPECTROMETRY; DENDRITIC CELLS; IKK-BETA; INNATE; SLC15A4; AUTOIMMUNITY; PATHOGENESIS; EXPRESSION; INSIGHTS	The interaction between TASL and SLC15A4 links endolysosomal Toll-like receptors to the transcription factor IRF5, providing a mechanistic explanation for the involvement of the complex in systemic lupus erythematosus. Toll-like receptors (TLRs) have a crucial role in the recognition of pathogens and initiation of immune responses(1-3). Here we show that a previously uncharacterized protein encoded by CXorf21-a gene that is associated with systemic lupus erythematosus(4,5)-interacts with the endolysosomal transporter SLC15A4, an essential but poorly understood component of the endolysosomal TLR machinery also linked to autoimmune disease(4,6-9). Loss of this type-I-interferon-inducible protein, which we refer to as 'TLR adaptor interacting with SLC15A4 on the lysosome' (TASL), abrogated responses to endolysosomal TLR agonists in both primary and transformed human immune cells. Deletion of SLC15A4 or TASL specifically impaired the activation of the IRF pathway without affecting NF-kappa B and MAPK signalling, which indicates that ligand recognition and TLR engagement in the endolysosome occurred normally. Extensive mutagenesis of TASL demonstrated that its localization and function relies on the interaction with SLC15A4. TASL contains a conserved pLxIS motif (in which p denotes a hydrophilic residue and x denotes any residue) that mediates the recruitment and activation of IRF5. This finding shows that TASL is an innate immune adaptor for TLR7, TLR8 and TLR9 signalling, revealing a clear mechanistic analogy with the IRF3 adaptors STING, MAVS and TRIF10,11. The identification of TASL as the component that links endolysosomal TLRs to the IRF5 transcription factor via SLC15A4 provides a mechanistic explanation for the involvement of these proteins in systemic lupus erythematosus(12-14).	[Heinz, Leonhard X.; Kapoor, Utkarsh; Kartnig, Felix; Sedlyarov, Vitaly; Papakostas, Konstantinos; Cesar-Razquin, Adrian; Essletzbichler, Patrick; Goldmann, Ulrich; Stefanovic, Adrijana; Bigenzahn, Johannes W.; Scorzoni, Stefania; Pizzagalli, Mattia D.; Bensimon, Ariel; Mueller, Andre C.; Girardi, Enrico; Rebsamen, Manuele; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria; [Lee, JangEun; King, F. James; Li Jun; Mbow, M. Lamine; Whitehurst, Charles E.] Boehringer Ingelheim Pharmaceut, Ridgefield, CT USA; [Superti-Furga, Giulio] Med Univ Vienna, Ctr Physiol & Pharmacol, Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Boehringer Ingelheim; Medical University of Vienna	Rebsamen, M; Superti-Furga, G (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria.; Superti-Furga, G (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Vienna, Austria.	mrebsamen@cemm.oeaw.ac.at; gsuperti@cemm.oeaw.ac.at	Rebsamen, Manuele/A-7980-2011; Kapoor, Utkarsh/B-8394-2017	Rebsamen, Manuele/0000-0001-6172-4211; Scorzoni, Stefania/0000-0002-2049-3688; Goldmann, Ulrich/0000-0003-1120-6912; Pizzagalli, Mattia/0000-0003-0074-1039; Whitehurst, Charles/0000-0003-3112-5458; Kapoor, Utkarsh/0000-0002-9406-3074; Sedlyarov, Vitaly/0000-0002-9872-3535; Stefanovic, Adrijana/0000-0002-5497-8843; Bigenzahn, Johannes/0000-0002-5214-4570; Heinz, Leonhard/0000-0002-6921-1493; Essletzbichler, Patrick/0000-0003-2237-0005; Mueller, Andre/0000-0002-0608-8176	Boehringer Ingelheim [BI-CeMM 238114]; Austrian Academy of Sciences; European Research Council (ERC) [AdG 695214]; Austrian Science Fund (FWF) [SFB F4711]	Boehringer Ingelheim(Boehringer Ingelheim); Austrian Academy of Sciences; European Research Council (ERC)(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank all members of the G.S.-F. laboratory, T. Pemovska, G. Boehmelt, T. Krausgruber and E. Salzer for discussions and feedback; the Proteomics and Metabolomics Facility (CeMM) for the proteomics analyses; the Biomedical Sequencing Facility (CeMM/Medical University of Vienna) for the NGS sequencing; the Core Facility Imaging of the Medical University of Vienna; and T. Maeda for kindly providing the CAL-1 cells. This work was supported by Boehringer Ingelheim (Research Collaboration Agreement BI-CeMM 238114 to L.X.H., UK, K.P., A.S. and M.R.), the Austrian Academy of Sciences (to G.S.-F., F.K., V.S. and A.C.-R.), the European Research Council (ERC AdG 695214 Game of Gates to G.S.-F., M.R., S.S., P.E., U.G., M.D.P., A.B. and E.G.) and Austrian Science Fund (FWF SFB F4711, to J.W.B.). Plasmids obtained through Addgene were a gift from F. Zhang, D. Trono and D. Golenbock.	Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arazi A, 2019, NAT IMMUNOL, V20, P902, DOI 10.1038/s41590-019-0398-x; Baccala R, 2013, P NATL ACAD SCI USA, V110, P2940, DOI 10.1073/pnas.1222798110; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; Bigenzahn JW, 2018, SCIENCE, V362, P1171, DOI 10.1126/science.aap8210; Blasius AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002915; Blasius AL, 2010, P NATL ACAD SCI USA, V107, P19973, DOI 10.1073/pnas.1014051107; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Blaszczyk M, 2019, BRIEF BIOINFORM, V20, P2299, DOI 10.1093/bib/bby080; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chen W, 2008, NAT STRUCT MOL BIOL, V15, P1213, DOI 10.1038/nsmb.1496; Choi Hyungwon, 2012, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0815s39; Chow KT, 2018, J IMMUNOL, V201, P3036, DOI 10.4049/jimmunol.1800221; Colas C, 2014, J IMMUNOL METHODS, V412, P1, DOI 10.1016/j.jim.2014.06.008; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Derr A, 2016, GENOME RES, V26, P1397, DOI 10.1101/gr.207902.116; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dosenovic P, 2015, IMMUNOL CELL BIOL, V93, P136, DOI 10.1038/icb.2014.82; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Eames HL, 2016, TRANSL RES, V167, P167, DOI 10.1016/j.trsl.2015.06.018; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Griffith AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32668-9; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harris VM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00578; Hu YJ, 2018, J IMMUNOL, V201, P652, DOI 10.4049/jimmunol.1800210; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kieser KJ, 2017, NAT REV IMMUNOL, V17, P376, DOI 10.1038/nri.2017.25; Kim S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6277; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Kobayashi T, 2014, IMMUNITY, V41, P375, DOI 10.1016/j.immuni.2014.08.011; Langefeld CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16021; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Libert C, 2010, NAT REV IMMUNOL, V10, P594, DOI 10.1038/nri2815; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Lopez-Pelaez M, 2014, P NATL ACAD SCI USA, V111, P17432, DOI 10.1073/pnas.1418399111; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maeda T, 2005, INT J HEMATOL, V81, P148, DOI 10.1532/IJH97.04116; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Marbach D, 2016, NAT METHODS, V13, P366, DOI [10.1038/NMETH.3799, 10.1038/nmeth.3799]; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Moulton VR, 2017, TRENDS MOL MED, V23, P615, DOI 10.1016/j.molmed.2017.05.006; Muskardin TLW, 2018, NAT REV RHEUMATOL, V14, P214, DOI 10.1038/nrrheum.2018.31; Nakamura N, 2014, NATURE, V509, P240, DOI 10.1038/nature13133; Newstead S, 2017, CURR OPIN STRUC BIOL, V45, P17, DOI 10.1016/j.sbi.2016.10.018; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Odhams CA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10106-2; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pelka K, 2016, IMMUNOL REV, V269, P60, DOI 10.1111/imr.12375; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pichlmair A, 2012, NATURE, V487, P486, DOI 10.1038/nature11289; Pollard KM, 2017, J IMMUNOL, V199, P3739, DOI 10.4049/jimmunol.1700332; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Ren JY, 2014, P NATL ACAD SCI USA, V111, P17438, DOI 10.1073/pnas.1418516111; Rudashevskaya EL, 2013, NAT PROTOC, V8, P75, DOI 10.1038/nprot.2012.133; Sasawatari S, 2011, GASTROENTEROLOGY, V140, P1513, DOI 10.1053/j.gastro.2011.01.041; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Steinhagen F, 2013, EUR J IMMUNOL, V43, P1896, DOI 10.1002/eji.201242792; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; The M, 2016, J AM SOC MASS SPECTR, V27, P1719, DOI 10.1007/s13361-016-1460-7; Troegeler A, 2014, IMMUNOL CELL BIOL, V92, P699, DOI 10.1038/icb.2014.39; Tsokos GC, 2016, NAT REV RHEUMATOL, V12, P716, DOI 10.1038/nrrheum.2016.186; Varjosalo M, 2013, NAT METHODS, V10, P307, DOI [10.1038/NMETH.2400, 10.1038/nmeth.2400]; Wright James C, 2016, J Proteomics Bioinform, V9, P176; Zhao BY, 2016, P NATL ACAD SCI USA, V113, pE3403, DOI 10.1073/pnas.1603269113	78	57	60	5	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY	2020	581	7808					316	+		10.1038/s41586-020-2282-0	http://dx.doi.org/10.1038/s41586-020-2282-0		MAY 2020	30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ2CZ	32433612	Green Accepted			2022-12-28	WOS:000532688300007
J	Schunemann, HJ; Khabsa, J; Solo, K; Khamis, AM; Brignardello-Petersen, R; El-Harakeh, A; Darzi, A; Hajizadeh, A; Bognanni, A; Bak, A; Izcovich, A; Cuello-Garcia, CA; Chen, C; Borowiack, E; Chamseddine, F; Schunemann, F; Morgano, GP; Muti-Schunemann, GEU; Chen, G; Zhao, H; Neumann, I; Brozek, J; Schmidt, J; Hneiny, L; Harrison, L; Reinap, M; Junek, M; Santesso, N; El-Khoury, R; Thomas, R; Nieuwlaat, R; Stalteri, R; Yaacoub, S; Lotfi, T; Baldeh, T; Piggott, T; Zhang, Y; Saad, Z; Rochwerg, B; Perri, D; Fan, E; Stehling, F; Akl, IB; Loeb, M; Garner, P; Aston, S; Alhazzani, W; Szczeklik, W; Chu, DK; Akl, EA				Schunemann, Holger J.; Khabsa, Joanne; Solo, Karla; Khamis, Assem M.; Brignardello-Petersen, Romina; El-Harakeh, Amena; Darzi, Andrea; Hajizadeh, Anisa; Bognanni, Antonio; Bak, Anna; Izcovich, Ariel; Cuello-Garcia, Carlos A.; Chen, Chen; Borowiack, Ewa; Chamseddine, Fatimah; Schunemann, Finn; Morgano, Gian Paolo; Muti-Schunemann, Giovanna E. U.; Chen, Guang; Zhao, Hong; Neumann, Ignacio; Brozek, Jan; Schmidt, Joel; Hneiny, Layal; Harrison, Leila; Reinap, Marge; Junek, Mats; Santesso, Nancy; El-Khoury, Rayane; Thomas, Rebecca; Nieuwlaat, Robby; Stalteri, Rosa; Yaacoub, Sally; Lotfi, Tamara; Baldeh, Tejan; Piggott, Thomas; Zhang, Yuan; Saad, Zahra; Rochwerg, Bram; Perri, Dan; Fan, Eddy; Stehling, Florian; Akl, Imad Bou; Loeb, Mark; Garner, Paul; Aston, Stephen; Alhazzani, Waleed; Szczeklik, Wojciech; Chu, Derek K.; Akl, Elie A.			Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19 A Living Systematic Review of Multiple Streams of Evidence	ANNALS OF INTERNAL MEDICINE			English	Review							FLOW NASAL CANNULA; CONVENTIONAL OXYGEN-THERAPY; ACUTE RESPIRATORY SYNDROME; HEALTH-CARE WORKERS; ENDOTRACHEAL INTUBATION; NONINVASIVE VENTILATION; MECHANICAL VENTILATION; FAILURE; GRADE; PRESSURE	Background: Mechanical ventilation is used to treat respiratory failure in coronavirus disease 2019 (COVID-19). Purpose: To review multiple streams of evidence regarding the benefits and harms of ventilation techniques for coronavirus infections, including that causing COVID-19. Data Sources: 21 standard, World Health Organization-specific and COVID-19-specific databases, without language restrictions, until 1 May 2020. Study Selection: Studies of any design and language comparing different oxygenation approaches in patients with coronavirus infections, including severe acute respiratory syndrome (SARS) or Middle East respiratory syndrome (MERS), or with hypoxemic respiratory failure. Animal, mechanistic, laboratory, and preclinical evidence was gathered regarding aerosol dispersion of coronavirus. Studies evaluating risk for virus transmission to health care workers from aerosol-generating procedures (AGPs) were included. Data Extraction: Independent and duplicate screening, data abstraction, and risk-of-bias assessment (GRADE for certainty of evidence and AMSTAR 2 for included systematic reviews). Data Synthesis: 123 studies were eligible (45 on COVID-19, 70 on SARS, 8 on MERS), but only 5 studies (1 on COVID-19, 3 on SARS, 1 on MERS) adjusted for important confounders. A study in hospitalized patients with COVID-19 reported slightly higher mortality with noninvasive ventilation (NIV) than with invasive mechanical ventilation (IMV), but 2 opposing studies, 1 in patients with MERS and 1 in patients with SARS, suggest a reduction in mortality with NIV (very-low-certainty evidence). Two studies in patients with SARS report a reduction in mortality with NIV compared with no mechanical ventilation (low-certainty evidence). Two systematic reviews suggest a large reduction in mortality with NIV compared with conventional oxygen therapy. Other included studies suggest increased odds of transmission from AGPs. Limitation: Direct studies in COVID-19 are limited and poorly reported. Conclusion: Indirect and low-certainty evidence suggests that use of NIV, similar to IMV, probably reduces mortality but may increase the risk for transmission of COVID-19 to health care workers. Primary Funding Source: World Health Organization. (PROSPERO: CRD42020178187)	[Schunemann, Holger J.; Solo, Karla; Brignardello-Petersen, Romina; Darzi, Andrea; Hajizadeh, Anisa; Bognanni, Antonio; Cuello-Garcia, Carlos A.; Schunemann, Finn; Morgano, Gian Paolo; Brozek, Jan; Schmidt, Joel; Harrison, Leila; Junek, Mats; Santesso, Nancy; Nieuwlaat, Robby; Stalteri, Rosa; Lotfi, Tamara; Baldeh, Tejan; Piggott, Thomas; Zhang, Yuan; Rochwerg, Bram; Perri, Dan; Loeb, Mark; Alhazzani, Waleed; Chu, Derek K.] McMaster Univ, HSC-2C,1280 Main St West, Hamilton, ON L8N 3Z5, Canada; [Khabsa, Joanne; El-Harakeh, Amena; Chamseddine, Fatimah; Hneiny, Layal; El-Khoury, Rayane; Yaacoub, Sally; Saad, Zahra; Akl, Imad Bou; Akl, Elie A.] Amer Univ Beirut, Med Ctr, Beirut 11072020, Lebanon; [Khamis, Assem M.] Univ Hull, Cottingham Rd, Kingston Upon Hull HU6 7RX, East Riding Of, England; [Bak, Anna; Borowiack, Ewa] Evidence Prime, Torunska 5, PL-30056 Krakow, Poland; [Izcovich, Ariel] German Hosp Buenos Aires, Pueyrredon 1640,C1118 AAT, Buenos Aires, DF, Argentina; [Chen, Chen] Guangzhou Univ Chinese Med, Jichang Rd 12, Guangzhou, Guangdong, Peoples R China; [Muti-Schunemann, Giovanna E. U.] Univ Vita Salute San Raffaele, Via Olgettina Milano 58, I-20132 Milan, Italy; [Chen, Guang] Beijing Univ Chinese Med, 5 HaiYun Cang, Beijing, Peoples R China; [Zhao, Hong] China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, 16 Nanxiaojie St, Beijing, Peoples R China; [Neumann, Ignacio] Pontificia Univ Catolica Chile, Alameda 340, Santiago, Chile; [Reinap, Marge] London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England; [Thomas, Rebecca; Garner, Paul] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Fan, Eddy] Toronto Gen Hosp, 585 Univ Ave,PMB 11-123, Toronto, ON M5G 2N2, Canada; [Stehling, Florian] Univ Essen Gesamthsch, Abt Padiat Pneumol, Klin Kinderheilkunde 3, Hufelandstr 55, D-45147 Essen, Germany; [Aston, Stephen] Liverpool Univ Hosp NHS Trust, Trop & Infect Dis Unit, Prescot St, Liverpool L7 8XP, Merseyside, England; [Szczeklik, Wojciech] Jagiellonian Univ Med Coll, Dept Intens Care & Perioperat Med, Krakow, Poland	McMaster University; American University of Beirut; University of Hull; Hospital Aleman; University of Buenos Aires; Guangzhou University of Chinese Medicine; Vita-Salute San Raffaele University; Beijing University of Chinese Medicine; China Academy of Chinese Medical Sciences; Institute of Acupuncture & Moxibustion, CACMS; Pontificia Universidad Catolica de Chile; University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Duisburg Essen; Jagiellonian University; Collegium Medicum Jagiellonian University	Schunemann, HJ (corresponding author), Michael G DeGroote Cochrane Canada, HSC-2C,1280 Main St West, Hamilton, ON L8N 3Z5, Canada.; Schunemann, HJ (corresponding author), McMaster Univ, McMaster GRADE Ctr, HSC-2C,1280 Main St West, Hamilton, ON L8N 3Z5, Canada.; Akl, EA (corresponding author), Amer Univ Beirut, Clin Res Inst, POB 11-0236 CRI E15, Beirut 11072020, Lebanon.; Akl, EA (corresponding author), Amer Univ Beirut, AUB GRADE Ctr, POB 11-0236 CRI E15, Beirut 11072020, Lebanon.	schuneh@mcmaster.ca; ea32@aub.edu.lb	Hneiny, Layal/AAU-7587-2020; Khamis, Assem/O-9365-2019; Akl, Elie/K-5269-2019; T, E/HII-8943-2022; Garner, Paul/HII-5856-2022; Stehling, Florian/AAX-9428-2020; Szczeklik, Wojciech/N-8096-2014; Neumann, Ignacio/ABB-5013-2020; Solo, Karla/I-4835-2018; Hnieny, Layal/AGQ-1697-2022; Reinap, Marge/ABC-3984-2020; Cuello-Garcia, Carlos/E-8620-2016	Hneiny, Layal/0000-0003-1073-4879; Khamis, Assem/0000-0002-5567-7065; Szczeklik, Wojciech/0000-0002-1349-1123; Cuello-Garcia, Carlos/0000-0002-1742-0242; Yaacoub, Sally/0000-0003-0819-1561; Baldeh, Tejan/0000-0001-9194-3319; Bognanni, Antonio/0000-0003-0128-903X; Chu, Derek/0000-0001-8269-4496; Garner, Paul/0000-0002-0607-6941; Lotfi, Tamara/0000-0001-6101-3946; Hajizadeh, Anisa/0000-0003-1919-5189; El Harakeh, Amena/0000-0003-4554-5875; Izcovich, Ariel/0000-0001-9053-4396; Junek, Mats/0000-0001-8416-3955; Darzi, Andrea/0000-0002-2498-1697; Khabsa, Joanne/0000-0002-4336-3501; Chen, Guang/0000-0001-6644-9618; Bou Akl, Imad/0000-0001-8984-6683; Piggott, Thomas/0000-0003-1643-5386; Reinap, Marge/0000-0001-5836-7516; Thomas, Rebecca/0000-0003-2607-000X; Aston, Stephen/0000-0002-0701-8364; Schunemann, Holger/0000-0003-3211-8479; Morgano, Gian Paolo/0000-0001-7577-7963	World Health Organization	World Health Organization(World Health Organization)	By the World Health Organization, which commissioned this review on 3 April 2020.	Adhikari U, 2019, RISK ANAL, V39, P2608, DOI 10.1111/risa.13389; Alanazi KH, 2019, INFECT CONT HOSP EP, V40, P79, DOI 10.1017/ice.2018.290; Alhazzani Waleed, 2020, Intensive Care Med, V46, P854, DOI [10.1007/s00134-020-06022-5, 10.1097/CCM.0000000000004363]; Alraddadi BM, 2019, INFLUENZA OTHER RESP, V13, P382, DOI 10.1111/irv.12635; Alraddadi BM, 2016, EMERG INFECT DIS, V22, P1915, DOI 10.3201/eid2211.160920; Anesi GL, 2020, UPTODATE; Angel L, 2020, ANN THORAC SURG, DOI [10.1016/j.athoracsur.2020.04.010, DOI 10.1016/J.ATH0RACSUR.2020.04.010]; [Anonymous], 2020, J NURSE TRAINING, DOI DOI 10.1080/07315724.2020.1751007; [Anonymous], 2020, NEW YORK TIMES STATE, DOI 10.1016/S2468-2667(20)30117-1; [Anonymous], 2020, ANN INTERN MED; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Auld S, 2020, ICU VENTILATOR MORTA, DOI [10.1101/2020.04.23.20076737, DOI 10.1101/2020.04.23.20076737]; Australian and New Zealand Intensive Care Society (ANZICS), 2020, ANZICS COVID 19 GUID; Berbenetz N, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005351.pub4; Bharadwaj SK, 2020, ARCH DIS CHILD FETAL, DOI [10.1136/archdischild-2019-318165, DOI 10.1136/ARCHDISCHILD-2019-318165]; Bocchile RL, 2019, COCHRANE DATABASE SY, V1, DOI 10.1002/ 14651858.CD011231.pub2; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Buchholz U, 2013, EURO SURVEILL, V18; Cai S J, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, P332, DOI 10.3760/cma.j.cn112147-20200222-00153; Chen WQ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-81; Chiang CH, 2004, MAYO CLIN PROC, V79, P1372, DOI 10.4065/79.11.1372; Chidini G, 2015, PEDIATRICS, V135, pE868, DOI 10.1542/peds.2014-1142; Choi WS, 2016, INFECT CHEMOTHER, V48, P118, DOI 10.3947/ic.2016.48.2.118; Duca A, PREPRINTS LANCET, DOI [10.2139/ssrn.3566170, DOI 10.2139/SSRN.3566170]; Fears A C, 2020, medRxiv, DOI 10.1101/2020.04.13.20063784; Fowler RA, 2004, AM J RESP CRIT CARE, V169, P1198, DOI 10.1164/rccm.200305-715OC; Garner P, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3507; Gattinoni L, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02880-z; Gattinoni L, 2020, AM J RESP CRIT CARE, V201, P1299, DOI 10.1164/rccm.202003-0817LE; Guo J, 2003, ZHONGGUO LINCHUANG Y, V31; Guo ZD, 2020, EMERG INFECT DIS, V26, P1586, DOI 10.3201/eid2607.200885; Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2013, J CLIN EPIDEMIOL, V66, P173, DOI 10.1016/j.jclinepi.2012.08.001; Hall AJ, 2014, EMERG INFECT DIS, V20, P2148, DOI 10.3201/eid2012.141211; He Y, 2020, PRACTICAL HOSP CLIN, V17, P59; Heinzerling A, 2020, MMWR-MORBID MORTAL W, V69, P472, DOI 10.15585/mmwr.mm6915e5; Higgins JP, 2019, COCHRANE HDB SYSTEMA; Hua DD, 2020, J PRACTICAL MED, P1; Hunter JC, 2016, EMERG INFECT DIS, V22, P647, DOI 10.3201/eid2204.151615; ICM Anaesthesia, 2020, CRIT CAR PREP MAN CO; Jat KR, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010473.pub3; Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6; Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797; Li H, 2003, J SHANXI MED U, V34; Li TS, 2007, J PHYSL 1, V580, P285, DOI [10.1113/jphysiol.2006.125336, DOI 10.1113/JPHYSI0L.2006.125336]; Liao X, 2020, CRITICAL CARE SEVERE, DOI [10.1101/2020.03.22.20041277, DOI 10.1101/2020.03.22.20041277]; Liu H, 2003, CRITICAL CARE MED CH, V15; Liu W, 2009, TROP MED INT HEALTH, V14, P52, DOI 10.1111/j.1365-3156.2009.02255.x; Liu X, 2020, WORKING PAPER; Loeb M, 2004, EMERG INFECT DIS, V10, P251, DOI 10.3201/eid1002.030838; Luo J, 2019, J PEDIATR-US, V215, P199, DOI 10.1016/j.jpeds.2019.07.059; Memish ZA, 2013, NEW ENGL J MED, V369, P884, DOI 10.1056/NEJMc1308698; Mo X, 2020, GUANGDONG MED, P1; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moskalewicz A, 2020, J CLIN EPIDEMIOL, V120, P94, DOI 10.1016/j.jclinepi.2019.12.013; Murad M.H., 2017, EVID BASED MED, V22, P85, DOI [10.1136/ebmed-2017-110668, DOI 10.1136/EBMED-2017-110668]; Nam HS, 2017, EPIDEMIOL HEALTH, V39, DOI 10.4178/epih.e2017052; National Health Service, 2020, AC US NONST ANT DRUG; Ng K, 2020, ANN INTERN MED, V172, P766, DOI 10.7326/L20-0175; Ni YN, 2018, AM J EMERG MED, V36, P226, DOI 10.1016/j.ajem.2017.07.083; Ni YN, 2017, CHEST, V151, P764, DOI 10.1016/j.chest.2017.01.004; Ou XF, 2017, CAN MED ASSOC J, V189, pE260, DOI 10.1503/cmaj.160570; Patel BK, 2016, JAMA-J AM MED ASSOC, V315, P2435, DOI 10.1001/jama.2016.6338; Pei Li-ying, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P271; Pyankov OV, 2018, J AEROSOL SCI, V115, P158, DOI 10.1016/j.jaerosci.2017.09.009; Qiangui L, 2004, CHINESE CRITICAL CAR, V16; Raboud J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010717; Rochwerg B, 2019, INTENS CARE MED, V45, P563, DOI 10.1007/s00134-019-05590-5; Santesso N, 2020, J CLIN EPIDEMIOL, V119, P126, DOI 10.1016/j.jclinepi.2019.10.014; Santesso N, 2016, J CLIN EPIDEMIOL, V74, P28, DOI 10.1016/j.jclinepi.2015.12.006; Scales DC, 2003, EMERG INFECT DIS, V9, P1205, DOI 10.3201/eid0910.030525; Schunemann HJ, 2015, SYST REV-LONDON, V4, DOI 10.1186/2046-4053-4-4; Shea BJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4008; Suarez-Garcia I, 2020, J HOSP INFECT, V106, P357, DOI 10.1016/j.jhin.2020.07.020; Teleman MD, 2004, EPIDEMIOL INFECT, V132, P797, DOI [10.1017/S0950268804002766, 10.1017/s0950268804002766]; Thayer KA, 2016, ENVIRON INT, V92-93, P585, DOI 10.1016/j.envint.2016.03.027; Wan GH, 2004, INFECT CONT HOSP EP, V25, P1113, DOI 10.1086/502353; Wang K, 2004, J CLIN ANESTHESIOLOG, V20; Wang K, 2020, INTENS CARE MED, V46, P1472, DOI 10.1007/s00134-020-06047-w; Wang K, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00653-z; Wells G, 2009, NEWCASTLE OTTAWA SCA; World Health Organization, 2020, MERS SIT UPD; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Xu XP, 2017, CRIT CARE MED, V45, pE727, DOI 10.1097/CCM.0000000000002361; Xu Y, 2010, CHINESE J RESP CRITI, V9, P575; Yam LYC, 2005, CHINESE MED J-PEKING, V118, P1413; Yang L, 2004, CRITICAL CARE MED CH, V16; Yang Z, 2003, ARMED POLICE MED, P563; Yu L, 2003, ICML; Zhao HY, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1760-8; Zheng X, 2019, EUR REV MED PHARMACO, V23, P4382, DOI 10.26355/eurrev_201905_17945; Zheng Z, 2004, J GUANGZHOU MED COLL, P21; Zhong Q, 2020, BRIT J ANAESTH, V124, P670, DOI 10.1016/j.bja.2020.03.007	95	69	72	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2020	173	3					204	+		10.7326/M20-2306	http://dx.doi.org/10.7326/M20-2306			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MW7BG	32442035	Green Accepted, Green Published			2022-12-28	WOS:000557186700008
J	Ackermann, M; Verleden, SE; Kuehnel, M; Haverich, A; Welte, T; Laenger, F; Vanstapel, A; Werlein, C; Stark, H; Tzankov, A; Li, WW; Li, VW; Mentzer, SJ; Jonigk, D				Ackermann, Maximilian; Verleden, Stijn E.; Kuehnel, Mark; Haverich, Axel; Welte, Tobias; Laenger, Florian; Vanstapel, Arno; Werlein, Christopher; Stark, Helge; Tzankov, Alexandar; Li, William W.; Li, Vincent W.; Mentzer, Steven J.; Jonigk, Danny			Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFECTION	BackgroundProgressive respiratory failure is the primary cause of death in the coronavirus disease 2019 (Covid-19) pandemic. Despite widespread interest in the pathophysiology of the disease, relatively little is known about the associated morphologic and molecular changes in the peripheral lung of patients who die from Covid-19. MethodsWe examined 7 lungs obtained during autopsy from patients who died from Covid-19 and compared them with 7 lungs obtained during autopsy from patients who died from acute respiratory distress syndrome (ARDS) secondary to influenza A(H1N1) infection and 10 age-matched, uninfected control lungs. The lungs were studied with the use of seven-color immunohistochemical analysis, micro-computed tomographic imaging, scanning electron microscopy, corrosion casting, and direct multiplexed measurement of gene expression. ResultsIn patients who died from Covid-19-associated or influenza-associated respiratory failure, the histologic pattern in the peripheral lung was diffuse alveolar damage with perivascular T-cell infiltration. The lungs from patients with Covid-19 also showed distinctive vascular features, consisting of severe endothelial injury associated with the presence of intracellular virus and disrupted cell membranes. Histologic analysis of pulmonary vessels in patients with Covid-19 showed widespread thrombosis with microangiopathy. Alveolar capillary microthrombi were 9 times as prevalent in patients with Covid-19 as in patients with influenza (P<0.001). In lungs from patients with Covid-19, the amount of new vessel growth - predominantly through a mechanism of intussusceptive angiogenesis - was 2.7 times as high as that in the lungs from patients with influenza (P<0.001). ConclusionsIn our small series, vascular angiogenesis distinguished the pulmonary pathobiology of Covid-19 from that of equally severe influenza virus infection. The universality and clinical implications of our observations require further research to define. (Funded by the National Institutes of Health and others.) Autopsy examination of lungs from seven patients who died from Covid-19 showed intussusceptive angiogenesis in greater profusion than was found in lungs from patients who died from influenza or in uninfected lungs that were rejected for transplantation.	[Ackermann, Maximilian] Univ Witten Herdecke, Inst Pathol, Helios Univ Clin Wuppertal, Wuppertal, Germany; [Ackermann, Maximilian] Univ Witten Herdecke, Dept Mol Pathol, Helios Univ Clin Wuppertal, Wuppertal, Germany; [Ackermann, Maximilian] Johannes Gutenberg Univ Mainz, Inst Funct & Clin Anat, Mainz, Germany; [Kuehnel, Mark; Laenger, Florian; Werlein, Christopher; Stark, Helge; Jonigk, Danny] Hannover Med Sch, Inst Pathol, Hannover, Germany; [Haverich, Axel] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany; [Welte, Tobias] Hannover Med Sch, Clin Pneumol, Hannover, Germany; [Kuehnel, Mark; Haverich, Axel; Welte, Tobias; Laenger, Florian; Werlein, Christopher; Stark, Helge; Jonigk, Danny] German Ctr Lung Res Biomed Res Endstage & Obstruc, Hannover, Germany; [Verleden, Stijn E.; Vanstapel, Arno] Katholieke Univ Leuven, Lab Resp Dis, BREATH, Dept Chron Dis Metab & Aging, Leuven, Belgium; [Tzankov, Alexandar] Univ Hosp Basel, Inst Pathol & Med Genet, Basel, Switzerland; [Li, William W.; Li, Vincent W.] Angiogenesis Fdn, Cambridge, England; [Mentzer, Steven J.] Harvard Med Sch, Lab Adapt & Re generat Biol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Mentzer, Steven J.] Harvard Med Sch, Div Thorac Surg, Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Witten Herdecke University; Witten Herdecke University; Johannes Gutenberg University of Mainz; Hannover Medical School; Hannover Medical School; Hannover Medical School; KU Leuven; University of Basel; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Mentzer, SJ (corresponding author), Harvard Med Sch, Div Thorac Surg, Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	smentzer@bwh.harvard.edu	Haverich, Axel/AAC-7552-2022; Vanstapel, Arno/AAD-6103-2020; Tzankov, Alexandar/H-5656-2019	Vanstapel, Arno/0000-0003-2412-8001; Tzankov, Alexandar/0000-0002-1100-3819; Verleden, Stijn/0000-0002-9656-5844; Laenger, Florian/0000-0003-1191-4855	National Institutes of Health [HL94567, HL134229]; Botnar Research Centre for Child Health; European Research Council Consolidator Grant (XHale) from Deutsche Forschungsgemeinschaft [771883, KFO311]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Botnar Research Centre for Child Health; European Research Council Consolidator Grant (XHale) from Deutsche Forschungsgemeinschaft	Supported by grants (HL94567 and HL134229, to Drs. Ackermann and Mentzer) from the National Institutes of Health, a grant from the Botnar Research Centre for Child Health (to Dr. Tzankov), a European Research Council Consolidator Grant (XHale) (771883, to Dr. Jonigk), and a grant (KFO311, to Dr. Jonigk) from Deutsche Forschungsgemeinschaft (Project Z2). Disclosure forms provided by the authors are available with the full text of this article at NEJM.org. We thank Kerstin Bahr, Jan Hinrich Braesen, Peter Braubach, Emily Brouwer, Annette Mueller Brechlin, Regina Engel-hardt, Jasmin Haslbauer, Anne Hoefer, Nicole Kroenke, Thomas Menter, Mahtab Taleb Naghsh, Christina Petzold, Vincent Schmidt, and Pauline Tittmann for technical support; Peter Boor of the German Covid-19 registry; and Lynnette Sholl, Hans Kreipe, Hans Michael Kvasnicka, and Jean Connors for helpful comments. Dr. Jonigk thanks Anita Swiatlak for her continued support.	Ackermann M, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00933-2019; Alsaad KO, 2018, HISTOPATHOLOGY, V72, P516, DOI 10.1111/his.13379; [Anonymous], 2020, LANCET, DOI DOI 10.1016/S0140-6736(20)30183-5; Barton LM, 2020, AM J CLIN PATHOL, V153, P725, DOI [10.1093/AJCP/AQAA062, 10.1093/ajcp/aqaa062]; Buja LM, 2020, CARDIOVASC PATHOL, V48, DOI 10.1016/j.carpath.2020.107233; Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; KATZENSTEIN ALA, 1976, AM J PATHOL, V85, P210; Liu PP, 2020, CIRCULATION, V142, P68, DOI 10.1161/CIRCULATIONAHA.120.047549; Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007; McGonagle D, 2020, LANCET RHEUMATOL, V2, pE437, DOI 10.1016/S2665-9913(20)30121-1; Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134; Mentzer SJ, 2014, ANGIOGENESIS, V17, P499, DOI 10.1007/s10456-014-9428-3; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Porfidia A, 2020, J THROMB HAEMOST; Raptis CA, 2020, AM J ROENTGENOL, V215, P839, DOI 10.2214/AJR.20.23202; Scholten EL, 2017, CHEST, V151, P215, DOI 10.1016/j.chest.2016.06.032; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]; Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Voltersvik P, 2016, INFLUENZA OTHER RESP, V10, P525, DOI 10.1111/irv.12410; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Zhu JY, 2020, J MED VIROL, V92, P1902, DOI [10.1002/jmv.25884, 10.1002/jmv.26085]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	25	2912	2993	38	172	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2020	383	2					120	128		10.1056/NEJMoa2015432	http://dx.doi.org/10.1056/NEJMoa2015432			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR9PO	32437596	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000571894800011
J	Bost, P; Giladi, A; Liu, Y; Bendjelal, Y; Xu, G; David, E; Blecher-Gonen, R; Cohen, M; Medaglia, C; Li, HJ; Deczkowska, A; Zhang, SY; Schwikowski, B; Zhang, Z; Amit, I				Bost, Pierre; Giladi, Amir; Liu, Yang; Bendjelal, Yanis; Xu, Gang; David, Eyal; Blecher-Gonen, Ronnie; Cohen, Merav; Medaglia, Chiara; Li, Hanjie; Deczkowska, Aleksandra; Zhang, Shuye; Schwikowski, Benno; Zhang, Zheng; Amit, Ido			Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients	CELL			English	Article							SINGLE-CELL ANALYSIS; RNA-SEQ; IMMUNE-RESPONSES; EXPRESSION; VIRUS; RECONSTRUCTION	Viruses are a constant threat to global health as highlighted by the current COVID-19 pandemic. Currently, lack of data underlying how the human host interacts with viruses, including the SARS-CoV-2 virus, limits effective therapeutic intervention. We introduce Viral-Track, a computational method that globally scans unmapped single-cell RNA sequencing (scRNA-seq) data for the presence of viral RNA, enabling transcriptional cell sorting of infected versus bystander cells. We demonstrate the sensitivity and specificity of Viral-Track to systematically detect viruses from multiple models of infection, including hepatitis B virus, in an unsupervised manner Applying Viral-Track to bronchoalveloar-lavage samples from severe and mild COVID-19 patients reveals a dramatic impact of the virus on the immune system of severe patients compared to mild cases. Viral-Track detects an unexpected co-infection of the human metapneumovirus, present mainly in monocytes perturbed in type-I interferon (IFN)-signaling. Viral-Track provides a robust technology for dissecting the mechanisms of viral-infection and pathology.	[Bost, Pierre; Giladi, Amir; David, Eyal; Blecher-Gonen, Ronnie; Cohen, Merav; Medaglia, Chiara; Li, Hanjie; Deczkowska, Aleksandra; Amit, Ido] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Bost, Pierre; Bendjelal, Yanis; Schwikowski, Benno] Inst Pasteur, Dept Computat Biol, Syst Biol Grp, F-75015 Paris, France; [Bost, Pierre; Bendjelal, Yanis; Schwikowski, Benno] Inst Pasteur, USR 3756, F-75015 Paris, France; [Bost, Pierre; Bendjelal, Yanis; Schwikowski, Benno] CNRS, F-75015 Paris, France; [Bost, Pierre] Sorbonne Univ, Complexite Vivant, F-75005 Paris, France; [Liu, Yang; Xu, Gang; Zhang, Zheng] Southern Univ Sci & Technol, Shenzhen Peoples Hosp 3, Natl Clin Res Ctr Infect Dis, Sch Med,Inst Hepatol, Shenzhen 518112, Guangdong, Peoples R China; [Zhang, Shuye] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 201508, Peoples R China; [Zhang, Shuye] Fudan Univ, Inst Biomed Sci, Shanghai 201508, Peoples R China	Weizmann Institute of Science; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Southern University of Science & Technology; Fudan University; Fudan University	Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, Rehovot, Israel.; Schwikowski, B (corresponding author), Inst Pasteur, Dept Computat Biol, Syst Biol Grp, F-75015 Paris, France.; Schwikowski, B (corresponding author), Inst Pasteur, USR 3756, F-75015 Paris, France.; Schwikowski, B (corresponding author), CNRS, F-75015 Paris, France.; Zhang, Z (corresponding author), Southern Univ Sci & Technol, Shenzhen Peoples Hosp 3, Natl Clin Res Ctr Infect Dis, Sch Med,Inst Hepatol, Shenzhen 518112, Guangdong, Peoples R China.	benno@pasteur.fr; zhangzheng1975@aliyun.com; ido.amit@weizmann.ac.il	Zhang, Shuye/ABG-7815-2021	Zhang, Shuye/0000-0002-4749-6790; Blecher, Ronnie/0000-0003-2847-1149; Bost, Pierre/0000-0003-1498-9385; Liu, Yang/0000-0002-5221-7725	Merck KGaA (Darmstadt, Germany); Chan Zuckerberg Initiative (CZI); HHMI International Scholar award; European Research Council Consolidator Grant (ERC-COG) [724471-HemTree2.0]; SCA award from the Wolfson Foundation; Thompson Family Foundation; Israel Science Foundation [703/15]; Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; NeuroMac DFG/Transregional Collaborative Research Center grant; International Progressive MS Alliance/NMSS [PA1604 08459]; Adelis Foundation; Ecole Normale Supe' rieure, Paris; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases'' [ANR-10-LABX-62-IBEID]; National Natural Science Foundation of China [91442127, 81700540]; MRA Established Investigator Award [509044]	Merck KGaA (Darmstadt, Germany); Chan Zuckerberg Initiative (CZI); HHMI International Scholar award(Howard Hughes Medical Institute); European Research Council Consolidator Grant (ERC-COG); SCA award from the Wolfson Foundation; Thompson Family Foundation; Israel Science Foundation(Israel Science Foundation); Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; NeuroMac DFG/Transregional Collaborative Research Center grant; International Progressive MS Alliance/NMSS; Adelis Foundation; Ecole Normale Supe' rieure, Paris; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases''(French National Research Agency (ANR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MRA Established Investigator Award	We thank Dr. Noam Stern Ginossar and Dr. Yoav Golan for careful evaluation of the manuscript; Dr. Etienne Simon-Loriere, Thomas Jacquemont, and Alice Balfourier for valuable advices; Tali Wiesel from the Scientific Illustration unit of the Weizmann Institute for artwork; and members of the Amit laboratory for discussions. I.A. is an Eden and Steven Romick Professorial Chair and supported by Merck KGaA (Darmstadt, Germany), the Chan Zuckerberg Initiative (CZI), an HHMI International Scholar award, the European Research Council Consolidator Grant (ERC-COG) 724471-HemTree2.0, an SCA award from the Wolfson Foundation and Family Charitable Trust, the Thompson Family Foundation, an MRA Established Investigator Award (509044), the Israel Science Foundation (703/15), the Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine, the Helen and Martin Kimmel award for innovative investigation, a NeuroMac DFG/Transregional Collaborative Research Center grant, an International Progressive MS Alliance/NMSS (PA1604 08459), and an Adelis Foundation grant. P.B. is supported by a PhD scholarship from the Ecole Normale Supe ' rieure, Paris. B.S. has received funding from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases'' (ANR-10-LABX-62-IBEID). Z.Z. and Y.L. were supported by fundings from the National Natural Science Foundation of China (91442127 to Z.Z.; 81700540 to Y.L.).	[Anonymous], 2020, UMAP UNIFORM MANIFOL; Bailey JR, 2019, GASTROENTEROLOGY, V156, P418, DOI 10.1053/j.gastro.2018.08.060; Baran Y, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1812-2; Beier JI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122839; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blecher-Gonen R, 2019, CELL SYST, V8, P109, DOI 10.1016/j.cels.2019.01.001; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bradley T, 2018, CELL REP, V25, P107, DOI 10.1016/j.celrep.2018.09.020; Burrell CJ, 2017, FENNER WHITES MED VI, V5th; Burton DR, 2019, NAT REV IMMUNOL, V19, P77, DOI 10.1038/s41577-018-0103-6; Chan PKS, 2003, EMERG INFECT DIS, V9, P1058; Chen J., 2020, J ZHEJIANG U MED SCI, V49, DOI [10.3785/j.issn.1008-9292.2020. 03.030, DOI 10.3785/J.ISSN.1008-9292.2020.03.030]; De Baets S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121491; Deffrasnes C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005478; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drayman N, 2019, ELIFE, V8, DOI 10.7554/eLife.46339; Dubois J, 2014, MBIO, V5, DOI 10.1128/mBio.00070-14; Faure-Dupuy S, 2019, J HEPATOL, V71, P1086, DOI 10.1016/j.jhep.2019.06.032; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Griffiths JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05083-x; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; HALLER O, 1980, NATURE, V283, P660, DOI 10.1038/283660a0; Harris ML, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003648; Hayashi T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02866-0; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Herold T., 2020, J ALLERGY CLIN IMMUN, DOI 10.1101/2020.04.01.20047381; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Itzhaki RF, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00324; Iwasaki A, 2020, NAT REV IMMUNOL, V20, P339, DOI 10.1038/s41577-020-0321-6; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Keren-Shaul H, 2019, NAT PROTOC, V14, P1841, DOI 10.1038/s41596-019-0164-4; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Lake BB, 2018, NAT BIOTECHNOL, V36, P70, DOI 10.1038/nbt.4038; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao M., 2020, MEDRXIV; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158; Lu HK, 2009, J BIOL CHEM, V284, P34839, DOI 10.1074/jbc.M109.035683; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; Medaglia C, 2017, SCIENCE, V358, P1622, DOI 10.1126/science.aao4277; Moustafa A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006292; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Muller S, 2002, J VIROL, V76, P2375, DOI 10.1128/JVI.76.5.2375-2383.2002; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Panda S, 2014, INT J INFECT DIS, V25, P45, DOI 10.1016/j.ijid.2014.03.1394; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y; Prompetchara E, 2020, ASIAN PAC J ALLERGY, V38, P1, DOI 10.12932/AP-200220-0772; Shnayder M, 2018, MBIO, V9, DOI 10.1128/mBio.00013-18; Silverman J. D., 2018, NAUGHT ALL ZEROS SEQ, DOI [10.1101/477794, DOI 10.1101/477794]; Smith T, 2017, GENOME RES, V27, P491, DOI 10.1101/gr.209601.116; Stano M, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw162; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svensson V., 2019, QUANTIFYING TRADEOFF; Svensson V, 2020, NAT BIOTECHNOL, V38, P147, DOI 10.1038/s41587-019-0379-5; Townes FW, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1861-6; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; [王科雯 Wang Kewen], 2020, [测绘通报, Bulletin of Surveying and Mapping], P1; Wang X.., 2020, FRONT CELL INFECT MI, DOI [10.1101/2020.03.20.20039818, DOI 10.1101/2020.03.20.20039818]; Xie C, 2020, PROC ASME CONF SMART; Yang SY, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-1950-6; Yofe I, 2020, NAT MED, V26, P171, DOI 10.1038/s41591-019-0736-4; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zanini F, 2018, P NATL ACAD SCI USA, V115, pE12363, DOI 10.1073/pnas.1813819115; Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	73	239	246	10	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2020	181	7					1475	+		10.1016/j.cell.2020.05.006	http://dx.doi.org/10.1016/j.cell.2020.05.006			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MD2SA	32479746	Bronze, Green Published			2022-12-28	WOS:000543822100008
J	Jacobsen, JC; Tran, KM; Jackson, VA; Rubin, EB				Jacobsen, Juliet C.; Tran, Kathy M.; Jackson, Vicki A.; Rubin, Emily B.			Case 19-2020: A 74-Year-Old Man with Acute Respiratory Failure and Unclear Goals of Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITAL CARDIAC-ARREST; CODE STATUS DISCUSSIONS; SHARED DECISION-MAKING; END; RESUSCITATION; SURVIVAL; LIFE; RECOMMENDATIONS; COMMUNICATION; INFORMATION	A 74-year-old man with lymphoma was admitted to the hospital during the Covid-19 pandemic because of rapidly progressive respiratory failure. Several years earlier, when he had been critically ill, he had expressed a desire for "do not resuscitate" status. More recently, he had indicated that he would try all therapies that may be helpful. A consultation was requested.	[Jacobsen, Juliet C.; Tran, Kathy M.; Jackson, Vicki A.; Rubin, Emily B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Jacobsen, Juliet C.; Tran, Kathy M.; Jackson, Vicki A.; Rubin, Emily B.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Jacobsen, JC (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Alfandre David, 2016, J Clin Ethics, V27, P21; Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Back AL, 2008, CANCER-AM CANCER SOC, V113, P1897, DOI 10.1002/cncr.23653; Back AL, 2011, ONCOLOGIST, V16, P342, DOI 10.1634/theoncologist.2010-0274; Baker Mike, 2020, NEW YORK TIMES; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Berkey FJ, 2018, AM FAM PHYSICIAN, V98, P99; Blinderman CD, 2012, JAMA-J AM MED ASSOC, V307, P917, DOI 10.1001/jama.2012.236; Curtis JR, 2008, J PALLIAT MED, V11, P610, DOI 10.1089/jpm.2007.0209; Curtis JR, 2020, JAMA-J AM MED ASSOC, V323, P1771, DOI 10.1001/jama.2020.4894; Cwrtis JR, 2007, CHEST, V132, P748, DOI 10.1378/chest.07-0745; de Vreede-Swagemakers JJM, 1998, HEART, V79, P356, DOI 10.1136/hrt.79.4.356; Einstein DJ, 2016, JAMA ONCOL, V2, P429, DOI 10.1001/jamaoncol.2015.6349; Einstein DJ, 2015, J PALLIAT MED, V18, P535, DOI 10.1089/jpm.2014.0373; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Evans LR, 2009, AM J RESP CRIT CARE, V179, P48, DOI 10.1164/rccm.200806-969OC; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; GREENE HL, 1990, AM J CARDIOL, V65, pB4; Herlitz J, 2002, HEART, V88, P579, DOI 10.1136/heart.88.6.579; Hoffmann TC, 2014, JAMA-J AM MED ASSOC, V312, P1295, DOI 10.1001/jama.2014.10186; Isenschmid C, 2019, RESUSCITATION, V136, P21, DOI 10.1016/j.resuscitation.2018.10.022; Jackson VA, 2013, J PALLIAT MED, V16, P894, DOI 10.1089/jpm.2012.0547; Jacobsen J, 2018, J PAIN SYMPTOM MANAG, V55, P1229, DOI 10.1016/j.jpainsymman.2017.12.488; Jacobsen J, 2011, J PALLIAT MED, V14, P331, DOI 10.1089/jpm.2010.0383; Klitzman R, 2020, NEW YORK TIMES; Kutner JS, 1999, SOC SCI MED, V48, P1341, DOI 10.1016/S0277-9536(98)00453-5; Laffey JG, 2016, INTENS CARE MED, V42, P1865, DOI 10.1007/s00134-016-4571-5; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1282; MARWICK TH, 1991, RESUSCITATION, V22, P129, DOI 10.1016/0300-9572(91)90003-H; Muscedere J, 2017, INTENS CARE MED, V43, P1105, DOI 10.1007/s00134-017-4867-0; Portanova J, 2015, RESUSCITATION, V96, P148, DOI 10.1016/j.resuscitation.2015.08.002; Prochaska MT, 2015, J PAIN SYMPTOM MANAG, V50, P693, DOI 10.1016/j.jpainsymman.2015.05.004; Quill TE, 1996, ANN INTERN MED, V125, P763, DOI 10.7326/0003-4819-125-9-199611010-00010; Rea TD, 2003, CIRCULATION, V107, P2780, DOI 10.1161/01.CIR.0000070950.17208.2A; Rea Thomas D, 2004, Curr Opin Crit Care, V10, P218, DOI 10.1097/01.ccx.0000125494.84614.fb; Schenker Y, 2013, J PALLIAT MED, V16, P243, DOI 10.1089/jpm.2012.0331; Sepucha KR, 2016, HEALTH AFFAIR, V35, P630, DOI 10.1377/hlthaff.2015.1376; Sharma RK, 2014, J GEN INTERN MED, V29, P750, DOI 10.1007/s11606-014-2791-3; Singer PA, 1998, ARCH INTERN MED, V158, P879, DOI 10.1001/archinte.158.8.879; Sudore RL, 2010, ANN INTERN MED, V153, P256, DOI 10.7326/0003-4819-153-4-201008170-00008; White DB, 2010, CRIT CARE MED, V38, P743, DOI 10.1097/CCM.0b013e3181c58842; Wong MKY, 2014, CIRCULATION, V130, P1883, DOI 10.1161/CIRCULATIONAHA.114.010633; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	43	4	4	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2020	382	25					2450	2457		10.1056/NEJMcpc2002419	http://dx.doi.org/10.1056/NEJMcpc2002419			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MF9FX	32459917	Bronze			2022-12-28	WOS:000545644400011
J	Lee, N; McGeer, A				Lee, Nelson; McGeer, Allison			The starting line for COVID-19 vaccine development	LANCET			English	Editorial Material							DOUBLE-BLIND		[Lee, Nelson] Univ Alberta, Div Infect Dis, Dept Med, Fac Med & Dent, Edmonton, AB T6G 2G3, Canada; [McGeer, Allison] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [McGeer, Allison] Sinai Hlth Syst, Toronto, ON, Canada	University of Alberta; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Lee, N (corresponding author), Univ Alberta, Div Infect Dis, Dept Med, Fac Med & Dent, Edmonton, AB T6G 2G3, Canada.	laishunn@ualberta.ca	Lee, Nelson/B-6418-2008	Lee, Nelson/0000-0002-0783-6607				Agrawal AS, 2016, HUM VACC IMMUNOTHER, V12, P2351, DOI 10.1080/21645515.2016.1177688; Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025; Braun J., 2020, PRESENCE SARS COV 2, DOI [DOI 10.1101/2020.04.17.20061440, 10.1101/2020.04.17.20061440]; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Hotez PJ, 2020, NAT REV IMMUNOL, P1; Lurie N, 2020, NEW ENGL J MED, V382, P1969, DOI 10.1056/NEJMp2005630; Le TT, 2020, NAT REV DRUG DISCOV, V19, P305, DOI 10.1038/d41573-020-00073-5; Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zhu FC, 2020, LANCET, V395, P1845, DOI 10.1016/S0140-6736(20)31208-3; Zhu FC, 2017, LANCET, V389, P621, DOI [10.1016/S0140-6736(16)32617-4, 10.1016/s0140-6736(16)32617-4]	13	17	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2020	395	10240					1815	+		10.1016/S0140-6736(20)31239-3	http://dx.doi.org/10.1016/S0140-6736(20)31239-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NH4GA	32473680	Green Published, Bronze			2022-12-28	WOS:000564628700006
J	McKay, D; Heisler, M; Mishori, R; Catton, H; Kloiber, O				McKay, Donna; Heisler, Michele; Mishori, Ranit; Catton, Howard; Kloiber, Otmar			Attacks against health-care personnel must stop, especially as the world fights COVID-19	LANCET			English	Editorial Material									[McKay, Donna; Heisler, Michele; Mishori, Ranit] Phys Human Rights, New York, NY 10018 USA; [Catton, Howard] Int Council Nurses, Geneva, Switzerland; [Kloiber, Otmar] World Med Assoc, Ferney Voltaire, France		McKay, D (corresponding author), Phys Human Rights, New York, NY 10018 USA.	dmckay@phr.org	Heisler, Michele/B-5774-2015	Heisler, Michele/0000-0002-6889-2063				[Anonymous], 2020, THE ECONOMIST; [Anonymous], 2020, BBC NEWS; [Anonymous], 2020, EC TIMES; Beaumont P., 2020, THE GUARDIAN; Burke Jason., 2019, GUARDIAN; Horton R., 2020, GUARDIAN; Insecurity Insight, 2020, ATT HLTH CAR; Internal Council of Nurses, 2020, ICN CALLS GOV ACT ST; International Committee of the Red Cross, 2020, SAF COVID 19 RESP CH; Mantovani C., 2020, REUTERS WORLD N 0506; Physicians for human rights, 2020, ILL ATT HLTH CAR SYR; Safeguarding Health in Conflict Coalition, 2019, IMP REM ATT HLTH CAR; Semple K., 2020, NY TIMES; WHO, 2020, VIOL HLTH WORK; Withnall A., 2020, INDEPENDENT	15	74	74	3	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2020	395	10239					1743	1745		10.1016/S0140-6736(20)31191-0	http://dx.doi.org/10.1016/S0140-6736(20)31191-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LZ1MK	32445692	Bronze, Green Published			2022-12-28	WOS:000540993600005
J	Dyer, C				Dyer, Clare			Johnson and Johnson pays hundreds of women in Scotland harmed by mesh implants	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2020	369								m2201	10.1136/bmj.m2201	http://dx.doi.org/10.1136/bmj.m2201			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0KV	32487670				2022-12-28	WOS:000548476700005
J	Dowdeswell, JA; Batchelor, CL; Montelli, A; Ottesen, D; Christie, FDW; Dowdeswell, EK; Evans, J				Dowdeswell, J. A.; Batchelor, C. L.; Montelli, A.; Ottesen, D.; Christie, F. D. W.; Dowdeswell, E. K.; Evans, J.			Delicate seafloor landforms reveal past Antarctic grounding-line retreat of kilometers per year	SCIENCE			English	Article							SCALE GLACIAL LINEATIONS; PINE ISLAND BAY; ICE-SHEET; WEST ANTARCTICA; ZONE WEDGES; CORRUGATION RIDGES; SHELF; STREAM; SEDIMENTATION; PENINSULA	A suite of grounding-line landforms on the Antarctic seafloor, imaged at submeter horizontal resolution from an autonomous underwater vehicle, enables calculation of ice sheet retreat rates from a complex of grounding-zone wedges on the Larsen continental shelf, western Weddell Sea. The landforms are delicate sets of up to 90 ridges, <1.5 meters high and spaced 20 to 25 meters apart. We interpret these ridges as the product of squeezing up of soft sediment during the rise and fall of the retreating ice sheet grounding line during successive tidal cycles. Grounding-line retreat rates of 40 to 50 meters per day (>10 kilometers per year) are inferred during regional deglaciation of the Larsen shelf. If repeated today, such rapid mass loss to the ocean would have clear implications for increasing the rate of global sea level rise.	[Dowdeswell, J. A.; Batchelor, C. L.; Montelli, A.; Christie, F. D. W.; Dowdeswell, E. K.] Univ Cambridge, Scott Polar Res Inst, Cambridge, England; [Batchelor, C. L.] Norwegian Univ Sci & Technol, Trondheim, Norway; [Ottesen, D.] Geol Survey Norway, Trondheim, Norway; [Evans, J.] Loughborough Univ, Dept Geog, Loughborough, Leics, England	University of Cambridge; Norwegian University of Science & Technology (NTNU); Geological Survey of Norway; Loughborough University	Dowdeswell, JA (corresponding author), Univ Cambridge, Scott Polar Res Inst, Cambridge, England.	jd16@cam.ac.uk	Christie, Frazer/AAI-2435-2021	Christie, Frazer/0000-0002-7378-4243; Dowdeswell, Julian/0000-0003-1369-9482; Dowdeswell, Evelyn/0000-0001-9256-8776	Flotilla Foundation; Marine Archaeology Consultants Switzerland	Flotilla Foundation; Marine Archaeology Consultants Switzerland	This research was funded by the Flotilla Foundation and Marine Archaeology Consultants Switzerland. The AUV and associated technical support were provided by Ocean Infinity and Deep Ocean Search. During this work, C.L.	ALLEY RB, 1989, MAR GEOL, V85, P101, DOI 10.1016/0025-3227(89)90150-3; Alley RB, 2007, SCIENCE, V315, P1838, DOI 10.1126/science.1138396; Anandakrishnan S, 2007, SCIENCE, V315, P1835, DOI 10.1126/science.1138393; Anderson J.B., 1999, ANTARCTIC MARINE GEO; Andreassen K, 2014, QUATERNARY SCI REV, V92, P246, DOI 10.1016/j.quascirev.2013.09.015; Arndt JE, 2013, GEOPHYS RES LETT, V40, P3111, DOI 10.1002/grl.50413; BARNES PW, 1988, GEOLOGY, V16, P1130, DOI 10.1130/0091-7613(1988)016<1130:IRSSTM>2.3.CO;2; Batchelor CL, 2019, ANTARCT SCI, V31, P218, DOI 10.1017/S0954102019000191; Batchelor CL, 2015, MAR GEOL, V363, P65, DOI 10.1016/j.margeo.2015.02.001; Bindschadler RA, 2003, SCIENCE, V301, P1087, DOI 10.1126/science.1087231; BOULTON GS, 1986, SEDIMENTOLOGY, V33, P677, DOI 10.1111/j.1365-3091.1986.tb01969.x; Brachfeld S, 2003, GEOLOGY, V31, P749, DOI 10.1130/G19643.1; Burton DJ, 2016, GEOL SOC MEM, V46, P71, DOI 10.1144/M46.35; Campo JM, 2017, GEOMORPHOLOGY, V280, P89, DOI 10.1016/j.geomorph.2016.11.022; CLARK CD, 1993, EARTH SURF PROCESSES, V18, P1, DOI 10.1002/esp.3290180102; Cofaigh CO, 2014, QUATERNARY SCI REV, V100, P87, DOI 10.1016/j.quascirev.2014.06.023; Cook AJ, 2014, ANTARCT SCI, V26, P614, DOI 10.1017/S0954102014000200; Dowdeswell JA, 2016, GEOL SOC MEM, V46, P519, DOI 10.1144/M46.183; Dowdeswell JA, 2016, GEOL SOC MEM, V46, P269, DOI 10.1144/M46.4; Dowdeswell JA, 2012, GEOL SOC AM BULL, V124, P1750, DOI 10.1130/B30628.1; Dowdeswell JA, 2008, J GLACIOL, V54, P661, DOI 10.3189/002214308786570773; Dupont TK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022024; Evans J, 2005, QUATERNARY SCI REV, V24, P741, DOI 10.1016/j.quascirev.2004.10.007; Evans J, 2016, GEOL SOC MEM, V46, P237, DOI 10.1144/M46.3; Goldberg D, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001227; Graham AGC, 2013, J GEOPHYS RES-EARTH, V118, P1356, DOI 10.1002/jgrf.20087; Halberstadt ARW, 2016, CRYOSPHERE, V10, P1003, DOI 10.5194/tc-10-1003-2016; Hillenbrand CD, 2013, GEOLOGY, V41, P35, DOI 10.1130/G33469.1; Holschuh N, 2016, J GEOPHYS RES-EARTH, V121, DOI 10.1002/2016JF003942; Jakobsson M, 2016, GEOL SOC MEM, V46, P265, DOI 10.1144/M46.5; Jakobsson M, 2011, GEOLOGY, V39, P691, DOI 10.1130/G32153.1; Jamieson SSR, 2012, NAT GEOSCI, V5, P799, DOI [10.1038/ngeo1600, 10.1038/NGEO1600]; Kim K, 2007, INT J REMOTE SENS, V28, P5357, DOI 10.1080/01431160601105850; King EC, 2009, NAT GEOSCI, V2, P585, DOI 10.1038/NGEO581; Klages JP, 2016, GEOL SOC MEM, V46, P349, DOI 10.1144/M46.147; Klages JP, 2015, GEOMORPHOLOGY, V245, P207, DOI 10.1016/j.geomorph.2015.05.020; Klages JP, 2013, QUATERNARY SCI REV, V61, P47, DOI 10.1016/j.quascirev.2012.11.007; Lavoie C, 2015, CRYOSPHERE, V9, P613, DOI 10.5194/tc-9-613-2015; Lien R., 1989, Polar Research, V7, P43, DOI 10.1111/j.1751-8369.1989.tb00603.x; Linden M, 2005, J QUATERNARY SCI, V20, P113, DOI 10.1002/jqs.902; Massom RA, 2018, NATURE, V558, P383, DOI 10.1038/s41586-018-0212-1; Minchew BM, 2017, J GEOPHYS RES-EARTH, V122, P167, DOI 10.1002/2016JF003971; Mouginot J, 2014, GEOPHYS RES LETT, V41, P1576, DOI 10.1002/2013GL059069; O'Brien PE, 1999, ANTARCT SCI, V11, P78, DOI 10.1017/S0954102099000115; Ottesen D, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000330; Padman L, 2002, ANN GLACIOL, V34, P247, DOI 10.3189/172756402781817752; Park JW, 2013, GEOPHYS RES LETT, V40, P2137, DOI 10.1002/grl.50379; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Pudsey CJ, 2006, QUATERNARY SCI REV, V25, P2357, DOI 10.1016/j.quascirev.2006.01.029; Rignot E, 2014, GEOPHYS RES LETT, V41, P3502, DOI 10.1002/2014GL060140; Scambos TA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020670; Shepherd A, 2019, GEOPHYS RES LETT, V46, P8174, DOI 10.1029/2019GL082182; Shipp SS, 2002, GEOL SOC SPEC PUBL, V203, P277, DOI 10.1144/GSL.SP.2002.203.01.15; Simkins LM, 2018, CRYOSPHERE, V12, P2707, DOI 10.5194/tc-12-2707-2018; Simkins LM, 2017, NAT GEOSCI, V10, P691, DOI [10.1038/NGEO3012, 10.1038/ngeo3012]; Smith JA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13496-5	56	20	21	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					1020	+		10.1126/science.aaz3059	http://dx.doi.org/10.1126/science.aaz3059			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LV3IK	32467392	Green Published, Green Submitted			2022-12-28	WOS:000538332600050
J	Wang, Y; Yu, JY; Mao, YF; Chen, J; Wang, S; Chen, HZ; Zhang, Y; Wang, SY; Chen, XJ; Li, T; Zhou, L; Ma, RM; Zhu, SN; Cai, WS; Zhu, J				Wang, Yang; Yu, Jianyu; Mao, Yi-Fei; Chen, Ji; Wang, Suo; Chen, Hua-Zhou; Zhang, Yi; Wang, Si-Yi; Chen, Xinjie; Li, Tao; Zhou, Lin; Ma, Ren-Min; Zhu, Shining; Cai, Wenshan; Zhu, Jia			Stable, high-performance sodium-based plasmonic devices in the near infrared	NATURE			English	Article							OPTICAL-CONSTANTS; SILVER FILMS; NANOSTRUCTURES; AG	Plasmonics enables the manipulation of light beyond the optical diffraction limit(1-4) and may therefore confer advantages in applications such as photonic devices(5-7), optical cloaking(8,9), biochemical sensing(10,11) and super-resolution imaging(12,13). However, the essential field-confinement capability of plasmonic devices is always accompanied by a parasitic Ohmic loss, which severely reduces their performance. Therefore, plasmonic materials (those with collective oscillations of electrons) with a lower loss than noble metals have long been sought(14-16). Here we present stable sodium-based plasmonic devices with state-of-the-art performance at near-infrared wavelengths. We fabricated high-quality sodium films with electron relaxation times as long as 0.42 picoseconds using a thermo-assisted spin-coating process. A direct-waveguide experiment shows that the propagation length of surface plasmon polaritons supported at the sodium-quartz interface can reach 200 micrometres at near-infrared wavelengths. We further demonstrate a room-temperature sodium-based plasmonic nanolaser with a lasing threshold of 140 kilowatts per square centimetre, lower than values previously reported for plasmonic nanolasers at near-infrared wavelengths. These sodium-based plasmonic devices show stable performance under ambient conditions over a period of several months after packaging with epoxy. These results indicate that the performance of plasmonic devices can be greatly improved beyond that of devices using noble metals, with implications for applications in plasmonics, nanophotonics and metamaterials.	[Wang, Yang; Yu, Jianyu; Chen, Ji; Chen, Xinjie; Li, Tao; Zhou, Lin; Zhu, Shining; Zhu, Jia] Nanjing Univ, Coll Engn & Appl Sci, Jiangsu Key Lab Artificial Funct Mat, Natl Lab Solid State Microstruct,Collaborat Innov, Nanjing, Peoples R China; [Mao, Yi-Fei; Wang, Suo; Chen, Hua-Zhou; Wang, Si-Yi; Ma, Ren-Min] Peking Univ, State Key Lab Mesoscop Phys, Beijing, Peoples R China; [Mao, Yi-Fei; Wang, Suo; Chen, Hua-Zhou; Wang, Si-Yi; Ma, Ren-Min] Peking Univ, Sch Phys, Beijing, Peoples R China; [Chen, Ji; Li, Tao; Zhou, Lin] Nanjing Univ, Key Lab Intelligent Opt Sensing & Manipulat, Minist Educ, Nanjing, Peoples R China; [Zhang, Yi] Zhejiang Gongshang Univ, Sch Informat & Elect Engn, Hangzhou, Peoples R China; [Ma, Ren-Min] Peking Univ, Frontier Sci Ctr Nanooptoelect, Beijing, Peoples R China; [Ma, Ren-Min] Peking Univ, Collaborat Innovat Ctr Quantum Matter, Beijing, Peoples R China; [Cai, Wenshan] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA	Nanjing University; Peking University; Peking University; Nanjing University; Zhejiang Gongshang University; Peking University; Peking University; University System of Georgia; Georgia Institute of Technology	Zhou, L; Zhu, SN; Zhu, J (corresponding author), Nanjing Univ, Coll Engn & Appl Sci, Jiangsu Key Lab Artificial Funct Mat, Natl Lab Solid State Microstruct,Collaborat Innov, Nanjing, Peoples R China.; Ma, RM (corresponding author), Peking Univ, State Key Lab Mesoscop Phys, Beijing, Peoples R China.; Ma, RM (corresponding author), Peking Univ, Sch Phys, Beijing, Peoples R China.; Zhou, L (corresponding author), Nanjing Univ, Key Lab Intelligent Opt Sensing & Manipulat, Minist Educ, Nanjing, Peoples R China.; Ma, RM (corresponding author), Peking Univ, Frontier Sci Ctr Nanooptoelect, Beijing, Peoples R China.; Ma, RM (corresponding author), Peking Univ, Collaborat Innovat Ctr Quantum Matter, Beijing, Peoples R China.	linzhou@nju.edu.cn; renminma@pku.edu.cn; zhusn@nju.edu.cn; jiazhu@nju.edu.cn	Li, Tao/ABF-7597-2021	li, tao/0000-0003-0049-471X; Wang, Yang/0000-0003-0455-4126; Chen, Ji/0000-0002-9376-6077	National Key Research and Development Program of China [2017YFA0205700, 2018YFA0704401]; National Natural Science Foundation of China [51925204, 11874211, 11621091, 61735008, 11774014, 11574012, 61521004, 91950115]; Beijing Natural Science Foundation [Z180011]; Fundamental Research Funds for the Central Universities [021314380140, 021314380150]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We thank H. Su and James N. Hilfiker at Genuine Optronics for help with ellipsometry measurements. We acknowledge the microfabrication centre of the National Laboratory of Solid State Microstructures (NLSSM) for technical support. This work is jointly supported by the National Key Research and Development Program of China (grant numbers 2017YFA0205700, 2018YFA0704401), National Natural Science Foundation of China (grant numbers 51925204, 11874211, 11621091, 61735008, 11774014, 11574012, 61521004 and 91950115), Beijing Natural Science Foundation (grant number Z180011) and the Fundamental Research Funds for the Central Universities (grant numbers 021314380140 and 021314380150).	Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Babar S, 2015, APPL OPTICS, V54, P477, DOI 10.1364/AO.54.000477; Berini P, 2012, NAT PHOTONICS, V6, P16, DOI 10.1038/nphoton.2011.285; Boltasseva A, 2011, SCIENCE, V331, P290, DOI 10.1126/science.1198258; Chen WQ, 2010, OPT EXPRESS, V18, P5124, DOI 10.1364/OE.18.005124; Chung T, 2011, SENSORS-BASEL, V11, P10907, DOI 10.3390/s111110907; Ciesielski A, 2017, APPL SURF SCI, V421, P349, DOI 10.1016/j.apsusc.2017.01.039; Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Fang YR, 2015, LIGHT-SCI APPL, V4, DOI 10.1038/lsa.2015.67; Gabrielli LH, 2009, NAT PHOTONICS, V3, P461, DOI 10.1038/NPHOTON.2009.117; Ge YC, 1998, SPECTROSC LETT, V31, P123, DOI 10.1080/00387019808006766; Gramotnev DK, 2010, NAT PHOTONICS, V4, P83, DOI 10.1038/nphoton.2009.282; Gwo S, 2016, REP PROG PHYS, V79, DOI 10.1088/0034-4885/79/8/086501; Hill MT, 2014, NAT PHOTONICS, V8, P908, DOI 10.1038/nphoton.2014.239; Hill MT, 2009, OPT EXPRESS, V17, P11107, DOI 10.1364/OE.17.011107; Ho JF, 2016, NANO LETT, V16, P2845, DOI 10.1021/acs.nanolett.6b00706; Ho JF, 2015, ACS PHOTONICS, V2, P165, DOI 10.1021/ph5003945; INAGAKI T, 1976, PHYS REV B, V13, P2305, DOI 10.1103/PhysRevB.13.2305; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Keshmarzi EK, 2018, NANOSCALE, V10, P5914, DOI 10.1039/c7nr09183d; Khajavikhan M, 2012, NATURE, V482, P204, DOI 10.1038/nature10840; Khurgin JB, 2015, NAT NANOTECHNOL, V10, P2, DOI 10.1038/nnano.2014.310; Kwon SH, 2011, IEEE J QUANTUM ELECT, V47, P1346, DOI 10.1109/JQE.2011.2166537; Kwon SH, 2010, NANO LETT, V10, P3679, DOI 10.1021/nl1021706; Lakhani AM, 2011, OPT EXPRESS, V19, P18237, DOI 10.1364/OE.19.018237; Lal S, 2007, NAT PHOTONICS, V1, P641, DOI 10.1038/nphoton.2007.223; Lee CJ, 2017, ACS PHOTONICS, V4, P1431, DOI 10.1021/acsphotonics.7b00184; Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368; Ma RM, 2019, NAT MATER, V18, P1152, DOI 10.1038/s41563-019-0513-2; Ma RM, 2019, NAT NANOTECHNOL, V14, P12, DOI 10.1038/s41565-018-0320-y; Ma RM, 2011, NAT MATER, V10, P110, DOI 10.1038/nmat2919; Maier S.A., 2007, PLASMONICS FUNDAMENT, DOI DOI 10.1007/0-387-37825-1; Marell MJH, 2011, OPT EXPRESS, V19, P15109, DOI 10.1364/OE.19.015109; McPeak KM, 2015, ACS PHOTONICS, V2, P326, DOI 10.1021/ph5004237; Mori T, 2018, ACS APPL MATER INTER, V10, P8333, DOI 10.1021/acsami.7b18367; Naik GV, 2013, ADV MATER, V25, P3264, DOI 10.1002/adma.201205076; Ning CZ, 2019, ADV PHOTONICS, V1, DOI 10.1117/1.AP.1.1.014002; Ozbay E, 2006, SCIENCE, V311, P189, DOI 10.1126/science.1114849; Palik E.D, 1998, HDB OPTICAL CONSTANT, V3, DOI DOI 10.1080/716099804A; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/NMAT2630, 10.1038/nmat2630]; SMITH NV, 1969, PHYS REV, V183, P635; Valentine J, 2008, NATURE, V455, P376, DOI 10.1038/nature07247; Wang DQ, 2018, CHEM REV, V118, P2865, DOI 10.1021/acs.chemrev.7b00424; Wang S, 2018, NANO LETT, V18, P7942, DOI 10.1021/acs.nanolett.8b03890; Wang S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01662-6; Werner WSM, 2009, J PHYS CHEM REF DATA, V38, P1013, DOI 10.1063/1.3243762; Yang AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7939; Yang R, 2015, PHYS REV B, V91, DOI [10.1103/PhysRevB.91.224507, 10.1103/PhysRevB.91.235137]; Zhou W, 2013, NAT NANOTECHNOL, V8, P506, DOI [10.1038/NNANO.2013.99, 10.1038/nnano.2013.99]	49	69	71	44	242	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 28	2020	581	7809					401	+		10.1038/s41586-020-2306-9	http://dx.doi.org/10.1038/s41586-020-2306-9			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU4TE	32461649				2022-12-28	WOS:000573635000001
J	Dagens, A; Sigfrid, L; Cai, EH; Lipworth, S; Cheung, V; Harris, E; Bannister, P; Rigby, I; Horby, P				Dagens, Andrew; Sigfrid, Louise; Cai, Erhui; Lipworth, Sam; Cheung, Vincent; Harris, Eli; Bannister, Peter; Rigby, Ishmeala; Horby, Peter			Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INFECTIOUS-DISEASES; MANAGEMENT; DIAGNOSIS; SOCIETY; ADULTS	OBJECTIVE To appraise the availability, quality, and inclusivity of clinical guidelines produced in the early stage of the coronavirus disease 2019 (covid-19) pandemic. DESIGN Rapid review. DATA SOURCES Ovid Medline, Ovid Embase, Ovid Global Health, Scopus, Web of Science Core Collection, and WHO Global Index Medicus, searched from inception to 14 Mar 2020. Search strategies applied the CADTH database guidelines search filter, with no limits applied to search results. Further studies were identified through searches of grey literature using the ISARIC network. INCLUSION CRITERIA Clinical guidelines for the management of covid-19, Middle East respiratory syndrome (MERS), and severe acute respiratory syndrome (SARS) produced by international and national scientific organisations and government and non-governmental organisations relating to global health were included, with no exclusions for language. Regional/hospital guidelines were excluded. Only the earliest version of any guideline was included. QUALITY ASSESSMENT Quality was assessed using the Appraisal of Guidelines for Research and Evaluation (AGREE) II tool. The quality and contents of early covid-19 guidelines were also compared with recent clinical guidelines for MERS and SARS. RESULTS 2836 studies were identified, of which 2794 were excluded after screening. Forty two guidelines were considered eligible for inclusion, with 18 being specific to covid-19. Overall, the clinical guidelines lacked detail and covered a narrow range of topics. Recommendations varied in relation to, for example, the use of antiviral drugs. The overall quality was poor, particularly in the domains of stakeholder involvement, applicability, and editorial independence. Links between evidence and recommendations were limited. Minimal provision was made for vulnerable groups such as pregnant women, children, and older people. CONCLUSIONS Guidelines available early in the covid-19 pandemic had methodological weaknesses and neglected vulnerable groups such as older people. A framework for development of clinical guidelines during public health emergencies is needed to ensure rigorous methods and the inclusion of vulnerable populations.	[Dagens, Andrew; Sigfrid, Louise; Cai, Erhui; Horby, Peter] Univ Oxford, Epidem Res Grp, Oxford OX3 7LG, England; [Lipworth, Sam] Univ Oxford, Modernising Med Microbiol, Oxford, England; [Cheung, Vincent] Univ Bristol, Ctr Res Synth & Decis Anal, Bristol, Avon, England; [Harris, Eli] Univ Oxford, Bodleian Lib, Oxford, England; [Bannister, Peter; Rigby, Ishmeala] Brighton & Sussex Med Sch, Sch Med, Brighton, E Sussex, England	University of Oxford; University of Oxford; University of Bristol; University of Oxford; University of Brighton; University of Sussex	Dagens, A (corresponding author), Univ Oxford, Epidem Res Grp, Oxford OX3 7LG, England.	drewdagens@doctors.org.uk		Rigby, Ishmeala/0000-0001-9236-7317; Cheng, Hung-Yuan/0000-0002-6162-4146; Dagens, Andrew/0000-0003-4982-6690; Sigfrid, Louise/0000-0003-2764-1177; Bannister, Peter/0000-0002-6279-2651	Wellcome Trust	Wellcome Trust(Wellcome Trust)	This work was supported by the Wellcome Trust. The funder had no role in study design, data collection, data analysis, or writing of the report.	[Anonymous], 2020, ANTIMICROBIAL THERAP; [Anonymous], [No title captured]; Arabi YM, 2018, AM J RESP CRIT CARE, V197, P757, DOI 10.1164/rccm.201706-1172OC; Brouwers MC, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1152; CADTH, 2021, STRINGS ATTACHED CAD; CDC, 2020, INT CLIN GUID MAN PA, DOI DOI 10.1016/J.CELL.2020.02.052; COREM Mission Nationale, 2020, COREM MISSION NATL; Dagens A., 2020, RAPID REV AVAILABILI; Delaney JW, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1230-8; Department of Health Jakarta, 2019, GUID COR DIS COV 19; Graham R, 2011, CLIN PRACTICE GUIDEL, DOI [10.17226/13058, DOI 10.17226/13058]; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hinweise zu Erkennung, 2020, DIAGN TREATM PAT COV; Japanese Association of Infectious Diseases, 2020, CONC ANT TREATM COVI; Johnston A, 2019, J CLIN EPIDEMIOL, V108, P64, DOI 10.1016/j.jclinepi.2018.11.030; Lim WS, 2007, THORAX, V62, P1, DOI 10.1136/thx.2006.073080; Metlay JP, 2019, AM J RESP CRIT CARE, V200, pE45, DOI 10.1164/rccm.201908-1581ST; Ministerio de Sanidad, 2020, PROT CLIN MAN NOV CO; Ministerio de Sanitarias (Madrid), 2020, TECHN DOC CLIN MAN P; Ministry of Health, 2020, TURK COVID 19 2019 N; Ministry of Health and Welfare, 2020, GUID CLIN MAN SEV AC; National Health Commission of China, 2020, DIAGN TREATM PROT PA; Norris SL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202782; Office of the Deputy Director-General of Health (Public Health), 2020, GUID COVID 19 MAN MA; Rodrigo C, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010406.pub2; Rodriguez A, 2012, MED INTENSIVA, V36, P103, DOI 10.1016/j.medin.2011.11.020; Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2; Saudi Arabian Centre for Disease Control, 2020, COR DIS 19 COVID 201; Shang LH, 2020, LANCET, V395, P683, DOI 10.1016/S0140-6736(20)30361-5; Societa Italiana di Malattie Infettive e Tropicali, 2020, THER ANDSSUPPORTIVE; Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343; Taiwan Centers for Disease Control, 2020, INT CLIN GUID MAN PA; VEDANARAYANAN V, 2013, NEUROLOGY S, V80; Villar J, 2020, LANCET RESP MED, V8, P267, DOI 10.1016/S2213-2600(19)30417-5; Vollaard A, 2020, PHARM TREATMENT STRA; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, P1, DOI 10.1111/j.1469-0691.2011.03602.x; Working Group on COVID 2019 in the Russian Federation, 2020, RUSS PREV DIAGN TREA; World Health Organization, 2019, WHO HDB GUID DEV; World Health Organization (WHO), 2019, CLIN MAN SEV AC RESP; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8	41	95	100	3	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2020	369								m1936	10.1136/bmj.m1936	http://dx.doi.org/10.1136/bmj.m1936			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JW	32457027	Green Published, hybrid			2022-12-28	WOS:000538337000003
J	O'Connor, E; Thomas, R; Senger, CA; Perdue, L; Robalino, S; Patnode, C				O'Connor, Elizabeth; Thomas, Rachel; Senger, Caitlyn A.; Perdue, Leslie; Robalino, Shannon; Patnode, Carrie			Interventions to Prevent Illicit and Nonmedical Drug Use in Children, Adolescents, and Young Adults Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; HOME-VISITING INTERVENTION; INDIAN TEEN MOTHERS; SUBSTANCE USE OUTCOMES; FAMILIES PROGRAM 10-14; PRIMARY-CARE; CANNABIS USE; HEALTHY SCHOOL; MARIJUANA USE; FOSTER-CARE	Importance Illicit and nonmedical (use in ways other than instructed) drug use is common in adolescents and young adults and increases the risk of harmful outcomes such as injuries, violence, and poorer academic performance. Objective To review the benefits and harms of interventions to prevent illicit and nonmedical drug use in children, adolescents, and young adults to inform the US Preventive Services Task Force. Data Sources MEDLINE, PubMED, PsycINFO, and the Cochrane Central Register of Controlled Trials (January 1, 2013, to January 31, 2019 [children and adolescents]; January 1, 1992, to January 31, 2019 [young adults <25 years]); surveillance through March 20, 2020. Study Selection Clinical trials of behavioral counseling interventions to prevent initiation of illicit and nonmedical drug use among young people. Data Extraction and Synthesis Critical appraisal was completed independently by 2 investigators. Data were extracted by 1 reviewer and checked by a second. Random-effects meta-analysis was used to estimate the effect sizes associated with the interventions. Main Outcomes and Measures Number of times illicit drugs were used; any illicit drug or any cannabis use. Results Twenty-nine trials (N = 18& x202f;353) met inclusion criteria. Health, social, or legal outcomes such as mental health symptoms, family functioning, consequences of drug use, and arrests were reported in 19 trials and most showed no group differences. The effects on illicit drug use in 26 trials among nonpregnant youth (n = 17& x202f;811) were highly variable; the pooled result did not show a clinically important or statistically significant association with illicit drug use (standardized mean difference, -0.08 [95% CI, -0.16 to 0.001]; 24 effects [from 23 studies]; n = 12& x202f;801; I-2 = 57.0%). The percentage of participants using illicit drugs ranged from 2.3% to 38.6% in the control groups and 2.4% to 33.7% in the intervention groups at 3 to 32 months' follow-up. The median absolute risk difference between groups was -2.8%, favoring the intervention group (range, -11.5% to 14.8%). The remaining 3 trials provided a perinatal home-visiting intervention to pregnant Native American youth. One trial (n=322) found a reduction in illicit drug use at 38 months (eg, cannabis use in the previous month, 10.7% in the intervention group and 15.6% in the control group) but not at earlier follow-up assessments. Across all 29 trials, only 1 trial reported on harms and found no statistically significant group differences. Conclusions and Relevance The evidence for behavioral counseling interventions to prevent initiation of illicit and nonmedical drug use among adolescents and young adults was inconsistent and imprecise, with some interventions associated with reduction in use and others associated with no benefit or increased use. Health, social, and legal outcomes were sparsely reported, and few showed improvements. This systematic review to support the 2020 US Preventive Services Task Force Recommendation Statement on interventions to prevent illicit and nonmedical drug use summarizes published evidence on the benefits and harms of primary care-based interventions to prevent illicit and nonmedical drug use in children, adolescents, and young adults.	[O'Connor, Elizabeth; Thomas, Rachel; Senger, Caitlyn A.; Perdue, Leslie; Patnode, Carrie] Kaiser Permanente, Evidence Based Practice Ctr, Ctr Hlth Res, Portland, OR USA; [Robalino, Shannon] Oregon Hlth & Sci Univ, Ctr Evidence Based Policy, Portland, OR 97201 USA	Kaiser Permanente; Oregon Health & Science University	O'Connor, E (corresponding author), Kaiser Permanente Northwest, Kaiser Permanente, Evidence Based Practice Ctr, Ctr Hlth Res, 3800 N Interstate Ave, Portland, OR 97227 USA.	Elizabeth.OConnor@kpchr.org	Robalino, Shannon/GRS-6021-2022; Robalino, Shannon/N-4113-2015	Robalino, Shannon/0000-0002-6359-1827	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA-290-2015-000017-I-EPC5]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA-290-2015-000017-I-EPC5, Task Order 5, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.	Agency for Healthcare Research and Quality, 2019, FIN RES PLAN DRUG US; [Anonymous], 2019, STRENGTH FAM PROGR; [Anonymous], 2019, NUMB NAT DRUG OV DEA; Baldus C, 2016, EUR J PUBLIC HEALTH, V26, P953, DOI 10.1093/eurpub/ckw082; Bannink R, 2014, J MED INTERNET RES, V16, P51, DOI 10.2196/jmir.3163; Barlow A, 2006, ARCH PEDIAT ADOL MED, V160, P1101, DOI 10.1001/archpedi.160.11.1101; Barlow A, 2015, AM J PSYCHIAT, V172, P154, DOI 10.1176/appi.ajp.2014.14030332; Barlow A, 2013, AM J PSYCHIAT, V170, P83, DOI 10.1176/appi.ajp.2012.12010121; Borenstein M., 2009, INTRO METAANALYSIS, DOI [10. 1002/9780470743386, DOI 10.1002/9780470743386]; Bourque J, 2018, JAMA PSYCHIAT, V75, P864, DOI 10.1001/jamapsychiatry.2018.1330; Broning S, 2017, PREV SCI, V18, P932, DOI 10.1007/s11121-017-0797-x; Broning S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-83; CASA Columbia University, 2000, MISS OPP NAT SURV PR; Coatsworth JD, 2002, CLIN CHILD FAM PSYCH, V5, P113, DOI 10.1023/A:1015420503275; D'Amico EJ, 2018, J CONSULT CLIN PSYCH, V86, P775, DOI 10.1037/ccp0000332; Dembo R, 1999, AGGRESS VIOLENT BEH, V4, P41, DOI 10.1016/S1359-1789(97)00028-1; Dembo R, 2016, J CHILD ADOLES SUBST, V25, P18, DOI 10.1080/1067828X.2013.872068; Di Forti M, 2019, LANCET PSYCHIAT, V6, P427, DOI 10.1016/S2215-0366(19)30048-3; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elvik R, 2013, ACCIDENT ANAL PREV, V60, P254, DOI 10.1016/j.aap.2012.06.017; Estrada Y, 2019, PREV SCI, V20, P68, DOI 10.1007/s11121-018-0905-6; Estrada Y, 2017, AM J PUBLIC HEALTH, V107, P607, DOI 10.2105/AJPH.2017.303653; Estrada Y, 2015, J ADOLESCENT HEALTH, V57, P651, DOI 10.1016/j.jadohealth.2015.07.006; Fang L, 2013, PSYCHOL ADDICT BEHAV, V27, P788, DOI 10.1037/a0030925; Fang L, 2010, J ADOLESCENT HEALTH, V47, P529, DOI 10.1016/j.jadohealth.2010.03.011; Foxcroft DR, 2017, EUR J PUBLIC HEALTH, V27, P494, DOI 10.1093/eurpub/ckw195; Gmel G, 2013, J SUBST ABUSE TREAT, V44, P231, DOI 10.1016/j.jsat.2012.07.005; Goldman-Mellor S, 2019, GEN HOSP PSYCHIAT, V56, P28, DOI 10.1016/j.genhosppsych.2018.12.004; Grant I, 2003, J INT NEUROPSYCH SOC, V9, P679, DOI 10.1017/S1355617703950016; Green KM, 2017, AM J DRUG ALCOHOL AB, V43, P567, DOI 10.1080/00952990.2016.1258706; Harris SK, 2012, PEDIATRICS, V129, P1072, DOI 10.1542/peds.2011-1624; Heitzeg MM, 2015, DEV COGN NEUROS-NETH, V16, P71, DOI 10.1016/j.dcn.2015.09.003; Hodder RK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004718; Hohl BC, 2017, JAMA INTERN MED, V177, P317, DOI 10.1001/jamainternmed.2016.8180; Jalling C, 2016, J CHILD FAM STUD, V25, P811, DOI 10.1007/s10826-015-0263-y; Kerr JC, 2013, AM J HEALTH EDUC, V44, P191, DOI 10.1080/19325037.2013.798218; Kim HK, 2013, J CHILD ADOLES SUBST, V22, P370, DOI 10.1080/1067828X.2013.788880; Kim HK, 2011, J CONSULT CLIN PSYCH, V79, P740, DOI 10.1037/a0025949; Knight JR, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.6258; Lee CM, 2010, PSYCHOL ADDICT BEHAV, V24, P265, DOI 10.1037/a0018859; Johnson S, 2015, AM J COMMUN PSYCHOL, V56, P36, DOI 10.1007/s10464-015-9734-y; Malmberg M, 2015, ADDICT BEHAV, V42, P194, DOI 10.1016/j.addbeh.2014.11.021; Malmberg M, 2014, ADDICTION, V109, P1031, DOI 10.1111/add.12526; Martin JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187320; Mason M, 2015, J SUBST ABUSE TREAT, V58, P16, DOI 10.1016/j.jsat.2015.06.013; Miech R., 2018, NATL ADOLESCENT DRUG; Moyer VA, 2014, ANN INTERN MED, V160, P634, DOI 10.7326/M14-0334; Mullany B, 2012, PREV SCI, V13, P504, DOI 10.1007/s11121-012-0277-2; Patnode CD, 2014, ANN INTERN MED, V160, P612, DOI 10.7326/M13-2064; Rhee Hyekyun, 2008, J Pediatr Nurs, V23, P439, DOI 10.1016/j.pedn.2008.01.079; Sanci L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137581; Schinke SP, 2009, PREV MED, V49, P429, DOI 10.1016/j.ypmed.2009.08.001; Schinke SP, 2009, ADDICT BEHAV, V34, P1060, DOI 10.1016/j.addbeh.2009.06.007; Schreiner AM, 2012, EXP CLIN PSYCHOPHARM, V20, P420, DOI 10.1037/a0029117; Schwinn T, 2017, ADDICT BEHAV, V65, P207, DOI 10.1016/j.addbeh.2016.10.011; Schwinn TM, 2018, J YOUTH ADOLESCENCE, V47, P490, DOI 10.1007/s10964-017-0714-4; Schwinn TM, 2010, PREV SCI, V11, P24, DOI 10.1007/s11121-009-0146-9; Schwinn TM, 2015, J ADOLESCENT HEALTH, V56, P571, DOI 10.1016/j.jadohealth.2014.12.015; Spoth RL, 2012, J ADOLESCENT HEALTH, V50, P414, DOI 10.1016/j.jadohealth.2011.06.010; Spoth RL, 2001, J CONSULT CLIN PSYCH, V69, P627, DOI 10.1037//0022-006X.69.4.627; Substance Abuse and Mental Health Services Administration, 2017, KEY SUBST MENT HLTH; Townsend L, 2007, CLIN CHILD FAM PSYCH, V10, P295, DOI 10.1007/s10567-007-0023-7; United Nations Development Programme, 2016, HUMAN DEV REPORT; US Preventive Services Task Force, 2015, US PREV SERV TASK FO; Walkup JT, 2009, J AM ACAD CHILD PSY, V48, P591, DOI 10.1097/CHI.0b013e3181a0ab86; Walton MA, 2014, ADDICTION, V109, P786, DOI 10.1111/add.12469; Walton MA, 2013, DRUG ALCOHOL DEPEN, V132, P646, DOI 10.1016/j.drugalcdep.2013.04.020	67	13	13	4	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					2067	2079		10.1001/jama.2020.1432	http://dx.doi.org/10.1001/jama.2020.1432			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LU8UM	32453373	Bronze			2022-12-28	WOS:000538023900038
J							US Preventive Serv Task Force	Primary Care-Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; HOME-VISITING INTERVENTION; SUBSTANCE USE; CANNABIS USE; MARIJUANA USE; PROGRAM; GIRLS; SCHOOL; RISK; EFFICACY	This 2020 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care-based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults (I statement). Importance In 2017, an estimated 7.9% of persons aged 12 to 17 years reported illicit drug use in the past month, and an estimated 50% of adolescents in the US had used an illicit drug by the time they graduated from high school. Young adults aged 18 to 25 years have a higher rate of current illicit drug use, with an estimated 23.2% currently using illicit drugs. Illicit drug use is associated with many negative health, social, and economic consequences and is a significant contributor to 3 of the leading causes of death among young persons (aged 10-24 years): unintentional injuries including motor vehicle crashes, suicide, and homicide. Objective To update its 2014 recommendation, the USPSTF commissioned a review of the evidence on the potential benefits and harms of interventions to prevent illicit drug use in children, adolescents, and young adults. Population This recommendation applies to children (11 years and younger), adolescents (aged 12-17 years), and young adults (aged 18-25 years), including pregnant persons. Evidence Assessment Because of limited and inadequate evidence, the USPSTF concludes that the benefits and harms of primary care-based interventions to prevent illicit drug use in children, adolescents, and young adults are uncertain and that the evidence is insufficient to assess the balance of benefits and harms. More research is needed. Recommendation The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care-based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults. (I statement)					Epling, John W/J-1097-2019	Epling, John W/0000-0001-9445-8669; Wong, John/0000-0003-4203-9010	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	[Anonymous], DRUG MIS PREV TARG I; [Anonymous], 2019, SCREEN ILL DRUG US I; [Anonymous], 2016, PEDIATRICS, V138; [Anonymous], 2019, PRIM CAR INT PREV CE; Baldus C, 2016, EUR J PUBLIC HEALTH, V26, P953, DOI 10.1093/eurpub/ckw082; Bannink R, 2014, J MED INTERNET RES, V16, P51, DOI 10.2196/jmir.3163; Barlow A, 2006, ARCH PEDIAT ADOL MED, V160, P1101, DOI 10.1001/archpedi.160.11.1101; Barlow A, 2013, AM J PSYCHIAT, V170, P83, DOI 10.1176/appi.ajp.2012.12010121; Crane E, 2015, EMERGENCY DEP VISITS; Curry SJ, 2018, JAMA-J AM MED ASSOC, V320, P1899, DOI 10.1001/jama.2018.16789; D'Amico EJ, 2018, J CONSULT CLIN PSYCH, V86, P775, DOI 10.1037/ccp0000332; Dembo R, 2014, J CHILD ADOLES SUBST, V23, P318, DOI 10.1080/1067828X.2014.928116; Drug Abuse Warning Network, 2013, 2011 NAT EST DRUG RE; Estrada Y, 2019, PREV SCI, V20, P68, DOI 10.1007/s11121-018-0905-6; Fang L, 2010, J ADOLESCENT HEALTH, V47, P529, DOI 10.1016/j.jadohealth.2010.03.011; Foxcroft DR, 2017, EUR J PUBLIC HEALTH, V27, P494, DOI 10.1093/eurpub/ckw195; Grant CN, 2017, PAED CHILD HEALT-CAN, V22, P98, DOI 10.1093/pch/pxx017; Grant I, 2003, J INT NEUROPSYCH SOC, V9, P679, DOI 10.1017/S1355617703950016; Green KM, 2017, AM J DRUG ALCOHOL AB, V43, P567, DOI 10.1080/00952990.2016.1258706; Hedegaard Holly, 2018, NCHS Data Brief, P1; Heron Melonie, 2018, Natl Vital Stat Rep, V67, P1; Jalling C, 2016, J CHILD FAM STUD, V25, P811, DOI 10.1007/s10826-015-0263-y; Johnston L, 2019, 2018 OVERVIEW KEY FI; Kann L, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6708a1; Kerr JC, 2013, AM J HEALTH EDUC, V44, P191, DOI 10.1080/19325037.2013.798218; Kim HK, 2011, J CONSULT CLIN PSYCH, V79, P740, DOI 10.1037/a0025949; Knight JR, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.6258; Lee CM, 2010, PSYCHOL ADDICT BEHAV, V24, P265, DOI 10.1037/a0018859; Lynskey MT, 2003, JAMA-J AM MED ASSOC, V289, P427, DOI 10.1001/jama.289.4.427; Malmberg M, 2014, ADDICTION, V109, P1031, DOI 10.1111/add.12526; Moyer VA, 2014, ANN INTERN MED, V160, P634, DOI 10.7326/M14-0334; Moyer VA, 2013, ANN INTERN MED, V159, P552, DOI 10.7326/0003-4819-159-8-201310150-00697; Nargiso JE, 2015, J STUD ALCOHOL DRUGS, V76, P5, DOI 10.15288/jsad.76.1.5; O'Connor E, 2019, AHRQ PUBLICATION; O'Connor E, 2020, JAMA-J AM MED ASSOC, V323, P2067, DOI 10.1001/jama.2020.1432; Rhee Hyekyun, 2008, J Pediatr Nurs, V23, P439, DOI 10.1016/j.pedn.2008.01.079; Sanci L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137581; Schinke SP, 2009, PREV MED, V49, P429, DOI 10.1016/j.ypmed.2009.08.001; Schinke SP, 2009, ADDICT BEHAV, V34, P1060, DOI 10.1016/j.addbeh.2009.06.007; Schreiner AM, 2012, EXP CLIN PSYCHOPHARM, V20, P420, DOI 10.1037/a0029117; Schwinn TM, 2018, J YOUTH ADOLESCENCE, V47, P490, DOI 10.1007/s10964-017-0714-4; Substance Abuse and Mental Health Services Administration, 2017, KEY SUBST US MENT HL; Substance Abuse and Mental Health Services Administration, 2017, SCREEN BRIEF INT REF; Townsend L, 2007, CLIN CHILD FAM PSYCH, V10, P295, DOI 10.1007/s10567-007-0023-7; U.S. Preventive Services Task Force, 2020, PROC MAN; Walkup JT, 2009, J AM ACAD CHILD PSY, V48, P591, DOI 10.1097/CHI.0b013e3181a0ab86; Walton MA, 2014, ADDICTION, V109, P786, DOI 10.1111/add.12469; Walton MA, 2013, DRUG ALCOHOL DEPEN, V132, P646, DOI 10.1016/j.drugalcdep.2013.04.020	48	12	12	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					2060	2066		10.1001/jama.2020.6774	http://dx.doi.org/10.1001/jama.2020.6774			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LU8UM	32453374	Bronze			2022-12-28	WOS:000538023900037
J	Dowling, JE				Dowling, John E.			Restoring vision to the blind	SCIENCE			English	Editorial Material									[Dowling, John E.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Dowling, JE (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dowling@mcb.harvard.edu						Bei FF, 2016, CELL, V164, P219, DOI 10.1016/j.cell.2015.11.036; Buforn A, 2015, INVEST EDU MAT, P191; Capowski EE, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.171686; Chew EY, 2019, OPHTHALMOLOGY, V126, P540, DOI 10.1016/j.ophtha.2018.09.041; Deemer AD, 2018, OPTOMETRY VISION SCI, V95, P694, DOI 10.1097/OPX.0000000000001278; Dowling J. E., 2014, T VIS SCI TECH, V3; Garafalo A.V., 2019, PROG RETIN EYE RES, DOI [10.1016/jpreteyeres.2019.100827, DOI 10.1016/JPRETEYERES.2019.100827]; Jorstad NL, 2017, NATURE, V548, P103, DOI 10.1038/nature23283; Martin JF, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.182642; Mehat MS, 2018, OPHTHALMOLOGY, V125, P1765, DOI 10.1016/j.ophtha.2018.04.037; Mills JO, 2017, EYE, V31, P1383, DOI 10.1038/eye.2017.65; Pearson RA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13029; Russell S, 2017, LANCET, V390, P849, DOI 10.1016/S0140-6736(17)31868-8; Sahel JA, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax2324; Varadarajan SG, 2018, CURR OPIN NEUROBIOL, V53, P198, DOI 10.1016/j.conb.2018.10.001	15	4	5	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					827	828		10.1126/science.aba2623	http://dx.doi.org/10.1126/science.aba2623			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU2DD	32439781				2022-12-28	WOS:000537569500027
J	Watts, G; Wilkinson, E				Watts, Geoff; Wilkinson, Emma			What the NHS is learning from the British army in the covid-19 crisis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												wattsg02@gmail.com; emmalwilkinson@gmail.com						Xinhuanet, 2020, XINHUANET       0302	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2020	369								m2055	10.1136/bmj.m2055	http://dx.doi.org/10.1136/bmj.m2055			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JU	32444350	Bronze			2022-12-28	WOS:000538336800013
J	Walli-Attaei, M; Joseph, P; Rosengren, A; Chow, CK; Rangarajan, S; Lear, SA; AlHabib, KF; Davletov, K; Dans, A; Lanas, F; Yeates, K; Poirier, P; Teo, KK; Bahonar, A; Camilo, F; Chifamba, J; Diaz, R; Didkowska, JA; Irazola, V; Ismail, R; Kaur, M; Khatib, R; Liu, XY; Manczuk, M; Miranda, JJ; Oguz, A; Perez-Mayorga, M; Szuba, A; Tsolekile, LP; Varma, RP; Yusufali, A; Yusuf, R; Wei, L; Anand, SS; Yusuf, S				Walli-Attaei, Marjan; Joseph, Philip; Rosengren, Annika; Chow, Clara K.; Rangarajan, Sumathy; Lear, Scott A.; AlHabib, Khalid F.; Davletov, Kairat; Dans, Antonio; Lanas, Fernando; Yeates, Karen; Poirier, Paul; Teo, Koon K.; Bahonar, Ahmad; Camilo, Felix; Chifamba, Jephat; Diaz, Rafael; Didkowska, Joanna A.; Irazola, Vilma; Ismail, Rosnah; Kaur, Manmeet; Khatib, Rasha; Liu, Xiaoyun; Manczuk, Marta; Miranda, J. Jaime; Oguz, Aytekin; Perez-Mayorga, Maritza; Szuba, Andrzej; Tsolekile, Lungiswa P.; Varma, Ravi Prasad; Yusufali, Afzalhussein; Yusuf, Rita; Wei, Li; Anand, Sonia S.; Yusuf, Salim			Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study	LANCET			English	Article							ACUTE CORONARY SYNDROMES; SEX-DIFFERENCES; MYOCARDIAL-INFARCTION; HEART-DISEASE; MORTALITY; PREVENTION; AFFORDABILITY; AVAILABILITY; GUIDELINES; MEDICINES	Background Some studies, mainly from high-income countries (HICs), report that women receive less care (investigations and treatments) for cardiovascular disease than do men and might have a higher risk of death. However, very few studies systematically report risk factors, use of primary or secondary prevention medications, incidence of cardiovascular disease, or death in populations drawn from the community. Given that most cardiovascular disease occurs in low-income and middle-income countries (LMICs), there is a need for comprehensive information comparing treatments and outcomes between women and men in HICs, middle-income countries, and low-income countries from community-based population studies. Methods In the Prospective Urban Rural Epidemiological study (PURE), individuals aged 35-70 years from urban and rural communities in 27 countries were considered for inclusion. We recorded information on participants' sociodemographic characteristics, risk factors, medication use, cardiac investigations, and interventions. 168 490 participants who enrolled in the first two of the three phases of PURE were followed up prospectively for incident cardiovascular disease and death. Findings From Jan 6, 2005 to May 6, 2019, 202 072 individuals were recruited to the study. The mean age of women included in the study was 50.8 (SD 9.9) years compared with 51.7 (10) years for men. Participants were followed up for a median of 9.5 (IQR 8.5-10.9) years. Women had a lower cardiovascular disease risk factor burden using two different risk scores (INTERHEART and Framingham). Primary prevention strategies, such as adoption of several healthy lifestyle behaviours and use of proven medicines, were more frequent in women than men. Incidence of cardiovascular disease (4.1 [95% CI 4.0-4.2] for women vs 6.4 [6.2-6.6] for men per 1000 person-years; adjusted hazard ratio [aHR] 0.75 [95% CI 0.72-0.79]) and all-cause death (4.5 [95% CI 4.4-4.7] for women vs 7.4 [7.2-7.7] for men per 1000 person-years; aHR 0.62 [95% CI 0.60-0.65]) were also lower in women. By contrast, secondary prevention treatments, cardiac investigations, and coronary revascularisation were less frequent in women than men with coronary artery disease in all groups of countries. Despite this, women had lower risk of recurrent cardiovascular disease events (20.0 [95% CI 18.2-21.7] versus 27.7 [95% CI 25.6-29.8] per 1000 person-years in men, adjusted hazard ratio 0.73 [95% CI 0.64-0.83]) and women had lower 30-day mortality after a new cardiovascular disease event compared with men (22% in women versus 28% in men; p<0.0001). Differences between women and men in treatments and outcomes were more marked in LMICs with little differences in HICs in those with or without previous cardiovascular disease. Interpretation Treatments for cardiovascular disease are more common in women than men in primary prevention, but the reverse is seen in secondary prevention. However, consistently better outcomes are observed in women than in men, both in those with and without previous cardiovascular disease. Improving cardiovascular disease prevention and treatment, especially in LMICs, should be vigorously pursued in both women and men. Copyright (c) 2020 Elsevier Ltd. All righst reserved.	[Walli-Attaei, Marjan; Joseph, Philip; Rangarajan, Sumathy; Teo, Koon K.; Anand, Sonia S.; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Walli-Attaei, Marjan; Joseph, Philip; Rangarajan, Sumathy; Teo, Koon K.; Anand, Sonia S.; Yusuf, Salim] Hamilton Hlth Sci, Hamilton, ON, Canada; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Rosengren, Annika] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Chow, Clara K.] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia; [Lear, Scott A.] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [AlHabib, Khalid F.] King Saud Univ, King Fahad Cardiac Ctr, Dept Cardiac Sci, Coll Med, Riyadh, Saudi Arabia; [Davletov, Kairat] Kazakh Natl Univ, Hlth Res Inst, Fac Med, Alma Ata, Kazakhstan; [Dans, Antonio] Univ Philippines, Dept Med, Manila, Philippines; [Lanas, Fernando] Univ La Frontera, Dept Med, Temuco, Chile; [Yeates, Karen] Queens Univ, Dept Med, Kingston, ON, Canada; [Poirier, Paul] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Bahonar, Ahmad] Isfahan Univ Med Sci, Cardiovasc Res Inst, Hypertens Res Ctr, Esfahan, Iran; [Camilo, Felix] Univ Tecnol Equinoccial, Fac Ciencias Med Eugenio Espejo, Quito, Ecuador; [Chifamba, Jephat] Univ Zimbabwe, Coll Hlth Sci, Dept Physiol, Harare, Zimbabwe; [Diaz, Rafael] Estudios Clin Latinoamer, Rosario, Argentina; [Didkowska, Joanna A.; Manczuk, Marta] Maria Sklodowska Curie Mem Canc Ctr & Inst, Dept Epidemiol & Canc Prevent, Warsaw, Poland; [Irazola, Vilma] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Irazola, Vilma] South Amer Ctr Excellence Cardiovasc Hlth, Buenos Aires, DF, Argentina; [Ismail, Rosnah] Univ Kebangsaan Malaysia, Dept Community Hlth, Fac Med, Med Ctr, Kuala Lumpur, Malaysia; [Kaur, Manmeet] Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Khatib, Rasha] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Palestine; [Liu, Xiaoyun] Chinese Acad Med Sci & Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis, Beijing, Peoples R China; [Miranda, J. Jaime] Univ Peruana Cayetano Heredia, Dept Med, Lima, Peru; [Oguz, Aytekin] Istanbul Medeniyet Univ, Dept Internal Med, Fac Med, Istanbul, Turkey; [Perez-Mayorga, Maritza] Univ Nueva Granada, Fac Med, Bogota, Colombia; [Perez-Mayorga, Maritza] Clin Marly, Bogota, Colombia; [Szuba, Andrzej] Wroclaw Med Univ, Dept Angiol Diabetol & Hypertens, Wroclaw, Poland; [Tsolekile, Lungiswa P.] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Varma, Ravi Prasad] Hlth Act People, Thiruvananthapuram, Kerala, India; [Varma, Ravi Prasad] Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Trivandrum, Kerala, India; [Yusufali, Afzalhussein] Dubai Med Univ, Hatta Hosp, Dubai Hlth Author, Dept Med, Dubai, U Arab Emirates; [Yusuf, Rita] Independent Univ, Sch Life Sci, Dhaka, Bangladesh; [Wei, Li] Chinese Acad Med Sci, Cardiovasc Inst, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Wei, Li] Chinese Acad Med Sci, Fuwai Hosp, Beijing, Peoples R China	McMaster University; Population Health Research Institute; McMaster University; University of Gothenburg; Sahlgrenska University Hospital; George Institute for Global Health; University of Sydney; Simon Fraser University; King Saud University; Al-Farabi Kazakh National University; University of the Philippines System; University of the Philippines Manila; Universidad de La Frontera; Queens University - Canada; Isfahan University Medical Science; University of Zimbabwe; Universiti Kebangsaan Malaysia; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Birzeit University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Universidad Peruana Cayetano Heredia; Istanbul Medeniyet University; Wroclaw Medical University; University of the Western Cape; Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Independent University Bangladesh (IUB); Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Walli-Attaei, M (corresponding author), Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada.	walliam@mcmaster.ca	Oguz, Aytekin/AAJ-2732-2021; Khatib, Rasha/GXV-8883-2022; Manczuk, Marta/GPK-8403-2022; Nor-Ashikin, Mohamed Noor Khan/P-2055-2015; Lanas, Fernando/AAE-8842-2022; Mohamed Noor Khan, Nor Ashikin/AAG-3988-2020; Didkowska, Joanna Aleksandra/ABG-8672-2020; Varma, Ravi Prasad/CAF-5363-2022; ISMAIL, ROSNAH/V-2910-2017; Varma, Ravi Prasad/AAV-3234-2020; Chifamba, Jephat/AHE-4535-2022; Szuba, Andrzej/AAY-1162-2020; Rozanska, Dorota/S-5239-2018	Oguz, Aytekin/0000-0002-2595-5167; Manczuk, Marta/0000-0002-4319-6424; Nor-Ashikin, Mohamed Noor Khan/0000-0002-1325-9236; Mohamed Noor Khan, Nor Ashikin/0000-0002-1325-9236; Didkowska, Joanna Aleksandra/0000-0001-9160-9118; Varma, Ravi Prasad/0000-0002-1147-9622; ISMAIL, ROSNAH/0000-0002-8178-3822; Chifamba, Jephat/0000-0001-8166-1182; Felix, Camilo/0000-0003-0224-2321; Tsolekile, Lungiswa/0000-0001-8597-141X; Lanas, Fernando/0000-0003-3595-9759; Regulska-Ilow, Bozena/0000-0002-5941-1715; Wolyniec, Maria/0000-0003-2054-1691; Miranda, J. Jaime/0000-0002-4738-5468; Davletov, Kairat/0000-0001-8534-1899; Rozanska, Dorota/0000-0002-0561-2749; Yusuf, Salim/0000-0003-4776-5601; Zatonska, Katarzyna/0000-0002-3772-5588; Szuba, Andrzej/0000-0002-7555-6201				American Heart Association, 2019, GO RED WOM; Anand SS, 2005, J AM COLL CARDIOL, V46, P1845, DOI 10.1016/j.jacc.2005.05.091; [Anonymous], 2019, LANCET, V393, P959, DOI 10.1016/S0140-6736(19)30510-0; [Anonymous], 2017, J AM HEART ASS; Attaei MW, 2017, LANCET PUBLIC HEALTH, V2, pE411, DOI 10.1016/S2468-2667(17)30141-X; Baart SJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210329; Barrett-Connor E, 2007, AM J EPIDEMIOL, V166, P506, DOI 10.1093/aje/kwm214; Benziger CP, 2016, GLOB HEART, V11, P393, DOI 10.1016/j.gheart.2016.10.024; Berger JS, 2009, JAMA-J AM MED ASSOC, V302, P874, DOI 10.1001/jama.2009.1227; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Bots SH, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000298; Bucholz EM, 2014, CIRCULATION, V130, P757, DOI 10.1161/CIRCULATIONAHA.114.009480; Bushnell C, 2014, STROKE, V45, P1545, DOI 10.1161/01.str.0000442009.06663.48; Canto JG, 2007, ARCH INTERN MED, V167, P2405, DOI 10.1001/archinte.167.22.2405; Cenko E, 2018, JAMA INTERN MED, V178, P632, DOI 10.1001/jamainternmed.2018.0514; Chow CK, 2018, LANCET DIABETES ENDO, V6, P798, DOI 10.1016/S2213-8587(18)30233-X; Colantonio LD, 2017, JAMA CARDIOL, V2, P890, DOI 10.1001/jamacardio.2017.0911; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dehghan M, 2012, CIRCULATION, V126, P2705, DOI 10.1161/CIRCULATIONAHA.112.103234; Dey S, 2009, HEART, V95, P20, DOI 10.1136/hrt.2007.138537; Greenwood BN, 2018, P NATL ACAD SCI USA, V115, P8569, DOI 10.1073/pnas.1800097115; Gudnadottir GS, 2017, AM HEART J, V191, P65, DOI 10.1016/j.ahj.2017.06.014; Hansen KW, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007785; Joseph P, 2018, HEART, V104, P581, DOI 10.1136/heartjnl-2017-311609; Karalis DG, 2016, J CLIN LIPIDOL, V10, P833, DOI 10.1016/j.jacl.2016.02.016; Khatib R, 2016, LANCET, V387, P61, DOI 10.1016/S0140-6736(15)00469-9; Khera S, 2015, J AM COLL CARDIOL, V66, P1961, DOI 10.1016/j.jacc.2015.08.865; Kruk ME, 2018, LANCET, V392, P2203, DOI [10.1016/S0140-6736(18)31668-4, 10.1016/s0140-6736(18)31668-4]; Lichtman JH, 2014, AM HEART J, V167, P376, DOI 10.1016/j.ahj.2013.11.001; Maas AHEM, 2017, MANUAL GYNECARDIOLOG, P1; McGorrian C, 2011, EUR HEART J, V32, P581, DOI 10.1093/eurheartj/ehq448; Mehran R, 2019, LANCET, V393, P967, DOI 10.1016/S0140-6736(19)30315-0; Millett ERC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4247; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Pagidipati NJ, 2016, NAT REV CARDIOL, V13, P471, DOI 10.1038/nrcardio.2016.89; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Peters SAE, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000080; Radovanovic D, 2012, EUR HEART J-ACUTE CA, V1, P183, DOI 10.1177/2048872612454021; Rosengren A, 2004, EUR HEART J, V25, P663, DOI 10.1016/j.ehj.2004.02.023; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Santema BT, 2019, LANCET, V394, P1254, DOI 10.1016/S0140-6736(19)31792-1; Soldin OP, 2009, CLIN PHARMACOKINET, V48, P143, DOI 10.2165/00003088-200948030-00001; Sun LY, 2018, CAN MED ASSOC J, V190, pE848, DOI 10.1503/cmaj.180177; VACCARINO V, 1995, CIRCULATION, V91, P1861, DOI 10.1161/01.CIR.91.6.1861; Wilkinson C, 2019, HEART, V105, P516, DOI 10.1136/heartjnl-2018-313959; World Health Organization, 2016, VERB AUT STAND 2016; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890	49	97	101	5	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2020	396	10244					97	109		10.1016/S0140-6736(20)30543-2	http://dx.doi.org/10.1016/S0140-6736(20)30543-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ2JY	32445693				2022-12-28	WOS:000552724600014
J							COVIDsurg Collaborative	Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study	LANCET			English	Article							CONSENSUS DEFINITIONS	Background The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (74.0%) had emergency surgery and 280 (24.8%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (26.1%) patients. 30-day mortality was 23.8% (268 of 1128). Pulmonary complications occurred in 577 (51.2%) of 1128 patients; 30-day mortality in these patients was 38.0% (219 of 577), accounting for 81.7% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 1.75 [95% CI 1.28-2.40], p<0.0001), age 70 years or older versus younger than 70 years (2.30 [1.65-3.22], p<0.0001), American Society of Anesthesiologists grades 3-5 versus grades 1-2 (2.35 [1.57-3.53], p<0.0001), malignant versus benign or obstetric diagnosis (1.55 [1.01-2.39], p=0.046), emergency versus elective surgery (1.67 [1.06-2.63], p=0.026), and major versus minor surgery (1.52 [1.01-2.31], p=0.047). Interpretation Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery.					Sohrabi, Catrin/AAQ-6271-2020; Muthu, Sathish/G-5756-2018; Cotsoglou, Christian/AAX-2988-2021; Abd-Elsalam, sherief M/L-3274-2018; Marwan, Hisham/Q-4735-2018; Pachl, Max/ABH-4107-2020; Ssentongo, Paddy/AAI-2436-2020; Granieri, Stefano/AAK-6946-2021; Hulst, Abraham Hendrikus/L-3872-2018; Pereira-Neves, António/AAS-6883-2021; Lapolla, Pierfrancesco/AAT-8407-2021; carvello, michele/HHN-5282-2022; hirji, sameer/AAF-7691-2019; Rey, Cristina/AAF-1292-2021; da Costa, Paulo Matos/ABD-1573-2021; Smith, Henry/AAK-8064-2021; Kurihara, Hayato/AAW-5550-2020; Gerogiannis, Ioannis/AAJ-6797-2020; Lauscher, Johannes/ABF-5142-2020; Ferrara, Francesco/A-4559-2014; Scanu, Antonio Mario/D-8984-2012; Kara, Yasin/GNH-2589-2022; Ryan, Eanna J/H-6829-2019; Hossain, Fahad/I-1771-2019; Outani, Oumaima/AAS-1164-2020; Abou Chaar, Mohamad K./AAB-5494-2021; ISIK, ARDA/H-4772-2019; Turri, Giulia/AAA-8971-2021; Diez-Alonso, Manuel/AAP-3604-2021; Georgiades, Fanourios/ABE-3638-2020; Nita, George E/F-4327-2016; Mazingi, Dennis/AAS-5727-2020; Bisagni, pietro/AAZ-6053-2020; Lederhuber, Hans/I-2185-2019; Ureña, Miguel Ángel García/AAK-2177-2020; Bruzzaniti, Placido/ABE-3207-2020; Sahni, Arun/C-3530-2019; leventoglu, sezai/AAO-8671-2021; Elfiky, Mahmoud/B-1569-2015; Migliore, Marcello/O-7545-2017; Durst, Alexander/W-6970-2019; Porcu, Alberto/AAH-3547-2021; Hing, Caroline/AAH-6777-2021; Lázaro, André/G-3184-2018; Lule, Herman/AAJ-8762-2021; Mele, Simone/AAC-9664-2022; Osorio, Alexander/GPX-6863-2022; Peros, Georgios/ABE-7237-2020; Abd-Elsalam, Sherief M/AAV-3342-2021; Pata, Francesco/AAH-4764-2019; Cox, Daniel/AAS-4620-2020; Kamphues, Carsten/AAG-1457-2021; Ureña, Miguel Angel Garcia/G-9069-2011; Mariani, Nicolò Maria/AAO-5964-2020; Iovino, Domenico/ABI-1470-2020; Kowal, Mikolaj/AAM-5550-2021; Totty, Joshua/AAP-6655-2020; Tawheed, Ahmed/ABA-4816-2020; Lizzi, Vincenzo/AGG-0642-2022; Emile, Sameh Hany/R-4473-2017; galleano, raffaele/ABB-5864-2021; Bueno-Cañones, Alejandro/GNM-8045-2022; Doussot, Alexandre/Y-9592-2019; Citterio, Davide/AAA-6590-2020; Tang, Alethea/AAV-1983-2020; Machairas, Nikolaos/AAA-2982-2020; de Sousa Silva, Jeancarllo/AAU-1662-2020; Jones, Gareth/AAR-2444-2020; vaccarella, gianpaolo/AFL-8776-2022; Löffler, Markus/K-2239-2014; Bouhuwaish, Ahmad/AAX-8333-2020; Cordera, Fernando/F-3878-2017; Abbott, Tom E F/J-7214-2015; Elhadi, Muhammed/AAU-5641-2020; Gaino, Francesca/ABG-4714-2020; Giorgakis, Emmanouil/K-7249-2019; MARINO, Marco Vito/AAP-9290-2020; van Ramshorst, Gabrielle H./H-9140-2019; Cirillo, Bruno/AAH-5622-2021; Maisonneuve, Emeline/AAT-7777-2021; Aljanadi, Firas/J-1347-2017; Marra, Angelo Alessandro/AAH-8805-2021; Mihanovic, Jakov/D-6421-2018; Fiore, Marco/AAA-1706-2021; Gomes, Gustavo Mendonça Ataíde/F-2970-2018; Marzi, Federica/ABB-5551-2020; Violante, Tommaso/ABB-1707-2020; Zizzo, Maurizio/AAE-2724-2020; Perra, Teresa/AAW-8098-2020; Youssef, Mina/AAP-1674-2021; Lakkis, Zaher/H-9378-2019; Nepogodiev, Dmitri/J-1041-2019; Falco, Giuseppe/AAA-7191-2021; Toh, Simon Khay Chuan/X-7081-2019; Sammarco, Giuseppe/ABG-8058-2020; Blanco-Colino, Ruth/AAC-7612-2019; Parente, Alessandro/ABC-5073-2020; Ghosh, Dhruva N/AAK-1231-2020; Naumann, David/S-9917-2019; gönüllü, emre/AAK-7837-2021; SALAMAH, ABDULRAUF A/AAX-8356-2020; Wade, Ryckie George/H-9277-2016; Francone, Elisa/AAC-6725-2019; Glasbey, James/I-2457-2019; Pinkney, Thomas/HGA-4022-2022; Alser, Osaid/P-5509-2017; Viswanath, Yirupaiahgari/AAI-8977-2021; Ravaioli, Matteo/D-6314-2016; Merdrignac, Aude/ABG-8121-2020; Martinelli, Fabio/J-4151-2013; Pinotti, Enrico/ABC-1951-2021; Thaha, Mohamed Adhnan/GLU-4345-2022; Gallo, Gaetano/I-6917-2019; Okugbo, Stanley/M-4798-2019; Mercante, Giuseppe/G-2542-2018; Guaglio, Marcello/I-2770-2017; Rolli, Luigi/I-1806-2017; Tierney, Sean/I-7740-2013; Bouchagier, Konstantinos/Z-3837-2019; Capitan-Morales, Luis-Cristobal/P-5531-2015; Boddy, Alex/B-6098-2014; Labib, Peter/C-2467-2015; El-Kassas, Mohamed/F-8306-2019; Santos-Sousa, Hugo/C-6734-2013; Di Franco, Gregorio/H-5323-2018; Mashbari, Hassan/S-2837-2017; Kudsk-Iversen, Soren/Y-9391-2018; Castoro, Carlo/GNM-8249-2022; Dean, Harry/D-3248-2019; Winter, Stuart C/O-8022-2018; Chan, Jeffrey Shi Kai/C-2982-2019; Di Saverio, Salomone/G-1437-2012	Sohrabi, Catrin/0000-0003-2773-5659; Muthu, Sathish/0000-0002-7143-4354; Cotsoglou, Christian/0000-0002-6348-0027; Abd-Elsalam, sherief M/0000-0003-4366-2218; Marwan, Hisham/0000-0001-9949-0262; Pachl, Max/0000-0001-7228-862X; Ssentongo, Paddy/0000-0003-1565-5731; Granieri, Stefano/0000-0001-9167-3400; Hulst, Abraham Hendrikus/0000-0001-9101-7649; Pereira-Neves, António/0000-0003-0209-7670; Lapolla, Pierfrancesco/0000-0002-3088-5263; carvello, michele/0000-0002-8650-2321; hirji, sameer/0000-0002-5032-675X; Rey, Cristina/0000-0001-9762-9742; da Costa, Paulo Matos/0000-0002-7550-8285; Smith, Henry/0000-0003-4218-4648; Kurihara, Hayato/0000-0002-8826-9631; Gerogiannis, Ioannis/0000-0002-8194-1990; Ferrara, Francesco/0000-0002-8208-1945; Scanu, Antonio Mario/0000-0001-7878-1167; Ryan, Eanna J/0000-0003-2609-0836; Hossain, Fahad/0000-0002-1983-0464; Abou Chaar, Mohamad K./0000-0002-9584-2184; Turri, Giulia/0000-0001-6150-6812; Diez-Alonso, Manuel/0000-0002-0993-8498; Georgiades, Fanourios/0000-0003-0440-2720; Nita, George E/0000-0002-5637-2044; Mazingi, Dennis/0000-0001-8217-4642; Bisagni, pietro/0000-0001-6680-4253; Lederhuber, Hans/0000-0002-9786-8054; Ureña, Miguel Ángel García/0000-0002-7356-6211; Bruzzaniti, Placido/0000-0003-1873-7687; Sahni, Arun/0000-0002-7183-872X; leventoglu, sezai/0000-0003-0680-0589; Elfiky, Mahmoud/0000-0003-1820-8603; Migliore, Marcello/0000-0002-6272-8983; Durst, Alexander/0000-0002-9236-0999; Hing, Caroline/0000-0003-0836-2885; Lázaro, André/0000-0003-3910-845X; Lule, Herman/0000-0002-0647-9716; Mele, Simone/0000-0003-3602-3733; Osorio, Alexander/0000-0001-7787-3027; Peros, Georgios/0000-0001-8308-4518; Pata, Francesco/0000-0003-2634-1199; Cox, Daniel/0000-0002-5092-4370; Kamphues, Carsten/0000-0002-5406-8540; Ureña, Miguel Angel Garcia/0000-0002-7356-6211; Mariani, Nicolò Maria/0000-0003-4360-187X; Iovino, Domenico/0000-0002-7911-2026; Kowal, Mikolaj/0000-0001-5628-4880; Totty, Joshua/0000-0002-0063-1414; Tawheed, Ahmed/0000-0002-9382-8733; Lizzi, Vincenzo/0000-0001-9387-9314; Emile, Sameh Hany/0000-0001-7854-5244; galleano, raffaele/0000-0001-9787-4908; Bueno-Cañones, Alejandro/0000-0001-6093-505X; Doussot, Alexandre/0000-0003-0543-1793; Citterio, Davide/0000-0002-0708-8733; Tang, Alethea/0000-0001-9681-9755; Machairas, Nikolaos/0000-0003-3239-3905; de Sousa Silva, Jeancarllo/0000-0002-4517-3357; Jones, Gareth/0000-0002-1035-9274; vaccarella, gianpaolo/0000-0002-0125-1843; Löffler, Markus/0000-0003-2513-1317; Bouhuwaish, Ahmad/0000-0001-7182-1277; Cordera, Fernando/0000-0002-1535-689X; Abbott, Tom E F/0000-0002-8664-3001; Elhadi, Muhammed/0000-0001-6406-4212; Gaino, Francesca/0000-0001-5670-0848; Giorgakis, Emmanouil/0000-0002-5019-5497; van Ramshorst, Gabrielle H./0000-0002-5368-582X; Cirillo, Bruno/0000-0003-1889-2644; Aljanadi, Firas/0000-0001-8654-5877; Marra, Angelo Alessandro/0000-0001-8384-5081; Mihanovic, Jakov/0000-0001-6450-2956; Fiore, Marco/0000-0001-8220-424X; Gomes, Gustavo Mendonça Ataíde/0000-0002-5885-9059; Violante, Tommaso/0000-0003-4439-5254; Zizzo, Maurizio/0000-0001-9841-7856; Perra, Teresa/0000-0001-7032-1289; Youssef, Mina/0000-0002-6807-313X; Lakkis, Zaher/0000-0002-2608-5896; Nepogodiev, Dmitri/0000-0002-2171-2862; Falco, Giuseppe/0000-0002-5725-0487; Toh, Simon Khay Chuan/0000-0001-5110-2371; Sammarco, Giuseppe/0000-0003-2898-9626; Blanco-Colino, Ruth/0000-0003-3303-0655; Parente, Alessandro/0000-0001-5506-224X; Ghosh, Dhruva N/0000-0003-2976-0241; Naumann, David/0000-0003-2243-2325; gönüllü, emre/0000-0001-6391-4414; SALAMAH, ABDULRAUF A/0000-0003-3088-7960; Wade, Ryckie George/0000-0001-8365-6547; Francone, Elisa/0000-0001-6393-6859; Glasbey, James/0000-0001-7688-5018; Pinkney, Thomas/0000-0001-7320-6673; Alser, Osaid/0000-0001-6743-803X; Viswanath, Yirupaiahgari/0000-0003-3880-1172; Ravaioli, Matteo/0000-0001-5862-6151; Merdrignac, Aude/0000-0002-0284-4755; Martinelli, Fabio/0000-0002-4863-1747; Pinotti, Enrico/0000-0003-3063-4170; Thaha, Mohamed Adhnan/0000-0002-5043-6107; Gallo, Gaetano/0000-0003-1066-4671; Okugbo, Stanley/0000-0002-1701-8907; Mercante, Giuseppe/0000-0002-1009-7892; Dean, Benjamin/0000-0002-8969-8868; Campanelli, Michela/0000-0002-2134-2275; Martin, Guy/0000-0002-5759-962X; Hernandez-Garcia, Miguel/0000-0002-6335-504X; Byrne, Matthew/0000-0002-2414-352X; Rajgor, Amarkumar D/0000-0002-9323-3107; Conti, Luigi/0000-0002-1623-5440; Aitken, Emma/0000-0001-8939-7478; Corbellini, Carlo/0000-0003-0814-0537; Schilling, Clare/0000-0001-8852-1270; Guaglio, Marcello/0000-0002-8194-9810; Borgstein, Alexander/0000-0002-5179-1207; Rolli, Luigi/0000-0002-6673-5785; Sasia, Diego/0000-0003-3162-4302; Outani, Oumaima/0000-0001-6986-0306; Spoletini, Domenico/0000-0001-5116-9963; Niquen-Jimenez, Milagros/0000-0001-5590-9076; Bhangu, Aneel/0000-0001-5999-4618; Palini, Gian Marco/0000-0003-2601-426X; Judkins, Nicholas/0000-0001-5696-1183; Caruana, Edward J/0000-0002-0257-7618; Hutchinson, Peter/0000-0002-2796-1835; Angelou, Dimitrios/0000-0002-8653-3742; Coughlin, Patrick/0000-0003-1342-1114; Holme, Thomas/0000-0002-4134-1472; De Virgilio, Armando/0000-0003-0738-8223; Dass, Debashis/0000-0003-3116-8124; Quante, Markus/0000-0002-2206-107X; Ford, Samuel/0000-0002-1739-964X; Tierney, Sean/0000-0002-1886-7214; Elfaituri, Muhammed K Elhadi/0000-0003-0310-8773; Castro Borges, Filipe/0000-0001-5529-2045; Gill, Charn/0000-0002-0706-6809; Evans, Jonathan/0000-0003-0090-1012; /0000-0003-4673-0386; Rio, Javier/0000-0002-0973-2684; Steinkamp, Pieter/0000-0003-4228-063X; Bouchagier, Konstantinos/0000-0002-3291-3619; Porcu, Alberto/0000-0001-6307-8938; Harries, Rhiannon/0000-0001-7095-3673; Davis, Niall/0000-0002-5298-1475; Singh, Aminder/0000-0002-9099-4162; Martin, Benjamin/0000-0001-9321-3651; Elsayed, ahmed/0000-0001-9023-7244; GOMEZ-ROSADO, JUAN-CARLOS/0000-0002-9467-1934; Mediratta, Saniya/0000-0002-5187-140X; Erridge, Simon/0000-0001-5871-6501; PEREZ-SABORIDO, BALTASAR/0000-0003-0842-1654; Faria, Carlos Silva/0000-0002-8470-152X; Al-Najjar, Hani/0000-0002-6251-8388; Ridgway, Paul/0000-0002-8500-8532; Bailon, Martin/0000-0001-8740-7003; Hammond, John Stotesbury/0000-0003-4400-8461; Capitan-Morales, Luis-Cristobal/0000-0003-2784-1232; Singh, Shailendra/0000-0002-7353-587X; Colletti, Gaia/0000-0001-9859-836X; Godbole, Chintamani/0000-0001-9234-7658; Sallam, Ibrahim/0000-0002-9486-498X; Parmar, Chetan/0000-0002-1238-6524; Haqqani, Maha/0000-0002-4900-872X; Danwaththa Liyanage, Aloka Suwanna/0000-0003-4973-4809; Ayorinde, John OO/0000-0001-6603-0139; Chakrabortee, Sohini/0000-0001-8488-6416; Baltazar, Gerard/0000-0001-6109-3843; Smillie, Robert/0000-0003-2662-8675; Flatman, Michael/0000-0002-0039-3399; Singh, Abhinav/0000-0002-7329-6792; Minaya Bravo, Ana Maria/0000-0002-7982-5499; Enjuto, Diego/0000-0001-7698-7284; Toledo Martinez, Enrique/0000-0001-8411-5283; Leung, Elaine/0000-0001-9748-7270; Wright, Naomi/0000-0003-4105-8009; Das, Rishi/0000-0003-0324-8258; Boddy, Alex/0000-0001-7243-0155; cannoletta, maria/0000-0002-5052-1539; Faustin, NTIRENGANYA/0000-0001-8886-8100; Nunes, Quentin/0000-0002-7513-8595; Senent-Boza, Ana/0000-0002-0033-5850; Labib, Peter/0000-0003-2362-9218; MATEO-SIERRA, OLGA/0000-0002-7313-040X; Warren, Oliver/0000-0001-8948-7473; Trujillo Diaz, Jeancarlos/0000-0001-9889-7116; Lima Buarque, Igor/0000-0002-9953-500X; Lin, Daniel J/0000-0002-0890-0148; Archer, James/0000-0001-7329-2401; Marino, Marco V./0000-0002-0466-4467; Bass, Gary Alan/0000-0002-1918-9443; Kinross, James/0000-0002-0427-7643; Ademuyiwa, Adesoji/0000-0003-2415-3098; Yurttas, Can/0000-0001-9720-8243; Etchill, Eric/0000-0002-5381-648X; Bueser, Teofila/0000-0001-9222-1705; Trompeter, Alex/0000-0001-7887-497X; El-Kassas, Mohamed/0000-0002-3396-6894; Mantoglu, Baris/0000-0002-2161-3629; Sampietro, Gianluca Matteo/0000-0001-7168-441X; Santos-Sousa, Hugo/0000-0001-6176-5654; Chebaro, Alexandre/0000-0001-7063-8315; Shackcloth, Michael/0000-0002-6494-9907; van Berge Henegouwen, Mark/0000-0001-8689-3134; Scalabre, Aurelien/0000-0001-7361-1900; FAMILIARI, PIETRO/0000-0003-0513-2312; Sileri, Pierpaolo/0000-0002-1104-6237; Khatri, Chetan/0000-0002-3961-1314; Sampaio-Alves, Mafalda/0000-0002-1214-8470; Di Franco, Gregorio/0000-0003-2156-369X; Fancellu, Alessandro/0000-0002-3997-8183; Lozano Lominchar, Pablo/0000-0002-5413-8449; Jordan, Caitlin/0000-0002-2730-0332; marrano, enrico/0000-0001-6818-0448; Lostoridis, Eftychios/0000-0002-7843-6838; Raptis, Dimitri Aristotle/0000-0002-0898-3270; Wright, Franklin/0000-0002-4433-5385; Petrone, Patrizio/0000-0002-7629-1663; Smith, Christopher/0000-0003-2795-0922; Krishnan, Emily/0000-0003-3443-6104; Ruiz Grande, Fernando/0000-0002-3358-5637; Mashbari, Hassan/0000-0002-8107-1542; Richards, Tomos/0000-0002-4060-7451; Kirmani, Bilal/0000-0002-5028-5505; Glen, Paul/0000-0002-5033-3626; Ballabio, Michele/0000-0001-5073-1002; Kudsk-Iversen, Soren/0000-0002-7112-3548; Brown, Benjamin/0000-0003-4478-4321; Shinkwin, Michael/0000-0003-0101-9400; KONTOVOUNISIOS, CHRISTOS/0000-0002-1828-1395; Ramallo-Solis, Irene/0000-0002-4973-1651; Watson, Laura Jayne/0000-0003-4489-3093; Castoro, Carlo/0000-0001-9601-9336; Barmpagianni, Christina/0000-0002-5260-6771; Spriano, Giuseppe/0000-0001-6458-5640; Martin, Janet/0000-0002-3599-8427; Bosanquet, David/0000-0003-2304-0489; CANDIANI, Massimo/0000-0002-2129-2626; Gracia, Isabel/0000-0001-8442-8247; Baig, Mirza MAS/0000-0002-7791-827X; LOWERY, AOIFE/0000-0002-8062-6235; Dean, Harry/0000-0003-0842-8987; Duchateau, Nicolas/0000-0003-0067-9685; Whitehall, Emma/0000-0003-3465-2843; Winter, Stuart C/0000-0002-8152-816X; Elfallal, Ahmed/0000-0002-7658-0596; Coleman, Natasha/0000-0003-0742-4597; Ward, Alex Elizabeth/0000-0002-9609-830X; di bartolomeo, alessandro/0000-0002-5384-1693; Kugler, Nadav/0000-0002-9126-0881; Siragusa, Leandro/0000-0001-9218-1176; Jeganathan, Reubendra/0000-0002-0043-9924; TONINI, VALERIA/0000-0003-3130-2928; Wormald, Justin/0000-0001-6197-4093; Aftab, Raiyyan/0000-0001-7643-9528; Podda, Mauro/0000-0001-9941-0883; Loubani, Mahmoud/0000-0003-1826-6686; Giuffrida, Maria Carmela/0000-0002-5596-8655; Chan, Jeffrey Shi Kai/0000-0003-0231-2393; Zanini, Nicola/0000-0002-4877-5759; Ramos, Diego/0000-0003-0191-1968; Sapienza, Paolo/0000-0002-0198-7930; Kamarajah, Sivesh K/0000-0002-2748-0011; Baldi, Caterina/0000-0002-5792-3880; Perivoliotis, Konstantinos/0000-0002-6622-5734; Tejero-Pintor, Francisco J/0000-0002-8807-8229; Edwards, John/0000-0002-7935-5327; McKay, Siobhan/0000-0003-0590-2153; Odeh, Abdulrahman/0000-0002-8481-9245; Patkar, Pradnya/0000-0001-7817-0577; Deeb, Haya/0000-0002-7044-7321; Rathinam, Sridhar/0000-0002-1065-0045; Ambler, Graeme/0000-0002-3024-6365; Diaz Garcia, Alberto/0000-0002-7334-7203; Chiozza, Matteo/0000-0002-0879-5229; Ashmore, Christopher/0000-0003-0244-5241; Seow, Sean Ezekiel/0000-0002-9331-3473; Moug, Susan/0000-0001-9969-9760; Sanders, Julie/0000-0002-7335-2803; Leo, Cosimo Alex/0000-0001-5759-0345; Gomez Diaz, Carlos Javier/0000-0002-3273-8793; Paiella, Salvatore/0000-0001-6893-8618; Di Saverio, Salomone/0000-0001-5685-5022; Jenny, Hillary/0000-0003-2275-9336; Vieira, Paula/0000-0001-6789-086X; Gisbertz, Suzanne/0000-0001-9655-7601; Santos, Irene/0000-0002-4984-4736; Tamimy, Muhammad Sarmad/0000-0002-9883-5318; Harrison, Ewen/0000-0002-5018-3066; Turrado-Rodriguez, Victor/0000-0002-0573-7373; Valdes-Hernandez, Javier/0000-0002-0837-8986; Seegert, Sara/0000-0003-4143-5556; Ban, Vin Shen/0000-0002-4532-8101; Leclercq, Wouter/0000-0003-1159-1857; Sravanam, Sanskrithi/0000-0003-2965-2400; Venn, Mary/0000-0002-3015-7039; LAWANI, Ismail/0000-0001-5022-6313; Barry, Conor/0000-0001-8411-0474; Meagher, Ashley/0000-0003-2429-2274; Dixon, Jan/0000-0003-0445-3026	National Institute for Health Research (NIHR); Association of Coloproctology of Great Britain and Ireland; Bowel and Cancer Research; Bowel Disease Research Foundation; Association of Upper Gastrointestinal Surgeons; British Association of Surgical Oncology; British Gynaecological Cancer Society; European Society of Coloproctology; NIHR Academy; Sarcoma UK; Vascular Society for Great Britain and Ireland; Yorkshire Cancer Research; MRC [MR/N029984/1] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Association of Coloproctology of Great Britain and Ireland; Bowel and Cancer Research; Bowel Disease Research Foundation; Association of Upper Gastrointestinal Surgeons; British Association of Surgical Oncology; British Gynaecological Cancer Society; European Society of Coloproctology; NIHR Academy; Sarcoma UK; Vascular Society for Great Britain and Ireland; Yorkshire Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research.	Abbott TEF, 2018, BRIT J ANAESTH, V120, P1066, DOI 10.1016/j.bja.2018.02.007; American College of Surgeons; American Society of Anesthesiologists; Association of Perioperative Registered Nurses; American Hospital Association, 2020, COVID 19 REC MAN EL; Aminian A, 2020, ANN SURG, V272, pE27, DOI 10.1097/SLA.0000000000003925; [Anonymous], 2016, BR J SURG, DOI DOI 10.1002/BJS.10151; Besnier E, 2020, WORLD J SURG, V44, P1695, DOI 10.1007/s00268-020-05501-6; Biccard BM, 2018, LANCET, V391, P1589, DOI [10.1016/S0140-6736(18)30001-1, 10.1016/s0140-6736(18)30001-1]; Cai M, 2020, BRIT J SURG, V107, pE183, DOI 10.1002/bjs.11643; Coccolini F, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00307-2; COVIDSurg Collaborative, 2020, BRIT J SURG, V107, P1097, DOI 10.1002/bjs.11646; Fernandez-Bustamante A, 2017, JAMA SURG, V152, P157, DOI 10.1001/jamasurg.2016.4065; Horton R, 2020, LANCET, V395, P1022, DOI 10.1016/S0140-6736(20)30727-3; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Intensive Care National Audit & Research Centre, 2020, ICNARC REP COVID 19; Kaafarani HMA, 2020, ANN SURG, V272, pE61, DOI 10.1097/SLA.0000000000004004; Kirmeier E, 2019, LANCET RESP MED, V7, P129, DOI 10.1016/S2213-2600(18)30294-7; Lei SQ, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100331; National Confidential Enquiry into Perioperative Deaths, 2003, WHO OP 2 REP NAT CON; NELA Project Team, 2019, 5 PAT REP NAT EM LAP; NELA Project Team, 2018, 4 PAT REP NAT EM LAP; Neto AS, 2018, EUR J ANAESTH, V35, P691, DOI 10.1097/EJA.0000000000000845; Pearse RM, 2017, MINERVA ANESTESIOL, V83, P175, DOI 10.23736/S0375-9393.16.11502-0; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Tao K X, 2020, Zhonghua Wai Ke Za Zhi, V58, pE001, DOI 10.3760/cma.j.issn.0529-5815.2020.0001; Tu RH, 2017, CANCER MED-US, V6, P2757, DOI 10.1002/cam4.1163; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; World Health Organization, 2020, MERS SIT UPD; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	28	944	969	12	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2020	396	10243					27	38		10.1016/S0140-6736(20)31182-X	http://dx.doi.org/10.1016/S0140-6736(20)31182-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ND0VO	32479829	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000561626100014
J	Zaccara, S; Jaffrey, SR				Zaccara, Sara; Jaffrey, Samie R.			A Unified Model for the Function of YTHDF Proteins in Regulating m(6)A-Modified mRNA	CELL			English	Article							M(6)A; TRANSLATION; N-6-METHYLADENOSINE; METHYLATION; SEQUENCE; REVEALS; LEUKEMIA; WRITERS; COMPLEX; DOMAIN	N-6-methyladenosine (m(6)A) is the most abundant mRNA nucleotide modification and regulates critical aspects of cellular physiology and differentiation, m(6)A is thought to mediate its effects through a complex network of interactions between different m(6)A sites and three functionally distinct cytoplasmic YTHDF m(6)A-binding proteins (DF1, DF2, and DF3). In contrast to the prevailing model, we show that DF proteins bind the same m(6)A-modified mRNAs rather than different mRNAs. Furthermore, we find that DF proteins do not induce translation in HeLa cells. Instead, the DF paralogs act redundantly to mediate mRNA degradation and cellular differentiation. The ability of DF proteins to regulate stability and differentiation becomes evident only when all three DF paralogs are depleted simultaneously. Our study reveals a unified model of m(6)A function in which all m(6)A-modified mRNAs are subjected to the combined action of YTHDF proteins in proportion to the number of m(6)A sites.	[Zaccara, Sara; Jaffrey, Samie R.] Cornell Univ, Dept Pharmacol, Weill Cornell Med, New York, NY 10065 USA	Cornell University	Jaffrey, SR (corresponding author), Cornell Univ, Dept Pharmacol, Weill Cornell Med, New York, NY 10065 USA.	srj2003@med.cornell.edu		ZACCARA, SARA/0000-0002-6569-2015	NIH [R35NS111631, R01CA186702]; American-Italian Cancer Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American-Italian Cancer Foundation	We thank members of the Jaffrey laboratory for comments and suggestions, in particular V. Despic, and D. Patil for early contributions to this project. We thank members of the Epigenomics and Flow Cytometry Weill Cornell Cores. We thank A. North and the Rockefeller Bio-Imaging Resource Center for assistance with SIM microscopy. We thank the Rockefeller High-Throughput Screening Resource Center for assistance with the MST experiments. We thank Y. Cheng and M. Kharas for advice regarding the experiments using leukemia cells. This work was supported by NIH grants R35NS111631 and R01CA186702 (to S.R.J.) and an American-Italian Cancer Foundation fellowship (to S.Z.).	Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Anders M, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800113; [Anonymous], [No title captured]; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Arguello AE, 2019, BIOCHEMISTRY-US, V58, P3386, DOI 10.1021/acs.biochem.9b00485; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barbieri I, 2017, NATURE, V552, P126, DOI 10.1038/nature24678; Birkaya B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-43; Calviello L, 2016, NAT METHODS, V13, P165, DOI [10.1038/NMETH.3688, 10.1038/nmeth.3688]; CANAANI D, 1979, NUCLEIC ACIDS RES, V6, P2879, DOI 10.1093/nar/6.8.2879; Chakrabarti AM, 2018, ANNU REV BIOMED DA S, V1, P235, DOI 10.1146/annurev-biodatasci-080917-013525; Choe J, 2018, NATURE, V561, P556, DOI 10.1038/s41586-018-0538-8; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Cui Q, 2017, CELL REP, V18, P2622, DOI 10.1016/j.celrep.2017.02.059; DIMOCK K, 1977, BIOCHEMISTRY-US, V16, P471, DOI 10.1021/bi00622a021; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Dominguez D, 2018, MOL CELL, V70, P854, DOI 10.1016/j.molcel.2018.05.001; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Guertin MJ, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky252; Han DL, 2019, NATURE, V566, P270, DOI 10.1038/s41586-019-0916-x; Hesser CR, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006995; Holehouse AS, 2017, BIOPHYS J, V112, P16, DOI 10.1016/j.bpj.2016.11.3200; Ke SD, 2017, GENE DEV, V31, P990, DOI 10.1101/gad.301036.117; Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002; Lancaster AK, 2014, BIOINFORMATICS, V30, P2501, DOI 10.1093/bioinformatics/btu310; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lauria F, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006169; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; Lee H, 2019, NAT CELL BIOL, V21, P700, DOI 10.1038/s41556-019-0318-1; Li A, 2017, CELL RES, V27, P444, DOI 10.1038/cr.2017.10; Li FD, 2014, CELL RES, V24, P1490, DOI 10.1038/cr.2014.153; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/nmeth.3453, 10.1038/NMETH.3453]; Liu J, 2018, NAT CELL BIOL, V20, P1074, DOI 10.1038/s41556-018-0174-4; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Markmiller S, 2018, CELL, V172, P590, DOI 10.1016/j.cell.2017.12.032; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McGlincy NJ, 2017, METHODS, V126, P112, DOI 10.1016/j.ymeth.2017.05.028; Merkurjev D, 2018, NAT NEUROSCI, V21, P1004, DOI 10.1038/s41593-018-0173-6; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; Olarerin-George Anthony O, 2017, Bioinformatics, V33, P1563, DOI 10.1093/bioinformatics/btx002; Ozoe A, 2013, FEBS LETT, V587, P2319, DOI 10.1016/j.febslet.2013.05.066; Paris J, 2019, CELL STEM CELL, V25, P137, DOI 10.1016/j.stem.2019.03.021; Park OH, 2019, MOL CELL, V74, P494, DOI 10.1016/j.molcel.2019.02.034; Patil DP, 2018, TRENDS CELL BIOL, V28, P113, DOI 10.1016/j.tcb.2017.10.001; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ries RJ, 2019, NATURE, V571, P424, DOI 10.1038/s41586-019-1374-1; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Shi HL, 2019, MOL CELL, V74, P640, DOI 10.1016/j.molcel.2019.04.025; Shi HL, 2018, NATURE, V563, P249, DOI 10.1038/s41586-018-0666-1; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Slobodin B, 2017, CELL, V169, P326, DOI 10.1016/j.cell.2017.03.031; SOMMER S, 1978, J MOL BIOL, V124, P487, DOI 10.1016/0022-2836(78)90183-3; Tirumuru N, 2016, ELIFE, V5, DOI [10.7554/eLife.15528, 10.7554/eLife.31482]; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, RNA BIOL, V11, P669, DOI 10.4161/rna.28829; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; WEI CM, 1976, BIOCHEMISTRY-US, V15, P397, DOI 10.1021/bi00647a024; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wheeler EC, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1436; Winkler R, 2019, NAT IMMUNOL, V20, P173, DOI 10.1038/s41590-018-0275-z; Wu CCC, 2019, MOL CELL, V73, P959, DOI 10.1016/j.molcel.2018.12.009; Xu C, 2015, J BIOL CHEM, V290, P24902, DOI 10.1074/jbc.M115.680389; Youn JY, 2018, MOL CELL, V69, P517, DOI 10.1016/j.molcel.2017.12.020; Zaccara S, 2019, NAT REV MOL CELL BIO, V20, P608, DOI 10.1038/s41580-019-0168-5; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883	73	215	216	27	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2020	181	7					1582	+		10.1016/j.cell.2020.05.012	http://dx.doi.org/10.1016/j.cell.2020.05.012			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MD2SA	32492408	Green Accepted, Bronze			2022-12-28	WOS:000543822100015
J	Bell, AD; Mello, CJ; Nemesh, J; Brumbaugh, SA; Wysoker, A; McCarroll, SA				Bell, Avery Davis; Mello, Curtis J.; Nemesh, James; Brumbaugh, Sara A.; Wysoker, Alec; McCarroll, Steven A.			Insights into variation in meiosis from 31,228 human sperm genomes	NATURE			English	Article							MEIOTIC RECOMBINATION; PATERNAL NONDISJUNCTION; CROSSOVER INTERFERENCE; DNA; ANEUPLOIDY; NUMBER; CELLS; RATES; MAPS; DECONDENSATION	Meiosis, although essential for reproduction, is also variable and error-prone: rates of chromosome crossover vary among gametes, between the sexes, and among humans of the same sex, and chromosome missegregation leads to abnormal chromosome numbers (aneuploidy)(1-8). To study diverse meiotic outcomes and how they covary across chromosomes, gametes and humans, we developed Sperm-seq, a way of simultaneously analysing the genomes of thousands of individual sperm. Here we analyse the genomes of 31,228 human gametes from 20 sperm donors, identifying 813,122 crossovers and 787 aneuploid chromosomes. Sperm donors had aneuploidy rates ranging from 0.01 to 0.05 aneuploidies per gamete; crossovers partially protected chromosomes from nondisjunction at the meiosis I cell division. Some chromosomes and donors underwent more-frequent nondisjunction during meiosis I, and others showed more meiosis II segregation failures. Sperm genomes also manifested manygenomic anomalies that could not be explained by simple nondisjunction. Diverse recombination phenotypes-from crossover rates to crossover location and separation, a measure of crossover interference-covaried strongly across individuals and cells. Our results can be incorporated with earlier observations into a unified model in which a core mechanism, the variable physical compaction of meiotic chromosomes, generates interindividual and cell-to-cell variation in diverse meiotic phenotypes.	[Bell, Avery Davis; Mello, Curtis J.; Nemesh, James; Brumbaugh, Sara A.; Wysoker, Alec; McCarroll, Steven A.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Bell, Avery Davis; Mello, Curtis J.; Nemesh, James; Brumbaugh, Sara A.; Wysoker, Alec; McCarroll, Steven A.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bell, AD; McCarroll, SA (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Bell, AD; McCarroll, SA (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.	averydavisbell@gmail.com; mccarroll@genetics.med.harvard.edu		Bell, Avery Davis/0000-0002-1837-302X	Broad Institute NextGen award; Harvard Medical School Program in Genetics and Genomics NIH Ruth L. Kirchstein training grant;  [R01 HG006855]	Broad Institute NextGen award; Harvard Medical School Program in Genetics and Genomics NIH Ruth L. Kirchstein training grant; 	We thank G. Genovese for suggestions on analyses; E. Macosko for advice on technology development; other members of the McCarroll laboratory, including C. Whelan, S. Burger and B. Handsaker, for advice; M. Daly, J. Hirschhorn, S. Elledge and S. Schilit for their insights; 10x Genomics for discussions about reagents; C. L. Usher and C. K. Patil for contributions to the text and figures; and those who commented on the preprint version of this article for their input. This work was supported by grant R01 HG006855 to S.A.M.; a Broad Institute NextGen award to S.A.M.; and a Harvard Medical School Program in Genetics and Genomics NIH Ruth L. Kirchstein training grant to A.D.B.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bansal V, 2008, BIOINFORMATICS, V24, pI153, DOI 10.1093/bioinformatics/btn298; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; Bell A. D, 2019, ZENODO, DOI [10.5281/zenodo.2581570, DOI 10.5281/ZENOD0.2581570]; Bell A. D., 2020, PROTOC EXCH, DOI [10.21203/rs.3.pex-823/v1, DOI 10.21203/RS.3.PEX-823/V1]; Bell A. D, 2019, ZENODO, DOI [10.5281/zenodo.2581595, DOI 10.5281/ZENOD0.2581595]; Bell AD, 2018, METHODS MOL BIOL, V1768, P143, DOI 10.1007/978-1-4939-7778-9_9; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Billings T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015340; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Broman KW, 2000, AM J HUM GENET, V66, P1911, DOI 10.1086/302923; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brown PW, 2005, AM J HUM GENET, V77, P556, DOI 10.1086/468188; Campbell CL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7260; Cheung VG, 2007, AM J HUM GENET, V80, P526, DOI 10.1086/512131; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Ferguson KA, 2007, HUM MOL GENET, V16, P2870, DOI 10.1093/hmg/ddm246; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gruhn JR, 2016, AM J HUM GENET, V98, P102, DOI 10.1016/j.ajhg.2015.11.019; Gruhn JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085075; Halldorsson BV, 2019, SCIENCE, V363, DOI 10.1126/science.aaw8705; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Hinch AG, 2019, SCIENCE, V363, P1300, DOI 10.1126/science.aau8861; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Housworth EA, 2003, AM J HUM GENET, V73, P188, DOI 10.1086/376610; Hyndman R. J., 2018, FORECAST FORECASTING; Hyndman RJ, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i03; Ioannou D, 2019, REPRODUCTION, V157, pR15, DOI 10.1530/REP-18-0318; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kirkness EF, 2013, GENOME RES, V23, P826, DOI 10.1101/gr.144600.112; Kleckner N, 2003, TRENDS GENET, V19, P623, DOI 10.1016/j.tig.2003.09.004; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2014, NAT GENET, V46, P11, DOI 10.1038/ng.2833; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Li H., 2013, ARXIV13033997 Q BIO; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Loh PR, 2016, NAT GENET, V48, P811, DOI 10.1038/ng.3571; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Ma S, 2006, HUM REPROD, V21, P980, DOI 10.1093/humrep/dei428; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller D, 2010, REPRODUCTION, V139, P287, DOI 10.1530/REP-09-0281; MONTAG M, 1992, MOL REPROD DEV, V33, P338, DOI 10.1002/mrd.1080330316; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Oliver TR, 2009, AM J MED GENET A, V149A, P1685, DOI 10.1002/ajmg.a.32942; Ottolini CS, 2015, NAT GENET, V47, P727, DOI 10.1038/ng.3306; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Petkolv PM, 2007, TRENDS GENET, V23, P539, DOI 10.1016/j.tig.2007.08.015; Plug AW, 1996, P NATL ACAD SCI USA, V93, P5920, DOI 10.1073/pnas.93.12.5920; Regan JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118270; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Samocha-Bone D, 1998, MOL HUM REPROD, V4, P133, DOI 10.1093/molehr/4.2.133; Savage AR, 1998, HUM MOL GENET, V7, P1221, DOI 10.1093/hmg/7.8.1221; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sun F, 2008, HUM REPROD, V23, P1691, DOI 10.1093/humrep/den027; Sun F, 2004, AM J HUM GENET, V74, P521, DOI 10.1086/382138; Taylor AC, 1997, MOL ECOL, V6, P383, DOI 10.1046/j.1365-294X.1997.00191.x; Tease C, 2004, CYTOGENET GENOME RES, V107, P208, DOI 10.1159/000080599; Templado C, 2013, MOL HUM REPROD, V19, P634, DOI 10.1093/molehr/gat039; Tyner C, 2017, NUCLEIC ACIDS RES, V45, pD626, DOI 10.1093/nar/gkw1134; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Wang SX, 2019, CELL, V177, P326, DOI 10.1016/j.cell.2019.02.021; Wang S, 2017, CELL, V168, P977, DOI 10.1016/j.cell.2017.02.002; Wang SX, 2015, CELL CYCLE, V14, P305, DOI 10.4161/15384101.2014.991185; Zhang LR, 2014, NATURE, V511, P551, DOI 10.1038/nature13442; Zhang LR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004042; Zheng GXY, 2016, NAT BIOTECHNOL, V34, P303, DOI 10.1038/nbt.3432; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	77	33	33	4	30	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 9	2020	583	7815					259	+		10.1038/s41586-020-2347-0	http://dx.doi.org/10.1038/s41586-020-2347-0		JUN 2020	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MH5KF	32494014	Green Accepted			2022-12-28	WOS:000537932200007
J	Bordley, DR				Bordley, Donald R.			Three (Not So) Easy Pieces	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Bordley, Donald R.] Univ Rochester, Rochester, NY USA	University of Rochester	Bordley, DR (corresponding author), Dept Med, 601 Elmwood Ave,Box MED, Rochester, NY 14642 USA.	donald_bordley@urmc.rochester.edu							0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2020	172	11					763	763		10.7326/M20-0097	http://dx.doi.org/10.7326/M20-0097			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MI6AJ	32479156				2022-12-28	WOS:000547487900013
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: Women's health campaigners sue FDA over access to medical abortion pills	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Guttmacher Institute, 2019, MED AB; Guttmacher Institute, 2016, US AB PAT	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2020	369								m2187	10.1136/bmj.m2187	http://dx.doi.org/10.1136/bmj.m2187			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0OM	32482621	Bronze			2022-12-28	WOS:000548486700011
J	Hartrampf, N; Saebi, A; Poskus, M; Gates, ZP; Callahan, AJ; Cowfer, AE; Hanna, S; Antilla, S; Schissel, CK; Quartararo, AJ; Ye, X; Mijalis, AJ; Simon, MD; Loas, A; Liu, S; Jessen, C; Nielsen, TE; Pentelute, BL				Hartrampf, N.; Saebi, A.; Poskus, M.; Gates, Z. P.; Callahan, A. J.; Cowfer, A. E.; Hanna, S.; Antilla, S.; Schissel, C. K.; Quartararo, A. J.; Ye, X.; Mijalis, A. J.; Simon, M. D.; Loas, A.; Liu, S.; Jessen, C.; Nielsen, T. E.; Pentelute, B. L.			Synthesis of proteins by automated flow chemistry	SCIENCE			English	Article							PHASE PEPTIDE-SYNTHESIS; TOTAL CHEMICAL-SYNTHESIS; STAPHYLOCOCCUS-AUREUS; ASPARTIMIDE FORMATION; BARSTAR; BARNASE; ACTIVATION; COMPLEX; DOMAIN; MDM2	Ribosomes can produce proteins in minutes and are largely constrained to proteinogenic amino acids. Here, we report highly efficient chemistry matched with an automated fast-flow instrument for the direct manufacturing of peptide chains up to 164 amino acids long over 327 consecutive reactions. The machine is rapid: Peptide chain elongation is complete in hours. We demonstrate the utility of this approach by the chemical synthesis of nine different protein chains that represent enzymes, structural units, and regulatory factors. After purification and folding, the synthetic materials display biophysical and enzymatic properties comparable to the biologically expressed proteins. High-fidelity automated flow chemistry is an alternative for producing single-domain proteins without the ribosome.	[Hartrampf, N.; Saebi, A.; Poskus, M.; Gates, Z. P.; Callahan, A. J.; Cowfer, A. E.; Hanna, S.; Antilla, S.; Schissel, C. K.; Quartararo, A. J.; Ye, X.; Mijalis, A. J.; Simon, M. D.; Loas, A.; Liu, S.; Pentelute, B. L.] MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Antilla, S.] MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Jessen, C.; Nielsen, T. E.] Novo Nordisk AS, Novo Nordisk Pk, DK-2760 Malov, Denmark; [Hartrampf, N.] Univ Zurich, Dept Chem, Wintherthurerstr 190, CH-8057 Zurich, Switzerland; [Gates, Z. P.] ASTAR, P53Lab, 8A Biomed Grove, Singapore 138648, Singapore; [Mijalis, A. J.] Harvard Med Sch, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA; [Simon, M. D.] Ginkgo Bioworks, 27 Drydock Ave, Boston, MA 02210 USA; [Liu, S.] East China Normal Univ, Dept Chem, 3663 North Zhongshan Rd, Shanghai 200062, Peoples R China	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Novo Nordisk; University of Zurich; Agency for Science Technology & Research (A*STAR); Harvard University; Harvard Medical School; East China Normal University	Pentelute, BL (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	blp@mit.edu	Hartrampf, Nina/AAI-8982-2020	Hartrampf, Nina/0000-0003-0875-6390; Cowfer, Amanda/0000-0002-5191-4895; Poskus, Mackenzie/0000-0003-0665-2547; Callahan, Alex/0000-0002-8414-1382; Gates, Zachary/0000-0003-0588-6157; Schissel, Carly/0000-0003-0773-5168; Antilla, Sarah/0000-0002-3592-0857; Quartararo, Anthony/0000-0003-4995-1424; Saebi, Azin/0000-0001-6782-0992	Novo Nordisk; National Science Foundation Graduate Research Fellowship [1122374]; MIT	Novo Nordisk(Novo Nordisk); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); MIT	Financial support for this project was provided by Novo Nordisk. A.S., A.E.C., and C.K.S. gratefully acknowledge support from the National Science Foundation Graduate Research Fellowship under grant no. 1122374; A.E.C. is additionally supported by an MIT Dean of Science Fellowship.	Agouridas V, 2019, CHEM REV, V119, P7328, DOI 10.1021/acs.chemrev.8b00712; Ahmed N, 2018, CHEM BIOL DRUG DES, V91, P647, DOI 10.1111/cbdd.13115; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; [Anonymous], THESIS; Arnold U, 2003, J AM CHEM SOC, V125, P7500, DOI 10.1021/ja0351239; BAYER E, 1970, TETRAHEDRON LETT, P4503; BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6; Bondalapati S, 2016, NAT CHEM, V8, P407, DOI [10.1038/NCHEM.2476, 10.1038/nchem.2476]; Bresson D, 2006, J CLIN INVEST, V116, P1371, DOI 10.1172/JCI27191; Brik A, 2003, ORG BIOMOL CHEM, V1, P5, DOI 10.1039/b208248a; Britton J, 2017, CHEM SOC REV, V46, P1250, DOI 10.1039/c6cs00830e; BUCKLE AM, 1994, BIOCHEMISTRY-US, V33, P8878, DOI 10.1021/bi00196a004; Chene P, 2004, MOL CANCER RES, V2, P20; Chin JW, 2017, NATURE, V550, P53, DOI 10.1038/nature24031; Czarna A, 2009, CELL CYCLE, V8, P1176, DOI 10.4161/cc.8.8.8185; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; Desnick RJ, 2002, NAT REV GENET, V3, P954, DOI 10.1038/nrg963; Durek T, 2007, P NATL ACAD SCI USA, V104, P4846, DOI 10.1073/pnas.0610630104; El-Faham A, 2011, CHEM REV, V111, P6557, DOI 10.1021/cr100048w; Fuse S, 2018, CHEM-ASIAN J, V13, P3818, DOI 10.1002/asia.201801488; Fuse S, 2014, ANGEW CHEM INT EDIT, V53, P851, DOI 10.1002/anie.201307987; Gasser E, 2017, NAT REV ENDOCRINOL, V13, P599, DOI 10.1038/nrendo.2017.78; Gordon CP, 2018, ORG BIOMOL CHEM, V16, P180, DOI 10.1039/c7ob02759a; HARTLEY RW, 1989, TRENDS BIOCHEM SCI, V14, P450, DOI 10.1016/0968-0004(89)90104-7; Johnson ECB, 2007, J AM CHEM SOC, V129, P11480, DOI 10.1021/ja072870n; Kelemen BR, 1999, NUCLEIC ACIDS RES, V27, P3696, DOI 10.1093/nar/27.18.3696; KELLIS JT, 1989, BIOCHEMISTRY-US, V28, P4914, DOI 10.1021/bi00437a058; Kent SBH, 2014, CURR OPIN CHEM BIOL, V22, pVIII, DOI 10.1016/j.cbpa.2014.09.037; Kent SBH, 2009, CHEM SOC REV, V38, P338, DOI 10.1039/b700141j; KNOWLES JR, 1987, SCIENCE, V236, P1252; Li JC, 2018, J AM CHEM SOC, V140, P15997, DOI 10.1021/jacs.8b07157; Ling JJJ, 2012, J AM CHEM SOC, V134, P10749, DOI 10.1021/ja302354v; LOEWENTHAL R, 1991, BIOCHEMISTRY-US, V30, P6775, DOI 10.1021/bi00241a021; Luisier S, 2010, CHEM COMMUN, V46, P8177, DOI 10.1039/c0cc03141k; LUKAS TJ, 1981, P NATL ACAD SCI-BIOL, V78, P2791, DOI 10.1073/pnas.78.5.2791; Lutz JF, 2013, SCIENCE, V341, P628, DOI 10.1126/science.1238149; Mergler M, 2003, J PEPT SCI, V9, P36, DOI 10.1002/psc.430; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Michels T, 2012, ORG LETT, V14, P5218, DOI 10.1021/ol3007925; Mijalis AJ, 2018, SCI SYNTH, P381, DOI 10.1055/sos-SD-228-00230; Mijalis A. J., 2020, AMIJALIS AFPS INTEGR; Mijalis AJ, 2017, NAT CHEM BIOL, V13, P464, DOI [10.1038/NCHEMBIO.2318, 10.1038/nchembio.2318]; Mong SK, 2014, CHEMBIOCHEM, V15, P721, DOI 10.1002/cbic.201300797; Nicholson EM, 1996, BIOCHEMISTRY-US, V35, P11369, DOI 10.1021/bi960863y; OKOROKOV AL, 1994, PROTEIN EXPRES PURIF, V5, P547, DOI 10.1006/prep.1994.1075; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Palasek SA, 2007, J PEPT SCI, V13, P143, DOI 10.1002/psc.804; Policarpo RL, 2014, ANGEW CHEM INT EDIT, V53, P9203, DOI 10.1002/anie.201403582; SCHNEIDER J, 1988, CELL, V54, P363, DOI 10.1016/0092-8674(88)90199-7; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; SERRANO L, 1992, J MOL BIOL, V224, P783, DOI 10.1016/0022-2836(92)90562-X; Sevcik J, 1998, ACTA CRYSTALLOGR D, V54, P954, DOI 10.1107/S0907444998004429; SHASTRY MCR, 1995, J MOL BIOL, V247, P1013, DOI 10.1006/jmbi.1994.0196; Simon MD, 2014, CHEMBIOCHEM, V15, P713, DOI 10.1002/cbic.201300796; Sletten ET, 2019, CHEM COMMUN, V55, P14598, DOI 10.1039/c9cc08421e; Spare LK, 2018, REACT CHEM ENG, V3, P875, DOI 10.1039/c8re00190a; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; TOTH MV, 1990, INT J PEPT PROT RES, V36, P544; Touti F, 2019, NAT CHEM BIOL, V15, P410, DOI 10.1038/s41589-019-0245-2; Truex NL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-56943-5; Vinogradov AA, 2015, CHEM SCI, V6, P2997, DOI 10.1039/c4sc03877k; Webb D, 2010, CHEM SCI, V1, P675, DOI 10.1039/c0sc00381f; Wheelan SJ, 2000, BIOINFORMATICS, V16, P613, DOI 10.1093/bioinformatics/16.7.613; Windsor I. W., 1988, CELL, V54, P363; Xia X, 2015, J PHARM SCI-US, V104, P566, DOI 10.1002/jps.24188; Xiao H, 2015, P NATL ACAD SCI USA, V112, P6961, DOI 10.1073/pnas.1507741112; Yang YW, 2010, J BIOL CHEM, V285, P7847, DOI 10.1074/jbc.C109.084921; Zhan CY, 2012, J AM CHEM SOC, V134, P6855, DOI 10.1021/ja301255n; Zompra AA, 2009, FUTURE MED CHEM, V1, P361, DOI 10.4155/FMC.09.23	71	91	93	35	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					980	+		10.1126/science.abb2491	http://dx.doi.org/10.1126/science.abb2491			103	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LV3IK	32467387	Green Published			2022-12-28	WOS:000538332600043
J	Armstrong, S				Armstrong, Stephen			Research on covid-19 is suffering "imperfect incentives at every stage"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												stephen.armstrong@me.com						[Anonymous], 2020, JAMA-J AM MED ASSOC, V24, DOI [10.1001/jama.2020.7681.32330939, DOI 10.1001/JAMA.2020.7681.32330939]; [Anonymous], 2020, EXP REACT UNP PREPR; [Anonymous], 2020, EXP REACT PREPR COVI; [Anonymous], 2020, EXP REACT PREPR BLOO; Ferguson NM, 9 IMP COLL COVID 19; Langreth R, 2020, BLOOMBERG; Pike WT, INT COMP 2 DERIVATIV, DOI [10.1101/2020.03.25.20041475, DOI 10.1101/2020.03.25.20041475]; Richardson S, 2020, JAMA-J AM MED ASSOC, V22, DOI [10.1001/jama.2020.6775.32320003, DOI 10.1001/JAMA.2020.6775.32320003]; Shah N, 2020, STAT; Yang G, 2020, ANGIOTENSIN 2 RECEPT, DOI [10.1101/2020.03.31.20038935, DOI 10.1101/2020.03.31.20038935]; Zhao J, 2020, RELATIONSHIP ABO BLO, DOI [10.1101/2020.03.11.20031096v1, DOI 10.1101/2020.03.11.20031096V1]	11	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2020	369								m2045	10.1136/bmj.m2045	http://dx.doi.org/10.1136/bmj.m2045			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JZ	32467100	Bronze			2022-12-28	WOS:000538337300004
J	Ball, P; Maxmen, A				Ball, Philip; Maxmen, Amy			BATTLING THE INFODEMIC	NATURE			English	News Item																		Chen E., 2020, PREPRINT; Cinelli Matteo, 2020, PREPRINT; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Jamieson K. H., 2020, HARVARD KENNEDY SCH, DOI [10.37016/mr-2020-012, DOI 10.37016/MR-2020-012]; Velasquez N., 2020, PREPRINT; Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559	6	110	116	6	46	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 28	2020	581	7809					371	374		10.1038/d41586-020-01452-z	http://dx.doi.org/10.1038/d41586-020-01452-z			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX9ZE	32461658	Bronze			2022-12-28	WOS:000576059500001
J	Jones, H				Jones, Helen			Why I . . . run	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2020	369								m1394	10.1136/bmj.m1394	http://dx.doi.org/10.1136/bmj.m1394			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JZ	32467088	Bronze			2022-12-28	WOS:000538337300001
J	Wu, MH; Zhang, ZB; Xu, XZ; Zhang, ZH; Duan, YR; Dong, JC; Qiao, RX; You, SF; Wang, L; Qi, JJ; Zou, DX; Shang, NZ; Yang, YB; Li, H; Zhu, L; Sun, JL; Yu, HJ; Gao, P; Bai, XD; Jiang, Y; Wang, ZJ; Ding, F; Yu, DP; Wang, EG; Liu, KH				Wu, Muhong; Zhang, Zhibin; Xu, Xiaozhi; Zhang, Zhihong; Duan, Yunrui; Dong, Jichen; Qiao, Ruixi; You, Sifan; Wang, Li; Qi, Jiajie; Zou, Dingxin; Shang, Nianze; Yang, Yubo; Li, Hui; Zhu, Lan; Sun, Junliang; Yu, Haijun; Gao, Peng; Bai, Xuedong; Jiang, Ying; Wang, Zhu-Jun; Ding, Feng; Yu, Dapeng; Wang, Enge; Liu, Kaihui			Seeded growth of large single-crystal copper foils with high-index facets	NATURE			English	Article							ABNORMAL GRAIN-GROWTH; SURFACE-ENERGY; CRYSTALLOGRAPHIC ORIENTATION; STRAIN-ENERGY; GRAPHENE; TEXTURE; CU	The production of large single-crystal metal foils with various facet indices has long been a pursuit in materials science owing to their potential applications in crystal epitaxy, catalysis, electronics and thermal engineering(1-5). For a given metal, there are only three sets of low-index facets ({100}, {110} and {111}). In comparison, high-index facets are in principle infinite and could afford richer surface structures and properties. However, the controlled preparation of single-crystal foils with high-index facets is challenging, because they are neither thermodynamically(6,7) nor kinetically(3) favourable compared to low-index facets(6-18). Here we report a seeded growth technique for building a library of single-crystal copper foils with sizes of about 30 x 20 square centimetres and more than 30 kinds of facet. A mild pre-oxidation of polycrystalline copper foils, followed by annealing in a reducing atmosphere, leads to the growth of high-index copper facets that cover almost the entire foil and have the potential of growing to lengths of several metres. The creation of oxide surface layers on our foils means that surface energy minimization is not a key determinant of facet selection for growth, as is usually the case. Instead, facet selection is dictated randomly by the facet of the largest grain (irrespective of its surface energy), which consumes smaller grains and eliminates grain boundaries. Our high-index foils can be used as seeds for the growth of other Cu foils along either the in-plane or the out-of-plane direction. We show that this technique is also applicable to the growth of high-index single-crystal nickel foils, and we explore the possibility of using our high-index copper foils as substrates for the epitaxial growth of two-dimensional materials. Other applications are expected in selective catalysis, low-impedance electrical conduction and heat dissipation.	[Wu, Muhong; Zhang, Zhibin; Qi, Jiajie; Shang, Nianze; Liu, Kaihui] Peking Univ, Sch Phys, Frontiers Sci Ctr Nanooptoelect, State Key Lab Mesoscop Phys, Beijing, Peoples R China; [Wu, Muhong; Zhang, Zhihong; Qiao, Ruixi; You, Sifan; Gao, Peng; Jiang, Ying; Wang, Enge; Liu, Kaihui] Peking Univ, Collaborat Innovat Ctr Quantum Matter, Int Ctr Quantum Mat, Beijing, Peoples R China; [Wu, Muhong; Wang, Enge] Chinese Acad Sci, Inst Phys, Songshan Lake Mat Lab, Beijing, Guangdong, Peoples R China; [Xu, Xiaozhi] South China Normal Univ, Sch Phys & Telecommun Engn, Guangdong Prov Key Lab Quantum Engn & Quantum Mat, Guangzhou, Peoples R China; [Duan, Yunrui; Dong, Jichen; Ding, Feng] Inst Basic Sci, Ctr Multidimens Carbon Mat, Ulsan, South Korea; [Duan, Yunrui; Li, Hui] Shandong Univ, Minist Educ, Key Lab Liquid Solid Struct Evolut & Proc Mat, Jinan, Peoples R China; [Wang, Li; Bai, Xuedong] Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing, Peoples R China; [Zou, Dingxin; Yu, Dapeng] Southern Univ Sci & Technol, Shenzhen Inst Quantum Sci & Engn, Shenzhen, Peoples R China; [Zou, Dingxin; Yu, Dapeng] Southern Univ Sci & Technol, Dept Phys, Shenzhen, Peoples R China; [Yang, Yubo; Yu, Haijun] Beijing Univ Technol, Coll Mat Sci & Engn, Beijing, Peoples R China; [Zhu, Lan] Peking Union Med Coll Hosp, Beijing, Peoples R China; [Sun, Junliang] Peking Univ, Coll Chem & Mol Engn, Beijing, Peoples R China; [Jiang, Ying] Huairou Natl Comprehens Sci Ctr, Phys Sci Lab, Beijing, Peoples R China; [Wang, Zhu-Jun] Eidgenoss Tech Hsch Zurich, Sci Ctr Opt & Electron Microscopy, Zurich, Switzerland; [Ding, Feng] Ulsan Natl Inst Sci Technol, Sch Mat Sci & Engn, Ulsan, South Korea; [Wang, Enge] Liaoning Univ, Sch Phys, Shenyang, Peoples R China	Peking University; Peking University; Chinese Academy of Sciences; Songshan Lake Materials Laboratory; South China Normal University; Institute for Basic Science - Korea (IBS); Shandong University; Chinese Academy of Sciences; Institute of Physics, CAS; Southern University of Science & Technology; Southern University of Science & Technology; Beijing University of Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Peking University; Ulsan National Institute of Science & Technology (UNIST); Liaoning University	Liu, KH (corresponding author), Peking Univ, Sch Phys, Frontiers Sci Ctr Nanooptoelect, State Key Lab Mesoscop Phys, Beijing, Peoples R China.; Wang, EG; Liu, KH (corresponding author), Peking Univ, Collaborat Innovat Ctr Quantum Matter, Int Ctr Quantum Mat, Beijing, Peoples R China.; Wang, EG (corresponding author), Chinese Acad Sci, Inst Phys, Songshan Lake Mat Lab, Beijing, Guangdong, Peoples R China.; Ding, F (corresponding author), Inst Basic Sci, Ctr Multidimens Carbon Mat, Ulsan, South Korea.; Yu, DP (corresponding author), Southern Univ Sci & Technol, Shenzhen Inst Quantum Sci & Engn, Shenzhen, Peoples R China.; Yu, DP (corresponding author), Southern Univ Sci & Technol, Dept Phys, Shenzhen, Peoples R China.; Ding, F (corresponding author), Ulsan Natl Inst Sci Technol, Sch Mat Sci & Engn, Ulsan, South Korea.; Wang, EG (corresponding author), Liaoning Univ, Sch Phys, Shenyang, Peoples R China.	f.ding@unist.ac.kr; yudp@sustc.edu.cn; egwang@pku.edu.cn; khliu@pku.edu.cn	Qiao, Ruixi/GQI-4163-2022; xu, xiaozhi/AAC-8545-2021; Yu, Haijun/ABG-1776-2021; Gao, Peng/AAC-8550-2019; Zhang, Zhihong/AAS-9446-2020; Liu, Kaihui/A-9938-2014; Zhang, Zhibin/V-1511-2017; DING, FENG/D-5938-2011	Yu, Haijun/0000-0003-0204-9943; Zhang, Zhihong/0000-0002-8718-4548; Liu, Kaihui/0000-0002-8781-2495; Zhang, Zhibin/0000-0002-9303-9793; DING, FENG/0000-0001-9153-9279; Gao, Peng/0000-0001-9868-2115; Wu, Muhong/0000-0003-3607-8945	National Natural Science Foundation of China [11888101, 51991340, 51991342, 21725302, 51522201]; National Key R&D Program of China [2016YFA0300903, 2016YFA0300804]; Beijing Natural Science Foundation [JQ19004]; Beijing Excellent Talents Training Support [2017000026833ZK11]; Beijing Municipal Science and Technology Commission [Z191100007219005]; Beijing Graphene Innovation Program [Z181100004818003]; Guangdong Provincial Science Fund for Distinguished Young Scholars [2020B1515020043]; Bureau of Industry and Information Technology of Shenzhen [201901161512]; Key R&D Program of Guangdong Province [2020B010189001, 2019B010931001, 2018B010109009, 2018B030327001]; Guangdong Innovative and Entrepreneurial Research Team Program [2016ZT06D348]; Science, Technology and Innovation Commission of Shenzhen Municipality [KYTDPT20181011104202253]; National Postdoctoral Program for Innovative Talents [BX201700014]; China Postdoctoral Science Foundation [2018M630017, 2019M660282]; National Equipment Program of China [ZDYZ2015-1]; Institute for Basic Science of South Korea [IBS-R019-D1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Excellent Talents Training Support; Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Beijing Graphene Innovation Program; Guangdong Provincial Science Fund for Distinguished Young Scholars; Bureau of Industry and Information Technology of Shenzhen; Key R&D Program of Guangdong Province; Guangdong Innovative and Entrepreneurial Research Team Program; Science, Technology and Innovation Commission of Shenzhen Municipality; National Postdoctoral Program for Innovative Talents; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Equipment Program of China; Institute for Basic Science of South Korea	This work was supported by the National Natural Science Foundation of China (11888101, 51991340, 51991342, 21725302 and 51522201), National Key R&D Program of China (2016YFA0300903 and 2016YFA0300804), Beijing Natural Science Foundation (JQ19004), Beijing Excellent Talents Training Support (2017000026833ZK11), Beijing Municipal Science and Technology Commission (Z191100007219005), Beijing Graphene Innovation Program (Z181100004818003), Guangdong Provincial Science Fund for Distinguished Young Scholars (2020B1515020043), Bureau of Industry and Information Technology of Shenzhen (Graphene platform 201901161512), The Key R&D Program of Guangdong Province (2020B010189001, 2019B010931001, 2018B010109009 and 2018B030327001), Guangdong Innovative and Entrepreneurial Research Team Program (2016ZT06D348), the Science, Technology and Innovation Commission of Shenzhen Municipality (KYTDPT20181011104202253), National Equipment Program of China (ZDYZ2015-1), National Postdoctoral Program for Innovative Talents (BX201700014), China Postdoctoral Science Foundation (2018M630017 and 2019M660282) and the Institute for Basic Science of South Korea (IBS-R019-D1). We acknowledge the Electron Microscopy Laboratory in Peking University for the use of the electron microscope. K.L. acknowledges discussions with L. Lu.	Betanda YA, 2015, ADV ENG MATER, V17, P1568, DOI 10.1002/adem.201500071; Birnbaum AJ, 2017, APPL PHYS LETT, V111, DOI 10.1063/1.4998741; Brown L, 2014, NANO LETT, V14, P5706, DOI 10.1021/nl502445j; Carpenter HCH, 1921, P R SOC LOND A-CONTA, V100, P329, DOI 10.1098/rspa.1921.0089; DUNN CG, 1962, T METALL SOC AIME, V224, P518; Huang X, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2472; Jin S, 2018, SCIENCE, V362, P1021, DOI 10.1126/science.aao3373; Kelso MV, 2018, J AM CHEM SOC, V140, P15812, DOI 10.1021/jacs.8b09108; Kusama T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00383-0; Lin C, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.076101; Ma F, 2005, APPL SURF SCI, V242, P55, DOI 10.1016/j.apsusc.2004.07.068; MCLEAN M, 1966, SURF SCI, V5, P466, DOI 10.1016/0039-6028(66)90042-2; MCLEAN M, 1971, ACTA METALL MATER, V19, P387, DOI 10.1016/0001-6160(71)90106-4; Mirpuri K, 2006, THIN SOLID FILMS, V496, P703, DOI 10.1016/j.tsf.2005.08.353; Na SM, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/12/125026; Omori T, 2013, SCIENCE, V341, P1500, DOI 10.1126/science.1238017; Park CH, 2008, NAT PHYS, V4, P213, DOI 10.1038/nphys890; Quan ZW, 2013, ACCOUNTS CHEM RES, V46, P191, DOI 10.1021/ar200293n; RHEAD GE, 1964, ACTA METALL MATER, V12, P401, DOI 10.1016/0001-6160(64)90010-0; Shan ZW, 2008, NAT MATER, V7, P115, DOI 10.1038/nmat2085; Tian N, 2007, SCIENCE, V316, P732, DOI 10.1126/science.1140484; Uecker R, 2014, J CRYST GROWTH, V401, P7, DOI 10.1016/j.jcrysgro.2013.11.095; Vitos L, 1998, SURF SCI, V411, P186, DOI 10.1016/S0039-6028(98)00363-X; Wang H, 2016, ADV MATER, V28, P8968, DOI 10.1002/adma.201603579; Wang L, 2019, NATURE, V570, P91, DOI 10.1038/s41586-019-1226-z; Wen YN, 2007, SOLID STATE COMMUN, V144, P163, DOI 10.1016/j.ssc.2007.07.012; Xu XZ, 2017, SCI BULL, V62, P1074, DOI 10.1016/j.scib.2017.07.005; Zhang JM, 2001, J CRYST GROWTH, V226, P168, DOI 10.1016/S0022-0248(01)01376-8; Zhang ZB, 2018, ADV MATER INTERFACES, V5, DOI 10.1002/admi.201800377; ZIELINSKI EM, 1995, APPL PHYS LETT, V67, P1078, DOI 10.1063/1.114455	30	73	78	61	439	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 28	2020	581	7809					406	+		10.1038/s41586-020-2298-5	http://dx.doi.org/10.1038/s41586-020-2298-5			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OO4RX	32461648				2022-12-28	WOS:000587368900001
J	Rimmer, A				Rimmer, Abi			Doctors welcome plan to scrap NHS fee for overseas staff	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		RIMMER A, 2019, BMJ-BRIT MED J, V365, P38541, DOI DOI 10.1136/BMJ.L2348; Rimmer A, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2054	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2020	369								m2073	10.1136/bmj.m2073	http://dx.doi.org/10.1136/bmj.m2073			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JU	32444352	Bronze			2022-12-28	WOS:000538336800016
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Nearly half of care homes in northeast England have had an outbreak	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Care Quality Commission, 2020, COVID 19 INS; Griffin S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2039	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2020	369								m2041	10.1136/bmj.m2041	http://dx.doi.org/10.1136/bmj.m2041			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JK	32434778	Bronze			2022-12-28	WOS:000538335800015
J	Rimmer, A				Rimmer, Abi			Physician trainees raise concerns about modified recruitment process	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		RIMMER A, 2019, BMJ-BRIT MED J, V366, DOI DOI 10.1136/BMJ.L5042	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2020	369								m2038	10.1136/bmj.m2038	http://dx.doi.org/10.1136/bmj.m2038			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JK	32434765	Bronze			2022-12-28	WOS:000538335800012
J	Viglione, G				Viglione, Giuliana			Are women publishing less during the pandemic? Here's what the data say	NATURE			English	News Item						Research management; Publishing		Early analyses suggest that female academics are posting fewer preprints and starting fewer research projects than their male peers. How female academics are losing ground during the pandemic Early analyses suggest that female academics are posting fewer preprints and starting fewer research projects than their male peers.											0	213	216	5	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY	2020	581	7809					365	366		10.1038/d41586-020-01294-9	http://dx.doi.org/10.1038/d41586-020-01294-9			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR6HN	32433639				2022-12-28	WOS:000535793900002
J	Bae, S; Kim, MC; Kim, JY; Cha, HH; Lim, JS; Jung, J; Kim, MJ; Oh, DK; Lee, MK; Choi, SH; Sung, M; Hong, SB; Chung, JW; Kim, SH				Bae, Seongman; Kim, Min-Chul; Kim, Ji Yeun; Cha, Hye-Hee; Lim, Joon Seo; Jung, Jiwon; Kim, Min-Jae; Oh, Dong Kyu; Lee, Mi-Kyung; Choi, Seong-Ho; Sung, Minki; Hong, Sang-Bum; Chung, Jin-Won; Kim, Sung-Han			RETRACTION: Effectiveness of Surgical and Cotton Masks in Blocking SARS-CoV-2 (Retraction of Vol 56, Pg 861, 2020)	ANNALS OF INTERNAL MEDICINE			English	Retraction													Kim, Ji Yeun/HGB-2981-2022					Bae S, 2020, ANN INTERN MED, V173, pW22, DOI 10.7326/M20-1342	1	14	15	3	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2020	173	1					79	79		10.7326/L20-0745	http://dx.doi.org/10.7326/L20-0745			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MI6BV	32479106	Green Published			2022-12-28	WOS:000547491700028
J	Fleming, TR; Labriola, D; Wittes, J				Fleming, Thomas R.; Labriola, Dominic; Wittes, Janet			Conducting Clinical Research During the COVID-19 Pandemic: Protecting Scientific Integrity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fleming, Thomas R.] Univ Washington, Dept Biostat, POB 357232, Seattle, WA 98195 USA; [Labriola, Dominic] Bristol Myers Squibb, Dept Biometr & Data Sci, Princeton, NJ USA; [Wittes, Janet] Stat Collaborat, Washington, DC USA	University of Washington; University of Washington Seattle; Bristol-Myers Squibb	Fleming, TR (corresponding author), Univ Washington, Dept Biostat, POB 357232, Seattle, WA 98195 USA.	tfleming@uw.edu						Bauchner H, 2020, JAMA-J AM MED ASSOC, V323, P2262, DOI 10.1001/jama.2020.8115; European Medicines Agency, 2020, GUID MAN CLIN TRIALS; Fleming TR, 2011, ANN INTERN MED, V154, P113, DOI 10.7326/0003-4819-154-2-201101180-00010; McDermott MM, 2020, JAMA-J AM MED ASSOC, V323, P2135, DOI 10.1001/jama.2020.4689; Panel on Handling Missing Data in Clinical Trials National Research Council, 2010, PREV TREATM MISS DAT	5	55	56	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2020	324	1					33	34		10.1001/jama.2020.9286	http://dx.doi.org/10.1001/jama.2020.9286			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM5FX	32463422	Bronze			2022-12-28	WOS:000568123600014
J	Grifoni, A; Weiskopf, D; Ramirez, SI; Mateus, J; Dan, JM; Moderbacher, CR; Rawlings, SA; Sutherland, A; Premkumar, L; Jadi, RS; Marrama, D; de Silva, AM; Frazier, A; Carlin, AF; Greenbaum, JA; Peters, B; Krammer, F; Smith, DM; Crotty, S; Sette, A				Grifoni, Alba; Weiskopf, Daniela; Ramirez, Sydney, I; Mateus, Jose; Dan, Jennifer M.; Moderbacher, Carolyn Rydyznski; Rawlings, Stephen A.; Sutherland, Aaron; Premkumar, Lakshmanane; Jadi, Ramesh S.; Marrama, Daniel; de Silva, Aravinda M.; Frazier, April; Carlin, Aaron F.; Greenbaum, Jason A.; Peters, Bjoern; Krammer, Florian; Smith, Davey M.; Crotty, Shane; Sette, Alessandro			Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals	CELL			English	Article							FOLLICULAR HELPER-CELLS; ANTIBODY-RESPONSES; SARS-CORONAVIRUS; PROTECTION; INFLUENZA; VACCINES; INFECTION; IMMUNITY; MEMORY; SHARE	Understanding adaptive immunity to SARS-CoV-2 is important for vaccine development, interpreting coronavirus disease 2019 (COVID-19) pathogenesis, and calibration of pandemic control measures. Using HLA class I and II predicted peptide "megapools," circulating SARS-CoV-2-specific CD8(+) and CD4(+) T cells were identified in similar to 70% and 100% of COVID-19 convalescent patients, respectively. CD4(+) T cell responses to spike, the main target of most vaccine efforts, were robust and correlated with the magnitude of the antiSARS-CoV-2 IgG and IgA titers. The M, spike, and N proteins each accounted for 11%-27% of the total CD4(+) response, with additional responses commonly targeting nsp3, nsp4, ORF3a, and ORF8, among others. For CD8(+) T cells, spike and M were recognized, with at least eight SARS-CoV-2 ORFs targeted. Importantly, we detected SARS-CoV-2-reactive CD4(+) T cells in similar to 40%-60% of unexposed individuals, suggesting cross-reactive T cell recognition between circulating "common cold" coronaviruses and SARS-CoV-2.	[Grifoni, Alba; Weiskopf, Daniela; Ramirez, Sydney, I; Mateus, Jose; Dan, Jennifer M.; Moderbacher, Carolyn Rydyznski; Sutherland, Aaron; Marrama, Daniel; Frazier, April; Greenbaum, Jason A.; Peters, Bjoern; Crotty, Shane; Sette, Alessandro] La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, La Jolla, CA 92037 USA; [Ramirez, Sydney, I; Dan, Jennifer M.; Rawlings, Stephen A.; Carlin, Aaron F.; Peters, Bjoern; Smith, Davey M.; Crotty, Shane; Sette, Alessandro] Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92037 USA; [Premkumar, Lakshmanane; Jadi, Ramesh S.; de Silva, Aravinda M.] Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC 27599 USA; [Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA	La Jolla Institute for Immunology; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Icahn School of Medicine at Mount Sinai	Crotty, S; Sette, A (corresponding author), La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, La Jolla, CA 92037 USA.; Crotty, S; Sette, A (corresponding author), Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92037 USA.	shane@lji.org; alex@lji.org	Sette, Alessandro/AFO-8916-2022; Rawlings, Stephen/ABA-6797-2020; desilva, Aravinda/ABE-6260-2020; Jadi, Ramesh/AAV-2059-2020; Krammer, Florian/H-3237-2019; Grifoni, Alba/AAS-7620-2021; Carlin, Aaron/AAK-3806-2021	Rawlings, Stephen/0000-0003-3637-1447; desilva, Aravinda/0000-0003-3317-5950; Jadi, Ramesh/0000-0002-5710-4893; Krammer, Florian/0000-0003-4121-776X; Grifoni, Alba/0000-0002-2209-5966; Marrama, Daniel/0000-0001-5821-6857; Ramirez, Sydney/0000-0002-7166-5195	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS); Pontificia Universidad Javeriana; NIH NIAID [AI42742]; National Institutes of Health [75N9301900065, U19 AI118626]; Bill and Melinda Gates Foundation; LJI Institutional Funds; Johnathan and Mary Tu Foundation; NIAID [AI135078]; UCSD Infectious Diseases Division [T32 AI007036, T32 AI007384]	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Pontificia Universidad Javeriana; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); LJI Institutional Funds; Johnathan and Mary Tu Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UCSD Infectious Diseases Division	We would like to thank Cheryl Kim, director of the LJI flow cytometry core facility for outstanding expertise. We thank Prof. Peter Kim, Abigail Powell, PhD, and colleagues (Stanford) for RBD protein synthesized from Prof. Florian Krammer (Mt. Sinai) constructs. J.M. was supported by PhD student fellowships from the Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS), and Pontificia Universidad Javeriana. This work was funded by the NIH NIAID under awards AI42742 (Cooperative Centers for Human Immunology) (S.C. and A.S.), National Institutes of Health contract Nr. 75N9301900065 (A.S. and D.W.), and U19 AI118626 (A.S. and B.P.). The BD FACSymphony purchase was partially funded by the Bill and Melinda Gates Foundation and LJI Institutional Funds (S.C. and A.S.). This work was additionally supported in part by the Johnathan and Mary Tu Foundation (D.M.S.), the NIAID under K08 award AI135078 (J.D.), and UCSD T32s AI007036 and AI007384 Infectious Diseases Division (S.I.R. and S.A.R.).	Alshukairi AN, 2018, MBIO, V9, DOI [10.1128/mbio.01985-18, 10.1128/mBio.01985-18]; Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007; Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; Antunes RDS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169086; Arlehamn CSL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005760; Bancroft T, 2016, CELL IMMUNOL, V304, P35, DOI 10.1016/j.cellimm.2016.05.002; Blanco-Melo D., 2020, SARS COV 2 LAUNCHES, V181, P1036, DOI [DOI 10.1128/JVI.00527-07, 10.1016/j.cell.2020.04.026, DOI 10.1101/2020.03.24.004655]; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3; Pro SC, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/763461; Choe PG, 2017, EMERG INFECT DIS, V23, P1079, DOI 10.3201/eid2307.170310; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Dan JM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau3776; Dan JM, 2016, J IMMUNOL, V197, P983, DOI 10.4049/jimmunol.1600318; Dhanda SK, 2019, NUCLEIC ACIDS RES, V47, pW502, DOI 10.1093/nar/gkz452; Dhanda SK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01369; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Gorse GJ, 2010, CLIN VACCINE IMMUNOL, V17, P1875, DOI 10.1128/CVI.00278-10; Gostic KM, 2016, SCIENCE, V354, P722, DOI 10.1126/science.aag1322; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Grifoni A, 2020, CELL HOST MICROBE, V27, P671, DOI 10.1016/j.chom.2020.03.002; Grifoni A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01309; Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017; Guo X., 2020, MEDRXIV, DOI 10.1101/2020.02.12.20021386v1; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Havenar-Daughton C, 2016, J IMMUNOL, V197, P994, DOI 10.4049/jimmunol.1600320; Herati RS, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2152; Hinz D, 2016, CLIN EXP ALLERGY, V46, P705, DOI 10.1111/cea.12692; Huang A.T., 2020, SYSTEMATIC REV ANTIB; Irigoyen N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005473; Jurtz V, 2017, J IMMUNOL, V199, P3360, DOI 10.4049/jimmunol.1700893; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Li CKF, 2008, J IMMUNOL, V181, P5490, DOI 10.4049/jimmunol.181.8.5490; Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158; Morou A, 2019, NAT IMMUNOL, V20, P1059, DOI 10.1038/s41590-019-0418-x; Moutaftsi M, 2010, FUTURE MICROBIOL, V5, P221, DOI [10.2217/fmb.09.110, 10.2217/FMB.09.110]; Okba NMA, 2019, EMERG INFECT DIS, V25, P1868, DOI [10.3201/eid2509.190051, 10.3201/eid2510.190051]; OSULLIVAN D, 1991, J IMMUNOL, V147, P2663; Paul Sinu, 2016, Curr Protoc Immunol, V114, DOI 10.1002/cpim.12; Paul S, 2015, J IMMUNOL METHODS, V422, P28, DOI 10.1016/j.jim.2015.03.022; Peeples L, 2020, P NATL ACAD SCI USA, V117, P8218, DOI 10.1073/pnas.2005456117; Reiss S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186998; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Severance EG, 2008, CLIN VACCINE IMMUNOL, V15, P1805, DOI 10.1128/CVI.00124-08; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Sidney J, 2010, J IMMUNOL, V185, P4189, DOI 10.4049/jimmunol.1001006; Sidney J, 2010, J IMMUNOL, V184, P2492, DOI 10.4049/jimmunol.0903655; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Southwood S, 1998, J IMMUNOL, V160, P3363; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Stadlbauer Daniel, 2020, Curr Protoc Microbiol, V57, pe100, DOI 10.1002/cpmc.100; Le TT, 2020, NAT REV DRUG DISCOV, V19, P305, DOI 10.1038/d41573-020-00073-5; Tian Y, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02125; VENNEMA H, 1990, J VIROL, V64, P1407, DOI 10.1128/JVI.64.3.1407-1409.1990; Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006; Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289; Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xie XP, 2020, CELL HOST MICROBE, V27, P841, DOI 10.1016/j.chom.2020.04.004; Zhao JC, 2016, IMMUNITY, V44, P1379, DOI 10.1016/j.immuni.2016.05.006; Zhao JC, 2011, J CLIN INVEST, V121, P4921, DOI 10.1172/JCI59777; Zhao JC, 2010, J VIROL, V84, P9318, DOI 10.1128/JVI.01049-10; Zhao JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000636; Zhao JX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan5393; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	70	1946	1991	25	276	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2020	181	7					1489	+		10.1016/j.cell.2020.05.015	http://dx.doi.org/10.1016/j.cell.2020.05.015			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MD2SA	32473127	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000543822100009
J	Bao, PL; She, L; McGill, M; Tsao, DY				Bao, Pinglei; She, Liang; McGill, Mason; Tsao, Doris Y.			A map of object space in primate inferotemporal cortex	NATURE			English	Article							FACE PATCH; MACAQUE; ORGANIZATION; NETWORK; AREA; SELECTIVITY; RESPONSES; NEURONS; SHAPE	Primate inferotemporal cortex contains a coarse map of object space consisting of four networks, identified using functional imaging, electrophysiology and deep networks. The inferotemporal (IT) cortex is responsible for object recognition, but it is unclear how the representation of visual objects is organized in this part of the brain. Areas that are selective for categories such as faces, bodies, and scenes have been found(1-5), but large parts of IT cortex lack any known specialization, raising the question of what general principle governs IT organization. Here we used functional MRI, microstimulation, electrophysiology, and deep networks to investigate the organization of macaque IT cortex. We built a low-dimensional object space to describe general objects using a feedforward deep neural network trained on object classification(6). Responses of IT cells to a large set of objects revealed that single IT cells project incoming objects onto specific axes of this space. Anatomically, cells were clustered into four networks according to the first two components of their preferred axes, forming a map of object space. This map was repeated across three hierarchical stages of increasing view invariance, and cells that comprised these maps collectively harboured sufficient coding capacity to approximately reconstruct objects. These results provide a unified picture of IT organization in which category-selective regions are part of a coarse map of object space whose dimensions can be extracted from a deep network.	[Bao, Pinglei; She, Liang; Tsao, Doris Y.] CALTECH, Tianqiao & Chrissy Chen Inst Neurosci, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Bao, Pinglei; Tsao, Doris Y.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [McGill, Mason; Tsao, Doris Y.] CALTECH, Computat & Neural Syst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Bao, PL; Tsao, DY (corresponding author), CALTECH, Tianqiao & Chrissy Chen Inst Neurosci, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Bao, PL; Tsao, DY (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.; Tsao, DY (corresponding author), CALTECH, Computat & Neural Syst, Pasadena, CA 91125 USA.	pbao@caltech.edu; dortsao@caltech.edu	She, Liang/FAP-1121-2022		NIH [DP1-NS083063, R01-EY030650]; Howard Hughes Medical Institute; Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech	This work was supported by NIH (DP1-NS083063, R01-EY030650), the Howard Hughes Medical Institute, and the Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech. We thank A. Flores for technical support, and members of the Tsao laboratory, N. Kanwisher, A. Kennedy, S. Kornblith, and A. Tsao for critical comments.	Aparicio PL, 2016, J NEUROSCI, V36, P12729, DOI 10.1523/JNEUROSCI.0237-16.2016; Arcaro MJ, 2017, NAT NEUROSCI, V20, P1404, DOI 10.1038/nn.4635; Baldassi C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003167; Bao PL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04126-7; Chang L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01912-7; Chang L, 2017, CELL, V169, P1013, DOI 10.1016/j.cell.2017.05.011; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dosovitskiy A., 2016, ADV NEURAL INFORM PR, P658; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Haile TM, 2019, NEUROIMAGE, V188, P427, DOI 10.1016/j.neuroimage.2018.11.060; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Konkle T, 2013, J NEUROSCI, V33, P10235, DOI 10.1523/JNEUROSCI.0983-13.2013; Konkle T, 2012, NEURON, V74, P1114, DOI 10.1016/j.neuron.2012.04.036; Kornblith S, 2013, NEURON, V79, P766, DOI 10.1016/j.neuron.2013.06.015; Krizhevsky A., P 25 INT C NEUR INF, P1097; Kumar S, 2019, CEREB CORTEX, V29, P215, DOI 10.1093/cercor/bhx320; Lafer-Sousa R, 2013, NAT NEUROSCI, V16, P1870, DOI 10.1038/nn.3555; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Long B, 2018, P NATL ACAD SCI USA, V115, pE9015, DOI 10.1073/pnas.1719616115; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; Ohayon S, 2013, J NEUROSCI, V33, P16684, DOI 10.1523/JNEUROSCI.2675-13.2013; Ohayon S, 2012, J NEUROSCI METH, V204, P389, DOI 10.1016/j.jneumeth.2011.11.031; Ponce CR, 2019, CELL, V177, P999, DOI 10.1016/j.cell.2019.04.005; Popivanov ID, 2014, J NEUROSCI, V34, P95, DOI 10.1523/JNEUROSCI.2748-13.2014; Rajalingham R, 2019, NEURON, V102, P493, DOI 10.1016/j.neuron.2019.02.001; Reuter M, 2011, NEUROIMAGE, V57, P19, DOI 10.1016/j.neuroimage.2011.02.076; Reveley C, 2017, CEREB CORTEX, V27, P4463, DOI 10.1093/cercor/bhw248; Saleem KS, 2012, COMBINED MRI HISTOLO; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Vaziri S, 2014, NEURON, V84, P55, DOI 10.1016/j.neuron.2014.08.043; Verhoef BE, 2015, J NEUROSCI, V35, P6952, DOI 10.1523/JNEUROSCI.5079-14.2015; Yamins DLK, 2014, P NATL ACAD SCI USA, V111, P8619, DOI 10.1073/pnas.1403112111; Yue XM, 2014, P NATL ACAD SCI USA, V111, pE3467, DOI 10.1073/pnas.1412616111; Zhuang CX, 2019, IEEE I CONF COMP VIS, P6001, DOI 10.1109/ICCV.2019.00610	41	74	74	16	72	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					103	+		10.1038/s41586-020-2350-5	http://dx.doi.org/10.1038/s41586-020-2350-5		JUN 2020	32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME6OV	32494012	Green Accepted			2022-12-28	WOS:000537932200009
J	Kiriakidou, M; Ching, CL				Kiriakidou, Marianthi; Ching, Cathy Lee			Systemic Lupus Erythematosus	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MYCOPHENOLATE-MOFETIL; DOUBLE-BLIND; DISEASE-ACTIVITY; MAINTENANCE THERAPY; NEPHRITIS; EFFICACY; SAFETY; RITUXIMAB; MANIFESTATIONS; HYDROXYCHLOROQUINE		[Kiriakidou, Marianthi; Ching, Cathy Lee] Thomas Jefferson Univ, Philadelphia, PA 19107 USA	Jefferson University	Kiriakidou, M (corresponding author), Thomas Jefferson Univ, Philadelphia, PA 19107 USA.				American College of Physicians	American College of Physicians	American College of Physicians.	Alarcon GS, 1999, LUPUS, V8, P197, DOI 10.1191/096120399678847704; Almaani S, 2017, CLIN J AM SOC NEPHRO, V12, P825, DOI 10.2215/CJN.05780616; Anderka MT, 2009, AM J MED GENET A, V149A, P1241, DOI 10.1002/ajmg.a.32685; Andrade-Ortega L, 2010, REUMATOL CLIN, V6, P250, DOI 10.1016/j.reuma.2009.11.004; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Aringer M, 2019, ARTHRITIS RHEUMATOL, V71, P1400, DOI [10.1136/annrheumdis-2018-214819, 10.1002/art.40930]; AUSTIN HA, 1986, NEW ENGL J MED, V314, P614, DOI 10.1056/NEJM198603063141004; Ball EMA, 2012, RHEUMATOLOGY, V51, P771, DOI 10.1093/rheumatology/ker381; Broen JCA, 2020, NAT REV RHEUMATOL, V16, P167, DOI 10.1038/s41584-020-0374-8; Buckley L, 2017, ARTHRITIS RHEUMATOL, V69, P1521, DOI 10.1002/art.40137; Buyon JP, 2015, ANN INTERN MED, V163, P153, DOI 10.7326/M14-2235; Carneiro JRM, 1999, J RHEUMATOL, V26, P1275; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; CHRISMAN OD, 1976, J BONE JOINT SURG AM, V58, P918, DOI 10.2106/00004623-197658070-00003; Contreras G, 2004, NEW ENGL J MED, V350, P971, DOI 10.1056/NEJMoa031855; Dooley MA, 2011, NEW ENGL J MED, V365, P1886, DOI 10.1056/NEJMoa1014460; Doria A, 2018, ARTHRITIS RHEUMATOL, V70, P1256, DOI 10.1002/art.40511; Duran S, 2008, ARTHRIT RHEUM-ARTHR, V59, P1332, DOI 10.1002/art.24020; Espinola RG, 2002, THROMB HAEMOSTASIS, V87, P518; Fortin PR, 2008, ARTHRIT RHEUM-ARTHR, V59, P1796, DOI 10.1002/art.24068; Hahn BH, 2012, ARTHRIT CARE RES, V64, P797, DOI 10.1002/acr.21664; Hochstadt Aviram, 2011, Harefuah, V150, P542; Houssiau FA, 2010, ANN RHEUM DIS, V69, P2083, DOI 10.1136/ard.2010.131995; Iaccarino L, 2015, CLIN EXP RHEUMATOL, V33, P449; Jais X, 2008, ARTHRITIS RHEUM-US, V58, P521, DOI 10.1002/art.23303; Jeong DY, 2018, AUTOIMMUN REV, V17, P553, DOI 10.1016/j.autrev.2017.12.011; Kamanamool N, 2018, LUPUS, V27, P647, DOI 10.1177/0961203317739131; Kamanamool N, 2010, MEDICINE, V89, P227, DOI 10.1097/MD.0b013e3181e93d00; Kamen DL, 2010, CLIN CHEST MED, V31, P479, DOI 10.1016/j.ccm.2010.05.001; Kostopoulou M, 2019, CURR VASC PHARM; Lee YH, 2016, LUPUS, V25, P727, DOI 10.1177/0961203315627202; Lee YH, 2011, LUPUS, V20, P636, DOI 10.1177/0961203310389486; Marmor MF, 2016, OPHTHALMOLOGY, V123, P1386, DOI 10.1016/j.ophtha.2016.01.058; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Mok CC, 2016, ANN RHEUM DIS, V75, P30, DOI 10.1136/annrheumdis-2014-206456; Mok CC, 2013, ANN RHEUM DIS, V72, P659, DOI 10.1136/annrheumdis-2012-201393; Moroni G, 2006, CLIN J AM SOC NEPHRO, V1, P925, DOI 10.2215/CJN.02271205; Neumann R, 1995, Retina, V15, P201; Omarjee O, 2019, AUTOIMMUN REV, V18, DOI 10.1016/j.autrev.2019.102361; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Radhakrishnan J, 2010, KIDNEY INT, V77, P152, DOI 10.1038/ki.2009.412; Rees F, 2017, RHEUMATOLOGY, V56, P1945, DOI 10.1093/rheumatology/kex260; Rovin BH, 2012, ARTHRITIS RHEUM-US, V64, P1215, DOI 10.1002/art.34359; Ruiz-Irastorza G, 2012, RHEUMATOLOGY, V51, P1145, DOI 10.1093/rheumatology/ker410; SEIBOLD JR, 1980, ARTHRITIS RHEUM, V23, P958, DOI 10.1002/art.1780230816; Sestak AL, 2011, ANN RHEUM DIS, V70, pI37, DOI 10.1136/ard.2010.138057; Silpa-archa S, 2016, BRIT J OPHTHALMOL, V100, P135, DOI 10.1136/bjophthalmol-2015-306629; Spetie DN, 2004, KIDNEY INT, V66, P2411, DOI 10.1111/j.1523-1755.2004.66030.x; STEINBERG AD, 1986, KIDNEY INT, V30, P769, DOI 10.1038/ki.1986.254; Stojan G, 2018, CURR OPIN RHEUMATOL, V30, P144, DOI 10.1097/BOR.0000000000000480; Tamirou F, 2016, ANN RHEUM DIS, V75, P526, DOI 10.1136/annrheumdis-2014-206897; Tanaka Y, 2016, MOD RHEUMATOL, V26, P80, DOI 10.3109/14397595.2015.1060665; Tseng CE, 2006, ARTHRITIS RHEUM-US, V54, P3623, DOI 10.1002/art.22198; van Vollenhoven RF, 2012, ANN RHEUM DIS, V71, P1343, DOI 10.1136/annrheumdis-2011-200937; Vera-Recabarren MA, 2010, BRIT J DERMATOL, V162, P91, DOI 10.1111/j.1365-2133.2009.09472.x; Vila LM, 2006, ARTHRIT RHEUM-ARTHR, V55, P799, DOI 10.1002/art.22224; Yazdany J, 2012, J GEN INTERN MED, V27, P1326, DOI 10.1007/s11606-012-2071-z; Yen EY, 2017, ANN INTERN MED, V167, P777, DOI 10.7326/M17-0102; Zhang L, 2016, KIDNEY INT, V89, P1337, DOI 10.1016/j.kint.2016.02.014	59	137	147	6	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2020	172	11					ITC81	ITC94		10.7326/AITC202006020	http://dx.doi.org/10.7326/AITC202006020			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MI6AJ	32479157				2022-12-28	WOS:000547487900001
J	McDowell, NG; Allen, CD; Anderson-Teixeira, K; Aukema, BH; Bond-Lamberty, B; Chini, L; Clark, JS; Dietze, M; Grossiord, C; Hanbury-Brown, A; Hurtt, GC; Jackson, RB; Johnson, DJ; Kueppers, L; Lichstein, JW; Ogle, K; Poulter, B; Pugh, TAM; Seidl, R; Turner, MG; Uriarte, M; Walker, AP; Xu, CG				McDowell, Nate G.; Allen, Craig D.; Anderson-Teixeira, Kristina; Aukema, Brian H.; Bond-Lamberty, Ben; Chini, Louise; Clark, James S.; Dietze, Michael; Grossiord, Charlotte; Hanbury-Brown, Adam; Hurtt, George C.; Jackson, Robert B.; Johnson, Daniel J.; Kueppers, Lara; Lichstein, Jeremy W.; Ogle, Kiona; Poulter, Benjamin; Pugh, Thomas A. M.; Seidl, Rupert; Turner, Monica G.; Uriarte, Maria; Walker, Anthony P.; Xu, Chonggang			Pervasive shifts in forest dynamics in a changing world	SCIENCE			English	Review							DELAYED TREE MORTALITY; CLIMATE-CHANGE; LAND-USE; ELEVATED CO2; BIOTIC DISTURBANCES; GROWTH ENHANCEMENT; SPECIES-RICHNESS; BOREAL FOREST; CARBON; VEGETATION		[McDowell, Nate G.] Pacific Northwest Natl Lab, Richland, WA 99354 USA; [Allen, Craig D.] US Geol Survey, Ft Collins Sci Ctr, New Mexico Landscapes Field Stn, Los Alamos, NM 87544 USA; [Anderson-Teixeira, Kristina] Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Front Royal, VA 22630 USA; [Anderson-Teixeira, Kristina] Smithsonian Trop Res Inst, Forest Global Earth Observ, Panama City, Panama; [Aukema, Brian H.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; [Bond-Lamberty, Ben] Pacific Northwest Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA; [Chini, Louise; Hurtt, George C.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Clark, James S.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Dietze, Michael] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Grossiord, Charlotte] Swiss Fed Inst Forest Snow & Landscape Res WSL, CH-8903 Birmensdorf, Switzerland; [Hanbury-Brown, Adam; Kueppers, Lara] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Jackson, Robert B.] Stanford Univ, Woods Inst Environm, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Jackson, Robert B.] Stanford Univ, Precourt Inst Energy, Stanford, CA 94305 USA; [Johnson, Daniel J.] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Kueppers, Lara] Lawrence Berkeley Natl Lab, Div Climate & Ecosyst Sci, Berkeley, CA 94720 USA; [Lichstein, Jeremy W.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Ogle, Kiona] No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86001 USA; [Poulter, Benjamin] NASA, Goddard Space Flight Ctr, Biospher Sci Lab, Greenbelt, MD 20771 USA; [Pugh, Thomas A. M.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England; [Pugh, Thomas A. M.] Univ Birmingham, Birmingham Inst Forest Res, Birmingham B15 2TT, W Midlands, England; [Seidl, Rupert] Univ Nat Resources & Life Sci Vienna, Dept Forest & Soil Sci, A-1180 Vienna, Austria; [Seidl, Rupert] Tech Univ Munich, Sch Life Sci, D-85354 Freising Weihenstephan, Germany; [Turner, Monica G.] Univ Wisconsin, Dept Integrat Biol, Madison, WI 53706 USA; [Uriarte, Maria] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Walker, Anthony P.] Oak Ridge Natl Lab, Div Environm Sci, POB 2008, Oak Ridge, TN 37831 USA; [Walker, Anthony P.] Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN 37831 USA; [Xu, Chonggang] Los Alamos Natl Lab, Div Earth & Environm Sci, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of the Interior; United States Geological Survey; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University System of Maryland; University of Maryland College Park; Duke University; Boston University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of California System; University of California Berkeley; Stanford University; Stanford University; State University System of Florida; University of Florida; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; State University System of Florida; University of Florida; Northern Arizona University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Birmingham; University of Birmingham; University of Natural Resources & Life Sciences, Vienna; Technical University of Munich; University of Wisconsin System; University of Wisconsin Madison; Columbia University; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	McDowell, NG (corresponding author), Pacific Northwest Natl Lab, Richland, WA 99354 USA.	nate.mcdowell@pnnl.gov	Poulter, Ben/ABB-5886-2021; Johnson, Daniel J./L-4899-2019; Turner, Monica G/B-2099-2010; Lichstein, Jeremy/GMW-6555-2022; Kueppers, Lara M/M-8323-2013; Walker, Anthony P/G-2931-2016; Bond-Lamberty, Benjamin/C-6058-2008; Allen, Craig D./K-1121-2019; Seidl, Rupert/ABE-6078-2020; Hanbury-Brown, Adam/AAR-8868-2020; Hurtt, George/A-8450-2012; Pugh, Thomas A M/A-3790-2010	Poulter, Ben/0000-0002-9493-8600; Johnson, Daniel J./0000-0002-8585-2143; Turner, Monica G/0000-0003-1903-2822; Kueppers, Lara M/0000-0002-8134-3579; Walker, Anthony P/0000-0003-0557-5594; Bond-Lamberty, Benjamin/0000-0001-9525-4633; Allen, Craig D./0000-0002-8777-5989; Seidl, Rupert/0000-0002-3338-3402; Hurtt, George/0000-0001-7278-202X; Pugh, Thomas A M/0000-0002-6242-7371; Aukema, Brian/0000-0003-4370-0499; Hanbury-Brown, Adam/0000-0003-3751-6257; Grossiord, Charlotte/0000-0002-9113-3671; Xu, Chonggang/0000-0002-0937-5744; Jackson, Robert/0000-0001-8846-7147; Teixeira, Kristina/0000-0001-8461-9713	DOE's Next Generation Ecosystem Experiment-Tropics (NGEE-Tropics); Pacific Northwest National Lab's (PNNL's) LDRD program; McIntire-Stennis [MIN-17-095]; U.S. Geological Survey; Joint Fire Science Program [16-3-01-4]; University of Wisconsin-Madison Vilas Trust; sDiv; Synthesis Centre of iDiv [DFG FZT 118]; DOE's NGEE-Tropics [LFR-18-542511]; University of California's Laboratory Fees Research Program [LFR-18-542511]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [758873]; Stanford's Center for Advanced Study in the Behavioral Sciences; Gordon and Betty Moore Foundation; NASA Carbon Monitoring System Program; NASA Interdisciplinary Science Program; UT-Battelle, LLC [DE-AC05-00OR22725]; Birmingham Institute of Forest Research [43]; PNNL's LDRD program	DOE's Next Generation Ecosystem Experiment-Tropics (NGEE-Tropics)(United States Department of Energy (DOE)); Pacific Northwest National Lab's (PNNL's) LDRD program; McIntire-Stennis; U.S. Geological Survey(United States Geological Survey); Joint Fire Science Program; University of Wisconsin-Madison Vilas Trust; sDiv; Synthesis Centre of iDiv; DOE's NGEE-Tropics; University of California's Laboratory Fees Research Program; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); Stanford's Center for Advanced Study in the Behavioral Sciences; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NASA Carbon Monitoring System Program; NASA Interdisciplinary Science Program(National Aeronautics & Space Administration (NASA)); UT-Battelle, LLC; Birmingham Institute of Forest Research; PNNL's LDRD program	This manuscript was derived from the Department of Energy (DOE) Workshop "Disturbance and vegetation dynamics in Earth System Models" held March 2018 in Washington, D.C. Funding was provided by: the DOE's Next Generation Ecosystem Experiment-Tropics (NGEE-Tropics) and Pacific Northwest National Lab's (PNNL's) LDRD program (N.G.M.), McIntire-Stennis MIN-17-095 (B.H.A.), the U.S. Geological Survey's Ecosystems and Land Resources mission areas (C.D.A.), the Joint Fire Science Program (16-3-01-4) and the University of Wisconsin-Madison Vilas Trust (M.G.T.), sabbatical fellowship support from sDiv (J.W.L.), the Synthesis Centre of iDiv (DFG FZT 118), DOE's NGEE-Tropics and the University of California's Laboratory Fees Research Program (grant LFR-18-542511 to C.X.), the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant 758873, TreeMort, to T.A.M.P.), paper number 43 of the Birmingham Institute of Forest Research, PNNL's LDRD program (B.B.-L.), sabbatical support from Stanford's Center for Advanced Study in the Behavioral Sciences and financial support from the Gordon and Betty Moore Foundation (R.B.J.), the NASA Carbon Monitoring System and NASA Interdisciplinary Science Programs (G.C.H. and B.P.). Oak Ridge National Laboratory is operated by UT-Battelle, LLC, under contract DE-AC05-00OR22725 to the United States Department of Energy.	Abatzoglou JT, 2016, P NATL ACAD SCI USA, V113, P11770, DOI 10.1073/pnas.1607171113; Adams HD, 2017, NAT ECOL EVOL, V1, P1285, DOI 10.1038/s41559-017-0248-x; Adams HD, 2015, GLOBAL CHANGE BIOL, V21, P4210, DOI 10.1111/gcb.13030; Adams HD, 2009, P NATL ACAD SCI USA, V106, P7063, DOI 10.1073/pnas.0901438106; Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Allen CD, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00203.1; Amiro BD, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001390; Andela N, 2017, SCIENCE, V356, P1356, DOI 10.1126/science.aal4108; Anderson-Teixeira KJ, 2013, GLOBAL CHANGE BIOL, V19, P2001, DOI 10.1111/gcb.12194; Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Bader MKF, 2013, J ECOL, V101, P1509, DOI 10.1111/1365-2745.12149; Balaguru K, 2018, GEOPHYS RES LETT, V45, P4238, DOI 10.1029/2018GL077597; Bennett AC, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.139, 10.1038/nplants.2015.139]; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Boone CK, 2011, CAN J FOREST RES, V41, P1174, DOI [10.1139/X11-041, 10.1139/x11-041]; Bowman DMJS, 2016, GLOBAL ECOL BIOGEOGR, V25, P1166, DOI 10.1111/geb.12484; Brienen RJW, 2015, NATURE, V519, P344, DOI 10.1038/nature14283; Buntgen U, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10174-4; Campbell JE, 2017, NATURE, V544, P84, DOI 10.1038/nature22030; Canham CD, 2001, CAN J FOREST RES, V31, P1, DOI 10.1139/cjfr-31-1-1; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Chaudhary A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23954; Chen JM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12257-8; Chen YY, 2018, GEOSCI MODEL DEV, V11, P771, DOI 10.5194/gmd-11-771-2018; Ciais P, 2019, NATURE, V568, P221, DOI 10.1038/s41586-019-1078-6; Comita LS, 2009, J ECOL, V97, P1346, DOI 10.1111/j.1365-2745.2009.01551.x; Curtis PG, 2018, SCIENCE, V361, P1108, DOI 10.1126/science.aau3445; Devaraju N, 2015, P NATL ACAD SCI USA, V112, P3257, DOI 10.1073/pnas.1423439112; Brugnera MDE, 2019, GLOBAL CHANGE BIOL, V25, P3767, DOI 10.1111/gcb.14769; Diffenbaugh NS, 2013, P NATL ACAD SCI USA, V110, P16361, DOI 10.1073/pnas.1307758110; Doughty CE, 2015, NATURE, V519, P78, DOI 10.1038/nature14213; Duan HL, 2014, PLANT CELL ENVIRON, V37, P1598, DOI 10.1111/pce.12260; Duveneck MJ, 2017, LANDSCAPE ECOL, V32, P1385, DOI 10.1007/s10980-016-0415-5; Ellsworth DS, 2017, NAT CLIM CHANGE, V7, P279, DOI [10.1038/nclimate3235, 10.1038/NCLIMATE3235]; Engelbrecht BMJ, 2003, OECOLOGIA, V136, P383, DOI 10.1007/s00442-003-1290-8; Erb KH, 2017, GLOBAL CHANGE BIOL, V23, P512, DOI 10.1111/gcb.13443; Fernandez-Martinez M, 2019, NAT CLIM CHANGE, V9, P73, DOI 10.1038/s41558-018-0367-7; Fisher RA, 2015, GEOSCI MODEL DEV, V8, P3593, DOI 10.5194/gmd-8-3593-2015; Fisher RA, 2018, GLOBAL CHANGE BIOL, V24, P35, DOI 10.1111/gcb.13910; Flynn DFB, 2010, BIOTROPICA, V42, P149, DOI 10.1111/j.1744-7429.2009.00581.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Forrest JRK, 2015, OIKOS, V124, P4, DOI 10.1111/oik.01386; Friedlingstein P, 2019, EARTH SYST SCI DATA, V11, P1783, DOI 10.5194/essd-11-1783-2019; Frolking S, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000911; Gardiner B, 2016, PLANT SCI, V245, P94, DOI 10.1016/j.plantsci.2016.01.006; Gaylord ML, 2013, NEW PHYTOL, V198, P567, DOI 10.1111/nph.12174; Gedalof Z, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003699; Girardin MP, 2016, P NATL ACAD SCI USA, V113, pE8406, DOI 10.1073/pnas.1610156113; Grime J. P., 1979, Plant strategies and vegetation processes.; Grossiord C, 2017, NEW PHYTOL, V213, P584, DOI 10.1111/nph.14192; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Hansen WD, 2019, ECOL MONOGR, V89, DOI 10.1002/ecm.1340; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harmon ME, 2001, J FOREST, V99, P24; Hartmann H, 2018, NEW PHYTOL, V217, P984, DOI 10.1111/nph.14988; Hember RA, 2012, GLOBAL CHANGE BIOL, V18, P2026, DOI 10.1111/j.1365-2486.2012.02669.x; Henkel TK, 2016, FOREST ECOL MANAG, V378, P222, DOI 10.1016/j.foreco.2016.07.036; Hicke JA, 2012, GLOBAL CHANGE BIOL, V18, P7, DOI 10.1111/j.1365-2486.2011.02543.x; Houghton RA, 2017, GLOBAL BIOGEOCHEM CY, V31, P456, DOI 10.1002/2016GB005546; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; Hurtt GC, 2020, GEOSCI MODEL DEV, V13, P5425, DOI 10.5194/gmd-13-5425-2020; Jentsch A, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2734; Johnson DJ, 2018, NAT ECOL EVOL, V2, P1436, DOI 10.1038/s41559-018-0626-z; Johnson DM, 2010, P NATL ACAD SCI USA, V107, P20576, DOI 10.1073/pnas.1010270107; Johnstone JF, 2016, FRONT ECOL ENVIRON, V14, P369, DOI 10.1002/fee.1311; Jolly WM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8537; Camarero JJ, 2015, GLOBAL CHANGE BIOL, V21, P738, DOI 10.1111/gcb.12787; Kautz M, 2017, GLOBAL ECOL BIOGEOGR, V26, P533, DOI 10.1111/geb.12558; Keenan TF, 2018, NAT CLIM CHANGE, V8, P825, DOI 10.1038/s41558-018-0258-y; Kemp KB, 2016, LANDSCAPE ECOL, V31, P619, DOI 10.1007/s10980-015-0268-3; Kennedy D, 2019, J ADV MODEL EARTH SY, V11, P485, DOI 10.1029/2018MS001500; Kitzberger T, 2016, NEW ZEAL J BOT, V54, P247, DOI 10.1080/0028825X.2016.1151903; Korner C, 2017, SCIENCE, V355, P130, DOI 10.1126/science.aal2449; Kueppers LM, 2017, GLOBAL CHANGE BIOL, V23, P2383, DOI 10.1111/gcb.13561; LaDeau SL, 2001, SCIENCE, V292, P95, DOI 10.1126/science.1057547; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Lawrence DM, 2016, GEOSCI MODEL DEV, V9, P2973, DOI 10.5194/gmd-9-2973-2016; Le Page Y, 2015, BIOGEOSCIENCES, V12, P887, DOI 10.5194/bg-12-887-2015; Lee X, 2011, NATURE, V479, P384, DOI 10.1038/nature10588; Lehsten V, 2019, GEOSCI MODEL DEV, V12, P893, DOI 10.5194/gmd-12-893-2019; Lejeune Q, 2015, CLIM DYNAM, V44, P2769, DOI 10.1007/s00382-014-2203-8; Lindenmayer DB, 2012, SCIENCE, V338, P1305, DOI 10.1126/science.1231070; Liu JJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam5690; Lloret F, 2012, GLOBAL CHANGE BIOL, V18, P797, DOI 10.1111/j.1365-2486.2011.02624.x; Lugo AE, 2008, AUSTRAL ECOL, V33, P368, DOI 10.1111/j.1442-9993.2008.01894.x; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Macek M, 2017, ECOL APPL, V27, P156, DOI 10.1002/eap.1429; Martin PA, 2015, FOREST ECOL MANAG, V356, P224, DOI 10.1016/j.foreco.2015.07.010; McDowell NG, 2016, NAT CLIM CHANGE, V6, P295, DOI [10.1038/nclimate2873, 10.1038/NCLIMATE2873]; McDowell N, 2018, NEW PHYTOL, V219, P851, DOI 10.1111/nph.15027; McDowell NG, 2018, TRENDS ECOL EVOL, V33, P15, DOI 10.1016/j.tree.2017.10.002; McDowell NG, 2013, NEW PHYTOL, V200, P304, DOI 10.1111/nph.12465; McDowell NG, 2011, TREE PHYSIOL-NETH, V4, P255, DOI 10.1007/978-94-007-1242-3_10; McDowell NG, 2015, NAT CLIM CHANGE, V5, P669, DOI [10.1038/nclimate2641, 10.1038/NCLIMATE2641]; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; McMahon SM, 2010, P NATL ACAD SCI USA, V107, P3611, DOI 10.1073/pnas.0912376107; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Miller KM, 2018, GLOBAL ECOL BIOGEOGR, V27, P57, DOI 10.1111/geb.12671; Mohan JE, 2007, ECOL APPL, V17, P1198, DOI 10.1890/05-1690; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Norby RJ, 2002, ECOL APPL, V12, P1261, DOI 10.1890/1051-0761(2002)012[1261:NPPOAC]2.0.CO;2; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Penuelas J, 2017, NAT ECOL EVOL, V1, P1438, DOI 10.1038/s41559-017-0274-8; Penuelas J, 2011, GLOBAL ECOL BIOGEOGR, V20, P597, DOI 10.1111/j.1466-8238.2010.00608.x; Perring MP, 2016, GLOBAL CHANGE BIOL, V22, P1361, DOI 10.1111/gcb.13146; Perry LG, 2013, NEW PHYTOL, V197, P532, DOI 10.1111/nph.12030; Peterson CJ, 2000, SCI TOTAL ENVIRON, V262, P287, DOI 10.1016/S0048-9697(00)00529-5; Poulter B., 2019, GLOBAL FOREST AGE DA, DOI [10.1594/PANGAEA.897392, DOI 10.1594/PANGAEA.897392]; Powell TL, 2018, NEW PHYTOL, V219, P932, DOI 10.1111/nph.15271; Pretzsch H, 2018, FOREST ECOL MANAG, V429, P589, DOI 10.1016/j.foreco.2018.07.045; Pretzsch H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5967; Pugh TAM, 2019, NAT GEOSCI, V12, P730, DOI 10.1038/s41561-019-0427-2; Pugh TAM, 2019, P NATL ACAD SCI USA, V116, P4382, DOI 10.1073/pnas.1810512116; Pureswaran DS, 2016, ENVIRON ENTOMOL, V45, P1333, DOI 10.1093/ee/nvw103; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Raffa KF, 2015, CABI CLIM CHANGE SER, V7, P173, DOI 10.1079/9781780643786.0173; Randerson JT, 2006, SCIENCE, V314, P1130, DOI 10.1126/science.1132075; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Rieu I, 2017, PLANT PHYSIOL, V173, P1967, DOI 10.1104/pp.16.01644; Roccaforte JP, 2018, FOREST ECOL MANAG, V428, P20, DOI 10.1016/j.foreco.2018.06.012; Rosenberger DW, 2018, J APPL ECOL, V55, P1526, DOI 10.1111/1365-2664.13064; Saintilan N, 2015, NEW PHYTOL, V205, P1062, DOI 10.1111/nph.13147; Schurman JS, 2018, GLOBAL CHANGE BIOL, V24, P2169, DOI 10.1111/gcb.14041; Seidl R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04096-w; Seidl R, 2017, NAT CLIM CHANGE, V7, P395, DOI [10.1038/NCLIMATE3303, 10.1038/nclimate3303]; Seidl R, 2014, NAT CLIM CHANGE, V4, P806, DOI [10.1038/NCLIMATE2318, 10.1038/nclimate2318]; Senf C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07539-6; Serrador JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18653-8; Simard M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001708; Slot M, 2015, OECOLOGIA, V177, P885, DOI 10.1007/s00442-014-3159-4; Smith B, 2001, GLOBAL ECOL BIOGEOGR, V10, P621, DOI 10.1046/j.1466-822X.2001.00256.x; Sommerfeld A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06788-9; Stovall AEL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12380-6; Tepley AJ, 2017, GLOBAL CHANGE BIOL, V23, P4117, DOI 10.1111/gcb.13704; Thom D, 2018, BIOGEOSCIENCES, V15, P5699, DOI 10.5194/bg-15-5699-2018; Thom D, 2017, ECOL MONOGR, V87, P665, DOI 10.1002/ecm.1272; Tippett MK, 2016, SCIENCE, V354, P1419, DOI 10.1126/science.aah7393; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P17, DOI 10.1038/NCLIMATE2067; Turner MG, 2019, P NATL ACAD SCI USA, V116, P11319, DOI 10.1073/pnas.1902841116; Turner MG, 2016, ECOLOGY, V97, P1260, DOI 10.1890/15-1585.1; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Uriarte M, 2016, FUNCT ECOL, V30, P157, DOI 10.1111/1365-2435.12576; Uriarte M, 2012, ECOLOGY, V93, P191, DOI 10.1890/10-2422.1; Uriarte M, 2009, ECOL MONOGR, V79, P423, DOI 10.1890/08-0707.1; van der Sleen P, 2015, NAT GEOSCI, V8, P24, DOI [10.1038/NGEO2313, 10.1038/ngeo2313]; van der Werf GR, 2017, EARTH SYST SCI DATA, V9, P697, DOI 10.5194/essd-9-697-2017; Vilen T, 2012, FOREST ECOL MANAG, V286, P203, DOI 10.1016/j.foreco.2012.08.048; Virgin GVJ, 2017, FOREST ECOL MANAG, V400, P129, DOI 10.1016/j.foreco.2017.05.057; Voelker SL, 2006, ECOL MONOGR, V76, P549, DOI 10.1890/0012-9615(2006)076[0549:HCGEDW]2.0.CO;2; Walck JL, 2011, GLOBAL CHANGE BIOL, V17, P2145, DOI 10.1111/j.1365-2486.2010.02368.x; Walker AP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08348-1; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Wright SJ, 2006, ECOL LETT, V9, P35, DOI 10.1111/j.1461-0248.2005.00851.x; Yanoviak SP, 2020, NEW PHYTOL, V225, P1936, DOI 10.1111/nph.16260; Yu KL, 2019, P NATL ACAD SCI USA, V116, P24662, DOI 10.1073/pnas.1821387116; Yuan WP, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax1396	157	299	300	121	614	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					964	+	aaz9463	10.1126/science.aaz9463	http://dx.doi.org/10.1126/science.aaz9463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LV3IK	32467364	Green Submitted, Green Accepted			2022-12-28	WOS:000538332600038
J	[Anonymous]				[Anonymous]			Covid-19: Doctors criticise Indian research agency for recommending hydroxychloroquine prophylaxis	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2126; Ministry of Health and Family Welfare Government of India, REV ADV US HYDR HCQ	2	12	12	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2020	369								m2170	10.1136/bmj.m2170	http://dx.doi.org/10.1136/bmj.m2170			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3KB	32471832	Bronze			2022-12-28	WOS:000538337500020
J	Slomski, A				Slomski, Anita			Gabapentin Treats Alcohol Use Disorder With Withdrawal Symptoms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					1999	1999		10.1001/jama.2020.7969	http://dx.doi.org/10.1001/jama.2020.7969			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OC4XG	32453366				2022-12-28	WOS:000579160500004
J	Liu, LJ; Han, J; Xu, L; Zhou, JS; Zhao, CY; Ding, SJ; Shi, HW; Xiao, MM; Ding, L; Ma, Z; Jin, CH; Zhang, ZY; Peng, LM				Liu, Lijun; Han, Jie; Xu, Lin; Zhou, Jianshuo; Zhao, Chenyi; Ding, Sujuan; Shi, Huiwen; Xiao, Mengmeng; Ding, Li; Ma, Ze; Jin, Chuanhong; Zhang, Zhiyong; Peng, Lian-Mao			Aligned, high-density semiconducting carbon nanotube arrays for high-performance electronics	SCIENCE			English	Article							FIELD-EFFECT TRANSISTORS; INTEGRATED-CIRCUITS; COMPLEMENTARY TRANSISTORS; LARGE-AREA; FREQUENCY; CONTACT; FILMS	Single-walled carbon nanotubes (CNTs) may enable the fabrication of integrated circuits smaller than 10 nanometers, but this would require scalable production of dense and electronically pure semiconducting nanotube arrays on wafers. We developed a multiple dispersion and sorting process that resulted in extremely high semiconducting purity and a dimension-limited self-alignment (DLSA) procedure for preparing well-aligned CNT arrays (within alignment of 9 degrees) with a tunable density of 100 to 200 CNTs per micrometer on a 10-centimeter silicon wafer. Top-gate field-effect transistors (FETs) fabricated on the CNT array show better performance than that of commercial silicon metal oxide-semiconductor FETs with similar gate length, in particular an on-state current of 1.3 milliamperes per micrometer and a recorded transconductance of 0.9 millisiemens per micrometer for a power supply of 1 volt, while maintaining a low room-temperature subthreshold swing of <90 millivolts per decade using an ionic-liquid gate. Batch-fabricated top-gate five-stage ring oscillators exhibited a highest maximum oscillating frequency of >8 gigahertz.	[Liu, Lijun; Han, Jie; Xu, Lin; Zhou, Jianshuo; Zhao, Chenyi; Shi, Huiwen; Xiao, Mengmeng; Ding, Li; Ma, Ze; Zhang, Zhiyong; Peng, Lian-Mao] Peking Univ, Dept Elect, Key Lab Phys & Chem Nanodevices, Beijing 100871, Peoples R China; [Liu, Lijun; Han, Jie; Xu, Lin; Zhou, Jianshuo; Zhao, Chenyi; Shi, Huiwen; Xiao, Mengmeng; Ding, Li; Ma, Ze; Zhang, Zhiyong; Peng, Lian-Mao] Peking Univ, Dept Elect, Ctr Carbon Based Elect, Beijing 100871, Peoples R China; [Ding, Sujuan; Jin, Chuanhong; Zhang, Zhiyong; Peng, Lian-Mao] Xiangtan Univ, Hunan Inst Adv Sensing & Informat Technol, Xiangtan 411105, Hunan, Peoples R China; [Ding, Sujuan; Jin, Chuanhong] Zhejiang Univ, Sch Mat Sci & Engn, State Key Lab Silicon Mat, Hangzhou 310027, Peoples R China; [Zhang, Zhiyong; Peng, Lian-Mao] Peking Univ, Frontiers Sci Ctr Nanooptoelect, Beijing 100871, Peoples R China	Peking University; Peking University; Xiangtan University; Zhejiang University; Peking University	Zhang, ZY; Peng, LM (corresponding author), Peking Univ, Dept Elect, Key Lab Phys & Chem Nanodevices, Beijing 100871, Peoples R China.; Zhang, ZY; Peng, LM (corresponding author), Peking Univ, Dept Elect, Ctr Carbon Based Elect, Beijing 100871, Peoples R China.; Zhang, ZY; Peng, LM (corresponding author), Xiangtan Univ, Hunan Inst Adv Sensing & Informat Technol, Xiangtan 411105, Hunan, Peoples R China.; Zhang, ZY; Peng, LM (corresponding author), Peking Univ, Frontiers Sci Ctr Nanooptoelect, Beijing 100871, Peoples R China.	zyzhang@pku.edu.cn; lmpeng@pku.edu.cn	Liu, Lijun/AAQ-4429-2021; zhang, zhiyong z/A-9502-2013; Peng, Lian-Mao/E-2089-2011	Liu, Lijun/0000-0002-3070-3204; zhang, zhiyong z/0000-0003-1622-3447; Peng, Lian-Mao/0000-0003-0754-074X; Xu, Lin/0000-0003-1781-1638	National Key Research & Development Program [2016YFA0201901, 2016YFA0201902]; National Natural Science Foundation of China [61888102]; Beijing Municipal Science and Technology Commission [Z181100004418011]	National Key Research & Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	Supported by the National Key Research & Development Program (grants 2016YFA0201901 and 2016YFA0201902), the National Natural Science Foundation of China (grant 61888102), and the Beijing Municipal Science and Technology Commission (grant Z181100004418011).	BOHR M, 1994, INTERNATIONAL ELECTRON DEVICES MEETING 1994 - IEDM TECHNICAL DIGEST, P273, DOI 10.1109/IEDM.1994.383414; Brady GJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601240; Brady GJ, 2014, ACS NANO, V8, P11614, DOI 10.1021/nn5048734; Brady GJ, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866577; Brand A., 1998, INTEL TECH J Q, V3, P1998; Cao Q, 2017, SCIENCE, V356, P1369, DOI 10.1126/science.aan2476; Cao Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6071; Cao Q, 2013, NAT NANOTECHNOL, V8, P180, DOI [10.1038/nnano.2012.257, 10.1038/NNANO.2012.257]; Cao Y, 2016, ACS NANO, V10, P6782, DOI 10.1021/acsnano.6b02395; Cao Y, 2016, NANO RES, V9, P363, DOI 10.1007/s12274-015-0915-7; Chau R, 2005, IEEE T NANOTECHNOL, V4, P153, DOI 10.1109/TNANO.2004.842073; Chen BY, 2016, NANO LETT, V16, P5120, DOI 10.1021/acs.nanolett.6b02046; Chen ZH, 2005, NANO LETT, V5, P1497, DOI 10.1021/nl0508624; Ding L, 2009, NANO LETT, V9, P800, DOI 10.1021/nl803496s; Engel M, 2008, ACS NANO, V2, P2445, DOI 10.1021/nn800708w; Franklin AD, 2013, NATURE, V498, P443, DOI 10.1038/498443a; Gu JT, 2016, SMALL, V12, P4993, DOI 10.1002/smll.201600398; Han SJ, 2017, NAT NANOTECHNOL, V12, P861, DOI [10.1038/NNANO.2017.115, 10.1038/nnano.2017.115]; He XW, 2016, NAT NANOTECHNOL, V11, P633, DOI [10.1038/NNANO.2016.44, 10.1038/nnano.2016.44]; Hills G, 2019, NATURE, V572, P595, DOI 10.1038/s41586-019-1493-8; Hu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7099; Jin SH, 2013, NAT NANOTECHNOL, V8, P347, DOI [10.1038/NNANO.2013.56, 10.1038/nnano.2013.56]; Joo Y, 2014, LANGMUIR, V30, P3460, DOI 10.1021/la500162x; Kapila G, 2007, IEEE ELECTR DEVICE L, V28, P232, DOI 10.1109/LED.2007.891263; Kim WS, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1954884; Kocabas C, 2008, P NATL ACAD SCI USA, V105, P1405, DOI 10.1073/pnas.0709734105; Lee CS, 2015, IEEE T ELECTRON DEV, V62, P3070, DOI 10.1109/TED.2015.2457424; Leonard F, 2006, NANOTECHNOLOGY, V17, P2381, DOI 10.1088/0957-4484/17/9/051; Liu LJ, 2019, ACS NANO, V13, P2526, DOI 10.1021/acsnano.8b09488; Ma Z, 2019, ACS APPL MATER INTER, V11, P11736, DOI 10.1021/acsami.8b21325; Ma Z, 2016, APPL PHYS LETT, V108, DOI 10.1063/1.4941813; Patil N, 2011, IEEE T NANOTECHNOL, V10, P744, DOI 10.1109/TNANO.2010.2076323; Perera MM, 2013, ACS NANO, V7, P4449, DOI 10.1021/nn401053g; Qiu CG, 2017, SCIENCE, V355, P271, DOI 10.1126/science.aaj1628; Qiu CG, 2015, ACS NANO, V9, P969, DOI 10.1021/nn506806b; Qiu S, 2019, ADV MATER, V31, DOI 10.1002/adma.201800750; Semiconductor industry association, 2015, 2015 INT TECHN ROADM; Shastry TA, 2013, SMALL, V9, P45, DOI 10.1002/smll.201201398; Shekhar S, 2011, ACS NANO, V5, P1739, DOI 10.1021/nn102305z; Shulaker M. M., 2014, IEEE INT EL DEV M IE; Shulaker MM, 2013, NATURE, V501, P526, DOI 10.1038/nature12502; Si J, 2018, ACS NANO, V12, P627, DOI 10.1021/acsnano.7b07665; Steiner M, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4742325; Sze S. M., 2006, PHYS SEMICONDUCTOR D; Tulevski GS, 2014, ACS NANO, V8, P8730, DOI 10.1021/nn503627h; Tyagi S, 2000, INTERNATIONAL ELECTRON DEVICES MEETING 2000, TECHNICAL DIGEST, P567, DOI 10.1109/IEDM.2000.904383; Xia JL, 2009, NAT NANOTECHNOL, V4, P505, DOI [10.1038/NNANO.2009.177, 10.1038/nnano.2009.177]; Xie X, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6332; Xu L, 2018, APPL PHYS LETT, V113, DOI 10.1063/1.5039967; Yang F, 2017, ACS NANO, V11, P186, DOI 10.1021/acsnano.6b06890; Yang S, 1998, INTERNATIONAL ELECTRON DEVICES MEETING 1998 - TECHNICAL DIGEST, P197, DOI 10.1109/IEDM.1998.746320; Yang YJ, 2017, ACS NANO, V11, P4124, DOI 10.1021/acsnano.7b00861; Ye JT, 2011, P NATL ACAD SCI USA, V108, P13002, DOI 10.1073/pnas.1018388108; Zhang J, 2012, IEEE T COMPUT AID D, V31, P453, DOI 10.1109/TCAD.2012.2187527; Zhang PP, 2015, NANO RES, V8, P1005, DOI 10.1007/s12274-014-0582-0; Zhao CY, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201808574; Zhong DL, 2018, NAT ELECTRON, V1, P40, DOI 10.1038/s41928-017-0003-y; Zhou WW, 2012, J AM CHEM SOC, V134, P14019, DOI 10.1021/ja3038992; Zhu MG, 2018, ADV MATER, V30, DOI 10.1002/adma.201707068	59	162	169	115	748	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					850	+		10.1126/science.aba5980	http://dx.doi.org/10.1126/science.aba5980			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU2DD	32439787				2022-12-28	WOS:000537569500039
J	Zhao, MY; Chen, YH; Wang, KX; Zhang, ZX; Streit, JK; Fagan, JA; Tang, JS; Zheng, M; Yang, CY; Zhu, Z; Sun, W				Zhao, Mengyu; Chen, Yahong; Wang, Kexin; Zhang, Zhaoxuan; Streit, Jason K.; Fagan, Jeffrey A.; Tang, Jianshi; Zheng, Ming; Yang, Chaoyong; Zhu, Zhi; Sun, Wei			DNA-directed nanofabrication of high-performance carbon nanotube field-effect transistors	SCIENCE			English	Article							INTEGRATED-CIRCUITS; SINGLE; ARRAYS; DENSE	Biofabricated semiconductor arrays exhibit smaller channel pitches than those created using existing lithographic methods. However, the metal ions within biolattices and the submicrometer dimensions of typical biotemplates result in both poor transport performance and a lack of large-area array uniformity. Using DNA-templated parallel carbon nanotube (CNT) arrays as model systems, we developed a rinsing-after-fixing approach to improve the key transport performance metrics by more than a factor of 10 compared with those of previous biotemplated field-effect transistors. We also used spatially confined placement of assembled CNT arrays within polymethyl methacrylate cavities to demonstrate centimeter-scale alignment. At the interface of high-performance electronics and biomolecular self-assembly, such approaches may enable the production of scalable biotemplated electronics that are sensitive to local biological environments.	[Zhao, Mengyu; Chen, Yahong; Wang, Kexin; Zhang, Zhaoxuan; Sun, Wei] Peking Univ, Key Lab Phys & Chem Nanodevices, Beijing 100871, Peoples R China; [Zhao, Mengyu; Chen, Yahong; Wang, Kexin; Zhang, Zhaoxuan; Sun, Wei] Peking Univ, Dept Elect, Ctr Carbon Based Elect, Beijing 100871, Peoples R China; [Chen, Yahong; Yang, Chaoyong; Zhu, Zhi] Xiamen Univ, MOE Key Lab Spectrochem Anal & Instrumentat, State Key Lab Phys Chem Solid Surfaces, Dept Chem Biol,Coll Chem & Chem Engn,Collaborat I, Xiamen 361005, Peoples R China; [Zhang, Zhaoxuan] Dalian Univ Technol, State Key Lab Fine Chem, Dalian 116024, Peoples R China; [Streit, Jason K.; Fagan, Jeffrey A.; Zheng, Ming] NIST, Mat Sci & Engn Div, Gaithersburg, MD 20899 USA; [Tang, Jianshi] Tsinghua Univ, Beijing Innovat Ctr Future Chips ICFC, Inst Microelect, Beijing Natl Res Ctr Informat Sci & Technol BNRis, Beijing 100084, Peoples R China	Peking University; Peking University; Xiamen University; Dalian University of Technology; National Institute of Standards & Technology (NIST) - USA; Tsinghua University	Sun, W (corresponding author), Peking Univ, Key Lab Phys & Chem Nanodevices, Beijing 100871, Peoples R China.; Sun, W (corresponding author), Peking Univ, Dept Elect, Ctr Carbon Based Elect, Beijing 100871, Peoples R China.; Zhu, Z (corresponding author), Xiamen Univ, MOE Key Lab Spectrochem Anal & Instrumentat, State Key Lab Phys Chem Solid Surfaces, Dept Chem Biol,Coll Chem & Chem Engn,Collaborat I, Xiamen 361005, Peoples R China.	zhuzhi@xmu.edu.cn; sunw@pku.edu.cn	Tang, Jianshi/I-5543-2014; Zhu, Zhi/D-3721-2011; yang, chaoyong/F-9741-2010	Tang, Jianshi/0000-0001-8369-0067; Zhu, Zhi/0000-0002-3287-4920; yang, chaoyong/0000-0002-2374-5342; Zhang, Zhaoxuan/0000-0001-6496-7323; chen, yahong/0000-0003-3948-7269; Fagan, Jeffrey/0000-0003-1483-5554; Streit, Jason/0000-0003-3209-2141	National Science Foundation of China [21775128, 21435004, 21974113, 21875003, 21991134, 61621061]; Peking University; NIST internal fund	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University(Peking University); NIST internal fund	W.S., M.Zha., Y.C., K.W., and Z.Zha. acknowledge the National Science Foundation of China (grant nos. 21875003, 21991134, and 61621061) and Peking University for financial support. Y.C., C.Y., and Z.Zhu. acknowledge the National Science Foundation of China (grant nos. 21775128, 21435004, and 21974113) for financial support. J.K.S., J.A.F., and M.Zhe. acknowledge the NIST internal fund.	Becerril HA, 2009, CHEM SOC REV, V38, P329, DOI 10.1039/b718440a; Brady GJ, 2017, J APPL PHYS, V122, DOI 10.1063/1.4996586; Brady GJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601240; Cao Q, 2017, SCIENCE, V356, P1369, DOI 10.1126/science.aan2476; Cao Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6071; Cao Q, 2013, NAT NANOTECHNOL, V8, P180, DOI [10.1038/nnano.2012.257, 10.1038/NNANO.2012.257]; Cao Y, 2016, ACS NANO, V10, P6782, DOI 10.1021/acsnano.6b02395; Gopinath A, 2014, ACS NANO, V8, P12030, DOI 10.1021/nn506014s; Han SJ, 2017, NAT NANOTECHNOL, V12, P861, DOI [10.1038/NNANO.2017.115, 10.1038/nnano.2017.115]; Han SP, 2012, NANO LETT, V12, P1129, DOI 10.1021/nl201818u; Hills G, 2018, IEEE T NANOTECHNOL, V17, P1259, DOI 10.1109/TNANO.2018.2871841; Hu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7099; Hung AM, 2010, NAT NANOTECHNOL, V5, P121, DOI [10.1038/nnano.2009.450, 10.1038/NNANO.2009.450]; Jones MR, 2015, SCIENCE, V347, DOI 10.1126/science.1260901; Keren K, 2003, SCIENCE, V302, P1380, DOI 10.1126/science.1091022; Lee D, 2016, ACS NANO, V10, P10894, DOI 10.1021/acsnano.6b05429; Liu LJ, 2019, ACS NANO, V13, P2526, DOI 10.1021/acsnano.8b09488; Mangalum A, 2013, J AM CHEM SOC, V135, P2451, DOI 10.1021/ja312191a; Maune HT, 2010, NAT NANOTECHNOL, V5, P61, DOI [10.1038/nnano.2009.311, 10.1038/NNANO.2009.311]; Mitra S., 2014, 2014 IEEE INT EL DEV, P33; Nakatsuka N, 2018, SCIENCE, V362, P319, DOI 10.1126/science.aao6750; Pei H, 2019, J AM CHEM SOC, V141, P11923, DOI 10.1021/jacs.9b03432; Qiu CG, 2018, SCIENCE, V361, P387, DOI 10.1126/science.aap9195; Qiu CG, 2017, SCIENCE, V355, P271, DOI 10.1126/science.aaj1628; Semiconductor Industry Association, 2013, 2013 INT TECHN ROADM; Shulaker M. M., 2014, 2014 IEEE INT EL DEV; Sun W, 2020, SCIENCE, V368, P874, DOI 10.1126/science.aaz7440; Tulevski GS, 2014, ACS NANO, V8, P8730, DOI 10.1021/nn503627h; Wu J, 2014, ADV MATER, V26, P6151, DOI 10.1002/adma.201401108; Wu J, 2013, SMALL, V9, P4142, DOI 10.1002/smll.201301547; Xiang L, 2018, NAT ELECTRON, V1, P237, DOI 10.1038/s41928-018-0056-6; Zhang J, 2012, IEEE T COMPUT AID D, V31, P453, DOI 10.1109/TCAD.2012.2187527; Zhang L, 2008, J AM CHEM SOC, V130, P2686, DOI 10.1021/ja7106492; Zhang L, 2009, J AM CHEM SOC, V131, P2454, DOI 10.1021/ja8096674; Zhao CY, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201808574; Zhong DL, 2018, NAT ELECTRON, V1, P40, DOI 10.1038/s41928-017-0003-y; Zhou F, 2016, ACS NANO, V10, P3069, DOI 10.1021/acsnano.5b05159	37	61	63	29	257	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					878	+		10.1126/science.aaz7435	http://dx.doi.org/10.1126/science.aaz7435			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU2DD	32439791				2022-12-28	WOS:000537569500044
J	Wise, J				Wise, Jacqui			Covid-19 and thrombosis: what do we know about the risks and treatment?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.041, 10.1016/j.thromres.2020.04.013]; Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888; Poissy J, 2020, CIRCULATION, V142, P184, DOI 10.1161/CIRCULATIONAHA.120.047430	3	24	24	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2020	369								m2058	10.1136/bmj.m2058	http://dx.doi.org/10.1136/bmj.m2058			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JS	32439704	Bronze			2022-12-28	WOS:000538336600017
J	Beigel, JH; Tomashek, KM; Dodd, LE; Mehta, AK; Zingman, BS; Kalil, AC; Hohmann, E; Chu, HY; Luetkemeyer, A; Kline, S; de Castilla, DL; Finberg, RW; Dierberg, K; Tapson, V; Hsieh, L; Patterson, TF; Paredes, R; Sweeney, DA; Short, WR; Touloumi, G; Lye, DC; Ohmagari, N; Oh, MD; Ruiz-Palacios, GM; Benfield, T; Fatkenheuer, G; Kortepeter, MG; Atmar, RL; Creech, CB; Lundgren, J; Babiker, AG; Pett, S; Neaton, JD; Burgess, TH; Bonnett, T; Green, M; Makowski, M; Osinusi, A; Nayak, S; Lane, HC				Beigel, John H.; Tomashek, Kay M.; Dodd, Lori E.; Mehta, Aneesh K.; Zingman, Barry S.; Kalil, Andre C.; Hohmann, Elizabeth; Chu, Helen Y.; Luetkemeyer, Annie; Kline, Susan; de Castilla, Diego Lopez; Finberg, Robert W.; Dierberg, Kerry; Tapson, Victor; Hsieh, Lanny; Patterson, Thomas F.; Paredes, Roger; Sweeney, Daniel A.; Short, William R.; Touloumi, Giota; Lye, David Chien; Ohmagari, Norio; Oh, Myoung-don; Ruiz-Palacios, Guillermo M.; Benfield, Thomas; Faetkenheuer, Gerd; Kortepeter, Mark G.; Atmar, Robert L.; Creech, C. Buddy; Lundgren, Jens; Babiker, Abdel G.; Pett, Sarah; Neaton, James D.; Burgess, Timothy H.; Bonnett, Tyler; Green, Michelle; Makowski, Mat; Osinusi, Anu; Nayak, Seema; Lane, H. Clifford		ACTT-1 Study Grp	Remdesivir for the Treatment of Covid-19-Final Report	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BackgroundAlthough several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious. MethodsWe conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection. Patients were randomly assigned to receive either remdesivir (200 mg loading dose on day 1, followed by 100 mg daily for up to 9 additional days) or placebo for up to 10 days. The primary outcome was the time to recovery, defined by either discharge from the hospital or hospitalization for infection-control purposes only. ResultsA total of 1062 patients underwent randomization (with 541 assigned to remdesivir and 521 to placebo). Those who received remdesivir had a median recovery time of 10 days (95% confidence interval [CI], 9 to 11), as compared with 15 days (95% CI, 13 to 18) among those who received placebo (rate ratio for recovery, 1.29; 95% CI, 1.12 to 1.49; P<0.001, by a log-rank test). In an analysis that used a proportional-odds model with an eight-category ordinal scale, the patients who received remdesivir were found to be more likely than those who received placebo to have clinical improvement at day 15 (odds ratio, 1.5; 95% CI, 1.2 to 1.9, after adjustment for actual disease severity). The Kaplan-Meier estimates of mortality were 6.7% with remdesivir and 11.9% with placebo by day 15 and 11.4% with remdesivir and 15.2% with placebo by day 29 (hazard ratio, 0.73; 95% CI, 0.52 to 1.03). Serious adverse events were reported in 131 of the 532 patients who received remdesivir (24.6%) and in 163 of the 516 patients who received placebo (31.6%). ConclusionsOur data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection. (Funded by the National Institute of Allergy and Infectious Diseases and others; ACTT-1 ClinicalTrials.gov number, NCT04280705.) In this randomized, double-blind trial in 1062 adults hospitalized with Covid-19, remdesivir was superior to placebo in shortening the time to recovery (10 days, vs. 15 days with placebo). The estimates of mortality by day 29 were 11.4% with remdesivir and 15.2% with placebo. The benefit of remdesivir was most apparent in patients who were receiving low-flow oxygen at baseline.	[Beigel, John H.; Tomashek, Kay M.; Dodd, Lori E.; Nayak, Seema; Lane, H. Clifford] NIAID, NIH, 5601 Fishers Ln,Rm 7E60,MSC 9826, Bethesda, MD 20892 USA; [Burgess, Timothy H.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Bonnett, Tyler] Frederick Natl Lab Canc Res, Clin Monitoring Res Program Directorate, Frederick, MD USA; [Green, Michelle; Makowski, Mat] Emmes, Rockville, MD USA; [Mehta, Aneesh K.] Emory Univ, Atlanta, GA 30322 USA; [Zingman, Barry S.] Montefiore Med Ctr, Albert Einstein Coll Med, New York, NY USA; [Dierberg, Kerry] NYU Langone Hlth, New York, NY USA; [Dierberg, Kerry] NYC Hlth & Hosp Bellevue, New York, NY USA; [Kalil, Andre C.; Kortepeter, Mark G.] Univ Nebraska Med Ctr, Omaha, NE USA; [Hohmann, Elizabeth] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Finberg, Robert W.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Chu, Helen Y.] Univ Washington, Seattle, WA 98195 USA; [de Castilla, Diego Lopez] Evergreen Hlth Med Ctr, Kirkland, WA USA; [Luetkemeyer, Annie] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Tapson, Victor] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Hsieh, Lanny] Univ Calif Irvine, Irvine, CA USA; [Sweeney, Daniel A.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Osinusi, Anu] Gilead Sci, Foster City, CA USA; [Kline, Susan] Univ Minnesota, Minneapolis, MN USA; [Neaton, James D.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Neaton, James D.] INSIGHT, Minneapolis, MN USA; [Patterson, Thomas F.] Univ Hlth Syst, Univ Texas Hlth San Antonio, San Antonio, TX USA; [Patterson, Thomas F.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Atmar, Robert L.] Baylor Coll Med, Houston, TX 77030 USA; [Paredes, Roger] Hosp Badalona Germans Trias & Pujol, Badalona, Spain; [Paredes, Roger] IrsiCaixa AIDS Res Inst, Badalona, Spain; [Short, William R.] Univ Penn, Philadelphia, PA 19104 USA; [Touloumi, Giota] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece; [Lye, David Chien] Tan Tock Seng Hosp, Natl Ctr Infect Dis, Lee Kong Chian Sch Med, Yong Loo Lin Sch Med, Singapore, Singapore; [Ohmagari, Norio] Natl Ctr Global Hlth & Med Hosp, Tokyo, Japan; [Oh, Myoung-don] Seoul Natl Univ Hosp, Seoul, South Korea; [Ruiz-Palacios, Guillermo M.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Benfield, Thomas] Univ Copenhagen, Dept Infect Dis, Amager Hvidovre Hosp, Hvidovre, Denmark; [Lundgren, Jens] Rigshosp, Dept Infect Dis CHIP, Copenhagen, Denmark; [Lundgren, Jens] INSIGHT, Copenhagen, Denmark; [Faetkenheuer, Gerd] Univ Hosp Cologne, Cologne, Germany; [Creech, C. Buddy] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Babiker, Abdel G.; Pett, Sarah] UCL, MRC Clin Trials Unit, London, England; [Babiker, Abdel G.; Pett, Sarah] INSIGHT, London, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Emory University; Montefiore Medical Center; Yeshiva University; NYU Langone Medical Center; Bellevue Hospital Center; University of Nebraska System; University of Nebraska Medical Center; Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Cedars Sinai Medical Center; University of California System; University of California Irvine; University of California System; University of California San Diego; Gilead Sciences; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Baylor College of Medicine; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; University of Pennsylvania; Athens Medical School; National & Kapodistrian University of Athens; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Centre for Infectious Diseases Singapore; National University of Singapore; Tan Tock Seng Hospital; National Center for Global Health & Medicine - Japan; Seoul National University (SNU); Seoul National University Hospital; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Cologne; Vanderbilt University; Medical Research Council Clinical Trials Unit; University of London; University College London	Beigel, JH (corresponding author), NIAID, NIH, 5601 Fishers Ln,Rm 7E60,MSC 9826, Bethesda, MD 20892 USA.	jbeigel@niaid.nih.gov	Ohmagari, Norio/GLN-5290-2022; Atmar, Robert/AFQ-5392-2022; Chia, Po Ying/GSD-9737-2022; Lye, David/ABF-4402-2021; Beigel, John H/GNP-2628-2022; Malin, Jakob J./L-7935-2019; Alaaeddine, Ghina/HHN-7143-2022; Maves, Ryan C/AGG-3988-2022; Koehler, Philipp/J-7985-2019; Gutierrez, Jose Muñoz/AAH-6954-2020; Beigel, John/AAQ-4289-2021; Ong, Sean/AAO-9560-2020; Frank, Maria (Gaby)/AHA-0816-2022; Jensen, Tomas/AFN-5759-2022; Lundgren, Jens/AAE-6876-2019; Ruiz-Palacios, Guillermo/GYQ-5462-2022; Chia, Po Ying/AAN-9657-2020; Llewelyn, Martin/A-7194-2011; Philips, Barbara/H-1670-2011; Mehta, Aneesh/B-8054-2012	Ohmagari, Norio/0000-0002-4622-8970; Atmar, Robert/0000-0001-9989-6772; Chia, Po Ying/0000-0002-8797-9527; Malin, Jakob J./0000-0002-2989-0436; Maves, Ryan C/0000-0001-6234-6160; Koehler, Philipp/0000-0002-7386-7495; Gutierrez, Jose Muñoz/0000-0002-0945-1735; Beigel, John/0000-0002-4879-4941; Ong, Sean/0000-0002-8570-436X; Jensen, Tomas/0000-0003-0398-4431; Chia, Po Ying/0000-0002-8797-9527; Colombo, Christopher/0000-0001-5499-3368; Dierberg, Kerry/0000-0001-8528-7159; Mateu, Lourdes/0000-0001-7223-7611; Staerke, Nina Breinholt/0000-0002-5834-2033; George, Sarah/0000-0002-9699-1042; Llewelyn, Martin/0000-0002-6811-1124; Philips, Barbara/0000-0002-1124-0988; wang, jennifer/0000-0002-2556-9100; Lindholm, David/0000-0001-5428-7404; Merrick, Blair/0000-0002-6061-6064; Wegel, Ashley/0000-0002-1643-0668; Jung, Jongtak/0000-0003-3497-0796; Paules, Catharine/0000-0002-9064-6678; Lye, David/0000-0003-0324-0205; Bonnett, Tyler/0000-0001-5545-6433; HELLEBERG, MARIE/0000-0002-2370-1657; Ortiz, Justin/0000-0002-3138-5965; Wulff Madsen, Lone/0000-0002-7864-1268; Ponce-de-Leon, Alfredo/0000-0003-2640-2916; Lindegaard, Birgitte/0000-0002-5236-8427; Goodman, Anna/0000-0003-0643-9017; Neumann, Henry/0000-0002-6276-1644; Mehta, Aneesh/0000-0002-6552-9162; Rajme-Lopez, Sandra/0000-0001-7809-9619; Wang, Jing/0000-0003-1580-1356; Price, David/0000-0002-0562-7326; Benfield, Thomas/0000-0003-0698-9385; Holodniy, Mark/0000-0002-6655-7982	NIAID, National Institutes of Health (NIH), Bethesda, MD; NIAID, NIH [HHSN261200800001E 75N910D00024, 75N91019F00130/75N91020F00010]; National Cancer Institute, NIH [HHSN261200800001E 75N910D00024, 75N91019F00130/75N91020F00010]; Department of Defense, Defense Health Program; NIAID of the NIH [UM1AI148684, UM1AI148576, UM1AI148573, UM1AI148575, UM1AI148452, UM1AI148685, UM1AI148450, UM1AI148689]; Seoul National University Hospital; United Kingdom Medical Research Council [MRC _UU_12023/23]; Sanofi Pasteur; Gilead; Gilead Sciences; Merck Sharp and Dohme; ViiV Healthcare; Gilead Sciences Europe; Pfizer; Novo Nordisk Foundation; Simonsen Foundation; Lundbeck Foundation; GlaxoSmithKline; Janssen; government of Denmark; government of Japan; government of Mexico; government of Singapore; MRC [MC_UU_12023/22] Funding Source: UKRI	NIAID, National Institutes of Health (NIH), Bethesda, MD; NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense, Defense Health Program; NIAID of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Seoul National University Hospital; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sanofi Pasteur; Gilead(Gilead Sciences); Gilead Sciences(Gilead Sciences); Merck Sharp and Dohme(Merck & Company); ViiV Healthcare; Gilead Sciences Europe(Gilead Sciences); Pfizer(Pfizer); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Simonsen Foundation; Lundbeck Foundation(Lundbeckfonden); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); government of Denmark; government of Japan; government of Mexico; government of Singapore; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The trial was sponsored and primarily funded by the NIAID, National Institutes of Health (NIH), Bethesda, MD. This trial has been funded in part with federal funds from the NIAID and the National Cancer Institute, NIH, under contract HHSN261200800001E 75N910D00024, task order number 75N91019F00130/75N91020F00010, and by the Department of Defense, Defense Health Program. This trial has been supported in part by the NIAID of the NIH under award numbers UM1AI148684, UM1AI148576, UM1AI148573, UM1AI148575, UM1AI148452, UM1AI148685, UM1AI148450, and UM1AI148689. The trial has also been funded in part by the governments of Denmark, Japan, Mexico, and Singapore. The trial site in South Korea received funding from the Seoul National University Hospital. Support for the London International Coordinating Centre was also provided by the United Kingdom Medical Research Council (MRC _UU_12023/23). Dr. Chu reports receiving consulting fees from Merck and GlaxoSmithKline, grant support from Sanofi Pasteur, and research supplies from Cepheid, Ellume, and Genentech; Dr. Luetkemeyer, receiving grant support, paid to the University of California, San Francisco, from Gilead; Dr. Paredes, receiving grant support and advisory fees from Gilead Sciences, Merck Sharp and Dohme, and ViiV Healthcare; Dr. Touloumi, receiving grant support from Gilead Sciences Europe; Dr. Benfield, receiving grant support from Pfizer, Novo Nordisk Foundation, Simonsen Foundation, and Lundbeck Foundation, grant support and advisory board fees from GlaxoSmithKline, grant support and lecture fees from Pfizer, teaching fees from Boehringer Ingelheim, grant support and teaching fees from Gilead, and teaching fees and advisory board fees from Merck Sharp and Dohme; Dr. Fatkenheuer, receiving grant support, advisory board fees, and travel support from Gilead Sciences and Janssen and grant support and advisory board fees from Merck Sharp and Dohme and ViiV Healthcare; Dr. Kortepeter, receiving consulting fees and serving on a board for Integrum Scientific; Dr. Pett, receiving grant support from Gilead Sciences and ViiV Healthcare; and Dr. Osinusi, being employed by Gilead Sciences. No other potential conflict of interest relevant to this article was reported.	Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18; Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857; Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282; de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117; de Wit E, 2013, P NATL ACAD SCI USA, V110, P16598, DOI 10.1073/pnas.1310744110; Helmy YA, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041225; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; King JC, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz137; Royal College of Physicians, 2017, NATL EARL WARN SCOR; Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6; Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653; Spinner CD, 2020, JAMA-J AM MED ASSOC, V324, P1048, DOI 10.1001/jama.2020.16349; The CONSORT Group, 3B CHANG TRIAL DES; Wang M., 2020, CELL RES, V30, P269, DOI [DOI 10.1038/s41422-020-0282-0, 10.1038/s41422-020-0282-0, 10.1038/s41422-020-0282-02020]; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9	16	3588	3657	44	245	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2020	383	19					1813	1826		10.1056/NEJMoa2007764	http://dx.doi.org/10.1056/NEJMoa2007764			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PN2SG	32445440	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000604334000010
J	Bornstein, S				Bornstein, Sue			The Challenges of Behavioral Health Integration: The Persistence of the Mind-Body Problem	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARE		[Bornstein, Sue] Texas Med Home Initiat, 3111 Beverly Dr, Dallas, TX 75205 USA		Bornstein, S (corresponding author), Texas Med Home Initiat, 3111 Beverly Dr, Dallas, TX 75205 USA.	suebornstein@gmail.com						Blackmore MA, 2018, PSYCHIAT SERV, V69, P1184, DOI 10.1176/appi.ps.201700569; Crowley RA, 2015, ANN INTERN MED, V163, P298, DOI 10.7326/M15-0510; Druss BG, 2011, 21 RW JOHNS FDN; Gendle Mathew H, 2016, Mens Sana Monogr, V14, P141, DOI 10.4103/0973-1229.193074; Institute of Medicine, 1996, PRIMARY CARE AMERICA; Jacobs C, 2018, FAM MED, V50, P380, DOI 10.22454/FamMed.2018.639260; Lardiere MR, 2014, ESSENTIAL ELEMENTS E; Malatre-Lansac A, 2020, ANN INTERN MED, V173, P92, DOI 10.7326/M20-0132; McIntosh A, 2020, ACA 10 HAS IT IMPACT, DOI [10.26099/2ajx-qg59, DOI 10.26099/2AJX-QG59]	9	1	1	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2020	173	2					151	152		10.7326/M20-2887	http://dx.doi.org/10.7326/M20-2887			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ0RK	32479171				2022-12-28	WOS:000552604300024
J	Psotka, MA; Teerlink, JR				Psotka, Mitchell A.; Teerlink, John R.			Assessing the lifetime benefit of heart failure therapies	LANCET			English	Editorial Material							2013 ACCF/AHA GUIDELINE; MANAGEMENT		[Psotka, Mitchell A.] Inova Heart & Vasc Inst, Falls Church, VA USA; [Teerlink, John R.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Teerlink, John R.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Inova Fairfax Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Teerlink, JR (corresponding author), San Francisco VA Med Ctr, San Francisco, CA 94121 USA.; Teerlink, JR (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	john.teerlink@ucsf.edu						Armstrong PW, 2020, NEW ENGL J MED, V382, P1883, DOI 10.1056/NEJMoa1915928; Braudel Fernand, 2009, REV FERNAND BRAUDEL, V32, P171; Greene SJ, 2018, J AM COLL CARDIOL, V72, P351, DOI 10.1016/j.jacc.2018.04.070; McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Rupp T, 2017, JAMA INTERN MED, V177, P276, DOI 10.1001/jamainternmed.2016.7761; Vaduganathan M, 2020, LANCET, V396, P121, DOI 10.1016/S0140-6736(20)30748-0; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1016/j.jacc.2017.04.025, 10.1161/CIR.0000000000000509]; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	11	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2020	396	10244					75	77		10.1016/S0140-6736(20)30929-6	http://dx.doi.org/10.1016/S0140-6736(20)30929-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2JY	32446325				2022-12-28	WOS:000552724600005
J	Sempowski, GD; Saunders, KO; Acharya, P; Wiehe, KJ; Haynes, BF				Sempowski, Gregory D.; Saunders, Kevin O.; Acharya, Priyamvada; Wiehe, Kevin J.; Haynes, Barton F.			Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19	CELL			English	Review							MONOCLONAL-ANTIBODIES; CORONAVIRUS; IDENTIFICATION; COMBINATION; PROTECTION; PURSUIT; CELLS; SPIKE	The SARS-CoV-2 pandemic that causes COVID-19 respiratory syndrome has caused global public health and economic crises, necessitating rapid development of vaccines and therapeutic countermeasures. The world-wide response to the COVID-19 pandemic has been unprecedented with government, academic, and private partnerships working together to rapidly develop vaccine and antibody countermeasures. Many of the technologies being used are derived from prior government-academic partnerships for response to other emerging infections.	[Sempowski, Gregory D.; Wiehe, Kevin J.; Haynes, Barton F.] Duke Univ, Dept Med, Duke Human Vaccine Inst, Sch Med, Durham, NC 27710 USA; [Sempowski, Gregory D.] Duke Univ, Sch Med, Dept Pathol, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Saunders, Kevin O.; Acharya, Priyamvada] Duke Univ, Sch Med, Dept Surg, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Haynes, Barton F.] Duke Univ, Sch Med, Dept Immunol, Duke Human Vaccine Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Sempowski, GD; Haynes, BF (corresponding author), Duke Univ, Dept Med, Duke Human Vaccine Inst, Sch Med, Durham, NC 27710 USA.; Sempowski, GD (corresponding author), Duke Univ, Sch Med, Dept Pathol, Duke Human Vaccine Inst, Durham, NC 27710 USA.; Haynes, BF (corresponding author), Duke Univ, Sch Med, Dept Immunol, Duke Human Vaccine Inst, Durham, NC 27710 USA.	gregory.sempowski@duke.edu; barton.haynes@duke.edu		Sempowski, Gregory/0000-0003-0391-6594; Acharya, Priyamvada/0000-0002-0089-277X	NIH [AI142596, AI145687, AI150415, AI058607]; Department of Defense [HR0011-17-2-0069]; Translating Duke Health Initiative	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Translating Duke Health Initiative	Funded by NIH grants AI142596 (B.F.H.), AI145687 and AI150415 (P.A.), AI058607 (G.D.S.); Department of Defense HR0011-17-2-0069 (G.D.S.); and the Translating Duke Health Initiative (P.A.). All authors wrote and edited the manuscript. We thank Megan Averill for editorial assistance and David Easterhoff and QiFeng Han for their contributions to the DARPA P3 program.	Andreano E., 2020, IDENTIFICATION NEUTR, DOI [10.1101/2020.05.05.078154, DOI 10.1101/2020.05.05.078154]; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Bolles M, 2011, J VIROL, V85, P12201, DOI 10.1128/JVI.06048-11; Brouwer P., 2020, POTENT NEUTRALIZING, DOI [10.1101/2020.05.12.088716, DOI 10.1101/2020.05.12.088716]; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Cable J, 2020, ANN NY ACAD SCI, V1462, P14, DOI 10.1111/nyas.14235; Carroll D, 2018, SCIENCE, V359, P872, DOI 10.1126/science.aap7463; Carter PJ, 2018, NAT REV DRUG DISCOV, V17, P197, DOI 10.1038/nrd.2017.227; Caskey M, 2019, NAT MED, V25, P547, DOI 10.1038/s41591-019-0412-8; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; DARPA, 2017, PAND PREV PLATF P3; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Empey KM, 2010, CLIN INFECT DIS, V50, P1258, DOI 10.1086/651603; Gaudinski MR, 2019, LANCET HIV, V6, pE667, DOI 10.1016/S2352-3018(19)30181-X; GISAID, 2020, NEXT HCOV 19 APP; Gouglas D, 2019, EPIDEMIOL REV, V41, P28, DOI 10.1093/epirev/mxz012; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Graham BS, 2018, JAMA-J AM MED ASSOC, V319, P1431, DOI 10.1001/jama.2018.0345; Graham BS, 2018, NAT IMMUNOL, V19, P20, DOI 10.1038/s41590-017-0007-9; Haynes BF, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaz2686; Haynes BF, 2016, CELL HOST MICROBE, V19, P292, DOI 10.1016/j.chom.2016.02.002; Henderson R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14196-w; Idusogie EE, 2001, J IMMUNOL, V166, P2571, DOI 10.4049/jimmunol.166.4.2571; Jaume M, 2011, J VIROL, V85, P10582, DOI 10.1128/JVI.00671-11; Ju B., 2020, BIORXIV, DOI [10.1101/2020.03.21.990770, 10.1101/ 2020.03.21.990770, DOI 10.1101/2020.03.21.990770]; Kaiser J, 2020, SCIENCE, V368, P351, DOI 10.1126/science.368.6489.351; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Korber B, 2020, SPIKE MUTATION PIPEL; Kose N, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw6647; Kwong PD, 2018, IMMUNITY, V48, P855, DOI 10.1016/j.immuni.2018.04.029; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; LaBranche CC, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008026; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158; Los Alamos National Laboratory, 2020, SARS COV 2 SEQ AN PI; Los Alamos National Laboratory, 2020, AL HIV SEQ DAT; Lu S., 2020, COMP SARS COV 2 INFE, DOI [10.1101/2020.04.08.031807, DOI 10.1101/2020.04.08.031807]; Mendoza P, 2018, NATURE, V561, P479, DOI 10.1038/s41586-018-0531-2; Murin CD, 2019, NAT MICROBIOL, V4, P734, DOI 10.1038/s41564-019-0392-y; Muthumani K, 2013, HUM VACC IMMUNOTHER, V9, P2253, DOI 10.4161/hv.26498; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Pardi N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14630; Peeples L, 2020, P NATL ACAD SCI USA, V117, P8218, DOI 10.1073/pnas.2005456117; Quinlan B.D., 2020, SARS COV 2 RECEPTOR, DOI [10.1101/2020.04.10.036418, DOI 10.1101/2020.04.10.036418]; Richards JO, 2008, MOL CANCER THER, V7, P2517, DOI 10.1158/1535-7163.MCT-08-0201; Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13; Rockx B., 2020, SCIENCE; Rogers T.F., 2020, RAPID ISOLATION POTE, DOI [10.1101/2020.05.11.088674, DOI 10.1101/2020.05.11.088674]; Saphire EO, 2018, CELL, V174, P938, DOI 10.1016/j.cell.2018.07.033; Saunders KO, 2019, SCIENCE, V366, P1215, DOI 10.1126/science.aay7199; Saunders KO, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01296; Seydoux E., 2020, CHARACTERIZATION NEU, DOI [10.1101/2020.05.12.091298, DOI 10.1101/2020.05.12.091298]; Shepard HM, 2017, CLIN MED, V17, P220, DOI 10.7861/clinmedicine.17-3-220; Sok D, 2018, NAT IMMUNOL, V19, P1179, DOI 10.1038/s41590-018-0235-7; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; Le TT, 2020, NAT REV DRUG DISCOV, V19, P305, DOI 10.1038/d41573-020-00073-5; Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421; Walker LM, 2018, NAT REV IMMUNOL, V18, P297, DOI 10.1038/nri.2017.148; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang L, 2018, J VIROL, V92, DOI 10.1128/JVI.01060-18; WHO, 2020, COR DIS COVID 2019 T; WHO, 2020, DRAFT LANDSC COVID 1; Wiehe K, 2018, CELL HOST MICROBE, V23, P759, DOI 10.1016/j.chom.2018.04.018; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Yu X.Q., 2016, ANTIMICROB AGENTS CH, V61, P61; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Zhao JC, 2016, IMMUNITY, V44, P1379, DOI 10.1016/j.immuni.2016.05.006; Zhou YS, 2018, EXPERT REV VACCINES, V17, P677, DOI 10.1080/14760584.2018.1506702	72	56	61	6	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2020	181	7					1458	1463		10.1016/j.cell.2020.05.041	http://dx.doi.org/10.1016/j.cell.2020.05.041			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MD2SA	32492407	Green Published, Bronze			2022-12-28	WOS:000543822100006
J	Vaduganathan, M; van Meijgaard, J; Mehra, MR; Joseph, J; O'Donnell, CJ; Warraich, HJ				Vaduganathan, Muthiah; van Meijgaard, Jeroen; Mehra, Mandeep R.; Joseph, Jacob; O'Donnell, Christopher J.; Warraich, Haider J.			Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Vaduganathan, Muthiah; Mehra, Mandeep R.] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [van Meijgaard, Jeroen] GoodRx, Santa Monica, CA USA; [Joseph, Jacob; O'Donnell, Christopher J.; Warraich, Haider J.] VA Boston Healthcare Syst, Dept Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Warraich, HJ (corresponding author), VA Boston Healthcare Syst, 1400 VFW Pkwy,4B-132, Boston, MA 02132 USA.	hwarraich@partners.org	Joseph, Jacob/GYR-1361-2022	Joseph, Jacob/0000-0002-7279-4896; van Meijgaard, Jeroen/0000-0002-3948-1556	NCATS NIH HHS [UL1 TR002541] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Food and Drug Administration, 2020, CURR RES DRUG SHORT; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Liu M, 2020, JAMA INTERN MED, V180, P1116, DOI 10.1001/jamainternmed.2020.1764; Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760; van Meijgaard J., 2020, GOODRX RES DATA DESC	5	74	74	3	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2524	2526		10.1001/jama.2020.9184	http://dx.doi.org/10.1001/jama.2020.9184			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32463459	Green Published, Bronze			2022-12-28	WOS:000590149400028
J	Poortmans, PM; Guarneri, V; Cardoso, MJ				Poortmans, Philip M.; Guarneri, Valentina; Cardoso, Maria-Joao			Cancer and COVID-19: what do we really know?	LANCET			English	Editorial Material							BREAST-CANCER		[Poortmans, Philip M.] Iridium Kankernetwerk, Dept Radiat Oncol, Antwerp, Belgium; [Poortmans, Philip M.] Univ Antwerp, Fac Med & Hlth Sci, B-2610 Antwerp, Belgium; [Guarneri, Valentina] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy; [Guarneri, Valentina] Ist Oncol Veneto IRCCS, Med Oncol 2, Padua, Italy; [Cardoso, Maria-Joao] Champalimaud Fdn, Champalimaud Clin Ctr, Breast Unit, Lisbon, Portugal; [Cardoso, Maria-Joao] Univ Lisbon, Nova Med Sch, Lisbon, Portugal	University of Antwerp; University of Padua; IRCCS Istituto Oncologico Veneto (IOV); Fundacao Champalimaud; Universidade de Lisboa	Poortmans, PM (corresponding author), Iridium Kankernetwerk, Dept Radiat Oncol, Antwerp, Belgium.; Poortmans, PM (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, B-2610 Antwerp, Belgium.	philip.poortmans@telenet.be		Cardoso, Maria Joao/0000-0002-8137-3700; GUARNERI, VALENTINA/0000-0002-2375-8397				Coles CE, 2020, CLIN ONCOL-UK, V32, P279, DOI 10.1016/j.clon.2020.03.006; Curigliano G, 2020, BREAST, V52, P8, DOI 10.1016/j.breast.2020.04.006; Kirkby C, 2020, RADIOTHER ONCOL, V147, P221, DOI 10.1016/j.radonc.2020.04.004; Kuderer NM, 2020, LANCET, V395, P1907, DOI 10.1016/S0140-6736(20)31187-9; Lambertini M, 2020, ESMO OPEN, V5, DOI 10.1136/esmoopen-2020-000759; Lee LYW, 2020, LANCET, V395, P1919, DOI 10.1016/S0140-6736(20)31173-9; Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6; Miyashita H, 2020, ANN ONCOL, V31, P1088, DOI 10.1016/j.annonc.2020.04.006; Nagar H, 2020, NAT REV CLIN ONCOL, V17, P332, DOI 10.1038/s41571-020-0375-1; Oberfeld B, 2020, CELL, V181, P954, DOI 10.1016/j.cell.2020.04.013; the European Society for Medical Oncology (ESMO), CANC PAT MAN COVID 1	11	22	24	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2020	395	10241					1884	1885		10.1016/S0140-6736(20)31240-X	http://dx.doi.org/10.1016/S0140-6736(20)31240-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2MV	32479827	Green Published, Bronze			2022-12-28	WOS:000552732200005
J	Ang, QY; Alexander, M; Newman, JC; Tian, Y; Cai, JW; Upadhyay, V; Turnbaugh, JA; Verdin, E; Hall, KD; Leibel, RL; Ravussin, E; Rosenbaum, M; Patterson, AD; Turnbaugh, PJ				Ang, Qi Yan; Alexander, Margaret; Newman, John C.; Tian, Yuan; Cai, Jingwei; Upadhyay, Vaibhav; Turnbaugh, Jessie A.; Verdin, Eric; Hall, Kevin D.; Leibel, Rudolph L.; Ravussin, Eric; Rosenbaum, Michael; Patterson, Andrew D.; Turnbaugh, Peter J.			Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells	CELL			English	Article							T-CELLS; KETONE-BODIES; HOMEOSTASIS; COMMENSAL; MUCUS	Very low-carbohydrate, high-fat ketogenic diets (KDs) induce a pronounced shift in metabolic fuel utilization that elevates circulating ketone bodies; however, the consequences of these compounds for host-microbiome interactions remain unknown. Here, we show that KDs alter the human and mouse gut microbiota in a manner distinct from high-fat diets (HFDs). Metagenomic and metabolomic analyses of stool samples from an 8-week inpatient study revealedmarked shifts in gutmicrobial community structure and function during the KD. Gradient diet experiments in mice confirmed the unique impact of KDs relative to HFDs with a reproducible depletion of bifidobacteria. In vitro and in vivo experiments showed that ketone bodies selectively inhibited bifidobacterial growth. Finally, mono-colonizations and human microbiome transplantations into germ-free mice revealed that the KD-associated gut microbiota reduces the levels of intestinal pro-inflammatory Th17 cells. Together, these results highlight the importance of trans-kingdom chemical dialogs for mediating the host response to dietary interventions.	[Ang, Qi Yan; Alexander, Margaret; Upadhyay, Vaibhav; Turnbaugh, Jessie A.; Turnbaugh, Peter J.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Newman, John C.; Verdin, Eric] Buck Inst Res Aging, Novato, CA 94945 USA; [Tian, Yuan; Cai, Jingwei; Patterson, Andrew D.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Hall, Kevin D.] Natl Inst Diabet & Digest & Kidney Dis, Bethesda, MD 20892 USA; [Leibel, Rudolph L.; Rosenbaum, Michael] Columbia Univ, Dept Pediat, Div Mol Genet, Vagelos Coll Phys & Surg, New York, NY 10032 USA; [Ravussin, Eric] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Turnbaugh, Peter J.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Buck Institute for Research on Aging; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Columbia University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Turnbaugh, PJ (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Turnbaugh, PJ (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	peter.turnbaugh@ucsf.edu	Patterson, Andrew/ABF-1575-2020; Newman, John C/L-8112-2013; Hall, Kevin/F-2383-2010	Patterson, Andrew/0000-0003-2073-0070; Hall, Kevin/0000-0003-4062-3133; Alexander, Margaret/0000-0003-2972-7521; Upadhyay, Vaibhav/0000-0002-7652-1043; Ang, Qi Yan/0000-0002-9788-1283; Ravussin, Eric/0000-0003-2129-547X; Turnbaugh, Peter/0000-0002-0888-2875; Cai, Jingwei/0000-0002-3626-3350	Nutrition Science Initiative; NIH [R01HL122593, R21CA227232, P30DK098722]; UCSF SSEW Initiative; Searle Scholars Program [SSP-2016-1352]; A*STAR; Pennsylvania Department of Health using Tobacco CURE funds; Burroughs Wellcome Fund; Damon Runyon Cancer Research Foundation [DRR-42-16]	Nutrition Science Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF SSEW Initiative; Searle Scholars Program; A*STAR(Agency for Science Technology & Research (A*STAR)); Pennsylvania Department of Health using Tobacco CURE funds; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Damon Runyon Cancer Research Foundation	We thank Jordan Bisanz and the rest of the Turnbaugh lab for advice and feedback, the UCSF Gnotobiotic Core staff (Jolie Ma and Kimberly Ly), K.C. Huang Stanford) for help with microscopy, and the CZ Biohub Sequencing Platform. This work was supported by the Nutrition Science Initiative, the NIH (R01HL122593, R21CA227232, and P30DK098722), the UCSF SSEW Initiative, and the Searle Scholars Program (SSP-2016-1352). Q.Y.A. was supported by A*STAR. A.D.P. is supported by the Pennsylvania Department of Health using Tobacco CURE funds. P.J.T. holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund, is a Chan Zuckerberg Biohub investigator, and is a Nadia's Gift Foundation Innovator supported, in part, by the Damon Runyon Cancer Research Foundation (DRR-42-16).	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bisanz JE, 2019, CELL HOST MICROBE, V26, P265, DOI 10.1016/j.chom.2019.06.013; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cai JW, 2017, ANAL CHEM, V89, P7900, DOI 10.1021/acs.analchem.7b00848; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2019, NAT METAB, V1, P34, DOI 10.1038/s42255-018-0017-4; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Cheng CW, 2019, CELL, V178, P1115, DOI 10.1016/j.cell.2019.07.048; Dalmasso G, 2014, GUT MICROBES, V5, P675, DOI 10.4161/19490976.2014.969989; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2; Earle KA, 2015, CELL HOST MICROBE, V18, P478, DOI 10.1016/j.chom.2015.09.002; Gohl DM, 2016, NAT BIOTECHNOL, V34, P942, DOI 10.1038/nbt.3601; Goldberg EL, 2020, NAT METAB, V2, P50, DOI 10.1038/s42255-019-0160-6; Hall KD, 2018, CURR OPIN CLIN NUTR, V21, P308, DOI 10.1097/MCO.0000000000000470; Hall KD, 2016, AM J CLIN NUTR, V104, P324, DOI 10.3945/ajcn.116.133561; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Johansson MEV, 2012, METHODS MOL BIOL, V842, P229, DOI 10.1007/978-1-61779-513-8_13; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kubinak JL, 2015, CELL HOST MICROBE, V17, P153, DOI 10.1016/j.chom.2014.12.009; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Kverneland M, 2015, EPILEPSY BEHAV, V53, P197, DOI 10.1016/j.yebeh.2015.10.021; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee YS, 2018, CELL, V172, P22, DOI 10.1016/j.cell.2017.12.025; Liu Hongyan, 2018, Epilepsia Open, V3, P9, DOI 10.1002/epi4.12098; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mardinoglu A, 2018, CELL METAB, V27, P559, DOI 10.1016/j.cmet.2018.01.005; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; Miyamoto J, 2019, P NATL ACAD SCI USA, V116, P23813, DOI 10.1073/pnas.1912573116; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Newman J.C., 2017, KETOGENIC DIET BHB I, DOI [10.1101/136226, DOI 10.1101/136226]; Newman JC, 2017, CELL METAB, V26, P547, DOI 10.1016/j.cmet.2017.08.004; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; Ni FF, 2016, SEIZURE-EUR J EPILEP, V38, P17, DOI 10.1016/j.seizure.2016.03.006; Olson CA, 2018, CELL, V173, P1728, DOI [10.1016/j.cell.2018.06.051, 10.1016/j.cell.2018.04.027]; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Powell N, 2017, NAT REV GASTRO HEPAT, V14, P143, DOI 10.1038/nrgastro.2016.191; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Sainsbury E, 2018, DIABETES RES CLIN PR, V139, P239, DOI 10.1016/j.diabres.2018.02.026; Sarafian MH, 2015, ANAL CHEM, V87, P9662, DOI 10.1021/acs.analchem.5b01556; Saslow LR, 2017, NUTR DIABETES, V7, DOI 10.1038/s41387-017-0006-9; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Silverman JD, 2017, ELIFE, V6, DOI 10.7554/eLife.21887; Tan TG, 2016, P NATL ACAD SCI USA, V113, pE8141, DOI 10.1073/pnas.1617460113; Tian Y, 2019, DRUG METAB DISPOS, V47, P86, DOI 10.1124/dmd.118.083691; Tian Y, 2018, J FUNCT FOODS, V45, P223, DOI 10.1016/j.jff.2018.04.008; Tognini P, 2017, CELL METAB, V26, P523, DOI 10.1016/j.cmet.2017.08.015; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Volek JS, 2009, LIPIDS, V44, P297, DOI 10.1007/s11745-008-3274-2; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Zheng XJ, 2013, METABOLOMICS, V9, P818, DOI 10.1007/s11306-013-0500-6	60	152	160	49	199	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2020	181	6					1263	+		10.1016/j.cell.2020.04.027	http://dx.doi.org/10.1016/j.cell.2020.04.027			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LY9TE	32437658	Bronze, Green Accepted			2022-12-28	WOS:000540869600010
J	Minard-Colin, V; Auperin, A; Pillon, M; Burke, GAA; Barkauskas, DA; Wheatley, K; Delgado, RF; Alexander, S; Uyttebroeck, A; Bollard, CM; Zsiros, J; Csoka, M; Kazanowska, B; Chiang, AK; Miles, RR; Wotherspoon, A; Adamson, PC; Vassal, G; Patte, C; Gross, TG				Minard-Colin, Veronique; Auperin, Anne; Pillon, Marta; Burke, G. A. Amos; Barkauskas, Donald A.; Wheatley, Keith; Delgado, Rafael F.; Alexander, Sarah; Uyttebroeck, Anne; Bollard, Catherine M.; Zsiros, Jozsef; Csoka, Monika; Kazanowska, Bernarda; Chiang, Alan K.; Miles, Rodney R.; Wotherspoon, Andrew; Adamson, Peter C.; Vassal, Gilles; Patte, Catherine; Gross, Thomas G.		European Intergrp Childhood Non-Ho	Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRIMARY MALIGNANCIES; ADOLESCENTS; INTERMEDIATE; LEUKEMIA; BFM; AL	BACKGROUND Rituximab added to chemotherapy prolongs survival among adults with B-cell cancer. Data on its efficacy and safety in children with high-grade, mature B-cell non-Hodgkin's lymphoma are limited. METHODS We conducted an open-label, international, randomized, phase 3 trial involving patients younger than 18 years of age with high-risk, mature B-cell non-Hodgkin's lymphoma (stage III with an elevated lactate dehydrogenase level or stage IV) or acute leukemia to compare the addition of six doses of rituximab to standard lymphomes malins B (LMB) chemotherapy with standard LMB chemotherapy alone. The primary end point was event-free survival. Overall survival and toxic effects were also assessed. RESULTS Analyses were based on 328 patients who underwent randomization (164 patients per group); 85.7% of the patients had Burkitt's lymphoma. The median follow-up was 39.9 months. Events were observed in 10 patients in the rituximab-chemotherapy group and in 28 in the chemotherapy group. Event-free survival at 3 years was 93.9% (95% confidence interval [CI], 89.1 to 96.7) in the rituximab-chemotherapy group and 82.3% (95% CI, 75.7 to 87.5) in the chemotherapy group (hazard ratio for primary refractory disease or first occurrence of progression, relapse after response, death from any cause, or second cancer, 0.32; 95% CI, 0.15 to 0.66; one-sided P=0.00096, which reached the significance level required for this analysis). Eight patients in the rituximab-chemotherapy group died (4 deaths were disease-related, 3 were treatment-related, and 1 was from a second cancer), as did 20 in the chemotherapy group (17 deaths were disease-related, and 3 were treatment-related) (hazard ratio, 0.36; 95% CI, 0.16 to 0.82). The incidence of acute adverse events of grade 4 or higher after prephase treatment was 33.3% in the rituximab-chemotherapy group and 24.2% in the chemotherapy group (P=0.07); events were related mainly to febrile neutropenia and infection. Approximately twice as many patients in the rituximab-chemotherapy group as in the chemotherapy group had a low IgG level 1 year after trial inclusion. CONCLUSIONS Rituximab added to standard LMB chemotherapy markedly prolonged event-free survival and overall survival among children and adolescents with high-grade, high-risk, mature B-cell non-Hodgkin's lymphoma and was associated with a higher incidence of hypogammaglobulinemia and, potentially, more episodes of infection.	[Minard-Colin, Veronique; Patte, Catherine] Univ Paris Saclay, Gustave Roussy, Dept Pediat & Adolescent Oncol, Villejuif, France; [Vassal, Gilles] Univ Paris Saclay, Gustave Roussy, Dept Clin Res, Villejuif, France; [Minard-Colin, Veronique] Univ Paris Saclay, Gustave Roussy, INSERM, Unite 1015, Villejuif, France; [Auperin, Anne] Univ Paris Saclay, Gustave Roussy, Unit Biostat & Epidemiol, Villejuif, France; [Auperin, Anne] Univ Paris Saclay, Gustave Roussy, INSERM, Unite 1018, Villejuif, France; [Pillon, Marta] Univ Padua, Dept Pediat Hematol & Oncol, Padua, Italy; [Burke, G. A. Amos] Cambridge Univ Hosp NHS Fdn Trust, Dept Paediat Haematol Oncol & Palliat Care, Addenbrookes Hosp, Cambridge, England; [Wheatley, Keith] Univ Birmingham, Canc Res UK Clin Trials Unit, Inst Canc & Genom Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Wotherspoon, Andrew] Royal Marsden NHS Fdn Trust, Dept Histopathol, London, England; [Barkauskas, Donald A.] Univ Southern Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90007 USA; [Delgado, Rafael F.] Univ Valencia, Dept Pediat Hematol & Oncol, Valencia, Spain; [Alexander, Sarah] Hosp Sick Children, Div Haematol Oncol, Toronto, ON, Canada; [Uyttebroeck, Anne] Univ Hosp Leuven, Dept Pediat Hematol & Oncol, Leuven, Belgium; [Bollard, Catherine M.] Childrens Natl Hlth Syst, Ctr Canc & Immunol Res, Washington, DC USA; [Bollard, Catherine M.] George Washington Univ, Washington, DC USA; [Zsiros, Jozsef] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands; [Csoka, Monika] Semmelweis Univ, Dept Pediat Hematol & Oncol, Budapest, Hungary; [Kazanowska, Bernarda] Wroclaw Med Univ, Dept Pediat Bone Marrow Transplantat Oncol & Hema, Wroclaw, Poland; [Chiang, Alan K.] Univ Hong Kong, Dept Pediat & Adolescent Med, Li Ka Shing Fac Med, Queen Mary Hosp, Hong Kong, Peoples R China; [Miles, Rodney R.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Adamson, Peter C.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Gross, Thomas G.] NCI, Ctr Global Hlth, Rockville, MD USA	UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; University of Padua; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cancer Research UK; University of Birmingham; Royal Marsden NHS Foundation Trust; University of Southern California; University of Valencia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); KU Leuven; University Hospital Leuven; Children's National Health System; George Washington University; Semmelweis University; Wroclaw Medical University; University of Hong Kong; Utah System of Higher Education; University of Utah; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Minard-Colin, V (corresponding author), Gustave Roussy, 114 Rue Edouard Vaillant, F-94805 Villejuif, France.	veronique.minard@gustaveroussy.fr	Astigarraga, I/I-1215-2014; Pillon, Marta/AAB-9581-2022; Burke, Amos/AAT-1358-2021; Csoka, Monika/AAT-8832-2021	Astigarraga, I/0000-0002-5012-0137; Pillon, Marta/0000-0002-1190-3198; Burke, Amos/0000-0003-2671-9972; Bollard, Catherine M./0000-0001-5140-9090; Nagasubramanian, Ramamoorthy/0000-0003-4629-3139; Minard-Colin, Veronique/0000-0002-0296-5207; Reis, AlessanRSS/0000-0001-8486-7469; Razzouk, Bassem/0000-0003-0536-6135; dandapani, madhumita/0000-0001-8444-6007; paillard, catherine/0000-0003-1662-5446; Kram, David/0000-0002-1928-001X; LENDINEZ-MOLINOS, FRANCISCO/0000-0002-1597-636X; Kazanowska, Bernarda/0000-0002-7198-9122	Clinical Research Hospital Program of the French Ministry of Health [PHRC2010]; Cancer Research UK; Clinical Research Hospital Program of the French Ministry of Health; National Institute for Health Research Clinical Research Network; Children's Cancer Foundation Hong Kong; U.S. National Cancer Institute [U10CA180886, U10CA180899]; F. Hoffmann-La RocheGenentech	Clinical Research Hospital Program of the French Ministry of Health; Cancer Research UK(Cancer Research UK); Clinical Research Hospital Program of the French Ministry of Health; National Institute for Health Research Clinical Research Network; Children's Cancer Foundation Hong Kong; U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); F. Hoffmann-La RocheGenentech(Hoffmann-La RocheRoche HoldingGenentech)	Supported by a grant (PHRC2010) from the Clinical Research Hospital Program of the French Ministry of Health, by Cancer Research UK, the National Institute for Health Research Clinical Research Network, and Children's Cancer Foundation Hong Kong, by grants (U10CA180886 and U10CA180899) from the U.S. National Cancer Institute, and by F. Hoffmann-La RocheGenentech.	[Anonymous], 2019, INT J GYNECOL CANCER, V29(Suppl4, pA1; Barth MJ, 2013, BRIT J HAEMATOL, V162, P678, DOI 10.1111/bjh.12434; Cairo MS, 2007, BLOOD, V109, P2736, DOI 10.1182/blood-2006-07-036665; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Ehrhardt MJ, 2019, J CLIN ONCOL, V37, P2556, DOI 10.1200/JCO.19.00525; Fleury I, 2016, ANN ONCOL, V27, P390, DOI 10.1093/annonc/mdv616; Goldman S, 2013, LEUKEMIA, V27, P1174, DOI 10.1038/leu.2012.255; Havelange V, 2016, BRIT J HAEMATOL, V173, P137, DOI 10.1111/bjh.13925; Kusumoto S, 2019, BLOOD, V133, P137, DOI 10.1182/blood-2018-04-848044; Lopez C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08578-3; Meinhardt A, 2010, J CLIN ONCOL, V28, P3115, DOI 10.1200/JCO.2009.26.6791; Minard-Colin V, 2011, ANN ONCOL, V22, P112; Minard-Colin V, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.10507; Minard-Colin V, 2015, J CLIN ONCOL, V33, P2963, DOI 10.1200/JCO.2014.59.5827; Patte C, 2007, BLOOD, V109, P2773, DOI 10.1182/blood-2006-07-036673; Patte C, 2010, PEDIATR BLOOD CANCER, V55, P795; Pearson ADJ, 2019, EUR J CANCER, V110, P74, DOI 10.1016/j.ejca.2019.01.013; Ribrag V, 2016, LANCET, V387, P2402, DOI 10.1016/S0140-6736(15)01317-3; Tao L, 2017, BRIT J HAEMATOL, V178, P72, DOI 10.1111/bjh.14638; Tout M, 2017, BLOOD, V129, P2616, DOI 10.1182/blood-2016-10-744292; Woessmann W, 2005, BLOOD, V105, P948, DOI 10.1182/blood-2004-03-0973	21	66	70	3	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2020	382	23					2207	2219		10.1056/NEJMoa1915315	http://dx.doi.org/10.1056/NEJMoa1915315			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV0NI	32492302	Green Accepted, Bronze			2022-12-28	WOS:000538140600014
J	Christopher, E				Christopher, Edward			Open access journals: what you should know	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												ech39@outlook.com						Beall J, 2012, NATURE, V489, P179, DOI 10.1038/489179a; Coalition S, PLAN S; Crawford Walt, 2018, GOAJ3 GOLD OPEN ACCE; DeVito NJ, 2019, BMJ EVID-BASED MED, V24, P53, DOI 10.1136/bmjebm-2018-111107; DYER O, 2019, BMJ-BRIT MED J, V367, DOI DOI 10.1136/BMJ.L7064; Elsevier, PREDATORY VS TRUSTWO; NIHR, 2019, NIHR GIV SUPP INT OP; Shamseer L, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0785-9; Suber P, 2013, GUARDIAN; Tennant Jonathan P, 2016, F1000Res, V5, P632; UK Research and Innovation, OP ACC POL; Wang XW, 2015, SCIENTOMETRICS, V103, P555, DOI 10.1007/s11192-015-1547-0	12	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2020	369								m1057	10.1136/bmj.m1057	http://dx.doi.org/10.1136/bmj.m1057			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1WU	32493698				2022-12-28	WOS:000548578300007
J	Mahase, E				Mahase, Elisabeth			Covid-19: Physical distancing of at least one metre is linked to large reduction in infection	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Schunemann H.J., 2020, LANCET	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2020	369								m2211	10.1136/bmj.m2211	http://dx.doi.org/10.1136/bmj.m2211			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1WU	32493692	Bronze			2022-12-28	WOS:000548578300006
J	O'Dowd, A				O'Dowd, Adrian			Covid-19: Easing lockdown could risk second spike, say public health doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2020	369								m2193	10.1136/bmj.m2193	http://dx.doi.org/10.1136/bmj.m2193			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0KV	32487515	Bronze			2022-12-28	WOS:000548476700012
J	von Dach, E; Albrich, WC; Brunel, AS; Prendki, V; Cuvelier, C; Flury, D; Gayet-Ageron, A; Huttner, B; Kohler, P; Lemmenmeier, E; McCallin, S; Rossel, A; Harbarth, S; Kaiser, L; Bochud, PY; Huttner, A				von Dach, Elodie; Albrich, Werner C.; Brunel, Anne-Sophie; Prendki, Virginie; Cuvelier, Clemence; Flury, Domenica; Gayet-Ageron, Angele; Huttner, Benedikt; Kohler, Philipp; Lemmenmeier, Eva; McCallin, Shawna; Rossel, Anne; Harbarth, Stephan; Kaiser, Laurent; Bochud, Pierre-Yves; Huttner, Angela			Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROCALCITONIN; MULTICENTER; THERAPY; INFECTION; SEPSIS	Key PointsQuestionDoes antibiotic treatment with C-reactive protein (CRP)-guided duration or fixed 7-day duration, compared with fixed 14-day duration, provide noninferior clinical failure rates in patients with uncomplicated gram-negative bacteremia? FindingsIn this randomized clinical trial that included 504 adults with uncomplicated gram-negative bacteremia, 30-day clinical failure occurred in 2.4% of patients assigned to receive CRP-guided antibiotic treatment duration, 6.6% assigned to 7-day treatment, and 5.5% assigned to 14-day treatment. The differences between CRP-guided treatment and 7-day treatment compared with 14-day treatment met the noninferiority criterion of 10%, but adherence to the CRP strategy or planned follow-up did not occur in 23% of patients. MeaningCRP-guided treatment and 7-day treatment were noninferior to 14-day treatment in patients with uncomplicated gram-negative bacteremia, but interpretation is limited by the large noninferiority margin compared with the low observed event rate and lower adherence in the CRP-guided group. ImportanceAntibiotic overuse drives antibiotic resistance. Gram-negative bacteremia is a common infection that results in substantial antibiotic use. ObjectiveTo compare the clinical effectiveness of C-reactive protein (CRP)-guided, 7-day, and 14-day antibiotic durations 30, 60, and 90 days after treatment initiation. Design, Setting, and ParticipantsMulticenter, noninferiority, point-of-care randomized clinical trial including adults hospitalized with gram-negative bacteremia conducted in 3 Swiss tertiary care hospitals between April 2017 and May 2019, with follow-up until August 2019. Patients and physicians were blinded between randomization and antibiotic discontinuation. Adults (aged >= 18 years) were eligible for randomization on day 5 (1 d) of microbiologically efficacious therapy for fermenting, gram-negative bacteria in blood culture(s) if they were afebrile for 24 hours without evidence for complicated infection (eg, abscess) or severe immunosuppression. InterventionRandomization in a 1:1:1 ratio to an individualized CRP-guided antibiotic treatment duration (discontinuation once CRP declined by 75% from peak; n=170), fixed 7-day treatment duration (n=169), or fixed 14-day treatment duration (n=165). Main Outcomes and MeasuresThe primary outcome was the clinical failure rate at day 30, defined as the presence of at least 1 of the following, with a non-inferiority margin of 10%: recurrent bacteremia, local suppurative complication, distant complication (growth of the same organism causing the initial bacteremia), restarting gram-negative-directed antibiotic therapy due to clinical worsening suspected to be due to the initial organism, or death due to any cause. Secondary outcomes included the clinical failure rate on day 90 of follow-up. ResultsAmong 504 patients randomized (median [interquartile range] age, 79 [68-86] years; 306 of 503 [61%] were women), 493 (98%) completed 30-day follow-up and 448 (89%) completed 90-day follow-up. Median antibiotic duration in the CRP group was 7 (interquartile range, 6-10; range, 5-28) days; 34 of the 164 patients (21%) who completed the 30-day follow-up had protocol violations related to treatment assignment. The primary outcome occurred in 4 of 164 (2.4%) patients in the CRP group, 11 of 166 (6.6%) in the 7-day group, and 9 of 163 (5.5%) in the 14-day group (difference in CRP vs 14-day group, -3.1% [1-sided 97.5% CI, -infinity to 1.1]; P<.001; difference in 7-day vs 14-day group, 1.1% [1-sided 97.5% CI, -<infinity> to 6.3]; P<.001). By day 90, clinical failure occurred in 10 of 143 patients (7.0%) in the CRP group, 16 of 151 (10.6%) in the 7-day group, and 16 of 153 (10.5%) in the 14-day group. Conclusions and RelevanceAmong adults with uncomplicated gram-negative bacteremia, 30-day rates of clinical failure for CRP-guided antibiotic treatment duration and fixed 7-day treatment were noninferior to fixed 14-day treatment. However, interpretation is limited by the large noninferiority margin compared with the low observed event rate, as well as low adherence and wide range of treatment durations in the CRP-guided group. Trial RegistrationClinicalTrials.gov Identifier: NCT03101072 This randomized trial compares the effects of C-reactive protein (CRP)-guided antibiotic duration (discontinuation once CRP declined by 75% of peak value) vs fixed 7- vs 14-day durations on 30-day clinical failure rate among patients with gram-negative bacteremia.	[von Dach, Elodie; Huttner, Benedikt; McCallin, Shawna; Harbarth, Stephan; Kaiser, Laurent; Huttner, Angela] Geneva Univ Hosp, Fac Med, Div Infect Dis, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland; [von Dach, Elodie; Gayet-Ageron, Angele] Geneva Univ Hosp, Fac Med, Clin Res Ctr, Geneva, Switzerland; [Albrich, Werner C.; Flury, Domenica; Kohler, Philipp; Lemmenmeier, Eva] Cantonal Hosp St Gallen, Div Infect Dis & Hosp Epidemiol, St Gallen, Switzerland; [Brunel, Anne-Sophie; Bochud, Pierre-Yves] Univ Lausanne, Univ Hosp, Infect Dis Serv, Lausanne, Switzerland; [Prendki, Virginie; Cuvelier, Clemence] Geneva Univ Hosp, Fac Med, Div Internal Med Aged, Geneva, Switzerland; [Gayet-Ageron, Angele] Geneva Univ Hosp, Dept Hlth & Community Med, Div Clin Epidemiol, Geneva, Switzerland; [Rossel, Anne] Geneva Univ Hosp, Dept Internal Med, Geneva, Switzerland	University of Geneva; University of Geneva; Kantonsspital St. Gallen; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Geneva; University of Geneva	Huttner, A (corresponding author), Geneva Univ Hosp, Fac Med, Div Infect Dis, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland.	angela.huttner@hcuge.ch	Huttner, Benedikt/M-5616-2014; Bochud, Pierre-Yves/ABE-5979-2020; Prendki, Virginie/ABI-1378-2020; Rossel, Anne/GQI-2225-2022	Huttner, Benedikt/0000-0002-1749-9464; Kohler, Philipp/0000-0003-0427-8934; Bochud, Pierre-Yves/0000-0002-2208-4757; Kaiser, Laurent/0000-0002-0857-2252; Gayet-Ageron, Angele/0000-0002-6164-9693; Rossel, Anne/0000-0001-7367-2340	National Science Foundation (National Research Program 74 "Smarter Health Care" grant) [407440_167359]	National Science Foundation (National Research Program 74 "Smarter Health Care" grant)(National Science Foundation (NSF))	The study was funded by the Swiss National Science Foundation (National Research Program 74 "Smarter Health Care" grant No. 407440_167359).	Albrich WC, 2015, INTENS CARE MED, V41, P1739, DOI 10.1007/s00134-015-3978-8; Angus DC, 2016, CRIT CARE MED, V44, pE113, DOI 10.1097/CCM.0000000000001730; Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13; Bouadma L, 2010, LANCET, V375, P463, DOI 10.1016/S0140-6736(09)61879-1; Chotiprasitsakul D, 2018, CLIN INFECT DIS, V66, P172, DOI 10.1093/cid/cix767; de Jong E, 2016, LANCET INFECT DIS, V16, P819, DOI 10.1016/S1473-3099(16)00053-0; Fitzpatrick JM, 2016, CLIN MICROBIOL INFEC, V22, P244, DOI 10.1016/j.cmi.2015.10.034; Fuchs BB, 2018, FUTURE MICROBIOL, V13, P1537, DOI 10.2217/fmb-2018-0157; Huttner A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017996; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P492, DOI 10.1111/1469-0691.12144; Lin KH, 2014, DIAGN MICR INFEC DIS, V80, P72, DOI 10.1016/j.diagmicrobio.2014.03.029; Oliveira CF, 2013, CRIT CARE MED, V41, P2336, DOI 10.1097/CCM.0b013e31828e969f; PITTET D, 1993, EUR J CLIN MICROBIOL, V12, P813, DOI 10.1007/BF02000400; Sandberg T, 2012, LANCET, V380, P484, DOI 10.1016/S0140-6736(12)60608-4; Spellberg B, 2012, CLIN INFECT DIS, V55, P1031, DOI 10.1093/cid/cis688; Tellier G, 2004, J ANTIMICROB CHEMOTH, V54, P515, DOI 10.1093/jac/dkh356; US Food and Drug Administration, 2016, GUID IND COLL RAC ET; Ward Caroline, 2018, BMJ Open Qual, V7, pe000391, DOI 10.1136/bmjoq-2018-000391; Yahav D, 2019, CLIN INFECT DIS, V69, P1091, DOI 10.1093/cid/ciy1054	19	62	62	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2020	323	21					2160	2169		10.1001/jama.2020.6348	http://dx.doi.org/10.1001/jama.2020.6348			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LY8YS	32484534	Bronze, Green Published			2022-12-28	WOS:000540816000020
J	Mahase, E				Mahase, Elisabeth			Covid-19: UK government's defence of senior aide has damaged public and NHS confidence, say experts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Philpotts E, 2020, 300 GPS URGE POLICE	1	6	6	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2020	369								m2109	10.1136/bmj.m2109	http://dx.doi.org/10.1136/bmj.m2109			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JX	32461219	Bronze			2022-12-28	WOS:000538337100013
J	Stokel-Walker, C				Stokel-Walker, Chris			Physician Moms Group: the support network that's needed more than ever during the covid-19 pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												stokel@gmail.com							0	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2020	369								m1499	10.1136/bmj.m1499	http://dx.doi.org/10.1136/bmj.m1499			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JW	32457097	Bronze			2022-12-28	WOS:000538337000002
J	Belkin, G				Belkin, Gary			Leadership for the Social Climate	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Our ability to implement the necessary responses to adapt to or mitigate climate and ecologic change, endure its consequences, and turn ambitious policy into results will depend on the social and emotional resilience and involvement of people and communities.	[Belkin, Gary] Harvard TH Chan Sch Publ Hlth, Ctr Climate Hlth & Global Environm C CHANGE, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health	Belkin, G (corresponding author), Harvard TH Chan Sch Publ Hlth, Ctr Climate Hlth & Global Environm C CHANGE, Boston, MA USA.							Di Marco M, 2020, P NATL ACAD SCI USA, V117, P3888, DOI 10.1073/pnas.2001655117; Doppelt B., 2017, TRANSFORMATIONAL RES; Hayes K, 2018, INT J MENT HEALTH SY, V12, DOI 10.1186/s13033-018-0210-6; Patel V, 2018, LANCET, V392, P1553, DOI 10.1016/S0140-6736(18)31612-X; Salas RN, 2019, NEW ENGL J MED, V381, P773, DOI 10.1056/NEJMe1909957	5	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2020	382	21					1975	1977		10.1056/NEJMp2001507	http://dx.doi.org/10.1056/NEJMp2001507			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LT1TD	32433837				2022-12-28	WOS:000536856000011
J	Lin, YH; Leibrandt, DR; Leibfriedz, D; Chou, CW				Lin, Yiheng; Leibrandt, David R.; Leibfriedz, Dietrich; Chou, Chin-wen			Quantum entanglement between an atom and a molecule	NATURE			English	Article							STATE DETECTION; SPECTROSCOPY; GENERATION; MANIPULATION; TRANSITION; DYNAMICS	Conventional information processors convert information between different physical carriers for processing, storage and transmission. It seems plausible that quantum information will also be held by different physical carriers in applications such as tests of fundamental physics, quantum enhanced sensors and quantum information processing. Quantum controlled molecules, in particular, could transduce quantum information across a wide range of quantum bit (qubit) frequencies-from a few kilohertz for transitions within the same rotational manifold(1), a few gigahertz for hyperfine transitions, a few terahertz for rotational transitions, to hundreds of terahertz for fundamental and overtone vibrational and electronic transitions-possibly all within the same molecule. Here we demonstrate entanglement between the rotational states of a (CaH+)-Ca-40 molecular ion and the internal states of a Ca-40(+) atomic ion(2). We extend methods used in quantum logic spectroscopy(1,3) for pure-state initialization, laser manipulation and state readout of the molecular ion. The quantum coherence of the Coulomb coupled motion between the atomic and molecular ions enables subsequent entangling manipulations. The qubit addressed in the molecule has a frequency of either 13.4 kilohertz(1) or 855 gigahertz(3), highlighting the versatility of molecular qubits. Our work demonstrates how molecules can transduce quantum information between qubits with different frequencies to enable hybrid quantum systems. We anticipate that our method of quantum control and measurement of molecules will find applications in quantum information science, quantum sensors, fundamental and applied physics, and controlled quantum chemistry. Quantum entanglement is realized between rotational levels of a molecular ion with energy differences spanning several orders of magnitude and long-lived internal states of a single atomic ion.	[Lin, Yiheng] Univ Sci & Technol China, Dept Modern Phys, CAS Key Lab Microscale Magnet Resonance, Hefei, Peoples R China; [Lin, Yiheng; Leibrandt, David R.; Leibfriedz, Dietrich; Chou, Chin-wen] NIST, Time & Frequency Div, Boulder, CO 80305 USA; [Lin, Yiheng] Univ Sci & Technol China, Hefei Natl Lab PhysicalSci Microscale, Hefei, Peoples R China; [Lin, Yiheng] Univ Sci & Technol China, Synerget Innovat Ctr Quantum Informat & Quantum P, Hefei, Peoples R China; [Leibrandt, David R.; Leibfriedz, Dietrich] Univ Colorado, Dept Phys, Boulder, CO 80309 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; National Institute of Standards & Technology (NIST) - USA; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Colorado System; University of Colorado Boulder	Lin, YH (corresponding author), Univ Sci & Technol China, Dept Modern Phys, CAS Key Lab Microscale Magnet Resonance, Hefei, Peoples R China.; Lin, YH (corresponding author), NIST, Time & Frequency Div, Boulder, CO 80305 USA.; Lin, YH (corresponding author), Univ Sci & Technol China, Hefei Natl Lab PhysicalSci Microscale, Hefei, Peoples R China.; Lin, YH (corresponding author), Univ Sci & Technol China, Synerget Innovat Ctr Quantum Informat & Quantum P, Hefei, Peoples R China.	yiheng@ustc.edu.cn		Leibrandt, David Ray/0000-0003-1452-4879	Intramural NIST DOC [9999-NIST] Funding Source: Medline	Intramural NIST DOC		Alighanbari S, 2018, NAT PHYS, V14, P555, DOI 10.1038/s41567-018-0074-3; Altuntas E, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.142501; Andreev V, 2018, NATURE, V562, P355, DOI 10.1038/s41586-018-0599-8; Ballance CJ, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.060504; Bartels A, 2004, OPT LETT, V29, P1081, DOI 10.1364/OL.29.001081; Bermudez A, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.041061; Bernien H, 2017, NATURE, V551, P579, DOI 10.1038/nature24622; Biesheuvel J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10385; Bohnet JG, 2016, SCIENCE, V352, P1297, DOI 10.1126/science.aad9958; Cairncross WB, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.153001; Campbell W. C., 2019, DIPOLE PHONON QUANTU; Cheuk L. W, 2020, OBSERVATION COLLISIO; Chou CW, 2020, SCIENCE, V367, P1458, DOI 10.1126/science.aba3628; Chou CW, 2017, NATURE, V545, P203, DOI 10.1038/nature22338; DeMille D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.067901; Ding S, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023028; Gaebler JP, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.060505; Hu MG, 2019, SCIENCE, V366, P1111, DOI 10.1126/science.aay9531; Hudson ER, 2018, PHYS REV A, V98, DOI 10.1103/PhysRevA.98.040302; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; Kozyryev I, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.133002; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; Leibfried D, 2005, NATURE, V438, P639, DOI 10.1038/nature04251; Leibfried D, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023029; Levine H, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.123603; Liu LR, 2018, SCIENCE, V360, P900, DOI 10.1126/science.aar7797; Luo XY, 2017, SCIENCE, V355, P620, DOI 10.1126/science.aag1106; McConnell R, 2015, NATURE, V519, P439, DOI 10.1038/nature14293; Merkel B, 2019, REV SCI INSTRUM, V90, DOI 10.1063/1.5080093; Moses SA, 2017, NAT PHYS, V13, P13, DOI 10.1038/nphys3985; Ni KK, 2018, CHEM SCI, V9, P6830, DOI 10.1039/c8sc02355g; Nie XR, 2009, PHYS LETT A, V373, P422, DOI 10.1016/j.physleta.2008.11.045; Omran A, 2019, SCIENCE, V365, P570, DOI 10.1126/science.aax9743; Ospelkaus S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.030402; Park JW, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.205302; Reinaudi G, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.115303; Roos C, 1999, PHYS REV LETT, V83, P4713, DOI 10.1103/PhysRevLett.83.4713; Roos CF, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.040302; Roos CF, 2000, PHYS REV LETT, V85, P5547, DOI 10.1103/PhysRevLett.85.5547; Rugango R, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/3/035009; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Safronova MS, 2018, REV MOD PHYS, V90, DOI 10.1103/RevModPhys.90.025008; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Schuster DI, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.012311; Sinhal M, 2020, SCIENCE, V367, P1213, DOI 10.1126/science.aaz9837; Truppe S, 2017, NAT PHYS, V13, P1173, DOI 10.1038/NPHYS4241; Wolf F, 2016, NATURE, V530, P457, DOI 10.1038/nature16513; Yan B, 2013, NATURE, V501, P521, DOI 10.1038/nature12483; Yang H, 2019, SCIENCE, V363, P261, DOI 10.1126/science.aau5322	50	30	30	11	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY	2020	581	7808					273	+		10.1038/s41586-020-2257-1	http://dx.doi.org/10.1038/s41586-020-2257-1			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ2CZ	32433622	Green Accepted, Green Submitted			2022-12-28	WOS:000534818200009
J	Washington, HA				Washington, Harriet A.			How environmental racism fuels pandemics	NATURE			English	Editorial Material						Society; Medical research		Toxic living conditions have long inflated death rates. Scientists must learn to track these patterns of inequality. Toxic living conditions have long inflated death rates. Scientists must learn to track these patterns of inequality.				hw2140@columbia.edu							0	14	15	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY	2020	581	7808					241	241		10.1038/d41586-020-01453-y	http://dx.doi.org/10.1038/d41586-020-01453-y			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP3YY	32427915	Bronze			2022-12-28	WOS:000534256000001
J	Whitcroft, KL; Hummel, T				Whitcroft, Katherine Lisa; Hummel, Thomas			Olfactory Dysfunction in COVID-19 Diagnosis and Management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Whitcroft, Katherine Lisa; Hummel, Thomas] Tech Univ Dresden, Smell & Taste Clin, Dept Otorhinolaryngol, Fetscherstr 74, D-01307 Dresden, Germany; [Whitcroft, Katherine Lisa] UCL, UCL Ear Inst, London, England	Technische Universitat Dresden; University of London; University College London	Hummel, T (corresponding author), Tech Univ Dresden, Smell & Taste Clin, Dept Otorhinolaryngol, Fetscherstr 74, D-01307 Dresden, Germany.	thummel@msx.tu-dresden.de						American Academy of Otolaryngology-Head and Neck Surgery, 2020, AN HYP DYSG SYMPT CO; [Anonymous], SYMPT COR; Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330; Hopkins C, 2020, LOSS SENSE SMELL MAR; Moein ST, 2020, INT FORUM ALLERGY RH, V10, P944, DOI 10.1002/alr.22587; Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08; Spinato G, 2020, JAMA-J AM MED ASSOC, V323, P2089, DOI 10.1001/jama.2020.6771; Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6; Whitcroft KL, 2019, JAMA OTOLARYNGOL, V145, P846, DOI 10.1001/jamaoto.2019.1728; Yan CH, 2020, NEUROSURGERY, V87, pE91, DOI 10.1093/neuros/nyz559	10	157	161	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2512	2514		10.1001/jama.2020.8391	http://dx.doi.org/10.1001/jama.2020.8391			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32432682	Bronze			2022-12-28	WOS:000590149400023
J	Slosky, LM; Bai, YS; Toth, K; Ray, C; Rochelle, LK; Badea, A; Chandrasekhar, R; Pogorelov, VM; Abraham, DM; Atluri, N; Peddibhotla, S; Hedrick, MP; Hershberger, P; Maloney, P; Yuan, H; Li, ZB; Wetsel, WC; Pinkerton, AB; Barak, LS; Caron, MG				Slosky, Lauren M.; Bai, Yushi; Toth, Krisztian; Ray, Caroline; Rochelle, Lauren K.; Badea, Alexandra; Chandrasekhar, Rahul; Pogorelov, Vladimir M.; Abraham, Dennis M.; Atluri, Namratha; Peddibhotla, Satyamaheshwar; Hedrick, Michael P.; Hershberger, Paul; Maloney, Patrick; Yuan, Hong; Li, Zibo; Wetsel, William C.; Pinkerton, Anthony B.; Barak, Lawrence S.; Caron, Marc G.			beta-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive Behaviors	CELL			English	Article							NEUROTENSIN GENE-EXPRESSION; PROTEIN-COUPLED RECEPTORS; NUCLEUS-ACCUMBENS; PREFRONTAL CORTEX; MICE LACKING; MOUSE-BRAIN; KINASE 2; DOPAMINE; COCAINE; AGONIST	Small molecule neurotensin receptor 1 (NTSR1) agonists have been pursued for more than 40 years as potential therapeutics for psychiatric disorders, including drug addiction. Clinical development of NTSR1 agonists has, however, been precluded by their severe side effects. NTSR1, a G protein-coupled receptor (GPCR), signals through the canonical activation of G proteins and engages beta-arrestins to mediate distinct cellular signaling events. Here, we characterize the allosteric NTSR1 modulator SBI-553. This small molecule not only acts as a beta-arrestin-biased agonist but also extends profound beta-arrestin bias to the endogenous ligand by selectively antagonizing G protein signaling. SBI-553 shows efficacy in animal models of psychostimulant abuse, including cocaine self-administration, without the side effects characteristic of balanced NTSR1 agonism. These findings indicate that NTSR1 G protein and beta-arrestin activation produce discrete and separable physiological effects, thus providing a strategy to develop safer GPCR-targeting therapeutics with more directed pharmacological action.	[Slosky, Lauren M.; Bai, Yushi; Toth, Krisztian; Ray, Caroline; Rochelle, Lauren K.; Chandrasekhar, Rahul; Atluri, Namratha; Wetsel, William C.; Barak, Lawrence S.; Caron, Marc G.] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Badea, Alexandra] Duke Univ, Brain Imaging & Anal Ctr, Dept Radiol, Durham, NC 27710 USA; [Badea, Alexandra] Duke Univ, Brain Imaging & Anal Ctr, Dept Neurol, Durham, NC 27710 USA; [Pogorelov, Vladimir M.; Wetsel, William C.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Abraham, Dennis M.] Duke Univ, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Abraham, Dennis M.] Duke Univ, Duke Cardiovasc Physiol Core, Durham, NC 27710 USA; [Wetsel, William C.; Caron, Marc G.] Duke Univ, Dept Neurobiol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Dept Med, Durham, NC 27710 USA; [Toth, Krisztian] Campbell Univ, Dept Pharmaceut Sci, Buies Creek, NC 27506 USA; [Peddibhotla, Satyamaheshwar; Hedrick, Michael P.; Hershberger, Paul; Maloney, Patrick; Pinkerton, Anthony B.] Sanford Burnham Prebys Med Discovery Inst, Conrad Prebys Ctr Chem Genom, La Jolla, CA 92037 USA; [Yuan, Hong; Li, Zibo] Univ North Carolina Chapel Hill, Biomed Res Imaging Ctr, Dept Radiol, Chapel Hill, NC 27599 USA; [Li, Zibo] Univ North Carolina Chapel Hill, UNC Linebarger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Campbell University; Sanford Burnham Prebys Medical Discovery Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Barak, LS; Caron, MG (corresponding author), Duke Univ, Dept Cell Biol, Durham, NC 27710 USA.; Caron, MG (corresponding author), Duke Univ, Dept Neurobiol, Durham, NC 27710 USA.; Caron, MG (corresponding author), Duke Univ, Dept Med, Durham, NC 27710 USA.; Pinkerton, AB (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Conrad Prebys Ctr Chem Genom, La Jolla, CA 92037 USA.	apinkerton@sbpdiscovery.org; lawrence.barak@duke.edu; marc.caron@duke.edu	Badea, Alexandra/ABC-8324-2020; , BRIC Small Animal Imaging Facility/AEV-1023-2022; Badea, Alexandra/S-6052-2016	Badea, Alexandra/0000-0001-6621-4560; , BRIC Small Animal Imaging Facility/0000-0002-0535-3214; Badea, Alexandra/0000-0001-6621-4560; Pinkerton, Anthony/0000-0003-4571-152X; Slosky, Lauren/0000-0002-9471-9117; Toth, Krisztian/0000-0002-6590-6394	Duke Center for In Vivo Microscopy [P41EB01589a, U24CA220245]; North Carolina Biotechnology Center; David Pall family part of the Long Island Community Foundation, a division of The New York Community Trust; UNC Biomedical Research Imaging Center (BRIC) [P30CA016086];  [F32DA043931];  [K99DA048970];  [1K01AG041211];  [K08HL125905-01];  [R21/33DA038019];  [P30DA029925];  [R37MH073853]	Duke Center for In Vivo Microscopy; North Carolina Biotechnology Center; David Pall family part of the Long Island Community Foundation, a division of The New York Community Trust; UNC Biomedical Research Imaging Center (BRIC); ; ; ; ; ; ; 	We thank Xiuqin Zhang and Wendy Roberts for managing our mouse colony, Dr. Ramona Rodriguiz for consulting on behavioral assessements, Dr. Asuka Inoue for providing TGFa shedding assay plasmids and cell lines, the UNC Biomedical Research Imaging Center (BRIC) (P30CA016086) for providing PET/CT imaging services, and the Duke Center for In Vivo Microscopy (P41EB01589a, U24CA220245) for supporting PET/CT image analysis. Equipment for studies conducted at the Duke Mouse Behavioral and Neuroendocrine Analysis Core Facility were supported by a grant from the North Carolina Biotechnology Center. We thank the Duke Cardiovascular Physiology Core and the Edna and Fred L. Mandel, Jr. Foundation for support in mouse cardiovascular phenotyping. For these studies, L.M.S. was supported by F32DA043931 and K99DA048970, A.B. by 1K01AG041211, D.M.A. by K08HL125905-01, A.B.P. by R21/33DA038019, L.S.B. and M.G.C. by P30DA029925, and M.G.C. by R37MH073853 and funds from the David Pall family part of the Long Island Community Foundation, a division of The New York Community Trust. We are grateful to Dr. Brigid Hogan for the critical reading of our manuscript.	Alvarez-Curto E, 2016, J BIOL CHEM, V291, P27147, DOI 10.1074/jbc.M116.754887; Anderson RJ, 2019, NEUROINFORMATICS, V17, P451, DOI 10.1007/s12021-018-9410-0; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Baicy K, 2007, ADDICTION, V102, P5, DOI 10.1111/j.1360-0443.2006.01777.x; Barak LS, 2016, ACS CHEM BIOL, V11, P1880, DOI 10.1021/acschembio.6b00291; Betancur C, 1997, MOL BRAIN RES, V44, P334, DOI 10.1016/S0169-328X(96)00289-6; Betancur C, 2001, NEUROPSYCHOPHARMACOL, V24, P170, DOI 10.1016/S0893-133X(00)00179-2; Binder EB, 2001, PHARMACOL REV, V53, P453; BISSETTE G, 1976, NATURE, V262, P607, DOI 10.1038/262607a0; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; BONETTI EP, 1982, PSYCHOPHARMACOLOGY, V78, P8, DOI 10.1007/BF00470579; Borroto-Escuela DO, 2013, BIOCHEM BIOPH RES CO, V435, P140, DOI 10.1016/j.bbrc.2013.04.058; Boules M, 2016, BEHAV PHARMACOL, V27, P236, DOI 10.1097/FBP.0000000000000227; Calabrese E, 2015, CEREB CORTEX, V25, P4628, DOI 10.1093/cercor/bhv121; Canals M, 2012, J BIOL CHEM, V287, P650, DOI 10.1074/jbc.M111.314278; Carey LM, 2017, DRUG DEVELOP RES, V78, P196, DOI 10.1002/ddr.21393; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Cathala L, 1997, J PHYSIOL-LONDON, V503, P87, DOI 10.1111/j.1469-7793.1997.087bi.x; Cervantes D, 2010, CIRC RES, V106, P79, DOI 10.1161/CIRCRESAHA.109.198580; Corrigan F, 2015, BRAIN BEHAV IMMUN, V45, P245, DOI 10.1016/j.bbi.2014.12.019; Deacon RMJ, 2013, JOVE-J VIS EXP, DOI 10.3791/2609; Evron T, 2014, J BIOL CHEM, V289, P33442, DOI 10.1074/jbc.M114.581397; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ferraro L, 2016, J PSYCHOPHARMACOL, V30, P112, DOI 10.1177/0269881115622240; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Green JL, 2015, BEHAV PHARMACOL, V26, P398, DOI 10.1097/FBP.0000000000000131; Griebel G, 2012, NAT REV DRUG DISCOV, V11, P462, DOI 10.1038/nrd3702; Groman SM, 2012, J NEUROSCI, V32, P5843, DOI 10.1523/JNEUROSCI.0029-12.2012; Grundmann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02661-3; Gulyas G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125601; Hefti FF, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S7; Ikeda M, 2007, GENES BRAIN BEHAV, V6, P107, DOI 10.1111/j.1601-183X.2006.00237.x; Inagaki S, 2015, BIOCHEMISTRY-US, V54, P4320, DOI 10.1021/acs.biochem.5b00285; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Kapur A, 2009, J BIOL CHEM, V284, P29817, DOI 10.1074/jbc.M109.050187; Khoury E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00068; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; King CP, 2016, PSYCHOPHARMACOLOGY, V233, P2593, DOI 10.1007/s00213-016-4306-x; Kitabgi P, 1992, Clin Neuropharmacol, V15 Suppl 1 Pt A, p313A; Kmiotek EK, 2012, JOVE-J VIS EXP, DOI 10.3791/3739; Lancelot S, 2010, TRENDS PHARMACOL SCI, V31, P411, DOI 10.1016/j.tips.2010.06.002; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Maccioni P, 2015, PSYCHOPHARMACOLOGY, V232, P3585, DOI 10.1007/s00213-015-4010-2; Mantsch JR, 2007, PSYCHOPHARMACOLOGY, V192, P581, DOI 10.1007/s00213-007-0754-7; McCorvy JD, 2018, NAT STRUCT MOL BIOL, V25, P787, DOI 10.1038/s41594-018-0116-7; Nehrenberg DL, 2009, BEHAV BRAIN RES, V201, P179, DOI 10.1016/j.bbr.2009.02.010; NEMEROFF CB, 1980, BIOL PSYCHIAT, V15, P283; O'Hayre M, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal3395; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Oneda B, 2011, PHARMACOGENOMICS J, V11, P258, DOI 10.1038/tpj.2010.37; OSBAHR AJ, 1979, EUR J PHARMACOL, V54, P299, DOI 10.1016/0014-2999(79)90090-6; Pack TF, 2018, J BIOL CHEM, V293, P6161, DOI 10.1074/jbc.RA117.001300; Parsegian A, 2014, NEUROPSYCHOPHARMACOL, V39, P811, DOI 10.1038/npp.2013.231; Peddibhotla S, 2013, ACS MED CHEM LETT, V4, P846, DOI 10.1021/ml400176n; Peterson SM, 2015, P NATL ACAD SCI USA, V112, P7097, DOI 10.1073/pnas.1502742112; Petrie KA, 2004, NEUROPSYCHOPHARMACOL, V29, P1878, DOI 10.1038/sj.npp.1300494; Pettibone DJ, 2002, J PHARMACOL EXP THER, V300, P305, DOI 10.1124/jpet.300.1.305; Pinkerton AB, 2019, J MED CHEM, V62, P8357, DOI 10.1021/acs.jmedchem.9b00340; Pitcher JA, 1998, J BIOL CHEM, V273, P12316, DOI 10.1074/jbc.273.20.12316; Porter-Stransky KA, 2017, J PHARMACOL EXP THER, V361, P341, DOI 10.1124/jpet.117.240622; Prus AJ, 2014, PROG NEURO-PSYCHOPH, V49, P78, DOI 10.1016/j.pnpbp.2013.11.011; Raehal KM, 2005, J PHARMACOL EXP THER, V314, P1195, DOI 10.1124/jpet.105.087254; Reimold M, 2006, J CEREBR BLOOD F MET, V26, P751, DOI 10.1038/sj.jcbfm.9600231; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Schiffmann SN, 2007, PROG NEUROBIOL, V83, P277, DOI 10.1016/j.pneurobio.2007.05.001; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Sharpe AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180710; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Smith J.S., 2019, NONCANONICAL SCAFFOL, DOI [10.1101/629576, DOI 10.1101/629576]; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Snyder JC, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0216-3; Sotnikova TD, 2005, PLOS BIOL, V3, P1488, DOI 10.1371/journal.pbio.0030271; St-Gelais F, 2004, J NEUROSCI, V24, P2566, DOI 10.1523/JNEUROSCI.5376-03.2004; St-Gelais F, 2006, J PSYCHIATR NEUROSCI, V31, P229; Stansley BJ, 2019, TRENDS PHARMACOL SCI, V40, P240, DOI 10.1016/j.tips.2019.02.006; Sun D, 2008, MOL PSYCHIATR, V13, P398, DOI 10.1038/sj.mp.4002036; Thanos PK, 2008, SYNAPSE, V62, P319, DOI 10.1002/syn.20503; Toth K, 2018, SYNAPSE, V72, DOI 10.1002/syn.22012; Urs NM, 2016, P NATL ACAD SCI USA, V113, pE8178, DOI 10.1073/pnas.1614347113; Urs NM, 2015, P NATL ACAD SCI USA, V112, pE2517, DOI 10.1073/pnas.1502740112; Urs NM, 2012, P NATL ACAD SCI USA, V109, P20732, DOI 10.1073/pnas.1215489109; Vadnie CA, 2014, NEUROPHARMACOLOGY, V85, P482, DOI 10.1016/j.neuropharm.2014.05.046; WATSON MA, 1992, J NEUROCHEM, V59, P1967, DOI 10.1111/j.1471-4159.1992.tb11035.x; Welch A, 2013, J NUCL MED, V54, P1946, DOI 10.2967/jnumed.113.121509; Willuhn I, 2010, CURR TOP BEHAV NEURO, V3, P29, DOI 10.1007/7854_2009_27; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; WU T, 1995, NEUROSCI LETT, V184, P121, DOI 10.1016/0304-3940(94)11185-L; WU T, 1995, BRAIN RES, V683, P242, DOI 10.1016/0006-8993(95)00379-5; WUSTROW DJ, 1995, BIOORG MED CHEM LETT, V5, P997, DOI 10.1016/0960-894X(95)00155-M	97	28	28	3	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2020	181	6					1364	+		10.1016/j.cell.2020.04.053	http://dx.doi.org/10.1016/j.cell.2020.04.053			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LY9TE	32470395	Bronze, Green Accepted			2022-12-28	WOS:000540869600016
J	Flanagin, A; Bauchner, H; Fontanarosa, PB				Flanagin, Annette; Bauchner, Howard; Fontanarosa, Phil B.			Patient and Study Participant Rights to Privacy in Journal Publication	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFORMED-CONSENT		[Flanagin, Annette] JAMA, 330 N Wabash Ave, Chicago, IL 60611 USA; [Flanagin, Annette] JAMA Network, 330 N Wabash Ave, Chicago, IL 60611 USA		Flanagin, A (corresponding author), JAMA, 330 N Wabash Ave, Chicago, IL 60611 USA.; Flanagin, A (corresponding author), JAMA Network, 330 N Wabash Ave, Chicago, IL 60611 USA.	Annette.flanagin@jamanetwork.org						[Anonymous], CONS PUBL ID MAT JAM; Barbour V, 2016, JOURNALS BEST PRACTI; Beauchamp T.L., 2012, PRINCIPLES BIOMEDICA, V7th; Beskow LM, 2001, JAMA-J AM MED ASSOC, V286, P2315, DOI 10.1001/jama.286.18.2315; Borg GJ, 1999, NEW ENGL J MED, V341, P1400; Botkin JR, 1998, JAMA-J AM MED ASSOC, V279, P1808, DOI 10.1001/jama.279.22.1808; Botkin JR, 2001, JAMA-J AM MED ASSOC, V285, P207, DOI 10.1001/jama.285.2.207; Clever LH, 1997, JAMA-J AM MED ASSOC, V278, P628, DOI 10.1001/jama.278.8.628; Cohen IG, 2019, JAMA-J AM MED ASSOC, V322, P1141, DOI 10.1001/jama.2019.11365; Counc. Int. Organ. Med. Sci, 2016, INT ETH GUID BIOM RE, V4th; Council of Europe, 2019, ADD PROT CONV HUM RI; COURT C, 1995, BRIT MED J, V311, P1245, DOI 10.1136/bmj.311.7015.1245; Emanuel EJ, 2011, OXFORD TXB CLIN RES; Flanagin A, 2020, AMA MANUAL STYLE GUI; Fontanarosa PB, 1997, JAMA-J AM MED ASSOC, V278, P682, DOI 10.1001/jama.278.8.682; Ghai B, 2005, ANAESTHESIA, V60, P289, DOI 10.1111/j.1365-2044.2005.04126.x; Gostin LO, 2018, JAMA-J AM MED ASSOC, V320, P233, DOI 10.1001/jama.2018.8374; International Committee of Medical Journal Editors, 2019, PROT RES PART REC CO; Koch CA, 2013, JAMA FACIAL PLAST SU, V15, P335, DOI 10.1001/jamafacial.2013.1411; Office for Human Research Protections US Department of Health and Human Services, 2016, INT COMP HUM SUBJ RE; Palus S, 2016, PATIENTS DID NOT OKA; Pitkin RM, 2001, OBSTET GYNECOL, V98, P198, DOI 10.1016/S0029-7844(01)01484-3; RIIS P, 1991, JAMA-J AM MED ASSOC, V265, P2720, DOI 10.1001/jama.265.20.2720; Robinson JK, 2014, JAMA DERMATOL, V150, P14, DOI 10.1001/jamadermatol.2013.8605; SLUE WE, 1989, NEW ENGL J MED, V321, P550, DOI 10.1056/NEJM198908243210823; SMITH J, 1991, BRIT MED J, V302, P1168, DOI 10.1136/bmj.302.6786.1168; Snider DE, 1997, JAMA-J AM MED ASSOC, V278, P624, DOI 10.1001/jama.278.8.624; Stern V, 2017, AUTHORS COULDNT FIND; Stern V, AUTHORS SAY PATIENT; Tester DJ, 2020, JAMA CARDIOL, V5, P340, DOI 10.1001/jamacardio.2019.5400; Tierney E, 2004, ANAESTHESIA, V59, P822; US Department of Health and Human Services, 2013, HLTH INF INF PRIV SU; Wachter RM, 2020, JAMA-J AM MED ASSOC, V323, P507, DOI 10.1001/jama.2019.21215; Yoshida A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-47	34	1	1	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2020	323	21					2147	2150		10.1001/jama.2020.3590	http://dx.doi.org/10.1001/jama.2020.3590			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LY8YS	32484519	Bronze			2022-12-28	WOS:000540816000018
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: GPs angry they were not told about changes to shielding advice	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, AUIDANCE SHIELDING P; Brennan S, 2020, HSJ; NHS England, 2020, GUID STAND OP PROC G	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2020	369								m2196	10.1136/bmj.m2196	http://dx.doi.org/10.1136/bmj.m2196			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0KV	32487514	Bronze			2022-12-28	WOS:000548476700003
J	Jakobsson, M				Jakobsson, Martin			Tracking the rapid pace of a retreating ice sheet	SCIENCE			English	Editorial Material							GROUNDING LINE RETREAT; PINE ISLAND		[Jakobsson, Martin] Stockholm Univ, Dept Geol Sci, Stockholm, Sweden; [Jakobsson, Martin] Stockholm Univ, Bolin Ctr Climate Res, Stockholm, Sweden	Stockholm University	Jakobsson, M (corresponding author), Stockholm Univ, Dept Geol Sci, Stockholm, Sweden.; Jakobsson, M (corresponding author), Stockholm Univ, Bolin Ctr Climate Res, Stockholm, Sweden.	martin.jakobsson@geo.su.se	Jakobsson, Martin/F-6214-2010					Andreassen K, 2014, QUATERNARY SCI REV, V92, P246, DOI 10.1016/j.quascirev.2013.09.015; BJORCK S, 1995, QUATERN INT, V27, P19, DOI 10.1016/1040-6182(94)00057-C; Dowdeswell JA, 2020, SCIENCE, V368, P1020, DOI 10.1126/science.aaz3059; Erdmann E., 1889, GEOL FOREN STOCKH FO, V11, P73; Graham AGC, 2013, J GEOPHYS RES-EARTH, V118, P1356, DOI 10.1002/jgrf.20087; Jakobsson M, 2011, GEOLOGY, V39, P691, DOI 10.1130/G32153.1; Lien R., 1989, Polar Research, V7, P43, DOI 10.1111/j.1751-8369.1989.tb00603.x; Rignot E, 2014, GEOPHYS RES LETT, V41, P3502, DOI 10.1002/2014GL060140	8	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					939	940		10.1126/science.abc3583	http://dx.doi.org/10.1126/science.abc3583			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LV3IK	32467377				2022-12-28	WOS:000538332600024
J	Nicolai, CJ; Raulet, DH				Nicolai, Christopher J.; Raulet, David H.			Killer cells add fire to fuel immunotherapy	SCIENCE			English	Editorial Material									[Nicolai, Christopher J.; Raulet, David H.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	raulet@berkeley.edu						Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015	1	6	6	3	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					943	+		10.1126/science.abc2502	http://dx.doi.org/10.1126/science.abc2502			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LV3IK	32467380				2022-12-28	WOS:000538332600027
J	Campbell, C; McKenney, PT; Konstantinovsky, D; Isaeva, OI; Schizas, M; Verter, J; Mai, C; Jin, WB; Guo, CJ; Violante, S; Ramos, RJ; Cross, JR; Kadaveru, K; Hambor, J; Rudensky, AY				Campbell, Clarissa; McKenney, Peter T.; Konstantinovsky, Daniel; Isaeva, Olga I.; Schizas, Michail; Verter, Jacob; Mai, Cheryl; Jin, Wen-Bing; Guo, Chun-Jun; Violante, Sara; Ramos, Ruben J.; Cross, Justin R.; Kadaveru, Krishna; Hambor, John; Rudensky, Alexander Y.			Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells	NATURE			English	Article							SALT BIOTRANSFORMATIONS; MURICHOLIC ACID; MICROBIOTA; DIFFERENTIATION; EXPRESSION; ANTIGENS; IMMUNITY; TOOLS	Intestinal health relies on the immunosuppressive activity of CD4(+) regulatory T (T-reg) cells(1). Expression of the transcription factor Foxp3 defines this lineage, and can be induced extrathymically by dietary or commensal-derived antigens in a process assisted by a Foxp3 enhancer known as conserved non-coding sequence 1 (CNS1)(2-4). Products of microbial fermentation including butyrate facilitate the generation of peripherally induced T-reg (pT(reg)) cells(5-7), indicating that metabolites shape the composition of the colonic immune cell population. In addition to dietary components, bacteria modify host-derived molecules, generating a number of biologically active substances. This is epitomized by the bacterial transformation of bile acids, which creates a complex pool of steroids(8) with a range of physiological functions(9). Here we screened the major species of deconjugated bile acids for their ability to potentiate the differentiation of pT(reg) cells. We found that the secondary bile acid 3 beta-hydroxydeoxycholic acid (isoDCA) increased Foxp3 induction by acting on dendritic cells (DCs) to diminish their immunostimulatory properties. Ablating one receptor, the farnesoid X receptor, in DCs enhanced the generation of T-reg cells and imposed a transcriptional profile similar to that induced by isoDCA, suggesting an interaction between this bile acid and nuclear receptor. To investigate isoDCA in vivo, we took a synthetic biology approach and designed minimal microbial consortia containing engineered Bacteroides strains. IsoDCA-producing consortia increased the number of colonic ROR gamma t-expressing T-reg cells in a CNS1-dependent manner, suggesting enhanced extrathymic differentiation.	[Campbell, Clarissa; McKenney, Peter T.; Schizas, Michail; Verter, Jacob; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [McKenney, Peter T.; Kadaveru, Krishna; Hambor, John] Boehringer Ingelheim Pharmaceut, SHINE Program, Res Borders, Ridgefield, CT USA; [Konstantinovsky, Daniel] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Isaeva, Olga I.] Skolkovo Inst Sci & Technol, Ctr Life Sci, Moscow, Russia; [Isaeva, Olga I.; Rudensky, Alexander Y.] BostonGene LLC, Lincoln, MA 01773 USA; [Mai, Cheryl] Weill Cornell Rockefeller Sloan Kettering Triinst, New York, NY USA; [Jin, Wen-Bing; Guo, Chun-Jun; Rudensky, Alexander Y.] Cornell Univ, Weill Cornell Med Coll, Immunol & Microbial Pathogenesis Program, New York, NY 10021 USA; [Violante, Sara; Ramos, Ruben J.; Cross, Justin R.] Mem Sloan Kettering Canc Ctr, Donald B & Catherine C Marron Canc Metab Ctr, 1275 York Ave, New York, NY 10021 USA; [Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Boehringer Ingelheim; Yale University; Skolkovo Institute of Science & Technology; Cornell University; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Campbell, C; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, 1275 York Ave, New York, NY 10021 USA.; Rudensky, AY (corresponding author), BostonGene LLC, Lincoln, MA 01773 USA.; Rudensky, AY (corresponding author), Cornell Univ, Weill Cornell Med Coll, Immunol & Microbial Pathogenesis Program, New York, NY 10021 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10021 USA.	campbec2@mskcc.org; rudenska@mskcc.org		jin, wenbing/0000-0002-3528-7297; Campbell, Clarissa/0000-0002-1918-0318; Mai, Cheryl/0000-0001-6214-2520; Isaeva, Olga/0000-0001-7377-0944	NIH [1DP2HD101401-01]; Ludwig Institute for Cancer Research; Hilton Foundation; Research Beyond Borders at Boehringer Ingelheim; NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; Hilton Foundation; Research Beyond Borders at Boehringer Ingelheim; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank F. Gonzalez (National Institutes of Health, NIH) for providing Nr1h4<SUP>fl</SUP> mice and F. Geissmann (MSKCC) for Csf1r<SUP>cre</SUP> mice. We thank J. Sonnenburg (Stanford University) for providing genetic tools to engineer B. theta. We thank S.-E. Brown, M. Rosenthal, T. Nguyen and P. Gonzales (Boehringer Ingelheim) and R. Pinedo (Weill Cornell Medical College) for assistance with germ-free mice. We thank O. Ouerfelli and the staff at the Organic Synthesis core at MSKCC for producing 6-oxoMCA. We thank A. Pickard (MKSCC) for assistance with metabolomic data analyses. We thank E. D. D'Andrea (University of Arizona) for assistance with DSF experiments. We thank J. van der Veeken for discussion of gene-expression data and all other members of the Rudensky laboratory for suggestions and technical assistance. This study was supported by NIH grant R37, the Ludwig Institute for Cancer Research, the Hilton Foundation, and Research Beyond Borders at Boehringer Ingelheim. W.G. and C.J.G were supported by NIH grant 1DP2HD101401-01. A.Y.R is an investigator with the Howard Hughes Medical Institute.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Campbell C, 2018, IMMUNITY, V48, P1245, DOI 10.1016/j.immuni.2018.04.013; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Devlin AS, 2015, NAT CHEM BIOL, V11, P685, DOI [10.1038/NCHEMBIO.1864, 10.1038/nchembio.1864]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edgar RC., 2016, BIORXIV, DOI [10.1101/074161, DOI 10.1101/074161, 10.1101/2020.05.12.088096]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EYSSEN H, 1983, APPL ENVIRON MICROB, V45, P141, DOI 10.1128/AEM.45.1.141-147.1983; Eyssen HJ, 1999, APPL ENVIRON MICROB, V65, P3158; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Hamilton JP, 2007, AM J PHYSIOL-GASTR L, V293, pG256, DOI 10.1152/ajpgi.00027.2007; Hang SY, 2019, NATURE, V576, P143, DOI 10.1038/s41586-019-1785-z; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; HOFMANN AF, 1967, ANNU REV MED, V18, P333, DOI 10.1146/annurev.me.18.020167.002001; Hooijberg E, 2000, BLOOD, V96, P459; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Nutsch K, 2016, CELL REP, V17, P206, DOI 10.1016/j.celrep.2016.08.092; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Ridlon JM, 2016, GUT MICROBES, V7, P22, DOI 10.1080/19490976.2015.1127483; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Schmidt J, 2015, SCI REP-UK, V5, DOI 10.1038/srep14782; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Song XY, 2020, NATURE, V577, P410, DOI 10.1038/s41586-019-1865-0; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Whitaker WR, 2017, CELL, V169, P538, DOI 10.1016/j.cell.2017.03.041; WHITE J, 1989, J IMMUNOL, V143, P1822; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	34	210	222	24	97	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 28	2020	581	7809					475	+		10.1038/s41586-020-2193-0	http://dx.doi.org/10.1038/s41586-020-2193-0			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX9ZL	32461639	Green Accepted			2022-12-28	WOS:000576060200009
J	Spector-Bagdady, K; Hutchinson, R; Kaleba, EO; Kheterpal, S				Spector-Bagdady, Kayte; Hutchinson, Raymond; Kaleba, Erin O'Brien; Kheterpal, Sachin			Sharing Health Data and Biospecimens with Industry - A Principle-Driven, Practical Approach	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Spector-Bagdady, Kayte] Univ Michigan, Michigan Med, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Hutchinson, Raymond] Univ Michigan, Michigan Med, Dept Pediat, Ann Arbor, MI 48109 USA; [Kheterpal, Sachin] Univ Michigan, Michigan Med, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Kaleba, Erin O'Brien] Univ Michigan, Michigan Med, Off Res, Ann Arbor, MI 48109 USA; [Spector-Bagdady, Kayte; Kheterpal, Sachin] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Spector-Bagdady, Kayte] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Spector-Bagdady, K (corresponding author), Univ Michigan, Michigan Med, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA.; Spector-Bagdady, K (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.; Spector-Bagdady, K (corresponding author), Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA.							Cohen IG, JAMA; Grady C, 2015, AM J BIOETHICS, V15, P34, DOI 10.1080/15265161.2015.1062162; Parasidis E, 2019, NEW ENGL J MED, V380, P1493, DOI 10.1056/NEJMp1816373; Peppercorn J, 2020, ONCOLOGIST, V25, P78, DOI 10.1634/theoncologist.2019-0365; Tomlinson T, 2015, JAMA-J AM MED ASSOC, V313, P417, DOI 10.1001/jama.2014.16363	5	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2020	382	22					2072	2075		10.1056/NEJMp1915298	http://dx.doi.org/10.1056/NEJMp1915298			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MA5NT	32459920				2022-12-28	WOS:000541960400011
J	Goodman, RP; Markhard, AL; Shah, HD; Sharma, R; Skinner, OS; Clish, CB; Deik, A; Patgiri, A; Hsu, YHH; Masia, R; Noh, HL; Suk, S; Goldberger, O; Hirschhorn, JN; Yellen, G; Kim, JK; Mootha, VK				Goodman, Russell P.; Markhard, Andrew L.; Shah, Hardik; Sharma, Rohit; Skinner, Owen S.; Clish, Clary B.; Deik, Amy; Patgiri, Anupam; Hsu, Yu-Han H.; Masia, Ricard; Noh, Hye Lim; Suk, Sujin; Goldberger, Olga; Hirschhorn, Joel N.; Yellen, Gary; Kim, Jason K.; Mootha, Vamsi K.			Hepatic NADH reductive stress underlies common variation in metabolic traits	NATURE			English	Article							INSULIN-RESISTANCE; MISSENSE VARIANT; GLUCOSE; FGF21; TRIGLYCERIDE; MANIPULATION; ASSOCIATION; SENSITIVITY; EXPRESSION; ETHANOL	The cellular NADH/NAD(+) ratio is fundamental to biochemistry, but the extent to which it reflects versus drives metabolic physiology in vivo is poorly understood. Here we report the in vivo application of Lactobacillus brevis (Lb)NOX1, a bacterial water-forming NADH oxidase, to assess the metabolic consequences of directly lowering the hepatic cytosolic NADH/NAD(+) ratio in mice. By combining this genetic tool with metabolomics, we identify circulating alpha-hydroxybutyrate levels as a robust marker of an elevated hepatic cytosolic NADH/NAD(+) ratio, also known as reductive stress. In humans, elevations in circulating alpha-hydroxybutyrate levels have previously been associated with impaired glucose tolerance(2), insulin resistance(3) and mitochondrial disease(4), and are associated with a common genetic variant in GCKR(5), which has previously been associated with many seemingly disparate metabolic traits. Using LbNOX, we demonstrate that NADH reductive stress mediates the effects of GCKR variation on many metabolic traits, including circulating triglyceride levels, glucose tolerance and FGF21 levels. Our work identifies an elevated hepatic NADH/NAD(+) ratio as a latent metabolic parameter that is shaped by human genetic variation and contributes causally to key metabolic traits and diseases. Moreover, it underscores the utility of genetic tools such as LbNOX to empower studies of 'causal metabolism'. The authors identify an increased hepatic NADH/NAD(+) ratio as an underlying metabolic parameter that is shaped by human genetic variation and contributes causally to key metabolic traits and diseases.	[Goodman, Russell P.; Markhard, Andrew L.; Shah, Hardik; Sharma, Rohit; Skinner, Owen S.; Patgiri, Anupam; Goldberger, Olga; Mootha, Vamsi K.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Goodman, Russell P.; Markhard, Andrew L.; Shah, Hardik; Sharma, Rohit; Skinner, Owen S.; Patgiri, Anupam; Goldberger, Olga; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Goodman, Russell P.] Massachusetts Gen Hosp, Liver Ctr, Div Gastroenterol, Boston, MA 02114 USA; [Clish, Clary B.; Deik, Amy; Hsu, Yu-Han H.; Hirschhorn, Joel N.; Mootha, Vamsi K.] Broad Inst, Cambridge, MA 02142 USA; [Hsu, Yu-Han H.; Hirschhorn, Joel N.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Hsu, Yu-Han H.; Hirschhorn, Joel N.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Hsu, Yu-Han H.; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Hsu, Yu-Han H.; Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA USA; [Masia, Ricard] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Masia, Ricard; Yellen, Gary] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA; [Noh, Hye Lim; Suk, Sujin; Kim, Jason K.] Univ Massachusetts, Med Sch, Program Mol Med, Worcester, MA 01605 USA; [Kim, Jason K.] Univ Massachusetts, Med Sch, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA 01605 USA; [Mootha, Vamsi K.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School	Mootha, VK (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.; Mootha, VK (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Mootha, VK (corresponding author), Broad Inst, Cambridge, MA 02142 USA.; Mootha, VK (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.	vamsi@hms.harvard.edu	Clish, Clary B/ABB-9374-2021	Clish, Clary B/0000-0001-8259-9245; Patgiri, Anupam/0000-0002-4184-5961; Shah, Hardik/0000-0001-8408-5686	US National Institutes of Health (NIH) [F32DK111132]; NIH [K08DK1158811, F32GM133047, T32DK110919, 5U2C-DK093000, R35GM122455, TR01GM099683]; Pinnacle Research Award from the American Association for the Study of Liver Diseases (AASLD)	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pinnacle Research Award from the American Association for the Study of Liver Diseases (AASLD)	We thank J. Avruch and members of the Mootha laboratory for valuable discussions and feedback. R.P.G. was supported by the US National Institutes of Health (NIH) grant F32DK111132 and NIH K08DK1158811. R.P.G. and R.M. were both supported by a Pinnacle Research Award from the American Association for the Study of Liver Diseases (AASLD). O.S.S. was supported by NIH F32GM133047. Y.-H.H.H. was supported by NIH T32DK110919. Part of this study was performed at the National Mouse Metabolic Phenotyping Center at University of Massachusetts supported by NIH 5U2C-DK093000 (to J.K.K.) This work was supported in part by a gift from the Marriott Mitochondrial Disorders Collaborative Research Network and grants from the NIH (R35GM122455 and TR01GM099683). V.K.M. is an investigator of the Howard Hughes Medical Institute.	ADER M, 1990, AM J PHYSIOL, V258, pE1020, DOI 10.1152/ajpendo.1990.258.6.E1020; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; BARAONA E, 1979, J LIPID RES, V20, P289; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cheung CYY, 2017, DIABETES, V66, P1723, DOI 10.2337/db16-1384; Cobb J, 2016, DIABETES CARE, V39, P988, DOI 10.2337/dc15-2752; Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107; Desai BN, 2017, MOL METAB, V6, P1395, DOI 10.1016/j.molmet.2017.08.004; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ferrannini E, 2013, DIABETES, V62, P1730, DOI 10.2337/db12-0707; Fiehn Oliver, 2016, Curr Protoc Mol Biol, V114, DOI 10.1002/0471142727.mb3004s114; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goodman RP, 2018, J BIOL CHEM, V293, P7508, DOI 10.1074/jbc.TM117.000258; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642; Jang C, 2019, CELL METAB, V30, P594, DOI 10.1016/j.cmet.2019.06.002; Kilpelainen TO, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10494; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; Kim W, 2019, CELL METAB, V29, P856, DOI 10.1016/j.cmet.2018.12.023; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Krebs H A, 1967, Adv Enzyme Regul, V5, P409, DOI 10.1016/0065-2571(67)90029-5; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Legault JT, 2015, CELL REP, V13, P981, DOI 10.1016/j.celrep.2015.09.054; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lu WY, 2018, ANTIOXID REDOX SIGN, V28, P167, DOI 10.1089/ars.2017.7014; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Masia R, 2018, AM J PHYSIOL-GASTR L, V314, pG97, DOI 10.1152/ajpgi.00093.2017; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Orho-Melander M, 2008, DIABETES, V57, P3112, DOI 10.2337/db08-0516; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Raimondo A, 2015, CURR OPIN LIPIDOL, V26, P88, DOI 10.1097/MOL.0000000000000155; Rhee EP, 2013, CELL METAB, V18, P130, DOI 10.1016/j.cmet.2013.06.013; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schlein C, 2016, CELL METAB, V23, P441, DOI 10.1016/j.cmet.2016.01.006; Schumann G, 2016, P NATL ACAD SCI USA, V113, P14372, DOI 10.1073/pnas.1611243113; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Titchenell PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8078; Titov DV, 2016, SCIENCE, V352, P231, DOI 10.1126/science.aad4017; Trammell SAJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12948; Trammell SAJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26933; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012	50	44	44	3	42	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					122	+		10.1038/s41586-020-2337-2	http://dx.doi.org/10.1038/s41586-020-2337-2		MAY 2020	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME6OV	32461692	Green Accepted			2022-12-28	WOS:000535878900003
J	Pashalidou, FG; Lambert, H; Peybernes, T; Mescher, MC; De Moraes, CM				Pashalidou, Foteini G.; Lambert, Harriet; Peybernes, Thomas; Mescher, Mark C.; De Moraes, Consuelo M.			Bumble bees damage plant leaves and accelerate flower production when pollen is scarce	SCIENCE			English	Article							FLORAL RESOURCES; CLIMATE; RESPONSES; POLLINATION; PHENOLOGY; ABUNDANCE; DRIVEN; GROWTH	Maintaining phenological synchrony with flowers is a key ecological challenge for pollinators that may be exacerbated by ongoing environmental change. Here, we show that bumble bee workers facing pollen scarcity damage leaves of flowerless plants and thereby accelerate flower production. Laboratory studies revealed that leaf-damaging behavior is strongly influenced by pollen availability and that bee-damaged plants flower significantly earlier than undamaged or mechanically damaged controls. Subsequent outdoor experiments showed that the intensity of damage inflicted varies with local flower availability; furthermore, workers from wild colonies of two additional bumble bee species were also observed to damage plant leaves. These findings elucidate a feature of bumble bee worker behavior that can influence the local availability of floral resources.	[Pashalidou, Foteini G.; Lambert, Harriet; Peybernes, Thomas; Mescher, Mark C.; De Moraes, Consuelo M.] Swiss Fed Inst Technol, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland; [Pashalidou, Foteini G.] Univ Paris Saclay, AgroParisTech, INRA, UMR Agron, F-78850 Thiverval Grignon, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Mescher, MC; De Moraes, CM (corresponding author), Swiss Fed Inst Technol, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland.	mescher@usys.ethz.ch; consuelo.demoraes@usys.ethz.ch		Lambert, harriet/0000-0001-7427-597X; Paschalidou, Foteini/0000-0001-5746-8227; Peybernes, Thomas/0000-0002-2114-691X	ETH Zurich, Switzerland	ETH Zurich, Switzerland(ETH Zurich)	This research was funded by ETH Zurich, Switzerland.	Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; [Anonymous], 2020, DRYAD; Bartomeus I, 2011, P NATL ACAD SCI USA, V108, P20645, DOI 10.1073/pnas.1115559108; Benton T., 2006, COLLINS NEW NATURALI, V98; Carvell C, 2017, NATURE, V543, P547, DOI 10.1038/nature21709; Crone EE, 2016, ECOL LETT, V19, P460, DOI 10.1111/ele.12581; Fagan WF, 2014, THEOR ECOL-NETH, V7, P289, DOI 10.1007/s12080-014-0218-8; Forrest JRK, 2011, ECOL MONOGR, V81, P469, DOI 10.1890/10-1885.1; Gervasi DDL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14691; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; HARDER LD, 1990, OECOLOGIA, V85, P41, DOI 10.1007/BF00317341; Kerr JT, 2015, SCIENCE, V349, P177, DOI 10.1126/science.aaa7031; Klinger EG, 2019, ENVIRON ENTOMOL, V48, P1249, DOI 10.1093/ee/nvz117; Kudo G, 2004, ECOL RES, V19, P255, DOI 10.1111/j.1440-1703.2003.00630.x; Lemoine NP, 2017, ECOLOGY, V98, P1817, DOI 10.1002/ecy.1855; Mallinger RE, 2016, LANDSCAPE ECOL, V31, P1523, DOI 10.1007/s10980-015-0332-z; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Mescher MC, 2015, J EXP BOT, V66, P425, DOI 10.1093/jxb/eru414; Mikat M, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2365-6; Miller-Struttmann NE, 2015, SCIENCE, V349, P1541, DOI 10.1126/science.aab0868; Ogilvie JE, 2017, ECOL LETT, V20, P1507, DOI 10.1111/ele.12854; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pashalidou F. G., 2020, BUMBLE BEES DAMAGE P, DOI [10.5061/dryad.9ghx3ffdv, DOI 10.5061/DRYAD.9GHX3FFDV]; Requier F, 2020, ECOLOGY, V101, DOI 10.1002/ecy.2946; Roulston TH, 2011, ANNU REV ENTOMOL, V56, P293, DOI 10.1146/annurev-ento-120709-144802; Schenk M, 2018, J ANIM ECOL, V87, P139, DOI 10.1111/1365-2656.12694; Settele J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.92, 10.1038/nplants.2016.92]; Smeets P, 2003, APIDOLOGIE, V34, P333, DOI 10.1051/apido:2003026; Stelzer RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009559; Takeno K, 2016, J EXP BOT, V67, P4925, DOI 10.1093/jxb/erw272; Thomson JD, 2010, PHILOS T R SOC B, V365, P3187, DOI 10.1098/rstb.2010.0115; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Willmer P, 2012, CURR BIOL, V22, pR131, DOI 10.1016/j.cub.2012.01.009; Zuur Alain F., 2009, P1	34	22	23	20	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					881	+		10.1126/science.aay0496	http://dx.doi.org/10.1126/science.aay0496			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU2DD	32439792				2022-12-28	WOS:000537569500045
J	Mahase, E				Mahase, Elisabeth			Covid-19: Two antibody tests are "highly specific" but vary in sensitivity, evaluations find	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2000	1	18	18	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2020	369								m2066	10.1136/bmj.m2066	http://dx.doi.org/10.1136/bmj.m2066			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JS	32439655	Bronze			2022-12-28	WOS:000538336600019
J	Long, T; Sun, YY; Hassan, A; Qi, XF; Li, XC				Long Tao; Sun Yingyuan; Hassan, Abdirahman; Qi Xiaofeng; Li Xiaochun			Structure of nevanimibe-bound tetrameric human ACAT1	NATURE			English	Article							COA-CHOLESTEROL ACYLTRANSFERASE; ACYL-COENZYME; O-ACYLTRANSFERASES; IDENTIFICATION; EXPRESSION; INHIBITOR; CLONING; DOMAIN; CELLS; MODEL	The structure of human ACAT1 in complex with the inhibitor nevanimibe is resolved by cryo-electron microscopy. Cholesterol is an essential component of mammalian cell membranes, constituting up to 50% of plasma membrane lipids. By contrast, it accounts for only 5% of lipids in the endoplasmic reticulum (ER)(1). The ER enzyme sterol O-acyltransferase 1 (also named acyl-coenzyme A:cholesterol acyltransferase, ACAT1) transfers a long-chain fatty acid to cholesterol to form cholesteryl esters that coalesce into cytosolic lipid droplets. Under conditions of cholesterol overload, ACAT1 maintains the low cholesterol concentration of the ER and thereby has an essential role in cholesterol homeostasis(2,3). ACAT1 has also been implicated in Alzheimer's disease(4), atherosclerosis(5) and cancers(6). Here we report a cryo-electron microscopy structure of human ACAT1 in complex with nevanimibe(7), an inhibitor that is in clinical trials for the treatment of congenital adrenal hyperplasia. The ACAT1 holoenzyme is a tetramer that consists of two homodimers. Each monomer contains nine transmembrane helices (TMs), six of which (TM4-TM9) form a cavity that accommodates nevanimibe and an endogenous acyl-coenzyme A. This cavity also contains a histidine that has previously been identified as essential for catalytic activity(8). Our structural data and biochemical analyses provide a physical model to explain the process of cholesterol esterification, as well as details of the interaction between nevanimibe and ACAT1, which may help to accelerate the development of ACAT1 inhibitors to treat related diseases.	[Long Tao; Sun Yingyuan; Hassan, Abdirahman; Qi Xiaofeng; Li Xiaochun] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Li Xiaochun] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Li, XC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.; Li, XC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.	xiaochun.li@utsouthwestern.edu	Sun, Yingyuan/HHS-7124-2022	HASSAN, ABDIRAHMAN/0000-0002-3967-9802; Li, Xiaochun/0000-0002-0177-0803	CPRIT Core Facility Support Award [RP170644]; National Institutes of Health [P01 HL020948, R01 GM134700, R01 GM135343]; Endowed Scholars Program in Medical Science of UT Southwestern Medical Center; O'Donnell Junior Faculty Funds; Welch Foundation [I-1957]; DDBrown Fellow of the Life Sciences Research Foundation; Damon Runyon Cancer Research Foundation [DRR-53-19]; Rita C. and William P. Clements Jr. Scholar in Biomedical Research at UT Southwestern Medical Center	CPRIT Core Facility Support Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endowed Scholars Program in Medical Science of UT Southwestern Medical Center; O'Donnell Junior Faculty Funds; Welch Foundation(The Welch Foundation); DDBrown Fellow of the Life Sciences Research Foundation; Damon Runyon Cancer Research Foundation; Rita C. and William P. Clements Jr. Scholar in Biomedical Research at UT Southwestern Medical Center	We thank M. Brown and J. Goldstein for support throughout the project. Data were collected at the UT Southwestern Medical Center Cryo-EM Facility (funded in part by the CPRIT Core Facility Support Award RP170644). We thank D. Stoddard for assistance with data collection; R. DeBose-Boyd, L. Esparza and L. Friedberg for technical support; E. Coutavas and E. Debler for discussion; and A. Lemoff at the UT Southwestern Proteomics Core for mass spectrometry identification. This work was supported by National Institutes of Health grants P01 HL020948, R01 GM134700 and R01 GM135343; the Endowed Scholars Program in Medical Science of UT Southwestern Medical Center; O'Donnell Junior Faculty Funds; and Welch Foundation grant I-1957 to X.L. X.Q. is the recipient of a DDBrown Fellow of the Life Sciences Research Foundation. X.L. is a Damon Runyon-Rachleff Innovator supported by the Damon Runyon Cancer Research Foundation (DRR-53-19) and a Rita C. and William P. Clements Jr. Scholar in Biomedical Research at UT Southwestern Medical Center.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; Brown MS, 2018, ANNU REV BIOCHEM, V87, P783, DOI 10.1146/annurev-biochem-062917-011852; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Chang CCY, 1998, J BIOL CHEM, V273, P35132, DOI 10.1074/jbc.273.52.35132; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Das A, 2008, J LIPID RES, V49, P1770, DOI 10.1194/jlr.M800131-JLR200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Guo ZY, 2007, BIOCHEMISTRY-US, V46, P10063, DOI 10.1021/bi7011367; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hutter-Paier B, 2004, NEURON, V44, P227, DOI 10.1016/j.neuron.2004.08.043; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; LaPensee CR, 2016, ENDOCRINOLOGY, V157, P1775, DOI 10.1210/en.2015-2052; Li XC, 2016, P NATL ACAD SCI USA, V113, P10079, DOI 10.1073/pnas.1611956113; Li XC, 2015, NATURE, V517, P104, DOI 10.1038/nature13797; Liu J, 2005, BIOCHEM J, V391, P389, DOI 10.1042/BJ20050428; Long T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13917-5; Long T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10279-w; Ma D, 2018, NATURE, V562, P286, DOI 10.1038/s41586-018-0568-2; Masumoto N, 2015, BIOCHEM SOC T, V43, P246, DOI 10.1042/BST20150018; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nissen SE, 2006, NEW ENGL J MED, V354, P1253, DOI 10.1056/NEJMoa054699; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeffer SR, 2019, J BIOL CHEM, V294, P1706, DOI 10.1074/jbc.TM118.004165; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rogers MA, 2015, J STEROID BIOCHEM, V151, P102, DOI 10.1016/j.jsbmb.2014.09.008; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Xu YQ, 2019, J BIOL CHEM, V294, P19306, DOI 10.1074/jbc.RA119.011160; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200; Yang W, 2016, NATURE, V531, P651, DOI 10.1038/nature17412; Yu CJ, 2002, BIOCHEMISTRY-US, V41, P3762, DOI 10.1021/bi0120188; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	41	29	28	3	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY	2020	581	7808					339	U214		10.1038/s41586-020-2295-8	http://dx.doi.org/10.1038/s41586-020-2295-8		MAY 2020	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ2CZ	32433613	Green Accepted			2022-12-28	WOS:000532688300009
J	Earnest, M				Earnest, Mark			On Becoming a Plague Doctor	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Despite its fearsome appearance, the plague doctor's costume - the "personal protective equipment" of the Middle Ages - had a noble purpose. It was intended to enable physicians to safely care for patients during the Black Death.	[Earnest, Mark] Univ Colorado, Div Gen Internal Med, Anschutz Med Campus, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Earnest, M (corresponding author), Univ Colorado, Div Gen Internal Med, Anschutz Med Campus, Aurora, CO 80045 USA.							Mussap CJ, 2019, INTERN MED J, V49, P671, DOI 10.1111/imj.14285	1	6	6	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2020	383	10							e64	10.1056/NEJMp2011418	http://dx.doi.org/10.1056/NEJMp2011418			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NO9YO	32433862	Bronze			2022-12-28	WOS:000569841600004
J	Chandrashekar, A; Liu, JY; Martinot, AJ; McMahan, K; Mercado, NB; Peter, L; Tostanoski, LH; Yu, JY; Maliga, Z; Nekorchuk, M; Busman-Sahay, K; Terry, M; Wrijil, LM; Ducat, S; Martinez, DR; Atyeo, C; Fischinger, S; Burke, JS; Slein, MD; Pessaint, L; Van Ry, A; Greenhouse, J; Taylor, T; Blade, K; Cook, A; Finneyfrock, B; Brown, R; Teow, E; Velasco, J; Zahn, R; Wegmann, F; Abbink, P; Bondzie, EA; Dagotto, G; Gebre, MS; He, X; Jacob-Dolan, C; Kordana, N; Li, ZF; Lifton, MA; Mahrokhian, SH; Maxfield, LF; Nityanandam, R; Nkolola, JP; Schmidt, AG; Miller, AD; Baric, RS; Alter, G; Sorger, PK; Estes, JD; Andersen, H; Lewis, MG; Barouch, DH				Chandrashekar, Abishek; Liu, Jinyan; Martinot, Amanda J.; McMahan, Katherine; Mercado, Noe B.; Peter, Lauren; Tostanoski, Lisa H.; Yu, Jingyou; Maliga, Zoltan; Nekorchuk, Michael; Busman-Sahay, Kathleen; Terry, Margaret; Wrijil, Linda M.; Ducat, Sarah; Martinez, David R.; Atyeo, Caroline; Fischinger, Stephanie; Burke, John S.; Slein, Matthew D.; Pessaint, Laurent; Van Ry, Alex; Greenhouse, Jack; Taylor, Tammy; Blade, Kelvin; Cook, Anthony; Finneyfrock, Brad; Brown, Renita; Teow, Elyse; Velasco, Jason; Zahn, Roland; Wegmann, Frank; Abbink, Peter; Bondzie, Esther A.; Dagotto, Gabriel; Gebre, Makda S.; He, Xuan; Jacob-Dolan, Catherine; Kordana, Nicole; Li, Zhenfeng; Lifton, Michelle A.; Mahrokhian, Shant H.; Maxfield, Lori F.; Nityanandam, Ramya; Nkolola, Joseph P.; Schmidt, Aaron G.; Miller, Andrew D.; Baric, Ralph S.; Alter, Galit; Sorger, Peter K.; Estes, Jacob D.; Andersen, Hanne; Lewis, Mark G.; Barouch, Dan H.			SARS-CoV-2 infection protects against rechallenge in rhesus macaques	SCIENCE			English	Article							REVERSE GENETICS; CORONAVIRUS; IMMUNITY; CDNA; SARS	An understanding of protective immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for vaccine and public health strategies aimed at ending the global coronavirus disease 2019 (COVID-19) pandemic. A key unanswered question is whether infection with SARS-CoV-2 results in protective immunity against reexposure. We developed a rhesus macaque model of SARS-CoV-2 infection and observed that macaques had high viral loads in the upper and lower respiratory tract, humoral and cellular immune responses, and pathologic evidence of viral pneumonia. After the initial viral clearance, animals were rechallenged with SARS-CoV-2 and showed 5 log(10) reductions in median viral loads in bronchoalveolar lavage and nasal mucosa compared with after the primary infection. Anamnestic immune responses after rechallenge suggested that protection was mediated by immunologic control. These data show that SARS-CoV-2 infection induced protective immunity against reexposure in nonhuman primates.	[Chandrashekar, Abishek; Liu, Jinyan; Martinot, Amanda J.; McMahan, Katherine; Mercado, Noe B.; Peter, Lauren; Tostanoski, Lisa H.; Yu, Jingyou; Abbink, Peter; Bondzie, Esther A.; Dagotto, Gabriel; Gebre, Makda S.; He, Xuan; Jacob-Dolan, Catherine; Kordana, Nicole; Li, Zhenfeng; Lifton, Michelle A.; Mahrokhian, Shant H.; Maxfield, Lori F.; Nityanandam, Ramya; Nkolola, Joseph P.; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Martinot, Amanda J.; Wrijil, Linda M.; Ducat, Sarah] Tufts Univ, Cummings Sch Vet Med, North Grafton, MA 01536 USA; [Maliga, Zoltan; Atyeo, Caroline; Dagotto, Gabriel; Gebre, Makda S.; Jacob-Dolan, Catherine; Sorger, Peter K.] Harvard Med Sch, Boston, MA 02115 USA; [Nekorchuk, Michael; Busman-Sahay, Kathleen; Terry, Margaret; Estes, Jacob D.] Oregon Hlth & Sci Univ, Beaverton, OR 97006 USA; [Martinez, David R.; Baric, Ralph S.] Univ N Carolina, Chapel Hill, NC 27599 USA; [Atyeo, Caroline; Fischinger, Stephanie; Burke, John S.; Slein, Matthew D.; Schmidt, Aaron G.; Alter, Galit; Barouch, Dan H.] MIT, Ragon Inst MGH, Cambridge, MA 02139 USA; [Atyeo, Caroline; Fischinger, Stephanie; Burke, John S.; Slein, Matthew D.; Schmidt, Aaron G.; Alter, Galit; Barouch, Dan H.] Harvard, Cambridge, MA 02139 USA; [Pessaint, Laurent; Van Ry, Alex; Greenhouse, Jack; Taylor, Tammy; Blade, Kelvin; Cook, Anthony; Finneyfrock, Brad; Brown, Renita; Teow, Elyse; Velasco, Jason; Andersen, Hanne; Lewis, Mark G.] Bioqual, Rockville, MD 20852 USA; [Zahn, Roland; Wegmann, Frank] Janssen Vaccines & Prevent BV, Leiden, Netherlands; [Schmidt, Aaron G.; Alter, Galit; Barouch, Dan H.] Massachusetts Consortium Pathogen Readiness, Boston, MA 02215 USA; [Miller, Andrew D.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Tufts University; Harvard University; Harvard Medical School; Oregon Health & Science University; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; BIOQUAL Inc.; Cornell University	Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Barouch, DH (corresponding author), MIT, Ragon Inst MGH, Cambridge, MA 02139 USA.; Barouch, DH (corresponding author), Harvard, Cambridge, MA 02139 USA.; Barouch, DH (corresponding author), Massachusetts Consortium Pathogen Readiness, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	martinez, david/GQI-0849-2022; Chandrashekar, Abishek/P-2610-2019; Mercado, Noe/ABE-8247-2020	Chandrashekar, Abishek/0000-0001-7821-5552; Ducat, Sarah/0000-0002-5285-7642; Slein, Matthew/0000-0001-8288-787X; Wegmann, Frank/0000-0002-9821-1492; Peter, Lauren/0000-0002-2105-7503; Jacob-Dolan, Catherine/0000-0001-6641-0342; Yu, Jingyou/0000-0002-0775-6623; Elyard, Hanne/0000-0003-1103-9608; Mercado, Noe/0000-0001-7769-7326; Tostanoski, Lisa/0000-0001-9255-5684; Gebre, Makda/0000-0001-8520-2178; Martinot, Amanda/0000-0001-6237-6191; Mahrokhian, Shant/0000-0003-4094-8739; Maliga, Zoltan/0000-0003-4209-7253	Ragon Institute of MGH, MIT, and Harvard; Mark and Lisa Schwartz Foundation; Beth Israel Deaconess Medical Center; Massachusetts Consortium on Pathogen Readiness (MassCPR); Bill & Melinda Gates Foundation [INV-006131]; Janssen Vaccines Prevention BV; National Institutes of Health [OD024917, AI129797, AI124377, AI128751, AI126603, AI135098, AI007387, AI007151, AI146779, 272201700036I-0-759301900131-1, AI100625, AI110700, AI132178, AI149644, AI108197, CA225088, OD011092, OD025002]; Mercatus Center at George Mason University; Burroughs Wellcome Fund Postdoctoral Enrichment Program Award	Ragon Institute of MGH, MIT, and Harvard; Mark and Lisa Schwartz Foundation; Beth Israel Deaconess Medical Center; Massachusetts Consortium on Pathogen Readiness (MassCPR); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Janssen Vaccines Prevention BV; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mercatus Center at George Mason University; Burroughs Wellcome Fund Postdoctoral Enrichment Program Award(Burroughs Wellcome Fund)	We acknowledge support from the Ragon Institute of MGH, MIT, and Harvard, Mark and Lisa Schwartz Foundation, Beth Israel Deaconess Medical Center, Massachusetts Consortium on Pathogen Readiness (MassCPR), Bill & Melinda Gates Foundation (INV-006131), Janssen Vaccines & Prevention BV, and the National Institutes of Health (OD024917, AI129797, AI124377, AI128751, AI126603 to D.H.B.; AI135098 to A.J.M.; AI007387 to L.H.T.; AI007151 to D.R.M.; AI146779 to A.G.S.; 272201700036I-0-759301900131-1, AI100625, AI110700, AI132178, AI149644, AI108197 to R.S.B.; CA225088 to P.K.S.; and OD011092, OD025002 to J.D.E.). We also acknowledge a Fast Grant, Emergent Ventures, from the Mercatus Center at George Mason University, to A.J.M. and a Burroughs Wellcome Fund Postdoctoral Enrichment Program Award to D.R.M.	Altfeld M, 2002, NATURE, V420, P434, DOI 10.1038/nature01200; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chung AW, 2015, CELL, V163, P988, DOI 10.1016/j.cell.2015.10.027; Deleage C, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87065; Deleage Claire, 2016, Pathog Immun, V1, P68; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Li Q., 2020, NEW ENGL J MED, V382, P1199; Lin JR, 2018, ELIFE, V7, DOI 10.7554/eLife.31657; Rockx Barry, 2020, Science, V368, P1012, DOI 10.1126/science.abb7314; Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110; WHO-Worl Health Organization, 2020, CRIT REL COVID 19 PA; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	21	524	534	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2020	369	6505					812	+		10.1126/science.abc4776	http://dx.doi.org/10.1126/science.abc4776			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA3RX	32434946	Green Published			2022-12-28	WOS:000559731300035
J	Heus, P; Reitsma, JB; Collins, GS; Damen, JAAG; Scholten, RJPM; Altman, DG; Moons, KGM; Hooft, L				Heus, Pauline; Reitsma, Johannes B.; Collins, Gary S.; Damen, Johanna A. A. G.; Scholten, Rob J. P. M.; Altman, Douglas G.; Moons, Karel G. M.; Hooft, Lotty			Transparent Reporting of Multivariable Prediction Models in Journal and Conference Abstracts: TRIPOD for Abstracts	ANNALS OF INTERNAL MEDICINE			English	Review							RISK; CONSORT; APPLICABILITY; IMPROVEMENT; VALIDATION; PROBAST; BIAS; TOOL	Clear and informative reporting in titles and abstracts is essential to help readers and reviewers identify potentially relevant studies and decide whether to read the full text. Although the TRIPOD (Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis) statement provides general recommendations for reporting titles and abstracts, more detailed guidance seems to be desirable. The authors present TRIPOD for Abstracts, a checklist and corresponding guidance for reporting prediction model studies in abstracts. A list of 32 potentially relevant items was the starting point for a modified Delphi procedure involving 110 experts, of whom 71 (65%) participated in the web-based survey. After 2 Delphi rounds, the experts agreed on 21 items as being essential to report in abstracts of prediction model studies. This number was reduced by merging some of the items. In a third round, participants provided feedback on a draft version of TRIPOD for Abstracts. The final checklist contains 12 items and applies to journal and conference abstracts that describe the development or external validation of a diagnostic or prognostic prediction model, or the added value of predictors to an existing model, regardless of the clinical domain or statistical approach used.	[Heus, Pauline; Reitsma, Johannes B.; Damen, Johanna A. A. G.; Scholten, Rob J. P. M.; Moons, Karel G. M.; Hooft, Lotty] Univ Utrecht, Univ Med Ctr Utrecht, Cochrane Netherlands & Julius Ctr Hlth Sci & Prim, Str 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands; [Collins, Gary S.] Univ Oxford, Botnar Res Ctr, Ctr Stat Med, Oxford, England; [Collins, Gary S.] John Radcliffe Hosp, Natl Inst Hlth Res Oxford Biomed Res Ctr, Oxford, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Botnar Res Ctr, Oxford, England; [Collins, Gary S.] Univ Oxford, Botnar Res Ctr, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England	Utrecht University; Utrecht University Medical Center; University of Oxford; University of Oxford; University of Oxford; University of Oxford	Heus, P (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Cochrane Netherlands & Julius Ctr Hlth Sci & Prim, Str 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands.	p.heus@umcutrecht.nl	Collins, Gary Stephen/A-2258-2014	Collins, Gary Stephen/0000-0002-2772-2316; Reitsma, Johannes/0000-0003-4026-4345	National Institute for Health Research Biomedical Research Centre, Oxford, United Kingdom; Cancer Research UK [C49297/A27294]; Netherlands Organization for Scientific Research [ZONMW 918.10.615, 91208004]	National Institute for Health Research Biomedical Research Centre, Oxford, United Kingdom(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Dr. Collins was supported by the National Institute for Health Research Biomedical Research Centre, Oxford, United Kingdom, and by programme grant C49297/A27294 from Cancer Research UK. Dr. Moons received grants from the Netherlands Organization for Scientific Research (ZONMW 918.10.615 and 91208004).	Beller EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001419; Bertens LCM, 2013, INT J CHRONIC OBSTR, V8, P493, DOI 10.2147/COPD.S49609; Chen JS, 2018, J DENT, V74, P23, DOI 10.1016/j.jdent.2018.04.025; Chhapola Viswas, 2018, J Evid Based Med, V11, P89, DOI 10.1111/jebm.12294; Chia YC, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-163; Chung-Esaki H, 2014, AM J EMERG MED, V32, P412, DOI 10.1016/j.ajem.2014.01.008; Cohen JF, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3751; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Cook NR, 2014, JAMA INTERN MED, V174, P1964, DOI 10.1001/jamainternmed.2014.5336; D'Agostino RB, 2014, CLIN INFECT DIS, V58, P1386, DOI 10.1093/cid/ciu107; Ghimire S, 2014, J CLIN EPIDEMIOL, V67, P658, DOI 10.1016/j.jclinepi.2013.10.012; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Heus P, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1099-2; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Keene SJ, 2019, INT J CHRONIC OBSTR, V14, P2395, DOI 10.2147/COPD.S212381; Lawton LD, 2014, EMERG MED J, V31, P384, DOI 10.1136/emermed-2012-201813; Martinez-Garcia MA, 2014, EUR RESPIR J, V43, P1357, DOI 10.1183/09031936.00026313; Mbuagbaw L, 2014, CONTEMP CLIN TRIALS, V38, P245, DOI 10.1016/j.cct.2014.05.012; Moons KGM, 2019, ANN INTERN MED, V170, pW1, DOI 10.7326/M18-1377; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Riley RD, 2019, PROGNOSIS RES HEALTH; Rundell SD, 2020, SPINE J, V20, P600, DOI 10.1016/j.spinee.2019.12.010; Speich B, 2019, WORLD J SURG, V43, P2371, DOI 10.1007/s00268-019-05064-1; Steyerberg E., 2009, CLIN PREDICTION MODE; Thangaratinam S, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0827-3; Vasquez-Cardenas J, 2019, AM J ORTHOD DENTOFAC, V156, P442, DOI 10.1016/j.ajodo.2019.05.009; Wang LQ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.6972; Wolff RF, 2019, ANN INTERN MED, V170, P51, DOI 10.7326/M18-1376	30	13	14	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2020	173	1					42	+		10.7326/M20-0193	http://dx.doi.org/10.7326/M20-0193			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MI6BV	32479165				2022-12-28	WOS:000547491700007
J	Shapiro, SD; Rothman, PB				Shapiro, Steven D.; Rothman, Paul B.			How Academic Health Systems Can Move Forward Once COVID-19 Wanes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses the role academic health systems can play in response to public health deficiencies identified in the coronavirus disease 2019 (COVID-19) pandemic, including developing early warning systems to identify future outbreaks, addressing community mental health needs more broadly, and working to reduce structural health inequities.	[Shapiro, Steven D.] Univ Pittsburgh, Med Ctr, 600 Grant St, Pittsburgh, PA 15219 USA; [Rothman, Paul B.] Johns Hopkins Med, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Medicine	Shapiro, SD (corresponding author), Univ Pittsburgh, Med Ctr, 600 Grant St, Pittsburgh, PA 15219 USA.	shapirosd@upmc.edu						Angus DC, 2020, JAMA-J AM MED ASSOC, V323, P1895, DOI 10.1001/jama.2020.4984; Bauchner H, 2020, JAMA-J AM MED ASSOC, V323, P1790, DOI 10.1001/jama.2020.6166; Galea S, 2020, JAMA INT MED; Kane CK, 2018, HEALTH AFFAIR, V37, P1923, DOI 10.1377/hlthaff.2018.05077; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548	7	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2020	323	23					2377	2378		10.1001/jama.2020.8002	http://dx.doi.org/10.1001/jama.2020.8002			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MC6EC	32433764	Bronze			2022-12-28	WOS:000543376700015
J	Esposito, E; Li, WL; Mandeville, ET; Park, JH; Sencan, I; Guo, SZ; Shi, JF; Lan, J; Lee, J; Hayakawa, K; Sakadzic, S; Ji, XM; Lo, EH				Esposito, Elga; Li, Wenlu; T. Mandeville, Emiri; Park, Ji-Hyun; Sencan, Ikbal; Guo, Shuzhen; Shi, Jingfei; Lan, Jing; Lee, Janice; Hayakawa, Kazuhide; Sakadzic, Sava; Ji, Xunming; Lo, Eng H.			Potential circadian effects on translational failure for neuroprotection	NATURE			English	Article							CEREBRAL-ISCHEMIA; ACUTE STROKE; CELL-DEATH; NXY-059; MK-801; DAMAGE; CLOCK; RATS; OPPORTUNITIES; THRESHOLDS	Neuroprotectant strategies that have worked in rodent models of stroke have failed to provide protection in clinical trials. Here we show that the opposite circadian cycles in nocturnal rodents versus diurnal humans(1,2) may contribute to this failure in translation. We tested three independent neuroprotective approaches-normobaric hyperoxia, the free radical scavenger alpha-phenyl-butyl-tert-nitrone (alpha PBN), and the N-methyl-d-aspartic acid (NMDA) antagonist MK801-in mouse and rat models of focal cerebral ischaemia. All three treatments reduced infarction in day-time (inactive phase) rodent models of stroke, but not in night-time (active phase) rodent models of stroke, which match the phase (active, day-time) during which most strokes occur in clinical trials. Laser-speckle imaging showed that the penumbra of cerebral ischaemia was narrower in the active-phase mouse model than in the inactive-phase model. The smaller penumbra was associated with a lower density of terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL)-positive dying cells and reduced infarct growth from 12 to 72 h. When we induced circadian-like cycles in primary mouse neurons, deprivation of oxygen and glucose triggered a smaller release of glutamate and reactive oxygen species, as well as lower activation of apoptotic and necroptotic mediators, in 'active-phase' than in 'inactive-phase' rodent neurons. alpha PBN and MK801 reduced neuronal death only in 'inactive-phase' neurons. These findings suggest that the influence of circadian rhythm on neuroprotection must be considered for translational studies in stroke and central nervous system diseases. Studies in rats and mice at different times of day suggest that the failure of neuroprotective strategies for stroke in translational studies might be related to the difference in circadian cycles between humans and rodents.	[Esposito, Elga; Li, Wenlu; T. Mandeville, Emiri; Park, Ji-Hyun; Guo, Shuzhen; Shi, Jingfei; Lan, Jing; Lee, Janice; Hayakawa, Kazuhide; Lo, Eng H.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Neuroprotect Res Labs, Boston, MA 02115 USA; [Esposito, Elga; Li, Wenlu; T. Mandeville, Emiri; Park, Ji-Hyun; Guo, Shuzhen; Shi, Jingfei; Lan, Jing; Lee, Janice; Hayakawa, Kazuhide; Lo, Eng H.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Neuroprotect Res Labs, Boston, MA 02115 USA; [Park, Ji-Hyun] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Sencan, Ikbal; Sakadzic, Sava] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Athinoula Martinos Ctr Biomed Imaging, Boston, MA 02115 USA; [Shi, Jingfei; Lan, Jing; Ji, Xunming] Capital Med Univ, XuanWu Hosp, Cerebrovasc Res Inst, Beijing, Peoples R China	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Seoul National University (SNU); Harvard University; Harvard Medical School; Massachusetts General Hospital; Capital Medical University	Lo, EH (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Neuroprotect Res Labs, Boston, MA 02115 USA.; Lo, EH (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Neuroprotect Res Labs, Boston, MA 02115 USA.	lo@helix.mgh.harvard.edu	Shi, Jingfei/AGG-5123-2022; Ji, Xunming/AAN-3370-2021; Sencan-Egilmez, Ikbal/GCE-9253-2022	Sencan-Egilmez, Ikbal/0000-0002-2903-041X; Ji, Xunming/0000-0003-0293-2744; Li, Wenlu/0000-0001-6507-392X; Shi, Jingfei/0000-0002-7879-9671	National Institutes of Health [K99MH120053, R01NS091230, R01MH111359]; Rappaport Foundation; Chinese Ministry of Education; National Research Foundation of Korea	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rappaport Foundation; Chinese Ministry of Education(Ministry of Education, China); National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported in part by grants from the National Institutes of Health (K99MH120053 (I.S.), R01NS091230 and R01MH111359 (S.S.)), the Rappaport Foundation (E.H.L.), the Chinese Ministry of Education (X.J.), and the National Research Foundation of Korea (J.-H.P.). The authors thank J. Lipton, M. Ning and W. Deng for discussions, Y. Sun and all team members of the MGH 149-8 animal facility for help with light schedule switching, and M. Ali and K. R. Lees for generous assistance and expert analysis of the VISTA database.	Ali Khalid, 2007, J Stroke Cerebrovasc Dis, V16, P239, DOI 10.1016/j.jstrokecerebrovasdis.2007.07.004; [Anonymous], 2019, VISTA DATABASE; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Banks WA, 2016, NAT REV DRUG DISCOV, V15, P275, DOI 10.1038/nrd.2015.21; Beker MC, 2018, MOL NEUROBIOL, V55, P2565, DOI 10.1007/s12035-017-0524-4; BUCHAN A, 1990, J NEUROSCI, V10, P311; BUCHAN AM, 1992, BRAIN RES, V574, P171, DOI 10.1016/0006-8993(92)90814-P; Campbell BCV, 2015, STROKE, V46, P2341, DOI 10.1161/STROKEAHA.114.007564; Campbell BCV, 2015, LANCET NEUROL, V14, P846, DOI 10.1016/S1474-4422(15)00140-4; CAO XH, 1994, BRAIN RES, V644, P267, DOI 10.1016/0006-8993(94)91689-6; Cederroth CR, 2019, CELL METAB, V30, P238, DOI 10.1016/j.cmet.2019.06.019; Chen CY, 2016, P NATL ACAD SCI USA, V113, P206, DOI 10.1073/pnas.1508249112; Ding JY, 2018, NEUROL RES, V40, P433, DOI 10.1080/01616412.2018.1454091; Donnan GA, 2009, LANCET NEUROL, V8, P261, DOI 10.1016/S1474-4422(09)70041-9; Durgan DJ, 2017, J CEREBR BLOOD F MET, V37, P2806, DOI 10.1177/0271678X16675879; Fan J, 2017, ADV NEUROBIOL, V15, P403, DOI 10.1007/978-3-319-57193-5_16; FOLBERGROVA J, 1995, P NATL ACAD SCI USA, V92, P5057, DOI 10.1073/pnas.92.11.5057; Ghorbel MT, 2003, MOL CELL NEUROSCI, V22, P396, DOI 10.1016/S1044-7431(02)00019-2; Green AR, 2003, PHARMACOL THERAPEUT, V100, P195, DOI 10.1016/j.pharmthera.2003.07.003; HEISS WD, 1992, STROKE, V23, P1668, DOI 10.1161/01.STR.23.11.1668; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Karmarkar SW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00313; Kim BJ, 2011, STROKE, V42, P1901, DOI 10.1161/STROKEAHA.110.602243; Kobayashi Y, 2015, NEURON, V86, P264, DOI 10.1016/j.neuron.2015.02.036; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Logan RW, 2019, NAT REV NEUROSCI, V20, P49, DOI 10.1038/s41583-018-0088-y; Lorenzano S, 2019, NEUROLOGY, V93, pE1288, DOI 10.1212/WNL.0000000000008158; Marshall JWB, 2003, STROKE, V34, P2228, DOI 10.1161/01.STR.0000087790.79851.A8; Marshall JWB, 2001, STROKE, V32, P190, DOI 10.1161/01.STR.32.1.190; Mure LS, 2018, SCIENCE, V359, P1232, DOI 10.1126/science.aao0318; Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317; Neuhaus AA, 2017, BRAIN, V140, P2079, DOI 10.1093/brain/awx126; Paschos GK, 2010, CIRC RES, V106, P833, DOI 10.1161/CIRCRESAHA.109.211706; Poli S, 2009, CURR MOL MED, V9, P227, DOI 10.2174/156652409787581619; Pritchett D, 2015, J BIOL RHYTHM, V30, P374, DOI 10.1177/0748730415592729; Pschorn U, 1996, J Stroke Cerebrovasc Dis, V6, P93, DOI 10.1016/S1052-3057(96)80010-3; REIMHERR FW, 1986, PSYCHOPHARMACOL BULL, V22, P237; Schulz JB, 1997, AM J PHYSIOL-HEART C, V272, pH1986, DOI 10.1152/ajpheart.1997.272.4.H1986; Schurr A, 2004, CURR DRUG TARGETS, V5, P603, DOI 10.2174/1389450043345209; Shi LG, 2018, J CEREBR BLOOD F MET, V38, P2073, DOI 10.1177/0271678X18798162; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; Tischkau SA, 2007, EXP NEUROL, V208, P314, DOI 10.1016/j.expneurol.2007.09.003; Vinall PE, 2000, J NEUROSURG, V93, P82, DOI 10.3171/jns.2000.93.1.0082; Wang TA, 2012, SCIENCE, V337, P839, DOI 10.1126/science.1222826	46	46	46	6	34	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 18	2020	582	7812					395	+		10.1038/s41586-020-2348-z	http://dx.doi.org/10.1038/s41586-020-2348-z		JUN 2020	15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QP4IP	32494010	Green Accepted			2022-12-28	WOS:000537932200008
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Review of ethnic disparities is labelled "whitewash" for lack of recommendations	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Public Health England, TERMS REF REV DISP R; RIMMER A, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1562; Soni R, 2020, INT J IMAGE GRAPH, V20, DOI 10.1142/S0219467820500096	3	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2020	369								m2208	10.1136/bmj.m2208	http://dx.doi.org/10.1136/bmj.m2208			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1WU	32493696	Bronze			2022-12-28	WOS:000548578300011
J	O'Dowd, A				O'Dowd, Adrian			Covid-19: Johnson is on back foot over next steps to control pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2109	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2020	369								m2152	10.1136/bmj.m2152	http://dx.doi.org/10.1136/bmj.m2152			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JZ	32467091	Bronze			2022-12-28	WOS:000538337300013
J	Qian, HW; Zhao, X; Yan, RH; Yao, X; Gao, S; Sun, X; Du, XM; Yang, HY; Wong, CCL; Yan, N				Qian Hongwu; Zhao Xin; Yan Renhong; Yao Xia; Gao Shuai; Sun Xue; Du Ximing; Yang Hongyuan; Wong, Catherine C. L.; Yan Nieng			Structural basis for catalysis and substrate specificity of human ACAT1	NATURE			English	Article							COA-CHOLESTEROL ACYLTRANSFERASE; ACYL-COENZYME; IDENTIFICATION; ENZYME; CELLS; ATHEROSCLEROSIS; ESTERIFICATION; PREGNENOLONE; PROGRESSION; INHIBITION	The structure of human ACAT1, which catalyses the transfer of an acyl group from acyl-coenzyme A to cholesterol to form cholesteryl ester, is resolved by cryo-electron microscopy. As members of the membrane-bound O-acyltransferase (MBOAT) enzyme family, acyl-coenzyme A:cholesterol acyltransferases (ACATs) catalyse the transfer of an acyl group from acyl-coenzyme A to cholesterol to generate cholesteryl ester, the primary form in which cholesterol is stored in cells and transported in plasma(1). ACATs have gained attention as potential drug targets for the treatment of diseases such as atherosclerosis, Alzheimer's disease and cancer(2-7). Here we present the cryo-electron microscopy structure of human ACAT1 as a dimer of dimers. Each protomer consists of nine transmembrane segments, which enclose a cytosolic tunnel and a transmembrane tunnel that converge at the predicted catalytic site. Evidence from structure-guided mutational analyses suggests that acyl-coenzyme A enters the active site through the cytosolic tunnel, whereas cholesterol may enter from the side through the transmembrane tunnel. This structural and biochemical characterization helps to rationalize the preference of ACAT1 for unsaturated acyl chains, and provides insight into the catalytic mechanism of enzymes within the MBOAT family(8).	[Qian Hongwu; Yao Xia; Gao Shuai; Yan Nieng] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Zhao Xin] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci,State Key Lab Membrane Biol, Beijing, Peoples R China; [Yan Renhong] Westlake Univ, Sch Life Sci, Key Lab Struct Biol Zhejiang Prov, Hangzhou, Peoples R China; [Yan Renhong] Westlake Inst Adv Study, Inst Biol, Hangzhou, Peoples R China; [Sun Xue; Wong, Catherine C. L.] Peking Univ, Peking Tsinghua Ctr Life Sci, State Key Lab Nat & Biomimet Drugs, Ctr Precis Med Multiom Res,Sch Pharmaceut Sci, Beijing, Peoples R China; [Du Ximing; Yang Hongyuan] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	Princeton University; Tsinghua University; Westlake University; Westlake University; Peking University; University of New South Wales Sydney	Qian, HW; Yan, N (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hongwuq@princeton.edu; nyan@princeton.edu	Qian, Hongwu/AAL-7468-2021; Yang, Hongyuan/AAR-1326-2020; Qian, Hongwu/GPT-1612-2022	Yang, Hongyuan/0000-0002-8482-6031; Yao, Xia/0000-0003-2406-268X; Sun, Xue/0000-0002-9716-7549; Gao, Shuai/0000-0002-8734-2489; Yan, Nieng/0000-0003-4829-7416	Princeton Center for Complex Materials; National Science Foundation (NSF)-MRSEC programme [DMR-1420541]; Ara Parseghian Medical Research Foundation; New Jersey Council for Cancer Research; Princeton University	Princeton Center for Complex Materials; National Science Foundation (NSF)-MRSEC programme(National Science Foundation (NSF)); Ara Parseghian Medical Research Foundation; New Jersey Council for Cancer Research; Princeton University(Princeton University)	We thank P. Shao for technical support during electron microscopy image acquisition; S. Kyin for technical support during the mass spectrometry analysis of cholesteryl oleate; and S. Dang for assistance with directional FSC analysis. We acknowledge the use of Princeton's Imaging and Analysis Center, which is partially supported by the Princeton Center for Complex Materials, and the National Science Foundation (NSF)-MRSEC programme (DMR-1420541). This work was supported in part by the Ara Parseghian Medical Research Foundation (N.Y). H.Q. is supported by the New Jersey Council for Cancer Research. N.Y. is supported by the Shirley M. Tilghman endowed professorship from Princeton University.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bhatt-Wessel B, 2018, ARCH BIOCHEM BIOPHYS, V655, P1, DOI 10.1016/j.abb.2018.08.001; Buglino JA, 2012, VITAM HORM, V88, P229, DOI 10.1016/B978-0-12-394622-5.00010-9; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Chang C, 2006, ACTA BIOCH BIOPH SIN, V38, P151, DOI 10.1111/j.1745-7270.2006.00154.x; Chang C.C.Y., 2011, FRONT BIOL, V6, P177, DOI DOI 10.1007/S11515-011-1149-Z; Chang CCY, 2010, BIOCHEMISTRY-US, V49, P9957, DOI 10.1021/bi1013936; Chang CCY, 2000, J BIOL CHEM, V275, P28083; Chang CCY, 1998, J BIOL CHEM, V273, P35132, DOI 10.1074/jbc.273.52.35132; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Dang SY, 2017, NATURE, V552, P426, DOI 10.1038/nature25024; Das A, 2008, J LIPID RES, V49, P1770, DOI 10.1194/jlr.M800131-JLR200; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ghosh S, 2010, VASC PHARMACOL, V52, P1, DOI 10.1016/j.vph.2009.10.002; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Guo ZY, 2007, BIOCHEMISTRY-US, V46, P10063, DOI 10.1021/bi7011367; Guo ZM, 2001, J LIPID RES, V42, P1282; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Hartmann T, 2007, J NEUROCHEM, V103, P159, DOI 10.1111/j.1471-4159.2007.04715.x; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hsiao YS, 2006, J BIOL CHEM, V281, P28480, DOI 10.1074/jbc.M602622200; Jiang Y, 2019, NATURE, V567, P257, DOI 10.1038/s41586-019-0987-8; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kojima M, 2016, J BIOCHEM, V160, P189, DOI 10.1093/jb/mvw046; Lee KA, 2003, J BIOL CHEM, V278, P44593, DOI 10.1074/jbc.M308312200; Li J, 2016, ONCOGENE, V35, P6378, DOI 10.1038/onc.2016.168; Liu J, 2005, BIOCHEM J, V391, P389, DOI 10.1042/BJ20050428; Ma D, 2018, NATURE, V562, P286, DOI 10.1038/s41586-018-0568-2; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Meuwese MC, 2009, JAMA-J AM MED ASSOC, V301, P1131, DOI 10.1001/jama.301.11.1131; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Nissen SE, 2006, NEW ENGL J MED, V354, P1253, DOI 10.1056/NEJMoa054699; Ohshiro T, 2011, ARTERIOSCL THROM VAS, V31, P1108, DOI 10.1161/ATVBAHA.111.223552; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rogers MA, 2012, J BIOL CHEM, V287, P17483, DOI 10.1074/jbc.M111.331306; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rudel LL, 2000, NAT MED, V6, P1313, DOI 10.1038/82110; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shibuya Y, 2015, FUTURE MED CHEM, V7, P2451, DOI 10.4155/fmc.15.161; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tardif JC, 2004, CIRCULATION, V110, P3372, DOI 10.1161/01.CIR.0000147777.12010.EF; Ulaganathan V, 2007, J MOL BIOL, V369, P305, DOI 10.1016/j.jmb.2007.03.039; Yang W, 2016, NATURE, V531, P651, DOI 10.1038/nature17412; Yu CJ, 2002, BIOCHEMISTRY-US, V41, P3762, DOI 10.1021/bi0120188; Yu CJ, 1999, J BIOL CHEM, V274, P36139, DOI 10.1074/jbc.274.51.36139; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang Y, 2003, J BIOL CHEM, V278, P11642, DOI 10.1074/jbc.M211559200; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	58	34	34	9	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY	2020	581	7808					333	+		10.1038/s41586-020-2290-0	http://dx.doi.org/10.1038/s41586-020-2290-0		MAY 2020	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ2CZ	32433614	Green Submitted			2022-12-28	WOS:000532688300004
J	Liang, GX; Zhao, CY; Zhang, HJ; Mattei, L; Sherrill-Mix, S; Bittinger, K; Kessler, LR; Wu, GD; Baldassano, RN; DeRusso, P; Ford, E; Elovitz, MA; Kelly, MS; Patel, MZ; Mazhani, T; Gerber, JS; Kelly, A; Zemel, BS; Bushman, FD				Liang, Guanxiang; Zhao, Chunyu; Zhang, Huanjia; Mattei, Lisa; Sherrill-Mix, Scott; Bittinger, Kyle; Kessler, Lyanna R.; Wu, Gary D.; Baldassano, Robert N.; DeRusso, Patricia; Ford, Eileen; Elovitz, Michal A.; Kelly, Matthew S.; Patel, Mohamed Z.; Mazhani, Tiny; Gerber, Jeffrey S.; Kelly, Andrea; Zemel, Babette S.; Bushman, Frederic D.			The stepwise assembly of the neonatal virome is modulated by breastfeeding	NATURE			English	Article							HUMAN-MILK; DYNAMICS; VIRUSES; DIVERSITY; SAPOVIRUS; DIARRHEA; INFANTS; DEATHS	The infant gut is colonized first by temperate bacteriophages induced from pioneer bacteria and later by viruses that replicate in human cells, the populations of which are modulated by breastfeeding. The gut of healthy human neonates is usually devoid of viruses at birth, but quickly becomes colonized, which-in some cases-leads to gastrointestinal disorders(1-4). Here we show that the assembly of the viral community in neonates takes place in distinct steps. Fluorescent staining of virus-like particles purified from infant meconium or early stool samples shows few or no particles, but by one month of life particle numbers increase to 10(9) per gram, and these numbers seem to persist throughout life(5-7). We investigated the origin of these viral populations using shotgun metagenomic sequencing of virus-enriched preparations and whole microbial communities, followed by targeted microbiological analyses. Results indicate that, early after birth, pioneer bacteria colonize the infant gut and by one month prophages induced from these bacteria provide the predominant population of virus-like particles. By four months of life, identifiable viruses that replicate in human cells become more prominent. Multiple human viruses were more abundant in stool samples from babies who were exclusively fed on formula milk compared with those fed partially or fully on breast milk, paralleling reports that breast milk can be protective against viral infections(8-10). Bacteriophage populations also differed depending on whether or not the infant was breastfed. We show that the colonization of the infant gut is stepwise, first mainly by temperate bacteriophages induced from pioneer bacteria, and later by viruses that replicate in human cells; this second phase is modulated by breastfeeding.	[Liang, Guanxiang; Sherrill-Mix, Scott; Kessler, Lyanna R.; Bushman, Frederic D.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Liang, Guanxiang; Zhao, Chunyu; Zhang, Huanjia; Mattei, Lisa; Bittinger, Kyle; Baldassano, Robert N.; DeRusso, Patricia; Ford, Eileen; Zemel, Babette S.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Wu, Gary D.] Univ Penn, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Elovitz, Michal A.] Univ Penn, Perelman Sch Med, Dept Obstet & Gynecol, Maternal & Child Hlth Res Ctr, Philadelphia, PA 19104 USA; [Kelly, Matthew S.] Duke Univ, Div Pediat Infect Dis, Durham, NC USA; [Patel, Mohamed Z.; Mazhani, Tiny] Univ Botswana, Dept Paediat & Adolescent Hlth, Fac Med, Gaborone, Botswana; [Gerber, Jeffrey S.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Kelly, Andrea] Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Duke University; University of Botswana; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Bushman, FD (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	bushman@pennmedicine.upenn.edu	Bittinger, Kyle/ABG-2342-2020; Liang, Guanxiang/CAG-8838-2022; Zemel, Babette S./D-1117-2009; Liang, Guanxiang/C-7108-2018; Gerber, Jeffrey/GYD-3567-2022	Zemel, Babette S./0000-0002-6164-7348; Liang, Guanxiang/0000-0002-7367-2516; Gerber, Jeffrey/0000-0002-3076-3186; Mattei, Lisa/0000-0002-2238-0281; Kessler, Lyanna/0000-0002-0021-7969; Sherrill-Mix, Scott/0000-0002-8955-8072	NIH [R61-HL137063, R01-HL113252, R01DK107565, K23 AI135090]; Penn Center for AIDS Research [P30 AI 045008]; PennCHOP Microbiome Program; Tobacco Formula grant under the Commonwealth Universal Research Enhancement (CURE) program [SAP 4100068710]; American Beverage Foundation; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000003, UL1TR001878]; Duke Center for AIDS Research [5P30 AI064518]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn Center for AIDS Research; PennCHOP Microbiome Program; Tobacco Formula grant under the Commonwealth Universal Research Enhancement (CURE) program; American Beverage Foundation; National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Duke Center for AIDS Research	We thank J. You and co-workers for help with imaging, M. Goulian and co-workers for bacterial strains, and F. Rohwer and associates for assistance with phage induction; members of the Bushman laboratory for help and suggestions; and L. Zimmerman for artwork and help with the manuscript. The Botswana Infant Microbiome Study team thank Copan Italia for their donation of the eNAT medium and flocked swabs used for the collection of rectal swab specimens. This work was supported by NIH grants R61-HL137063 (F.D.B.), R01-HL113252 (F.D.B.) and R01DK107565 (G.D.W. and E.F.). The project described was also supported by the Penn Center for AIDS Research (P30 AI 045008) (F.D.B.), the PennCHOP Microbiome Program (F.D.B., G.D.W. and R.N.B.) and a Tobacco Formula grant under the Commonwealth Universal Research Enhancement (CURE) program (grant number SAP 4100068710) (F.D.B. and R.N.B.). Funding was also provided by an unrestricted donation from the American Beverage Foundation for a Healthy America to the Children's Hospital of Philadelphia to support the Healthy Weight Program (C.Z., K.B., E.F., J.S.G. and B.S.Z.). The project was also supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through grants UL1TR000003 and UL1TR001878 (E.F.). Funding for the Botswana Infant Microbiome Study was provided by the Duke Center for AIDS Research (5P30 AI064518) and the NIH (K23 AI135090).	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Abbas AA, 2017, AM J TRANSPLANT, V17, P1313, DOI 10.1111/ajt.14076; Abbas AA, 2019, AM J TRANSPLANT, V19, P1086, DOI 10.1111/ajt.15116; Aggarwala V, 2017, MOBILE DNA-UK, V8, DOI 10.1186/s13100-017-0095-y; Arifeen S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e67; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Bahl R, 2005, B WORLD HEALTH ORGAN, V83, P418; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Baumann-Dudenhoeffer AM, 2018, NAT MED, V24, P1822, DOI 10.1038/s41591-018-0216-2; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Breitbart M, 2008, RES MICROBIOL, V159, P367, DOI 10.1016/j.resmic.2008.04.006; Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Chehoud C, 2016, MBIO, V7, DOI 10.1128/mBio.00322-16; Clarke EL, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0658-x; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5; Dutilh BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5498; Guerin E, 2018, CELL HOST MICROBE, V24, P653, DOI 10.1016/j.chom.2018.10.002; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hoyles L, 2014, RES MICROBIOL, V165, P803, DOI 10.1016/j.resmic.2014.10.006; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; JACOB F, 1954, CR HEBD ACAD SCI, V239, P317; JACOB F, 1962, CR HEBD ACAD SCI, V254, P4214; Jothikumar N, 2005, APPL ENVIRON MICROB, V71, P3131, DOI 10.1128/AEM.71.6.3131-3136.2005; Kao DM, 2012, GENOMICS, V100, P157, DOI 10.1016/j.ygeno.2012.06.002; Kim MS, 2011, APPL ENVIRON MICROB, V77, P8062, DOI 10.1128/AEM.06331-11; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lauder AP, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0172-3; Lepage P, 2008, GUT, V57, DOI 10.1136/gut.2007.134668; Lewis ED, 2017, CLIN PERINATOL, V44, P23, DOI 10.1016/j.clp.2016.11.008; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lim ES, 2015, NAT MED, V21, P1228, DOI 10.1038/nm.3950; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; McNair K, 2012, BIOINFORMATICS, V28, P614, DOI 10.1093/bioinformatics/bts014; Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110; Minot S, 2012, P NATL ACAD SCI USA, V109, P3962, DOI 10.1073/pnas.1119061109; Munnink BBO, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020042; Newburg DS, 2005, ANNU REV NUTR, V25, P37, DOI 10.1146/annurev.nutr.25.050304.092553; Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Ptashne M, 1986, GENETIC SWITCH; Pundir Sangya, 2015, Curr Protoc Bioinformatics, V50, DOI 10.1002/0471250953.bi0127s50; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rolfe KJ, 2007, J CLIN VIROL, V39, P318, DOI 10.1016/j.jcv.2007.05.005; Shkoporov AN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07225-7; Theis KR, 2019, AM J OBSTET GYNECOL, V220, DOI 10.1016/j.ajog.2018.10.018; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Turin Christie G, 2014, Curr Trop Med Rep, V1, P97; van Maarseveen NM, 2010, J CLIN VIROL, V49, P205, DOI 10.1016/j.jcv.2010.07.019; Verstrepen WA, 2001, J CLIN MICROBIOL, V39, P4093, DOI 10.1128/JCM.39.11.4093-4096.2001; VICTORA CG, 1989, AM J EPIDEMIOL, V129, P1032, DOI 10.1093/oxfordjournals.aje.a115207; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Wolf YI, 2018, MBIO, V9, DOI 10.1128/mBio.02329-18; Young GR, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-23; Yutin N, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0053-y	59	90	92	11	69	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 28	2020	581	7809					470	+		10.1038/s41586-020-2192-1	http://dx.doi.org/10.1038/s41586-020-2192-1		APR 2020	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX9ZL	32461640	Green Accepted			2022-12-28	WOS:000534394600001
J	Kilaru, AS; Mahoney, KB				Kilaru, Austin S.; Mahoney, Kevin B.			The Death Throes of Mercy - Our Shared Responsibility When Hospitals Close	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kilaru, Austin S.] Univ Penn, Perelman Sch Med, Natl Clinician Scholars Program, Philadelphia, PA 19104 USA; [Kilaru, Austin S.] Univ Penn, Perelman Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA; [Mahoney, Kevin B.] Univ Penn, Perelman Sch Med, Univ Penn Hlth Syst, Off Chief Execut Officer, Philadelphia, PA 19104 USA; [Kilaru, Austin S.] Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Kilaru, AS (corresponding author), Univ Penn, Perelman Sch Med, Natl Clinician Scholars Program, Philadelphia, PA 19104 USA.; Kilaru, AS (corresponding author), Univ Penn, Perelman Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA.; Kilaru, AS (corresponding author), Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA 19104 USA.			Kilaru, Austin/0000-0002-3141-1772				Brubaker Harold, 2019, PHILADELPHIA INQUIRE; Frakt AB, 2019, JAMA-J AM MED ASSOC, V321, P2271, DOI 10.1001/jama.2019.7377; Laderman M, 2016, JT COMM J QUAL PATIE, V42, P331, DOI 10.1016/S1553-7250(16)42046-5; Rosenbaum L, 2019, NEW ENGL J MED, V381, P1193, DOI 10.1056/NEJMp1911307; Tsai TC, 2020, HLTH AFFAIRS BLOG	5	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2020	383	8					706	708		10.1056/NEJMp2002953	http://dx.doi.org/10.1056/NEJMp2002953			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NG2MJ	32459915	Bronze			2022-12-28	WOS:000563818700009
J	Beach, SL				Beach, Shire Lynn			Of Heroes and Cowards	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Beach, Shire Lynn] Univ Calif Los Angeles, Dept Internal Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Beach, SL (corresponding author), Univ Calif Los Angeles, Dept Internal Med, Los Angeles, CA 90095 USA.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2020	383	6							e36	10.1056/NEJMp2013266	http://dx.doi.org/10.1056/NEJMp2013266			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NB3TI	32492297	Bronze			2022-12-28	WOS:000560438400002
J	Strasser, BJ; Schlich, T				Strasser, Bruno J.; Schlich, Thomas			The art of medicine A history of the medical mask and the rise of throwaway culture	LANCET			English	Editorial Material									[Strasser, Bruno J.] Univ Geneva, CH-1211 Geneva 4, Switzerland; [Schlich, Thomas] McGill Univ, Dept Social Studies Med, Montreal, PQ, Canada	University of Geneva; McGill University	Strasser, BJ (corresponding author), Univ Geneva, CH-1211 Geneva 4, Switzerland.	bruno.strasser@unige.ch	Strasser, Bruno J/E-9337-2012	Strasser, Bruno J./0000-0002-2773-6670					0	47	48	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2020	396	10243					19	20		10.1016/S0140-6736(20)31207-1	http://dx.doi.org/10.1016/S0140-6736(20)31207-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0VO	32450110	Green Published, Bronze			2022-12-28	WOS:000561626100009
J	Adams, JM				Adams, Jerome M.			Smoking Cessation-Progress, Barriers, and New Opportunities: The Surgeon General's Report on Smoking Cessation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Adams, Jerome M.] US Dept HHS, Off Surg Gen, US PHS, 200 Independence Ave SW, Washington, DC 20201 USA	United States Public Health Service	Adams, JM (corresponding author), US Dept HHS, Off Surg Gen, US PHS, 200 Independence Ave SW, Washington, DC 20201 USA.	surgeongeneral@hhs.gov						Creamer MR, 2019, MMWR-MORBID MORTAL W, V68, P1013, DOI 10.15585/mmwr.mm6845a2; King BA, 2018, NICOTINE TOB RES, V20, P1033, DOI 10.1093/ntr/ntx266; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; U.S. Department of Health Education and Welfare, 1964, SMOK HLTH REP ADV CO; U.S. Surgeon General, 2018, SURG GEN ADV E CIG U; US Department of Health and Human Services, 2020, SMOK CESS REP SURG G; US Department of Health and Human Services, 1990, DHHS PUBL CDC, V(CDC) 90-8416	7	14	14	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2470	2471		10.1001/jama.2020.6647	http://dx.doi.org/10.1001/jama.2020.6647			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32432659				2022-12-28	WOS:000590149400013
J	Starr, P				Starr, Paul			Using Controlled Trials to Resolve Key Unknowns About Policy During the COVID-19 Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint proposes implementing comparison groups for policy decisions, for example assessing disease transmission with alternative housing vs in-home isolation of individuals who test positive for coronavirus disease 2019 (COVID-19), or with different durations or cycles of school openings, to gather data that could make broader and future policy implementations more informed and effective.	[Starr, Paul] Princeton Univ, 124 Wallace Hall, Princeton, NJ 08544 USA	Princeton University	Starr, P (corresponding author), Princeton Univ, 124 Wallace Hall, Princeton, NJ 08544 USA.	starr@princeton.edu						Centers for Disease Control and Prevention, COR DIS 2019 COVID 1, DOI DOI 10.1016/S0140-6736(20)30211-7; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Jones TC, 2020, ANAL SARS COV 2 VIRA; Kolata G, DID CLOSING SCH ACTU; National Centre for Immunisation Research and Surveillance NCIRS, COVID 19 SCH EXP NSW; State of New Jersey, GOV MURPH ANN ROAD B; Yglesias M, SUCCESSFUL ASIAN COR	7	5	5	2	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2020	323	23					2369	2370		10.1001/jama.2020.8573	http://dx.doi.org/10.1001/jama.2020.8573			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MC6EC	32463427	Bronze			2022-12-28	WOS:000543376700011
J	Sternberg, CN; Fizazi, K; Saad, F; Shore, ND; De Giorgi, U; Penson, DF; Ferreira, U; Efstathiou, E; Madziarska, K; Kolinsky, MP; Cubero, DIG; Noerby, B; Zohren, F; Lin, X; Modelska, K; Sugg, J; Steinberg, J; Hussain, M				Sternberg, Cora N.; Fizazi, Karim; Saad, Fred; Shore, Neal D.; De Giorgi, Ugo; Penson, David F.; Ferreira, Ubirajara; Efstathiou, Eleni; Madziarska, Katarzyna; Kolinsky, Michael P.; Cubero, Daniel I. G.; Noerby, Bettina; Zohren, Fabian; Lin, Xun; Modelska, Katharina; Sugg, Jennifer; Steinberg, Joyce; Hussain, Maha		PROSPER Investigators	Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND; MEN; BICALUTAMIDE; APALUTAMIDE	BACKGROUND Preliminary trial results showed that enzalutamide significantly improved metastasis-free survival among men who had nonmetastatic, castration-resistant prostate cancer and rapidly increasing prostate-specific antigen (PSA) levels while taking androgen-deprivation therapy. Results from the final analysis of overall survival have not yet been reported. METHODS In this double-blind, phase 3 trial, men with nonmetastatic, castration-resistant prostate cancer (defined on the basis of conventional imaging and a PSA doubling time of <= 10 months) who were continuing to receive androgen-deprivation therapy were randomly assigned (in a 2:1 ratio) to receive enzalutamide at a dose of 160 mg or placebo once daily. Overall survival was assessed with a group sequential testing procedure and an O'Brien-Fleming-type alpha-spending function. RESULTS As of October 15, 2019, a total of 288 of 933 patients (31%) in the enzalutamide group and 178 of 468 (38%) in the placebo group had died. Median overall survival was 67.0 months (95% confidence interval [CI], 64.0 to not reached) in the enzalutamide group and 56.3 months (95% CI, 54.4 to 63.0) in the placebo group (hazard ratio for death, 0.73; 95% CI, 0.61 to 0.89; P=0.001). The exposure-adjusted rate of adverse events of grade 3 or higher was 17 per 100 patient-years in the enzalutamide group and 20 per 100 patient-years in the placebo group. Adverse events in the enzalutamide group were consistent with those previously reported for enzalutamide; the most frequently reported events were fatigue and musculoskeletal events. CONCLUSIONS Enzalutamide plus androgen-deprivation therapy resulted in longer median overall survival than placebo plus androgen-deprivation therapy among men with nonmetastatic, castration-resistant prostate cancer and a rapidly rising PSA level. The risk of death associated with enzalutamide was 27% lower than with placebo. Adverse events were consistent with the established safety profile of enzalutamide.	[Sternberg, Cora N.] Weill Cornell Med, Englander Inst Precis Med, New York, NY USA; [Fizazi, Karim] Univ Paris Saclay, Villejuif, France; [Saad, Fred] Univ Montreal Hosp Ctr, Montreal, PQ, Canada; [Kolinsky, Michael P.] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada; [Shore, Neal D.] Carolina Urol Res Ctr, Myrtle Beach, SC USA; [De Giorgi, Ugo] IRCCS, Ist Sci Romagnolo Studio & Cura Tumori IRST, Meldola, Italy; [Penson, David F.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Ferreira, Ubirajara] State Univ Campinas Unicamp, Campinas, Brazil; [Cubero, Daniel I. G.] ABC Fdn Sch Med, Santo Andre, SP, Brazil; [Efstathiou, Eleni] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Madziarska, Katarzyna] Wroclaw Med Univ, Wroclaw, Poland; [Noerby, Bettina] Sygehus Lillebaelt, Vejle, Denmark; [Zohren, Fabian; Lin, Xun] Pfizer, La Jolla, CA USA; [Modelska, Katharina] Pfizer, San Francisco, CA USA; [Sugg, Jennifer; Steinberg, Joyce] Astellas Pharma, Northbrook, IL USA; [Hussain, Maha] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Cornell University; UDICE-French Research Universities; Universite Paris Saclay; Universite de Montreal; University of Alberta; Carolina Urologic Research Center; IRCCS Meldola (IRST); Vanderbilt University; Universidade Estadual de Campinas; University of Texas System; UTMD Anderson Cancer Center; Wroclaw Medical University; Pfizer; Pfizer; Astellas Pharmaceuticals; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Sternberg, CN (corresponding author), Weill Cornell Med, Belfer Res Bldg,413 E 69th St,Rm 1412, New York, NY 10021 USA.	cns9006@med.cornell.edu	Cubero, Daniel IG/N-8720-2013; Cubero, Daniel/ABD-1856-2020; Lin, Xun/AAM-9287-2021	Cubero, Daniel IG/0000-0002-1936-2605; Cubero, Daniel/0000-0002-1936-2605; Lacombe, Louis/0000-0003-4811-0308; Alcaraz Asensio, Antonio/0000-0003-2612-5250; OUDARD, Stephane/0000-0003-0893-285X; ZAPATERO, ALMUDENA/0000-0003-2930-2312; LADOIRE, Sylvain/0000-0002-0331-9194; Calabro', Fabio/0000-0002-7863-3540; de Jong, Igle J./0000-0002-3444-5548	Pfizer; Astellas Pharma	Pfizer(Pfizer); Astellas Pharma(Astellas Pharmaceuticals)	Funded by Pfizer and Astellas Pharma; PROSPER ClinicalTrials.gov number, NCT02003924.	Afshar M, 2015, UROL ONCOL, V33, P338, DOI DOI 10.1016/J.UR0L0NC.2015.05.003; [Anonymous], 2020, DAR PLUS ANDR DEPR T; [Anonymous], 2018, XTAND ENZ PRESCR INF; Appukkuttan S, 2020, PHARMACOECON-OPEN, V4, P439, DOI 10.1007/s41669-019-00185-8; Armstrong AJ, 2019, J CLIN ONCOL, V37, P2974, DOI 10.1200/JCO.19.00799; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Fendler WP, 2019, CLIN CANCER RES, V25, P7448, DOI 10.1158/1078-0432.CCR-19-1050; Fizazi K, 2019, NEW ENGL J MED, V380, P1235, DOI 10.1056/NEJMoa1815671; Gillessena S, 2020, EUR UROL, V77, P508, DOI 10.1016/j.eururo.2020.01.012; Hussain M, 2018, NEW ENGL J MED, V378, P2465, DOI 10.1056/NEJMoa1800536; Jenkins V, 2019, CLIN ONCOL-UK, V31, P99, DOI 10.1016/j.clon.2018.11.001; Mateo J, 2019, EUR UROL, V75, P285, DOI 10.1016/j.eururo.2018.07.035; Penson DF, 2016, J CLIN ONCOL, V34, P2098, DOI 10.1200/JCO.2015.64.9285; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Shore ND, 2016, LANCET ONCOL, V17, P153, DOI 10.1016/S1470-2045(15)00518-5; Small EJ, 2019, ANN ONCOL, V30, P1813, DOI 10.1093/annonc/mdz397; Smith MR, 2018, NEW ENGL J MED, V378, P1408, DOI 10.1056/NEJMoa1715546; Smith MR, 2005, J CLIN ONCOL, V23, P2918, DOI 10.1200/JCO.2005.01.529; Tombal B, 2019, LANCET ONCOL, V20, P556, DOI 10.1016/S1470-2045(18)30898-2; WHO, 2020, 59 HLTH ASS; Xie WL, 2017, J CLIN ONCOL, V35, P3097, DOI 10.1200/JCO.2017.73.9987	21	153	157	3	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2020	382	23					2197	2206		10.1056/NEJMoa2003892	http://dx.doi.org/10.1056/NEJMoa2003892			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV0NI	32469184	Bronze, Green Published			2022-12-28	WOS:000538140600013
J	Callahan, A; Shah, NH; Chen, JH				Callahan, Alison; Shah, Nigam H.; Chen, Jonathan H.			Research and Reporting Considerations for Observational Studies Using Electronic Health Record Data	ANNALS OF INTERNAL MEDICINE			English	Article							CAUSAL INFERENCE; PROPENSITY SCORES; MISSING DATA; ALGORITHMS; SUPERIOR	Electronic health records (EHRs) are an increasingly important source of real-world health care data for observational research. Analyses of data collected for purposes other than research require careful consideration of data quality as well as the general research and reporting principles relevant to observational studies. The core principles for observational research in general also apply to observational research using EHR data, and these are well addressed in prior literature and guidelines. This article provides additional recommendations for EHR-based research. Considerations unique to EHR-based studies include assessment of the accuracy of computer-executable cohort definitions that can incorporate unstructured data from clinical notes and management of data challenges, such as irregular sampling, missingness, and variation across time and place. Principled application of existing research and reporting guidelines alongside these additional considerations will improve the quality of EHR-based observational studies.	[Callahan, Alison; Shah, Nigam H.] Stanford Univ, Sch Med, Ctr Biomed Informat Res, Stanford, CA 94305 USA; [Chen, Jonathan H.] Stanford Univ, Sch Med, Div Hosp Med, Stanford, CA 94305 USA; [Callahan, Alison; Shah, Nigam H.; Chen, Jonathan H.] Stanford Univ, Med Sch, Room X231,Off Bldg,1265 Welch Rd, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Callahan, A (corresponding author), Stanford Univ, Med Sch, Room X231,Off Bldg,1265 Welch Rd, Stanford, CA 94305 USA.	acallaha@stanford.edu		Chen, Jonathan H./0000-0002-4387-8740	National Institutes of Health (NIH) National Library of Medicine [5R01LM01136906]; NIH National Institute of General Medical Sciences [5R01GM10143005]; NIH Big Data to Knowledge initiative via the National Institute of Environmental Health Sciences [K01ES026837]	National Institutes of Health (NIH) National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH Big Data to Knowledge initiative via the National Institute of Environmental Health Sciences	Drs. Callahan and Shah are supported by the National Institutes of Health (NIH) National Library of Medicine under award 5R01LM01136906 and the NIH National Institute of General Medical Sciences under award 5R01GM10143005. Dr. Chen is supported by the NIH Big Data to Knowledge initiative via the National Institute of Environmental Health Sciences under award K01ES026837.	Agniel D, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1479; Al Achkar M, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1246-7; Arbogast PG, 2011, AM J EPIDEMIOL, V174, P613, DOI 10.1093/aje/kwr143; Austin PC, 2014, STAT MED, V33, P1057, DOI 10.1002/sim.6004; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Averill RF, 2003, ALL PATIENT REFINED; Banda JM, 2018, ANNU REV BIOMED DA S, V1, P53, DOI 10.1146/annurev-biodatasci-080917-013315; Bartlett VL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.12869; Beaulieu-Jones BK, 2018, JMIR MED INF, V6, DOI 10.2196/medinform.8960; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Berdahl CT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.11390; Biondi-Zoccai G, 2011, CONTEMP CLIN TRIALS, V32, P731, DOI 10.1016/j.cct.2011.05.006; Brown JS, 2013, MED CARE, V51, pS22, DOI 10.1097/MLR.0b013e31829b1e2c; Cafri G, 2019, STAT METHODS MED RES, V28, P3142, DOI 10.1177/0962280218799540; Callahan Tiffany J, 2017, EGEMS (Wash DC), V5, P8, DOI 10.5334/egems.223; Carrell DS, 2015, INT J MED INFORM, V84, P1057, DOI 10.1016/j.ijmedinf.2015.09.002; Chen JH, 2017, INT J MED INFORM, V102, P71, DOI 10.1016/j.ijmedinf.2017.03.006; Chen JH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004760; Chescheir N, 2009, OBSTET GYNECOL, V114, P217, DOI 10.1097/AOG.0b013e3181ad9533; Chute CG, 2014, AM J EPIDEMIOL, V179, P759, DOI 10.1093/aje/kwt443; CommonDataModel, COMM; Eekhout I, 2012, EPIDEMIOLOGY, V23, P729, DOI 10.1097/EDE.0b013e3182576cdb; FISHER ES, 1992, AM J PUBLIC HEALTH, V82, P243, DOI 10.2105/AJPH.82.2.243; Freemantle N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6409; Hariharan J, 2007, J GEN INTERN MED, V22, P485, DOI 10.1007/s11606-006-0084-1; Hirschtick RE, 2006, JAMA-J AM MED ASSOC, V295, P2335, DOI 10.1001/jama.295.20.2335; Hripcsak G, 2015, STUD HEALTH TECHNOL, V216, P574, DOI 10.3233/978-1-61499-564-7-574; Huser V, 2018, BIOCOMPUT-PAC SYM, P628; Huser Vojtech, 2016, EGEMS (Wash DC), V4, P1239, DOI 10.13063/2327-9214.1239; Jung K, 2015, J BIOMED INFORM, V58, P168, DOI 10.1016/j.jbi.2015.10.006; Kirby JC, 2016, J AM MED INFORM ASSN, V23, P1046, DOI 10.1093/jamia/ocv202; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Levinson W, 2018, JAMA-J AM MED ASSOC, V319, P1975, DOI 10.1001/jama.2018.2202; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; Madden JM, 2016, J AM MED INFORM ASSN, V23, P1143, DOI 10.1093/jamia/ocw021; Mandel JC, 2016, J AM MED INFORM ASSN, V23, P899, DOI 10.1093/jamia/ocv189; Manning C, 1999, FDN STAT NATURAL LAN; Manning CD, 2008, INTRO INFORM RETRIEV; Marafino Ben J, 2018, AMIA Jt Summits Transl Sci Proc, V2017, P166; Moreno-Torres JG, 2012, PATTERN RECOGN, V45, P521, DOI 10.1016/j.patcog.2011.06.019; Newton KM, 2013, J AM MED INFORM ASSN, V20, pE147, DOI 10.1136/amiajnl-2012-000896; Pearl J, 2009, STAT SURV, V3, P96, DOI 10.1214/09-SS057; Perkins NJ, 2018, AM J EPIDEMIOL, V187, P568, DOI 10.1093/aje/kwx348; Reker DM, 2001, J REHABIL RES DEV, V38, P281; Richesson RL, 2016, ARTIF INTELL MED, V71, P57, DOI 10.1016/j.artmed.2016.05.005; Rosenbluth G, 2016, BMJ QUAL SAF, V25, P324, DOI 10.1136/bmjqs-2015-004585; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Shivade C, 2014, J AM MED INFORM ASSN, V21, P221, DOI 10.1136/amiajnl-2013-001935; Smith M, 2012, BEST CARE LOWER COST; Stuart EA, 2013, GEMS WASH DC, V1, DOI [10.13063/2327-9214.1038, DOI 10.13063/2327-9214.1038]; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Toh S, 2011, PHARMACOEPIDEM DR S, V20, P849, DOI 10.1002/pds.2152; Vashisht R, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1755; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Walsh CG, 2017, J BIOMED INFORM, V76, P9, DOI 10.1016/j.jbi.2017.10.008; Wei WQ, 2016, J AM MED INFORM ASSN, V23, pE20, DOI 10.1093/jamia/ocv130; Wells Brian J, 2013, EGEMS (Wash DC), V1, P1035, DOI 10.13063/2327-9214.1035; Wood Angela M, 2004, Clin Trials, V1, P368; Wright A, 2015, INT J MED INFORM, V84, P784, DOI 10.1016/j.ijmedinf.2015.06.011; Xu S, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.10967	60	18	19	2	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2020	172			11			S79	S84		10.7326/M19-0873	http://dx.doi.org/10.7326/M19-0873			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MH8ZH	32479175	Green Accepted			2022-12-28	WOS:000547009900003
J	Trost, BM; Wang, YL; Buckl, AK; Huang, ZX; Nguyen, MH; Kuzmina, O				Trost, Barry M.; Wang, Youliang; Buckl, Andreas K.; Huang, Zhongxing; Nguyen, Minh H.; Kuzmina, Olesya			Total synthesis of bryostatin 3	SCIENCE			English	Article							SOUTHERN-HEMISPHERE; PATHWAY; ANALOGS	Bryostatins are a family of 21 complex marine natural products with a wide range of potent biological activities. Among all the 21 bryostatins, bryostatin 3 is structurally the most complex. Whereas nine total syntheses of bryostatins have been achieved to date, bryostatin 3 has only been targeted once and required the highest number of steps to synthesize (43 steps in the longest linear sequence and 88 total steps). Here, we report a concise total synthesis of bryostatin 3 using 22 steps in the longest linear sequence and 31 total steps through a highly convergent synthetic plan by the use of highly atom-economical and chemoselective transformations in which alkynes played a major role in reducing step count.	[Trost, Barry M.; Wang, Youliang; Buckl, Andreas K.; Huang, Zhongxing; Nguyen, Minh H.; Kuzmina, Olesya] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Trost, BM (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	bmtrost@stanford.edu	Nguyen, Minh/F-6701-2014; Wang, Youliang/Q-9035-2018	Nguyen, Minh/0000-0003-3280-5375; Wang, Youliang/0000-0002-2613-3616; Huang, Zhongxing/0000-0003-0196-3469				Alkon DL, 2007, TRENDS PHARMACOL SCI, V28, P51, DOI 10.1016/j.tips.2006.12.002; Allen JV, 2008, TETRAHEDRON LETT, V49, P6352, DOI 10.1016/j.tetlet.2008.08.075; De B. J., 2009, PURE APPL CHEM, V68, P715; Evans DA, 1999, J AM CHEM SOC, V121, P7540, DOI 10.1021/ja990860j; Fandrick DR, 2010, J AM CHEM SOC, V132, P7600, DOI 10.1021/ja103312x; Hale KJ, 2010, CHEM-ASIAN J, V5, P704, DOI 10.1002/asia.200900634; Hale KJ, 2003, ORG LETT, V5, P503, DOI 10.1021/ol027393m; Hale KJ, 2002, NAT PROD REP, V19, P413, DOI 10.1039/b009211h; Hale KJ, 2001, ORG LETT, V3, P3791, DOI 10.1021/ol016800b; HALE KJ, 1995, TETRAHEDRON LETT, V36, P1359, DOI 10.1016/0040-4039(94)02477-S; INANAGA J, 1979, B CHEM SOC JPN, V52, P1989, DOI 10.1246/bcsj.52.1989; KAGEYAMA M, 1990, J AM CHEM SOC, V112, P7407, DOI 10.1021/ja00176a058; Keck GE, 2011, J AM CHEM SOC, V133, P744, DOI 10.1021/ja110198y; Loy BA, 2015, J AM CHEM SOC, V137, P3678, DOI 10.1021/jacs.5b00886; Lu Y, 2011, J AM CHEM SOC, V133, P13876, DOI 10.1021/ja205673e; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Manaviazar S, 2006, ORG LETT, V8, P4477, DOI 10.1021/ol061626i; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Negishi EI, 2003, ORG LETT, V5, P1597, DOI 10.1021/ol030010F; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P1378, DOI 10.1002/anie.200462207; Ohmori K, 2000, ANGEW CHEM INT EDIT, V39, P2290; PETTIT GR, 1970, NATURE, V227, P962, DOI 10.1038/227962a0; PETTIT GR, 1982, J AM CHEM SOC, V104, P6846, DOI 10.1021/ja00388a092; ROY R, 1989, J CHEM SOC CHEM COMM, P1308, DOI 10.1039/c39890001308; SCHAUFELBERGER DE, 1991, MAGN RESON CHEM, V29, P366, DOI 10.1002/mrc.1260290414; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Shaha SP, 2009, CLIN EXP IMMUNOL, V158, P186, DOI 10.1111/j.1365-2249.2009.04003.x; STORK G, 1989, TETRAHEDRON LETT, V30, P2173, DOI 10.1016/S0040-4039(00)99640-0; Sun MK, 2009, P NATL ACAD SCI USA, V106, P14676, DOI 10.1073/pnas.0907842106; Trost BM, 2008, NATURE, V456, P485, DOI 10.1038/nature07543; Trost BM, 2005, ORG LETT, V7, P4761, DOI 10.1021/ol0520065; TROST BM, 1995, J AM CHEM SOC, V117, P7255, DOI 10.1021/ja00132a030; Trost BM, 1997, J AM CHEM SOC, V119, P698, DOI 10.1021/ja9624937; Voight EA, 2004, ORG LETT, V6, P4045, DOI 10.1021/ol0483044; Wang SJ, 2003, BLOOD, V101, P3648, DOI 10.1182/blood-2002-09-2739; WENDER PA, 1988, P NATL ACAD SCI USA, V85, P7197, DOI 10.1073/pnas.85.19.7197; Wender PA, 2017, SCIENCE, V358, P218, DOI 10.1126/science.aan7969; Wender PA, 2011, J AM CHEM SOC, V133, P9228, DOI 10.1021/ja203034k; Wu RZ, 2020, CHEM-EUR J, V26, P1166, DOI 10.1002/chem.201903128; Yadav JS, 2001, TETRAHEDRON LETT, V42, P4907, DOI 10.1016/S0040-4039(01)00841-3; Yamazaki S, 2010, ORG BIOMOL CHEM, V8, P2377, DOI 10.1039/b926575a; Yu HB, 2015, J NAT PROD, V78, P1169, DOI 10.1021/acs.jnatprod.5b00081; Zhang YB, 2018, ANGEW CHEM INT EDIT, V57, P942, DOI 10.1002/anie.201711452	43	11	12	7	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					1007	+		10.1126/science.abb7271	http://dx.doi.org/10.1126/science.abb7271			76	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LV3IK	32467391				2022-12-28	WOS:000538332600047
J	Lee, YR; Yehia, L; Kishikawa, T; Ni, Y; Leach, B; Zhang, JF; Panch, N; Liu, J; Wei, WY; Eng, C; Pandolfi, PP				Lee, Yu-Ru; Yehia, Lamis; Kishikawa, Takahiro; Ni, Ying; Leach, Brandie; Zhang, Jinfang; Panch, Nivedita; Liu, Jing; Wei, Wenyi; Eng, Charis; Pandolfi, Pier Paolo			WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GERMLINE PTEN; TUMOR-SUPPRESSOR; COWDEN-SYNDROME; HECT FAMILY; MUTATION; SMURF2	Background Patients with PTEN hamartoma tumor syndrome (PHTS) have germline mutations in the tumor-suppressor gene encoding phosphatase and tensin homologue (PTEN). Such mutations have been associated with a hereditary predisposition to multiple types of cancer, including the Cowden syndrome. However, a majority of patients who have PHTS-related phenotypes have tested negative for PTEN mutations. In a previous study, we found that the E3 ubiquitin ligase WWP1 negatively regulates the function of PTEN. Methods In a prospective cohort study conducted from 2005 through 2015, we enrolled 431 patients with wild-type PTEN who met at least the relaxed diagnostic criteria of the International Cowden Consortium. Patients were scanned for WWP1 germline variants. We used the Cancer Genome Atlas (TCGA) data set as representative of apparently sporadic cancers and the Exome Aggregation Consortium data set excluding TCGA (non-TCGA ExAC) and the noncancer Genome Aggregation Database (gnomAD) as representative of population controls without a reported cancer diagnosis. We established both in vitro and murine in vivo models to functionally characterize representative WWP1 variants. Results The existence of germline WWP1 variants was first established in a family with wild-type PTEN who had oligopolyposis and early-onset colon cancers. A validation series indicated that WWP1 germline variants occurred in 5 of 126 unrelated patients (4%) with oligopolyposis as a predominant phenotype. Germline WWP1 variants, particularly the WWP1 K740N and N745S alleles, were enriched in patients who did not have PHTS but had prevalent sporadic cancers, including PTEN-related cancer types in TCGA (odds ratio, 1.5; 95% confidence interval, 1.1 to 2.1; P=0.01). The prioritized WWP1 variants resulted in gain-of-function effects, which led to aberrant enzymatic activation with consequent PTEN inactivation, thereby triggering hyperactive growth-promoting PI3K signaling in cellular and murine models. Conclusions In this study involving patients with disorders resulting in a predisposition to the development of multiple malignant neoplasms without PTEN germline mutations, we confirmed the function of WWP1 as a cancer-susceptibility gene through direct aberrant regulation of the PTEN-PI3K signaling axis. (Funded by the National Institutes of Health and others.) PTEN defects underlie disorders with several heritable neoplasms, including the Cowden syndrome, but many patients with these syndromes do not carry PTEN mutations. Some patients with hamartomatous inherited tumors have enhanced function of the WWP1 ubiquitin ligase that increases PTEN degradation and fosters tumor-promoting PI3K activity.	[Lee, Yu-Ru; Kishikawa, Takahiro; Zhang, Jinfang; Panch, Nivedita; Liu, Jing; Wei, Wenyi; Pandolfi, Pier Paolo] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Canc Res Inst, Beth Israel Deaconess Canc Ctr, Boston, MA 02115 USA; [Lee, Yu-Ru; Kishikawa, Takahiro; Panch, Nivedita; Pandolfi, Pier Paolo] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Zhang, Jinfang; Liu, Jing; Wei, Wenyi; Pandolfi, Pier Paolo] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Yehia, Lamis; Ni, Ying; Leach, Brandie; Eng, Charis] Case Western Reserve Univ, Sch Med, Genom Med Inst, Cleveland, OH USA; [Ni, Ying] Case Western Reserve Univ, Sch Med, Dept Quantitat Hlth Sci, Cleveland, OH USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, Lerner Res Inst, Cleveland Clin,Taussig Canc Inst, Cleveland, OH USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH USA; [Eng, Charis] Case Western Reserve Univ, Germline High Risk Canc Focus Grp, Cleveland, OH USA; [Zhang, Jinfang] Wuhan Univ, Dept Radiat & Med Oncol, Zhongnan Hosp, Wuhan, Peoples R China; [Zhang, Jinfang] Wuhan Univ, Med Res Inst, Wuhan, Peoples R China; [Pandolfi, Pier Paolo] Univ Turin, Mol Biotechnol Ctr, Dept Mol Biotechnol & Hlth Sci, Turin, Italy	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University; Wuhan University; Wuhan University; University of Turin	Pandolfi, PP (corresponding author), Univ Turin, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy.; Eng, C (corresponding author), Cleveland Clin, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44195 USA.	engc@ccf.org; pierpaolo.pandolfiderinaldis@unito.it	Kishikawa, Takahiro/ABD-7420-2020; Lee, Yu-Ru/AAH-6409-2021; LIU, JING/ABA-6639-2021	Kishikawa, Takahiro/0000-0002-8602-5916; LIU, JING/0000-0002-3113-4015; Lee, Yu-Ru/0000-0001-6592-6806	National Institutes of Health [R01 CA82328, R35 CA197529]; National Cancer Institute [P01 CA124570, R01 CA118989]; American Cancer Society Clinical Research Professorship; Breast Cancer Research Foundation; Doris Duke Distinguished Clinical Scientist Award; Postdoctoral Research Abroad Program Fellowship; Taiwan National Science Council [W81XWH-16-1-0249]; Department of Defense Prostate Cancer Research Program; Overseas Research Fellowships of the Japan Society for the Promotion of Science; Uehara Memorial Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society Clinical Research Professorship(American Cancer Society); Breast Cancer Research Foundation; Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Postdoctoral Research Abroad Program Fellowship; Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Department of Defense Prostate Cancer Research Program(United States Department of Defense); Overseas Research Fellowships of the Japan Society for the Promotion of Science; Uehara Memorial Foundation(Uehara Memorial Foundation)	Supported by grants (R01 CA82328 and R35 CA197529, to Dr. Pandolfi) from the National Institutes of Health, by grants (P01 CA124570 and R01 CA118989, to Dr. Eng) from the National Cancer Institute, and by grants (all to Dr. Eng) from the American Cancer Society Clinical Research Professorship, Breast Cancer Research Foundation, and Doris Duke Distinguished Clinical Scientist Award. Dr. Lee was supported in part by the Postdoctoral Research Abroad Program Fellowship, the Taiwan National Science Council, and a postdoctoral training award (W81XWH-16-1-0249) from the Department of Defense Prostate Cancer Research Program; Dr. Yehia, in part by the Cancer Genomic Medicine Clinical Fellowship Training Program of the Ambrose Monell Foundation at the Cleveland Clinic Genomic Medicine Institute; and Dr. Kishikawa, by the Overseas Research Fellowships of the Japan Society for the Promotion of Science and a research fellowship of the Uehara Memorial Foundation.	[Anonymous], 2019, BMJ-BRIT MED J, V364, pl320; Balasubramanian S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00443-5; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Chen Z, 2017, MOL CELL, V66, p345e6; Cheng Q, 2014, BIOCHEM BIOPH RES CO, V448, P248, DOI 10.1016/j.bbrc.2014.04.117; Eng C, 2000, J MED GENET, V37, P828, DOI 10.1136/jmg.37.11.828; GORLIN RJ, 1992, AM J MED GENET, V44, P307, DOI 10.1002/ajmg.1320440309; Heald B, 2010, GASTROENTEROLOGY, V139, P1927, DOI 10.1053/j.gastro.2010.06.061; Huang KL, 2018, CELL, V173, P355, DOI 10.1016/j.cell.2018.03.039; Lee YR, 2018, NAT REV MOL CELL BIO, V19, P547, DOI 10.1038/s41580-018-0015-0; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Ngeow J, 2014, J CLIN ONCOL, V32, P1818, DOI 10.1200/JCO.2013.53.6656; Ngeow J, 2013, GASTROENTEROLOGY, V144, P1402, DOI 10.1053/j.gastro.2013.02.001; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Rahman N, 2014, NATURE, V505, P302, DOI 10.1038/nature12981; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sanarico AG, 2018, LEUKEMIA, V32, P911, DOI 10.1038/leu.2017.342; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Tan MH, 2012, CLIN CANCER RES, V18, P400, DOI 10.1158/1078-0432.CCR-11-2283; Wan LX, 2011, MOL CELL, V44, P721, DOI 10.1016/j.molcel.2011.09.024; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yehia L, 2019, J CLIN INVEST, V129, P452, DOI 10.1172/JCI121277; Yehia L, 2018, ENDOCR-RELAT CANCER, V25, pT121, DOI 10.1530/ERC-18-0162; Zhang L, 2015, TUMOR BIOL, V36, P787, DOI 10.1007/s13277-014-2696-0	28	25	25	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2020	382	22					2103	2116		10.1056/NEJMoa1914919	http://dx.doi.org/10.1056/NEJMoa1914919			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MA5NT	32459922	Green Accepted, Bronze			2022-12-28	WOS:000541960400016
J	Stokel-Walker, C				Stokel-Walker, Chris			Covid-19: The doctors turned YouTubers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												stokel@gmail.com						Ent UK, 2020, ADV PAT NEW ONS AN C; Medlife Crisis, 2020, WELL BEAT CORONAVIRU	2	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2020	369								m1563	10.1136/bmj.m1563	http://dx.doi.org/10.1136/bmj.m1563			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JZ	32467087	Bronze			2022-12-28	WOS:000538337300002
J	Benton, DJ; Gamblin, SJ; Rosenthal, PB; Skehel, JJ				Benton, Donald J.; Gamblin, Steven J.; Rosenthal, Peter B.; Skehel, John J.			Structural transitions in influenza haemagglutinin at membrane fusion pH	NATURE			English	Article							BEAM-INDUCED MOTION; VIRUS HEMAGGLUTININ; BAYESIAN-APPROACH; RECEPTOR-BINDING; GLYCOPROTEIN; EVOLUTION; PEPTIDE	Cryo-electron microscopy studies of the influenza haemagglutinin glycoprotein at the low pH of host endosomes reveals structural intermediates, offering a dynamic view of how the protein mediates membrane fusion. Infection by enveloped viruses involves fusion of their lipid envelopes with cellular membranes to release the viral genome into cells. For HIV, Ebola, influenza and numerous other viruses, envelope glycoproteins bind the infecting virion to cell-surface receptors and mediate membrane fusion. In the case of influenza, the receptor-binding glycoprotein is the haemagglutinin (HA), and following receptor-mediated uptake of the bound virus by endocytosis(1), it is the HA that mediates fusion of the virus envelope with the membrane of the endosome(2). Each subunit of the trimeric HA consists of two disulfide-linked polypeptides, HA1 and HA2. The larger, virus-membrane-distal, HA1 mediates receptor binding; the smaller, membrane-proximal, HA2 anchors HA in the envelope and contains the fusion peptide, a region that is directly involved in membrane interaction(3). The low pH of endosomes activates fusion by facilitating irreversible conformational changes in the glycoprotein. The structures of the initial HA at neutral pH and the final HA at fusion pH have been investigated by electron microscopy(4,5) and X-ray crystallography(6-8). Here, to further study the process of fusion, we incubate HA for different times at pH 5.0 and directly image structural changes using single-particle cryo-electron microscopy. We describe three distinct, previously undescribed forms of HA, most notably a 150 angstrom-long triple-helical coil of HA2, which may bridge between the viral and endosomal membranes. Comparison of these structures reveals concerted conformational rearrangements through which the HA mediates membrane fusion.	[Benton, Donald J.; Gamblin, Steven J.; Skehel, John J.] Francis Crick Inst, Struct Biol Dis Proc Lab, London, England; [Rosenthal, Peter B.] Francis Crick Inst, Struct Biol Cells & Viruses Lab, London, England	Francis Crick Institute; Francis Crick Institute	Benton, DJ (corresponding author), Francis Crick Inst, Struct Biol Dis Proc Lab, London, England.; Rosenthal, PB (corresponding author), Francis Crick Inst, Struct Biol Cells & Viruses Lab, London, England.	donald.benton@crick.ac.uk; peter.rosenthal@crick.ac.uk		Gamblin, Steve/0000-0001-5331-639X; Benton, Donald/0000-0001-6748-9339	Francis Crick Institute; Cancer Research UK [FC001078, FC001143]; UK Medical Research Council [FC001078, FC001143]; Wellcome Trust [FC001078, FC001143]	Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank A. Nans of the Structural Biology Science Technology Platform for assistance with data collection; P. Walker and A. Purkiss of the Structural Biology Science Technology Platform; the Scientific Computing Science Technology Platform for computational support; and L. Calder for discussions. This work was funded by the Francis Crick Institute, which receives its core funding from Cancer Research UK (grant numbers FC001078 and FC001143), the UK Medical Research Council (FC001078 and FC001143), and the Wellcome Trust (FC001078 and FC001143).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bangaru S, 2019, CELL, V177, P1136, DOI 10.1016/j.cell.2019.04.011; Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; Benton DJ, 2018, P NATL ACAD SCI USA, V115, P10112, DOI 10.1073/pnas.1810927115; BIZEBARD T, 1995, NATURE, V376, P92, DOI 10.1038/376092a0; BRUNNER J, 1989, FEBS LETT, V257, P369, DOI 10.1016/0014-5793(89)81574-1; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Calder LJ, 2016, NAT STRUCT MOL BIOL, V23, P853, DOI 10.1038/nsmb.3271; Cardone G, 2013, J STRUCT BIOL, V184, P226, DOI 10.1016/j.jsb.2013.08.002; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; Collins PJ, 2014, P NATL ACAD SCI USA, V111, P11175, DOI 10.1073/pnas.1406606111; Cossart P, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016972; DANIELS RS, 1985, CELL, V40, P431, DOI 10.1016/0092-8674(85)90157-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GODLEY L, 1992, CELL, V68, P635, DOI 10.1016/0092-8674(92)90140-8; Ilca SL, 2019, NATURE, V570, P252, DOI 10.1038/s41586-019-1229-9; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Lorieau JL, 2012, P NATL ACAD SCI USA, V109, P19994, DOI 10.1073/pnas.1213801109; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; RUIGROK RWH, 1988, J GEN VIROL, V69, P2785, DOI 10.1099/0022-1317-69-11-2785; RUIGROK RWH, 1986, EMBO J, V5, P41, DOI 10.1002/j.1460-2075.1986.tb04175.x; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; WARD CW, 1980, AUST J BIOL SCI, V33, P441; Watanabe A, 2019, CELL, V177, P1124, DOI 10.1016/j.cell.2019.03.048; WHARTON SA, 1986, VIROLOGY, V149, P27, DOI 10.1016/0042-6822(86)90083-8; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Xu R, 2011, J VIROL, V85, P5172, DOI 10.1128/JVI.02430-10; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	37	57	57	2	39	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					150	+		10.1038/s41586-020-2333-6	http://dx.doi.org/10.1038/s41586-020-2333-6		MAY 2020	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME6OV	32461688	Green Accepted			2022-12-28	WOS:000535878900005
J	Rimmer, A				Rimmer, Abi			Anosmia: five minutes with ... ENT consultant Claire Hopkins	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2020	369								m2095	10.1136/bmj.m2095	http://dx.doi.org/10.1136/bmj.m2095			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JW	32457085	Bronze			2022-12-28	WOS:000538337000011
J	Slomski, A				Slomski, Anita			Integrated Care Cut Mortality in Patients With Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					1999	1999		10.1001/jama.2020.7968	http://dx.doi.org/10.1001/jama.2020.7968			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU8UM	32453365				2022-12-28	WOS:000538023900017
J	Thomson, AW; Tevar, AD				Thomson, Angus W.; Tevar, Amit D.			Kidney transplantation: a safe step forward for regulatory immune cell therapy Comment	LANCET			English	Editorial Material							TOLERANCE; GVHD		[Thomson, Angus W.; Tevar, Amit D.] Univ Pittsburgh, Sch Med, Starzl Transplantat Inst, Pittsburgh, PA 15238 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thomson, AW (corresponding author), Univ Pittsburgh, Sch Med, Starzl Transplantat Inst, Pittsburgh, PA 15238 USA.	thomsonaw@upmc.edu			US National Institutes of Health	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	AWT reports grants from the US National Institutes of Health and has University of Pittsburgh patent invention disclosures issued.ADT is a sponsor or investigator of ongoing clinical trials of regulatory immune cell therapy in organ transplantation at the University of Pittsburgh Medical Center.	Abbas AK, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat1482; Bezie S, 2019, BLOOD ADV, V3, P3522, DOI 10.1182/bloodadvances.2019000411; Braza MS, 2018, IMMUNITY, V49, P819, DOI 10.1016/j.immuni.2018.09.008; Chandran S, 2017, AM J TRANSPLANT, V17, P2945, DOI 10.1111/ajt.14415; Gallon L, 2018, J AM SOC NEPHROL, V29, P423, DOI 10.1681/ASN.2017030348; June CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3643; Koehn BH, 2015, BLOOD, V126, P1621, DOI 10.1182/blood-2015-03-634691; Mathew JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25574-7; Morris H, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010760; Overacre AE, 2016, CURR OPIN IMMUNOL, V39, P39, DOI 10.1016/j.coi.2015.12.009; Raffin C, 2020, NAT REV IMMUNOL, V20, P158, DOI 10.1038/s41577-019-0232-6; Sanchez-Fueyo A, 2020, AM J TRANSPLANT, V20, P1125, DOI 10.1111/ajt.15700; Savage TM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124086; Sawitzki B, 2020, LANCET, V395, P1627, DOI 10.1016/S0140-6736(20)30167-7; Sicard A, 2020, AM J TRANSPLANT, V20, P1562, DOI 10.1111/ajt.15787; Sicard A, 2018, CURR OPIN ORGAN TRAN, V23, P509, DOI 10.1097/MOT.0000000000000566; Tang QZ, 2017, J CLIN INVEST, V127, P2505, DOI 10.1172/JCI90598; Thomson AW, 2018, HUM IMMUNOL, V79, P314, DOI 10.1016/j.humimm.2017.10.017; Todo S, 2016, HEPATOLOGY, V64, P632, DOI 10.1002/hep.28459	19	3	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2020	395	10237					1589	1591		10.1016/S0140-6736(20)30803-5	http://dx.doi.org/10.1016/S0140-6736(20)30803-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LZ1JO	32446400				2022-12-28	WOS:000540986100008
J	Pulliainen, J; Luojus, K; Derksen, C; Mudryk, L; Lemmetyinen, J; Salminen, M; Ikonen, J; Takala, M; Cohen, J; Smolander, T; Norberg, J				Pulliainen, Jouni; Luojus, Kari; Derksen, Chris; Mudryk, Lawrence; Lemmetyinen, Juha; Salminen, Miia; Ikonen, Jaakko; Takala, Matias; Cohen, Juval; Smolander, Tuomo; Norberg, Johannes			Patterns and trends of Northern Hemisphere snow mass from 1980 to 2018	NATURE			English	Article							WATER EQUIVALENT; RADIOMETER DATA; BOREAL; COVER; DEPTH; CLIMATE; MODEL	Warming surface temperatures have driven a substantial reduction in the extent and duration of Northern Hemisphere snow cover(1-3). These changes in snow cover affect Earth's climate system via the surface energy budget, and influence freshwater resources across a large proportion of the Northern Hemisphere(4-6). In contrast to snow extent, reliable quantitative knowledge on seasonal snow mass and its trend is lacking(7-9). Here we use the new GlobSnow 3.0 dataset to show that the 1980-2018 annual maximum snow mass in the Northern Hemisphere was, on average, 3,062 +/- 35 billion tonnes (gigatonnes). Our quantification is for March (the month that most closely corresponds to peak snow mass), covers non-alpine regions above 40 degrees N and, crucially, includes a bias correction based on in-field snow observations. We compare our GlobSnow 3.0 estimates with three independent estimates of snow mass, each with and without the bias correction. Across the four datasets, the bias correction decreased the range from 2,433-3,380 gigatonnes (mean 2,867) to 2,846-3,062 gigatonnes (mean 2,938)-a reduction in uncertainty from 33% to 7.4%. On the basis of our bias-corrected GlobSnow 3.0 estimates, we find different continental trends over the 39-year satellite record. For example, snow mass decreased by 46 gigatonnes per decade across North America but had a negligible trend across Eurasia; both continents exhibit high regional variability. Our results enable a better estimation of the role of seasonal snow mass in Earth's energy, water and carbon budgets. Applying a bias correction to a state-of-the-art dataset covering non-alpine regions of the Northern Hemisphere and to three other datasets yields a more constrained quantification of snow mass in March from 1980 to 2018.	[Pulliainen, Jouni; Luojus, Kari; Lemmetyinen, Juha; Salminen, Miia; Ikonen, Jaakko; Takala, Matias; Cohen, Juval; Smolander, Tuomo; Norberg, Johannes] Finnish Meteorol Inst, Helsinki, Finland; [Derksen, Chris; Mudryk, Lawrence] Environm & Climate Change Canada, Climate Res Div, Toronto, ON, Canada	Finnish Meteorological Institute; Environment & Climate Change Canada	Pulliainen, J (corresponding author), Finnish Meteorol Inst, Helsinki, Finland.	jouni.pulliainen@fmi.fi	Salminen, Miia A/C-3912-2018; Smolander, Tuomo/B-5022-2018; Derksen, Chris/S-9828-2017; Pulliainen, Jouni/Y-4810-2019; Lemmetyinen, Juha/B-3739-2016	Salminen, Miia A/0000-0003-1847-6472; Smolander, Tuomo/0000-0003-1592-8920; Derksen, Chris/0000-0001-6821-5479; Pulliainen, Jouni/0000-0003-1157-2920; Lemmetyinen, Juha/0000-0003-4434-9696; Luojus, Kari/0000-0002-4066-6005; Cohen, Juval/0000-0001-6396-1536				Alexander LV, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P3; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Bintanja R, 2017, NAT CLIM CHANGE, V7, P263, DOI [10.1038/NCLIMATE3240, 10.1038/nclimate3240]; Bokhorst S, 2016, AMBIO, V45, P516, DOI 10.1007/s13280-016-0770-0; Bormann KJ, 2018, NAT CLIM CHANGE, V8, P923, DOI 10.1038/s41558-018-0318-3; Bronnimann S, 2018, B AM METEOROL SOC, V99, P1851, DOI 10.1175/BAMS-D-17-0229.1; Brown RD, 2003, ATMOS OCEAN, V41, P1, DOI 10.3137/ao.410101; Brown RD, 2019, ATMOS OCEAN, V57, P149, DOI 10.1080/07055900.2019.1598843; Brown RD, 2009, J CLIMATE, V22, P2124, DOI 10.1175/2008JCLI2665.1; Brun E, 2013, J HYDROMETEOROL, V14, P203, DOI 10.1175/JHM-D-12-012.1; Chang A., 1987, ANN GLACIOL, V9, P39, DOI [10.3189/S0260305500200736, DOI 10.3189/S0260305500200736, 10.1017/S0260305500200736, DOI 10.1017/S0260305500200736]; Cohen J, 2015, IEEE T GEOSCI REMOTE, V53, P6593, DOI 10.1109/TGRS.2015.2444422; de Rosnay P, 2014, SURV GEOPHYS, V35, P607, DOI 10.1007/s10712-012-9207-x; Derksen C, 2005, REMOTE SENS ENVIRON, V96, P315, DOI 10.1016/j.rse.2005.02.014; Derksen C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053387; Derksen C, 2009, J HYDROMETEOROL, V10, P448, DOI 10.1175/2008JHM1074.1; Flanner MG, 2011, NAT GEOSCI, V4, P151, DOI 10.1038/NGEO1062; Frei A, 2012, ADV SPACE RES, V50, P1007, DOI 10.1016/j.asr.2011.12.021; Gelaro R, 2017, J CLIMATE, V30, P5419, DOI 10.1175/JCLI-D-16-0758.1; Global Modeling and Assimilation Office, 2015, MERRA 2 TAVG1 2D LND, DOI 10.5067/RKPHT8KC1Y1T; Henderson GR, 2018, NAT CLIM CHANGE, V8, P954, DOI 10.1038/s41558-018-0295-6; Hori M, 2017, REMOTE SENS ENVIRON, V191, P402, DOI 10.1016/j.rse.2017.01.023; Il Jeong D, 2017, CLIM DYNAM, V48, P3645, DOI 10.1007/s00382-016-3291-4; Kelly RE, 2003, IEEE T GEOSCI REMOTE, V41, P230, DOI 10.1109/TGRS.2003.809118; Kittler F, 2017, GLOBAL BIOGEOCHEM CY, V31, P1704, DOI 10.1002/2017GB005774; Kontu A, 2017, REMOTE SENS ENVIRON, V194, P33, DOI 10.1016/j.rse.2016.12.021; Kruopis N, 1999, IEEE T GEOSCI REMOTE, V37, P2699, DOI 10.1109/36.803417; Lehtinen M, 1988, STAT INVERSION THEOR; Lemmetyinen J, 2011, REMOTE SENS ENVIRON, V115, P3695, DOI 10.1016/j.rse.2011.09.008; Lemmetyinen J, 2009, IEEE T GEOSCI REMOTE, V47, P965, DOI 10.1109/TGRS.2008.2006358; Liu JL, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.084688; Luojus K., 2020, **DATA OBJECT**, DOI [10.1594/PANGAEA.911944, DOI 10.1594/PANGAEA.911944]; MATZLER C, 1994, METEOROL ATMOS PHYS, V54, P241, DOI 10.1007/BF01030063; Metsamaki S, 2015, REMOTE SENS ENVIRON, V156, P96, DOI 10.1016/j.rse.2014.09.018; Mudryk L, 2018, ARCTIC REPORT CARD; Mudryk LR, 2015, J CLIMATE, V28, P8037, DOI 10.1175/JCLI-D-15-0229.1; Natali SM, 2019, NAT CLIM CHANGE, V9, P852, DOI 10.1038/s41558-019-0592-8; Neumann NN, 2006, ATMOS OCEAN, V44, P257, DOI 10.3137/ao.440304; Pulliainen J, 2006, REMOTE SENS ENVIRON, V101, P257, DOI 10.1016/j.rse.2006.01.002; PULLIAINEN J, 1993, IEEE T GEOSCI REMOTE, V31, P268, DOI 10.1109/36.210466; Pulliainen J, 2017, P NATL ACAD SCI USA, V114, P11081, DOI 10.1073/pnas.1707889114; Pulliainen JT, 1999, IEEE T GEOSCI REMOTE, V37, P1378, DOI 10.1109/36.763302; Sturm M, 2017, WATER RESOUR RES, V53, P3534, DOI 10.1002/2017WR020840; Takala M, 2011, REMOTE SENS ENVIRON, V115, P3517, DOI 10.1016/j.rse.2011.08.014; Wrzesien ML, 2018, GEOPHYS RES LETT, V45, P1423, DOI 10.1002/2017GL076664; Yue S, 2002, HYDROL PROCESS, V16, P1807, DOI 10.1002/hyp.1095	46	116	120	17	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY	2020	581	7808					294	+		10.1038/s41586-020-2258-0	http://dx.doi.org/10.1038/s41586-020-2258-0			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ2CZ	32433620				2022-12-28	WOS:000534818200013
J	Boulware, DR; Pullen, MF; Bangdiwala, AS; Pastick, KA; Lofgren, SM; Okafor, EC; Skipper, CP; Nascene, AA; Nicol, MR; Abassi, M; Engen, NW; Cheng, MP; LaBar, D; Lother, SA; MacKenzie, LJ; Drobot, G; Marten, N; Zarychanski, R; Kelly, LE; Schwartz, IS; McDonald, EG; Rajasingham, R; Lee, TC; Hullsiek, KH				Boulware, David R.; Pullen, Matthew F.; Bangdiwala, Ananta S.; Pastick, Katelyn A.; Lofgren, Sarah M.; Okafor, Elizabeth C.; Skipper, Caleb P.; Nascene, Alanna A.; Nicol, Melanie R.; Abassi, Mahsa; Engen, Nicole W.; Cheng, Matthew P.; LaBar, Derek; Lother, Sylvain A.; MacKenzie, Lauren J.; Drobot, Glen; Marten, Nicole; Zarychanski, Ryan; Kelly, Lauren E.; Schwartz, Ilan S.; McDonald, Emily G.; Rajasingham, Radha; Lee, Todd C.; Hullsiek, Kathy H.			A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BackgroundCoronavirus disease 2019 (Covid-19) occurs after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the standard of care is observation and quarantine. Whether hydroxychloroquine can prevent symptomatic infection after SARS-CoV-2 exposure is unknown. MethodsWe conducted a randomized, double-blind, placebo-controlled trial across the United States and parts of Canada testing hydroxychloroquine as postexposure prophylaxis. We enrolled adults who had household or occupational exposure to someone with confirmed Covid-19 at a distance of less than 6 ft for more than 10 minutes while wearing neither a face mask nor an eye shield (high-risk exposure) or while wearing a face mask but no eye shield (moderate-risk exposure). Within 4 days after exposure, we randomly assigned participants to receive either placebo or hydroxychloroquine (800 mg once, followed by 600 mg in 6 to 8 hours, then 600 mg daily for 4 additional days). The primary outcome was the incidence of either laboratory-confirmed Covid-19 or illness compatible with Covid-19 within 14 days. ResultsWe enrolled 821 asymptomatic participants. Overall, 87.6% of the participants (719 of 821) reported a high-risk exposure to a confirmed Covid-19 contact. The incidence of new illness compatible with Covid-19 did not differ significantly between participants receiving hydroxychloroquine (49 of 414 [11.8%]) and those receiving placebo (58 of 407 [14.3%]); the absolute difference was -2.4 percentage points (95% confidence interval, -7.0 to 2.2; P=0.35). Side effects were more common with hydroxychloroquine than with placebo (40.1% vs. 16.8%), but no serious adverse reactions were reported. ConclusionsAfter high-risk or moderate-risk exposure to Covid-19, hydroxychloroquine did not prevent illness compatible with Covid-19 or confirmed infection when used as postexposure prophylaxis within 4 days after exposure. (Funded by David Baszucki and Jan Ellison Baszucki and others; ClinicalTrials.gov number, NCT04308668.) In this double-blind, randomized trial, 821 asymptomatic persons with a high-risk or moderate-risk exposure to SARS-CoV-2 were assigned to receive hydroxychloroquine or placebo within 4 days after the exposure. No benefit in preventing illness compatible with Covid-19 was found.	[Boulware, David R.; Pullen, Matthew F.; Bangdiwala, Ananta S.; Pastick, Katelyn A.; Lofgren, Sarah M.; Okafor, Elizabeth C.; Skipper, Caleb P.; Nascene, Alanna A.; Nicol, Melanie R.; Abassi, Mahsa; Engen, Nicole W.; Rajasingham, Radha; Hullsiek, Kathy H.] Univ Minnesota, 689 23rd Ave, Minneapolis, MN 55455 USA; [LaBar, Derek] M Hlth Fairview Invest Drug Serv Pharm, Minneapolis, MN USA; [Cheng, Matthew P.; McDonald, Emily G.; Lee, Todd C.] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada; [Cheng, Matthew P.; McDonald, Emily G.; Lee, Todd C.] McGill Univ, Dept Med, Clin Practice Assessment Unit, Montreal, PQ, Canada; [Lother, Sylvain A.; MacKenzie, Lauren J.; Drobot, Glen; Marten, Nicole; Zarychanski, Ryan] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Zarychanski, Ryan] Univ Manitoba, CancerCare Manitoba, Res Inst Oncol & Hematol, Winnipeg, MB, Canada; [Kelly, Lauren E.] George & Fay Yee Ctr Healthcare Innovat, Winnipeg, MB, Canada; [Schwartz, Ilan S.] Univ Alberta, Edmonton, AB, Canada	University of Minnesota System; University of Minnesota Twin Cities; McGill University; McGill University; University of Manitoba; CancerCare Manitoba Foundation; University of Manitoba; University of Alberta	Boulware, DR (corresponding author), Univ Minnesota, 689 23rd Ave, Minneapolis, MN 55455 USA.	boulw001@umn.edu	Zarychanski, Ryan/AAB-6369-2022; Pullen, Matthew/AAF-8739-2022; Nicol, Melanie R/AAB-2342-2020; Boulware, David R/GRS-0999-2022; Boulware, David R/AAF-7124-2021; Pullen, Matthew/AFK-1436-2022; Schwartz, Ilan S./J-5666-2019; Kelly, Lauren E/I-5543-2019; MacKenzie, Lauren/I-5278-2015	Pullen, Matthew/0000-0002-4644-7487; Nicol, Melanie R/0000-0001-5513-5509; Boulware, David R/0000-0002-4715-0060; Pullen, Matthew/0000-0002-4644-7487; Schwartz, Ilan S./0000-0002-7522-0281; Kelly, Lauren E/0000-0001-7567-0816; Pastick, Katelyn/0000-0002-1306-1713; Lofgren, Sarah M/0000-0001-6717-2614; MacKenzie, Lauren/0000-0002-4794-9120	Alliance of Minnesota Chinese Organizations; Minnesota Chinese Chamber of Commerce; University of Minnesota; Doris Duke Charitable Foundation through the Doris Duke International Clinical Research Fellows Program at the University of Minnesota; National Institute of Allergy and Infectious Diseases [K08AI134262, K23AI138851, T32AI055433]; National Institute of Mental Health [K23MH121220]; Fogarty International Center [D43TW009345]; Lyonel G. Israels Professor of Hematology at the University of Manitoba; Clinical Practice Assessment Unit of the McGill University Health Centre; McGill Interdisciplinary Initiative in Infection and Immunity Emergency Covid-19 Research Funding Program; Manitoba Medical Service Foundation; Research Manitoba; Northern Alberta Clinical Trials and Research Centre Covid-19 Clinical Research Grant; National Institutes of Health National Center for Advancing Translational Sciences [UL1TR002494]	Alliance of Minnesota Chinese Organizations; Minnesota Chinese Chamber of Commerce; University of Minnesota(University of Minnesota System); Doris Duke Charitable Foundation through the Doris Duke International Clinical Research Fellows Program at the University of Minnesota; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Lyonel G. Israels Professor of Hematology at the University of Manitoba; Clinical Practice Assessment Unit of the McGill University Health Centre; McGill Interdisciplinary Initiative in Infection and Immunity Emergency Covid-19 Research Funding Program; Manitoba Medical Service Foundation; Research Manitoba; Northern Alberta Clinical Trials and Research Centre Covid-19 Clinical Research Grant; National Institutes of Health National Center for Advancing Translational Sciences	Supported by David Baszucki and Jan Ellison Baszucki, the Alliance of Minnesota Chinese Organizations, the Minnesota Chinese Chamber of Commerce, and the University of Minnesota. Ms. Pastick and Ms. Okafor are supported by the Doris Duke Charitable Foundation through a grant supporting the Doris Duke International Clinical Research Fellows Program at the University of Minnesota. Drs. Nicol, Rajasingham, and Pullen are supported by the National Institute of Allergy and Infectious Diseases (K08AI134262, K23AI138851, T32AI055433). Dr. Lofgren is supported by the National Institute of Mental Health (K23MH121220). Dr. Skipper is supported by the Fogarty International Center (D43TW009345). Drs. Lee and McDonald receive salary support from Fonds de Recherche du Quebec-Sante. Dr. Zarychanski receives research support as the Lyonel G. Israels Professor of Hematology at the University of Manitoba. In Quebec, funds were received from the Clinical Practice Assessment Unit of the McGill University Health Centre and the McGill Interdisciplinary Initiative in Infection and Immunity Emergency Covid-19 Research Funding Program. In Manitoba, research support was received from the Manitoba Medical Service Foundation and Research Manitoba. In Alberta, the trial was funded by the Northern Alberta Clinical Trials and Research Centre Covid-19 Clinical Research Grant. Purolator Canada provided in-kind courier support for the participating Canadian sites. The REDCap software was supported by the National Institutes of Health National Center for Advancing Translational Sciences (grant UL1TR002494).	Al-Kofahi M, 2020, CLIN PHARMACOL THER, V108, P766, DOI 10.1002/cpt.1874; [Anonymous], INT 20 ID 01 STAND S; Burke RM, 2020, MMWR-MORBID MORTAL W, V69, P245, DOI 10.15585/mmwr.mm6909e1; CDC COVID-19 Response Team, 2020, MMWR Morb Mortal Wkly Rep, V69, P477, DOI 10.15585/mmwr.mm6915e6; Centers for Disease Control and Prevention, 2021, FAQ COVID 19 DAT SUR; Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Lee SH, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105988; Li Q., 2020, NEW ENGL J MED, V382, P1199; Liu K, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-019-0132-8; Lother SA, 2020, CAN J ANAESTH; McMichael TM, 2020, NEW ENGL J MED, V382, P2005, DOI 10.1056/NEJMoa2005412; Mehra MR, 2020, LANCET, V395, P1820, DOI [10.1016/S0140-6736(20)31324-6, 10.1016/S0140-6736(20)31180-6]; Park SY, 2020, EMERG INFECT DIS; Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630; The Lancet Hiv null, 2020, LANCET HIV, V7, pe75; Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69; Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237	18	792	826	5	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2020	383	6					517	525		10.1056/NEJMoa2016638	http://dx.doi.org/10.1056/NEJMoa2016638			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB3TI	32492293	Bronze, Green Published			2022-12-28	WOS:000560438400014
J	Yu, H; Spyrou, MA; Karapetian, M; Shnaider, S; Radzeviciute, R; Nagele, K; Neumann, GU; Penske, S; Zech, J; Lucas, M; LeRoux, P; Roberts, P; Pavlenok, G; Buzhilova, A; Posth, C; Jeong, C; Krause, J				Yu, He; Spyrou, Maria A.; Karapetian, Marina; Shnaider, Svetlana; Radzeviciute, Rita; Naegele, Kathrin; Neumann, Gunnar U.; Penske, Sandra; Zech, Jana; Lucas, Mary; LeRoux, Petrus; Roberts, Patrick; Pavlenok, Galina; Buzhilova, Alexandra; Posth, Cosimo; Jeong, Choongwon; Krause, Johannes			Paleolithic to Bronze Age Siberians Reveal Connections with First Americans and across Eurasia	CELL			English	Article							CIS-BAIKAL REGION; HOLOCENE HUNTER-GATHERERS; ANCIENT HUMAN GENOMES; YERSINIA-PESTIS; MIDDLE HOLOCENE; LAKE BAIKAL; RESERVOIR OFFSETS; STABLE CARBON; STRONTIUM ISOTOPES; POPULATION HISTORY	Modern humans have inhabited the Lake Baikal region since the Upper Paleolithic, though the precise history of its peoples over this long time span is still largely unknown. Here, we report genome-wide data from 19 Upper Paleolithic to Early Bronze Age individuals from this Siberian region. An Upper Paleolithic genome shows a direct link with the First Americans by sharing the admixed ancestry that gave rise to all non-Arctic Native Americans. We also demonstrate the formation of Early Neolithic and Bronze Age Baikal populations as the result of prolonged admixture throughout the eighth to sixth millennium BP. Moreover, we detect genetic interactions with western Eurasian steppe populations and reconstruct Yersinia pestis genomes from two Early Bronze Age individuals without western Eurasian ancestry. Overall, our study demonstrates the most deeply divergent connection between Upper Paleolithic Siberians and the First Americans and reveals human and pathogen mobility across Eurasia during the Bronze Age.	[Yu, He; Spyrou, Maria A.; Radzeviciute, Rita; Naegele, Kathrin; Neumann, Gunnar U.; Penske, Sandra; Posth, Cosimo; Jeong, Choongwon; Krause, Johannes] Max Planck Inst Sci Human Hist, Dept Archaeogenet, D-07745 Jena, Germany; [Karapetian, Marina; Buzhilova, Alexandra] Moscow MV Lomonosov State Univ, Res Inst, Moscow 125009, Russia; [Karapetian, Marina; Buzhilova, Alexandra] Moscow MV Lomonosov State Univ, Museum Anthropol, Moscow 125009, Russia; [Shnaider, Svetlana; Pavlenok, Galina] Russian Acad Sci, Inst Archaeol & Ethnog, Siberian Branch, Novosibirsk 630090, Russia; [Zech, Jana; Lucas, Mary; Roberts, Patrick] Max Planck Inst Sci Human Hist, Dept Archaeol, D-07745 Jena, Germany; [LeRoux, Petrus] Univ Cape Town, Dept Geol Sci, ZA-7701 Rondebosch, South Africa; [Posth, Cosimo] Univ Tubingen, Inst Archaeol Sci Archaeo & Palaeogenet, D-72070 Tubingen, Germany; [Jeong, Choongwon] Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea	Lomonosov Moscow State University; Lomonosov Moscow State University; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences; University of Cape Town; Eberhard Karls University of Tubingen; Seoul National University (SNU)	Posth, C; Jeong, C; Krause, J (corresponding author), Max Planck Inst Sci Human Hist, Dept Archaeogenet, D-07745 Jena, Germany.; Posth, C (corresponding author), Univ Tubingen, Inst Archaeol Sci Archaeo & Palaeogenet, D-72070 Tubingen, Germany.; Jeong, C (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea.	posth@shh.mpg.de; jeong@shh.mpg.de; krause@shh.mpg.de	Yu, He/AAS-5791-2020; le Roux, Petrus J./AAD-4755-2021; Krause, Johannes/AFP-2642-2022; Pavlenok, Galina/Q-5407-2016; Posth, Cosimo/AAL-6219-2021	Yu, He/0000-0003-1323-4730; le Roux, Petrus J./0000-0002-5930-4995; Krause, Johannes/0000-0001-9144-3920; Pavlenok, Galina/0000-0003-3727-776X; Neumann, Gunnar U./0000-0003-3825-8536; Roberts, Patrick/0000-0002-4403-7548; Jeong, Choongwon/0000-0003-3049-2352; Karapetian, Marina/0000-0003-1886-8943	Russian Foundation for Basic Research [19-59-44010]; Max Planck Society; European Research Council [ERC-CoG 771234]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission)	We thank the wet laboratory and computational teams at MPI-SHH. We are grateful to Matthias Meyer and Sarah Nagel from the Max Planck Institute for Evolutionary Anthropology in Leipzig for generating the single-stranded library of UKY. We thank Stephan Schiffels for his suggestions and comments and Aida Andrades Valtuen~ a for computational support. G.P. was supported by the Russian Foundation for Basic Research (Project No. 19-59-44010). The human and pathogen genomics research were funded by the Max Planck Society and the European Research Council ERC-CoG 771234 PALEoRIDER.	Alekseev V.P., 1979, SOV ETNOGR, V5, P49; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; [Anonymous], 1929, VLASTTRUDA, V17, P4; [Anonymous], 1928, VLASTTRUDA, V246, P4; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; Bazaliiskii V.I., 2012, IZVESTIIA LABORATORI, V9, P43; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bentley RA, 2004, J ARCHAEOL SCI, V31, P365, DOI 10.1016/j.jas.2003.09.003; Bentley RA, 2003, ARCHAEOMETRY, V45, P471, DOI 10.1111/1475-4754.00122; Bos KI, 2016, ELIFE, V5, DOI 10.7554/eLife.12994; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Brock F, 2013, RADIOCARBON, V55, P211; Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Capo RC, 1998, GEODERMA, V82, P197, DOI 10.1016/S0016-7061(97)00102-X; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Damgaard PD, 2018, NATURE, V557, P369, DOI 10.1038/s41586-018-0094-2; Damgaard PD, 2018, SCIENCE, V360, P1422, DOI 10.1126/science.aar7711; Debecz G. F, 1948, PALEOANTROPOLOGIYA S, V4; Debets G.F., 1930, RUSSKIY ANTROPOLOGIC, VXIX, P7; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Demeure CE, 2019, GENES IMMUN, V20, P357, DOI 10.1038/s41435-019-0065-0; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eroshenko GA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187230; Feldman M, 2016, MOL BIOL EVOL, V33, P2911, DOI 10.1093/molbev/msw170; Flegontov P, 2019, NATURE, V570, P236, DOI 10.1038/s41586-019-1251-y; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Fuller BT, 2003, J ARCHAEOL SCI, V30, P1673, DOI 10.1016/S0305-4403(03)00073-6; Gansauge MT, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx033; Garcia E, 2007, ADV EXP MED BIOL, V603, P17; GRAUSTEIN WC, 1983, SCIENCE, V219, P289, DOI 10.1126/science.219.4582.289; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Haverkort CM, 2010, PREHISTORIC HUNTER-GATHERERS OF THE BAIKAL REGION, SIBERIA, P217; HILLSON S, 1996, DENT ANTHR; Hubler R, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1903-0; Jeong C, 2019, NAT ECOL EVOL, V3, P966, DOI 10.1038/s41559-019-0878-2; Jeong C, 2018, P NATL ACAD SCI USA, V115, pE11248, DOI 10.1073/pnas.1813608115; Jones ER, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9912; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Jorkov MLS, 2009, AM J PHYS ANTHROPOL, V138, P199, DOI 10.1002/ajpa.20919; Katzenberg MA, 2010, PREHISTORIC HUNTER-GATHERERS OF THE BAIKAL REGION, SIBERIA, P175; Katzenberg MA, 1999, J ARCHAEOL SCI, V26, P651, DOI 10.1006/jasc.1998.0382; Keller M, 2019, P NATL ACAD SCI USA, V116, P12363, DOI 10.1073/pnas.1820447116; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Kislichkina AA, 2018, GENOME ANNOUNCEMENTS, V6, DOI [10.1128/genomea.01440-17, 10.1128/genomeA.01440-17]; Kislichkina AA, 2018, GENOME ANNOUNCEMENTS, V6, DOI 10.1128/genomeA.00536-18; Kislichkina AA, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01342-15; Kiyashko SI, 1998, CR ACAD SCI III-VIE, V321, P509, DOI 10.1016/S0764-4469(98)80783-X; Korlevic P, 2015, BIOTECHNIQUES, V59, P87, DOI 10.2144/000114320; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Kutyrev VV, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01106; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Mamonova N.N., 1973, PROBLEMY ARHEOLOGII, P8; Mamonova N.N., 2008, CHELOVEK ADAPTATSIYA, P127; Mamonova N.N., 1989, SOVETSKAIA ARKHEOLOG, V1, P19; Mathieson I, 2018, NATURE, V555, P197, DOI 10.1038/nature25778; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Minnich SA, 2007, ADV EXP MED BIOL, V603, P298; Mittnik A, 2019, SCIENCE, V366, P731, DOI 10.1126/science.aax6219; Mittnik A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02825-9; Montgomery J, 2010, ANN HUM BIOL, V37, P325, DOI 10.3109/03014461003649297; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Moreno-Mayar JV, 2018, NATURE, V553, P203, DOI 10.1038/nature25173; Movsesian A.A., 2015, VESTN MOSK U 23, V3, P94; Movsesian AA, 2014, AM J PHYS ANTHROPOL, V155, P559, DOI 10.1002/ajpa.22608; Namouchi A, 2018, P NATL ACAD SCI USA, V115, pE11790, DOI 10.1073/pnas.1812865115; Nier AO, 1938, PHYS REV, V54, P275, DOI 10.1103/PhysRev.54.275; Nomokonova T, 2013, QUATERN INT, V290, P110, DOI 10.1016/j.quaint.2012.06.007; Okladnikov A.P., 1928, IZV VSORGO, V53, P125; Okladnikov A.P., 1955, MAT ISSLED ARHEOL SS, V43; Okladnikov A.P., 1929, VLAST T, V185, P4; Okladnikov A.P., 1977, ARCH I ARKHEOLOGII E, P78; Okladnikov A.P., 1926, KRAEVED IRKUTSK GUBE, V3, P29; Okladnikov A.P., 1950, MAT ISSLED ARHEOL SS, V18; Okladnikov A.P., 1979, ARCH I ARKHEOLOGII E, P21; Olalde I, 2018, NATURE, V555, P190, DOI 10.1038/nature25738; Orlova L.A., 1995, METHODS NATURAL SCI, P207; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pavlenok GD, 2019, ARCHAEOL ETHNOL ANTH, V47, P3, DOI 10.17746/1563-0102.2019.47.3.003-011; Pavlenok G.D., 2015, TEKHNOLOGIYA OBRABOT; Pavlenok G.D., 2014, GUMANITARNYE NAUKI S, V2, P14; Pavlenok G.D., 2015, IZVESTIIA ALTAISKOGO, V87, P178; Peltzer A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0918-z; Posth C, 2018, CELL, V175, P1185, DOI 10.1016/j.cell.2018.10.027; Poznik G.D., 2016, IDENTIFYING Y CHROMO, DOI [10.1101/088718, DOI 10.1101/088718]; Pradel E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004029; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; PRICE TD, 1986, AM J PHYS ANTHROPOL, V70, P365, DOI 10.1002/ajpa.1330700311; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Development Core Team, 2008, COMPUTATIONAL MANY P; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Ramsey CB, 2014, RADIOCARBON, V56, P789, DOI 10.2458/56.17160; Rascovan N, 2019, CELL, V176, P295, DOI 10.1016/j.cell.2018.11.005; Rasmussen M, 2015, NATURE, V523, P455, DOI 10.1038/nature14625; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Rasmussen S, 2015, CELL, V163, P571, DOI 10.1016/j.cell.2015.10.009; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Renaud G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0776-0; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rohland N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0624; ROKITA E, 1993, J CRYST GROWTH, V130, P543, DOI 10.1016/0022-0248(93)90543-6; Saag L, 2017, CURR BIOL, V27, P2185, DOI 10.1016/j.cub.2017.06.022; Scheib CL, 2018, SCIENCE, V360, P1024, DOI 10.1126/science.aar6851; Schubert Mikkel, 2016, BMC Res Notes, V9, P88, DOI 10.1186/s13104-016-1900-2; Schuenemann VJ, 2011, P NATL ACAD SCI USA, V108, pE746, DOI 10.1073/pnas.1105107108; Schulting RJ, 2015, RADIOCARBON, V57, P581, DOI 10.2458/azu_rc.57.18458; Schulting RJ, 2014, RADIOCARBON, V56, P991, DOI 10.2458/56.17963; SEALY JC, 1987, GEOCHIM COSMOCHIM AC, V51, P2707, DOI 10.1016/0016-7037(87)90151-7; Sikora M, 2019, NATURE, V570, P182, DOI 10.1038/s41586-019-1279-z; Siska V, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601877; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Spiliopoulou A, 2017, GENETICS, V206, P91, DOI 10.1534/genetics.117.200063; Spyrou MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12154-0; Spyrou MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04550-9; Spyrou MA, 2016, CELL HOST MICROBE, V19, P874, DOI 10.1016/j.chom.2016.05.012; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sun YC, 2014, CELL HOST MICROBE, V15, P578, DOI 10.1016/j.chom.2014.04.003; Tashak V.I., 2000, KAMENNII VEK YUJNOI, P59; Tashak V.I., 2005, PALEOLITICHESKIE MEZ; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vagene AJ, 2018, NAT ECOL EVOL, V2, P520, DOI 10.1038/s41559-017-0446-6; Valtuena AA, 2017, CURR BIOL, V27, P3683, DOI 10.1016/j.cub.2017.10.025; Wang CC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08220-8; WEBER A, 1995, J WORLD PREHIST, V9, P99, DOI 10.1007/BF02221004; Weber AW, 2016, QUATERN INT, V419, P74, DOI 10.1016/j.quaint.2015.12.003; Weber AW, 2010, J ANTHROPOL ARCHAEOL, V29, P491, DOI 10.1016/j.jaa.2010.08.002; Weber AW, 2006, RADIOCARBON, V48, P127, DOI 10.1017/S0033822200035463; Weber AW, 2002, J ANTHROPOL ARCHAEOL, V21, P230, DOI 10.1006/jaar.2001.0395; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; ZHGENTI E, 2015, GENOME ANNOUNC, V3, P3; Zhou DS, 2009, INFECT IMMUN, V77, P2242, DOI 10.1128/IAI.01477-08; Zimbler DL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8487; Zotkina L.V., 2018, ARCHAEOL CULT ANTHR, V1, P181; Zubkov V.S., 2010, IZV LAB DREVNIH TEKH, V8, P135	153	40	41	3	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2020	181	6					1232	+		10.1016/j.cell.2020.04.037	http://dx.doi.org/10.1016/j.cell.2020.04.037			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	LY9TE	32437661	Bronze			2022-12-28	WOS:000540869600008
J	Legrand, M; Rossignol, P				Legrand, Matthieu; Rossignol, Patrick			Cardiovascular Consequences of Acute Kidney Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GELATINASE-ASSOCIATED LIPOCALIN; RENAL-REPLACEMENT THERAPY; HEART-FAILURE; CARDIORENAL SYNDROME; NATRIURETIC PEPTIDE; INHIBITION; RISK; GALECTIN-3; OUTCOMES; DISEASE	Acute kidney injury is associated with many short- and long-term adverse events. This review considers the cardiovascular consequences and strategies that can be used during acute kidney injury and recovery, with the aim of reducing subsequent cardiovascular risks.	[Legrand, Matthieu] Univ Calif San Francisco, Dept Anesthesiol & Perioperat Care, San Francisco, CA 94143 USA; [Legrand, Matthieu] Lariboisiere Hosp, INSERM 942, Paris, France; [Legrand, Matthieu] Invest Network Initiat Cardiovasc & Renal Clin Tr, French Clin Res Infrastruct Network, Paris, France; [Rossignol, Patrick] Univ Lorraine, INSERM, Ctr Invest Clin Plurithemat 1433, INSERM Unite 1116,Ctr Hosp Reg Univ CHRU, Nancy, France; [Rossignol, Patrick] F CRIN INI CRCT, Nancy, France	University of California System; University of California San Francisco; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine	Legrand, M (corresponding author), Univ Calif San Francisco, Dept Anesthesiol & Perioperat Care, UCSF Med Ctr, 500 Parnassus Ave, San Francisco, CA 94143 USA.	matthieu.legrand@ucsf.edu						Alge JL, 2013, CRIT CARE, V17, DOI 10.1186/cc12612; Alge JL, 2013, CLIN J AM SOC NEPHRO, V8, P2043, DOI 10.2215/CJN.03510413; [Anonymous], 2014, PREV CHRONIC DIS, V11, pE62; Bagshaw SM, 2013, CONTRIB NEPHROL, V182, P137, DOI 10.1159/000349971; Bansal N, 2019, J AM COLL CARDIOL, V73, P2691, DOI 10.1016/j.jacc.2019.02.071; Bansal N, 2018, AM J KIDNEY DIS, V71, P236, DOI 10.1053/j.ajkd.2017.08.027; Barbar SD, 2018, NEW ENGL J MED, V379, P1431, DOI 10.1056/NEJMoa1803213; Bartekova M, 2018, HEART FAIL REV, V23, P733, DOI 10.1007/s10741-018-9716-x; Brar S, 2018, JAMA INTERN MED, V178, P1681, DOI 10.1001/jamainternmed.2018.4749; Calvier L, 2015, JACC-HEART FAIL, V3, P59, DOI 10.1016/j.jchf.2014.08.002; Christov M, 2019, SEMIN NEPHROL, V39, P57, DOI 10.1016/j.semnephrol.2018.10.005; Christov M, 2013, KIDNEY INT, V84, P776, DOI 10.1038/ki.2013.150; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Crowley SD, 2017, J AM SOC NEPHROL, V28, P1350, DOI 10.1681/ASN.2016101066; Depret F, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0509-8; Depret F, 2017, NEPHRON, V137, P273, DOI 10.1159/000476077; Dessap AM, 2012, AM J RESP CRIT CARE, V186, P1256, DOI 10.1164/rccm.201205-0939OC; Donadio C, 2014, CRIT CARE, V18, DOI 10.1186/cc13752; Douvris A, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1965-5; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Faubel S, 2016, ADV CHRONIC KIDNEY D, V23, P179, DOI 10.1053/j.ackd.2016.02.007; Faubel S, 2016, NAT REV NEPHROL, V12, P48, DOI 10.1038/nrneph.2015.158; Forfia PR, 2005, J AM COLL CARDIOL, V45, P1667, DOI 10.1016/j.jacc.2005.01.046; Fox BM, 2019, KIDNEY INT, V95, P590, DOI 10.1016/j.kint.2018.10.020; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Gaudry S, 2016, NEW ENGL J MED, V375, P122, DOI 10.1056/NEJMoa1603017; Gayat E, 2018, INTENS CARE MED, V44, P598, DOI 10.1007/s00134-018-5160-6; Ghorbani A, 2018, J AM COLL CARDIOL, V72, P3246, DOI 10.1016/j.jacc.2018.09.076; Go AS, 2018, CLIN J AM SOC NEPHRO, V13, P833, DOI 10.2215/CJN.12591117; Harel Z, 2013, KIDNEY INT, V83, P901, DOI 10.1038/ki.2012.451; Hollinger A, 2018, KIDNEY INT REP, V3, P1424, DOI 10.1016/j.ekir.2018.08.006; Horkan CM, 2015, CRIT CARE MED, V43, P354, DOI 10.1097/CCM.0000000000000706; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Hromadka M, 2017, INT J CARDIOL, V249, P448, DOI 10.1016/j.ijcard.2017.08.072; Hsu CY, 2016, J AM SOC NEPHROL, V27, P914, DOI 10.1681/ASN.2014111114; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Kaddourah A, 2017, NEW ENGL J MED, V376, P11, DOI 10.1056/NEJMoa1611391; Kellum JA, 2019, NAT REV NEPHROL, V15, P663, DOI 10.1038/s41581-019-0203-y; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46; KOHMOTO O, 1990, CIRC RES, V66, P622, DOI 10.1161/01.RES.66.3.622; Kompotiatis P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209994; Legrand M, 2020, INTENS CARE MED, V46, P510, DOI 10.1007/s00134-019-05864-y; Legrand M, 2019, CRIT CARE MED, V47, pE953, DOI 10.1097/CCM.0000000000004010; Legrand M, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3247-1; Legrand M, 2013, CRIT CARE, V17, DOI 10.1186/cc13133; Linder A, 2014, AM J RESP CRIT CARE, V189, P1075, DOI 10.1164/rccm.201311-2097OC; Marants R, 2019, J AM SOC NEPHROL, V30, P1086, DOI 10.1681/ASN.2018121194; Martin L, 2019, CHEST, V155, P427, DOI 10.1016/j.chest.2018.08.1037; Martin-Lorenzo M, 2017, J MOL MED, V95, P1399, DOI 10.1007/s00109-017-1594-5; Martinez-Martinez E, 2017, HYPERTENSION, V70, P1148, DOI 10.1161/HYPERTENSIONAHA.117.09791; Meersch M, 2017, INTENS CARE MED, V43, P1551, DOI 10.1007/s00134-016-4670-3; Niizuma S, 2019, KIDNEY BLOOD PRESS R, V44, P1050, DOI 10.1159/000502232; Odutayo A, 2017, J AM SOC NEPHROL, V28, P377, DOI 10.1681/ASN.2016010105; Palmer SC, 2009, EUR J HEART FAIL, V11, P832, DOI 10.1093/eurjhf/hfp099; Polhemus DJ, 2017, J AM COLL CARDIOL, V70, P2139, DOI 10.1016/j.jacc.2017.08.056; Prowle JR, 2014, NAT REV NEPHROL, V10, P37, DOI 10.1038/nrneph.2013.232; Prud'homme M, 2019, JACC-BASIC TRANSL SC, V4, P717, DOI 10.1016/j.jacbts.2019.06.005; Rabb H, 2016, J AM SOC NEPHROL, V27, P371, DOI 10.1681/ASN.2015030261; ROBINSON SC, 1992, J PHARM PHARMACOL, V44, P1007, DOI 10.1111/j.2042-7158.1992.tb07083.x; Ronco C, 2019, LANCET, V394, P1949, DOI 10.1016/S0140-6736(19)32563-2; Ronco C, 2018, ADV CHRONIC KIDNEY D, V25, P382, DOI 10.1053/j.ackd.2018.08.004; Sawhney S, 2017, AM J KIDNEY DIS, V69, P18, DOI 10.1053/j.ajkd.2016.05.018; Schetz M, 2017, INTENS CARE MED, V43, P880, DOI 10.1007/s00134-017-4788-y; Schou M, 2005, J APPL PHYSIOL, V99, P1676, DOI 10.1152/japplphysiol.00641.2005; Sharp TE, 2018, J AM COLL CARDIOL, V72, P2609, DOI 10.1016/j.jacc.2018.08.2186; Siew ED, 2012, J AM SOC NEPHROL, V23, P305, DOI 10.1681/ASN.2011030315; Silver SA, 2018, J AM SOC NEPHROL, V29, P1001, DOI 10.1681/ASN.2017080882; Silver SA, 2017, AM J MED, V130, P163, DOI 10.1016/j.amjmed.2016.09.016; Song YB, 2014, AM J PHYSIOL-ENDOC M, V306, pE1055, DOI 10.1152/ajpendo.00428.2013; Sumida M, 2015, J AM SOC NEPHROL, V26, P2378, DOI 10.1681/ASN.2014080750; Tarjus A, 2015, HYPERTENSION, V66, P158, DOI 10.1161/HYPERTENSIONAHA.115.05431; Tecson KM, 2019, CARDIORENAL MED, V9, P252, DOI 10.1159/000499669; Turin TC, 2012, NEPHROL DIAL TRANSPL, V27, P3182, DOI 10.1093/ndt/gfs052; Vergaro G, 2016, HYPERTENSION, V67, P606, DOI 10.1161/HYPERTENSIONAHA.115.06161; Vieira JM, 2007, CRIT CARE MED, V35, P184, DOI 10.1097/01.CCM.0000249828.81705.65; Xu K, 2017, J AM SOC NEPHROL, V28, P1729, DOI 10.1681/ASN.2016090974; Yang L, 2015, LANCET, V386, P1465, DOI 10.1016/S0140-6736(15)00344-X; Yu LL, 2013, CIRC-HEART FAIL, V6, P107, DOI 10.1161/CIRCHEARTFAILURE.112.971168; Zannad F, 2018, CIRCULATION, V138, P929, DOI 10.1161/CIRCULATIONAHA.117.028814; 2019, BRAIN STIMUL MAR, V12, pE0058	82	49	50	3	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2020	382	23					2238	2247		10.1056/NEJMra1916393	http://dx.doi.org/10.1056/NEJMra1916393			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV0NI	32492305	Green Published			2022-12-28	WOS:000538140600017
J	Rudin, RS; Friedberg, MW; Shekelle, P; Shah, N; Bates, DW				Rudin, Robert S.; Friedberg, Mark W.; Shekelle, Paul; Shah, Neel; Bates, David W.			Getting Value From Electronic Health Records: Research Needed to Improve Practice	ANNALS OF INTERNAL MEDICINE			English	Article							SHARED DECISION-MAKING; BAR-CODE TECHNOLOGY; EARLY-ONSET SEPSIS; CARE; INFORMATION; INTERVENTION; QUALITY; ADULTS; RISK	Electronic health records (EHRs) are now widely adopted in the United States, but health systems have barely begun using them to deliver high-value care. More directed and rigorous research is needed to fulfill the promise of EHRs to not only store information but also support the delivery of better care. This article describes 4 potential benefits of EHR-based research: improving clinical decisions, supporting triage decisions, enabling collaboration among the care team (including patients), and increasing productivity via automation of tasks. Six recommendations are made for conducting and reporting research to catalyze value creation: develop interventions systematically by using user-centered design and a building-block approach; assess value in terms of cost, quality, outcomes, and work required of providers and patients; consider the time horizon for the intervention; test best practices for implementation in a range of real-world contexts; assess subtleties of behavior change tools used to improve high-value behaviors; and report the intervention in enough detail that it can be replicated, including context. Just as research played a critical role in developing early EHR prototypes and demonstrating their value to justify dissemination, research will continue to be essential in the next phase: expanding EHR-based interventions and maximizing their role in creating value.	[Rudin, Robert S.; Friedberg, Mark W.] RAND Corp, 20 Pk Plaza,Suite 920, Boston, MA 02116 USA; [Friedberg, Mark W.] Blue Cross & Blue Shield Massachusetts, Boston, MA USA; [Shekelle, Paul] RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA; [Shah, Neel; Bates, David W.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA; [Bates, David W.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA	RAND Corporation; RAND Corporation; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Rudin, RS (corresponding author), RAND Corp, 20 Pk Plaza,Suite 920, Boston, MA 02116 USA.	rrudin@rand.org		Friedberg, Mark/0000-0002-7907-8358	RAND Center of Excellence on Health System Performance [1U19HS024067-01]	RAND Center of Excellence on Health System Performance	Drs. Rudin, Friedberg and Shekelle were supported through the RAND Center of Excellence on Health System Performance, which is funded through a cooperative agreement (1U19HS024067-01) between the RAND Corporation and the Agency for Healthcare Research and Quality.	Ahluwalia SC, 2017, JT COMM J QUAL PATIE, V43, P450, DOI 10.1016/j.jcjq.2017.03.010; [Anonymous], 2013, BEST CARE LOWER COST; Bates DW, 2015, BMJ QUAL SAF, V24, P1, DOI 10.1136/bmjqs-2014-003499; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Beeler PE, 2016, J AM MED INFORM ASSN, V23, pE93, DOI 10.1093/jamia/ocv117; Blanchard Janice C, 2016, Rand Health Q, V5, P2; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Bowles Kathryn H, 2017, AMIA Annu Symp Proc, V2017, P465; Brown H, 2014, AM J MED, V127, P226, DOI 10.1016/j.amjmed.2013.12.004; Delgado MK, 2018, J GEN INTERN MED, V33, P409, DOI 10.1007/s11606-017-4286-5; Escobar GJ, 2016, J HOSP MED, V11, pS18, DOI 10.1002/jhm.2652; Escobar GJ, 2014, PEDIATRICS, V133, P30, DOI 10.1542/peds.2013-1689; Feblowitz JC, 2011, J BIOMED INFORM, V44, P688, DOI 10.1016/j.jbi.2011.03.008; Ford I, 2016, NEW ENGL J MED, V375, P454, DOI 10.1056/NEJMra1510059; Fossa AJ, 2018, J AM MED INFORM ASSN, V25, P1153, DOI 10.1093/jamia/ocy083; Friedberg Mark W, 2014, Rand Health Q, V3, P1; Friedberg MW, 2013, HEALTH AFFAIR, V32, P268, DOI 10.1377/hlthaff.2012.1084; Greenhalgh T, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.8775; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Hussey PS, 2014, JAMA INTERN MED, V174, P742, DOI 10.1001/jamainternmed.2014.245; Jones SS, 2014, ANN INTERN MED, V160, P48, DOI 10.7326/M13-1531; Kohli M, 2017, AM J ROENTGENOL, V208, P754, DOI 10.2214/AJR.16.17224; Kuo AMS, 2018, MED DECIS MAKING, V38, P1040, DOI 10.1177/0272989X18796223; Kuzniewicz MW, 2016, JT COMM J QUAL PATIE, V42, P232, DOI 10.1016/S1553-7250(16)42030-1; Lenert L, 2014, MED DECIS MAKING, V34, P987, DOI 10.1177/0272989X14550102; Levine DM, 2016, JAMA INTERN MED, V176, P1778, DOI 10.1001/jamainternmed.2016.6217; McCluskey P., 2015, BOSTON GLOBE; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Meeker D, 2016, JAMA-J AM MED ASSOC, V315, P562, DOI 10.1001/jama.2016.0275; Melton LD, 2012, AM J MANAG CARE, V18, P838; Menachemi N, 2018, J AM MED INFORM ASSN, V25, P1259, DOI 10.1093/jamia/ocy035; Parikh RB, 2016, JAMA-J AM MED ASSOC, V315, P651, DOI 10.1001/jama.2015.19417; Patel MS, 2016, JAMA INTERN MED, V176, P847, DOI 10.1001/jamainternmed.2016.1691; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; Poon EG, 2006, ANN INTERN MED, V145, P426, DOI 10.7326/0003-4819-145-6-200609190-00006; Poon EG, 2010, NEW ENGL J MED, V362, P1698, DOI 10.1056/NEJMsa0907115; Ratwani RM, 2017, ANN EMERG MED, V70, P683, DOI 10.1016/j.annemergmed.2017.04.036; Rudin Robert S, 2017, Rand Health Q, V6, P2; Rudin RS, 2016, AM J MANAG CARE, V22, pE317; Rudin RS, 2016, NEW ENGL J MED, V375, P815, DOI 10.1056/NEJMp1606884; Rudin RS, 2014, ANN INTERN MED, V161, P803, DOI 10.7326/M14-0877; Rudin RS, 2014, J AM MED INFORM ASSN, V21, P13, DOI 10.1136/amiajnl-2013-001737; Rudin RS, 2014, AM J MANAG CARE, V20, peSP1; Rudin RS, 2018, DEFINING EVALUATING; Sedrak MS, 2017, JAMA INTERN MED, V177, P939, DOI 10.1001/jamainternmed.2017.1144; Semigran HL, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3480; Stead W, 2017, HLTH INFORM PRIVACY; *SUPPORT PRINC INV, 1996, JAMA-J AM MED ASSOC, V275, P1232, DOI DOI 10.1001/JAMA.1995.03530200027032; Tang N, 2014, J GEN INTERN MED, V29, P1513, DOI 10.1007/s11606-014-2942-6; Tannenbaum D, 2015, J GEN INTERN MED, V30, P298, DOI 10.1007/s11606-014-3051-2; Torkzadeh R, 2018, J AHIMA, V89, P30; Wachter R, 2018, HARVARD BUSINESS REV; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; Wilcox AR, 2014, J AM MED INFORM ASSN, V21, pE117, DOI 10.1136/amiajnl-2013-001965	54	13	14	2	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2020	172			11			S130	S136		10.7326/M19-0878	http://dx.doi.org/10.7326/M19-0878			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MH8ZH	32479182				2022-12-28	WOS:000547009900010
J	Kmietowicz, Z				Kmietowicz, Zosia			NHS launches Race and Health Observatory after BMJ's call to end inequalities	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		ADEBOWALE V, 2020, BMJ-BRIT MED J, V368, P51166, DOI DOI 10.1136/BMJ.M530	1	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2020	369								m2191	10.1136/bmj.m2191	http://dx.doi.org/10.1136/bmj.m2191			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0OM	32482618	Bronze			2022-12-28	WOS:000548486700014
J	Rimmer, A				Rimmer, Abi			Sixty seconds on . . . the clap	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, CLINONCDOC; [Anonymous], 2020, BBC NEWS	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2020	369								m2183	10.1136/bmj.m2183	http://dx.doi.org/10.1136/bmj.m2183			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0OM	32482620	Bronze			2022-12-28	WOS:000548486700007
J	Torjesen, I				Torjesen, Ingrid			Covid-19: Doctors need proper mental health support, says BMA	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	8	8	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2020	369								m2192	10.1136/bmj.m2192	http://dx.doi.org/10.1136/bmj.m2192			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MK0OM	32482682	Bronze			2022-12-28	WOS:000548486700009
J	Krawczyk, K; Xue, S; Buchmann, P; Charpin-El-Hamri, G; Saxena, P; Hussherr, MD; Shao, JW; Ye, HF; Xie, MQ; Fussenegger, M				Krawczyk, Krzysztof; Xue, Shuai; Buchmann, Peter; Charpin-El-Hamri, Ghislaine; Saxena, Pratik; Hussherr, Marie-Didiee; Shao, Jiawei; Ye, Haifeng; Xie, Mingqi; Fussenegger, Martin			Electrogenetic cellular insulin release for real-time glycemic control in type 1 diabetic mice	SCIENCE			English	Article							MAMMALIAN-CELLS; TRANSGENE EXPRESSION; BILIVERDIN REDUCTASE; GLUCOSE-HOMEOSTASIS; OPTOGENETIC CONTROL; CALCIUM-CHANNELS; GENE-EXPRESSION; BIONIC PANCREAS; SECRETION; ACTIVATION	Sophisticated devices for remote-controlled medical interventions require an electrogenetic interface that uses digital electronic input to directly program cellular behavior. We present a cofactor-free bioelectronic interface that directly links wireless powered electrical stimulation of human cells to either synthetic promoter-driven transgene expression or rapid secretion of constitutively expressed protein therapeutics from vesicular stores. Electrogenetic control was achieved by coupling ectopic expression of the L-type voltage-gated channel Ca(v)1.2 and the inwardly rectifying potassium channel K(ir)2.1 to the desired output through endogenous calcium signaling. Focusing on type 1 diabetes, we engineered electrosensitive human beta cells ((Electro)beta cells). Wireless electrical stimulation of (Electro)beta cells inside a custom-built bioelectronic device provided real-time control of vesicular insulin release; insulin levels peaked within 10 minutes. When subcutaneously implanted, this electrotriggered vesicular release system restored normoglycemia in type 1 diabetic mice.	[Krawczyk, Krzysztof; Xue, Shuai; Buchmann, Peter; Saxena, Pratik; Hussherr, Marie-Didiee; Xie, Mingqi; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Xue, Shuai; Shao, Jiawei; Ye, Haifeng] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Xue, Shuai; Shao, Jiawei; Ye, Haifeng] East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Charpin-El-Hamri, Ghislaine] Inst Univ Technol Lyon 1, Dept Genie Biol, F-69622 Villeurbanne, France; [Shao, Jiawei; Xie, Mingqi] Westlake Univ, Sch Life Sci, Key Lab Growth Regulat & Transformat Res Zheijang, Hangzhou, Peoples R China; [Fussenegger, Martin] Univ Basel, Fac Sci, CH-4058 Basel, Switzerland; [Krawczyk, Krzysztof] Novartis Pharma AG, CH-4002 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; East China Normal University; East China Normal University; Westlake University; University of Basel; Novartis	Fussenegger, M (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.; Fussenegger, M (corresponding author), Univ Basel, Fac Sci, CH-4058 Basel, Switzerland.	fussenegger@bsse.ethz.ch		Hussherr, Marie-Didiee/0000-0002-2610-7952; Ye, Haifeng/0000-0002-5482-8116; Krawczyk, Krzysztof/0000-0001-7896-7519; Xie, Mingqi/0000-0001-5657-532X; shao, jia wei/0000-0002-3213-3575	European Research Council (ERC) advanced grant (ElectroGene) [785800]; Swiss National Science Foundation (SNF) National Centre of Competence in Research (NCCR) for Molecular Systems Engineering; Juvenile Diabetes Research Foundation (JDRF) [31-2008-416]	European Research Council (ERC) advanced grant (ElectroGene)(European Research Council (ERC)); Swiss National Science Foundation (SNF) National Centre of Competence in Research (NCCR) for Molecular Systems Engineering(Swiss National Science Foundation (SNSF)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation)	Supported by a European Research Council (ERC) advanced grant (ElectroGene; grant no. 785800) and in part by the Swiss National Science Foundation (SNF) National Centre of Competence in Research (NCCR) for Molecular Systems Engineering. ECIT was supported by the Juvenile Diabetes Research Foundation (JDRF; grant 31-2008-416).	Aichberger KJ, 2005, CANCER RES, V65, P9436, DOI 10.1158/0008-5472.CAN-05-0972; Andersson HA, 2014, VACCINES-BASEL, V2, P216, DOI 10.3390/vaccines2020216; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; Auner BG, 2003, J CONTROL RELEASE, V89, P321, DOI 10.1016/S0168-3659(03)00124-X; Aye MM, 2014, DRUG HEALTHC PATIENT, V6, P55, DOI 10.2147/DHPS.S59566; Beyer HM, 2015, ACS SYNTH BIOL, V4, P951, DOI 10.1021/acssynbio.5b00004; Burns SM, 2015, CELL METAB, V21, P126, DOI 10.1016/j.cmet.2014.12.010; Buzzetti R, 2017, NAT REV ENDOCRINOL, V13, P674, DOI 10.1038/nrendo.2017.99; D'Arco M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003355; Desai T, 2017, NAT REV DRUG DISCOV, V16, P338, DOI 10.1038/nrd.2016.232; Evron Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23862-w; Folcher M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6392; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P1203, DOI 10.1038/81208; Gitzinger M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1251; Gitzinger M, 2009, P NATL ACAD SCI USA, V106, P10638, DOI 10.1073/pnas.0901501106; Goto A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4533; Gromada J, 2018, NAT REV ENDOCRINOL, V14, P694, DOI 10.1038/s41574-018-0097-y; Helton TD, 2005, J NEUROSCI, V25, P10247, DOI 10.1523/JNEUROSCI.1089-05.2005; Henry RR, 2018, DIABETES, V67, DOI 10.2337/db18-138-OR; Henry RR, 2018, DIABETES S1, V67, P138, DOI DOI 10.2337/DB18-138-0R; Hinds TD, 2016, J BIOL CHEM, V291, P25179, DOI 10.1074/jbc.M116.731703; Hollander PA, 2001, DIABETES CARE, V24, P983, DOI 10.2337/diacare.24.6.983; Hu ZZ, 2015, INT J MOL SCI, V16, P22621, DOI 10.3390/ijms160922621; Huang H, 2010, NAT NANOTECHNOL, V5, P602, DOI [10.1038/NNANO.2010.125, 10.1038/nnano.2010.125]; Jacobs-Tulleneers-Thevissen D, 2013, DIABETOLOGIA, V56, P1605, DOI 10.1007/s00125-013-2906-0; Jarockyte G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081193; Jiang YQ, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-67; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P5824, DOI 10.1210/jc.86.12.5824; Katz D, 2007, ANN NONINVAS ELECTRO, V12, P223, DOI 10.1111/j.1542-474X.2007.00165.x; Keenan D Barry, 2009, J Diabetes Sci Technol, V3, P1207; Kim T, 2004, BIOCHEM BIOPH RES CO, V324, P401, DOI 10.1016/j.bbrc.2004.09.069; Kim T, 2015, ANGEW CHEM INT EDIT, V54, P5933, DOI 10.1002/anie.201412204; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kowarz E, 2015, BIOTECHNOL J, V10, P647, DOI 10.1002/biot.201400821; Kushibiki T, 2015, GENE THER, V22, P553, DOI 10.1038/gt.2015.23; Leese GP, 2003, DIABETES CARE, V26, P1176, DOI 10.2337/diacare.26.4.1176; Lin YX, 2004, J NEUROPHYSIOL, V92, P2820, DOI 10.1152/jn.00048.2004; Llucia-Valldeperas A, 2015, J TISSUE ENG REGEN M, V9, pE76, DOI 10.1002/term.1710; Maher BA, 2016, P NATL ACAD SCI USA, V113, P10797, DOI 10.1073/pnas.1605941113; Manabe Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052592; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; McCluskey JT, 2011, J BIOL CHEM, V286, P21982, DOI 10.1074/jbc.M111.226795; Mond HG, 2014, PACE, V37, P1728, DOI 10.1111/pace.12526; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Ortner V, 2012, J CONTROL RELEASE, V158, P424, DOI 10.1016/j.jconrel.2011.12.006; Prindle A, 2014, NATURE, V508, P387, DOI 10.1038/nature13238; Qi Meirigeng, 2014, Adv Med, V2014, P429710, DOI 10.1155/2014/429710; Rattner B., 2015, HOST RESPONSE BIOMAT, P37; Russell SJ, 2016, LANCET DIABETES ENDO, V4, P233, DOI 10.1016/S2213-8587(15)00489-1; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; Schmelzeisen-Redeker Gunther, 2015, J Diabetes Sci Technol, V9, P1006, DOI 10.1177/1932296815590154; Shao JW, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2298; Stanley SA, 2015, NAT MED, V21, P92, DOI 10.1038/nm.3730; Stanley SA, 2012, SCIENCE, V336, P604, DOI 10.1126/science.1216753; Stockley JH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00829-x; Thelen MHM, 1997, BIOCHEM J, V321, P845, DOI 10.1042/bj3210845; Tschirhart T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14030; Uda Y, 2017, P NATL ACAD SCI USA, V114, P11962, DOI 10.1073/pnas.1707190114; Uduku C, 2017, CURR OPIN PHARMACOL, V36, P29, DOI 10.1016/j.coph.2017.07.006; Wang H, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv326; Weber W, 2004, NAT BIOTECHNOL, V22, P1440, DOI 10.1038/nbt1021; Weber W, 2002, NAT BIOTECHNOL, V20, P901, DOI 10.1038/nbt731; Weber W, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp014; Xie M, 2016, SCIENCE, V354, P1296, DOI 10.1126/science.aaf4006; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yamashita H, 2014, METHODS MOL BIOL, V1098, P145, DOI 10.1007/978-1-62703-718-1_12; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654	70	65	66	15	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					993	+		10.1126/science.aau7187	http://dx.doi.org/10.1126/science.aau7187			64	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LV3IK	32467389	Green Accepted			2022-12-28	WOS:000538332600045
J	Rubin, R				Rubin, Rita			Improper Drug Disposal After Patients on Home Hospice Care Die	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					1998	1998		10.1001/jama.2020.8128	http://dx.doi.org/10.1001/jama.2020.8128			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU8UM	32453352				2022-12-28	WOS:000538023900013
J	Selby, NM; Forni, LG; Laing, CM; Horne, KL; Evans, RDR; Lucas, BJ; Fluck, RJ				Selby, Nicholas M.; Forni, Lui G.; Laing, Christopher M.; Horne, Kerry L.; Evans, Rhys D. R.; Lucas, Bethany J.; Fluck, Richard J.			Covid-19 and acute kidney injury in hospital: summary of NICE guidelines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Selby, Nicholas M.; Lucas, Bethany J.] Univ Nottingham, Ctr Kidney Res & Innovat, Nottingham, England; [Forni, Lui G.] Royal Surrey Cty Hosp NHS Fdn Trust, Dept Intens Care, Guildford, Surrey, England; [Forni, Lui G.] Univ Surrey, Sch Biosci & Med, Sect Clin Med, Guildford, Surrey, England; [Laing, Christopher M.; Evans, Rhys D. R.] UCL, Royal Free Hosp, Dept Renal Med, London, England; [Horne, Kerry L.; Fluck, Richard J.] Royal Derby Hosp, Dept Renal Med, Derby, England	University of Nottingham; Royal Surrey County Hospital; University of Surrey; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Nottingham	Selby, NM (corresponding author), Univ Nottingham, Ctr Kidney Res & Innovat, Nottingham, England.	nicholas.selby@nottingham.ac.uk		Lucas, Bethany/0000-0002-1217-6252; Selby, Nicholas/0000-0003-0351-8326				Batlle D, 2020, J AM SOC NEPHROL; Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005; Gross O, 2020, LANCET, V395, pE87, DOI 10.1016/S0140-6736(20)31041-2; Intensive Care National Audit and Research Centre, 2020, ICNARC REPORT COVID; Larsen CP, 2020, KIDNEY INT REP, V5, P935, DOI 10.1016/j.ekir.2020.04.002; Nasr SH, 2020, KIDNEY INT REP, V5, P759, DOI 10.1016/j.ekir.2020.04.030; National Institute for Health and Care Excellence, 2020, COVID 19 RAP GUID AC; National Institute for Health and Care Excellence, 2019, SOD ZIRC CYCL TREAT; National Institute for Health and Care Excellence, 2020, INTR FLUID THER AD H; National Institute for Health and Care Excellence, 2020, PAT TREAT HYP TECHN; National Institute for Health and Care Excellence, 2020, INT PROC METH DEV RA; NHS England, 2020, CLIN GUID REN REPL O; NHS England, 2020, AC KIDN INJ AKI ALG; Pei G, 2020, J AM SOC NEPHROL, V31; Peleg Y, 2020, KIDNEY INT REP, V5, P940, DOI 10.1016/j.ekir.2020.04.017; Public Health England, 2020, GUID TOP 4 EQ ACC CE; Public Health England, 2020, COVID 19 MAN EXP STA; Public Health England, 2020, GUID PUBL MENT HLTH; Royal College of General Practitioners Think Kidneys AKI Programme, 2020, THINK KIDN AKI PROGR; Royal College of Physicians, 2020, NEWS2 DET COVID 19; Su H, 2020, KIDNEY INT; The Renal Association, 2020, COVID 19 INF GUID RE; Think Kidneys, 2016, GUID MED OPT AC KIDN	23	29	30	4	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2020	369								m1963	10.1136/bmj.m1963	http://dx.doi.org/10.1136/bmj.m1963			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JW	32457068	Green Published, Bronze			2022-12-28	WOS:000538337000004
J	Chittka, L				Chittka, Lars			The secret lives of bees as horticulturists?	SCIENCE			English	Editorial Material							BUMBLEBEES		[Chittka, Lars] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	University of London; Queen Mary University London	Chittka, L (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	l.chittka@qmul.ac.uk			EPSRC [EP/P006094/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Alem S, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002564; Chittka L, 1998, J EXP BIOL, V201, P515; Forrest J, 2010, AM J BOT, V97, P38, DOI 10.3732/ajb.0900083; Leadbeater E, 2008, P ROY SOC B-BIOL SCI, V275, P1669, DOI 10.1098/rspb.2008.0270; LUNAU K, 1991, ETHOLOGY, V88, P203, DOI 10.1111/j.1439-0310.1991.tb00275.x; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Pashalidou FG, 2020, SCIENCE, V368, P881, DOI 10.1126/science.aay0496; ROSENHEIM JA, 1987, BEHAV ECOL SOCIOBIOL, V21, P401, DOI 10.1007/BF00299935; Stelzer RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009559; Takeno K, 2016, J EXP BOT, V67, P4925, DOI 10.1093/jxb/erw272; Thomson JD, 2010, PHILOS T R SOC B, V365, P3187, DOI 10.1098/rstb.2010.0115; Woodgate JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160333	12	0	0	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					824	825		10.1126/science.abc2451	http://dx.doi.org/10.1126/science.abc2451			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU2DD	32439779				2022-12-28	WOS:000537569500025
J	Hillen, HS; Kokic, G; Farnung, L; Dienemann, C; Tegunov, D; Cramer, P				Hillen, Hauke S.; Kokic, Goran; Farnung, Lucas; Dienemann, Christian; Tegunov, Dimitry; Cramer, Patrick			Structure of replicating SARS-CoV-2 polymerase	NATURE			English	Article							RNA-POLYMERASE; CRYO-EM; CORONAVIRUS; SARS; ENZYMES	The new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses an RNA-dependent RNA polymerase (RdRp) for the replication of its genome and the transcription of its genes(1-3). Here we present a cryo-electron microscopy structure of the SARS-CoV-2 RdRp in an active form that mimics the replicating enzyme. The structure comprises the viral proteins non-structural protein 12 (nsp12), nsp8 and nsp7, and more than two turns of RNA template-product duplex. The active-site cleft of nsp12 binds to the first turn of RNA and mediates RdRp activity with conserved residues. Two copies of nsp8 bind to opposite sides of the cleft and position the second turn of RNA. Long helical extensions in nsp8 protrude along exiting RNA, forming positively charged 'sliding poles'. These sliding poles can account for the known processivity of RdRp that is required for replicating the long genome of coronaviruses(3). Our results enable a detailed analysis of the inhibitory mechanisms that underlie the antiviral activity of substances such as remdesivir, a drug for the treatment of coronavirus disease 2019 (COVID-19)(4). A cryo-electron microscopy structure of the RNA-dependent RNA polymerase of SARS-CoV-2 sheds light on coronavirus replication and enables the analysis of the inhibitory mechanisms of candidate antiviral drugs.	[Hillen, Hauke S.; Kokic, Goran; Farnung, Lucas; Dienemann, Christian; Tegunov, Dimitry; Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany	Max Planck Society	Cramer, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany.	patrick.cramer@mpibpc.mpg.de	; Tegunov, Dimitry/D-7834-2015	Farnung, Lucas/0000-0002-8200-2493; Tegunov, Dimitry/0000-0001-7019-3221; Dienemann, Christian/0000-0002-2172-5110; Hillen, Hauke/0000-0002-1206-0129	Deutsche Forschungsgemeinschaft [FOR2848]; ERC Advanced Investigator Grant TRANSREGULON [693023]; Volkswagen Foundation; Deutsche Forschungsgemeinschaft, Germany's Excellence Strategy [SFB860, SPP2191, EXC 2067/1-390729940]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC Advanced Investigator Grant TRANSREGULON; Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft, Germany's Excellence Strategy(German Research Foundation (DFG))	We thank all members of the Department of Molecular Biology at the Max-Planck-Institute for Biophysical Chemistry for support; J. Schmitzova for helpful discussions and advice; and H. Urlaub for mass spectrometry. H.S.H. was supported by the Deutsche Forschungsgemeinschaft (FOR2848). P.C. was supported by the Deutsche Forschungsgemeinschaft (SFB860, SPP2191), Germany's Excellence Strategy (EXC 2067/1-390729940), the ERC Advanced Investigator Grant TRANSREGULON (grant agreement no. 693023) and the Volkswagen Foundation.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18; Ahn DG, 2012, ARCH VIROL, V157, P2095, DOI 10.1007/s00705-012-1404-x; Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210; Bouvet M, 2012, P NATL ACAD SCI USA, V109, P9372, DOI 10.1073/pnas.1201130109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao Y, 2020, SCIENCE, V368, P779, DOI 10.1126/science.abb7498; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Gordon CJ, 2020, J BIOL CHEM, V295, P4773, DOI 10.1074/jbc.AC120.013056; Hilgenfeld R, 2013, ANTIVIR RES, V100, P286, DOI 10.1016/j.antiviral.2013.08.015; Huang CC, 2014, NUCLEIC ACIDS RES, V42, pW478, DOI 10.1093/nar/gku377; Jordan Paul C., 2018, Antiviral Chemistry & Chemotherapy, V26, p2040206618764483, DOI 10.1177/2040206618764483; Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3; Kupferschmidt K, 2020, SCIENCE, V367, P1412, DOI 10.1126/science.367.6485.1412; Ledford Heidi, 2020, Nature, DOI 10.1038/d41586-020-01295-8; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Posthuma CC, 2017, VIRUS RES, V234, P58, DOI 10.1016/j.virusres.2017.01.023; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653; Snijder EJ, 2016, ADV VIRUS RES, V96, P59, DOI 10.1016/bs.aivir.2016.08.008; Subissi L, 2014, P NATL ACAD SCI USA, V111, pE3900, DOI 10.1073/pnas.1323705111; Subissi L, 2014, ANTIVIR RES, V101, P122, DOI 10.1016/j.antiviral.2013.11.006; Tchesnokov EP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040326; Vos SM, 2016, ELIFE, V5, DOI 10.7554/eLife.14981; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Xiao YB, 2012, J VIROL, V86, P4444, DOI 10.1128/JVI.06635-11; Yin W., 2020, STRUCTURAL BASIS INH, P1, DOI [10.1101/2020.04.08.032763, DOI 10.1101/2020.04.08.032763]; Yin WC, 2020, SCIENCE, V368, P1499, DOI 10.1126/science.abc1560; Zamyatkin DF, 2009, J MOL BIOL, V390, P10, DOI 10.1016/j.jmb.2009.04.069; Zhai YJ, 2005, NAT STRUCT MOL BIOL, V12, P980, DOI 10.1038/nsmb999; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X	34	349	358	8	80	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					154	+		10.1038/s41586-020-2368-8	http://dx.doi.org/10.1038/s41586-020-2368-8		MAY 2020	11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB1QU	32438371	Bronze, Green Submitted			2022-12-28	WOS:000554511100001
J	Williamson, DA; Chen, MY				Williamson, Deborah A.; Chen, Marcus Y.			Emerging and Reemerging Sexually Transmitted Infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							UNITED-STATES; NEISSERIA-MENINGITIDIS; MYCOPLASMA-GENITALIUM; MENINGOCOCCAL DISEASE; LYMPHOGRANULOMA-VENEREUM; RESISTANT SHIGELLOSIS; ZIKA VIRUS; MEN; SEX; TRANSMISSION	Sexually transmitted infections are increasing in frequency, and resistant strains are complicating treatment. Genomic technologies, education, and cooperation between government and nongovernmental organizations with community involvement may foster improved control.	[Williamson, Deborah A.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, 792 Elizabeth St, Melbourne, Vic 3100, Australia; [Williamson, Deborah A.] Royal Melbourne Hosp, Dept Microbiol, Melbourne, Vic, Australia; [Chen, Marcus Y.] Monash Univ, Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Chen, Marcus Y.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia	University of Melbourne; Royal Melbourne Hospital; Monash University; Monash University	Williamson, DA (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, 792 Elizabeth St, Melbourne, Vic 3100, Australia.	deborah.williamson@unimelb.edu.au		Williamson, Deborah/0000-0001-7363-6665				[Anonymous], 2017, J ENDOCRINOL METAB D, V22, pS1; [Anonymous], 2017, OUTBREAKS EU EEA MOS; [Anonymous], 2020, EB VIR DIS FACT SHEE; Aragon TJ, 2007, CLIN INFECT DIS, V44, P327, DOI 10.1086/510593; Baker KS, 2015, LANCET INFECT DIS, V15, P913, DOI 10.1016/S1473-3099(15)00002-X; Bazan JA, 2017, CLIN INFECT DIS, V65, P92, DOI 10.1093/cid/cix215; Beale MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11216-7; Beymer MR, 2014, SEX TRANSM INFECT, V90, P567, DOI 10.1136/sextrans-2013-051494; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2321, DOI 10.1001/jama.2016.5824; Bissessor M, 2013, SEX TRANSM DIS, V40, P768, DOI 10.1097/OLQ.0000000000000022; Bowen A, 2016, EMERG INFECT DIS, V22, P1613, DOI 10.3201/eid2209.160624; Bozio CH, 2018, MMWR-MORBID MORTAL W, V67, P1060, DOI 10.15585/mmwr.mm6738a4; Brennan J, 2019, MMWR-MORBID MORTAL W, V68, P328, DOI 10.15585/mmwr.mm6814a3; Centers for Disease Control and Prevention, 2018, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention, 2019, ICML; Chen GJ, 2017, J INFECT DIS, V215, P1339, DOI 10.1093/infdis/jix123; Chen MY, 2019, LANCET INFECT DIS, V19, P833, DOI 10.1016/S1473-3099(19)30116-1; Chen WC, 2019, EUROSURVEILLANCE, V24, P38, DOI 10.2807/1560-7917.ES.2019.24.14.1800133; Chiou CS, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.12.021; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; de Vries HJC, 2019, J EUR ACAD DERMATOL, V33, P1821, DOI 10.1111/jdv.15729; de Vries HJC, 2019, CURR OPIN INFECT DIS, V32, P43, DOI [10.1097/qco.0000000000000519, 10.1097/QCO.0000000000000519]; Dionne-Odom J, 2018, CLIN INFECT DIS, V66, P796, DOI 10.1093/cid/cix853; Durukan D, 2019, CLIN INFECT DIS; *EUR CDCP, 2018, ANN EP REP 2016; Eyre DW, 2019, EUROSURVEILLANCE, V24, P2, DOI 10.2807/1560-7917.ES.2019.24.10.1900147; Folaranmi TA, 2017, CLIN INFECT DIS, V65, P756, DOI 10.1093/cid/cix438; Foster MA, 2019, MMWR-MORBID MORTAL W, V68, P413, DOI 10.15585/mmwr.mm6818a2; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Gaudreau C, 2015, CLIN INFECT DIS, V61, P1549, DOI 10.1093/cid/civ570; Gaydos CA, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01125-19; Gilbart VL, 2015, SEX TRANSM INFECT, V91, P598, DOI 10.1136/sextrans-2015-052014; Golden M, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/jcm.00572-19, 10.1128/JCM.00572-19]; Golden MR, 2017, J INFECT DIS, V216, pS420, DOI 10.1093/infdis/jix200; Handsfield HH, 2018, SEX TRANSM DIS, V45, P409, DOI 10.1097/OLQ.0000000000000853; Hughes G, 2013, SEX TRANSM INFECT, V89, P542, DOI 10.1136/sextrans-2013-051051; Hung CC, 2012, LANCET INFECT DIS, V12, P729, DOI 10.1016/S1473-3099(12)70147-0; Ingle DJ, 2019, CLIN INFECT DIS, V69, P1535, DOI 10.1093/cid/ciz005; JANDA WM, 1980, JAMA-J AM MED ASSOC, V244, P2060, DOI 10.1001/jama.244.18.2060; Jennison AV, 2019, EUROSURVEILLANCE, V24, P15, DOI 10.2807/1560-7917.ES.2019.24.8.1900118; Jensen JS, 2016, J EUR ACAD DERMATOL, V30, P1650, DOI 10.1111/jdv.13849; Kamiya H, 2015, MMWR-MORBID MORTAL W, V64, P1256, DOI 10.15585/mmwr.mm6444a6; Koch J, 2016, EUROSURVEILLANCE, V21, P12, DOI 10.2807/1560-7917.ES.2016.21.5.30122; Leeyaphan C, 2016, EMERG INFECT DIS, V22, P1778, DOI 10.3201/eid2210.160986; Ma KC, 2017, J CLIN MICROBIOL, V55, P3374, DOI 10.1128/JCM.01018-17; MacNeil JR, 2016, MMWR-MORBID MORTAL W, V65, P1189, DOI 10.15585/mmwr.mm6543a3; Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773; Miglietta A, 2018, EUROSURVEILLANCE, V23; Mohan K, 2018, SEX TRANSM INFECT, V94, P67, DOI 10.1136/sextrans-2016-052962; Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027; Murray GL, 2017, EMERG INFECT DIS, V23, P809, DOI 10.3201/eid2305.161745; Murray K, 2017, EMERG INFECT DIS, V23, P332, DOI 10.3201/eid2302.161203; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Nanduri S, 2016, MMWR-MORBID MORTAL W, V65, P939, DOI 10.15585/mmwr.mm6535e1; Ndumbi P, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.33.1700641; Newman KL, 2019, CLIN INFECT DIS; Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Retchless AC, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4560-x; Rivas V, 2018, EUROSURVEILLANCE, V23, P9, DOI DOI 10.2807/1560-7917; Ruscher C, 2019, EUROSURVEILLANCE, V24, P32, DOI 10.2807/1560-7917.ES.2019.24.21.1800460; Shea S, 2017, J CLIN MICROBIOL, V55, P10, DOI [10.1128/jcm.01624-16, 10.1128/JCM.01624-16]; Simms I, 2014, EUROSURVEILLANCE, V19, P10, DOI 10.2807/1560-7917.ES2014.19.43.20946; Simons R, 2018, SEX TRANSM DIS, V45, P406, DOI 10.1097/OLQ.0000000000000772; Sissoko D, 2017, LANCET GLOB HEALTH, V5, pE80, DOI 10.1016/S2214-109X(16)30243-1; Soni S, 2019, INT J STD AIDS, V30, P938, DOI 10.1177/0956462419825948; Spaargaren J, 2005, EMERG INFECT DIS, V11, P1787, DOI 10.3201/eid1111.050821; Stafford IA, 2019, JAMA; Tao YS, 2020, CLIN INFECT DIS, V70, P136, DOI 10.1093/cid/ciz331; Taylor SN, 2018, NEW ENGL J MED, V379, P1835, DOI 10.1056/NEJMoa1706988; Taylor SN, 2018, CLIN INFECT DIS, V67, P504, DOI 10.1093/cid/ciy145; Taylor-Robinson D, 2011, CLIN MICROBIOL REV, V24, P498, DOI 10.1128/CMR.00006-11; Toh E, 2017, EMERG INFECT DIS, V23, P336, DOI 10.3201/eid2302.161434; Towns JM, 2016, SEX TRANSM INFECT, V92, P110, DOI 10.1136/sextrans-2015-052219; TULLY JG, 1981, LANCET, V1, P1288; Werner RN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208107; Williamson D, 2019, NEW ENGL J MED, V381, P2477, DOI 10.1056/NEJMc1910648; World Health Organization, 2018, REP GLOB SEX TRANSM; World Health Organization, 2019, WHO GUID PREV SEX TR; Wu HH, 2019, SEX TRANSM INFECT, V95, P67, DOI 10.1136/sextrans-2017-053410; Yang CJ, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.04.018	81	39	40	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2020	382	21					2023	2032		10.1056/NEJMra1907194	http://dx.doi.org/10.1056/NEJMra1907194			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LT1TD	32433838				2022-12-28	WOS:000536856000017
J	Kuehn, BM				Kuehn, Bridget M.			Study Suggests a Second Patient Has Been Cured of HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2020	323	19					1886	1886		10.1001/jama.2020.7626	http://dx.doi.org/10.1001/jama.2020.7626			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LT2XF	32427310				2022-12-28	WOS:000536934300026
J	Werner, RM; Hoffman, AK; Coe, NB				Werner, Rachel M.; Hoffman, Allison K.; Coe, Norma B.			Long-Term Care Policy after Covid-19-Solving the Nursing Home Crisis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Covid-19 has exposed the cracks in the U.S. system of providing and funding long-term care, and there are no easy fixes. We need comprehensive policies that take the care of aging Americans seriously and fund it accordingly and in a wider range of settings.	[Werner, Rachel M.; Hoffman, Allison K.; Coe, Norma B.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Werner, Rachel M.; Coe, Norma B.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hoffman, Allison K.] Univ Penn, Penn Law, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Werner, RM (corresponding author), Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA.; Werner, RM (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.			Coe, Norma/0000-0003-1228-0938; Werner, Rachel/0000-0003-3435-4221				Coe NB, 2018, J AM GERIATR SOC, V66, P2003, DOI 10.1111/jgs.15552; Goldstein M., 2020, NEW YORK TIMES; Weiner J, 2020, POLICY OPTIONS FINAN, V23; Werner RM, 2018, JAMA-J AM MED ASSOC, V319, P1616, DOI 10.1001/jama.2018.2408; Yourish K, 2020, NEW YORK TIMES	5	62	62	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2020	383	10					903	905		10.1056/NEJMp2014811	http://dx.doi.org/10.1056/NEJMp2014811			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NO9YO	32459918	Green Submitted, Bronze			2022-12-28	WOS:000569841600009
J	Studdert, DM; Zhang, YF; Swanson, SA; Prince, L; Rodden, JA; Holsinger, EE; Spittal, MJ; Wintemute, GJ; Miller, M				Studdert, David M.; Zhang, Yifan; Swanson, Sonja A.; Prince, Lea; Rodden, Jonathan A.; Holsinger, Erin E.; Spittal, Matthew J.; Wintemute, Garen J.; Miller, Matthew			Handgun Ownership and Suicide in California	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CASE-FATALITY RATES; NATIONAL COMORBIDITY; UNITED-STATES; RISK-FACTORS; FIREARMS; ASSOCIATION; MORTALITY; HOMICIDE; HOME; PURCHASE	Background Research has consistently identified firearm availability as a risk factor for suicide. However, existing studies are relatively small in scale, estimates vary widely, and no study appears to have tracked risks from commencement of firearm ownership. Methods We identified handgun acquisitions and deaths in a cohort of 26.3 million male and female residents of California, 21 years old or older, who had not previously acquired handguns. Cohort members were followed for up to 12 years 2 months (from October 18, 2004, to December 31, 2016). We used survival analysis to estimate the relationship between handgun ownership and both all-cause mortality and suicide (by firearm and by other methods) among men and women. The analysis allowed the baseline hazard to vary according to neighborhood and was adjusted for age, race and ethnic group, and ownership of long guns (i.e., rifles or shotguns). Results A total of 676,425 cohort members acquired one or more handguns, and 1,457,981 died; 17,894 died by suicide, of which 6691 were suicides by firearm. Rates of suicide by any method were higher among handgun owners, with an adjusted hazard ratio of 3.34 for all male owners as compared with male nonowners (95% confidence interval [CI], 3.13 to 3.56) and 7.16 for female owners as compared with female nonowners (95% CI, 6.22 to 8.24). These rates were driven by much higher rates of suicide by firearm among both male and female handgun owners, with a hazard ratio of 7.82 for men (95% CI, 7.26 to 8.43) and 35.15 for women (95% CI, 29.56 to 41.79). Handgun owners did not have higher rates of suicide by other methods or higher all-cause mortality. The risk of suicide by firearm among handgun owners peaked immediately after the first acquisition, but 52% of all suicides by firearm among handgun owners occurred more than 1 year after acquisition. Conclusions Handgun ownership is associated with a greatly elevated and enduring risk of suicide by firearm. (Funded by the Fund for a Safer Future and others.) In this analysis of handgun acquisitions and deaths in California, the authors found a strong association between handgun ownership and death by firearm suicide. The increased risk was highest immediately after acquiring a handgun but persisted. About half of firearm suicides among handgun owners occurred after the first year.	[Studdert, David M.] Stanford Univ, Stanford Law Sch, Stanford, CA 94305 USA; [Studdert, David M.; Zhang, Yifan; Prince, Lea; Holsinger, Erin E.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Rodden, Jonathan A.] Stanford Univ, Dept Polit Sci, Stanford, CA 94305 USA; [Wintemute, Garen J.] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA; [Swanson, Sonja A.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Spittal, Matthew J.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Miller, Matthew] Northeastern Univ, Bouve Coll Hlth Sci, Boston, MA 02115 USA	Stanford University; Stanford University; Stanford University; University of California System; University of California Davis; Erasmus University Rotterdam; Erasmus MC; University of Melbourne; Northeastern University	Studdert, DM (corresponding author), Stanford Hlth Policy, 615 Crothers Way, Stanford, CA 94305 USA.		Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537	Fund for a Safer Future [GA004696]; Joyce Foundation [17-37241]; Stanford Law School; Stanford University School of Medicine	Fund for a Safer Future; Joyce Foundation; Stanford Law School; Stanford University School of Medicine	Supported by the Fund for a Safer Future (grant no. GA004696), the Joyce Foundation (grant no. 17-37241), and internal funds from Stanford Law School and the Stanford University School of Medicine.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Anglemyer A, 2014, ANN INTERN MED, V160, P101, DOI 10.7326/M13-1301; [Anonymous], 2019, INT J GYNECOL CANCER, V29(Suppl4, pA1; [Anonymous], 2018, REL FIR AV SUIC; [Anonymous], ANN GUN LAW SCOR; California Department of Public Health, EPICENTER CAL INJ DA; Cardiovascular Disease and Risk Management, 2019, DIABETES CARE, V2, pS103, DOI 10.2337/dc19-S010; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Centers for Disease Control and Prevention, NAT VIOL DEATH REP S; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; Conner A, 2019, ANN INTERN MED; Conwell Y, 2002, AM J GERIAT PSYCHIAT, V10, P407, DOI 10.1176/appi.ajgp.10.4.407; Cummings P, 1997, AM J PUBLIC HEALTH, V87, P974, DOI 10.2105/AJPH.87.6.974; Dahlberg LL, 2004, AM J EPIDEMIOL, V160, P929, DOI 10.1093/aje/kwh309; Grassel KM, 2003, INJ PREV, V9, P48, DOI 10.1136/ip.9.1.48; Hanlon TJ, 2019, J ADOLESCENT HEALTH, V65, P366, DOI 10.1016/j.jadohealth.2019.03.015; Hernan M.A., 2020, CAUSAL INFERENCE; Ilgen MA, 2008, PSYCHIAT SERV, V59, P198, DOI 10.1176/ps.2008.59.2.198; Imai K, 2016, POLIT ANAL, V24, P263, DOI 10.1093/pan/mpw001; Karp A., 2018, SMALL ARMS SURVEY; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617; Kravitz-Wirtz N, 2019, INJ PREV; Kung HC, 2003, SOC PSYCH PSYCH EPID, V38, P419, DOI 10.1007/s00127-003-0656-x; Lesko CR, 2018, AM J EPIDEMIOL, V187, P623, DOI 10.1093/aje/kwx281; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Mathur MB, 2018, EPIDEMIOLOGY, V29, pE45, DOI 10.1097/EDE.0000000000000864; Miller M, 1999, AGGRESS VIOLENT BEH, V4, P59, DOI 10.1016/S1359-1789(97)00057-8; Miller M, 2016, EPIDEMIOL REV, V38, P62, DOI 10.1093/epirev/mxv011; Miller M, 2004, ANN EMERG MED, V43, P723, DOI 10.1016/j.annemergmed.2004.01.018; Miller M, 2009, INJURY PREV, V15, P183, DOI 10.1136/ip.2008.021352; Miller M, 2007, J TRAUMA, V62, P1029, DOI 10.1097/01.ta.0000198214.24056.40; Miller M, 2013, AM J EPIDEMIOL, V178, P946, DOI 10.1093/aje/kwt197; Mullen L, 2019, PACKAGE GENDER PREDI; Murphy GE., 2000, INT HDB SUICIDE ATTE, P135; Naghavi M, 2018, JAMA-J AM MED ASSOC, V320, P792, DOI 10.1001/jama.2018.10060; Nordentoft M, 2011, ARCH GEN PSYCHIAT, V68, P1058, DOI 10.1001/archgenpsychiatry.2011.113; Norstrom T, 2016, ARCH SUICIDE RES, V20, P489, DOI 10.1080/13811118.2016.1158678; Owens D, 2002, BRIT J PSYCHIAT, V181, P193, DOI 10.1192/bjp.181.3.193; Rimkeviciene J, 2015, J AFFECT DISORDERS, V171, P93, DOI 10.1016/j.jad.2014.08.044; Shenassa ED, 2003, J EPIDEMIOL COMMUN H, V57, P120, DOI 10.1136/jech.57.2.120; SK AZ, 2016, DIABETOL STOFFWECHS, V11, pS01; Sorenson SB, 2008, EVALUATION REV, V32, P239, DOI 10.1177/0193841X08315871; Spicer RS, 2000, AM J PUBLIC HEALTH, V90, P1885, DOI 10.2105/AJPH.90.12.1885; Stroebe W, 2013, AGGRESS VIOLENT BEH, V18, P709, DOI 10.1016/j.avb.2013.07.025; United States Census Bureau, 2004, GEOGR AR REF MAN; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wakefield J, 2008, ANNU REV PUBL HEALTH, V29, P75, DOI 10.1146/annurev.publhealth.29.020907.090821; Wiebe DJ, 2003, ANN EMERG MED, V41, P771, DOI 10.1067/mem.2003.187; Wilcox HC, 2004, DRUG ALCOHOL DEPEN, V76, pS11, DOI 10.1016/j.drugalcdep.2004.08.003; Wintemute GJ, 1999, NEW ENGL J MED, V341, P1583, DOI 10.1056/NEJM199911183412106; Zhang YF, 2020, INJURY PREV, V26, P153, DOI 10.1136/injuryprev-2019-043385	53	66	66	3	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2020	382	23					2220	2229		10.1056/NEJMsa1916744	http://dx.doi.org/10.1056/NEJMsa1916744			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LV0NI	32492303	Bronze			2022-12-28	WOS:000538140600015
J	Ruan, Z; Orozco, IJ; Du, J; Lu, W				Ruan, Zheng; Orozco, Ian J.; Du, Juan; Lu, Wei			Structures of human pannexin 1 reveal ion pathways and mechanism of gating	NATURE			English	Article							BEAM-INDUCED MOTION; ATP RELEASE; PURINERGIC RECEPTORS; BAYESIAN-APPROACH; CHANNELS; ACTIVATION; CELLS; VISUALIZATION; HEMICHANNELS; INFLAMMATION	Cryo-electron microscopy structures of the ATP-permeable channel pannexin 1 reveal a gating mechanism involving multiple distinct ion-conducting pathways. Pannexin 1 (PANX1) is an ATP-permeable channel with critical roles in a variety of physiological functions such as blood pressure regulation(1), apoptotic cell clearance(2) and human oocyte development(3). Here we present several structures of human PANX1 in a heptameric assembly at resolutions of up to 2.8 angstrom, including an apo state, a caspase-7-cleaved state and a carbenoxolone-bound state. We reveal a gating mechanism that involves two ion-conducting pathways. Under normal cellular conditions, the intracellular entry of the wide main pore is physically plugged by the C-terminal tail. Small anions are conducted through narrow tunnels in the intracellular domain. These tunnels connect to the main pore and are gated by a long linker between the N-terminal helix and the first transmembrane helix. During apoptosis, the C-terminal tail is cleaved by caspase, allowing the release of ATP through the main pore. We identified a carbenoxolone-binding site embraced by W74 in the extracellular entrance and a role for carbenoxolone as a channel blocker. We identified a gap-junction-like structure using a glycosylation-deficient mutant, N255A. Our studies provide a solid foundation for understanding the molecular mechanisms underlying the channel gating and inhibition of PANX1 and related large-pore channels.	[Ruan, Zheng; Orozco, Ian J.; Du, Juan; Lu, Wei] Van Andel Inst, Grand Rapids, MI 49503 USA	Van Andel Institute	Du, J; Lu, W (corresponding author), Van Andel Inst, Grand Rapids, MI 49503 USA.	juan.du@vai.org; wei.lu@vai.org		Ruan, Zheng/0000-0002-4412-4916; Lu, Wei/0000-0002-3009-1025	National Institutes of Health (NIH) [R56HL144929]; McKnight Scholar Award; Sloan Research Fellowship in neuroscience; NIH [R01NS111031]; American Heart Association postdoctoral fellowship [20POST35120556]; Klingenstein-Simon Scholar Award	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Scholar Award; Sloan Research Fellowship in neuroscience; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association); Klingenstein-Simon Scholar Award	We thank B. Roth for the initial construct screening; G. Zhao and X. Meng for the support with data collection at the David Van Andel Advanced Cryo-Electron Microscopy Suite; the HPC team of VARI for computational support; and D. Nadziejka for technical editing. W.L. is supported by the National Institutes of Health (NIH) (grant R56HL144929). J.D. is supported by a McKnight Scholar Award, a Klingenstein-Simon Scholar Award, a Sloan Research Fellowship in neuroscience and the NIH (grant R01NS111031). Z.R. is supported by an American Heart Association postdoctoral fellowship (grant 20POST35120556).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adamson SE, 2015, MOL METAB, V4, P610, DOI 10.1016/j.molmet.2015.06.009; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P814, DOI 10.1107/S2059798318009324; [Anonymous], 2020, PYMOL MOL GRAPH SYST; Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beckmann A, 2016, CELL TISSUE RES, V363, P751, DOI 10.1007/s00441-015-2281-x; Billaud M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005824; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chiu YH, 2018, J GEN PHYSIOL, V150, P19, DOI 10.1085/jgp.201711888; Chiu YH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14324; Choi W, 2019, NATURE, V576, P163, DOI 10.1038/s41586-019-1781-3; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Dahl G, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0191; DeLalio LJ, 2019, J BIOL CHEM, V294, P6940, DOI 10.1074/jbc.RA118.006982; Denault J-B, 2002, CURR PROTOC PROTEIN, V30, P21131; Deneka D, 2018, NATURE, V558, P254, DOI 10.1038/s41586-018-0134-y; Deng Z, 2020, CRYO STRUCTURES ATP, DOI DOI 10.1101/2020.01.05.895235V1; Dourado M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099596; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furlow PW, 2015, NAT CELL BIOL, V17, P943, DOI 10.1038/ncb3194; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Haley E, 2019, J VIS EXP, V143; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kasuya G, 2018, NAT STRUCT MOL BIOL, V25, P797, DOI 10.1038/s41594-018-0109-6; Kefauver JM, 2018, ELIFE, V7, DOI 10.7554/eLife.38461; Kern DM, 2019, ELIFE, V8, DOI 10.7554/eLife.42636; Le TTT, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01633; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Ma WH, 2012, PFLUG ARCH EUR J PHY, V463, P585, DOI 10.1007/s00424-012-1077-z; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Makarenkova HP, 2018, J INFLAMM RES, V11, P273, DOI 10.2147/JIR.S128401; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Michalski K, 2020, ELIFE, V9, DOI 10.7554/eLife.54670; Michalski K, 2018, J GEN PHYSIOL, V150, P1758, DOI 10.1085/jgp.201711804; Michalski K, 2016, J GEN PHYSIOL, V147, P165, DOI 10.1085/jgp.201511505; Myers JB, 2018, NATURE, V564, P372, DOI 10.1038/s41586-018-0786-7; Nielsen BS, 2020, J PHYSIOL-LONDON, V598, P361, DOI 10.1113/JP278759; Oshima A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13681; Penuela S, 2008, CELL COMMUN ADHES, V15, P133, DOI 10.1080/15419060802014115; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poon IKH, 2014, NATURE, V507, P329, DOI 10.1038/nature13147; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Ren JH, 2008, PURINERG SIGNAL, V4, P255, DOI 10.1007/s11302-007-9088-5; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Romanov RA, 2012, J CELL SCI, V125, P5514, DOI 10.1242/jcs.111062; Sahu G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04955; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Sang Q, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav8731; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Seminario-Vidal L, 2009, J BIOL CHEM, V284, P20638, DOI 10.1074/jbc.M109.004762; Shen MR, 2000, J PHYSIOL-LONDON, V529, P385, DOI 10.1111/j.1469-7793.2000.00385.x; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Syrjanen JL, 2020, NAT STRUCT MOL BIOL, V27, P150, DOI 10.1038/s41594-019-0369-9; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Tozaki-Saitoh H, 2011, ADV PHARMACOL, V61, P495, DOI 10.1016/B978-0-12-385526-8.00015-1; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Tsuda M, 2010, BRAIN RES REV, V63, P222, DOI 10.1016/j.brainresrev.2009.11.003; Wang JJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005431; Wang JJ, 2010, J GEN PHYSIOL, V136, P515, DOI 10.1085/jgp.201010440; Weilinger NL, 2016, NAT NEUROSCI, V19, P432, DOI 10.1038/nn.4236; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Yanguas SC, 2017, BBA-MOL CELL RES, V1864, P51, DOI 10.1016/j.bbamcr.2016.10.006; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X	79	68	68	5	30	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 27	2020	584	7822					646	+		10.1038/s41586-020-2357-y	http://dx.doi.org/10.1038/s41586-020-2357-y		JUN 2020	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NF3UH	32494015	Green Accepted, Green Published			2022-12-28	WOS:000537932200006
J	Rimmer, A				Rimmer, Abi			How can I make the most of working from home?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2020	369								m2120	10.1136/bmj.m2120	http://dx.doi.org/10.1136/bmj.m2120			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0OM	32482708	Bronze			2022-12-28	WOS:000548486700003
J	Subbaraman, N				Subbaraman, Nidhi			SCIENCE FUNDING FACES POST-PANDEMIC UPHEAVALS	NATURE			English	News Item																			0	4	4	1	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN	2020	582	7811					164	165		10.1038/d41586-020-01519-x	http://dx.doi.org/10.1038/d41586-020-01519-x			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LW3IT	32488187	Bronze			2022-12-28	WOS:000539039000003
J	Amrute, AP; Lodziana, Z; Schreyer, H; Weidenthaler, C; Schuth, F				Amrute, Amol P.; Lodziana, Zbigniew; Schreyer, Hannah; Weidenthaler, Claudia; Schueth, Ferdi			Response to Comment on "High-surface-area corundum by mechanochemically induced phase transformation of boehmite"	SCIENCE			English	Editorial Material							SELECTIVE CORROSION; NANOPARTICLES	Li et al. commented that our report claims that methods reported thus far cannot enable the production of high-purity corundum with surface areas greater than 100 m(2) g(-1), and that our obtained material could be porous aggregates rather than nanoparticles. We disagree with both of these suggestions.	[Amrute, Amol P.; Schreyer, Hannah; Weidenthaler, Claudia; Schueth, Ferdi] Max Planck Inst Kohlenforsch, Dept Heterogeneous Catalysis, D-45470 Mulheim, Germany; [Lodziana, Zbigniew] Polish Acad Sci, INP, PL-31342 Krakow, Poland	Max Planck Society; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences	Amrute, AP; Schuth, F (corresponding author), Max Planck Inst Kohlenforsch, Dept Heterogeneous Catalysis, D-45470 Mulheim, Germany.	amrute@kofo.mpg.de; schueth@kofo.mpg.de	Lodziana, Zbigniew/V-5029-2017; Amrute, Dr. Amol P./J-9194-2014	Lodziana, Zbigniew/0000-0002-4713-6891; Weidenthaler, Claudia/0000-0003-3006-1333; Amrute, Dr. Amol P./0000-0002-3362-0842	Max-Planck-Institut fur Kohlenforschung	Max-Planck-Institut fur Kohlenforschung	Supported by the Max-Planck-Institut fur Kohlenforschung.	Amrute AP, 2019, SCIENCE, V366, P485, DOI 10.1126/science.aaw9377; Chauruka SR, 2015, CHEM ENG SCI, V134, P774, DOI 10.1016/j.ces.2015.06.004; Dong LQ, 2020, J COMPUT APPL MATH, V368, DOI 10.1016/j.cam.2019.112567; Garg A. K., 1993, European patent, Patent No. [EP 0554908 A1, 0554908]; Guo RY, 2016, J AM CERAM SOC, V99, P3556, DOI 10.1111/jace.14403; Li L, 2018, ADV POWDER TECHNOL, V29, P2194, DOI 10.1016/j.apt.2018.06.003; Ma HW, 2002, KEY ENG MAT, V206-2, P43, DOI 10.4028/www.scientific.net/KEM.206-213.43; McHale JM, 1997, SCIENCE, V277, P788, DOI 10.1126/science.277.5327.788; Michen B., 2014, IMAGING MICROSC, V6, P39; Michen B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09793; Pu SX, 2015, SCI REP-UK, V5, DOI 10.1038/srep11575; TSUCHIDA T, 1990, J MATER SCI, V25, P4423, DOI 10.1007/BF00581103; Yanagida H., 1966, J CERAM ASS JPN, V74, P94; Zielinski P. A., 1993, J MATER RES, V8	14	0	0	5	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494							abb0948	10.1126/science.abb0948	http://dx.doi.org/10.1126/science.abb0948			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LV3IK	32467361				2022-12-28	WOS:000538332600002
J	Evans, NG				Evans, Nicholas G.			Covid-19: the ethics of clinical research in quarantine	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Evans, Nicholas G.] Univ Massachusetts, Dept Philosophy, 883 Broadway St,Dugan 200F, Lowell, MA 01852 USA	University of Massachusetts System; University of Massachusetts Lowell	Evans, NG (corresponding author), Univ Massachusetts, Dept Philosophy, 883 Broadway St,Dugan 200F, Lowell, MA 01852 USA.	nicholas_evans@uml.edu						Alenichev Arsenii, 2019, Glob Bioeth, V30, P1, DOI 10.1080/11287462.2019.1566973; Centers for Disease Control and Prevention, 2019, SARS CDC GUID S D CO; Childress JF, 2002, J LAW MED ETHICS, V30, P170, DOI 10.1111/j.1748-720X.2002.tb00384.x; Diamond B, 2003, NAT MED, V9, P1441, DOI 10.1038/nm1203-1441a; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Ferguson NM, 2020, IMPACT NONPHARMACEUT; Gostin L, 2007, ETHICAL CONSIDERATIO; Gostin LO, 2020, JAMA-J AM MED ASSOC, V323, P1131, DOI 10.1001/jama.2020.2025; Gostin LO, 2020, HLTH AFF, V10, DOI [10.1377/hblog20200310.824973/full/, DOI 10.1377/HBLOG20200310.824973/FULL/]; Hills K., 2016, REJECTING QUARANTINE; Inui Shohei, 2020, Radiol Cardiothorac Imaging, V2, pe204002, DOI [10.1148/ryct.2020200110, 10.1148/ryct.2020204002]; Kim H, 2020, BLOOMBERG; Kupferschmidt K, STUDY CLAIMING NEW C; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Moreno J., 2013, UNDUE RISK, DOI [10.4324/9780203388464, DOI 10.4324/9780203388464]; Peak CM, 2017, P NATL ACAD SCI USA, V114, P4023, DOI 10.1073/pnas.1616438114; Selgelid MJ, 2005, BIOETHICS, V19, P272, DOI 10.1111/j.1467-8519.2005.00441.x; Tabata S, CLIN CHARACTERISTICS, DOI [10.1101/2020.03.18.20038125v2, DOI 10.1101/2020.03.18.20038125V2]; Valdman M, 2008, SOCIAL THEORY PRACTI, V34, P551, DOI [10.5840/soctheorpract200834430, DOI 10.5840/soctheorpract200834430]; WHO, 2005, INT HLTH REG 2005, P34; WHO, CONS QUAR IND CONT C; World Health Organization, COR DIS 2019 COVID 1	23	7	7	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2020	369								m2060	10.1136/bmj.m2060	http://dx.doi.org/10.1136/bmj.m2060			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LV3KB	32471893	Bronze			2022-12-28	WOS:000538337500002
J	Torjesen, I				Torjesen, Ingrid			Covid-19: Charities call for clear advice after "utter mess" of shielding texts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		KMIETOWICZ Z, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M1170; NHS Digital, 2020, COR LETT SENT ERR DE; Tellier M, 2020, MOBILE DNA-UK, V11, DOI 10.1186/s13100-020-0200-5	3	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2020	369								m2173	10.1136/bmj.m2173	http://dx.doi.org/10.1136/bmj.m2173			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3KB	32471823	Bronze			2022-12-28	WOS:000538337500022
J	Kuehn, BM				Kuehn, Bridget M.			Hybrid Influenza Strain in Idaho	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					2000	2000		10.1001/jama.2020.6735	http://dx.doi.org/10.1001/jama.2020.6735			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU8UM	32453375				2022-12-28	WOS:000538023900019
J	Griffin, S				Griffin, Shaun			Covid-19: UK's response has so far cost "unprecedented" 124.3bn pound	BMJ-BRITISH MEDICAL JOURNAL			English	News Item													Griffin, Shaun/GLT-2847-2022					King's Fund, 2020, NHS BUDG IT HAS CHAN; National Audit Office, 2020, OV UK GOV RESP COV 1	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2020	369								m2057	10.1136/bmj.m2057	http://dx.doi.org/10.1136/bmj.m2057			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JS	32439636	Bronze			2022-12-28	WOS:000538336600016
J	Moberly, T				Moberly, Tom			Covid-19: Two hundred thank yous	BMJ-BRITISH MEDICAL JOURNAL			English	News Item												tmoberly@bmj.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2020	369								m2015	10.1136/bmj.m2015	http://dx.doi.org/10.1136/bmj.m2015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JI	32430310	Bronze			2022-12-28	WOS:000538335600008
J	Smith, JA; Wilson, KB; Sonstrom, RE; Kelleher, PJ; Welch, KD; Pert, EK; Westendorff, KS; Dickie, DA; Wang, XP; Pate, BH; Harman, WD				Smith, Jacob A.; Wilson, Katy B.; Sonstrom, Reilly E.; Kelleher, Patrick J.; Welch, Kevin D.; Pert, Emmit K.; Westendorff, Karl S.; Dickie, Diane A.; Wang, Xiaoping; Pate, Brooks H.; Harman, W. Dean			Preparation of cyclohexene isotopologues and stereoisotopomers from benzene	NATURE			English	Article							HETEROGENEOUS CATALYSTS; ACTIVATION; HYDROGENATION; DEUTERIUM; TRITIATION; COMPLEXES; MECHANISM; FORM	The hydrogen isotopes deuterium (D) and tritium (T) have become essential tools in chemistry, biology and medicine(1). Beyond their widespread use in spectroscopy, mass spectrometry and mechanistic and pharmacokinetic studies, there has been considerable interest in incorporating deuterium into drug molecules(1). Deutetrabenazine, a deuterated drug that is promising for the treatment of Huntington's disease(2), was recently approved by the United States' Food and Drug Administration. The deuterium kinetic isotope effect, which compares the rate of a chemical reaction for a compound with that for its deuterated counterpart, can be substantial(1,3,4). The strategic replacement of hydrogen with deuterium can affect both the rate of metabolism and the distribution of metabolites for a compound(5), improving the efficacy and safety of a drug. The pharmacokinetics of a deuterated compound depends on the location(s) of deuterium. Although methods are available for deuterium incorporation at both early and late stages of the synthesis of a drug(6,7), these processes are often unselective and the stereoisotopic purity can be difficult to measure(7,8). Here we describe the preparation of stereoselectively deuterated building blocks for pharmaceutical research. As a proof of concept, we demonstrate a four-step conversion of benzene to cyclohexene with varying degrees of deuterium incorporation, via binding to a tungsten complex. Using different combinations of deuterated and proteated acid and hydride reagents, the deuterated positions on the cyclohexene ring can be controlled precisely. In total, 52 unique stereoisotopomers of cyclohexene are available, in the form of ten different isotopologues. This concept can be extended to prepare discrete stereoisotopomers of functionalized cyclohexenes. Such systematic methods for the preparation of pharmacologically active compounds as discrete stereoisotopomers could improve the pharmacological and toxicological properties of drugs and provide mechanistic information related to their distribution and metabolism in the body. Cyclohexene isotopologues and stereoisotopomers with varying degrees of deuteration are formed by binding a tungsten complex to benzene, which facilitates the selective incorporation of deuterium into any position on the ring.	[Smith, Jacob A.; Wilson, Katy B.; Sonstrom, Reilly E.; Kelleher, Patrick J.; Welch, Kevin D.; Pert, Emmit K.; Westendorff, Karl S.; Dickie, Diane A.; Pate, Brooks H.; Harman, W. Dean] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Wang, Xiaoping] Oak Ridge Natl Lab, Neutron Scattering Div, Oak Ridge, TN 37830 USA	University of Virginia; United States Department of Energy (DOE); Oak Ridge National Laboratory	Harman, WD (corresponding author), Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA.	wdh5z@virginia.edu	Wang, Xiaoping/E-8050-2012; Dickie, Diane A./B-1647-2010	Wang, Xiaoping/0000-0001-7143-8112; Dickie, Diane A./0000-0003-0939-3309; Smith, Jacob/0000-0003-1008-1476; Kelleher, Patrick/0000-0003-2790-4942; Sonstrom, Reilly/0000-0003-0497-6660; Westendorff, Karl/0000-0001-6565-1945	NIGMS NIH HHS [R01 GM132205] Funding Source: Medline; NIH HHS [1R01GM132205-01] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arashiba K, 2006, ORGANOMETALLICS, V25, P560, DOI 10.1021/om0510573; Baldwin JE, 2009, J ORG CHEM, V74, P3866, DOI 10.1021/jo900430w; Dean M, 2018, DRUG DES DEV THER, V12, P313, DOI 10.2147/DDDT.S138828; EISEN MS, 1992, J AM CHEM SOC, V114, P10358, DOI 10.1021/ja00052a036; Gant TG, 2014, J MED CHEM, V57, P3595, DOI 10.1021/jm4007998; HARMAN WD, 1988, J AM CHEM SOC, V110, P7906, DOI 10.1021/ja00231a068; Harrison DP, 2011, ORGANOMETALLICS, V30, P2587, DOI 10.1021/om200183m; Jamison C. J., 2007, EMAGRES, DOI [10.1002/9780470034590.emrstm0251, DOI 10.1002/9780470034590.EMRSTM0251]; Joannou MV, 2018, ACS CATAL, V8, P5276, DOI 10.1021/acscatal.8b00924; JONES RA, 1985, J CHEM SOC CHEM COMM, P373, DOI 10.1039/c39850000373; Lankenau AW, 2015, J AM CHEM SOC, V137, P3649, DOI 10.1021/jacs.5b00490; Leiris S, 2010, EUR J MED CHEM, V45, P4140, DOI 10.1016/j.ejmech.2010.06.003; LEONG VS, 1988, J AM CHEM SOC, V110, P2644, DOI 10.1021/ja00216a047; Liebov BK, 2017, CHEM REV, V117, P13721, DOI 10.1021/acs.chemrev.7b00480; Lis EC, 2006, ORGANOMETALLICS, V25, P5051, DOI 10.1021/om060434o; Llamazares A, 2001, ORGANOMETALLICS, V20, P5277, DOI 10.1021/om010409c; Loh YY, 2017, SCIENCE, V358, P1182, DOI 10.1126/science.aap9674; Murray RW, 1996, J ORG CHEM, V61, P1830, DOI 10.1021/jo951864j; Nelson SD, 2003, DRUG METAB DISPOS, V31, P1481, DOI 10.1124/dmd.31.12.1481; Perez C, 2013, CHEM PHYS LETT, V571, P1, DOI 10.1016/j.cplett.2013.04.014; SANG CS, 1988, J HETEROCYCLIC CHEM, V25, P1383; Sarkar N, 2008, J AM CHEM SOC, V130, P9222, DOI 10.1021/ja8028153; Sharp WB, 2001, J AM CHEM SOC, V123, P8143, DOI 10.1021/ja002738m; THIBBLIN A, 1989, CHEM SOC REV, V18, P209, DOI 10.1039/cs9891800209; THIBBLIN A, 1995, J PHYS ORG CHEM, V8, P186, DOI 10.1002/poc.610080309; THOMPSON RL, 1991, ORGANOMETALLICS, V10, P1657, DOI 10.1021/om00052a006; Ungureanu I, 2000, ANGEW CHEM INT EDIT, V39, P4615, DOI 10.1002/1521-3773(20001215)39:24<4615::AID-ANIE4615>3.3.CO;2-M; Welch KD, 2007, ORGANOMETALLICS, V26, P2791, DOI 10.1021/om070034g; Wilson KB, 2019, J ORG CHEM, V84, P6094, DOI 10.1021/acs.joc.9b00279; Wilson KB, 2017, J AM CHEM SOC, V139, P11401, DOI 10.1021/jacs.7b05118; Yu RP, 2016, NATURE, V529, P195, DOI 10.1038/nature16464	31	21	21	5	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY	2020	581	7808					288	+		10.1038/s41586-020-2268-y	http://dx.doi.org/10.1038/s41586-020-2268-y			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ2CZ	32433618	Green Accepted, Green Submitted			2022-12-28	WOS:000534818200012
J	Paldi, F; Alver, B; Robertson, D; Schalbetter, SA; Kerr, A; Kelly, DA; Baxter, J; Neale, MJ; Marston, AL				Paldi, Flora; Alver, Bonnie; Robertson, Daniel; Schalbetter, Stephanie A.; Kerr, Alastair; Kelly, David A.; Baxter, Jonathan; Neale, Matthew J.; Marston, Adele L.			Convergent genes shape budding yeast pericentromeres	NATURE			English	Article							COHESIN; KINETOCHORE; LOOP; CHROMOSOMES; SPINDLE; ASSOCIATION; SEPARATION; TENSION; DNA	The three-dimensional structure of pericentromeres in budding yeast is defined by convergent genes, which mark pericentromere borders and trap cohesin complexes loaded at centromeres, generating an architecture that allows correct chromosome segregation. The three-dimensional architecture of the genome governs its maintenance, expression and transmission. The cohesin protein complex organizes the genome by topologically linking distant loci, and is highly enriched in specialized chromosomal domains surrounding centromeres, called pericentromeres(1-6). Here we report the three-dimensional structure of pericentromeres in budding yeast (Saccharomyces cerevisiae) and establish the relationship between genome organization and function. We find that convergent genes mark pericentromere borders and, together with core centromeres, define their structure and function by positioning cohesin. Centromeres load cohesin, and convergent genes at pericentromere borders trap it. Each side of the pericentromere is organized into a looped conformation, with border convergent genes at the base. Microtubule attachment extends a single pericentromere loop, size-limited by convergent genes at its borders. Reorienting genes at borders into a tandem configuration repositions cohesin, enlarges the pericentromere and impairs chromosome biorientation during mitosis. Thus, the linear arrangement of transcriptional units together with targeted cohesin loading shapes pericentromeres into a structure that is competent for chromosome segregation. Our results reveal the architecture of the chromosomal region within which kinetochores are embedded, as well as the restructuring caused by microtubule attachment. Furthermore, we establish a direct, causal relationship between the three-dimensional genome organization of a specific chromosomal domain and cellular function.	[Paldi, Flora; Alver, Bonnie; Robertson, Daniel; Kerr, Alastair; Kelly, David A.; Marston, Adele L.] Univ Edinburgh, Inst Cell Biol, Sch Biol Sci, Wellcome Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Schalbetter, Stephanie A.; Baxter, Jonathan; Neale, Matthew J.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England	University of Edinburgh; University of Sussex	Marston, AL (corresponding author), Univ Edinburgh, Inst Cell Biol, Sch Biol Sci, Wellcome Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	adele.marston@ed.ac.uk	Baxter, Jonathan/M-4045-2019	Baxter, Jonathan/0000-0002-4455-9717; Robertson, Daniel/0000-0003-3894-7200; Schalbetter, Stephanie/0000-0001-7563-169X; Kerr, Alastair/0000-0001-9207-6050; Paldi, Flora/0000-0002-8776-5879; Neale, Matthew/0000-0002-6453-1877; Marston, Adele/0000-0002-3596-9407	Wellcome Senior Research Fellowship [107827]; Wellcome PhD studentship [109091]; European Research Council (ERC) Consolidator Award [311336]; Wellcome Trust Investigator Award [200843];  [203149]; BBSRC [BB/S001425/1] Funding Source: UKRI	Wellcome Senior Research Fellowship; Wellcome PhD studentship; European Research Council (ERC) Consolidator Award(European Research Council (ERC)); Wellcome Trust Investigator Award(Wellcome Trust); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank B. Baying and V. Benes (Genecore, EMBL) for next-generation sequencing and library preparation; the Wellcome Centre for Cell Biology bioinformatics core for computational support; the Centre Optical Imaging Laboratory for support with microscopy; and W. Borek for help with statistical analysis. We thank R. Allshire, S. Bresson and D. Tollervey for helpful discussions; P. Megee for yeast strains; and W. Borek, S. Hinshaw, V. Makrantoni and P. Rome for comments on the manuscript. This study was funded by a Wellcome Senior Research Fellowship (grant 107827 to A.L.M., B.A. and F.P.); a Wellcome PhD studentship (109091 to F.P.); core funding for the Wellcome Centre for Cell Biology (203149 to A.L.M., F.P., B.A., D.R., A.K. and D.A.K.); a European Research Council (ERC) Consolidator Award (311336 to M.J.N. and S.A.S.); and a Wellcome Trust Investigator Award (200843 to M.J.N. and S.A.S.).	Bausch C, 2007, MOL CELL BIOL, V27, P8522, DOI 10.1128/MCB.01007-07; Belton Jon-Matthew, 2015, Cold Spring Harb Protoc, V2015, P649, DOI 10.1101/pdb.prot085209; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Bresson S, 2017, MOL CELL, V65, P787, DOI 10.1016/j.molcel.2017.01.005; Davidson IF, 2019, SCIENCE, V366, P1338, DOI 10.1126/science.aaz3418; Eckert CA, 2007, GENE DEV, V21, P278, DOI 10.1101/gad.1498707; Fernius J, 2013, CURR BIOL, V23, P599, DOI 10.1016/j.cub.2013.02.022; Fernius J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000629; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Ganji M, 2018, SCIENCE, V360, P102, DOI 10.1126/science.aar7831; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Hinshaw SM, 2017, CELL, V171, P72, DOI 10.1016/j.cell.2017.08.017; Hinshaw SM, 2015, ELIFE, V4, DOI 10.7554/eLife.06057; Hu B, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv670; Kerpedjiev P, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1486-1; Kim Y, 2019, SCIENCE, V366, P1345, DOI 10.1126/science.aaz4475; Lazar-Stefanita L, 2017, EMBO J, V36, P2684, DOI 10.15252/embj.201797342; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lopez-Serra L, 2013, CURR BIOL, V23, P64, DOI 10.1016/j.cub.2012.11.030; Nerusheva OO, 2014, GENE DEV, V28, P1291, DOI 10.1101/gad.240291.114; Ng TM, 2009, MOL BIOL CELL, V20, P3818, DOI 10.1091/mbc.E09-04-0330; Ocampo-Hafalla M, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150178; Ocampo-Hafalla MT, 2007, CHROMOSOMA, V116, P531, DOI 10.1007/s00412-007-0118-4; Peplowska K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004411; Perea-Resa C, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00263-18; Rowley MJ, 2018, NAT REV GENET, V19, P789, DOI 10.1038/s41576-018-0060-8; Schalbetter SA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12629-0; Schalbetter SA, 2017, NAT CELL BIOL, V19, P1071, DOI 10.1038/ncb3594; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Stempor P., 2014, WELLCOME OPEN RES, V1, P14; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Verzijlbergen KF, 2014, ELIFE, V3, DOI 10.7554/eLife.01374; Vian L, 2018, CELL, V173, P1165, DOI 10.1016/j.cell.2018.03.072; Weber SA, 2004, PLOS BIOL, V2, P1340, DOI 10.1371/journal.pbio.0020260; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019	37	26	26	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2020	582	7810					119	+		10.1038/s41586-020-2244-6	http://dx.doi.org/10.1038/s41586-020-2244-6		APR 2020	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LY1IO	32494069	Green Submitted, Green Accepted			2022-12-28	WOS:000529600400003
J	von Appen, A; LaJoie, D; Johnson, IE; Trnka, MJ; Pick, SM; Burlingame, AL; Ullman, KS; Frost, A				von Appen, Alexander; LaJoie, Dollie; Johnson, Isabel E.; Trnka, Michael J.; Pick, Sarah M.; Burlingame, Alma L.; Ullman, Katharine S.; Frost, Adam			LEM2 phase separation promotes ESCRT-mediated nuclear envelope reformation	NATURE			English	Article							TO-AUTOINTEGRATION FACTOR; STRUCTURAL-ANALYSIS; VISUALIZATION; ORGANIZATION; PREDICTION	Following cell division, phase separation of the transmembrane adaptor LEM2 ensures that the ESCRT machinery remodels microtubules and seals the nuclear envelope. During cell division, remodelling of the nuclear envelope enables chromosome segregation by the mitotic spindle(1). The reformation of sealed nuclei requires ESCRTs (endosomal sorting complexes required for transport) and LEM2, a transmembrane ESCRT adaptor(2-4). Here we show how the ability of LEM2 to condense on microtubules governs the activation of ESCRTs and coordinated spindle disassembly. The LEM motif of LEM2 binds BAF, conferring on LEM2 an affinity for chromatin(5,6), while an adjacent low-complexity domain (LCD) promotes LEM2 phase separation. A proline-arginine-rich sequence within the LCD binds to microtubules and targets condensation of LEM2 to spindle microtubules that traverse the nascent nuclear envelope. Furthermore, the winged-helix domain of LEM2 activates the ESCRT-II/ESCRT-III hybrid protein CHMP7 to form co-oligomeric rings. Disruption of these events in human cells prevented the recruitment of downstream ESCRTs, compromised spindle disassembly, and led to defects in nuclear integrity and DNA damage. We propose that during nuclear reassembly LEM2 condenses into a liquid-like phase and coassembles with CHMP7 to form a macromolecular O-ring seal at the confluence between membranes, chromatin and the spindle. The properties of LEM2 described here, and the homologous architectures of related inner nuclear membrane proteins(7,8), suggest that phase separation may contribute to other critical envelope functions, including interphase repair(8-13) and chromatin organization(14-17).	[von Appen, Alexander; Johnson, Isabel E.; Frost, Adam] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94110 USA; [LaJoie, Dollie; Ullman, Katharine S.] Univ Utah, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Trnka, Michael J.; Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Pick, Sarah M.] Univ Freiburg, Fac Chem & Pharm, Freiburg, Germany; [Frost, Adam] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Frost, Adam] Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of California System; University of California San Francisco; University of Freiburg; University of California System; University of California San Francisco	Frost, A (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94110 USA.; Ullman, KS (corresponding author), Univ Utah, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.; Frost, A (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Frost, A (corresponding author), Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA 94143 USA.	katharine.ullman@hci.utah.edu; adam.frost@ucsf.edu		Johnson, Isabel/0000-0002-3294-4423; Frost, Adam/0000-0003-2231-2577; von Appen, Alexander/0000-0001-6528-2123; Ullman, Katharine/0000-0003-3693-2830; Trnka, Michael/0000-0002-8808-5146; Pick, Sarah Maria/0000-0001-5091-2719	NIH [P50 GM082545, 1DP2-GM110772, 1R01-GM131052]; Huntsman Cancer Foundation; Huntsman Cancer Institute Cancer Center Support Grant [NIH P30CA042014]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; EMBO [ALTF 455-2016]; German Research Foundation [DFG AP 298/1-1]; NSF Graduate Research Fellowship [1000232072]; Mortiz-Heyman Discovery Fellowship;  [NIH S10OD016229]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huntsman Cancer Foundation; Huntsman Cancer Institute Cancer Center Support Grant; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; EMBO(European Molecular Biology Organization (EMBO)); German Research Foundation(German Research Foundation (DFG)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Mortiz-Heyman Discovery Fellowship; 	We thank W. I. Sundquist and S. Redding for critically reading the manuscript. For reagents, technical advice, and discussions we thank the Redding, Narlikar, Ullman, and Frost laboratories, as well as the Nikon Imaging Center at UCSF. We thank L. Williams for helping to score cell phenotypes and M. Mendoza and J. Rosenblatt for sharing microscope and other resources. We also thank the UCSF Center for Advanced cryoEM, including A. Myasnikov, D. Bulkley and M. Braunfeld. Our research was supported by NIH grants P50 GM082545, 1DP2-GM110772 (A.F.), 1R01-GM131052 (K.S.U.), and the Huntsman Cancer Foundation (K.S.U.). Shared resources used at the University of Utah were funded in part by the Huntsman Cancer Institute Cancer Center Support Grant NIH P30CA042014. Mass spectrometry analysis at the UCSF Mass Spectrometry Resource was supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and a shared instrument grant (NIH S10OD016229). A.v.A. was funded by EMBO (ALTF 455-2016) and the German Research Foundation (DFG AP 298/1-1). I.E.J. was funded by the NSF Graduate Research Fellowship (1000232072) and a Mortiz-Heyman Discovery Fellowship. A.F. is a Chan Zuckerberg Biohub investigator and an HHMI faculty scholar.	Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Bajorek M, 2009, MOL BIOL CELL, V20, P1360, DOI 10.1091/mbc.E08-05-0475; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Barrales RR, 2016, GENE DEV, V30, P133, DOI 10.1101/gad.271288.115; Barton LJ, 2015, CURR OPIN CELL BIOL, V34, P1, DOI 10.1016/j.ceb.2015.03.005; Boeynaems S, 2019, P NATL ACAD SCI USA, V116, P7889, DOI 10.1073/pnas.1821038116; Brachner A, 2005, J CELL SCI, V118, P5797, DOI 10.1242/jcs.02701; Bradley CM, 2005, NAT STRUCT MOL BIOL, V12, P935, DOI 10.1038/nsmb989; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Cai ML, 2007, J BIOL CHEM, V282, P14525, DOI 10.1074/jbc.M700576200; Chmielewska M, 2011, CELL TISSUE RES, V344, P97, DOI 10.1007/s00441-011-1129-2; Combe CW, 2015, MOL CELL PROTEOMICS, V14, P1137, DOI 10.1074/mcp.O114.042259; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; Donahue DA, 2016, J VIROL, V90, P4199, DOI 10.1128/JVI.03202-15; Ebrahimi H, 2018, ELIFE, V7, DOI 10.7554/eLife.32911; Gibson BA, 2019, CELL, V179, P470, DOI 10.1016/j.cell.2019.08.037; Gu MY, 2017, P NATL ACAD SCI USA, V114, pE2166, DOI 10.1073/pnas.1613916114; Halfmann CT, 2019, J CELL BIOL, V218, P2136, DOI 10.1083/jcb.201901116; Hamon L, 2011, BIOPHYS J, V101, P205, DOI 10.1016/j.bpj.2011.05.022; Haraguchi T, 2001, J CELL SCI, V114, P4575; Herrada I, 2016, METHOD ENZYMOL, V569, P43, DOI 10.1016/bs.mie.2015.07.008; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huguet F, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070687; Im YJ, 2009, DEV CELL, V17, P234, DOI 10.1016/j.devcel.2009.07.008; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kosinski J, 2015, J STRUCT BIOL, V189, P177, DOI 10.1016/j.jsb.2015.01.014; Lee KK, 2001, J CELL SCI, V114, P4567; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Mackay DR, 2010, J CELL BIOL, V191, P923, DOI 10.1083/jcb.201007124; Mackay DR, 2009, MOL BIOL CELL, V20, P1652, DOI 10.1091/mbc.E08-08-0883; Margalit A, 2005, P NATL ACAD SCI USA, V102, P3290, DOI 10.1073/pnas.0408364102; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McCullough J, 2015, SCIENCE, V350, P1548, DOI 10.1126/science.aad8305; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Muller F, 2018, J AM SOC MASS SPECTR, V29, P405, DOI 10.1007/s13361-017-1837-2; Olmos Y, 2015, NATURE, V522, P236, DOI 10.1038/nature14503; Penfield L, 2018, MOL BIOL CELL, V29, P852, DOI [10.1091/mbc.E17-06-0374, 10.1091/mbc.e17-06-0374]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper GH, 2020, DEV CELL, V53, P27, DOI 10.1016/j.devcel.2020.01.028; Raab M, 2016, SCIENCE, V352, P359, DOI 10.1126/science.aad7611; Rai AK, 2018, NATURE, V559, P211, DOI 10.1038/s41586-018-0279-8; Samwer M, 2017, CELL, V170, P956, DOI 10.1016/j.cell.2017.07.038; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Tang SG, 2015, ELIFE, V4, DOI 10.7554/eLife.12548; Thaller DJ, 2019, ELIFE, V8, DOI 10.7554/eLife.45284; Trnka MJ, 2014, MOL CELL PROTEOMICS, V13, P420, DOI 10.1074/mcp.M113.034009; Ulbert S, 2006, FEBS LETT, V580, P6435, DOI 10.1016/j.febslet.2006.10.060; Ungricht R, 2017, NAT REV MOL CELL BIO, V18, P229, DOI 10.1038/nrm.2016.153; Vietri M, 2015, NATURE, V522, P231, DOI 10.1038/nature14408	52	55	55	3	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 4	2020	582	7810					115	+		10.1038/s41586-020-2232-x	http://dx.doi.org/10.1038/s41586-020-2232-x		APR 2020	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE2ZB	32494070	Green Submitted, Green Accepted			2022-12-28	WOS:000529600400002
J	Oran, DP; Topol, EJ				Oran, Daniel P.; Topol, Eric J.			Prevalence of Asymptomatic SARS-CoV-2 Infection A Narrative Review	ANNALS OF INTERNAL MEDICINE			English	Review								Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly throughout the world since the first cases of coronavirus disease 2019 (COVID-19) were observed in December 2019 in Wuhan, China. It has been suspected that infected persons who remain asymptomatic play a significant role in the ongoing pandemic, but their relative number and effect have been uncertain. The authors sought to review and synthesize the available evidence on asymptomatic SARS-CoV-2 infection. Asymptomatic persons seem to account for approximately 40% to 45% of SARS-CoV-2 infections, and they can transmit the virus to others for an extended period, perhaps longer than 14 days. Asymptomatic infection may be associated with subclinical lung abnormalities, as detected by computed tomography. Because of the high risk for silent spread by asymptomatic persons, it is imperative that testing programs include those without symptoms. To supplement conventional diagnostic testing, which is constrained by capacity, cost, and its one-off nature, innovative tactics for public health surveillance, such as crowdsourcing digital wearable data and monitoring sewage sludge, might be helpful.	[Oran, Daniel P.; Topol, Eric J.] Scripps Res Translat Inst, 3344 North Torrey Pines Court,3rd Floor, La Jolla, CA 92037 USA		Topol, EJ (corresponding author), Scripps Res Translat Inst, 3344 North Torrey Pines Court,3rd Floor, La Jolla, CA 92037 USA.	etopol@scripps.edu		Oran, Daniel P./0000-0002-1749-2019; Topol, Eric/0000-0002-1478-4729				Ackley SF, 2020, HEALTH INFORM J, V26, P2148, DOI 10.1177/1460458219897152; [Anonymous], 2020, COVID 19 CAS TRACK; [Anonymous], 2020, FIGARO; [Anonymous], 2020, LE PARISIEN; [Anonymous], 2020, NAVY LIVE       0424; [Anonymous], 2020, NBC 7 SAN DIEGO; Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Baggett TP, COVID 19 OUTBREAK LA, DOI 10.1101/2020.04.12.20059618; Baggett TP, 2020, JAMA-J AM MED ASSOC, V323, P2191, DOI 10.1001/jama.2020.6887; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Barrett Emily S, 2020, medRxiv, DOI 10.1101/2020.04.20.20072470; Centers for Disease Control and Prevention, 2020, NAT TRENDS COMM HUM; Chou E, 2020, LOS ANGELES DAI 0421; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Ing AJ, 2020, THORAX, V75, P693, DOI 10.1136/thoraxjnl-2020-215091; Inui Shohei, 2020, Radiol Cardiothorac Imaging, V2, pe204002, DOI [10.1148/ryct.2020200110, 10.1148/ryct.2020204002]; IU, 2020, IU ISDH REL PREL FIN; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Lavezzo E., 2020, SUPPRESSION COVID 1, DOI [10.1101/2020.04.17.20053157v1, DOI 10.1101/2020.04.17.20053157V1, 10.1038/s41586-020-2488-1]; Lytras T, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa054; McFarling UL, 2020, STAT; Miller AC, 2018, CLIN INFECT DIS, V67, P388, DOI 10.1093/cid/ciy073; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Moriarty LF, 2020, MMWR-MORBID MORTAL W, V69, P347, DOI 10.15585/mmwr.mm6912e3; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; Peccia J., 2020, SARS COV 2 RNA CONCE, DOI [10.1101/2020.05.19.20105999, DOI 10.1101/2020.05.19.20105999]; Peniston B, 2020, DEFENSE ONE     0407; Radin JM, 2020, LANCET DIGIT HEALTH, V2, pE85, DOI 10.1016/S2589-7500(19)30222-5; Ratliff V, 2020, NEWS TRIBUNE    0514; Seligman L., 2020, POLITICO; Smith G, 2020, REUTERS; Stewart P., 2020, REUTERS; Sutton D, 2020, NEW ENGL J MED, V382, P2163, DOI 10.1056/NEJMc2009316; Yang RR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10182; Zhang F., 2020, PROTOCOL DETECTION C, DOI [10.5281/zenodo.4921924(2021, DOI 10.5281/ZENODO.4921924(2021]; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	37	1031	1064	15	97	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2020	173	5					362	+		10.7326/M20-3012	http://dx.doi.org/10.7326/M20-3012			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK9XI	32491919	Green Published			2022-12-28	WOS:000567080900010
J	Yu, JY; Tostanoski, LH; Peter, L; Mercado, NB; McMahan, K; Mahrokhian, SH; Nkolola, JP; Liu, JY; Li, ZF; Chandrashekar, A; Martinez, DR; Loos, C; Atyeo, C; Fischinger, S; Burke, JS; Slein, MD; Chen, YZ; Zuiani, A; Lelis, FJN; Travers, M; Habibi, S; Pessaint, L; Van Ry, A; Blade, K; Brown, R; Cook, A; Finneyfrock, B; Dodson, A; Teow, E; Velasco, J; Zahn, R; Wegmann, F; Bondzie, EA; Dagotto, G; Gebre, MS; He, X; Jacob-Dolan, C; Kirilova, M; Kordana, N; Lin, ZJ; Maxfield, LF; Nampanya, F; Nityanandam, R; Ventura, JD; Wan, HH; Cai, YF; Chen, B; Schmidt, AG; Wesemann, DR; Baric, RS; Alter, G; Andersen, H; Lewis, MG; Barouch, DH				Yu, Jingyou; Tostanoski, Lisa H.; Peter, Lauren; Mercado, Noe B.; McMahan, Katherine; Mahrokhian, Shant H.; Nkolola, Joseph P.; Liu, Jinyan; Li, Zhenfeng; Chandrashekar, Abishek; Martinez, David R.; Loos, Carolin; Atyeo, Caroline; Fischinger, Stephanie; Burke, John S.; Slein, Matthew D.; Chen, Yuezhou; Zuiani, Adam; Lelis, Felipe J. N.; Travers, Meghan; Habibi, Shaghayegh; Pessaint, Laurent; Van Ry, Alex; Blade, Kelvin; Brown, Renita; Cook, Anthony; Finneyfrock, Brad; Dodson, Alan; Teow, Elyse; Velasco, Jason; Zahn, Roland; Wegmann, Frank; Bondzie, Esther A.; Dagotto, Gabriel; Gebre, Makda S.; He, Xuan; Jacob-Dolan, Catherine; Kirilova, Marinela; Kordana, Nicole; Lin, Zijin; Maxfield, Lori F.; Nampanya, Felix; Nityanandam, Ramya; Ventura, John D.; Wan, Huahua; Cai, Yongfei; Chen, Bing; Schmidt, Aaron G.; Wesemann, Duane R.; Baric, Ralph S.; Alter, Galit; Andersen, Hanne; Lewis, Mark G.; Barouch, Dan H.			DNA vaccine protection against SARS-CoV-2 in rhesus macaques	SCIENCE			English	Article							LENGTH INFECTIOUS CDNA; NEUTRALIZING ANTIBODY; SARS CORONAVIRUS; REVERSE GENETICS; IMMUNE-RESPONSES; PNEUMONIA; EFFICACY; SPIKE	The global coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made the development of a vaccine a top biomedical priority. In this study, we developed a series of DNA vaccine candidates expressing different forms of the SARS-CoV- 2 spike (S) protein and evaluated them in 35 rhesus macaques. Vaccinated animals developed humoral and cellular immune responses, including neutralizing antibody titers at levels comparable to those found in convalescent humans and macaques infected with SARS-CoV-2. After vaccination, all animals were challenged with SARS- CoV-2, and the vaccine encoding the full-length S protein resulted in >3.1 and >3.7 log(10) reductions in median viral loads in bronchoalveolar lavage and nasal mucosa, respectively, as compared with viral loads in sham controls. Vaccine-elicited neutralizing antibody titers correlated with protective efficacy, suggesting an immune correlate of protection. These data demonstrate vaccine protection against SARS-CoV-2 in nonhuman primates.	[Yu, Jingyou; Tostanoski, Lisa H.; Peter, Lauren; Mercado, Noe B.; McMahan, Katherine; Mahrokhian, Shant H.; Nkolola, Joseph P.; Liu, Jinyan; Li, Zhenfeng; Chandrashekar, Abishek; Bondzie, Esther A.; Dagotto, Gabriel; Gebre, Makda S.; He, Xuan; Jacob-Dolan, Catherine; Kirilova, Marinela; Kordana, Nicole; Lin, Zijin; Maxfield, Lori F.; Nampanya, Felix; Nityanandam, Ramya; Ventura, John D.; Wan, Huahua; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Martinez, David R.; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Loos, Carolin; Atyeo, Caroline; Fischinger, Stephanie; Burke, John S.; Slein, Matthew D.; Schmidt, Aaron G.; Alter, Galit; Barouch, Dan H.] MIT, Ragon Inst MGH, Cambridge, MA 02139 USA; [Loos, Carolin; Atyeo, Caroline; Fischinger, Stephanie; Burke, John S.; Slein, Matthew D.; Schmidt, Aaron G.; Alter, Galit; Barouch, Dan H.] Harvard, Cambridge, MA 02139 USA; [Chen, Yuezhou; Zuiani, Adam; Lelis, Felipe J. N.; Travers, Meghan; Habibi, Shaghayegh; Wesemann, Duane R.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Pessaint, Laurent; Van Ry, Alex; Blade, Kelvin; Brown, Renita; Cook, Anthony; Finneyfrock, Brad; Dodson, Alan; Teow, Elyse; Velasco, Jason; Andersen, Hanne; Lewis, Mark G.] Bioqual, Rockville, MD 20852 USA; [Zahn, Roland; Wegmann, Frank] Janssen Vaccines & Prevent BV, Leiden, Netherlands; [Cai, Yongfei; Chen, Bing] Childrens Hosp, Boston, MA 02115 USA; [Chen, Bing; Schmidt, Aaron G.; Wesemann, Duane R.; Alter, Galit; Barouch, Dan H.] Massachusetts Consortium Pathogen Readiness, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; BIOQUAL Inc.; Harvard University; Boston Children's Hospital	Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Barouch, DH (corresponding author), MIT, Ragon Inst MGH, Cambridge, MA 02139 USA.; Barouch, DH (corresponding author), Harvard, Cambridge, MA 02139 USA.; Barouch, DH (corresponding author), Massachusetts Consortium Pathogen Readiness, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Lelis, Felipe/AAF-1164-2019; Zahn, Roland/ABE-8779-2021; Chandrashekar, Abishek/P-2610-2019; martinez, david/GQI-0849-2022; Cai, Yongfei/ABI-7748-2020; Mercado, Noe/ABE-8247-2020	Lelis, Felipe/0000-0002-3708-3810; Chandrashekar, Abishek/0000-0001-7821-5552; Cai, Yongfei/0000-0002-3628-3802; Ventura, John/0000-0002-4373-3242; Wegmann, Frank/0000-0002-9821-1492; Mahrokhian, Shant/0000-0003-4094-8739; Gebre, Makda/0000-0001-8520-2178; Zuiani, Adam/0000-0002-2625-6595; Slein, Matthew/0000-0001-8288-787X; Wesemann, Duane/0000-0002-6690-944X; Tostanoski, Lisa/0000-0001-9255-5684; Lin, Zijin/0000-0002-6706-5410; Elyard, Hanne/0000-0003-1103-9608; Peter, Lauren/0000-0002-2105-7503; Yu, Jingyou/0000-0002-0775-6623; Mercado, Noe/0000-0001-7769-7326; Jacob-Dolan, Catherine/0000-0001-6641-0342; Nampanya, Felix/0000-0003-4102-1265	Ragon Institute of MGH, MIT, and Harvard; Mark and Lisa Schwartz Foundation; Beth Israel Deaconess Medical Center; Massachusetts Consortium on Pathogen Readiness (MassCPR); Janssen Vaccines Prevention BV; National Institutes of Health [OD024917, AI129797, AI124377, AI128751, AI126603, AI007151, AI146779, AI121394, AI139538, 272201700036I-0-759301900131-1, AI100625, AI110700, AI132178, AI149644, AI108197]; Burroughs Wellcome Fund Postdoctoral Enrichment Program Award	Ragon Institute of MGH, MIT, and Harvard; Mark and Lisa Schwartz Foundation; Beth Israel Deaconess Medical Center; Massachusetts Consortium on Pathogen Readiness (MassCPR); Janssen Vaccines Prevention BV; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Postdoctoral Enrichment Program Award(Burroughs Wellcome Fund)	We acknowledge support from the Ragon Institute of MGH, MIT, and Harvard; the Mark and Lisa Schwartz Foundation; Beth Israel Deaconess Medical Center; the Massachusetts Consortium on Pathogen Readiness (MassCPR); Janssen Vaccines & Prevention BV; and the National Institutes of Health (OD024917, AI129797, AI124377, AI128751, and AI126603 to D.H.B.; AI007151 to D.R.M.; AI146779 to A.G.S.; AI121394 and AI139538 to D.R.W.; and 272201700036I-0-759301900131-1, AI100625, AI110700, AI132178, AI149644, and AI108197 to R.S.B.). We also acknowledge a Burroughs Wellcome Fund Postdoctoral Enrichment Program Award to D.R.M.	Abbink P, 2019, SCIENCE, V365, P1029, DOI 10.1126/science.aaw8562; Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chung AW, 2015, CELL, V163, P988, DOI 10.1016/j.cell.2015.10.027; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Kirchdoerfer RN, 2016, NATURE, V531, P118, DOI 10.1038/nature17200; Kobinger GP, 2007, VACCINE, V25, P5220, DOI 10.1016/j.vaccine.2007.04.065; Li Q., 2020, NEW ENGL J MED, V382, P1199; Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158; Liu RQ, 2018, ANTIVIR RES, V150, P30, DOI 10.1016/j.antiviral.2017.12.007; Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026; Muthumani K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7462; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110; Tseng CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053096; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100; Zhou J, 2005, VACCINE, V23, P3202, DOI 10.1016/j.vaccine.2004.11.075; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	30	620	637	11	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2020	369	6505					806	+		10.1126/science.abc6284	http://dx.doi.org/10.1126/science.abc6284			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA3RX	32434945	Green Published, Green Submitted			2022-12-28	WOS:000559731300034
J	Shen, B; Yi, X; Sun, YT; Bi, XJ; Du, JP; Zhang, C; Quan, S; Zhang, FF; Sun, R; Qian, LJ; Ge, WG; Liu, W; Liang, S; Chen, H; Zhang, Y; Li, J; Xu, JQ; He, ZB; Chen, BF; Wang, J; Yan, HX; Zheng, YF; Wang, DL; Zhu, JS; Kong, ZQ; Kang, ZY; Liang, X; Ding, X; Ruan, G; Xiang, N; Cai, X; Gao, HH; Li, L; Li, SN; Xiao, Q; Lu, T; Zhu, Y; Liu, HF; Chen, HX; Guo, TN				Shen, Bo; Yi, Xiao; Sun, Yaoting; Bi, Xiaojie; Du, Juping; Zhang, Chao; Quan, Sheng; Zhang, Fangfei; Sun, Rui; Qian, Liujia; Ge, Weigang; Liu, Wei; Liang, Shuang; Chen, Hao; Zhang, Ying; Li, Jun; Xu, Jiaqin; He, Zebao; Chen, Baofu; Wang, Jing; Yan, Haixi; Zheng, Yufen; Wang, Donglian; Zhu, Jiansheng; Kong, Ziqing; Kang, Zhouyang; Liang, Xiao; Ding, Xuan; Ruan, Guan; Xiang, Nan; Cai, Xue; Gao, Huanhuan; Li, Lu; Li, Sainan; Xiao, Qi; Lu, Tian; Zhu, Yi; Liu, Huafen; Chen, Haixiao; Guo, Tiannan			Proteomic and Metabolomic Characterization of COVID-19 Patient Sera	CELL			English	Article							ACUTE RESPIRATORY SYNDROME; EARLY-STAGE; LUNG; COMPLEMENT; DISEASE; SYSTEM; LIPIDS	Early detection and effective treatment of severe COVID-19 patients remain major challenges. Here, we performed proteomic and metabolomic profiling of sera from 46 COVID-19 and 53 control individuals. We then trained a machine learning model using proteomic and metabolomic measurements from a training cohort of 18 non-severe and 13 severe patients. The model was validated using 10 independent patients, 7 of which were correctly classified. Targeted proteomics and metabolomics assays were employed to further validate this molecular classifier in a second test cohort of 19 COVID-19 patients, leading to 16 correct assignments. We identified molecular changes in the sera of COVID-19 patients compared to other groups implicating dysregulation of macrophage, platelet degranulation, complement system pathways, and massive metabolic suppression. This study revealed characteristic protein and metabolite changes in the sera of severe COVID-19 patients, which might be used in selection of potential blood biomarkers for severity evaluation.	[Shen, Bo; Bi, Xiaojie; Du, Juping; Zhang, Ying; Li, Jun; Xu, Jiaqin; He, Zebao; Chen, Baofu; Wang, Jing; Yan, Haixi; Zheng, Yufen; Wang, Donglian; Zhu, Jiansheng; Chen, Haixiao] Wenzhou Med Univ, Taizhou Hosp, 150 Ximen St, Linhai 317000, Zhejiang, Peoples R China; [Yi, Xiao; Sun, Yaoting; Zhang, Fangfei; Sun, Rui; Qian, Liujia; Ge, Weigang; Liu, Wei; Liang, Shuang; Chen, Hao; Liang, Xiao; Ding, Xuan; Ruan, Guan; Xiang, Nan; Cai, Xue; Gao, Huanhuan; Li, Lu; Li, Sainan; Xiao, Qi; Lu, Tian; Zhu, Yi; Guo, Tiannan] Westlake Univ, Sch Life Sci, Key Lab Struct Biol Zhejiang Prov, 18 Shilongshan Rd, Hangzhou 310024, Zhejiang, Peoples R China; [Yi, Xiao; Sun, Yaoting; Zhang, Fangfei; Sun, Rui; Qian, Liujia; Ge, Weigang; Liu, Wei; Liang, Shuang; Chen, Hao; Liang, Xiao; Ding, Xuan; Ruan, Guan; Xiang, Nan; Cai, Xue; Gao, Huanhuan; Li, Lu; Li, Sainan; Xiao, Qi; Lu, Tian; Zhu, Yi; Guo, Tiannan] Westlake Inst Adv Study, Inst Basic Med Sci, 18 Shilongshan Rd, Hangzhou 310030, Zhejiang, Peoples R China; [Zhang, Chao; Quan, Sheng; Kong, Ziqing; Kang, Zhouyang; Liu, Huafen] Calibra Lab DIAN Diagnost, 329 Jinpeng St, Hangzhou 310030, Zhejiang, Peoples R China	Wenzhou Medical University; Westlake University; Westlake University	Chen, HX (corresponding author), Wenzhou Med Univ, Taizhou Hosp, 150 Ximen St, Linhai 317000, Zhejiang, Peoples R China.; Zhu, Y; Guo, TN (corresponding author), Westlake Univ, Sch Life Sci, Key Lab Struct Biol Zhejiang Prov, 18 Shilongshan Rd, Hangzhou 310024, Zhejiang, Peoples R China.; Zhu, Y; Guo, TN (corresponding author), Westlake Inst Adv Study, Inst Basic Med Sci, 18 Shilongshan Rd, Hangzhou 310030, Zhejiang, Peoples R China.; Liu, HF (corresponding author), Calibra Lab DIAN Diagnost, 329 Jinpeng St, Hangzhou 310030, Zhejiang, Peoples R China.	zhuyi@westlake.edu.cn; liuhf1@dazd.cn; chenhx@enzemed.com; guotiannan@westlake.edu.cn	Guo, Tiannan/AAR-3568-2020; Qian, Liu/GYU-5886-2022; liu, qian/HDM-2936-2022; Liang, Shuang/GWQ-9336-2022; Liu, Wei/B-5023-2019	Guo, Tiannan/0000-0003-3869-7651; Sun, Yaoting/0000-0001-7613-648X; Liu, Wei/0000-0002-5925-3059; Ge, Weigang/0000-0002-1803-4327; Yi, Xiao/0000-0002-6288-5233; Qian, Liujia/0000-0002-0870-7479	Tencent Foundation (2020); National Natural Science Foundation of China [81972492, 21904107, 81672086]; Zhejiang Provincial Natural Science Foundation for Distinguished Young Scholars [LR19C050001]; Hangzhou Agriculture and Society Advancement Program [20190101A04]	Tencent Foundation (2020); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation for Distinguished Young Scholars; Hangzhou Agriculture and Society Advancement Program	This work is supported by grants from Tencent Foundation (2020), National Natural Science Foundation of China (81972492, 21904107, and 81672086), Zhejiang Provincial Natural Science Foundation for Distinguished Young Scholars (LR19C050001), and Hangzhou Agriculture and Society Advancement Program (20190101A04). We thank Drs. R. Aebersold, O.L. Kon, H. Yu, and D. Li and the Guomics team for invaluable comments to this study. We thank Westlake University Supercomputer Center for assistance in data storage and computation.	Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949; Arabi YM, 2018, AM J RESP CRIT CARE, V197, P757, DOI 10.1164/rccm.201706-1172OC; Assinger A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00649; Auerbach DJ, 2012, P NATL ACAD SCI USA, V109, P9569, DOI 10.1073/pnas.1207314109; Baganz NL, 2013, ACS CHEM NEUROSCI, V4, P48, DOI 10.1021/cn300186b; Barnum SR, 2017, PHARMACOL THERAPEUT, V172, P63, DOI 10.1016/j.pharmthera.2016.11.014; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Chirco KR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00539; Escher C, 2012, PROTEOMICS, V12, P1111, DOI 10.1002/pmic.201100463; Fedson DS, 2020, MBIO, V11, DOI 10.1128/mBio.00398-20; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gao HH, 2020, J PROTEOME RES, V19, P1982, DOI 10.1021/acs.jproteome.9b00790; Garcia CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064443; Ghinai I, 2020, LANCET, V395, P1137, DOI 10.1016/S0140-6736(20)30607-3; Gralinski LE, 2018, MBIO, V9, DOI 10.1128/mBio.01753-18; Gu JG, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-154; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Heaton NS, 2011, TRENDS MICROBIOL, V19, P368, DOI 10.1016/j.tim.2011.03.007; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hou YCC, 2020, P NATL ACAD SCI USA, V117, P3053, DOI 10.1073/pnas.1909378117; Jiang YT, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0063-8; Keshavan P, 2005, J IMMUNOL, V174, P3709, DOI 10.4049/jimmunol.174.6.3709; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lee AH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08794-x; Lefrancais E, 2017, NATURE, V544, P105, DOI 10.1038/nature21706; Lercher A, 2019, IMMUNITY, V51, P1074, DOI 10.1016/j.immuni.2019.10.014; Li GM, 2007, MICROBES INFECT, V9, P96, DOI 10.1016/j.micinf.2006.10.015; Li JM, 2020, NAT METHODS, V17, P399, DOI 10.1038/s41592-020-0781-4; Li TB, 2018, NAT METHODS, V15, P543, DOI 10.1038/s41592-018-0039-6; Li XK, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat4162; Liang T., 2020, HDB COVID 19 PREVENT, DOI DOI 10.1101/2020.1102.1123.20026690; Liao M., 2020, MEDRXIV; Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mantovani A, 2013, NAT IMMUNOL, V14, P768, DOI 10.1038/ni.2666; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Minhas PS, 2019, NAT IMMUNOL, V20, P50, DOI 10.1038/s41590-018-0255-3; Murthy S, 2020, JAMA-J AM MED ASSOC, V323, P1499, DOI 10.1001/jama.2020.3633; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; NHCPRC (National Health Commission of the PRC), 2020, DIAGN TREATM PROT CO; Nie S., 2020, METABOLIC DISTURBANC, DOI [10.1101/2020.03.24.20042283., DOI 10.1101/2020.03.24.20042283.]; Pang RTK, 2006, CLIN CHEM, V52, P1202, DOI 10.1373/clinchem.2006.068395; Poon TCW, 2012, ELECTROPHORESIS, V33, P1894, DOI 10.1002/elps.201200002; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rouzer CA, 2007, BIOCHEMISTRY-US, V46, P6026, DOI 10.1021/bi0621617; Rowland A, 2013, INT J BIOCHEM CELL B, V45, P1121, DOI 10.1016/j.biocel.2013.02.019; Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2; Sanchez-Lopez E, 2019, CELL METAB, V29, P1350, DOI 10.1016/j.cmet.2019.03.011; Schoggins JW, 2013, CELL HOST MICROBE, V14, P379, DOI 10.1016/j.chom.2013.09.010; Sun SH, 2015, CLIN INFECT DIS, V60, P586, DOI 10.1093/cid/ciu887; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang RX, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.28; Wilder-Smith A, 2004, CLIN INFECT DIS, V39, P1818, DOI 10.1086/426029; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yan BP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010073; Zheng YFF, 2020, CLIN CHEM LAB MED, V58, P1106, DOI 10.1515/cclm-2020-0377; ZHOU YY, 2019, NAT COMMUN, V10, DOI [10.1038/S41467-019-09234-6, DOI 10.1038/s41587-020-0546-8, DOI 10.1038/S41467-019-09234-6]; Zou ZS, 2004, CLIN INFECT DIS, V38, P483, DOI 10.1086/380973	61	457	480	73	152	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2020	182	1					59	+		10.1016/j.cell.2020.05.032	http://dx.doi.org/10.1016/j.cell.2020.05.032			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ML0RP	32492406	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000549184500008
J	Lee, LYW; Cazier, JB; Angelis, V; Arnold, R; Bisht, V; Campton, NA; Chackathayil, J; Cheng, VWT; Curley, HM; Fittall, MW; Freeman-Mills, L; Gennatas, S; Goel, A; Hartley, S; Hughes, DJ; Kerr, D; Lee, AJX; Lee, RJ; McGrath, SE; Middleton, CP; Murugaesu, N; Newsom-Davis, T; Okines, AFC; Olsson-Brown, AC; Palles, C; Pan, Y; Pettengell, R; Powles, T; Protheroe, EA; Purshouse, K; Sharma-Oates, A; Sivakumar, S; Smith, AJ; Starkey, T; Turnbull, CD; Varnai, C; Yousaf, N; Kerr, R; Middleton, G				Lee, Lennard Y. W.; Cazier, Jean Baptiste; Angelis, Vasileios; Arnold, Roland; Bisht, Vartika; Campton, Naomi A.; Chackathayil, Julia; Cheng, Vinton W. T.; Curley, Helen M.; Fittall, Matthew W.; Freeman-Mills, Luke; Gennatas, Spyridon; Goel, Anshita; Hartley, Simon; Hughes, Daniel J.; Kerr, David; Lee, Alvin J. X.; Lee, Rebecca J.; McGrath, Sophie E.; Middleton, Christopher P.; Murugaesu, Nirupa; Newsom-Davis, Thomas; Okines, Alicia F. C.; Olsson-Brown, Anna C.; Palles, Claire; Pan, Yi; Pettengell, Ruth; Powles, Thomas; Protheroe, Emily A.; Purshouse, Karin; Sharma-Oates, Archana; Sivakumar, Shivan; Smith, Ashley J.; Starkey, Thomas; Turnbull, Chris D.; Varnai, Csilla; Yousaf, Nadia; Kerr, Rachel; Middleton, Gary		UK Coronavirus Canc Monitoring Pro	COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study	LANCET			English	Article								Background Individuals with cancer, particularly those who are receiving systemic anticancer treatments, have been postulated to be at increased risk of mortality from COVID-19. This conjecture has considerable effect on the treatment of patients with cancer and data from large, multicentre studies to support this assumption are scarce because of the contingencies of the pandemic. We aimed to describe the clinical and demographic characteristics and COVID-19 outcomes in patients with cancer. Methods In this prospective observational study, all patients with active cancer and presenting to our network of cancer centres were eligible for enrolment into the UK Coronavirus Cancer Monitoring Project (UKCCMP). The UKCCMP is the first COVID-19 clinical registry that enables near real-time reports to frontline doctors about the effects of COVID-19 on patients with cancer. Eligible patients tested positive for severe acute respiratory syndrome coronavirus 2 on RT-PCR assay from a nose or throat swab. We excluded patients with a radiological or clinical diagnosis of COVID-19, without a positive RT-PCR test. The primary endpoint was all-cause mortality, or discharge from hospital, as assessed by the reporting sites during the patient hospital admission. Findings From March 18, to April 26, 2020, we analysed 800 patients with a diagnosis of cancer and symptomatic COVID-19. 412 (52%) patients had a mild COVID-19 disease course. 226 (28%) patients died and risk of death was significantly associated with advancing patient age (odds ratio 9.42 [95% CI 6.56-10.02]; p<0.0001), being male (1.67 [1.19-2.34]; p=0.003), and the presence of other comorbidities such as hypertension (1.95 [1.36-2.80]; p<0.001) and cardiovascular disease (2.32 [1.47-3.64]). 281 (35%) patients had received cytotoxic chemotherapy within 4 weeks before testing positive for COVID-19. After adjusting for age, gender, and comorbidities, chemotherapy in the past 4 weeks had no significant effect on mortality from COVID-19 disease, when compared with patients with cancer who had not received recent chemotherapy (1.18 [0.81-1.72]; p=0.380). We found no significant effect on mortality for patients with immunotherapy, hormonal therapy, targeted therapy, radiotherapy use within the past 4 weeks. Interpretation Mortality from COVID-19 in cancer patients appears to be principally driven by age, gender, and comorbidities. We are not able to identify evidence that cancer patients on cytotoxic chemotherapy or other anticancer treatment are at an increased risk of mortality from COVID-19 disease compared with those not on active treatment. Copyright (C) 2020 Elsevier Ltd. All rights reserved.	[Lee, Lennard Y. W.; Cazier, Jean Baptiste; Arnold, Roland; Curley, Helen M.; Goel, Anshita; Middleton, Christopher P.; Palles, Claire; Pan, Yi; Starkey, Thomas; Varnai, Csilla] Univ Birmingham, Inst Canc & Genom Sci, Birmingham B15 2TT, W Midlands, England; [Lee, Lennard Y. W.; Cazier, Jean Baptiste; Bisht, Vartika; Hartley, Simon; Middleton, Christopher P.; Pan, Yi; Varnai, Csilla] Univ Birmingham, Ctr Computat Biol, Birmingham, W Midlands, England; [Hartley, Simon] Univ Birmingham, Sch Med, Adv Res Computing, Birmingham, W Midlands, England; [Protheroe, Emily A.] Univ Birmingham, Sch Med, Birmingham, W Midlands, England; [Sharma-Oates, Archana] Univ Birmingham, Inst Inflammat & Ageing, Birmingham, W Midlands, England; [Middleton, Gary] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England; [Lee, Lennard Y. W.; Cazier, Jean Baptiste; Bisht, Vartika] Univ Birmingham, Birmingham, W Midlands, England; [Angelis, Vasileios; Fittall, Matthew W.; Gennatas, Spyridon; McGrath, Sophie E.; Okines, Alicia F. C.; Yousaf, Nadia] Royal Marsden Hosp NHS Fdn Trust, London, England; [Campton, Naomi A.] Birmingham Hlth Partners, Inst Translat Med, Birmingham, W Midlands, England; [Chackathayil, Julia] St Georges Univ Hosp NHS Fdn Trust, Canc Res Clin Res Facil, London, England; [Cheng, Vinton W. T.] Univ Leeds, Leeds Inst Med Res, Leeds, W Yorkshire, England; [Freeman-Mills, Luke] Glasgow Royal Infirm, Glasgow, Lanark, Scotland; [Hughes, Daniel J.] Kings Coll London, Dept Canc Imaging, London, England; [Kerr, David; Sivakumar, Shivan] Univ Oxford, Dept Oncol, Oxford, England; [Kerr, David] Univ Oxford, Nuffield Div Clin & Lab Serv, Oxford, England; [Turnbull, Chris D.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Lee, Alvin J. X.] UCL, UCL Canc Inst, London, England; [Lee, Rebecca J.] Univ Manchester, Manchester, Lancs, England; [Lee, Rebecca J.] Christie NHS Fdn Trust, Manchester, Lancs, England; [Murugaesu, Nirupa] St Georges Univ Hosp NHS Fdn Trust, London, England; [Newsom-Davis, Thomas] Chelsea & Westminster Hosp NHS Fdn Trust, Dept Oncol, London, England; [Olsson-Brown, Anna C.] Clatterbridge Canc Ctr, Wirral, Merseyside, England; [Pettengell, Ruth] St Georges Univ London, London, England; [Powles, Thomas] Barts Canc Inst, London, England; [Purshouse, Karin] Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland; [Smith, Ashley J.] Consultancy Support, Oxford, England; [Lee, Lennard Y. W.; Middleton, Gary] Univ Hosp Birmingham, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; Royal Marsden NHS Foundation Trust; University of Leeds; University of Glasgow; University of London; King's College London; University of Oxford; University of Oxford; University of Oxford; University of London; University College London; University of Manchester; Christie NHS Foundation Trust; Imperial College London; Clatterbridge Cancer Centre; St Georges University London; University of London; Queen Mary University London; University of Edinburgh; University of Birmingham	Lee, LYW (corresponding author), Univ Birmingham, Inst Canc & Genom Sci, Birmingham B15 2TT, W Midlands, England.	l.lee.2@bham.ac.uk	Cazier, Jean-Baptiste/GLR-2949-2022; Várnai, Csilla/AAB-6348-2022; Cazier, Jean-Baptiste/F-2369-2010; Bisht, Vartika/ABE-4370-2020; Arnold, Roland/AAC-5256-2022; Smith, Ashley/GZB-0298-2022; Gennatas, Spyridon/ABE-4559-2020; Lee, Alvin/A-1047-2017	Cazier, Jean-Baptiste/0000-0001-7581-9051; Várnai, Csilla/0000-0003-0048-9507; Cazier, Jean-Baptiste/0000-0001-7581-9051; Bisht, Vartika/0000-0002-1880-0597; Arnold, Roland/0000-0002-7496-7578; Gennatas, Spyridon/0000-0002-5635-7696; Lee, Alvin/0000-0002-7427-9142; Lee, Rebecca/0000-0003-2540-2009; Purshouse, Karin/0000-0003-0942-6342; Turnbull, Christopher/0000-0001-8942-5424; Hughes, Daniel Johnathan/0000-0003-2641-7632; Starkey, Thomas/0000-0002-6692-9563; hartley, simon/0000-0001-7991-0581	University of Birmingham; University of Oxford; National Institute for Health Research Oxford Biomedical Research; MRC [MR/N025989/1, MR/K017047/1] Funding Source: UKRI	University of Birmingham; University of Oxford; National Institute for Health Research Oxford Biomedical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the oncologists, acute physicians, and health-care staff working tirelessly on the frontlines of the COVID-19 pandemic. We would like to thank David Adams for giving support and approval for this project. This project was funded by the University of Birmingham (data collection and grants to JPC, LYWL, UKCCMP, and GM) and the University of Oxford (RK grants). LYWL is supported by the National Institute for Health Research Oxford Biomedical Research. Expanded UKCCMP acknowledgments are given in the appendix.	[Anonymous], COMP ACC OR NAS SWAB; Coronavirus Project Supporters, COR PROJ SUPP; Dai MY, 2020, CANCER DISCOV, V10, P783, DOI 10.1158/2159-8290.CD-20-0422; GOV.UK, COVID 19 TRACK COR C; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; ICNARC, OUR NAT AUD PROGR NA; Khleif SN, 2016, SKEELS HDB CANC THER; Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6; Miyashita H, 2020, ANN ONCOL, V31, P1088, DOI 10.1016/j.annonc.2020.04.006; Rhodes A, 2012, INTENS CARE MED, V38, P1647, DOI 10.1007/s00134-012-2627-8; Saini KS, 2020, LANCET HAEMATOL, V7, pE432, DOI 10.1016/S2352-3026(20)30123-X; The Lancet Oncology, 2020, Lancet Oncol, V21, P467, DOI 10.1016/S1470-2045(20)30175-3; UK Coronavirus Canc, 2020, LANCET ONCOL, V21, P622, DOI 10.1016/S1470-2045(20)30230-8; UK Office for National Statistics, CHAR NTHOS DYING COV; van de Haar J, 2020, NAT MED, V26, P665, DOI [10.1038/s41591-020-0874-8, 10.1038/s41591-020-0948-7]; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yu J, 2020, JAMA ONCOL, V6, P1108, DOI 10.1001/jamaoncol.2020.0980	18	381	392	6	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2020	395	10241					1919	1926		10.1016/S0140-6736(20)31173-9	http://dx.doi.org/10.1016/S0140-6736(20)31173-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ2MV	32473682	Green Published, Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000552732200032
J	Griffiths, CD; Bilawchuk, LM; McDonough, JE; Jamieson, KC; Elawar, F; Cen, YC; Duan, WM; Lin, C; Song, H; Casanova, JL; Ogg, S; Jensen, LD; Thienpont, B; Kumar, A; Hobman, TC; Proud, D; Moraes, TJ; Marchant, DJ				Griffiths, Cameron D.; Bilawchuk, Leanne M.; McDonough, John E.; Jamieson, Kyla C.; Elawar, Farah; Cen, Yuchen; Duan, Wenming; Lin, Cindy; Song, Haeun; Casanova, Jean-Laurent; Ogg, Steven; Jensen, Lionel Dylan; Thienpont, Bernard; Kumar, Anil; Hobman, Tom C.; Proud, David; Moraes, Theo J.; Marchant, David J.			IGF1R is an entry receptor for respiratory syncytial virus	NATURE			English	Article							PROTEIN-KINASE; INFECTION; FUSION; CELLS; ACTIVATION; NUCLEOLIN; TYPE-3	Respiratory syncytial virus enters cells by binding to cell-surface IGFR1, which activates PKC zeta and induces trafficking of the NCL coreceptor to the RSV particles at the cell surface. Pneumonia resulting from infection is one of the leading causes of death worldwide. Pulmonary infection by the respiratory syncytial virus (RSV) is a large burden on human health, for which there are few therapeutic options(1). RSV targets ciliated epithelial cells in the airways, but how viruses such as RSV interact with receptors on these cells is not understood. Nucleolin is an entry coreceptor for RSV2 and also mediates the cellular entry of influenza, the parainfluenza virus, some enteroviruses and the bacterium that causes tularaemia(3,4). Here we show a mechanism of RSV entry into cells in which outside-in signalling, involving binding of the prefusion RSV-F glycoprotein with the insulin-like growth factor-1 receptor, triggers the activation of protein kinase C zeta (PKC zeta). This cellular signalling cascade recruits nucleolin from the nuclei of cells to the plasma membrane, where it also binds to RSV-F on virions. We find that inhibiting PKC zeta activation prevents the trafficking of nucleolin to RSV particles on airway organoid cultures, and reduces viral replication and pathology in RSV-infected mice. These findings reveal a mechanism of virus entry in which receptor engagement and signal transduction bring the coreceptor to viral particles at the cell surface, and could form the basis of new therapeutics to treat RSV infection.	[Griffiths, Cameron D.; Bilawchuk, Leanne M.; Elawar, Farah; Ogg, Steven; Jensen, Lionel Dylan; Kumar, Anil; Hobman, Tom C.; Marchant, David J.] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada; [Griffiths, Cameron D.; Bilawchuk, Leanne M.; Elawar, Farah; Ogg, Steven; Jensen, Lionel Dylan; Kumar, Anil; Hobman, Tom C.; Marchant, David J.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [McDonough, John E.] Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT USA; [Jamieson, Kyla C.; Proud, David] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Cen, Yuchen; Duan, Wenming; Lin, Cindy; Song, Haeun; Moraes, Theo J.] Hosp Sick Children Res Inst, Program Translat Med, Toronto, ON, Canada; [Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Casanova, Jean-Laurent] Necker Hosp Sick Children, INSERM, U1163, Lab Human Genet Infect Dis,Necker Branch, Paris, France; [Casanova, Jean-Laurent] Paris Descartes Univ, Imagine Inst, Paris, France; [Casanova, Jean-Laurent] Necker Hosp Sick Children, Pediat Immunol Hematol Unit, Paris, France; [Casanova, Jean-Laurent] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Thienpont, Bernard] Katholieke Univ Leuven, Dept Human Genet, Lab Funct Epigenet, Leuven, Belgium; [Kumar, Anil; Hobman, Tom C.] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada; [Moraes, Theo J.] Univ Toronto, Dept Paediat, Toronto, ON, Canada; [Moraes, Theo J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Alberta; University of Alberta; Yale University; University of Calgary; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute; Rockefeller University; KU Leuven; University of Alberta; University of Toronto; University of Toronto	Marchant, DJ (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada.; Marchant, DJ (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.	marchant@ualberta.ca	de Andrés San Cristóbal, Marta/ABF-5806-2021; Moraes, Theo/CAJ-3254-2022; Griffiths, Cameron/AAG-4958-2021	Moraes, Theo/0000-0001-9968-6601; Griffiths, Cameron/0000-0002-1280-3615; Victoria Ansalem, Anil Kumar/0000-0002-6179-4516; McDonough, John/0000-0003-2497-0258; Thienpont, Bernard/0000-0002-8772-6845	Women's and Children's Health Research Institute (WCHRI); Li Ka Shing Institute of Virology (LKSIOV); Lung Association of Canada; Canadian Institutes of Health Research; Lung Association - Alberta NWT; The Canadian Lung Association	Women's and Children's Health Research Institute (WCHRI); Li Ka Shing Institute of Virology (LKSIOV); Lung Association of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Lung Association - Alberta NWT; The Canadian Lung Association	We thank J. S. McLellan for providing input into the work and for the recombinant purified prefusion-RSV-F, DS-Cav1 and NCL proteins; C. M. Overall for discussion about the project, and Q. Kieser for technical support. This work was funded by grants from Women's and Children's Health Research Institute (WCHRI), Li Ka Shing Institute of Virology (LKSIOV), The Lung Association of Canada, and the Canadian Institutes of Health Research. C.D.G. was supported by studentships from The Lung Association - Alberta & NWT and The Canadian Lung Association.	Bareja A, 2018, J BIOL CHEM, V293, P6449, DOI 10.1074/jbc.RA118.002406; Barel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014193; Battles MB, 2019, NAT REV MICROBIOL, V17, P233, DOI 10.1038/s41579-019-0149-x; Bilawchuk LM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080207; Bose S, 2004, J VIROL, V78, P8146, DOI 10.1128/JVI.78.15.8146-8158.2004; CHURCHILL L, 1989, AM REV RESPIR DIS, V140, P449, DOI 10.1164/ajrccm/140.2.449; Currier MG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005622; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Ekyalongo RC, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0017-y; Elawar F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12001-6; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Griffiths C, 2017, CLIN MICROBIOL REV, V30, P277, DOI 10.1128/CMR.00010-16; Krunkosky TM, 2007, MICROB PATHOGENESIS, V42, P98, DOI 10.1016/j.micpath.2006.11.003; Krzyzaniak MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003309; Kwilas S, 2009, J VIROL, V83, P10710, DOI 10.1128/JVI.00986-09; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Marchant D, 2010, J VIROL, V84, P11359, DOI 10.1128/JVI.00804-10; Mastrangelo P, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030027; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; Monick MM, 2001, J IMMUNOL, V166, P2681, DOI 10.4049/jimmunol.166.4.2681; Monick MM, 2003, J BIOL CHEM, V278, P53035, DOI 10.1074/jbc.M308093200; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; SRINIVASAKUMAR N, 1991, J VIROL, V65, P4063, DOI 10.1128/JVI.65.8.4063-4069.1991; Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	29	45	45	4	43	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 23	2020	583	7817					615	+		10.1038/s41586-020-2369-7	http://dx.doi.org/10.1038/s41586-020-2369-7		JUN 2020	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MP1EM	32494007				2022-12-28	WOS:000537663800002
J	Boksenberg, A				Boksenberg, Alec			Eleanor Margaret Burbidge (1919-2020)	SCIENCE			English	Biographical-Item									[Boksenberg, Alec] Univ Cambridge, Inst Astron, Cambridge, England	University of Cambridge	Boksenberg, A (corresponding author), Univ Cambridge, Inst Astron, Cambridge, England.	boksy@ast.cam.ac.uk						BURBIDGE EM, PUBLICATION LIST	1	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					947	947		10.1126/science.abc6555	http://dx.doi.org/10.1126/science.abc6555			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LV3IK	32467381				2022-12-28	WOS:000538332600029
J	Thornton, J				Thornton, Jacqui			Covid-19: Millions of women and children at risk as visits to essential services plummet	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Every Woman Every Child, WOM LEAD COVID 19 RE; Fore HH, 2020, LANCET GLOB HEALTH, V8, pE861, DOI 10.1016/S2214-109X(20)30238-2; Kaljulaid K, OPINION WOMEN CHILDR; Thornton J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1969; United Nations Population Fund, 2020, NEW UNFPA PROJ PRED	5	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2020	369								m2171	10.1136/bmj.m2171	http://dx.doi.org/10.1136/bmj.m2171			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3KB	32471817	Bronze			2022-12-28	WOS:000538337500021
J	Karczewski, KJ; Francioli, LC; Tiao, G; Cummings, BB; Alfoldi, J; Wang, QB; Collins, RL; Laricchia, KM; Ganna, A; Birnbaum, DP; Gauthier, LD; Brand, H; Solomonson, M; Watts, NA; Rhodes, D; Singer-Berk, M; England, EM; Seaby, EG; Kosmicki, JA; Walters, RK; Tashman, K; Farjoun, Y; Banks, E; Poterba, T; Wang, A; Seed, C; Whiffin, N; Chong, JX; Samocha, KE; Pierce-Hoffman, E; Zappala, Z; O'Donnell-Luria, AH; Minikel, EV; Weisburd, B; Lek, M; Ware, JS; Vittal, C; Armean, IM; Bergelson, L; Cibulskis, K; Connolly, KM; Covarrubias, M; Donnelly, S; Ferriera, S; Gabriel, S; Gentry, J; Gupta, N; Jeandet, T; Kaplan, D; Llanwarne, C; Munshi, R; Novod, S; Petrillo, N; Roazen, D; Ruano-Rubio, V; Saltzman, A; Schleicher, M; Soto, J; Tibbetts, K; Tolonen, C; Wade, G; Talkowski, ME; Neale, BM; Daly, MJ; MacArthur, DG				Karczewski, Konrad J.; Francioli, Laurent C.; Tiao, Grace; Cummings, Beryl B.; Alfoldi, Jessica; Wang, Qingbo; Collins, Ryan L.; Laricchia, Kristen M.; Ganna, Andrea; Birnbaum, Daniel P.; Gauthier, Laura D.; Brand, Harrison; Solomonson, Matthew; Watts, Nicholas A.; Rhodes, Daniel; Singer-Berk, Moriel; England, Eleina M.; Seaby, Eleanor G.; Kosmicki, Jack A.; Walters, Raymond K.; Tashman, Katherine; Farjoun, Yossi; Banks, Eric; Poterba, Timothy; Wang, Arcturus; Seed, Cotton; Whiffin, Nicola; Chong, Jessica X.; Samocha, Kaitlin E.; Pierce-Hoffman, Emma; Zappala, Zachary; O'Donnell-Luria, Anne H.; Minikel, Eric Vallabh; Weisburd, Ben; Lek, Monkol; Ware, James S.; Vittal, Christopher; Armean, Irina M.; Bergelson, Louis; Cibulskis, Kristian; Connolly, Kristen M.; Covarrubias, Miguel; Donnelly, Stacey; Ferriera, Steven; Gabriel, Stacey; Gentry, Jeff; Gupta, Namrata; Jeandet, Thibault; Kaplan, Diane; Llanwarne, Christopher; Munshi, Ruchi; Novod, Sam; Petrillo, Nikelle; Roazen, David; Ruano-Rubio, Valentin; Saltzman, Andrea; Schleicher, Molly; Soto, Jose; Tibbetts, Kathleen; Tolonen, Charlotte; Wade, Gordon; Talkowski, Michael E.; Neale, Benjamin M.; Daly, Mark J.; MacArthur, Daniel G.		Genome Aggregation Database Consor	The mutational constraint spectrum quantified from variation in 141,456 humans	NATURE			English	Article							DE-NOVO MUTATIONS; VARIANTS; BURDEN; MODEL	Genetic variants that inactivate protein-coding genes are a powerful source of information about the phenotypic consequences of gene disruption: genes that are crucial for the function of an organism will be depleted of such variants in natural populations, whereas non-essential genes will tolerate their accumulation. However, predicted loss-of-function variants are enriched for annotation errors, and tend to be found at extremely low frequencies, so their analysis requires careful variant annotation and very large sample sizes(1). Here we describe the aggregation of 125,748 exomes and 15,708 genomes from human sequencing studies into the Genome Aggregation Database (gnomAD). We identify 443,769 high-confidence predicted loss-of-function variants in this cohort after filtering for artefacts caused by sequencing and annotation errors. Using an improved model of human mutation rates, we classify human protein-coding genes along a spectrum that represents tolerance to inactivation, validate this classification using data from model organisms and engineered human cells, and show that it can be used to improve the power of gene discovery for both common and rare diseases.	[Karczewski, Konrad J.; Francioli, Laurent C.; Tiao, Grace; Cummings, Beryl B.; Alfoldi, Jessica; Wang, Qingbo; Collins, Ryan L.; Laricchia, Kristen M.; Ganna, Andrea; Birnbaum, Daniel P.; Brand, Harrison; Solomonson, Matthew; Watts, Nicholas A.; Singer-Berk, Moriel; England, Eleina M.; Seaby, Eleanor G.; Kosmicki, Jack A.; Walters, Raymond K.; Tashman, Katherine; Poterba, Timothy; Wang, Arcturus; Seed, Cotton; Whiffin, Nicola; Pierce-Hoffman, Emma; Zappala, Zachary; O'Donnell-Luria, Anne H.; Minikel, Eric Vallabh; Ware, James S.; Armean, Irina M.; Donnelly, Stacey; Gupta, Namrata; Saltzman, Andrea; Schleicher, Molly; Talkowski, Michael E.; Neale, Benjamin M.; Daly, Mark J.; MacArthur, Daniel G.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Karczewski, Konrad J.; Francioli, Laurent C.; Tiao, Grace; Cummings, Beryl B.; Alfoldi, Jessica; Wang, Qingbo; Laricchia, Kristen M.; Ganna, Andrea; Birnbaum, Daniel P.; Solomonson, Matthew; Watts, Nicholas A.; Singer-Berk, Moriel; England, Eleina M.; Seaby, Eleanor G.; Kosmicki, Jack A.; Walters, Raymond K.; Tashman, Katherine; Poterba, Timothy; Wang, Arcturus; Seed, Cotton; Whiffin, Nicola; Pierce-Hoffman, Emma; Zappala, Zachary; O'Donnell-Luria, Anne H.; Vittal, Christopher; Armean, Irina M.; Neale, Benjamin M.; Daly, Mark J.; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Cummings, Beryl B.] Harvard Med Sch, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Wang, Qingbo; Collins, Ryan L.; Kosmicki, Jack A.] Harvard Med Sch, Program Bioinformat & Integrat Genom, Boston, MA 02115 USA; [Collins, Ryan L.; Brand, Harrison] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Ganna, Andrea; Daly, Mark J.] Inst Mol Med Finland, Helsinki, Finland; [Gauthier, Laura D.; Farjoun, Yossi; Banks, Eric; Weisburd, Ben; Bergelson, Louis; Cibulskis, Kristian; Covarrubias, Miguel; Gentry, Jeff; Jeandet, Thibault; Kaplan, Diane; Llanwarne, Christopher; Munshi, Ruchi; Novod, Sam; Petrillo, Nikelle; Roazen, David; Ruano-Rubio, Valentin; Soto, Jose; Tibbetts, Kathleen; Tolonen, Charlotte; Wade, Gordon] Broad Inst MIT & Harvard, Data Sci Platform, Cambridge, MA 02142 USA; [Rhodes, Daniel] Queen Mary Univ, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Translat Bioinformat, London, England; [Rhodes, Daniel] Barts Hearth NHS Trust, London, England; [Walters, Raymond K.; Tashman, Katherine; Poterba, Timothy; Wang, Arcturus; Seed, Cotton; Vittal, Christopher; Neale, Benjamin M.; Daly, Mark J.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Whiffin, Nicola; Ware, James S.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Whiffin, Nicola; Ware, James S.] Imperial Coll London, MRC London Inst Med Sci, London, England; [Whiffin, Nicola; Ware, James S.] Royal Brompton & Harefierd Hosp NHS Trust, Cardiovasc Res Ctr, London, England; [Chong, Jessica X.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Samocha, Kaitlin E.] Wellcome Sanger Inst, Wellcome Genome Campus, Cambridge, England; [Zappala, Zachary] Vertex Pharmaceut Inc, Boston, MA USA; [O'Donnell-Luria, Anne H.; Talkowski, Michael E.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA USA; [O'Donnell-Luria, Anne H.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Lek, Monkol] Yale Sch Med, Dept Genet, New Haven, CT USA; [Connolly, Kristen M.; Ferriera, Steven; Gabriel, Stacey; Gupta, Namrata] Broad Inst MIT & Harvard, Broad Genom, Cambridge, MA 02142 USA; [Talkowski, Michael E.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [MacArthur, Daniel G.] Garvan Inst Med Res, Ctr Populat Genom, Sydney, NSW, Australia; [MacArthur, Daniel G.] UNSW Sydney, Sydney, NSW, Australia; [MacArthur, Daniel G.] Murdoch Childrens Res Inst, Ctr Populat Genom, Melbourne, Vic, Australia	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of London; Queen Mary University London; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Imperial College London; Imperial College London; University of Washington; University of Washington Seattle; Wellcome Trust Sanger Institute; Vertex Pharmaceuticals; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Garvan Institute of Medical Research; University of New South Wales Sydney; Murdoch Children's Research Institute	Karczewski, KJ; MacArthur, DG (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Karczewski, KJ; MacArthur, DG (corresponding author), Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA.; MacArthur, DG (corresponding author), Garvan Inst Med Res, Ctr Populat Genom, Sydney, NSW, Australia.; MacArthur, DG (corresponding author), UNSW Sydney, Sydney, NSW, Australia.; MacArthur, DG (corresponding author), Murdoch Childrens Res Inst, Ctr Populat Genom, Melbourne, Vic, Australia.	konradk@broadinstitute.org; d.macarthur@garvan.org.au	Färkkilä, Martti/AAG-6970-2021; Chong, Jessica/GZH-1625-2022; Ware, James S/G-5139-2012; Ma, Ronald/C-2788-2009; Kaprio, Jaakko/A-1820-2008; Cohen, Bruce M./AAZ-4986-2020; Rioux, John D/A-9599-2015; Bown, Matthew/P-1957-2016; Glaser, Benjamin/F-8411-2017; Erdmann, Jeanette/P-7513-2014; Loos, Ruth/Q-2862-2016; sokol, harry/E-2290-2019	Färkkilä, Martti/0000-0002-0250-8559; Ware, James S/0000-0002-6110-5880; Ma, Ronald/0000-0002-1227-803X; Kaprio, Jaakko/0000-0002-3716-2455; Rioux, John D/0000-0001-7560-8326; Collins, Ryan/0000-0003-1268-9995; Bown, Matthew/0000-0002-6180-3611; Glaser, Benjamin/0000-0003-4711-5000; Tuomi, Tiinamaija/0000-0002-8306-6202; Cibulskis, Kristian/0000-0003-1343-1582; Erdmann, Jeanette/0000-0002-4486-6231; solinas, emilia/0000-0003-3532-1317; Ganna, Andrea/0000-0002-8147-240X; Palotie, Aarno/0000-0002-2527-5874; Loos, Ruth/0000-0002-8532-5087; ELOSUA, ROBERTO/0000-0001-8235-0095; Tai, E Shyong/0000-0003-2929-8966; Dichgans, Martin/0000-0002-0654-387X; MacArthur, Daniel/0000-0002-5771-2290; Wang, Qingbo/0000-0002-9110-5830; sokol, harry/0000-0002-2914-1822; Melander, Olle/0000-0002-2581-484X; O'Donnell-Luria, Anne/0000-0001-6418-9592; Francioli, Laurent/0000-0002-3039-8895; Armean, Irina/0000-0002-1043-4756; Seaby, Eleanor/0000-0002-6814-8648; Rhodes, Daniel/0000-0002-2021-4773; Solomonson, Matthew/0000-0002-5344-9026	NHLBI [UM1 HG006493, U24 HG008956]; NIGMS [F32 GM115208, R01 GM104371]; Swiss National Science Foundation [177853]; NIDDK [U54 DK105566]; NHGRI [UM1 HG008900]; BioMarin Pharmaceutical Inc.; Sanofi Genzyme Inc.; NICHD [HD081256]; NIMH [MH115957]; NHGRI; MRC [MC_UP_1102/20] Funding Source: UKRI	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); BioMarin Pharmaceutical Inc.; Sanofi Genzyme Inc.; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the many individuals whose sequence data are aggregated in gnomAD for their contributions to research, and the users of gnomAD for their collaborative feedback. We also thank D. Altshuler for contributions to the development of the gnomAD resource, and A. Martin, E. Fauman, J. Bloom, D. King and the Hail team for discussions. The results published here are in part based on data: (1) generated by The Cancer Genome Atlas (TCGA) managed by the NCI and NHGRI (accession: phs000178.v10.p8); information about TCGA can be found at http://cancergenome.nih.gov; (2) generated by the Genotype-Tissue Expression Project (GTEx) managed by the NIH Common Fund and NHGRI (accession: phs000424.v7.p2); (3) generated by the Exome Sequencing Project, managed by NHLBI; (4) generated by the Alzheimer's Disease Sequencing Project (ADSP), managed by the NIA and NHGRI (accession: phs000572.v7.p4). K.J.K. was supported by NIGMS F32 GM115208. L.C.F. was supported by the Swiss National Science Foundation (Advanced Postdoc.Mobility 177853). J.X.C. was supported by NHGRI and NHLBI grants UM1 HG006493 and U24 HG008956. Analysis of the Genome Aggregation Database was funded by NIDDK U54 DK105566, NHGRI UM1 HG008900, BioMarin Pharmaceutical Inc., and Sanofi Genzyme Inc. Development of LOFTEE was funded by NIGMS R01 GM104371. D.G.M, K.M.L, and M.E.T. were supported by NICHD HD081256. D.G.M., R.L.C. and M.E.T. were supported by NIMH MH115957. The complete acknowledgments can be found in the Supplementary Information. We have complied with all relevant ethical regulations.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Bamshad MJ, 2019, AM J HUM GENET, V105, P448, DOI 10.1016/j.ajhg.2019.07.011; Cassa CA, 2017, NAT GENET, V49, P806, DOI 10.1038/ng.3831; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Collins RL, 2020, NATURE, V581, P444, DOI 10.1038/s41586-020-2287-8; Cummings BB, 2020, NATURE, V581, P452, DOI 10.1038/s41586-020-2329-2; de Andrade KC, 2019, HUM MUTAT, V40, P97, DOI 10.1002/humu.23673; DeBoever C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03910-9; Diaz-Papkovich A, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008432; Eilbeck K, 2017, NAT REV GENET, V18, P599, DOI 10.1038/nrg.2017.52; El-Brolosy MA, 2019, NATURE, V568, P193, DOI 10.1038/s41586-019-1064-z; Emdin CA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03911-8; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Feiglin A, 2017, CELL SYST, V5, P140, DOI 10.1016/j.cels.2017.06.016; Findlay GM, 2018, NATURE, V562, P217, DOI 10.1038/s41586-018-0461-z; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Fuller ZL, 2019, NAT GENET, V51, P772, DOI 10.1038/s41588-019-0383-1; Ganna A, 2018, AM J HUM GENET, V102, P1204, DOI 10.1016/j.ajhg.2018.05.002; Ganna A, 2016, NAT NEUROSCI, V19, P1563, DOI 10.1038/nn.4404; Genovese G, 2016, NAT NEUROSCI, V19, P1433, DOI 10.1038/nn.4402; Glassberg EC, 2019, GENETICS, V211, P757, DOI 10.1534/genetics.118.301833; Gravel S, 2016, GENETICS, V203, P451, DOI 10.1534/genetics.115.184630; Hart T, 2017, G3-GENES GENOM GENET, V7, P2719, DOI 10.1534/g3.117.041277; Henn BM, 2015, NAT REV GENET, V16, P333, DOI 10.1038/nrg3931; Jonsson H, 2017, NATURE, V549, P519, DOI 10.1038/nature24018; Laver TW, 2017, HUM MUTAT, V38, P1442, DOI 10.1002/humu.23289; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2018, NAT METHODS, V15, P595, DOI 10.1038/s41592-018-0054-7; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; McInnes L., 2018, J OPEN SOURCE SOFTW, V3, P861, DOI [10.21105/joss.00861, DOI 10.21105/JOSS.00861]; Minikel EV, 2020, NATURE, V581, P459, DOI 10.1038/s41586-020-2267-z; Motenko H, 2015, MAMM GENOME, V26, P325, DOI 10.1007/s00335-015-9573-z; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Petrovski S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005492; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Satterstrom FK, 2019, NAT NEUROSCI, V22, P1961, DOI 10.1038/s41593-019-0527-8; Schneeberger K, 2014, NAT REV GENET, V15, P662, DOI 10.1038/nrg3745; Short PJ, 2018, NATURE, V555, P611, DOI 10.1038/nature25983; Sundaram L, 2018, NAT GENET, V50, P1161, DOI 10.1038/s41588-018-0167-z; Tuladhar R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12028-5; VanderAuwera GA, 2013, CURR PROTOC BIOINFOR, V43; Walters J. T. R., 2017, NAT GENET, V511, P421; Wang QB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-12438-5; Whiffin N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-10717-9; Whiffin N, 2020, NAT MED, V26, P869, DOI 10.1038/s41591-020-0893-5; Zambrowicz BP, 2003, NAT REV DRUG DISCOV, V2, P38, DOI 10.1038/nrd987; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	51	2927	2935	23	107	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 28	2020	581	7809					434	+		10.1038/s41586-020-2308-7	http://dx.doi.org/10.1038/s41586-020-2308-7			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX9ZL	32461654	Green Published, hybrid			2022-12-28	WOS:000576060200003
J	Ohringer, AR; Haight, B				Ohringer, Alison Rose; Haight, Bruce			Nervous Breakdown-and-Across	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Arts and Medicine feature presents a neurology-themed crossword puzzle with clinical clues and other brain teasers.	[Ohringer, Alison Rose] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	University of Miami	Ohringer, AR (corresponding author), Univ Miami, Miller Sch Med, Miami, FL 33136 USA.	aohringer@med.miami.edu	Ohringer, Alison/AAJ-7339-2021	Ohringer, Alison/0000-0001-6523-2556					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					1992	1992		10.1001/jama.2020.6812	http://dx.doi.org/10.1001/jama.2020.6812			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU8UM	32453347				2022-12-28	WOS:000538023900001
J	Docherty, AB; Harrison, EM; Green, CA; Hardwick, HE; Pius, R; Norman, L; Holden, KA; Read, JM; Dondelinger, F; Carson, G; Merson, L; Lee, J; Plotkin, D; Sigfrid, L; Halpin, S; Jackson, C; Gamble, C; Horby, PW; Nguyen-Van-Tam, JS; Ho, A; Russell, CD; Dunning, J; Openshaw, PJ; Baillie, JK; Semple, MG				Docherty, Annemarie B.; Harrison, Ewen M.; Green, Christopher A.; Hardwick, Hayley E.; Pius, Riinu; Norman, Lisa; Holden, Karl A.; Read, Jonathan M.; Dondelinger, Frank; Carson, Gail; Merson, Laura; Lee, James; Plotkin, Daniel; Sigfrid, Louise; Halpin, Sophie; Jackson, Clare; Gamble, Carrol; Horby, Peter W.; Nguyen-Van-Tam, Jonathan S.; Ho, Antonia; Russell, Clark D.; Dunning, Jake; Openshaw, Peter Jm; Baillie, J. Kenneth; Semple, Malcolm G.		ISARIC4C Investigators	Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; ILLNESS	OBJECTIVE To characterise the clinical features of patients admitted to hospital with coronavirus disease 2019 (covid-19) in the United Kingdom during the growth phase of the first wave of this outbreak who were enrolled in the International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) World Health Organization (WHO) Clinical Characterisation Protocol UK (CCP-UK) study, and to explore risk factors associated with mortality in hospital. DESIGN Prospective observational cohort study with rapid data gathering and near real time analysis. SETTING 208 acute care hospitals in England, Wales, and Scotland between 6 February and 19 April 2020. A case report form developed by ISARIC and WHO was used to collect clinical data. A minimal follow-up time of two weeks (to 3 May 2020) allowed most patients to complete their hospital admission. PARTICIPANTS 20133 hospital inpatients with covid-19. MAIN OUTCOME MEASURES Admission to critical care (high dependency unit or intensive care unit) and mortality in hospital. RESULT The median age of patients admitted to hospital with covid-19, or with a diagnosis of covid-19 made in hospital, was 73 years (interquartile range 58-82, range 0-104). More men were admitted than women (men 60%, n=12 068; women 40%, n=8065). The median duration of symptoms before admission was 4 days (interquartile range 1-8). The commonest comorbidities were chronic cardiac disease (31%, 5469/17 702), uncomplicated diabetes (21%, 3650/17 599), non-asthmatic chronic pulmonary disease (18%, 3128/17 634), and chronic kidney disease (16%, 2830/17 506); 23% (4161/18 525) had no reported major comorbidity. Overall, 41% (8199/20133) of patients were discharged alive, 26% (5165/20 133) died, and 34% (6769/20 133) continued to receive care at the reporting date. 17% (3001/18 183) required admission to high dependency or intensive care units; of these, 28% (826/3001) were discharged alive, 32% (958/3001) died, and 41% (1217/3001) continued to receive care at the reporting date. Of those receiving mechanical ventilation, 17% (276/1658) were discharged alive, 37% (618/1658) died, and 46% (764/1658) remained in hospital. Increasing age, male sex, and comorbidities including chronic cardiac disease, non-asthmatic chronic pulmonary disease, chronic kidney disease, liver disease and obesity were associated with higher mortality in hospital. CONCLUSIONS ISARIC WHO CCP-UK is a large prospective cohort study of patients in hospital with covid-19. The study continues to enrol at the time of this report. In study participants, mortality was high, independent risk factors were increasing age, male sex, and chronic comorbidity, including obesity. This study has shown the importance of pandemic preparedness and the need to maintain readiness to launch research studies in response to outbreaks.	[Docherty, Annemarie B.; Harrison, Ewen M.; Pius, Riinu; Norman, Lisa] Univ Edinburgh, Usher Inst, Ctr Med Informat, Edinburgh, Midlothian, Scotland; [Docherty, Annemarie B.; Baillie, J. Kenneth] Royal Infirm Edinburgh NHS Trust, Intens Care Unit, Edinburgh, Midlothian, Scotland; [Green, Christopher A.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Hardwick, Hayley E.] Natl Inst Hlth Res NIHR, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England; [Hardwick, Hayley E.] Univ Liverpool, Inst Infect & Global Hlth, Fac Hlth & Life Sci, Liverpool, Merseyside, England; [Holden, Karl A.] Univ Liverpool, Inst Translat Med, Fac Hlth & Life Sci, Liverpool, Merseyside, England; [Read, Jonathan M.; Dondelinger, Frank] Univ Lancaster, Ctr Hlth Informat Comp & Stat, Lancaster Med Sch, Bailrigg, England; [Carson, Gail; Merson, Laura; Lee, James; Plotkin, Daniel; Sigfrid, Louise] Univ Oxford, ISARIC Global Support Ctr, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Merson, Laura] Univ Oxford, Infect Dis Data Observ, Ctr Trop Med & Global Hlth, Oxford, England; [Halpin, Sophie; Jackson, Clare; Gamble, Carrol] Univ Liverpool, Liverpool Clin Trials Ctr, Liverpool, Merseyside, England; [Horby, Peter W.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Int Hlth, Oxford, England; [Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Sch Med, Div Epidemiol & Publ Hlth, Nottingham, England; [Ho, Antonia] Univ Glasgow, Ctr Virus Res, Med Res Council, Glasgow, Lanark, Scotland; [Russell, Clark D.] Univ Edinburgh, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Dunning, Jake] Publ Hlth England, Natl Infect Serv, London, England; [Dunning, Jake] Imperial Coll London, Fac Med, London, England; [Openshaw, Peter Jm] Imperial Coll London, Fac Med, Natl Heart & Lung Inst, London, England; [Baillie, J. Kenneth] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Semple, Malcolm G.] Univ Liverpool, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool, Merseyside, England; [Semple, Malcolm G.] Univ Liverpool, Inst Translat Med, Fac Hlth & Life Sci, Liverpool, Merseyside, England; [Semple, Malcolm G.] Univ Liverpool, Alder Hey Childrens Hosp, Alder Hey Childrens Hosp, Resp Med,Inst Pk, Liverpool L12 2AP, Merseyside, England	University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Birmingham; University of Liverpool; University of Liverpool; Lancaster University; University of Oxford; University of Oxford; University of Liverpool; University of Oxford; University of Nottingham; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Glasgow; University of Edinburgh; Public Health England; Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Liverpool; University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool	Semple, MG (corresponding author), Univ Liverpool, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool, Merseyside, England.; Semple, MG (corresponding author), Univ Liverpool, Inst Translat Med, Fac Hlth & Life Sci, Liverpool, Merseyside, England.; Semple, MG (corresponding author), Univ Liverpool, Alder Hey Childrens Hosp, Alder Hey Childrens Hosp, Resp Med,Inst Pk, Liverpool L12 2AP, Merseyside, England.	m.g.semple@liverpool.ac.uk	Baillie, John Kenneth/F-3124-2011; Dushianthan, Ahilanandan/T-8390-2019; Semple, Malcolm Gracie/A-8790-2008; Clark, Jordan/GOJ-7992-2022; Gkrania-Klotsas, Effrossyni/AAT-8424-2021; Baillie, Kenneth/AEK-6650-2022; Dunning, Jake/U-7181-2019	Baillie, John Kenneth/0000-0001-5258-793X; Dushianthan, Ahilanandan/0000-0002-0165-3359; Semple, Malcolm Gracie/0000-0001-9700-0418; Clark, Jordan/0000-0003-1790-7883; Gkrania-Klotsas, Effrossyni/0000-0002-0930-8330; Baillie, Kenneth/0000-0001-5258-793X; Dunning, Jake/0000-0002-4035-4562; McDonald, Sarah/0000-0003-2776-7415; Gamble, Carrol/0000-0002-3021-1955; McEvoy, Laurence/0000-0002-2169-6735; Moore, Shona/0000-0001-8610-2806; Harrison, Ewen/0000-0002-5018-3066; Ho, Antonia/0000-0003-1465-3785; Green, Christopher/0000-0002-1984-4014; Penrice-Randal, Rebekah/0000-0002-0653-2097; Halpin, Sophie/0000-0003-1310-2594; Dondelinger, Frank/0000-0003-1816-6300; Lee, James/0000-0002-4360-7326; Sigfrid, Louise/0000-0003-2764-1177; Read, Jonathan/0000-0002-9697-0962	National Institute for Health Research (NIHR) [CO-CIN-01]; Medical Research Council (MRC) [MC_PC_19059]; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections at University of Liverpool; Public Health England (PHE); Liverpool School of Tropical Medicine; University of Oxford (NIHR) [200907]; Wellcome Trust; Department for International Development (DID) [215091/Z/18/Z]; Bill and Melinda Gates Foundation [OPP1209135]; Liverpool Experimental Cancer Medicine Centre [C18616/A25153]; EPSRC [EP/N014499/1] Funding Source: UKRI; MRC [MR/R005982/1, MR/R502121/1, MC_PC_19026, MC_UU_12014/9, MC_PC_19025] Funding Source: UKRI; UKRI [MR/S032304/1] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Health Protection Research Unit in Emerging and Zoonotic Infections at University of Liverpool; Public Health England (PHE); Liverpool School of Tropical Medicine; University of Oxford (NIHR); Wellcome Trust(Wellcome Trust); Department for International Development (DID); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Liverpool Experimental Cancer Medicine Centre; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UKRI	This work is supported by grants from: the National Institute for Health Research (NIHR; award CO-CIN-01), the Medical Research Council (MRC; grant MC_PC_19059), the NIHR Health Protection Research Unit in Emerging and Zoonotic Infections at University of Liverpool in partnership with Public Health England (PHE), in collaboration with Liverpool School of Tropical Medicine and the University of Oxford (NIHR award 200907), Wellcome Trust and Department for International Development (DID; 215091/Z/18/Z), and the Bill and Melinda Gates Foundation (OPP1209135), and Liverpool Experimental Cancer Medicine Centre for providing infrastructure support for this research (grant reference C18616/A25153). JSN-V-T is seconded to the Department of Health and Social Care, England (DHSC). The views expressed are those of the authors and not necessarily those of the DHSC, DID, NIHR, MRC, Wellcome Trust, or PHE.	Alraddadi BM, 2016, EMERG INFECT DIS, V22, P49, DOI 10.3201/eid2201.151340; [Anonymous], 2020, JAMA, V323, P2098, DOI 10.1001/jama.2020.7681; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Fitzner J, 2018, B WORLD HEALTH ORGAN, V96, P122, DOI 10.2471/BLT.17.194514; Gebert S., 2019, HLTH SURVEY ENGLAND; GOV.UK, 2020, SCI ADV GROUP EM; GOV.UK, 2020, SCI PAND INFL GROUP; GOV.UK, 2020, NEW EM RESP VIR THRE; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; ICNARC, 2020, ICNARC REP COVID 19; Myles PR, 2012, THORAX, V67, P709, DOI 10.1136/thoraxjnl-2011-200266; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Richardson S, 2020, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775]; Simpson CR, 2019, LANCET INFECT DIS, V19, pE295, DOI 10.1016/S1473-3099(18)30786-2; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; WHO, 2003, WHO PREL CLIN DESCR; World Health Organization, 2021, RADIOPAEDIA	22	1544	1565	5	70	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2020	369								m1985	10.1136/bmj.m1985	http://dx.doi.org/10.1136/bmj.m1985			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JU	32444460	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000538336800003
J	Lewnard, JA; Liu, VX; Jackson, ML; Schmidt, MA; Jewell, BL; Flores, JP; Jentz, C; Northrup, GR; Mahmud, A; Reingold, AL; Petersen, M; Jewell, NP; Young, S; Bellows, J				Lewnard, Joseph A.; Liu, Vincent X.; Jackson, Michael L.; Schmidt, Mark A.; Jewell, Britta L.; Flores, Jean P.; Jentz, Chris; Northrup, Graham R.; Mahmud, Ayesha; Reingold, Arthur L.; Petersen, Maya; Jewell, Nicholas P.; Young, Scott; Bellows, Jim			Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WUHAN	OBJECTIVE To understand the epidemiology and burden of severe coronavirus disease 2019 (covid-19) during the first epidemic wave on the west coast of the United States. DESIGN Prospective cohort study. SETTING Kaiser Permanente integrated healthcare delivery systems serving populations in northern California, southern California, and Washington state. PARTICIPANTS 1840 people with a first acute hospital admission for confirmed covid-19 by 22 April 2020, among 9596321 healthcare plan enrollees. Analyses of hospital length of stay and clinical outcomes included 1328 people admitted by 9 April 2020 (534 in northern California, 711 in southern California, and 83 in Washington). MAIN OUTCOME MEASURES Cumulative incidence of first acute hospital admission for confirmed covid-19, and subsequent probabilities of admission to an intensive care unit (ICU) and mortality, as welt as duration of hospital stay and ICU stay. The effective reproduction number (R-E) describing transmission dynamics was estimated for each region. RESULTS As of 22 April 2020, cumulative incidences of a first acute hospital admission for covid-19 were 15.6 per 100000 cohort members in northern California, 23.3 per 100000 in southern California, and 14.7 per 100000 in Washington. Accounting for censoring of incomplete hospital stays among those admitted by 9 April 2020, the estimated median duration of stay among survivors was 9.3 days (with 95% staying 0.8 to 32.9 days) and among non-survivors was 12.7 days (1.6 to 37.7 days). The censoring adjusted probability of ICU admission for male patients was 48.5% (95% confidence interval 41.8% to 56.3%) and for female patients was 32.0% (26.6% to 38.4%). For patients requiring critical care, the median duration of ICU stay was 10.6 days (with 95% staying 1.3 to 30.8 days). The censoring adjusted case fatality ratio was 23.5% (95% confidence interval 19.6% to 28.2%) among male inpatients and 14.9% (11.8% to 18.6%) among female inpatients; mortality risk increased with age for both male and female patients. Reductions in R-E were identified over the study period within each region. CONCLUSIONS Among residents of California and Washington state enrolled in Kaiser Permanente healthcare plans who were admitted to hospital with covid-19, the probabilities of ICU admission, of long hospital stay, and of mortality were identified to be high. Incidence rates of new hospital admissions have stabilized or declined in conjunction with implementation of social distancing interventions.	[Lewnard, Joseph A.; Reingold, Arthur L.; Petersen, Maya; Jewell, Nicholas P.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA USA; [Lewnard, Joseph A.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Lewnard, Joseph A.; Northrup, Graham R.] Univ Calif Berkeley, Coll Engn, Ctr Computat Biol, Berkeley, CA 94720 USA; [Liu, Vincent X.] Kaiser Permanente, Div Res, Oakland, CA USA; [Jackson, Michael L.] Kaiser Permanente Washington, Hlth Res Inst, Seattle, WA USA; [Schmidt, Mark A.] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA; [Jewell, Britta L.] Imperial Coll London, MRC Ctr Global Infect Dis Anal, Abdul Latif Jameel Inst Dis & Emergency Analyt, London, England; [Jewell, Britta L.] Imperial Coll London, Dept Infect Dis Epidemiol, London, England; [Flores, Jean P.; Jentz, Chris; Young, Scott; Bellows, Jim] Kaiser Permanente, Care Management Inst, Oakland, CA 94612 USA; [Mahmud, Ayesha] Univ Calif Berkeley, Dept Demog, Berkeley, CA 94720 USA; [Jewell, Nicholas P.] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Young, Scott] Kaiser Permanente, Permanente Federat, Oakland, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Imperial College London; Imperial College London; Kaiser Permanente; University of California System; University of California Berkeley; University of London; London School of Hygiene & Tropical Medicine; Kaiser Permanente	Lewnard, JA (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA USA.; Lewnard, JA (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.; Lewnard, JA (corresponding author), Univ Calif Berkeley, Coll Engn, Ctr Computat Biol, Berkeley, CA 94720 USA.	jlewnard@berkeley.edu		Northrup, Graham/0000-0003-2500-3905	Kaiser Permanente [R35GM128672]; US National Institutes of Health	Kaiser Permanente; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by Kaiser Permanente. VXL was supported by grant R35GM128672 from the US National Institutes of Health. VXL, MLJ, MAS, JPF, CJ, SY, and JB are employees of Kaiser Permanente; however, Kaiser Permanente officers and employees other than the authors did not play a role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. All authors had full access to all of the data (including statistical reports and tables) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis.	Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Centers for Disease Control and Prevention, COR DIS 2019 COVID 1, DOI DOI 10.1016/S0140-6736(20)30211-7; Centers for Disease Control and Prevention, 2020, INT GUID DISC TRANSM; Centre for the Mathematical Modelling of Infectious Disases London School of Hygiene and Tropical Medicine, 2020, TEMP VAR TRANSM COVI; Chowell G, 2020, LANCET, V395, P1093, DOI 10.1016/S0140-6736(20)30743-1; Du ZW, 2020, EMERG INFECT DIS, V26, P1341, DOI [10.1101/2020.02.19.20025452, 10.3201/eid2606.200357]; Ferguson NM, 2020, IMPACT NONPHARMACEUT; Fuller T., 2020, NEW YORK TIMES; Gordon Nancy, 2016, Perm J, V20, P15, DOI 10.7812/TPP/15-225; Gordon NP, SIMILARITY ADULT KAI; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Jewell NP, 2020, JAMA-J AM MED ASSOC, V323, P1893, DOI 10.1001/jama.2020.6585; Jewell NP, 2020, ANN INTERN MED, V173, P226, DOI 10.7326/M20-1565; Jit M, 2020, 20054528 MEDRXIV; Kaiser Permanente Emergency Management, 2020, COVID 19 INT CAR UN; Khan S, 2020, CLIN MICROBIOL INFEC, V26, P399, DOI 10.1016/j.cmi.2020.02.005; Koebnick Corinna, 2012, Perm J, V16, P37; Lasry A, 2020, MMWR-MORBID MORTAL W, V69, P451, DOI 10.15585/mmwr.mm6915e2; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744; Mahani AS, 2019, J STAT SOFTW, V89, DOI 10.18637/jss.v089.i09; Myers LC, 2020, JAMA-J AM MED ASSOC, V323, P2195, DOI 10.1001/jama.2020.7202; Nishiura H, 2020, INT J INFECT DIS, V93, P284, DOI 10.1016/j.ijid.2020.02.060; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Petrilli CM, 2020, FACTORS ASS HOSPITAL, V2020, P4, DOI [DOI 10.1101/2020.04.08.20057794, 10.1101/2020.04.08.20057794, DOI 10.1136/BMJ.M1966]; Qian GQ, 2020, QJM-INT J MED, V113, P474, DOI 10.1093/qjmed/hcaa089; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Richardson S, 2020, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775]; Ryan C.L., 2016, ED ATTAINMENT US 201; Salje H, 2020, SCIENCE, V369, P208, DOI 10.1126/science.abc3517; Saunders KW, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P223; Stiefel Matthew C, 2019, Perm J, V23, DOI 10.7812/TPP/18-091; Tanne JH, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1090; Tindale L, 2020, 2002998 MEDRXIV; Tuite AR, 2020, CAN MED ASSOC J, V192, pE497, DOI 10.1503/cmaj.200476; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; World Health Organization, 2020, COR DIS COVID 19 PAN; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhang JJ, 2020, LANCET INFECT DIS, V20, P793, DOI 10.1016/S1473-3099(20)30230-9; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	47	116	118	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2020	369								m1923	10.1136/bmj.m1923	http://dx.doi.org/10.1136/bmj.m1923			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JU	32444358	hybrid, Green Published			2022-12-28	WOS:000538336800001
J	Sullivan, MJP; Lewis, SL; Affum-Baffoe, K; Castilho, C; Costa, F; Sanchez, AC; Ewango, CEN; Hubau, W; Marimon, B; Monteagudo-Mendoza, A; Qie, L; Sonke, B; Martinez, RV; Baker, TR; Brienen, RJW; Feldpausch, TR; Galbraith, D; Gloor, M; Malhi, Y; Aiba, SI; Alexiades, MN; Almeida, EC; de Oliveira, EA; Davila, EA; Loayza, PA; Andrade, A; Vieira, SA; Aragao, LEOC; Araujo-Murakami, A; Arets, EJMM; Arroyo, L; Ashton, P; Aymard, CG; Baccaro, FB; Banin, LF; Baraloto, C; Camargo, PB; Barlow, J; Barroso, J; Bastin, JF; Batterman, SA; Beeckman, H; Begne, SK; Bennett, AC; Berenguer, E; Berry, N; Blanc, L; Boeckx, P; Bogaert, J; Bonal, D; Bongers, F; Bradford, M; Brearley, FQ; Brncic, T; Brown, F; Burban, B; Camargo, JL; Castro, W; Ceron, C; Ribeiro, SC; Moscoso, VC; Chave, J; Chezeaux, E; Clark, CJ; de Souza, FC; Collins, M; Comiskey, JA; Valverde, FC; Medina, MC; da Costa, L; Dancak, M; Dargie, GC; Davies, S; Cardozo, ND; de Haulleville, T; de Medeiros, MB; Pasquel, JD; Derroire, G; Di Fiore, A; Doucet, JL; Dourdain, A; Droissart, V; Duque, LF; Ekoungoulou, R; Elias, F; Erwin, T; Esquivel-Muelbert, A; Fauset, S; Ferreira, J; Llampazo, GF; Foli, E; Ford, A; Gilpin, M; Hall, JS; Hamer, KC; Hamilton, AC; Harris, DJ; Hart, TB; Hedl, R; Herault, B; Herrera, R; Higuchi, N; Hladik, A; Coronado, EH; Huamantupa-Chuquimaco, I; Huasco, WH; Jeffery, KJ; Jimenez-Rojas, E; Kalamandeen, M; Djuikouo, MNK; Kearsley, E; Umetsu, RK; Kho, LK; Killeen, T; Kitayama, K; Klitgaard, B; Koch, A; Labriere, N; Laurance, W; Laurance, S; Leal, ME; Levesley, A; Lima, AJN; Lisingo, J; Lopes, AP; Lopez-Gonzalez, G; Lovejoy, T; Lovett, JC; Lowe, R; Magnusson, WE; Malumbres-Olarte, J; Manzatto, AG; Marimon, BH; Marshall, AR; Marthews, T; Reis, SMD; Maycock, C; Melgaco, K; Mendoza, C; Metali, F; Mihindou, V; Milliken, W; Mitchard, ETA; Morandi, PS; Mossman, HL; Nagy, L; Nascimento, H; Neill, D; Nilus, R; Vargas, PN; Palacios, W; Camacho, NP; Peacock, J; Pendry, C; Mora, MCP; Pickavance, GC; Pipoly, J; Pitman, N; Playfair, M; Poorter, L; Poulsen, JR; Poulsen, AD; Preziosi, R; Prieto, A; Primack, RB; Ramirez-Angulo, H; Reitsma, J; Reejou-Meechain, M; Correa, ZR; de Sousa, TR; Bayona, LR; Roopsind, A; Rudas, A; Rutishauser, E; Abu Salim, K; Salomao, RP; Schietti, J; Sheil, D; Silva, RC; Espejo, JS; Valeria, CS; Silveira, M; Simo-Droissart, M; Simon, MF; Singh, J; Shareva, YCS; Stahl, C; Stropp, J; Sukri, R; Sunderland, T; Svatek, M; Swaine, MD; Swamy, V; Taedoumg, H; Talbot, J; Taplin, J; Taylor, D; ter Steege, H; Terborgh, J; Thomas, R; Thomas, SC; Torres-Lezama, A; Umunay, P; Gamarra, LV; van der Heijden, G; van der Hout, P; van der Meer, P; van Nieuwstadt, M; Verbeeck, H; Vernimmen, R; Vicentini, A; Vieira, ICG; Torre, EV; Vleminckx, J; Vos, V; Wang, O; White, LJT; Willcock, S; Woods, JT; Wortel, V; Young, K; Zagt, R; Zemagho, L; Zuidema, PA; Zwerts, JA; Phillips, OL				Sullivan, Martin J. P.; Lewis, Simon L.; Affum-Baffoe, Kofi; Castilho, Carolina; Costa, Flavia; Sanchez, Aida Cuni; Ewango, Corneille E. N.; Hubau, Wannes; Marimon, Beatriz; Monteagudo-Mendoza, Abel; Qie, Lan; Sonke, Bonaventure; Vasquez Martinez, Rodolfo; Baker, Timothy R.; Brienen, Roel J. W.; Feldpausch, Ted R.; Galbraith, David; Gloor, Manuel; Malhi, Yadvinder; Aiba, Shin-Ichiro; Alexiades, Miguel N.; Almeida, Everton C.; de Oliveira, Edmar Almeida; Alvarez Davila, Esteban; Loayza, Patricia Alvarez; Andrade, Ana; Vieira, Simone Aparecida; Aragao, Luiz E. O. C.; Araujo-Murakami, Alejandro; Arets, Eric J. M. M.; Arroyo, Luzmila; Ashton, Peter; Aymard, Gerardo C.; Baccaro, Fabricio B.; Banin, Lindsay F.; Baraloto, Christopher; Camargo, Plinio Barbosa; Barlow, Jos; Barroso, Jorcely; Bastin, Jean-Francois; Batterman, Sarah A.; Beeckman, Hans; Begne, Serge K.; Bennett, Amy C.; Berenguer, Erika; Berry, Nicholas; Blanc, Lilian; Boeckx, Pascal; Bogaert, Jan; Bonal, Damien; Bongers, Frans; Bradford, Matt; Brearley, Francis Q.; Brncic, Terry; Brown, Foster; Burban, Benoit; Camargo, Jose Luis; Castro, Wendeson; Ceron, Carlos; Ribeiro, Sabina Cerruto; Moscoso, Victor Chama; Chave, Jerome; Chezeaux, Eric; Clark, Connie J.; de Souza, Fernanda Coelho; Collins, Murray; Comiskey, James A.; Cornejo Valverde, Fernando; Corrales Medina, Massiel; da Costa, Lola; Dancak, Martin; Dargie, Greta C.; Davies, Stuart; Davila Cardozo, Nallaret; de Haulleville, Thales; de Medeiros, Marcelo Brilhante; del Aguila Pasquel, Jhon; Derroire, Geraldine; Di Fiore, Anthony; Doucet, Jean-Louis; Dourdain, Aurelie; Droissart, Vincent; Fernanda Duque, Luisa; Ekoungoulou, Romeo; Elias, Fernando; Erwin, Terry; Esquivel-Muelbert, Adriane; Fauset, Sophie; Ferreira, Joice; Flores Llampazo, Gerardo; Foli, Ernest; Ford, Andrew; Gilpin, Martin; Hall, Jefferson S.; Hamer, Keith C.; Hamilton, Alan C.; Harris, David J.; Hart, Terese B.; Hedl, Radim; Herault, Bruno; Herrera, Rafael; Higuchi, Niro; Hladik, Annette; Honorio Coronado, Euridice; Huamantupa-Chuquimaco, Isau; Huaraca Huasco, Walter; Jeffery, Kathryn J.; Jimenez-Rojas, Eliana; Kalamandeen, Michelle; Djuikouo, Marie Noel Kamdem; Kearsley, Elizabeth; Umetsu, Ricardo Keichi; Kho, Lip Khoon; Killeen, Timothy; Kitayama, Kanehiro; Klitgaard, Bente; Koch, Alexander; Labriere, Nicolas; Laurance, William; Laurance, Susan; Leal, Miguel E.; Levesley, Aurora; Lima, Adriano J. N.; Lisingo, Janvier; Lopes, Aline P.; Lopez-Gonzalez, Gabriela; Lovejoy, Tom; Lovett, Jon C.; Lowe, Richard; Magnusson, William E.; Malumbres-Olarte, Jagoba; Manzatto, Angelo Gilberto; Marimon, Ben Hur, Jr.; Marshall, Andrew R.; Marthews, Toby; de Almeida Reis, Simone Matias; Maycock, Colin; Melgaco, Karina; Mendoza, Casimiro; Metali, Faizah; Mihindou, Vianet; Milliken, William; Mitchard, Edward T. A.; Morandi, Paulo S.; Mossman, Hannah L.; Nagy, Laszlo; Nascimento, Henrique; Neill, David; Nilus, Reuben; Nunez Vargas, Percy; Palacios, Walter; Camacho, Nadir Pallqui; Peacock, Julie; Pendry, Colin; Penuela Mora, Maria Cristina; Pickavance, Georgia C.; Pipoly, John; Pitman, Nigel; Playfair, Maureen; Poorter, Lourens; Poulsen, John R.; Poulsen, Axel Dalberg; Preziosi, Richard; Prieto, Adriana; Primack, Richard B.; Ramirez-Angulo, Hirma; Reitsma, Jan; Rejou-Mechain, Maxime; Restrepo Correa, Zorayda; de Sousa, Thaiane Rodrigues; Rodriguez Bayona, Lily; Roopsind, Anand; Rudas, Agustin; Rutishauser, Ervan; Abu Salim, Kamariah; Salomao, Rafael P.; Schietti, Juliana; Sheil, Douglas; Silva, Richarlly C.; Silva Espejo, Javier; Valeria, Camila Silva; Silveira, Marcos; Simo-Droissart, Murielle; Simon, Marcelo Fragomeni; Singh, James; Soto Shareva, Yahn Carlos; Stahl, Clement; Stropp, Juliana; Sukri, Rahayu; Sunderland, Terry; Svatek, Martin; Swaine, Michael D.; Swamy, Varun; Taedoumg, Hermann; Talbot, Joey; Taplin, James; Taylor, David; ter Steege, Hans; Terborgh, John; Thomas, Raquel; Thomas, Sean C.; Torres-Lezama, Armando; Umunay, Peter; Valenzuela Gamarra, Luis; van der Heijden, Geertje; van der Hout, Peter; van der Meer, Peter; van Nieuwstadt, Mark; Verbeeck, Hans; Vernimmen, Ronald; Vicentini, Alberto; Guimaraes Vieira, Ima Celia; Torre, Emilio Vilanova; Vleminckx, Jason; Vos, Vincent; Wang, Ophelia; White, Lee J. T.; Willcock, Simon; Woods, John T.; Wortel, Verginia; Young, Kenneth; Zagt, Roderick; Zemagho, Lise; Zuidema, Pieter A.; Zwerts, Joeri A.; Phillips, Oliver L.			Long-term thermal sensitivity of Earth's tropical forests	SCIENCE			English	Article							CARBON-CYCLE FEEDBACKS; CO2 FERTILIZATION; LEAF RESPIRATION; CLIMATE; BIOMASS; PRODUCTIVITY; TREE; PHOTOSYNTHESIS; GROWTH; ACCLIMATION	The sensitivity of tropical forest carbon to climate is a key uncertainty in predicting global climate change. Although short-term drying and warming are known to affect forests, it is unknown if such effects translate into long-term responses. Here, we analyze 590 permanent plots measured across the tropics to derive the equilibrium climate controls on forest carbon. Maximum temperature is the most important predictor of aboveground biomass (-9.1 megagrams of carbon per hectare per degree Celsius), primarily by reducing woody productivity, and has a greater impact per degrees C in the hottest forests (>32.2 degrees C). Our results nevertheless reveal greater thermal resilience than observations of short-term variation imply. To realize the long-term climate adaptation potential of tropical forests requires both protecting them and stabilizing Earth's climate.	[Sullivan, Martin J. P.; Lewis, Simon L.; Hubau, Wannes; Baker, Timothy R.; Brienen, Roel J. W.; Galbraith, David; Gloor, Manuel; Batterman, Sarah A.; Begne, Serge K.; Bennett, Amy C.; de Souza, Fernanda Coelho; Dargie, Greta C.; Gilpin, Martin; Kalamandeen, Michelle; Levesley, Aurora; Lopez-Gonzalez, Gabriela; Lovett, Jon C.; Melgaco, Karina; Camacho, Nadir Pallqui; Peacock, Julie; Pickavance, Georgia C.; Talbot, Joey; Phillips, Oliver L.] Univ Leeds, Sch Geog, Leeds, W Yorkshire, England; [Sullivan, Martin J. P.; Brearley, Francis Q.; Mossman, Hannah L.; Preziosi, Richard] Manchester Metropolitan Univ, Dept Nat Sci, Manchester, Lancs, England; [Lewis, Simon L.] UCL, Dept Geog, London, England; [Affum-Baffoe, Kofi] Forestry Commiss Ghana, Mensurat Unit, Kumasi, Ghana; [Castilho, Carolina] Brazilian Agr Res Corp EMBRAPA, Embrapa Roraima, Brasilia, DF, Brazil; [Costa, Flavia; Higuchi, Niro; Lima, Adriano J. N.; Nascimento, Henrique; de Sousa, Thaiane Rodrigues; Schietti, Juliana; Vicentini, Alberto] Inst Nacl Pesquisas Amazonia INPA, Manaus, Amazonas, Brazil; [Sanchez, Aida Cuni] Colorado State Univ, Dept Ecosyst Sci & Sustainabil, Ft Collins, CO 80523 USA; [Sanchez, Aida Cuni; Marshall, Andrew R.] Univ York, Dept Geog & Environm, York, N Yorkshire, England; [Ewango, Corneille E. N.] Wildlife Conservat Soc, DR Congo Programme, Kisangani, DEM REP CONGO; [Ewango, Corneille E. N.] Ctr Format & Rech Conservat Forestiere CEFRECOF, Epulu, DEM REP CONGO; [Ewango, Corneille E. N.; Djuikouo, Marie Noel Kamdem; Lisingo, Janvier] Univ Kisangani, Fac Gest Ressources Nat Renouvelables, Kisangani, DEM REP CONGO; [Hubau, Wannes; Beeckman, Hans; de Haulleville, Thales] Royal Museum Cent Africa, Serv Wood Biol, Tervuren, Belgium; [Hubau, Wannes; Djuikouo, Marie Noel Kamdem] Univ Ghent, Lab Wood Technol Woodlab, Dept Environm, Ghent, Belgium; [Marimon, Beatriz; de Almeida Reis, Simone Matias; Morandi, Paulo S.] Univ Estado Mato Grosso, UNEMAT, Nova Xavantina, MT, Brazil; [Monteagudo-Mendoza, Abel; Vasquez Martinez, Rodolfo; Moscoso, Victor Chama; Soto Shareva, Yahn Carlos; Valenzuela Gamarra, Luis] Jardin Bot Missouri, Oxapampa, Peru; [Qie, Lan] Univ Lincoln, Sch Life Sci, Lincoln, England; [Sonke, Bonaventure; Begne, Serge K.; Djuikouo, Marie Noel Kamdem; Marimon, Ben Hur, Jr.; Simo-Droissart, Murielle; Zemagho, Lise] Univ Yaounde I, Higher Teachers Training Coll, Plant Systemat & Ecol Lab, Yaounde, Cameroon; [Feldpausch, Ted R.; Aragao, Luiz E. O. C.] Univ Exeter, Coll Life & Environm Sci, Geog, Exeter, Devon, England; [Malhi, Yadvinder; Berenguer, Erika; de Almeida Reis, Simone Matias] Univ Oxford, Sch Geog & Environm, Environm Change Inst, Oxford, England; [Aiba, Shin-Ichiro] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan; [Alexiades, Miguel N.] Univ Kent, Sch Anthropol & Conservat, Canterbury, Kent, England; [Almeida, Everton C.] Univ Fed Oeste Para, Inst Biodiversidade & Florestas, Santarem, PA, Brazil; [de Oliveira, Edmar Almeida] Univ Estadual Mato Grosso, Caceres, MT, Brazil; [Alvarez Davila, Esteban] Natl Open Univ & Distance, Escuela Ciencias Agricolas Pecuarias & Medio Ambi, Bogota, Colombia; [Loayza, Patricia Alvarez; Clark, Connie J.; Poulsen, John R.; Terborgh, John] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Andrade, Ana; Camargo, Jose Luis] Inst Nacl de Pesquisas da Amazonia, Projeto Dinam Biol Fragmentos Florestais, Manaus, Amazonas, Brazil; [Vieira, Simone Aparecida] Univ Estadual Campinas, Campinas, SP, Brazil; [Aragao, Luiz E. O. C.; Lopes, Aline P.] Natl Inst Space Res INPE, Sao Jose Dos Campos, Brazil; [Araujo-Murakami, Alejandro] Univ Autonoma Gabriel Rene Moreno, Museo Hist Nat Noel Kempff Mercado, Santa Cruz, Bolivia; [Arets, Eric J. M. M.] Wageningen Environm Res, Wageningen, Netherlands; [Arroyo, Luzmila] Univ Autonoma Gabriel Rene Moreno, Direcc Carrera Biol, Santa Cruz, Bolivia; [Ashton, Peter] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Aymard, Gerardo C.] Herbario Univ, Programa Ciencias Agro & Mar, Guanare, Venezuela; [Baccaro, Fabricio B.] Univ Fed Amazonas, Dept Biol, Manaus, Amazonas, Brazil; [Banin, Lindsay F.] UK Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland; [Baraloto, Christopher; Vleminckx, Jason] Florida Int Univ, Dept Biol Sci, Int Ctr Trop Bot, Miami, FL 33199 USA; [Camargo, Plinio Barbosa] Univ Sao Paulo, Ctr Energia Nucl Agr, Sao Paulo, SP, Brazil; [Barlow, Jos; Berenguer, Erika; Valeria, Camila Silva] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Barroso, Jorcely] Univ Fed Acre, Ctr Multidisciplinar, Cruzeiro Do Sul, AC, Brazil; [Bastin, Jean-Francois] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland; [Bastin, Jean-Francois; Kearsley, Elizabeth; Verbeeck, Hans] Univ Ghent, Computat & Appl Vegetat Ecol CAVELab, Dept Environm, Ghent, Belgium; [Batterman, Sarah A.] Univ Leeds, Priestley Int Ctr Climate, Leeds, W Yorkshire, England; [Batterman, Sarah A.; Rutishauser, Ervan] Smithsonian Trop Res Inst, Panama City, Panama; [Batterman, Sarah A.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Berry, Nicholas] Landscapes & Livelihoods Grp, Edinburgh, Midlothian, Scotland; [Blanc, Lilian] CIRAD, UR Forest & Soc, Montpellier, France; [Boeckx, Pascal; Herault, Bruno] Univ Ghent, Isotope Biosci Lab ISOFYS, Ghent, Belgium; [Bogaert, Jan; de Haulleville, Thales] Univ Liege, Gembloux AgroBio Tech, Liege, Belgium; [Bonal, Damien] INRAE, UMR Silva, Nancy, France; [Bongers, Frans; Poorter, Lourens; Zuidema, Pieter A.] Wageningen Univ, Forest Ecol & Forest Management Grp, Wageningen, Netherlands; [Bradford, Matt; Ford, Andrew] CSIRO Land & Water, Canberra, ACT, Australia; [Brncic, Terry] Wildlife Conservat Soc, Congo Programme, Brazzavile, DEM REP CONGO; [Brown, Foster] Woods Hole Res Ctr, Falmouth, MA USA; [Burban, Benoit; Stahl, Clement] Univ Guyane, Univ Antilles, AgroParisTech, INRAE,UMR EcoFoG,CNRS,CIRAD, Kourou 97310, French Guiana; [Castro, Wendeson] Univ Fed Acre, Programa Posgrad Ecol & Manejo Recursos Nat, Rio Branco, AC, Brazil; [Ceron, Carlos] Univ Cent Ecuador, Herbario Alfredo Paredes, Quito, Ecuador; [Ribeiro, Sabina Cerruto; Silva, Richarlly C.; Silveira, Marcos] Univ Fed Acre, Ctr Ciencias Biol & Nat, Rio Branco, AC, Brazil; [Chave, Jerome; Labriere, Nicolas] CNRS, Lab Evolut & Divers Biol, UMR 5174 CNRS IRD UPS, Toulouse, France; [Chezeaux, Eric] Rougier Gabon, Libreville, Gabon; [Collins, Murray] Grantham Res Inst Climate Change & Environm, London, England; [Collins, Murray; Mitchard, Edward T. A.] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Comiskey, James A.] Natl Pk Serv, Inventory & Monitoring Program, Fredericksburg, VA USA; [Comiskey, James A.] Smithsonian Inst, Washington, DC USA; [Cornejo Valverde, Fernando] Proyecto Castana, Made De Dios, Peru; [Corrales Medina, Massiel] Univ Nacl San Agustin Arequipa, Arequipa, Peru; [da Costa, Lola] Univ Fed Para, Fac Meteorol, Inst Geociencias, Belem, PA, Brazil; [Dancak, Martin] Palacky Univ, Dept Ecol & Environm Sci, Fac Sci, Olomouc, Czech Republic; [Davies, Stuart] Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Panama City, Panama; [Davila Cardozo, Nallaret] Univ Nacl Amazonia Peruana, Fac Ciencias Biol, Iquitos, Peru; [de Medeiros, Marcelo Brilhante; Simon, Marcelo Fragomeni] Brazilian Agr Res Corp EMBRAPA, Embrapa Genet Resources & Biotechnol, Brasilia, DF, Brazil; [del Aguila Pasquel, Jhon; Honorio Coronado, Euridice] Inst Invest Amazonia Peruana, Iquitos, Peru; [Derroire, Geraldine; Dourdain, Aurelie] Univ Guyane, Univ Antilles, Cirad,UMR EcoFoG AgroParisTech, CNRS,INRAE, Kourou, French Guiana; [Di Fiore, Anthony] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Doucet, Jean-Louis] Univ Liege, Gembloux AgroBio Tech, Forest Resources Management, Liege, Belgium; [Droissart, Vincent; Rejou-Mechain, Maxime] Univ Montpellier, INRAE, AMAP, IRD,CNRS,CIRAD, Montpellier, France; [Fernanda Duque, Luisa] Fdn Con Vida, Socioecosistemas & Cambio Climat, Medellin, Colombia; [Ekoungoulou, Romeo] Beijing Forestry Univ, Sch Forestry, Beijing, Peoples R China; [Elias, Fernando] Univ Fed Para, Inst Biol Sci, Belem, PA, Brazil; [Erwin, Terry] Smithsonian Inst, Natl Museum Amer Hist, Washington, DC 20560 USA; [Esquivel-Muelbert, Adriane] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Fauset, Sophie] Univ Plymouth, Sch Geog Earth & Environm Sci, Plymouth, Devon, England; [Ferreira, Joice] Brazilian Agr Res Corp EMBRAPA, Embrapa Amazonia Oriental, Brasilia, DF, Brazil; [Flores Llampazo, Gerardo] Univ Nacl Jorge Basadre Grohmann UNJBG, Tacna, Peru; [Foli, Ernest] Forestry Res Inst Ghana FORIG, Kumasi, Ghana; [Hall, Jefferson S.] Smithsonian Trop Res Inst, Smithsonian Inst Forest Global Earth Observ Fores, Washington, DC USA; [Hamer, Keith C.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Hamilton, Alan C.] 128 Busbridge Lane, Surrey, England; [Harris, David J.; Pendry, Colin; Poulsen, Axel Dalberg] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Hart, Terese B.] Lukuru Wildlife Res Fdn, Kinshasa, DEM REP CONGO; [Hart, Terese B.] Yale Peabody Museum Nat Hist, Div Vertebrate Zool, New Haven, CT USA; [Hedl, Radim] Czech Acad Sci, Inst Bot, Brno, Czech Republic; [Hedl, Radim] Palacky Univ, Dept Bot, Olomouc, Czech Republic; [Herault, Bruno] UPR Forets & Soc, CIRAD, Yamoussoukro, Cote Ivoire; [Herault, Bruno] INP HB, Inst Natl Polytech Felix Houphouet Boigny, Yamoussoukro, Cote Ivoire; [Herrera, Rafael; Nunez Vargas, Percy] Inst Venezolano Invest Cient IVIC, Caracas, Venezuela; [Hladik, Annette] Museum Natl Hist Nat, Dept Hommes, Paris, France; [Huamantupa-Chuquimaco, Isau; Huaraca Huasco, Walter] Univ Nacl San Antonio Abad Cusco, Cuzco, Peru; [Jeffery, Kathryn J.; White, Lee J. T.] Univ Stirling, Biol & Environm Sci, Stirling, Scotland; [Jimenez-Rojas, Eliana] Univ Nacl Colombia, Inst IMANI, Leticia, Colombia; [Kalamandeen, Michelle] Laurentian Univ, Living Lakes Ctr, Sudbury, ON, Canada; [Kalamandeen, Michelle] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Djuikouo, Marie Noel Kamdem] Univ Buea, Fac Sci, Dept Bot & Plant Physiol, Buea, Cameroon; [Umetsu, Ricardo Keichi] Univ Estado Mato Grosso, PELD, Nova Xavantina, MT, Brazil; [Kho, Lip Khoon] Malaysian Palm Oil Board, Trop Peat Res Inst, Selangor, Malaysia; [Killeen, Timothy] Agteca, Santa Cruz, Bolivia; [Kitayama, Kanehiro] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Klitgaard, Bente; Lovett, Jon C.; Milliken, William] Royal Bot Gardens Kew, London, England; [Koch, Alexander] Univ Hong Kong, Dept Earth Sci, Pok Ful Lam, Hong Kong, Peoples R China; [Laurance, William; Laurance, Susan] James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Douglas, QLD, Australia; [Laurance, William; Laurance, Susan] James Cook Univ, Coll Marine & Environm Sci, Douglas, QLD, Australia; [Leal, Miguel E.] Wildlife Conservat Soc, Uganda Programme, Kampala, Uganda; [Lovejoy, Tom] George Mason Univ, Environm Sci & Policy, Fairfax, VA USA; [Lowe, Richard] Univ Ibadan, Bot Dept, Ibadan, Nigeria; [Magnusson, William E.] INPA, Coordenacao Biodiversidade, Mauaus, Brazil; [Malumbres-Olarte, Jagoba] Univ Acores, CE3c Ctr Ecol Evolut & Environm Changes, Azorean Biodivers Grp, Angra Do Heroismo, Azores, Portugal; [Malumbres-Olarte, Jagoba] Univ Helsinki, Finnish Museum Nat Hist, LIBRe Lab Integrat Biodivers Res, Helsinki, Finland; [Manzatto, Angelo Gilberto] Univ Fed Rondonia, Lab Biogeoquim Ambiental Wolfgang C Pfeiffer, Porto Velho, RO, Brazil; [Marimon, Ben Hur, Jr.] Univ Estado Mato Grosso, Fac Ciencias Agr Biol & Sociais Aplicadas, Nova Xavantina, MT, Brazil; [Marshall, Andrew R.] Univ Sunshine Coast, Trop Forests & People Res Ctr, Sippy Downs, QLD, Australia; [Marshall, Andrew R.] Flamingo Land Ltd, Kirby Misperton, N Yorkshire, England; [Marthews, Toby] UK Ctr Ecol & Hydrol, Wallingford, England; [Maycock, Colin] Univ Malaysia Sabah, Sch Int Trop Forestry, Kota Kinabalu, Malaysia; [Mendoza, Casimiro] Univ Mayor San Simon, Unidad Acad Trop, Escuela Ciencias Forestales, Sacta, Bolivia; [Metali, Faizah; Abu Salim, Kamariah; Sukri, Rahayu] Univ Brunei Darussalam, Fac Sci, Bandar Seri Begawan, Brunei; [Mihindou, Vianet; White, Lee J. T.] Agence Natl Parcs Nationaux, Libreville, Gabon; [Mihindou, Vianet] Minist Foret Mer Environm Charge Plan Climat, Libreville, Gabon; [Nagy, Laszlo] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil; [Neill, David] Univ Estatal Amazon, Fac Ingn Ambiental, Puyo, Pastaza, Ecuador; [Nilus, Reuben] Forest Res Ctr, Sabah Forestry Dept, Sepilok, Malaysia; [Palacios, Walter] Univ Tecn Norte, Carrera Ingn Forestal, Ibarra, Ecuador; [Penuela Mora, Maria Cristina] Univ Reg Amazon Ikiam, Grp Ecosistemas Trop & Cambio Globa, Tena, Ecuador; [Pipoly, John] Publ Commun & Outreach Grp, Pk & Recreat Div, Oakland Pk, FL USA; [Pitman, Nigel] Field Museum, Keller Sci Act Ctr, Chicago, IL USA; [Playfair, Maureen; Zwerts, Joeri A.] Ctr Agr Res Suriname CELOS, Paramaribo, Suriname; [Prieto, Adriana; Rudas, Agustin] Univ Nacl Colombia, Inst Ciencias Nat, Leticia, Colombia; [Primack, Richard B.] Boston Univ, Dept Biol, Boston, MA USA; [Ramirez-Angulo, Hirma] Univ los Andes, Inst Res Forestry Dev INDEFOR, Merida, Venezuela; [Reitsma, Jan] Bur Waardenburg, Culemborg, Netherlands; [Restrepo Correa, Zorayda] Fdn Con Vida, Socioecosistemas & Cambio Climat, Medellin, Colombia; [Rodriguez Bayona, Lily] Centro Conservac, Investigac Manejo Areas Natur, CIMA Cordillera Azul, Lima, Peru; [Roopsind, Anand; Thomas, Raquel] Iwokrama Int Ctr Rainforest Conservat & Dev, Georgetown, Guyana; [Rutishauser, Ervan] Carboforexpert, Geneva, Switzerland; [Salomao, Rafael P.] Univ Fed Rural Amazonia CAPES, Belem, PA, Brazil; [Salomao, Rafael P.] Museu Paraense Emilio Goeldi, Belem, PA, Brazil; [Sheil, Douglas] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway; [Silva, Richarlly C.; Guimaraes Vieira, Ima Celia] Inst Fed Acre, Rio Branco, AC, Brazil; [Silva Espejo, Javier] Univ San Antonio Abad de Cusco, Cuzco, Peru; [Singh, James] Guyana Forestry Commiss, Georgetown, Guyana; [Stropp, Juliana] Museo Nacl Ciencias Natur, Dept Biogeog & Cambio Global, CSIC, Madrid, Spain; [Sunderland, Terry] Ctr Int Forestry Res, Sustainable Landscapes & Food Syst, Bogor, Indonesia; [Sunderland, Terry] Univ British Columbia, Fac Forestry, Vancouver, BC, Canada; [Svatek, Martin] Mendel Univ Brno, Dept Forest Bot Dendrol & Geobiocoenol, Brno, Czech Republic; [Swaine, Michael D.] Univ Aberdeen, Sch Biol Sci, Dept Plant and Soil Sci, Aberdeen, Scotland; [Swamy, Varun] San Diego Zoo, Inst Conservat Res, San Diego, CA USA; [Taedoumg, Hermann] Univ Yaounde I, Fac Sci, Dept Plant Biol, Yaounde, Cameroon; [Taedoumg, Hermann] Biovers Int, Yaounde, Cameroon; [Taplin, James] Innovate UK, UK Res & Innovat, London, England; [Taylor, David] Natl Univ Singapore, Dept Geog, Singapore, Singapore; [ter Steege, Hans] Naturalis Biodivers Ctr, Leiden, Netherlands; [ter Steege, Hans] Vrije Univ Amsterdam, Syst Ecol, Amsterdam, Netherlands; [Thomas, Sean C.] Univ Toronto, Fac Forestry, Toronto, ON, Canada; [Torres-Lezama, Armando] Univ los Andes, Merida, Colombia; [Umunay, Peter] Wildlife Conservat Soc, New York, NY USA; [Umunay, Peter] Yale Univ, Yale Sch Forestry & Environm Studies, New Haven, CT USA; [van der Heijden, Geertje] Univ Notingham, Sch Geog, Nottingham, England; [van der Hout, Peter] Van der Hout Forestry Consulting, Rotterdam, Netherlands; [van der Meer, Peter] Van Hall Larenstein Univ Appl Sci, Velp, Netherlands; [van Nieuwstadt, Mark; Zwerts, Joeri A.] Univ Utrecht, Utrecht, Netherlands; [Vernimmen, Ronald] Data Sustainabil, Axel, Netherlands; [Torre, Emilio Vilanova] Univ Washington, Sch Environm & Forest Sci, Seattle, OR USA; [Vos, Vincent] Ctr Invest & Promoc Campesinado, La Paz, Bolivia; [Vos, Vincent] Univ Autonoma Beni Jose Ballivian, Riberalta, Bolivia; [Wang, Ophelia] No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Flagstaff, AZ USA; [White, Lee J. T.] Inst Rech Ecol Trop, Libreville, Gabon; [Willcock, Simon] Univ Bangor, Sch Nat Sci, Bangor, Wales; [Woods, John T.] Univ Liberia, Monrovia, Liberia; [Wortel, Verginia] Ctr Agr Res Suriname CELOS, Forest Management, Paramaribo, Suriname; [Young, Kenneth] Univ Texas Austin, Dept Geog & Environm, Austin, TX USA; [Zagt, Roderick] Tropenbos Int, Wageningen, Netherlands; [Di Fiore, Anthony] Univ San Francisco Quito, Coll Biol & Environm Sci, Cumbaya, Ecuador; [Talbot, Joey] Univ Leeds, Inst Transport Studies, Leeds, England	University of Leeds; Manchester Metropolitan University; University of London; University College London; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Institute Nacional de Pesquisas da Amazonia; Colorado State University; University of York - UK; Royal Museum for Central Africa; Ghent University; Universidade do Estado de Mato Grosso; University of Lincoln; University of Yaounde I; University of Exeter; University of Oxford; Hokkaido University; University of Kent; Universidade Federal do Oeste do Para; Universidade do Estado de Mato Grosso; Duke University; Institute Nacional de Pesquisas da Amazonia; Universidade Estadual de Campinas; Instituto Nacional de Pesquisas Espaciais (INPE); Wageningen University & Research; Harvard University; Universidade Federal de Amazonas; UK Centre for Ecology & Hydrology (UKCEH); State University System of Florida; Florida International University; Universidade de Sao Paulo; Lancaster University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Ghent University; University of Leeds; Smithsonian Institution; Smithsonian Tropical Research Institute; Cary Institute of Ecosystem Studies; CIRAD; Ghent University; University of Liege; INRAE; Universite de Lorraine; Wageningen University & Research; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Woods Hole Research Center; AgroParisTech; CIRAD; INRAE; Universidade Federal do Acre (UFAC); Universidad Central del Ecuador; Universidade Federal do Acre (UFAC); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Edinburgh; United States Department of the Interior; Smithsonian Institution; Universidad Nacional de San Agustin de Arequipa; Universidade Federal do Para; Palacky University Olomouc; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad Nacional de la Amazonia Peruana; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); CIRAD; INRAE; University of Texas System; University of Texas Austin; University of Liege; Centre National de la Recherche Scientifique (CNRS); CIRAD; INRAE; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Beijing Forestry University; Universidade Federal do Para; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Birmingham; University of Plymouth; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Smithsonian Institution; Smithsonian Tropical Research Institute; University of Leeds; Yale University; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Palacky University Olomouc; CIRAD; Museum National d'Histoire Naturelle (MNHN); Universidad Nacional de San Antonio Abad del Cusco; University of Stirling; Universidad Nacional de Colombia; Laurentian University; University of Cambridge; Universidade do Estado de Mato Grosso; Malaysian Palm Oil Board; Kyoto University; Royal Botanic Gardens, Kew; University of Hong Kong; James Cook University; James Cook University; George Mason University; University of Ibadan; Universidade dos Acores; University of Helsinki; Universidade Federal de Rondonia; Universidade do Estado de Mato Grosso; University of the Sunshine Coast; UK Centre for Ecology & Hydrology (UKCEH); Universiti Malaysia Sabah; University Brunei Darussalam; Universidade de Sao Paulo; Universidade Estadual de Campinas; Pusat Penyelidikan Hutan; Field Museum of Natural History (Chicago); Universidad Nacional de Colombia; Boston University; University of Los Andes Venezuela; Museu Paraense Emilio Goeldi; Norwegian University of Life Sciences; Instituto Federal do Acre (IFAC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); CGIAR; Center for International Forestry Research (CIFOR); University of British Columbia; Mendel University in Brno; University of Aberdeen; Zoological Society of San Diego; University of Yaounde I; Alliance; Bioversity International; UK Research & Innovation (UKRI); Innovate UK; National University of Singapore; Naturalis Biodiversity Center; Vrije Universiteit Amsterdam; University of Toronto; Universidad de los Andes (Colombia); Wildlife Conservation Society; Yale University; University of Nottingham; Utrecht University; Northern Arizona University; Bangor University; University of Texas System; University of Texas Austin; University of Leeds	Sullivan, MJP (corresponding author), Univ Leeds, Sch Geog, Leeds, W Yorkshire, England.; Sullivan, MJP (corresponding author), Manchester Metropolitan Univ, Dept Nat Sci, Manchester, Lancs, England.	m.j.sullivan@leeds.ac.uk	de Camargo, Plínio B./D-6635-2012; Bradford, Matt G/D-3389-2011; Hubau, Wannes/ABA-7432-2020; Steege, Hans ter/B-5866-2011; Baraloto, Christopher/ABG-2500-2020; Koch, Alexander/F-2741-2019; Vieira, Simone/H-1225-2011; Baccaro, Fabricio/HIR-4297-2022; Pitman, Nigel C A/A-7681-2008; Manzatto, Angelo Gilberto/F-6557-2015; Camargo, José Luís C/C-3137-2015; Malumbres-Olarte, Jagoba/Q-2927-2016; Poulsen, John/O-5332-2019; Baccaro, Fabricio/H-3885-2012; Hérault, Bruno/B-2765-2011; Schietti, Juliana/B-8226-2015; Derroire, Géraldine/I-8959-2012; Elias, Fernando/P-4400-2014; Higuchi, Niro/ABC-9134-2020; hubau, wannes/AAA-8502-2019; Junior, Ben Hur Marimon/AAT-9354-2020; Vos, Vincent Antoine/I-7209-2019; Silva, Richarlly da Costa/GRS-5933-2022; Umunay, Peter/AAS-4870-2020; Schietti, Juliana/AAV-7451-2020; Barlow, Jos/E-7861-2014; Barlow, Jos/HGE-9486-2022; Dančák, Martin/AAB-9537-2019; Brienen, Roel/AAU-9959-2020; Foli, Ernest/GYE-0219-2022; Reis, Simone MA/N-1528-2017; Sunderland, Terence/AAS-5080-2021; Higuchi, Niro/ABC-8890-2020; Svatek, Martin/C-1890-2014; Ribeiro, Sabina Cerruto/E-4172-2016; Castro, Wendeson/AGH-6805-2022; Medeiros, Marcelo/AAR-7172-2020; Ford, Andrew J/D-3761-2011; Marimon, Beatriz/J-6389-2012; Higuchi, Niro/J-1287-2016; Marthews, Toby Richard/H-6264-2014; Poorter, Lourens/AAL-1709-2021; Costa, Flavia/K-4386-2014; Aymard, Gerardo/ABE-9203-2020; Feldpausch, Ted/ABH-3123-2020; Aiba, Shin-ichiro/A-3011-2010; Pontes-Lopes, Aline/I-4043-2016; Phillips, Oliver/A-1523-2011; Vos, Vincent/ABA-1492-2020; de Castilho, Carolina Volkmer/I-6618-2019; Lima, Adriano/ABE-4468-2020; Arets, Eric/C-1050-2008; Laurance, Susan/G-6021-2011; Swamy, Varun/F-6547-2014; Honorio Coronado, Euridice Nora/K-3412-2015; Barroso, Jorcely/H-5852-2017; Sheil, Douglas/A-3867-2015; Pallqui Camacho, Nadir Carolina/G-2529-2017; Droissart, Vincent/K-2507-2016	de Camargo, Plínio B./0000-0002-0696-3778; Hubau, Wannes/0000-0003-3795-4986; Steege, Hans ter/0000-0002-8738-2659; Baraloto, Christopher/0000-0001-7322-8581; Koch, Alexander/0000-0002-4693-4453; Vieira, Simone/0000-0002-0129-4181; Baccaro, Fabricio/0000-0003-4747-1857; Pitman, Nigel C A/0000-0002-9211-2880; Manzatto, Angelo Gilberto/0000-0002-6414-8966; Malumbres-Olarte, Jagoba/0000-0002-6878-5719; Poulsen, John/0000-0002-1532-9808; Baccaro, Fabricio/0000-0003-4747-1857; Hérault, Bruno/0000-0002-6950-7286; Schietti, Juliana/0000-0002-1687-4373; Derroire, Géraldine/0000-0001-7239-2881; Elias, Fernando/0000-0001-9190-1733; Higuchi, Niro/0000-0002-1203-4502; Vos, Vincent Antoine/0000-0002-0388-8530; Silva, Richarlly da Costa/0000-0002-8312-760X; Schietti, Juliana/0000-0002-1687-4373; Dančák, Martin/0000-0002-3851-4969; Brienen, Roel/0000-0002-5397-5755; Foli, Ernest/0000-0003-4069-5620; Svatek, Martin/0000-0003-2328-4627; Ribeiro, Sabina Cerruto/0000-0002-4504-3050; Castro, Wendeson/0000-0002-5592-9891; Marimon, Beatriz/0000-0003-3105-2914; Higuchi, Niro/0000-0002-1203-4502; Marthews, Toby Richard/0000-0003-3727-6468; Costa, Flavia/0000-0002-9600-4625; Aymard, Gerardo/0000-0001-9405-0508; Feldpausch, Ted/0000-0002-6631-7962; Aiba, Shin-ichiro/0000-0002-3844-0138; Pontes-Lopes, Aline/0000-0001-7668-1226; Phillips, Oliver/0000-0002-8993-6168; Vos, Vincent/0000-0002-0388-8530; de Castilho, Carolina Volkmer/0000-0002-1064-2758; Lima, Adriano/0000-0001-7865-2410; Sukri, Rahayu Sukmaria/0000-0002-2662-399X; Campana Camargo, Jose Luis/0000-0003-0370-9878; Esquivel-Muelbert, Adriane/0000-0001-5335-1259; Simon, Marcelo/0000-0002-5732-1716; Taylor, David/0000-0002-6098-5636; Arets, Eric/0000-0001-7209-9028; Verbeeck, Hans/0000-0003-1490-0168; del Aguila-Pasquel, Jhon/0000-0003-2103-7390; Laurance, Susan/0000-0002-2831-2933; Sullivan, Martin/0000-0002-5955-0483; Swamy, Varun/0000-0001-9203-212X; Sousa, Thaiane/0000-0003-0598-4996; Neill, David Alan/0000-0002-5143-9430; Vernimmen, Ronald/0000-0002-9899-3826; Stropp, Juliana/0000-0002-2831-4066; Honorio Coronado, Euridice Nora/0000-0003-2314-590X; Barroso, Jorcely/0000-0003-3017-9462; Rejou-Mechain, Maxime/0000-0003-2824-267X; Vicentini, Alberto/0000-0002-5906-9358; Sheil, Douglas/0000-0002-1166-6591; /0000-0001-6026-0275; Sunderland, Terence/0000-0002-1985-9849; Pallqui Camacho, Nadir Carolina/0000-0003-4596-0905; Talbot, Joey/0000-0002-6520-4560; Comiskey, James/0000-0001-6710-1269; Pendry, Colin Alistair/0000-0002-7619-824X; Droissart, Vincent/0000-0001-9798-5616; Zwerts, Joeri/0000-0003-3841-6389; Ewango, Corneille/0000-0001-5622-5127; Galbraith, David/0000-0002-5555-4823	European Research Council; Natural Environment Research Council; European Union; Royal Society; Leverhulme Trust; Gordon and Betty Moore Foundation; David and Lucile Packard Foundation; State of Sao Paulo Research Foundation (FAPESP); National Council for Science and Technology Development of Brazil (CNPq); Agence Nationale de la Recherche; Conservation International; Missouri Botanical Garden; Smithsonian Institution; Wildlife Conservation Society; National Geographic Society; Centre for International Forestry; Gabon's National Park Agency; NERC [NE/M022021/1, NE/J023418/1, NE/I02982X/1, NE/P001092/1, NE/K016431/1, NE/N012453/1, NE/F005806/1, NE/N012542/1, NE/D005590/1, NE/N011570/1, NE/N004655/1] Funding Source: UKRI; Natural Environment Research Council [NE/N012453/1, NE/P001092/1, NE/J023418/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Union(European Commission); Royal Society(Royal Society of London); Leverhulme Trust(Leverhulme Trust); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); State of Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Science and Technology Development of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Conservation International; Missouri Botanical Garden; Smithsonian Institution(Smithsonian Institution); Wildlife Conservation Society; National Geographic Society(National Geographic Society); Centre for International Forestry; Gabon's National Park Agency; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Our plot monitoring networks have been supported by multiple grants from a large number of funding bodies: European Research Council; Natural Environment Research Council; European Union's Fifth, Sixth, and Seventh Framework Programme; Royal Society, Leverhulme Trust; Gordon and Betty Moore Foundation; David and Lucile Packard Foundation; State of Sao Paulo Research Foundation (FAPESP); National Council for Science and Technology Development of Brazil (CNPq); Agence Nationale de la Recherche; Conservation International; Missouri Botanical Garden; Smithsonian Institution; Wildlife Conservation Society; National Geographic Society; Centre for International Forestry; and Gabon's National Park Agency. Data from RAINFOR, AfriTRON, and T-FORCES are stored and curated by ForestPlots. net, a cyber-infrastructure initiative developed at the University of Leeds that unites permanent plot records and their contributing scientists from the world's tropical forests. Many of the bodies listed above funded the development of ForestPlots.net and curation of most data analyzed here. For details of additional support and grant references, see the extended acknowledgments in the supplementary materials.	Anderegg WRL, 2018, NATURE, V561, P538, DOI 10.1038/s41586-018-0539-7; Anderegg WRL, 2015, P NATL ACAD SCI USA, V112, P15591, DOI 10.1073/pnas.1521479112; ANDERSON AB, 1981, BIOTROPICA, V13, P199, DOI 10.2307/2388125; [Anonymous], 2005, WORLDCLIM GLOBAL CLI; Avitabile V, 2016, GLOBAL CHANGE BIOL, V22, P1406, DOI 10.1111/gcb.13139; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Ballantyne A, 2017, NAT CLIM CHANGE, V7, P148, DOI [10.1038/NCLIMATE3204, 10.1038/nclimate3204]; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; BARTON K, 2015, MUMIN MULTIMODEL INF, V15, P1; Booth BBB, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024002; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brienen RJW, 2015, NATURE, V519, P344, DOI 10.1038/nature14283; Brown JH, 1997, P NATL ACAD SCI USA, V94, P9729, DOI 10.1073/pnas.94.18.9729; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Clark DB, 2000, FOREST ECOL MANAG, V137, P185, DOI 10.1016/S0378-1127(99)00327-8; Clark DA, 2013, J GEOPHYS RES-BIOGEO, V118, P783, DOI 10.1002/jgrg.20067; Cox PM, 2013, NATURE, V494, P341, DOI 10.1038/nature11882; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Domingues TF, 2018, OECOLOGIA, V187, P933, DOI 10.1007/s00442-018-4195-2; DRAY S, 2006, ECOL MODEL, V196, P483, DOI DOI 10.1016/J.EC0LM0DEL.2006.02.015; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Dusenge ME, 2019, NEW PHYTOL, V221, P32, DOI 10.1111/nph.15283; Erb KH, 2018, NATURE, V553, P73, DOI 10.1038/nature25138; Fauset S, 2012, ECOL LETT, V15, P1120, DOI 10.1111/j.1461-0248.2012.01834.x; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fontes CG, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2018.0209; Galbraith D, 2013, PLANT ECOL DIVERS, V6, P139, DOI 10.1080/17550874.2013.770578; Goodman RC, 2013, FOREST ECOL MANAG, V310, P994, DOI 10.1016/j.foreco.2013.09.045; Graham EA, 2003, P NATL ACAD SCI USA, V100, P572, DOI 10.1073/pnas.0133045100; Green JK, 2019, NATURE, V565, P476, DOI 10.1038/s41586-018-0848-x; Gunderson CA, 2010, GLOBAL CHANGE BIOL, V16, P2272, DOI 10.1111/j.1365-2486.2009.02090.x; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hengl T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169748; Hijmans R.J., 2021, DISMO SPECIES DISTRI; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hubau W, 2020, NATURE, V579, P80, DOI 10.1038/s41586-020-2035-0; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Kicklighter DW, 1999, TELLUS B, V51, P343, DOI 10.1034/j.1600-0889.1999.00017.x; Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953; Kohyama TS, 2018, METHODS ECOL EVOL, V9, P809, DOI 10.1111/2041-210X.12929; Laurance WF, 2008, AUSTRAL ECOL, V33, P399, DOI 10.1111/j.1442-9993.2008.01895.x; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Liu JJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam5690; Lopez-Gonzalez G., 2009, FORESTPLOTS; Lopez-Gonzalez G., 2015, BIOMASAFP TOOLS ANAL; Lopez-Gonzalez G, 2011, J VEG SCI, V22, P610, DOI 10.1111/j.1654-1103.2011.01312.x; Malhi Y, 2015, GLOBAL CHANGE BIOL, V21, P2283, DOI 10.1111/gcb.12859; Malhi Y, 2012, J ECOL, V100, P65, DOI 10.1111/j.1365-2745.2011.01916.x; Marley D, 2016, HEALTH QUAL LIFE OUT, V14; Martin AR, 2018, NAT GEOSCI, V11, P915, DOI 10.1038/s41561-018-0246-x; Matthews HD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032388; McDowell N, 2018, NEW PHYTOL, V219, P851, DOI 10.1111/nph.15027; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Mitchard ETA, 2014, GLOBAL ECOL BIOGEOGR, V23, P935, DOI 10.1111/geb.12168; Mitchard Edward Ta, 2013, Carbon Balance Manag, V8, P10, DOI 10.1186/1750-0680-8-10; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Ow LF, 2008, NEW PHYTOL, V178, P123, DOI 10.1111/j.1469-8137.2007.02357.x; Pau S, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2311; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; PEZESHKI SR, 1991, TREES-STRUCT FUNCT, V5, P180, DOI 10.1007/BF00204341; Phillips O. L., 2001, RAINFOR FIELD MANUAL; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Piao SL, 2013, GLOBAL CHANGE BIOL, V19, P2117, DOI 10.1111/gcb.12187; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Slik JWF, 2018, P NATL ACAD SCI USA, V115, P1837, DOI 10.1073/pnas.1714977115; Slot M, 2017, NEW PHYTOL, V214, P1103, DOI 10.1111/nph.14469; Slot M, 2014, GLOBAL CHANGE BIOL, V20, P2915, DOI 10.1111/gcb.12563; Smith MD, 2009, ECOLOGY, V90, P3279, DOI 10.1890/08-1815.1; Smith WK, 2016, NAT CLIM CHANGE, V6, P306, DOI [10.1038/nclimate2879, 10.1038/NCLIMATE2879]; Sullivan M. J. P., 2020, FORESTPLOTS NET, DOI [10.5521/forestplots.net/2020_2, DOI 10.5521/FORESTPLOTS.NET/2020_2]; Sullivan M. J. P., 2020, FORESTPLOTS, DOI 10.5521/forestplots.net/2020_2; Sullivan MJP, 2018, METHODS ECOL EVOL, V9, P1179, DOI 10.1111/2041-210X.12962; Talbot J, 2014, FOREST ECOL MANAG, V320, P30, DOI 10.1016/j.foreco.2014.02.021; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Terrer C, 2019, NAT CLIM CHANGE, V9, P684, DOI 10.1038/s41558-019-0545-2; Thomas SC, 1996, AM J BOT, V83, P556, DOI 10.2307/2445913; Wang WL, 2013, P NATL ACAD SCI USA, V110, P13061, DOI 10.1073/pnas.1219683110; Wenzel S, 2014, J GEOPHYS RES-BIOGEO, V119, P794, DOI 10.1002/2013JG002591	85	117	119	30	225	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					869	+		10.1126/science.aaw7578	http://dx.doi.org/10.1126/science.aaw7578			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU2DD	32439789	Green Accepted, Green Submitted			2022-12-28	WOS:000537569500042
J	Kuehn, BM				Kuehn, Bridget M.			WHO: Strengthen Nurse Workforce	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2020	323	19					1886	1886		10.1001/jama.2020.6430	http://dx.doi.org/10.1001/jama.2020.6430			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LT2XF	32427309				2022-12-28	WOS:000536934300025
J	Feldmann, H; Sprecher, A; Geisbert, TW				Feldmann, Heinz; Sprecher, Armand; Geisbert, Thomas W.			Ebola	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							VIRUS DISEASE; CONTROLLED-TRIAL; SIERRA-LEONE; PATHOGENESIS; MANAGEMENT; FILOVIRUSES; PERSISTENCE; MORTALITY; DISCOVERY; OUTBREAK		[Feldmann, Heinz] NIAID, Lab Virol, Div Intramural Res, Rocky Mt Labs, Hamilton, MT USA; [Sprecher, Armand] Med Sans Frontieres, Brussels, Belgium; [Geisbert, Thomas W.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Geisbert, Thomas W.] Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77555 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Doctors Without Borders; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Feldmann, H (corresponding author), Rocky Mt Labs, 903 S 4th St, Hamilton, MT 59840 USA.	feldmannh@niaid.nih.gov						Agua-Agum J, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002170; [Anonymous], 2009, 1 FDA APPR VACC PREV; [Anonymous], 2020, 742019 WHO; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Baseler L, 2017, ANNU REV PATHOL-MECH, V12, P387, DOI 10.1146/annurev-pathol-052016-100506; Bornholdt ZA, 2019, CELL HOST MICROBE, V25, P49, DOI 10.1016/j.chom.2018.12.005; Brannan JM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08040-w; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Callendret B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192312; Cantoni D, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00322-16; Carroll MW, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00325-17, 10.1128/mspheredirect.00325-17]; Cherif MS, 2017, EUR J CLIN MICROBIOL, V36, P689, DOI 10.1007/s10096-016-2850-2; Coarsey CT, 2017, CRIT REV MICROBIOL, V43, P779, DOI [10.1080/1040841x.2017.1313814, 10.1080/1040841X.2017.1313814]; Coca A, 2015, DISASTER MED PUBLIC, V9, P536, DOI 10.1017/dmp.2015.97; Cross RW, 2018, NAT REV DRUG DISCOV, V17, P413, DOI 10.1038/nrd.2017.251; Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330; de Wit E, 2016, EMERG INFECT DIS, V22, P323, DOI 10.3201/eid2202.151656; Deng IM, 1978, B WORLD HEALTH ORGAN, V56, P247; Diallo B, 2016, CLIN INFECT DIS, V63, P1353, DOI 10.1093/cid/ciw601; Dodd LE, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1049; Dokubo EK, 2018, LANCET INFECT DIS, V18, P1015, DOI 10.1016/S1473-3099(18)30417-1; Dunning J, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001997; Emanuel J, 2018, ADV VIRUS RES, V100, P189, DOI 10.1016/bs.aivir.2017.12.002; Falasca L, 2015, CELL DEATH DIFFER, V22, P1250, DOI 10.1038/cdd.2015.67; Feldmann H, 2018, ANNU REV MICROBIOL, V72, P423, DOI 10.1146/annurev-micro-090817-062414; Fitzpatrick G, 2015, J INFECT DIS, V212, P1752, DOI 10.1093/infdis/jiv304; Frick WF, 2019, ANN N Y ACAD SCI; Goldstein T, 2018, NAT MICROBIOL, V3, P1084, DOI 10.1038/s41564-018-0227-2; Gross L, 2018, INT J INFECT DIS, V74, P83, DOI 10.1016/j.ijid.2018.06.022; Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6; Hoenen T, 2019, NAT REV MICROBIOL, V17, P593, DOI 10.1038/s41579-019-0233-2; Hoenen T, 2012, J VIROL, V86, P11779, DOI 10.1128/JVI.01525-12; Jagadesh S, 2018, CLIN INFECT DIS, V66, P131, DOI 10.1093/cid/cix705; JAHRLING PB, 1990, LANCET, V335, P502, DOI 10.1016/0140-6736(90)90737-P; Kennedy SB, 2017, NEW ENGL J MED, V377, P1438, DOI 10.1056/NEJMoa1614067; KILEY MP, 1982, INTERVIROLOGY, V18, P24, DOI 10.1159/000149300; Kudra Maliro A-H, 2019, AP NEWS         0419; Kuhn JH, 2019, J GEN VIROL, V100, P911, DOI 10.1099/jgv.0.001252; LEGUENNO B, 1995, LANCET, V345, P1271, DOI 10.1016/S0140-6736(95)90925-7; Leligdowicz A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1325-2; Martines RB, 2015, J PATHOL, V235, P153, DOI 10.1002/path.4456; McElroy Anita, 2015, Clin Adv Hematol Oncol, V13, P29; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; Munoz-Fontela C, 2017, CURR TOP MICROBIOL, V411, P141, DOI 10.1007/82_2017_11; Munster VJ, 2018, NEW ENGL J MED, V379, P1198, DOI 10.1056/NEJMp1807691; Nakkazi E, 2018, LANCET, V392, P2338, DOI 10.1016/S0140-6736(18)33011-3; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Nicastri E, 2019, INFECT DIS CLIN N AM, V33, P953, DOI 10.1016/j.idc.2019.08.005; Olival KJ, 2014, VIRUSES-BASEL, V6, P1759, DOI 10.3390/v6041759; Pan YY, 2014, ARCH VIROL, V159, P1129, DOI 10.1007/s00705-012-1477-6; Poliquin PG, 2016, J INFECT DIS, V214, pS145, DOI 10.1093/infdis/jiw198; Prescott JB, 2017, NAT REV IMMUNOL, V17, P195, DOI 10.1038/nri.2016.138; Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996; Sahr F, 2017, J INFECTION, V74, P302, DOI 10.1016/j.jinf.2016.11.009; Saurabh S, 2017, AFR HEALTH SCI, V17, P225, DOI 10.4314/ahs.v17i1.28; Shi M, 2018, NATURE, V556, P197, DOI 10.1038/s41586-018-0012-7; Shorten RJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004948; Siegel D, 2017, J MED CHEM, V60, P1648, DOI 10.1021/acs.jmedchem.6b01594; SIEGERT R, 1967, DEUT MED WOCHENSCHR, V92, P2341, DOI 10.1055/s-0028-1106144; Sissoko D, 2017, CLIN INFECT DIS, V64, P513, DOI 10.1093/cid/ciw793; Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967; Sprecher A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.7, 10.1038/nmicrobiol.2016.7]; Terry M., 2019, BIOSPACE; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Uyeki TM, 2016, NEW ENGL J MED, V374, P636, DOI 10.1056/NEJMoa1504874; van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812; Vetter P, 2016, J INFECT DIS, V214, pS177, DOI 10.1093/infdis/jiw254; Vinck P, 2019, LANCET INFECT DIS, V19, P529, DOI 10.1016/S1473-3099(19)30063-5; WHO, 2019, WHO AD EB VACC STRAT; Wilkinson A, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0305; World Health Organization, 2019, PREL RES EFF RVSV ZE; World Health Organization, 2017, COND SAF DIGN BUR PA; World Health Organization, 2014, CAS DEF REC EB MARB; World Health Organization, 2014, INT INF PREV CONTR G; Yang XL, 2019, NAT MICROBIOL, V4, P390, DOI 10.1038/s41564-018-0328-y	76	64	66	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2020	382	19					1832	1842		10.1056/NEJMra1901594	http://dx.doi.org/10.1056/NEJMra1901594			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LO1TS	32441897				2022-12-28	WOS:000533411000014
J	Bekelman, JE; Emanuel, EJ; Navathe, AS				Bekelman, Justin E.; Emanuel, Ezekiel J.; Navathe, Amol S.			Outpatient Treatment at Home for Medicare Beneficiaries During and After the COVID-19 Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bekelman, Justin E.] Univ Penn, Perlman Sch Med, Penn Ctr Canc Care Innovat, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Bekelman, Justin E.; Emanuel, Ezekiel J.; Navathe, Amol S.] Univ Penn, Perlman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.; Navathe, Amol S.] Univ Penn, Perlman Sch Med, Healthcare Transformat Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Bekelman, JE (corresponding author), Univ Penn, Perelman Sch Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	bekelman@upenn.edu		Navathe, Amol/0000-0001-7182-4988				Centers for Medicare & Medicaid Services, 2020, HOSP CMS FLEX FIGHT; Hwang TJ, 2019, JAMA INTERN MED, V179, P374, DOI 10.1001/jamainternmed.2018.6417; Medicare Payment Advisory Commission, 2019, C MED PAYM POL; Ornstein KA, 2015, JAMA INTERN MED, V175, P1180, DOI 10.1001/jamainternmed.2015.1849	4	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2020	324	1					21	22		10.1001/jama.2020.9017	http://dx.doi.org/10.1001/jama.2020.9017			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM5FX	32492089	Bronze			2022-12-28	WOS:000568123600008
J	Meeske, AJ; Jia, N; Cassel, AK; Kozlova, A; Liao, JQ; Wiedmann, M; Patel, DJ; Marraffini, LA				Meeske, Alexander J.; Jia, Ning; Cassel, Alice K.; Kozlova, Albina; Liao, Jingqiu; Wiedmann, Martin; Patel, Dinshaw J.; Marraffini, Luciano A.			A phage-encoded anti-CRISPR enables complete evasion of type VI-A CRISPR-Cas immunity	SCIENCE			English	Article							CRYO-EM; RNA; REPEATS; SYSTEM	The CRISPR RNA (crRNA)-guided nuclease Cas13 recognizes complementary viral transcripts to trigger the degradation of both host and viral RNA during the type VI CRISPR-Cas antiviral response. However, how viruses can counteract this immunity is not known. We describe a listeriaphage (phi LS46) encoding an anti-CRISPR protein (AcrVIA1) that inactivates the type VI-A CRISPR system of Listeria seeligeri. Using genetics, biochemistry, and structural biology, we found that AcrVIA1 interacts with the guide-exposed face of Cas13a, preventing access to the target RNA and the conformational changes required for nuclease activation. Unlike inhibitors of DNA-cleaving Cas nucleases, which cause limited immunosuppression and require multiple infections to bypass CRISPR defenses, a single dose of AcrVIA1 delivered by an individual virion completely dismantles type VI-A CRISPR-mediated immunity.	[Meeske, Alexander J.; Cassel, Alice K.; Kozlova, Albina; Marraffini, Luciano A.] Rockefeller Univ, Lab Bacteriol, New York, NY 10065 USA; [Jia, Ning; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Liao, Jingqiu; Wiedmann, Martin] Cornell Univ, Dept Food Sci, Ithaca, NY 14583 USA; [Liao, Jingqiu; Wiedmann, Martin] Cornell Univ, Grad Field Microbiol, Ithaca, NY 14583 USA; [Marraffini, Luciano A.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Howard Hughes Medical Institute; Rockefeller University	Marraffini, LA (corresponding author), Rockefeller Univ, Lab Bacteriol, New York, NY 10065 USA.; Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.; Marraffini, LA (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	pateld@mskcc.org; marraffini@rockefeller.edu	Jia, Ning/ABE-3888-2020; Wiedmann, Martin/A-9683-2008; Liao, Jingqiu/AAW-2093-2021	Wiedmann, Martin/0000-0002-4168-5662; Liao, Jingqiu/0000-0002-2579-8157; Cassel, Alice/0000-0002-2077-7402; Jia, Ning/0000-0002-0672-454X; Meeske, Alexander/0000-0003-3878-531X; Kozlova, Albina/0000-0003-4249-0282	National Institutes of Health Director's Pioneer Award [1DPIGM128184-01]; Geoffrey Beene Cancer Research Center; Memorial Sloan-Kettering Cancer Center Core Grant [P30CAO08748]; NIH [GM129430]	National Institutes of Health Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geoffrey Beene Cancer Research Center; Memorial Sloan-Kettering Cancer Center Core Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a National Institutes of Health Director's Pioneer Award (1DPIGM128184-01 to LA.M.), funds from the Geoffrey Beene Cancer Research Center and NIH GM129430 to D.J.P., and by a Memorial Sloan-Kettering Cancer Center Core Grant (P30CAO08748). LA.M. is an investigator of the Howard Hughes Medical Institute. A.J.M. is a Helen Hay Whitney postdoctoral fellow.	Abudayyeh OO, 2017, NATURE, V550, P280, DOI 10.1038/nature24049; Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhoobalan-Chitty Y, 2019, CELL, V179, P448, DOI 10.1016/j.cell.2019.09.003; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Borges AL, 2018, CELL, V174, P917, DOI 10.1016/j.cell.2018.06.013; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cox DBT, 2017, SCIENCE, V358, P1019, DOI 10.1126/science.aaq0180; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujita M, 2000, GENES CELLS, V5, P79, DOI 10.1046/j.1365-2443.2000.00307.x; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jackson RN, 2017, CURR OPIN MICROBIOL, V37, P110, DOI 10.1016/j.mib.2017.05.010; Landsberger M, 2018, CELL, V174, P908, DOI 10.1016/j.cell.2018.05.058; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Lemaitre JP, 2015, APPL ENVIRON MICROB, V81, P2117, DOI 10.1128/AEM.03235-14; Lin P., 2020, CELL, VS1097-2765, P30225; Lin P., 2020, MOL CELL, VS1097-2765, P30225; Liu L, 2017, CELL, V170, P714, DOI 10.1016/j.cell.2017.06.050; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; Mahendra C, 2020, NAT MICROBIOL, V5, P872, DOI 10.1038/s41564-020-0726-9; Makarova KS, 2020, NAT REV MICROBIOL, V18, P67, DOI 10.1038/s41579-019-0299-x; Marino ND, 2018, SCIENCE, V362, P240, DOI 10.1126/science.aau5174; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Meeske AJ, 2019, NATURE, V570, P241, DOI 10.1038/s41586-019-1257-5; Meeske AJ, 2018, MOL CELL, V71, P791, DOI 10.1016/j.molcel.2018.07.013; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; ROCOURT J, 1987, PATHOL BIOL, V35, P1075; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Slaymaker IM, 2019, CELL REP, V26, P3741, DOI 10.1016/j.celrep.2019.02.094; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Watters KE, 2018, SCIENCE, V362, P236, DOI 10.1126/science.aau5138; Zhang B, 2018, CELL RES, V28, P1198, DOI 10.1038/s41422-018-0109-4; Zhang C, 2018, CELL, V175, P212, DOI 10.1016/j.cell.2018.09.001; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	45	38	39	3	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					54	+		10.1126/science.abb6151	http://dx.doi.org/10.1126/science.abb6151			52	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MK4IZ	32467331	Green Accepted			2022-12-28	WOS:000548751700044
J	Klemm, F; Maas, RR; Bowman, RL; Kornete, M; Soukup, K; Nassiri, S; Brouland, JP; Iacobuzio-Donahue, CA; Brennan, C; Tabar, V; Gutin, PH; Daniel, RT; Hegi, ME; Joyce, JA				Klemm, Florian; Maas, Roeltje R.; Bowman, Robert L.; Kornete, Mara; Soukup, Klara; Nassiri, Sina; Brouland, Jean-Philippe; Iacobuzio-Donahue, Christine A.; Brennan, Cameron; Tabar, Viviane; Gutin, Philip H.; Daniel, Roy T.; Hegi, Monika E.; Joyce, Johanna A.			Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells	CELL			English	Article							MACROPHAGE POLARIZATION; CANCER PROGRESSION; INHIBITION; RESISTANCE; DATABASE	Brain malignancies encompass a range of primary and metastatic cancers, including low-grade and high-grade gliomas and brain metastases (BrMs) originating from diverse extracranial tumors. Our understanding of the brain tumor microenvironment (TME) remains limited, and it is unknown whether it is sculpted differentially by primary versus metastatic disease, We therefore comprehensively analyzed the brain TME landscape via flow cytometry, RNA sequencing, protein arrays, culture assays, and spatial tissue characterization. This revealed disease-specific enrichment of immune cells with pronounced differences in proportional abundance of tissue-resident microglia, infiltrating monocyte-derived macrophages, neutrophils, and T cells, These integrated analyses also uncovered multifaceted immune cell activation within brain malignancies entailing converging transcriptional trajectories while maintaining disease- and cell-typespecific programs. Given the interest in developing TME-targeted therapies for brain malignancies, this comprehensive resource of the immune landscape offers insights into possible strategies to overcome tumor-supporting TME properties and instead harness the TME to fight cancer.	[Klemm, Florian; Maas, Roeltje R.; Kornete, Mara; Soukup, Klara; Nassiri, Sina; Joyce, Johanna A.] Univ Lausanne, Dept Oncol, Lausanne, Switzerland; [Klemm, Florian; Maas, Roeltje R.; Kornete, Mara; Soukup, Klara; Nassiri, Sina; Joyce, Johanna A.] Univ Lausanne, Ludwig Inst Canc Res, Lausanne, Switzerland; [Maas, Roeltje R.; Hegi, Monika E.] CHU Vaudois, Neurosci Res Ctr, Lausanne, Switzerland; [Maas, Roeltje R.; Daniel, Roy T.; Hegi, Monika E.] CHU Vaudois, Dept Neurosurg, Lausanne, Switzerland; [Bowman, Robert L.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Nassiri, Sina] SIB Swiss Inst Bioinformat, Bioinformat Core Facil, Lausanne, Switzerland; [Brouland, Jean-Philippe] CHU Vaudois, Dept Pathol, Lausanne, Switzerland; [Iacobuzio-Donahue, Christine A.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY USA; [Brennan, Cameron; Tabar, Viviane; Gutin, Philip H.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, 1275 York Ave, New York, NY 10021 USA	University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Memorial Sloan Kettering Cancer Center; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Joyce, JA (corresponding author), Univ Lausanne, Dept Oncol, Lausanne, Switzerland.; Joyce, JA (corresponding author), Univ Lausanne, Ludwig Inst Canc Res, Lausanne, Switzerland.	johanna.joyce@unil.ch	Bowman, Robert/ABF-1007-2021; Iacobuzio-Donahue, Christine/ABF-1295-2020; Hegi, Monika/O-4796-2015	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Hegi, Monika/0000-0003-0855-6495; Klemm, Florian/0000-0002-8944-9175; Bowman, Robert/0000-0002-8294-8748; Soukup, Klara/0000-0003-2764-4845; Maas, Roeltje/0000-0002-1040-6560	Swiss Cancer League, a Swiss Bridge award; Ludwig Institute for Cancer Research; University of Lausanne; Breast Cancer Research Foundation; Cancer Research UK; German Research Foundation (DFG) [KL2491/1-1]; Fondation Medic; Austrian Science Fund (FWF) [J4343-B28]	Swiss Cancer League, a Swiss Bridge award; Ludwig Institute for Cancer Research; University of Lausanne; Breast Cancer Research Foundation; Cancer Research UK(Cancer Research UK); German Research Foundation (DFG)(German Research Foundation (DFG)); Fondation Medic; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank Prof. Ron Stoop, Dr. Nathalie Piazzon, and the Neurosurgery/Neurooncology clinical and nursing teams at CHUV and MSKCC for excellent infrastructural support; the Joyce lab members for insightful discussions; the Hegi lab members for technical help during sample processing; and Vladimir Wischnewski for critical manuscript review. We thank the UNIL and MSKCC Flow Cytometry Core Facilities for exceptional technical assistance, especially Romain Bedel. Finally, we convey our immense gratitude to all patients who volunteered to participate in this study. Research in the Joyce lab is supported by the Swiss Cancer League, a Swiss Bridge award, the Ludwig Institute for Cancer Research, the University of Lausanne, the Breast Cancer Research Foundation, and Cancer Research UK. F.K. was supported in part by the German Research Foundation (DFG, KL2491/1-1) and Fondation Medic and K.S. by the Austrian Science Fund (FWF, J4343-B28). The results shown here are in part based on data generated by the TCGA Research Network (https://www.cancer.gov/tcga).	Afik R, 2016, J EXP MED, V213, P2315, DOI 10.1084/jem.20151193; Aldape K, 2019, NAT REV CLIN ONCOL, V16, P509, DOI 10.1038/s41571-019-0177-5; Baddeley A, 2016, CHAP HALL CRC INTERD, P1; Barletta KE, 2012, ARTERIOSCL THROM VAS, V32, P856, DOI 10.1161/ATVBAHA.111.226845; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Bouralexis S, 2005, APOPTOSIS, V10, P35, DOI 10.1007/s10495-005-6060-0; Bournazos S, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0045-2016; Bowman RL, 2016, CELL REP, V17, P2445, DOI 10.1016/j.celrep.2016.10.052; Cagney DN, 2017, NEURO-ONCOLOGY, V19, P1511, DOI 10.1093/neuonc/nox077; Carrero RMS, 2019, P NATL ACAD SCI USA, V116, P599, DOI 10.1073/pnas.1814642116; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chen HM, 2018, J CLIN INVEST, V128, P5647, DOI 10.1172/JCI97570; Chen ZH, 2017, CANCER RES, V77, P2266, DOI 10.1158/0008-5472.CAN-16-2310; Chongsathidkiet P, 2018, NAT MED, V24, P1459, DOI 10.1038/s41591-018-0135-2; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Cui Z, 2019, MATRIX BIOL, V78-79, P255, DOI 10.1016/j.matbio.2018.08.002; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Filkova M, 2009, CLIN IMMUNOL, V133, P157, DOI 10.1016/j.clim.2009.07.013; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gabrusiewicz K, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85841; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Georgoudaki AM, 2016, CELL REP, V15, P2000, DOI 10.1016/j.celrep.2016.04.084; Glodde N, 2017, IMMUNITY, V47, P789, DOI 10.1016/j.immuni.2017.09.012; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; Gutmann DH, 2019, NEURON, V104, P442, DOI 10.1016/j.neuron.2019.08.028; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hendriks LEL, 2019, J THORAC ONCOL, V14, P1244, DOI 10.1016/j.jtho.2019.02.009; Huang QQ, 2008, J BIOL CHEM, V283, P25887, DOI 10.1074/jbc.M801163200; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Isobe M, 2018, J BIOL CHEM, V293, P3793, DOI 10.1074/jbc.RA117.000696; Jackson CM, 2019, NAT IMMUNOL, V20, P1100, DOI 10.1038/s41590-019-0433-y; Kai F, 2019, DEV CELL, V49, P332, DOI 10.1016/j.devcel.2019.03.026; Klemm F, 2015, TRENDS CELL BIOL, V25, P198, DOI 10.1016/j.tcb.2014.11.006; Kobayashi M, 2019, CLIN CANCER RES, V25, P828, DOI 10.1158/1078-0432.CCR-18-0330; Kowal J, 2019, IMMUNOTHERAPY-UK, V11, P677, DOI 10.2217/imt-2018-0156; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lecuyer MA, 2017, P NATL ACAD SCI USA, V114, pE524, DOI 10.1073/pnas.1614336114; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110064; Li YM, 2018, EXP CELL RES, V368, P167, DOI 10.1016/j.yexcr.2018.04.023; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lim M, 2018, NAT REV CLIN ONCOL, V15, P422, DOI 10.1038/s41571-018-0003-5; Liu QK, 2019, NAT IMMUNOL, V20, P1023, DOI 10.1038/s41590-019-0421-2; Loffler-Wirth H, 2015, BIOINFORMATICS, V31, P3225, DOI 10.1093/bioinformatics/btv342; Long GV, 2018, LANCET ONCOL, V19, P672, DOI 10.1016/S1470-2045(18)30139-6; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Meng XQ, 2019, EBIOMEDICINE, V41, P185, DOI 10.1016/j.ebiom.2019.01.067; Mohan V, 2020, SEMIN CANCER BIOL, V62, P192, DOI 10.1016/j.semcancer.2019.09.004; Morianos I, 2019, J AUTOIMMUN, V104, DOI 10.1016/j.jaut.2019.102314; Muller S, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1362-4; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Mushtaq MU, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0376-0; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Olson OC, 2015, NAT REV CANCER, V15, P712, DOI 10.1038/nrc4027; Ortolan E, 2019, IMMUNOL LETT, V205, P59, DOI 10.1016/j.imlet.2018.06.007; Van P, 2018, BIOINFORMATICS, V34, P3951, DOI 10.1093/bioinformatics/bty441; Puchalski RB, 2018, SCIENCE, V360, P660, DOI 10.1126/science.aaf2666; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qiao S, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-018-1389-9; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Quail DF, 2016, SCIENCE, V352, DOI 10.1126/science.aad3018; R Development Core Team, 2009, R LANG ENV STAT COMP; Racle J, 2017, ELIFE, V6, DOI 10.7554/eLife.26476; Rau A, 2013, BIOINFORMATICS, V29, P2146, DOI 10.1093/bioinformatics/btt350; Richards J, 2015, J MOL CELL CARDIOL, V79, P21, DOI 10.1016/j.yjmcc.2014.11.002; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Robinson JT, 2017, CANCER RES, V77, pE31, DOI 10.1158/0008-5472.CAN-17-0337; Rodon L, 2014, CANCER DISCOV, V4, P1230, DOI 10.1158/2159-8290.CD-14-0275; Sankowski R, 2019, NAT NEUROSCI, V22, P2098, DOI 10.1038/s41593-019-0532-y; Schalper KA, 2019, NAT MED, V25, P470, DOI 10.1038/s41591-018-0339-5; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Szulzewsky F, 2016, GLIA, V64, P1416, DOI 10.1002/glia.23014; Tawbi HA, 2018, NEW ENGL J MED, V379, P722, DOI 10.1056/NEJMoa1805453; Thapa B, 2019, BMB REP, V52, P360, DOI 10.5483/BMBRep.2019.52.6.140; Tsukamoto H, 2018, CANCER RES, V78, P5011, DOI 10.1158/0008-5472.CAN-18-0118; van der Touw W, 2017, CANCER IMMUNOL IMMUN, V66, P1079, DOI 10.1007/s00262-017-2023-x; Vareslija D, 2019, JNCI-J NATL CANCER I, V111, P388, DOI 10.1093/jnci/djy110; Venteicher AS, 2017, SCIENCE, V355, DOI 10.1126/science.aai8478; Vivian J, 2017, NAT BIOTECHNOL, V35, P314, DOI 10.1038/nbt.3772; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Xu PF, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1777-9; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yan D, 2017, ONCOGENE, V36, P6049, DOI 10.1038/onc.2017.261; Yang TH, 2018, J IMMUNOL, V201, P1389, DOI 10.4049/jimmunol.1800324; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zaiss DMW, 2015, IMMUNITY, V42, P216, DOI 10.1016/j.immuni.2015.01.020; Zhai LJ, 2018, CELL MOL IMMUNOL, V15, P447, DOI 10.1038/cmi.2017.143; Zhao JJE, 2017, IMMUNITY, V46, P165, DOI 10.1016/j.immuni.2017.02.003; Zhao YF, 2019, WORLD ENVIRONMENTAL AND WATER RESOURCES CONGRESS 2019: HYDRAULICS, WATERWAYS, AND WATER DISTRIBUTION SYSTEMS ANALYSIS, P1	95	277	281	20	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2020	181	7					1643	+		10.1016/j.cell.2020.05.007	http://dx.doi.org/10.1016/j.cell.2020.05.007			35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MD2SA	32470396	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000543822100019
J	Galea, S				Galea, Sandro			The art of medicine Compassion in a time of COVID-19	LANCET			English	Editorial Material									[Galea, Sandro] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA	Boston University	Galea, S (corresponding author), Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA.	sgalea@bu.edu	Galea, Sandro/GLR-6066-2022						0	21	21	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2020	395	10241					1897	1898		10.1016/S0140-6736(20)31202-2	http://dx.doi.org/10.1016/S0140-6736(20)31202-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2MV	32450108	Green Published, Bronze			2022-12-28	WOS:000552732200015
J	Shore, ND; Saad, F; Cookson, MS; George, DJ; Saltzstein, DR; Tutrone, R; Akaza, H; Bossi, A; van Veenhuyzen, DF; Selby, B; Fan, XL; Kang, V; Walling, J; Tombal, B				Shore, Neal D.; Saad, Fred; Cookson, Michael S.; George, Daniel J.; Saltzstein, Daniel R.; Tutrone, Ronald; Akaza, Hideyuki; Bossi, Alberto; van Veenhuyzen, David F.; Selby, Bryan; Fan, Xiaolin; Kang, Vicky; Walling, Jackie; Tombal, Bertrand		HERO Study Investigators	Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GONADOTROPIN-RELEASING-HORMONE; GNRH ANTAGONIST; ABIRATERONE ACETATE; TAK-385 RELUGOLIX; CLINICAL-TRIALS; RISK; RECOMMENDATIONS; ASSOCIATION; SUPPRESSION; GUIDELINES	BACKGROUND Injectable luteinizing hormone-releasing hormone agonists (e.g., leuprolide) are the standard agents for achieving androgen deprivation for prostate cancer despite the initial testosterone surge and delay in therapeutic effect. The efficacy and safety of relugolix, an oral gonadotropin-releasing hormone antagonist, as compared with those of leuprolide are not known. METHODS In this phase 3 trial, we randomly assigned patients with advanced prostate cancer, in a 2:1 ratio, to receive relugolix (120 mg orally once daily) or leuprolide (injections every 3 months) for 48 weeks. The primary end point was sustained testosterone suppression to castrate levels (<50 ng per deciliter) through 48 weeks. Secondary end points included noninferiority with respect to the primary end point, castrate levels of testosterone on day 4, and profound castrate levels (<20 ng per deciliter) on day 15. Testosterone recovery was evaluated in a subgroup of patients. RESULTS A total of 622 patients received relugolix and 308 received leuprolide. Of men who received relugolix, 96.7% (95% confidence interval [CI], 94.9 to 97.9) maintained castration through 48 weeks, as compared with 88.8% (95% CI, 84.6 to 91.8) of men receiving leuprolide. The difference of 7.9 percentage points (95% CI, 4.1 to 11.8) showed noninferiority and superiority of relugolix (P<0.001 for superiority). All other key secondary end points showed superiority of relugolix over leuprolide (P<0.001). The percentage of patients with castrate levels of testosterone on day 4 was 56.0% with relugolix and 0% with leuprolide. In the subgroup of 184 patients followed for testosterone recovery, the mean testosterone levels 90 days after treatment discontinuation were 288.4 ng per deciliter in the relugolix group and 58.6 ng per deciliter in the leuprolide group. Among all the patients, the incidence of major adverse cardiovascular events was 2.9% in the relugolix group and 6.2% in the leuprolide group (hazard ratio, 0.46; 95% CI, 0.24 to 0.88). CONCLUSIONS In this trial involving men with advanced prostate cancer, relugolix achieved rapid, sustained suppression of testosterone levels that was superior to that with leuprolide, with a 54% lower risk of major adverse cardiovascular events.	[Shore, Neal D.] Carolina Urol Res Ctr, 823 82nd Pkwy,Suite B, Myrtle Beach, SC 29572 USA; [Saad, Fred] Univ Montreal, Ctr Hosp, Montreal, PQ, Canada; [Cookson, Michael S.] Univ Oklahoma, Hlth Sci Ctr, Dept Urol, Oklahoma City, OK USA; [George, Daniel J.] Duke Univ, Duke Canc Inst, Ctr Prostate & Urol Canc, Durham, NC USA; [Saltzstein, Daniel R.] Urol San Antonio, San Antonio, TX USA; [Tutrone, Ronald] Chesapeake Urol, Towson, MD USA; [Akaza, Hideyuki] Univ Tokyo, Dept Strateg Invest Comprehens Canc Network, Interfac Initiat Informat Studies, Grad Sch Interdisciplinary Informat Studies, Tokyo, Japan; [Bossi, Alberto] Gustave Roussy Canc Inst, Dept Radiat Oncol, Villejuif, France; [van Veenhuyzen, David F.; Selby, Bryan; Fan, Xiaolin; Kang, Vicky; Walling, Jackie] Myovant Sci, Brisbane, CA USA; [Tombal, Bertrand] Clin Univ St Luc, Serv Urol, Brussels, Belgium	Carolina Urologic Research Center; Universite de Montreal; University of Oklahoma System; University of Oklahoma Health Sciences Center; Duke University; University of Tokyo; UNICANCER; Gustave Roussy; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Shore, ND (corresponding author), Carolina Urol Res Ctr, 823 82nd Pkwy,Suite B, Myrtle Beach, SC 29572 USA.	nshore@gsuro.com	Sundar, Santhanam/AAF-3011-2021	Sundar, Santhanam/0000-0003-0850-5161; Collette, Laurence/0000-0003-2518-7281; Lacombe, Louis/0000-0003-4811-0308; Calabro', Fabio/0000-0002-7863-3540	Myovant Sciences	Myovant Sciences	Funded by Myovant Sciences; HERO ClinicalTrials.gov number, NCT03085095.	Albertsen PC, 2014, EUR UROL, V65, P565, DOI 10.1016/j.eururo.2013.10.032; Behl AS, 2017, AM HEALTH DRUG BENEF, V10, P296; Ben-Josef E, 1999, J UROLOGY, V161, P970, DOI 10.1016/S0022-5347(01)61831-7; Bubley GJ, 1999, J CLIN ONCOL, V17, P3461, DOI 10.1200/JCO.1999.17.11.3461; CONN PM, 1994, ANNU REV MED, V45, P391, DOI 10.1146/annurev.med.45.1.391; Cornford P, 2017, EUR UROL, V71, P630, DOI 10.1016/j.eururo.2016.08.002; Crawford ED, 2018, SCAND J UROL, V52, P349, DOI 10.1080/21681805.2018.1522372; Crawford ED, 2009, ONCOLOGY-NY, V23, P626; Crook JM, 2012, NEW ENGL J MED, V367, P895, DOI 10.1056/NEJMoa1201546; DAVIS MK, 2015, J ONCOL, V2015, DOI DOI 10.1155/2015/820403; Dearnaley DP, EUR UROL; Food and Drug Administration, NON CLIN TRIALS EST; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Hopmans SN, 2014, UROL ONCOL-SEMIN ORI, V32, P1126, DOI 10.1016/j.urolonc.2014.06.018; Keating NL, 2010, J NATL CANCER I, V102, P39, DOI 10.1093/jnci/djp404; Klotz L, 2008, BJU INT, V102, P1531, DOI 10.1111/j.1464-410X.2008.08183.x; Knutsson A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26220; Krakowsky Y, 2019, EUR UROL FOCUS, V5, P81, DOI 10.1016/j.euf.2017.06.008; Lafeuille MH, 2014, J MANAG CARE SPEC PH, V20, P477, DOI 10.18553/jmcp.2014.20.5.477; Leong DP, 2020, J UROL; MacLean DB, 2015, J CLIN ENDOCR METAB, V100, P4579, DOI 10.1210/jc.2015-2770; Margel D, 2019, J UROLOGY, V202, P1199, DOI 10.1097/JU.0000000000000384; McLeod DG, 2003, UROLOGY, V61, P3, DOI 10.1016/S0090-4295(02)02393-2; Miwa K, 2011, J MED CHEM, V54, P4998, DOI 10.1021/jm200216q; Nakata D, 2014, EUR J PHARMACOL, V723, P167, DOI 10.1016/j.ejphar.2013.12.001; National Comprehensive Cancer Network, 2019, CLIN PRACT GUID ONC; Oh WK, 2010, UROLOGY, V75, P642, DOI 10.1016/j.urology.2009.08.008; Ritch Chad, 2018, F1000Res, V7, DOI 10.12688/f1000research.15382.1; Saad F, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.5034; SCHALLY AV, 1971, SCIENCE, V173, P1036, DOI 10.1126/science.173.4001.1036; Scher HI, 2016, J CLIN ONCOL, V34, P1402, DOI 10.1200/JCO.2015.64.2702; Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238; Siddiqui ZA, 2018, TRANSL ANDROL UROL, V7, P378, DOI 10.21037/tau.2018.01.06; Skinner DC, 2009, J NEUROENDOCRINOL, V21, P282, DOI 10.1111/j.1365-2826.2009.01842.x; Stattin P, 2017, EUR UROL, V72, P125, DOI [10.1016/j.eururo.2016.07.023, 10.1016/j.eururo.2017.06.036]; Sturgeon KM, 2019, EUR HEART J, V40, P3889, DOI 10.1093/eurheartj/ehz766; Suzuki H, 2019, CANCER MED-US, V8, P5891, DOI 10.1002/cam4.2442; Van Poppel H, 2012, INT J UROL, V19, P594, DOI 10.1111/j.1442-2042.2012.02997.x; Vis AN, 2015, UROL ONCOL-SEMIN ORI, V33, P7, DOI 10.1016/j.urolonc.2014.04.016; Zietman AL, 1997, INT J RADIAT ONCOL, V38, P1067, DOI 10.1016/S0360-3016(97)00309-X	40	149	150	5	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2020	382	23					2187	2196		10.1056/NEJMoa2004325	http://dx.doi.org/10.1056/NEJMoa2004325			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV0NI	32469183	Bronze, Green Published			2022-12-28	WOS:000538140600012
J	Zhang, ZW; Will, CL; Bertram, K; Dybkov, O; Hartmuth, K; Agafonov, DE; Hofele, R; Urlaub, H; Kastner, B; Luhrmann, R; Stark, H				Zhang, Zhenwei; Will, Cindy L.; Bertram, Karl; Dybkov, Olexandr; Hartmuth, Klaus; Agafonov, Dmitry E.; Hofele, Romina; Urlaub, Henning; Kastner, Berthold; Luehrmann, Reinhard; Stark, Holger			Molecular architecture of the human 17S U2 snRNP	NATURE			English	Article							SMALL NUCLEAR RIBONUCLEOPROTEIN; CRYO-EM STRUCTURE; INTERACTION NETWORK; HUMAN SPLICEOSOME; ATPASE PRP5; RNA; PROTEINS; RECOGNITION; ASSOCIATION; SELECTION	The U2 small nuclear ribonucleoprotein (snRNP) has an essential role in the selection of the precursor mRNA branch-site adenosine, the nucleophile for the first step of splicing'. Stable addition of U2 during early spliceosome formation requiresthe DEAD-box ATPase PRP5(2-7). Yeast U2 small nuclear RNA (snRNA) nucleotides that form base pairs with the branch site are initially sequestered in a branchpoint-interacting stem-loop (BSL)(8), but whether the human U2 snRNA folds in a similar manner is unknown. The U2 SF3B1 protein, a common mutational target in haematopoietic cancers(9), contains a HEAT domain (SF3B1(HEAT)) with an open conformation in isolated SF3b(10), but a closed conformation in spliceosomes(11), which is required for stable interaction between U2 and the branch site. Here we report a 3D cryo-electron microscopy structure ofthe human 17S U2 snRNP at a core resolution of 4.1 angstrom and combine it with protein crosslinking data to determine the molecular architecture of this snRNP. Our structure reveals that SF3B1(HEAT) interacts with PRP5 and TAT-SF1, and maintains its open conformation in U2 snRNP, and that U2 snRNA forms a BSL that is sandwiched between PRP5, TAT-SF1 and SF3B1(HEAT). Thus, substantial remodelling of the BSL and displacement of BSL-interacting proteins must occur to allow formation of the U2-branch-site helix. Our studies provide a structural explanation of why TAT-SF1 must be displaced before the stable addition of U2 to the spliceosome, and identify RNP rearrangements facilitated by PRP5 that are required for stable interaction between U2 and the branch site.	[Zhang, Zhenwei; Bertram, Karl; Stark, Holger] MPI Biophys Chem, Dept Struct Dynam, Gottingen, Germany; [Will, Cindy L.; Dybkov, Olexandr; Hartmuth, Klaus; Agafonov, Dmitry E.; Kastner, Berthold; Luehrmann, Reinhard] MPI Biophys Chem, Cellular Biochem, Gottingen, Germany; [Hofele, Romina; Urlaub, Henning] MPI Biophys Chem, Bioanalyt Mass Spectrometry, Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Inst Clin Chem, Bioanalyt Grp, Gottingen, Germany; [Hofele, Romina] AstraZeneca, Gaithersburg, MD USA	Max Planck Society; Max Planck Society; Max Planck Society; University of Gottingen; AstraZeneca	Stark, H (corresponding author), MPI Biophys Chem, Dept Struct Dynam, Gottingen, Germany.; Luhrmann, R (corresponding author), MPI Biophys Chem, Cellular Biochem, Gottingen, Germany.	reinhard.luehrmann@mpi-bpc.mpg.de; hstark1@gwdg.de			Max Planck Society; Deutsche Forschungsgemeinschaft [SFB 860]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank T. Conrad for the production of HeLa cells in a bioreactor, H. Kohansal for preparing HeLa cell nuclear extract, and G. Heyne, U. Steuerwald, W. Lendeckel, M. Raabe and U. Plessmann for technical assistance. This work was supported by the Max Planck Society and the Deutsche Forschungsgemeinschaft (SFB 860 grants to H.U., R.L. and H.S.).	Abu Dayyeh BK, 2002, J BIOL CHEM, V277, P20221, DOI 10.1074/jbc.M109553200; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agafonov DE, 2016, SCIENCE, V351, P1416, DOI 10.1126/science.aad2085; Agafonov DE, 2011, MOL CELL BIOL, V31, P2667, DOI 10.1128/MCB.05266-11; Alsafadi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10615; Antczak M, 2019, BIOINFORMATICS, V35, P152, DOI 10.1093/bioinformatics/bty609; BEHRENS SE, 1993, MOL CELL BIOL, V13, P307, DOI 10.1128/MCB.13.1.307; Bertram K, 2017, CELL, V170, P701, DOI 10.1016/j.cell.2017.07.011; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Carrocci TJ, 2017, NUCLEIC ACIDS RES, V45, P4837, DOI 10.1093/nar/gkw1349; Charenton C, 2019, SCIENCE, V364, P362, DOI 10.1126/science.aax3289; Chen ZL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11337-z; Cretu C, 2018, MOL CELL, V70, P265, DOI 10.1016/j.molcel.2018.03.011; Cretu C, 2016, MOL CELL, V64, P307, DOI 10.1016/j.molcel.2016.08.036; Crisci A, 2015, NUCLEIC ACIDS RES, V43, P10456, DOI 10.1093/nar/gkv952; Darman RB, 2015, CELL REP, V13, P1033, DOI 10.1016/j.celrep.2015.09.053; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haselbach D, 2018, CELL, V172, P454, DOI 10.1016/j.cell.2018.01.010; Kastner B, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032417; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Korneta I, 2012, NUCLEIC ACIDS RES, V40, P7046, DOI 10.1093/nar/gks347; Kramer A, 1999, J CELL BIOL, V145, P1355, DOI 10.1083/jcb.145.7.1355; Liang WW, 2015, GENE DEV, V29, P81, DOI 10.1101/gad.253708.114; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Loerch S, 2019, J BIOL CHEM, V294, P2892, DOI 10.1074/jbc.RA118.006764; MACMILLAN AM, 1994, GENE DEV, V8, P3008, DOI 10.1101/gad.8.24.3008; ODay CL, 1996, J BIOL CHEM, V271, P33261, DOI 10.1074/jbc.271.52.33261; Pan C, 2010, RNA BIOL, V7, P667, DOI 10.4161/rna.7.6.13571; Papasaikas P, 2016, TRENDS BIOCHEM SCI, V41, P33, DOI 10.1016/j.tibs.2015.11.003; Perriman R, 2003, P NATL ACAD SCI USA, V100, P13857, DOI 10.1073/pnas.2036312100; Perriman R, 2010, MOL CELL, V38, P416, DOI 10.1016/j.molcel.2010.02.036; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaschka C, 2018, NATURE, V559, P420, DOI 10.1038/s41586-018-0323-8; Plaschka C, 2017, NATURE, V546, P617, DOI 10.1038/nature22799; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; RUBY SW, 1993, GENE DEV, V7, P1909, DOI 10.1101/gad.7.10.1909; Shao W, 2012, MOL CELL BIOL, V32, P470, DOI 10.1128/MCB.06234-11; Spadaccini R, 2006, RNA, V12, P410, DOI 10.1261/rna.2271406; Talkish J, 2019, RNA, V25, P1020, DOI 10.1261/rna.070649.119; Tang Q, 2016, GENE DEV, V30, P2710, DOI 10.1101/gad.291872.116; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Will CL, 2001, EMBO J, V20, P4536, DOI 10.1093/emboj/20.16.4536; Xu YZ, 2007, MOL CELL, V28, P838, DOI 10.1016/j.molcel.2007.09.022; Xu YZ, 2004, EMBO J, V23, P376, DOI 10.1038/sj.emboj.7600050; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Zhan XC, 2018, CELL RES, V28, P1129, DOI 10.1038/s41422-018-0094-7; Zhang J, 2019, MOL CELL, V76, P82, DOI 10.1016/j.molcel.2019.07.017; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang XF, 2018, CELL RES, V28, P307, DOI 10.1038/cr.2018.14; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	52	27	28	2	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 9	2020	583	7815					310	+		10.1038/s41586-020-2344-3	http://dx.doi.org/10.1038/s41586-020-2344-3		JUN 2020	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MH5KF	32494006				2022-12-28	WOS:000537932200004
J	Skourtanioti, E; Erdal, YS; Frangipane, M; Restelli, FB; Yener, KA; Pinnock, F; Matthiae, P; Ozbal, R; Schoop, UD; Guliyev, F; Akhundov, T; Lyonnet, B; Hammer, EL; Nugent, SE; Burri, M; Neumann, GU; Penske, S; Ingman, T; Akar, M; Shafiq, R; Palumbi, G; Eisenmann, S; D'Andrea, M; Rohrlach, AB; Warinner, C; Jeong, C; Stockhammer, PW; Haak, W; Krause, J				Skourtanioti, Eirini; Erdal, Yilmaz S.; Frangipane, Marcella; Restelli, Francesca Balossi; Yener, K. Aslihan; Pinnock, Frances; Matthiae, Paolo; Ozbal, Rana; Schoop, Ulf-Dietrich; Guliyev, Farhad; Akhundov, Tufan; Lyonnet, Bertille; Hammer, Emily L.; Nugent, Selin E.; Burri, Marta; Neumann, Gunnar U.; Penske, Sandra; Ingman, Tara; Akar, Murat; Shafiq, Rula; Palumbi, Giulio; Eisenmann, Stefanie; D'Andrea, Marta; Rohrlach, Adam B.; Warinner, Christina; Jeong, Choongwon; Stockhammer, Philipp W.; Haak, Wolfgang; Krause, Johannes			Genomic History of Neolithic to Bronze Age Anatolia, Northern Levant, and Southern Caucasus	CELL			English	Article							EARLY FARMERS; GENETIC HISTORY; ANCIENT DNA; ADMIXTURE; ARSLANTEPE; INSIGHTS; POPULATIONS; MIGRATION; SEQUENCE; PATTERNS	Here, we report genome-wide data analyses from 110 ancient Near Eastern individuals spanning the Late Neolithic to Late Bronze Age, a period characterized by intense interregional interactions for the Near East. We find that 6th millennium BCE populations of North/Central Anatolia and the Southern Caucasus shared mixed ancestry on a genetic cline that formed during the Neolithic between Western Anatolia and regions in today's Southern Caucasus/Zagros. During the Late Chalcolithic and/or the Early Bronze Age, more than half of the Northern Levantine gene pool was replaced, while in the rest of Anatolia and the Southern Caucasus, we document genetic continuity with only transient gene flow. Additionally, we reveal a genetically distinct individual within the Late Bronze Age Northern Levant. Overall, our study uncovers multiple scales of population dynamics through time, from extensive admixture during the Neolithic period to long-distance mobility within the globalized societies of the Late Bronze Age.	[Skourtanioti, Eirini; Burri, Marta; Neumann, Gunnar U.; Penske, Sandra; Eisenmann, Stefanie; Rohrlach, Adam B.; Warinner, Christina; Jeong, Choongwon; Stockhammer, Philipp W.; Haak, Wolfgang; Krause, Johannes] Max Planck Inst Sci Human Hist, Dept Archaeogenet, D-07745 Jena, Germany; [Erdal, Yilmaz S.] Hacettepe Univ, Dept Anthropol, TR-06800 Ankara, Turkey; [Frangipane, Marcella; Restelli, Francesca Balossi; Pinnock, Frances; Matthiae, Paolo; D'Andrea, Marta] Sapienza Univ Rome, Dept Class, I-00185 Rome, Italy; [Yener, K. Aslihan] NYU, Inst Study Ancient World ISAW, New York, NY 10028 USA; [Ozbal, Rana; Ingman, Tara] Koc Univ, Dept Archaeol & Hist Art, TR-34450 Istanbul, Turkey; [Schoop, Ulf-Dietrich] Univ Edinburgh, Sch Hist Class & Archaeol, Edinburgh EH8 9AG, Midlothian, Scotland; [Guliyev, Farhad; Akhundov, Tufan] Azerbaijan Natl Acad Sci, Inst Archaeol & Ethnog, AZ-1073 Baku, Azerbaijan; [Lyonnet, Bertille] French Natl Ctr Sci Res, UMR Lab, PROCLAC, UMR 7192, F-75005 Paris, France; [Hammer, Emily L.] Univ Penn, Near Eastern Languages & Civilizat, Philadelphia, PA 19104 USA; [Nugent, Selin E.] Univ Oxford, Sch Anthropol & Museum Ethnog, Oxford OX2 6PE, England; [Akar, Murat] Mustafa Kemal Univ, Dept Archaeol, TR-31060 Alahan Antakya, Hatay, Turkey; [Shafiq, Rula] Ibn Haldun Univ, Hist Dept, TR-34494 Istanbul, Turkey; [Palumbi, Giulio] Univ Nice Sophia Antipolis, CEPAM Cultures & Environm Prehist Antiquite Moyen, CNRS UMR 7264, F-06357 Nice, France; [Rohrlach, Adam B.] Univ Adelaide, ARC Ctr Excellence Math & Stat Frontiers, Adelaide, SA 5005, Australia; [Warinner, Christina] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; [Jeong, Choongwon] Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea; [Stockhammer, Philipp W.] Ludwig Maximilians Univ Munchen, Inst Pre & Protohist Archaeol & Archaeol Roman Pr, D-80539 Munich, Germany	Hacettepe University; Sapienza University Rome; New York University; Koc University; University of Edinburgh; Azerbaijan National Academy of Sciences (ANAS); Institute of Archaeology & Ethnography of the Azerbaijan National Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Pratique des Hautes Etudes (EPHE); University of Pennsylvania; University of Oxford; Mustafa Kemal University; Ibn Haldun University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Cote d'Azur; University of Adelaide; Harvard University; Seoul National University (SNU); University of Munich	Warinner, C; Jeong, C; Stockhammer, PW; Haak, W; Krause, J (corresponding author), Max Planck Inst Sci Human Hist, Dept Archaeogenet, D-07745 Jena, Germany.; Warinner, C (corresponding author), Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA.; Jeong, C (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea.; Stockhammer, PW (corresponding author), Ludwig Maximilians Univ Munchen, Inst Pre & Protohist Archaeol & Archaeol Roman Pr, D-80539 Munich, Germany.	warinner@fas.harvard.edu; cwjeong@snu.ac.kr; philipp.stockhammer@lmu.de; haak@shh.mpg.de; krause@shh.mpg.de	Krause, Johannes/AFP-2642-2022; Erdal, Yilmaz Selim/I-7614-2013; Ozbal, Rana/AAW-5613-2020; Nugent, Selin/AAC-5028-2022; Akar, Murat/C-4497-2019; Haak, Wolfgang/Z-4947-2019; Rohrlach, Adam B/H-8415-2017	Krause, Johannes/0000-0001-9144-3920; Erdal, Yilmaz Selim/0000-0001-8143-8159; Nugent, Selin/0000-0001-9346-7926; Akar, Murat/0000-0001-5485-8465; Haak, Wolfgang/0000-0003-2475-2007; Rohrlach, Adam B/0000-0002-4204-5018; Guliyev, Farhad/0000-0003-1994-4776; Warinner, Christina/0000-0002-4528-5877; Ozbal, Rana/0000-0001-6765-2765; Neumann, Gunnar U./0000-0003-3825-8536; Jeong, Choongwon/0000-0003-3049-2352; Hammer, Emily/0000-0002-7774-1988; Ingman, Tara/0000-0002-0338-0489; Skourtanioti, Eirini/0000-0003-2975-3869	French-German National Agency for Research (ANR); Centre national de la recherche scientifique (CNRS); French Ministry of Foreign Affairs; Max Planck Society; Max Planck-Harvard Research Center for the Archaeoscience of the Ancient Mediterranean	French-German National Agency for Research (ANR)(French National Research Agency (ANR)); Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Foreign Affairs; Max Planck Society(Max Planck SocietyFoundation CELLEX); Max Planck-Harvard Research Center for the Archaeoscience of the Ancient Mediterranean	We thank G. Brandt, A. Wissgott, C. Freund, and R. Bianco (MPI-SHH) for support in laboratory work. We thank A. Motsch for support in organization and sample management. We thank Michal Feldman, Stephen Clayton, Kay Prufer, and the members of the population genetics group and the Max Planck-Harvard Research center for the Archaeoscience of the ancient Mediterranean (MHAAM) group in the Department of Archaeogenetics, MPI-SHH for their input and support. We thank Michelle O'Reilly and Hans Sell for graphics and video production support and Jason Ur for consultation on the manuscript. We thank the French-German National Agency for Research (ANR), the Centre national de la recherche scientifique (CNRS), and the French Ministry of Foreign Affairs for funding the excavation of Mentesh Tepe. We thank Jurgen Seeher and Andreas Schachner (Bogazkoy Expedition of the German Archaeological Institute) for the permission to use samples from the site and for their support of this study. We thank Dr. Silvia Mogliazza for the analysis of the human skeletal remains from Tell Mardikh (Ebla). This study was funded by the Max Planck Society and the Max Planck-Harvard Research Center for the Archaeoscience of the Ancient Mediterranean.	Akar M., 2017, QUESTIONS APPROACHES; Akar M., 2013, BORDER LATE BRONZE I, V1; Akar M., 2019, TELL ATCHANA ALALAKH; Akar M, 2020, ANATOL STUD, V70, P77, DOI 10.1017/S0066154619000139; Akhundov T., 2007, CULTURES CAUCASE 6 3; Akhundov T.I., 2018, CONTEXT CONNECTION S; [Ахундов Туфан Исаак оглу Akhundov Tufan], 2011, [Археология и культурная антропология, Stratum plus: Archaeology and Cultural Anthropology, Arkheologiya i kul'turnaya antropologiya], P219; Akkermans P. M. M. G., 2003, ARCHAEOLOGY SYRIA CO; Algaze, 1996, ANATOLICA, V22, P129; Algaze G., 2005, URUK WORLD SYSTEM DY; Algaze G., 1995, ANATOLICA, V21, P13; Algaze G., 1997, ANATOLICA, V23, P61; Algaze G., 2001, ANATOLICA, V27, P23; Alkim U.B., 1988, 1 2 SEASONS EXCAVATI; Allen M, 2004, AM ANTIQUITY, V69, P152, DOI 10.2307/4128356; [Anonymous], 2014, PALEORIENT, V40, P115; [Anonymous], 2004, ANATOLICA, DOI DOI 10.2143/ANA.30.0.2015518; [Anonymous], 2011, ARCHAEOL ANZ; Badalyan RS, 2010, TUBA-AR-TURK ACAD SC, V13, P185; Baffi Guardata F., 2000, P 1 INT C ARCH ANC N; Baffi Guardata F., 1986, WIRTSCHAFT GESELLSCH, P4; Balossi Restelli F., 2012, LATE CHALCOLITHIC 3, V27, P235; Barnes E., 2012, ATLAS DEV FIELD ANOM, DOI DOI 10.1002/9781118430699; Baudouin E., 2019, PALEORIENT, V45, P115; Bilgi O., 2004, ANADOLU ARASTIRMALAR, VXVII, P25; Bonatz D., 2013, BORDER LATE BRONZE I; Brami MN, 2015, ARCHAEOL ANTHROP SCI, V7, P319, DOI 10.1007/s12520-014-0193-4; Breniquet C., 1996, ORIGINES CULTURE DOB; Brothwell D.R., 1981, DIGGING BONES EXCAVA; Broushaki F, 2016, SCIENCE, V353, P499, DOI 10.1126/science.aaf7943; Bryce T., 2005, KINGDOM HITTITES; Bulu M., 2017, OVERTURNING CERTAINT; Bulu M., 2016, P 9 INT C ARCH ANC N; Byers S., 2011, INTRO FORENSIC ANTHR, Vfourth; Calcagnile L., 2013, EBLA ITS LANDSCAPE E; Carter R.A., 2010, TRANSFORMATION INTEG; Chataigner C., 2014, NEOLITHIC CAUCASUS; Conti A.M., 1993, RIVERS MOUNTAINS; Courcier A, 2017, ANCIENT METALLURGY A, P25; D'Andrea M., 2014, ANN ARCHEOLOGIQUES A; Daley T, 2013, NAT METHODS, V10, P325, DOI 10.1038/nmeth.2375; Daly KG, 2018, SCIENCE, V361, P85, DOI 10.1126/science.aas9411; DAndrea M., 2019, PEARLS STUDIES NEAR; DAndrea M., 2018, LEVANT, P1; During BS, 2013, J WORLD PREHIST, V26, P75, DOI 10.1007/s10963-013-9065-6; Eisenmann S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31123-z; Erdal OD, 2012, INT J OSTEOARCHAEOL, V22, P1, DOI 10.1002/oa.1177; Erdal YS, 2012, ORIGINI, V34, P301; FABIO RA, 2013, EBLA ITS LANDSCAPE E, V4, DOI DOI 10.3389/FPSYG.2013.00911; Feldman M.H., 2006, DIPLOMACY DESIGN; Feldman M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09209-7; Frangipane M., 2015, INT S E AN S CAUC CU; Frangipane M., 2001, PALEORIENT, V27, P105, DOI DOI 10.3406/PALE0.2001.4733; FRANGIPANE M, 2014, PALEORIENT, V40, P169, DOI DOI 10.3406/PALEO.2014.5641; Frangipane M, 2018, J ARCHAEOL RES, V26, P3, DOI 10.1007/s10814-017-9106-2; Frangipane M, 2015, P NATL ACAD SCI USA, V112, P9182, DOI 10.1073/pnas.1419883112; Frangipane M, 2012, ORIGINI, V34, P19; Frangipane M, 2012, ORIGINI, V34, P237; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Gonzalez Fortes G, 2017, CURR BIOL, V27, P1801, DOI 10.1016/j.cub.2017.05.023; Greenberg R., 2015, CAMBRIDGE PREHISTORY; Greenberg R., 2014, PALEORIENT, V40, P183, DOI [DOI 10.3406/PALE0.2014.5642, DOI 10.3406/PALEO.2014.5642]; Gunther T, 2015, P NATL ACAD SCI USA, V112, P11917, DOI 10.1073/pnas.1509851112; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Haas J., 1994, STAND DAT COLL HUM S; Haber M, 2017, AM J HUM GENET, V101, P274, DOI 10.1016/j.ajhg.2017.06.013; Harney E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05649-9; Heinz M., 1992, TELL ATCHANA ALALAKH; Hillson S, 2014, TOOTH DEVELOPMENT IN HUMAN EVOLUTION AND BIOARCHAEOLOGY, P1, DOI 10.1017/CBO9780511894916; Hofmanova Z, 2016, P NATL ACAD SCI USA, V113, P6886, DOI 10.1073/pnas.1523951113; Horowitz M.T., 2019, TELL ATCHANA; Horowitz MT, 2015, UCL INST ARCH PUB, V67, P153; Ingman T., 2017, OVERTURNING CERTAINT; Ingman T., 2020, ALALAKH ITS NEIGHBOR; Irvine B.T., 2017, ISOTOPIC ANAL DIETAR; Jeong C, 2019, NAT ECOL EVOL, V3, P966, DOI 10.1038/s41559-019-0878-2; Jeong C, 2018, P NATL ACAD SCI USA, V115, pE11248, DOI 10.1073/pnas.1813608115; Jones ER, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9912; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Kadowaki S, 2017, INT J OSTEOARCHAEOL, V27, P245, DOI 10.1002/oa.2534; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kennett DJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14115; Kilinc GM, 2016, CURR BIOL, V26, P2659, DOI 10.1016/j.cub.2016.07.057; Killebrew A.E., 2014, OXFORD HDB ARCHAEOLO, P8000; Klengel H., 1992, HDB POLITICAL HIST; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Kwong Y, 2011, AM J ROENTGENOL, V196, P1156, DOI 10.2214/AJR.10.5719; Laneri N., E W, V52, P9; Laneri N, 2007, J NEAR EASTERN STUD, V66, P241, DOI 10.1086/524179; Lauinger Jacob, 2015, FOLLOWING MAN YAMHAD; Lazaridis I, 2017, NATURE, V548, P214, DOI 10.1038/nature23310; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lipson M, 2017, NATURE, V551, P368, DOI 10.1038/nature24476; Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330; Lyonnet B., 2007, CULTURES CAUCASE VIE; Lyonnet B., ANCIENT KURA 2010 20, V44, P97; Lyonnet B., 2016, SARIANIDI MEMORIAL V; Lyonnet B., 2008, AMIT, V40, P27; Lyonnet B., 2017, ARCHAOLOGIE IRAN TUR, V16, P141; Lyonnet B, 2016, QUATERN INT, V395, P170, DOI 10.1016/j.quaint.2015.02.038; Mann R. W., 2005, PHOTOGRAPHIC REGIONA; Manuelli F., 2013, HITTITE INFLUENCE LO; Marchetti N., 1995, BERYTUS, V42, P9; Marsh B, 2010, ARCHAEOL ANZ, V2010, P201; Martiniano R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006852; Mathieson I, 2018, NATURE, V555, P197, DOI 10.1038/nature25778; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; Matney T, 2012, INT J OSTEOARCHAEOL, V22, P338, DOI 10.1002/oa.1213; Matney T., 1999, ANATOLICA, V25, P185, DOI DOI 10.2143/ANA.25.0.2015489; Matney T., 1995, B AM SCH ORIENT RES, V299/300, P33; Matthiae P, 1993, RIVERS MOUNTAINS ARC; Matthiae P., 2002, PAPERS ARCHAEOLOGY H; Matthiae P., 2006, CR HEBD ACAD SCI, V150, P447; Matthiae P., 2010, ARCHEOLOGIA STORIA, P492; Matthiae P., 1993, CR HEBD ACAD SCI, V137, P613; Matthiae P., 2009, CR HEBD ACAD SCI, V153, P747; Matthiae P., 2009, SCI ANTICHITA, V15, P165; Matthiae P., 2013, EBLA ITS LANDSCAPE E; Matthiae P., 2020, NEW HORIZONS STUDY E; Matthiae P., 2013, STUDIES HIST ARCHAEO; Matthiae P, 2007, CRAIBL, V151, P481, DOI DOI 10.3406/CRAI.2007.92216; Matthiae P., 2011, CR HEBD ACAD SCI, V155, P735, DOI DOI 10.3406/crai.2011.93199; Mazzoni S., 1991, PAROLA PASSATO, V46, P163; McColl H, 2018, SCIENCE, V361, P88, DOI 10.1126/science.aat3628; McMahon G., 2012, OXFORD HDB ANCIENT A; Mell M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207376; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mittnik A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02825-9; Mondal M, 2016, NAT GENET, V48, P1066, DOI 10.1038/ng.3621; Montesanto M., 2020, ALALAKH ITS NEIGHBOR; Moorjani P, 2016, P NATL ACAD SCI USA, V113, P5652, DOI 10.1073/pnas.1514696113; Moorjani P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001373; Moreno-Mayar JV, 2018, SCIENCE, V362, DOI 10.1126/science.aav2621; Morgan M., 2019, R PACKAGE VERSION 1; Narasimhan VM, 2019, SCIENCE, V365, P999, DOI 10.1126/science.aat7487; Nigro L., 2002, BIBLIOTHEQUE ARCHEOL; Nishiaki Y, 2015, AM J ARCHAEOL, V119, P279, DOI 10.3764/aja.119.3.0279; Olalde I, 2019, SCIENCE, V363, P1230, DOI 10.1126/science.aav4040; Olalde I, 2018, NATURE, V555, P190, DOI 10.1038/nature25738; Olalde I, 2015, MOL BIOL EVOL, V32, P3132, DOI 10.1093/molbev/msv181; Ozbal R.F., 2006, THESIS; Ozdemir K., 2012, TURKIYEDE ARKEOMETRI; Ozdogan M., 2014, DOCUMENTA PRAEHISTOR, V41, P33, DOI DOI 10.4312/DP.41.2; Palumbi G., 2017, NO FRONTIER NEAR E A; Palumbi G., 2014, PALEORIENT, V40, P247, DOI DOI 10.3406/PALE0.2014.5645; Palumbi G., 2011, ANCESTRAL LANDSCAPES, P47; Papadopoulou I., 2012, ARCHAEOL ANZ, V2012, P123; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pecqueur L., 2017, KURA PROJECTS NEW RE; Peltzer A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0918-z; Pickard C, 2017, ARCHAEOL ANTHROP SCI, V9, P1349, DOI 10.1007/s12520-016-0386-0; Pickrell JK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2140; Pinhasi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117301; Pinnock F., 2009, LEVANT TRANSITION; Poulmarc'h M., 2014, PALEORIENT, V40, P231; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prufer K, 2017, SCIENCE, V358, P655, DOI 10.1126/science.aao1887; Pucci M., 2020, ALALAKH ITS NEIGHBOR; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Renaud G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0776-0; Roaf M., 1998, BILDATLAS WELTKULTUR; Roberts C.A., 2007, ARCHAEOLOGY DIS; Rohland N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0624; Rothman M., 2011, HIGH ROAD; Rothschild B, 2002, AM J HUM BIOL, V14, P417, DOI 10.1002/ajhb.10078; Sagona A., 2017, ARCHAEOLOGY CAUCASUS; Scandone Matthiae G., 2002, MAT STUDI ARCHEOLOGI; Schaefer Maureen, 2009, JUVENILE OSTEOLOGY L; Schoop U.-D., 2011, OXFORD HDB ANCIENT A; Schoop U.-D., 2015, ARCHAEOLOGY ANATOLIA; Schoop U.-D., 2009, ARCHAOLOGISCHER ANZ, V2009, P66; Schoop U.-D., 2012, ARCHAEOL ANZ, V2012, P115; Schoop U.-D., 2018, BAUWERKE BEFUNDE GRA; SCHOOP U. D., 2005, TUBA-AR-TURK ACAD SC, V8, P15; Schubert Mikkel, 2016, BMC Res Notes, V9, P88, DOI 10.1186/s13104-016-1900-2; Schultz M., 2003, IDENTIFICATION PATHO; Scott G.R., 2017, HUMAN TOOTH CROWN RO; Seguin-Orlando A, 2014, SCIENCE, V346, P1113, DOI 10.1126/science.aaa0114; Shafiq R., 2020, ALALAKH ITS NEIGHBOR; SIRACUSANO G., 2014, P 8 INT C ARCHAEOLOG, V3; Skoglund P, 2017, CELL, V171, P59, DOI 10.1016/j.cell.2017.08.049; Skoglund P, 2016, NATURE, V538, P510, DOI 10.1038/nature19844; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Steiner M. L., 2014, OHAL, P367; Tan Chee-Beng, 2017, ROUTLEDGE HDB ARCHAE; Thissen L., 1993, ANATOL STUD, V43, P207; Thomas J.-L., 2012, ARCHAEOL ANZ, V2012, P121; Thomas J.-L., 2017, CHILDREN DEATH BURIA; Thomas J.-L., 2011, ARCHAOLOGISCH ANZEIG, V2011, P73; Vacca A., 2015, STUDIA EBLAITICA STU, V1, P1; Vacca A., 2014, STUDIES HIST ARCHAEO; Von Dassow E., 2008, STATE SOC LATE BRONZ; von Dassow Eva, 2005, B AM SCH ORIENTAL RE, V338, P1; von den Driesch A., 2004, VOR FRUHGESCHICHTLIC; Vyas DN, 2017, AM J PHYS ANTHROPOL, V164, P736, DOI 10.1002/ajpa.23312; Waldron T., 2001, SHADOWS SOIL HUMAN B; Wang CC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08220-8; Weiss H, 2017, MEGADROUGHT COLLAPSE; Welton M.L., 2010, MOBILITY SOCIAL ORG; Wittke A.-M., 2010, HIST ATLAS ANCIENT W; Woolley C.L., 1939, ANTIQ J, V19, P1; Woolley C. Leonard, 1955, ALALAKH ACCOUNT EXCA; Yener K.A., 2011, METALLURGY UNDERSTAN; Yener K.A, 2015, TREASURES SYRIA ESSA; Yener K.A., 2010, AMUQ VALLEY REGIONAL; Yener K.A., 2015, NOSTOI INDIGENOUS CU; Yener K. A., 2013, BORDER LATE BRONZE I; Yener K.A., 2013, STUDIES HONOR GUNTER; Yener K.A., 2019, 2006 2010 EXCAVATION; Yener K. Aslihan, 2017, OVERTURNING CERTAINT; Yener K. Aslihan, 2005, AMUQ VALLEY REGIONAL, VI	219	33	34	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2020	181	5					1158	+		10.1016/j.cell.2020.04.044	http://dx.doi.org/10.1016/j.cell.2020.04.044			46	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LT9QF	32470401	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000537399500019
J	Dyer, O				Dyer, Owen			World leaders adopt resolution to study WHO's response to covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer O, 2004, BRIT MED J, V328, P185, DOI 10.1136/bmj.328.7433.185; Jan T., 2020, WASHINGTON POST; MAHASE E, 2020, BMJ-BRIT MED J, V369, P95763, DOI DOI 10.1136/BMJ.M1502; Trump Donald, 2020, TWITTER; World Health Organization, 2020, 73 WORLD HLTH ASS 18	5	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2020	369								m2044	10.1136/bmj.m2044	http://dx.doi.org/10.1136/bmj.m2044			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JK	32434800	Bronze			2022-12-28	WOS:000538335800016
J	[Anonymous]				[Anonymous]			Drospirenone (Slynd)-A New Progestin-Only Oral Contraceptive (Reprinted from JAMA, vol 62, pg 18-19, 2020)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint								This Medical Letter review summarizes the mechanism of action and drug interactions of drospirenone, a new progestin-only oral contraceptive, and compares it with norethindrone, its competitor.										[Anonymous], 2018, MED LETT DRUGS THER, V60, P161; [Anonymous], 2020, JAMA, V323; [Anonymous], 2019, INHIBITORS INDUCERS; Duijkers IJM, 2016, CONTRACEPTION, V93, P303, DOI 10.1016/j.contraception.2015.12.007; Madigan D, 2018, OPEN ACCESS J CONTR, V9, P29, DOI 10.2147/OAJC.S161737; Palacios S, 2019, ACTA OBSTET GYN SCAN, V98, P1549, DOI 10.1111/aogs.13688; Trussell J., 2018, CONTRACEPTIVE TECHNO, V21st ed.; 2020, MED LETT DRUGS THERA, V62, P18	8	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2020	323	19					1963	1964		10.1001/jama.2020.1603	http://dx.doi.org/10.1001/jama.2020.1603			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LT2XF	32427303				2022-12-28	WOS:000536934300023
J	Goldman, JD; Lye, DCB; Hui, DS; Marks, KM; Bruno, R; Montejano, R; Spinner, CD; Galli, M; Ahn, MY; Nahass, RG; Chen, YS; SenGupta, D; Hyland, RH; Osinusi, AO; Cao, HY; Blair, C; Wei, XL; Gaggar, A; Brainard, DM; Towner, WJ; Munoz, J; Mullane, KM; Marty, FM; Tashima, KT; Diaz, G; Subramanian, A				Goldman, Jason D.; Lye, David C. B.; Hui, David S.; Marks, Kristen M.; Bruno, Raffaele; Montejano, Rocio; Spinner, Christoph D.; Galli, Massimo; Ahn, Mi-Young; Nahass, Ronald G.; Chen, Yao-Shen; SenGupta, Devi; Hyland, Robert H.; Osinusi, Anu O.; Cao, Huyen; Blair, Christiana; Wei, Xuelian; Gaggar, Anuj; Brainard, Diana M.; Towner, William J.; Munoz, Jose; Mullane, Kathleen M.; Marty, Francisco M.; Tashima, Karen T.; Diaz, George; Subramanian, Aruna		GS-US-540-5773 Investigators	Remdesivir for 5 or 10 Days in Patients with Severe Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GS-5734	BackgroundRemdesivir is an RNA polymerase inhibitor with potent antiviral activity in vitro and efficacy in animal models of coronavirus disease 2019 (Covid-19). MethodsWe conducted a randomized, open-label, phase 3 trial involving hospitalized patients with confirmed SARS-CoV-2 infection, oxygen saturation of 94% or less while they were breathing ambient air, and radiologic evidence of pneumonia. Patients were randomly assigned in a 1:1 ratio to receive intravenous remdesivir for either 5 days or 10 days. All patients received 200 mg of remdesivir on day 1 and 100 mg once daily on subsequent days. The primary end point was clinical status on day 14, assessed on a 7-point ordinal scale. ResultsIn total, 397 patients underwent randomization and began treatment (200 patients for 5 days and 197 for 10 days). The median duration of treatment was 5 days (interquartile range, 5 to 5) in the 5-day group and 9 days (interquartile range, 5 to 10) in the 10-day group. At baseline, patients randomly assigned to the 10-day group had significantly worse clinical status than those assigned to the 5-day group (P=0.02). By day 14, a clinical improvement of 2 points or more on the ordinal scale occurred in 64% of patients in the 5-day group and in 54% in the 10-day group. After adjustment for baseline clinical status, patients in the 10-day group had a distribution in clinical status at day 14 that was similar to that among patients in the 5-day group (P=0.14). The most common adverse events were nausea (9% of patients), worsening respiratory failure (8%), elevated alanine aminotransferase level (7%), and constipation (7%). ConclusionsIn patients with severe Covid-19 not requiring mechanical ventilation, our trial did not show a significant difference between a 5-day course and a 10-day course of remdesivir. With no placebo control, however, the magnitude of benefit cannot be determined. (Funded by Gilead Sciences; GS-US-540-5773 ClinicalTrials.gov number, NCT04292899.) A randomized trial comparing a 5-day course of intravenous remdesivir with a 10-day course in patients with Covid-19 pneumonia and hypoxemia who were not yet receiving mechanical ventilation showed no significant differences in outcome related to the duration of treatment.	[Goldman, Jason D.] Swedish Med Ctr, Swedish Ctr Res & Innovat, Seattle, WA USA; [Goldman, Jason D.] Univ Washington, Seattle, WA 98195 USA; [Diaz, George] Providence Reg Med Ctr, Everett, WA USA; [Lye, David C. B.] Tan Tock Seng Hosp, Natl Ctr Infect Dis, Lee Kong Chian Sch Med, Singapore, Singapore; [Hui, David S.] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong, Peoples R China; [Marks, Kristen M.] New York Presbyterian Hosp, New York, NY USA; [Marks, Kristen M.] Weill Cornell Med, New York, NY USA; [Bruno, Raffaele] Pavia Univ Pavia, Malattie Infett Fdn IRCCS Policlin San Matteo, Pavia, Italy; [Galli, Massimo] Univ Milan, Dept Biomed & Clin Sci, L Sacco Infect Dis Unit, ASST Fatebenefratelli Sacco, Milan, Italy; [Montejano, Rocio] Hosp Univ La Paz, IdiPAZ, Madrid, Spain; [Munoz, Jose] Univ Barcelona, Barcelona Inst Global Hlth ISGlobal, Hosp Clin, Barcelona, Spain; [Spinner, Christoph D.] Tech Univ Munich, Sch Med, Univ Hosp Rechts Isar, Munich, Germany; [Ahn, Mi-Young] Seoul Med Ctr, Seoul, South Korea; [Nahass, Ronald G.] ID Care, Hillsborough, NJ USA; [Nahass, Ronald G.] Robert Wood Johnson Univ Hosp Somerset, Somerville, NJ USA; [Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan; [SenGupta, Devi; Hyland, Robert H.; Osinusi, Anu O.; Cao, Huyen; Blair, Christiana; Wei, Xuelian; Gaggar, Anuj; Brainard, Diana M.] Gilead Sci, 333 Lakeside Dr, Foster City, CA 94404 USA; [Towner, William J.] Kaiser Permanente, Los Angeles, CA USA; [Subramanian, Aruna] Stanford Univ, Palo Alto, CA 94304 USA; [Mullane, Kathleen M.] Univ Chicago, Chicago, IL 60637 USA; [Marty, Francisco M.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Marty, Francisco M.] Harvard Med Sch, Boston, MA 02115 USA; [Tashima, Karen T.] Brown Univ, Miriam Hosp, Warren Alpert Med Sch, Providence, RI USA	Swedish Medical Center; University of Washington; University of Washington Seattle; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Centre for Infectious Diseases Singapore; Tan Tock Seng Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; NewYork-Presbyterian Hospital; Cornell University; University of Milan; Hospital Universitario La Paz; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; Technical University of Munich; Seoul Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Kaohsiung Veterans General Hospital; Gilead Sciences; Kaiser Permanente; Stanford University; University of Chicago; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Brown University; Lifespan Health Rhode Island; Miriam Hospital	Brainard, DM (corresponding author), Gilead Sci, 333 Lakeside Dr, Foster City, CA 94404 USA.	diana.brainard@gilead.com	Marty, Francisco M./H-7088-2019; Hui, David Shu-Cheong/O-2754-2015; Goldman, Jason D./AAD-9419-2020; Gutierrez, Jose Muñoz/AAH-6954-2020; Ong, Sean/AAO-9560-2020; Montejano, Rocio/H-5344-2017; Goldman, Jason/AEL-9703-2022; Lye, David/ABF-4402-2021; Gottlieb, Robert/AAM-8310-2020; Haddad, Esther Isabel Arbona/AAX-4726-2020; Gutiérrez, José/GSJ-1846-2022; Montejano, Rocio/P-6141-2019; Bruno, Raffaele/AAB-9491-2022; Chia, Po Ying/GSD-9737-2022; Díaz Pollán, Beatriz/ABA-9452-2021; Chia, Po Ying/AAN-9657-2020; Mora-Rillo, Marta/E-8211-2015	Marty, Francisco M./0000-0002-3708-8734; Hui, David Shu-Cheong/0000-0003-4382-2445; Goldman, Jason D./0000-0002-3825-6832; Gutierrez, Jose Muñoz/0000-0002-0945-1735; Ong, Sean/0000-0002-8570-436X; Montejano, Rocio/0000-0002-3446-0545; Gottlieb, Robert/0000-0001-8376-8709; Haddad, Esther Isabel Arbona/0000-0001-6264-423X; Montejano, Rocio/0000-0002-3446-0545; Bruno, Raffaele/0000-0002-0235-9207; Chia, Po Ying/0000-0002-8797-9527; Díaz Pollán, Beatriz/0000-0002-7241-4208; Chia, Po Ying/0000-0002-8797-9527; Spinner, Christoph/0000-0002-3875-5367; Malhotra, Uma/0000-0003-0132-0885; Lye, David/0000-0003-0324-0205; Subramanian, Aruna/0000-0002-1373-6768; Muelas Fernandez, Magdalena/0000-0002-4342-4191; de la Calle-Prieto, Fernando/0000-0003-2544-3492; Mora-Rillo, Marta/0000-0002-2735-5931	Gilead Sciences	Gilead Sciences(Gilead Sciences)	Supported by Gilead Sciences.	Abi-Habib M., 2020, NEW YORK TIMES; [Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y; Baden LR, 2020, NEW ENGL J MED, V382, P1851, DOI 10.1056/NEJMe2005477; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282; Centers for Disease Control and Prevention, COR DIS 2019 COVID 1, DOI DOI 10.1016/S0140-6736(20)30211-7; de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117; European Medicines Agency, 2020, SUMM COMP US REMD GI; Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Moreira F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58931-6; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; Norrie JD, 2020, LANCET, V395, P1525, DOI 10.1016/S0140-6736(20)31023-0; Pizzorno A, 2020, CHARACTERIZATION TRE, DOI DOI 10.1101/2020.03.31.017889V1; Richardson S, 2020, JAMA; Romm Tony, 2020, WASH POST; Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180; WHO, WHO R D BLUEPR NOV C; Williamson BN, 2020, CLIN BENEFIT REMDESI, DOI DOI 10.1101/2020.04.15.043166V2; Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1	23	747	763	10	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2020	383	19					1827	1837		10.1056/NEJMoa2015301	http://dx.doi.org/10.1056/NEJMoa2015301			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PN2SG	32459919	Bronze, Green Published			2022-12-28	WOS:000604334000011
J	Paik, PK; Felip, E; Veillon, R; Sakai, H; Cortot, AB; Garassino, MC; Mazieres, J; Viteri, S; Senellart, H; Van Meerbeeck, J; Raskin, J; Reinmuth, N; Conte, P; Kowalski, D; Cho, BC; Patel, JD; Horn, L; Griesinger, F; Han, JY; Kim, YC; Chang, GC; Tsai, CL; Yang, JCH; Chen, YM; Smit, EF; van der Wekken, AJ; Kato, T; Juraeva, D; Stroh, C; Bruns, R; Straub, J; Johne, A; Scheele, J; Heymach, JV; Le, XI				Paik, Paul K.; Felip, Enriqueta; Veillon, Remi; Sakai, Hiroshi; Cortot, Alexis B.; Garassino, Marina C.; Mazieres, Julien; Viteri, Santiago; Senellart, Helene; Van Meerbeeck, Jan; Raskin, Jo; Reinmuth, Niels; Conte, Pierfranco; Kowalski, Dariusz; Cho, Byoung Chul; Patel, Jyoti D.; Horn, Leora; Griesinger, Frank; Han, Ji-Youn; Kim, Young-Chul; Chang, Gee-Chen; Tsai, Chen-Liang; Yang, James C. -H.; Chen, Yuh-Min; Smit, Egbert F.; van der Wekken, Anthonie J.; Kato, Terufumi; Juraeva, Dilafruz; Stroh, Christopher; Bruns, Rolf; Straub, Josef; Johne, Andreas; Scheele, Juergen; Heymach, John V.; Le, Xiuning			Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INHIBITOR TEPOTINIB; ACQUIRED-RESISTANCE; CRIZOTINIB; AMPLIFICATION; CARCINOMA; NSCLC	BACKGROUND A splice-site mutation that results in a loss of transcription of exon 14 in the oncogenic driverMEToccurs in 3 to 4% of patients with non-small-cell lung cancer (NSCLC). We evaluated the efficacy and safety of tepotinib, a highly selective MET inhibitor, in this patient population. METHODS In this open-label, phase 2 study, we administered tepotinib (at a dose of 500 mg) once daily in patients with advanced or metastatic NSCLC with a confirmedMETexon 14 skipping mutation. The primary end point was the objective response by independent review among patients who had undergone at least 9 months of follow-up. The response was also analyzed according to whether the presence of aMETexon 14 skipping mutation was detected on liquid biopsy or tissue biopsy. RESULTS As of January 1, 2020, a total of 152 patients had received tepotinib, and 99 patients had been followed for at least 9 months. The response rate by independent review was 46% (95% confidence interval [CI], 36 to 57), with a median duration of response of 11.1 months (95% CI, 7.2 to could not be estimated) in the combined-biopsy group. The response rate was 48% (95% CI, 36 to 61) among 66 patients in the liquid-biopsy group and 50% (95% CI, 37 to 63) among 60 patients in the tissue-biopsy group; 27 patients had positive results according to both methods. The investigator-assessed response rate was 56% (95% CI, 45 to 66) and was similar regardless of the previous therapy received for advanced or metastatic disease. Adverse events of grade 3 or higher that were considered by investigators to be related to tepotinib therapy were reported in 28% of the patients, including peripheral edema in 7%. Adverse events led to permanent discontinuation of tepotinib in 11% of the patients. A molecular response, as measured in circulating free DNA, was observed in 67% of the patients with matched liquid-biopsy samples at baseline and during treatment. CONCLUSIONS Among patients with advanced NSCLC with a confirmedMETexon 14 skipping mutation, the use of tepotinib was associated with a partial response in approximately half the patients.Peripheral edema was the main toxic effect of grade 3 or higher.	[Paik, Paul K.] Mem Sloan Kettering Canc Ctr, 530 E 74th St, New York, NY 10065 USA; [Felip, Enriqueta] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Dept Oncol, Barcelona, Spain; [Viteri, Santiago] Dexeus Univ Hosp, Dr Rosell Oncol Inst, Quironsalud Grp, Barcelona, Spain; [Veillon, Remi] Ctr Hosp Univ CHU Bordeaux, Serv Malad Resp, Bordeaux, France; [Cortot, Alexis B.] Univ Lille, Thorac Oncol Dept, Inst Pasteur Lille, CHU Lille,CNRS,INSERM,UMR9020,UMR S 1277 Canther, Lille, France; [Mazieres, Julien] Univ Paul Sabatier, Inst Univ Canc Toulouse, CHU Toulouse, Toulouse, France; [Sakai, Hiroshi; Senellart, Helene] Inst Cancerol Ouest Rene Gauducheau Ctr, St Herblain, France; [Sakai, Hiroshi] Saitama Canc Ctr, Saitama, Japan; [Kato, Terufumi] Kanagawa Canc Ctr, Dept Thorac Oncol, Yokohama, Kanagawa, Japan; [Garassino, Marina C.] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy; [Conte, Pierfranco] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy; [Conte, Pierfranco] IRCCS, Ist Oncol Veneto, Oncol Med 2, Padua, Italy; [Van Meerbeeck, Jan; Raskin, Jo] Univ Hosp, Edegem, Belgium; [Reinmuth, Niels] Asklepios Lung Clin, Munich, Germany; [Griesinger, Frank] Univ Med Oldenburg, Pius Hosp Oldenburg, Oldenburg, Germany; [Juraeva, Dilafruz] Merck, Dept Bioinformat, Translat Med, Darmstadt, Germany; [Stroh, Christopher] Merck, Translat Innovat Platform, Oncol, Darmstadt, Germany; [Bruns, Rolf] Merck, Dept Biostat, Darmstadt, Germany; [Straub, Josef] Merck, Dept Clin Biomarkers & Compan Diagnost, Translat Med, Darmstadt, Germany; [Johne, Andreas; Scheele, Juergen] Merck, Global Clin Dev, Darmstadt, Germany; [Kowalski, Dariusz] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Lung Canc & Thorac Oncol, Warsaw, Poland; [Cho, Byoung Chul] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea; [Han, Ji-Youn] Natl Canc Ctr, Ctr Lung Canc, Goyang, South Korea; [Kim, Young-Chul] Chonnam Natl Univ, Sch Med, Hwasun, South Korea; [Kim, Young-Chul] Hwasun Hosp, Hwasun, South Korea; [Patel, Jyoti D.] Northwestern Univ, Lurie Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Horn, Leora] Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN USA; [Chang, Gee-Chen] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan; [Tsai, Chen-Liang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Chest Med, Taipei, Taiwan; [Yang, James C. -H.] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Chen, Yuh-Min] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Chen, Yuh-Min] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chang, Gee-Chen] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Smit, Egbert F.] Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands; [van der Wekken, Anthonie J.] Univ Groningen, Dept Pulmonol, Groningen, Netherlands; [van der Wekken, Anthonie J.] Univ Med Ctr Groningen, Groningen, Netherlands; [Heymach, John V.; Le, Xiuning] Univ Texas Houston, MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA	Memorial Sloan Kettering Cancer Center; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); quironsalud Group; CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Kanagawa Prefectural Cancer Center; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Padua; IRCCS Istituto Oncologico Veneto (IOV); Pius-Hospital Oldenburg; Merck & Company; Merck & Company Germany; Merck & Company; Merck & Company Germany; Merck & Company; Merck & Company Germany; Merck & Company; Merck & Company Germany; Merck & Company; Merck & Company Germany; Yonsei University; Yonsei University Health System; National Cancer Center - Korea (NCC); Chonnam National University; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Vanderbilt University; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Netherlands Cancer Institute; University of Groningen; University of Groningen; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Paik, PK (corresponding author), Mem Sloan Kettering Canc Ctr, 530 E 74th St, New York, NY 10065 USA.	paikp@mskcc.org	van der Wekken, Anthonie/AAE-2328-2021; van Meerbeeck, Jan/ABA-5109-2020; Viteri, Santiago/ABE-4563-2020; MAZIERES, JULIEN/M-3986-2014	Raskin, Jo/0000-0001-8029-4093; Cho, Byoung Chul/0000-0002-5562-270X; Tsai, Chen-Liang/0000-0001-9783-5423; Kowalski, Dariusz/0000-0002-9452-3229; Smit, Egbert/0000-0002-7329-6995; Sakai, Hiroshi/0000-0002-3185-0804; van der Wekken, Anthonie/0000-0001-7175-0026	Merck (Darmstadt, Germany)	Merck (Darmstadt, Germany)(Merck & Company)	Supported by Merck (Darmstadt, Germany).	[Anonymous], 2018, ASS REP KEYTR INT NO; [Anonymous], 2018, J VASC INTERV RADIOL, V29, pS105; Awad MM, 2016, J CLIN ONCOL, V34, P721, DOI 10.1200/JCO.2015.63.4600; AWAD MM, 2018, J CLIN ONCOL S, V36; Bahcall M, 2018, CLIN CANCER RES, V24, P5963, DOI 10.1158/1078-0432.CCR-18-0876; Bahcall M, 2016, CANCER DISCOV, V6, P1334, DOI 10.1158/2159-8290.CD-16-0686; Barone C, 2018, ANN ONCOL, V29, DOI DOI 10.1093/ANNONC/MDY432.004; Bladt F, 2013, CLIN CANCER RES, V19, P2941, DOI 10.1158/1078-0432.CCR-12-3247; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Cortot AB, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw262; Drilon A, 2020, NAT MED, V26, P47, DOI 10.1038/s41591-019-0716-8; Falchook GS, 2020, CLIN CANCER RES, V26, P1237, DOI 10.1158/1078-0432.CCR-19-2860; Frampton GM, 2015, CANCER DISCOV, V5, P850, DOI 10.1158/2159-8290.CD-15-0285; Fujino T, 2019, J THORAC ONCOL, V14, P1753, DOI 10.1016/j.jtho.2019.06.023; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Garajova Ingrid, 2015, Transl Oncogenomics, V7, P13, DOI 10.4137/TOG.S30534; Heist RS, 2019, J THORAC ONCOL, V14, pS1126; Heist RS, 2016, J THORAC ONCOL, V11, P1242, DOI 10.1016/j.jtho.2016.06.013; Jamme P, 2020, J THORAC ONCOL, V15, P741, DOI 10.1016/j.jtho.2020.01.027; Mazieres J, 2019, ANN ONCOL, V30, P1321, DOI 10.1093/annonc/mdz167; Merker JD, 2018, J CLIN ONCOL, V36, P1631, DOI 10.1200/JCO.2017.76.8671; Ou SHI, 2017, J THORAC ONCOL, V12, P145, DOI 10.1016/j.jtho.2016.09.131; Paik PK, 2015, CANCER DISCOV, V5, P842, DOI 10.1158/2159-8290.CD-14-1467; Paz-Ares L, 2018, NEW ENGL J MED, V379, P2040, DOI 10.1056/NEJMoa1810865; Peters S, 2017, NEW ENGL J MED, V377, P829, DOI 10.1056/NEJMoa1704795; Pruis MA, 2020, LUNG CANCER, V140, P46, DOI 10.1016/j.lungcan.2019.11.010; Qi J, 2011, CANCER RES, V71, P1081, DOI 10.1158/0008-5472.CAN-10-1623; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Recondo G, 2020, CLIN CANCER RES, V26, P2615, DOI 10.1158/1078-0432.CCR-19-3608; Rothenstein JM, 2014, CURR ONCOL, V21, P19, DOI 10.3747/co.21.1740; Rotow JK, 2020, CLIN CANCER RES, V26, P439, DOI 10.1158/1078-0432.CCR-19-1667; Sabari JK, 2018, ANN ONCOL, V29, P2085, DOI 10.1093/annonc/mdy334; Salgia R, 2020, CANCER TREAT REV, V87, DOI 10.1016/j.ctrv.2020.102022; Shaw AT, 2014, NEW ENGL J MED, V371, P1963, DOI 10.1056/NEJMoa1406766; Socinski MA, 2018, NEW ENGL J MED, V378, P2288, DOI 10.1056/NEJMoa1716948; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Suzawa K, 2019, CLIN CANCER RES, V25, P1248, DOI 10.1158/1078-0432.CCR-18-1640; Takeda M, 2019, CANCERS, V11, DOI 10.3390/cancers11060742; Tong JH, 2016, CLIN CANCER RES, V22, P3048, DOI 10.1158/1078-0432.CCR-15-2061; Wu YL, 2020, LANCET RESP MED, V8, P1132, DOI 10.1016/S2213-2600(20)30154-5	40	254	262	9	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2020	383	10					931	943		10.1056/NEJMoa2004407	http://dx.doi.org/10.1056/NEJMoa2004407			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NO9YO	32469185	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000569841600013
J	Charles, P; Perrodeau, E; Samson, M; Bonnotte, B; Neel, A; Agard, C; Huart, A; Karras, A; Lifermann, F; Godmer, P; Cohen, P; Hanrotel-Saliou, C; Martin-Silva, N; Pugnet, G; Maurier, F; Sibilia, J; Carron, PL; Gobert, P; Meaux-Ruault, N; Le Gallou, T; Vinzio, S; Viallard, JF; Hachulla, E; Vinter, C; Puechal, X; Terrier, B; Ravaud, P; Mouthon, L; Guillevin, L				Charles, Pierre; Perrodeau, Elodie; Samson, Maxime; Bonnotte, Bernard; Neel, Antoine; Agard, Christian; Huart, Antoine; Karras, Alexandre; Lifermann, Francois; Godmer, Pascal; Cohen, Pascal; Hanrotel-Saliou, Catherine; Martin-Silva, Nicolas; Pugnet, Gregory; Maurier, Francois; Sibilia, Jean; Carron, Pierre-Louis; Gobert, Pierre; Meaux-Ruault, Nadine; Le Gallou, Thomas; Vinzio, Stephane; Viallard, Jean-Francois; Hachulla, Eric; Vinter, Christine; Puechal, Xavier; Terrier, Benjamin; Ravaud, Philippe; Mouthon, Luc; Guillevin, Loic		French Vasculitis Study Grp	Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							ANCA; MAINTENANCE; INDUCTION; GRANULOMATOSIS; POLYANGIITIS; WEGENERS; RELAPSE; CYCLOPHOSPHAMIDE	Background: Biannual rituximab infusions over 18 months effectively maintain remission after a "standard" remission induction regimen for patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV). Objective: To evaluate the efficacy of prolonged rituximab therapy in preventing AAV relapses in patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA) who have achieved complete remission after completing an 18-month maintenance regimen. Design: Randomized controlled trial. (ClinicalTrials.gov: NCT02433522) Setting: 39 clinical centers in France. Patients: 68 patients with GPA and 29 with MPA who achieved complete remission after the first phase of maintenance therapy. Intervention: Rituximab or placebo infusion every 6 months for 18 months (4 infusions). Measurements: The primary end point was relapse-free survival at month 28. Relapse was defined as new or reappearing symptoms or worsening disease, with a Birmingham Vasculitis Activity Score greater than 0. Results: From March 2015 to April 2016, 97 patients (mean age, 63.9 years; 35% women) were randomly assigned, 50 to the rituximab and 47 to the placebo group. Relapse-free survival estimates at month 28 were 96% (95% CI, 91% to 100%) and 74% (CI, 63% to 88%) in the rituximab and placebo groups, respectively, an absolute difference of 22% (CI, 9% to 36%) with a hazard ratio of 7.5 (CI, 1.67 to 33.7) (P = 0.008). Major relapse-free survival estimates at month 28 were 100% (CI, 93% to 100%) versus 87% (CI, 78% to 97%) (P = 0.009), respectively. At least 1 serious adverse event developed in 12 patients (24%) in the rituximab group (with 9 infectious serious adverse events occurring among 6 patients [12%]) versus 14 patients (30%) in the placebo group (with 6 infectious serious adverse events developing among 4 patients [9%]). No deaths occurred in either group. Limitation: Potential selection bias based on previous rituximab response and tolerance. Conclusion: Extended therapy with biannual rituximab infusions over 18 months was associated with a lower incidence of AAV relapse compared with standard maintenance therapy.	[Charles, Pierre] Paris Descartes Univ, Cochin Hosp, Paris, France; [Charles, Pierre] Inst Mutualiste Montsouris, Paris, France; [Perrodeau, Elodie; Ravaud, Philippe] Univ Paris 05, Sorbonne Paris Cite, Ctr Epidemiol Clin, INSERM,U1153,Hop Hotel Dieu, Paris, France; [Samson, Maxime; Bonnotte, Bernard] Univ Bourgogne Franche Comte, CHU Dijon, INSERM, UMR 1098,FHU INCREASE, Dijon, France; [Neel, Antoine] Univ Nantes, INSERM, CRTI UMR 1064, Nantes, France; [Neel, Antoine; Agard, Christian] CHU Nantes, Nantes, France; [Huart, Antoine; Pugnet, Gregory] CHU Toulouse, Toulouse, France; [Karras, Alexandre] Univ Paris 05, Hop Europeen Georges Pompidou, Paris, France; [Lifermann, Francois] Ctr Hosp Dax, Dax, France; [Gobert, Pierre] Ctr Hosp Bretagne Atlantique Vannes, Vannes, France; [Cohen, Pascal; Vinter, Christine; Puechal, Xavier; Terrier, Benjamin; Mouthon, Luc; Guillevin, Loic] Paris Descartes Univ, Cochin Hosp, Paris, France; [Hanrotel-Saliou, Catherine] CHU Brest, Hop Cavale Blanche, Brest, France; [Meaux-Ruault, Nadine] CHU Caen, Caen, France; [Maurier, Francois] Hop Prives Metz, Metz, France; [Sibilia, Jean] CHU Strasbourg, Hop Hautepierre, Strasbourg, France; [Carron, Pierre-Louis] CHU Grenoble Alpes, Grenoble, France; [Gobert, Pierre] Clin Rhone Durance, Avignon, France; [Meaux-Ruault, Nadine] CHU Jean Minjoz, Besancon, France; [Le Gallou, Thomas] CHU Rennes, Rennes, France; [Vinzio, Stephane] Grp Hosp Mutualiste Grenoble, Grenoble, France; [Viallard, Jean-Francois] CHU Bordeaux, Pessac, France; [Hachulla, Eric] CHU Lille, Lille, France; [Charles, Pierre] 42 Blvd Jourdan, F-75014 Paris, France; [Perrodeau, Elodie; Ravaud, Philippe] 1 Parvis Notre Dame,Pl Jean Paul II, F-75004 Paris, France; [Samson, Maxime; Bonnotte, Bernard] 14 Rue Paul Gaffarel, F-21000 Dijon, France; [Neel, Antoine; Agard, Christian] 1 Pl Alexis Ricordeau, F-44000 Nantes, France; [Huart, Antoine] 1 Ave Pr Jean Poulhes, F-31300 Toulouse, France; [Karras, Alexandre] 20 Rue Leblanc, F-75015 Paris, France; [Lifermann, Francois] Blvd Yves du Manoir, F-40100 Dax, France; [Godmer, Pascal] 20 Blvd Gen Guillaudot, F-56017 Vannes, France; [Cohen, Pascal; Vinter, Christine; Puechal, Xavier; Terrier, Benjamin; Mouthon, Luc; Guillevin, Loic] 27 Rue Faubourg St Jacques, F-75014 Paris, France; [Hanrotel-Saliou, Catherine] Blvd Tanguy Prigent, F-29200 Brest, France; [Martin-Silva, Nicolas] Ave Cote Nacre, F-14000 Caen, France; [Pugnet, Gregory] 1 Pl Docteur Baylac, F-31300 Toulouse, France; [Maurier, Francois] 13 Rue Gendarmerie, F-57000 Metz, France; [Sibilia, Jean] 1 Ave Moliere, F-67200 Strasbourg, France; [Carron, Pierre-Louis] Blvd Chantourne, F-38700 La Tronche, France; [Gobert, Pierre] 1750 Chemin Lavarin, F-84000 Avignon, France; [Meaux-Ruault, Nadine] 3 Blvd Alexandre Fleming, F-25000 Besancon, France; [Le Gallou, Thomas] 2 Rue Henri le Guilloux, F-35000 Rennes, France; [Vinzio, Stephane] 8 Rue Dr Calmette, F-38000 Grenoble, France; [Viallard, Jean-Francois] Ave Magellan, F-33604 Pessac, France; [Hachulla, Eric] 2 Ave Oscar Lambret, F-59000 Lille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Brest; Universite de Bretagne Occidentale; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Grenoble Alpes; Universite de Franche-Comte; CHU Besancon; CHU Rennes; CHU Bordeaux; Universite de Lille - ISITE; CHU Lille	Guillevin, L (corresponding author), Hop Cochin, Referral Ctr Rare Syst & Autoimmune Dis Vasculiti, Dept Internal Med, 27 Rue Faubourg St Jacques, F-75679 Paris 14, France.	loic.guillevin@orange.fr	Samson, Maxime/ABE-1461-2021; Bonnotte, Bernard/ABA-2525-2021	Samson, Maxime/0000-0002-6547-232X; Bonnotte, Bernard/0000-0002-1098-4598; Jourde-Chiche, Noemie/0000-0001-9315-1577; Sibilia, Jean/0000-0002-1601-4795; chatelus, emmanuel/0000-0002-7360-6527	French Ministry of Health [AOM11145]; Hoffman-La Roche; Assistance Publique-Hopitaux de Paris	French Ministry of Health; Hoffman-La Roche; Assistance Publique-Hopitaux de Paris	This study was funded by research grants from the French Ministry of Health (PHRC National 2011 AOM11145) and from Hoffman-La Roche; it was sponsored by Assistance Publique-Hopitaux de Paris. Hoffmann-La Roche also provided rituximab for the study.	Cartin-Ceba R, 2012, ARTHRITIS RHEUM-US, V64, P3770, DOI 10.1002/art.34584; Charles P, 2018, ANN RHEUM DIS, V77, P1144, DOI 10.1136/annrheumdis-2017-212878; Charles P, 2014, RHEUMATOLOGY, V53, P532, DOI 10.1093/rheumatology/ket381; de Groot K, 2009, ANN INTERN MED, V150, P670, DOI 10.7326/0003-4819-150-10-200905190-00004; Flossmann O, 2007, ANN RHEUM DIS, V66, P283, DOI 10.1136/ard.2005.051078; Guillevin L, 2014, NEW ENGL J MED, V371, P1771, DOI 10.1056/NEJMoa1404231; Hogan SL, 2005, ANN INTERN MED, V143, P621, DOI 10.7326/0003-4819-143-9-200511010-00005; Jennette JC, 2017, CLIN J AM SOC NEPHRO, V12, P1680, DOI 10.2215/CJN.02500317; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Karras A, 2017, ANN RHEUM DIS, V76, P1662, DOI 10.1136/annrheumdis-2017-211123; Thai LH, 2014, AUTOIMMUN REV, V13, P313, DOI 10.1016/j.autrev.2013.11.003; Puechal X, 2016, ARTHRITIS RHEUMATOL, V68, P690, DOI 10.1002/art.39450; Specks U, 2013, NEW ENGL J MED, V369, P417, DOI 10.1056/NEJMoa1213277; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; Terrier B, 2018, ANN RHEUM DIS, V77, P1151, DOI 10.1136/annrheumdis-2017-212768; Tieu J, 2020, RHEUMATOLOGY, V59, pe24, DOI 10.1093/rheumatology/kez640; Tomasson G, 2012, RHEUMATOLOGY, V51, P100, DOI 10.1093/rheumatology/ker280; Walsh M, 2012, ARTHRITIS RHEUM-US, V64, P542, DOI 10.1002/art.33361; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Yates M, 2016, ANN RHEUM DIS, V75, P1583, DOI 10.1136/annrheumdis-2016-209133	20	76	77	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2020	173	3					179	+		10.7326/M19-3827	http://dx.doi.org/10.7326/M19-3827			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MW7BG	32479166				2022-12-28	WOS:000557186700005
J	Prather, KA; Wang, CC; Schooley, RT				Prather, Kimberly A.; Wang, Chia C.; Schooley, Robert T.			Reducing transmission of SARS-CoV-2 Masks and testing are necessary to combat asymptomatic spread in aerosols and droplets	SCIENCE			English	Editorial Material									[Prather, Kimberly A.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA; [Wang, Chia C.] Natl Sun Yat Sen Univ, Dept Chem, Kaohsiung 804, Taiwan; [Wang, Chia C.] Natl Sun Yat Sen Univ, Aerosol Sci Res Ctr, Kaohsiung 804, Taiwan; [Schooley, Robert T.] Univ Calif San Diego, Sch Med, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; National Sun Yat Sen University; National Sun Yat Sen University; University of California System; University of California San Diego	Prather, KA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA.		Prather, Kim/A-3892-2008	Prather, Kim/0000-0003-3048-9890	NSFCenter for Aerosol Impacts on Chemistry of the Environment [CHE1801971]; National Institute of Allergy and Infectious Diseases [R01 AI131424]; Ministry of Science andTechnology [MOST 108-2113-M-110-003]; Higher Education Sprout Project of the Ministry of Education,Taiwan, ROC	NSFCenter for Aerosol Impacts on Chemistry of the Environment; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ministry of Science andTechnology; Higher Education Sprout Project of the Ministry of Education,Taiwan, ROC	The authors thank S. Strathdee, D. Petras, and L. Marr for helpful discussions. K.A.P. is supported by the NSFCenter for Aerosol Impacts on Chemistry of the Environment (CHE1801971). R.T.S. is supported bythe National Institute of Allergy and Infectious Diseases (R01 AI131424). C.C.W. is supported by the Ministry of Science andTechnology (MOST 108-2113-M-110-003) and the Higher Education Sprout Project of the Ministry of Education,Taiwan, ROC.	Anderson EL, 2020, RISK ANAL, V40, P902, DOI 10.1111/risa.13500; Asadi S, 2020, AEROSOL SCI TECH, V54, P635, DOI 10.1080/02786826.2020.1749229; Buonanno G, 2020, ENVIRON INT, V141, DOI 10.1016/j.envint.2020.105794; Chan JFW, 2020, CLIN INFECT DIS, V71, P2139, DOI 10.1093/cid/ciaa644; Chu H, 2020, CLIN INFECT DIS, V71, P1400, DOI 10.1093/cid/ciaa410; Conticini E, 2020, ENVIRON POLLUT, V261, DOI 10.1016/j.envpol.2020.114465; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Konda A, 2020, ACS NANO, V14, P6339, DOI 10.1021/acsnano.0c03252; Leung CC, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30520-1; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Liu Y, 2020, NATURE, V582, P557, DOI 10.1038/s41586-020-2271-3; Mittal R, 2020, J FLUID MECH, V894, DOI 10.1017/jfm.2020.330; Morawska L, 2020, ENVIRON INT, V139, DOI 10.1016/j.envint.2020.105730; Stadnytskyi V., 2020, P NATL ACAD SCI USA; Tellier R, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3707-y	15	435	446	11	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1422	1424		10.1126/science.abc6197	http://dx.doi.org/10.1126/science.abc6197			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF3SA	32461212				2022-12-28	WOS:000545264600019
J	Rodriguez, JA; Clark, CR; Bates, DW				Rodriguez, Jorge A.; Clark, Cheryl R.; Bates, David W.			Digital Health Equity as a Necessity in the 21st Century Cures Act Era	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses inequities in broadband access and digital health literacy in the US, and proposes policies and actions to bring equity to patient-facing digital health tools, in the context of a 2020 final rule release giving patients more control of their health data from the US Office of the National Coordinator (ONC) for Health Information Technology's Cures (HI-TEC) Act.	[Rodriguez, Jorge A.; Clark, Cheryl R.; Bates, David W.] Harvard Med Sch, Div Gen Internal Med, Brigham & Womens Hosp, 1620 Tremont St, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Rodriguez, JA (corresponding author), Harvard Med Sch, Div Gen Internal Med, Brigham & Womens Hosp, 1620 Tremont St, Boston, MA 02120 USA.	jarodrigueil@bwh.harvard.edu		Rodriguez, Jorge/0000-0002-1833-6819				Anderson M, MOBILE TECHNOLOGY HO; Anthony DL, 2018, HEALTH AFFAIR, V37, P1948, DOI 10.1377/hlthaff.2018.05117; Dunn P, 2019, INT J CARDIOL, V293, P294, DOI 10.1016/j.ijcard.2019.06.039; Rock Health, 2019 DIG HLTH MARK I; Sarkar U, 2016, J GEN INTERN MED, V31, P1417, DOI 10.1007/s11606-016-3771-6; The Office of the National Coordinator for Health Information Technology, ONC CUR ACT FIN RUL; usability.gov, US CTR DES BAS; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wong JEL, 2020, JAMA-J AM MED ASSOC, V323, P1243, DOI 10.1001/jama.2020.2467; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548	10	89	89	6	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2020	323	23					2381	2382		10.1001/jama.2020.7858	http://dx.doi.org/10.1001/jama.2020.7858			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MC6EC	32463421				2022-12-28	WOS:000543376700017
J	Toubiana, J; Poirault, C; Corsia, A; Bajolle, F; Fourgeaud, J; Angoulvant, F; Debray, A; Basmaci, R; Salvador, E; Biscardi, S; Frange, P; Chalumeau, M; Casanova, JL; Cohen, JF; Allali, S				Toubiana, Julie; Poirault, Clement; Corsia, Alice; Bajolle, Fanny; Fourgeaud, Jacques; Angoulvant, Francois; Debray, Agathe; Basmaci, Romain; Salvador, Elodie; Biscardi, Sandra; Frange, Pierre; Chalumeau, Martin; Casanova, Jean -Laurent; Cohen, Jeremie F.; Allali, Slimane			Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HUMAN CORONAVIRUS; DISEASE; SHOCK; ASSOCIATION; DYSFUNCTION; INFECTION	OBJECTIVES To describe the characteristics of children and adolescents affected by an outbreak of Kawasaki-like multisystem inflammatory syndrome and to evaluate a potential temporal association with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. DESIGN Prospective observational study. SETTING General paediatric department of a university hospital in Paris, France. PARTICIPANTS 21 children and adolescents (aged <= 18 years) with features of Kawasaki disease who were admitted to hospital between 27 April and 11 May 2020 and followed up until discharge by 15 May 2020. MAIN OUTCOME MEASURES The primary outcomes were clinical and biological data, imaging and echocardiographic findings, treatment, and outcomes. Nasopharyngeal swabs were prospectively tested for SARS-CoV-2 using reverse transcription-polymerase chain reaction (RT-PCR) and blood samples were tested for IgG antibodies to the virus. RESULTS 21 children and adolescents (median age 7.9 (range 3.7-16.6) years) were admitted with features of Kawasaki disease over a 15 day period, with 12 (57%) of African ancestry. 12 (57%) presented with Kawasaki disease shock syndrome and 16 (76%) with myocarditis. 17 (81%) required intensive care support. All 21 patients had noticeable gastrointestinal symptoms during the early stage of illness and high levels of inflammatory markers. 19 (90%) had evidence of recent SARS-CoV-2 infection (positive RT-PCR result in 8/21, positive IgG antibody detection in 19/21). All 21 patients received intravenous immunoglobulin and 10 (48%) also received corticosteroids. The clinical outcome was favourable in all patients. Moderate coronary artery dilations were detected in 5 (24%) of the patients during hospital stay. By 15 May 2020, after 8 (5-17) days of hospital stay, all patients were discharged home. CONCLUSIONS The ongoing outbreak of Kawasaki-like multisystem inflammatory syndrome among children and adolescents in the Paris area might be related to SARS-CoV-2. In this study an unusually high proportion of the affected children and adolescents had gastrointestinal symptoms, Kawasaki disease shock syndrome, and were of African ancestry.	[Toubiana, Julie; Poirault, Clement; Debray, Agathe; Chalumeau, Martin; Cohen, Jeremie F.; Allali, Slimane] Univ Paris, Necker Enfants Malades Univ Hosp, AP HP, Dept Gen Paediat & Paediat Infect Dis, 149 Rue Sevres, F-75015 Paris, France; [Toubiana, Julie] Inst Pasteur, Biodivers & Epidemiol Bacterial Pathogens, Paris, France; [Corsia, Alice; Salvador, Elodie] Univ Paris, Necker Enfants Malades Univ Hosp, AP HP, Paediat Intens Care Unit, Paris, France; [Bajolle, Fanny] Univ Paris, M3C Necker Enfants Malades Univ Hosp, Paris, France; [Fourgeaud, Jacques] Univ Paris, Necker Enfants Malades Univ Hosp, AP HP, Virol Lab, Paris, France; [Angoulvant, Francois] Univ Paris, Necker Enfants Malades Univ Hosp, AP HP, Pediat Emergency Dept, Paris, France; [Angoulvant, Francois] Univ Paris, INSERM, Ctr Rech Cordeliers, UMRS 1138, Paris, France; [Basmaci, Romain] Univ Paris, Louis Mourier Hosp, Pediat & Emergency Unit, Paris, France; [Biscardi, Sandra] Hop Intercommunal Creteil, Pediat Emergency Unit, Creteil, France; [Frange, Pierre] Univ Paris, Necker Enfants Malades Univ Hosp, AP HP, Dept Clin Microbiol, Paris, France; [Frange, Pierre] Univ Paris, Imagine Inst, PACT, EHU 7328, Paris, France; [Chalumeau, Martin; Cohen, Jeremie F.] Univ Paris, Ctr Res Epidemiol & Stat, Obstet Perinatal & Pediat Epidemiol Res Team, INSERM, Paris, France; [Casanova, Jean -Laurent] Univ Paris, Necker Enfants Malades Hosp, AP HP,Pediat Hematol & Immunol Unit, Lab Human Genet Infect Dis,Necker Branch,Imagine, Paris, France; [Casanova, Jean -Laurent] Rockefeller Unvers, Rockefeller Branch, Howard Hughes Med Inst, St Giles Lab Human Genet Infect Dis, New York, NY USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute	Chalumeau, M (corresponding author), Univ Paris, Necker Enfants Malades Univ Hosp, AP HP, Dept Gen Paediat & Paediat Infect Dis, 149 Rue Sevres, F-75015 Paris, France.	martin.chalumeau@aphp.fr	Cohen, Jérémie/H-4707-2019; Fourgeaud, Jacques/HDM-6334-2022; Frange, Pierre/O-6311-2017; Toubiana, Julie/AAZ-8996-2020; Allali, Slimane/AGW-0037-2022	Cohen, Jérémie/0000-0003-3572-8985; Fourgeaud, Jacques/0000-0003-3631-184X; Toubiana, Julie/0000-0001-9561-669X; 				Bajolle F, 2014, PATHOL BIOL, V62, P365, DOI 10.1016/j.patbio.2014.06.002; Bouaziz JD, 2020, J EUR ACAD DERMATOL, V34, pE451, DOI 10.1111/jdv.16544; Bryan A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00941-20; Castagnoli R, 2020, JAMA PEDIATR, V174, P882, DOI 10.1001/jamapediatrics.2020.1467; Catalano-Pons C, 2005, CLIN INFECT DIS, V41, pE53, DOI 10.1086/432578; Chang LY, 2014, J FORMOS MED ASSOC, V113, P148, DOI 10.1016/j.jfma.2013.12.008; Colomba C, 2018, J PEDIATR-US, V202, P186, DOI 10.1016/j.jpeds.2018.06.034; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; ECDC, 2020, PAED INFL MULT SYNDR; Esper F, 2005, J INFECT DIS, V191, P499, DOI 10.1086/428291; Casas CG, 2020, BRIT J DERMATOL, V183, P71, DOI 10.1111/bjd.19163; Gardner-Medwin JMM, 2002, LANCET, V360, P1197, DOI 10.1016/S0140-6736(02)11279-7; Gatterre P, 2012, INTENS CARE MED, V38, P872, DOI 10.1007/s00134-012-2473-8; Giudicessi JR, 2020, HEART RHYTHM; Harada M, 2012, HISTOPATHOLOGY, V61, P1156, DOI 10.1111/j.1365-2559.2012.04332.x; Holman RC, 2010, PEDIATR INFECT DIS J, V29, P483, DOI 10.1097/INF.0b013e3181cf8705; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jones Veena G, 2020, Hosp Pediatr, V10, P537, DOI 10.1542/hpeds.2020-0123; Kanegaye JT, 2009, PEDIATRICS, V123, pE783, DOI 10.1542/peds.2008-1871; KAO CH, 1993, NUCL MED COMMUN, V14, P539, DOI 10.1097/00006231-199307000-00004; Kim Ja Hye, 2012, Korean J Pediatr, V55, P470, DOI 10.3345/kjp.2012.55.12.470; L'Huillier AG, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00524; Lee KY, 2012, YONSEI MED J, V53, P262, DOI 10.3349/ymj.2012.53.2.262; Lehmann C, 2009, PEDIATR INFECT DIS J, V28, P553, DOI 10.1097/INF.0b013e31819f41b6; Li YD, 2019, PEDIATR RHEUMATOL, V17, DOI 10.1186/s12969-018-0303-4; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Makino N, 2019, PEDIATR INT, V61, P397, DOI 10.1111/ped.13809; Mallapaty S, 2020, NATURE, V582, P467, DOI 10.1038/d41586-020-01738-2; McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; MIYAKE T, 1987, PEDIATR RADIOL, V17, P383, DOI 10.1007/BF02396613; Noorani M, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1306-5; Riphagen Shelley, 2020, Lancet, V395, P1607, DOI 10.1016/S0140-6736(20)31094-1; Saundankar J, 2014, PEDIATRICS, V133, pE1009, DOI 10.1542/peds.2013-2936; Schnabel A, 2019, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00421; Turnier JL, 2015, PEDIATRICS, V136, pE609, DOI 10.1542/peds.2015-0950; Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X; World Health Organization, 2020, MULT INFL SYNDR CHIL, DOI DOI 10.1007/S00246-021-02738-3; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; YUTANI C, 1981, ARCH PATHOL LAB MED, V105, P470	40	587	604	2	43	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2020	369								m2094	10.1136/bmj.m2094	http://dx.doi.org/10.1136/bmj.m2094			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1WU	32493739	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000548578300002
J	Auerbach, A; Bates, DW				Auerbach, Andrew; Bates, David W.			Introduction: Improvement and Measurement in the Era of Electronic Health Records	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Auerbach, Andrew] Univ Calif San Francisco, 533 Parnassus Ave, San Francisco, CA 94117 USA; [Bates, David W.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital	Auerbach, A (corresponding author), Univ Calif San Francisco, 533 Parnassus Ave, San Francisco, CA 94117 USA.				Gordon and Betty Moore Foundation, Palo Alto, California	Gordon and Betty Moore Foundation, Palo Alto, California(Gordon and Betty Moore Foundation)	By the Gordon and Betty Moore Foundation, Palo Alto, California.	Bates DW, 2020, ANN INTERN MED, V172, pS137, DOI 10.7326/M19-0872; Callahan A, 2020, ANN INTERN MED, V172, pS79, DOI 10.7326/M19-0873; Haynes RB, 2020, ANN INTERN MED, V172, pS73, DOI 10.7326/M19-0874; Kawamoto K, 2020, ANN INTERN MED, V172, pS101, DOI 10.7326/M19-0875; Lyles CR, 2020, ANN INTERN MED, V172, pS123, DOI 10.7326/M19-0876; Ogrinc Greg, 2016, BMJ Qual Saf, V25, P986, DOI 10.1136/bmjqs-2015-004411; Pletcher MJ, 2020, ANN INTERN MED, V172, pS85, DOI 10.7326/M19-0877; Rudin RS, 2020, ANN INTERN MED, V172, pS130, DOI 10.7326/M19-0878; Singh H, 2020, ANN INTERN MED, V172, pS92, DOI 10.7326/M19-0879; Washington V, 2017, NEW ENGL J MED, V377, P904, DOI 10.1056/NEJMp1703370; Wright A, 2020, ANN INTERN MED, V172, pS110, DOI 10.7326/M19-0880; Zheng K, 2020, ANN INTERN MED, V172, pS116, DOI 10.7326/M19-0871	12	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2020	172			11			S69	S72		10.7326/M19-0870	http://dx.doi.org/10.7326/M19-0870			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MH8ZH	32479178				2022-12-28	WOS:000547009900001
J	Lent-Schochet, D; Yiu, G				Lent-Schochet, Daniella; Yiu, Glenn			Drusen in dense deposit disease: not just age-related macular degeneration	LANCET			English	Editorial Material									[Lent-Schochet, Daniella] Calif Northstate Univ, Coll Med, Elk Grove, CA USA; [Yiu, Glenn] Univ Calif Davis, Dept Ophthalmol & Vis Sci, Sacramento, CA 95817 USA	University of California System; University of California Davis	Yiu, G (corresponding author), Univ Calif Davis, Dept Ophthalmol & Vis Sci, Sacramento, CA 95817 USA.	gyiu@ucdavis.edu							0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2020	395	10238					1726	1726						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0PJ	32473679				2022-12-28	WOS:000561610000026
J	Jiao, C; Sorensen, I; Sun, XP; Sun, HH; Behar, H; Alseekh, S; Philippe, G; Lopez, KP; Sun, L; Reed, R; Jeon, S; Kiyonami, R; Zhang, S; Fernie, AR; Brumer, H; Domozych, DS; Fei, ZJ; Rose, JKC				Jiao, Chen; Sorensen, Iben; Sun, Xuepeng; Sun, Honghe; Behar, Hila; Alseekh, Saleh; Philippe, Glenn; Lopez, Kattia Palacio; Sun, Li; Reed, Reagan; Jeon, Susan; Kiyonami, Reiko; Zhang, Sheng; Fernie, Alisdair R.; Brumer, Harry; Domozych, David S.; Fei, Zhangjun; Rose, Jocelyn K. C.			The Penium margaritaceum Genome: Hallmarks of the Origins of Land Plants	CELL			English	Article							BRASSINOSTEROID SIGNAL-TRANSDUCTION; CELL-WALL; PHYLOGENETIC ANALYSIS; TRANSCRIPTION FACTORS; READ ALIGNMENT; GRAS PROTEINS; GREEN-ALGAE; EVOLUTION; ANNOTATION; REVEALS	The evolutionary features and molecular innovations that enabled plants to first colonize land are not well understood. Here, insights are provided through our report of the genome sequence of the unicellular alga Penium margaritaceum, a member of the Zygnematophyceae, the sister lineage to land plants. The genome has a high proportion of repeat sequences that are associated with massive segmental gene duplications, likely facilitating neofunctionalization. Compared with representatives of earlier diverging algal lineages, P. margaritaceum has expanded repertoires of gene families, signaling networks, and adaptive responses that highlight the evolutionary trajectory toward terrestrialization. These encompass a broad range of physiological processes and protective cellular features, such as flavonoid compounds and large families of modifying enzymes involved in cell wall biosynthesis, assembly, and remodeling. Transcriptome profiling further elucidated adaptations, responses, and selective pressures associated with the semi-terrestrial ecosystems of P. margaritaceum, where a simple body plan would be an advantage.	[Jiao, Chen; Sun, Xuepeng; Sun, Honghe; Fei, Zhangjun] Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Sorensen, Iben; Philippe, Glenn; Rose, Jocelyn K. C.] Cornell Univ, Sch Integrat Plant Sci, Plant Biol Sect, Ithaca, NY 14853 USA; [Behar, Hila; Brumer, Harry] Univ British Columbia, Smith Labs, 2185 East Mall, Vancouver, BC V6T 1Z4, Canada; [Behar, Hila; Brumer, Harry] Univ British Columbia, Life Sci Ctr, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada; [Alseekh, Saleh; Fernie, Alisdair R.] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Alseekh, Saleh; Fernie, Alisdair R.] Ctr Plant Syst Biol & Biotechnol, Plovdiv 4000, Bulgaria; [Lopez, Kattia Palacio; Sun, Li; Reed, Reagan; Jeon, Susan; Domozych, David S.] Skidmore Coll, Saratoga Springs, NY 12866 USA; [Kiyonami, Reiko] Thermo Fisher Sci, 355 River Oaks Pkwy, San Jose, CA USA; [Zhang, Sheng] Cornell Univ, Inst Biotechnol, Ithaca, NY USA; [Brumer, Harry] Univ British Columbia, Dept Bot, 3200-6270 Univ Blvd, Vancouver, BC V6H 1Z4, Canada; [Brumer, Harry] Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z4, Canada; [Fei, Zhangjun] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; University of British Columbia; University of British Columbia; Max Planck Society; Skidmore College; Thermo Fisher Scientific; Cornell University; University of British Columbia; University of British Columbia; United States Department of Agriculture (USDA)	Fei, ZJ (corresponding author), Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA.; Rose, JKC (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Plant Biol Sect, Ithaca, NY 14853 USA.; Domozych, DS (corresponding author), Skidmore Coll, Saratoga Springs, NY 12866 USA.; Fei, ZJ (corresponding author), USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA.	ddomoz@skidmore.edu; zf25@cornell.edu; jr286@cornell.edu	Fei, Zhangjun/H-5152-2012; Jiao, Chen/F-7882-2013; Jiao, Chen/AAM-7701-2020	Jiao, Chen/0000-0002-3327-0547; Sorensen, Iben/0000-0002-9768-620X	National Science Foundation [MCB-1517546, IOS-1339287]; Agriculture and Food Research Initiative of the United States Department of Agriculture [2016-67013-24732]; European Union Project PlantaSyst [SGA-CSA 664621, 739582, FPA 664620]; Cornell Atkinson Center for Sustainability; Chemical Sciences, Geo-sciences and Biosciences Division, Office of Basic Energy Sciences, U.S. Department of Energy [DE-SC0015662]	National Science Foundation(National Science Foundation (NSF)); Agriculture and Food Research Initiative of the United States Department of Agriculture; European Union Project PlantaSyst; Cornell Atkinson Center for Sustainability; Chemical Sciences, Geo-sciences and Biosciences Division, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE))	We thank Sandra Raimundo, Eleanore Ritter, and Stephen Snyder for technical support and the Imaging, Genomics, and Metabolomics Facilities of the Biotechnology Resource Center, Institute of Biotechnology, Cornell University. This research was supported by grants from the National Science Foundation MCB-1517546 to D.D. and J.K.C.R. and IOS-1339287 to Z.F. and J.K.C.R., the Agriculture and Food Research Initiative of the United States Department of Agriculture (2016-67013-24732) to J.K.C.R., and European Union Project PlantaSyst (SGA-CSA 664621 and 739582 under FPA 664620) to S.A. and A.R.F. J.K.C.R. was also supported by the Cornell Atkinson Center for Sustainability. The mucilage analysis was supported by the Chemical Sciences, Geo-sciences and Biosciences Division, Office of Basic Energy Sciences, U.S. Department of Energy (DE-SC0015662) to Dr. Parastoo Azadi at the Complex Carbohydrate Research Center, University of Georgia.	Agarwal PK, 2017, J EXP BOT, V68, P2135, DOI 10.1093/jxb/erx118; Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; Bak Soren, 2011, Arabidopsis Book, V9, pe0144, DOI 10.1199/tab.0144; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Behar H, 2018, PLANT J, V95, P1114, DOI 10.1111/tpj.14004; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Bowman JL, 2019, CURR OPIN PLANT BIOL, V47, P64, DOI 10.1016/j.pbi.2018.09.009; Bowman JL, 2017, CELL, V171, P287, DOI 10.1016/j.cell.2017.09.030; Burton RA, 2010, NAT CHEM BIOL, V6, P724, DOI [10.1038/nchembio.439, 10.1038/NCHEMBIO.439]; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campbell MS, 2014, PLANT PHYSIOL, V164, P513, DOI 10.1104/pp.113.230144; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cheng SF, 2019, CELL, V179, P1057, DOI 10.1016/j.cell.2019.10.019; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Clavijo BJ, 2017, GENOME RES, V27, P885, DOI 10.1101/gr.217117.116; Cosgrove DJ, 2015, CURR OPIN PLANT BIOL, V25, P162, DOI 10.1016/j.pbi.2015.05.014; Cosgrove DJ, 2014, CURR OPIN PLANT BIOL, V22, P122, DOI 10.1016/j.pbi.2014.11.001; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; De Clerck O, 2018, CURR BIOL, V28, P2921, DOI 10.1016/j.cub.2018.08.015; de Vries J, 2018, P NATL ACAD SCI USA, V115, pE3471, DOI 10.1073/pnas.1719230115; de Vries J, 2017, PLANT CELL PHYSIOL, V58, P934, DOI 10.1093/pcp/pcx037; Dehors J, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00441; Delaux PM, 2015, P NATL ACAD SCI USA, V112, P13390, DOI 10.1073/pnas.1515426112; Delwiche CF, 2011, CURR BIOL, V21, pR417, DOI 10.1016/j.cub.2011.04.021; Delwiche CF, 2015, CURR BIOL, V25, pR899, DOI 10.1016/j.cub.2015.08.029; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Domozych DS, 2007, PROTOPLASMA, V230, P99, DOI 10.1007/s00709-006-0197-8; Domozych DS, 2008, MICROB ECOL, V55, P81, DOI 10.1007/s00248-007-9253-y; Domozych DS, 2014, PLANT PHYSIOL, V165, P105, DOI 10.1104/pp.114.236257; Domozych DS, 2005, BIOFILMS, V2, P129, DOI [DOI 10.1017/S147905050500181X, 10.1017/S147905050500181X]; Eklof JM, 2013, J BIOL CHEM, V288, P15786, DOI 10.1074/jbc.M113.462887; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Emiliani G, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-7; Engstrom EM, 2011, PLANT SIGNAL BEHAV, V6, P850, DOI 10.4161/psb.6.6.15203; Feist M, 2005, AM J BOT, V92, P1152, DOI 10.3732/ajb.92.7.1152; Fich EA, 2016, ANNU REV PLANT BIOL, V67, P207, DOI 10.1146/annurev-arplant-043015-111929; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Garrison Erik., 2012, HAPLOTYPE BASED VARI, DOI DOI 10.48550/ARXIV.1207.3907; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Han YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq862; Herburger K, 2015, PLANT CELL PHYSIOL, V56, P2259, DOI 10.1093/pcp/pcv139; Hernandez-Garcia J, 2019, MOL BIOL EVOL, V36, P908, DOI 10.1093/molbev/msz009; Holzinger A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00678; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; Hu XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126012; Jackman SD, 2017, GENOME RES, V27, P768, DOI 10.1101/gr.214346.116; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Ju CL, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2014.4, 10.1038/NPLANTS.2014.4]; Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; KNOX JP, 1990, PLANTA, V181, P512, DOI 10.1007/BF00193004; Kondo S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00952; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leebens-Mack JH, 2019, NATURE, V574, P679, DOI 10.1038/s41586-019-1693-2; Li FW, 2018, NAT PLANTS, V4, P460, DOI 10.1038/s41477-018-0188-8; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li ZY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051138; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; LOVE MI, 2014, TRENDS PLANT SCI, V15, DOI DOI 10.1186/S13059-014-0550-8; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Ma HS, 2010, J EXP BOT, V61, P4011, DOI 10.1093/jxb/erq217; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mapleson D, 2017, BIOINFORMATICS, V33, P574, DOI 10.1093/bioinformatics/btw663; Martin-Arevalillo R, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008400; McGregor N, 2017, PLANT J, V89, P651, DOI 10.1111/tpj.13421; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Morris JL, 2018, P NATL ACAD SCI USA, V115, pE2274, DOI 10.1073/pnas.1719588115; Mutte SK, 2018, ELIFE, V7, DOI 10.7554/eLife.33399; Nadalin F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S8; Narasimhan V, 2016, BIOINFORMATICS, V32, P1749, DOI 10.1093/bioinformatics/btw044; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Nichols HW, 1973, HDB PHYCOLOGICAL MET, P7; Niklas KJ, 2017, J EXP BOT, V68, P5261, DOI 10.1093/jxb/erx215; Nishiyama T, 2018, CELL, V174, P448, DOI 10.1016/j.cell.2018.06.033; Ohtaka K, 2017, PLANT PHYSIOL, V174, P1621, DOI 10.1104/pp.17.00274; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Panchy N, 2016, PLANT PHYSIOL, V171, P2294, DOI 10.1104/pp.16.00523; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Philippe G, 2020, CURR OPIN PLANT BIOL, V55, P11, DOI 10.1016/j.pbi.2020.01.008; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; Quint M, 2006, CURR OPIN PLANT BIOL, V9, P448, DOI [10.1016/j.pbi.2006.07.006, 10.1104/pp.17.00765]; Raimundo SC, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0284-9; Ren H, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007904; Renault H, 2019, CURR OPIN BIOTECH, V56, P105, DOI 10.1016/j.copbio.2018.10.011; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rensing SA, 2018, CURR OPIN PLANT BIOL, V42, P49, DOI 10.1016/j.pbi.2018.02.006; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rossel JB, 2007, PLANT CELL, V19, P4091, DOI 10.1105/tpc.106.045898; Rydahl MG, 2015, METHODS MOL BIOL, V1242, P1, DOI 10.1007/978-1-4939-1902-4_1; Salmela L, 2014, BIOINFORMATICS, V30, P3506, DOI 10.1093/bioinformatics/btu538; Scrucca L, 2016, R J, V8, P289; Signorelli S, 2019, TRENDS PLANT SCI, V24, P413, DOI 10.1016/j.tplants.2019.02.001; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Sorensen I, 2014, PLANT J, V77, P339, DOI 10.1111/tpj.12375; Sorensen I, 2011, PLANT J, V68, P201, DOI 10.1111/j.1365-313X.2011.04686.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanke M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s11; Steinbiss S, 2009, NUCLEIC ACIDS RES, V37, P7002, DOI 10.1093/nar/gkp759; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; Tenhaken R, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00771; Terrett OM, 2019, CURR OPIN BIOTECH, V56, P97, DOI 10.1016/j.copbio.2018.10.010; Thalmann M, 2017, NEW PHYTOL, V214, P943, DOI 10.1111/nph.14491; Vanneste K, 2013, MOL BIOL EVOL, V30, P177, DOI 10.1093/molbev/mss214; Viborg AH, 2019, J BIOL CHEM, V294, P15973, DOI 10.1074/jbc.RA119.010619; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wan T, 2018, NAT PLANTS, V4, P82, DOI 10.1038/s41477-017-0097-2; Wang SB, 2020, NAT PLANTS, V6, P95, DOI 10.1038/s41477-019-0560-3; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Wilhelmsson PKI, 2017, GENOME BIOL EVOL, V9, P3384, DOI 10.1093/gbe/evx258; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737; Yonekura-Sakakibara K, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00943; Zamil MS, 2017, PHYS BIOL, V14, DOI 10.1088/1478-3975/aa5ba5; Zhang DP, 2012, BIOINFORMATICS, V28, P2407, DOI 10.1093/bioinformatics/bts464; Zhang H, 2018, NUCLEIC ACIDS RES, V46, pW95, DOI 10.1093/nar/gky418; Zheng Y, 2016, MOL PLANT, V9, P1667, DOI 10.1016/j.molp.2016.09.014; Zheng Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-453; Zhong RQ, 2019, NEW PHYTOL, V221, P1703, DOI 10.1111/nph.15537; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476	150	80	81	12	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2020	181	5					1097	+		10.1016/j.cell.2020.04.019	http://dx.doi.org/10.1016/j.cell.2020.04.019			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LT9QF	32442406	Green Submitted, Bronze			2022-12-28	WOS:000537399500015
J	Netea, MG; Giamarellos-Bourboulis, EJ; Dominguez-Andres, J; Curtis, N; van Crevel, R; van de Veerdonk, FL; Bonten, M				Netea, Mihai G.; Giamarellos-Bourboulis, Evangelos J.; Dominguez-Andres, Jorge; Curtis, Nigel; van Crevel, Reinout; van de Veerdonk, Frank L.; Bonten, Marc			Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection	CELL			English	Review							NONSPECIFIC PROTECTION; VIRUS-INFECTION; CYTOKINE STORM; MICE; RESISTANCE; INTERFERON	SARS-CoV-2 infection is mild in the majority of individuals but progresses into severe pneumonia in a small proportion of patients. The increased susceptibility to severe disease in the elderly and individuals with co-morbidities argues for an initial defect in anti-viral host defense mechanisms. Long-term boosting of innate immune responses, also termed "trained immunity,'' by certain live vaccines (BCG, oral polio vaccine, measles) induces heterologous protection against infections through epigenetic, transcriptional, and functional reprogramming of innate immune cells. We propose that induction of trained immunity by whole-microorganism vaccines may represent an important tool for reducing susceptibility to and severity of SARS-CoV-2.	[Netea, Mihai G.; Dominguez-Andres, Jorge; van Crevel, Reinout; van de Veerdonk, Frank L.] Radboud Univ Nijmegen, Dept Internal Med, NL-6500 Nijmegen, Netherlands; [Netea, Mihai G.; Dominguez-Andres, Jorge; van Crevel, Reinout; van de Veerdonk, Frank L.] Radboud Univ Nijmegen, Ctr Infect Dis, NL-6500 Nijmegen, Netherlands; [Netea, Mihai G.] Univ Bonn, Immunol & Metab Life & Med Sci Inst, D-53115 Bonn, Germany; [Giamarellos-Bourboulis, Evangelos J.] Natl & Kapodistrian Univ Athens, Dept Internal Med 4, Athens 12462, Greece; [Curtis, Nigel] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Curtis, Nigel] Royal Childrens Hosp Melbourne, Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Bonten, Marc] Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Bonn; National & Kapodistrian University of Athens; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Utrecht University; Utrecht University Medical Center	Netea, MG (corresponding author), Radboud Univ Nijmegen, Dept Internal Med, NL-6500 Nijmegen, Netherlands.; Netea, MG (corresponding author), Radboud Univ Nijmegen, Ctr Infect Dis, NL-6500 Nijmegen, Netherlands.; Netea, MG (corresponding author), Univ Bonn, Immunol & Metab Life & Med Sci Inst, D-53115 Bonn, Germany.	mihai.netea@radboudumc.nl	van de Veerdonk, Frank L/C-7256-2008; van Crevel, reinout/A-6636-2010; Dominguez-Andres, Jorge/S-6211-2017	van de Veerdonk, Frank L/0000-0002-1121-4894; van Crevel, reinout/0000-0002-6233-6410; Dominguez-Andres, Jorge/0000-0002-9091-1961	ERC [833247]; Spinoza grant of the Netherlands Association for Scientific Research; National Institutes of Health [R01AI145781]; European Union [RIA2018CO-2514-PROTID]	ERC(European Research Council (ERC)European Commission); Spinoza grant of the Netherlands Association for Scientific Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission)	M.G.N. was supported by an ERC advanced grant (833247) and a Spinoza grant of the Netherlands Association for Scientific Research. R.v.C. is supported by the National Institutes of Health (R01AI145781) and European Union (RIA2018CO-2514-PROTID).	Arts RJW, 2018, CELL HOST MICROBE, V23, P89, DOI 10.1016/j.chom.2017.12.010; Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004; Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x; Dayal D., 2020, CONNECTING BCG VACCI, DOI [10.1101/2020.04.07.20053272, DOI 10.1101/2020.04.07.20053272]; FLOCH F, 1976, ANN INST PASTEUR IMM, VC127, P173; Freyne B, 2015, T ROY SOC TROP MED H, V109, P52, DOI 10.1093/trstmh/tru197; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Goodridge HS, 2016, NAT REV IMMUNOL, V16, P392, DOI 10.1038/nri.2016.43; Green CM, 2020, MEDRXIV, V2020, DOI [10.1101/2020.04.10.20060905, DOI 10.1101/2020.04.10.20060905]; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hatherill M, 2014, VACCINE, V32, P3982, DOI 10.1016/j.vaccine.2014.04.084; Higgins JPT, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5170; Huang KJ, 2005, J MED VIROL, V75, P185, DOI 10.1002/jmv.20255; ISHIHARA C, 1987, VACCINE, V5, P295, DOI 10.1016/0264-410X(87)90155-1; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kumaki Y, 2017, ANTIVIR RES, V139, P1, DOI 10.1016/j.antiviral.2016.12.007; Machiels B, 2017, NAT IMMUNOL, V18, P1310, DOI 10.1038/ni.3857; Miller A., 2020, MEDRXIV, DOI 10.1101/2020.03.24.20042937; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Moorlag SJCFM, 2019, CLIN MICROBIOL INFEC, V25, P1473, DOI 10.1016/j.cmi.2019.04.020; Mukherjee S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180143; Nemes E, 2018, NEW ENGL J MED, V379, P138, DOI [10.1056/NEJMoa1714021, 10.1056/nejmoa1714021]; Netea MG, 2020, NAT REV IMMUNOL, V20, P375, DOI 10.1038/s41577-020-0285-6; Nieuwenhuizen NE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01147; Ohrui Takashi, 2005, Nihon Ronen Igakkai Zasshi, V42, P34; Ong EZY, 2020, CELL HOST MICROBE, V27, P879, DOI 10.1016/j.chom.2020.03.021; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Sheahan T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000240; Shi CS, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0181-7; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; SPENCER JC, 1977, J INFECT DIS, V136, P171, DOI 10.1093/infdis/136.2.171; STARR SE, 1976, P SOC EXP BIOL MED, V152, P57; SUENAGA T, 1978, INFECT IMMUN, V20, P312, DOI 10.1128/IAI.20.1.312-314.1978; ter Horst R, 2016, CELL, V167, P1111, DOI 10.1016/j.cell.2016.10.018; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; Totura AL, 2015, MBIO, V6, DOI 10.1128/mBio.00638-15; Wardhana, 2011, Acta Med Indones, V43, P185; Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x; Wu DD, 2020, J MICROBIOL IMMUNOL, V53, P368, DOI 10.1016/j.jmii.2020.03.005; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yao YS, 2018, CELL, V175, P1634, DOI 10.1016/j.cell.2018.09.042; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	44	245	247	8	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2020	181	5					969	977		10.1016/j.cell.2020.04.042	http://dx.doi.org/10.1016/j.cell.2020.04.042			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LT9QF	32437659	Green Published, Bronze			2022-12-28	WOS:000537399500005
J	Griffin, S				Griffin, Shaun			Covid-19: "Huge rise" in deaths at home is not fully explained by virus, say experts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item													Griffin, Shaun/GLT-2847-2022					[Anonymous], 2020, DEATHS INV COVID 19; Office for National Statistics, 2020, DEATHS REG WEEKL ENG	2	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2020	369								m2115	10.1136/bmj.m2115	http://dx.doi.org/10.1136/bmj.m2115			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JX	32461232	Bronze			2022-12-28	WOS:000538337100014
J	Armstrong, S				Armstrong, Stephen			Covid-19: Deadline for roll out of UK's tracing app will be missed	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, UK GOV NOW BUILD 2 C; Culnane C, 2020, SECURITY ANAL NHS CO; Etherington D., 2020, CONTAGION TRACING IS; IACOBUCCI G, 2020, BMJ-BRIT MED J, V369, P76638, DOI DOI 10.1136/BMJ.M1845; Kelion L., 2020, BBC NEWS; University of Oxford, 2020, DIG CONT TRAC CAN SL	6	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2020	369								m2085	10.1136/bmj.m2085	http://dx.doi.org/10.1136/bmj.m2085			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JW	32457165	Bronze			2022-12-28	WOS:000538337000010
J	Baxter, BT; Matsumura, J; Curci, JA; McBride, R; Larson, L; Blackwelder, W; Lam, D; Wijesinha, M; Terrin, M				Baxter, B. Timothy; Matsumura, Jon; Curci, John A.; McBride, Ruth; Larson, LuAnn; Blackwelder, William; Lam, Diana; Wijesinha, Marniker; Terrin, Michael		N-TA3CT Investigators	Effect of Doxycycline on Aneurysm Growth Among Patients With Small Infrarenal Abdominal Aortic Aneurysms A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOSE-DOXYCYCLINE; DOUBLE-BLIND; INHIBITION; BIOMARKERS; DISEASE; MATRIX-METALLOPROTEINASE-9; AZITHROMYCIN; ACTIVATION; EXPRESSION; REPAIR	IMPORTANCE Abdominal aortic aneurysms affect more than 3% of US older adults. OBJECTIVE To test whether doxycycline reduces the growth of abdominal aortic aneurysm over 2 years as measured by maximum transverse diameter. DESIGN, SETTING, AND PARTICIPANTS Parallel, 2-group, randomized clinical trial that was conducted at 22 US clinical centers between May 2013 and January 2017, and enrolled patients 50 years or older with small (3.5-5.0 cm for men, 3.5-4.5 cm for women) infrarenal aneurysms. The final date of follow-up was July 31, 2018. INTERVENTIONS Patients were randomized to receive twice daily for 2 years doxycycline 100 mg orally (as capsules) (n = 133) or placebo (n = 128). MAIN OUTCOMES AND MEASURES The primary outcome was change in abdominal aortic aneurysm maximum transverse diameter measured from CT images at baseline and follow-up at 2 years. Patients were assigned ranks based on the maximum transverse diameter (measured or imputed) of the aorta and also if they underwent aneurysm repair or died. The ranks were converted to scores having a normal distribution to facilitate the primary analysis ("normal scores"). RESULTS Of 261 patients randomized, no follow-up CT scans were obtained on 7 (3%), leaving a final analysis set of 129 patients assigned to doxycycline and 125 to placebo (mean [SD] age, 71.0 years [7.4 years], 35 women [14%]). The outcome normal scores used in the primary analysis were based on maximum transverse diameter (measured or imputed) in 113 patients (88%) in the doxycycline group and 112 patients (90%) in the placebo group; aneurysm repair in 13 (10%) and 9 (7%), and death in 3 (2%) and 4 (3%), respectively. The primary outcome, normal scores reflecting change in aortic diameter, did not differ significantly between the 2 groups, mean change in normal scores, 0.0262 vs -0.0258 (1-sided P = .71). Mean (SD) baseline maximum transverse diameter was 4.3 cm (0.4 cm) for doxycycline and 4.3 cm (0.4 cm) for placebo. At the 2-year follow-up, the change in measured maximum transverse diameter was 0.36 cm (95% CI, 0.31 to 0.40 cm) for 96 patients in the doxycycline group vs 0.36 cm (95% CI, 0.30 to 0.41 cm) for 101 patients in the placebo group (difference, 0.0; 95% CI, -0.07 to 0.07 cm; 2-sided P = .93). No patients were withdrawn from the study because of adverse effects. Joint pain occurred in 84 of 129 patients (65%) with doxycycline and 79 of 125 (63%) with placebo. CONCLUSIONS AND RELEVANCE Among patients with small infrarenal abdominal aortic aneurysms, doxycycline compared with placebo did not significantly reduce aneurysm growth at 2 years. These findings do not support the use of doxycycline for reducing the growth of small abdominal aortic aneurysms.	[Baxter, B. Timothy; Larson, LuAnn] Univ Nebraska, Sch Med, Dept Surg, Omaha, NE 68198 USA; [Matsumura, Jon] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA; [Curci, John A.] Vanderbilt Univ, Dept Surg, Sch Med, Nashville, TN 37240 USA; [McBride, Ruth] Axio Res LLC, Seattle, WA USA; [Blackwelder, William; Wijesinha, Marniker; Terrin, Michael] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 660 W Redwood St,Ste 200, Baltimore, MD 21201 USA; [Lam, Diana] Genentech Inc, Oakland, CA USA	University of Nebraska System; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University; University System of Maryland; University of Maryland Baltimore; Roche Holding; Genentech	Terrin, M (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 660 W Redwood St,Ste 200, Baltimore, MD 21201 USA.	mterrin@som.umaryland.edu	Curci, John A./J-4238-2019; Wijesinha, Marniker/ABA-7688-2020	Curci, John A./0000-0002-9928-9400; 	NIA [R34 AG028684, R01 AG037120, T32 AG000262, P30 AG0288747]; NIH	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants R34 AG028684, R01 AG037120, T32 AG000262, and P30 AG0288747 from the NIA. N-TA3CT was funded by the NIH through a grant award to the University of Maryland, Baltimore.	Barnard J, 1999, BIOMETRIKA, V86, P948, DOI 10.1093/biomet/86.4.948; Baxter BT, 2016, CONTEMP CLIN TRIALS, V48, P91, DOI 10.1016/j.cct.2016.03.008; Benson RA, 2016, J VASC SURG, V63, P301, DOI 10.1016/j.jvs.2015.08.091; Bicknell CD, 2016, EUR HEART J, V37, P3213, DOI 10.1093/eurheartj/ehw257; Bouvet C, 2008, ARTERIOSCL THROM VAS, V28, P856, DOI 10.1161/ATVBAHA.107.153056; Cramer CL, 2017, POSTGRAD MED, V129, P493, DOI 10.1080/00325481.2017.1285677; Curci JA, 2000, J VASC SURG, V31, P325, DOI 10.1016/S0741-5214(00)90163-0; Curci JA, 1998, J VASC SURG, V28, P1082, DOI 10.1016/S0741-5214(98)70035-7; Daye D, 2018, CARDIOVASC DIAGN THE, V8, pS138, DOI 10.21037/cdt.2017.09.17; Grondal N, 2015, BRIT J SURG, V102, P902, DOI 10.1002/bjs.9825; Karthikesalingam A, 2016, NEW ENGL J MED, V375, P2051, DOI 10.1056/NEJMoa1600931; Kobayashi Y, 2013, J PHARMACOL EXP THER, V345, P76, DOI 10.1124/jpet.112.200733; Lachin JM, 2005, STAT MED, V24, P2747, DOI 10.1002/sim.2151; Laupacis A, 2002, J VASC SURG, V35, P72, DOI 10.1067/mva.2002.121308; Lederle FA, 2015, BRIT J SURG, V102, P1480, DOI 10.1002/bjs.9895; Lederle FA, 2013, ANN INTERN MED, V159, P852, DOI 10.7326/0003-4819-159-12-201312170-00012; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Ludbrook J, 2013, CLIN EXP PHARMACOL P, V40, P357, DOI 10.1111/1440-1681.12086; Meijer CA, 2013, ANN INTERN MED, V159, P815, DOI 10.7326/0003-4819-159-12-201312170-00007; Mosorin M, 2001, J VASC SURG, V34, P606, DOI 10.1067/mva.2001.117891; Muehling BM, 2011, VASC ENDOVASC SURG, V45, P63, DOI 10.1177/1538574410380935; Parnham MJ, 2014, PHARMACOL THERAPEUT, V143, P225, DOI 10.1016/j.pharmthera.2014.03.003; Payne JB, 2011, J AM DENT ASSOC, V142, P262, DOI 10.14219/jada.archive.2011.0165; Petrinec D, 1996, J VASC SURG, V23, P336, DOI 10.1016/S0741-5214(96)70279-3; Pinchbeck JL, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009866; Powell JT, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7661; Prall AK, 2002, J VASC SURG, V35, P923, DOI 10.1067/mva.2002.123757; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Sillesen H, 2015, BRIT J SURG, V102, P894, DOI 10.1002/bjs.9824; Stather PW, 2014, BRIT J SURG, V101, P1358, DOI 10.1002/bjs.9593; Tuter G, 2007, J CLIN PERIODONTOL, V34, P673, DOI 10.1111/j.1600-051X.2007.01104.x	33	47	47	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					2029	2038		10.1001/jama.2020.5230	http://dx.doi.org/10.1001/jama.2020.5230			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU8UM	32453369	Bronze, Green Published			2022-12-28	WOS:000538023900034
J	Rubin, R				Rubin, Rita			Fish-Rich Mediterranean Diet Associated With Higher Cognition	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					1998	1998		10.1001/jama.2020.7061	http://dx.doi.org/10.1001/jama.2020.7061			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU8UM	32453351				2022-12-28	WOS:000538023900012
J	Dyer, C				Dyer, Clare			DNACPR notices: campaigner for patients' right to be consulted says government has misunderstood her demands	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1856	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2020	369								m2034	10.1136/bmj.m2034	http://dx.doi.org/10.1136/bmj.m2034			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JK	32434757	Bronze			2022-12-28	WOS:000538335800010
J	Gerry, S; Bonnici, T; Birks, J; Kirtley, S; Virdee, PS; Watkinson, PJ; Collins, GS				Gerry, Stephen; Bonnici, Timothy; Birks, Jacqueline; Kirtley, Shona; Virdee, Pradeep S.; Watkinson, Peter J.; Collins, Gary S.			Early warning scores for detecting deterioration in adult hospital patients: systematic review and critical appraisal of methodology	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INTENSIVE-CARE-UNIT; MULTIVARIABLE PREDICTION MODEL; INFLAMMATORY RESPONSE SYNDROME; LOGISTIC-REGRESSION MODELS; ELECTRONIC HEALTH RECORDS; ORGAN FAILURE ASSESSMENT; CARDIAC-ARREST; CLINICAL DETERIORATION; MEDICAL ADMISSIONS; VITAL SIGNS	OBJECTIVE To provide an overview and critical appraisal of early warning scores for adult hospital patients. DESIGN Systematic review. DATA SOURCES Medline, CINAHL, PsycInfo, and Embase until June 2019. ELIGIBILITY CRITERIA FOR STUDY SELECTION Studies describing the development or external validation of an early warning score for adult hospital inpatients. RESULTS 13 171 references were screened and 95 articles were included in the review. 11 studies were development only, 23 were development and external validation, and 61 were external validation only. Most early warning scores were developed for use in the United States (n=13/34, 38%) and the United Kingdom (n=10/34, 29%). Death was the most frequent prediction outcome for development studies (n=10/23, 44%) and validation studies (n=66/84, 79%), with different time horizons (the most frequent was 24 hours). The most common predictors were respiratory rate (n=30/34, 88%), heart rate (n=28/34, 83%), oxygen saturation, temperature, and systolic blood pressure (all n=24/34, 71%). Age (n=13/34, 38%) and sex (n=3/34, 9%) were less frequently included. Key details of the analysis populations were often not reported in development studies (n=12/29, 41%) or validation studies (n=33/84, 39%). Small sample sizes and insufficient numbers of event patients were common in model development and external validation studies. Missing data were often discarded, with just one study using multiple imputation. Only nine of the early warning scores that were developed were presented in sufficient detail to allow individualised risk prediction. Internal validation was carried out in 19 studies, but recommended approaches such as bootstrapping or cross validation were rarely used (n=4/19, 22%). Model performance was frequently assessed using discrimination (development n=18/22, 82%; validation n=69/84, 82%), while calibration was seldom assessed (validation n=13/84, 15%). All included studies were rated at high risk of bias. CONCLUSIONS Early warning scores are widely used prediction models that are often mandated in daily clinical practice to identify early clinical deterioration in hospital patients. However, many early warning scores in clinical use were found to have methodological weaknesses. Early warning scores might not perform as well as expected and therefore they could have a detrimental effect on patient care. Future work should focus on following recommended approaches for developing and evaluating early warning scores, and investigating the impact and safety of using these scores in clinical practice.	[Gerry, Stephen; Birks, Jacqueline; Kirtley, Shona; Virdee, Pradeep S.; Collins, Gary S.] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Bonnici, Timothy] Univ Coll London Hosp NHS Trust, Crit Care Div, London, England; [Birks, Jacqueline; Collins, Gary S.] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [Watkinson, Peter J.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England	University of Oxford; University College London Hospitals NHS Foundation Trust; University of London; University College London; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Collins, GS (corresponding author), Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England.; Collins, GS (corresponding author), Oxford Univ Hosp NHS Fdn Trust, Oxford, England.	stephen.gerry@csm.ox.ac.uk	Virdee, Pradeep/AAI-1261-2019; Collins, Gary Stephen/A-2258-2014	Virdee, Pradeep/0000-0002-3006-8730; Collins, Gary Stephen/0000-0002-2772-2316; Kirtley, Shona/0000-0002-7801-5777; Watkinson, Peter/0000-0003-1023-3927; Gerry, Stephen/0000-0003-4654-7311	National Institute for Health Research (NIHR) Doctoral Research Fellowship [DRF-2016-09-173]; NIHR Oxford Biomedical Research Centre; Cancer Research UK [C49297/A27294]; NIHR Doctoral Research Fellowship [DRF2018-11-ST2-057]	National Institute for Health Research (NIHR) Doctoral Research Fellowship(National Institute for Health Research (NIHR)); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); NIHR Doctoral Research Fellowship	SG is funded by a National Institute for Health Research (NIHR) Doctoral Research Fellowship (DRF-2016-09-173). JB, PJW, and GSC are funded by the NIHR Oxford Biomedical Research Centre. SK and GSC are funded by Cancer Research UK (grant No C49297/A27294). PV is funded by an NIHR Doctoral Research Fellowship (DRF2018-11-ST2-057). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health and Social Care, or Cancer Research UK.	Abbott TEF, 2016, EUR J INTERN MED, V35, P78, DOI 10.1016/j.ejim.2016.06.014; Abbott TEF, 2015, RESUSCITATION, V92, P89, DOI 10.1016/j.resuscitation.2015.04.020; Alam N, 2014, RESUSCITATION, V85, P587, DOI 10.1016/j.resuscitation.2014.01.013; Albert BL, 2011, DIMENS CRIT CARE NUR, V30, P283, DOI 10.1097/DCC.0b013e318227761d; Alvarez CA, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-28; Ambler G, 2007, STAT METHODS MED RES, V16, P277, DOI 10.1177/0962280206074466; Atmaca O, 2018, TURK J MED SCI, V48, P1087, DOI 10.3906/sag-1706-67; Austin PC, 2016, STAT MED, V35, P4056, DOI 10.1002/sim.6994; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Austin PC, 2014, STAT MED, V33, P517, DOI 10.1002/sim.5941; Badriyah T, 2014, RESUSCITATION, V85, P418, DOI 10.1016/j.resuscitation.2013.12.011; Bartkowiak B, 2019, ANN SURG, V269, P1059, DOI 10.1097/SLA.0000000000002665; Beane A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019387; Blanche P, 2013, STAT MED, V32, P5381, DOI 10.1002/sim.5958; Bleyer AJ, 2011, RESUSCITATION, V82, P1387, DOI 10.1016/j.resuscitation.2011.06.033; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Brabrand M, 2018, LUNG, V196, P359, DOI 10.1007/s00408-018-0105-y; Brabrand M, 2017, EUR J INTERN MED, V45, P32, DOI 10.1016/j.ejim.2017.09.042; Brangan E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022528; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Cei M, 2009, INT J CLIN PRACT, V63, P591, DOI 10.1111/j.1742-1241.2008.01986.x; Christodoulou E, 2019, J CLIN EPIDEMIOL, V110, P12, DOI 10.1016/j.jclinepi.2019.02.004; Churpek MM, 2017, CRIT CARE MED, V45, P1805, DOI 10.1097/CCM.0000000000002648; Churpek MM, 2017, AM J RESP CRIT CARE, V195, P906, DOI 10.1164/rccm.201604-0854OC; Churpek MM, 2016, RESUSCITATION, V102, P1, DOI 10.1016/j.resuscitation.2016.02.005; Churpek MM, 2014, AM J RESP CRIT CARE, V190, P649, DOI 10.1164/rccm.201406-1022OC; Churpek MM, 2014, CRIT CARE MED, V42, P841, DOI 10.1097/CCM.0000000000000038; Churpek MM, 2013, CHEST, V143, P1758, DOI 10.1378/chest.12-1605; Churpek MM, 2013, RESUSCITATION, V84, P564, DOI 10.1016/j.resuscitation.2012.09.024; Churpek MM, 2012, CRIT CARE MED, V40, P2102, DOI 10.1097/CCM.0b013e318250aa5a; Churpek MM, 2012, CHEST, V141, P1170, DOI 10.1378/chest.11-1301; Collins GS, 2016, STAT MED, V35, P214, DOI 10.1002/sim.6787; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Collins GS, 2013, J CLIN EPIDEMIOL, V66, P268, DOI 10.1016/j.jclinepi.2012.06.020; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Cooksley T, 2012, QJM-INT J MED, V105, P1083, DOI 10.1093/qjmed/hcs138; Corfield AR, 2014, EMERG MED J, V31, P482, DOI 10.1136/emermed-2012-202186; Cuthbertson BH, 2010, J ROY COLL PHYS EDIN, V40, P19, DOI 10.4997/JRCPE.2010.105; Damen JAAG, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2416; De Meester K, 2013, RESUSCITATION, V84, P184, DOI 10.1016/j.resuscitation.2012.06.017; DeVoe B, 2016, HEART LUNG, V45, P497, DOI 10.1016/j.hrtlng.2016.08.010; Douw G, 2017, J CLIN NURS, V26, P2605, DOI 10.1111/jocn.13648; Douw G, 2016, INT J NURS STUD, V59, P134, DOI 10.1016/j.ijnurstu.2016.04.006; Duckitt RW, 2007, BRIT J ANAESTH, V98, P769, DOI 10.1093/bja/aem097; Dziadzko MA, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2194-7; Eccles SR, 2014, RESUSCITATION, V85, P109, DOI 10.1016/j.resuscitation.2013.08.277; Escobar GJ, 2012, J HOSP MED, V7, P388, DOI 10.1002/jhm.1929; Fairclough E, 2009, CLIN MED, V9, P30, DOI 10.7861/clinmedicine.9-1-30; Faisal M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022939; Finlay GD, 2014, J HOSP MED, V9, P116, DOI 10.1002/jhm.2132; Forster S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020269; Gao HY, 2007, INTENS CARE MED, V33, P667, DOI 10.1007/s00134-007-0532-3; Garcea G, 2006, J GASTROINTEST SURG, V10, P1008, DOI 10.1016/j.gassur.2006.03.008; Gardner-Thorpe J, 2006, ANN ROY COLL SURG, V88, P571, DOI 10.1308/003588406X130615; Gerds TA, 2014, STAT MED, V33, P3191, DOI 10.1002/sim.6152; Gerds TA, 2012, STAT MED, V31, P3921, DOI 10.1002/sim.5459; Gerry S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-019268; Ghanem-Zoubi NO, 2011, CRIT CARE, V15, DOI 10.1186/cc10102; Ghosh E, 2018, RESUSCITATION, V122, P99, DOI 10.1016/j.resuscitation.2017.10.026; Goldhill DR, 2004, BRIT J ANAESTH, V92, P882, DOI 10.1093/bja/aeh113; Goldstein BA, 2017, STAT MED, V36, P2750, DOI 10.1002/sim.7308; Goldstein BA, 2017, J AM MED INFORM ASSN, V24, P198, DOI 10.1093/jamia/ocw042; Green M, 2018, RESUSCITATION, V123, P86, DOI 10.1016/j.resuscitation.2017.10.028; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Harrison GA, 2006, RESUSCITATION, V71, P327, DOI 10.1016/j.resuscitation.2006.05.008; Hillman KM, 2002, INTENS CARE MED, V28, P1629, DOI 10.1007/s00134-002-1496-y; Hodgson LE, 2017, THORAX, V72, P23, DOI 10.1136/thoraxjnl-2016-208436; Hydes TJ, 2018, CLIN GASTROENTEROL H, V16, P1657, DOI 10.1016/j.cgh.2017.12.035; Inada-Kim M, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k1260; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; Jo S, 2016, AM J EMERG MED, V34, P536, DOI 10.1016/j.ajem.2015.12.067; Jones M, 2012, CLIN MED, V12, P501, DOI 10.7861/clinmedicine.12-6-501; Kellett J, 2006, QJM-INT J MED, V99, P771, DOI 10.1093/qjmed/hcl112; Kellett J, 2008, RESUSCITATION, V78, P52, DOI 10.1016/j.resuscitation.2008.02.011; Kellett J, 2016, RESUSCITATION, V102, P94, DOI 10.1016/j.resuscitation.2016.02.020; Kellett J, 2012, RESUSCITATION, V83, P297, DOI 10.1016/j.resuscitation.2011.08.022; Kim D, 2018, CLIN EXP EMERG MED, V5, P219, DOI 10.15441/ceem.17.268; Kim WY, 2017, J CRIT CARE, V40, P213, DOI 10.1016/j.jcrc.2017.04.024; Kipnis P, 2016, J BIOMED INFORM, V64, P10, DOI 10.1016/j.jbi.2016.09.013; Kirkland LL, 2013, AM J MED QUAL, V28, P135, DOI 10.1177/1062860612450459; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, P17, DOI [10.17226/9728, DOI 10.17226/9728, https://doi.org/10.17226/9728]; Kovacs C, 2016, BRIT J SURG, V103, P1385, DOI 10.1002/bjs.10267; Kruisselbrink R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151408; Kwon JM, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008678; Kyriacos U, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087073, 10.1371/journal.pone.0087320]; Le Lagadec MD, 2020, AUST CRIT CARE, V33, P47, DOI 10.1016/j.aucc.2019.03.001; Lee YS, 2018, J CRIT CARE, V47, P222, DOI 10.1016/j.jcrc.2018.07.011; Liljehult J, 2016, ACTA NEUROL SCAND, V133, P261, DOI 10.1111/ane.12452; Linnen DT, 2019, J HOSP MED, V14, P161, DOI 10.12788/jhm.3151; Little R.J.A., 2002, STAT ANAL MISSING DA, V2nd Edn, DOI [10.1002/9781119013563, DOI 10.1002/9781119013563]; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; Luis L, 2018, AUST CRIT CARE, V31, P376, DOI 10.1016/j.aucc.2017.11.004; McGaughey J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005529; Meads C, 2012, BREAST CANCER RES TR, V132, P365, DOI 10.1007/s10549-011-1818-2; Moher David, 2009, Open Med, V3, pe123; Moore CC, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000344; Morgan R.L, 1997, EARLY WARNING SCORIN; Mulligan Alison, 2010, Intensive Crit Care Nurs, V26, P196, DOI 10.1016/j.iccn.2010.03.002; National Institute for Health and Care Excellence, AC ILL AD HOSP REC R; Nickel CH, 2016, RESUSCITATION, V106, P49, DOI 10.1016/j.resuscitation.2016.06.012; Ohman MC, 2018, QJM-INT J MED, V111, P385, DOI 10.1093/qjmed/hcy053; Opio M O, 2013, Acute Med, V12, P135; Opio MO, 2013, RESUSCITATION, V84, P743, DOI 10.1016/j.resuscitation.2013.02.007; Pedersen NE, 2018, ACTA ANAESTH SCAND, V62, P242, DOI 10.1111/aas.13020; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Perera Yashasvi Sanja, 2011, Acute Med, V10, P126; Pimentel MAF, 2019, RESUSCITATION, V134, P147, DOI 10.1016/j.resuscitation.2018.09.026; Plate Joost Dj, 2018, World J Crit Care Med, V7, P39, DOI 10.5492/wjccm.v7.i3.39; Prince Charles Hospital, MOD EARL WARN SCOR M; Prytherch DR, 2010, RESUSCITATION, V81, P932, DOI 10.1016/j.resuscitation.2010.04.014; Redfern OC, 2018, RESUSCITATION, V133, P75, DOI 10.1016/j.resuscitation.2018.09.021; Redfern OC, 2018, CRIT CARE MED, V46, P1923, DOI 10.1097/CCM.0000000000003359; Riley RD, 2019, STAT MED, V38, P5672, DOI 10.1002/sim.8409; Roberts D, 2017, AM J EMERG MED, V35, P1601, DOI 10.1016/j.ajem.2017.04.072; Romero-Brufau S, 2017, J HOSP MED, V12, P217, DOI 10.12788/jhm.2712; Romero-Brufau S, 2014, RESUSCITATION, V85, P549, DOI 10.1016/j.resuscitation.2013.12.017; Royal College of Physicians, 2017, ROYAL COLL PHYS NAT; Rylance J, 2009, T ROY SOC TROP MED H, V103, P790, DOI 10.1016/j.trstmh.2009.05.004; Silcock DJ, 2015, RESUSCITATION, V89, P31, DOI 10.1016/j.resuscitation.2014.12.029; Silke B, 2010, QJM-INT J MED, V103, P23, DOI 10.1093/qjmed/hcp149; Smith GB, 2008, RESUSCITATION, V77, P170, DOI 10.1016/j.resuscitation.2007.12.004; Smith GB, 2016, CRIT CARE MED, V44, P2171, DOI 10.1097/CCM.0000000000002000; Smith GB, 2013, RESUSCITATION, V84, P465, DOI 10.1016/j.resuscitation.2012.12.016; Smith HJ, 2016, GYNECOL ONCOL, V143, P105, DOI 10.1016/j.ygyno.2016.08.153; Smith M E Beth, 2014, Ann Am Thorac Soc, V11, P1454, DOI 10.1513/AnnalsATS.201403-102OC; Spagnolli W, 2017, INT J CLIN PRACT, V71, DOI 10.1111/ijcp.12934; Stark AP, 2015, AM SURGEON, V81, P916; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Straede M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105695; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Suppiahl A, 2014, J PANCREAS, V15, P569, DOI 10.6092/1590-8577/2829; Tarassenko L, 2011, RESUSCITATION, V82, P1013, DOI 10.1016/j.resuscitation.2011.03.006; Tirkkonen J, 2014, ACTA ANAESTH SCAND, V58, P411, DOI 10.1111/aas.12277; Tirotta D, 2017, QJM-INT J MED, V110, P369, DOI 10.1093/qjmed/hcw229; Van Calster B, 2018, EUR UROL, V74, P796, DOI 10.1016/j.eururo.2018.08.038; Van Calster B, 2016, J CLIN EPIDEMIOL, V74, P167, DOI 10.1016/j.jclinepi.2015.12.005; van Smeden M, 2019, STAT METHODS MED RES, V28, P2455, DOI 10.1177/0962280218784726; Vaughn JL, 2018, LEUKEMIA LYMPHOMA, V59, P1498, DOI 10.1080/10428194.2017.1376744; Vergouwe Y, 2010, J CLIN EPIDEMIOL, V63, P205, DOI 10.1016/j.jclinepi.2009.03.017; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; von Lilienfeld-Toal M, 2007, BIOL BLOOD MARROW TR, V13, P568, DOI 10.1016/j.bbmt.2006.12.455; Watkinson PJ, 2018, RESUSCITATION, V129, P55, DOI 10.1016/j.resuscitation.2018.06.003; Wheeler I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059830; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wolbers M, 2014, EUR HEART J, V35, P2936, DOI 10.1093/eurheartj/ehu131; Wolbers M, 2009, EPIDEMIOLOGY, V20, P555, DOI 10.1097/EDE.0b013e3181a39056; Wolff RF, 2019, ANN INTERN MED, V170, P51, DOI 10.7326/M18-1376; Wong D, 2015, BMC MED INFORM DECIS, V15, DOI [10.1186/s12911-016-0257-8, 10.1186/s12911-015-0186-y]; Wynants L, 2019, Diagn Progn Res, V3, P6, DOI 10.1186/s41512-019-0046-9	152	88	89	2	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2020	369								m1501	10.1136/bmj.m1501	http://dx.doi.org/10.1136/bmj.m1501			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LV3JK	32434791	Green Published, hybrid			2022-12-28	WOS:000538335800002
J	Sorensen, JJWH; Pedersen, MK; Munch, M; Haikka, P; Jensen, JH; Planke, T; Andreasen, MG; Gajdacz, M; Molmer, K; Lieberoth, A; Sherson, JF				Sorensen, Jens Jakob W. H.; Pedersen, Mads Kock; Munch, Michael; Haikka, Pinja; Jensen, Jesper Halkjaer; Planke, Tilo; Andreasen, Morten Ginnerup; Gajdacz, Miroslav; Molmer, Klaus; Lieberoth, Andreas; Sherson, Jacob F.			Editorial Expression of Concern: Exploring the quantum speed limit with computer games	NATURE			English	Editorial Material									[Sorensen, Jens Jakob W. H.; Pedersen, Mads Kock; Munch, Michael; Haikka, Pinja; Jensen, Jesper Halkjaer; Planke, Tilo; Andreasen, Morten Ginnerup; Gajdacz, Miroslav; Molmer, Klaus; Lieberoth, Andreas; Sherson, Jacob F.] Aarhus Univ, Dept Phys, Astronomy, Aarhus, Denmark	Aarhus University	Sherson, JF (corresponding author), Aarhus Univ, Dept Phys, Astronomy, Aarhus, Denmark.	sherson@phys.au.dk		Munch, Michael/0000-0002-3692-4091; Lieberoth, Andreas/0000-0003-0214-5791; Gajdacz, Miroslav/0000-0003-1134-758X					0	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY	2020	581	7808					E7	E7		10.1038/s41586-020-2274-0	http://dx.doi.org/10.1038/s41586-020-2274-0		MAY 2020	1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ2CZ	32433605	Bronze			2022-12-28	WOS:000531504000001
J	Price-Haywood, EG; Burton, MPHJ; Fort, D; Seoane, L				Price-Haywood, Eboni G.; Burton, M. P. H. Jeffrey; Fort, Daniel; Seoane, Leonardo			Hospitalization and Mortality among Black Patients and White Patients with Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BACKGROUND Many reports on coronavirus disease 2019 (Covid-19) have highlighted age- and sex-related differences in health outcomes. More information is needed about racial and ethnic differences in outcomes from Covid-19. METHODS In this retrospective cohort study, we analyzed data from patients seen within an integrated-delivery health system (Ochsner Health) in Louisiana between March 1 and April 11, 2020, who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, the virus that causes Covid-19) on qualitative polymerase-chain-reaction assay. The Ochsner Health population is 31% black non-Hispanic and 65% white non-Hispanic. The primary outcomes were hospitalization and in-hospital death. RESULTS A total of 3626 patients tested positive, of whom 145 were excluded (84 had missing data on race or ethnic group, 9 were Hispanic, and 52 were Asian or of another race or ethnic group). Of the 3481 Covid-19-positive patients included in our analyses, 60.0% were female, 70.4% were black non-Hispanic, and 29.6% were white non-Hispanic. Black patients had higher prevalences of obesity, diabetes, hypertension, and chronic kidney disease than white patients. A total of 39.7% of Covid-19-positive patients (1382 patients) were hospitalized, 76.9% of whom were black. In multivariable analyses, black race, increasing age, a higher score on the Charlson Comorbidity Index (indicating a greater burden of illness), public insurance (Medicare or Medicaid), residence in a low-income area, and obesity were associated with increased odds of hospital admission. Among the 326 patients who died from Covid-19, 70.6% were black. In adjusted time-to-event analyses, variables that were associated with higher in-hospital mortality were increasing age and presentation with an elevated respiratory rate; elevated levels of venous lactate, creatinine, or procalcitonin; or low platelet or lymphocyte counts. However, black race was not independently associated with higher mortality (hazard ratio for death vs. white race, 0.89; 95% confidence interval, 0.68 to 1.17). CONCLUSIONS In a large cohort in Louisiana, 76.9% of the patients who were hospitalized with Covid-19 and 70.6% of those who died were black, whereas blacks comprise only 31% of the Ochsner Health population. Black race was not associated with higher in-hospital mortality than white race, after adjustment for differences in socio-demographic and clinical characteristics on admission.	[Price-Haywood, Eboni G.; Burton, M. P. H. Jeffrey; Fort, Daniel] Ochsner Hlth Ctr Outcomes & Hlth Serv Res, New Orleans, LA USA; [Price-Haywood, Eboni G.; Seoane, Leonardo] Univ Queensland, Ochsner Clin Sch, New Orleans, LA USA	Ochsner Health System; University of Queensland	Price-Haywood, EG (corresponding author), Ctr Outcomes & Hlth Serv Res, Acad Ctr, 2nd Fl,1514 Jefferson Hwy, New Orleans, LA 70121 USA.	eboni.pricehaywood@ochsner.org	Price-Haywood, Eboni/L-5527-2014; Burton, Jeffrey/P-5910-2015	Price-Haywood, Eboni/0000-0003-2901-3852; Burton, Jeffrey/0000-0001-5267-1277				[Anonymous], 2020, COVID 19 CAS US; Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen QQ, 2020, INFECTION, V48, P543, DOI 10.1007/s15010-020-01432-5; Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P545, DOI 10.15585/mmwr.mm6918e1; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Han E, 2009, INT J OBESITY, V33, P249, DOI 10.1038/ijo.2008.193; Henry BM, 2020, CLIN CHEM LAB MED, V58, P1135, DOI 10.1515/cclm-2020-0272; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Johnston KJ, 2019, J GEN INTERN MED, V34, P1645, DOI 10.1007/s11606-019-05009-3; Louisiana Department of Health, 2018, LOUIS HLTH REP CARD; Louisiana Workforce Commission, 2015, LOUIS LAB FORC DIV D; Nedelec Y, 2016, CELL, V167, P657, DOI 10.1016/j.cell.2016.09.025; Ochsner Health, FACTS STAT; Richardson S, 2020, JAMA; United States Census Bureau, QUICK FACTS LOUIS; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	22	938	944	6	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2020	382	26					2534	2543		10.1056/NEJMsa2011686	http://dx.doi.org/10.1056/NEJMsa2011686			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MF9CW	32459916	Bronze, Green Published			2022-12-28	WOS:000545636400024
J	Koff, A; Malinis, M				Koff, Alan; Malinis, Maricar			Chest Pain and a Cavitary Lung Mass in a Woman With Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GUIDELINES; DIAGNOSIS	A woman from the Southeastern US with a history of smoking, poorly controlled diabetes, and inhalational medical marijuana use had 4 months of productive cough, weight loss, subjective fevers, 3 days of worsening chest pain, and a large right upper lobe cavitary mass on chest CT unresponsive to antibiotics. AFB smear and GeneXpert MTB/RIF testing were negative; she developed a right-sided tension pneumothorax after intubation for hypoxemia, and chest tube placement yielded charcoal-colored pleural fluid. What is the diagnosis and what would you do next?	[Koff, Alan; Malinis, Maricar] Yale Sch Med, Infect Dis Sect, Dept Med, New Haven, CT USA	Yale University	Malinis, M (corresponding author), Yale Sch Med, POB 208022, New Haven, CT 06520 USA.	maricar.malinis@yale.edu		Koff, Alan/0000-0003-1229-7860				Denning DW, 2016, EUR RESPIR J, V47, P45, DOI 10.1183/13993003.00583-2015; Endo S, 2001, ANN THORAC SURG, V72, P889, DOI 10.1016/S0003-4975(01)02884-3; Patterson TF, 2016, CLIN INFECT DIS, V63, pE1, DOI 10.1093/cid/ciw326	3	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2020	323	23					2421	2422		10.1001/jama.2020.4111	http://dx.doi.org/10.1001/jama.2020.4111			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MC6EC	32442247				2022-12-28	WOS:000543376700026
J	Parks, JM; Smith, JC				Parks, Jerry M.; Smith, Jeremy C.			How to Discover Antiviral Drugs Quickly	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Parks, Jerry M.; Smith, Jeremy C.] Univ Tennessee, Oak Ridge Natl Lab, Ctr Mol Biophys, Biosci Div, Oak Ridge, TN 37830 USA; [Smith, Jeremy C.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Parks, JM (corresponding author), Univ Tennessee, Oak Ridge Natl Lab, Ctr Mol Biophys, Biosci Div, Oak Ridge, TN 37830 USA.			Parks, Jerry/0000-0002-3103-9333				Amaro RE, 2018, BIOPHYS J, V114, P2271, DOI 10.1016/j.bpj.2018.02.038; Gorgulla C, 2020, NATURE, V580, P663, DOI 10.1038/s41586-020-2117-z; Smith M, 2020, PREPRINT, DOI [DOI 10.26434/CHEMRXIV.11871402.V3, 10.26434/chemrxiv.11871402.v4]	3	42	44	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2020	382	23					2261	2264		10.1056/NEJMcibr2007042	http://dx.doi.org/10.1056/NEJMcibr2007042			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LV0NI	32433861	Bronze, Green Submitted			2022-12-28	WOS:000538140600022
J	Vico-Alonso, C; Palencia-Perez, S				Vico-Alonso, Cristina; Palencia-Perez, Sara			Linear IgA Bullous Dermatosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vico-Alonso, Cristina; Palencia-Perez, Sara] Hosp Univ 12 Octubre, Madrid, Spain	Hospital Universitario 12 de Octubre	Vico-Alonso, C (corresponding author), Hosp Univ 12 Octubre, Madrid, Spain.	c.vicoalonso@gmail.com		Palencia-Perez, Sara-Isabel/0000-0002-4930-0042					0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2020	382	23					2248	2248		10.1056/NEJMicm1913412	http://dx.doi.org/10.1056/NEJMicm1913412			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LV0NI	32492306				2022-12-28	WOS:000538140600018
J	Man, SM; Xian, Y; Holmes, DN; Matsouaka, RA; Saver, JL; Smith, EE; Bhatt, DL; Schwamm, LH; Fonarow, GC				Man, Shumei; Xian, Ying; Holmes, DaJuanicia N.; Matsouaka, Roland A.; Saver, Jeffrey L.; Smith, Eric E.; Bhatt, Deepak L.; Schwamm, Lee H.; Fonarow, Gregg C.			Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; GUIDELINES-STROKE; MYOCARDIAL-INFARCTION; HEART-ASSOCIATION; PHYSICAL-ACTIVITY; TASK-FORCE; OUTCOMES; QUALITY; PERFORMANCE; MANAGEMENT	Key PointsQuestionIs there an association between shorter door-to-needle time with thrombolytic therapy and long-term mortality and hospital readmission in patients with acute ischemic stroke? FindingsIn this US retrospective cohort study that included 61426 patients with acute ischemic stroke treated with intravenous tissue plasminogen activator, longer door-to-needle times (within 90 minutes after hospital arrival) were significantly associated with higher all-cause mortality at 1 year (hazard ratio per 15-minute increase in time, 1.04) and higher likelihood of all-cause readmission at 1 year (hazard ratio per 15-minute increase in time, 1.02). MeaningThese findings support efforts to shorten time to thrombolytic therapy. ImportanceEarlier administration of intravenous tissue plasminogen activator (tPA) in acute ischemic stroke is associated with reduced mortality by the time of hospital discharge and better functional outcomes at 3 months. However, it remains unclear whether shorter door-to-needle times translate into better long-term outcomes. ObjectiveTo examine whether shorter door-to-needle times with intravenous tPA for acute ischemic stroke are associated with improved long-term outcomes. Design, Setting, and ParticipantsThis retrospective cohort study included Medicare beneficiaries aged 65 years or older who were treated for acute ischemic stroke with intravenous tPA within 4.5 hours from the time they were last known to be well at Get With The Guidelines-Stroke participating hospitals between January 1, 2006, and December 31, 2016, with 1-year follow-up through December 31, 2017. ExposuresDoor-to-needle times for intravenous tPA. Main Outcomes and MeasuresThe primary outcomes were 1-year all-cause mortality, all-cause readmission, and the composite of all-cause mortality or readmission. ResultsAmong the 61426 patients treated with tPA within 4.5 hours, the median age was 80 years and 43.5% were male. The median door-to-needle time was 65 minutes (interquartile range, 49-88 minutes). The 48666 patients (79.2%) who were treated with tPA and had door-to-needle times of longer than 45 minutes, compared with those treated within 45 minutes, had significantly higher all-cause mortality (35.0% vs 30.8%, respectively; adjusted HR, 1.13 [95% CI, 1.09-1.18]), higher all-cause readmission (40.8% vs 38.4%; adjusted HR, 1.08 [95% CI, 1.05-1.12]), and higher all-cause mortality or readmission (56.0% vs 52.1%; adjusted HR, 1.09 [95% CI, 1.06-1.12]). The 34367 patients (55.9%) who were treated with tPA and had door-to-needle times of longer than 60 minutes, compared with those treated within 60 minutes, had significantly higher all-cause mortality (35.8% vs 32.1%, respectively; adjusted hazard ratio [HR], 1.11 [95% CI, 1.07-1.14]), higher all-cause readmission (41.3% vs 39.1%; adjusted HR, 1.07 [95% CI, 1.04-1.10]), and higher all-cause mortality or readmission (56.8% vs 53.1%; adjusted HR, 1.08 [95% CI, 1.05-1.10]). Every 15-minute increase in door-to-needle times was significantly associated with higher all-cause mortality (adjusted HR, 1.04 [95% CI, 1.02-1.05]) within 90 minutes after hospital arrival, but not after 90 minutes (adjusted HR, 1.01 [95% CI, 0.99-1.03]), higher all-cause readmission (adjusted HR, 1.02; 95% CI, 1.01-1.03), and higher all-cause mortality or readmission (adjusted HR, 1.02 [95% CI, 1.01-1.03]). Conclusions and RelevanceAmong patients aged 65 years or older with acute ischemic stroke who were treated with tissue plasminogen activator, shorter door-to-needle times were associated with lower all-cause mortality and lower all-cause readmission at 1 year. These findings support efforts to shorten time to thrombolytic therapy. This cohort study estimates associations between intravenous tissue plasminogen activator (tPA) door-to-needle times of less than 4.5 hours for acute ischemic stroke and 1-year mortality or readmission among Medicare beneficiaries aged 65 years or older.	[Man, Shumei] Cleveland Clin, Dept Neurol, Cleveland, OH 44106 USA; [Man, Shumei] Cleveland Clin, Neurol Inst, Cerebrovasc Ctr, Cleveland, OH 44106 USA; [Xian, Ying; Holmes, DaJuanicia N.; Matsouaka, Roland A.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Matsouaka, Roland A.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Saver, Jeffrey L.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Smith, Eric E.] Univ Calgary, Dept Clin Neurosci, Hotchkiss Brain Inst, Calgary, AB, Canada; [Bhatt, Deepak L.] Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Schwamm, Lee H.] Massachusetts Gen Hosp, Dept Neurol, Comprehens Stroke Ctr, Boston, MA 02114 USA; [Schwamm, Lee H.] Harvard Med Sch, Boston, MA 02115 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Duke University; Duke University; University of California System; University of California Los Angeles; University of Calgary; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles	Fonarow, GC (corresponding author), Univ Calif Los Angeles, Med Ctr, Ahmanson UCLA Cardiomyopathy Ctr, 10833 LeConte Ave, Los Angeles, CA 90095 USA.	gfonarow@mednet.ucla.edu	Smith, Eric E/C-5443-2012; Matsouaka, Roland/K-6730-2019	Smith, Eric E/0000-0003-3956-1668; Matsouaka, Roland/0000-0002-0271-5400; Xian, Ying/0000-0002-1237-1162	American Heart Association/American Stroke Association; Novartis; Boehringer Ingelheim Lilly; Novo Nordisk; Sanofi; AstraZeneca; Bayer	American Heart Association/American Stroke Association(American Heart Association); Novartis(Novartis); Boehringer Ingelheim Lilly(Boehringer IngelheimEli Lilly); Novo Nordisk(Novo Nordisk); Sanofi; AstraZeneca(AstraZeneca); Bayer(Bayer AG)	The Get With The Guidelines-Stroke (GWTG-Stroke) program is provided by the American Heart Association/American Stroke Association. GWTG-Stroke is sponsored, in part, by Novartis, Boehringer Ingelheim Lilly, Novo Nordisk, Sanofi, AstraZeneca, and Bayer.	Ali-Ahmed F, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.119.005609; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Fonarow GC, 2012, JAMA-J AM MED ASSOC, V308, P257, DOI 10.1001/jama.2012.7870; Fonarow GC, 2011, STROKE, V42, P2983, DOI 10.1161/STROKEAHA.111.621342; Fonarow GC, 2011, CIRCULATION, V123, P750, DOI 10.1161/CIRCULATIONAHA.110.974675; Fonarow GC, 2010, CIRC-CARDIOVASC QUAL, V3, P291, DOI 10.1161/CIRCOUTCOMES.109.921858; Franco OH, 2005, ARCH INTERN MED, V165, P2355, DOI 10.1001/archinte.165.20.2355; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Johnston SC, 2003, STROKE, V34, P2446, DOI 10.1161/01.STR.0000090842.81076.68; Johnston SC, 2001, STROKE, V32, P1061, DOI 10.1161/01.STR.32.5.1061; Kwatkowski TG, 1999, NEW ENGL J MED, V340, P1781; Lanier JB, 2016, AM FAM PHYSICIAN, V93, P919; Lansberg MG, 2009, STROKE, V40, P2079, DOI 10.1161/STROKEAHA.108.540708; Ma H, 2019, NEW ENGL J MED, V380, P1795, DOI 10.1056/NEJMoa1813046; Messe SR, 2016, NEUROLOGY, V87, P1565, DOI 10.1212/WNL.0000000000003198; Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]; Poythress JC, 2020, PHARM STAT, V19, P4, DOI 10.1002/pst.1966; Reeves MJ, 2012, STROKE, V43, P44, DOI 10.1161/STROKEAHA.111.626978; Reeves MJ, 2009, STROKE, V40, P569, DOI 10.1161/STROKEAHA.108.519355; Sandercock P, 2013, LANCET NEUROL, V12, P768, DOI 10.1016/S1474-4422(13)70130-3; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Schoen Bandeali D, MEDICARE 50 YEARS EN; Schwamm LH, 2010, CIRCULATION, V121, P1492, DOI 10.1161/CIRCULATIONAHA.109.881490; Smith EE, 2017, CIRCULATION, V136, P2303, DOI 10.1161/CIRCULATIONAHA.117.031097; Smith EE, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005207; Smith EE, 2010, CIRCULATION, V122, P1496, DOI 10.1161/CIRCULATIONAHA.109.932822; Therrien M, 2001, HISPANIC POPULATION; Wardlaw J M, 2003, Cochrane Database Syst Rev, pCD000213; Xian Y, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.116.003227; Xian Y, 2012, AM HEART J, V163, P392, DOI 10.1016/j.ahj.2011.12.012	34	49	51	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2020	323	21					2170	2184		10.1001/jama.2020.5697	http://dx.doi.org/10.1001/jama.2020.5697			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LY8YS	32484532	Bronze, Green Published			2022-12-28	WOS:000540816000021
J	Mahase, E				Mahase, Elisabeth			Covid-19: Two thirds of people contacted through tracing did not fully cooperate, pilot scheme finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Community Contact Tracers, 2020, SHEFFIELD COMMUNITY; MAHASE E, 2020, BMJ-BRIT MED J, V369, P32070, DOI DOI 10.1136/BMJ.M1638	2	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2020	369								m2169	10.1136/bmj.m2169	http://dx.doi.org/10.1136/bmj.m2169			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3KB	32471811	Bronze			2022-12-28	WOS:000538337500019
J	Swanton, C; Scowcroft, H				Swanton, Charles; Scowcroft, Henry			Protecting "covid protected" cancer hubs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Swanton, Charles] Francis Crick Inst, London, England; [Scowcroft, Henry] Canc Res UK, London, England	Francis Crick Institute; Cancer Research UK	Swanton, C (corresponding author), Francis Crick Inst, London, England.	Charles.Swanton@crick.ac.uk						Akahoshi N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030818; [Anonymous], 2020, ESMO; Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Ben-Assa N., 2020, SARS COV 2 SPOT VIRU, DOI [10.1101/2020.04.22.20072389, DOI 10.1101/2020.04.22.20072389]; Black JRM, 2020, LANCET, V395, P1418, DOI 10.1016/S0140-6736(20)30917-X; Butler Daniel J, 2020, bioRxiv, DOI 10.1101/2020.04.20.048066; Chau NVV., 2020, CLIN INFECT DIS, V71, P2679, DOI 10.1093/cid/ciaa711; Day M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1375; Desai A, 2020, JCO GLOB ONCOL, V6, P557, DOI 10.1200/GO.20.00097; Jha AK, 2020, HGHI NPR PUBLISH NEW; Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6; Mason R, 2020, GUARDIAN; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Moss L, 2020, BBC NEWS; Our World in Data, TOTAL COVID 19 TESTS; Philpotts E., 2020, GP URGENT CANC REFER; Rivett L, 2020, ELIFE, V9, DOI 10.7554/eLife.58728; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Smyrlaki I., 2020, MASSIVE RAPID COVID, DOI [10.1101/2020.04.17.20067348, DOI 10.1101/2020.04.17.20067348]; Tong ZD, 2020, EMERG INFECT DIS, V26, P1052, DOI 10.3201/eid2605.200198; Wright O., 2020, TIMES; Wyllie A.L., 2020, SALIVA IS MORE SENSI, V8, P12, DOI [10.1101/2020.04.16.20067835, DOI 10.1101/2020.04.16.20067835]; Ye F, 2020, INT J INFECT DIS, V94, P133, DOI 10.1016/j.ijid.2020.03.042; Yu L., 2020, RAPID COLORIMETRIC D, DOI 10.1101/2020.02.20.20025874	25	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2020	369								m2062	10.1136/bmj.m2062	http://dx.doi.org/10.1136/bmj.m2062			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3KB	32471824	Bronze			2022-12-28	WOS:000538337500003
J	Parisi, R; Iskandar, IYK; Kontopantelis, E; Augustin, M; Griffiths, CEM; Ashcroft, DM				Parisi, Rosa; Iskandar, Ireny Y. K.; Kontopantelis, Evangelos; Augustin, Matthias; Griffiths, Christopher E. M.; Ashcroft, Darren M.		Global Psoriasis Atlas	National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-FEATURES; GLOBAL BURDEN; SKIN-DISEASE; PRIMARY-CARE; PREVALENCE; TRENDS; ARTHRITIS; MORTALITY; COMMON	OBJECTIVE To systematically review and provide information on the incidence of psoriasis and quantify global, regional, and country specific estimates of its prevalence. DESIGN Systematic review and meta-analysis. DATA SOURCES Medline, Embase, Web of Science, SciELO, Korean Journal Databases, Russian Science Citation Index, WPRIM, SaudiMedlit, Informit, IndMed, and HERDIN were searched systematically from their inception dates to October 2019. METHODS Studies were included if they reported on the incidence or prevalence of psoriasis in the general population. Incidence data were summarised descriptively, whereas bayesian hierarchical models were fitted to estimate the global, regional, and country specific prevalence of psoriasis. RESULTS 41 164 records were identified and 168 studies met the inclusion criteria. In adults, the incidence of psoriasis varied from 30.3 per 100000 person years (95% confidence interval 26.6 to 34.1) in Taiwan to 321.0 per 100 000 person years in Italy. The prevalence of psoriasis varied from 0.14% (95% uncertainty interval 0.05% to 0.40%) in east Asia to 1.99% (0.64% to 6.60%) in Australasia. The prevalence of psoriasis was also high in western Europe (1.92%, 1.07% to 3.46%), central Europe (1.83%, 0.62% to 5.32%), North America (1.50%, 0.63% to 3.60%), and high income southern Latin America (1.10%, 0.36% to 2.96%). CONCLUSIONS Eighty one per cent of the countries of the world lack information on the epidemiology of psoriasis. The disease occurs more frequently in adults than in children. Psoriasis is unequally distributed across geographical regions; it is more frequent in high income countries and in regions with older populations. The estimates provided can help guide countries and the international community when making public health decisions on the appropriate management of psoriasis and assessing its natural history over time.	[Parisi, Rosa; Iskandar, Ireny Y. K.; Ashcroft, Darren M.] Univ Manchester, Div Pharm & Optometry, Manchester, Lancs, England; [Parisi, Rosa; Kontopantelis, Evangelos] Univ Manchester, Div Informat Imaging & Data Sci, Manchester, Lancs, England; [Augustin, Matthias] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Care Res Dermatol & Nursing, Hamburg, Germany; [Griffiths, Christopher E. M.] Salford Royal NHS Fdn Trust, Dermatol Ctr, Manchester, Lancs, England; [Griffiths, Christopher E. M.; Ashcroft, Darren M.] Univ Manchester, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Hamburg; University Medical Center Hamburg-Eppendorf; Salford Royal NHS Foundation Trust; University of Manchester	Parisi, R (corresponding author), Univ Manchester, Sch Hlth Sci, Div Informat Imaging & Data Sci, Manchester M13 9PT, Lancs, England.	rosa.parisi@manchester.ac.uk	Ashcroft, Darren/G-3244-2015	Ashcroft, Darren/0000-0002-2958-915X; Kontopantelis, Evangelos/0000-0001-6450-5815; Parisi, Rosa/0000-0002-0968-9153	Leo Foundation; Abbvie; Eli Lilly UK; Novartis Pharma AG; UCB; Almirall; National Institute for Health Research (NIHR) Manchester Biomedical Research Centre	Leo Foundation(LEO Pharma); Abbvie(AbbVie); Eli Lilly UK(Eli Lilly); Novartis Pharma AG; UCB(UCB Pharma SA); Almirall(Almirall); National Institute for Health Research (NIHR) Manchester Biomedical Research Centre(National Institute for Health Research (NIHR))	The Global Psoriasis Atlas (GPA) project is delivered by the academic project staff based at the University of Manchester and University Medical Center Hamburg-Eppendorf. The GPA is a collaboration between three leading international organisations in the world of dermatology: the International Federation of Psoriasis Associations (IFPA), The International League of Dermatological Societies (ILDS), and the International Psoriasis Council (IPC). The GPA has been supported by grants and sponsorship from the Leo Foundation, Abbvie, Eli Lilly UK, Novartis Pharma AG, UCB, and Almirall. All decisions concerning analysis, interpretation, and publication are made independently of any industrial contribution. DMA and CEMG are funded in part by the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre.	BELL LM, 1991, ARCH DERMATOL, V127, P1184, DOI 10.1001/archderm.127.8.1184; Cantarutti A, 2015, PEDIATR DERMATOL, V32, P668, DOI 10.1111/pde.12568; Downes MJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011458; Eder L, 2019, ARTHRIT CARE RES, V71, P1084, DOI 10.1002/acr.23743; Egeberg A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028116; Egeberg A, 2017, ACTA DERM-VENEREOL, V97, P808, DOI 10.2340/00015555-2672; Enamandram M, 2013, J INVEST DERMATOL, V133, P287, DOI 10.1038/jid.2012.434; Farber E, 1998, EPIDEMIOLOGY NATURAL; Finucane MM, 2014, STAT SCI, V29, P18, DOI 10.1214/13-STS427; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Hay RJ, 2014, J INVEST DERMATOL, V134, P1527, DOI 10.1038/jid.2013.446; Huerta C, 2007, ARCH DERMATOL, V143, P1559, DOI 10.1001/archderm.143.12.1559; Icen M, 2009, J AM ACAD DERMATOL, V60, P394, DOI 10.1016/j.jaad.2008.10.062; JACOB C, 2016, VALUE HEALTH, V19, pA566, DOI DOI 10.1016/J.JVAL.2016.09.1269; James SL, 2018, LANCET, V392, P1789, DOI 10.1016/s0140-6736(18)32279-7; Javitz HS, 2002, J AM ACAD DERMATOL, V46, P850, DOI 10.1067/mjd.2002.119669; Karimkhani C, 2017, JAMA DERMATOL, V153, P406, DOI 10.1001/jamadermatol.2016.5538; Khalid JM, 2013, BMC DERMATOL, V13, DOI 10.1186/1471-5945-13-9; Kubanova Anna A., 2017, Vestnik Dermatologii i Venerologii, P22, DOI 10.25208/0042-4609-2017-93-6-22-33; Langley RGB, 2005, ANN RHEUM DIS, V64, P18, DOI 10.1136/ard.2004.033217; Li R, 2012, RHEUMATOLOGY, V51, P721, DOI 10.1093/rheumatology/ker370; [Одинец А.В. Odinets A.V.], 2017, [Клиническая дерматология и венерология, Klinicheskaya dermatologiya i venerologiya], V16, P32, DOI 10.17116/klinderma201716632-37; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Springate DA, 2017, BRIT J DERMATOL, V176, P650, DOI 10.1111/bjd.15021; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x; Tollefson MM, 2010, J AM ACAD DERMATOL, V62, P979, DOI 10.1016/j.jaad.2009.07.029; United Nations Department of Economic and Social Affairs Population Division, 2017, WORLD POP PROSP 2017, VII; Vena GA, 2010, EUR J DERMATOL, V20, P593, DOI 10.1684/ejd.2010.1017; Wei JCC, 2018, J RHEUMATOL, V45, P385, DOI 10.3899/jrheum.170516; WHO, 2016, GLOB REP PSOR	30	196	203	10	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2020	369								m1590	10.1136/bmj.m1590	http://dx.doi.org/10.1136/bmj.m1590			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JZ	32467098	Green Published, hybrid			2022-12-28	WOS:000538337300003
J	Vieira-Silva, S; Falony, G; Belda, E; Nielsen, T; Aron-Wisnewsky, J; Chakaroun, R; Forslund, SK; Assmann, K; Valles-Colomer, M; Nguyen, TTD; Proost, S; Prifti, E; Tremaroli, V; Pons, N; Le Chatelier, E; Andreelli, F; Bastard, JP; Coelho, LP; Galleron, N; Hansen, TH; Hulot, JS; Lewinter, C; Pedersen, HK; Quinquis, B; Rouault, C; Roume, H; Salem, JE; Sondertoft, NB; Touch, S; Dumas, ME; Ehrlich, SD; Galan, P; Gotze, JP; Hansen, T; Holst, JJ; Kober, L; Letunic, I; Nielsen, J; Oppert, JM; Stumvoll, M; Vestergaard, H; Zucker, JD; Bork, P; Pedersen, O; Backhed, F; Clement, K; Raes, J				Vieira-Silva, Sara; Falony, Gwen; Belda, Eugeni; Nielsen, Trine; Aron-Wisnewsky, Judith; Chakaroun, Rima; Forslund, Sofia K.; Assmann, Karen; Valles-Colomer, Mireia; Nguyen, Thi Thuy Duyen; Proost, Sebastian; Prifti, Edi; Tremaroli, Valentina; Pons, Nicolas; Le Chatelier, Emmanuelle; Andreelli, Fabrizio; Bastard, Jean-Phillippe; Coelho, Luis Pedro; Galleron, Nathalie; Hansen, Tue H.; Hulot, Jean-Sebastien; Lewinter, Christian; Pedersen, Helle K.; Quinquis, Benoit; Rouault, Christine; Roume, Hugo; Salem, Joe-Elie; Sondertoft, Nadja B.; Touch, Sothea; Dumas, Marc-Emmanuel; Ehrlich, Stanislav Dusko; Galan, Pilar; Gotze, Jens P.; Hansen, Torben; Holst, Jens J.; Kober, Lars; Letunic, Ivica; Nielsen, Jens; Oppert, Jean-Michel; Stumvoll, Michael; Vestergaard, Henrik; Zucker, Jean-Daniel; Bork, Peer; Pedersen, Oluf; Backhed, Fredrik; Clement, Karine; Raes, Jeroen		MetaCardis Consortium	Statin therapy is associated with lower prevalence of gut microbiota dysbiosis	NATURE			English	Article								Microbiome community typing analyses have recently identified the Bacteroides2 (Bact2) enterotype, an intestinal microbiota configuration that is associated with systemic inflammation and has a high prevalence in loose stools in humans(1,2). Bact2 is characterized by a high proportion of Bacteroides, a low proportion of Faecalibacterium and low microbial cell densities(1,2), and its prevalence varies from 13% in a general population cohort to as high as 78% in patients with inflammatory bowel disease(2). Reported changes in stool consistency(3) and inflammation status(4) during the progression towards obesity and metabolic comorbidities led us to propose that these developments might similarly correlate with an increased prevalence of the potentially dysbiotic Bact2 enterotype. Here, by exploring obesity-associated microbiota alterations in the quantitative faecal metagenomes of the cross-sectional MetaCardis Body Mass Index Spectrum cohort (n = 888), we identify statin therapy as a key covariate of microbiome diversification. By focusing on a subcohort of participants that are not medicated with statins, we find that the prevalence of Bact2 correlates with body mass index, increasing from 3.90% in lean or overweight participants to 17.73% in obese participants. Systemic inflammation levels in Bact2-enterotyped individuals are higher than predicted on the basis of their obesity status, indicative of Bact2 as a dysbiotic microbiome constellation. We also observe that obesity-associated microbiota dysbiosis is negatively associated with statin treatment, resulting in a lower Bact2 prevalence of 5.88% in statin-medicated obese participants. This finding is validated in both the accompanying MetaCardis cardiovascular disease dataset (n = 282) and the independent Flemish Gut Flora Project population cohort (n = 2,345). The potential benefits of statins in this context will require further evaluation in a prospective clinical trial to ascertain whether the effect is reproducible in a randomized population and before considering their application as microbiota-modulating therapeutics.	[Vieira-Silva, Sara; Falony, Gwen; Valles-Colomer, Mireia; Nguyen, Thi Thuy Duyen; Proost, Sebastian; Raes, Jeroen] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Lab Mol Bacteriol, Leuven, Belgium; [Vieira-Silva, Sara; Falony, Gwen; Valles-Colomer, Mireia; Nguyen, Thi Thuy Duyen; Proost, Sebastian; Raes, Jeroen] VIB, Ctr Microbiol, Leuven, Belgium; [Belda, Eugeni; Aron-Wisnewsky, Judith; Assmann, Karen; Prifti, Edi; Andreelli, Fabrizio; Rouault, Christine; Touch, Sothea; Zucker, Jean-Daniel; Clement, Karine] Sorbonne Univ, Nutr & Obes Syst Approaches Res Unit NutriOm, INSERM, Paris, France; [Belda, Eugeni; Prifti, Edi; Zucker, Jean-Daniel] Inst Cardiometab & Nutr, Integr Unit, Paris, France; [Nielsen, Trine; Hansen, Tue H.; Pedersen, Helle K.; Sondertoft, Nadja B.; Hansen, Torben; Holst, Jens J.; Vestergaard, Henrik; Pedersen, Oluf; Backhed, Fredrik] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Aron-Wisnewsky, Judith; Oppert, Jean-Michel; Clement, Karine] Hop La Pitie Salpetriere, AP HP, Nutr Dept, Paris, France; [Chakaroun, Rima; Stumvoll, Michael] Univ Leipzig, Med Dept Endocrinol 3, Nephrol, Med Ctr,Rheumatol, Leipzig, Germany; [Forslund, Sofia K.] Charite, Expt & Clin Res Ctr, Berlin, Germany; [Forslund, Sofia K.] Max Delbruck Ctr, Berlin, Germany; [Forslund, Sofia K.; Coelho, Luis Pedro; Bork, Peer] European Mol Biol Lab, Struct & Computat Biol, Heidelberg, Germany; [Forslund, Sofia K.] Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, Berlin, Germany; [Forslund, Sofia K.] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany; [Prifti, Edi; Zucker, Jean-Daniel] Sorbonne Univ, Unite Modelisat Math & Informat Syst Complexes, UMMISCO, IRD, Bondy, France; [Tremaroli, Valentina; Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden; [Tremaroli, Valentina; Backhed, Fredrik] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Pons, Nicolas; Le Chatelier, Emmanuelle; Galleron, Nathalie; Quinquis, Benoit; Roume, Hugo; Ehrlich, Stanislav Dusko] Univ Paris Saclay, INRAE, Metagenopolis, Jouy En Josas, France; [Andreelli, Fabrizio] Hop La Pitie Salpetriere, AP HP, Diabet Dept, Paris, France; [Bastard, Jean-Phillippe] Tenon Hosp, AP HP, Biochem & Hormonol Dept, UF Biomarqueurs Inflammatoires & Metab, Paris, France; [Bastard, Jean-Phillippe] Sorbonne Univ, Ctr Rech St Antoine, IHU ICAN, INSERM,UMR S 938, Paris, France; [Coelho, Luis Pedro] Fudan Univ, Inst Sci & Technol Brain Inspired Intelligence, Shanghai, Peoples R China; [Hulot, Jean-Sebastien; Salem, Joe-Elie] Sorbonne Univ, Pitie Salpetriere Hosp, NICO Cardiooncol Program, INSERM,Dept Pharmacol,AP HP,CIC 1421, Paris, France; [Hulot, Jean-Sebastien] Univ Paris, PARCC, INSERM, Paris, France; [Hulot, Jean-Sebastien] Hop Europeen Georges Pompidou, AP HP, CIC1418, Paris, France; [Hulot, Jean-Sebastien] Hop Europeen Georges Pompidou, AP HP, DMU CARTE, Paris, France; [Lewinter, Christian; Kober, Lars] Univ Copenhagen, Dept Cardiol, Rigshospitalet, Copenhagen, Denmark; [Dumas, Marc-Emmanuel] Imperial Coll London, Dept Metab Digest & Reprod, Computat & Syst Med, Fac Med, London, England; [Dumas, Marc-Emmanuel] Imperial Coll London, Natl Heart & Lung Inst, Gen & Environm Med, Fac Med, London, England; [Galan, Pilar] Univ Paris, Nutr Epidemiol Res Team EREN, Epidemiol & Stat Res Ctr CRESS, Sorbonne Paris Cite,CNAM,INRA,INSERM,U1153,U1125, Bobigny, France; [Gotze, Jens P.] Univ Copenhagen, Dept Clin Biochem, Rigshospitalet, Copenhagen, Denmark; [Letunic, Ivica] Biobyte Solut, Heidelberg, Germany; [Nielsen, Jens] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden; [Stumvoll, Michael] Univ Leipzig, Helmholtz Inst Metab Obes & Vasc Res HI MAG, Helmholtz Zentrum Munchen, Leipzig, Germany; [Bork, Peer] Heidelberg Univ, Mol Med Partnership Unit, Heidelberg, Germany; [Bork, Peer] European Mol Biol Lab, Heidelberg, Germany; [Bork, Peer] Univ Wurzburg, Dept Bioinformat, Bioctr, Wurzburg, Germany	KU Leuven; Flanders Institute for Biotechnology (VIB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Novo Nordisk Foundation; University of Copenhagen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; German Centre for Cardiovascular Research; UDICE-French Research Universities; Sorbonne Universite; Cadi Ayyad University of Marrakech; Hanoi University of Science & Technology; Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; University of Yaounde I; University of Gothenburg; University of Gothenburg; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Fudan University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; Imperial College London; Imperial College London; heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; Chalmers University of Technology; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); University of Wurzburg	Raes, J (corresponding author), Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Lab Mol Bacteriol, Leuven, Belgium.; Raes, J (corresponding author), VIB, Ctr Microbiol, Leuven, Belgium.; Clement, K (corresponding author), Sorbonne Univ, Nutr & Obes Syst Approaches Res Unit NutriOm, INSERM, Paris, France.; Clement, K (corresponding author), Hop La Pitie Salpetriere, AP HP, Nutr Dept, Paris, France.	karine.clement@inserm.fr; jeroen.raes@kuleuven.be	Bork, Peer/F-1813-2013; Stumvoll, Michael/ABE-1121-2021; Letunic, Ivica/K-1102-2019; Coelho, Luis Pedro/D-1260-2009; Proost, Sebastian/AAB-9845-2022; Vieira-Silva, Sara/ABE-1247-2021; Hansen, Tue Haldor/S-7724-2016; Belda, Eugeni/ABI-1349-2020; Dumas, Marc-Emmanuel/C-1736-2008; BLOTTIERE, Hervé M/C-6120-2011; Hulot, Jean-Sébastien/A-2278-2016; Falony, Gwen/AAN-5011-2020; Tremaroli, Valentina/AAE-8001-2019; Prifti, Edi/F-3967-2019; raes, jeroen/D-7835-2018; Pedersen, Oluf/Z-1731-2019; Holst, Jens/AAA-8022-2022; Letunic, Ivica/A-6032-2009; ZUCKER, Jean-Daniel/K-3008-2016; Chakaroun, Rima/AAU-3660-2020	Bork, Peer/0000-0002-2627-833X; Stumvoll, Michael/0000-0001-6225-8240; Letunic, Ivica/0000-0003-3560-4288; Coelho, Luis Pedro/0000-0002-9280-7885; Proost, Sebastian/0000-0002-6792-9442; Vieira-Silva, Sara/0000-0002-4616-7602; Hansen, Tue Haldor/0000-0001-5948-8993; Belda, Eugeni/0000-0003-4307-5072; Dumas, Marc-Emmanuel/0000-0001-9523-7024; BLOTTIERE, Hervé M/0000-0002-8390-0607; Hulot, Jean-Sébastien/0000-0001-5463-6117; Falony, Gwen/0000-0003-2450-0782; Tremaroli, Valentina/0000-0002-9150-4233; Prifti, Edi/0000-0001-8861-1305; raes, jeroen/0000-0002-1337-041X; Pedersen, Oluf/0000-0002-3321-3972; ZUCKER, Jean-Daniel/0000-0002-5597-7922; Chakaroun, Rima/0000-0001-9901-1815; Nielsen, Trine/0000-0002-2066-7895; Forslund, Sofia K/0000-0003-4285-6993; Kober, Lars/0000-0002-6635-1466; Valles-Colomer, Mireia/0000-0002-1988-6054; Assmann, Karen/0000-0003-3618-9573; Kerneis, Mathieu/0000-0002-7141-5209; Holst, Jens Juul/0000-0001-6853-3805; Engelbrechtsen, Line/0000-0002-0666-0830; Salem, Joe-Elie/0000-0002-0331-3307; Hansen, Torben/0000-0001-8748-3831; Pedersen, Helle Krogh/0000-0001-9609-7377	European Union's Seventh Framework Programme for research, technological development and demonstration [HEALTH-F4-2012-305312]; French National Agency of Research (ANR) [ANR-11-DPBS-0001, ICAN ANR-10-IAHU-05]; Research Foundation Flanders (FWO Vlaanderen); VIB Grand Challenges programme, KU Leuven; Rega Institute for Medical Research; FWO EOS program [30770923]; Novo Nordisk Foundation; NIHR Imperial Biomedical Research Centre	European Union's Seventh Framework Programme for research, technological development and demonstration; French National Agency of Research (ANR)(French National Research Agency (ANR)); Research Foundation Flanders (FWO Vlaanderen)(FWO); VIB Grand Challenges programme, KU Leuven; Rega Institute for Medical Research(KU Leuven); FWO EOS program; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NIHR Imperial Biomedical Research Centre	We thank the study participants and nurses for their contributions to the project. MetaCardis was funded by European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement HEALTH-F4-2012-305312 (MetaCardis project) and the French National Agency of Research (ANR; 'Investissement d'Avenir' FORCE, Metagenopolis grant ANR-11-DPBS-0001 and ICAN ANR-10-IAHU-05). The promotor of the clinical study was the Assistance Publique Hopitaux de Paris (APHP). S.V.-S. was supported by a post-doctoral fellowship from the Research Foundation Flanders (FWO Vlaanderen). The Raes laboratory is supported by the VIB Grand Challenges programme, KU Leuven, the Rega Institute for Medical Research, and the FWO EOS program (30770923). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research institution at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation. M.-E.D. was funded by the NIHR Imperial Biomedical Research Centre.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Criscuolo A, 2013, GENOMICS, V102, P500, DOI 10.1016/j.ygeno.2013.07.011; Darzi Y, 2016, ISME J, V10, P1025, DOI 10.1038/ismej.2015.188; Depommier C, 2019, NAT MED, V25, P1096, DOI 10.1038/s41591-019-0495-2; Ding T, 2014, NATURE, V509, P357, DOI 10.1038/nature13178; Duvallet C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01973-8; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Falony G, 2015, ANNU REV MICROBIOL, V69, P305, DOI 10.1146/annurev-micro-091014-104422; Ford ES, 1999, DIABETES CARE, V22, P1971, DOI 10.2337/diacare.22.12.1971; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Fox J., 2019, R COMPANION APPL REG, V.; Gardiner BJ, 2015, J CLIN MICROBIOL, V53, P626, DOI 10.1128/JCM.02926-14; Grant RL, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7450; Grip O, 2008, BRIT J PHARMACOL, V155, P1085, DOI 10.1038/bjp.2008.369; Harrell F.E., 2018, PACKAGE HMISC 4 7 0; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Khan TJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19013-2; Kriss M, 2018, CURR OPIN MICROBIOL, V44, P34, DOI 10.1016/j.mib.2018.07.003; Kultima JR, 2016, BIOINFORMATICS, V32, P2520, DOI 10.1093/bioinformatics/btw183; Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Litvak Y, 2018, SCIENCE, V362, P1017, DOI 10.1126/science.aat9076; Louis P, 2004, J BACTERIOL, V186, P2099, DOI 10.1128/JB.186.7.2099-2106.2004; Ludecke D., 2019, SJSTATS STAT FUNCTIO; Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Morgan M., 2017, DIRICHLETMULTINOMIAL; Muscogiuri G, 2014, ENDOCR RES, V39, P137, DOI 10.3109/07435800.2014.952018; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Ogle D, 2017, FSA FISHERIES STOCK; Prest EI, 2013, WATER RES, V47, P7131, DOI 10.1016/j.watres.2013.07.051; Prifti E., 2015, METAOMINER QUANTITAT; PROBERT CSJ, 1995, QJM-MON J ASSOC PHYS, V88, P311; Quevrain E, 2016, GUT, V65, P415, DOI 10.1136/gutjnl-2014-307649; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Sze MA, 2016, MBIO, V7, DOI 10.1128/mBio.01018-16; Touch S, 2018, FASEB J, V32, P5078, DOI 10.1096/fj.201800052RR; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ungaro R, 2016, AM J GASTROENTEROL, V111, P1416, DOI 10.1038/ajg.2016.233; Valles-Colomer M, 2019, NAT MICROBIOL, V4, P623, DOI 10.1038/s41564-018-0337-x; Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460; Venables WN., 2002, MODERN APPL STAT S; Vieira-Silva S, 2019, NAT MICROBIOL, V4, P1826, DOI 10.1038/s41564-019-0483-9; Vieira-Silva S, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.88, 10.1038/NMICROBIOL.2016.88]; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Yun Y, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1052-0; Zeiser R, 2018, IMMUNOLOGY, V154, P69, DOI 10.1111/imm.12902	53	132	137	14	87	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 28	2020	581	7809					310	+		10.1038/s41586-020-2269-x	http://dx.doi.org/10.1038/s41586-020-2269-x			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QI3GR	32433607	Green Accepted			2022-12-28	WOS:000618867700001
J	O'Dowd, A				O'Dowd, Adrian			Covid-19: Papers justifying government's plans to reopen schools are "inconclusive," say union bosses	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Gov.uk, 2020, SCI ADV GROUP EM SAG; Independent SAGE, 2020, SHOULD SCH REOP DRAF; Wise J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2079	3	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2020	369								m2108	10.1136/bmj.m2108	http://dx.doi.org/10.1136/bmj.m2108			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JX	32461199	Bronze			2022-12-28	WOS:000538337100012
J	Brenner, L				Brenner, Logan			An end and a beginning	SCIENCE			English	Editorial Material									[Brenner, Logan] Barnard Coll, New York, NY 10027 USA		Brenner, L (corresponding author), Barnard Coll, New York, NY 10027 USA.								0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					906	906		10.1126/science.368.6493.906	http://dx.doi.org/10.1126/science.368.6493.906			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU2DD	32439796				2022-12-28	WOS:000537569500050
J	Snyder-Mackler, N; Burger, JR; Gaydosh, L; Belsky, DW; Noppert, GA; Campos, FA; Bartolomucci, A; Yang, YC; Aiello, AE; O'Rand, A; Harris, KM; Shively, CA; Alberts, SC; Tung, J				Snyder-Mackler, Noah; Burger, Joseph Robert; Gaydosh, Lauren; Belsky, Daniel W.; Noppert, Grace A.; Campos, Fernando A.; Bartolomucci, Alessandro; Yang, Claire Yang; Aiello, Allison E.; O'Rand, Angela; Harris, Kathleen Mullan; Shively, Carol A.; Alberts, Susan C.; Tung, Jenny			Social determinants of health and survival in humans and other animals	SCIENCE			English	Review							ADVERSE CHILDHOOD EXPERIENCES; LIFETIME REPRODUCTIVE SUCCESS; SOCIOECONOMIC-STATUS; DOMINANCE RANK; RISK-FACTORS; RELATIVE IMPORTANCE; ALLOSTATIC LOAD; HOST-RESISTANCE; JOHN-HENRYISM; GROUP-SIZE	The social environment, both in early life and adulthood, is one of the strongest predictors of morbidity and mortality risk in humans. Evidence from long-term studies of other social mammals indicates that this relationship is similar across many species. In addition, experimental studies show that social interactions can causally alter animal physiology, disease risk, and life span itself. These findings highlight the importance of the social environment to health and mortality as well as Darwinian fitness-outcomes of interest to social scientists and biologists alike. They thus emphasize the utility of cross-species analysis for understanding the predictors of, and mechanisms underlying, social gradients in health.	[Snyder-Mackler, Noah; Burger, Joseph Robert; Gaydosh, Lauren; Belsky, Daniel W.; Noppert, Grace A.; Campos, Fernando A.; Yang, Claire Yang; Aiello, Allison E.; O'Rand, Angela; Harris, Kathleen Mullan; Shively, Carol A.; Alberts, Susan C.; Tung, Jenny] Social & Biol Determinants Hlth Working Grp, Durham, NC 27708 USA; [Alberts, Susan C.; Tung, Jenny] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Snyder-Mackler, Noah] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Snyder-Mackler, Noah] Arizona State Univ, Ctr Evolut & Med, Tempe, AZ USA; [Burger, Joseph Robert; Belsky, Daniel W.; Noppert, Grace A.; Alberts, Susan C.; Tung, Jenny] Duke Univ, Populat Res Inst, Durham, NC 27708 USA; [Burger, Joseph Robert] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Burger, Joseph Robert] Univ Arizona, Inst Environm, Tucson, AZ USA; [Gaydosh, Lauren] Vanderbilt Univ, Ctr Med Hlth & Soc, 221 Kirkland Hall, Nashville, TN 37235 USA; [Belsky, Daniel W.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Belsky, Daniel W.] Columbia Univ, Mailman Sch Publ Hlth, Robert N Butler Columbia Aging Ctr, New York, NY USA; [Noppert, Grace A.; Alberts, Susan C.; Tung, Jenny] Duke Univ, Ctr Populat Hlth & Aging, Durham, NC 27708 USA; [Noppert, Grace A.; Yang, Claire Yang; Aiello, Allison E.; Harris, Kathleen Mullan] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27515 USA; [Noppert, Grace A.] Duke Univ, Ctr Study Aging & Human Dev, Durham, NC USA; [Campos, Fernando A.; Alberts, Susan C.; Tung, Jenny] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Campos, Fernando A.] Univ Texas San Antonio, Dept Anthropol, San Antonio, TX USA; [Bartolomucci, Alessandro] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN USA; [Yang, Claire Yang; Harris, Kathleen Mullan] Univ N Carolina, Dept Sociol, Chapel Hill, NC 27515 USA; [Yang, Claire Yang] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27515 USA; [Aiello, Allison E.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Shively, Carol A.] Wake Forest Sch Med, Dept Pathol, Comparat Med Sect, Winston Salem, NC 27101 USA; [Alberts, Susan C.; Tung, Jenny] Inst Primate Res, Nairobi, Kenya	Duke University; University of Washington; University of Washington Seattle; Arizona State University; Arizona State University-Tempe; Duke University; University of Arizona; University of Arizona; Vanderbilt University; Columbia University; Columbia University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; University of Texas System; University of Texas at San Antonio (UTSA); University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University	Tung, J (corresponding author), Social & Biol Determinants Hlth Working Grp, Durham, NC 27708 USA.; Tung, J (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA.; Tung, J (corresponding author), Duke Univ, Populat Res Inst, Durham, NC 27708 USA.; Tung, J (corresponding author), Duke Univ, Ctr Populat Hlth & Aging, Durham, NC 27708 USA.; Tung, J (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.; Tung, J (corresponding author), Inst Primate Res, Nairobi, Kenya.	jenny.tung@duke.edu	Campos, Fernando A./I-2525-2019; Belsky, Daniel/HDN-5118-2022; Belsky, Daniel/AAB-4785-2021	Campos, Fernando A./0000-0001-9826-751X; Belsky, Daniel/0000-0001-5463-2212; Bartolomucci, Alessandro/0000-0001-6439-8829; Snyder-Mackler, Noah/0000-0003-3026-6160	Duke Center for Population Health and Aging; NIH [P30AG034424, P2C HD050924, R01AG057235, R01HD088558, R01GM102562, R00AG051764, R01AG060931, T32AG000139, R01HL087103, R01AG057800, R24AG065172, R01AG053308, P01AG031719, P01HD031921, R01HD087061]; Carolina Population Center; Triangle Center for Evolutionary Medicine; Duke Social Sciences Research Institute; Human Frontier Science Program Research Grant; Minnesota Partnership for Biotechnology and Medical Genomics [18.04]; Jacobs Foundation Early Career Fellowship; Bridging Biodiversity and Conservation Science program at the University of Arizona; National Inst of Health [F32HD084117, R01DK102496, R01MD013349, R01MD011728, T32HD091058, 1K99AG062749-01A1, T32HD007168, T32AG000029]	Duke Center for Population Health and Aging; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carolina Population Center; Triangle Center for Evolutionary Medicine; Duke Social Sciences Research Institute; Human Frontier Science Program Research Grant(Human Frontier Science Program); Minnesota Partnership for Biotechnology and Medical Genomics; Jacobs Foundation Early Career Fellowship; Bridging Biodiversity and Conservation Science program at the University of Arizona; National Inst of Health	The Triangle Area Social and Biological Determinants of Health Working Group is supported by the Duke Center for Population Health and Aging (with funding from NIH P30AG034424), the Carolina Population Center (with funding from NIH P2C HD050924), the Triangle Center for Evolutionary Medicine, and the Duke Social Sciences Research Institute. This work was also supported by NIH grants R01AG057235, R01HD088558, and R01GM102562 to J.T.; R00AG051764, R01AG060931, and T32AG000139 to N.S.-M.; R01HL087103 to C.A.S.; R01AG057800 to Y.C.Y; R24AG065172 to J.T., A.B., and K.M.H.; R01AG053308 and P01AG031719 to S.C.A.; P01HD031921 and R01HD087061 to K.M.H.; F32HD084117 to L.G.; R01DK102496 to A.B.; R01MD013349, R01MD011728, and T32HD091058 to A.E.A.; a Human Frontier Science Program Research Grant to J.T.; a Minnesota Partnership for Biotechnology and Medical Genomics 18.04 to A.B.; and a Jacobs Foundation Early Career Fellowship to D.W.B.; G.A.N. received support from NIH T32HD091058 and NIH 1K99AG062749-01A1, L.G. received support from NIH T32HD007168, J.R.B. received support from the Bridging Biodiversity and Conservation Science program at the University of Arizona, and G.A.N. and N.S.-M. received support from NIH T32AG000029.	ABBOTT DH, 1981, J REPROD FERTIL, V63, P335; Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Adler N, 2012, P NATL ACAD SCI USA, V109, P17154, DOI 10.1073/pnas.1121399109; Almberg ES, 2015, ECOL LETT, V18, P660, DOI 10.1111/ele.12444; Anderson JA, 2020, COSTS COMPETITION HI, V22, P961052, DOI [10.1101/2020.02.22.961052, DOI 10.1101/2020.02.22.961052]; Anderson M, 2012, ECON J, V122, P555, DOI 10.1111/j.1468-0297.2011.02472.x; [Anonymous], 2016, WHO GLOB HLTH EST 20; Archie EA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1261; Archie EA, 2012, P NATL ACAD SCI USA, V109, P9017, DOI 10.1073/pnas.1206391109; Barocas A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022375; Bartolomucci A, 2007, FRONT NEUROENDOCRIN, V28, P28, DOI 10.1016/j.yfrne.2007.02.001; Beehner JC, 2017, HORM BEHAV, V91, P68, DOI 10.1016/j.yhbeh.2017.03.003; Beehner JC, 2006, BEHAV ECOL SOCIOBIOL, V59, P469, DOI 10.1007/s00265-005-0071-2; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Berens AE, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0895-4; Berger V, 2018, AM NAT, V192, P525, DOI 10.1086/699513; Berghanel A, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1304; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Blomquist GE, 2011, INT J PRIMATOL, V32, P193, DOI 10.1007/s10764-010-9461-z; Blumstein DT, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.1934; Boen CE, 2018, CANCER EPIDEM BIOMAR, V27, P541, DOI 10.1158/1055-9965.EPI-17-0836; Botero CA, 2015, P NATL ACAD SCI USA, V112, P184, DOI 10.1073/pnas.1408589111; Braveman P, 2014, PUBLIC HEALTH REP, V129, P19, DOI 10.1177/00333549141291S206; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Brown DW, 2009, AM J PREV MED, V37, P389, DOI 10.1016/j.amepre.2009.06.021; Burmeister SS, 2005, PLOS BIOL, V3, P1996, DOI 10.1371/journal.pbio.0030363; Campbell LAD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24373-4; Capitanio JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110307; Case A, 2011, ECON J, V121, pF183, DOI 10.1111/j.1468-0297.2011.02447.x; CASSEL J, 1976, AM J EPIDEMIOL, V104, P107, DOI 10.1093/oxfordjournals.aje.a112281; Cavigelli SA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0103; Chang SWC, 2013, P NATL ACAD SCI USA, V110, P10387, DOI 10.1073/pnas.1301213110; Cheney DL, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160255; Chetty R, 2017, SCIENCE, V356, P398, DOI 10.1126/science.aal4617; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Cohen S, 1997, PSYCHOSOM MED, V59, P213, DOI 10.1097/00006842-199705000-00001; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Colchero F, 2016, P NATL ACAD SCI USA, V113, pE7681, DOI 10.1073/pnas.1612191113; Cole SW, 2019, CURR OPIN BEHAV SCI, V28, P31, DOI 10.1016/j.cobeha.2019.01.008; Cole SW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004601; Conti G, 2012, P NATL ACAD SCI USA, V109, P8866, DOI 10.1073/pnas.1205340109; Cooper EB, 2018, EVOL LETT, V2, P460, DOI 10.1002/evl3.79; Costello EJ, 2010, JAMA-J AM MED ASSOC, V303, P1954, DOI 10.1001/jama.2010.621; Cram DL, 2018, CURR BIOL, V28, P2934, DOI 10.1016/j.cub.2018.07.021; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Dantzer B, 2013, SCIENCE, V340, P1215, DOI 10.1126/science.1235765; Darwin, 1859, ORIGINS SPECIES MEAN; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; Douhard M, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0510; Douhard M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0276; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Durant SM, 2004, BEHAV ECOL, V15, P11, DOI 10.1093/beheco/arg098; Ellis S, 2017, Proc Biol Sci, V284, DOI 10.1098/rspb.2017.1313; Ellis S, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1991; Elo IT, 2009, ANNU REV SOCIOL, V35, P553, DOI 10.1146/annurev-soc-070308-115929; Epel ES, 2014, J GERONTOL A-BIOL, V69, pS10, DOI 10.1093/gerona/glu055; Farine DR, 2015, J ANIM ECOL, V84, P1144, DOI 10.1111/1365-2656.12418; FEDIGAN LM, 1986, FOLIA PRIMATOL, V47, P143, DOI 10.1159/000156271; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Ferraro KF, 2016, AM SOCIOL REV, V81, P107, DOI 10.1177/0003122415619617; Ferraro KF, 2009, GERONTOLOGIST, V49, P333, DOI 10.1093/geront/gnp034; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Gager Y, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0056-1; Gaydosh L, 2018, P NATL ACAD SCI USA, V115, P109, DOI 10.1073/pnas.1714616114; Gesquiere LR, 2011, SCIENCE, V333, P357, DOI 10.1126/science.1207120; GETZ LL, 1993, J MAMMAL, V74, P44, DOI 10.2307/1381904; Gluckman PD, 2005, TRENDS ECOL EVOL, V20, P527, DOI 10.1016/j.tree.2005.08.001; Gluckman PD, 2009, LANCET, V373, P1654, DOI 10.1016/S0140-6736(09)60234-8; Goldenberg SZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14712-2; Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007; Hajat A, 2011, AM J EPIDEMIOL, V173, P192, DOI 10.1093/aje/kwq348; Hamad R, 2016, AM J EPIDEMIOL, V183, P775, DOI 10.1093/aje/kwv317; Harper S, 2012, EPIDEMIOLOGY, V23, P795, DOI 10.1097/EDE.0b013e31826d078d; Harris KM, 2018, ANNU REV SOCIOL, V44, P361, DOI 10.1146/annurev-soc-060116-053339; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Hayward Adam D., 2013, Evolution Medicine and Public Health, P106, DOI 10.1093/emph/eot007; Hayward AD, 2013, P NATL ACAD SCI USA, V110, P13886, DOI 10.1073/pnas.1301817110; Hayward MD, 2004, DEMOGRAPHY, V41, P87, DOI 10.1353/dem.2004.0005; Hermes GL, 2009, P NATL ACAD SCI USA, V106, P22393, DOI 10.1073/pnas.0910753106; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Hoffmann R, 2019, SOC INDIC RES, V141, P1341, DOI 10.1007/s11205-018-1871-x; Holekamp KE, 2012, MOL ECOL, V21, P613, DOI 10.1111/j.1365-294X.2011.05240.x; Holt-Lunstad J, 2018, ANNU REV PSYCHOL, V69, P437, DOI 10.1146/annurev-psych-122216-011902; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Jacobs J, 2012, VULNERABLE CHILD YOU, V7, P103, DOI 10.1080/17450128.2012.658886; JAMES SA, 1987, AM J EPIDEMIOL, V126, P664, DOI 10.1093/oxfordjournals.aje.a114706; JAMES SA, 1983, J BEHAV MED, V6, P259, DOI 10.1007/BF01315113; Johnson SL, 2012, PSYCHOL BULL, V138, P692, DOI 10.1037/a0027503; Johnson W, 2014, WILEY HANDBOOK OF GENIUS, P269; Kane JB, 2018, SOC SCI MED, V207, P89, DOI 10.1016/j.socscimed.2018.04.049; Kane JB, 2018, SOC FORCES, V96, P949, DOI 10.1093/sf/sox079; KAPLAN JR, 1982, ARTERIOSCLEROSIS, V2, P359, DOI 10.1161/01.ATV.2.5.359; Kappeler PM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aay1276; Kittleson MM, 2006, ARCH INTERN MED, V166, P2356, DOI 10.1001/archinte.166.21.2356; Koch R, 1890, Br Med J, V2, P380; Kohn J, 2016, DEV PRIMATOL-PROG PR, P49, DOI 10.1007/978-3-319-30872-2_4; Kroger H, 2015, EUR J PUBLIC HEALTH, V25, P951, DOI 10.1093/eurpub/ckv111; Laforsch C, 2006, LIMNOL OCEANOGR, V51, P1466, DOI 10.4319/lo.2006.51.3.1466; Lantz PM, 2010, SOC SCI MED, V70, P1558, DOI 10.1016/j.socscimed.2010.02.003; Lea AJ, 2018, P NATL ACAD SCI USA, V115, pE12163, DOI 10.1073/pnas.1811967115; Lea AJ, 2017, EVOL MED PUBLIC HLTH, P162, DOI 10.1093/emph/eox019; Lea AJ, 2015, AM NAT, V185, P809, DOI 10.1086/681016; Lea AJ, 2014, ANIM BEHAV, V94, P87, DOI 10.1016/j.anbehav.2014.05.019; Lehmann J, 2016, BEHAV ECOL, V27, P20, DOI 10.1093/beheco/arv169; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Lukas D, 2013, SCIENCE, V341, P526, DOI 10.1126/science.1238677; Markham AC, 2012, ANIM BEHAV, V84, P399, DOI 10.1016/j.anbehav.2012.05.009; Marmot M, 2006, SOCIAL DETERMINANTS; Marmot M., 2005, SOCIAL DETERMINANTS, P6; Marmot M.G., 2014, SOCIALITY HIERARCHY, P372; MARMOT MG, 1978, BMJ-BRIT MED J, V2, P1109, DOI 10.1136/bmj.2.6145.1109; Marmot M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m693; Matthews GA, 2016, CELL, V164, P617, DOI 10.1016/j.cell.2015.12.040; McDade TW, 2019, AM J PHYS ANTHROPOL, V169, P3, DOI 10.1002/ajpa.23800; McEwen BS, 2008, METABOLISM, V57, pS11, DOI 10.1016/j.metabol.2008.07.006; McEwen BS, 2015, NAT NEUROSCI, V18, P1353, DOI 10.1038/nn.4086; McEwen BS, 1999, ANN NY ACAD SCI, V896, P30, DOI 10.1111/j.1749-6632.1999.tb08103.x; McFarland R, 2015, J ANIM ECOL, V84, P871, DOI 10.1111/1365-2656.12329; McFarland R, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0428; Meier HCS, 2016, SOC SCI MED, V166, P77, DOI 10.1016/j.socscimed.2016.07.004; Miller GE, 2015, P NATL ACAD SCI USA, V112, P10325, DOI 10.1073/pnas.1505063112; Monaghan P, 2015, EARLY HUM DEV, V91, P643, DOI 10.1016/j.earlhumdev.2015.08.008; Monaghan P, 2014, J EXP BIOL, V217, P57, DOI 10.1242/jeb.090043; Montero AP, 2020, ANIM BEHAV, V160, P113, DOI 10.1016/j.anbehav.2019.12.013; Muennig P, 2008, J HEALTH CARE POOR U, V19, P574, DOI 10.1353/hpu.0.0018; National Center for Health Statistics, 2015, NAT HLTH INT STUD 20; Nesse RM, 2010, P NATL ACAD SCI USA, V107, P1800, DOI 10.1073/pnas.0906224106; Nettle D, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1610; Nettle D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1343; Nunez CMV, 2015, BEHAV ECOL, V26, P138, DOI 10.1093/beheco/aru163; O'Rand AM, 2005, J GERONTOL B-PSYCHOL, V60, P117, DOI 10.1093/geronb/60.Special_Issue_2.S117; ORand A., 2018, FUTURE DIRECTIONS DE, P67; Ozer EJ, 2011, INT J EPIDEMIOL, V40, P1565, DOI 10.1093/ije/dyr103; PACKER C, 1995, NATURE, V373, P60, DOI 10.1038/373060a0; Panagakis A, 2017, AM NAT, V189, P667, DOI 10.1086/691388; Pudrovska T, 2014, J GERONTOL B-PSYCHOL, V69, P451, DOI 10.1093/geronb/gbt122; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; Razzoli M, 2018, AGING CELL, V17, DOI 10.1111/acel.12778; Rittschof CC, 2014, P NATL ACAD SCI USA, V111, P17929, DOI 10.1073/pnas.1420369111; Rogers J, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau6947; ROSE G, 1981, BRIT HEART J, V45, P13, DOI 10.1136/hrt.45.1.13; Rowntree B. S., 1901, POVERTY STUDY TOWN L; Sanchez-Tojar A, 2018, J ANIM ECOL, V87, P594, DOI 10.1111/1365-2656.12776; Sanz J, 2020, P NATL ACAD SCI USA, V117, P23317, DOI 10.1073/pnas.1820846116; Sapolsky RM, 2004, ANNU REV ANTHROPOL, V33, P393, DOI 10.1146/annurev.anthro.33.070203.144000; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Sapolsky RM, 2004, PLOS BIOL, V2, P534, DOI 10.1371/journal.pbio.0020106; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; Sealy-Jefferson S, 2015, AM J EPIDEMIOL, V182, P485, DOI 10.1093/aje/kwv106; SEYFARTH RM, 1977, J THEOR BIOL, V65, P671, DOI 10.1016/0022-5193(77)90015-7; Shively CA, 1998, BIOL PSYCHIAT, V44, P882, DOI 10.1016/S0006-3223(97)00437-X; Shively CA, 2016, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/978-3-319-30872-2; Shively CA, 2015, NEUROBIOL STRESS, V1, P156, DOI 10.1016/j.ynstr.2014.11.005; Shively CA, 2009, AM J PRIMATOL, V71, P742, DOI 10.1002/ajp.20706; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Silk JB, 2018, ANIM BEHAV, V140, P207, DOI 10.1016/j.anbehav.2018.04.013; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Snyder-Mackler N, 2019, P NATL ACAD SCI USA, V116, P1219, DOI 10.1073/pnas.1811758115; Snyder-Mackler N, 2018, CURR OPIN GENET DEV, V53, P105, DOI 10.1016/j.gde.2018.08.001; Snyder-Mackler N, 2016, SCIENCE, V354, P1041, DOI 10.1126/science.aah3580; Snyder-Mackler N, 2016, ANIM BEHAV, V111, P307, DOI 10.1016/j.anbehav.2015.10.033; Stanton MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047508; Stearns SC, 2010, P NATL ACAD SCI USA, V107, P1691, DOI 10.1073/pnas.0914475107; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Strauss ED, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2019.2969; Strauss ED, 2019, P NATL ACAD SCI USA, V116, P8919, DOI 10.1073/pnas.1810384116; Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; Swindell WR, 2012, AGEING RES REV, V11, P254, DOI 10.1016/j.arr.2011.12.006; Taylor SE, 1997, ANNU REV PSYCHOL, V48, P411, DOI 10.1146/annurev.psych.48.1.411; Thompson NA, 2018, ECOL EVOL, V8, P1604, DOI 10.1002/ece3.3781; Tung J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11181; Tung J, 2012, P NATL ACAD SCI USA, V109, P6490, DOI 10.1073/pnas.1202734109; Uller T, 2013, J EVOLUTION BIOL, V26, P2161, DOI 10.1111/jeb.12212; van Noordwijk MA, 1999, PRIMATES, V40, P105, DOI 10.1007/BF02557705; Vander Wal E, 2015, ECOLOGY, V96, P631, DOI 10.1890/14-1320.1; von Holst D, 1999, NATURWISSENSCHAFTEN, V86, P388, DOI 10.1007/s001140050638; Wasser SK, 1998, HUM REPROD UPDATE, V4, P430, DOI 10.1093/humupd/4.4.430; West KM, 2017, JAMA-J AM MED ASSOC, V317, P1831, DOI 10.1001/jama.2017.3096; Wilkinson R., 2003, Social determinants of health: the solid facts; Willson AE, 2007, AM J SOCIOL, V112, P1886, DOI 10.1086/512712; World Health Organization, 2017, SOC DET HLTH; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; Yang YC, 2020, J GERONTOL B-PSYCHOL, V75, P613, DOI 10.1093/geronb/gby108; Yang YC, 2017, BIODEMOGR SOC BIOL, V63, P87, DOI 10.1080/19485565.2017.1279536; Yang YC, 2016, P NATL ACAD SCI USA, V113, P578, DOI 10.1073/pnas.1511085112; Yang YC, 2013, J HEALTH SOC BEHAV, V54, P182, DOI 10.1177/0022146513485244; Young RL, 2019, P NATL ACAD SCI USA, V116, P1331, DOI 10.1073/pnas.1813775116; Zelikowsky M, 2018, CELL, V173, P1265, DOI 10.1016/j.cell.2018.03.037; Zhou TT, 2018, CURR OPIN NEUROBIOL, V49, P99, DOI 10.1016/j.conb.2018.01.006; Zipple MN, 2019, ELIFE, V8, DOI 10.7554/eLife.47433	198	173	174	19	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					843	+	eaax9553	10.1126/science.aax9553	http://dx.doi.org/10.1126/science.aax9553			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU2DD	32439765	Green Accepted			2022-12-28	WOS:000537569500036
J	Botvinik-Nezer, R; Holzmeister, F; Camerer, CF; Dreber, A; Huber, J; Johannesson, M; Kirchler, M; Iwanir, R; Mumford, JA; Adcock, RA; Avesani, P; Baczkowski, BM; Bajracharya, A; Bakst, L; Ball, S; Barilari, M; Bault, N; Beaton, D; Beitner, J; Benoit, RG; Berkers, RMWJ; Bhanji, JP; Biswal, BB; Bobadilla-Suarez, S; Bortolini, T; Bottenhorn, KL; Bowring, A; Braem, S; Brooks, HR; Brudner, EG; Calderon, CB; Camilleri, JA; Castrellon, JJ; Cecchetti, L; Cieslik, EC; Cole, ZJ; Collignon, O; Cox, RW; Cunningham, WA; Czoschke, S; Dadi, K; Davis, CP; Luca, AD; Delgado, MR; Demetriou, L; Dennison, JB; Di, X; Dickie, EW; Dobryakova, E; Donnat, CL; Dukart, J; Duncan, NW; Durnez, J; Eed, A; Eickhoff, SB; Erhart, A; Fontanesi, L; Fricke, GM; Fu, SG; Galvan, A; Gau, R; Genon, S; Glatard, T; Glerean, E; Goeman, JJ; Golowin, SAE; Gonzalez-Garcia, C; Gorgolewski, KJ; Grady, CL; Green, MA; Moreira, JFG; Guest, O; Hakimi, S; Hamilton, JP; Hancock, R; Handjaras, G; Harry, BB; Hawco, C; Herholz, P; Herman, G; Heunis, S; Hoffstaedter, F; Hogeveen, J; Holmes, S; Hu, CP; Huettel, SA; Hughes, ME; Iacovella, V; Iordan, AD; Isager, PM; Isik, AI; Jahn, A; Johnson, MR; Johnstone, T; Joseph, MJE; Juliano, AC; Kable, JW; Kassinopoulos, M; Koba, C; Kong, XZ; Koscik, TR; Kucukboyaci, NE; Kuhl, BA; Kupek, S; Laird, AR; Lamm, C; Langner, R; Lauharatanahirun, N; Lee, HM; Lee, SG; Leemans, A; Leo, A; Lesage, E; Li, FR; Li, MYC; Lim, PC; Lintz, EN; Liphardt, SW; Vermeer, ALB; Love, BC; Mack, ML; Malpica, N; Marins, T; Maumet, C; McDonald, K; McGuire, JT; Melero, H; Leal, AMS; Meyer, B; Meyer, KN; Mihai, G; Mitsis, GD; Moll, J; Nielson, DM; Nilsonne, G; Notter, MP; Olivetti, E; Onicas, AI; Papale, P; Patil, KR; Peelle, JE; Perez, A; Pischedda, D; Poline, JB; Prystauka, Y; Ray, S; Reuter-Lorenz, PA; Reynolds, RC; Ricciardi, E; Rieck, JR; Rodriguez-Thompson, AM; Romyn, A; Salo, T; Samanez-Larkin, GR; Sanz-Morales, E; Schlichting, ML; Schultz, DH; Shen, Q; Sheridan, MA; Silvers, JA; Skagerlund, K; Smith, A; Smith, DV; Sokol-Hessner, P; Steinkamp, SR; Tashjian, SM; Thirion, B; Thorp, JN; Tinghog, G; Tisdall, L; Tompson, SH; Toro-Serey, C; Tresols, JJT; Tozzi, L; Truong, V; Turella, L; van 't Veer, AE; Verguts, T; Vettel, JM; Vijayarajah, S; Vo, K; Wall, MB; Weeda, WD; Weis, S; White, DJ; Wisniewski, D; Xifra-Porxas, A; Yearling, EA; Yoon, S; Yuan, R; Yuen, KSL; Zhang, L; Zhang, X; Zosky, JE; Nichols, TE; Poldrack, RA; Schonberg, T				Botvinik-Nezer, Rotem; Holzmeister, Felix; Camerer, Colin F.; Dreber, Anna; Huber, Juergen; Johannesson, Magnus; Kirchler, Michael; Iwanir, Roni; Mumford, Jeanette A.; Adcock, R. Alison; Avesani, Paolo; Baczkowski, Blazej M.; Bajracharya, Aahana; Bakst, Leah; Ball, Sheryl; Barilari, Marco; Bault, Nadege; Beaton, Derek; Beitner, Julia; Benoit, Roland G.; Berkers, Ruud M. W. J.; Bhanji, Jamil P.; Biswal, Bharat B.; Bobadilla-Suarez, Sebastian; Bortolini, Tiago; Bottenhorn, Katherine L.; Bowring, Alexander; Braem, Senne; Brooks, Hayley R.; Brudner, Emily G.; Calderon, Cristian B.; Camilleri, Julia A.; Castrellon, Jaime J.; Cecchetti, Luca; Cieslik, Edna C.; Cole, Zachary J.; Collignon, Olivier; Cox, Robert W.; Cunningham, William A.; Czoschke, Stefan; Dadi, Kamalaker; Davis, Charles P.; Luca, Alberto De; Delgado, Mauricio R.; Demetriou, Lysia; Dennison, Jeffrey B.; Di, Xin; Dickie, Erin W.; Dobryakova, Ekaterina; Donnat, Claire L.; Dukart, Juergen; Duncan, Niall W.; Durnez, Joke; Eed, Amr; Eickhoff, Simon B.; Erhart, Andrew; Fontanesi, Laura; Fricke, G. Matthew; Fu, Shiguang; Galvan, Adriana; Gau, Remi; Genon, Sarah; Glatard, Tristan; Glerean, Enrico; Goeman, Jelle J.; Golowin, Sergej A. E.; Gonzalez-Garcia, Carlos; Gorgolewski, Krzysztof J.; Grady, Cheryl L.; Green, Mikella A.; Guassi Moreira, Joao F.; Guest, Olivia; Hakimi, Shabnam; Hamilton, J. Paul; Hancock, Roeland; Handjaras, Giacomo; Harry, Bronson B.; Hawco, Colin; Herholz, Peer; Herman, Gabrielle; Heunis, Stephan; Hoffstaedter, Felix; Hogeveen, Jeremy; Holmes, Susan; Hu, Chuan-Peng; Huettel, Scott A.; Hughes, Matthew E.; Iacovella, Vittorio; Iordan, Alexandru D.; Isager, Peder M.; Isik, Ayse I.; Jahn, Andrew; Johnson, Matthew R.; Johnstone, Tom; Joseph, Michael J. E.; Juliano, Anthony C.; Kable, Joseph W.; Kassinopoulos, Michalis; Koba, Cemal; Kong, Xiang-Zhen; Koscik, Timothy R.; Kucukboyaci, Nuri Erkut; Kuhl, Brice A.; Kupek, Sebastian; Laird, Angela R.; Lamm, Claus; Langner, Robert; Lauharatanahirun, Nina; Lee, Hongmi; Lee, Sangil; Leemans, Alexander; Leo, Andrea; Lesage, Elise; Li, Flora; Li, Monica Y. C.; Lim, Phui Cheng; Lintz, Evan N.; Liphardt, Schuyler W.; Losecaat Vermeer, Annabel B.; Love, Bradley C.; Mack, Michael L.; Malpica, Norberto; Marins, Theo; Maumet, Camille; McDonald, Kelsey; McGuire, Joseph T.; Melero, Helena; Mendez Leal, Adriana S.; Meyer, Benjamin; Meyer, Kristin N.; Mihai, Glad; Mitsis, Georgios D.; Moll, Jorge; Nielson, Dylan M.; Nilsonne, Gustav; Notter, Michael P.; Olivetti, Emanuele; Onicas, Adrian I.; Papale, Paolo; Patil, Kaustubh R.; Peelle, Jonathan E.; Perez, Alexandre; Pischedda, Doris; Poline, Jean-Baptiste; Prystauka, Yanina; Ray, Shruti; Reuter-Lorenz, Patricia A.; Reynolds, Richard C.; Ricciardi, Emiliano; Rieck, Jenny R.; Rodriguez-Thompson, Anais M.; Romyn, Anthony; Salo, Taylor; Samanez-Larkin, Gregory R.; Sanz-Morales, Emilio; Schlichting, Margaret L.; Schultz, Douglas H.; Shen, Qiang; Sheridan, Margaret A.; Silvers, Jennifer A.; Skagerlund, Kenny; Smith, Alec; Smith, David V.; Sokol-Hessner, Peter; Steinkamp, Simon R.; Tashjian, Sarah M.; Thirion, Bertrand; Thorp, John N.; Tinghog, Gustav; Tisdall, Loreen; Tompson, Steven H.; Toro-Serey, Claudio; Torre Tresols, Juan Jesus; Tozzi, Leonardo; Truong, Vuong; Turella, Luca; van 't Veer, Anna E.; Verguts, Tom; Vettel, Jean M.; Vijayarajah, Sagana; Vo, Khoi; Wall, Matthew B.; Weeda, Wouter D.; Weis, Susanne; White, David J.; Wisniewski, David; Xifra-Porxas, Alba; Yearling, Emily A.; Yoon, Sangsuk; Yuan, Rui; Yuen, Kenneth S. L.; Zhang, Lei; Zhang, Xu; Zosky, Joshua E.; Nichols, Thomas E.; Poldrack, Russell A.; Schonberg, Tom			Variability in the analysis of a single neuroimaging dataset by many teams	NATURE			English	Article							NEURAL BASIS; CHOICES	Data analysis workflows in many scientific domains have become increasingly complex and flexible. Here we assess the effect of this flexibility on the results of functional magnetic resonance imaging by asking 70 independent teams to analyse the same dataset, testing the same 9 ex-ante hypotheses(1). The flexibility of analytical approaches is exemplified by the fact that no two teams chose identical workflows to analyse the data. This flexibility resulted in sizeable variation in the results of hypothesis tests, even for teams whose statistical maps were highly correlated at intermediate stages of the analysis pipeline. Variation in reported results was related to several aspects of analysis methodology. Notably, a meta-analytical approach that aggregated information across teams yielded a significant consensus in activated regions. Furthermore, prediction markets of researchers in the field revealed an overestimation of the likelihood of significant findings, even by researchers with direct knowledge of the dataset(2-5). Our findings show that analytical flexibility can have substantial effects on scientific conclusions, and identify factors that may be related to variability in the analysis of functional magnetic resonance imaging. The results emphasize the importance of validating and sharing complex analysis workflows, and demonstrate the need for performing and reporting multiple analyses of the same data. Potential approaches that could be used to mitigate issues related to analytical variability are discussed. The results obtained by seventy different teams analysing the same functional magnetic resonance imaging dataset show substantial variation, highlighting the influence of analytical choices and the importance of sharing workflows publicly and performing multiple analyses.	[Botvinik-Nezer, Rotem; Iwanir, Roni; Schonberg, Tom] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Botvinik-Nezer, Rotem; Iwanir, Roni; Schonberg, Tom] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, Tel Aviv, Israel; [Botvinik-Nezer, Rotem; Schultz, Douglas H.] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; [Holzmeister, Felix; Huber, Juergen; Kirchler, Michael] Univ Innsbruck, Dept Banking & Finance, Innsbruck, Austria; [Camerer, Colin F.] CALTECH, HSS & CNS, Pasadena, CA 91125 USA; [Dreber, Anna; Johannesson, Magnus] Stockholm Sch Econ, Dept Econ, Stockholm, Sweden; [Dreber, Anna] Univ Innsbruck, Dept Econ, Innsbruck, Austria; [Mumford, Jeanette A.] Univ Wisconsin, Ctr Hlth Minds, Madison, WI USA; [Adcock, R. Alison; Castrellon, Jaime J.; Green, Mikella A.; Hakimi, Shabnam; Samanez-Larkin, Gregory R.; Vo, Khoi] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA; [Adcock, R. Alison; Yuen, Kenneth S. L.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Avesani, Paolo; Olivetti, Emanuele] Fdn Bruno Kessler, Neuroinformat Lab, Trento, Italy; [Avesani, Paolo; Collignon, Olivier; Iacovella, Vittorio; Olivetti, Emanuele; Turella, Luca] Univ Trento, Ctr Mind Brain Sci CIMeC, Rovereto, Italy; [Baczkowski, Blazej M.] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Bajracharya, Aahana; Peelle, Jonathan E.] Washington Univ, Dept Otolaryngol, St Louis, MO 63110 USA; [Bakst, Leah; McGuire, Joseph T.; Toro-Serey, Claudio] Boston Univ, Dept Psychol & Brain Sci, Boston, MA 02215 USA; [Bakst, Leah; McGuire, Joseph T.; Toro-Serey, Claudio] Boston Univ, Ctr Syst Neurosci, Boston, MA 02215 USA; [Ball, Sheryl; Smith, Alec] Virginia Tech, Dept Econ, Blacksburg, VA USA; [Ball, Sheryl; Smith, Alec] Virginia Tech, Sch Neurosci, Blacksburg, VA USA; [Barilari, Marco; Collignon, Olivier; Gau, Remi] UCLouvain, Crossmodal Percept & Plast Lab, Inst Res Psychol IPSY & Neurosci IoNS, Louvain La Neuve, Belgium; [Bault, Nadege] Univ Plymouth, Sch Psychol, Plymouth, Devon, England; [Beaton, Derek; Grady, Cheryl L.; Rieck, Jenny R.] Baycrest Hlth Sci Ctr, Rotman Res Inst, Toronto, ON, Canada; [Beitner, Julia] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Beitner, Julia] Goethe Univ, Dept Psychol, Frankfurt, Germany; [Benoit, Roland G.; Berkers, Ruud M. W. J.] Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp, Adapt Memory, Leipzig, Germany; [Bhanji, Jamil P.; Brudner, Emily G.] Rutgers State Univ, Dept Psychol, Newark, NJ USA; [Biswal, Bharat B.; Bobadilla-Suarez, Sebastian; Delgado, Mauricio R.; Di, Xin; Ray, Shruti] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Biswal, Bharat B.; Di, Xin] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu, Peoples R China; [Marins, Theo; Moll, Jorge] UCL, Dept Expt Psychol, London, England; [Bortolini, Tiago; Marins, Theo; Moll, Jorge] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil; [Bottenhorn, Katherine L.; Salo, Taylor] Florida Int Univ, Dept Psychol, Miami, FL 33199 USA; [Bowring, Alexander; Nichols, Thomas E.] Univ Oxford, Nuffield Dept Populat Hlth, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford Big Data Inst, Oxford, England; [Adcock, R. Alison; Braem, Senne; Calderon, Cristian B.; Gonzalez-Garcia, Carlos; Lesage, Elise; Verguts, Tom; Wisniewski, David] Univ Ghent, Dept Expt Psychol, Ghent, Belgium; [Braem, Senne] Vrije Univ Brussel, Dept Psychol, Brussels, Belgium; [Brooks, Hayley R.; Erhart, Andrew; Sokol-Hessner, Peter] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [Camilleri, Julia A.; Cieslik, Edna C.; Dukart, Juergen; Eickhoff, Simon B.; Genon, Sarah; Hoffstaedter, Felix; Langner, Robert; Patil, Kaustubh R.; Weis, Susanne] Res Ctr Julich, Inst Neurosci & Med, Brain & Behav INM 7, Julich, Germany; [Camilleri, Julia A.; Cieslik, Edna C.; Dukart, Juergen; Eickhoff, Simon B.; Genon, Sarah; Hoffstaedter, Felix; Langner, Robert; Patil, Kaustubh R.; Weis, Susanne] Heinrich Heine Univ Dusseldorf, Inst Syst Neurosci, Fac Med, Dusseldorf, Germany; [Castrellon, Jaime J.; Green, Mikella A.; Huettel, Scott A.; McDonald, Kelsey; Samanez-Larkin, Gregory R.; Vo, Khoi] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA; [Handjaras, Giacomo; Koba, Cemal; Leo, Andrea; Onicas, Adrian I.; Papale, Paolo; Ricciardi, Emiliano] IMT Sch Adv Studies Lucca, MoMiLab Res Unit, Lucca, Italy; [Cecchetti, Luca; Cole, Zachary J.; Johnson, Matthew R.; Lim, Phui Cheng; Lintz, Evan N.; Schultz, Douglas H.; Zosky, Joshua E.] Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA; [Cox, Robert W.] NIMH, NIH, Bethesda, MD 20892 USA; [Cunningham, William A.; Mack, Michael L.; Romyn, Anthony; Schlichting, Margaret L.; Vijayarajah, Sagana] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Czoschke, Stefan] Goethe Univ, Inst Med Psychol, Frankfurt, Germany; [Thirion, Bertrand; Torre Tresols, Juan Jesus] Univ Paris Saclay, CEA, Inria, Palaiseau, France; [Davis, Charles P.; Li, Monica Y. C.; Prystauka, Yanina; Yearling, Emily A.] Univ Connecticut, Dept Psychol Sci, Storrs, CT USA; [Davis, Charles P.; Hancock, Roeland; Li, Monica Y. C.; Prystauka, Yanina; Yearling, Emily A.; Zhang, Xu] Univ Connecticut, Brain Imaging Res Ctr, Storrs, CT USA; [Davis, Charles P.; Hancock, Roeland; Li, Monica Y. C.; Prystauka, Yanina; Zhang, Xu] Univ Connecticut, Connecticut Inst Brain & Cognit Sci, Storrs, CT USA; [Luca, Alberto De; Leemans, Alexander] Univ Med Ctr Utrecht, Image Sci Inst, PROVIDI Lab, Utrecht, Netherlands; [Dadi, Kamalaker; Demetriou, Lysia] Imperial Coll London, Fac Med, Sect Endocrinol & Invest Med, London, England; [Dadi, Kamalaker; Demetriou, Lysia] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England; [Dennison, Jeffrey B.; Smith, David V.] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA; [Dickie, Erin W.] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Krembil Ctr Neuroinformat, Toronto, ON, Canada; [Dickie, Erin W.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Dobryakova, Ekaterina] Kessler Fdn, Ctr Traumat Brain Injury Res, E Hanover, NJ USA; [Donnat, Claire L.; Holmes, Susan] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Duncan, Niall W.; Truong, Vuong] Taipei Med Univ, Grad Inst Mind Brain & Consciousness, Taipei, Taiwan; [Duncan, Niall W.; Truong, Vuong] TMU ShuangHo Hosp, Brain & Consciousness Res Ctr, New Taipei, Taiwan; [Durnez, Joke] Stanford Univ, Dept Psychol, Stanford, CA USA; [Durnez, Joke] Stanford Univ, Stanford Ctr Reproducible Neurosci, Stanford, CA 94305 USA; [Eed, Amr] CSIC UMH, Inst Neurociencias, Alicante, Spain; [Fontanesi, Laura] Univ Basel, Fac Psychol, Basel, Switzerland; [Fricke, G. Matthew] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Fu, Shiguang; Shen, Qiang] Zhejiang Univ Technol, Sch Management, Hangzhou, Peoples R China; [Fu, Shiguang; Shen, Qiang] Zhejiang Univ Technol, Inst Neuromanagement, Hangzhou, Peoples R China; [Galvan, Adriana; Guassi Moreira, Joao F.; Mendez Leal, Adriana S.; Silvers, Jennifer A.; Tashjian, Sarah M.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Glatard, Tristan] Concordia Univ, Dept Comp Sci & Software Engn, Montreal, PQ, Canada; [Glerean, Enrico] Aalto Univ, Dept Neurosci & Biomed Engn, Espoo, Finland; [Goeman, Jelle J.; Golowin, Sergej A. E.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands; [Gorgolewski, Krzysztof J.; Moll, Jorge; Tisdall, Loreen; Poldrack, Russell A.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Guest, Olivia] Res Ctr Interact Media Smart Syst & Emerging Tech, Nicosia, Cyprus; [Hamilton, J. Paul] Linkoping Univ, Dept Biomed & Clin Sci, Ctr Social & Affect Neurosci, Linkoping, Sweden; [Harry, Bronson B.] Western Sydney Univ, MARCS Inst Brain Behav & Dev, Sydney, NSW, Australia; [Hawco, Colin; Herman, Gabrielle; Joseph, Michael J. E.] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada; [Herholz, Peer; Perez, Alexandre; Poline, Jean-Baptiste] McGill Univ, Fac Med, Neuro Montreal Neurol Inst Hosp, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Heunis, Stephan] Eindhoven Univ Technol, Dept Elect Engn, Eindhoven, Netherlands; [Heunis, Stephan] Epilepsy Ctr Kempenhaeghe, Dept Res & Dev, Heeze, Netherlands; [Hogeveen, Jeremy] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Hogeveen, Jeremy] Univ New Mexico, Psychol Clin Neurosci Ctr, Albuquerque, NM 87131 USA; [Hu, Chuan-Peng; Meyer, Benjamin; Yuen, Kenneth S. L.] LIR, Mainz, Germany; [Hughes, Matthew E.; Johnstone, Tom] Swinburne Univ Technol, Sch Hlth Sci, Hawthorn, Vic, Australia; [Iordan, Alexandru D.; Reuter-Lorenz, Patricia A.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Isager, Peder M.] Eindhoven Univ Technol, Dept Ind Engn & Innovat Sci, Eindhoven, Netherlands; [Isik, Ayse I.] Max Planck Inst Empir Aesthet, Dept Neurosci, Frankfurt, Germany; [Jahn, Andrew] Univ Michigan, FMRI Lab, Ann Arbor, MI 48109 USA; [Johnson, Matthew R.; Kucukboyaci, Nuri Erkut; Lim, Phui Cheng; Zosky, Joshua E.] Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE USA; [Juliano, Anthony C.] Kessler Fdn, Ctr Neuropsychol & Neurosci Res, E Hanover, NJ USA; [Kable, Joseph W.; Lee, Sangil] Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA; [Kable, Joseph W.] Univ Penn, MindCORE, Philadelphia, PA 19104 USA; [Kassinopoulos, Michalis; Xifra-Porxas, Alba] McGill Univ, Grad Program Biol & Biomed Engn, Montreal, PQ, Canada; [Kong, Xiang-Zhen] Max Planck Inst Psycholinguist, Language & Genet Dept, Nijmegen, Netherlands; [Koscik, Timothy R.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Kucukboyaci, Nuri Erkut] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Kuhl, Brice A.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Kupek, Sebastian] Univ Innsbruck, Fac Econ & Stat, Innsbruck, Austria; [Laird, Angela R.] Florida Int Univ, Dept Phys, Miami, FL 33199 USA; [Lamm, Claus; Losecaat Vermeer, Annabel B.; Zhang, Lei] Univ Vienna, Fac Psychol, Dept Cognit Emot & Methods Psychol, Vienna, Austria; [Lamm, Claus] Univ Vienna, Vienna Cognit Sci Hub, Vienna, Austria; [Lauharatanahirun, Nina; Lee, Hongmi; Tompson, Steven H.] US CCDC Army Res Lab, Human Res & Engn Directorate, Aberdeen Proving Ground, MD USA; [Lauharatanahirun, Nina] Univ Penn, Annenberg Sch Commun, Philadelphia, PA 19104 USA; Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD USA; [Li, Flora] Fralin Biomed Res Inst, Roanoke, VA USA; [Li, Flora] Nanjing Audit Univ, Econ Expt Lab, Nanjing, Peoples R China; [Li, Monica Y. C.] Haskins Labs Inc, New Haven, CT USA; [Liphardt, Schuyler W.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Love, Bradley C.; Sheridan, Margaret A.] Alan Turing Inst, London, England; [Malpica, Norberto; Melero, Helena; Sanz-Morales, Emilio] Univ Rey Juan Carlos, Lab Anal Imagen Med & Biometria LAIMBIO, Madrid, Spain; [Maumet, Camille] Univ Rennes, Empenn ERL U 1228, IRISA UMR 6074, CNRS,INSERM,INRIA, Rennes, France; [Melero, Helena] CES Cardenal Cisneros, Div Psicol, Dept Psicobiol, Madrid, Spain; [Melero, Helena] Northeastern Univ, Biomed Imaging Ctr, Boston, MA 02115 USA; [Meyer, Benjamin; Yuen, Kenneth S. L.] Johannes Gutenberg Univ Mainz, Neuroimaging Ctr NIC, Focus Program Translat Neurosci FTN, Med Ctr Mainz, Mainz, Germany; [Meyer, Kristin N.; Rodriguez-Thompson, Anais M.] Univ N Carolina, Dept Psychol & Neurosci, Chapel Hill, NC 27515 USA; [Mihai, Glad] Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp Neural Mech Human Commun, Leipzig, Germany; [Mihai, Glad] Tech Univ Dresden, Fac Psychol, Chair Cognit & Clin Neurosci, Dresden, Germany; [Mitsis, Georgios D.] McGill Univ, Dept Bioengn, Montreal, PQ, Canada; [Nielson, Dylan M.] NIMH, Data Sci & Sharing Team, NIH, Bethesda, MD 20892 USA; [Adcock, R. Alison; Avesani, Paolo; Nilsonne, Gustav] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Nilsonne, Gustav] Stockholm Univ, Dept Psychol, Stockholm, Sweden; [Notter, Michael P.] Univ Hosp Ctr, Dept Radiol, Lab Invest Neurophysiol LINE, Lausanne, Switzerland; [Notter, Michael P.] Univ Lausanne, Lausanne, Switzerland; [Papale, Paolo] Netherlands Inst Neurosci, Dept Vis & Cognit, Amsterdam, Netherlands; [Pischedda, Doris] Charite, Bernstein Ctr Computat Neurosci, Berlin, Germany; [Pischedda, Doris] Charite, Berlin Ctr Adv Neuroimaging, Berlin, Germany; [Pischedda, Doris] Charite, Neurol Clin, Berlin, Germany; [Pischedda, Doris] Free Univ Berlin, Berlin, Germany; [Pischedda, Doris] Humboldt Univ, Berlin, Germany; [Pischedda, Doris] Berlin Inst Hlth, Berlin, Germany; [Pischedda, Doris] Tech Univ Berlin, Cluster Excellence Sci Intelligence, Berlin, Germany; [Pischedda, Doris] Humboldt Univ, Berlin, Germany; [Pischedda, Doris] NeuroMI Milan Ctr Neurosci, Milan, Italy; [Poline, Jean-Baptiste] Univ Calif Berkeley, Helen Wills Neurosci Inst, Henry H Wheeler Jr Brain Imaging Ctr, Berkeley, CA 94720 USA; [Reynolds, Richard C.] NIMH, Sci & Stat Comp Core, NIH, Bethesda, MD 20892 USA; [Skagerlund, Kenny] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Skagerlund, Kenny] Linkoping Univ, Dept Clin & Expt Med, Ctr Social & Affect Neurosci, Linkoping, Sweden; [Steinkamp, Simon R.] Res Ctr Julich, Cognit Neuroscience INM 3, Inst Neurosci & Med, Julich, Germany; [Thorp, John N.] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Tinghog, Gustav] Linkoping Univ, Dept Management & Engn, Linkoping, Sweden; [Tinghog, Gustav] Linkoping Univ, Dept Hlth Med & Caring Sci, Linkoping, Sweden; [Tisdall, Loreen] Univ Basel, Ctr Cognit & Decis Sci, Basel, Switzerland; [Tozzi, Leonardo; Yuan, Rui] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA; [van 't Veer, Anna E.; Weeda, Wouter D.] Leiden Univ, Inst Psychol, Methodol & Stat Unit, Leiden, Netherlands; [Vettel, Jean M.] US Combat Capabil Dev Command Army Res Lab, Aberdeen, MD USA; [Vettel, Jean M.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Vettel, Jean M.] Univ Penn, Philadelphia, PA 19104 USA; [Wall, Matthew B.] Invicro, London, England; [Wall, Matthew B.; White, David J.] Imperial Coll London, Fac Med, London, England; [Wall, Matthew B.] UCL, Clin Psychopharmacol Unit, London, England; Swinburne Univ, Ctr Human Psychopharmacol, Hawthorn, Vic, Australia; [Yoon, Sangsuk] Univ Dayton, Sch Business, Dept Management & Mkt, Dayton, OH 45469 USA; [Zhang, Xu] Univ Connecticut, Dept Biomed Engn, Storrs, CT USA	Tel Aviv University; Tel Aviv University; Dartmouth College; University of Innsbruck; California Institute of Technology; Stockholm School of Economics; University of Innsbruck; University of Wisconsin System; University of Wisconsin Madison; Duke University; Duke University; Fondazione Bruno Kessler; University of Trento; Max Planck Society; Washington University (WUSTL); Boston University; Boston University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Universite Catholique Louvain; University of Plymouth; University of Toronto; University Toronto Affiliates; Baycrest; University of Amsterdam; Goethe University Frankfurt; Max Planck Society; Rutgers State University Newark; Rutgers State University New Brunswick; New Jersey Institute of Technology; University of Electronic Science & Technology of China; University of London; University College London; IDOR - Instituto D'Or de Ensino e Pesquisa; State University System of Florida; Florida International University; University of Oxford; Ghent University; Vrije Universiteit Brussel; University of Denver; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Duke University; IMT School for Advanced Studies Lucca; University of Nebraska System; University of Nebraska Lincoln; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Toronto; Goethe University Frankfurt; CEA; Inria; UDICE-French Research Universities; Universite Paris Saclay; University of Connecticut; University of Connecticut; University of Connecticut; Utrecht University; Utrecht University Medical Center; Imperial College London; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Stanford University; Taipei Medical University; Stanford University; Stanford University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); University of Basel; University of New Mexico; Zhejiang University of Technology; Zhejiang University of Technology; University of California System; University of California Los Angeles; Concordia University - Canada; Aalto University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Stanford University; Linkoping University; Western Sydney University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; McGill University; Eindhoven University of Technology; University of New Mexico; University of New Mexico; Swinburne University of Technology; University of Michigan System; University of Michigan; Eindhoven University of Technology; University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Lincoln; University of Pennsylvania; University of Pennsylvania; McGill University; Max Planck Society; University of Iowa; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Oregon; University of Innsbruck; State University System of Florida; Florida International University; University of Vienna; University of Vienna; University of Pennsylvania; Johns Hopkins University; Nanjing Audit University; Yale University; Haskins Laboratories; University of New Mexico; Universidad Rey Juan Carlos; Centre National de la Recherche Scientifique (CNRS); Inria; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Northeastern University; Johannes Gutenberg University of Mainz; University of North Carolina; University of North Carolina Chapel Hill; Max Planck Society; Technische Universitat Dresden; McGill University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Karolinska Institutet; Stockholm University; University of Lausanne; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Technical University of Berlin; Humboldt University of Berlin; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Linkoping University; Linkoping University; Helmholtz Association; Research Center Julich; Columbia University; Linkoping University; Linkoping University; University of Basel; Stanford University; Leiden University; Leiden University - Excl LUMC; University of California System; University of California Santa Barbara; University of Pennsylvania; Imperial College London; University of London; University College London; Swinburne University of Technology; University of Dayton; University of Connecticut	Schonberg, T (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.; Schonberg, T (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, Tel Aviv, Israel.; Nichols, TE (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford Big Data Inst, Oxford, England.; Poldrack, RA (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	thomas.nichols@bdi.ox.ac.uk; poldrack@stanford.edu; schonberg@tauex.tau.ac.il	Calderon, cristian/GQA-7422-2022; Rieck, Jenny/I-1056-2019; Samanez-Larkin, Gregory/A-1139-2007; Ricciardi, Emiliano/E-6929-2011; Tinghög, Gustav/K-2961-2012; Verguts, Tom/A-4792-2008; González-García, Carlos/AAA-1572-2020; Wisniewski, David/ABD-4969-2021; Pischedda, Doris/P-1233-2018; Melero, Helena/O-1323-2019; Nielson, Dylan/ABD-1615-2021; Avesani, Paolo/AAY-9704-2021; Joseph, Michael/AAU-1118-2020; Zhang, Lei/C-8936-2016; Holzmeister, Felix/G-8051-2018; Dobryakova, Ekaterina/ABD-2853-2021; Bault, Nadège/L-9907-2019; Lamm, Claus/B-3357-2014; Schultz, Douglas/AAB-2365-2020; Chuan-Peng, Hu/AAC-3050-2019; Guest, Olivia/M-2116-2013; Isager, Peder M./AAE-5076-2021; Johannesson, Magnus/E-9680-2011; Olivetti, Emanuele/AAT-2384-2020; Hogeveen, Jeremy/AFT-6630-2022; Di, Xin/B-2009-2009; Moll, Jorge/AAF-8388-2021; Smith, David V./A-5487-2011; Turella, Luca/AAB-2327-2019; Botvinik-Nezer, Rotem/GRX-9478-2022; De Luca, Alberto/I-2717-2019; Dennison, Jeffrey B/AAT-6296-2020; Losecaat Vermeer, Annabel B/S-5461-2019; Herholz, Peer/ABA-1704-2021; Schonberg, Tom/AAK-3946-2021; Mitsis, Georgios D/AGY-4548-2022; Herholz, Peer/AAU-5999-2020; Goeman, Jelle/AAT-1300-2020; Salo, Taylor/J-4747-2015; Perez-Lebel, Alexandre/GLR-5308-2022; Iordan, Alexandru D./P-6322-2019; Nichols, Thomas E./N-9902-2017; Adcock, R Alison/AAX-6649-2020; Malpica, Norberto/I-2090-2015; Johnstone, Tom/C-5909-2011; Laird, Angela/B-5800-2010	Rieck, Jenny/0000-0002-3242-6407; Samanez-Larkin, Gregory/0000-0001-7846-3804; Ricciardi, Emiliano/0000-0002-7178-9534; Tinghög, Gustav/0000-0002-8159-1249; Verguts, Tom/0000-0002-7783-4754; González-García, Carlos/0000-0001-6627-5777; Wisniewski, David/0000-0003-4793-1171; Pischedda, Doris/0000-0003-4694-2493; Melero, Helena/0000-0002-5373-6711; Nielson, Dylan/0000-0003-4613-6643; Avesani, Paolo/0000-0001-8943-8911; Joseph, Michael/0000-0002-0068-230X; Zhang, Lei/0000-0002-9586-595X; Holzmeister, Felix/0000-0001-9606-0427; Dobryakova, Ekaterina/0000-0002-6005-2115; Bault, Nadège/0000-0001-8244-6062; Schultz, Douglas/0000-0003-0809-9036; Chuan-Peng, Hu/0000-0002-7503-5131; Guest, Olivia/0000-0002-1891-0972; Johannesson, Magnus/0000-0001-8759-6393; Olivetti, Emanuele/0000-0001-7653-1519; Hogeveen, Jeremy/0000-0001-9612-2085; Di, Xin/0000-0002-2422-9016; Moll, Jorge/0000-0002-4297-591X; Smith, David V./0000-0001-5754-9633; Turella, Luca/0000-0003-1096-2150; Botvinik-Nezer, Rotem/0000-0003-2669-1877; De Luca, Alberto/0000-0002-2553-7299; Dennison, Jeffrey B/0000-0003-0557-3548; Losecaat Vermeer, Annabel B/0000-0001-5631-0233; Herholz, Peer/0000-0002-9840-6257; Herholz, Peer/0000-0002-9840-6257; Goeman, Jelle/0000-0003-4283-0259; Salo, Taylor/0000-0001-9813-3167; Perez-Lebel, Alexandre/0000-0003-0556-0763; Iordan, Alexandru D./0000-0002-1391-785X; Nichols, Thomas E./0000-0002-4516-5103; Adcock, R Alison/0000-0002-7859-5484; Dukart, Juergen/0000-0003-0492-5644; Duncan, Niall/0000-0002-3225-9119; Camerer, Colin/0000-0003-4049-1871; Marins, Theo/0000-0002-5017-707X; Eed, Amr/0000-0002-9370-4917; Smith, Alec/0000-0002-1938-4660; Glatard, Tristan/0000-0003-2620-5883; Schonberg, Tom/0000-0002-4485-816X; Onicas, Adrian/0000-0002-5953-8548; Poldrack, Russell/0000-0001-6755-0259; Zosky, Joshua/0000-0002-1962-3633; Fricke, George/0000-0002-4466-8649; Malpica, Norberto/0000-0003-4618-7459; Tashjian, Sarah/0000-0002-0946-6662; Lim, Phui Cheng/0000-0002-5709-8956; Ray, Shruti/0000-0002-1864-386X; van 't Veer, Anna/0000-0002-2733-1841; Truong, Vuong/0000-0003-1412-498X; Beitner, Julia/0000-0002-2539-7011; Yoon, Sangsuk/0000-0002-3399-1096; Tisdall, Loreen/0000-0001-6303-6148; Dreber, Anna/0000-0003-3989-9941; Koscik, Timothy/0000-0002-2551-8127; Herman, Gabrielle/0000-0003-4695-5251; Kirchler, Michael/0000-0002-5416-2545; Hughes, Matthew/0000-0001-5057-5556; Weeda, W. D./0000-0001-8619-2645; Baczkowski, Blazej/0000-0001-9827-797X; Tozzi, Leonardo/0000-0002-9429-6476; Huber, Juergen/0000-0003-0073-0321; Johnstone, Tom/0000-0001-8635-8158; Maumet, Camille/0000-0002-6290-553X; Papale, Paolo/0000-0002-6249-841X; Bajracharya, Aahana/0000-0002-7361-6020; Cieslik, Edna/0000-0001-5491-5837; Holmes, Susan/0000-0002-2208-8168; Bottenhorn, Katherine/0000-0002-7796-8795; Gau, Remi/0000-0002-1535-9767; Laird, Angela/0000-0003-3379-8744; Steinkamp, Simon Richard/0000-0002-6437-0700; White, David/0000-0001-8694-1474; Toro-Serey, Claudio/0000-0002-5273-2276; Lesage, Elise/0000-0002-5517-6965	Austrian Science Fund [P29362-G27]; Israel Science Foundation [ISF 2004/15]; Swedish Foundation for Humanities and Social Sciences [NHS14-1719:1]; National Institutes of Health (NIH) [R24MH117179]; Austrian Science Fund (FWF) [SFB F63, P 32686]; Research Foundation Flanders (FWO); European Union [665501]; University of Basel Research Fund; Research Foundation Flanders [12T2517N]; Marie Skodowska-Curie Actions under COFUND [665501]; Obra Social La Caixa; Vienna Science and Technology Fund [WWTF VRG13-007]; National Natural Science Foundation of China [71801110, 71971199, 71602175, 71942004]; MOE (Ministry of Education in China) Project of Humanities and Social Sciences [18YJC630268]; China Postdoctoral Science Foundation [2018M633270]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy 'Science of Intelligence' (EXC 2002/1) [390523135]; Brain Canada; Health Canada; NIH [NIH-NIBIB P41 EB019936, NIH-NIMH R01 MH083320, NIH RF1 MH120021, R01 DA041353]; National Institute Of Mental Health of the NIH [R01MH096906]; Canada First Research Excellence Fund; European Union's Horizon 2020 Research and Innovation Programme [785907]; Max Planck Society; Dutch foundation LSH-TKI [LSHM16053-SGF]; NSF [1631325]; T32 Predoctoral Fellowship from the NIH; Deutsche Forschungsgemeinschaft [CRC1193]; Australian National Imaging Facility; National Collaborative Research Infrastructure Strategy (NCRIS) capability; VIDI from the Netherlands Organisation for Scientific Research [452-17-013]; Swedish Research Council; NIH IRP [ZICMH002888, ZICMH002960]; Tianqiao and Chrissy Center for Social and Decision Neuroscience Center Leadership Chair; Belgian Excellence of Science program (EOS) from the FNRS-Belgium [30991544]; EraNET Neuron [R4195]; Ministry of Education of Humanities and Social Science [16YJC630103]; Wellcome Trust [100309/Z/12/Z]	Austrian Science Fund(Austrian Science Fund (FWF)); Israel Science Foundation(Israel Science Foundation); Swedish Foundation for Humanities and Social Sciences; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Research Foundation Flanders (FWO)(FWO); European Union(European Commission); University of Basel Research Fund; Research Foundation Flanders(FWO); Marie Skodowska-Curie Actions under COFUND; Obra Social La Caixa(La Caixa Foundation); Vienna Science and Technology Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOE (Ministry of Education in China) Project of Humanities and Social Sciences; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy 'Science of Intelligence' (EXC 2002/1)(German Research Foundation (DFG)); Brain Canada; Health Canada; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute Of Mental Health of the NIH; Canada First Research Excellence Fund; European Union's Horizon 2020 Research and Innovation Programme; Max Planck Society(Max Planck SocietyFoundation CELLEX); Dutch foundation LSH-TKI; NSF(National Science Foundation (NSF)); T32 Predoctoral Fellowship from the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Australian National Imaging Facility; National Collaborative Research Infrastructure Strategy (NCRIS) capability; VIDI from the Netherlands Organisation for Scientific Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); NIH IRP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tianqiao and Chrissy Center for Social and Decision Neuroscience Center Leadership Chair; Belgian Excellence of Science program (EOS) from the FNRS-Belgium; EraNET Neuron; Ministry of Education of Humanities and Social Science; Wellcome Trust(Wellcome Trust)	Neuroimaging data collection, performed at Tel Aviv University, was supported by the Austrian Science Fund (P29362-G27), the Israel Science Foundation (ISF 2004/15 to T. Schonberg) and the Swedish Foundation for Humanities and Social Sciences (NHS14-1719:1). Hosting of the data on OpenNeuro was supported by a National Institutes of Health (NIH) grant (R24MH117179). We thank M. C. Frank, Y. Assaf and N. Daw for comments on an earlier draft; the Texas Advanced Computing Center for providing computing resources for preprocessing of the data; the Stanford Research Computing Facility for hosting the data; and D. Roll for assisting with data processing. T. Schonberg thanks The Alfredo Federico Strauss Center for Computational Neuroimaging at Tel Aviv University; A.D. thanks the Knut and Alice Wallenberg Foundation and the Marianne and Marcus Wallenberg Foundation (A.D. is a Wallenberg Scholar), the Austrian Science Fund (FWF, SFB F63) and the Jan Wallander and Tom Hedelius Foundation (Svenska Handelsbankens Forskningsstiftelser); F. Holzmeister, J. Huber and M. Kirchler thank the Austrian Science Fund (FWF, SFB F63); D.W. was supported by the Research Foundation Flanders (FWO) and the European Union's Horizon 2020 research and innovation programme (https://ec.europa.eu/programmes/horizon2020/en) under the Marie Skodowska-Curie grant agreement no. 665501; L. Tisdall was supported by the University of Basel Research Fund for Junior Researchers; C.B.C. was supported by grant 12O7719N from the Research Foundation Flanders; E.L. was supported by grant 12T2517N from the Research Foundation Flanders and Marie Skodowska-Curie Actions under COFUND grant agreement 665501; A. Eed was supported by a predoctoral fellowship La Caixa-Severo Ochoa from Obra Social La Caixa and also acknowledges Comunidad de Calculo Cientifico del CSIC for the high-performance computing (HPC) use; C.L. was supported by the Vienna Science and Technology Fund (WWTF VRG13-007) and Austrian Science Fund (FWF P 32686); A.B.L.V. was supported by the Vienna Science and Technology Fund (WWTF VRG13-007); L.Z. was supported by the Vienna Science and Technology Fund (WWTF VRG13-007), the National Natural Science Foundation of China (no. 71801110), MOE (Ministry of Education in China) Project of Humanities and Social Sciences (no. 18YJC630268) and China Postdoctoral Science Foundation (no. 2018M633270); D.P. is currently supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy 'Science of Intelligence' (EXC 2002/1, project number 390523135); P.H. was supported in part by funding provided by Brain Canada, in partnership with Health Canada, for the Canadian Open Neuroscience Platform initiative; J.-B.P. was partially funded by the NIH (NIH-NIBIB P41 EB019936 (ReproNim), NIH-NIMH R01 MH083320 (CANDIShare) and NIH RF1 MH120021 (NIDM)) and the National Institute Of Mental Health of the NIH under award number R01MH096906 (Neurosynth), as well as the Canada First Research Excellence Fund, awarded to McGill University for the Healthy Brains for Healthy Lives initiative and the Brain Canada Foundation with support from Health Canada; S.B.E. was supported by the European Union's Horizon 2020 Research and Innovation Programme under grant agreement no. 785907 (HBP SGA2); G.M. was supported by the Max Planck Society; S. Heunis has received funding from the Dutch foundation LSH-TKI (grant LSHM16053-SGF); J.F.G.M. was supported by a Graduate Research Fellowship from the NSF and T32 Predoctoral Fellowship from the NIH; B.M.; r was supported by the Deutsche Forschungsgemeinschaft (grant CRC1193, subproject B01); A.R.L. was supported by NSF 1631325 and NIH R01 DA041353; M.E.H., T.J. and D.J.W. were supported by the Australian National Imaging Facility, a National Collaborative Research Infrastructure Strategy (NCRIS) capability; P.M.I. was supported by VIDI grant 452-17-013 from the Netherlands Organisation for Scientific Research; B.M.B. was supported by the Max Planck Society; J.P.H. was supported by a grant from the Swedish Research Council; R.W.C. and R.C.R. were supported by NIH IRP project number ZICMH002888; D.M.N., R.W.C., and R.C.R. used the computational resources of the National Institutes of Health High Performance Computing Biowulf cluster (http://hpc.nih.gov); D.M.N. was supported by NIH IRP project number ZICMH002960; C.F.C. was supported by the Tianqiao and Chrissy Center for Social and Decision Neuroscience Center Leadership Chair; R.G.B. was supported by the Max Planck Society; R.M.W.J.B. was supported by the Max Planck Society; M.B., O.C. and R.G. were supported by the Belgian Excellence of Science program (EOS project 30991544) from the FNRS-Belgium; O.C. is a research associate at the FRS-FNRS of Belgium; A.D.L. was supported by grant R4195 "Repimpact" of EraNET Neuron; Q.S. was funded by grant no. 71971199,71602175 and 71942004 from the National Natural Science Foundation of China and no. 16YJC630103 of the Ministry of Education of Humanities and Social Science; and T.E.N. was supported by the Wellcome Trust award 100309/Z/12/Z.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Abraham A, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00014; Acikalin MY, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00001; Arrow KJ, 2008, SCIENCE, V320, P877, DOI 10.1126/science.1157679; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Botvinik-Nezer R, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0113-7; Camerer CF, 2018, NAT HUM BEHAV, V2, P637, DOI 10.1038/s41562-018-0399-z; Camerer CF, 2016, SCIENCE, V351, P1433, DOI 10.1126/science.aaf0918; Canessa N, 2013, J NEUROSCI, V33, P14307, DOI 10.1523/JNEUROSCI.0497-13.2013; Carp J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00149; Chen Y.P., 2005, THESIS; De Martino B, 2010, P NATL ACAD SCI USA, V107, P3788, DOI 10.1073/pnas.0910230107; Dreber A, 2015, P NATL ACAD SCI USA, V112, P15343, DOI 10.1073/pnas.1516179112; Eickhoff SB, 2016, NEUROIMAGE, V137, P70, DOI 10.1016/j.neuroimage.2016.04.072; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Esteban O, 2019, NAT METHODS, V16, P111, DOI 10.1038/s41592-018-0235-4; Forsell E, 2019, J ECON PSYCHOL, V75, DOI 10.1016/j.joep.2018.10.009; Fountain J, 2011, APPL ECON LETT, V18, P267, DOI 10.1080/13504850903559575; Gorgolewski KJ, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.44; Gorgolewski KJ, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00008; Hanson R., 2007, J PREDICTION MARKETS, V1, P3, DOI [DOI 10.5750/JPM.V1I1.417, 10.5750/jpm.v1i1.417]; Hughett P., 2007, J STAT SOFTW CODE SN, V23, P1, DOI 10.18637/jss.v023.c01; LaConte S, 2003, NEUROIMAGE, V18, P10, DOI 10.1006/nimg.2002.1300; Lubke GH, 2017, STRUCT EQU MODELING, V24, P230, DOI 10.1080/10705511.2016.1252265; Manski CF, 2006, ECON LETT, V91, P425, DOI 10.1016/j.econlet.2006.01.004; Markiewicz C., 2019, W621 25 ANN M ORG HU; Nichols TE, 2017, NAT NEUROSCI, V20, P299, DOI 10.1038/nn.4500; Nosek BA, 2018, P NATL ACAD SCI USA, V115, P2600, DOI 10.1073/pnas.1708274114; Nosek BA, 2014, SOC PSYCHOL-GERMANY, V45, P137, DOI 10.1027/1864-9335/a000192; Patel CJ, 2015, J CLIN EPIDEMIOL, V68, P1046, DOI 10.1016/j.jclinepi.2015.05.029; Silberzahn R, 2018, ADV METH PRACT PSYCH, V1, P337, DOI 10.1177/2515245917747646; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simonsohn U., 2015, SSRN ELECT J, DOI [10.2139/ssrn.2694998, DOI 10.2139/SSRN.2694998]; Steegen S, 2016, PERSPECT PSYCHOL SCI, V11, P702, DOI 10.1177/1745691616658637; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Wicherts JM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01832; Wolfers J., 2006, INTERPRETING PREDICT, DOI [10.3386/w12200, DOI 10.3386/W12200]; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]	40	301	306	25	196	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 4	2020	582	7810					84	+		10.1038/s41586-020-2314-9	http://dx.doi.org/10.1038/s41586-020-2314-9		MAY 2020	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NE2YK	32483374	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000535225300001
J	Morgan, M				Morgan, Matt			Matt Morgan: Treating a VIP patient	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Morgan, Matt] Univ Hosp Wales, Cardiff, Wales	Cardiff University	Morgan, M (corresponding author), Univ Hosp Wales, Cardiff, Wales.	mmorgan@bmj.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2020	369								m1973	10.1136/bmj.m1973	http://dx.doi.org/10.1136/bmj.m1973			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JI	32430345	Bronze			2022-12-28	WOS:000538335600004
J	Hall, MA; Mello, MM; Studdert, DM				Hall, Mark A.; Mello, Michelle M.; Studdert, David M.			The Legal Authority for States' Stay-at-Home Orders	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								To prevent officials from trampling civil liberties during emergencies, some checks on their power are essential, but in striking down the state's renewed stay-at-home order, the Wisconsin Supreme Court misapprehended how such checks ought to function.	[Hall, Mark A.] Wake Forest Univ, Sch Law, Wake Forest, NC 27109 USA; [Hall, Mark A.] Wake Forest Univ, Sch Med, Wake Forest, NC 27109 USA; [Mello, Michelle M.; Studdert, David M.] Stanford Law Sch, Stanford, CA USA; [Mello, Michelle M.; Studdert, David M.] Stanford Univ, Sch Med, Stanford, CA USA	Wake Forest University; Wake Forest University; Stanford University; Stanford University	Hall, MA (corresponding author), Wake Forest Univ, Sch Law, Wake Forest, NC 27109 USA.; Hall, MA (corresponding author), Wake Forest Univ, Sch Med, Wake Forest, NC 27109 USA.		Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537; Mello, Michelle/0000-0003-2877-4270; Hall, Mark A./0000-0001-6277-144X				Ballotpedia, 2020, LAWS STAT ACT POL RE; Pei S., 2020, DIFFERENTIAL EFFECTS, DOI [10.1101/2020.05.15.20103655v2, DOI 10.1101/2020.05.15.20103655V2]; Rossi J, 2006, DUKE LAW J, V56, P237; Studdert DM, 2020, NEW ENGL J MED, V382, pxxx; Sunshine G, 2019, HEALTH SECUR, V17, P156, DOI 10.1089/hs.2018.0126	5	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2020	383	5							e29	10.1056/NEJMp2019662	http://dx.doi.org/10.1056/NEJMp2019662			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MW2GI	32492296	Bronze			2022-12-28	WOS:000556861800004
J	Awdish, RLA				Awdish, Rana L. A.			The Liminal Space	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								There is so much talk of "endings" and "after this" and even of "returning" to some way that we used to be. None of those imagined times and places feel real to me. Only this timeless space feels real. This is the pause before a new beginning.	[Awdish, Rana L. A.] Henry Ford Hosp, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Awdish, RLA (corresponding author), Henry Ford Hosp, Detroit, MI 48202 USA.								0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2020	383	4							e17	10.1056/NEJMp2012147	http://dx.doi.org/10.1056/NEJMp2012147			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MU1XJ	32492299	Bronze			2022-12-28	WOS:000555465900002
J	Grabowski, DC; Mor, V				Grabowski, David C.; Mor, Vincent			Nursing Home Care in Crisis in the Wake of COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSTACUTE CARE		[Grabowski, David C.] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [Mor, Vincent] Brown Univ, Dept Hlth Serv Policy & Practice, Sch Publ Hlth, Providence, RI 02912 USA; [Mor, Vincent] Providence Vet Adm Med Ctr, Providence, RI USA	Harvard University; Harvard Medical School; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Grabowski, DC (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	grabowski@hcp.med.harvard.edu		Grabowski, David/0000-0003-2915-5770				Barnett ML, 2019, NEW ENGL J MED, V381, P302, DOI 10.1056/NEJMp1901896; Chidambaram P, KAISER FAMILY FDN IS; Grabowski DC, 2020, JAMA-J AM MED ASSOC, V323, P2007, DOI 10.1001/jama.2020.4686; Grabowski DC, 2019, SENATE FINANCE COMMI; McCarthy EP, 2020, JAMA INTERN MED, V180, P385, DOI 10.1001/jamainternmed.2019.6130; Mor V, 2016, JAMA INTERN MED, V176, P119, DOI 10.1001/jamainternmed.2015.6508; Teno JM, 2017, JAMA INTERN MED, V177, P1376, DOI 10.1001/jamainternmed.2017.2136	7	126	126	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2020	324	1					23	24		10.1001/jama.2020.8524	http://dx.doi.org/10.1001/jama.2020.8524			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM5FX	32442303	Bronze			2022-12-28	WOS:000568123600009
J	Orthofer, M; Valsesia, A; Magi, R; Wang, QP; Kaczanowska, J; Kozieradzki, I; Leopoldi, A; Cikes, D; Zopf, LM; Tretiakov, EO; Demetz, E; Hilbe, R; Boehm, A; Ticevic, M; Noukas, M; Jais, A; Spirk, K; Clark, T; Amann, S; Lepamets, M; Neumayr, C; Arnold, C; Dou, ZC; Kuhn, V; Novatchkova, M; Cronin, SJF; Tietge, UJF; Muller, S; Pospisilik, JA; Nagy, V; Hui, CC; Lazovic, J; Esterbauer, H; Hagelkruys, A; Tancevski, I; Kiefer, FW; Harkany, T; Haubensak, W; Neely, GG; Metspalu, A; Hager, J; Gheldof, N; Penninger, JM				Orthofer, Michael; Valsesia, Armand; Maegi, Reedik; Wang, Qiao-Ping; Kaczanowska, Joanna; Kozieradzki, Ivona; Leopoldi, Alexandra; Cikes, Domagoj; Zopf, Lydia M.; Tretiakov, Evgenii O.; Demetz, Egon; Hilbe, Richard; Boehm, Anna; Ticevic, Melita; Noukas, Margit; Jais, Alexander; Spirk, Katrin; Clark, Teleri; Amann, Sabine; Lepamets, Maarja; Neumayr, Christoph; Arnold, Cosmas; Dou, Zhengchao; Kuhn, Volker; Novatchkova, Maria; Cronin, Shane J. F.; Tietge, Uwe J. F.; Mueller, Simone; Pospisilik, J. Andrew; Nagy, Vanja; Hui, Chi-Chung; Lazovic, Jelena; Esterbauer, Harald; Hagelkruys, Astrid; Tancevski, Ivan; Kiefer, Florian W.; Harkany, Tibor; Haubensak, Wulf; Neely, G. Gregory; Metspalu, Andres; Hager, Jorg; Gheldof, Nele; Penninger, Josef M.			Identification of ALK in Thinness	CELL			English	Article							ANAPLASTIC LYMPHOMA KINASE; RECEPTOR TYROSINE KINASE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; GENOME-WIDE ASSOCIATION; NERVOUS-SYSTEM OUTFLOW; BODY-MASS INDEX; ADIPOSE-TISSUE; GROWTH-FACTOR; WEIGHT-GAIN; OBESITY	There is considerable inter-individual variability in susceptibility to weight gain despite an equally obesogenic environment in large parts of the world. Whereas many studies have focused on identifying the genetic susceptibility to obesity, we performed a GWAS on metabolically healthy thin individuals (lowest 6th percentile of the population-wide BMI spectrum) in a uniquely phenotyped Estonian cohort. We discovered anaplastic lymphoma kinase (ALK) as a candidate thinness gene. In Drosophila, RNAi mediated knockdown of Alk led to decreased triglyceride levels. In mice, genetic deletion of Alk resulted in thin animals with marked resistance to diet- and leptin-mutation-induced obesity. Mechanistically, we found that ALK expression in hypothalamic neurons controls energy expenditure via sympathetic control of adipose tissue lipolysis. Our genetic and mechanistic experiments identify ALK as a thinness gene, which is involved in the resistance to weight gain.	[Orthofer, Michael; Kozieradzki, Ivona; Leopoldi, Alexandra; Cikes, Domagoj; Ticevic, Melita; Cronin, Shane J. F.; Hagelkruys, Astrid; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; [Valsesia, Armand; Hager, Jorg; Gheldof, Nele] EPFL Innovat Pk, Nestle Res, Metab Phenotyping, CH-1015 Lausanne, Switzerland; [Maegi, Reedik; Noukas, Margit; Lepamets, Maarja; Metspalu, Andres] Univ Tartu, Inst Genom, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Wang, Qiao-Ping] Sun Yat Sen Univ, Sch Pharmaceut Sci Shenzhen, Guangzhou 510275, Peoples R China; [Kaczanowska, Joanna; Neumayr, Christoph; Arnold, Cosmas; Novatchkova, Maria; Haubensak, Wulf] Inst Mol Pathol, IMP, A-1030 Vienna, Austria; [Tretiakov, Evgenii O.; Harkany, Tibor] Med Univ Vienna, Dept Mol Neurosci, Ctr Brain Res, Spitalgasse 4, A-1090 Vienna, Austria; [Demetz, Egon; Hilbe, Richard; Boehm, Anna; Kuhn, Volker; Tancevski, Ivan] Innsbruck Med Univ, Dept Internal Med 2, A-6020 Innsbruck, Austria; [Jais, Alexander; Amann, Sabine; Esterbauer, Harald] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria; [Spirk, Katrin; Kiefer, Florian W.] Med Univ Vienna, Div Endocrinol & Metab, Dept Med 3, A-1090 Vienna, Austria; [Clark, Teleri; Neely, G. Gregory] Univ Sydney, Centenary Inst, Charles Perkins Ctr, Dr John & Anne Chong Lab Funct Genom, Camperdown, NSW 2006, Australia; [Clark, Teleri; Neely, G. Gregory] Univ Sydney, Sch Life & Environm Sci, Camperdown, NSW 2006, Australia; [Dou, Zhengchao; Hui, Chi-Chung] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 0A4, Canada; [Dou, Zhengchao; Hui, Chi-Chung] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Tietge, Uwe J. F.] Karolinska Inst, Dept Lab Med, Div Clin Chem, S-14152 Huddinge, Sweden; [Tietge, Uwe J. F.] Karolinska Univ Hosp, Karolinska Univ Lab, Clin Chem, S-14186 Stockholm, Sweden; [Mueller, Simone] Univ Vet Med Vienna, Inst Anim Breeding & Genet, Vet Pl 1, A-1210 Vienna, Austria; [Pospisilik, J. Andrew] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA; [Nagy, Vanja] Ludwig Boltzmann Inst Rare & Undiagnosed Dis, A-1090 Vienna, Austria; [Harkany, Tibor] Biomedicum 7D, Sect Chem Neurotransmiss, Dept Neurosci, Solnavagen 9, S-17165 Solna, Sweden; [Penninger, Josef M.] Univ British Columbia, Life Sci Inst, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; [Zopf, Lydia M.; Lazovic, Jelena] Vienna BioCtr Core Facil GmbH VBCF, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Nestle SA; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Tartu; Sun Yat Sen University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Medical University of Vienna; Medical University of Innsbruck; Medical University of Vienna; Medical University of Vienna; University of Sydney; Centenary Institute; University of Sydney; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Veterinary Medicine Vienna; Van Andel Institute; University of British Columbia	Penninger, JM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria.; Hager, J; Gheldof, N (corresponding author), EPFL Innovat Pk, Nestle Res, Metab Phenotyping, CH-1015 Lausanne, Switzerland.; Penninger, JM (corresponding author), Univ British Columbia, Life Sci Inst, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada.	jorg.hager@rd.nestle.com; nele.gheldof@rd.nestle.com; josef.penninger@ubc.ca	Tancevski, Ivan/AID-5169-2022; Neely, Greg/AAB-4642-2020; Tretiakov, Eugene O/P-9283-2016; Jais, Alexander/AAQ-9102-2021; Lazovic Zinnanti, Jelena/HGD-8286-2022; Mägi, Reedik/AAJ-9679-2021; Penninger, Josef M/I-6860-2013	Tancevski, Ivan/0000-0001-5116-8960; Neely, Greg/0000-0002-1957-9732; Tretiakov, Eugene O/0000-0001-5920-2190; Jais, Alexander/0000-0002-9897-4983; Lazovic Zinnanti, Jelena/0000-0001-7646-6104; Penninger, Josef M/0000-0002-8194-3777; Cikes, Domagoj/0000-0003-0350-5672; Demetz, Egon/0000-0002-5723-927X; Leopoldi, Alexandra/0000-0002-8747-5783; Esterbauer, Harald/0000-0001-7343-7455; Haubensak, Wulf/0000-0002-2034-9184; Gheldof, Nele/0000-0001-8922-7372; Nagy, Vanja/0000-0002-9521-4794	Estonian Research Council [IUT20-60]; European Union Horizon 2020 [692145]; European Union through the European Regional Development Fund [2014-2020.4.01.15-0012 GENTRANSMED]; Natural Science Foundation of Guangdong Province [2018B030306002]; Natural Science Foundation of China [31800993]; Austrian Science Fund (FWF) [DOC 33-B27]; Swedish Research Council (Vetenskapsraodet) [2013-3080, 201802838]; Swedish Brain Foundation (Hjarnfonden) [FO2017-0293, FO2019-0277]; European Research Council (SECRET-CELLS) [2015-AdG-695136]; European Community's Seventh Framework Programme (FP/2007-2013)/ERC grant [311701]; Research Institute of Molecular Pathology (IMP); Boehringer Ingelheim; Austrian Research Promotion Agency (FFG); IMBA; Austrian Academy of Sciences; T. von Zastrow Foundation; FWF Wittgenstein award [Z 271-B19]; Canadian government [C150]	Estonian Research Council(Estonian Research Council); European Union Horizon 2020; European Union through the European Regional Development Fund(European Commission); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Swedish Research Council (Vetenskapsraodet)(Swedish Research Council); Swedish Brain Foundation (Hjarnfonden); European Research Council (SECRET-CELLS); European Community's Seventh Framework Programme (FP/2007-2013)/ERC grant; Research Institute of Molecular Pathology (IMP); Boehringer Ingelheim(Boehringer Ingelheim); Austrian Research Promotion Agency (FFG); IMBA; Austrian Academy of Sciences; T. von Zastrow Foundation; FWF Wittgenstein award(Austrian Science Fund (FWF)); Canadian government	We would like to thank all members of our laboratories for constructive critiques and expert advice. Furthermore, we acknowledge Life Science Editors for editorial support and the IMP-IMBA graphics department for support on illustrations. We thank Alexander Stark for help with designing the enhancer assay. We are grateful to the Biomedical Sequencing Facility at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences for assistance with next-generation sequencing and G.A. Bazykin for providing access to the 2TB RAM ``Makarich'' computational cluster for OMICS data analysis. We also thank Jeremy Schwartzentruber for feedback on annotation of the variants and Solenn Pruvost from the Nestle genomics core for help with sequencing. This work was supported by the Estonian Research Council (IUT20-60), European Union Horizon 2020 (692145), and European Union through the European Regional Development Fund (2014-2020.4.01.15-0012 GENTRANSMED). Q.-P.W. was supported by the Natural Science Foundation of Guangdong Province (no. 2018B030306002) and Natural Science Foundation of China (no. 31800993). E.O.T. is supported by a Ph.D. fellowship from the Austrian Science Fund (FWF) (DOC 33-B27), and T.H. is supported by the Swedish Research Council (Vetenskapsraodet; grants 2013-3080 and 201802838), the Swedish Brain Foundation (Hjarnfonden; grants FO2017-0293 and FO2019-0277), and the European Research Council (SECRET-CELLS, 2015-AdG-695136). W.H. was supported by a grant from the European Community's Seventh Framework Programme (FP/2007-2013)/ERC grant agreement no. 311701), the Research Institute of Molecular Pathology (IMP), Boehringer Ingelheim, and the Austrian Research Promotion Agency (FFG). J.M.P. is supported by grants from IMBA, the Austrian Academy of Sciences, the T. von Zastrow Foundation, the FWF Wittgenstein award (Z 271-B19), and a C150 grant from the Canadian government.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; APFELBAUM M, 1982, REV PRATICIEN, V32, P245; Bamshad M, 1998, AM J PHYSIOL-REG I, V275, pR291, DOI 10.1152/ajpregu.1998.275.1.R291; Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569, DOI 10.1152/ajpregu.1999.276.6.R1569; Bartness TJ, 2014, FRONT NEUROENDOCRIN, V35, P473, DOI 10.1016/j.yfrne.2014.04.001; Becares N, 2019, CELL REP, V26, P984, DOI 10.1016/j.celrep.2018.12.094; Bilsland JG, 2008, NEUROPSYCHOPHARMACOL, V33, P685, DOI 10.1038/sj.npp.1301446; Bulik C M, 2001, Obes Rev, V2, P107, DOI 10.1046/j.1467-789x.2001.00030.x; Burgess S, 2014, INT J EPIDEMIOL, V43, P922, DOI 10.1093/ije/dyu005; Caron A, 2016, MOL METAB, V5, P102, DOI 10.1016/j.molmet.2015.11.005; Cheng LY, 2011, CELL, V146, P435, DOI 10.1016/j.cell.2011.06.040; Conway JR, 2017, BIOINFORMATICS, V33, P2938, DOI 10.1093/bioinformatics/btx364; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Davies NM, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k601; Davis SR, 2012, CLIMACTERIC, V15, P419, DOI 10.3109/13697137.2012.707385; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Della Corte CM, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0776-2; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Duncan L, 2017, AM J PSYCHIAT, V174, P850, DOI 10.1176/appi.ajp.2017.16121402; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Estour B, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00175; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fischer AW, 2018, MOL METAB, V7, P161, DOI 10.1016/j.molmet.2017.10.009; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foster MT, 2010, OBESITY, V18, P682, DOI 10.1038/oby.2009.345; Fox CS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S18; Franklin K., 2007, MOUSE BRAIN STEREOTA; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Germain N, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.17; Guan JK, 2015, ELIFE, V4, DOI 10.7554/eLife.09811; Guo SS, 1999, AM J CLIN NUTR, V70, P405; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hallberg B, 2016, ANN ONCOL, V27, P4, DOI 10.1093/annonc/mdw301; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hill Jennifer W, 2012, Indian J Endocrinol Metab, V16, pS627, DOI 10.4103/2230-8210.105581; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; Horvat S, 2000, MAMM GENOME, V11, P2, DOI 10.1007/s003350010002; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huckins LM, 2019, NAT GENET, V51, P659, DOI 10.1038/s41588-019-0364-4; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Kamat MA, 2019, BIOINFORMATICS, V35, P4851, DOI 10.1093/bioinformatics/btz469; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Khrunin AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058552; Laplante M, 2012, CELL METAB, V16, P202, DOI 10.1016/j.cmet.2012.07.008; Lasek AW, 2011, J NEUROSCI, V31, P14134, DOI 10.1523/JNEUROSCI.3415-11.2011; Lasek AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022636; LASKARZEWSKI PM, 1983, INT J OBESITY, V7, P505; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Li DF, 2019, NUCLEIC ACIDS RES, V47, pW158, DOI 10.1093/nar/gkz348; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Li WD, 2015, SCI REP-UK, V5, DOI 10.1038/srep13422; Ling Y, 2019, AM J CLIN NUTR, V110, P605, DOI 10.1093/ajcn/nqz144; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2018, NAT GENET, V50, P906, DOI 10.1038/s41588-018-0144-6; Loren CE, 2001, GENES CELLS, V6, P531, DOI 10.1046/j.1365-2443.2001.00440.x; Lotta LA, 2019, CELL, V177, P597, DOI 10.1016/j.cell.2019.03.044; Lu YC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10495; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Magnusson PKE, 2002, INT J OBESITY, V26, P1225, DOI 10.1038/sj.ijo.0802041; Mangieri RA, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00533; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McInnes L., 2018, ARXIV180203426, DOI [10.48550/arXiv.1802.03426, DOI 10.48550/ARXIV.1802.03426]; Meigs JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S16; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Morton NM, 2005, DIABETES, V54, P3371, DOI 10.2337/diabetes.54.12.3371; Muerdter F, 2018, NAT METHODS, V15, P141, DOI 10.1038/nmeth.4534; Murray PB, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005916; Oldfield BJ, 2002, NEUROSCIENCE, V110, P515, DOI 10.1016/S0306-4522(01)00555-3; Palmer ND, 2015, DIABETES, V64, P1853, DOI 10.2337/db14-0732; Pan W, 2014, GENETICS, V197, P1081, DOI 10.1534/genetics.114.165035; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ran S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45025; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Riveros-McKay F, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007603; Romanov RA, 2017, NAT NEUROSCI, V20, P176, DOI 10.1038/nn.4462; Saag L, 2019, CURR BIOL, V29, P1701, DOI 10.1016/j.cub.2019.04.026; Sainz N, 2015, METABOLISM, V64, P35, DOI 10.1016/j.metabol.2014.10.015; Scopelliti A, 2019, CELL METAB, V29, P269, DOI 10.1016/j.cmet.2018.09.021; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Simmons DM, 2009, J COMP NEUROL, V516, P423, DOI 10.1002/cne.22126; Staley JR, 2016, BIOINFORMATICS, V32, P3207, DOI 10.1093/bioinformatics/btw373; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sved AF, 2001, CLIN EXP PHARMACOL P, V28, P115, DOI 10.1046/j.1440-1681.2001.03403.x; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Tung YCL, 2014, CELL METAB, V20, P710, DOI 10.1016/j.cmet.2014.09.010; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vernersson E, 2006, GENE EXPR PATTERNS, V6, P448, DOI 10.1016/j.modgep.2005.11.006; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Weiss JB, 2012, PHARMACOL BIOCHEM BE, V100, P566, DOI 10.1016/j.pbb.2011.10.024; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Yengo L, 2018, BIORXIV, DOI [10.1101/274654, DOI 10.1101/274654, 10.1093/hmg/ddy271]; Yengo L, 2018, HUM MOL GENET, V27, P3641, DOI 10.1093/hmg/ddy271; Yi CX, 2013, MOL METAB, V2, P63, DOI 10.1016/j.molmet.2013.03.002; Yu YH, 2015, OBES REV, V16, P234, DOI 10.1111/obr.12246; Zeng WW, 2015, CELL, V163, P84, DOI 10.1016/j.cell.2015.08.055; Zhou X, 2012, CELL MOL LIFE SCI, V69, P819, DOI 10.1007/s00018-011-0794-3; Zillikens MC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00031-7	110	27	27	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2020	181	6					1246	+		10.1016/j.cell.2020.04.034	http://dx.doi.org/10.1016/j.cell.2020.04.034			39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LY9TE	32442405	Bronze			2022-12-28	WOS:000540869600009
J	Zeggini, E; Baumann, M; Gotz, M; Herzig, S; de Angelis, MH; Tschop, MH				Zeggini, Eleftheria; Baumann, Michael; Goetz, Magdalena; Herzig, Stephan; de Angelis, Martin Hrabe; Tschoep, Matthias H.			Biomedical Research Goes Viral: Dangers and Opportunities	CELL			English	Editorial Material							CANCER; OBESITY	Researchers around the globe have been mounting, accelerating, and redeploying efforts across disciplines and organizations to tackle the SARS-CoV-2 outbreak. However, humankind continues to be afflicted by numerous other devastating diseases in increasing numbers. Here, we outline considerations and opportunities toward striking a good balance between maintaining and redefining research priorities.	[Zeggini, Eleftheria; Goetz, Magdalena; Herzig, Stephan; de Angelis, Martin Hrabe; Tschoep, Matthias H.] Helmholtz Zentrum Munchen, Neuherberg, Germany; [Zeggini, Eleftheria; Herzig, Stephan; de Angelis, Martin Hrabe; Tschoep, Matthias H.] Tech Univ Munich, Munich, Germany; [Baumann, Michael] German Canc Res Ctr, Deutsches Krebsforschungszentrum, Heidelberg, Germany; [Baumann, Michael] Tech Univ Dresden, Dresden, Germany; [Baumann, Michael] Heidelberg Univ, Heidelberg, Germany; [Goetz, Magdalena] Ludwig Maximilians Univ Munchen, Munich, Germany; [Goetz, Magdalena] Excellence Cluster SYNERGY, Munich, Germany; [Herzig, Stephan; de Angelis, Martin Hrabe; Tschoep, Matthias H.] German Ctr Diabet Res DZD, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Technische Universitat Dresden; Ruprecht Karls University Heidelberg; University of Munich	Zeggini, E; Tschop, MH (corresponding author), Helmholtz Zentrum Munchen, Neuherberg, Germany.; Zeggini, E; Tschop, MH (corresponding author), Tech Univ Munich, Munich, Germany.; Tschop, MH (corresponding author), German Ctr Diabet Res DZD, Neuherberg, Germany.	eleftheria.zeggini@helmholtz-muenchen.de; matthias.tschoep@helmholtz-muenchen.de	de Angelis, Martin Hrabe/F-5531-2012	de Angelis, Martin Hrabe/0000-0002-7898-2353; Baumann, Michael/0000-0002-9340-974X	Novo Nordisk; Sanofi-Aventis	Novo Nordisk(Novo Nordisk); Sanofi-Aventis(Sanofi-Aventis)	Dr. Matthias Tschop is a member of the scientific advisory board of ERX Pharmaceuticals, Cambridge, Mass. He was a member of the Research Cluster Advisory Panel (ReCAP) of the Novo Nordisk Foundation between 2017 and 2019. He attended a scientific advisory board meeting of the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, in 2016. He received funding for his research projects by Novo Nordisk (2016-2020) and Sanofi-Aventis (2012-2019). He was a consultant for Bionorica SE (2013-2017), Menarini Ricerche S.p.A. (2016), and Bayer Pharma AG Berlin (2016). As former Director of the Helmholtz Diabetes Center and the Institute for Diabetes and Obesity at Helmholtz Zentrum Munchen (2011-2018), and since 2018, as CEO of Helmholtz Zentrum Munchen, he has been responsible for collaborations with a multitude of companies and institutions, worldwide. In this capacity, he discussed potential projects with and has signed/signs contracts for his institute(s) and for the staff for research funding and/or collaborations with industry and academia, worldwide, including but not limited to pharmaceutical corporations like Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Medigene, Arbormed, BioSyngen, and others. In this role, he was/is further responsible for commercial technology transfer activities of his institute(s), including diabetes related patent portfolios of Helmholtz Zentrum Munchen as, e.g., WO/2016/188932 A2 or WO/2017/194499 A1. Dr. Tschop confirms that to the best of his knowledge none of the above funding sources were involved in the preparation of this paper.	Baumann M, 2016, NAT REV CANCER, V16, P234, DOI 10.1038/nrc.2016.18; Dagogo-Jack I, 2018, NAT REV CLIN ONCOL, V15, P81, DOI 10.1038/nrclinonc.2017.166; de Martel C, 2020, LANCET GLOB HEALTH, V8, pE180, DOI 10.1016/S2214-109X(19)30488-7; Eggermont AMM, 2019, MOL ONCOL, V13, P521, DOI 10.1002/1878-0261.12447; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gallagher EJ, 2015, PHYSIOL REV, V95, P727, DOI 10.1152/physrev.00030.2014; Garcia-Jimenez C, 2016, BRIT J CANCER, V114, P716, DOI 10.1038/bjc.2016.37; Li CR, 2020, IMMUNOL REV, V295, P114, DOI 10.1111/imr.12850; Malehmir M, 2019, NAT MED, V25, P641, DOI 10.1038/s41591-019-0379-5; Overgaard J, 2015, NAT REV CLIN ONCOL, V12, P5, DOI 10.1038/nrclinonc.2014.205; Ringborg U, 2019, MOL ONCOL, V13, P517, DOI 10.1002/1878-0261.12450; Shapiro CL, 2018, NEW ENGL J MED, V379, P2438, DOI 10.1056/NEJMra1712502; WHO, 2016, GLOB REP PSOR; Wild CP, 2019, MOL ONCOL, V13, P528, DOI 10.1002/1878-0261.12455	14	4	4	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2020	181	6					1189	1193		10.1016/j.cell.2020.05.014	http://dx.doi.org/10.1016/j.cell.2020.05.014			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LY9TE	32442404	Green Published, Bronze			2022-12-28	WOS:000540869600001
J	Haushofer, J; Metcalf, CJE				Haushofer, Johannes; Metcalf, C. Jessica E.			Which interventions work best in a pandemic?	SCIENCE			English	Editorial Material							DESIGNS		[Haushofer, Johannes] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Haushofer, Johannes] Princeton Univ, Woodrow Wilson Sch Publ Affairs, Princeton, NJ 08544 USA; [Haushofer, Johannes] Natl Bur Econ Res, Cambridge, MA USA; [Haushofer, Johannes] Busara Ctr Behav Econ, Nairobi, Kenya; [Haushofer, Johannes] Ctr Global Dev, Washington, DC USA; [Haushofer, Johannes; Metcalf, C. Jessica E.] Max Planck Inst Collect Goods, Bonn, Germany; [Haushofer, Johannes; Metcalf, C. Jessica E.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Haushofer, Johannes; Metcalf, C. Jessica E.] Princeton Univ, Woodrow Wilson Sch Publ Affairs, Princeton, NJ 08544 USA	Princeton University; Princeton University; National Bureau of Economic Research; Max Planck Society; Princeton University; Princeton University	Haushofer, J (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.; Haushofer, J (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ Affairs, Princeton, NJ 08544 USA.; Haushofer, J (corresponding author), Natl Bur Econ Res, Cambridge, MA USA.; Haushofer, J (corresponding author), Busara Ctr Behav Econ, Nairobi, Kenya.; Haushofer, J (corresponding author), Ctr Global Dev, Washington, DC USA.; Haushofer, J (corresponding author), Max Planck Inst Collect Goods, Bonn, Germany.; Haushofer, J (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.; Haushofer, J (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ Affairs, Princeton, NJ 08544 USA.	haushofer@princeton.edu; cmetcalf@princeton.edu						ANDERSON R M, 1991; Benjamin-Chung J, 2018, INT J EPIDEMIOL, V47, P332, DOI 10.1093/ije/dyx201; Di Lauroy F., TIMING ONE SHOT INTE; Egger D., 2019, 26600 NBER 26600 NBER; Fang H, 2020, HUMAN MOBILITY RESTR; Ferguson Niall, 2020, WORKING PAPER; Flaxman S., 2020, WORKING PAPER; HALLORAN ME, 1991, EPIDEMIOLOGY, V2, P331, DOI 10.1097/00001648-199109000-00004; Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6; Kennedy L., 2020, MEDRXIV20087429, DOI DOI 10.1101/202005.01.20087429; Metcalf CJE, 2016, LANCET, V388, P728, DOI 10.1016/S0140-6736(16)30164-7; Miguel E, 2004, ECONOMETRICA, V72, P159, DOI 10.1111/j.1468-0262.2004.00481.x; Miller JC, 2012, B MATH BIOL, V74, P2125, DOI 10.1007/s11538-012-9749-6; Ravvson T., 2020, MEDRXIV20084517, DOI [10.1101/2020.04.29.20084517, DOI 10.1101/2020.04.29.20084517]; Tran H., 2020, SCIENCE, V368, P638, DOI [10.1126/sciencaabb6105 kledline, DOI 10.1126/SCIENCAABB6105]	15	59	60	3	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2020	368	6495					1063	+		10.1126/science.abb6144	http://dx.doi.org/10.1126/science.abb6144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LX3MF	32439658				2022-12-28	WOS:000539738400029
J	Kamber, U; Bergman, A; Eich, A; Iusan, D; Steinbrecher, M; Hauptmann, N; Nordstrom, L; Katsnelson, MI; Wegner, D; Eriksson, O; Khajetoorians, AA				Kamber, Umut; Bergman, Anders; Eich, Andreas; Iusan, Diana; Steinbrecher, Manuel; Hauptmann, Nadine; Nordstrom, Lars; Katsnelson, Mikhail I.; Wegner, Daniel; Eriksson, Olle; Khajetoorians, Alexander A.			Self-induced spin glass state in elemental and crystalline neodymium	SCIENCE			English	Article							SURFACE-ELECTRONIC-STRUCTURE; MAGNETIC PHASE-TRANSITIONS; VUV-PHOTOEMISSION; SKYRMION LATTICE; ULTRATHIN GD; ND FILMS; GD(0001); TEMPERATURE; DYNAMICS; GROWTH		[Kamber, Umut; Eich, Andreas; Steinbrecher, Manuel; Hauptmann, Nadine; Katsnelson, Mikhail I.; Wegner, Daniel; Khajetoorians, Alexander A.] Radboud Univ Nijmegen, Inst Mol & Mat, Nijmegen, Netherlands; [Bergman, Anders; Iusan, Diana; Nordstrom, Lars; Eriksson, Olle] Uppsala Univ, Dept Phys & Astron, Uppsala, Sweden; [Eriksson, Olle] Orebro Univ, Sch Sci & Technol, Orebro, Sweden	Radboud University Nijmegen; Uppsala University; Orebro University	Wegner, D; Khajetoorians, AA (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, Nijmegen, Netherlands.	d.wegner@science.ru.nl; a.khajetoorians@science.ru.nl	Wegner, Daniel/F-9700-2015; Iusan, Diana M/C-2356-2011; Khajetoorians, Alexander A/F-9698-2015; Katsnelson, Mikhail I./D-4359-2012	Wegner, Daniel/0000-0002-1625-2830; Iusan, Diana M/0000-0001-7467-9317; Steinbrecher, Manuel/0000-0003-3250-402X; Eich, Andreas/0000-0002-0828-9385; Kamber, Umut/0000-0002-1616-8866; Nordstrom, Lars/0000-0002-1400-2336	Swedish National Infrastructure for Computing (SNIC); NWO; VIDI project [680-47-534]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (SPINAPSE) [818399]; Swedish Research Council (VR); Knut and Alice Wallenberg Foundation (KAW); Foundation for Strategic Research (SSF); Energimyndigheten; eSSENCE; StandUP	Swedish National Infrastructure for Computing (SNIC); NWO(Netherlands Organization for Scientific Research (NWO)); VIDI project; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (SPINAPSE)(European Research Council (ERC)); Swedish Research Council (VR)(Swedish Research Council); Knut and Alice Wallenberg Foundation (KAW)(Knut & Alice Wallenberg Foundation); Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Energimyndigheten; eSSENCE; StandUP	This work was supported by the Swedish National Infrastructure for Computing (SNIC), NWO, and VIDI project no. 680-47-534, "Manipulating the interplay between superconductivity and chiral magnetism at the single-atom level." This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (SPINAPSE: grant no. 818399). We also acknowledge support from the Swedish Research Council (VR), the Knut and Alice Wallenberg Foundation (KAW), the Foundation for Strategic Research (SSF), Energimyndigheten, eSSENCE, and StandUP.	Arnold CS, 2000, PHYS REV LETT, V85, P5202, DOI 10.1103/PhysRevLett.85.5202; ASPELMEIER A, 1994, J MAGN MAGN MATER, V132, P22, DOI 10.1016/0304-8853(94)90296-8; BAK P, 1978, PHYS REV LETT, V40, P800, DOI 10.1103/PhysRevLett.40.800; Bauer A, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.075421; Berbil-Bautista L, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064411; BINDER K, 1986, REV MOD PHYS, V58, P801, DOI 10.1103/RevModPhys.58.801; Bode M, 1999, PHYS REV LETT, V83, P3017, DOI 10.1103/PhysRevLett.83.3017; Bode M, 2007, SURF SCI, V601, P3308, DOI 10.1016/j.susc.2007.06.017; Bode M, 1998, APPL PHYS A-MATER, V66, pS121, DOI 10.1007/s003390051113; Bode M, 1998, PHYS REV LETT, V81, P4256, DOI 10.1103/PhysRevLett.81.4256; BODENBACH M, 1994, PHYS REV B, V50, P14446, DOI 10.1103/PhysRevB.50.14446; Bramwell ST, 2001, SCIENCE, V294, P1495, DOI 10.1126/science.1064761; Chamon C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.040402; Cocker TL, 2016, NATURE, V539, P263, DOI 10.1038/nature19816; Davila ME, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.035411; Dobrich KM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.246401; Donath M, 1996, PHYS REV LETT, V77, P5138, DOI 10.1103/PhysRevLett.77.5138; Dufour C, 2002, J CRYST GROWTH, V234, P447, DOI 10.1016/S0022-0248(01)01719-5; Ediger MD, 2000, ANNU REV PHYS CHEM, V51, P99, DOI 10.1146/annurev.physchem.51.1.99; EDWARDS SF, 1976, J PHYS F MET PHYS, V6, P1927, DOI 10.1088/0305-4608/6/10/022; EDWARDS SF, 1975, J PHYS F MET PHYS, V5, P965, DOI 10.1088/0305-4608/5/5/017; Eriksson O, 2017, ATOMISTIC SPIN DYNAMICS: FOUNDATIONS AND APPLICATIONS; EVERITT BA, 1995, J MAGN MAGN MATER, V140, P769, DOI 10.1016/0304-8853(94)00809-4; Everitt BA, 1997, PHYS REV B, V56, P5452, DOI 10.1103/PhysRevB.56.5452; FARLE M, 1993, PHYS REV B, V47, P11571, DOI 10.1103/PhysRevB.47.11571; Fecher GH, 1999, EUR PHYS J B, V11, P161, DOI 10.1007/s100510050926; Fischer K.H., 1993, SPIN GLASSES; FORGAN EM, 1989, PHYS REV LETT, V62, P470, DOI 10.1103/PhysRevLett.62.470; FORGAN EM, 1992, J MAGN MAGN MATER, V104, P911, DOI 10.1016/0304-8853(92)90419-O; Getzlaff M, 1999, PHYS REV B, V59, P8195, DOI 10.1103/PhysRevB.59.8195; Goff JP, 1997, PHYSICA B, V241, P714, DOI 10.1016/S0921-4526(97)00701-1; Goff JP, 1997, PHYS REV B, V55, P12537, DOI 10.1103/PhysRevB.55.12537; Hanaguri T, 2004, NATURE, V430, P1001, DOI 10.1038/nature02861; Heigl F, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.035417; Heinze S, 2011, NAT PHYS, V7, P713, DOI [10.1038/NPHYS2045, 10.1038/nphys2045]; Hertz JA, 2018, INTRO THEORY NEURAL; Jenkins AC, 2000, J PHYS-CONDENS MAT, V12, P10441, DOI 10.1088/0953-8984/12/50/307; Jo S, 1999, JPN J APPL PHYS 1, V38, P6878, DOI 10.1143/JJAP.38.6878; Katayama N, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.113702; KIM B, 1992, PHYS REV LETT, V68, P1931, DOI 10.1103/PhysRevLett.68.1931; KOEHLER WC, 1965, J APPL PHYS, V36, P1078, DOI 10.1063/1.1714108; Kohn W, 1996, PHYS REV LETT, V76, P3168, DOI 10.1103/PhysRevLett.76.3168; Kolmus A, 2020, NEW J PHYS, V22, DOI 10.1088/1367-2630/ab6f91; Krause S, 2006, EUROPHYS LETT, V76, P637, DOI 10.1209/epl/i2006-10307-2; Kurz P, 2002, J PHYS-CONDENS MAT, V14, P6353, DOI 10.1088/0953-8984/14/25/305; Kvashnin YO, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.125133; LEBECH B, 1979, PHYS REV LETT, V43, P65, DOI 10.1103/PhysRevLett.43.65; LEBECH B, 1994, J PHYS-CONDENS MAT, V6, P5201, DOI 10.1088/0953-8984/6/27/029; LI H, 1992, PHYS REV B, V45, P3853, DOI 10.1103/PhysRevB.45.3853; Lindgard PA, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/28/286201; Loptien P, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/42/425703; Lundgren E, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.136102; LUNDGREN L, 1983, PHYS REV LETT, V51, P911, DOI 10.1103/PhysRevLett.51.911; Maiti K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.167205; MCEWEN KA, 1990, J MAGN MAGN MATER, V90-1, P94, DOI 10.1016/S0304-8853(10)80035-6; Melnikov A, 2004, J MAGN MAGN MATER, V272, P1001, DOI 10.1016/j.jmmm.2003.12.359; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mezard M, 1996, J PHYS A-MATH GEN, V29, P6515, DOI 10.1088/0305-4470/29/20/009; Mezard M., 1987, WORLD SCI LECT NOT P, V9; MOON RM, 1964, J APPL PHYS, V35, P1041, DOI 10.1063/1.1713369; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Nandkishore RM, 2019, ANNU REV CONDEN MA P, V10, P295, DOI 10.1146/annurev-conmatphys-031218-013604; Nepijko SA, 2000, SURF SCI, V466, P89, DOI 10.1016/S0039-6028(00)00724-X; Ostertag C, 1997, SURF SCI, V377, P427, DOI 10.1016/S0039-6028(96)01425-2; Ott H, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214408; Principi A, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.137201; Principi A, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.054410; QUINN J, 1992, PHYS REV B, V46, P9694, DOI 10.1103/PhysRevB.46.9694; RAMMAL R, 1986, REV MOD PHYS, V58, P765, DOI 10.1103/RevModPhys.58.765; Realpe H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.056102; Rehbein A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.033403; Rieger H., 1997, COMPLEX BEHAV GLASSY; Romming N, 2013, SCIENCE, V341, P636, DOI 10.1126/science.1240573; Schmalian J, 2000, PHYS REV LETT, V85, P836, DOI 10.1103/PhysRevLett.85.836; Schussler-Langeheine C, 2000, PHYS REV LETT, V84, P5624, DOI 10.1103/PhysRevLett.84.5624; Skubic B, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/31/315203; Skubic B, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.024411; Soriano S, 2006, J PHYS-CONDENS MAT, V18, P4995, DOI 10.1088/0953-8984/18/22/001; Tober ED, 1996, PHYS REV B, V53, P5444, DOI 10.1103/PhysRevB.53.5444; Tober ED, 1998, PHYS REV LETT, V81, P2360, DOI 10.1103/PhysRevLett.81.2360; von Allworden H, 2018, REV SCI INSTRUM, V89, DOI 10.1063/1.5020045; von Bergmann K, 2015, NANO LETT, V15, P3280, DOI 10.1021/acs.nanolett.5b00506; Waller O, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.014303; Wegner D, 2006, JPN J APPL PHYS 1, V45, P1941, DOI 10.1143/JJAP.45.1941; Wegner D, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.113410; Wegner D, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.165415; WELLER D, 1986, J APPL PHYS, V59, P2908, DOI 10.1063/1.336951; Weschke E, 1996, PHYS REV LETT, V77, P3415, DOI 10.1103/PhysRevLett.77.3415; Weschke E, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.157204; Weschke E, 2001, J PHYS-CONDENS MAT, V13, P11133, DOI 10.1088/0953-8984/13/49/303; Weschke E, 1995, J ELECTRON SPECTROSC, V75, P233, DOI 10.1016/0368-2048(95)02540-5; Westfahl H, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.174203; Wills JM, 2010, SPRINGER SER SOLID-S, V167, P3, DOI 10.1007/978-3-642-15144-6; WU SC, 1991, PHYS REV B, V44, P13720, DOI 10.1103/PhysRevB.44.13720; Yu XZ, 2010, NATURE, V465, P901, DOI 10.1038/nature09124; Zhou Y, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.025003; ZOCHOWSKI SW, 1991, J PHYS-CONDENS MAT, V3, P8079, DOI 10.1088/0953-8984/3/41/007	98	14	14	4	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					966	+	eaay6757	10.1126/science.aay6757	http://dx.doi.org/10.1126/science.aay6757			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LV3IK	32467362	Green Published, Green Submitted			2022-12-28	WOS:000538332600040
J	Rubin, R				Rubin, Rita			Traumatic Brain Injury Hospital Stays Are Longer, More Costly	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					1998	1998		10.1001/jama.2020.8130	http://dx.doi.org/10.1001/jama.2020.8130			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU8UM	32453353				2022-12-28	WOS:000538023900014
J	Fulchand, S				Fulchand, Shivali			Covid-19 and cardiovascular disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													Fulchand, Shivali/AET-0921-2022	Fulchand, Shivali/0000-0003-2918-3931				European Society of Cardiology, 2020, ESC GUID DIAGN MAN C; Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923; NHS England, 2020, CLIN GUID MAN CARD P; Public Health England, 2020, GUID SHIELD PROT PEO; Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975; UK Cabinet Office, 2020, GUID STAYING HOM AW	6	11	11	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2020	369								m1997	10.1136/bmj.m1997	http://dx.doi.org/10.1136/bmj.m1997			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JK	32434891	Bronze			2022-12-28	WOS:000538335800006
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on... following the science	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2020	369								m2014	10.1136/bmj.m2014	http://dx.doi.org/10.1136/bmj.m2014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JI	32430299	Bronze			2022-12-28	WOS:000538335600007
J	Raikkonen, K; Gissler, M; Kajantie, E				Raikkonen, Katri; Gissler, Mika; Kajantie, Eero			Associations Between Maternal Antenatal Corticosteroid Treatment and Mental and Behavioral Disorders in Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EUROPEAN CONSENSUS GUIDELINES; RESPIRATORY-DISTRESS; PSYCHIATRIC-DISORDERS; PRETERM BIRTH; CHILDHOOD; OUTCOMES; BETAMETHASONE; MANAGEMENT; RISK	This population cohort study uses national Finnish birth registry data to assess associations between antenatal corticosteroid treatment to accelerate fetal maturation and mental and behavioral disorders in term and preterm children. Question Is maternal antenatal corticosteroid treatment associated with mental and behavioral disorders in children? Findings In this population-based retrospective cohort study that included 670 & x202f;097 children, exposure to maternal antenatal corticosteroid treatment, compared with nonexposure, was significantly associated with mental and behavioral disorders in children (hazard ratio, 1.33). Meaning These findings may help inform decisions about maternal antenatal corticosteroid treatment. Importance Maternal antenatal corticosteroid treatment is standard care to accelerate fetal maturation when birth before 34 weeks is imminent. Recently, expansion of the indications beyond 34 gestational weeks has been debated. However, data about long-term outcomes remain limited, especially among infants who after treatment exposure are born at term. Objective To study if antenatal corticosteroid treatment is associated with mental and behavioral disorders in children born at term (>= 37 weeks 0 days' gestation) and preterm (<37 weeks 0 days' gestation) and if unmeasured familial confounding explains these associations. Design, Setting, and Participants Population-based retrospective cohort study using nationwide registries of all singleton live births in Finland surviving until 1 year and a within-sibpair comparison among term siblings. Children were born between January 1, 2006, and December 31, 2017, and followed up until December 31, 2017. Exposures Maternal antenatal corticosteroid treatment. Main Outcomes and Measures Primary outcome was any childhood mental and behavioral disorder diagnosed in public specialized medical care settings. Results Of the 674 & x202f;877 singleton children born in Finland during the study period, 670 & x202f;097 were eligible for analysis. The median length of follow-up was 5.8 (interquartile-range, 3.1-8.7) years. Of the 14 & x202f;868 (2.22%; 46.1% female) corticosteroid treatment-exposed children, 6730 (45.27%) were born at term and 8138 (54.74%) were born preterm; of the 655 & x202f;229 (97.78%; 48.9% female) nonexposed children, 634 & x202f;757 (96.88%) were born at term and 20 & x202f;472 (3.12%) were born preterm. Among the 241 & x202f;621 eligible term-born maternal sibpairs nested within this population, 4128 (1.71%) pairs were discordant for treatment exposure. Treatment exposure, compared with nonexposure, was significantly associated with higher risk of any mental and behavioral disorder in the entire cohort of children (12.01% vs 6.45%; absolute difference, 5.56% [95% CI, 5.04%-6.19%]; adjusted hazard ratio [HR], 1.33 [95% CI, 1.26-1.41]), in term-born children (8.89% vs 6.31%; absolute difference, 2.58% [95% CI, 1.92%-3.29%]; HR, 1.47 [95% CI, 1.36-1.69]), and when sibpairs discordant for treatment exposure were compared with sibpairs concordant for nonexposure (6.56% vs 4.17% for within-sibpair differences; absolute difference, 2.40% [95% CI, 1.67%-3.21%]; HR, 1.38 [95% CI, 1.21-1.58]). In preterm-born children, the cumulative incidence rate of any mental and behavioral disorder was also significantly higher for the treatment-exposed compared with the nonexposed children, but the HR was not significant (14.59% vs 10.71%; absolute difference, 3.38% [95% CI, 2.95%-4.87%]; HR, 1.00 [95% CI, 0.92-1.09]). Conclusions and Relevance In this population-based cohort study, exposure to maternal antenatal corticosteroid treatment was significantly associated with mental and behavioral disorders in children. These findings may help inform decisions about maternal antenatal corticosteroid treatment.	[Raikkonen, Katri] Univ Helsinki, Dept Psychol & Logoped, Fac Med, POB 21 Haartmaninkatu 3, Helsinki 00014, Finland; [Gissler, Mika] THL Finnish Inst Hlth & Welf, Informat Serv Dept, Helsinki, Finland; [Gissler, Mika] Univ Turku, Res Ctr Child Psychiat, Turku, Finland; [Gissler, Mika] Karolinska Inst, Dept Neurobiol, Stockholm, Sweden; [Kajantie, Eero] THL Finnish Inst Hlth & Welf, Dept Publ Hlth Solut, Helsinki, Finland; [Kajantie, Eero] THL Finnish Inst Hlth & Welf, Dept Publ Hlth Solut, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu Univ Hosp, PEDEGO Res Unit, MRC Oulu, Oulu, Finland; [Kajantie, Eero] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway; [Kajantie, Eero] Univ Helsinki, Helsinki Univ Hosp, Childrens Hosp, Helsinki, Finland	University of Helsinki; University of Turku; Karolinska Institutet; University of Oulu; Norwegian University of Science & Technology (NTNU); University of Helsinki; Helsinki University Central Hospital	Raikkonen, K (corresponding author), Univ Helsinki, Dept Psychol & Logoped, Fac Med, POB 21 Haartmaninkatu 3, Helsinki 00014, Finland.	katri.raikkonen@helsinki.fi		Raikkonen, Katri/0000-0003-3124-3470	Academy of Finland; European Commission (Horizon 2020) [SC1-2016-RTD-733280 RECAP]; European Commission Dynamics of Inequality Across the Life-course: structures and processes (DIAL) [724363]; Foundation for Pediatric Research; Signe and Ane Gyllenberg Foundation; Novo Nordisk Foundation; Sigrid Juselius Foundation; Juho Vainio Foundation	Academy of Finland(Academy of Finland); European Commission (Horizon 2020)(European Commission); European Commission Dynamics of Inequality Across the Life-course: structures and processes (DIAL); Foundation for Pediatric Research; Signe and Ane Gyllenberg Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Juho Vainio Foundation	This study was funded by the Academy of Finland, European Commission (Horizon 2020 Award SC1-2016-RTD-733280 RECAP), European Commission Dynamics of Inequality Across the Life-course: structures and processes (DIAL) No. 724363 for PremLife, Foundation for Pediatric Research, the Signe and Ane Gyllenberg Foundation, the Novo Nordisk Foundation, the Sigrid Juselius Foundation, and the Juho Vainio Foundation.	Asztalos E, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-272; Copel J, 2017, OBSTET GYNECOL, V130, pE210, DOI [10.1097/AOG.0000000000002355, 10.1097/AOG.0000000000002237]; Copeland WE, 2015, JAMA PSYCHIAT, V72, P892, DOI 10.1001/jamapsychiatry.2015.0730; Copeland WE, 2009, ARCH GEN PSYCHIAT, V66, P764, DOI 10.1001/archgenpsychiatry.2009.85; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; Crowther CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0947; Crowther CA, 2016, NEW ENGL J MED, V374, P1376, DOI 10.1056/NEJMe1601867; Gissler M., 2010, FINN YEARB POPUL RES, V45, P171, DOI [10.23979/fypr.45059, DOI 10.23979/FYPR.45059]; Gyamfi-Bannerman C, 2016, NEW ENGL J MED, V374, P1311, DOI 10.1056/NEJMoa1516783; Heinonen K, 2016, PSYCHOL MED, V46, P2227, DOI 10.1017/S0033291716000830; Kamath-Rayne BD, 2016, AM J OBSTET GYNECOL, V215, P423, DOI 10.1016/j.ajog.2016.06.023; Kerstjens JM, 2012, PEDIATRICS, V130, pE265, DOI 10.1542/peds.2012-0079; Kong LH, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0776; Lahti M, 2015, PSYCHOL MED, V45, P985, DOI 10.1017/S0033291714001998; Lampi KM, 2010, ACTA PAEDIATR, V99, P1425, DOI 10.1111/j.1651-2227.2010.01835.x; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; Pyhala R, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2690; Reynolds RM, 2012, J CLIN ENDOCR METAB, V97, P3457, DOI 10.1210/jc.2012-3201; Roberts D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub3; Rodriguez A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002746; Saccone G, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5044; Seckl JR, 2004, ANN NY ACAD SCI, V1032, P63, DOI 10.1196/annals.1314.006; Sotiriadis A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006614.pub2; Stutchfield P, 2005, BMJ-BRIT MED J, V331, P662, DOI 10.1136/bmj.38547.416493.06; Sudan M, 2014, J EXPO SCI ENV EPID, V24, P482, DOI 10.1038/jes.2013.56; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Sweet DG, 2019, NEONATOLOGY, V115, P432, DOI 10.1159/000499361; Sweet DG, 2017, NEONATOLOGY, V111, P107, DOI 10.1159/000448985; Wolford E, 2020, PSYCHOL MED, V50, P247, DOI 10.1017/S0033291718004129; World Health Organization, 2015, WHO RECOMMENDATIONS	30	94	100	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2020	323	19					1924	1933		10.1001/jama.2020.3937	http://dx.doi.org/10.1001/jama.2020.3937			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LT2XF	32427304	Green Published, Bronze			2022-12-28	WOS:000536934300019
J	Neeleman, M; Prochaska, JX; Kanekar, N; Rafelski, M				Neeleman, Marcel; Prochaska, J. Xavier; Kanekar, Nissim; Rafelski, Marc			A cold, massive, rotating disk galaxy 1.5 billion years after the Big Bang	NATURE			English	Article							STAR-FORMATION; HOST GALAXIES; REDSHIFT; GAS; EMISSION; CURVES; ORIGIN	Massive disk galaxies like the Milky Way are expected to form at late times in traditional models of galaxy formation(1,2), but recent numerical simulations suggest that such galaxies could form as early as a billion years after the Big Bang through the accretion of cold material and mergers(3,4). Observationally, it has been difficult to identify disk galaxies in emission at high redshift(5,6) in order to discern between competing models of galaxy formation. Here we report imaging, with a resolution of about 1.3 kiloparsecs, of the 158-micrometre emission line from singly ionized carbon, the far-infrared dust continuum and the near-ultraviolet continuum emission from a galaxy at a redshift of 4.2603, identified by detecting its absorption of quasar light. These observations show that the emission arises from gas inside a cold, dusty, rotating disk with a rotational velocity of about 272 kilometres per second. The detection of emission from carbon monoxide in the galaxy yields a molecular mass that is consistent with the estimate from the ionized carbon emission of about 72 billion solar masses. The existence of such a massive, rotationally supported, cold disk galaxy when the Universe was only 1.5 billion years old favours formation through either cold-mode accretion or mergers, although its large rotational velocity and large content of cold gas remain challenging to reproduce with most numerical simulations(7,8). A massive rotating disk galaxy was formed a mere 1.5 billion years after the Big Bang, a surprisingly short time after the origin of the Universe.	[Neeleman, Marcel] Max Planck Inst Astron, Heidelberg, Germany; [Prochaska, J. Xavier] Univ Calif Santa Cruz, Dept Astron & Astrophys, UCO Lick Observ, Santa Cruz, CA 95064 USA; [Prochaska, J. Xavier] Univ Tokyo, Kavli Inst Phys & Math Universe Kavli IPMU, Kashiwa, Chiba, Japan; [Kanekar, Nissim] Pune Univ, Tata Inst Fundamental Res, Natl Ctr Radio Astrophys, Pune, Maharashtra, India; [Rafelski, Marc] Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA; [Rafelski, Marc] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA	Max Planck Society; University of California System; University of California Santa Cruz; University of Tokyo; Savitribai Phule Pune University; Tata Institute of Fundamental Research (TIFR); National Centre for Radio Astrophysics (NCRA), Pune; Space Telescope Science Institute; Johns Hopkins University	Neeleman, M (corresponding author), Max Planck Inst Astron, Heidelberg, Germany.	neeleman@mpia.de		Prochaska, J. Xavier/0000-0002-7738-6875				Ade PAR, 2016, ASTRON ASTROPHYS, V594, DOI 10.1051/0004-6361/201525830; Banados E, 2019, ASTROPHYS J LETT, V881, DOI 10.3847/2041-8213/ab3659; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Beuther H, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201424757; Bird JC, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/43; Bolatto AD, 2013, ANNU REV ASTRON ASTR, V51, P207, DOI 10.1146/annurev-astro-082812-140944; Brown AGA, 2018, ASTRON ASTROPHYS, V616, DOI 10.1051/0004-6361/201833051; Burkert A, 2010, ASTROPHYS J, V725, P2324, DOI 10.1088/0004-637X/725/2/2324; Calzetti D, 2010, ASTROPHYS J, V714, P1256, DOI 10.1088/0004-637X/714/2/1256; Carilli CL, 2013, ANNU REV ASTRON ASTR, V51, P105, DOI 10.1146/annurev-astro-082812-140953; Cormier D, 2019, ASTRON ASTROPHYS, V626, DOI 10.1051/0004-6361/201834457; Croxall KV, 2017, ASTROPHYS J, V845, DOI 10.3847/1538-4357/aa8035; da Cunha E, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/13; Daddi E, 2010, ASTROPHYS J, V713, P686, DOI 10.1088/0004-637X/713/1/686; de Blok WJG, 2008, ASTRON J, V136, P2648, DOI 10.1088/0004-6256/136/6/2648; de Blok WJG, 2016, ASTRON J, V152, DOI 10.3847/0004-6256/152/2/51; De Looze I, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201322489; Decarli R, 2018, ASTROPHYS J, V854, DOI 10.3847/1538-4357/aaa5aa; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Dessauges-Zavadsky M, 2015, ASTRON ASTROPHYS, V577, DOI 10.1051/0004-6361/201424661; Di Teodoro EM, 2015, MON NOT R ASTRON SOC, V451, P3021, DOI 10.1093/mnras/stv1213; Elmegreen BG, 2008, ASTROPHYS J, V688, P67, DOI 10.1086/592190; FALL SM, 1980, MON NOT R ASTRON SOC, V193, P189, DOI 10.1093/mnras/193.2.189; Genzel R, 2017, NATURE, V543, P397, DOI 10.1038/nature21685; Grand RJJ, 2017, MON NOT R ASTRON SOC, V467, P179, DOI 10.1093/mnras/stx071; Gullberg B, 2018, ASTROPHYS J, V859, DOI 10.3847/1538-4357/aabe8c; Herrera-Camus R, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/1; Ho LC, 2007, ASTROPHYS J, V669, P821, DOI 10.1086/521917; Hodge JA, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/11; Jones MG, 2018, MON NOT R ASTRON SOC, V477, P2, DOI 10.1093/mnras/sty521; Kennicutt RC, 2012, ANNU REV ASTRON ASTR, V50, P531, DOI 10.1146/annurev-astro-081811-125610; Keres D, 2005, MON NOT R ASTRON SOC, V363, P2, DOI 10.1111/j.1365-2966.2005.09451.x; KRON RG, 1980, ASTROPHYS J SUPPL S, V43, P305, DOI 10.1086/190669; Lynden-Bell D, 1965, MNRAS, V130, P97, DOI DOI 10.1093/MNRAS/130.2.97; McMullin JP, 2007, ASTR SOC P, V376, P127; Neeleman M, 2019, ASTROPHYS J, V882, DOI 10.3847/1538-4357/ab2ed3; Neeleman M, 2019, ASTROPHYS J LETT, V870, DOI 10.3847/2041-8213/aaf871; Neeleman M, 2017, SCIENCE, V355, P1285, DOI 10.1126/science.aal1737; PERSSON CJL, 1987, ASTROPHYS J, V314, P513, DOI 10.1086/165082; Pillepich A, 2019, MON NOT R ASTRON SOC, V490, P3196, DOI 10.1093/mnras/stz2338; Price SH, 2016, ASTROPHYS J, V819, DOI 10.3847/0004-637X/819/1/80; REES MJ, 1977, MON NOT R ASTRON SOC, V179, P541, DOI 10.1093/mnras/179.4.541; Riechers DA, 2013, NATURE, V496, P329, DOI 10.1038/nature12050; Schreiber NMF, 2009, ASTROPHYS J, V706, P1364, DOI 10.1088/0004-637X/706/2/1364; Scoville N, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/84; Simons RC, 2017, ASTROPHYS J, V843, DOI 10.3847/1538-4357/aa740c; Smit R, 2018, NATURE, V553, P178, DOI 10.1038/nature24631; TOOMRE A, 1964, ASTROPHYS J, V139, P1217, DOI 10.1086/147861; Venemans BP, 2019, ASTROPHYS J LETT, V874, DOI 10.3847/2041-8213/ab11cc; Walter F, 1997, ASTRON J, V113, P2031, DOI 10.1086/118415; Wang R, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/44; Zanella A, 2018, MON NOT R ASTRON SOC, V481, P1976, DOI 10.1093/mnras/sty2394	52	46	46	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY	2020	581	7808					269	+		10.1038/s41586-020-2276-y	http://dx.doi.org/10.1038/s41586-020-2276-y			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ2CZ	32433621	Green Submitted			2022-12-28	WOS:000534818200008
J	Li, BX; Suutari, BS; Sun, SD; Luo, ZY; Wei, CC; Chenouard, N; Mandelberg, NJ; Zhang, GA; Wamsley, B; Tian, GL; Sanchez, S; You, SK; Huang, LY; Neubert, TA; Fishell, G; Tsien, RW				Li, Boxing; Suutari, Benjamin S.; Sun, Simon(e) D.; Luo, Zhengyi; Wei, Chuanchuan; Chenouard, Nicolas; Mandelberg, Nataniel J.; Zhang, Guoan; Wamsley, Brie; Tian, Guoling; Sanchez, Sandrine; You, Sikun; Huang, Lianyan; Neubert, Thomas A.; Fishell, Gordon; Tsien, Richard W.			Neuronal Inactivity Co-opts LTP Machinery to Drive Potassium Channel Splicing and Homeostatic Spike Widening	CELL			English	Article							KINASE KINASE-BETA; INTRINSIC EXCITABILITY; CALCIUM-CHANNELS; RNA-BINDING; K+ CHANNELS; RAT-BRAIN; NEUROTRANSMITTER RELEASE; CREB PHOSPHORYLATION; PRESYNAPTIC FUNCTION; NETWORK HOMEOSTASIS	Homeostasis of neural firing properties is important in stabilizing neuronal circuitry, but how such plasticity might depend on alternative splicing is not known. Here we report that chronic inactivity homeostatically increases action potential duration by changing alternative splicing of BK channels; this requires nuclear export of the splicing factor Nova-2. Inactivity and Nova-2 relocation were connected by a novel synapto-nuclear signaling pathway that surprisingly invoked mechanisms akin to Hebbian plasticity: Ca2+-permeable AMPA receptor upregulation, L-type Ca2+ channel activation, enhanced spine Ca2+ transients, nuclear translocation of a CaM shuttle, and nuclear CaMKIV activation. These findings not only uncover commonalities between homeostatic and Hebbian plasticity but also connect homeostatic regulation of synaptic transmission and neuronal excitability. The signaling cascade provides a full-loop mechanism for a classic autoregulatory feedback loop proposed similar to 25 years ago. Each element of the loop has been implicated previously in neuropsych iatric disease.	[Li, Boxing; Wei, Chuanchuan; You, Sikun; Huang, Lianyan] Sun Yat Sen Univ, Zhongshan Sch Med, Guangdong Prov Key Lab Brain Funct & Dis, Neurosci Program, Guangzhou 510810, Peoples R China; [Li, Boxing; Wei, Chuanchuan; You, Sikun; Huang, Lianyan] Sun Yat Sen Univ, Affiliated Hosp 5, Guangzhou 510810, Peoples R China; [Li, Boxing; Suutari, Benjamin S.; Sun, Simon(e) D.; Chenouard, Nicolas; Mandelberg, Nataniel J.; Wamsley, Brie; Tian, Guoling; Sanchez, Sandrine; Fishell, Gordon; Tsien, Richard W.] NYU, Inst Neurosci, Dept Neurosci & Physiol, Grossman Med Ctr, New York, NY 10016 USA; [Suutari, Benjamin S.; Sun, Simon(e) D.; Tsien, Richard W.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Luo, Zhengyi] Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Zhongshan Sch Med, RNA Biomed Inst,Sun Yat Sen Mem Hosp, Guangzhou 510120, Peoples R China; [Zhang, Guoan; Neubert, Thomas A.] NYU, Grossman Med Ctr, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Zhang, Guoan; Neubert, Thomas A.] NYU, Grossman Med Ctr, Skirball Inst, New York, NY 10016 USA; [Wamsley, Brie; Fishell, Gordon] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA	Sun Yat Sen University; Sun Yat Sen University; New York University; New York University; Sun Yat Sen University; New York University; New York University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Li, BX (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Guangdong Prov Key Lab Brain Funct & Dis, Neurosci Program, Guangzhou 510810, Peoples R China.; Li, BX (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 5, Guangzhou 510810, Peoples R China.; Li, BX; Tsien, RW (corresponding author), NYU, Inst Neurosci, Dept Neurosci & Physiol, Grossman Med Ctr, New York, NY 10016 USA.; Tsien, RW (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	liboxing@mail.sysu.edu.cn; richard.tsien@nyulangone.org		Fishell, Gordon/0000-0002-9640-9278; Sun, Simon(e)/0000-0002-9532-7537	NIGMS [GM058234]; NINDS [NS24067]; NIMH [MH071739]; NIDA [DA040484]; Druckenmiller Foundation; Simons Foundation; Mathers Foundation; Burnett Family Foundation; National Key RAMP;D Program of China [2018YFA0108300]; National Natural Science Foundation of China [81622016, 31571034, 81871048, 81741063]; Guangdong Natural Science Foundation [2015A030306019, 2018B030311034]; Guangdong Provincial Key RD Programs [2018B030332001, 2018B030335001]	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Druckenmiller Foundation; Simons Foundation; Mathers Foundation; Burnett Family Foundation; National Key RAMP;D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Provincial Key RD Programs	We thank Dr. Robert B. Darnell for providing human anti-Nova serum and Dr. Peter Stoilov and Dr. Douglas Black for providing AS reporter constructs. We thank Xiaohan Wang and other Tsien lab members for advice and comments on the manuscript. This work was supported by research grants from the NIGMS (GM058234), NINDS (NS24067), NIMH (MH071739), NIDA (DA040484), Druckenmiller Foundation, Simons Foundation, Mathers Foundation, and Burnett Family Foundation (to R.W.T.); the National Key R&D Program of China (2018YFA0108300 to B.L.); the National Natural Science Foundation of China (81622016 and 31571034 to B.L. and 81871048 and 81741063 to L.H.); the Guangdong Natural Science Foundation (Grants for Distinguished Young Scholars 2015A030306019 to B.L. and 2018B030311034 to L.H.); and the Guangdong Provincial Key R&D Programs (Key Technologies for Treatment of Brain Disorders 2018B030332001 and Development of New Tools for Diagnosis and Treatment of Autism 2018B030335001 to L.H. and B.L.).	Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Bhat S, 2012, PROG NEUROBIOL, V99, P1, DOI 10.1016/j.pneurobio.2012.06.001; Bischofberger J, 2002, J NEUROSCI, V22, P10593; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Borst JGG, 1998, J PHYSIOL-LONDON, V506, P143, DOI 10.1111/j.1469-7793.1998.143bx.x; Bridi MCD, 2018, NAT NEUROSCI, V21, P843, DOI 10.1038/s41593-018-0150-0; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; Byrne JH, 1996, J NEUROSCI, V16, P425; Cao WG, 2011, RNA BIOL, V8, P1061, DOI 10.4161/rna.8.6.16691; Cohen SM, 2016, NEURON, V90, P292, DOI 10.1016/j.neuron.2016.03.001; CRUZALEGUI FH, 1993, J BIOL CHEM, V268, P26171; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deng PY, 2013, NEURON, V77, P696, DOI 10.1016/j.neuron.2012.12.018; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Ding XL, 2017, NAT NEUROSCI, V20, P690, DOI 10.1038/nn.4536; Dittmer PJ, 2017, CELL REP, V19, P321, DOI 10.1016/j.celrep.2017.03.056; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Edelman AM, 1996, J BIOL CHEM, V271, P10806, DOI 10.1074/jbc.271.18.10806; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Eom T, 2013, ELIFE, V2, DOI 10.7554/eLife.00178; Fodor AA, 2009, ANNU REV PHYSIOL, V71, P19, DOI 10.1146/annurev.physiol.010908.163124; Furlanis E, 2018, ANNU REV CELL DEV BI, V34, P451, DOI 10.1146/annurev-cellbio-100617-062826; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Green MF, 2011, CELL SIGNAL, V23, P2005, DOI 10.1016/j.cellsig.2011.07.014; Green MF, 2011, J BIOL CHEM, V286, P28066, DOI 10.1074/jbc.M111.251504; Ha TS, 2000, EUR J BIOCHEM, V267, P910, DOI 10.1046/j.1432-1327.2000.01076.x; Harnett MT, 2012, NATURE, V491, P599, DOI 10.1038/nature11554; Harreman MT, 2004, J BIOL CHEM, V279, P20613, DOI 10.1074/jbc.M401720200; Hebert B, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0124-6; Helton TD, 2005, J NEUROSCI, V25, P10247, DOI 10.1523/JNEUROSCI.1089-05.2005; Higgins JJ, 2008, NEUROGENETICS, V9, P219, DOI 10.1007/s10048-008-0128-2; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Iijima T, 2011, CELL, V147, P1601, DOI 10.1016/j.cell.2011.11.028; JACKSON MB, 1991, P NATL ACAD SCI USA, V88, P380, DOI 10.1073/pnas.88.2.380; Jakawich SK, 2010, NEURON, V68, P1143, DOI 10.1016/j.neuron.2010.11.034; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Joseph A, 2017, J NEUROSCI, V37, P6778, DOI 10.1523/JNEUROSCI.0618-17.2017; Karacosta LG, 2012, J BIOL CHEM, V287, P24832, DOI 10.1074/jbc.M112.370783; Kim J, 2008, NEURON, V58, P925, DOI 10.1016/j.neuron.2008.05.009; Kim S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001900; Kimm T, 2015, J NEUROSCI, V35, P16404, DOI 10.1523/JNEUROSCI.5291-14.2015; Kimura Y, 2002, EMBO REP, V3, P962, DOI 10.1093/embo-reports/kvf191; Kuwano Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024723; Laumonnier F, 2006, AM J PSYCHIAT, V163, P1622, DOI 10.1176/appi.ajp.163.9.1622; Lee JA, 2007, PLOS BIOL, V5, P281, DOI 10.1371/journal.pbio.0050040; Lee JA, 2016, NEURON, V89, P113, DOI 10.1016/j.neuron.2015.11.025; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; Lee KY, 2014, NEUROSCIENCE, V277, P610, DOI 10.1016/j.neuroscience.2014.07.038; Lee KY, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0094-1; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Li BX, 2016, SCIENCE, V351, P863, DOI 10.1126/science.aad3647; Li BX, 2014, NAT NEUROSCI, V17, P1055, DOI 10.1038/nn.3744; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lindskog M, 2010, P NATL ACAD SCI USA, V107, P21806, DOI 10.1073/pnas.1016399107; Liu GD, 2012, J BIOL CHEM, V287, P22709, DOI 10.1074/jbc.M112.357343; LLINAS R, 1982, P NATL ACAD SCI-BIOL, V79, P2415, DOI 10.1073/pnas.79.7.2415; Luo XJ, 2014, MOL PSYCHIATR, V19, P774, DOI 10.1038/mp.2013.103; Ma H, 2014, CELL, V159, P281, DOI 10.1016/j.cell.2014.09.019; Ma WP, 2013, J NEUROSCI, V33, P11276, DOI 10.1523/JNEUROSCI.5598-12.2013; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Maghsoodi B, 2008, P NATL ACAD SCI USA, V105, P16015, DOI 10.1073/pnas.0804801105; Marcelo KL, 2016, TRENDS ENDOCRIN MET, V27, P706, DOI 10.1016/j.tem.2016.06.001; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Matthews EA, 2009, J NEUROSCI, V29, P4750, DOI 10.1523/JNEUROSCI.0384-09.2009; Mauger O, 2016, NEURON, V92, P1266, DOI 10.1016/j.neuron.2016.11.032; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mullins C, 2016, NEURON, V89, P1131, DOI 10.1016/j.neuron.2016.02.017; NAKAMURA Y, 1995, NEUROSCIENCE, V68, P181, DOI 10.1016/0306-4522(95)00092-W; Nakamura Y, 2001, NEUROSCI RES, V39, P175, DOI 10.1016/S0168-0102(00)00209-1; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; O'Brien MT, 2017, SCI REP-UK, V7, DOI 10.1038/srep43264; O'Leary T, 2014, NEURON, V82, P809, DOI 10.1016/j.neuron.2014.04.002; O'Leary T, 2010, J PHYSIOL-LONDON, V588, P157, DOI 10.1113/jphysiol.2009.181024; Obermair GJ, 2004, EUR J NEUROSCI, V19, P2109, DOI 10.1111/j.0953-816X.2004.03272.x; Ogundijo OE, 2017, EURASIP J BIOINFORM, DOI 10.1186/s13637-016-0055-8; Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009; Parikshak NN, 2016, NATURE, V540, P423, DOI 10.1038/nature20612; Penney J, 2012, NEURON, V74, P166, DOI 10.1016/j.neuron.2012.01.030; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Racca C, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.005.2010; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Sabatini BL, 1997, J NEUROSCI, V17, P3425; Saito Y, 2016, ELIFE, V5, DOI 10.7554/eLife.14371; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Schanzenbacher CT, 2016, NEURON, V92, P358, DOI 10.1016/j.neuron.2016.09.058; Schaukowitch K, 2017, CELL REP, V18, P1512, DOI 10.1016/j.celrep.2017.01.033; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SELBERT MA, 1995, J BIOL CHEM, V270, P17616, DOI 10.1074/jbc.270.29.17616; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Shelley C, 2013, J GEN PHYSIOL, V142, P585, DOI 10.1085/jgp.201311072; Shipston MJ, 2016, INT REV NEUROBIOL, V128, P91, DOI 10.1016/bs.irn.2016.02.012; SIEGEL M, 1994, P NATL ACAD SCI USA, V91, P11308, DOI 10.1073/pnas.91.24.11308; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Stanika R, 2016, SCI REP-UK, V6, DOI 10.1038/srep34528; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Styr B, 2018, NAT NEUROSCI, V21, P463, DOI 10.1038/s41593-018-0080-x; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Tokumitsu H, 1996, J BIOL CHEM, V271, P5617, DOI 10.1074/jbc.271.10.5617; Trasande CA, 2007, J CLIN NEUROPHYSIOL, V24, P154, DOI 10.1097/WNP.0b013e318033787f; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Vuong CK, 2016, NAT REV NEUROSCI, V17, P265, DOI 10.1038/nrn.2016.27; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wheeler DG, 2012, CELL, V149, P1112, DOI 10.1016/j.cell.2012.03.041; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; Wondolowski J, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00223; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Xu DR, 2012, MOL BIOL CELL, V23, P3677, DOI 10.1091/mbc.E12-01-0046; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; Zarei MM, 2001, J BIOL CHEM, V276, P16232, DOI 10.1074/jbc.M008852200; Zhang L, 2006, MED HYPOTHESES, V67, P41, DOI 10.1016/j.mehy.2005.09.055	129	12	13	5	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2020	181	7					1547	+		10.1016/j.cell.2020.05.013	http://dx.doi.org/10.1016/j.cell.2020.05.013			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MD2SA	32492405	Bronze, Green Accepted			2022-12-28	WOS:000543822100013
J	Song, ZR				Song, Zirui			Potential Implications of Lowering the Medicare Eligibility Age to 60	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Song, Zirui] Harvard Med Sch, Dept Hlth Care Policy, 180A Longwood Ave, Boston, MA 02115 USA; [Song, Zirui] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Song, ZR (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180A Longwood Ave, Boston, MA 02115 USA.	song@hcp.med.harvard.edu			National Institutes of Health; Laura and John Arnold Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laura and John Arnold Foundation	Dr Song reported receiving grants from the National Institutes of Health and the Laura and John Arnold Foundation; receiving personal fees from the Research Triangle Institute for work on risk adjustment, from the International Foundation of Employee Benefit Plans for a lecture outside of this work, and for providing expert testimony outside of this work.	Congressional Budget Office, 2018, RAIS AG EL MED 67; Kaiser Family Foundation, 2019, KFF HLTH TRACKING PO; Levitt L, 2019, JAMA-J AM MED ASSOC, V322, P16, DOI 10.1001/jama.2019.8268; Neuman P, 2015, HEALTH AFFAIR, V34, P335, DOI 10.1377/hlthaff.2014.1371; Song ZR, 2019, JAMA-J AM MED ASSOC, V322, P395, DOI 10.1001/jama.2019.8245; US Bureau of Labor Statistics, 2020, EFF COVID 19 PAND EM; Wallace J, 2016, HEALTH AFFAIR, V35, P864, DOI 10.1377/hlthaff.2015.1195	7	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2472	2473		10.1001/jama.2020.7245	http://dx.doi.org/10.1001/jama.2020.7245			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OS4QL	32469394				2022-12-28	WOS:000590149400014
J	Tolles, J; Luong, T				Tolles, Juliana; ThaiBinh Luong			Modeling Epidemics With Compartmental Models	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Tolles, Juliana] Harbor UCLA Med Ctr, Dept Emergency Med, 1000 W Carson St,Bldg D9, Torrance, CA 90502 USA; [Tolles, Juliana] Univ Calif Los Angeles, David Geffen Sch Med, Dept Emergency Med, Los Angeles, CA 90095 USA; [ThaiBinh Luong] Univ Penn Hlth Syst, Predict Healthcare, Philadelphia, PA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Pennsylvania	Tolles, J (corresponding author), Harbor UCLA Med Ctr, Dept Emergency Med, 1000 W Carson St,Bldg D9, Torrance, CA 90502 USA.	jtolles@emedharbor.edu						Clancy D, 2008, BAYESIAN ANAL, V3, P737, DOI 10.1214/08-BA328; Jewell NP, 2020, JAMA-J AM MED ASSOC, V323, P1893, DOI 10.1001/jama.2020.6585; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Lourenco J., 2020, MEDRXIV, DOI [10.1101/2020.03.24.20042291, 10.1101/2020.03.24.20042291v1, DOI 10.1101/2020.03.24.20042291]; Murray CJ, 2020, MEDRX, DOI [10.1101/2020.03.27.20043752, DOI 10.1101/2020.03.27.20043752]; Weissman GE, 2020, ANN INTERN MED, V173, P21, DOI 10.7326/M20-1260; Zlojutro A, 2019, SCI REP, V9, P1	7	57	59	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2515	2516		10.1001/jama.2020.8420	http://dx.doi.org/10.1001/jama.2020.8420			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32459319	Bronze			2022-12-28	WOS:000590149400024
J	Kuppermann, M; Kaimal, AJ; Blat, C; Gonzalez, J; Thiet, MP; Bermingham, Y; Altshuler, AL; Bryant, AS; Bacchetti, P; Grobman, WA				Kuppermann, Miriam; Kaimal, Anjali J.; Blat, Cinthia; Gonzalez, Juan; Thiet, Mari-Paule; Bermingham, Yamilee; Altshuler, Anna L.; Bryant, Allison S.; Bacchetti, Peter; Grobman, William A.			Effect of a Patient-Centered Decision Support Tool on Rates of Trial of Labor After Previous Cesarean Delivery: The PROCEED Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH; WOMEN; MODE; AIDS	Key PointsQuestionDoes use of a patient-centered decision support tool increase the likelihood of trial of labor after previous cesarean delivery? FindingsIn this randomized clinical trial of 1485 women with previous cesarean delivery, use of a decision support tool compared with usual care resulted in rates of trial of labor of 43.3% vs 46.2%, a difference that was not statistically significant. MeaningThe use of this decision support tool did not affect rates of trial of labor, but further research may be needed to assess its efficacy in other clinical settings. ImportanceReducing cesarean delivery rates in the US is an important public health goal; despite evidence of the safety of vaginal birth after cesarean delivery, most women have scheduled repeat cesarean deliveries. A decision support tool could help increase trial-of-labor rates. ObjectiveTo analyze the effect of a patient-centered decision support tool on rates of trial of labor and vaginal birth after cesarean delivery and decision quality. Design, Setting, and ParticipantsMulticenter, randomized, parallel-group clinical trial conducted in Boston, Chicago, and the San Francisco Bay area. A total of 1485 English- or Spanish-speaking women with 1 prior cesarean delivery and no contraindication to trial of labor were enrolled between January 2016 and January 2019; follow-up was completed in June 2019. InterventionsParticipants were randomized to use a tablet-based decision support tool prior to 25 weeks' gestation (n=742) or to receive usual care (without the tool) (n=743). Main Outcomes and MeasuresThe primary outcome was trial of labor; vaginal birth was the main secondary outcome. Other secondary outcomes focused on maternal and neonatal outcomes and decision quality. ResultsAmong 1485 patients (mean age, 34.0 [SD, 4.5] years), 1470 (99.0%) completed the trial (n=735 in both randomization groups) and were included in the analysis. Trial-of-labor rates did not differ significantly between intervention and control groups (43.3% vs 46.2%, respectively; adjusted absolute risk difference, -2.78% [95% CI, -7.80% to 2.25%]; adjusted relative risk, 0.94 [95% CI, 0.84-1.05]). There were no statistically significant differences in vaginal birth rates (31.8% in both groups; adjusted absolute risk difference, -0.04% [95% CI, -4.80% to 4.71%]; adjusted relative risk, 1.00 [95% CI, 0.86-1.16]) or in any of the other 6 clinical maternal and neonatal secondary outcomes. There also were no significant differences between the intervention and control groups in the 5 decision quality measures (eg, mean decisional conflict scores were 17.2 and 17.5, respectively; adjusted mean difference, -0.38 [95% CI, -1.81 to 1.05]; scores >25 are considered clinically important). Conclusions and RelevanceAmong women with 1 previous cesarean delivery, use of a decision support tool compared with usual care did not significantly change the rate of trial of labor. Further research may be needed to assess the efficacy of this tool in other clinical settings or when implemented at other times in pregnancy. This randomized clinical trial compares the effect of a patient-centered decision support tool vs usual care on rates of trial of labor among women with a previous cesarean delivery.	[Kuppermann, Miriam; Blat, Cinthia; Gonzalez, Juan; Thiet, Mari-Paule] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 550 16th St,MH7402, San Francisco, CA 94143 USA; [Kuppermann, Miriam; Bacchetti, Peter] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Kaimal, Anjali J.; Bryant, Allison S.] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA; [Bermingham, Yamilee] Marin Community Clin, San Rafael, CA USA; [Altshuler, Anna L.] Calif Pacific Med Ctr, San Francisco, CA USA; [Grobman, William A.] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; California Pacific Medical Center; Northwestern University; Feinberg School of Medicine	Kuppermann, M (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 550 16th St,MH7402, San Francisco, CA 94143 USA.	miriam.kuppermann@ucsf.edu			NIH [R01 HD078748]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grant R01 HD078748 (Dr Kuppermann) from the NIH.	Ananth CV, 2017, EPIDEMIOLOGY, V28, P567, DOI 10.1097/EDE.0000000000000658; [Anonymous], 2019, OBSTET GYNECOL, V133, pe1, DOI DOI 10.1097/AOG.0000000000003078; [Anonymous], MAT INF CHILD HLTH 2; Attanasio LB, 2019, BIRTH-ISS PERINAT C, V46, P51, DOI 10.1111/birt.12386; Bernstein S, 2012, AM J OBSTET GYNECOL, V206, pS21, DOI 10.1016/j.ajog.2011.10.057; Clark EAS, 2011, AM J OBSTET GYNECOL, V205, pS2, DOI 10.1016/j.ajog.2011.09.028; Coates D, 2020, BIRTH-ISS PERINAT C, V47, P169, DOI 10.1111/birt.12478; Coulter A, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S2; Creanga AA, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.05.002; Cunningham F Gary, 2010, NIH Consens State Sci Statements, V27, P1; de Vries M, 2013, PATIENT EDUC COUNS, V91, P154, DOI 10.1016/j.pec.2012.11.016; Doherr H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173904; Eden KB, 2014, JOGNN-J OBST GYN NEO, V43, P568, DOI 10.1111/1552-6909.12485; Garvelink MM, 2019, MED DECIS MAKING, V39, P315, DOI 10.1177/0272989X19851346; Gregory KD, 2010, SEMIN PERINATOL, V34, P237, DOI 10.1053/j.semperi.2010.03.002; Guise Jeanne-Marie, 2010, Evid Rep Technol Assess (Full Rep), P1; HolmesRovner M, 1996, MED DECIS MAKING, V16, P58, DOI 10.1177/0272989X9601600114; Ibrahim SA, 2017, NEW ENGL J MED, V376, P2509, DOI 10.1056/NEJMp1703432; Jeffries E, 2019, MDM POLICY PRACT, V4, DOI 10.1177/2381468319850830; Kahan BC, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5840; Kaimal AJ, 2019, J PERINATOL, V39, P1340, DOI 10.1038/s41372-019-0399-5; Kaimal AJ, 2010, SEMIN PERINATOL, V34, P331, DOI 10.1053/j.semperi.2010.05.006; Kriston L, 2010, PATIENT EDUC COUNS, V80, P94, DOI 10.1016/j.pec.2009.09.034; Kuppermann M, 2014, JAMA-J AM MED ASSOC, V312, P1210, DOI 10.1001/jama.2014.11479; Little MO, 2008, OBSTET GYNECOL, V112, P913, DOI 10.1097/AOG.0b013e3181888fd8; Martin JA, 2018, NATL VITAL STAT REP, V68, P1; Metz TD, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.011; Montgomery AA, 2007, BMJ-BRIT MED J, V334, P1307, DOI 10.1136/bmj.39217.671019.55; Ng YK, 2018, PATIENT PREFER ADHER, V12, P615, DOI 10.2147/PPA.S159113; O'Connor A.M., 2002, USER MANUAL DECISION; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Sepucha KR, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S12; Shorten A, 2005, BIRTH-ISS PERINAT C, V32, P252, DOI 10.1111/j.0730-7659.2005.00383.x; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; Thompson-Leduc P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011490; Wennberg JE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1513; Wise MR, 2019, AUST NZ J OBSTET GYN, V59, P684, DOI 10.1111/ajo.12955; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	39	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2020	323	21					2151	2159		10.1001/jama.2020.5952	http://dx.doi.org/10.1001/jama.2020.5952			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LY8YS	32484533	Bronze, Green Published			2022-12-28	WOS:000540816000019
J	Torregrosa, T				Torregrosa, Tess			You never know until you try	SCIENCE			English	Editorial Material									[Torregrosa, Tess] Northeastern Univ, Boston, MA 02115 USA	Northeastern University	Torregrosa, T (corresponding author), Northeastern Univ, Boston, MA 02115 USA.								0	0	0	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2020	368	6494					1026	1026		10.1126/science.368.6494.1026	http://dx.doi.org/10.1126/science.368.6494.1026			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LV3IK	32467393				2022-12-28	WOS:000538332600051
J	Agranat-Tamir, L; Waldman, S; Martin, MAS; Gokhman, D; Mishol, N; Eshel, T; Cheronet, O; Rohland, N; Mallick, S; Adamski, N; Lawson, AM; Mah, M; Michel, M; Oppenheimer, J; Stewardson, K; Candilio, F; Keating, D; Gamarra, B; Tzur, S; Novak, M; Kalisher, R; Bechar, S; Eshed, V; Kennett, DJ; Faerman, M; Yahalom-Mack, N; Monge, JM; Govrin, Y; Erel, Y; Yakir, B; Pinhasi, R; Carmi, S; Finkelstein, I; Carmel, L; Reich, D				Agranat-Tamir, Lily; Waldman, Shamam; Martin, Mario A. S.; Gokhman, David; Mishol, Nadav; Eshel, Tzilla; Cheronet, Olivia; Rohland, Nadin; Mallick, Swapan; Adamski, Nicole; Lawson, Ann Marie; Mah, Matthew; Michel, Megan; Oppenheimer, Jonas; Stewardson, Kristin; Candilio, Francesca; Keating, Denise; Gamarra, Beatriz; Tzur, Shay; Novak, Mario; Kalisher, Rachel; Bechar, Shlomit; Eshed, Vered; Kennett, Douglas J.; Faerman, Marina; Yahalom-Mack, Naama; Monge, Janet M.; Govrin, Yehuda; Erel, Yigal; Yakir, Benjamin; Pinhasi, Ron; Carmi, Shai; Finkelstein, Israel; Carmel, Liran; Reich, David			The Genomic History of the Bronze Age Southern Levant	CELL			English	Article							READ ALIGNMENT; ANCIENT DNA; ADMIXTURE; CONTAMINATION; ASSOCIATION; MIGRATION; ISOTOPES; ISRAEL; LEAD	We report genome-wide DNA data for 73 individuals from five archaeological sites across the Bronze and Iron Ages Southern Levant. These individuals, who share the "Canaanite'' material culture, can be modeled as descending from two sources: (1) earlier local Neolithic populations and (2) populations related to the Chalcolithic Zagrosor theBronzeAgeCaucasus. The non-local contribution increased over time, as evinced by three outliers who can be modeled as descendants of recent migrants. We show evidence that different "Canaanite'' groups genetically resemble each other more than other populations. We find that Levant-related modern populations typically have substantial ancestry coming from populations related to the Chalcolithic Zagros and the Bronze Age Southern Levant. These groups also harbor ancestry fromsources we cannot fullymodelwith the available data, highlighting the critical role of post-Bronze-Age migrations into the region over the past 3,000 years.	[Agranat-Tamir, Lily; Gokhman, David; Mishol, Nadav; Carmel, Liran] Hebrew Univ Jerusalem, Fac Sci, Alexander Silberman Inst Life Sci, Dept Genet, Edmond J Safra Campus, IL-9190401 Jerusalem, Israel; [Agranat-Tamir, Lily; Yakir, Benjamin] Hebrew Univ Jerusalem, Dept Stat, IL-9190501 Jerusalem, Israel; [Waldman, Shamam; Tzur, Shay; Carmi, Shai] Hebrew Univ Jerusalem, Braun Sch Publ Hlth & Community Med, Jerusalem, Israel; [Martin, Mario A. S.; Finkelstein, Israel] Tel Aviv Univ, Inst Archaeol, IL-6997801 Tel Aviv, Israel; [Eshel, Tzilla; Erel, Yigal] Hebrew Univ Jerusalem, Fredy & Nadine Herrmann Inst Earth Sci, Edmond J Safra Campus, IL-9190401 Jerusalem, Israel; [Cheronet, Olivia; Pinhasi, Ron] Univ Vienna, Dept Evolutionary Anthropol, Vienna, Austria; [Rohland, Nadin; Mallick, Swapan; Adamski, Nicole; Lawson, Ann Marie; Mah, Matthew; Michel, Megan; Oppenheimer, Jonas; Stewardson, Kristin; Reich, David] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Rohland, Nadin; Mallick, Swapan; Mah, Matthew; Reich, David] Broad Inst, Cambridge, MA 02138 USA; [Mallick, Swapan; Adamski, Nicole; Lawson, Ann Marie; Mah, Matthew; Michel, Megan; Oppenheimer, Jonas; Stewardson, Kristin; Reich, David] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Mallick, Swapan; Reich, David] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Candilio, Francesca; Keating, Denise; Gamarra, Beatriz] Univ Coll Dublin, Sch Archaeol, Dublin, Ireland; [Candilio, Francesca; Keating, Denise; Gamarra, Beatriz] Univ Coll Dublin, Earth Inst, Dublin, Ireland; [Candilio, Francesca] Soprintendenza ABAP Citta Metropolitana Cagliari, Cagliari, Italy; [Gamarra, Beatriz] Inst Catala Paleoecol Humana & Evolucio Socia, Tarragona, Spain; [Gamarra, Beatriz] Univ Rovira & Virgili, Area Prehist, Tarragona, Spain; [Kalisher, Rachel] Brown Univ, Joukowsky Inst Archaeol & Ancient World, Providence, RI 02912 USA; [Bechar, Shlomit; Yahalom-Mack, Naama] Hebrew Univ Jerusalem, Inst Archaeol, IL-9190501 Jerusalem, Israel; [Eshed, Vered] Israel Antiqu Author, POB 586, IL-91004 Jerusalem, Israel; [Kennett, Douglas J.] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; [Faerman, Marina] Hebrew Univ Jerusalem, Fac Dent Med, Inst Dent Sci, Lab Bioanthropol & Ancient DNA, IL-9112001 Jerusalem, Israel; [Monge, Janet M.] Univ Penn, Museum Archaeol & Anthropol, Philadelphia, PA 19104 USA; [Govrin, Yehuda] Hebrew Union Coll, Nelson Glueck Sch Bibl Archaeol, IL-9410125 Jerusalem, Israel; [Novak, Mario] Inst Anthropol Res, Zagreb, Croatia	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University; Hebrew University of Jerusalem; University of Vienna; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; University College Dublin; University College Dublin; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; Brown University; Hebrew University of Jerusalem; University of California System; University of California Santa Barbara; Hebrew University of Jerusalem; University of Pennsylvania; Institute for Anthropological Research Zagreb	Carmel, L (corresponding author), Hebrew Univ Jerusalem, Fac Sci, Alexander Silberman Inst Life Sci, Dept Genet, Edmond J Safra Campus, IL-9190401 Jerusalem, Israel.; Carmi, S (corresponding author), Hebrew Univ Jerusalem, Braun Sch Publ Hlth & Community Med, Jerusalem, Israel.; Finkelstein, I (corresponding author), Tel Aviv Univ, Inst Archaeol, IL-6997801 Tel Aviv, Israel.; Pinhasi, R (corresponding author), Univ Vienna, Dept Evolutionary Anthropol, Vienna, Austria.; Reich, D (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Reich, D (corresponding author), Broad Inst, Cambridge, MA 02138 USA.; Reich, D (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA.; Reich, D (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.; Novak, M (corresponding author), Inst Anthropol Res, Zagreb, Croatia.	mario.novak@inantro.hr; ron.pinhasi@univie.ac.at; shai.carmi@mail.huji.ac.il; fink2@tauex.tau.ac.il; liran.carmel@huji.ac.il; reich@genetics.med.harvard.edu	Gamarra, Beatriz/J-1969-2017; Pinhasi, Ron/AAT-1531-2020; Novak, Mario/AAW-6417-2021; Novak, Mario/AAX-1795-2021; Candilio, Francesca/C-8634-2019; Carmi, Shai/F-4817-2010	Gamarra, Beatriz/0000-0003-3764-497X; Pinhasi, Ron/0000-0003-1629-8131; Candilio, Francesca/0000-0002-4668-1361; Michel, Megan/0000-0002-5484-7974; Oppenheimer, Jonas/0000-0001-7973-6173; Kalisher, Rachel/0000-0002-7765-2352; Gokhman, David/0000-0002-3536-9006; Carmi, Shai/0000-0002-0188-2610; Lawson, Ann Marie/0000-0003-0990-2329	Israel Science Foundation ISF [1009/17, 407/17]; National Science Foundation HOMINID [BCS-1032255]; National Institutes of Health [GM100233]; Allen Discovery Center grant; John Templeton Foundation [61220]; Dan David Foundation; Shmunis Family Foundation	Israel Science Foundation ISF(Israel Science Foundation); National Science Foundation HOMINID; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allen Discovery Center grant; John Templeton Foundation; Dan David Foundation; Shmunis Family Foundation	We thank Reuven Amitai, Menachem Ben-Sasson, Tom Booth, Pontus Skoglund, Philipp Stockhammer, Jason Ur, and several anonymous reviewers for critical comments. This study was funded by the Israel Science Foundation ISF grant 1009/17 to L.C. and B.Y. and ISF grant 407/17 to S.C. D.R. is an Investigator of the Howard Hughes Medical Institute and his ancient DNA laboratory work was supported by National Science Foundation HOMINID grant BCS-1032255, by National Institutes of Health grant GM100233, by an Allen Discovery Center grant, and by grant 61220 from the John Templeton Foundation. Work at Megiddo is supported by the Dan David Foundation, the Shmunis Family Foundation, Mark Weismann, and Vivian and Norman Belmonte.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Atzmon G, 2010, AM J HUM GENET, V86, P850, DOI 10.1016/j.ajhg.2010.04.015; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Beherec MA, 2016, J ARCHAEOL SCI, V65, P70, DOI 10.1016/j.jas.2015.10.006; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bienkowski P, 1999, ANTIQUITY, V73, P708, DOI 10.1017/S0003598X00065340; Carmi S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5835; Dabney J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012567; Eisenmann S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31123-z; Erel Y., 2006, GEOCHIM COSMOCHIM AC, DOI [10.1016/j.gca-2006.08.019, DOI 10.1016/J.GCA-2006.08.019]; ERICSON JE, 1979, NEW ENGL J MED, V300, P946, DOI 10.1056/NEJM197904263001703; Feldman MI, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0061; Finnegan M., 1986, LATE BRONZE EARLY IR, P295; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Goren Y, 2004, EMERY CLAIRE YASS PU; Greenberg R., 2009, TRANSCAUCASIAN MIGRA; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Haber M, 2017, AM J HUM GENET, V101, P274, DOI 10.1016/j.ajhg.2017.06.013; Harney E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05649-9; Hartman G, 2014, GEOCHIM COSMOCHIM AC, V126, P250, DOI 10.1016/j.gca.2013.11.015; Horstwood MSA, 2008, GEOCHIM COSMOCHIM AC, V72, P5659, DOI 10.1016/j.gca.2008.08.016; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Korlevic P, 2015, BIOTECHNIQUES, V59, P87, DOI 10.2144/000114320; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Kozlov K, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S9; Lawson DJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05257-7; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Lazaridis I, 2017, NATURE, V548, P214, DOI 10.1038/nature23310; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Lemche N. P., 1991, JSOTSUP, V110; Leslie S, 2015, NATURE, V519, P309, DOI 10.1038/nature14230; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li N, 2003, GENETICS, V165, P2213; Martin MAS, 2020, B AM SCH ORIENTAL RE, V384, P211, DOI 10.1086/709576; Mazar A, 1992, ARCHAEOLOGY LAND BIB; McGovern P., 1986, LATE BRONZE EARLY IR; Miroschedji P.D., 2014, OXFORD HDB ARCHAEOLO, P308; Na'aman Nadav, 1994, UGARIT FORSCHUNGEN, V26, P397; Na'aman Nadav, 1994, LEVANT, V26, p[175, 1], DOI DOI 10.1179/LEV.1994.26.1.175; Olalde I, 2019, SCIENCE, V363, P1230, DOI 10.1126/science.aav4040; Olalde I, 2018, NATURE, V555, P190, DOI 10.1038/nature25738; PATTERSON C, 1991, SCI TOTAL ENVIRON, V107, P205, DOI 10.1016/0048-9697(91)90260-L; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Perry MA, 2002, NEAR EAST ARCHAEOL, V65, P265, DOI 10.2307/3210858; Perry MA, 2008, GEOARCHAEOLOGY, V23, P528, DOI 10.1002/gea.20230; Perry MA, 2011, J ARCHAEOL SCI, V38, P558, DOI 10.1016/j.jas.2010.10.010; Pinhasi R, 2019, NAT PROTOC, V14, P1194, DOI 10.1038/s41596-019-0137-7; Pinhasi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117301; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Rohland N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0624; Schroeter DJ, 2008, JEWISH SOC STUD, V15, P145; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Toffolo MB, 2014, RADIOCARBON, V56, P221, DOI 10.2458/56.16899; van den Brink ECM, 2017, LEVANT, V49, P105, DOI 10.1080/00758914.2017.1368204; Wang J, 2015, BIOINFORMATICS, V31, P318, DOI 10.1093/bioinformatics/btu668; Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW58, DOI 10.1093/nar/gkw233; Yasur-Landau A., 2010, PHILISTINES AEGEAN M	64	16	16	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2020	181	5					1146	+		10.1016/j.cell.2020.04.024	http://dx.doi.org/10.1016/j.cell.2020.04.024			23	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LT9QF	32470400	Bronze			2022-12-28	WOS:000537399500018
J	Collins, RL; Brand, H; Karczewski, KJ; Zhao, X; Alfoldi, J; Francioli, LC; Khera, AV; Lowther, C; Gauthier, LD; Wang, H; Watts, NA; Solomonson, M; O'Donnell-Luria, A; Baumann, A; Munshi, R; Walker, M; Whelan, CW; Huang, YQ; Brookings, T; Sharpe, T; Stone, MR; Valkanas, E; Fu, J; Tiao, G; Laricchia, KM; Ruano-Rubio, V; Stevens, C; Gupta, N; Cusick, C; Margolin, L; Taylor, KD; Lin, HJ; Rich, SS; Post, WS; Chen, YDI; Rotter, JI; Nusbaum, C; Philippakis, A; Lander, E; Gabriel, S; Neale, BM; Kathiresan, S; Daly, MJ; Banks, E; MacArthur, DG; Talkowski, ME				Collins, Ryan L.; Brand, Harrison; Karczewski, Konrad J.; Zhao, Xuefang; Alfoldi, Jessica; Francioli, Laurent C.; Khera, Amit, V; Lowther, Chelsea; Gauthier, Laura D.; Wang, Harold; Watts, Nicholas A.; Solomonson, Matthew; O'Donnell-Luria, Anne; Baumann, Alexander; Munshi, Ruchi; Walker, Mark; Whelan, Christopher W.; Huang, Yongqing; Brookings, Ted; Sharpe, Ted; Stone, Matthew R.; Valkanas, Elise; Fu, Jack; Tiao, Grace; Laricchia, Kristen M.; Ruano-Rubio, Valentin; Stevens, Christine; Gupta, Namrata; Cusick, Caroline; Margolin, Lauren; Taylor, Kent D.; Lin, Henry J.; Rich, Stephen S.; Post, Wendy S.; Chen, Yii-Der Ida; Rotter, Jerome, I; Nusbaum, Chad; Philippakis, Anthony; Lander, Eric; Gabriel, Stacey; Neale, Benjamin M.; Kathiresan, Sekar; Daly, Mark J.; Banks, Eric; MacArthur, Daniel G.; Talkowski, Michael E.		Genome Aggregation Database Prod T; Genome Aggregation Database Consor	A structural variation reference for medical and population genetics	NATURE			English	Article							COPY NUMBER VARIATION; GENOME; IMPACT; REARRANGEMENTS; EVOLUTION; VARIANTS; PATTERNS; DELETION	Structural variants (SVs) rearrange large segments of DNA(1) and can have profound consequences in evolution and human disease(2,3). As national biobanks, disease-association studies, and clinical genetic testing have grown increasingly reliant on genome sequencing, population references such as the Genome Aggregation Database (gnomAD)(4) have become integral in the interpretation of single-nucleotide variants (SNVs)(5). However, there are no reference maps of SVs from high-coverage genome sequencing comparable to those for SNVs. Here we present a reference of sequence-resolved SVs constructed from 14,891 genomes across diverse global populations (54% non-European) in gnomAD. We discovered a rich and complex landscape of 433,371 SVs, from which we estimate that SVs are responsible for 25-29% of all rare protein-truncating events per genome. We found strong correlations between natural selection against damaging SNVs and rare SVs that disrupt or duplicate protein-coding sequence, which suggests that genes that are highly intolerant to loss-of-function are also sensitive to increased dosage(6). We also uncovered modest selection against noncoding SVs in cis-regulatory elements, although selection against protein-truncating SVs was stronger than all noncoding effects. Finally, we identified very large (over one megabase), rare SVs in 3.9% of samples, and estimate that 0.13% of individuals may carry an SV that meets the existing criteria for clinically important incidental findings(7). This SV resource is freely distributed via the gnomAD browser(8) and will have broad utility in population genetics, disease-association studies, and diagnostic screening.	[Collins, Ryan L.; Brand, Harrison; Karczewski, Konrad J.; Zhao, Xuefang; Alfoldi, Jessica; Francioli, Laurent C.; Khera, Amit, V; Lowther, Chelsea; Gauthier, Laura D.; Wang, Harold; Watts, Nicholas A.; Solomonson, Matthew; O'Donnell-Luria, Anne; Walker, Mark; Stone, Matthew R.; Valkanas, Elise; Fu, Jack; Tiao, Grace; Laricchia, Kristen M.; Stevens, Christine; Gupta, Namrata; Cusick, Caroline; Margolin, Lauren; Nusbaum, Chad; Lander, Eric; Gabriel, Stacey; Neale, Benjamin M.; Kathiresan, Sekar; Daly, Mark J.; MacArthur, Daniel G.; Talkowski, Michael E.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Collins, Ryan L.; Brand, Harrison; Zhao, Xuefang; Khera, Amit, V; Lowther, Chelsea; Wang, Harold; Stone, Matthew R.; Valkanas, Elise; Fu, Jack; Neale, Benjamin M.; Kathiresan, Sekar; Daly, Mark J.; MacArthur, Daniel G.; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Collins, Ryan L.; Valkanas, Elise] Harvard Med Sch, Div Med Sci, Boston, MA 02115 USA; [Brand, Harrison; Zhao, Xuefang; Lowther, Chelsea; Fu, Jack; Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Brand, Harrison; Zhao, Xuefang; Lowther, Chelsea; Fu, Jack; Talkowski, Michael E.] Harvard Med Sch, Boston, MA 02115 USA; [Karczewski, Konrad J.; Alfoldi, Jessica; Francioli, Laurent C.; Watts, Nicholas A.; Solomonson, Matthew; O'Donnell-Luria, Anne; Tiao, Grace; Laricchia, Kristen M.; Neale, Benjamin M.; Daly, Mark J.; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Francioli, Laurent C.; Kathiresan, Sekar; MacArthur, Daniel G.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Gauthier, Laura D.; Baumann, Alexander; Munshi, Ruchi; Walker, Mark; Whelan, Christopher W.; Huang, Yongqing; Brookings, Ted; Sharpe, Ted; Ruano-Rubio, Valentin; Philippakis, Anthony; Banks, Eric] Broad Inst MIT & Harvard, Data Sci Platform, Cambridge, MA 02142 USA; [Taylor, Kent D.; Lin, Henry J.; Chen, Yii-Der Ida; Rotter, Jerome, I] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Post, Wendy S.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Lander, Eric] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Lander, Eric] MIT, Dept Biol, Cambridge, MA USA; [Neale, Benjamin M.; Daly, Mark J.; Talkowski, Michael E.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Nusbaum, Chad] Cellarity Inc, Cambridge, MA USA; [MacArthur, Daniel G.] Garvan Inst Med Res, Ctr Populat Genom, Sydney, NSW, Australia; [MacArthur, Daniel G.] UNSW Sydney, Sydney, NSW, Australia; [MacArthur, Daniel G.] Murdoch Childrens Res Inst, Ctr Populat Genom, Melbourne, Vic, Australia	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of Virginia; Johns Hopkins University; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Garvan Institute of Medical Research; University of New South Wales Sydney; Murdoch Children's Research Institute	Talkowski, ME (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Talkowski, ME (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA.; Talkowski, ME (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.; Talkowski, ME (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Talkowski, ME (corresponding author), Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.		Färkkilä, Martti/AAG-6970-2021; Rioux, John D/A-9599-2015; Ware, James S/G-5139-2012; Cohen, Bruce M./AAZ-4986-2020; Ma, Ronald/C-2788-2009; Kaprio, Jaakko/A-1820-2008; Rotter, Jerome/AAY-6598-2021; Glaser, Benjamin/F-8411-2017; sokol, harry/E-2290-2019; Bown, Matthew/P-1957-2016; Loos, Ruth/Q-2862-2016; Erdmann, Jeanette/P-7513-2014	Färkkilä, Martti/0000-0002-0250-8559; Rioux, John D/0000-0001-7560-8326; Ware, James S/0000-0002-6110-5880; Ma, Ronald/0000-0002-1227-803X; Kaprio, Jaakko/0000-0002-3716-2455; Zhao, Xuefang/0000-0003-4036-9577; Collins, Ryan/0000-0003-1268-9995; Glaser, Benjamin/0000-0003-4711-5000; ELOSUA, ROBERTO/0000-0001-8235-0095; Francioli, Laurent/0000-0002-3039-8895; Tuomi, Tiinamaija/0000-0002-8306-6202; sokol, harry/0000-0002-2914-1822; Whelan, Christopher/0000-0001-8446-8468; Bown, Matthew/0000-0002-6180-3611; Solomonson, Matthew/0000-0002-5344-9026; Loos, Ruth/0000-0002-8532-5087; Armean, Irina/0000-0002-1043-4756; O'Donnell-Luria, Anne/0000-0001-6418-9592; Cibulskis, Kristian/0000-0003-1343-1582; Palotie, Aarno/0000-0002-2527-5874; Stevens, Christine/0000-0002-2621-2234; MacArthur, Daniel/0000-0002-5771-2290; Rich, Stephen/0000-0003-3872-7793; Melander, Olle/0000-0002-2581-484X; Tai, E Shyong/0000-0003-2929-8966; solinas, emilia/0000-0003-3532-1317; Erdmann, Jeanette/0000-0002-4486-6231	National Institutes of Health (NIH) [R01MH115957, UM1HG008895, R01HD081256, P01GM061354, R01HD091797, R01HD096326, R01MH111776, R01HD099547, U01MH105669, P50HD028138, P01HD068250]; Simons Foundation for Autism Research Initiative (SFARI) [573206]; Broad Institute; NHGRI [T32HG002295, K08HG010155]; NSF GRFP [2017240332]; NIDCR [K99DE026824]; Desmond and Ann Heathwood; National Heart, Lung, and Blood Institute (NHLBI); National Center for Research Resources [UL1RR033176]; National Center for Advancing Translational Sciences [ULTR001881]; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant [DK063491]; NHLBI;  [HHSN268201500003I];  [N01-HC-95159];  [N01-HC-95160];  [N01-HC-95161];  [N01-HC-95162];  [N01-HC-95163];  [N01-HC-95164];  [N01-HC-95165];  [N01-HC-95166];  [N01-HC-95167];  [N01-HC-95168];  [N01-HC-95169];  [UL1-TR-000040];  [UL1-TR-00107];  [UL1-TR-001420];  [R01HL071051];  [R01HL071205];  [R01HL071250];  [R01HL071251];  [R01HL071258];  [R01HL071259]; MRC [MC_UP_1102/20] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation for Autism Research Initiative (SFARI); Broad Institute; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Desmond and Ann Heathwood; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the many individuals whose sequence data are aggregated in gnomAD for their contributions to research, and the users of gnomAD for their collaborative feedback. We are grateful to the families at the participating Simons Simplex Collection (SSC) sites, as well as the SSC principal investigators. We thank T. Hefferon of the NIH National Center for Biotechnology Information for his help hosting gnomAD-SV on dbVar. We have complied with all relevant ethical regulations. Research and contributing authors were supported by resources from the Broad Institute, the National Institutes of Health (NIH) (R01MH115957 to M.E.T., B.N. and D.G.M.; UM1HG008895 to M.J.D., B.N., S.G., E.S.L., S.K., M.E.T.; R01HD081256, P01GM061354, R01HD091797, R01HD096326, R01MH111776, R01HD099547 to M.E.T.; U01MH105669 to M.J.D., B.N. and M.E.T.; P50HD028138 to B.N. and M.E.T.; P01HD068250 to H.B.) and the Simons Foundation for Autism Research Initiative (SFARI #573206 to M.E.T.). R.L.C. was supported by NHGRI T32HG002295 and NSF GRFP #2017240332. H.B. was supported by NIDCR K99DE026824. A.V.K. was supported by NHGRI K08HG010155. M.E.T. was supported by Desmond and Ann Heathwood. MESA and the MESA SHARe project are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, UL1-TR-000040, UL1-TR-00107, and UL1-TR-001420. MESA family is conducted and supported by the NHLBI in collaboration with MESA investigators. Support is provided by grants and contracts R01HL071051, R01HL071205, R01HL071250, R01HL071251, R01HL071258 and R01HL071259, by the National Center for Research Resources, grant UL1RR033176, and the National Center for Advancing Translational Sciences ULTR001881, and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant DK063491 to the Southern California Diabetes Endocrinology Research Center.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Audano PA, 2019, CELL, V176, P663, DOI 10.1016/j.cell.2018.12.019; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brand H, 2015, AM J HUM GENET, V97, P170, DOI 10.1016/j.ajhg.2015.05.012; Brandler WM, 2018, SCIENCE, V360, P327, DOI 10.1126/science.aan2261; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Chaisson MJP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08148-z; Chiang C, 2017, NAT GENET, V49, P692, DOI 10.1038/ng.3834; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Choi SH, 2018, JAMA-J AM MED ASSOC, V320, P2354, DOI 10.1001/jama.2018.18179; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Collins RL, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1158-6; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Dennis MY, 2016, CURR OPIN GENET DEV, V41, P44, DOI 10.1016/j.gde.2016.08.001; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Franke M, 2016, NATURE, V538, P265, DOI 10.1038/nature19800; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hehir-Kwa JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12989; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Huddleston J, 2017, GENOME RES, V27, P677, DOI 10.1101/gr.214007.116; Hurles ME, 2008, TRENDS GENET, V24, P238, DOI 10.1016/j.tig.2008.03.001; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, pD840, DOI 10.1093/nar/gkw971; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Kosugi S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1720-5; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Natarajan P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05747-8; Neale B., 2018, UK BIOBANK GWAS ROUN; Owen D, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5292-7; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/nmeth.3454, 10.1038/NMETH.3454]; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; Redin C, 2017, NAT GENET, V49, P36, DOI 10.1038/ng.3720; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Ruderfer DM, 2016, NAT GENET, V48, P1107, DOI 10.1038/ng.3638; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Turner TN, 2017, CELL, V171, P710, DOI 10.1016/j.cell.2017.08.047; Walsh R, 2017, GENET MED, V19, P192, DOI 10.1038/gim.2016.90; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Werling DM, 2018, NAT GENET, V50, P727, DOI 10.1038/s41588-018-0107-y; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Xie JY, 2016, J AM SOC NEPHROL, V27, P3187, DOI 10.1681/ASN.2015111210; Zhao Xuefang, 2017, GigaScience, V6, P1, DOI 10.1093/gigascience/gix061	49	245	248	4	27	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 28	2020	581	7809					444	+		10.1038/s41586-020-2287-8	http://dx.doi.org/10.1038/s41586-020-2287-8			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX9ZL	32461652	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000576060200004
J	Swanton, C				Swanton, Charles			Take lessons from cancer evolution to the clinic	NATURE			English	Editorial Material									[Swanton, Charles] Canc Res UK TRACERx Clin Study, London, England; [Swanton, Charles] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England; [Swanton, Charles] UCL Canc Inst, London, England	Francis Crick Institute; University of London; University College London	Swanton, C (corresponding author), Canc Res UK TRACERx Clin Study, London, England.; Swanton, C (corresponding author), Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England.; Swanton, C (corresponding author), UCL Canc Inst, London, England.	charles.swanton@crick.ac.uk						Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364; AbdulJabbar K., NATURE MED; Chemi F, 2019, NAT MED, V25, P1534, DOI 10.1038/s41591-019-0593-1; de Koning HJ, 2020, NEW ENGL J MED, V382, P503, DOI 10.1056/NEJMoa1911793; Ghorani E., NATURE CANC; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Joshi K, 2019, NAT MED, V25, P1549, DOI 10.1038/s41591-019-0592-2; Lopez S, 2020, NAT GENET, V52, P283, DOI 10.1038/s41588-020-0584-7; McFadden DG, 2016, P NATL ACAD SCI USA, V113, pE6409, DOI 10.1073/pnas.1613601113; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Rosenthal R, 2019, NATURE, V567, P479, DOI 10.1038/s41586-019-1032-7; Rozenblatt-Rosen O, 2017, NATURE, V550, P451, DOI 10.1038/550451a	13	9	10	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 28	2020	581	7809					382	383		10.1038/d41586-020-01347-z	http://dx.doi.org/10.1038/d41586-020-01347-z			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX9ZI	32461644	Bronze			2022-12-28	WOS:000576059900001
J	Gerada, C				Gerada, Clare			Clare Gerada: Some good must come out of covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gerada, Clare] Hurley Grp, London, England		Gerada, C (corresponding author), Hurley Grp, London, England.	clare.gerada@nhs.net						Hartzband P, 2020, NEW ENGL J MED, V382, P2485, DOI 10.1056/NEJMp2003149; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1	2	3	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2020	369								m2043	10.1136/bmj.m2043	http://dx.doi.org/10.1136/bmj.m2043			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JW	32457205	Bronze			2022-12-28	WOS:000538337000007
J	Sawitzki, B; Harden, PN; Reinke, P; Moreau, A; Hutchinson, JA; Game, DS; Tang, QZ; Guinan, EC; Battaglia, M; Burlingham, WJ; Roberts, ISD; Streitz, M; Josien, R; Boger, CA; Scotta, C; Markmann, JF; Hester, JL; Juerchott, K; Braudeau, C; James, B; Contreras-Ruiz, L; van der Net, JB; Bergler, T; Caldara, R; Petchey, W; Edinger, M; Dupas, N; Kapinsky, M; Mutzbauer, I; Otto, NM; Ollinger, R; Hernandez-Fuentes, MP; Issa, F; Ahrens, N; Meyenberg, C; Karitzky, S; Kunzendorf, U; Knechtle, SJ; Grinyo, J; Morris, PJ; Brent, L; Bushell, A; Turka, LA; Bluestone, JA; Lechler, RI; Schlitt, HJ; Cuturi, MC; Schlickeiser, S; Friend, PJ; Miloud, T; Scheffold, A; Secchi, A; Crisalli, K; Kang, SM; Hilton, R; Banas, B; Blancho, G; Volk, HD; Lombardi, G; Wood, KJ; Geissler, EK				Sawitzki, Birgit; Harden, Paul N.; Reinke, Petra; Moreau, Aurelie; Hutchinson, James A.; Game, David S.; Tang, Qizhi; Guinan, Eva C.; Battaglia, Manuela; Burlingham, William J.; Roberts, Ian S. D.; Streitz, Mathias; Josien, Regis; Boeger, Carsten A.; Scotta, Cristiano; Markmann, James F.; Hester, Joanna L.; Juerchott, Karsten; Braudeau, Cecile; James, Ben; Contreras-Ruiz, Laura; van der Net, Jeroen B.; Bergler, Tobias; Caldara, Rossana; Petchey, William; Edinger, Matthias; Dupas, Nathalie; Kapinsky, Michael; Mutzbauer, Ingrid; Otto, Natalie M.; Oellinger, Robert; Hernandez-Fuentes, Maria P.; Issa, Fadi; Ahrens, Norbert; Meyenberg, Christoph; Karitzky, Sandra; Kunzendorf, Ulrich; Knechtle, Stuart J.; Grinyo, Josep; Morris, Peter J.; Brent, Leslie; Bushell, Andrew; Turka, Laurence A.; Bluestone, Jeffrey A.; Lechler, Robert I.; Schlitt, Hans J.; Cuturi, Maria C.; Schlickeiser, Stephan; Friend, Peter J.; Miloud, Tewfik; Scheffold, Alexander; Secchi, Antonio; Crisalli, Kerry; Kang, Sang-Mo; Hilton, Rachel; Banas, Bernhard; Blancho, Gilles; Volk, Hans-Dieter; Lombardi, Giovanna; Wood, Kathryn J.; Geissler, Edward K.			Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials	LANCET			English	Article							T-CELLS; IMMUNOSUPPRESSION; MINIMIZATION; STRATEGIES; TOLERANCE; MONOCYTES; INFECTION; EXPANSION	Background Use of cell-based medicinal products (CBMPs) represents a state-of-the-art approach for reducing general immunosuppression in organ transplantation. We tested multiple regulatory CBMPs in kidney transplant trials to establish the safety of regulatory CBMPs when combined with reduced immunosuppressive treatment. Methods The ONE Study consisted of seven investigator-led, single-arm trials done internationally at eight hospitals in France, Germany, Italy, the UK, and the USA (60 week follow-up). Included patients were living-donor kidney transplant recipients aged 18 years and older. The reference group trial (RGT) was a standard-of-care group given basiliximab, tapered steroids, mycophenolate mofetil, and tacrolimus. Six non-randomised phase 1/2A cell therapy group (CTG) trials were pooled and analysed, in which patients received one of six CBMPs containing regulatory T cells, dendritic cells, or macrophages; patient selection and immunosuppression mirrored the RGT, except basiliximab induction was substituted with CBMPs and mycophenolate mofetil tapering was allowed. None of the trials were randomised and none of the individuals involved were masked. The primary endpoint was biopsy-confirmed acute rejection (BCAR) within 60 weeks after transplantation; adverse event coding was centralised. The RTG and CTG trials are registered with ClinicalTrials.gov, NCT01656135, NCT02252055, NCT02085629, NCT02244801, NCT02371434, NCT02129881, and NCT02091232. Findings The seven trials took place between Dec 11, 2012, and Nov 14, 2018. Of 782 patients assessed for eligibility, 130 (17%) patients were enrolled and 104 were treated and included in the analysis. The 66 patients who were treated in the RGT were 73% male and had a median age of 47 years. The 38 patients who were treated across six CTG trials were 71% male and had a median age of 45 years. Standard-of-care immunosuppression in the recipients in the RGT resulted in a 12% BCAR rate (expected range 3.2-18.0). The overall BCAR rate for the six parallel CTG trials was 16%. 15 (40%) patients given CBMPs were successfully weaned from mycophenolate mofetil and maintained on tacrolimus monotherapy. Combined adverse event data and BCAR episodes from all six CTG trials revealed no safety concerns when compared with the RGT. Fewer episodes of infections were registered in CTG trials versus the RGT. Interpretation Regulatory cell therapy is achievable and safe in living-donor kidney transplant recipients, and is associated with fewer infectious complications, but similar rejection rates in the first year. Therefore, immune cell therapy is a potentially useful therapeutic approach in recipients of kidney transplant to minimise the burden of general immunosuppression. Copyright (C) 2020 Elsevier Ltd. All rights reserved.	[Sawitzki, Birgit; Streitz, Mathias; Schlickeiser, Stephan; Volk, Hans-Dieter] Charite Univ Med Berlin, Inst Med Immunol, Berlin, Germany; [Streitz, Mathias; Juerchott, Karsten; Schlickeiser, Stephan; Volk, Hans-Dieter] Charite Univ Med Berlin, Charite, BIH Ctr Regenerat Therapies, Berlin, Germany; [Streitz, Mathias; Juerchott, Karsten; Schlickeiser, Stephan; Volk, Hans-Dieter] Charite Univ Med Berlin, Berlin Inst Hlth, Berlin, Germany; [Harden, Paul N.; van der Net, Jeroen B.; Petchey, William] Univ Oxford, Oxford Univ Hosp NHS Fdn Trust, Oxford Transplantat Ctr, Oxford, England; [Reinke, Petra; Otto, Natalie M.] Charite Univ Med Berlin, BCRT, BeCAT, Berlin, Germany; [Reinke, Petra; Otto, Natalie M.] Charite Univ Med Berlin, Dept Nephrol & Intens Care, Berlin, Germany; [Reinke, Petra; Otto, Natalie M.] Berlin Inst Hlth, Berlin, Germany; [Moreau, Aurelie; Josien, Regis; Braudeau, Cecile; Cuturi, Maria C.; Blancho, Gilles] Nantes Univ, Ctr Rech Transplantat & Immunol, INSERM, Nantes, France; [Moreau, Aurelie; Josien, Regis; Braudeau, Cecile; Cuturi, Maria C.; Blancho, Gilles] Ctr Hosp Univ, Inst Transplantat Urol Nephrol, Nantes, France; [Josien, Regis; Braudeau, Cecile] Ctr Hosp Univ, Lab Immunol, Cimna, Nantes, France; [Hutchinson, James A.; James, Ben; Mutzbauer, Ingrid; Schlitt, Hans J.; Geissler, Edward K.] Univ Regensburg, Univ Hosp Regensburg, Dept Surg, Regensburg, Germany; [Boeger, Carsten A.; Bergler, Tobias; Banas, Bernhard] Univ Regensburg, Univ Hosp Regensburg, Dept Nephrol, Regensburg, Germany; [Ahrens, Norbert] Univ Regensburg, Univ Hosp Regensburg, Inst Clin Chem & Lab Med, Transfus Med, Regensburg, Germany; [Edinger, Matthias] Univ Regensburg, Univ Hosp Regensburg, Dept Internal Med 3, Regensburg, Germany; [Game, David S.; Hilton, Rachel] Guys & St Thomas NHS Fdn Trust, Guys Hosp, London, England; [Tang, Qizhi; Kang, Sang-Mo] Univ Calif San Francisco, Dept Surg, Div Transplantat, San Francisco, CA USA; [Bluestone, Jeffrey A.] Univ Calif San Francisco, UCSF Diabet Ctr, San Francisco, CA 94143 USA; [Guinan, Eva C.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Guinan, Eva C.] Harvard Med Sch, Boston, MA 02115 USA; [Battaglia, Manuela] Ist Sci San Raffaele, Ist Ricovero & Cura Carattere Sci, Diabet Res Inst, Milan, Italy; [Secchi, Antonio] Ist Sci San Raffaele, Ist Ricovero & Cura Carattere Sci, Vita Salute San Raffaele Univ Milan, Milan, Italy; [Caldara, Rossana] Ist Sci San Raffaele, Ist Ricovero & Cura Carattere Sci, Transplant Med, Milan, Italy; [Burlingham, William J.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Div Transplantat, Madison, WI USA; [Roberts, Ian S. D.] Oxford Univ Hosp NHS Fdn Trust, Dept Cellular Pathol, Oxford, England; [Scotta, Cristiano; Hernandez-Fuentes, Maria P.; Lechler, Robert I.; Lombardi, Giovanna] Kings Coll London, Sch Immunol & Microbial Sci, MRC Ctr Transplantat, Peter Gorer Dept Immunobiol, London, England; [Markmann, James F.; Turka, Laurence A.; Crisalli, Kerry] Mass Gen Hosp, Ctr Transplantat Sci, Boston, MA USA; [Hester, Joanna L.; Issa, Fadi; Bushell, Andrew; Wood, Kathryn J.] Univ Oxford, Nuffield Dept Surg Sci, Transplantat Res & Immunol Grp, Oxford, England; [Contreras-Ruiz, Laura] DFCI, Dept Expt Med, Boston, MA USA; [Dupas, Nathalie; Miloud, Tewfik] Beckman Coulter Life Sci, Immunotech, Marseille, France; [Kapinsky, Michael] Beckman Coulter, Krefeld, Germany; [Oellinger, Robert] Charite Univ Med Berlin, Campus Virchow Klinikum, Charite Campus Mitte, Dept Surg, Berlin, Germany; [Meyenberg, Christoph] KOEHLER eClin, Freiburg, Germany; [Karitzky, Sandra] Miltenyi Biotec, Bergisch Gladbach, Germany; [Kunzendorf, Ulrich] Univ Kiel, Univ Clin Schleswig Holstein, Clin Nephrol & Hypertens, Kiel, Germany; [Scheffold, Alexander] Univ Kiel, Univ Clin Schleswig Holstein, Inst Immunol, Kiel, Germany; [Knechtle, Stuart J.] Duke Univ, Med Ctr, Dept Surg, Duke Transplant Ctr, Durham, NC 27710 USA; [Grinyo, Josep] Barcelona Univ, Bellvitge Univ Hosp, Dept Nephrol, Kidney Transplant Unit,IDIBELL, Barcelona, Spain; [Morris, Peter J.] Royal Coll Surgeons England, Ctr Evidence Transplantat, Clin Effectiveness Unit, London, England; [Brent, Leslie] St Marys Hosp, Transplant Unit, London, England; [Morris, Peter J.; Friend, Peter J.] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [James, Ben; Mutzbauer, Ingrid; Geissler, Edward K.] Fraunhofer Inst Expt Med & Toxicol, Div Personalized Tumor Therapy, Regensburg, Germany; [Edinger, Matthias; Geissler, Edward K.] Univ Regensburg, Regensburg Ctr Intervent Immunol, Regensburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; Guy's & St Thomas' NHS Foundation Trust; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; IRCCS Ca Granda Ospedale Maggiore Policlinico; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Wisconsin System; University of Wisconsin Madison; Oxford University Hospitals NHS Foundation Trust; University of London; King's College London; Harvard University; Massachusetts General Hospital; University of Oxford; Harvard University; Dana-Farber Cancer Institute; Beckman Coulter Inc.; Beckman Coulter Inc.; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Miltenyi Biotec; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Duke University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Royal College of Surgeons of England; Imperial College London; University of Oxford; Fraunhofer Gesellschaft; University of Regensburg	Geissler, EK (corresponding author), Univ Regensburg, Univ Hosp Regensburg, Dept Surg, Div Expt Surg, D-93053 Regensburg, Germany.	edward.geissler@klinik.uni-regensburg.de	Ahrens, Norbert/M-6197-2016; Moreau, Aurelie/J-4139-2017; Schlitt, Hans J./ABG-4368-2020; volk, hans-dieter/AAV-8053-2021; Scheffold, Alexander/S-2090-2016; Issa, Fadi/HDM-8760-2022; Josien, Regis/L-7468-2015; Hernandez-Fuentes, Maria/B-5011-2010	Ahrens, Norbert/0000-0002-4680-2688; Moreau, Aurelie/0000-0002-8519-2632; volk, hans-dieter/0000-0002-7743-6668; Scheffold, Alexander/0000-0002-0626-343X; Issa, Fadi/0000-0002-8279-7732; Hester, Joanna/0000-0002-7466-3849; Banas, Bernhard/0000-0003-2076-2195; Schlickeiser, Stephan/0000-0003-3142-2890; Josien, Regis/0000-0001-7900-7413; Tang, Qizhi/0000-0001-7313-3574; Sawitzki, Birgit/0000-0001-8166-8579; Hernandez-Fuentes, Maria/0000-0002-7558-9441; Otto, Natalie/0000-0001-8769-7493; Jurchott, Karsten/0000-0003-1589-0037	EU; MRC [MR/N027930/1] Funding Source: UKRI	EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The 7th EU Framework Programme.	Appelgren D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02242; Bamoulid J, 2015, TRANSPL INT, V28, P891, DOI 10.1111/tri.12553; Braza F, 2015, J AM SOC NEPHROL, V26, P1795, DOI 10.1681/ASN.2014050480; Chandran S, 2017, AM J TRANSPLANT, V17, P2945, DOI 10.1111/ajt.14415; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Fishman JA, 2017, AM J TRANSPLANT, V17, P856, DOI 10.1111/ajt.14208; Fraser H, 2018, MOL THER-METH CLIN D, V8, P198, DOI 10.1016/j.omtm.2018.01.006; Gray M, 2015, INT IMMUNOL, V27, P505, DOI 10.1093/intimm/dxv045; Guinan EC, 2016, AM J TRANSPLANT, V16, P2187, DOI 10.1111/ajt.13725; Hutchinson JA, 2008, TRANSPL INT, V21, P728, DOI 10.1111/j.1432-2277.2008.00680.x; Hutchinson JA, 2008, TRANSPL INT, V21, P742, DOI 10.1111/j.1432-2277.2008.00692.x; Hutchinson JA, 2017, TRANSPL INT, V30, P765, DOI 10.1111/tri.12988; Hutchinson JA, 2015, KIDNEY INT, V87, P1116, DOI 10.1038/ki.2015.50; Kverneland AH, 2016, CYTOM PART A, V89A, P543, DOI 10.1002/cyto.a.22855; Landwehr-Kenzel S, 2018, KIDNEY INT, V93, P1452, DOI 10.1016/j.kint.2018.01.021; Makwana N, 2017, EUR J IMMUNOL, V47, P1324, DOI 10.1002/eji.201747018; Marin E, 2019, CELL METAB, V30, P1075, DOI 10.1016/j.cmet.2019.11.011; Marin E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00274; Mathew JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25574-7; Meijers RWJ, 2015, AM J TRANSPLANT, V15, P3143, DOI 10.1111/ajt.13396; Meijers RWJ, 2013, CLIN EXP IMMUNOL, V174, P424, DOI 10.1111/cei.12188; Putnam AL, 2013, AM J TRANSPLANT, V13, P3010, DOI 10.1111/ajt.12433; Rickert CG, 2019, CURR OPIN ORGAN TRAN, V24, P441, DOI 10.1097/MOT.0000000000000670; Riquelme P, TIGIT ITREGS ELICITE; Roufosse C, 2018, TRANSPLANTATION, V102, P1795, DOI 10.1097/TP.0000000000002366; Safinia N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00354; Streitz M, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-17; Todo S, 2016, HEPATOLOGY, V64, P632, DOI 10.1002/hep.28459; Ulrich C, 2008, AM J TRANSPLANT, V8, P103, DOI 10.1111/j.1600-6143.2007.02035.x; van den Bosch TPP, 2017, AM J TRANSPLANT, V17, P2659, DOI 10.1111/ajt.14280; Vereyken EJF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070152; Wekerle T, 2017, LANCET, V389, P2152, DOI 10.1016/S0140-6736(17)31283-7	32	151	154	2	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2020	395	10237					1627	1639						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LZ1JO	32446407	Green Submitted, Green Accepted			2022-12-28	WOS:000540986100026
J	Mervis, J; Stellino, M				Mervis, Jeffrey; Stellino, Molly			HARD LESSONS	SCIENCE			English	Editorial Material									[Stellino, Molly] Arizona State Univ, Phoenix, AZ USA	Arizona State University; Arizona State University-Downtown Phoenix									0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					814	817		10.1126/science.368.6493.814	http://dx.doi.org/10.1126/science.368.6493.814			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU2DD	32439774				2022-12-28	WOS:000537569500020
J	Nakamura, T; Davila-Rodriguez, J; Leopardi, H; Sherman, JA; Fortier, TM; Xie, XJ; Campbell, JC; McGrew, WF; Zhang, XG; Hassan, YS; Nicolodi, D; Beloy, K; Ludlow, AD; Diddams, SA; Quinlan, F				Nakamura, Takuma; Davila-Rodriguez, Josue; Leopardi, Holly; Sherman, Jeff A.; Fortier, Tara M.; Xie, Xiaojun; Campbell, Joe C.; McGrew, William F.; Zhang, Xiaogang; Hassan, Youssef S.; Nicolodi, Daniele; Beloy, Kyle; Ludlow, Andrew D.; Diddams, Scott A.; Quinlan, Franklyn			Coherent optical clock down-conversion for microwave frequencies with 10(-18) instability	SCIENCE			English	Article							PHASE-CONTROL; NOISE; COMB; CARRIER; LASER; MULTIBRANCH; GENERATION; METROLOGY	Optical atomic clocks are poised to redefine the Systeme International (SI) second, thanks to stability and accuracy more than 100 times better than the current microwave atomic clock standard. However, the best optical clocks have not seen their performance transferred to the electronic domain, where radar, navigation, communications, and fundamental research rely on less stable microwave sources. By comparing two independent optical-to-electronic signal generators, we demonstrate a 10-gigahertz microwave signal with phase that exactly tracks that of the optical clock phase from which it is derived, yielding an absolute fractional frequency instability of 1 x 10(-18) in the electronic domain. Such faithful reproduction of the optical clock phase expands the opportunities for optical clocks both technologically and scientifically for time dissemination, navigation, and long-baseline interferometric imaging.	[Nakamura, Takuma; Davila-Rodriguez, Josue; Leopardi, Holly; Sherman, Jeff A.; Fortier, Tara M.; McGrew, William F.; Zhang, Xiaogang; Hassan, Youssef S.; Nicolodi, Daniele; Beloy, Kyle; Ludlow, Andrew D.; Diddams, Scott A.; Quinlan, Franklyn] NIST, Time & Frequency Div, 325 Broadway, Boulder, CO 80305 USA; [Nakamura, Takuma; Leopardi, Holly; Fortier, Tara M.; McGrew, William F.; Zhang, Xiaogang; Hassan, Youssef S.; Nicolodi, Daniele; Ludlow, Andrew D.; Diddams, Scott A.; Quinlan, Franklyn] Univ Colorado, Dept Phys, 440 UCB, Boulder, CO 80309 USA; [Xie, Xiaojun; Campbell, Joe C.] Univ Virginia, Dept Elect & Comp Engn, Charlottesville, VA 22904 USA; Univ Virginia, Dept Elect & Comp Engn, Charlottesville, VA 22904 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Virginia; University of Virginia	Nakamura, T; Quinlan, F (corresponding author), NIST, Time & Frequency Div, 325 Broadway, Boulder, CO 80305 USA.; Nakamura, T; Quinlan, F (corresponding author), Univ Colorado, Dept Phys, 440 UCB, Boulder, CO 80309 USA.	takuma.nakamura@nist.gov; franklyn.quinlan@nist.gov	Nicolodi, Daniele/AAO-4189-2021; Hassan, Youssef/GLV-4763-2022; Diddams, Scott A/L-2819-2013; Hassan, Youssef/E-5795-2015	Nicolodi, Daniele/0000-0003-1467-1756; Diddams, Scott A/0000-0002-2144-0764; Nakamura, Takuma/0000-0003-1350-549X; Xie, Xiaojun/0000-0001-7885-6181; Hassan, Youssef/0000-0001-9539-8362; Sherman, Jeff/0000-0002-8560-481X; FORTIER, TARA/0000-0003-2282-4986	National Institute of Standards and Technology; DARPA PULSE program	National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); DARPA PULSE program	This paper is supported by the National Institute of Standards and Technology and the DARPA PULSE program.	AnalogDevices, 1999, TECHN TUT DIG SIGN S; Baynes FN, 2015, OPTICA, V2, P141, DOI 10.1364/OPTICA.2.000141; Brewer SM, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.033201; Clivati C, 2017, SCI REP-UK, V7, DOI 10.1038/srep40992; Davila-Rodriguez J, 2018, OPT EXPRESS, V26, P30532, DOI 10.1364/OE.26.030532; DREVER RWP, 1983, APPL PHYS B-PHOTO, V31, P97, DOI 10.1007/BF00702605; Fortier TM, 2011, NAT PHOTONICS, V5, P425, DOI [10.1038/NPHOTON.2011.121, 10.1038/nphoton.2011.121]; Giunta M, 2020, NAT PHOTONICS, V14, P44, DOI 10.1038/s41566-019-0520-5; Godun RM, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.210801; Gurvits LI, 2020, ADV SPACE RES, V65, P868, DOI 10.1016/j.asr.2019.05.042; Hartnett JG, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4709479; Hudson DD, 2005, OPT LETT, V30, P2948, DOI 10.1364/OL.30.002948; Johnson LAM, 2015, METROLOGIA, V52, DOI 10.1088/0026-1394/52/1/62; Jones DJ, 2000, SCIENCE, V288, P635, DOI 10.1126/science.288.5466.635; Kashiwagi K, 2018, OPT EXPRESS, V26, P8831, DOI 10.1364/OE.26.008831; Katori H, 2011, NAT PHOTONICS, V5, P203, DOI [10.1038/nphoton.2011.45, 10.1038/NPHOTON.2011.45]; Kolkowitz S, 2016, PHYS REV D, V94, DOI 10.1103/PhysRevD.94.124043; Leopardi H, 2017, OPTICA, V4, P879, DOI 10.1364/OPTICA.4.000879; Ludlow AD, 2015, REV MOD PHYS, V87, P637, DOI 10.1103/RevModPhys.87.637; MA LS, 1994, OPT LETT, V19, P1777, DOI 10.1364/OL.19.001777; McGrew WF, 2019, OPTICA, V6, P448, DOI 10.1364/OPTICA.6.000448; McGrew WF, 2018, NATURE, V564, P87, DOI 10.1038/s41586-018-0738-2; Nakajima Y, 2010, OPT EXPRESS, V18, P1667, DOI 10.1364/OE.18.001667; Nakamura T., 2020, NIST PUBLIC DATA REP, DOI [10.18434/M32206, DOI 10.18434/M32206]; Newbury NR, 2007, OPT LETT, V32, P3056, DOI 10.1364/OL.32.003056; Oelker E, 2019, NAT PHOTONICS, V13, P714, DOI 10.1038/s41566-019-0493-4; Ohmae N, 2017, APPL PHYS EXPRESS, V10, DOI 10.7567/APEX.10.062503; Papoulis A., 1991, COMMUNICATIONS SIGNA; Papoulis A., 1991, PROBABILITY RANDOM V; Quinlan F, 2013, NAT PHOTONICS, V7, P290, DOI [10.1038/NPHOTON.2013.33, 10.1038/nphoton.2013.33]; Quinlan F, 2011, OPT LETT, V36, P3260, DOI 10.1364/OL.36.003260; Riehle F, 2018, METROLOGIA, V55, P188, DOI 10.1088/1681-7575/aaa302; Rolland A, 2018, OPTICA, V5, P1070, DOI 10.1364/OPTICA.5.001070; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Schioppo M, 2017, NAT PHOTONICS, V11, P48, DOI [10.1038/nphoton.2016.231, 10.1038/NPHOTON.2016.231]; Sherman JA, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4950898; Sinclair LC, 2016, APPL PHYS LETT, V109, DOI 10.1063/1.4963130; Taylor J, 2011, IEEE PHOTONICS J, V3, P140, DOI 10.1109/JPHOT.2011.2109703; Udem T, 2002, NATURE, V416, P233, DOI 10.1038/416233a; Volder J.E., 1959, IRE T ELECTRON COM, P330, DOI [10.1109/TEC.1959.5222693, DOI 10.1109/TEC.1959.5222693]; WALLS WF, 1992, PROCEEDINGS OF THE 1992 IEEE FREQUENCY CONTROL SYMPOSIUM, P257, DOI 10.1109/FREQ.1992.270007; Weyers S, 2018, METROLOGIA, V55, P789, DOI 10.1088/1681-7575/aae008; Xie XJ, 2017, J LIGHTWAVE TECHNOL, V35, P1718, DOI 10.1109/JLT.2016.2641967; Xie XJ, 2014, OPTICA, V1, P429, DOI 10.1364/OPTICA.1.000429; Xie XP, 2017, NAT PHOTONICS, V11, P44, DOI [10.1038/NPHOTON.2016.215, 10.1038/nphoton.2016.215]; Yao Y, 2016, NATL SCI REV, V3, P463, DOI 10.1093/nsr/nww063; Ye J, 2000, OPT LETT, V25, P1675, DOI 10.1364/OL.25.001675; Zhang W, 2012, APPL PHYS B-LASERS O, V106, P301, DOI 10.1007/s00340-011-4710-1; Zhang W, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3431299	49	40	41	4	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2020	368	6493					889	+		10.1126/science.abb2473	http://dx.doi.org/10.1126/science.abb2473			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU2DD	32439794	Green Submitted			2022-12-28	WOS:000537569500047
J	Wise, J				Wise, Jacqui			Covid-19: MPs call on Public Health England to publish evidence for decision to drop community testing	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		UK Parliament, 2020, COMM WRIT PRIM MIN L	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2020	369								m2022	10.1136/bmj.m2022	http://dx.doi.org/10.1136/bmj.m2022			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JI	32430482	Bronze			2022-12-28	WOS:000538335600010
J	Krause, DW; Hoffmann, S; Hu, YM; Wible, JR; Rougier, GW; Kirk, EC; Groenke, JR; Rogers, RR; Rossie, JB; Schultz, JA; Evans, AR; von Koenigswald, W; Rahantarisoa, LJ				Krause, David W.; Hoffmann, Simone; Hu, Yaoming; Wible, John R.; Rougier, Guillermo W.; Kirk, E. Christopher; Groenke, Joseph R.; Rogers, Raymond R.; Rossie, James B.; Schultz, Julia A.; Evans, Alistair R.; von Koenigswald, Wighart; Rahantarisoa, Lydia J.			Skeleton of a Cretaceous mammal from Madagascar reflects long-term insularity	NATURE			English	Article							ADAPTATION; EVOLUTION; REMAINS; ISLAND; RULE; EAR	The fossil record of mammaliaforms (mammals and their closest relatives) of the Mesozoic era from the southern supercontinent Gondwana is far less extensive than that from its northern counterpart, Laurasia(1,2). Among Mesozoic mammaliaforms, Gondwanatheria is one of the most poorly known clades, previously represented by only a single cranium and isolated jaws and teeth(1-5). As a result, the anatomy, palaeobiology and phylogenetic relationships of gondwanatherians remain unclear. Here we report the discovery of an articulated and very well-preserved skeleton of a gondwanatherian of the latest age (72.1-66 million years ago) of the Cretaceous period from Madagascar that we assign to a new genus and species, Adalatherium hui. To our knowledge, the specimen is the most complete skeleton of a Gondwanan Mesozoic mammaliaform that has been found, and includes the only postcranial material and ascending ramus of the dentary known for any gondwanatherian. A phylogenetic analysis including the new taxon recovers Gondwanatheria as the sister group to Multituberculata. The skeleton, which represents one of the largest of the Gondwanan Mesozoic mammaliaforms, is particularly notable for exhibiting many unique features in combination with features that are convergent on those of therian mammals. This uniqueness is consistent with a lineage history for A. hui of isolation on Madagascar for more than 20 million years. Adalatherium hui, a newly discovered gondwanatherian mammal from Madagascar dated to near the end of the Cretaceous period, shows features consistent with a long evolutionary trajectory of isolation in an insular environment.	[Krause, David W.] Denver Museum Nat & Sci, Dept Earth Sci, Denver, CO 80205 USA; [Krause, David W.; Hu, Yaoming; Groenke, Joseph R.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Hoffmann, Simone] New York Inst Technol, Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA; [Wible, John R.] Carnegie Museum Nat Hist, Sect Mammals, Pittsburgh, PA USA; [Rougier, Guillermo W.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Kirk, E. Christopher] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Kirk, E. Christopher] Univ Texas Austin, Jackson Sch Museum Earth Hist, Austin, TX 78712 USA; [Groenke, Joseph R.] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [Rogers, Raymond R.] Macalester Coll, Geol Dept, St Paul, MN 55105 USA; [Rossie, James B.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; [Schultz, Julia A.; von Koenigswald, Wighart] Univ Bonn, Inst Geowissensch, Bonn, Germany; [Evans, Alistair R.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Evans, Alistair R.] Museums Victoria, Geosci, Melbourne, Vic, Australia; [Rahantarisoa, Lydia J.] Univ Antananarivo, Dept Sci Terre & Environm, Antananarivo, Madagascar	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; New York Institute Technology; University of Louisville; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University System of Ohio; Ohio University; Macalester College; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Bonn; Monash University; University Antananarivo	Krause, DW (corresponding author), Denver Museum Nat & Sci, Dept Earth Sci, Denver, CO 80205 USA.; Krause, DW (corresponding author), SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA.	David.Krause@dmns.org	Evans, Alistair R/D-4239-2011	Evans, Alistair R/0000-0002-4078-4693; Kirk, Chris/0000-0001-9439-3041; Hoffmann, Simone/0000-0001-8984-0601; Groenke, Joseph/0000-0002-9527-1887	National Geographic Society; National Science Foundation	National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF))	We thank the Universite d'Antananarivo, the Madagascar Institut pour la Conservation des Ecosystemes Tropicaux and the villagers of the Berivotra Study Area for logistical support of fieldwork; the ministries of Mines and Higher Education of the Republic of Madagascar for permission to conduct field research; members of the 1999 field research team for their efforts; and the National Geographic Society and the National Science Foundation for funding. Full acknowledgments are provided in the Supplementary Information.	Ali JR, 2011, J BIOGEOGR, V38, P1855, DOI 10.1111/j.1365-2699.2011.02546.x; AZZAROLI A, 1982, PALAEONTOLOGY ESSENT, P193; Benton MJ, 2010, PALAEOGEOGR PALAEOCL, V293, P438, DOI 10.1016/j.palaeo.2010.01.026; Bi SD, 2014, NATURE, V514, P579, DOI 10.1038/nature13718; Butler PM, 2005, ACTA PALAEONTOL POL, V50, P185; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Csiki-Sava Z, 2018, P NATL ACAD SCI USA, V115, P4857, DOI 10.1073/pnas.1801143115; de Vos John, 2007, V29, P315; Han G, 2017, NATURE, V551, P451, DOI 10.1038/nature24483; Huttenlocker AK, 2018, NATURE, V558, P108, DOI 10.1038/s41586-018-0126-y; Jungers WL, 2008, DEV PRIMATOL-PROG PR, P343, DOI 10.1007/978-0-387-73896-3_23; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; King B., 2019, BAYESIAN TIP DATED P, DOI [10.1101/533885, DOI 10.1101/533885]; Krause D.W., 2014, J VERTEBR PALEONTOL, V34; Krause DW, 2019, ANNU REV EARTH PL SC, V47, P519, DOI 10.1146/annurev-earth-053018-060051; Krause DW, 2014, NATURE, V515, P512, DOI 10.1038/nature13922; Krause DW, 2010, NATURE, V463, P613, DOI 10.1038/463613a; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; Lomolino MV, 2013, J BIOGEOGR, V40, P1427, DOI 10.1111/jbi.12096; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Luo ZX, 2017, NATURE, V548, P326, DOI 10.1038/nature23483; Luo ZX, 2015, P NATL ACAD SCI USA, V112, pE7101, DOI 10.1073/pnas.1519387112; Mao FY, 2019, ZOOL J LINN SOC-LOND, V186, P529, DOI 10.1093/zoolinnean/zly088; McClain CR, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0989; McNab BK, 2010, OECOLOGIA, V164, P13, DOI 10.1007/s00442-010-1621-5; Meiri S, 2008, P ROY SOC B-BIOL SCI, V275, P141, DOI 10.1098/rspb.2007.1056; Meng J, 2014, NATL SCI REV, V1, P521, DOI 10.1093/nsr/nwu070; Metais G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206181; O'Connor PM, 2019, ACTA PALAEONTOL POL, V64, P65, DOI 10.4202/app.00568.2018; Pascual R, 1999, J VERTEBR PALEONTOL, V19, P373, DOI 10.1080/02724634.1999.10011148; Reeves C, 2014, J AFR EARTH SCI, V94, P45, DOI 10.1016/j.jafrearsci.2013.07.011; Rogers RR, 2000, J GEOL, V108, P275, DOI 10.1086/314403; Samonds KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062086; Schoene B, 2019, SCIENCE, V363, P862, DOI 10.1126/science.aau2422; Sigogneau-Russell D., 1991, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1991, P119; Smith T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132550; Sondaar P.Y., 1977, MAJOR PATTERNS VERTE, P671, DOI DOI 10.1007/978-1-4684-8851-7; Unay Engin, 2003, Deinsea (Rotterdam), V10, P531; Van der Geer A., 2010, EVOLUTION ISLAND MAM; Van Valen L, 1973, EVOL THEORY, V49, P31, DOI DOI 10.1007/S13398-014-0173-7.2; Weston EM, 2009, NATURE, V459, P85, DOI 10.1038/nature07922; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Worthy TH, 2006, P NATL ACAD SCI USA, V103, P19419, DOI 10.1073/pnas.0605684103; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239; Zheng XT, 2013, NATURE, V500, P199, DOI 10.1038/nature12353	45	35	36	1	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 28	2020	581	7809					421	+		10.1038/s41586-020-2234-8	http://dx.doi.org/10.1038/s41586-020-2234-8		APR 2020	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX9ZL	32461642				2022-12-28	WOS:000529600400005
J	Chokshi, DA; Katz, MH				Chokshi, Dave A.; Katz, Mitchell H.			Emerging Lessons From COVID-19 Response in New York City	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Chokshi, Dave A.; Katz, Mitchell H.] New York City Hlth Hosp, 160Water St, New York, NY 10038 USA; [Chokshi, Dave A.] NYU Sch Med, New York, NY USA	New York University	Chokshi, DA (corresponding author), New York City Hlth Hosp, 160Water St, New York, NY 10038 USA.	Dave.Chokshi@nychhc.org		Chokshi, Dave/0000-0001-7467-4591					0	9	9	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					1996	1997		10.1001/jama.2020.7310	http://dx.doi.org/10.1001/jama.2020.7310			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PB5XQ	32453355	Bronze			2022-12-28	WOS:000596394000001
J	Mehra, MR; Ruschitzka, F; Patel, AN				Mehra, Mandeep R.; Ruschitzka, Frank; Patel, Amit N.			RETRACTION: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis (Retraction of 10.1016/S0140-6736(20)31180-6, 2020)	LANCET			English	Retraction									[Mehra, Mandeep R.] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Mehra, Mandeep R.] Harvard Med Sch, Boston, MA 02115 USA; [Ruschitzka, Frank] Univ Hosp Zurich, Univ Heart Ctr, Zurich, Switzerland; [Patel, Amit N.] Univ Utah, Dept Biomed Engn, Salt Lake City, UT USA; [Patel, Amit N.] HCA Res Inst, Nashville, TN USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Zurich; University Zurich Hospital; Utah System of Higher Education; University of Utah	Mehra, MR (corresponding author), Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA.; Mehra, MR (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	mmehra@bwh.harvard.edu						Mehra MR, 2020, LANCET, V395, P1820, DOI [10.1016/S0140-6736(20)31324-6, 10.1016/S0140-6736(20)31180-6]	1	773	817	17	63	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2020	395	10240					1820	1820		10.1016/S0140-6736(20)31324-6	http://dx.doi.org/10.1016/S0140-6736(20)31324-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NH4GA	32511943	Green Published, Bronze			2022-12-28	WOS:000564628700009
J	Petrilli, CM; Jones, SA; Yang, J; Rajagopalan, H; O'Donnell, L; Chernyak, Y; Tobin, KA; Cerfolio, RJ; Francois, F; Horwitz, LI				Petrilli, Christopher M.; Jones, Simon A.; Yang, Jie; Rajagopalan, Harish; O'Donnell, Luke; Chernyak, Yelena; Tobin, Katie A.; Cerfolio, Robert J.; Francois, Fritz; Horwitz, Leora I.			Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MORTALITY; INFLUENZA	OBJECTIVE To describe outcomes of people admitted to hospital with coronavirus disease 2019 (covid-19) in the United States, and the clinical and laboratory characteristics associated with severity of illness. DESIGN Prospective cohort study. SETTING Single academic medical center in New York City and Long Island. PARTICIPANTS 5279 patients with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection between 1 March 2020 and 8 April 2020. The final date of follow up was 5 May 2020. MAIN OUTCOME MEASURES Outcomes were admission to hospital, critical illness (intensive care, mechanical ventilation, discharge to hospice care, or death), and discharge to hospice care or death. Predictors included patient characteristics, medical history, vital signs, and laboratory results. Multivariable logistic regression was conducted to identify risk factors for adverse outcomes, and competing risk survival analysis for mortality. RESULTS Of 11544 people tested for SARS-Cov-2, 5566 (48.2%) were positive. After exclusions, 5279 were included. 2741 of these 5279 (51.9%) were admitted to hospital, of whom 1904 (69.5%) were discharged alive without hospice care and 665 (24.3%) were discharged to hospice care or died. Of 647 (23.6%) patients requiring mechanical ventilation, 391 (60.4%) died and 170 (26.2%) were extubated or discharged. The strongest risk for hospital admission was associated with age, with an odds ratio of >2 for all age groups older than 44 years and 37.9 (95% confidence interval 26.1 to 56.0) for ages 75 years and older. Other risks were heart failure (4.4, 2.6 to 8.0), male sex (2.8, 2.4 to 3.2), chronic kidney disease (2.6, 1.9 to 3.6), and any increase in body mass index (BMI) (eg, for BMI >40: 2.5, 1.8 to 3.4). The strongest risks for critical illness besides age were associated with heart failure (1.9,1.4 to 2.5), BMI >40 (1.5, 1.0 to 2.2), and male sex (1.5, 1.3 to 1.8). Admission oxygen saturation of <88% (3.7, 2.8 to 4.8), troponin level >1 (4.8, 2.1 to 10.9), C reactive protein level >200 (5.1, 2.8 to 9.2), and D-dimer level >2500 (3.9, 2.6 to 6.0) were, however, more strongly associated with critical illness than age or comorbidities. Risk of critical illness decreased significantly over the study period. Similar associations were found for mortality alone. CONCLUSIONS Age and comorbidities were found to be strong predictors of hospital admission and to a lesser extent of critical illness and mortality in people with covid-19; however, impairment of oxygen on admission and markers of inflammation were most strongly associated with critical illness and mortality. Outcomes seem to be improving over time, potentially suggesting improvements in care.	[Petrilli, Christopher M.; O'Donnell, Luke; Horwitz, Leora I.] NYU, Dept Med, Grossman Sch Med, Div Gen Internal Med & Clin Innovat, 550 1St Ave, New York, NY 10016 USA; [Petrilli, Christopher M.; Rajagopalan, Harish; Chernyak, Yelena; Tobin, Katie A.; Cerfolio, Robert J.; Francois, Fritz] NYU, Langone Hlth, New York, NY USA; [Jones, Simon A.; Horwitz, Leora I.] NYU, Grossman Sch Med, Dept Populat Hlth, Div Healthcare Delivery Sci, 227 East 30th St 633, New York, NY 10016 USA; [Jones, Simon A.; Yang, Jie; Horwitz, Leora I.] NYU, Langone Hlth, Ctr Healthcare Innovat & Delivery Sci, New York, NY 10016 USA; [Cerfolio, Robert J.] NYU, Grossman Sch Med, Dept Cardiothorac Surg, New York, NY USA; [Francois, Fritz] NYU, Dept Med, Grossman Sch Med, Div Gastroenterol, 550 1St Ave, New York, NY 10016 USA	New York University; New York University; New York University; New York University; New York University; New York University	Horwitz, LI (corresponding author), NYU, Dept Med, Grossman Sch Med, Div Gen Internal Med & Clin Innovat, 550 1St Ave, New York, NY 10016 USA.; Horwitz, LI (corresponding author), NYU, Grossman Sch Med, Dept Populat Hlth, Div Healthcare Delivery Sci, 227 East 30th St 633, New York, NY 10016 USA.; Horwitz, LI (corresponding author), NYU, Langone Hlth, Ctr Healthcare Innovat & Delivery Sci, New York, NY 10016 USA.	leora.horwitz@nyulangone.org	Horwitz, Leora/ABD-1292-2020	Jones, Simon/0000-0002-8267-5647; Cerfolio, Robert/0000-0002-5598-599X; Francois, Fritz/0000-0003-4491-2637; BEZERRA HOLANDA, JORGE LUIS/0000-0001-9334-6411; Santos Leite Pessoa, Mariana/0000-0003-3495-0779	Kenneth C Griffin Charitable Fund	Kenneth C Griffin Charitable Fund	This work was funded in part by the Kenneth C Griffin Charitable Fund, which had no role in the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the article for publication.	Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Caer C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02660-w; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Cecconi M, 2018, LANCET, V392, P75, DOI 10.1016/S0140-6736(18)30696-2; Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2; Danzi GB, 2020, EUR HEART J, V41, P1858, DOI 10.1093/eurheartj/ehaa254; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; Geovanini GR, 2018, CLIN SCI, V132, P1243, DOI 10.1042/CS20180306; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Grey RJ, 2019, ANN STAT, V16, P1141; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017; Halpin DMG, 2020, LANCET RESP MED, V8, P436, DOI 10.1016/S2213-2600(20)30167-3; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; JACOBS D, 1992, CIRCULATION, V86, P1046, DOI 10.1161/01.CIR.86.3.1046; Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e132; Livingston Edward, 2020, JAMA, V323, P1335, DOI 10.1001/jama.2020.4344; Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007; Melby C, 2020, MAPPING NEW YORK CIT; NYC Health, 2020, CAS HOSP DEATHS; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Popescu I, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8577; Richardson S, 2020, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775]; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Schmidt FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121971; Sfumato P, 2020, GOODNESS FIT TIME EV; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; VENZON DJ, 1988, J R STAT SOC C-APPL, V37, P87, DOI 10.2307/2347496; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wang ZL, 2020, CLIN INFECT DIS, V71, P769, DOI 10.1093/cid/ciaa272; World Health Organization, 2020, HOSP BEDS PER 10 000; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	38	1360	1378	16	65	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2020	369								m1966	10.1136/bmj.m1966	http://dx.doi.org/10.1136/bmj.m1966			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV3JU	32444366	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000538336800002
